,patient_filename,text,split,gold
49,TCGA-WK-A8XO.1AE1A944-8D73-405E-9670-5ADC3F8906E8,"Report Status: Final. Type : Surgical Pathology. Specimen Type: Peritoneum. Procedure Date: Resident: PATHOLOGIC DIAGNOSIS: A. LEFT PELVIC SIDE WALL DEPOSIT: Fibrovascular tissue with chronic inflammation. and foreign body giant cell reaction, negative. for tumor. B. RIGHT RETROPERITONEAL MASS. DEDIFFERENTIATED LIPOSARCOMA. 5 cm. Mitoses number 40:10 HPF. No necrosis identified. C. OMENTAL NODULE: DEDIFFERENTIATED LIPOSARCOMA involving. fibroadipose tissue. D. ILEUM AND RIGHT COLON: DEDIFFERENTIATED LIPOSARCOMA, 1.9 cm, involving the wall. of the small intestine, invading into the submucosa. Colonic and ileal resection margins are negative for tumor. Four lymph nodes, negative for tumor (0:4). E. SMALL BOWEL MESENTERY LYMPH NODES: Three lymph nodes, negative for tumor (0:3). CLINICAL DATA: History: Dedif LPS. Operation: Resection of duodenal liposarcoma, sm bowel resection. Operative Findings: Not provided. Clinical Diagnosis: Duodenal liposarcoma. TISSUE SUBMITTED: A. LT pelvic side wall deposit. B. RT retroperitoneal mass - short sup - long lat - tissue bank. C. Omental nodule. D. Ileum + RT colon. E. Sm bowel mesentery lymph node. GROSS DESCRIPTION: The specimen is received fresh, in five parts, labeled with the patient's name. and unit number. Part A, ""#1. Left pelvic sidewall deposits"", consists of soft tissue fragments. of 2.5 x 1.0 x 1.0 cm. Micro A1: Soft tissue fragments, 1 frag,. Part B, ""#2. Right retroperitoneal mass stitch superior, long posterior tissue. bank"", consists of a 35.5-g tan/yellow lobulated multifocally disrupted. oriented soft tissue mass (5 x 5 x 4.5 cm) with a short stitch superior and. long stitch lateral. The excision appears marginal grossly. The specimen is. inked per protocol. There is on the lateral aspect of the specimen additional. fatty piece attached measuring 2.7 x 2.1 x 0.6 cm. There is a tan/white. lobulated firm cut surface of the tumor. Representative section of the tumor. Page: 1 of 2. la. is submitted for cytogenetics and tissue bank and for. lab. Photograph is taken. Micro B1: Medial inferior lateral margin, 1 frag,. Micro B2: Anterior medial margin, 1 frag,. Micro B3: Posterior inferior margin. 1 frag,. Micro B4: Lateral margin, 2 frag,. Micro B5: Medial superior margin, 1 frag,. Micro B6: Anterior inferior margin, 1 frag,. Micro B7: Superior resection margin, 1 frag,. Micro B8-B10: Additional tumor sampling, 3 frags,. Part C, ""#3. Omental nodule"", consists of a white firm nodule of 1.2 cm in. diameter. Micro C1-C2: Nodule bisected, 2 frags,. Part D, ""#4. Ileum and right colon frozen section"", consists of a segment of. ileum measuring 34.0 cm in length x 3.0 cm in diameter with a right colon of. 12.0 cm in length x 8.0 cm in diameter with a radial resection margin of 6.0. cm. The mucosa of the bowel is unremarkable. There is mesenteric nodule in. the terminal ileum measuring 1.6 cm in diameter pushing the submucosa located. at 20.0 cm from the ileal resection margin and 11.0 cm from the ICV. Micro D1: Ileal resection margin, 1 frag,. Micro D2: Colon resection margin, 1 frag,. Micor D3: Radial resection margin, 2 frags,. Micor D4: Lymph node?, 1 frag,. Micro D5: Lymph node, 1 frag,. Micro D6: Lymph node, 2 frags,. Micro D7-D8: Ileal mesenteric mass, 1 frag,. Micro D9-D10: colonic mucosa, 4 frags. Micro D11-D14: Ileal mucosa, 8 frags,. Part E, ""#5. Small bowel mesentery lymph node"", consists of a lymph node of 1.3. x 0.5 x 0.5 cm with fibroadipose tissue measuring 2.0 x 1.0 x 1.0 cm in. aggregate. Micro E1: Lymph node and fibroadipose tissue, 3 frags,. By his/her signature below, the senior physician certifies that he/she. personally conducted a microscopic examination (""gross only"" exam if so stated). of the described specimen (s) and rendered or confirmed the diagnosis (es). related thereto. Final Diagnosis by.",train,5 cm;1.9 cm
94,TCGA-D7-A4Z0.372DC7F5-D739-42B5-8899-CD22F6B219D8,"Gender: F. Examination result No. Unit in charge: (. Clinical diagnosis (suspicion) Stomach cancer. Date of admission: (urgency: Standard). Material: 1) Material: stomach, stomach with the tumour. Method of collection: Total organ resection. Histopathological diagnosis: Stomach adenocarcinoma mucinous with metastases to lymph nodes (G3, pT2, pNI). (8140/3 T-63000). Macroscopic description: The specimen containing the stomach, incised along the lesser curvature sized 1 9 x 13 cm. Tumour with. ulceration sized 7x5x2 cm in the pyloric region. Distance from the proximal end: 12 cm, from distal end: 0.5 cm. Microscopic description: Gastric adenocarcinoma mucocellulare (G3, diffuse type acc. to Lauren class.). The lesion invades the. submucosa and the muscular layer of the stomach wall. Incision lines free of neoplastic lesions. Metastases to 3/10 lymph nodes.",train,7x5x2 cm
134,TCGA-L5-A8NR.38414781-8AFA-4477-A239-1E9921C4B9BF,"PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 1. PATIENT NBR: SEX: F. BIRTHDATE: ADM DATE: OPER DATE: REQ DOC: PROCEDURE: with. history of dysphagia, heartburn, regurg and weight. loss. Adenocarcinoma of distal esophagus. Operative Procedure: Esophagectomy. PROCEDURE: 1. ""Thoracic esophagus. A 15 cm long segment of esophagus and 2 x 3 cm. proximal stomach. The specimen is received open. Near the GE junction there is. a 3.5 x 2 cm ulcerated mass with depth of invasion 1.3 cm all the way through. muscularis propria and closely approximating to serosal surface. The mass. occupies 70% of the lumen circumference and with marked Lumen occlusion. Tumor. closely approximates the distal gastric surgical margin within 0.2 cm. The. remaining esophagus and stomach are grossly unremarkable. Several gross. positive lymph nodes identified, up to 1 cm in greatest dimension with no. obvious actual capsular extension. 1A-B. Tumor with deepest invasion and adjacent gastric mucosa. 1C-D. Tumor with deepest invasion with adjacent esophagus. 1E. Tumor with closest distal surgical margin after shaving the stapled. mucosa. 1F. Shaved stapled gastric mucosa. 1G. Normal appearing GE junction overlying the tumor. 1H. Normal appearing esophagus and unremarkable gastric mucosa. 11. Grossly positive Lymph nodes. Sectioned. 1J. Two grossly positive lymph nodes. Larger bisected and inked yellow. 1K. Grossly unremarkable lymph nodes. 1L. Grossly unremarkable lymph nodes. 2. ""Proximal cervical margin."" A 0.5 cm long segment of unremarkable. esophagus. 3. ""Lesser curve lymph node."" Two 0.3 to 0.5 cm lymph nodes. PROCEDURE: VERIFIED 8Y: ESOPHAGEAL, CARDIAC AND GASTROESOPHAGEAL JUNCTION CARCINOMA: Type of carcinoma: Adenocarcinoma. If adenocarcinoma, is it arising in Barrett's mucosa, gastric cardia, or. GE. junction: GE junction. Depth of invasion: Adventitia. PREVIOUS DIAGNOSIS INQUIRY. 2. REPORT DATE: PATIENT NBR: SEX: F. ADM DATE: BIRTHDATE: OPER DATE: REQ DOC: Number of positive Lymph nodes, the total number sampled is irrelevant: 7/10. Extranodal metastasis: None. Pattern of invasion: Infiltrative. Esophageal and gastric resection margins involved: No. Deep resection margin involved: No. TNM classification: T3 N1 Mx. PROCEDURE: 1. Esophagus and proximal stomach, resection: Adenocarcinoma arising at the. GE junction with extension to perigastric and eriesophageal adipose tissue. Free margins of excision. Seven of 10 Lymph nodes positive for carcinoma. See. template. 2. Segment of esophagus, resection: Negative for carcinoma. 3. Lymph node of Lesser curvature of stomach, excision: One of two lymph. nodes positive for carcinoma. 1,. , the signing staff pathologist, have personally examined and. interpreted the slides from this case. Code: END OF PREVIOUS DIAGNOSIS INQUIRY.",train,
151,TCGA-29-A5NZ.B7F69EE0-E844-434B-A76B-390590C85864,"CLINICAL HISTORY: Outside hospital left ovarian mass increased CA125, abdominal swelling. GROSS EXAMINATION: A. ""Omentum"", received fresh for frozen and placed in formalin on'. at. is a 19 x 9 x 2 cm fragment of yellow adipose tissue that is firm,. solid and multinodular. Sectioning of the specimen reveals a tan-yellow, firm. parenchyma with some mucous. A representative section was submitted in frozen. in AF1 and submitted in A1. Another representative section will be submitted. as A2. A portion of the specimen was sent for research. B. ""Uterus, cervix, bilateral tubes and ovaries"", received fresh and placed in. formalin on. a 92.6 gram, previously opened hysterectomy. specimen with uterus and cervix, bilateral tubes, and ovaries. The uterus is. 4.5 cm from cornu to cornu, 2.1 cm from anterior to posterior, and 9.1 cm from. superior to inferior. The cervix measures 2.7 cm in diameter with a 1.1 cm. round patent os. The endometrium is grossly unremarkable. The anterior. endometrium measures 1.1 cm from cornu to cornu and 4.5 cm in length. The. posterior endometrium is 0.9 cm from cornu to cornu and 4.1 cm in length. The. ectocervix is tan smooth and glistening with areas of pinpoint hemorrhage. The. endocervical canal also has a 1.8 x 1.5 x 0.5 cm clear mucous deposit. The. uterine serosa is smooth tan and glistening with multiple nodular adhesions. that range in size from 0.2 to 0.4 cm in diameter. There is also an adherent. tan-brown cauterized mass that is adhesed to the serosa, fallopian tube, and. left ovary. The right fallopian tube is also studded with multiple 0.1 to 0.3. cm nodules. The left ovary is extensively adherent to uterus. It is 4.1. x. 3.2 x 2.5 cm and is tan-white and cerebriform with a disrupted capsule that. has tumor grossly extending out of the capsule. The right fallopian tube is. studded with grossly apparent tumor nodules that range in size from 0.1 to 0.3. cm. The left and right parametria are also grossly studded with tumor nodules. that range in size from 0.1 to 0. cm in diameter. The tumor grossly appears. to be adherent to the tube and uterus, and possibly invades the myometrium. The disrupted capsule with the tumor extruding from it is inked. The left. fimbriated tube is 6.1 cm long x 0.4 cm in diameter with a pinpoint patent. lumen, but the tube is stenosed and strictured. The right fimbriated tube is. 4.1 cm long x 0.5 cm in diameter with a pinpoint patent lumen and a strictured. tube. The right ovary is tan-white and cerebriform and is 2.5 x 1.9 x 1.2 cm. The outer surface of the right ovary does not appear to be grossly involved. The right ovary on sectioning is firm tan-white with a hemorrhagic center. The. left ovary on sectioning reveals a heterogeneous parenchyma that is. hemorrhagic, necrotic, and with tumor grossly extending outside the capsule. BLOCK SUMMARY: B1- representative section of anterior cervix. B2- - representative section of posterior cervix. B3- anterior full thickness endometrium. B4- possible tumor to normal myometrium, anterior. B5- posterior full thickness with additional section to serosal nodule. B6- left parametrium. B7- right parametrium. B8- left fallopian tube. B9- right fallopian tube. B10-11- right ovary. B12-15- left ovary with capsule disruption. B17-18- adherent left ovary to uterus. C. ""Left gutter"", received fresh and placed in formalin on. is a 5.5 x 4.2 x 2.5 cm fragment of yellow fibroadipose tissue with some. vessels present. The specimen is firm and nodular with some areas of. cauterized tissue. A representative section is submitted in C1-2. D. ""Omentum # 2"", received fresh and placed in formalin on. is a 12 x 11.5 x 2.4 cm aggregate of yellow fibroadipose tissue with some. solid nodular areas. Representative sections are submitted in B1. E. ""Small bowel nodule"", received fresh and placed in formalin on. is a 5 x 2.9 x 2.4 cm fragment of tan-white tissue that is firm and. has a large nodular area that covers most of the specimen. A representative. section is submitted in E1. INTRA OPERATIVE CONSULTATION: A. ""Omentum"" AF1 (rep) - adenocarcinoma with papillary features (Dr. MICROSCOPIC EXAMINATION: Microscopic examination is performed. PATHOLOGIC STAGE: PROCEDURE: Exploratory laparotomy, total abdominal hysterectomy, bilateral. salpingo-oophorectomy, infragastric omentectomy, removal abdominal wall mass,. and optimal tumor debulking to less than 1 cm of maximal residual disease. PATHOLOGIC STAGE (AJCC 7th Edition) : pT3c pNX pMX. NOTE: Information on pathology stage and the operative procedure is. transmitted to this Institution's Cancer Registry as required for. accreditation by the Commission on Cancer. Pathology stage is based solely. upon the current tissue specimen being evaluated, and does not incorporate. information on any specimens submitted separately to our Cytology section,. past pathology information, imaging studies, or clinical or operative. findings. Pathology stage is only a component to be considered in determining. the clinical stage, and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon's operative report. DIAGNOSIS: A. OMENTUM (RESECTION) : INVOLVED BY HIGH GRADE PAPILLARY SEROUS ADENOCARCINOMA. B. UTERUS, CERVIX, BILATERAL FALLOPIAN TUBES AND OVARIES (TOTAL HYSTERECTOMY. AND BILATERAL SALPINGO-OOPHORECTOMY) : LEFT OVARY: TYPE: PAPILLARY SEROUS ADENOCARCINOMA. SEE NOTE. TUMOR GRADE: HIGH GRADE. TUMOR SIZE: 4.1 X 3.2 X 2.5 CM. SEROSA: DISRUPTED CAPSULE WITH TUMOR PRESENT MOSTLY ON SURFACE, BUT ALSO. WITHIN PARENCHYMA. SEE NOTE. UTERUS: CERVIX: NO DIAGNOSTIC ABNORMALITY. ENDOMETRIUM: ATROPHIC. LEFT FALLOPIAN TUBE: ACUTE SALPINGITIS AND SEROSITIS. RIGHT OVARY SURFACE SEROSAL ADHESIONS AND MESOTHELIAL HYPERPLASIA WITH. DETACHED FRAGMENTS OF CARCINOMA. SPECIMENS WITH METASTATIC/IMPLANTED TUMOR: RIGHT FALLOPIAN TUBE, LEFT. PARAMETRIUM, MYOMETRIUM AND SEROSA. NOTE: The tumor seen in the left ovary involves predominantly the ovarian. surface with only limited parenchymal involvement. Per clinical history, the. bulk of this tumor is present within the peritoneum/omentum. According to. criteria, a tumor mass greater than 5 mm involving the ovarian parenchyma. should be staged as an ovarian primary, which is the case in this material. Having said that, we suspect that in this particular case, a peritoneal origin. is more likely. Clinical correlation is highly recommended. C. LEFT GUTTER (RESECTION) : INVOLVED BY HIGH GRADE PAPILLARY SEROUS ADENOCARCINOMA. D. OMENTUM #2 (RESECTION) : INVOLVED BY HIGH GRADE PAPILLARY SEROUS ADENOCARCINOMA. E. SMALL BOWEL NODULE (RESECTION) : INVOLVED BY HIGH GRADE PAPILLARY SEROUS ADENOCARCINOMA. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). Attending MD:",train,4.1 X 3.2 X 2.5 CM
239,TCGA-OR-A5KZ.22298C81-A72D-4E22-99DD-6541FB0953A4,"Procedure: adrenalectomy. Gross description: 14x9 X 5cm, 336g. Reference Pathology only: Diagnosis: adrenocortical carcinoma, with unusually high proliferation rate, KI67 60%. Weiss score: 8. Hough score: 4.89. Van Slooten score: 22.7.",train,
303,TCGA-AA-A02W.257FBF57-5DB1-44D5-994D-64EFD1CA4E57,"'nternal Sample ID: Diagnosis: This is a moderately differentiated adenocarcinoma of the sigmoid colon with. histopathological grade G2 differentiation, with erosions of the inner tumor surface, with. peritumorous, chronic recurrent concomitant inflammation, with tumor infiltration of the. parietal layers of the sigmoid colon extending to the outer layers of the tunica muscularis,. with chronic lymphadenitis of the tumor-free lymph nodes (0/12) and tumor-free overview. sections from the resection margins and from the region of the vascular ligature. According to these section preparations, the tumor spread of the sigmoid colon carcinoma. corresponds to a tumor stage of pT2, pNo, MX, R0.",train,
306,TCGA-B5-A11O.078AA8A2-E812-4603-9084-8414937B88E1,"CLINICAL HISTORY: Malignant neocorpus uteri-182.0. GROSS EXAMINATION: A. ""Uterus, cervix, bilateral tubes and ovaries (AF1-2) "". Received fresh is. a. 99 gram uterus (9 x 6 x 3 cm ) with attached left ovary (1.9 x 1.8 x 0.8 cm),. left fimbriated fallopian tube (3.6 cm long x 0.4 cm in diameter, right ovary. (2.6 x 1.5 x 1.2 cm) and right fimbriated fallopian tube (3.2 cm long x 0.5 cm. in diameter) The endometrial cavity is 2.7 cm from cornu to cornu and. expands 4.8 cm and contains an ill-defined fundal soft gray-tan endometrial. mass (1.3 x 1 x 0.7 cm) that slightly traces into the anterior and posterior. endometrium, 4.5 cm and 3.1 cm from the anterior and posterior lower uterine. segments respectively. The mass penetrates 0.2 cm into a 1.5 cm thick. trabeculated myometrium that contains a single white whorled intramural nodule. (1 x 1 x 0.9 cm). The mass was partially frozen as representative AF1. The. remainder of the endometrium is red-tan and diffusely coarse (0.1 cm thick). with a second soft gray-tan mass (1.6 x 1.3 x 0.2 cm) that is 1.1 cm from the. lower uterine segment. The second mass extends 0.2 cm into the underlying. myometrium. The uterine serosa is pink-tan, smooth and glistening. The. exocervix is red-white and smooth with diffuse erythema surrounding a 1 cm. cervical--os-that-leads into- a-2.5 cm trabeculated endocervical canal. The. left and right ovary are grossly unremarkable. The left and right fimbriated. fallopian tubes are both discontinuous and grossly unremarkable. BLOCK SUMMARY: A1- frozen section remnant from AF1. A2-. anterior endomyometrium full thickness with mass. A3- posterior endomyometrium full thickness with mass. A4-. anterior endomyometrium full thickness with second mass. A5-. perpendicular section of anterior lower uterine segment with second mas. A6-. perpendicular section of posterior lower uterine segment. A7-. intramural nodule. A8-. anterior cervix. A9- posterior cervix. A10- left tube and ovary. All- right tube and ovary. A12- remnant from AF2 which is the deep tissue to from AF1 which was not. frozen due to ""chucking out"" during frozen section. B. ""Left pelvic lymph node"". Received unfixed and placed in formalin is a 9.3. x 5.8 x 2.4 cm aggregate of adipose tissue that has eight lymph node. candidates ranging from 0. x 0.5 x 0.5 cm up to 2.1 x 1.7 x 1.6 cm. Each. lymph node has a fatty cut surface. BLOCK SUMMARY: B1-. two lymph node candidates, one is inked black and bisected. B2-. one lymph node candidate bisected. B3-. one lymph node candidate bisected. B4-. one lymph node candidate bisected. B5-. one lymph node candidate bisected. B6-. one lymph node candidate bisected. B7-8-. one lymph node candidate serially sectioned. C. ""Right pelvic lymph nodes"". Received unfixed and placed in formalin is a. 7.3 x 5.2 x 1.8 cm aggregate of adipose tissue that has eleven lymph node. candidates ranging from 1 x 0.8 x 0.4 cm up to 2.1 x 1.2 x 0.5 cm. Each lymph. node has a fatty cut surface. BLOCK SUMMARY: C1-. three lymph node candidates. C2-. one lymph node candidate. C3-. one lymph node candidate. C4-. one lymph node candidate. C5-. two lymph node candidates, each bisected and one inked black. C6-. one lymph node candidate bisected. C7-. one lymph node candidate bisected. C8-. one lymph node candidate bisected. INTRA OPERATIVE CONSULTATION: A. ""Uterus, cervix, bilateral tubes and ovaries"": AF1 (mass at fundus) : adenocarcinoma with mucinous features,. FIGO grade 1, ?2 at most. AF2 not frozen. MICROSCOPIC EXAMINATION: Microscopic examination is performed. PATHOLOGIC STAGE: PROCEDURE: HYSTERECTOMY, OOPHORECTOMY & LYMPHADENECTOMY. PATHOLOGIC STAGE (AJCC 6th Edition) : pT1B pNO pMX. NOTE: Information on pathology stage and the operative procedure is. transmitted to this Institution's Cancer Registry as required for. accreditation by-the--Commission on Cancer.-Pathology stage-is-based solely. upon the current tissue specimen being evaluated, and does not incorporate. information on any specimens submitted separately to our Cytology section,. past pathology information, imaging studies, or clinical or operative. findings. Pathology stage is only a component to be considered in determining. the clinical stage, and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon's operative report. DIAGNOSIS: A. UTERUS: 99 GRAMS. ENDOMETRIUM: TUMOR SITE: FUNDUS. HISTOLOGIC TYPE: ENDOMETRIOID ADENOCARCINOMA. FIGO GRADE: 1. TUMOR SIZE: 1.3 x 1 x 0.7 CM. MAXIMUM DEPTH OF MYOMETRIAL INVASION: 0.2 CM, IN A 1.5 THICK WALL. LYMPHATIC/VASCULAR INVASION: NEGATIVE. ADJACENT NON-NEOPLASTIC ENDOMETRIUM: ATROPHIC. REMAINING MYOMETRIUM: LEIOMYOMA, SMALL. CERVIX: NO PATHOLOGIC DIAGNOSIS. SEROSA: NO PATHOLOGIC DIAGNOSIS. SPECIMEN MARGINS: NOT INVOLVED. THE FOLLOWING SPECIMENS ARE FREE OF TUMOR: A. OVARIES AND FALLOPIAN TUBES, BILATERAL: NO PATHOLOGIC DIAGNOSIS. B. LEFT PELVIC LYMPH NODES: NO TUMOR IN 7 LYMPH NODES (0/7). C. RIGHT PELVIC LYMPH NODES: NO TUMOR IN 11 LYMPH NODES (0/11). I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). CI ADDENDUM 1: Please see Image Cytometry Report. or results of supplementary. tests.",train,1.3 x 1 x 0.7 CM
352,TCGA-CR-6492.b0e618c4-a37c-4cec-90d2-059312245712,"DIAGNOSIS: 1) MUCOSA, RIGHT DEEP MARGIN, EXCISION: INVOLVED BY SQUAMOUS CELL. CARCINOMA. 2) SOFT TISSUE, POSTERIOR MUCOSAL MARGIN, EXCISION: SQUAMOUS MUCOSA WITH. CHRONIC INFLAMMATION, NEGATIVE FOR MALIGNANCY. 3) SOFT TISSUE, LEFT MUCOSAL MARGIN, EXCISION: SQUAMOUS MUCOSA WITH CHRONIC. INFLAMMATION, NEGATIVE FOR MALIGNANCY. 4) SOFT TISSUE, NEW DEEP RIGHT MARGIN, EXCISION: FIBROADIPOSE TISSUE,. NEGATIVE FOR MALIGNANCY. 5) LYMPH NODE, RIGHT NECK LEVELS 2-5, EXCISION: 1 OF 33 LYMPH NODES. INVOLVED BY SQUAMOUS CELL CARCINOMA, LARGEST FOCUS MEASURING 2.4 CM,. (1/33), NEGATIVE FOR EXTRACAPSULAR EXTENSION. 6) SALIVARY GLAND AND LYMPH NODE, RIGHT NECK LEVEL 1, EXCISION: BENIGN. SALIVARY GLAND, 4 LYMPH NODES NEGATIVE FOR MALIGNANCY (0/4). 7) PALATE, EXCISION: INVASIVE SQUAMOUS CELL CARCINOMA, MODERATELY TO. POORLY-DIFFERENTIATED, 3.5 CM IN GREATEST DIMENSION, INVOLVING THE DEEP. (BLACK) TISSUE EDGE; PERINEURAL INVASION PRESENT; BENIGN SALIVARY GLAND,. (SEE COMMENT #1). 8) SOFT TISSUE, ADDITIONAL RIGHT DEEP MARGIN, EXCISION: BENIGN SALIVARY. GLAND, NEGATIVE FOR MALIGNANCY, (SEE COMMENT #1). COMMENT #1: Although tumor is present at the deep tissue edge of specimen. #7, specimen #8 (additional R deep margin) supersedes this area, thus the. final margin is negative for malignancy. These findings correspond to AJCC. Edition pathologic Stage III (pT2, pN1, pMn/a). Upper Aerodigestive Tract-including Minor Salivary Glands, Lip, Oral. cavity, Nasal Cavity, Paranasal Sinuses, Oropharynx, Nasopharynx, and. Hypopharynx Summary of Findings: Specimen Type: palatectomy with selective right neck level 1-5 dissection. Tumor Site: palate. Tumor Size: 3.5 cm. Laterality: Right. Margins: All final margins negative for malignancy. Histologic Type: Squamous cell carcinoma. Histologic Grade: moderately to poorly differentiated. Pathologic Staging (pTMN) III. Primary tumor (pT): pT2. Regional Lymph Nodes (pN): pN1. Number examined: 33. Numbered involved: 1. Extracapsular extension: No. Perineural invasion: Yes. CLINICAL DATA. Clinical Features: Unspecified. Operator: Operation: Unspecified. Operative Findings: Unspecified. Operative Diagnosis: Unspecified. Tissue Submitted: 1) deep right margin; 2) posterior mucosal. margin; 3)left mucosal margin; 4)new deep. right margin; 5)right neck levels 2-5;. 6)right neck level 1; 7)palate;. 8)additional right deep tissue. GROSS DESCRIPTION: 1) SOURCE: Deep Right Margin. The specimen is received fresh in a container labeled with the patient's. name and medical record number along with the designation ""deep right. margin"" and consists of a 0.6 X 0.5 X 0.2 cm piece of red soft tissue. The. entire specimen is submitted for frozen section diagnosis. Summary of sections: 1AFSC, entire specimen, 1/1. 2) SOURCE: Posterior Mucosal Margin. Received fresh and submitted for frozen section is a 3.5 x 0.2 X 0.1 cm. piece of red-tan tissue with a mucosal surface. The tissue is submitted. entirely for frozen section. Summary of sections: 2AFSC, 1/1. 3) SOURCE: Left Mucosal Margin. Received fresh in a container and submitted for frozen section labeled. ""left mucosal margin"" are 2 strips of tissue with a mucosal surface, each. measuring 1.0 X 0.3 X 0.3 cm. The tissue is submitted entirely for frozen. section. Summary of sections: 3AFSC, 2/1. 4) SOURCE: New Deep Right Margin. The specimen is received fresh in a container labeled with the patient's. name and medical record number, as well as the designation ""new deep right. margin"" and consists of two pieces of cauterized red, soft tissue which. measures 4.0 X 3.0 X 1.0 cm and 4.0 X 2.0 X 1.0 cm. The entire specimen is. submitted for frozen section diagnosis. Summary of sections: 4AFSC, tissue for frozen section diagnosis, 2/1. 5) SOURCE: Right Neck Levels 2-5. Received fresh labeled ""right neck level 2-5 stitch superior"" is a radical. neck dissection with a possible submandibular gland, a stitch through the. superior margin. The gland measures 3.0 X 2.5 X 2.0 cm. The remainder of. the neck measures 10.0 X 6.0 X 2.2 cm. Multiple metallic clips are. identified. No jugular vein is grossly identified attached to the specimen. The metallic clips are removed. The outer surface of the gland is inked. The cut surfaces of the submandibular gland are pale yellow-white, vaguely. nodular with a cystic area measuring 1.4 X 1.0 X 0.7 cm. The cystic area. contains brown-tan grumous material. Multiple candidate lymph nodes are. recovered. Summary of sections: 5A-5C, submandibular gland, 1/1 each, level 3 lymph. nodes, superior to inferior 5D, 1 possible lymph node, 2/1; 5E, 1 possible. lymph node, 2/1; 5F, 1 possible lymph node, 5/1; 5G, 2 possible lymph. nodes, 2/1; level 4, superior to inferior possible candidate lymph nodes;. 5H, 2 possible lymph nodes, 2/1; 5I, 1 possible lymph node bisected, 2/1;. 5J, 1 possible lymph node bisected, 2/1; 5K, 1 possible lymph node. trisected, 3/1; 5L, 1 possible lymph node bisected, 2/1; 5M, 2 possible. lymph nodes, 2/1 each, level 5 lymph nodes superior to inferior 5N-5W, 1. possible lymph node in each cassette bisected, 2/1 each; 5X, 2 possible. candidate lymph nodes, 2/1; 5Y, 1 lymph node bisected, 2/1. 6) SOURCE: Right Neck Level 1. Received fresh in a container labeled ""right neck level 1"" is a 5 cm X 3 cm. X 2 cm piece of yellow lobulated tissue when palpated reveals 4 candidate. lymph nodes. Bisecting these lymph nodes reveals a firm white area with a. small portion of grossly normal appearing lymph node parenchyma. Summary of sections: 6A, 2 lymph nodes bisected, 4/1; 6B, 1 bisected lymph. node with 1 smaller lymph node, 3/1. 7) SOURCE: Palate. Received fresh in container labeled with patient's name, medical record. number and palate, is a 4.5 X 4.0 X 1.2 cm palate excision. A stitch is. placed to indicate the anterior margin. There is a 3.5 cm X 2.7 cm. exophytic lesion on the mucosal surface of the palate excision. This lesion. is centrally located within the mucosal surface and is grossly 0.2 cm from. the posterior margin as its closest margin. It is located 0.3 cm from. anterior margin, 0.7 cm from superior margin, and 0.3 cm from inferior. margin. The deep margin has significant cautery artifact. The specimen is. inked in the following fashion: Deep cut surface black, anterior red,. posterior orange, superior yellow, inferior blue. Summary of sections: The specimen is then serially sectioned from anterior. to posterior to reveal the exophytic mass extending into the deep tissue,. abutting the black inked margin. Grossly, the specimen appears not to. involve the remaining margin. Representative sections of each margin with. closest tumor are submitted. Summary of sections: 7A, anterior and posterior margin, 2/1; 7B, tumor to. deep black margin, 2/1; 7C, tumor closest to yellow inked margin, 1/1; 7D,. tumor closest to blue inked margin, 1/1; 7E, representative tumor to blue. inked and black margin (this is not closest margin), 2/1. 8) SOURCE: Additional Right Deep Tissue. Received fresh in a container labeled ""additional"" are aggregates of tissue. measuring 3.0 X 1.0 X 0.6 cm. The tissue has cautery artifact associated. with submitted tissue. Tissue is submitted entirely over two cassettes. Summary of sections: 8A-8B, M/1 each. Slides and report reviewed by Attending Pathologist. SURGICAL PATHOLOGY INTRAOPERATIVE CONSULTATION. 1) SOURCE: Deep Right Margin. FROZEN SECTION DIAGNOSIS: INVOLVED BY SQUAMOUS CELL CARCINOMA. 2) SOURCE: Posterior Mucosal Margin. FROZEN SECTION DIAGNOSIS: BENIGN. J. 3) SOURCE: Left Mucosal Margin. FROZEN SECTION DIAGNOSIS: BENIGN. 4) SOURCE: New Deep Right Margin. FROZEN SECTION DIAGNOSIS: BENIGN. SNOMED: T-01000,T-01000,M-80103 -.",train,2.4 cm;3.5 CM;3.5 cm
366,TCGA-G2-A2ES.A9EE4140-E3B4-4DF3-A898-65CCEAFE4072,"DIAGNOSIS. (A) LEFT DISTAL URETER. INK AT MARGIN: Segment of ureter, no tumor present. (B) RIGHT DISTAL URETER, INK AT MARGIN: Segment of ureter, no tumor present. (C) BLADDER, PROSTATE AND SEMINAL VESICLES: BLADDER -. UROTHELIAL CARCINOMA NON-PAPILLARY TYPE, HIGH GRADE WITH FOCAL. SQUAMOUS DIFFERENTIATION. TUMOR INVADES BLADDER WALL TRANSMURALLY AND EXTENDS TO. PERIVESICAL FAT. Serosal surface, free of tumor. No lymphovascular invasion is identified. Resection margins, free of tumor. PROSTATE -. UROTHELIAL CARCINOMA EXTENDS TO THE PERIURETHRAL PROSTATIC. DUCTS AND SHOWS SUPERFICIAL. INVASION OF THE PERIDUCTAL STROMA. Prostatic tissue with glandular atrophy, paribasal cell hyperplasia with atypia consistent. with treatment effect. No evidence of residual prostatic carcinoma. Prostatic tissue with chronic and focally acute inflammation. (D) LEFT EXTERNAL ILIAC LYMPH NODES: Four lymph nodes, no tumor present (0/4). (E) LEFT OBTURATOR LYMPH NODES: Nine lymph nodes, no tumor present (0/9). (F) LEFT COMMON ILIAC LYMPH NODES: Four lymph nodes, no tumor present (0/4). (G) RIGHT OBTURATOR LYMPH NODES: Eight lymph nodes, no tumor present (0/8). (H) RIGHT EXTERNAL ILIAC LYMPH NODES: Four lymph nodes, no tumor present (0/4). (I) RIGHT COMMON ILIAC LYMPH NODES: One lymph node, no tumor present (0/1). (J) LEFT URETER, FINAL MARGIN: Wall of ureter with unremarkable urothelium. (K) RIGHT URETER, FINAL MARGIN: Wall of ureter with unremarkable urothelium. GROSS DESCRIPTION. (A) LEFT DISTAL URETER - A segment of ureter (0.8 cm in length) with marked true. margin. The margin submitted en face for frozen in A. FS/DX: URETER. NEGATIVE FOR CARCINOMA OR HIGH-GRADE. DYSPLASIA. BAC: (B) RIGHT DISTAL URETER - A 1.5 cm segment of ureter with true margin marked. The. margin submitted en face for frozen section in B. FS/DX: URETER. NEGATIVE FOR CARCINOMA OR HIGH-GRADE. DYSPLASIA. BAC: (C) BLADDER, PROSTATE AND SEMINAL VESICLES - A radical cystoprostatectomy. specimen consisting of a urinary bladder ( 12 x 10 x 2 cm opened), prostate gland ( 4.5 x 4.5 x 3. cm), seminal vesicles and attached perivesical adipose tissue measuring overall 16 x 14 x 4 cm. Located in the left lateral wall and anterior wall of the bladder is an exophytic tumor (5.5 x 3.9. cm). The tumor invades into the bladder wall and extends into the perivesical fat. The tumor. does not extend to the inked margin of the specimen. The right and left ureteral orifices are not. involved by tumor. The prostatic tissue is firm. No gross lesions are identified within the prostate. Tissue is. submitted for tumor bank. Representative section of bladder wall and attached prostate are. submitted as per enclosed map of cystoprostatectomy specimen. SECTION CODE: C1-C47,sections of the bladder including tumor submitted. sequentially from the dome to the bladder base; C48-C57, sections of the prostate gland. including seminal vesicles; C58, urethral margin. (D) LEFT EXTERNAL ILIAC LYMPH NODE - A 4.0 x 3.0 x 1.2 cm aggregate of. fibroadipose tissue. The tissue is dissected to reveal five possible lymph nodes ranging from 0.5. x 0.4 x 0.3 cm-2.0 x 0.6 x 0.5 cm. SECTION CODE: D1, two possible lymph nodes; D2, two possible lymph nodes; D3,. one possible lymph node serially sectioned. (E) LEFT OBTURATOR LYMPH NODE - A 6.0 x 3.0 x 2.0 cm aggregate of fibroadipose. tissue. The tissue is dissected to reveal ten possible lymph nodes ranging from 0.6 x 0.5 x 0.3. cm-2.2 x 1.7 x 0.7 cm. SECTION CODE: E1, two possible lymph nodes; E2, three possible lymph nodes; E3,. one possible lymph node serially sectioned; E4, one possible lymph node serially sectioned; E5,. one possible lymph nodes serially sectioned; E6, one possible lymph nodes serially sectioned;. E7, E8, one possible lymph node serially sectioned. (F) LEFT COMMON ILIAC LYMPH NODES - A 3.0 x 2.2 x 1.0 cm aggregate of fibroadipose. tissue. The tissue is dissected to reveal four possible lymph nodes ranging from 0.6 x 0.3 x 0.3. cm-2.0 x 1.0 x 0.5 cm. SECTION CODE: F1, three possible lymph nodes; F2, F3, one possible lymph node. serially sectioned. Entire specimen is submitted. (G) RIGHT OBTURATOR LYMPH NODE - A 5.0 x 5.0 x 1.5 cm aggregate of fibroadipose. tissue. The tissue is dissected to reveal eight possible lymph nodes ranging from 0.2 x 0.2 x 0.2. cm-3.5 x 0.8 x 0.5 cm. SECTION CODE: G1, one possible lymph node; G2, two possible lymph nodes; G3, two. possible lymph nodes; G4, one possible lymph node serially sectioned; G5, one possible lymph. node serially sectioned; G6, G7, one possible lymph node serially sectioned. (H) RIGHT EXTERNAL ILIAC LYMPH NODE - A 4.7 x 4.0 x 1.8 cm aggregate of. fibroadipose tissue. The tissue was dissected to reveal five possible lymph nodes ranging from. 0.5 x 0.3 x 0.2 cm-2.5 x 1.7 x 0.8 cm. SECTION CODE: H1, one possible lymph node; H2, one possible lymph node serially. sectioned; H3, one possible node serially sectioned; H4, H5, one possible lymph node serially. sectioned; H6, H7, one possible lymph node serially sectioned. (I) RIGHT COMMON ILIAC LYMPH NODE - A 2.0 x 2.0 x 1.3 cm lymph node. SECTION CODE: Il and I2, one possible lymph node serially sectioned. Entire. specimen is submitted. (J) LEFT URETER, FINAL MARGIN - A 1.8 x 0.5 cm portion of ureter that is oriented by the. surgeon with a suture. The side where the suture is inked blue and the opposite side is inked. black. SECTION CODE: J1, side with the suture, en face; J2, side opposite suture, en face. (K) RIGHT URETER, FINAL MARGIN - A 2.0 x 0.2 cm portion of ureter that is oriented by. the surgeon with a suture on one end. The side where the suture is inked blue and the opposite. side is inked black. SECTION CODE: K1, side with suture, en face; K2, side opposite suture, en face. CLINICAL HISTORY. None given.",train,5.5 x 3.9. cm
374,TCGA-RQ-A68N.B40907C0-DA7B-436F-993A-53DA4C9A56A9,"Microscopic Description: Sections demonstrate sheets of poorly cohesive, large cells. These have large atypical, somewhat open. nuclei, usually with multiple nucleoli. They have only a modest amount of cytoplasm. Numerous mitotic. figures are seen. Individual apoptotic cells are seen without frank necrosis. The tumor has an expansive. interface with the surrounding parenchyma but an angiocentric pattern is also appreciated. Areas of. apparent glial and fibrous scarring are also noted. Diagnosis: Brainstem Tumor: diffuse Large Cell Lymphoma, B-cell type. PERMANENT CHART COPY. NEUROPATHOLOGY REPORT. GROSS DESCRIPTION: MICROSCOPIC DESCRIPTION: 1, 2. Sections demonstrate sheets of poorly cohesive, large cells. These have. large atypical, somewhat open nuclei, usually with multiple nucleoli. They. have only a modest amount of cytoplasm. Numerous mitotic figures are seen. Individual apoptotic cells are seen without frank necrosis. The tumor has an. expansive interface with the surrounding parenchyma but an angiocentric. pattern is also appreciated. Areas of apparent glial and fibrous scarring are. also noted. The neoplastic cells are immunoreactive for CD45 and CD20, confirming B-cell. lymphocytic origin. They are negative for GFAP, S-100 and cytokeratin 8/18. The neoplastic cells demonstrate aberrant expression of the T-cell marker CD43. but are negative for CD3 and CD45 ro. They demonstrate BCL2 and BCL6. positivity but are negative for CD10. Overall, the immunophenotype is. consistent with a diffuse large cell B-cell lymphoma. DIAGNOSIS: (PROVISIONAL). 1, 2. BRAINSTEM TUMOR, BIOPSIES: DIFFUSE CELL B-CELL TYPE. The LARGE tumor LYMPHOMA, is negative for test co3.",train,
403,TCGA-BH-A0GY.A997FF30-F112-48BE-8FF1-15F8266A5E62,"FINAL DIAGNOSIS: PART 1: LEFI BREAST, SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA, NOTTINGHAM SCORE 8/9 (TUBULES 3, NUCLEI 3, MITOSIS 2), 2.6 CM. B. DUCTAL CARCINOMA IN SITU, MICROPAPILLARY AND SOLID TYPES WITH COMEDO NECROSIS, NUCLEAR. GRADE 3, REPRESENTING 5% OF THE TUMOR VOLUME. C. LYMPHOVASCULAR SPACE INVOLVEMENT SEEN. D. INVASIVE CARCINOMA IS 0.1 CM FROM INFERIOR MARGIN. E. DUCTAL CARCINOMA IN SITU IS <0.1 CM (1MM) FROM INFERIOR MARGIN. F. MARGINS FREE OF LESION. G. MICROCALCIFICATION ASSOCIATED WITH BENIGN CHANGES AND TUMOR. H. CHANGES CONSISTENT WITH BIOPSY SITE. I. PROLIFERATIVE FIBROCYSTIC CHANGES WITH ATYPICAL DUCTAL EPITHELIAL HYPERPLASIA AND. COLUMNAR CELL CHANGES. J. MICROSCOPIC PERIPHERAL PAPILLOMA AND SCLEROSING ADENOSIS. K. SKIN NOT REMARKABLE. PART 2: LEFT AXILLA, SENTINEL LYMPH NODE #1, EXCISION -. A. ONE LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA (0.9 CM). B. NO EXTRACAPSULAR EXTENSION SEEN. PART 3: LEFT AXILLA, SENTINEL LYMPH NODE #2, EXCISION -. ONE LYMPH NODE WITH RARE CLUSTERS OF METASTATIC TUMOR CELLS IN PERIPHERAL SINUS. PART 4: LEFT AXILLA, LYMPH NODE EXCISION -. ONE LYMPH NODE WITH EXTENSIVE THERMAL EFFECT, PROBABLY FREE OF TUMOR. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Lower outer quadrant. SIZE OF TUMOR: MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: Maximum dimension invasive component: 2.6 cm. TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 3. Mitotic activity score: 2. Total Nottingham score: 8. ANGIOLYMPHATIC INVASION: Nottingham grade (1, 2, 3): 3. DERMAL LYMPHATIC INVASION: CALCIFICATION: Yes, benign zones. TUMOR TYPE, IN SITU: Yes, malignant zones. Soia. Micropapillary. Comedo. DCIS admixed and outside of invasive carcinoma component. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Percent of tumor occupied by in situ component: 5 %. SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of invasive tumor to closest margin: 1 mm. PAGET'S DISEASE OF NIPPLE: Distance of in situ disease to closest margin: 0.7 mm. LYMPH NODES POSITIVE: 2. LYMPH NODES EXAMINED: 3. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: SIZE OF NODAL METASTASES: LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: Diameter of largest lymph node metastasis: 9 mm. SKIN INVOLVED (ULCERATION): NON-NEOPLASTIC BREAST TISSUE: ADH, Papilloma, FCD. T STAGE, PATHOLOGIC: pT2. N STAGE, PATHOLOGIC: pN1a. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive.",train,2.6 CM;2.6 CM
434,TCGA-BH-A1EX.FA86A743-EA67-4554-ABA2-BB8C1DBDB0B1,"PATIENT HISTORY: SPECIMENS TAKEN BY PATH DATE of LMP: (NOT LISTED ON REQUISITION). DATE or LAST DELIVERY: PRE-OP DIAGNOSIS: RIGHT BREAST CANCER. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: R SENTINEL LYMPH NODE, R SEGMENTAL MASTECTOMY. CLINICAL HISTORY: SPECIMENS TAKEN BY PATH. MATERIAL SUBMITTED: A) RIGHT SENTINEL LYMPH NODE, PROCUREMENT BY SURGICAL PROCEDURE. B) RIGHT BREAST BICPSY/TISSUE, PROCUREMENT BY SURGICAL PROCEDURE. Long-lat,med-med, sht-superior. INTRAOPERATIVE CONSULTATION: R SENTINEL LYMPH NODE #1: One lymph node, 0.8 by 0.6 by 0.5 cm. Touch Prep. Diagnosis: Negative. ADDENDA: Addendum. FISH analysis using DNA probe for Her-2/neu gene showed that, the ratio of Her-2/neu signals to chromosome 17. centromere signais is 0.94 (> 2.0 ratio is considered amplified). Therefore, Her-2/neu gene is not amplified. Bv Pathologi. My signature is attestation that I have personally reviewed the submitted material(s) and the above diagnosis reflects that evaluation. Addendum. MATERIAL SUBMITTED: BLOCK ""B3"" FOR ER/PR AND HER-2/NEU (BREAST CANCER). FINAL DIAGNOSIS: ESTROGEN/PROGESTERONT RECEPTORS AND HER-2/NEU PERFORMED ON RIGHT BREAST TISSUE. ESTROGEN RECEPTOR (0- 40%; 1+ 40%; 2+ 10%; 3+ 10%) HSCORE OF 90. ESTROGEN RECEPTOR IS INTERPRETED AS. POSITIVE. PROGESTERONS RECEPTOR (0- 70%; 1+ 10%; 2+ 10%; 3+ 10%) HSCORE OF 60. PROGESTERONI RECEPTOR IS INTERPRETED AS. POSITIVE. HER-2/NEU-DAKO HERCEPTEST. A WEAK TO MODERATE COMPLETE MEMBRANE STAINING IS OBSERVED IN MORE THAN 10% OF THE. TUMOR CELLS. HER-2/NEU IS INTERPRETED AS POSITIVE (SCORE 2+). HSCORE: <= 15 NEGATIVE. >15<=30 BORDERLINE. FINAL DIAGNOSIS: FINAL DIAGNOSIS: A) RIGHT SENTINEL LYMPH NODE #1: - MICROMIETASTATIC DUCTAL CARCINOMA OF THE BREAST (SEE NOTE). B) RIGHT SEGMENTAL MASTECTOMY: INFILTRATING MODERATELY DIFFERENTIATED DUCTAL CARCINOMA) NOTTINGHAM SCORE 6/9 (TUBULES=3, NUCLEI=2,. MITOSIS-1) SIZE 2.5 BY 2.0 BY 1.5 CX. - DUCTAL CARCINOMA IN SITU, NON-COMEDO TYPE, SOLID AND CRIBRIFORK) NUCLEAR GRADK 1, CONSTITUTES 5% or. ENTIRE. TUMOR MASS. - SEVERAL MICROSCOPIC FOCI OF INFILTRATING ADENOCARCINOMA, UP TO 0.5 CM, IN THE REMAINING BREAST TISSUE. #9, #12). - LATERAL AND INFERIOR SURGICAL MARGINS POSITIVE FOR INVASIVE TUMOR. - INTRADUCTAL PAPILLOMA AND PROLIFERATIVE FIBROCYSTIC CHANGES IN THE REMAINING BREAST TISSUE. FOCAL NECROSIS AND GRANULATION TISSUL, STATUS-POST CORE BIOPSY or BREAST (CROSS REFER. NOTE: Minute clusters of metastatic ductal carcinoma was found in serial section ""Al"", but it ie best. visualized with the immunoperoxidase stain AB1/AR3 in serial section A2. The immunostain was repeated and. the presence of metastatic neoplastic cells in the lymph node section ""Al"" was confirmed by. immunostaining (""A26A3""). The later serial sections of the lymph nodes are negative. The touch prep of. the. sentinel node was re- reviewed and no malignant cells are identified ER/PR immunoperoxidase assay and Her-. 2/NEU testing will be performed on block ""B3"". The special stains and/or immunoperoxidase tests used in thi ~ase hatra bean and their performance. characterietics determined by the Department of Pathology at. They have not been cleared or approved by the U.S. Food and Drug Administration.",train,2.5 BY 2.0 BY 1.5 CX;0.5 CM
456,TCGA-PE-A5DE.6D2FA4DD-285F-4815-9494-76B297FA04AF,"SPECIMEN: Sex: F. Date Collected: Date Received: Clinical History/Diagnosis: Left breast cancer. Source of Specimen(s): 1: Sentinel Nodes-left axilla. 2: left breast lumpectomy. 3: Margin-final medial. Gross Description: Received in three parts. Source of Tissue: 1. Labeled # 1, ""sentinel node left axilla"". Touch Preparation Evaluation: 1TP- NO TUMOR SEEN PER. (VERIFIED). Gross Description: Received fresh for intraoperative consultation/touch. impression in a container labeled ""sentinel node left axilla"". It consists of a tan to light. brown rubbery lymph node measuring 1.6 x 1.3 x 1.0 cm. There is a stitch at one end. marking the bluest portion. The node is sectioned. Touch impression of the bluest. end was submitted as 1TPA and the tissue is subsequently submitted in 1A. Touch impression of the opposite end was submitted as 1TPB and. subsequently the tissue is submitted in 1B. Source of Tissue: 2. Labeled # 2, ""left breast lumpectomy"". Gross Description: Received fresh in a container labeled ""left breast lumpectomy"". It. consists of a 7.4 x 7.4 x 3.5 cm ovoid rubbery fragment of fibroadipose tissue. There is a. short stitch marking the superior and a long marking the lateral. The anterior is. inked blue and the remaining margins are inked black. The specimen is. sectioned disclosing a large firm tan lesion with moderately defined. borders measuring 3.8 x 2.6 x 1.9 cm. The lesion occupies an appreciable. amount of the lumpectomy specimen. Laterally in the tumor there is. inspissated blood consistent with previous biopsy site changes. The. lesion comes very close to the medial, superior, and anterior resection. margins. Also adjacently the breast parenchyma is fibrous and there is a. 0.4 cm blue dome cyst noted. Representative sections are submitted in. 2A-K. Designation of Sections: 2A-2C- breast tissue with tumor in relationship. to anterior margin, 2D-2F- breast tissue with tumor in relationship to. posterior margin, 2G- additional sections of tumor, no margins are. represented with biopsy site, 2H- perpendicular sections of superior. resection margin, 2I- perpendicular sections of medial resection margin. [Note: specimen 3 presumably supercedes this margin.], 2J- perpendicular. sections of inferior margin, 2K- perpendicular sections of lateral margin. Source of Tissue: 3. Labeled # 3, ""final medial margin"". Gross Description: Received fresh in a container labeled "" final medial margin"". It. consists of a fragment of fibroadipose tissue measuring 2.5 x 2.0 x 1.0 cm. There is a. stitch marking the final margin which is inked black prior to sectioning. Sections disclose no obvious residual lesional tissue. Entirely submitted. in 3A and 3B. Final Diagnosis: 1. Sentinel lymph node, left axilla, excision: - One lymph node with no tumor seen (0/1). - Negative immunohistochemical staining for cytokeratin AE1/AE3. 2. Left breast, lumpectomy: Invasive and in situ lobular carcinoma. - Invasive lobular carcinoma, 3.8 cm in greatest dimension grossly, grade. II-III. Lobular carcinoma in situ, nuclear grade II-III, comprising. approximately 5% of the tumor mass. - Lymphovascular invasion is not identified. - Invasive carcinoma is less than 1mm to the inked closest medial margin. (see specimen 3 for final medial margin status), and remaining margins. with no tumor seen. - Changes consistent with prior biopsy site seen. Non-neoplastic breast tissue shows fibrocystic changes with. microcalcifications. 3. Left breast, final medial margin, excision: - Benign breast tissue, no tumor seen. Note: Case reviewed with. who concurs with the. diagnosis. Procedures/Addenda. Addendum Date Ordered: Date Complete: Addendum Diagnosis. Specimen sent tc. for additional. testing. Antibody/Tests. Prognostic. Grouping. DNA INDEX/PLOIDY. 1.59 Aneuploid. S-Phase. See Below. Ki-67 (MIB-1). <10%. Favorable. An accurate S-phase fraction (SPF) value cannot be determined due to DNA. aneuploid/tetraploidy cell population <20% of total cells analyzed. INVASIVE BREAST CANCER TEMPLATE: Excisions and Mastectomies. Specimen Type. Excision. Lymph Node Sampling. Sentinel lymph node only. Specimen Size (for excisions less than total mastectomy). Greatest dimension: 7.4 cm. Laterality. Left. Tumor Site(s). Not specified. Invasive Component. Solitary. Greatest dimension: 3.8 cm (grossly). Histologic Type(s). Lobular carcinoma in situ. Invasive lobular. Invasive Lobular Carcinoma Type. Classical, singet-ring, and pleomorphic. Invasion. Invasion confined to breast parenchyma. Angiolymphatic Invasion. Absent. Microcalcifications Associated with Carcinoma In Situ. Margins. Margins uninvolved by invasive carcinoma and in situ carcinoma. Regional Lymph Nodes. 1 regional lymph node examined. No regional lymph node metastasis histologically and by. immunohistochemical staining for cytokeratin AE1/AE3 (NO). Ancillary Immunopathology Studies (performed on. ER. Positive. PR. Positive. Her2-Neu. Negative (score 0). pTNM: T2 NO Mx.",train,3.8 cm;3.8 cm
470,TCGA-HC-7745.4a65a2d9-6007-4ff2-9711-46351f540367,"Result date: Clinical History. Prostate cancer. Specimen. #1. Prostate. #2. Right pelvic lymph nodes. #3. Left pelvic lymph nodes. Gross Examination. #1. Received fresh and labeled prostate, is a 35 gram, 4.0 cm (right to left). X 3.7 cm (apex to base) X 3.5 cm (anterior to posterior) prostate with attached. right and left seminal vesicles (2.5 X 1.2 X 0.8 cm, 3.0 X 2.0 X 0.8 cm,. respectively). There are portions of attached right and left vasa deferentia. (each 0.5 cm long) . Also present within the specimen container there is a 2.5 X. 1.5 X up to 0.7 cm aggregate of three irregular fragments of tubular rubbery,. grey tan tissue. The right half of the prostate is inked black and the left. half is inked blue. The prostate is serially sectioned from apex to base to. demonstrate a 1.5 cm ill-defined focal firm area of pale tan discoloration. within the mid aspect of the left posterior prostate, coming to within 0.1 cm of. the blue inked outer surface. The parenchyma otherwise consists of tan, rubbery. glistening parenchyma with a moderate amount of periurethral nodularity. There. are no additional abnormalities identified. A total of thirty-four sections are submitted in fifteen cassettes ""A - O"". Block summary: ""A"", right apex longitudinally sectioned; ""B"", left apex. longitudinally sectioned; ""C"", right bladder neck longitudinally sectioned; ""D"",. left bladder neck longitudinally sectioned; ""E-G"", right posterior prostate,. from apex to base respectively; ""H-J"", left posterior prostate, from apex to. base respectively; ""K"", right lateral prostate; ""L"", left lateral prostate; ""M"",. anterior prostate; ""N"", right seminal vesicle and prostate, including right vas;. ""O"", left seminal vesicle and prostate, including left vas. Following explicit. written consent of the patient, tissue is taken for the Cancer Genome Atlas. Project. #2. Labeled right pelvic lymph node, is a 3.2 X 1.0 X 0.8 cm portion of tan. yellow fibroadipose tissue. Within the tissue there is a 0.8 cm lymph node. candidate. The candidate is bisected and submitted as two sections in one. cassette. #3. Labeled left pelvic lymph node, is a 4.0 X 2.5 X 1.0 cm aggregate of. multiple irregular fragments of tan yellow fibroadipose tissue. Within the. tissue there are two lymph node candidates, 0.4 and 2.5 cm in greatest. dimension. The candidates are submitted as five sections in three: ""A-C"". Block summary ""A"", one candidate; ""B,C"", larger candidate, sectioned. OR Consultation. #1. PROSTATE, RADICAL PROSTATECTOMY : TISSUE TRIAGE FOR. Signature Line. Microscopic Examination. #1-#3 Microscopic examination performed. Comment. Portions of this case have been reviewed in consultation with one additional. departmental pathologist. Final Diagnosis. #1. PROSTATE GLAND PROSTATIC ADENOCARCINOMA. GLEASON SCORE: 4+3=7. TUMOR SIZE: AT LEAST 2.0 X 1.0 CM (AS MEASURED ON GLASS SLIDE ""I""). PERCENT PROSTATE INVOLVEMENT, ESTIMATE: 25% OF EXAMINED SECTIONS. TUMOR LOCATION BILATERAL. EXTRAPROSTATIC EXTENSION: MULTIFOCAL. SURGICAL MARGIN STATUS: NEGATIVE. SEMINAL VESICLE AND VASA DEFERENTIA STATUS: BILATERAL INVOLVEMENT. BY CARCINOMA. LYMPHATIC (SMALL VESSEL) INVASION: ABSENT. VENOUS (LARGE VESSEL) INVASION: ABSENT. #2 RIGHT PELVIC LYMPH NODE: BENIGN LYMPH NODE. #3 LEFT PELVIC LYMPH NODES: BENIGN LYMPH NODES (x 2). PATHOLOGIC STAGE (TNM CLASSIFICATION) : pT3b pNO .",train,2.0 X 1.0 CM
477,TCGA-CR-7371.d6bfea59-7f79-4cfc-9098-e96e3407349f,"DIAGNOSIS: 1, .5) PHARYNX, LARYNX, PHARYNGOLARYNGECTOMY: MODERATELY DIFFERENTIATED. KERATINIZING SQUAMOUS CELL CARCINOMA OF THE EPIGLOTTIS, 2.3 CM IN GREATEST. EXTENT, INVOLVING THE ANTERIOR COMMISURE, RIGHT AND LEFT FALSE VOCAL FOLDS,. AND THE PRE-EPIGLOTTIS, EXTENSION INTO THE EPIGLOTTIC CARTILAGE; FOCALLY. INVOLVING THE SUPERIOR INKED LEFT ANTERIOR SOFT TISSUE RESECTION MARGIN,. ALL OTHER MARGINS, NEGATIVE FOR MALIGNANCY (SEE COMMENT). 2) MARGIN, POSTERIOR CRICOID, EXCISION: NEGATIVE FOR MALIGNANCY. 3) MARGIN, LEFT HYPOPHARYNX, EXCISION: NEGATIVE FOR MALIGNANCY. 4) MARGIN, RIGHT HYPOPHARYNX, EXCISION: NEGATIVE FOR MALIGNANCY. 6) LYMPH NODES, LEFT NECK LEVEL 4, DISSECTION: 19 LYMPH NODES, NEGATIVE FOR. MALIGNANCY. 7) LYMPH NODES, LEFT NECK LEVEL 2A, 3, DISSECTION: 43 LYMPH NODES, NEGATIVE. FOR MALIGNANCY. 8) LYMPH NODES, RIGHT NECK LEVEL 2, 3, 4, DISSECTION: 1 OF 40 LYMPH NODES. INVOLVED BY METASTATIC SQUAMOUS CELL CARCINOMA. 9) LYMPH NODES, LEVEL 1A, EXCISIONAL BIOPSY: 2 LYMPH NODES, NEGATIVE FOR. MALIGNANCY. COMMENT: These findings correspond to AJCC 6TH Edition Pathologic Stage III. (pT3N1Mn/a). CLINICAL DATA. Clinical Features: Unspecified. Operator: Operation: Unspecified. Operative Findings: Unspecified. Operative Diagnosis: Unspecified. Tissue Submitted: 1) epiglottis, 2) post cricoid, 3) left. hypopharynx, 4) right hypopharynx, 5). pharyngolaryngectomy; 6)left neck level. 4; 7)left neck levels 2A, 3; 8)right neck. levels 2,3,4;9)neck dissection level 1A. INSTRUCTIONS TO PATHOLOGIST: Frozen. GROSS DESCRIPTION: 1) SOURCE: Epiglottis. Received fresh labeled, ""epiglottis,"" is a 0.6 X 0.4 X 0.3 cm piece of. tan-white tissue. The specimen is submitted entirely for frozen section. Summary of sections: 1AFSC, 1/1. 2) SOURCE: Post Cricoid. The specimen labeled ""post cricoid,"" is received fresh and is comprised of. a 2.4 X 0.2 X 0.2 cm strip of pink-tan mucosa. The specimen is submitted. entirely for frozen section. Summary of sections: 2AFSC, entirely submitted, 1/1. 3) SOURCE: Left Hypopharynx. The specimen labeled ""left hypopharynx,"" is received fresh and is comprised. of a 2.7 X 0.2 X 0.2 cm strip of tan-pink mucosa. The specimen is inked. black, and submitted entirely for frozen section. Summary of sections: 3AFSC, 1/1. 4) SOURCE: Right Hypopharynx. The specimen labeled ""right hypopharynx,"" is received fresh and is. comprised of two pieces of tissue, one measuring 1.8 X 0.3 X 0.2 cm, the. second measuring 1.4 X 0.2 X 0.2 cm. The first piece of tissue does not. have an easily identifiable mucosal surface. The second strip of tissue. does have an identifiable mucosal surface. Each of these pieces of tissue. are inked blue, and the specimen is submitted entirely for frozen section. Summary of sections: 4AFSC, entirely submitted, 2/1. 5) SOURCE: Pharyngolaryngectomy. The specimen labeled ""pharyngolaryngectomy"" is received fresh and is. comprised of a laryngectomy with attached epiglottis, thyroid cartilage. with extension of the mucosa and trachea inferior to the thyroid cartilage. The thyroid gland is not present with the specimen. The specimen measures. 8.0 cm superior to inferior X 5.0 cm left to right X 4.8 cm anterior to. posterior. The specimen has been opened prior to receipt along the. posterior aspect. The specimen is inked as follows: anterior-orange,. posterior-black, superior-yellow, inferior-green, right-red, left-blue. Examination of the specimen shows a 2.3 X 1.8 cm ulcerated lesion on the. posterior face of the epiglottis present centrally, extending to the left. and right (more prominently leftward), and towards the epiglottic vocal. folds. The right and left superior vocal folds are involved, medially, with. the left involved laterally. The anterior commissure is involved. On. sectioning, the lesion penetrates 0.4 cm deep from the mucosal surface. There is a prominent 0.8 X 0.7 X 0.7 cm nodule in the left anterior. superior portion of the specimen abutting the anterior superior margin. There is no gross tumor involvement of the thyroid cartilage. The tumor. mass has borders and comes within 0.3 cm of the hyoid bone, which is. present with the specimen. The tumor mass does appear to wrap around the. superior aspect of the thyroid cartilage. There is no apparent extension. inferior to the vocal folds. Representative sections are submitted. Summary of sections: 5A, inferior margin, 1/1; 5B, anterior commissure,. 1/1; 5C, right superior margin with epiglottis, 1/1; 5D, right medial vocal. folds, 1/1; 5E, right lateral vocal folds, 1/1; 5F, right aryepiglottic. mucosa, 1/1; 5G, left anterior superior margin with prominent nodule, 2/1. (single section bisected); 2/1; 5H, left medial vocal fold with closest. approach to hyoid bone, 1/1; 5I, left lateral vocal fold, 1/1; 5J, left. aryepiglottic mucosa, 1/1; 5K, right and left soft tissue margins, 2/1; 5L,. anterior and posterior soft tissue margins, 2/1. NOTE: Appropriate sections. are decalcified. 6) SOURCE: Left Neck Level 4. The specimen labeled ""left neck level 4"" is received in saline, and is. comprised of a 5.2 X 4.2 X 0.5 cm collection of fibroadipose tissue. containing lymph node candidates. Lymph node candidates range in. measurement from 0.3 to 0.5 cm. The specimen is dissected and 21 lymph node. candidates are removed. These lymph node candidates are submitted entirely. Summary of sections: 6A, lymph node candidates, M/1; 6B, lymph node. candidates, m/1; 6C, lymph node candidates, M/1. 7) SOURCE: Left Neck Levels 2A&3. The specimen labeled ""left neck levels 2A, 3"" is received in saline and is. comprised of a 13.5 X 4.5 X 0.5 cm collection of fibroadipose tissue. containing lymph nodes and vessels, with suture ties investing the vascular. end. The specimen is dissected to reveal the presence of numerous lymph. node candidates measuring from 0.2 to 1.0 cm in greatest extent. The lymph. node candidates are submitted entirely. Summary of sections: 7A, lymph node candidates, M/1; 7B, lymph node. candidates, M/1; 7C, lymph node candidates, M/1; 7D, lymph node candidates,. 6/1; 7E, two lymph nodes, each bisected, one inked black, 4/1. 8) SOURCE: Right Neck Level 2,3,&4. The specimen labeled ""right neck level 2, 3, 4"" is received fresh and is. comprised of a 15.2 X 5.2 X 0.6 cm collection of fibroadipose tissue. containing lymph nodes and vessels. The specimen is dissected to reveal the. presence of numerous lymph nodes measuring from 0.2 to 1.2 cm. Lymph node. candidates are submitted entirely. Summary of sections: 8A, lymph node candidates, M/1; 8B, lymph node. candidates, M/1; 8C, lymph node candidates, M/1; 8D, lymph node candidates,. M/1; 8E, lymph node candidates, 2/1; 8F, single lymph node, bisected, 2/1. 9) SOURCE: Neck Dissection Level 1A. The specimen labeled ""neck dissection level 1A"" is received in saline and. is comprised of a 2.5 X 2.0 X 0.5 cm collection of fibroadipose tissue. containing lymph node candidates. The specimen is divided to reveal the. presence of possible lymph nodes measuring from 0.3 to 0.5 cm. The specimen. is submitted entirely. Summary of sections: 9A, 2/1; 9B, 2/1; 9C, 2/1. Slides and report reviewed by Attending Pathologist. SURGICAL PATHOLOGY INTRAOPERATIVE CONSULTATION. 1) SOURCE: Epiglottis. FROZEN SECTION DIAGNOSIS: SQUAMOUS CELL CARCINOMA. 2) SOURCE: Post Cricoid. FROZEN SECTION DIAGNOSIS: BENIGN. 3) SOURCE: Left Hypopharynx. FROZEN SECTION DIAGNOSIS: BENIGN. 4) SOURCE: Right Hypopharynx. FROZEN SECTION DIAGNOSIS: BENIGN. The following special studies were performed on this case and the. interpretation is incorporated in the diagnostic report above: 1xDECALCIFICATION. In some tests, analyte specific reagents (ASRs) are used. In the case of. an ASR, this test was developed and its performance characteristics. determined by this laboratory. It has not been cleared or approved by the. US Food and Drug Administration. The FDA has determined that such. clearance or approval is not necessary. This test is used for clinical. purposes. It should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of. (CLIA '88) as qualified to perform high complexity. clinical laboratory testing.",train,2.3 CM
531,TCGA-98-7454.d2607098-3918-4967-9b7f-8ea9cd0e43b9,"Observation Date. Last Edited Date. Diagnosis. A. Lymph node, #7, excision: -Negative for tumor(0/6). B. Lymph node, #8, excision: -Negative for tumor(0/2). C. Lymph node, #9, excision: -Negative for tumor(0/2). D. Lymph node, #10, excision: -Negative for tumor(0/9). E. ""Lymph node"", #2, excision: -Benign adipose tissue, no lymph node is identified. F. .Lymph node, #4, excision: -Negative for umor(0/10). G.Bronchial margin, excision: - Negative for tumor. H. Lung, right upper lobe, lobectomy: -Squamous cell carcinoma, moderately differentiated, comprise 90% of the tumor. -Adenocarcinoma, comprise 10% of the tumor, adenosquamous carcinoma (slides H6). -Tumor measures 3.5cm in greatest dimension. -Surgical margins and pleura free of tumor. -pT2aNO. (Electronically signed by). Clinical Information. The patient is a. male with a clinical history of lung cancer. Frozen Section Diagnosis. GFS1: Bronchial margin, biopsy: - Negative for tumor. HFS1: Lung, right upper lobe, excision: - Squamous cell carcinoma. Per Dr. Gross Description. The specimen is received in eight containers, each labeled with the patients name and medical. record number. The first container is further labeled ""#1 - # 7 lymph node."" It consists of multiple. pieces of lymphoid tissue measuring 2x 1.5 X 0,6 cm in aggregate. The specimen is submitted in its. entirety. The second container is further labeled ""#2 - # 8 lymph node."" It consists of two pieces of. lymphoid tissue measuring 0.6 X 0.5. X 0.4 cm in aggregate. The specimen is submitted in its entirety. The third container is further labeled ""#3 - # 9 lymph node."" It consists of a single piece of lymphoid. adipose tissue measuring 0.9 X 0.3 x 0.2 cm. One lymph node is identified. The fourth container is. further labeled ""#4 - #10 lymph node."" It consists of multiple pieces of lymphoid adipose tissue. measuring 2.5 x 2 X 1.5 cm in aggregate. Multiple lymph node fragments are identified. The fifth container is further labeled ""#5 - # 2 lymph node."" It consists of a single piece of soft tissue. measuring 0.4 X 0.2 X 0.2 cm. The specimen is submitted in its entirety. The sixth container is further. labeled ""#6 - # 4 lymph node.' It consists of lymphoid adipose tissue measuring 3.5 X 1.2 X 2.3. cm in. greatest dimensions. Multiple possible lymph nodes are identified. The seventh container is further. labeled ""#7 - bronchial margin.' It consists of a single piece of tan-pink soft tissue. measuring 0.6 X. 0.2 X 0.3 cm. The specimen will be entirely submitted for frozen and now resubmitted for permanent. The. eighth. specimen is labeled ""right upper lobe."" It contains a single lung specimen that has been. previously incised and. partly inked measuring 15 X 7.5 X 3.5 cm. On examination of the specimen the. lesion is a totally circumscribed white tan in. coloration with areas of hemorrhage with green-tan. exudate, possibly reflective of necrosis. The lesional area measures 3.5 X 3 X 3 cm. The lesional. area is approximately 1 cm from the vascular resection margin and approximately 1 cm from the bronchial. margin. The closest the tumor to a surgical resection margin is 0.4 cm. The tissue immediately. underneath the surgical staple. line is inked green. On serially sectioning through the rest of the lung. specimen no other apparent gross abnormality is. identified. Representative sections of the lesional. area are submitted per the block summary. There was a representative section of the lesion that was. originally submitted fresh for frozen section is now entirely. resubmitted for permanent section in. cassette H1. Dr. Block Summary. A1-. #7 Lymph node. B1-. #8 Lymph node. C1-. #9 Lymph node. D1-D2 #10 Lymph node (D2 one lymph node bisected). E1-. #2 Lymph node. F1-F2. #4 Lymph node (F1 multiple lymph node, F2 remaining adipose tissue). G1-. Bronchial margin. H1-. Right upper lobe lesion. H2-. Vascular and bronchial margin. H3-H4 Tumor in relation to surgical staple line and pleura. H5-H6. Tumor in relation to pleura. H7-. Tumor in relation to bronchus. Microscopic Description. A microscopic examination has been performed. SP Synoptic Report. H: Thorax Lung. SPECIMEN: Lobe(s) of lung: right upper lobe. PROCEDURE: Lobectomy. SPECIMEN INTEGRITY: Intact. SPECIMEN LATERALITY: Right. TUMOR SITE: Upper lobe. TUMOR SIZE: Greatest dimension: 3.5 cm. TUMOR FOCALITY: Unifocal. HISTOLOGIC TYPE: Adenosquamous carcinoma. HISTOLOGIC GRADE: G2: Moderately differentiated. TUMOR EXTENSION: Not identified. BRONCHIAL MARGIN: Uninvolved by invasive carcinoma. VASCULAR MARGIN: Uninvolved by invasive carcinoma. PARENCHYMAL MARGIN: Uninvolved by invasive carcinoma. PARIETAL PLEURAL MARGIN: Uninvolved by invasive carcinoma. CHEST WALL MARGIN: Not applicable. OTHER ATTACHED TISSUE MARGIN. TREATMENT EFFECT: Not applicable. LYMPH-VASCULAR INVASION: Not identified. LYMPH NODES. PRIMARY TUMOR (pT): pT2a: Tumor > 3 cm, and < 5 cm in greatest dimension surrounded by. lung or visceral pleura, without bronchoscopic evidence of. invasion in the main bronchus; or Tumor. < 5 cm in greatest dimension with any of the following: involves main bronchus, 2 cm or more distal. to the carina; invades the visceral pleura; associated with atelectasis or. obstructive pneumonitis that. extends to the hilar region. REGIONAL LYMPH NODES (pN): pNO: No regional lymph node metastasis. DISTANT METASTASIS (pM): Not applicable.",train,3.5 cm;3.5cm
584,TCGA-MP-A4T2.EC30FFC5-3C51-49E7-8996-18D9BCFC8552,"surgical Pathology. TISSUE DESCRIPTION: A1 B1 B2 C1 D1 E1. Tissue from left lower lobe lung (12.57 grams; 5 x 1.7 x 1.5 cm) ,. superior (right lower paratracheal) and inferior (subcarinal). mediastinal Tymph nodes. DIAGNOSIS: Lung, left lower lobe, wedge excision: Invasive grade 3 (of 4). adenocarcinoma forming a peripheral 2.1 x 2 x 1 cm mass. The. visceral pleura is not involved. The surgical margin of resection. is negative for tumor. Lymph nodes, superior (right lower paratracheal) and inferior. (subcarinal) mediastinal, excision: Multiple superior (8 right. lower paratracheal) and inferior (4 subcarinal) mediastinal Tymph. nodes are negative for tumor.",train,2.1 x 2 x 1 cm
585,TCGA-CW-5580.2eb52034-fd54-417a-8073-3ed405e723a7,"Patient. Identifier: TISSUE DESCRIPTION: Right kidney (14.5 x 7.5 x 6.5 cm) wich 8.5 cm right ureter. DIAGNOSIS: Kidney, right, nephrectomy: Grade 3 (of 4) renal cell carcinana,. clear cell type, forms a B x 8 x 6 cm mass located in the superior. mid kidney The tumor exhibits extension into perineghric fat. The. renal vein is free of involvement Coagulative tumor necrosis is. present. The surgical margins are negative. No renal hilar 1ympt. nodes are identified. No adrenal gland is present.",train,
594,TCGA-D6-A6EK.9D693044-26F6-4406-8735-8854BF18358C,"Gender: M. Examination result No. Surgery and Laryngological Oncology Dept. Clinical diagnosis (suspicion) Laryngeal carcinoma (Hist.pat.: Ca planoepitheliale verrucosae). Date of admission: (urgency: intraoperative). Material: 1) Material: tumour of the larynx. Please examine the marked margins. Method of collection: Collection of specimens for. laboratory examination. Histopathological Diagnosis. Invasive squamous carcinoma of the larynx, keratinizing. Carcinoma planoepitheliale keratodes invasivum (verrucosum) laryngis. G1, pT2, pNO (Delphian). codes according to ICD-O-3 or SNOMED. Macroscopic description: Surgical specimen sized 9 x 5.5 x 5cm, including larynx with the hyoid bone. Tumour sized 2.6 x 2.6 x 1.0 cm in the glottis region,. right side, infiltrating the subglottal and supraglottal regions. Microscopic description: Carcinoma planoepitheliale keratodes invasivum (verrucosum)G1 glotis. The tumour invading the subglottal and supraglottal regions. Surgical incision lines off cancer invaded area. No signs of vascular and nerve invasion found. Sinus histiocytosis lymphonodorum No I (Delphian). Results of intraoperative examination: Neoplastic lesions not found. Final reply to be given after the analysis of paraffin specimens.",train,2.6 x 2.6 x 1.0 cm
662,TCGA-FA-A6HO.E2645414-D707-419D-B43D-92AE9D56DCD1,"Gross Description: Lymph node is enlarged with 1.5x1x1cm in size, soft, dark brown and gray surface. Microscopic Description: Tumor architectures are replaced by diffuse pattern. The tumor cells are. composed of small or enlarged transformed lymphoid cells with irregular hyperchromatic nuclei Tumor. cells are oval or round in shape with scant cytoplasm. Nucleoli is single or multiple. Mitotic figures are. commnon. Diagnosis Details: Malignant lymphoma, large B cell, diffuse type. Comments: Formatted Path Reports: Diagnosis: Diffuse large B-cell lymphoma. Tumor location: Lymph node, cervical. Tumor size: 1.5 X 1x 1cm. Tumor markers: CD20(+), CD3(-).",train,1.5 X 1x 1cm
674,TCGA-E2-A1B6.539FF792-534D-401D-87A6-B3B7C2BC2EFC,"SPECIMENS: A. SENTINEL LYMPH NODE #1 LEFT AXILLA. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. C. SENTINEL LYMPH NODE #3 LEFT AXILLA. D. SENTINEL LYMPH NODE #4 LEFT AXILLA. E. LEFT BREAST. F. ADDITIONAL SKIN UPPER SUPERIOR FLAP. G. RIGHT BREAST. SPECIMEN(S): A. SENTINEL LYMPH NODE #1 LEFT AXILLA. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. C. SENTINEL LYMPH NODE #3 LEFT AXILLA. D. SENTINEL LYMPH NODE #4 LEFT AXILLA. E. LEFT BREAST. F. ADDITIONAL SKIN UPPER SUPERIOR FLAP. G. RIGHT BREAST. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA-TPD: sentinel nodes #1-#4, left axilla: All negative for tumor cells on touch prep, called to Dr. at. by Dr. GROSS DESCRIPTION: A. SENTINEL LYMPH NODE #1 LEFT AXILLA. Received fresh labeled with the patient's identification of a fragment of beige tan soft tissue measuring 1. x. 1 x 0.3 cm. Touch preparations are performed. The entire specimen is submitted in cassette A1. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. Received fresh labeled with the patient's identification of a fragment of beige tan soft tissue measuring 1. x 1 x 0.3 cm. Touch preparations are performed. The entire specimen is submitted in cassette B1 and. B2. C. SENTINEL LYMPH NODE # 3 LEFT AXILLA. Received fresh labeled with the patient's identification are two possible lymph nodes measuring 0.5 x. 0.5 x 0.2 cm each. Both lymph nodes are entirely submitted separately in C1 and C2. D. SENTINEL LYMPH NODE # 4 LEFT AXILLA. Received fresh labeled with the patient's identification of a fragment of beige tan soft tissue measuring. 0.7 x 0.7 x 0.5 cm. Touch preparations are performed. The entire specimen is submitted in cassette. D1. E. LEFT BREAST. Received fresh labeled with the patient's identification and designated ""Part E., left breast"" is an. orientated 399g, 18 x 17 x 3 cm mastectomy specimen with a 5.2 x 3.3 cm skin ellipse, and 1.2cm. everted nipple. Ink code: Anterior/superior-blue, anterior/inferior-orange, posterior-black. Specimen is. serially sectioned into 9 slices from medial to lateral with nipple in slice 3 revealing a 3.5 x 3.1 x 2 cm. firm beige spiculated mass at the 12 o'clock position (slices 5-7) closest to the anterior margin at 0.9cm. and located 2.2cm from the deep margin. Tissue is procured. Representatively submitted: E1: Perpendicular sections, nipple. E2: Bisected nipple base. E3: Sections of skin. E4: Tumor, slice 5. E5-E8: Tumor, slice 6. E9: Overlying deep margin, slice 6. E10: Tumor, slice 7. E11: Tumor and closest anterior margin, slice 7. E12: Additional tumor, slice 7. E13: Upper outer quadrant. E14: Lower outer quadrant. E15: Upper inner quadrant. E16: Lower inner quadrant. F. ADDITIONAL SKIN UPPER SUPERIOR FLAP. Received in formalin in a container labeled with the patient's identification is a brown tan crescent. shaped excision of skin measuring 6.1 x 2.5 x 0.3 cm. A suture designates superior. The specimen. is. inked as follows: Superior-blue, inferior-orange, deep-black. The surface of the skin demonstrates no. obvious gross abnormality. The specimen is serially sectioned from medial to lateral and submitted. entirely for microscopic evaluation. Cassettes are submitted as follows: F1: Medial tip. F2-F6: Serial sections. F7: Lateral tip. G. RIGHT BREAST. Received fresh labeled with the patient's identification and ""Right Breast-Stitch marks axillary tail"" is an. oriented 339g, 23 x 14 x 3cm simple mastectomy with 5 x 3cm tan pink skin ellipse, and a 1.3cm. centrally located, raised nipple. Ink Code: Anterior-Superior: Blue, Anterior-Inferior: Orange, Posterior: Black. The specimen is serially sectioned from lateral to medial into 15 slices. The nipple is located in. slice 12. The cut surfaces reveal a blue dome cyst 0.8 x 0.4cm in the LC of slice 12, more than 1cm. from the closest deep margin. No lesions are grossly identified. Representative sections are submitted. as follows: G1: nipple slice 12. G2: skin slice 12. G3: UOQ slice 8. G4: UOQ slice 9. G5: LOQ slice 7. G6: LOQ slice 10. G7: blue dome cyst LC slice 12. G8: LC with inferior margin slice 12. G9: UC slice 12. G10: UIQ slice 13. G11: UIQ slice 14. G12: LIQ slice 13. G13: LIQ slice 14. DIAGNOSIS: A. SENTINEL LYMPH NODE #1, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). B. SENTINEL LYMPH NODE #2, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). C. SENTINEL LYMPH NODE #3, LEFT AXILLA, BIOPSY: - TWO LYMPH NODES, NO TUMOR SEEN (0/2). D. SENTINEL LYMPH NODE #4, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). E. BREAST, LEFT, MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, POORLY DIFFERENTIATED. (SBR GRADE 3) (SEE NOTE). - TUMOR MEASURES 3.5 CM IN GREATEST DIMENSION. - MARGINS, FREE OF TUMOR. - DUCTAL CARCINOMA IN SITU (DCIS), SOLID TYPE, NUCLEAR GRADE 3,. WITH NECROSIS, MICROCALCIFICATIONS AND ASSOCIATED. LYMPHOID INFILTRATE. - SKIN AND NIPPLE, NO TUMOR SEEN. NOTE: Biomarkers and lymphvascular invasion status will be reported in an addendum. F. SKIN, UPPER SUPERIOR FLAP, EXCISION: - BASAL CELL CARCINOMA, SUPERFICIAL TYPE (SEE NOTE). - MARGINS, FREE OF TUMOR. NOTE: The basal cell carcinoma is focally 2 mm from the superior margin. G. BREAST, RIGHT, PROPHYLACTIC MASTECTOMY: - SMALL FIBROADENOMA, PSEUDOLACTATIONAL CHANGE, APOCRINE. METAPLASIA, STROMAL FIBROSIS, AND MICROCALCIFICATIONS. - BENIGN SKIN AND NIPPLE. SYNOPTIC REPORT - BREAST. Specimen Type: Mastectomy. Needle Localization: No. Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 3.5cm. Tumor Site: 12:00. Margins: Negative. Distance from closest margin: 0.5cm. anterior superior. Tubular Score: 3. Nuclear Grade: 3. Mitotic Score: 3. Modified Scarff Bloom Richardson Grade: 3. Necrosis: Present. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/5. DCIS present. Margins uninvolved by DCIS : 0.5cm from anterior superior margin. DCIS Quantity: Estimate 40%. DCIS Type: Solid. DCIS Location: Associated with invasive tumor. Nuclear grade: High. Necrosis: Present. Location of CA++: DCIS. Pathological staging (pTN): pT 2N0. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: None given. ADDENDUM: NOTE: A CD31 stain was performed on block E6 and is negative, showing no evidence of. lymphvascular invasion. SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimen: Surgical Excision. Block Number: E10. ER: Negative Allred Score: 0 = Proportion Score 0 + Intensity Score 0. PR: Negative Allred Score: 0 = Proportion Score 0 + Intensity Score 0. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the. proportion score (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of. cells staining, 4 = 31-60% of cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak. intensity of staining, 2 = intermediate intensity of staining, 3 = strong intensity of staining), with a scoring. range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score. of less than or equal to 2. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Immunohistochemistry was performed using the mouse anti-human ER (ER 1D5, 1:100) and PR (PGR. 136, 1:100) provided by Dakc. bllowing the manufacturer s instructions. This. assay was not modified. Interpretation of the ER/PR immunohistochemical stain is guided by published. results in the medical literature, information provided by the reagent manufacturer and by internal. review of staining performance. SYNOPTIC REPORT - BREAST HER-2 RESULTS. Specimen: Surgical Excision. Block Number: E10. Interpretation: EQUIVOCAL. Intensity: 2+. % Tumor Staining: 15%. Fish Ordered: Yes, on Date. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Her2 analysis was performed using the FDA approved Dako HercepTest (TM) test kit. C. using rabbit anti-human HER2. This assay was not modified. External kit-slides. provided by the manufacturer (cell lines with high, low and negative HER2 protein expression) and in-. house known HER2 amplified control tissue were evaluated along with the test tissue. Adequate, well. preserved, clear-cut invasive carcinoma was identified for HER2 evaluation. Interpretation of the HER2. immunohistochemical stain is guided by published results in the medical literature, information provided. by the reagent manufacturer and by internal review of staining performance. This assay has been validated according to the. int recommendations and guidelines from. ASCO and CAP and from the NCCN HER2 testing in Breast Cancer Task Force. The Pathology. Department takes full responsibility for this test's performance. PathVysion HER-2 DNA Probe Kit. Analytical Interpretation of Results: HER-2 NOT AMPLIFIED. Clinical Interpretation of results. Amplification of the HER-2 gene was evaluated with interphase fluorescence in-situ. hybridization (FISH) on formalin-fixed paraffin embedded tissue sections using a chromosome. 17. centromeric probe and a HER-2 probe that spans the entire HER-2 gene in the. by Dr. A majority of tumors cells displayed 2 chromosome 17. signals and 2 HER-2 signals, with a HER-2/CEP 17 Ratio </=2.0, consistent with no. amplification of the HER2/neu gene. Block used E10. Source of case: Tissue fixation. formalin-fixed tissue. Outside Case No: NA. Tissue source. breast Results interpreted: HER2/CEP17 ratio: 1.03. This ratio is derived by dividing the total number of LSI HER-2/neu signals by the total number of. CEP17 signals in at least 20 interphase nuclei with nonoverlapping nuclei in the neoplastic. mammary epithelial cells. Cells with no signals or with signals of only one color are disregarded. Method of ratio enumeration: manual count. Limitations. The Vysis PathVysion Kit is not intended for use to screen for or diagnose breast cancer. It is. intended to be used as an adjunct to other prognostic factors currently used to predict disease-free. and overall survival in stage II, node-positive breast cancer patients. In making decisions regarding. adjuvant CAF treatment, all other available clinical information should also be taken into. consideration, such as tumor size, number of involved lymph nodes, and steroid receptor status. treatment decision for stage II, node-positive breast cancer patients should be based on HER-. 2/neu. gene amplification status alone. Overview of this test. FDA APPROVED REAGENT. PathVysion HER-2 DNA Probe Kit is FDA approved for selection of. patients for whom Herceptin therapy is being considered. These tests were performed in the. under the direction. of Dr. The results of these studies should always be interpreted in the context of the. clinical, morphological, and immunophenotypic diagnosis. Microscopic/Diagnostic Dictation: Pathologist, 1. Final Review: Pathologist,. Final Review: Pathologist,. Final: Pathologist, r. Addendum: Pathologiat. Addendum Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist.",train,3.5 CM;3.5cm
734,TCGA-C5-A1M7.ABC2B2A7-E5EE-4198-80E0-E64A6305B47A,"I. Gynecology. MRN : Hospital #. M.D. DIAGNOSIS: inconclusive DEOVIX RADICAL. SQUAMOUS CELL CARCINOMA, MOCERATELY CIFFERENTIATED, 2.5 CM IN CREATEST. DIMENSION. TUMOR INVADES TO A DEPTH OF 0.7 CM (TOTAL WALL THICKNESS 1.8 CM). - NO LYMPHVASCULAR SPACE INVASION is INENTIFIED. - RESECTION MARGING ARE FREE OF CARCINCMA. PARAMETRIA, RADICAL HYSTERECTOMY. - NO CARCINOMA IDENTIFIED. LYMPH NODES, PARAMETRIA, RADICAL HYSTERECTOMY. - NO CARCINOMA IDENTIFIED IN ELEVEN LYMPH NODES (0/11). VAGINA, RADICAL HYSTERECTOMY. . NO DYSPLASIA OR CARCINOMA IDENTIFIED. UTERUS, ENDOMETRIUM, RADICAL HYSTERECTOMY. - SECRETORY ENDOMETRIUM. UTERUS, MYOMETRIUM, RADICAL HYSTERECTOMY. - NO HISTOPATHOLOGIC ABNORMALITY. OVARIES, RIGHT AND LEFT, SALPINGO-OOPHORECTOMY. . PARA-OVARIAN ADHESIONS. FALLOPIAN TUBES, RIGHT AND LEFT, SALPINGO-OOPHORECTOMY. - PERITUBAL ADHESIONS. - HYDROSALPINX. LYMPH NODE, RIGHT EXTERNAL ILIAC, EXCISION (FS1). - NO CARCINOMA IDENTIFIED IN ONE LYMPH NODE (0/1). LYMPH NODES, RIGHT EXTERNAL ILIAC, EXCISION. - NO CARCINOMA IDENTIFIED IN FIVE LYMPH NODES (0/5).",train,2.5 CM
767,TCGA-Z6-AAPN.75067A62-80E7-4AE9-B43D-6991CDCF8F99,"Male. Clinical diagnosis: Anaplastic Squamous cell carcinoma of the esophagus. Sample: histology #. Gross description: Esophageal fragment with gastric 25x20x20. Section. reveals gray tumor mass 1 cm in thickness. Paraesophageal lymphatic node. 1,5x0,4 cm with dark-red surface. Microscopic description: Sections reveal ulcerative infiltrated tumor,. anaplastic squamous cell carcinoma with heavy lymphoid infiltration. Surgical. borders are clear. Paraesophageal lymphatic node shows metastatic cells. Paragastric lymphatic nodes and greater omentum show no sign of metastasis. Final diagnosis: Anaplastic Squamous cell carcinoma of the esophagus. Confidential.",train,1 cm
774,TCGA-AR-A24K.BC7B3577-CA6C-41AD-98E2-89D357D29D37,"Final Diagnosis. Yeast, left, wide local excision: Invasive ductal carcinoma, Nottingham grade III (of III), forming a 2.7 x 2.7 x 1.5 cm mass. (AJCC pT2). The margins, including the separately submitted superior margin, are negative for tumor. The closest margin. (superior) is free by 1.5 cm. Lymph nodes, left axillary sentinel, excision: Multiple (2) left axillary sentinel lymph nodes are negative for tumor [AJCCpNO (i-. sn)]. Blue dye is identified in both left axillary sentinel lymph nodes. Immunohistochemical cytokeratin stain was performed on. the paraffin embedded sentinel lymph node tissue and confirms the H&E impression.",train,2.7 x 2.7 x 1.5 cm
875,TCGA-DD-AACE.63AE7F04-F180-486A-89FB-6E509AF91E0B,"CLINICAL DIAGNOSIS: HCC. Specimen : liver. Gross Photo : GROSS: 1. Specimen: Liver: 13.0 X 7.5 x 4.5 cm, 185.0 gm, unfixed. 2. Tumor location: segment 8. Tumor number: one. Tumor size: 4.0 X 3.0 X 3.8 cm. 3. Satellite nodule: no. 4. Gross type. HCC: expanding nodular. 5. Tumor necrosis: no. 6. Hemorrhage/peliosis: no. 7. Portal vein invasion: no. 8. Bile duct invasion: no. Gross photo present. Blocks. TB, T1-4, tumor mass X 5. RM, resection margin X 1. NB, A, non-tumorous liver parenchyme x 2. MICROSCOPIC: 1. Hepatocellular carcinoma: yes. -1. Differentiation. The worst differentiation III. The major differentiation II. 1-2. Histologic type: trabecular, pseudoglandular. 1-3. Cell type: hepatic. 1-4. Fatty change: no. 2. Fibrous capsule formation: complete capsule. 3. Capsular infiltration: no. 4. Septum formation: no. 5. Surgical resection margin invasion: no, margin of the clearence (1.0 cm). 6. Serosal invasion: no. 7. Portal vein invasion: no. 8. Bile duct invasion: no. 9. Hepatic vein invasion: no. 10. Hepatic artery invasion: no. 11. Microvessel invasion: no. 12. Intrahepatic metastasis: no. 13. Multicentric occurrence: no. Non-tumor liver pathology. 1. Chronic hepatitis: yes. 1-1. Etiology: HBV. 1-2. Grade, lobular: minimal. 1-3. Grade, portoperiportal: minimal. 1-4. Stage (fibrosis): cirrhosis. 1-5. Cirrhosis: micronodular. 2. Dysplastic nodule: no. 3. Ductal epithelial dysplasia: no. 4. Other liver diseases: no. SPECIAL STAIN: Trichrome (+ stage (3-4)). NOT reported. Gross: Tunica vaginalis, inguinal, ligation, Hernial sac. Stomach, angle, scopic, chronic gastritis, H. pylori, associated. Stomach, angle, scopic, ulcer. Liver, ectomy, hepatocellular carcinoma, cirrhosis. T56000, P10, M81703, M49500. DIAGNOSIS: Liver, segment 8, segmentectomy: Hepatocellular carcinoma, moderately differentiated. Cirrhosis, micronodular. Suggestion :",train,4.0 X 3.0 X 3.8 cm
912,TCGA-BJ-A2P4.A2756544-345C-4797-9DDE-B56048CF0009,"PATIENT HISTORY: CHIEF COMPLAINT/HISTORY OF PRESENT ILLNESS (INCLUDING PREOP AND POSTOP DIAGNOSIS): Thyroid nodule. PROCEDURE: Thyroidectomy. SPECIFIC CLINICAL QUESTION TO ANSWER:.Not answered. OUTSIDE TISSUE DIAGNOSIS ON THIS SPECIMEN: No. PRIOR CANCER/MALIGNANCYITUMOR: No. CHEMORADIATION THERAPY: No. HISTORY OF ORGAN TRANSPLANT: No. HISTORY OF IMMUNOSUPPRESSION: No. ANY OTHER UNDERLYING DISEASES: No. FINAL DIAGNOSIS: PART 1: THYROID GLAND, LEFT LOBE. LOBECTOMY (14 GRAMS) -. A. PAPILLARY THYROID CARCINOMA, 3.3 CM, WITH DOMINANT FOLLICULAR GROWTH PATTERN (see. comment). B. EXTRATHYROIDAL EXTENSION IS ABSENT. C. VASCULAR INVASION IS ABSENT. D. CARCINOMA IS 0.1 CM FROM MARGIN. E. PATHOLOGIC STAGE: T2. PART 2: THYROID GLAND, RIGHT LOBE, LOBECTOMY (2.6 AND 0.7 GRAMS) -. BENIGN THYROID TISSUE. COMMENT: Previously, fine needle aspiration of the left thyrold lobe. was shown to be positive for HRAS. mutation (see addendum for. r further details). CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY THYROID TUMORS. SPECIMEN TYPE: Total Thyroidectomy. TUMOR SITE: Left Lobe. TUMOR FOCALITY: Unifocal. TUMOR SIZE (largest nodule): Greatest Dimension: 3.3 cm. HISTOLOGIC TYPE: Papillary carcinoma. PRIMARY TUMOR (pT): pT2. REGIONAL LYMPH NODES (pN): pNX. DISTANT METASTASIS (pM): Not applicable. EXTRATHYROIDAL EXTENSION: Not identified. MARGINS: Margins uninvolved by carcinoma. LYMPH-VASCULAR INVASION: Distance of invasive carcinoma to closest margin: 1 mm. Not identified.",train,3.3 CM;3.3 cm
913,TCGA-EJ-5519.57861c52-0d80-484a-a800-65c3481327db,"PATIENT HISTORY: The patient is a. with a history of PSA value of 15,. The patient also has a history of biopsy on. this biopsy reveals: right apex= Gleason grade. 4+4 = 8; right mid = Gleason grade 4+4 = 8; right base = Gleason grade 4+3 = 7; left base = Gleason grade 4+3 = 7; left mid =. Gleason grade 4+3 = 7; left apex = Gleason grade 4+4 = 8. PRE-OP DIAGNOSIS: Prostate cancer. POST-OP DIAGNOSIS: Same. PROCEDURE: Radical prostatectomy. FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT PELVIC, EXCISION -. METASTATIC CARCINOMA IN ONE OF SIX (1/6) LYMPH NODES EXAMINED. PART 2: LYMPH NODES, LEFT PELVIC, EXCISION -. METASTATIC CARCINOMA IN TWO OF SIX (2/6) LYMPH NODES EXAMINED. PART 3: PROSTATE AND BILATERAL SEMINAL VESICLES, RADICAL PROSTATECTOMY -. A. INVASIVE POORLY-DIFFERENTIATED ADENOCARCINOMA, GLEASON SCORE 4 + 4 = 8 WITH TERTIARY. GLEASON PATTERN 3. B. THE CARCINOMA INVOLVES BOTH THE RIGHT AND LEFT LOBES AND HAS A GREATEST NODULAR DIAMETER. OF 2.6 CM. C. THE CARCINOMA INVOLVES 70% OF THE EXAMINED PROSTATE VOLUME. D. THE CARCINOMA SHOWS SHOWS ESTABLISHED EXTRACAPSULAR EXTENSION IN THE RIGHT AND LEFT. POSTERIOR BASE REGIONS AND FOCALLY INVOLVES THE INKED SURGICAL MARGINS IN THESE REGIONS. (SLIDES 3W, 3X, 3BB). E. BILATERAL SEMINAL VESICLES ARE INVOLVED BY CARCINOMA. F. ALL OTHER MARGINS ARE NEGATIVE FOR TUMOR. G. PERINEURAL INVASION IS IDENTIFIED. H. ANGIOLYMPHATIC INVASION IS IDENTIFIED. I. HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA IS IDENTIFIED. J. PATHOLOGIC TNM STAGE: p3b N1 MX,. K. TNM HISTOLOGIC GRADE = G3-4. L. BENIGN PROSTATIC HYPERTROPHY AND CHRONIC MODERATELY ACTIVE PROSTATITIS ARE NOTED. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY PROSTATE TUMORS. CLINICAL DATA: PSA value: 15. INVASIVE CA IDENTIFIED?: TUMOR HISTOLOGY: Adenocarcinoma NOS. PRIMARY GLEASON GRADE: 4. SECONDARY GLEASON GRADE: 4. GLEASON SUM SCORE: 8. GLEASON 4/5 PERCENTAGE: 90%. WEIGHT OF PROSTATE: 52.81gm. TUMOR SIZE: Maximum dimension: 2.4 cm. LOBE LATERALITY: Right and Left Lobes. PERCENT OF SPECIMEN INVOLVED BY TUMOR: > 25%. MULTIFOCAL DISEASE: HIGH GRADE PIN: Yes - multifocal. EXTRAPROSTATIC EXTENSION: Yes - Established (> 0.8mm). PERINEURAL INVASION: ANGIOLYMPHATIC INVASION: SEMINAL VESICLE INVASION: SURGICAL MARGIN INVOLVEMENT: Widespread tumor involvement at margin. LYMPH NODES EXAMINED: 12. LYMPH NODES POSITIVE: 3. EXTRANODAL EXTENSION: Unknown. T STAGE, PATHOLOGIC: pT3b-. N STAGE, PATHOLOGIC: pN1. M STAGE, PATHOLOGIC: pMX. HISTOLOGIC GRADE: G3-4, Poorly differentiated/undifferentiated.",train,2.6 CM;2.4 cm
949,TCGA-HC-A631.70585F33-CB9E-4365-9CA2-E384BED102DD,"Report for. TEST: Surgical Pathology. Collected Date & Time: Result Name. Reference Range. Patient Name: : (Age: Gender: M. Physician (s) : Specimen (s) Received. A: Right external iliac and obturator lymph nodes. B: Prostate. Pathologic Diagnosis. Lymph nodes, right external iliac and obturator, excision (A) : 2 lymph nodes, negative for malignancy (0/2). Prostate, excision (B) : Prostatic adenocarcinoma, Gleason score 4+5=9. High-grade prostatic intraepithelial neoplasia. Note: The prostatic adenocarcinoma is centered in the right lobe. of the prostate and demonstrates a majority of Gleason 4 pattern. with a secondary Gleason 5 pattern. Focally, the right posterior. lateral margin of the prostate is involved by adenocarcinoma. Along the posterior and posterolateral margins on the right side,. the tumor is present within a fraction of a millimeter of the. inked margin of excision. SURGICAL PATHOLOGY CANCER CASE SUMMARY CHECKLIST: PROSTATE GLAND,. RADICAL PROSTATECTOMY. Procedure: Radical prostatectomy. Prostate Size: Weight: 34 g. Size: 4.0 x 3.5 x 3.3 cm. Lymph Node Sampling: Pelvic lymph node dissection. Histologic Type: Adenocarcinoma, acinar, NOS. Histologic Grade/Gleason Pattern: Primary Pattern: Grade 4. Secondary Pattern: Grade 5. Tertiary Pattern: Grade 3. Total Gleason Score: 4+5=9. Tumor Quantitation: Proportion of prostate involved by tumor: Approximately 40%. Extraprostatic Extension: Not identified. Seminal Vesicle Invasion: Not identified. Margins: Margins involved by invasive carcinoma, unifocal, right. posterolateral. Treatment Effect on Carcinoma: Not identified. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Present. Pathologic Staging: Primary Tumor: pT2c. Regional lymph nodes: pNO. Number of lymph nodes examined: 2. Number of lymph nodes involved: 0. Distant metastasis: Not applicable. NOTE: Information on pathology stage and the operative procedure. for is accreditation by the Commission on Cancer. Pathology stage. transmitted to this Institution's Cancer Registry as required. is based solely upon the current tissue specimen being evaluated. and does not incorporate other relevant data. Pathology stage is. only a component to be considered in determining the clinical. stage and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon's. operative report. Primarv Pathologist: Clinical History. Prostate cancer, additional information is provided. Intraoperative Consultation. A. Right external iliac obturator lymph nodes: Four benign. lvmph nodes. (microscopic evaluation). Ph.D. Gross Description. A. Received fresh for frozen section labeled ""right external. iliac obturator lymph nodes"" is a 6.0 x 5.0 x 1.0 cm aggregate of. fat. There are four lymph nodes dissected out, ranging from 0.7. to 4.5 cm in greatest dimension. The lymph nodes are submitted. as follows: A1FS - 4.5 cm lymph node inked black and bisected. A2FS - three lymph nodes (one orange, one yellow, one blue). B. Received in formalin labeled ""prostate"" is a 34 g, 4.0 cm. from left to right, 3.3 cm from anterior to posterior, 3.5 cm. from apex to bladder neck margin prostatectomy specimen with. attached right seminal vesicle (4.0 x 1. x 0.3 cm), right vas. deferens (3.2 x 0.5 x 0.4 cm), left seminal vesicle (3.2 x 1.7 x. 0.6 cm), left vas deferens (3.0 x 0.5 x 0.4 cm). The prostate is. inked as follows: right prostate is inked blue, left prostate is. inked black, and bladder neck margin is inked yellow. The prostate is serially sectioned from apex to bladder neck. margin to reveal a 2.2 cm in greatest dimension firm white-tan. lesion located in the right anterior and right posterior prostate. that extends from apex to bladder neck margin. The lesion. grossly approaches the apex margin. There are no other discrete. nodules or masses grossly identified. 85% of the specimen is. submitted in cassettes B1 through B20. Sections are submitted as. follows: B1, B2 - right apex perpendicularly cut. B3, B4 - left apex perpendicularly cut. B5, B6 - right bladder neck margin perpendicularly cut. B7, B8 - left bladder neck margin perpendicularly cut. B9 - right seminal vesicle insertion point and cross-section. through right seminal vesicle and vas deferens. B10 - left seminal vesicle insertion point and cross-section. through left seminal vesicle and vas deferens. B11 - right anterior prostate. B12-B15 - right posterior prostate from apex to bladder neck. margin. B16 - left anterior prostate. B17-B20 - left posterior prostate from apex to bladder neck. margin. Microscopic Description. Microscopic examination has been performed on all slides. The. pathologic diagnosis encompasses the essential microscopic. findings of this case. Interpretation performed at. If imsunohistochemistry or in situ hybridization was used the. following applies: This test was developed and its performance. It. characteristic determined by. has not been cleared or approved by the U. S. Food and Drug. Administration (FDA) . The FDA does not require this test to go. through premarket FDA review. This test is used for clinical. purposes. It should not be regarded as investigational or for. research. This laboratory is certified under the Clinical. Laboratory Improvement Amendments (CLIA) as qualified to perform. high complexity clinical laboratory testing. All special stains. used have adequate controls.",train,
962,TCGA-HC-7209.87f8ff1b-d58b-470e-9156-144cbe34b71c,"MRN #: Ref Phyame. SPECIMEN INFORMATION. Acct./Reg #: DIAGNOSIS. DIAGNOSIS: A. Pelvic lymph nodes, biopsy: Two benign lymph nodes, negative for metastatic tumor (0/2). B. Prostate, radical prostatectomy: Tumor Characteristics: 1. Histologic type: Adenocarcinoma. 2. Prostate size: 4.8x4.5x4.3cm. 3. Tumor quantitation: Tumor involves both lobes. 4. Gleason grade: a. Primary pattern: 3/5,. b. Secondary pattern: 3/5. c. Total Gleason score: 6/10. 5. Extraprostatic extension: No. 6. Seminal vesicle involvement: No. 7. Lymphovascular space invasion: No. 8. High grade PIN: Yes, extensive. 9. Treatment effect: Not identified. 10. Perineural invasion: Yes. Surgical Margin Status: 1. All margins are free of carcinoma. Lymph Node Status: 1. Total number of lymph nodes received: 2. 2. Total number of lymph nodes containing metastatic carcinoma: 0 (0/2). Other: 1. Other significant findings: High grade PIN and benign prostatic hyperplasia. 2. pTNM stage: T2c NO Mx. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Right pelvic lymph nodes. B. Prostate. SPECIMEN DATA. GROSS DESCRIPTION: The specimen is received in two formalin filled containers labeled with the patient's name. A. Additionally labeled #1 and contains a 4,8 x 4.0 x 1.5 cm aggregate of yellow-tan fibrofatty soft tissue. On palpation, two firm fatty possible lymph. nodes. are. identified 0.9 and 1.2 cm in greatest dimension. The largest is inked. Both pieces are bisected and all tissue is submitted in cassette A labeled. B. Additionally labeled #2 and contains a 44.9 gram, 4.8 x 4.5 x 4.3 cm prostate received with attached bilateral adnexa having overall dimensions of 3.5. x 3.5 x 1.1 cm. Prostatic capsule is pink-tan and shaggy. The specimen is inked as follows: right side - blue; and left side - black. The base and apical. margins are coned and serially sectioned. The remainder of the specimen is serially sectioned from apex to base to reveal a 0.8 x 0.6 x 0.4 cm well. circumscribed yellow-tan firm nodule located in the posterior aspect and approaching to within 0.3 cm of the inked capsule. The remainder of the cut. surface is pink-tan and focally cystic with diffuse periurethral nodularity. No additional discrete lesions are identified. Representative sections are. submitted in cassettes B1-18 labeled. designated as follows: 1-right prostate/seminal vesicle junction; 2-left prostate/seminal vesicle. junction;. 3-4-apical. margin,. perpendicular,. 5-6-pase margin, perpendicular; 7-9-right anterior, apex to base; 10-12-right posterior, apex to base; 13-. 15-left. anterior, apex to base; 16-18-left posterior, apex to base, Additionally, a yellow and green cassette are submitted for Genomics research each. labeled.",train,
969,TCGA-BH-A0B6.06602AD0-AC4D-4674-B4B0-2D207C3E78DC,"FINAL DIAGNOSIS: PART 1: LYMPH NODE, LEFT SENTINEL #1, BIOPSY -. ONE LYMPH NODE, FREE OF TUMOR (0/1). PART 2: LYMPH NODE, LEFT SENTINEL #2, BIOPSY -. ONE LYMPH NODE, FREE OF TUMOR (0/1). PART 3: BREAST, LEFT, SEGMENTAL MASTECTOMY -. A. (NEILTRATING DUCIAL CARCINOMA (3A, 3B, 3C, 3D, 3E, AND 3F). THE TUMOR COMES TO WITHIN 1.0 MM. FROM THE NEAREST ANTERIOR RESECTION MARGIN (3A AND 3B). B. THE TUMOR SIZE IS 1.5 X 1.2 X 1.1 CM. C. NOTTINGHAM SCORE IS 6/9 (TUBULES 3, NUCLEI 2, MITOSIS 1). D. LYMPHOVASCULAR PERMEATION IS NOT APPRECIATED. E. DUCTAL CARCINOMA IN SITU, CRIBRIFORM AND SOLID TYPES, NUCLEAR GRADE 2, REPRESENTING. ABOUT 2% OF TUMOR VOLUME. F. DUCTAL CARCINOMA IN SITU IS ADMIXED WITH INVASIVE TUMOR AND COMES TO WITHIN 1.0 MM FROM. THE NEAREST ANTERIOR RESECTION MARGIN. G. CHANGES CONSISTENT WITH PREVIOUS BIOPSY SITE, SEE PRIOR. H. FIBROCYSTIC CHANGES WITH FIBROADENOMATOID CHANGES, DUCTAL EPITHELIAL HYPERPLASIA,. COLUMNAR CELL CHANGES AND ASSOCIATED MULTIFOCAL MICROCALCIFICATIONS. I. IMMUNOHISTOCHEMICAL STAINING FOR ESTROGEN RECEPTOR, PROGESTERONE RECEPTOR AND HER-. 2/NEU WERE PREVIOUSLY PERFORMED ON. AND WERE REPORTED AS FOLLOWS: ESTROGEN RECEPTOR - POSITIVE, PROGESTERONE RECEPTOR - POSITIVE, HER-2/NEU - NEGATIVE. (SCORE +1). PART 4: LYMPH NODE, LEFT SENTINEL #3, BIOPSY -. ONE LYMPH NODE, FREE OF TUMOR (0/1). PART 5: LYMPH NODE, LEFT SENTINEL #4, BIOPSY -. ONE LYMPH NODE, FREE OF TUMOR (0/1). CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 1.5 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: Yes, benign zones. TUMOR TYPE, IN SITU: Cribriform, Solid, DCIS admixed with invasive carcinoma, Percent of tumor occupied. by in situ component: 2 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 1 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of in situ disease to closest margin: 1 mm. LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 4. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. T PATHOLOGIC: NON-NEOPLASTIC STAGE, BREAST TISSUE: Fibroadenoma, FCD. pT1c. N STAGE, PATHOLOGIC: M STAGE, PATHOLOGIC: pNo. ESTROGEN RECEPTORS: pMX. PROGESTERONE RECEPTORS: positive. positive. HER2/NEU: zero or 1+.",train,1.5 X 1.2 X 1.1 CM;1.5 cm
1099,TCGA-28-1757.9d377e4b-f2dc-4c21-a0d6-cc1b49efb34c,"JA-28-1757 -. Department of Pathology & Laboratory. Medicine. Addendum - Please See End of Report. Reason for Addendum #1: Additional studies/stains/opinion(s). DIAGNOSIS: A. BRAIN, RIGHT TEMPORAL, BIOPSY: Glioblastoma multiforme, WHO grade IV. B. BRAIN, RIGHT TEMPORAL, BIOPSY, NCI #1: Glioblastoma multiforme, WHO grade IV. 30% of tumor necrosis. 80% of tumor cellularity. C. BRAIN, RIGHT TEMPORAL, BIOPSY NCI #2: Glioblastoma multiforme, WHO grade IV. 70% of tumor necrosis. 90% of viable tumor cellularity. D. BRAIN, RIGHT TEMPORAL, BIOPSY NCI #3: Glioblastoma multiforme, WHO grade IV. 80% of tumor necrosis. 10% of viable tumor cellularity. E. BRAIN, RIGHT TEMPORAL, BIOPSY NCI #4: Glioblastoma multiforme, WHO grade IV. 90% of tumor necrosis. 5% of viable tumor cellularity. F. BRAIN, RIGHT TEMPORAL, BIOPSY NCI #5: Glioblastoma multiforme, WHO grade IV. 30% of tumor cellularity. 90% of tumor necrosis. G. BRAIN, RIGHT TEMPORAL, EXCISION: Glioblastoma multiforme, WHO grade IV. H. BRAIN, RIGHT TEMPORAL, EXCISIONAL BIOPSY: Glioblastoma multiforme, WHO grade IV. COMMENT: Patient Case(s). PATIENT Dot RISULIS. DR. NURSE. Addendum - Please See End of Report. A high percentage of tumor cells (greater than 20%) immunostainino for MGMT has been reported to. be. associated. with a relatively diminished response to Temodar. Hence, the low 5% result in. this case suggests a likelihood of this tumor being responsive to Temodar. Recent studies have shown that co-expression of EGFRvIII and PTEN as detected by immunostaining was. significantly correlated with a clinical response of glioblastomas to EGFR kinase inhibitors. Hence the preserved expression of PTEN in this case, when combined with EGFRvIII. mutation, permits a possibility of this tumor being responsive to EGFR-kinase inhibitors. Retained expression of PTEN was found in be associated with. grade aliomas). n. Molecular subclasses of high-grade glioma. predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell,. Recent studies indicated an adverse prognostic significance of increased expression of laminin heta 1 and decreased. expression of laminin beta 2 predicting a worse survival of patients with gliomas. between laminin-8 and glial tumor grade, recurrence, and patient survival. Accordingly, elevated expression of B1 and 32 in this tumor suggest the tumor aggressveness intermediate between. the Bill (or normal)/22 normal (or ii) (the most favorable prognosis) and Bill/ (least favorable prognosis). Presence of activated (phosphorylated) p42/44 Mitogen-Activated Protein Kinase (pMAPK) has been shown to be. associated with a relative resistance of glioblastoma multiforme to radiation therapy. Prognostic Associations of Activated Mitogen-Activated Protein Kinase and Akt Pathways in. Glioblastoma. Clin Cancer Res. Correspondingly, a high percentage of tumor cells immunoreactive to pMAPK antibody in this case predicts a. relative resistance to radiation therapy. The use of these tests in guiding therapy has limitations. Review of the relevant literature and clinical correlation is. advised. These test results do not obligate or preclude use of the relevant therapeutic agents. IDC2a: Selected slides were reviewed in consultation with. HISTORY: Tumor brain. MICROSCOPIC: This extensively necrotizing malignant infiltrating glioma features nuclear pleomorphism, scattered mitotic activity,. focal microvascular endothelial proliferation. IMMUNOSTAINS: MGMT (G1): Up to 5% of tumor nuclei are positive. PTEN (G1): Retained (1-2+ in 80% of tumor cells). pMAPK (G1): 40% of tumor nuclei are positive and 70% of tumor cytoplasm is positive. Laminin beta-1 (8/411) (G1): Upregulated (3+ in endothelial cells). Laminin beta-2 (9/421) (G1): Upregulated (2+ in endothelial cells). GROSS: A. RIGHT TEMPORAL BRAIN TUMOR FS 1. Labeled with patient's name, labeled right temporal brain tumor FS 1"", is a 0.6 x 0.5 x 0.2 cm piece of soft tan. tissue. Specimen is entirely submitted for frozen section diagnosis. Entirely submitted. A1. Frozen section control for FS #1 (specimen A) - 1. Addendum - Please See End of Report. PATIENT: &. B. RIGHT TEMPORAL NCI #1. Labeled with patient's name, labeled ""right temporal #1 NCI"", and received fresh in the Operating Room for. research tissue procurement is a 1.7 x 1.2 x 0.4 cm portion of pink-tan, focally hemorrhagic tissue. Specimen is. entirely submitted. B1, 1. C. RIGHT TEMPORAL NCI #2. Labeled with patient's name, labeled ""right temporal NCI #2"", and received fresh in the Operating Room for. research tissue procurement and is subsequently fixed in formalin and is a 2.0 x 1.5 X 0.5 cm light tan focally. hemorrhagic tissue fragment. Specimen is entirely submitted. CI. 1. D. RIGHT TEMPORAL NCI #3. Labeled with patient's name, labeled ""right temporal NCI #3"", and received fresh in the Operating Room for. research tissue procurement and is subsequently fixed in formalin and is a 1.5 x 1.0 x 0.5 cm light tan tissue. fragment. Specimen is entirely submitted. D1. 1. E. RIGHT TEMPORAL NCI #4. Labeled with patient's name, labeled ""right temporal NCI #4"", and received fresh in the Operating Room for. research tissue procurement and is subsequently fixed in formalin and is a 1.7 x 1.0 x 0.5 cm light tan focally. hemorrhagic tissue fragment. Specimen is entirely submitted. E1. 1. F. RIGHT TEMPORAL NCI #5. Labeled with patient's name, labeled ""right NCI #5"", and received fresh in the Operating Room for research tissue. procurement and is subsequently fixed in formalin and is a 2.0 x 1.0 x 0.5 cm portion of hemorrhagic light tan. tissue. Specimen is entirely submitted. F1. I. G. RIGHT TEMPORAL FOR PERMANENTS. Labeled with patient's name, labeled ""right temporal"", and received in formalin are two portions of light tan. hemorrhagic somewhat friable tissue. Tissues serially sectioned and entirely submitted. G1, G2. 2 each. H. RIGHT TEMPORAL. Labeled with patient's name, labeled ""right temporal"", and received in formalin are three pieces of semi-firm friable. pink-white soft tissue ranging in size from 0.7 up to 1.0 cm in greatest dimension. Tissues are entirely submitted. H1, H2. 4, 3. OPERATIVE CALL. OPERATIVE CONSULT (FROZEN): A. RIGHT TEMPORAL FS: Glioma. If this report includes inmmunohistochemical test results. please note the following: Addendum - Please See End of Report. Numavone. ?mical tests were developed and their performance characteristics determined by. and Laboratory Medicine. Those inmunolistochemical tests have not been cleared or approved by the. U.S. Food and Drug Administration (FDA). and FDA approval is not required. I have personally examined the specimen, interpreted the results, reviewed the report and signed it electronically. ADDENDUM. FISH (FLUORESCENCE IN SITU HYBRIDIZATION) for EGFR. Number of cells analyzed: 40. Ratio of EGFR/CEP: 8.3. Percentage of cells with >4 copies of EGFR: 10%. Amplification: YES. High Level of Polysomy: NO. INTERPRETATION: 1. Samples are interpreted as Positive if : a. EGFR to CEP 7 signal ratio is > 2.0 in > 10% of analyzed cells. b. When high level of polysomy (> four copies of EGFR in 40% of cells) is present. 2. Samples are interpreted as Negative if EGFR to CEP 7 signal ratio is < 2.0 or in the absence of high. level of polysomy (> four copies of EGFR). 3,. Samples are considered inconclusive, requiring consult with the pathologist, when EGFR to CEP 7. signal ratio is 2.0 in < 10% of analyzed cells or when high level of polysomy (> four copies of. EGFR) is present in < 40% of cells. These cases also need to be co-read. REFERENCES. Addendum - Please See End of Report. 1 have personally examined the specimen, interpreted the results. reviewed the report and signed it electronically.",train,
1121,TCGA-23-2072.b0475cc1-edd5-451c-8f26-ec3594811f2e,"SURGICI. A/S: Rec: Col: Attending MD: Copies To: DIAGNOSIS: 1. OMENTUM, BIOPSY: - -Infiltrating serous papillary adenocarcinoma. -High grade. 2. RIGHT TUBE AND OVARY: -Serous papillary adenocarcinoma, ovary. -High grade. -Psammoma bodies. -Unremarkable fallopian tube. LEFT TUBE AND OVARY: -Serous papillary adenocarcinoma, ovary. -High grade. -Tumor invades fallopian tube from serosa up to the outer. portions of mucosa. - -Psammoma bodies. 4. UTERUS AND CERVIX: -Serous papillary adenocarcinoma invading uterine wall serosa. and outer portions of myometrium. -Psammoma bodies. -Adenomyomatous polyp, endometrial/endocervical polyp. -Leiomyoma, subserosal, minute. -Benign endocervical mucosa with focal squamous metaplasia,. nabothian cyst and mild chronic non-specific inflammation. 5. PELVIC MASS: -Serous papillary adenocarcinoma. -High grade. 6. SIGMOID MASS: -Serous papillary adenocarcinoma. -High grade. 7. ANTERIOR LIVER TUMOR: -Serous papillary adenocarcinoma, metastatic. 8. POSTERIOR LIVER TUMOR: -Serous papillary adenocarcinoma, metastatic. 9. RIGHT RETROPERITONEAL TUMOR: -Serous papillary adenocarcinoma. 10. OMENTUM TUMOR: -Serous papillary adenocarcinoma. -Psammoma bodies. 11. ABDOMINAL TUMOR: -Serous papillary adenocarcinoma, metastatic. -Psammoma bodies. HISTORY: Pelvic mass; ovarian carcinoma. MICROSCOPIC: See Diagnosis. GROSS: 1: OMENTUM. Labeled ""omentum"" and received in formalin is a 5.5 x 3.5 x 2.5 cm. firm, yellow, nodular adipose tissue with red-brown discoloration. Cut surface is yellow-tan, firm and remarkable for two white. circular nodules measuring 0.6 and 0.5 cm in diameter. A. Representative sections - 3. 2: RIGHT TUBE AND OVARY. Labeled ""right tube and ovary"" and received in formalin is a 7.0 cm. in length, 0.5 cm in diameter segment of fallopian tube with. fimbriated end. The serosa is pink-tan and focally hyperemic. Cut. surface reveals a 0.1 cm wall with a patent pinpoint lumen. Attached. is a 3.5 x 2.0 x 2.0 cm ovary with a pink-tan, focally hyperemic,. firm, nodular cortical surface. The cut surface is remarkable for. pink-tan, friable tissue; a 1.7 x 1.0 x 1.0 cm subcortical, smooth-. walled cyst; a 2.0 x 1.0 x 0.6 cm firm, white, homogeneous nodule and. a. scant amount of normal variegated, pink-tan ovarian parenchyma with. two corpora albicantia. The mesovarium is markedly hemorrhagic. Representative sections submitted. B. cross section of ovary including friable tissue, firm white. tissue, cyst, normal ovarian parenchyma with corpus albicans - 1. C. Cross section of ovary with fallopian tube - 2. 3: LEFT TUBE AND OVARY. Labeled left tube and ovary"" and received in formalin is a 60 gram,. 7.0 x 5.0 x 4.5 cm ovary with a pink-tan distended cortical surface. with numerous (greater than ten) pink-tan, friable tumor studs. ranging from 0.5 x 0.3 x 0.3 cm up to 3.0 x 2.8 x 2.0 cm. The cut. surface is remarkable for both solid and cystic areas. The largest. cyst measures 4.0 x 4.0 x 4.0 cm and is remarkable for 30 CC of amber. serous fluid and multiple yellow-pink papillary excrescences. extending from the inner lining of the cyst wall. Attached is a. 3.0 cm in length, 0.4 cm in average diameter segment of fallopian. tube with pink-tan focally hyperemic serosa. Fimbriated end is. present. Cut surface reveals a 0.1 cm wall with patent pinpoint. lumen. Also present is a moderate amount of pink-tan, moderately. hemorrhagic mesovarium tissue. Representative sections submitted. D. Cross section of cystic and solid area of tumor, fallopian. tube - 2. E. Cross section of cystic and solid tumor and fallopian tube - 3. 4: UTERUS AND CERVIX. Labeled ""uterus and cervix"" and received in formalin is a 75 gram. symmetric uterus with cervix and without bilateral adnexa, measuring. 4.0 cm cornu to cornu, 7.0 cm superior to inferior and 4.0 cm. anterior to posterior. The serosa is pink-tan and focally disrupted. by a 4.0 x 3.0 cm area of hemorrhage on the anterior surface,. multiple cysts ranging from 0.2 up to 0.7 cm in diameter and patchy. areas of grey-tan fibrinous exudate. There is a 0.5 x 0,5 x 0.4 cm. tan-white subserosal spherical nodule on the posterior corpus which. on cut section has a tan-white, homogeneous, whorled surface without. hemorrhage, calcification or necrosis. The cervix measures 3.3. x. 2.8 cm in area with a 0.7 cm in width anterior vaginal cuff and. 1.5 cm in width posterior vaginal cuff. The ectocervical mucosa is. tan-pink and moderately hyperemic. The os measures 1.5 x 1.0 cm, is. round and has a pink-tan, firm, nodular polyp extending 2.0 cm from. the opening. The specimen is bivalved to reveal a 2.5 cm in length,. 1.0 cm in width endocervical canal with a tan-pink, smooth mucosa. The endometrial cavity measures 3.7 cm in length, 1.7 cm in width. The endometrial lining measures 0.1 cm in thickness and is tan-pink. and lush. The lining is significant for a 6.5 x 2.2 x 1.5 cm polyp. which extends from the anterior lower uterine segment through the. endocervical canal with multiple foci of adhesions and then continues. out through the cervical os, extending 2.0 cm from the opening. Also. present is a 0.5 x 0.2 x 0.2 cm white endometrial polyp extending. from the posterior lower uterine segment. The myometrium measures. 1.6 cm in maximum thickness and is tan-pink. No lesions are grossly. identified. Representative sections submitted. F. Anterior ectocervix - 1. G. Anterior lower uterine segment including base of large polyp. and area of disruption on serosa of hemorrhage and fibrinous. adhesions - 1. H. Continuation of large polyp -. I. Full thickness myometrium of anterior corpus - 1. J. Posterior ectocervix and vaginal cuff - 1. K. Posterior lower uterine segment with small polyp - 1. L. Full thickness myometrium, posterior corpus - 1. M. Subserosal nodule - 1. N. Cross section of serosa at anterior corpus in area of. hemorrhage and fibrous adhesions - 1. 5: PELVIC MASS. Labeled ""pelvic mass"" and received in formalin is a 1.0 x 0.7 x. 0.7 cm pink-tan, friable, papillary fragment of tissue with foci of. hemorrhage and yellow fibrinous adhesions. o. All embedded - 1. 6: SIGMOID MASS. Labeled ""sigmoid mass"", received fresh in the Operating Room for. intraoperative frozen section diagnosis and subsequently fixed in. formalin, are two soft, pink-tan 2.0 x 1.1 x 0.3 cm and 1.0 x 1.5 x. 0.9 cm fragments of tissue. Representative sections submitted. P. Frozen section remnant -. Q. Cross sections of fragments - 2. 7: ANTERIOR LIVER TUMOR. Labeled anterior liver tumor"" and received in formalin is a 7.0 x. 7.0 x 4.0 cm tan-pink, focally hemorrhagic, friable aggregate of. papillary tissue and blood clot. R. Representative sections - 2. POSTERIOR LIVER TUMOR. Labeled posterior liver tumor"" and received in formalin is a 4.0 x. 3.0 x 2.5 cm aggregate of pink-tan friable papillary tissue. S. Representative sections - 2. 9: RIGHT RETROPERITONEAL TUMOR. Labeled ""right peritoneal tumor"" and received in formalin is a 7.0 x. 6.0 x 2.5 cm aggregate of tan-pink friable papillary tissue fragments. and blood clot. T. Representative sections - 2. 10: OMENTUM TUMOR. Labeled ""omentum tumor"" and received in formalin is an 8.0 x 5.0 x. 3.5 cm aggregate of pink-tan friable nodular adipose tissue with red-. brown discoloration and adherent blood clot. Cross section reveals a. 5.0 x 2.5 x 2.0 cm yellow-white, firm nodular mass surrounded by the.",train,7.0 x. 7.0 x 4.0 cm;4.0 x. 3.0 x 2.5 cm;7.0 x. 6.0 x 2.5 cm;8.0 x 5.0 x. 3.5 cm
1157,TCGA-DD-A73E.10881D8D-1C62-4F3D-ACF6-36AD1F23B0A9,"Male. DIAGNOSIS : A. Liver, portion of segment V, subsegmental resection: Hepatocellular carcinoma, well-differentiated, 5.3 cm in greatest. dimension. Resection margin negative for tumor (tumor free margin,. 0.3 cm). . Vascular invasion is absent. AJCC stage (with available surgical material) : pT1 (7th edition) . This final pathology report is based on the gross/macroscopic. examination and the frozen section histologic evaluation of the. specimen (s) . Hematoxylin and Eosin (H&E) permanent sections are. reviewed to confirm these findings. Any substantive changes. identified on permanent section review will be reflected in a. revised report. Interpreted by: ADDENDUM: The background liver parenchyma shows marked steatosis and zone. 3. congestion. A trichrome stain shows no significant fibrosis. A. PAS-D stain shows no cytoplasmic globules within hepatocytes. An. iron stain is negative.",train,5.3 cm
1172,TCGA-CQ-6227.bbbd981a-4264-45d3-beb2-ceac32d3c55f,"Specimen(s) Received. 1. Nck: contents left neck. 2. Oral cavity:It.oral major resection -short medial long anterior. 3. Oral Cavity: t.posterior margin. 4. Oral avity:It.anterior margin. 5. Oral Cavity:It.lateral mucosa margin. 6. Oral Cavity:deep muscle margin. 7. Surgical Waste. 8. Neck: contents rt neck. 9. Lymph node: lt. facial node. 10. Lymph node:It neck III node. 11. Lymph node:It facial node. Diagnosis. 1. Contents left neck. Metastatic squamous cell carcinoma involving six of thirty-five lymph nodes (6/35). a. The involved lymph nodes are in levels I, II, and III. b. The largest involved lymph node measures 3.1 cm. C. Extranodal invasion is present. Submandibular gland with no pathologic changes. 2. Oral cavity; left oral resection. Squamous cell carcinoma, moderately differentiated. a. Maximum tumor diameter 5.5 cm. b. Tumor thickness 2.5 cm. C. Perineural invasion is present. d. No lymphovascular invasion. e. The tumor is close to deep tongue and posterior soft tissue margins (0.2 cm). The remaining. margins are negative for tumor. 3. Left posterior margin. Negative for tumor. 4. Left anterior margin. Negative for tumor. 5. Left lateral mucosa margin. Negative for tumor. 6. Deep muscle margin. Negative for tumor. 7. Surgical waste. Skin and soft tissues with no pathologic changes. (Gross examination only). 8. Contents right neck. Metastatic squamous cell carcinoma involving two of twenty-one lymph nodes (2/21). a. The involved lymph nodes are in levels Il and III. b. The largest involved lymph node measures 1.0 cm. C. No extranodal invasion present. Submandibular gland with no pathologic changes. 9. Left facial lymph node. One lymph node negative for tumor (0/1). 10. Left neck III lymph node. Soft tissues with no pathologic changes. 11. Left facial lymph node. Two lymph nodes negative for tumor (0/2). Synoptic Data. Specimen Type: Resection:left oral resection. Tumor Site: Oral Cavity. Histologic Type: Squamous cell carcinoma, conventional. Tumor Size: Greatest dimension: 5.5 cm. Tumor thickness: 2.5 cm. Histologic Grade: G2: Moderately differentiated. Venous/Lymphatic (Large/Small Vessel) Invasion (V/L): Absent. Perineural Invasion: Present. Margins: Margins uninvolved by tumor. Pathologic Staging (pTNM): pT3: Tumor or lip or oral cavity more than 4 cm in. greatest dimension. pN2c: Metastasis in bilateral or contralateral lymph nodes,. none more than 6 cm in greatest dimension for all. aerodigestive sites except nasopharynx. Number of regional lymph nodes examined: 59. Number of regional lymph nodes involved: 8. Extra-capsular extension of nodal tumor: Present. pMX: Distant metastasis cannot be assessed. Gross Description. 1. The specimen is labeled with the patient's name and as ""contents left neck of"". It consists of. an oriented left neck dissection with overall dimensions of 17.0 X 1.2 X 13.5 cm. The specimen. includes levels IA to IV. There is a portion of muscle measuring 4.0 X 2.0 X 0.5 cm. The. submandibular gland measures 3.7 X 3.0 X 0.9 cm and is unremarkable. Multiple lymph nodes. ranging from 0.2 to 3.1 cm are identified in multiple levels with the largest node being in level IIA. Representative sections are submitted. 1A-1B multiple lymph nodes per block, level IA. 1C. submandibular gland. 1D. multiple lymph nodes, level IB. 1E. muscle. 1F. largest lymph node level IIA. 1G. one lymph node level Il. 1H. multiple lymph nodes level Il. 1I-1J. multiple lymph nodes per block level llb. 1K. one lymph node level llb. 1L. one lymph node level llb. 1M-1N multiple lymph nodes per block level III. 10. one lymph node level III. 1P. one lymph node level III. 1Q. multiple lymph nodes, level IV. 2. The specimen is labeled the patient's name and as ""LT oral major resection short-medial long. anterior"". It consists of an oriented portion of left tongue, floor of mouth with overall dimensions. of 6.5 cm SI X 3.9 cm ML X 8.1 cm AP. The portion of tongue measures 2.2 cm X SI 3.4 cm ML X. 8.1 cm AP. The floor of mouth measures 2.0 cm SI X 4.0 cm ML X 6.0 cm AP cm. There is a. tumor involving the tongue and floor of mouth. The tumor measures 3.5 cm SI X 2.5 cm ML X 5.5. cm AP. The tumor has an ulcerated center with rolled edges. The cut surface is white-tan. It is. located at 0.5 cm from the lateral margin, 1.4 cm from the medial margin, 1.2 cm from the deep. margin, 0.5 cm from the anterior (floor of mouth) margin, and 0.6 cm from the posterior (junction. of tongue and floor of mouth) margin. The remaining tongue mucosa is unremarkable. Tissue is. taken for the for the tissue bank. Representative sections are submitted. 2A. anterior floor of mouth margin with tumor. 2B. posterior margin (junction of tongue and floor of mouth) with tumor. 2C. medial margin with tumor. 2D. lateral floor of mouth margin with tumor. 2E. dorsum of tongue with tumor. 2F. deep margin with tumor. 2G. tumor with medial margin. 2H. lateral margin with tumor and sublingual gland. 3. The specimen is labeled with the patient's name and as ""LT posterior tongue"". It consists of a. fragment of tissue measuring 1.5 X 0.9 X 0.6 cm. The specimen is submitted in toto for frozen. section. 3A. frozen section control. 4. The specimen is labeled with the patient's name and as ""LT anterior tongue"". It consists of a. fragment of tissue measuring 1.4 X 0.4 X 0.2 cm. The specimen is submitted in toto for frozen. section. 4A. frozen section control. 5. The specimen is labeled with the patient's name and as ""LT lateral margin mucosa"". It consists. of a fragment of tissue measuring 1.1 X 0.4 X 0.1 cm. The specimen is submitted in toto for. frozen section. 5A. frozen section control. 6. The specimen is labeled with the patient's name and as ""deep muscle margin"". It consists of a. fragment of tissue measuring 1.0 X 0.7 x 0.2 cm. The specimen is submitted in toto for frozen. section. 6A. frozen section control. 7. The specimen labeled with the patient's name and as ""surgical waste"". It consists of multiple. pieces of adipose tissue, seven with skin on one aspect, ranging in size from 3.0 to 10.5 cm. Also received is muscle. All of the pieces are grossly appear unremarkable. No sections are. taken for microscopic examination. 8. The specimen is labeled with the patient's name and as ""contents RT neck"". It consists of an. oriented right neck dissection with overall dimensions of 10.0 SI X 2.2 ML X 8.7 AP cm. The. specimen includes levels I to III. The submandibular gland measures 4.5 X 2.8 X 1.8 cm and is. unremarkable. Multiple lymph nodes ranging from 0.2 to 1.5 cm are identified in multiple levels. with the largest nodes in level II. Representative sections are submitted. 8A. submandibular gland. 8B-8C multiple lymph nodes per block level I. 8D-8H multiple lymph nodes per block level Il. 8I. one lymph node level Il. 8J. one lymph node level Il. 8K. multiple lymph nodes level III. 9. The specimen is labeled with the patient's name and as ""LT facial node #16"". It contains two. pieces of adipose tissue ,measuring 0.7 and 1.8 cm each in maximum dimension. A single lymph. node, is identified within the largest piece of adipose tissue. 9A. one lymph node. 10. The specimen is labeled with the patient's name and as ""LT level III node neck"". It consists of. a piece of adipose tissue measuring 1.5 X 0.5 X 0.1 cm. No lymph nodes are grossly identified. 10A. specimen in toto. 11. The specimen is labeled with the patient's name and as ""LT facial node #2"". It consists of a. piece of adipose tissue measuring 1.8 X 1.2 X 0.4 cm. Multiple lymph nodes ranging from 0.3 to. 0.7 cm in maximum dimension are identified. 11A. multiple lymph nodes. Quick Section Diagnosis. 3. Left posterior margin: Negative for malignancy. 4. Left anterior margin: Negative for malignancy. 5. Left lateral margin: Negative for malignancy. 6. Deep muscle margin: Negative for malignancy.",train,5.5 cm;3.5 cm SI X 2.5 cm ML X 5.5. cm;5.5 cm;2.5 cm;2.5 cm
1188,TCGA-HC-8260.12d41624-f0a9-4ba1-aa55-18fea0b733af,"IAGNOSIS. DIAGNOSIS: A. Soft tissue, right lateral margin of prostatectomy, biopsy: No malignancy identified. B. Lymph nodes, pelvic, resection; negative for malignancy, nine nodes. C. Prostate gland, radical prostatectomy: Tumor Characteristics: 1. Histologic type: Adenocarcinoma, conventional type. 2. Prostate size: 35.7 grams. 3. Tumor. quantitation: Malignancy is present peripherally and in the apex, bilaterally, and accounts for an estimated 25% of the total prostate volume. 4. Gleason grade: a. Primary pattern: 3/5. b. Secondary pattern: 4/5. C. Total Gleason score: 7/10. 5. Extraprostatic extension: Not identified. 6. Seminal vesicle involvement: Not identified. 7. Lymphovascular space invasion: Not identified. 8. High grade PIN: Present focally. 9. Perineural invasion: Present, and extensive. 9. Treatment effect: Not identified. Surgical Margin Status: 1. Malignancy extends to the inked left posterior apical margin. 2. Malignancy extends to less than 0.05 cm in multiple additional areas, bilaterally. Lymph Node Status: 1. See part B. Other: 1. pTNM stage: pT2c, NO. COMMENTS: No prior material for review and comparison is identified in our files. Correlation with previous biopsy material is suggested. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Prostate cancer. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Right lateral margin. B. Pelvic lymph nodes. C. Prostate. SPECIMEN DATA. GROSS DESCRIPTION: The specimen is received in three formalin filled containers labeled with the patient's name. A. Additionally labeled right lateral margin and contains a 1.3 x 1.0 x 0.7 cm pink-tan rubbery, cauterized soft tissue. The specimen is trisected and. entirely submitted in cassette A labelec. B. Additionally labeled pelvic lymph node and contains two yellow-tan fibrofatty soft tissues 2.8 x 2.0 x 1.3 cm and 3.5 x 2.5 X 1.0 cm. Designation is not. offered or possible. On section and palpation, multiple firm fatty possible lymph nodes are identified ranging from 0.1 up to 2.5 cm in greatest dimension. They are entirely submitted in cassettes B1-4 labeled. designated as follows: B1--five whole possible lymph nodes; B2--four whole possible. lymph nodes; B3-4--one whole possible lymph node, senally sectioned. C. Additionally labeled prostate and contains a 35.7 gram, 4.3 x 4.3 x 3.5 cm prostate received with attached bilateral adnexa which has overall. dimensions of 4.8 x 2.5 x 0.7 cm. The prostatic capsule is pink-tan and shaggy. The specimen is inked as follows: right side - blue and left side - black. The base and apical margins are coned and serially sectioned. The remainder of the gland is serially sectioned from apex to base to reveal a pink-tan. focally cystir cut eurface with diffuse periurethral nodularity. Discrete masses are not identified. Representative sections are submitted in cassettes C1-. 18 labeled. designated as follows: 1-right prostate/seminal vesicle junction; 2--left prostate/seminal vesicle junction; 3 and 4--apical margin,. perpendicular; 5 anu 6--base margin, perpendicular; 7-9--right anterior, apex to base; 10-12--right posterior, apex to base; 13-15--left anterior, apex to. base; 16-18--left posterior, apex to base. Additionally, a yellow and green cassette are submitted for. esearch each labeled.",train,
1248,TCGA-B6-A0I2.CA834E5F-30DC-46CF-AF33-AD11226FC09E,"Surgical Pathology: Final. OUID:CA834E5F-30DC-46CF-AF33-AD11226FC09E. CLINICAL HISTORY: Bilateral carcinoma of the breast. GROSS EXAMINATION: A. ""Medial margin right breast biopsy"", fresh. The specimen consists of 3.7 x. 2.2 x 0.6 cm disc of firm white, unremarkable breast tissue; four sutures. denote the true margin, which is inked black. Serial radial sections are. submitted as follows: BLOCK SUMMARY: A1 frozen section remnant Af1. A2 frozen section remnant AF2. A3 frozen section remnant AF3. A4 additional tissue. B. ""Right breast biopsy sample"". Contains an irregular 10 x 0.5 x 1.7 cm disc. tan-brown coarsely papillary tissue. Portions are submitted for ER/PR and for. tissue. bank and for frozen section. Frozen section remnant submitted in Block. B1. C. ""Left breast tumor, wide reexcision, long suture lateral, short suture. superior"", fresh. The specimen consists of a 4.5 x 4.3 x 2.2 cm wide. reexcision of the breast. The long suture denotes the lateral aspect of the. specimen and a short suture the superior. The superior pole of the tissue is. inked black, and the inferior blue. On cut section, there is a 1.3 x 1.3 x 1 cm round, white, firm, gritty,. sharply-circumscribed tumor in the superior portion of the resection. The. tumor extends to within 2 mm of the superior margin, and does not approach. closely to any other margin. The remainder of the breast consists of firm,. white and tan admixed breast parenchyma. Tissue is divided into deep (towards. chest wall) and superficial (towards skin) halves and submitted from medial to. lateral as follows: BLOCK SUMMARY: C1 frozen section remnant Cfl. C2-C8 superficial half from medial to lateral. C9-C15 deep half from medial to lateral. D. ""Right axillary dissection and wide reexcision"", fresh. The specimen. consists of an excisional breast biopsy and attached axillary dissection. The. biopsy is incised, to obtain tissue for frozen section, ER/PR, and tissue. bank, prior to receipt by pathology. The biopsy measures 6.7 x 6.5 x 3.2 cm. The axillary tail measures 10 x 2.3 x 0.9 cm. The medial surface (not a true. margin) is inked in red, the inferior margin black and the superior margin in. blue. On cut section, there is a 4.5 x 2.3 x 2.5 cm white firm tumor, composed of. tan-yellow loose aggregates of tumor. The tumor approaches to within 3 mm of. the inked superior margin of resection and to within 1 cm of the superior and. 5 mm of the inferior margin. Tumor approaches to within 4 mm of the deep. margin of resection. The remainder of the breast is unremarkable. The axillary dissection is divided into low, mid and distal level. There are. numerous lymph nodes, ranging from 0.3 to 1.4 cm, none grossly involved by. tumor. BLOCK SUMMARY: 1 of 2. D1-D5 Anterior (superficial) tumor from lateral to medial. D6-D10 Posterior (deep) tumor from lateral to medial. D11 - Lower lymph node candidate. D12 - One mid-level lymph node, bisected. D13 - Five mid-level lymph node candidates. D14 - Four distal lymph node candidates. D15 - Highest lymph node. E. ""Left axillary dissection, silk on apex"", fresh. The specimen consists of. a 6 x 9 x 1.7 cm lymph node dissection, with a black suture at one pole. The. lymph node dissection is divided into three sections, lower, middle and. distal. Numerous lymph nodes are identified ranging from 0.3 to 1.7 cm in. greatest dimension. None grossly contains tumor. BLOCK SUMMARY: E1 Lower nodes, 3 lymph node candidates. E2 Three lymph node candidates, lower node. E3 Middle nodes, 2 lymph node candidates. E4 Middle nodes, 2 lymph node candidates. E5 Three lymph node candidates, upper lobe. E6 Upper nodes, 1 lymph node candidate. E7 Upper node, 1 lymph node candidates, bisected. E8 Highest apical node. INTRA OPERATIVE CONSULTATION: AF1-Af3: ""Medial margin right breast biopsy"": Inked margin free of carcinoma. (KR). Bf1: ""Right breast biopsy sample"": Carcinoma. Cf1: ""Left breast biopsy"": Carcinoma. DIAGNOSIS: A. ""MEDIAL MARGIN RIGHT BREAST BIOPSY"": BENIGN BREAST TISSUE. B. ""RIGHT BREAST BIOPSY"": POORLY-DIFFERENTIATED ADENOCARCINOMA. C. ""LEFT BREAST TUMOR, WIDE RE-EXCISION"": INVASIVE AND INTRADUCTAL ADENOCARCINOMA. 1.3 x 1.3 x 1.3 CM. NSABP HISTOLOGIC GRADE 3, NUCLEAR GRADE 3. NON-COMEDO TYPE INTRADUCTAL COMPONENT COMPRISES 5% OF TUMOR. VASCULAR SPACE INVASION IDENTIFIED (C13) . INKED MARGINS OF RESECTION FREE OF TUMOR. EXTENDING TO WITHIN 1 MM OF INKED SUPERIOR MARGIN OF RESECTION (C14) . ASSOCIATED WITH MICROCALCIFICATION. REMAINDER OF BREAST WITH APOCRINE METAPLASIA AND MICROCYST FORMATION. D. ""RIGHT AXILLARY RESECTION OF BREAST AND WIDE RE-EXCISION"": INVASIVE AND INTRADUCTAL CARCINOMA. 4.5 x 2.3 x 2.5 CM. NSABP HISTOLOGIC GRADE 3, NUCLEAR GRADE 2. NON-COMEDO TYPE INTRADUCTAL CARCINOMA COMPRISES 5% OF TUMOR. INTRADUCTAL CARCINOMA EXTENDS BEYOND TUMOR MASS. VASCULAR SPACE INVASION NOT IDENTIFIED. TUMOR APPROACHES TO WITHIN 100 MICRONS OF INKED MARGIN OF RESECTION. (D7, D8, D9, D10, D6), SEE NOTE. REMAINDER OF BREAST WITH MICROCYST FORMATION AND FIBROADENOMATOUS CHANGE. 10 REGIONAL LYMPH NODES WITH NO TUMOR SEEN (0/10) . E. ""LEFT AXILLARY DISSECTION"": 8 LYMPH NODES WITH NO TUMOR SEEN (0/8) . NOTE: FOCALLY, CAUTERY ARTIFACT EXTENDS TO TUMOR inal. 2 of 2.",train,1.3 x 1.3 x 1 cm;4.5 x 2.3 x 2.5 cm;1.3 x 1.3 x 1.3 CM;4.5 x 2.3 x 2.5 CM
1258,TCGA-D1-A16F.E89C4CBF-45D5-405D-A673-F67186C206B3,"Surgical Pathology Site Code, Endometrium (54.1. TISSUE DESCRIPTION: A1 A2 A3 A4 A5 A6 A7 B1 B2 C1 C2 C3 C4 C5 D1 E1. E2 E3 E4. F1 F2 G1 G2 G3 G4. Uterus (82.21 grams), right ovary (2.9 X 2.5 X 0.7 cm). with 7.5 cm. segment of right fallopian tube, and separately submitted. left ovary. (2.5 X 2.0 X 1.3 cm) with 4.0 cm segment of left fallopian. tube,. right and left pelvic lymph nodes (laparoscopically). right and left. para-aortic lymph nodes above and below the inferior. mesenteric. artery (laparoscopically) . DIAGNOSIS : Uterus, hysterectomy : Endometrial adenocarcinoma,. endometrioid. type, FIGO grade II (of III) endometrioid type, forming a. polypoid. mass (7.5 x 2.5 X 1.3 cm) The tumor, which demonstrates. focal. squamous differentiation, invades the myometrium to a. maximal depth. of 0.5 cm (2.0 cm total myometrial thickness) and extends. to involve. the lower uterine segment. The cervix is uninvolved. Ovary and fallopian tube, right salpingo-oophorectomy: diagnostic abnormalities. Ovary and fallopian tube, left salpingo-oophorectomy: : No. diagnostic. abnormalities. Lymph nodes, right pelvic, lymphadenectomy: Multiple (5). right. pelvic lymph nodes are negative for tumor. Lymph nodes, left pelvic, lymphadenectomy : Multiple (10). left. pelvic lymph nodes are negative for tumor. Lymph nodes, right and left para-aortic, lymphadenectomy: Multiple. (5 above the inferior mesenteric artery and 1 below the. inferior. mesenteric artery) para-aortic lymph nodes are negative. for tumor. This final pathology report is based on the. gross/macroscopic. examination and frozen section histologic evaluation of. the. specimen (s) .",train,
1299,TCGA-AN-A0AR.0E27F140-3D60-4027-A370-68127564DE38,Sex: Female. Diagnosis: Breast Cancer Histological description: Infiltrative ductal carcinoma. Anatomic Site: Right Breast Tumor location: Primary. Tissue Specification: Tumor Specimen Matrix: Tissue Specimen Format: Frozen. Container: cryomold Type of Procurement: Radical mastectomy Grade: 3. T Stage: 2 N Stage: 0 M Stage: 0 Treatment: none. Treatment Details: n/a. Normal Sample. Anatomic Site: Blood Sample Type: Normal Type of Procurement: blood draw. Matrix: Blood Specimen Format: frozen Container: tube.,train,
1330,TCGA-G7-A8LC.A3E4073B-A147-4E07-B3F2-1FEB1FB7523E,"SPECIMENS: A. RIGHT RENAL TUMOR BASE. B. RIGHT KIDNEY TUMOR. SPECIMEN(S): A. RIGHT RENAL TUMOR BASE. B. RIGHT KIDNEY TUMOR. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSA-right renal tumor base: No malignancy identified. Diagnosis called by Dr. to Dr. at. DIAGNOSIS: A. KIDNEY, RIGHT, TUMOR BASE, EXCISION: - NEGATIVE FOR CARCINOMA. B. KIDNEY, RIGHT, PARTIAL NEPHRECTOMY: - PAPILLARY RENAL CELL CARCINOMA, TYPE 2. - TUMOR SIZE: 2.5 CM IN GREATEST DIMENSION. - SURGICAL RESECTION MARGIN IS INVOLVED BY CARCINOMA. - SEE SYNOPTIC REPORT. COMMENT;. The surface inked orange is not real margin as per conversation with Dr. on. SYNOPTIC REPORT - KIDNEY (PARTIAL OR RADICAL). Specimens Involved. Specimens: A: RIGHT RENAL TUMOR BASE. B: RIGHT KIDNEY TUMOR. Specimen Type: Partial nephrectomy. Without adrenal gland. Laterality: Right. Tumor Site: Not specified. Focality: Unifocal. Tumor Size (largest tumor if multiple): Greatest dimension: 2.5cm. Macroscopic Extent of Tumor: Tumor limited to kidney. WHO CLASSIFICATION. Papillary renal cell carcinoma 8260/3. Histologic Grade (Fuhrman Nuclear Grade): G2: Nuclei slightly irregular, approximately 15 u;. nucleoli evident. Invasion of Vascular/Lymphatic: Absent. Perinephric Tissue Invasion: Absent. Margins: Margin(s) involved by invasive carcinoma. Include: Renal parenchymal margin (partial nephrectomy only). Adrenal Gland: Not present. Regional Lymph Nodes: None sampled. Additional Findings: None identified. Pathological Staging (pTNM): pT 1a N x M x. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. pMX: Cannot be assessed. SUMMARY OF IMMUNOHISTOCHEMISTRY/SPECIAL STAINS. Material: Block B2. Population: Tumor Cells. Stain/Marker:Result: Comment: CYTOKERATIN 7. Positive. CD 10. Positive. Material: Block B5. Population: Tumor Cells. Stain/Marker:Result: Comment: RACEMACE Positive. Carbonic Anhydrase IX. Positive Equivocal. The interpretation of the above immunohistochemistry stain or stains is guided by published results in. the medical literature, provided package information from the manufacturer and by internal review of. staining performance and assay validation within the. The use. of one or more reagents in the above tests is regulated as an analyte specific reagent (ASR). These. tests were developed and their performance characteristic determined by the. They have not been cleared or approved by the U.S. Food and Drug Administration. The. FDA has determined that such clearance or approval is not necessary. Special stains and/or immunohistochemical stains were performed with appropriately stained positive. and/or negative controls. GROSS DESCRIPTION: A. RIGHT RENAL TUMOR BASE. Received fresh labeled the patient's identification and ""right renal tumor base"" is a 0.3 x 0.2 x 0.1 cm. piece of red-tan soft tissue; submitted in the frozen section diagnosis, FSA. B. RIGHT KIDNEY TUMOR. Received fresh labeled with the patient's identification and ""right kidney tumor"" is a 9 g, 3.7 x 2.5 x 1.3. cm piece of kidney with 1.3 x 0.5 x 0.5 cm piece of attached perinephric fat. The surface has a 1.5 x 1. cm defect. The specimen is oriented by Dr.. The true margin (surrounding the defect) is inked black and. the remainder of the specimen is inked orange. On sectioning, there is a well-circumscribed mottled tan. and brown nodule, 2.5 x 2.3 x 1.8 cm, which abuts the true margin. Photographs are taken and tissue is. procured; submitted entirely, B1-B8. CLINICAL HISTORY: None Given. PRE-OPERATIVE DIAGNOSIS: Right renal mass. Microscopic/Diagnostic Dictation: Final Review:. Pathologist. Final: Pathologist,.",train,2.5 CM;2.5cm;2.5 x 2.3 x 1.8 cm
1330,TCGA-G7-A8LC.A3E4073B-A147-4E07-B3F2-1FEB1FB7523E,"SPECIMENS: A. RIGHT RENAL TUMOR BASE. B. RIGHT KIDNEY TUMOR. SPECIMEN(S): A. RIGHT RENAL TUMOR BASE. B. RIGHT KIDNEY TUMOR. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSA-right renal tumor base: No malignancy identified. Diagnosis called by Dr. to Dr. at. DIAGNOSIS: A. KIDNEY, RIGHT, TUMOR BASE, EXCISION: - NEGATIVE FOR CARCINOMA. B. KIDNEY, RIGHT, PARTIAL NEPHRECTOMY: - PAPILLARY RENAL CELL CARCINOMA, TYPE 2. - TUMOR SIZE: 2.5 CM IN GREATEST DIMENSION. - SURGICAL RESECTION MARGIN IS INVOLVED BY CARCINOMA. - SEE SYNOPTIC REPORT. COMMENT;. The surface inked orange is not real margin as per conversation with Dr. on. SYNOPTIC REPORT - KIDNEY (PARTIAL OR RADICAL). Specimens Involved. Specimens: A: RIGHT RENAL TUMOR BASE. B: RIGHT KIDNEY TUMOR. Specimen Type: Partial nephrectomy. Without adrenal gland. Laterality: Right. Tumor Site: Not specified. Focality: Unifocal. Tumor Size (largest tumor if multiple): Greatest dimension: 2.5cm. Macroscopic Extent of Tumor: Tumor limited to kidney. WHO CLASSIFICATION. Papillary renal cell carcinoma 8260/3. Histologic Grade (Fuhrman Nuclear Grade): G2: Nuclei slightly irregular, approximately 15 u;. nucleoli evident. Invasion of Vascular/Lymphatic: Absent. Perinephric Tissue Invasion: Absent. Margins: Margin(s) involved by invasive carcinoma. Include: Renal parenchymal margin (partial nephrectomy only). Adrenal Gland: Not present. Regional Lymph Nodes: None sampled. Additional Findings: None identified. Pathological Staging (pTNM): pT 1a N x M x. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. pMX: Cannot be assessed. SUMMARY OF IMMUNOHISTOCHEMISTRY/SPECIAL STAINS. Material: Block B2. Population: Tumor Cells. Stain/Marker:Result: Comment: CYTOKERATIN 7. Positive. CD 10. Positive. Material: Block B5. Population: Tumor Cells. Stain/Marker:Result: Comment: RACEMACE Positive. Carbonic Anhydrase IX. Positive Equivocal. The interpretation of the above immunohistochemistry stain or stains is guided by published results in. the medical literature, provided package information from the manufacturer and by internal review of. staining performance and assay validation within the. The use. of one or more reagents in the above tests is regulated as an analyte specific reagent (ASR). These. tests were developed and their performance characteristic determined by the. They have not been cleared or approved by the U.S. Food and Drug Administration. The. FDA has determined that such clearance or approval is not necessary. Special stains and/or immunohistochemical stains were performed with appropriately stained positive. and/or negative controls. GROSS DESCRIPTION: A. RIGHT RENAL TUMOR BASE. Received fresh labeled the patient's identification and ""right renal tumor base"" is a 0.3 x 0.2 x 0.1 cm. piece of red-tan soft tissue; submitted in the frozen section diagnosis, FSA. B. RIGHT KIDNEY TUMOR. Received fresh labeled with the patient's identification and ""right kidney tumor"" is a 9 g, 3.7 x 2.5 x 1.3. cm piece of kidney with 1.3 x 0.5 x 0.5 cm piece of attached perinephric fat. The surface has a 1.5 x 1. cm defect. The specimen is oriented by Dr.. The true margin (surrounding the defect) is inked black and. the remainder of the specimen is inked orange. On sectioning, there is a well-circumscribed mottled tan. and brown nodule, 2.5 x 2.3 x 1.8 cm, which abuts the true margin. Photographs are taken and tissue is. procured; submitted entirely, B1-B8. CLINICAL HISTORY: None Given. PRE-OPERATIVE DIAGNOSIS: Right renal mass. Microscopic/Diagnostic Dictation: Final Review:. Pathologist. Final: Pathologist,.",duplicate record,
1333,TCGA-BP-4766.939d54df-ce2d-4a4d-801d-6d7059ad8ace,"Clinical Diagnosis & History: with 3,9 x 3 cm hypervascular right renal mass. Specimens Submitted: 1: SP: Right kidney tumor. 2: SP: Deep margin #2. DIAGNOSIS: 1). KIDNEY, RIGHT; PARTIAL NEPHRECTOMY: - RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE, NUCLEAR GRADE III/IV. - THE PATTERN OF GROWTH IS SOLID. - THE TUMOR GREATEST DIAMETER IS 3.9 CM. - THE TUMOR IS CONFINED WITHIN THE RENAL CAPSULE. . THE SURGICAL MARGIN IS FREE OF TUMOR. - THE NON-NEOPLASTIC KIDNEY IS UNREMARKABLE. 2). MARGIN, DEEP #2; BIOPSY: - BENIGN RENAL PARENCHYMA. 1). The specimen Is received fresh for frozen section consultation labeled, ""Right kidney tumor, stitch marks deep margin"". consists of a partial nephrectomy specimen measuring 5.0 X 4.0 x 1.5 cm. The area with the black stitch is inked blue. Cut. section the specimen shows a 3.9 X 3.8 x 3.8 cm round, well encapsulated, hemorrhagic orange tumor mass located 0.2 cm from. the resected margin. The remainder of the kidney parenchyma is brown tan and unremarkable. Representatives sections are. frozen. Representative sections are submitted. A sample of the tumor Is given to. Summary of sections: FSCA - frozen section control A (tumor). FSCB - frozen section control B (margin). T- tumor. RS -representative section of uninvolved parenchyma. 2). The specimen is received fresh for frozen section consultation labeled, ""Deep margin #2"". It consists of a piece of gray. (an soft tissue measuring 0.4 x 0.2 x 0.2 cm in aggregate. The specimen is entirely frozen. Summary of sections: FSC - frozen section control. Summary of Sections: Part 1: SP: Right kidney tumor. Block. Sect. Site. PCs. fsca. 1. 1. fscb. 1. rs. 1. 4. Part 2: SP: Deep margin #2. Block. Sect. Site. PCs. 1. fsc. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative. consultation. 1A). FROZEN SECTION DIAGNOSIS: TUMOR: CORTICAL CELL NEOPLASM, FAVOR RENAL CARCINOMA/CLEAR. CELL CONVENTIONAL TYPE. PERMANENT DIAGNOSIS: SAME. 1B). FROZEN SECTION DIAGNOSIS: MARGIN: BENIGN. PERMANENT DIAGNOSIS: SAME,. 2). FROZEN SECTION DIAGNOSIS: BENIGN. PERMANENT DIAGNOSIS: SAME.",train,3.9 CM
1404,TCGA-3H-AB3O.D5828CA0-5ED9-4AF6-9E3C-CBE57826E43F,"M. DIAGNOSIS. (A) LYMPH NODE, 4R, LYMPHADENECTOMY: Two lymph nodes, no tumor present (0/2). (B) LYMPH NODE, STATION 7, LYMPHADENECTOMY: One lymph node, no tumor present (0/1). (C) DIAPHRAGM, BIOPSY: Portion of diaphragm, no tumor present. (D) RIGHT LIVER, BIOPSY: Liver parenchyma with fibrosis, no tumor present. (E) RIGHT PLEURA, BIOPSY: EPITHELIOID MALIGNANT MESOTHELIOMA. GROSS DESCRIPTION. (A). 4R LYMPH NODE - Received are two possible lymph nodes measuring 0.6 to 1.0 cm in greatest dimension. Specimen. submitted entirely in A. (B). STATION. 7 LYMPH NODE - Received is one possible lymph node measuring 0.6 cm in greatest dimension. Specimen. submitted entirely in B. (C). BIOPSY OF DIAPHRAGM - Received is a single fragment of tan-pink soft tissue measuring 0.2 cm in greatest dimension. Specimen submitted entirely in C. (D) RIGHT LIVER BIOPSY - Received are two fragments of tan-pink soft tissue both measuring 0.2 cm in greatest dimension. Specimen submitted entirely in D. (E). RIGHT. PLEURAL TUMOR - A single (2.3 X 1.1 x 0.9 cm) portion of pink-tan to white fibrous tissue that is entirely submitted for. frozen section evaluation in E. FS/DX: POSITIVE MALIGNANT MESOTHELIOMA. CLINICAL HISTORY. Mesothelioma. SNOMED CODES. T-2900, M-90503. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by: END OF REPORT----. Page : 2. M.",train,2.3 X 1.1 x 0.9 cm
1409,TCGA-AO-A03R.D779EEF8-C83C-4CCA-A140-9BF15DCF14AE,"Clinical Diagnosis & History: y/o femnle with left breast cancer on core biopsy IDC/DCIS. Specimens Submitted: 1: SP: Sentinel node #1, level one . left axilla (fs). 2: SP: Sentinel node #2, level one, left axilla (fs). 3: SP: Sentinel node #3, level one, left axilla (fs). 4: SP: Left breast. 5: SP: Levels one and two left axillary contents (. 6: SP: Level two left axillary contents. 7: SP: Level three left axillary contents. DIAGNOSIS: 1). LYMPH NODE, SENTINEL #1 LEVEL I LEFT AXILLA; BIOPSY: - METASTATIC CARCINOMA IN ONE LYMPH NODE (1/1). - THERE IS EXTRANODAL CAPSULAR EXTENSION OF CARCINOMA (<2 MN). 2). LYMPH NODES, SENTINEL #2 LEVEL I LEFT AXILLA; BIOPSY: - METASTATIC CARCINOMA IN ONE LYMPH NODE (1/1), 2.1 MM FOCUS, SEE NOTE. THERE IS NO EXTRANODAL EXTENSION OF CARCINOMA. NOTE: THE CARCINOMA IS NO LONGER PRESENT ON DEEPER H&E STAINED SECTIONS. 3). LYMPH NODE, SENTINEL #3 LEVEL I LEFT AXILLA; BIOPSY: - ONE BENIGN LYMPH NODE (0/1). 4). BREAST, LEFT; TOTAL MASTECTOMY: - INVASIVE POORLY DIFFERENTIATED DUCTAL CARCINOMA, NOS TYPE, HISTOLOGIC. GRADE III/III (SLIGHT OR NO TUBULE FORMATION) NUCLEAR GRADE III/III (MARKED. VARIATION IN SIZE AND SHAPE) MEASURING 5.0 CM IN LARGEST DIMENSION GROSSLY. DUCTAL CARCINOMA IN SITU (DCIS) IS ALSO IDENTIFIED, SOLID AND CRIBRIFORM. TYPES, WITH HIGH NUCLEAR GRADE AND MODERATE NECROSIS. THE DCIS CONSTITUTES <= 25% OF THE TOTAL TUMOR MASS, AND IS PRESENT. ADMIXED WITH AND AWAY FROM THE INVASIVE COMPONENT. - THE INVASIVE CARCINOMA IS LOCATED IN THE UPPER OUTER QUADRANT AND UPPER. INNER QUADRANT. THE DCIS IS LOCATED IN THE UPPER INNER QUADRANT AND LOWER INNER QUADRANT. - NO INVOLVEMENT OF THE NIPPLE BY EITHER IN SITU OR INVASIVE CARCINOMA IS. IDENTIFIED. NO CALCIFICATIONS ARE IDENTIFIED IN EITHER THE INVASIVE OR IN SITU. COMPONENT. - CALCIFICATIONS ARE PRESENT IN THE BENIGN BREAST PARENCHYMA. - EXTENSIVE VASCULAR INVASION IS PRESENT. - POSITIVE PERINEURAL INVASION. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY EITHER INVASIVE OR IN SITU. CARCINOMA IS IDENTIFIED. NO SKIN INVOLVEMENT BY CARCINOMA IS IDENTIFIED. - THE ATTACHED SKELETAL MUSCLE IS NEGATIVE FOR TUMOR. THE NON-NEOPLASTIC BREAST TISSUE SHOWS BIOPSY SITE CHANGES, FIBROCYSTIC. CHANGES AND FIBROADENOMATOUS CHANGES. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF POSITIVE. LYMPH NODES IN RELATION TO THE TOTAL NUMBER OF LYMPH NODES EXAMINED) : LEVEL. I: 0/1. 5). LYMPH NODES, LEVELS I AND II LEFT AXILLARY CONTENTS; EXCISION: - MICROMETASTATIC CARCINOMA IN ONE OUT OF EIGHTEEN LYMPH NODES (1/18). - THERE IS NO EXTRANODAL EXTENSION OF CARCINOMA. 6). LYMPH NODE, LEVEL II LEFT AXILLARY CONTENTS; EXCISION: - UNREMARKABLE FIBROADIPOSE TISSUE. 7). LYMPH NODES, LEVEL III LEFT AXILLARY CONTENTS; EXCISION: FOUR BENIGN LYMPH NODES (0/4). NOTE: RESULTS OF SPECIAL STAINS (ER,PR,HER2-neu) WILL BE REPORTED AS AN. ADDENDUM. SUMMARY OF LYMPH NODES: 3/26. TUMOR STAGE: T2, pN1a, MX STAGE GROUPING IIB. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) . AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. M.D.,. Special Studies: Special Stain. Comment. RECUT. level. ER-C. PR-C. HER2-0. NEG CONT. IMM RECUT. NEG-HER2. Gross Description: 1) The specimen is received fresh for frozen section consultation, labeled. ""Sentinel node number one, level 1, left axilla"" and consists of a single. lymph node measuring 1.3 x 0.9 x 0.7 cm. The specimen is bisected. Entirely. submitted for frozen section. Summary of sections: FSC -- frozen section control. 2). The specimen is received fresh for frozen section consultation, labeled. ""Sentinel node number two, level 1, left axilla"" and consists of two lymph. nodes measuring 1.1 x 0.5 x 0.5 and 0.8 x 0.6 x 0.4 cm. The larger lymph. node is inked black. Entirely submitted for frozen section. Summary of sections: FSC -- frozen section control. 3) The specimen is received fresh for frozen section consultation, labeled. ""Sentinel node number three, level 1, left axilla"" and consists of a single. lymph node measuring 1.0 x 0.7 x 0.6 cm. Lymph node is bisected. Entirely. submitted for frozen section. Summary of sections: FSC -- frozen section control. 4). The specimen is received fresh labeled, ""left breast, stitch marks. axillary tail"" and consists of a breast with attached axillary tail. The. breast measures 28.0 x 25.0 x 5.0 cm with overlying skin ellipse measuring. 22.0 x 10.0 cm. Situated eccentrically on the skin surface is a nipple. measuring 1.2 x 1.2 cm and areola measuring 2.0 x 2.0 cm. A suture. demarcates the axillary tail which measures 6.0 x 5.0 cm. The posterior. surface of the breast is inked black, anterior superior - blue, anterior. inferior - green and the specimen is serially sectioned to reveal a firm. white mass measuring 5.0 x 2.5 x 2.0 cm, and located in the upper inner. quadrant extending to the upper outer quadrant, measuring 2.0 cm from the. closest deep margin. The remaining breast tissue shows a fibrofatty cut. surface. The axillary tissue is dissected to reveal a lymph node. Representative sections are submitted, including the lymph node. Summary of sections: N nipple. NB - nipple base. S skim. D - deep margin. T - tumor. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. AA-axillary tail. AALN-a bisected lymph node in axillary area. 5). The specimen is received fresh, labeled ""Levels 1 and 2 left axillary. contents"". It consists of a 3 x 2 x 1 cm portion of fibroadipose tissue. Multiple lymph nodes identified measuring from 0.5 to 1.1 cm in greatest. dimension. All lymph nodes are submitted. Summary of sections: LN - lymph nodes. 6) The specimen is received in formalin, labeled ""level 2, left axillary. contents"" and consists of a 1.7 x 1.3 x 0.3 cm portion of fatty tissue. Entirely submitted. Summary of sections: U-undesignated. 7) The specimen is received in formalin, labeled ""level 3, left axillary. contents"" and consists of two lymph nodes measuring 0.5 cm and 1.3 cm in. maximum dimension. Entirely submitted. Summary of sections: LN- lymph node. BLN- bisected lymph node. Summary of Sections: Part 1: SP: Sentinel node #1, level one , left axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 2: SP: Sentinel node #2, level one, left axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 3: SP: Sentinel node #3, level one, left axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 4: SP: Left breast. Block. Sect. Site. PCs. 1. aa. 1. aaln. 2. d. 2. 3. liq. 3. 2. loq. 2. 1. n. 1. 1. nb. 1. 1. s. 1. 10. 10. 2. uiq. 2. 2. uog. 2. Part 5: SP: Levels one and two left axillary contents. Block. Sect. Site. PCs. 6. LN. 18. Part 6: SP: Level two left axillary contents. Block. Sect. Site. PCs. 1. u. 1. Part 7: SP: Level three left axillary contents. Block. Sect. Site. PCs. 1. bln. 1. 1. In. 1. Procedures/Addenda: Addendum. Date Complete: Addendum Diagnosis. ADDENDUM REPORT. SITE: LEFT BREAST (PART 4). ER: 95% NUCLEAR STAINING WITH MODERATE INTENSITY. PR: <5% NUCLEAR STAINING WITH MODERATE INTENSITY. HER2/NEU (HERCEPTEST) : NEGATIVE (STAINING INTENSITY OF 0). CONTROLS ARE SATISFACTORY. . M.D. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: METASTATIC CARCINOM'. PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS: METASTATIC CARCINOMA. PERMANENT DIAGNOSIS: SAME. 3). FROZEN SECTION DIAGNOSIS: BENIGN LYMPH NODE. PERMANENT DIAGNOSIS: SAME.",train,5.0 cm
1442,TCGA-3A-A9IV.A0D8875D-EBF7-4D76-945F-3CDFB6B9A351,"Final Diagnosis. A. LYMPH NODE, HEPATIC ARTERY, EXCISION: One lymph node, negative for metastatic carcinoma (0/1). B. PANCREAS AND SPLEEN, SUBTOTAL PANCREATECTOMY AND SPLENECTOMY: Pancreatic endocrine neoplasm, grade 2. Tumor size: 3 x 2.5: cm. Surgical margins: Free of tumor. Necrosis: present. Mitotic rate: 7/10 HPFs. Fifteen regional lymph nodes with no evidence of metastasis. Unremarkable spleen. See Key Pathological Findings. C. ACCESSORY SPLEEN, ""SPLENULE"", EXCISION: Unremarkable splenic parenchyma. D. GALLBLADDER, CHOLECYSTECTOMY: Chronic cholecystitis and cholesterolosis. No evidence of dysplasia or malignancy. I,. the attending pathologiat, personally reviewed all. aliues and / or materials and rendered the final diagnosis. Electronically. Key Pathological Findings. B: Pancreas Endocrine. SPECIMEN: Tail of pancreas. Spleen. SPECIMEN: Splenectomy. TUMOR SITE: Pancreatic fail. TUMOR SIZE: Greatest dimension: 3.0 cm. Additional dimensions: 2.5x2.0 cm. TUMOR FOCALITY: Unifocal. HISTOLOGIC TYPE: Well-differentiated neuroendocrine tumor. WORLD HEALTH ORGANIZATION CLASSIFICATION: Well-differentiated endocrine tumor, uncertain behavior. FUNCTIONAL TYPE: Cannot be assessed. MITOTIC ACTIVITY: Greater than or equal to 2 mitoses/10 HPF to 10 mitoses/10 HPF; number of mitoses per 10. HPF: 7 mitoses / 10 high power fields. Ki67 LABELING INDEX: 3%-20% Ki67-positive cells. TUMOR NECROSIS: Present. MICROSCOPIC TUMOR EXTENSION: Tumor is confined to pancreas. MARGINS: Margina uninvolved by tumor. Distance of tumor from closest margin: 0.2 mm. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT): pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension. REGIONAL LYMPH NODES (pN): pNO: No regional fymph node metastasis. Number examined: 16. Number involved: 0. DISTANT METASTASIS. ADDITIONAL PATHOLOGIC FINDINGS: PANIN lla. ANCILLARY STUDIES: The neoplastic cells are positive for synaptophysin, focally positive for chromogranin by. immunohistochemistry. The Ki-67 immunostain is positive in approximately 15% of the. neoplastic cells. COMMENT(S). B2-7 adequate for molecular studies. Specimen(s) Received. A. HEPATIC ARTERY LYMPH NODE. B. SUBTOTAL PANCREATECTOMY AND SPLENECTOMY FS. C. SPLENULE. D. GALLBLADDER GROSSLY CHECK FOR POLYP. Clinical History. Y/O FEMALE MORBID OBESITY, HM-ASTHMA. Preoperative Diagnosis. PANCREATIC NEUROENDOCRINE TUMOR. Intraoperative Consultation. FSB1 SUBTOTAL PANCREATECTOMY AND SPLENECTOMY: Pancreatic margin, no evidence of malignancy. GROSS EXAMINATION. D. GALLBLADDER GROSSLY CHECK FOR POLYP: Partially calcified mucosal polyps, measuring 3 mm to 5 mm. FSD1 GALLBLADDER GROSSLY CHECK FOR POLYP: Largest polyp no evidence of malignancy. Intradepartmental Consultation: The case was also reviewed by. MD, who concurs. with the above interpretation (FSD1). Comment: These frozen section diagnoses/results were communicated to and acknowledged by Dr. I.D., have performed the intraoperative consultations and issued the above. diagnosis. Gross Description. A. Specimen A is received fresh labeled ""hepatic artery lymph node."" The specimen consists of. a 2.0 x 1.5 x 1.0, moderately firm gray tan irregular lymph node which is serially sectioned and entirely. submitted as A1-A2. B. Specimen B is received fresh for frozen section analysis labeled ""subtotal pancreatectomy and. spienectomy."" The specimen consists of a subtotal pancreatectomy (8.0 x 4.0 x 2.5 cm) attached to a. grossly unremarkable spleen (14.0 x 8.0 x 6.0 cm). Both specimens are adherent to a moderate. amount of fat. The pancreatic margin of resection is stapled. The staples are removed and the. underlying tissue is removed tangentially and entirely submitted on frozen section as FSB1. The. pancreatic duct is markedly dilated but is probe-patent for approximately 2 cm where it is filled with. a. soft brown tan protruding tissue (possible tumor). The end of the pancreas which attaches to the. spleen is markedly indurated and exhibits a gray white smooth ill-defined mass (3.0 x 2.5 x 2.0 cm). abutting the soft tissue margin of resection and is approximately 4 cm from the pancreatic margin of. resection. The mass at this point totally occludes the pancreatic duct. The mass occupies. approximately 75% of the pancreas. The random pancreatic parenchyma is lobulated gray tan grossly. unremarkable. The capsule of the spleen is brown tan and intact. The cut surface exhibits a soft red brown tissue. with grossly unremarkable parenchyma. Sectioning of the adipose tissue isolates no definitive fymph. nodes. A representative section of the tumor is submitted to Tissue Procurement Laboratory. Representative sections are submitted as: B2: Mirror image of tumor submitted to Tissue Bank. B3-B6: Sections of tumor showing relationship to soft tissue margin of resection. B7-B8: Sections of tumor showing relationship to pancreatic duct. B9: Grossly unremarkable pancreatic parenchyma. B10: Grossly unremarkable spleen. B11-B26: Representative sections of adipose tissue. c. Specimen C is received fresh labeled ""splenule."" The specimen consists of what grossly. appears to be a lobule of spienic tissue partially covered by adipose tissue (2.5 x 2.0 x 2.0 cm). The. overlying adipose tissue is marked with black ink. The specimen is serially sectioned and reveals a. red brown grossly unremarkable splenic parenchyma. Representative sections submitted as C1. D. Specimen D is received fresh for frozen section analysis labeled ""gallbladder grossly check for. polyps. The specimen consists of a club-shaped gallbladder (8.0 x 3.0 x 1.5 cm). Te external surface. is green yellow, wrinkled with a small amount of attached fibroadipose tissue. The lumen is filled with. a. green vicile bile. No calculi grossly appreciated. There are several adherent soft lesions (possible. polyps) ranging from 0.2 cm to 0.5 cm in greatest dimension. A representative section of these. lesions is submitted for frozen section as FSD1. The remainder of the mucosal surface is. green-yellow, velvet-like and grossly unremarkable. Permanent representative sections are submitted. as D2-D3.",train,3 x 2.5: cm;3.0 cm;2.5x2.0 cm
1442,TCGA-3A-A9IV.A0D8875D-EBF7-4D76-945F-3CDFB6B9A351,"Final Diagnosis. A. LYMPH NODE, HEPATIC ARTERY, EXCISION: One lymph node, negative for metastatic carcinoma (0/1). B. PANCREAS AND SPLEEN, SUBTOTAL PANCREATECTOMY AND SPLENECTOMY: Pancreatic endocrine neoplasm, grade 2. Tumor size: 3 x 2.5: cm. Surgical margins: Free of tumor. Necrosis: present. Mitotic rate: 7/10 HPFs. Fifteen regional lymph nodes with no evidence of metastasis. Unremarkable spleen. See Key Pathological Findings. C. ACCESSORY SPLEEN, ""SPLENULE"", EXCISION: Unremarkable splenic parenchyma. D. GALLBLADDER, CHOLECYSTECTOMY: Chronic cholecystitis and cholesterolosis. No evidence of dysplasia or malignancy. I,. the attending pathologiat, personally reviewed all. aliues and / or materials and rendered the final diagnosis. Electronically. Key Pathological Findings. B: Pancreas Endocrine. SPECIMEN: Tail of pancreas. Spleen. SPECIMEN: Splenectomy. TUMOR SITE: Pancreatic fail. TUMOR SIZE: Greatest dimension: 3.0 cm. Additional dimensions: 2.5x2.0 cm. TUMOR FOCALITY: Unifocal. HISTOLOGIC TYPE: Well-differentiated neuroendocrine tumor. WORLD HEALTH ORGANIZATION CLASSIFICATION: Well-differentiated endocrine tumor, uncertain behavior. FUNCTIONAL TYPE: Cannot be assessed. MITOTIC ACTIVITY: Greater than or equal to 2 mitoses/10 HPF to 10 mitoses/10 HPF; number of mitoses per 10. HPF: 7 mitoses / 10 high power fields. Ki67 LABELING INDEX: 3%-20% Ki67-positive cells. TUMOR NECROSIS: Present. MICROSCOPIC TUMOR EXTENSION: Tumor is confined to pancreas. MARGINS: Margina uninvolved by tumor. Distance of tumor from closest margin: 0.2 mm. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT): pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension. REGIONAL LYMPH NODES (pN): pNO: No regional fymph node metastasis. Number examined: 16. Number involved: 0. DISTANT METASTASIS. ADDITIONAL PATHOLOGIC FINDINGS: PANIN lla. ANCILLARY STUDIES: The neoplastic cells are positive for synaptophysin, focally positive for chromogranin by. immunohistochemistry. The Ki-67 immunostain is positive in approximately 15% of the. neoplastic cells. COMMENT(S). B2-7 adequate for molecular studies. Specimen(s) Received. A. HEPATIC ARTERY LYMPH NODE. B. SUBTOTAL PANCREATECTOMY AND SPLENECTOMY FS. C. SPLENULE. D. GALLBLADDER GROSSLY CHECK FOR POLYP. Clinical History. Y/O FEMALE MORBID OBESITY, HM-ASTHMA. Preoperative Diagnosis. PANCREATIC NEUROENDOCRINE TUMOR. Intraoperative Consultation. FSB1 SUBTOTAL PANCREATECTOMY AND SPLENECTOMY: Pancreatic margin, no evidence of malignancy. GROSS EXAMINATION. D. GALLBLADDER GROSSLY CHECK FOR POLYP: Partially calcified mucosal polyps, measuring 3 mm to 5 mm. FSD1 GALLBLADDER GROSSLY CHECK FOR POLYP: Largest polyp no evidence of malignancy. Intradepartmental Consultation: The case was also reviewed by. MD, who concurs. with the above interpretation (FSD1). Comment: These frozen section diagnoses/results were communicated to and acknowledged by Dr. I.D., have performed the intraoperative consultations and issued the above. diagnosis. Gross Description. A. Specimen A is received fresh labeled ""hepatic artery lymph node."" The specimen consists of. a 2.0 x 1.5 x 1.0, moderately firm gray tan irregular lymph node which is serially sectioned and entirely. submitted as A1-A2. B. Specimen B is received fresh for frozen section analysis labeled ""subtotal pancreatectomy and. spienectomy."" The specimen consists of a subtotal pancreatectomy (8.0 x 4.0 x 2.5 cm) attached to a. grossly unremarkable spleen (14.0 x 8.0 x 6.0 cm). Both specimens are adherent to a moderate. amount of fat. The pancreatic margin of resection is stapled. The staples are removed and the. underlying tissue is removed tangentially and entirely submitted on frozen section as FSB1. The. pancreatic duct is markedly dilated but is probe-patent for approximately 2 cm where it is filled with. a. soft brown tan protruding tissue (possible tumor). The end of the pancreas which attaches to the. spleen is markedly indurated and exhibits a gray white smooth ill-defined mass (3.0 x 2.5 x 2.0 cm). abutting the soft tissue margin of resection and is approximately 4 cm from the pancreatic margin of. resection. The mass at this point totally occludes the pancreatic duct. The mass occupies. approximately 75% of the pancreas. The random pancreatic parenchyma is lobulated gray tan grossly. unremarkable. The capsule of the spleen is brown tan and intact. The cut surface exhibits a soft red brown tissue. with grossly unremarkable parenchyma. Sectioning of the adipose tissue isolates no definitive fymph. nodes. A representative section of the tumor is submitted to Tissue Procurement Laboratory. Representative sections are submitted as: B2: Mirror image of tumor submitted to Tissue Bank. B3-B6: Sections of tumor showing relationship to soft tissue margin of resection. B7-B8: Sections of tumor showing relationship to pancreatic duct. B9: Grossly unremarkable pancreatic parenchyma. B10: Grossly unremarkable spleen. B11-B26: Representative sections of adipose tissue. c. Specimen C is received fresh labeled ""splenule."" The specimen consists of what grossly. appears to be a lobule of spienic tissue partially covered by adipose tissue (2.5 x 2.0 x 2.0 cm). The. overlying adipose tissue is marked with black ink. The specimen is serially sectioned and reveals a. red brown grossly unremarkable splenic parenchyma. Representative sections submitted as C1. D. Specimen D is received fresh for frozen section analysis labeled ""gallbladder grossly check for. polyps. The specimen consists of a club-shaped gallbladder (8.0 x 3.0 x 1.5 cm). Te external surface. is green yellow, wrinkled with a small amount of attached fibroadipose tissue. The lumen is filled with. a. green vicile bile. No calculi grossly appreciated. There are several adherent soft lesions (possible. polyps) ranging from 0.2 cm to 0.5 cm in greatest dimension. A representative section of these. lesions is submitted for frozen section as FSD1. The remainder of the mucosal surface is. green-yellow, velvet-like and grossly unremarkable. Permanent representative sections are submitted. as D2-D3.",duplicate record,
1446,TCGA-60-2719.1843b1c7-9197-4595-ad5d-862e0f1ec3f8,"SPECIMEN(S): A. 4R LYMPH NODE. B. LEVEL 7. C. 4L LYMPH NODE. D. RIGHT LEVEL 4 LNODE. E. RIGHT UPPER LOBE. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: RUL small cell lung ca. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSA-FSD: Lymph nodes - negative for tumor. FSE: Bronchial margin - negative for tumor. GROSS DESCRIPTION: A. 4R LYMPH NODE. Received fresh for frozen section is a tan-pink lymph node 0.4 x 0.2 x 0.1 cm. The specimen is. submitted entirely for frozen section in FSA1. B. LEVEL 7. Is a tan-pink aggregate of lymphoid tissue 0.7 x 0,4 x 0.2 cm. The entire specimen is submitted. for frozen section in FSB1. C. 4L LYMPH NODE. Is an aggregate of lymphoid tissue 0,5 X 0.3 x 0.2 cm. The specimen is submitted entirely for. frozen section in FSC1. D. RIGHT LEVEL 4 LYMPH NODE. Is a tan-pink aggregate of lymphoid tissue 0.8 x 0.8 x 0.3 cm. The specimen is submitted entirely. for frozen section in FSD1. E.LUNG, RIGHT UPPER LOBE,LOBECTOMY;. Received fresh and labeled with the patient name. right upper lobe"", is a. 121-gram lobectomy specimen measuring 14.5 x 10.7 x 2.3 cm. There is a defect on the pleural. surface exposing a mass measuring 3.0 x 2.5x1.5 cm. The mass is hemorrhagic and necrotic. It. extends to within 0.3 cm of the pleural margin and 1.2 cm from the bronchial margin. A shave. section is taken of the bronchial margin for frozen section. The bronchi are opened and they. have a smooth tan appearance. The lung is sectioned and the parenchyma has a variegated pink. and anthracotic appearance as well as areas of congestion. Possible anthracotic lymph nodes are. identified. Portions of mass were submitted for tissue procurement. Representative sections are. submitted as follows: FSE1: Shave section of bronchial margin. E2-E5: Sections of mass including relationship to normal appearing parenchyma and. pleural margin. E6: Additional portions of uninvolved parenchyma. E7: Possible lymph nodes. DIAGNOSIS: A. 4R RIGHT LYMPH NODE. - ANTHRACOSIS OF ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). B. LEVEL 7 LYMPH NODE: - ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). C. 4L LEFT LYMPH NODE: - ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). D. RIGHT LEVEL 4 LYMPH NODE: ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). E. LUNG, RIGHT UPPER LOBE, LOBECTOMY SPECIMEN: - NON SMALL CELL CARCINOMA (CONSISTENT WITH MODERATE TO. POORLY DIFFERENTIATED SQUAMOUS CELL CARCINOMA) WITH AREAS OF. NECROSIS OF UPPER LOBE OF RIGHT LUNG. - SIZE OF TUMOR 3.0 X 2.5 X 1.5 CM. - CONGESTION AND FOCAL ATELECTATIC CHANGE. - SIX PERIBRONCHIAL LYMPH NODES - (0/6) NEGATIVE FOR TUMOR. - MARGINS OF RESECTION - NEGATIVE FOR TUMOR. SYNOPTIC REPORT - LUNG. Specimens Involved. Specimens: E: RIGHT UPPER LOBE. Surgical Procedure: Lobectomy. Laterality: Right. Tumor Site: Upper lobe. Tumor Location: Central. Tumor Size: Greatest diameter: 3cm. Additional dimensions: 2.5cm x 1.5cm. WHO CLASSIFICATION. Squamous cell carcinoma. Comment(s): Non small cell carcinoma. Histologic Grade: poorly to moderately differentiated. Angiolymphatic Invasion: Absent. Bronchial Margins: Bronchial margins uninvolved. Tumor Distance from margin: 1.2cm. Visceral Pleural Involvement: Absent. Satellite Tumor(s): Absent. Lymph Node Involvement: N1: Ipsilateral Hilar and/or Peribronchial (levels 10-14). Negative 016. N2: Ipsilateral Mediastinal and/or Subcarinal (Levels 1-9). Negative 0/3. N3: Contralateral Mediastinal/Hilar, Scalene or Supraclavicular. Negative 0/1. Non-Neoplastic Lung: Emphysematous changes. congestion and focal atelectatic change. Additional Pathologic Findings: None identified. Pathological Staging (pTNM): pT 1. M x.",train,3.0 x 2.5 x 1.5 CM;3cm;2.5cm x 1.5cm
1467,TCGA-OK-A5Q2.8F2F2141-EC62-4321-B799-054D32FEBA87,"Infiltrating Lobular Carcinoma. CATEGORY: BREAST INVASIVE CARCINOMA-INFILTRATING LOBULAR. CARCINOMA. FROM PRIMARY BREAST SURGERY. CLINICAL HX - Invasive lobular carcinoma. RIGHT BREAST, MASTECTOMY - Invasive lobular carcinoma, focally pleomorphic type,. 3.0cm in greatest microscopic dimension, associated with extensive duct carcinoma in-situ. (DCIS), intermediate nuclear grade, solid type with comedo necrosis. [Nottingham histologic. grading system utilized- SBR score 7; architectural grade 3, nuclear grade 2, mitotic grade 2). No. lymphatic invasion is identified. Deep margin negative for tumor. Vessel wall calcifications. Intraductal papilloma, radial scar and fibrocystic changes including sclerosing adenosis. Skin and. nipple, unremarkable. Prior biopsy site changes. RIGHT AXILLARY CONTENTS, EXCISION - Metastatic carcinoma present in two of the. thirteen lymph nodes (2/13). Largest metastatic focus measures 4mm in greatest microscopic. dimension. No extranodal extension is identified. Comment: AJCC pathologic stage pT2N1aMx. Synoptic summary will follow as an addendum. ADDENDUM 1: RIGHT BREAST, MASTECTOMY - Immunohistochemical stain for HER-2-NEU oncoprotein. is negative (performed on formalin-fixed paraffin embedded sections by manual semiquantitative. morphometric analysis with appropriate positive and negative controls). No membranous staining. is seen. The HER-2-NEU procedure was performed using monoclonal antibody 4B5 and DAB. detection system. (Staining interpretation: Weak = 1+; Moderate = 2+; Strong = 3+.). NOTE. This evaluation was performed according to ASCO/CAP guidelines: Positive HER2/neu. cases are those with strong and complete membrane staining (3+) in greater than 30% of invasive. cancer cells. Negative cases are defined as those with no staining (0) or weak, incomplete. membrane staining (1+) in any proportion of cells. Equivocal cases are those cases with strong. staining in less than or equal to 30% of cells, or less than strong but complete membrane staining. (2+) in at least 10% of cells. Immunohistochemical stains were performed on formalin-fixed. paraffin embedded tissue with appropriate positive and negative controls. ADDENDUM 2. Specimen Type - Mastectomy. Lymph node Sampling - Axillary dissection. Specimen Size. Greatest dimension 3cm. Histologic Type - Invasive lobular. Grading System - Nottingham. Tubule Formation - Minimal less than 10% (score = 3). Nuclear Pleomorphism - Moderate. increase in size, etc (score = 2). Mitotic Count - 40X objective field with a field area of 0.152. mm2: 6 to 10 mitoses per 10 HPF (score = 2). Total Nottingham Score - Grade II: 6-7 points. Margins uninvolved by invasive carcinoma. Distance from closest margin: 5mm. Deep Primary. Tumor [pT]: pT2 - Tumor greater than or equal to 2.0-5.0cm. Regional Nodes [pN]: pN1a: Metastasis in 1 to 3 axillary lymph nodes (at least 1 tumor deposit greater than 2.0mm). Number. involved: 2. Number examined: 13. Distant Metastasis [pM]: pMX - cannot be assessed. FROM DIAGNOSIS. CLINICAL HX - Right irregular mass, Right ax tail lymph node. RIGHT BREAST, 10:00. MASS, CORE BIOPSY - Invasive, lobular carcinoma with focal duct carcinoma in situ, solid. type, low nuclear grade. Intraductal papilloma involved by lobular carcinoma in-situ. RIGHT. AXILLA, LYMPH NODE, CORE BIOPSY - Lymph node with metastatic carcinoma. histologically identical to breast carcinoma. COMMENT. Prognostic/predictive markers are. being performed and results will follow as an addendum. ADDENDUM: Results of. immunoperoxidase steroid receptor protein determination on paraffin sections, visually evaluated. using DAB detection system and monoclonal antibodies (manual semiquantitative morphometric. 7. analysis): ESTROGEN RECEPTOR PROTEIN (ER- clone SP1): POSITIVE; PROGESTERONE. RECEPTOR PROTEIN (PR- clone 1E2): POSITIVE. Estimated percentage of nuclei staining. positive (ER): 100; Estimated percentage of nuclei staining positive (PR): 25. Intensity of. staining, ER: 3+ (strong). Intensity of staining, PR: 3+ (strong). Immunohistochemical stain for. HER-2-NEU oncoprotein is NEGATIVE (performed on formalin-fixed paraffin embedded. sections by manual semiquanitative morphometric analysis). No membranous staining is seen. The HER-2-NEU procedure was performed using monoclonal antibody 4B5 and DAB detection. system. 8.",train,3.0cm
1484,TCGA-69-8255.d807cbcd-b72d-47f5-975b-347782728e94,"De-Identified Specimen Code: M. SPECIMEN SUBMITTED: Part A: POSTERIOR SEGMENT RIGHT. UPPER LOBE. Part B: LEVEL 10 R. Final Diagnosis. 1. Right lung, upper lobe, wedge excision (A) Adenocarcinoma, solid predominant (40%) with. acinar (40%), and lepidic (20%) patterns. - Mild centrilobular emphysema. - See comment. 2. Lymph node, level 10R, excision (B) Hylanized lymph node, negative for neoplasm. Diagnosis Comment: 1. The tumor measures 1.6 cm in greatest dimension. No invasion into or through the pleural is seen. The. parenchymal margin of excision is negative for neoplasm. Further studies to define the origin of this. adenocarcinoma will be performed and the results of those studies reported as an addendum. Intraoperative Diagnosis: A. Adenocarcinoma. Margin negative. Clinical Diagnosis: LUNG NODULES. Gross Description: A. Received fresh for frozen section diagnosis labeled ""posterior segment right upper lobe"" is a wedge. of lung measuring 14.8 X 5.2 x 2.7 cm, and weighing 39.1 grams. A staple line is present and inked. orange. The pleural surface displays a puckered area measuring 1.2 X 0.8 cm and is located 3.2 cm. from the orange inked parenchymal margin. The remainder of the pleural surface is smooth and. glistening. The puckered area is inked blue. Upon sectioning, a stellate tan-gray firm nodule is identified. in the puckered region measuring 1.6 X 1.2 X 1.0 cm, and extending within 2.7 cm of the parenchymal. line of resection and appears to extend into, but not through the pleura. The remainder of the. parenchyma is unremarkable. Other masses, lesions, nodules are not present. The mass is totally. submitted. The nodule is totally submitted as follows: A1 nodule with closest pleural involvement, A2. perpendicular line of resection representative section, A3-A5 nodule with pleural surface, A6 remainder. of nodule totally submitted, A7 additional representative section of parenchymal margin, A8. representative section of apparent uninvolved tissue. B. Received fresh is a tan-black nodule resembling lymph node measuring 0.4 X 0.3 X 0.2 cm. The. specimen is not sectioned. Totally submitted in one cassette. Microscopic: {Not Entered}.",train,1.6 cm
1493,TCGA-55-6968.87f5cbe6-cce1-4a8c-8189-c6feabd3b4bb,"DIAGNOSIS. DIAGNOSIS: Lymph node, level 9, biopsy: Anthracosis. Negative for malignancy (two small lymph nodes). Lymph nodes, level 7, excisional biopsy: Anthracosis and reactive change, two lymph nodes. Both are negative for malignancy. Lung, right lower lobe, wedge resection: Adenocarcinoma, poorly differentiated, with extensive necrosis. Stapled surgical margin is free of malignancy. Malignancy extends to within 0.1 mm of free pleural surface. Malignancy is 1.6 cm in greatest dimension. Definite lymphovascular space invasion is not identified. COMMENTS: The malignancy is poorly differentiated, present in sheets in some areas. Focally, however, definite gland formation is present. The small cell compone. is not identified. The frozen section diagnosis is confirmed. Staging sheet # 22. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: with right lung masses, rule out malignancy. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Level 9 lymph node. B. Level 7 lymph node. C. Right lower lobe lung nodule. SPECIMEN DATA. GROSS DESCRIPTION: is a 0.5 cm soft yellow slightly lobular fragment. It is submitted whole in one cassette. is a 1.1 x 0.6 x 0.2 cm rubbery brown lymph node. It is bisected and entirely submitted in one cassette. and RLL nodule is a 6.3 gram wedge of lung tissue, 4.5 X 1.5 X 0.7 cm. The specimen has been partially sampled for frozen section. The. margin is inked stapled. The pleura is gray and remarkable for an area of firm yellow discoloration and nodularity. The staple is removed, the margin is inked and shaved. Further sectioning reveals a yellow chalky firm nodule, 1.6 x 1.5 x 1.4 cm. The. nodule. is. 0.2. from the shave staple margin and less than 0.1 cm from the inked pleura. The uninvolved tissue is brown and spongy. Representative sections are submitted as follows: 1--frozen section residue; 2 and 3--shave staple margin; 4 to 6--perpendicular sections through lesic. 7--uninvolved tissue. Cassette A research tissue labeled. INTRA-OPERATIVE CONSULTATION:",train,1.6 cm
1548,TCGA-EJ-5507.153de441-fbe9-4c8b-9a84-9cdf9c5edcf2,"PATIENT HISTORY. The patient is a. vith a history of PSA value of 8.85. The patient also has a history of biopsy on. his biopsy reveals: poorly-differentiated prostatic adenocarcinoma, Gleason score 4+3 = 7 in the left apex, teit. base, right rapex, right mid and right base of the prostate and poorly-differentiated prostatic adenocarcinoma, Gleason score- 3+4. =. 7 in the left mid of the prostate. The patient also has a history of a. PRE-OP DIAGNOSIS: Prostate cancer. POST-OP DIAGNOSIS: Same. PROCEDURE: Radical prostatectomy. ADDENDA: Addendum. Specimen labeled ""right pedicle margin"" has been evaluated with multiple levels and PSA, racemase, CK903 and p63. iimmunohistochemical stains. The immunohistochemical stains show PSA expression in the glands, confirming prostatic origin. Immunohistochemical. stains show expression of racemase in these glands. Presence of basal cells is confirmed by CK903 and p63. immunohistochemical stains. This immunohistochemical profile suggests these glands represent high grade prostatic intraepithellal neoplasia. No. evidence of invasive carcinoma is seen. FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT PELVIC, EXCISION -. A. METASTATIC CARCINOMA IN 1 OF 13 LYMPH NODES (1/13). B. EXTRANODAL EXTENSION IS PRESENT. PART 2: LYMPH NODES, LEFT PELVIC, EXCISION -. METASTATIC CARCINOMA IN 1 OF 8 LYMPH NODES (1/8). PART 3: PROSTATE AND BILATERAL SEMINAL VESICLES, RADICAL PROSTATECTOMY. A. PROSTATE ADENOCARCINOMA, GLEASON SCORE 4 + 5 = 9. B. THE CARCINOMA INVOLVES BOTH THE RIGHT AND LEFT LOBES AND HAS A GREATEST NODULAR DIAMETER OF. 2 CM IN ONE HISTOLOGIC SECTION (SLIDE 3U). C. THE CARCINOMA INVOLVES 35% OF THE EXAMINED PROSTATE VOLUME. D. EXTENSIVE EXTRAPROSTATIC EXTENSION IS PRESENT. E. BILATERAL SEMINAL VESICLES ARE INVOLVED BY CARCINOMA,. F. THE INKED MARGINS OF RESECTION ARE FREE OF CARCINOMA. G. EXTENSIVE PERINEURAL INVASION IS IDENTIFIED. H. HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA IS IDENTIFIED. 1. PATHOLOGIC TNM STAGE: pT3b N1 MX. J. BACKGROUND PROSTATE TISSUE WITH NODULAR HYPERPLASIA AND CHRONIC INFLAMMATION. PART 4: RIGHT PEDICLE MARGIN, BIOPSY-. A. FIBROVASCULAR TISSUE, WITH PROMINENT CRUSH ARTIFACT, AND FOCAL ATYPICAL AREAS. B. IMMUNOHISTOCHEMICAL STAINS PENDING, REPORT TO FOLLOW IN AN ADDENDUM. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY PROSTATE TUMORS. CLINICAL DATA: PSA value: 8.85. INVASIVE CA IDENTIFIED?: TUMOR HISTOLOGY: Adenocarcinoma NOS. PRIMARY GLEASON GRADE;. 4. SECONDARY GLEASON GRADE: 5. GLEASON SUM SCORE: 9. GLEASON 4/5 PERCENTAGE: 95%. WEIGHT OF PROSTATE: 41.11gm. TUMOR SIZE: Maximum dimension: 2 cm. LOBE LATERALITY: Right and Left Lobes. PERCENT OF SPECIMEN INVOLVED BY TUMOR: > 25%. MULTIFOCAL DISEASE: HIGH GRADE PIN: Yes multifocal. EXTRAPROSTATIC EXTENSION: Yes - Established (> 0.8mm). PERINEURAL INVASION: ANGIOLYMPHATIC INVASION: Unknown. SEMINAL VESICLE INVASION: SURGICAL MARGIN INVOLVEMENT: All surgical margins free of tumor. RESIDUAL TUMOR: LYMPH NODES EXAMINED: 21. LYMPH NODES POSITIVE: 2. EXTRANODAL EXTENSION: SIZE OF NODAL METASTASIS: 1.5mm. T STAGE, PATHOLOGIC: pT3b. N STAGE, PATHOLOGIC: pN1. M STAGE, PATHOLOGIC: pMX. HISTOLOGIC GRADE: G3-4, Poorly differentiated/undifferentiated.",train,2 cm
1557,TCGA-19-0964.ba3dbed0-2bee-4188-9857-dff35f8d6a01,"DATUAL onv REDORT. FINAL DIAGNOSIS. A-C. LEFT TEMPORAL LOBE OF BRAIN, TUMOR, EPIDURAL TISSUE, AND DURA: -- GLIOBLASTOMA WITH EXTENSIVE SPINDLE CELL DIFFERENTIATION (""GLIOSARCOMA""). INVOLVING LEPTOMENINGES, DURA MATER, AND SKULL. Note: Immunohistochemical stains were used in the assessment of this malignancy. By the signature on this report, the individual or group listed as making the Final Interpretation/Diagnosis certifies that they. have reviewed this case. Intraoperative Consult Diagnosis. A. Touch Imprint: Meningioma, at least Grade 2. B. Touch Imprint: Meningioma, at least Grade 2. Addendum/Procedures: ANCILLARY TESTING. Date Complete: Results-Comments. One or more of the reagents used to perform assays on this specimen MAY have contained components. considered to be analyte specific reagents (ASR's). ASR's have not been cleared or approved by the U.S.Food. and Drug Administration. These assays were developed and their performance characteristics determined by. the The assays were performed with appropriate positive and negative controls. Clinical History: LEFT BRAIN TUMOR. Specimens Submitted As: A: TUMOR AND EPIDURAL TISSUE. B: DURA. C: TUMIOR CEREBRAL. Gross Description: A: Received fresh, for intraoperative consultation, labelled with the patient's name, number and. ""tumor and epidural tissue"", are multiple irregularly-shaped fragments of tan-white and hemorrhagic. portions of membranous and rubbery tissue, 1.8 X 0.8 X 0.3 cm in aggregate. A portion of the. fragments are submitted for frozen section. The specimen is submitted entirely in two cassettes. B: Received fresh, for intraoperative consultation, labelled with the patient's name, number and. ""dura"", is a 4.8 x 3.2 X 0.1 cm tan-white, membranous fragment of tissue. The specimen is serially. sectioned and submitted entirely in three cassettes. C:Received in formalin labeled with the patient's name and number, are multiple irregular, opaque. white to pink-tan, soft cerebriform tissue fragments measuring in aggregate 4.0 X 3.0 : X 1.1 cm. Submitted entirely in three cassettes. Summary of Cassettes: Specimen. Label. Site. A. 1. frozen section. 2. remainder of the specimen.",train,
1566,TCGA-KR-A7K0.34BFDBBD-A66F-4436-AD51-D6AA979F2CD3,"PREVIOUS DIAGNOSIS INQUIRY. 10. REPORT DATE: SEX: M. ADM DATE: BIRTHDATE: OPER DATE: PROCEDURE: SPHS. Liver cancer. Operative Procedure/Tissue Submitted: Laparoscopic assisted. liver resection. PROCEDURE: SPGD. 1. ""Gallbladder."" Received in formalin in a medium container is a previously. disrupted 11.8 x 4.6 x 1.6 cm gallbladder with focally adhesed serosa. The. Lumen is devoid of content. The mucosa is red-tan, velvety with a 0.2 cm. average wall thickness. The cystic duct is patent and there are no separate. stones in the container. 1A. Gallbladder. 2. ""Segment 5-6 liver resection, gross margins."" A 5.5 x 5.0 x 4.8 cm, 65 gm. resection of liver with nodular capsular surface. The margin is inked black. A. 2.1 cm nodule is 1.9 cm from the margin. The nodular mass comes to within 0.1. cm of the capsule. The remaining parenchyma has multiple nodules that average. 0.4 cm in greatest dimension. The diffuse nodular parenchyma is focally. fibrous. 2A-D. Mass with nodular parenchyma and surgical margin. INTRAOPERATIVE GROSS: PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 11. SEX: M. BIRTHDATE: ADM DATE: OPER DATE: 2. A 2.1 cm nodule is 1.9 cm from margin. PROCEDURE: SPMI. LIVER: HEPATOCELLULAR CARCINOMA. WAS THE TUMOR PREVIOUSLY TREATED?: No. TUMOR TYPE: Ordinary. SINGLE OR MULTIPLE MASSES: Single. MAXIMUM DIAMETER OF LARGEST MASS: 2.1 cm. ARE THE MARGINS OF RESECTION FREE OF TUMOR?: Yes. VASCULAR INVASION?: No. INVASION THROUGH THE CAPSULE TO THE SEROSAL SURFACE?: No. LYMPH NODE METASTASES?: Unknown. DISTANT METASTASES?: Unknown. IS THE LIVER CIRRHOTIC?: Yes, cryptogenic. pT1 NX. PROCEDURE: SPDX. 1. Gallbladder, resection: No significant abnormality. 2. Liver, segments 5 and 6, resection: Well-differentiated hepatocellular. carcinoma (2.1cm). Margins negative. Cryptogenic cirrhosis. Please see. TEMPLATE for details.",train,
1581,TCGA-EL-A3ZQ.1C104C06-BB8E-49C8-851E-79D0EC5C89B0,"Case type: Surgical Case. DIAGNOSIS. (A) TOTAL THYROIDECTOMY: PAPILLARY THYROID CARCINOMA, CONVENTIONAL TYPE. Location: Right lobe. Multi-focal: No. Size = 3.6 cm. Extrathyroidal extension: Absent. Lymphovascular invasion: Absent. Resection Margins: Negative. Background Thyroid: mild chronic lymphocytic thyroiditis. Lymph nodes: No tumor present in 1 lymph node. GROSS DESCRIPTION. (A) TOTAL THYROIDECTOMY, DOMINANT NODULE ON RIGHT - an asymmetric thyroid with right lobe distended (4.0 x 3.1. x. 2.0. cm), isthmus (2.0 x 1.0 0.3 cm) and left lobe (4.5 x 1.5 x 0.8 cm) with smooth surface overlying the entire gland. The right lobe is replaced by a pink-tan nodule filling the lobe (3.6 x 2.8 x 2.0, with scant rim of normal parenchyma. grossly identified. The isthmus and left lobes are unremarkable without extension of the mass into this region. SECTION CODE: A1-3, Left lobe representative superior to inferior; A4-5, isthmus; A6-A16 Right lobe from superior. to inferior with mass. CLINICAL HISTORY. Papillary thyroid carcinoma. SNOMED CODES. T-B6000, M-80503, M-B0630. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been specifically cleared or. approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by: i.",train,3.6 cm
1619,TCGA-DW-7836.d04b8436-e888-42d1-9e9e-37754888704b,"DIAGNOSIS: 1. Kidney, right, tumor #1, excision: Renal cell carcinoma with features of papillary RCC type 1 with solid and. clear cell areas; see note. 2. Kidney, right, tumor #2, excision: Multiple foci of renal cell carcinoma with features of papillary RCC type 1 with. solid areas; see note. NOTE: The case will be discussed with. and a supplemental report will follow, if indicated. CLINICAL INFORMATION: Brief Clinical History: with HPRC and right renal mass. Specimen Taken For Protocol: 01 - Yes Allocate Order to Protocol: PROCEDURE: Operative Findings: two right renal masses Post-Operative Diagnosis: renal mass Pre-Operative Diagnosis: renal mass. SPECIMENS SUBMITTED: 1. TUMOR, #1. 2. TUMOR, #2 Right Kidney. GROSS DESCRIPTION: Received for procurement labeled with the patient's name, medical record number, and. further described as follows are: 1. ""Tumor #1"" is a 1. 1 X 1.1 x 1 cm white soft tissue fragment. The cut surface is tan homogeneous. 60% is. procured for the. a 0.1 CC amount is procured for electron microscopy, and the remainder is sent to Surgical. Pathology. At Surgical Pathology, the specimen is received and matches the above description. It is serially. sectioned and entirely submitted in cassette. for permanent processing. 2. ""Tumor #2 right kidney"" is a 2.5 X 2.2 X 2 cm soft tissue fragment with a white/tan, variegated cut surface. Attached normal parenchyma is seen. 35% is procured the. a 0.1 CC fragment is sent for electron. microscopy, and the remainder is sent to. At. the specimen is received. and matches the above description and is entirely submitted in cassette. for permanent. processing. The above procurement was performed by. on. No consultants.",train,1. 1 x 1.1 x 1 cm;2.5 X 2.2 X 2 cm
1640,TCGA-BT-A42C.8716FEB2-A4DD-4EFF-B1A6-D679A5C75C76,"FINAL DIAGNOSIS: PART 1: RIGHT URETER, DISTAL, SHAVE MARGIN, BIOPSY-. A. BENIGN URETER. B. NEGATIVE FOR NEOPLASIA. PART 2: LEFT, URETER, DISTAL, SHAVE MARGIN, BIOPSY-. A. BENIGN URETER. B. NEGATIVE FOR NEOPLASIA. PART 3: URINARY BLADDER, DISTAL URETERS, PROSTATE, BILATERAL SEMINAL VESICLES, AND BILATERAL DISTAL. VASA DEFERENTIA, RADICAL CYSTOPROSTATECTOMY -. A. INVASIVE UROTHELIAL CARCINOMA, HIGH-GRADE (2004 WHO/ISUP) (SLIDES 3E, 3F, 3L, 3R, 3S, 3T, 3U, 3V),. ASSOCIATED WITH FOCAL HIGH-GRADE PAPILLARY UROTHELIAL CARCINOMA (SLIDES 3H, 30, 3S). TUMOR. MEASURES 3.5 x 1.5 x 0.4 CM, AND IS PRESENT IN THE LEFT LATERAL WALL AND TRIGONE. CARCINOMA. INFILTRATES INTO THE SUPERFICIAL DETRUSOR MUSCLE (INNER HALF). B. UROTHELIAL DYSPLASIA THROUGH CARCINOMA IN SITU IS PRESENT IN THE RIGHT URETERAL OSTIUM. (SLIDE 3G), LEFT URETERAL OSTIUM (SLIDE 3H), AND ANTERIOR WALL / DOME (SLIDE 3N). C. NO DEFINITIVE ANGIOLYMPHATIC INVASION IS IDENTIFIED (SLIDE 3E). D. ALL EXAMINED SURGICAL RESECTION MARGINS ARE FREE OF UROTHELIAL NEOPLASIA. E. TNM PATHOLOGIC STAGE: pT2a NO MX (SEE SYNOPTIC). F. BACKGROUND BLADDER WITH GRANULOMATOUS INFLAMMATION (HISTORY OF BCG THERAPY) AND. BIOPSY SITE CHANGES. G. BENIGN PROSTATE WITH MULTIFOCAL NECROTIZING GRANULOMAS (HISTORY OF BCG THERAPY),. NODULAR HYPERPLASIA, FOCAL GLANDULAR ATROPHY, AND CHRONIC INFLAMMATION. H. BENIGN BILATERAL SEMINAL VESICLES. PART 4: LYMPH NODES, RIGHT PELVIC, EXCISION. A. NO EVIDENCE OF MALIGNANCY IN SEVENTEEN LYMPH NODES (0/17). B. ONE LYMPH NODE WITH FEW NON-NECROTIZING GRANULOMAS (SLIDE 4B). PART 5: LYMPH NODES, LEFT PELVIC, EXCISION. A. NO EVIDENCE OF NEOPLASIA IN SIX LYMPH NODES (0/6). B. ONE LYMPH NODE WITH A SMALL NON-NECROTIZING GRANULOMA (SLIDE 4K). CASE SYNOPSIS: SYNOPTIC DATA . PRIMARY URINARY BLADDER TUMORS. SPECIMEN TYPE: Radical cystoprostatectomy. TUMOR SITE: Trigone, Left lateral wall. TUMOR SIZE: Greatest dimension: 3.5 cm. Additional dimensions: 1.5 x 0.4 cm. HISTOLOGIC TYPE: Urothelial (transitional cell) carcinoma. ASSOCIATED EPITHELIAL LESIONS: None identified. HISTOLOGIC GRADE: Urothelial carcinoma - High-grade. TUMOR CONFIGURATION: Papillary, Flat, Ulcerated. PATHOLOGIC STAGING (pTNM): pT2a. pNO. Number of nodes examined: 23. Number of nodes involved: o. pMX. MARGINS: Margins uninvolved by invasive carcinoma. Margin(s) uninvolved by carcinoma in situ. VENOUS/LYMPHATIC (LARGE/SMALL) VESSEL INVASION (V/L): Absent. DIRECT EXTENSION OF INVASIVE TUMOR: None identified. ADDITIONAL PATHOLOGIC FINDINGS: Urothelial carcinoma in situ. Therapy-related changes.",train,3.5 x 1.5 x 0.4 CM;3.5 cm;1.5 x 0.4 cm
1640,TCGA-BT-A42C.8716FEB2-A4DD-4EFF-B1A6-D679A5C75C76,"FINAL DIAGNOSIS: PART 1: RIGHT URETER, DISTAL, SHAVE MARGIN, BIOPSY-. A. BENIGN URETER. B. NEGATIVE FOR NEOPLASIA. PART 2: LEFT, URETER, DISTAL, SHAVE MARGIN, BIOPSY-. A. BENIGN URETER. B. NEGATIVE FOR NEOPLASIA. PART 3: URINARY BLADDER, DISTAL URETERS, PROSTATE, BILATERAL SEMINAL VESICLES, AND BILATERAL DISTAL. VASA DEFERENTIA, RADICAL CYSTOPROSTATECTOMY -. A. INVASIVE UROTHELIAL CARCINOMA, HIGH-GRADE (2004 WHO/ISUP) (SLIDES 3E, 3F, 3L, 3R, 3S, 3T, 3U, 3V),. ASSOCIATED WITH FOCAL HIGH-GRADE PAPILLARY UROTHELIAL CARCINOMA (SLIDES 3H, 30, 3S). TUMOR. MEASURES 3.5 x 1.5 x 0.4 CM, AND IS PRESENT IN THE LEFT LATERAL WALL AND TRIGONE. CARCINOMA. INFILTRATES INTO THE SUPERFICIAL DETRUSOR MUSCLE (INNER HALF). B. UROTHELIAL DYSPLASIA THROUGH CARCINOMA IN SITU IS PRESENT IN THE RIGHT URETERAL OSTIUM. (SLIDE 3G), LEFT URETERAL OSTIUM (SLIDE 3H), AND ANTERIOR WALL / DOME (SLIDE 3N). C. NO DEFINITIVE ANGIOLYMPHATIC INVASION IS IDENTIFIED (SLIDE 3E). D. ALL EXAMINED SURGICAL RESECTION MARGINS ARE FREE OF UROTHELIAL NEOPLASIA. E. TNM PATHOLOGIC STAGE: pT2a NO MX (SEE SYNOPTIC). F. BACKGROUND BLADDER WITH GRANULOMATOUS INFLAMMATION (HISTORY OF BCG THERAPY) AND. BIOPSY SITE CHANGES. G. BENIGN PROSTATE WITH MULTIFOCAL NECROTIZING GRANULOMAS (HISTORY OF BCG THERAPY),. NODULAR HYPERPLASIA, FOCAL GLANDULAR ATROPHY, AND CHRONIC INFLAMMATION. H. BENIGN BILATERAL SEMINAL VESICLES. PART 4: LYMPH NODES, RIGHT PELVIC, EXCISION. A. NO EVIDENCE OF MALIGNANCY IN SEVENTEEN LYMPH NODES (0/17). B. ONE LYMPH NODE WITH FEW NON-NECROTIZING GRANULOMAS (SLIDE 4B). PART 5: LYMPH NODES, LEFT PELVIC, EXCISION. A. NO EVIDENCE OF NEOPLASIA IN SIX LYMPH NODES (0/6). B. ONE LYMPH NODE WITH A SMALL NON-NECROTIZING GRANULOMA (SLIDE 4K). CASE SYNOPSIS: SYNOPTIC DATA . PRIMARY URINARY BLADDER TUMORS. SPECIMEN TYPE: Radical cystoprostatectomy. TUMOR SITE: Trigone, Left lateral wall. TUMOR SIZE: Greatest dimension: 3.5 cm. Additional dimensions: 1.5 x 0.4 cm. HISTOLOGIC TYPE: Urothelial (transitional cell) carcinoma. ASSOCIATED EPITHELIAL LESIONS: None identified. HISTOLOGIC GRADE: Urothelial carcinoma - High-grade. TUMOR CONFIGURATION: Papillary, Flat, Ulcerated. PATHOLOGIC STAGING (pTNM): pT2a. pNO. Number of nodes examined: 23. Number of nodes involved: o. pMX. MARGINS: Margins uninvolved by invasive carcinoma. Margin(s) uninvolved by carcinoma in situ. VENOUS/LYMPHATIC (LARGE/SMALL) VESSEL INVASION (V/L): Absent. DIRECT EXTENSION OF INVASIVE TUMOR: None identified. ADDITIONAL PATHOLOGIC FINDINGS: Urothelial carcinoma in situ. Therapy-related changes.",duplicate record,
1655,TCGA-DX-A6YR.1F59D39D-6F6A-4962-91E3-DA592B27CFCE,"Clinical Diagnosis & History: with a chest wall mass. Specimens Submitted: 1: Radical resection of right chest wall mass. DIAGNOSIS: 1. Soft tissue, right chest wall, mass; radical resection: - Myxofibrosarcoma, high grade. - Tumor measures 6 cm in greatest dimension. - Tumor involves deep soft tissue and skeletal muscle. - Mitoses 12 / 10 high power fields. - Surgical resection margins are free of tumor. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Report kiectronically signed Out. Gross Description: 1) The specimen is received fresh, labeled . radical resection of right. chest wall mass Short stitch superior margin, long stitchlateral. . and it. consists of a oriented tissue associated with skin ellipse (11.5 x2 cm) and. skeletal muscle measuring 13 cm from medial to lateral, 9.5 cm from. superficial to deep, 6 cm from superior to inferior. Ink is placed as: deepblack,. superiorblue, inferiorgreen, medial red, lateral yellow. Sectioning along deep to superficial axis reveals a 6 x 5.8 x 5.4 cm well. defined intra-muscular mass. It is 3 cm from the skin, 0.5 cm from the deep,. 0.4 cm from the lateral, 2 cm from the medial 1.5 cm from the superior, 1.5. cm from inferior. The cut surface is white and homogenous, gelatinous. appearance is appreciated. A small portion of the mass is submitted for. TPS, gross photos were taken. Representative sections are submitted. Summary of sections: SXMtumor and superior margin. IXMtumor and inferior margin. MXMtumor and medial margin. LXMtumor and lateral margin. DXMtumor and deep margin. ---tumor. SKakin. Summary of Sections: Part 1: Radical resection of right chest wall mass. Block. Sect. Site. PCs. 2. DXM. 3. 2. IXM. 3. 2. LXM. 3. 2. MXM. 3. 2. SK. 3. 2. SXM. 3. 6. 7. icirciel: me.",train,6 cm
1688,TCGA-IE-A4EJ.223D6CAF-EC1D-4538-A14B-01FBB37453A4,"Operative Procedure: Right thigh soft tissue sarcoma excision. Right thigh sarcoma; stitch is distal. Final Pathologic Diagnosis: Soft tissue, right thigh, resection: Pleomorphic undifferentiated sarcoma (8.5 cm in greatest dimension). See Synoptic Report and Note below. Synoptic Report. Procedure: Resection. Tumor site: Right thigh. Tumor size: 8.5 cm (greatest dimension). Macroscopic extent of tumor: Intramuscular. Histologic type: Undifferentiated pleomorphic sarcoma. Mitotic rate: 5/10 high-power fields (HPF). Necrosis: Not identified. Histologic grade: High grade. Margins: Sarcoma extends to peripheral margin. Pathologic staging (pTNM). TNM descriptors: None known. Primary tumor (pT): pT2b: Tumor more than 5 cm in greatest. dimension, deep tumor. Regional lymph nodes (pN): pNx Cannot be assessed. Distant metastasis (pM): pMx Cannot be assessed. Additional pathologic findings: None. Ancillary studies. Immunohistochemistry: Not performed. Cytogenetics: Not performed. Molecular Pathology: Not performed. Preresection treatment: No known therapy. Treatment effect: Not applicable. The examination of this case material and the preparation of this report were. Gross Description: The specimen is received in a single formalin filled container labeled with the. patient name and ""right thigh sarcoma, stitch is distal"" and. consists of a portion of ovoid fibromuscular soft tissue that is 14.8 x 11.0 x. 6.0 cm. There is a black stitch marking the distal aspect. This will be. designated as 6 o'clock. The specimen has been previously incised one peripheral. aspect. The specimen is inked as follows: the previously incised peripheral. aspect is inked black and the opposite peripheral aspect in blue. Sectioning. reveals a white-tan somewhat soft mass that is 8.5 x 6.0 x 4.5 cm. This lesion. measures 4 cm from the distal aspect and 4.5 cm from the proximal aspect. The. mass does not appear to be encapsulated; however the previously incised aspect. of the specimen has an overlying fibrous band which does not appear to be. penetrated by the tumor. Otherwise, the lesion does abut the fibrous band. The. lesion is approximately 1 cm from the nearest not previously incised peripheral. aspect. Representative sections are submitted as follows: 1. distal tip;. 2. proximal tip;. 3-10 representative sections of mass to include the black inked surface. and blue inked surface. Microscopic Description: The final diagnosis of each specimen incorporates the microscopic examination. findings. Gender: F.",train,8.5 cm;8.5 cm
1690,TCGA-61-1911.ba6325b4-af61-42cc-b84c-aacee9d7ecc8,"FINAL DIAGNOSIS: PART 1:: RIGHT PELVIC PERITONEUM, BIOPSY -. NEGATIVE FOR TUMOR (SEE COMMENT). PART 2: RIGHT PERICOLIC TISSUE, BIOPSY -. NEGATIVE FOR TUMOR. PART 3: LEFT PERICOLIC GUTTER, BIOPSY -. NEGATIVE FOR TUMOR (SEE COMMENT). PART 4: PELVIC, BIOPSY -. NEGATIVE FOR TUMOR (SEE COMMENT). PART 5: OVARY AND FALLOPIAN TUBE, LEFT, SALPINGO-OOPHORECTOMY -. A. OVARY WITH HIGH-GRADE SEROUS CARCINOMA (7 CM) INVOLVING FIMBRIATED SEGMENT OF. FALLOPIAN TUBE. B. OVARIAN SURFACE INVOLVED BY TUMOR. C. LYMPHOVASCULAR INVASIN IS IDENTIFIED. D. UNINVOLVED FALLOPIAN TUBE, HISTOLOGICALLY UNREMARKABLE. E. RECEPTOR STUDIES: ER-POSITIVE, PR-NEGATIVE. F. PELVIC WASH AND DIAPHRAGMATIC SCRAPINGS ARE NEGATIVE FOR TUMOR (SEE COMMENT). G. PATHOLOGIC STAGE: T2a NO Mx. H. FIGO: II A. PART 6: POST PERITONEUM, BIOPSY -. NEGATIVE FOR TUMOR. PART 7: UTERUS WITH RIGHT OVARY AND RIGHT FALLOPIAN TUBE, TOTAL ABDOMINAL HYSTERECTOMY AND. RIGHT SALPINGO-OOPHORECTOMY -. A. ENDOMETRIAL POLYP. B. INACTIVE ENDOMETRIUM. C. CERVIX WITH SQUAMOUS METAPLASIA. D. RIGHT OVARY AND FALLOPIAN TUBE, HISTOLOGICALLY UNREMARKABLE. PART 8: LYMPH NODES, LEFT PELVIC, BIOPSY -. FIVE LYMPH NODES, NEGATIVE FOR METASTATIC TUMOR (0/5). PART 9: LYMPH NODES, RIGHT PELVIC, BIOPSY -. FIVE LYMPH NODES, NEGATIVE FOR METASTATIC TUMOR (0/5). PART 10: LYMPH NODES, LEFT PERIAORTIC, BIOPSY -. ONE LYMPH NODES, NEGATIVE FOR METASTATIC TUMOR (0/1). PART 11: LYMPH NODES, RIGHT PERIAORTIC, BIOPSY -. TWO LYMPH NODES, NEGATIVE FOR T METASTATIC UMOR (0/2). PART 12: OMENTUM, BIOPSY -. NEGATIVE FOR TUMOR (SEE COMMENT). MICROSCOPIC: SYNOPTIC - PRIMARY OVARIAN TUMORS INCLUDING BORDERLINE TUMORS. TUMOR LOCATION: Left. PROCEDURE: TAH with salpingo-oophorectomy. TUMOR SIZE: Maximum dimension: 7 cm. TUMOR TYPE: Papillary serous carcinoma. HISTOLOGIC SILVERBERG GRADE: Poorly differentiated (8-9 pts). ARCHITECTURAL PATTERN: Solid (3). CYTOLOGIC ATYPIA: Marked (3). MITOTIC COUNTS / 10hpf: > or = 25 (3). VASCULAR INVASION: TUMOR CAPSULE: Ruptured. SURFACE IMPLANTS: Not present. MALIGNANT CELLS IN ASCITES OR. PERITONEAL WASHING: LYMPH NODES EXAMINED: Total number of lymph nodes examined: 13. T STAGE, PATHOLOGIC: pT2a. N STAGE, PATHOLOGIC: pNO. M STAGE PATHOL nair. nMV.",train,7 CM;7 cm
1703,TCGA-A8-A07C.DC5B662B-1ADD-4D6E-A6E3-3EF8B922BC71,"Diagnosis: 1. and 2. Bifocal poorly differentiated invasive ductal carcinoma (tumor diameters: 2.8 and. 0.8 cm). Concluding tumor classification: NOS, G III, pT2(mult)NOLOVORO.",train,2.8;0.8 cm
1744,TCGA-EL-A3T6.146DAFAC-42A9-4AFB-805A-6E970520D880,"Pathology. port. Pathology,. Case type: Surgical Case. DIAGNOSIS. (A) TOTAL THYROIDECTOMY: PAPILLARY THYROID CARCINOMA (4.5 CM). TUMOR CONFINED WITHIN THYROID TISSUE. No extracapsular extension identified. Unremarkable parathyroid tissue, no tumor present. One lymph node, no tumor present. Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) TOTAL THYROIDECTOMY - A total thyroidectomy with overall measurements, 8.0 x 5.0 x 3.5 cm. The right lobe appears. unremarkable and measures 4.0 x 3.0 x 1.0 cm and mostly appears fibrotic. The left lobe measures 6.0 X 5.0 X 3.5 cm and. contains well-defined friable light tan and soft mass measuring 4.5 x 4.0 x 3.0 cm. The tumor abuts the external surface and the. capsule of the lobe. No gross involvement of the surgical margin, but tumor is noted. The tumor also appears friable and. papillary in nature. The specimen is submitted entirely in A1-A5, sequential sectioning of the right lobe from superior to inferior;. A5, A6, isthmus; A8-A22, sequential sectioning of the left lobe from superior inferior including tumor and adjacent soft. tissue. CLINICAL HISTORY. History of papillary thyroid cancer. SNOMED CODES. T-B6000, M-80503. Released by:",train,4.5 CM
1759,TCGA-ZB-A96E.3CB6F5C3-25B8-41F3-8E21-32F865CF0FF0,"Identifier: Tumor Type : Thymoma. Pathology Report-Summary: Material: tumor: 8.0 X 8.0 X 3.0 cm. focal invasion through capsule. Diagnosis: Type A-Thymoma (with focal TypeA/B). pT2, pNO (0/7). Masaoka: II.1. Immunhistochemistry. epithelial cells positive for: CK5/6. strong membrane staining for EGFR. epithelial cells negative for: c-kit, CD5. CD1a, CD99-positive immature T-lymphocytes, partially also positive for CD5. sparsely CD20-positive lymphocytes.",train,8.0 X 8.0 X 3.0 cm
1822,TCGA-CN-A497.14081B59-D4AA-45AD-B7A4-F4BDF2987D2B,"CORRECTED. Report Type. Date of Event. M. Hosp/Group. Record Status. ADDENDA: Addendum. PROBE: LSI EGFR/CEP7 Jual-Color Probe. Cytogenetic Location: 7p12 / 7p11.1-q11.1. EGFR FISH STUDIES PERFORMED ON THE SQUAMOUS CELL CARCINOMA ARE. NEGATIVE. Number of cells analyzed: 71. Ratio EGFR/CEP7: 1.3. High Polysomy : 0%. SNR (signal to nucleus ratio) : 2.3. Low Polysomy: 13 (18.3%). Trisomy: 9(12.7%). Disomy: 49(69.0%). This result should be integrated with all clinical and pathologic data. in the. determination of a comprehensive diagnostic and treatment plan. EGFR FISH analysis was manually performed and quantitatively assessed. analysis of a minimum of 60 cells using the EGFR SpectrumOrange and. the CEP7. SpectrumGreen probes. EGFR FISH positive: High Polysomy: > four gene copies in > 40% of cells. Gene Amplification: Ratio gene/chromosome more than two or > 15 gene. copies in. > 10% of cells. EGFR FISH negative: Disomy < two gene copies in more than 90% of the cells. Trisomy: three gene copies in more than 10% of cells. Low Polysomy: > four gene copies in more than 10% but less than 40% of. cells. References: Rogers SJ, Box C, Chambers P, Barbachano Y, Nutting CM, Rhys-Evans P,. Workman. P, Harrington KJ, Eccles SA. Determinants of response to epidermal. growth. factor receptor tyrosine kinase inhibition in squamous cell carcinoma. of the. head and neck. J Pathol. 2009 May;218(1) 122-30. Chung CH, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N,. Jarrett. C, Carter J, Murphy BA, Netterville J, Burkey BB, Sinard R, Cmelak A,. Levy. S, Yarbrough WG, Slebos RJ, Hirsch FR. Increased epidermal growth factor. receptor gene copy number is associated with poor prognosis in head and. neck. squamous cell carcinomas. J Clin Oncol. 2006 Sep 1;24(25) : 4170-6. My signature is attestation that I have personally reviewed the. submitted. material (s) and the above diagnosis reflects that evaluation. Addendum. Immunoperoxidase stain for EGFR is positive. Immunoperoxidase stain. for p16. is focally positive but negative as a surrogate marker for HPV. In-. situ. hybridization for HPV is negative. My signature is attestation that I have personally reviewed the. submitted. material (s) and the above diagnosis reflects that evaluation. FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT CERVICAL, LEVELS 2, 3, AND 4, SELECTIVE. DISSECTION. TWENTY-EIGHT LYMPH NODES, NO TUMOR PRESENT (0/28). PART 2: LYMPH NODES, LEFT CERVICAL, LEVELS 2, 3, AND 4, SELECTIVE. DISSECTION. A. MICROSCOPIC FOCUS OF METASTATIC SQUAMOUS CELL CARCINOMA IN. ONE OUT. OF THIRTY-TWO LYMPH NODES (1/32). B. THE LYMPH NODE WITH METASTATIC SQUAMOUS CELL CARCINOMA IS IN. LEVEL 3. AND THERE IS NO EXTRACAPSULAR EXTENSION. PART 3: LARYNX, TOTAL LARYNGECTOMY. A. SUPRAGLOTTIC INVASIVE SQUAMOUS CELL CARCINOMA,. NONKERATINIZING. (2. 5 CM) . B. ANGIOLYMPHATIC INVASION PRESENT. C. PERINEURAL INVASION ABSENT. D. RESECTION MARGINS ARE FREE OF CARCINOMA (ALSO SEE PART 4). E. NINE LYMPH NODES, NO TUMOR PRESENT (0/9). F. PATHOLOGIC STAGE: pT1 N2. PART 4: LEFT LATERAL MARGIN, BIOPSY. NO TUMOR PRESENT. My signature is attestation that I have personally reviewed the. submitted. tissue. Grossly, there is a 2.5 X 2.3 X 0.9 cm tan-white, firm,. exophytic. supraglottic tumor mainly involving the right side. Anterior. commissure,. preepiglottic soft tissue, vocal cords, and aryepiglottic folds are not. involved. The rest of the mucosa is unremarkable. There are two possible lymph nodes attached to the left side of the. larynx. measuring in greatest dimension 1.8 cm each. Multiple possible lymph. nodes. from anterior soft tissue are identified ranging in greatest dimension. from. 0.1 to .5 cm. The tumor is entirely submitted. Normal tissue and tissue from tumor is banked for SPORE Head and Neck. Tissue. Bank. Digital imaging photographs are taken. INK CODE: Black anterior soft tissue. Blue pre-epiglottic soft tissue. Orange area under hyoid bone, not true margin. Red banked area. CASSETTE CODE: 3A base of tongue margin, shave. 3B left lateral edge, shave,. 3C right lateral margin, shave. 3D inferior margin, shave (including superior portion of the. tracheostomy. mucosal site). 3E tracheostomy skin site, perpendicular. 3F tracheostomy soft tissue opening, perpendicular. 3G. representative of left vocal cords. 3H representative of right vocal cords. 3I-J. tumor and preepiglottic soft tissue, right to left. 3K-L reminder of tumor,. 3M-N one lymph node in each, bisected (attached to left larynx). 30 one lymph node, bisected, anterior soft tissue. 3P one lymph node, anterior soft tissue. 3Q possible lymph nodes, anterior soft tissue. Part 4 is received fresh labeled with the patient's name, initials XX. and. ""left lateral margin"". Received are two, pale yellow-tan soft tissue. fragments cervical and some is 0.3 X 0.2 and 1.5 x 0.5 X 0.4 cm. A. frozen. section is performed with an intraoperative diagnosis completed. The. specimen. is entirely submitted for processing in a cassette labeled 4AFS. INTRAOPERATIVE CONSULTATION: 4AFS: LARYNX, LEFT LATERAL MARGIN, (frozen section) -. A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR SEEN. MICROSCOPIC: Microscopic examination substantiates the above diagnosis. material (s) and the final diagnosis reflects that evaluation. GROSS DESCRIPTION: The specimen is received in 4 parts. Part 1 is received fresh labeled with the patient's name, initials. and. ""right neck levels 2, 3, 4"". Received is an unoriented, irregular mass. of. finely lobulated to coarsely lobulated 11 x 6 x 2 cm adipose tissue. The. specimen is divided into 3 equal segments and designated as levels A. (finely. lobulated segment) through C. Multiple lymph nodes are identified. ranging in. size from 0.1 to 2 cm. The lymph nodes are entirely submitted. Section code: 1A - level A -bisected lymph node. 1B - level A - bisected lymph node. 1C - level A - 4 possible lymph nodes. 1D - level B - 2 larger lymph nodes. 1E - level B - 4 lymph nodes. 1F - level B - 2 bisected lymph nodes. 1G - level B. - 6 smallest lymph nodes. 1H - level C - 4 possible lymph nodes. 1I - level C - 3 possible lymph nodes. Part 2 is received fresh labeled with the patient's name, initials. and. ""left neck-levels 2, 3, 4 (tie superior)"" Received is an oriented,. irregular, 12 x 3 x 3 cm, adipose neck dissection with a single suture. designating superior. The specimen is subdivided into 3 equal segments. and. designated as levels 2 through 4. Multiple lymph nodes are identified. ranging. in size from 0.2 to 2.6 cm in greatest dimension. Several of the. larger lymph. nodes within level 2 appear suspicious. The lymph nodes are entirely. submitted. Section code: 2A - 2C - level 2 - trisected largest lymph node. 2D - level 2-bisected lymph node. 2E - level 2-two bisected lymph nodes (one LN inked blue). 2F - level 2- two possible smaller lymph nodes. 2G - level 3-bisected lymph node. 2H - level 3-bisected lymph node. 2I - level 3-four possible lymph nodes. 2J - level 3-three smaller possible lymph nodes. 2K - level 4- - four possible lymph nodes. 2L - level 4-five possible lymph nodes. 2M - level 4-seven minute possible lymph nodes. Part 3 is received fresh labeled with the patient's name, initials. and. ""larynx"". It consists of a total laryngectomy measuring 11.5 X 8.0 X. 7.0 cm. with attached hyoid bone, skin (4.0 x 3.5 cm) with a tracheostomy site,. and. fibroadipose tissue with multiple lymph nodes attached the anterior. soft. The following statement applies to all immunohistochemistry, Insitu. Hybridization Assays (ISH & FISH), Molecular Anatomic Pathology, and. Immunofluorescent Testing: The testing was developed and its performance characteristics. determined by. the. Department of Pathology, as required by. the CLIA. '88 regulations. The testing has not been cleared or approved for the. specific use by the U.S. Food and Drug Administration, but the FDA has. determined such approval is not necessary for clinical use. Tissue. fixation. ranges from a minimum of 2 to a maximum of 84 hours. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (""CLIA"") as qualified to perform high-complexity. clinical. testing. Pursuant to the requirements of CLIA, ASR's used in this. laboratory. have been established and verified for accuracy and precision. Additional. information about this type of test is available upon request. CASE SYNOPSIS: SYNOPTIC DATA - LARYNX RESECTIONS. TYPE OF LARYNGECTOMY : Total. TUMOR LATERALITY : Other location: Primary right with extension. across. midline. ATTACHED STRUCTURES: Pyriform sinus, Base of tongue, Tracheotomy,. Skin. TUMOR LOCATION/SEGMENT : Supraglottic. TUMOR SIZE: Maximum dimension: 2.5 cm. HISTOLOGIC TYPE OF TUMOR: Squamous cell carcinoma. HISTOLOGIC GRADE: Moderately differentiated. STRUCTURES INVOLVED BY TUMOR: Epiglottis. LYMPH NODES: Lymph nodes positive, Right: 0. Total number of right sided lymph nodes examined: 28. Lymph nodes positive, Left: 1. Total number of left sided lymph nodes examined: 32. Site of 'other' lymph nodes: Anterior soft tissue. Lymph nodes positive, 'other': 0. Total number of 'other' lymph nodes examined: 9. EXTRACAPSULAR SPREAD OF LYMPH NODE METASTASES. INTRA-PERINEURAL INVASION: Absent. VASCULAR INVASION: SURGICAL MARGIN INVOLVEMENT. Free (2 mm or more). T STAGE, PATHOLOGIC: Supraglottis, pT1. N STAGE, PATHOLOGIC: pN2. M STAGE, PATHOLOGIC: pMX. PATIENT HISTORY: As a negative shorter one with a CHIEF COMPLAINT/PRE-OP/POST-OP. DIAGNOSIS: Cancer of larynx. PROCEDURE: Laryngectomy and bilateral neck dissections. SPECIFIC CLINICAL QUESTION: Margins and nodes. OUTSIDE TISSUE DIAGNOSIS: Yes-squamous cell carcinoma. PRIOR MALIGNANCY: No. CHEMORADIATION: No. ORGAN TRANSPLANT: No. IMMUNOSUPPRESSION No. OTHER DISEASES: No. HISTO TISSUE SUMMARY/SLIDES REVIEWED: Part 1: Neck Dissection, Level 2, 3, 4. Stain. Block. H&E X 1. A. H&E x 1. B. H&E x 1. C. H&E x 1. D. H&E x 1. E. H&E X 1. H&E x 1. G. H&E x 1. H. H&E X 1. Part 2: Neck Dissection Levels 7. 3. 4. Stair. Block. H&E X 1. A. H&E x 1. B. H&E X 1. C. H&E x 1. D. H&E x 1. E. H&E x 1. F. H&E x 1. G. H&E X 1. H. H&E x 1. I. H&E X 1. H&E X 1. K. H&E x 1. L. H&E x 1. M. Part 3: Larynx, Total Laryngectomy. Stain/. Block. H&E x 1. A. H&E x 1. B. H&E x 1. C. H&E x 1. D. H&E x 1. E. H&E x 1. F. H&E X 1. G. H&E X 1. H. H&E Recut x. 1. IEGFR x 1. IBNKNC x 1. I. IBNKNC x 1. IBNKNC x 1. IBNKNC X 1. IBNKNC X 1. IBNKNC X 1. H&E x 1. HPV X 1. IISH X 1. IISH x 1. P16 X 1. V-EGFR X 1. H&E x 1. H&E x 1. K. H&E X 1. H&E x 1. M. H&E X 1. N. H&E x 1. O. H&E X 1. P. H&E x 1. Q. H&E x 1. R. Part 4: Left Lateral Margin. Stain/. Block. H&E X 1. A FS. TC1.",train,2. 5 CM;2.5 cm;2.5 X 2.3 X 0.9 cm
1826,TCGA-B5-A1MV.E536759E-F47A-4EE9-B855-AFEC6BCF5EE0,"CLINICAL HISTORY: Malignant neo corpus uteri. GROSS EXAMINATION: A. ""Uterus and cervix (AF1) "", received fresh for frozen section diagnosis is a. 68 gm, 8 x 5.5 x 3 cm hysterectomy specimen with attached cervix (3 cm in. length x 3 cm in diameter) with a patent os of 0.6 cm. The serosal surface is. pink-tan and grossly unremarkable. The paracervical soft tissue is inked. entirely in blue and the specimen is opened laterally on each side. The. cervical canal (2.5 cm length x 2.4 cm wide) is tan-pink, has a herringbone. pattern. The endometrial canal (4.5 cm in length x 3 cm from cornu to cornu). demonstrates a large, contiguous, fungating mass on the posterior portion. (beginning 1.5 cm superior to the lower uterine segment and continuing to the. anterior endometrium approximately 2.6 cm from the lower uterine segment. Both. lower uterine segments are grossly uninvolved. Serial sectioning of the. endometrium demonstrates a focally 1 cm thick endometrium overlying a 1.1 cm. thick myometrium. The area of deepest invasion is located on the posterior. surface and appears to grossly invade 0.8 cm into a 1.7 cm myometrium. The. deepest invasion on the anterior endometrium is 0.3 cm into a 1.7 cm. myometrium. BLOCK SUMMARY: A1- AF1 rep of deepest invasion. A2- anterior cervix. A3- posterior cervix. A4- anterior lower uterine segment. A5- posterior lower uterine segment. A6-A7 representative of deepest invasion anterior endomyometrium. A8-A9 representative deepest invasion posterior endomyometrium. B. ""Hernia sac"", received fresh and placed in formalin. is. a 9.5 x 9 x 3.2 cm aggregate of fibroadipose tissue. The specimen is. sectioned revealing benign fibroadipose tissue. Representative sections. in. B1-B3. C. ""Right tube and ovary"", received fresh and placed in formalin. is an 8 gm, 6 x 3.1 x 1.8 cm tube and ovary specimen. The fallopian. tube (7.5 cm in length x 0. cm in diameter) is upon sectioning tan-white and. grossly unremarkable. The fimbriae is also grossly unremarkable. The right. ovary (2.5 x 1.6 x 0.9 cm) is white-tan, cerebriform and upon sectioning. demonstrates a 1 x 0.5 x 0.2 cm corpus albicans. BLOCK SUMMARY: C1- tube and fimbriae. C2- ovary. D. ""Left tube and ovary"", received fresh and placed in formalin. s an 11 gm, 6.8 x 3 x 2 cm tube and ovary. The fallopian tube (7.6. cm in length x 0.4 cm in diameter) appears on sectioning grossly unremarkable. the attached fimbriae is grossly unremarkable. The left ovary (3 x 1.2 x 0.8. cm) is white-tan cerebriform and upon sectioning is grossly unremarkable. BLOCK SUMMARY: D1- left tube and fimbriae. D2-. left ovary. 1 of 4. E. ""Left pelvic lymph node"", received fresh and placed in formalin. is a 5 x 2.3 x 1.8 cm aggregate of fibroadipose tissue which is. dissected for lymph nodes. Six lymph node candidates are identified. Submitted as follows: E1- one lymph node candidate (mostly fat). E2- two lymph node candidates. E3- two lymph node candidates. E4-. one lymph node candidate. F. ""Left common"", received fresh and placed in formalin. is a 1 x 0.6 x 0.6 cm fragment of soft brown tissue which is submitted in its. entirety in F1. G. ""Aortic"", received is a 2.8 x 2 x 0.6 cm aggregate of fibroadipose tissue. which is dissected for lymph nodes. One lymph node candidate measuring 2.6 cm. in length x 0.4 cm is bisected and submitted in its entirety in G1 and G2. H. ""Rinht pelvic node"", received fresh and placed in formalin. is a 5.5 x 4.5 x 0.8 cm aggregate of fibroadipose tissue which. is. dissected for lymph nodes. The largest lymph node is 2 x 1.5 x 0.8 cm. BLOCK SUMMARY: H1- three lymph nodes. H2- three lymph nodes. H3- two lymph nodes. H4-. one lymph node bisected. H5-. one lymph node bisected. I. ""Right aortic lymph node"", received fresh and placed in formalin. is a 3.5 x 3.2 x 0.8 cm aggregate of fibroadipose tissue which is. dissected for lymph nodes. Two lymph nodes are found ranging from 1.3 cm in. greatest dimension to 0.5 cm. BLOCK SUMMARY: Il- one lymph node bisected. I2-. one lymph. Dr. slides to Dr. INTRA OPERATIVE CONSULTATION: A. ""Uterus and cervix"": AF1 (rep) 0.8 cm into a 1.7 cm myometrium,. endometrioid adenocarcinoma FIGO grade 2. MICROSCOPIC EXAMINATION: Microscopic examination is performed. Depth of invasion is best seen on the. frozen section slide (AF1), as the tissue did not survive processing intact. PATHOLOGIC STAGE: PROCEDURE: Total hysterectomy. PATHOLOGIC STAGE (AJCC 7th Edition) : pTla pNO pMX. NOTE: Information on pathology stage and the operative procedure is. transmitted to this Institution's Cancer Registry as required for. accreditation by the Commission on Cancer. Pathology stage is based solely. upon the current tissue specimen being evaluated, and does not incorporate. information on any specimens submitted separately to our Cytology section,. past pathology information, imaging studies, or clinical or operative. findings. Pathology stage is only a component to be considered in determining. the clinical stage, and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon's operative report. DIAGNOSIS: A. UTERUS AND CERVIX (TOTAL HYSTERECTOMY) : UTERUS: 68 GRAMS. CARCINOMA OF THE ENDOMETRIUM: TUMOR SITE: DIFFUSE. HISTOLOGIC TYPE: ENDOMETRIOID ADENOCARCINOMA WITH SQUAMOUS. DIFFERENTIATION. FIGO GRADE; 2. TUMOR SIZE: 4.9 x 3 x 0.8 CM. MAXIMUM DEPTH OF MYOMETRIAL INVASION: 0.8 CM IN A 1.7 CM THICK WALL. LYMPHATIC/VASCULAR INVASION: ABSENT. ADJACENT NON-NEOPLASTIC ENDOMETRIUM: ATROPHIC. REMAINING MYOMETRIUM: UNREMARKABLE. CERVIX: FREE OF TUMOR. MULTIPLE NABOTHIAN CYSTS. SEROSA: FREE OF TUMOR. SPECIMEN MARGINS: NOT INVOLVED. B. HERNIA SAC (HERNIORRHAPHY) : MESOTHELIAL LINED FIBROADIPOSE TISSUE, CONSISTENT WITH HERNIA SAC. C. RIGHT TUBE AND OVARY (SALPINGO-OOPHORECTOMY) : OVARY AND FALLOPIAN TUBE WITH NO SIGNIFICANT PATHOLOGIC ALTERATION. NEGATIVE FOR CARCINOMA. D. LEFT TUBE AND OVARY (SALPINGO-OOPHORECTOMY) : OVARY AND FALLOPIAN TUBE WITH NO SIGNIFICANT PATHOLOGIC ALTERATION. NEGATIVE FOR CARCINOMA. E. LEFT PELVIC LYMPH NODE (BIOPSY) : SIX LYMPH NODES, NEGATIVE FOR CARCINOMA (0/6). F. LEFT COMMON LYMPH NODE (BIOPSY) : TWO LYMPH NODES, NEGATIVE FOR CARCINOMA (0/2) . G. AORTIC LYMPH NODE (BIOPSY) : TWO LYMPH NODES, NEGATIVE FOR CARCINOMA (0/2) . H. RIGHT PELVIC LYMPH NODE (BIOPSY) : ELEVEN LYMPH NODES, NEGATIVE FOR CARCINOMA (0/11) . SEE COMMENT. I. RIGHT AORTIC LYMPH NODE (BIOPSY) : FIVE LYMPH NODES, NEGATIVE FOR CARCINOMA (0/5) . COMMENT: The right pelvic nodes (part H) have a prominent histiocytic. infiltrate. Special stains for fungi and acid fast bacilli will be performed. and the results reported in an addendum. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). ADDENDUM 1: This addendum is issued to report the results of special stains. The original. diagnoses remain unchanged. Special stains (performed on block H2) for fungi (PAS) and acid-fast bacilli. (TBC) are NEGATIVE. certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). CI ADDENDUM 1: Please see Image Cytometry Report. for results of supplementary. tests. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). Consulting MDs:",train,4.9 x 3 x 0.8 CM
1894,TCGA-F7-A61S.2FDEE481-0B8C-4553-8EA4-4FAB8AE66160,"Gross Description: Tongue tissue up to 8 cm in size with gray dense-elastic tumor up to 5 cm in size,. with ulceration. Microscopic Description: Squamous carcinoma of the tongue, G-1, keratinizing type. Fatty tissue from. the left side is with hemorrhages. In the fatty tissue from the right side there are six lymph nodes with. normal morphological structure. Diagnosis Details: Tumor Features: Indeterminate, Tumor Extent: Localized, NOS, Venous Invasion: Present, Margins: Absent, Treatment Effect: Comments: Formatted Path Reports: HEAD & NECK CHECKLIST. Squamous cell carcinoma, keratinizing of the oral cavity. Tumor size: 5cm. Laterality: Midline.",train,5cm;5 cm
1905,TCGA-D9-A4Z5.93502F24-F9FE-4978-811E-E3B7F47A7BF0,"Gender: M. Examination result. Clinical diagnosis (suspicion) Melanoma of the nasal cavity right side. Malignant melanoma ulcerating. Material: 1) Material: nose, tumor of the nose. Histopathological Diagnosis: Malignant melanoma of the mucous membrane of the nose pT4a, pNO. Macroscopic description: Surgical specimen sized 5 x 6 x 1.2cm, including cartilage and skin 3.5 x 2.5 cm in length. Tumour sized 3.5 x 3 X 1.5. cm. Microscopic description: Malignant melanoma of the mucous membrane of the nose. Thickness min.: 12mm. Surgical incision lines off cancer invaded area. No signs of vascular, nerve and cartilage invasion found.",train,3.5 x 3 X 1.5. cm
1925,TCGA-36-2537.9b122691-9140-439e-9ef6-16701081b905,"Receive Date: PHN: Final Diagnosis: Hysterectomy, bilateral salpingo-oophorectomy, omentectomy and pelvic/peritoneal. washing specimens showing: 1. High-grade serous carcinoma of left ovary with implants of metastatic. serous carcinoma to right ovary, fallopian tubes, serosal surface of the. uterus and omentum. 2. Benign uterine leiomyomas. 3. Proliferative endometrium. 4. Benign endo- and exocervical mucosa. 5. Peritoneal fluid (cytology specimen. is positive for serous. carcinoma. 6. Please see Comment. Final Diagnosis Comment: This unusual tumour shows both high-grade and low-grade architectural growth. patterns; however, on closer examination it has a high mitotic rate throughout and is. best classified as high-grade serous carcinoma. The tumour involves both ovaries, the. serosal surface of the uterus and omentum. No fallopian tube mucosal involvement is. identified. Clinical History as Provided by. with pelvic mass. Cytology. A. Uterus, cervix, bilateral tubes and ovaries. B. Omentum. Specimens Received: A: urterus + cervix + bilateral tubes + ovaries. B: omentum. Gross Description: Two specimens are received, both labelled with the patient's demographics. Peritoneal. fluid washing for cytology (cytology 7. is also received. Specimen A is labelled UTERUS, CERVIX, BILATERAL TUBES AND OVARIES. It. consists of a bilateral salpingo-oophorectomy and a total hysterectomy specimen. The. left ovary is completely replaced by a tan complex cystic mass with solid and papillary. areas measuring approximately 15 cm in diameter. Multiple tumour implants are. identified on the serosal surface of this cyst. The left fallopian tube measures 4 cm in. length and 1 cm in diameter. Its serosal surface is also involved by the tumour implants,. with possible mural and luminal involvement. The right ovary measures 2.5 X 2.2 X 5.5. cm, and it is partially replaced by the same tumour, with serosal implants identified. The. uterine body measures 5.6 X 5 X 4 cm. Its posterior surface/cul-de-sac is extensively. involved by tumour implants. The anterior surface is also involved, albeit less. extensively. The endometrium appears grossly unremarkable. Several leiomyomata,. measuring up to 1.2 cm, are identified. The cervix measures 4.5 cm in length and 4.5. cm in diameter. It appears grossly unremarkable. The serosal surfaces of the right and. left adnexa and uterus are inked blue. The resection margins are inked black. Representative sections are submitted as follows: A1-A2 -sections obtained during the frozen section. A3-A8 -representative sections of the left ovarian mass. A9 -left fallopian tube. A10-A12-right ovary. A13 -right fallopian tube. A14-A17 -anterior endomyometrium, from superior to inferior, with A15-A16. being from the same level. A18 -anterior junction of the lower uterine segment and endocervix. A19 -anterior junction of the endocervix and ectocervix. A20-A23 -posterior endomyometrium, from superior to inferior, with A20-A21. from the same level and A22-A23 from the same level. A24-A25 -posterior junction of the lower uterine segment and endocervix,. with A25 being from cul-de-sac. A26 -posterior junction of the endocervix and ectocervix. Specimen B is labelled OMENTUM. It consists of a fibrofatty tissue measuring 13 X 6 X. 3.5 cm. Multiple tumour deposits are identified in this specimen. Representative. sections are submitted as B1 to B4. Intraoperative Consultation: FSA/1,2. Gross Description: Large left sided mass, cystic, multiple with solid and papillary. excrescences with serosal implants right side adnexal and elsewhere on uterus. F/S: cyst (L) -A1, opposite side -A2. Provisional Diagnosis: Serous carcinoma, variably differentiated.",train,
2051,TCGA-EJ-7325.6E9EC98C-FD89-47DA-BF8A-B7F4229C9E09,"FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT AND LEFT PELVIC, EXCISION -. NO EVIDENCE OF NEOPLASIA IN 9 LYMPH NODES (0/9). PART 2: PROSTATE AND BILATERAL SEMINAL VESICLES, RADICAL PROSTATECTOMY -. A. PROSTATE ADENOCARCINOMA, GLEASON SCORE 3+4=7. B. THE CARCINOMA INVOLVES BOTH THE RIGHT AND LEFT LOBES AND HAS A GREATEST NODULAR DIAMETER OF. 2.0 CM IN ONE HISTOLOGIC SECTION. c. THE CARCINOMA INVOLVES 10% OF THE EXAMINED PROSTATE VOLUME. D. THE CARCINOMA SHOWS EVIDENCE OF EXTRACAPSULAR EXTENSION. E. CARCINOMA INVOLVES BILATERAL SEMINAL VESICLES. F. ALL EXAMINED SURGICAL RESECTION MARGINS ARE FREE OF CARCINOMA. G. EXTENSIVE PERINEURAL INVASION IS IDENTIFIED. H. NO ANGIOLYMPHATIC INVASION IS IDENTIFIED. HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA IS IDENTIFIED. J. PATHOLOGIC TNM STAGE: pT3b NO MX. K. BACKGROUND PROSTATE TISSUE WITH NODULAR HYPERPLASIA AND CHRONIC INFLAMMATION. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY PROSTATE TUMORS. INVASIVE CA IDENTIFIED?: TUMOR HISTOLOGY: Adenocarcinoma NOS. PRIMARY GLEASON GRADE: 3. SECONDARY GLEASON GRADE: 4. GLEASON SUM SCORE: 7. GLEASON 4/5 PERCENTAGE: 20%. WEIGHT OF PROSTATE: 42.3gm. TUMOR SIZE: Maximum dimension: 2 cm. LOBE LATERALITY: Right and Left Lobes. PERCENT OF SPECIMEN INVOLVED BY TUMOR: 5 -25%. MULTIFOCAL DISEASE: HIGH GRADE PIN: Yes - multifocal. EXTRAPROSTATIC EXTENSION: Yes - Established (> 0.8mm). PERINEURAL INVASION: ANGIOLYMPHATIC INVASION: SEMINAL VESICLE INVASION: SURGICAL MARGIN INVOLVEMENT: All surgical margins free of tumor. LYMPH NODES EXAMINED: 9. LYMPH NODES POSITIVE: 0. T STAGE, PATHOLOGIC: pT3b. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. HISTOLOGIC GRADE: G3-4, Poorly differentiated/undifferentiated.",train,2 cm
2080,TCGA-30-1862.a6b7b0c1-5954-487b-b27d-73850a08a194,"Report Status: Type: Surgical Pathology. Pathology Repor. MUSCLE BIOPSY. DIAGNOSIS: SPECIMEN LABELED ""OMENTAL TUMOR MASS"" (including FSA) : PAPILLARY SEROUS ADENOCARCINOMA (3.2 cm). SPECIMEN LABELED ""TUMOR FROM STOMACH"": PAPILLARY SEROUS ADENOCARCINOMA (3.2 cm). SPECIMEN LABELED ""RIGHT TUBE AND OVARY"": PAPILLARY SEROUS ADENOCARCINOMA grade 2 of 3 involving surface of ovary. and fallopian tube, and minimally invading ovarian parenchyma. Peritubal adhesions. SPECIMEN LABELED ""LEFT TUBE AND OVARY"": PAPILLARY SEROUS ADENOCARCINOMA involving surface of ovary and fallopian. tube. SPECIMEN LABELED ""CUL DE SAC TUMOR"": PAPILLARY SEROUS ADENOCARCINOMA. SPECIMEN LABELED ""UTERUS AND CERVIX"" (98g) : Cervix: Squamous metaplasia. Endometrium: Inactive endometrium. Endometrial polyps. Myometrium: Leiomyomata. Adenomyosis. Serosa: PAPILLARY SEROUS ADENOCARCINOMA. SPECIMEN LABELED ""CUL DE SAC TUMOR II"": PAPILLARY SEROUS ADENOCARCINOMA,. SPECIMEN LABELED ""TUMOR ON APPENDIX"": PAPILLARY SEROUS ADENOCARCINOMA. SPECIMEN LABELED ""APPENDIX AND TUMOR"": PAPILLARY SEROUS ADENOCARCINOMA. SPECIMEN LABELED ""UMBILICAL HERNIA"": Fibroadipose tissue with acute and chronic inflammation. Note: The tumor distribution favors a PRIMARY PERITONEAL SEROUS CARCINOMA. CLINICAL DATA: History: - CA125 1500, ascites, omental cake, ?ovarian. cancer. Clinical Diagnosis: Ascites. TISSUE SUBMITTED: 1. Rectal muscles to research. 2. Omental tumor mass (FS). 3. Tumor from stomach. 4. Right tube and ovary. 5. Left tube and ovary. 6. Cul de sac tumor. 7. Uterus and cervix. Page: 1 of 3. 8. Cul de sac tumor II. 9. Tumor on appendix. 10. Appendix and tumor. 11. Umbilical hernia sac. O.R. CONSULTATION: SPECIMEN LABELED ""#2 OMENTAL TUMOR MASS' (FSA) : Poorly differentiated carcinoma, consistent with ovarian origin. GROSS DESCRIPTION: The specimen is received fresh, in 11 parts, each Tabeled with the patient's. name and unit number. Part 1, ""rectus muscles"", consists of one fragment of red/tan/brown soft tissue. (2.5 x 2.3 x 1.5 cm) grossly consistent with skeletal muscle. The entire. specimen is submitted for special studies. Part 2, ""omental tumor mass - FS"", consists of one fragment of yellow/tan/pinl. fibroadipose tissue (34 x 8 x 4 cm) with multiple firm, yellow/white nodules. (up to 6 cm) A representative section of one nodule is frozen and submitted. as. ""FSA"". Representative nodules are submitted for special studies and tumor. bank. Some of the nodules have areas of hemorrhage and necrosis. Representative sections are submitted. Micro 1. FSA remnant, 1 frag,. Micro 2. omental tumor mass, 1 frag,. Part 3, ""tumor from stomach"", consists of a 5 x 4 x 4 cm fragment of. yellow/tan/white fibroadipose tissue with a 3.2 x 3 x 1.6 cm firm, white/tan,. ill-defined mass. Representative sections are submitted. Micro 3. - tumor from stomach, 3 frags,. Part 4, ""right tube and ovary"", consists of a 5.3 x 4.0 x 1.9 cm ovary and. fallopian tube. The fallopian tube (approximately 5.8 x 1.1 cm) has areas of. edema and adhesions to a 3.1 x 1.6 x 1.4 cm ovary. Ther are multiple papillary. exarescences in the adnexal tissue. Representative sections are submitted. Micro 4-6 - right tube and ovary, 1-2 frags each,. Part 5, ""left tube and ovary"", consists of a 5.0 x 1.0 cm fimbriated edematous. fallopian tube, a 2.6 x 1.4 X 1.3 cm ovary and associated adnexal tissue. The. ovary has a yellow/white, slightly rough, nodular surface. There are multiple. tan, papillary excrescences (up to 0.4 cm) throughout the adnexa. Representative sections are submitted. Micro 7-9 - left tube and ovary, 1-2 frags each,. Part 6, ""cul de sac tumor"", consists of multiple fragments of firm,. yellow/white, hemorrhagic tissue (6 x 5 x 2 cm in aggregate) . Representative. sections are submitted. Micro 10-11 - cul de sac tumor, 3 frags each,. Part 7, ""uterus and cervix"", consists of a 98g hysterectomy specimen (9 x 6 x 4. cm. in overall dimensions) which has a rough, nodular, focally hemorrhagic. serosal surface and a subserosal leiomyoma (2 cm) The exocervix (3. 1 cm in. diameter) has a 0. : cm slit-like os leading to a 2.4 x 1.0 cm endocervical. canal. The endocervix has a tan, glistening herringbone-lik appearance. The endometrium (4.4 cm from cornu to cornu, 4.5 cm in length and 0.2 cm in. thickness) is tan and glistening with multiple polyps (from 0. to 2.5 cm). The myometrium (1.3 cm in average thickness) has an intramural leiomyoma (0.6. cm) Representative sections are submitted. Micro 12. anterior cervix, 1 frag,. Micro 13. posterior cervix, 1 frag. Micro 14. LUS, 1 frag,. Micro 15-16. - anterior endometrium, serosal nodules & polyps, 1-2 frags each,. Micro 17. posterior endometrium, polyps & leios, 1 frag each. Page: 2 of 3. Part 8, ""cul de sac tumor II"", consists of two fragments of white/tan/yellow. soft tissue with a papillary, friable texture (in aggregate 5 x 4.2 x 2.1 cm). Representative sections are submitted. Micro 19. - cul de sac tumor II, 3 frags,. Part 9, ""tumor on appendix"", consists of a 2.1 x 1.1 x 1.1 cm fragment o. white/tan, papillary appearing, firm tissue. Representative sections ar. submitted. Micro 20. - tumor on appendix, 2 frags. Part 10, ""appendix and tumor"", consists of a 4.5 x 3 x 2.1 cm multiloculated. cystic mass filled with green and tan mucinous fluid. Near the. re-section. margin is a 1 x 1 x 1 cm area of white/tan, nodular, firm tissue. The. resection margin of the appendix is 0.6 cm in diameter and has an obliterated. lumen. Representative sections are submitted. Micro 21. resection margin & possible tip, 2 frags,. Micro 22. appendix & tumor, 3 frags,. Part 11, ""umbilical hernia sac"", consists of a 3.9 x 2.6 x 0.7 cm fragment of. yellow/tan, hemorrhagic soft tissue. Representative sections are submitted. Micro 23. - umbilical hernia sac, 3 frags,. Reports to: SPECIMEN TYPE: MUSCLE. BIOPSY. ADDITIONAL SPECIMEN TYPE: SOFT TISSUE TUMOR EXTENSIVE RESECTION. ADDITIONAL SPECIMEN TYPE: SOFT TISSUE MASS OR SIMPLE EXCISION. ADDITIONAL SPECIMEN TYPE: UTERUS WITH OR WITHOUT TUBES & OVARIES,NEOPLASTIC. ADDITIONAL SPECIMEN TYPE: SOFT TISSUE MASS OR SIMPLE EXCISION. ADDITIONAL SPECIMEN TYPE: SOFT TISSUE BIOPSY. ADDITIONAL SPECIMEN TYPE: SOFT TISSUE BIOPSY. ADDITIONAL SPECIMEN TYPE: APPENDIX, OTHER THAN INCIDENTAL. ADDITIONAL SPECIMEN TYPE: HERNIA SAC (ANY LOCATION). Page: 3 of 3.",train,3.2 cm;3.2 cm;2 cm;3.2 x 3 x 1.6 cm;2.1 x 1.1 x 1.1 cm;4.5 x 3 x 2.1 cm;6 x 5 x 2 cm
2118,TCGA-5X-AA5U.28F20F49-20C6-4B93-957D-8DAEF04657AE,"WholeBlood. Ovarian Tumor. year old black female. Collected date: Diagnosis. Ovary and Fallopian tube, left, excision: - Papillary serous adenocarcinoma. - Ovarian capsule is intact. - The size of tumor is 9.5 cm in maximum dimension. - Fallopian tube is not identified. Ovary and Fallopian tube, right, excision: - Papillary serous adenocarcinoma. - Ovarian capsule is intact. - The size of tumor is 19.0 cm in maximum dimension. - Fallopian tube is not identified. Omentum, excision: - No evidence of malignancy. - See comment. Pathologist Comment. Both ovaries show significant involvement by tumor resulting in large bilateral tumor masses. I favor. synchronnous tumors because capsules seems to be intact. However metastatic tumor cannot be ruled. out. Synoptic Report. SPECIMEN;. Right ovary. Left ovary. Right fallopian tube. Left fallopian tube. Omentum. PROCEDURE: Bilateral salpingo-oophorectomy. Omentectomy. LYMPH NODE SAMPLING: Not performed. SPECIMEN INTEGRITY: Capsule intact. Left ovary. Capsule intact. PRIMARY TUMOR SITE: Bilateral ovarian involvement. OVARIAN SURFACE INVOLVEMENT: Uncertain/cannot be determined. TUMOR SIZE: Right Ovary - Greatest dimension: 19.0 cm. Left Ovary - Greatest dimension: 9.5 cm. HISTOLOGIC TYPE: Serous, carcinoma. HISTOLOGIC GRADE: High grade. EXTENT OF INVOLVEMENT OF OTHER TISSUES/ORGANS: Right ovary: Involved. Left ovary: Involved. Right fallopian tube: Not applicable. Left fallopian tube: Not applicable. Omentum: Not involved. PRIMARY TUMOR (pT) [FIGO]: pT1b [IB]: Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface. No. malignant cells in ascites or peritoneal washings. REGIONAL LYMPH NODES (pN): pNX: Cannot be assessed. Clinical Information. The patient is a. year old female with a history of pelvic pain and pelvic mass. Frozen Section Diagnosis. AFS1: Left tube and ovary, excision: - Positive for carcinoma. Gross Description. The specimen is received in three containers labeled with the patient's name and medical record number. The first container is labeled, ""left tube and ovary"". Received is a frozen section cassettes and ovary. according to the frozen section paperwork it is a 4.0 x 3.5 papillary mass. This mass appears to have. been within a cyst that measures approximately 8.0 cm. The entire specimen measures 9.5 X 8.5 X 2.5. cm. Attached to the papillary lesion, the section of firm white tissue that measures 8.0 x 5.0 cm. The second container is labeled, ""right tube and ovary"". Received is the ovary and possible fallopian tube. that measures 5.0 x 0.6 cm. The ovary has been opened intraoperatively and appears cystic. The ovary. measures 14.5 x 7.5 X 2.5 cm. Within the open cyst, the papillary lesion that measures 3.0 X 2.5 cm. The. outside will be inked. The cystic region measures 7.5 X 7.0 cm. Further examination of the cyst reveals. there are multiple papillary regions. There is an additional section that measures 4.5 x 1.0 cm. There is a. separate cystic area that measures 4.0 x 2.0 X 2.0 cm. The cyst contains brown fluid as well as what. appears to be necrotic material. The third container is labeled, ""omentum"". Received is a section of omentum that measures 25.0 x 8.0 x. 2.0 cm. Section through the omentum reveals multiple small sections with hemorrhage and firm tissue. Representative sections will be submitted. Block Summary. A1-A2- Frozen sections. A3-A5- Full thickness section through papillary lesion and outside of ovary. A6- Additional section through papillary lesion. A7-A8- Representative sections through firm white tissue. A9- Section through possibly hemorrhagic/necrotic tissue and cyst wall. A10- Additional cystic tissue. B1- Fallopian tube. B2-B4- Representative sections through papillary lesion. B5-B6- Additional sections through separate papillary lesion. B7- Representative sections through second cyst. B8-B9- Representative sections through ovary. B10- Section through necrotic tissue. C1-C5- Representative sections of omentum. Microscopic Description. Bilateral ovaries show malignant tumor with papillary architecture and high grade cytologic atypia. consistent with papillary serous adenocarcinoma. Bilateral ovaries are involved by tumor. Fallopian tubes. are not histologically identified. Omentum is free of malignancy.",train,9.5 cm;19.0 cm;19.0 cm
2144,TCGA-19-0963.49671c76-94c6-4ebd-9397-2340dad64f6b,"FINAL DIAGNOSIS. A. LEFT BRAIN CYSTIC TUMOR, REMOVAL: -- GLIOBLASTOMA MULTIFORME (WHO GRADE IV). Note: The tumor demonstrates focal circumscription with pilomyxoid degeneration. Necrosis is not identified,. however, microvascular proliferation is prominent. B. SPECIMEN LABELED CYST WALL, BIOPSY: -- GLIOBLASTOMA MULTIFORME. Note: Immunohistochemical stains confirm the diagnosis. C. TEMPORAL TIP, BIOPSY: -- CEREBRAL CORTEX DEMONSTRATING MILD ASTROCYTIC HYPERCELLULARITY. One or more of the reagents used to perform assays on this specimen MAY have contained components considered. to be analyte specific reagents (ASR's). ASR's have not been cleared or approved by the U.S.Food and Drug. Administration. These assays were developed and their performance characteristics determined by the. The assays. were performed with appropriate positive and negative controls. By the signature on this report, the individual or group listed as making the Final Interpretation/Diagnosis certifies that they have reviewed this case. Intraoperative Consult Diagnosis. A & B: Touch Imprint: High grade glioma. Clinical History: Left brain cystic lesion. Specimens Submitted As: A: TUMOR. B: CYST WALL. C: TEMPORAL TIP. Gross Description: A: Received fresh for intraoperative consultation, labelled with the patient's name and hospital number, are multiple,. irregular fragments of tan-brown and gray, soft tissue, measuring approximately 3.5 X 3x 1.5 cm. A touch imprint and. frozen section is performed on this tissue. The entire specimen is submitted in total of five cassettes. B: Received fresh for intraoperative consultation, labelled with the patient's name and number, are multiple, irregular. fragments of tan-brown and gray, soft tissue, measuring approximately 1.5 x 1 X 0.4 cm in aggregate. A touch imprint. and frozen section are performed on the specimen, and the entire specimen is submitted in two cassettes. C: Received fresh for intraoperative consultation, are multiple, irregular fragments of tan-gray, soft tissue, measuring. approximately 1.5) 0.8 X 0.4 cm in aggregate. A frozen section and touch imprint were performed and submitted in. one cassette. Summary of Cassettes: A. 1FS. 2-5. remainder of the specimen. B. 1FS. 2. remainder of the specimen. C. 1. entire specimen of tan-gray, soft tissue.",train,
2147,TCGA-AG-3887.2e39b422-bca0-4176-899f-1d55f656902e,"Structured findings: The material in I) is an advanced carcinoma, namely a mucinous adenocarcinoma of the colon. with penetration of all parietal layers and vascular infiltrates (G3, pT3, L1, V1), with regard to. the resection margins of the mucosa they show a regular mucosa, submucosa and muscularis,. with regard to the radial resection margin they show a free resection margin with mature fatty. connective tissue and related vascular portions,. with regard to the lymph nodes they show free lymph nodes (0/14).",train,
2151,TCGA-CG-5734.1c1ed591-33dc-4b7e-b2c2-9f3db9307b2b,"Findings and diagnosis in response to the question: I) involves regular splenic tissue, divided into red and white pulp with the appropriate. trabecular structure. II) involves free fatty tissue and free lymph nodes. III) involves a poorly differentiated advanced gastric carcinoma. in this case an. invasive adenocarcinoma of the intestinal type,. with infiltration of all wall layers (p T 2b),. with extensive lymphatic vessel penetration (L 1 -. also below),. with free resection margins in the mucosal area. In addition, in eight cut surfaces there are lymph node metastases from the carcinoma. described and, adjacent to these, indurated fatty connective tissue and. infiltration of the omental tissue and. partially also of the serosa (p T 3). IV) involves regular anastomotic rings, here of the small bowel type with appropriate. villous and crypt relief, lined with cylinder cells and goblet cells. In respect of the pancreatic situation, further secondary resections will follow (p T 3/. p T 4). A consultation was held about the definitive TNM classification. This is defined by the infiltration of the omental tissue, in this case with infiltration of the. peritoneum and, additionally to the initial findings, with infiltration of the lymph nodes in. the area of the omentum in four cut surfaces. In the pancreas these are inflammatory reactive changes. The tumour classification is as follows: ICDO-DA-M 8140/3. pT3, p N 1, L 1. In respect of the operative specimen a clear margin of healthy tissue was removed locally. (cf. also where necessary the corresponding operative report).",train,
2158,TCGA-24-1923.6ae8158a-e236-4cc0-88d2-50756216f0e7,"Amended. Physician (s) : other Related Clinical Data: DIAGNOSIS: OVARY, RIGHT, BILATERAL SALPINGO-OOPHORECTOMY. - POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA (SEE SYNOPSIS). - THE TUMOR INVOLVES THE OVARIAN SURFACE AND AND PARAOVARIAN SOFT TISSUE. - LYMPHATIC-VASCULAF SPACE INVASION ARE IDENTIFIED. OVARY, LEFT, BILATERAL SALPINGO-OOPHORECTOMY. - POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA (SEE SYNOPSIS). - THE TUMOR INVOLVES THE OVARIAN SURFACE AND AND PARAOVARIAN SOFT TISSUE. - LYMPHATIC-VASCULAR SPACE INVASION ARE IDENTIFIED. FALLOPIAN TUBE, RIGHT, BILATERAL SALPINGO-OOPHORECTOMY. - METASTATIC SEROUS ADENOCARCINOMA. FALLOPIAN TUBE, LEFT, BILATERAL SALPINGO-OOPHORECTOMY. - METASTATIC SEROUS ADENOCARCINOMA. UTERUS WITH CERVIX, TOTAL ABDOMINAL HYSTERECTOMY. - METASTATIC SEROUS ADENOCARCINOMA INVOLVING EXTENSIVELY SEROSA, SUBSEROSAL MYOMETRIUM,. ECTOCERVIX AND FOCALLY ENDOCERVIX. - INACTIVE ENDOMETRIUM. - ADENOMYOSIS. BLADDER MUCOSA, BIOPSY. - METASTATIC SEROUS ADENOCARCINOMA. APPENDIX, APPENDECTOMY. - METASTATIC SEROUS ADENOCARCINOMA. GASTROCOLIC OMENTUM, EXCISION. - METASTATIC SEROUS ADENOCARCINOMA. RECTAL PLAQUE, BIOPSY. - METASTATIC SEROUS ADENOCARCINOMA WITH NECROSIS. By this signature, I attest that the above diagnosis is based upon my. personal. examination of the slides (and/or other material indicated in the diagnosis). Intraoperative Consultation: An intraoperative non-microscopic consultation was obtained and interpreted as: ""Called to. pick-up uterus/cervix/right and left tubes and ovaries' consisting of a 102 gram corpus. uteri and cervix with bilateral attached fallopian tubes and ovaries. The ovaries are. sectioned and tissue is procured for. request. The uterus measures 6.8 cm. from fundus to cervix, 3 cm from cornu to cornu, and 4 cm from anterior to posterior. All. for permanents,. Microscopic Description and Comment: tantiates the above cited diagnosis. History: The patient is a. of unstated race, with ovarian cancer. Operative. procedure: Evaluation under anesthesia, exploratory laparotomy, transabdominal hysterectomy. - bilateral salpingo-oophorectomy, tumor debulking, and appendectomy. Specimen (s) Received: A: HYSTERECTOMY, BSO. B: BLADDER SEROSA. C: APPENDIX. D: GASTRO COLIC OMENTUM, ROUTINE. E: RECTAL PLAQUE. Gross Description. The specimens are received in five containers of formalin, each labelled with the patient's. name. The first container is labelled ""uterus/cervix/right and left tubes and ovaries. It. consists of a uterus, with dimensions consistent with those in intraoperative consultation,. attached cervix, measuring 3 x 3 x 2.5 cm, left and right fallopian tubes, measuring 6.5. cm and 6 cm, respectively, and left and right ovaries measuring 3 x 2.5 x 1 cm each. The. specimen has been previously bivalved for fixation. The external surface of cervix and. uterus shows irregular adhesions. No recognizable vaginal cuff or parametrial tissue is. present. The ectocervix measures 3 x 1 cm anteriorly, and 3.5 x 1.5 cm posteriorly. The. reconstituted os is somewhat irregular, measuring 0.5 cm. An area of hemorrhage, otherwise. smooth is noted along the posterior ectocervix measuring 1 x 1 cm in extent. The cervical. canal measuring 2.5 cm in length shows mucus. A slight irregularity is noted along the. anterior endocervical canal with attached mucus, measuring 1 x 1.2 cm. The endometrial. cavity is triangular and measures 2.5 x 2 cm. The anterior and posterior endomyometrium. is diffusely thickened with a smooth, trabeculated appearance. The anterior endomyometrium. measures 2.3 cm in thickness and the posterior endomyometrium measures 2.7 cm in the. maximally thickened area. The endometrial-myometrial interface is grossly obliterated. The. left adnexal structures are congested and edematous in appearance. Adhesions are grossly. identified with some firm areas. The fimbriated end of the left fallopian tube is grossly. obliterated and shows a soft, grey-white nodule, measuring 0.3 cm in immediate vicinity. The left ovary, although not grossly enlarged, has a nodular, granular outer surface with. areas showing exudate. The cut surface is also somewhat nodular and firm. No gross extension. of tumor into the meso-ovarian or adjacent, middle-third of fallopian tube is noted. The. right fallopian tube is thickened along the middle-third with serosal congestion and exudate. on the surface. The fimbriated end is obliterated and somewhat firm. There are areas of. congestion and firmness with exudate-like deposits in the left adnexal soft tissue. The. right ovary is similar in gross appearance to the left ovary. Labelled A1-A5, anterior. cervix with A1. and _A2 containing the nodular_ thickening; A6-A8, posterior cervix; A9 and. A10, synchronous sections of anterior endomyometriun; A11 and A12, synchronous sections of. posterior endomyometrium; A13, posterior serosal adhesions on uterine corpus; A14, anterior. serosal adhesions; A15-A17, left ovary and fallopian tube; A18-A20, right ovary, right. adnexa and fallopian tube; A21-A25, the remaining entire cervix; A26 -A33, the remaining. entire endometrium. The second container is labelled ""bladder serosa"" and contains an irregular fragment of. congested, soft, membranous tissue measuring 3.5 x 2.5 x 0.3 cm. Attached adipose tissue. is noted on the smooth surface. The opposite surface is somewhat rough and hemorrhagic. Serially sectioned. Labelled B1 and B2. The third container is labelled ""appendix"" and contains an appendix with attached fat,. measuring 6 cm in length. The tip is swollen and congested and shows grey-white exudate on. the surface. It measures 1.2 cm in greatest dimension. The cut surface in the swollen area. shows an obliterated lumen with no gross evidence of tumor involvement. Serial sectioning. through the remaining appendix shows a thin, 0.3 cm appendix with obliterated lumen. The. adjacent adpose tissue is grossly unremarkable. Labelled C1 and C2, entire firm area around. putative tip; C3, random appendix. The fourth container is labelled ""gastro-colic omentum. It consists of a stretch of. omentum, measuring 40 x 18 x 3.5 cm in maximum dimensions. There are geographic areas of. thickening and omental caking, involving the edges of the omentum. Cut sections of these. areas show grey-white, firm cut'surface with areas of necrosis. Random representative. sections labelled D1-D4. The fifth container is labelled ""rectal plaque"" and contains multiple plaque-like,. hemorrhagic fragments measuring 1.5 CC in aggregate. Labelled E1. Jar 0. Synopsis. SYNOPTIC REPORTING FORM FOR MALIGNANT OVARIAN NEOPLASMS. 1. A neoplasm is PRESENT. 2. The HISTOLOGIC DIAGNOSIS is. Serous adenocarcinoma. 3. The LOCATION(S) OF THE PRIMARY TUMOR (S) is/are: Right and left ovary (synchronous primary tumors). The FIGO GRADE of the tumor is: III (Tumor composed of >50% solid cellular nests). 5. The NUCLEAR (BRODERS') GRADE of the tumor is: G3. Poorly-differentiated). 6. Tumor IS identified on the ovarian surface(s) . 7. Tumor DOES invade the mesovarium. 8. Tumor DOES invade the adjacent fallopian tube. 9. Tumor DOES invade the pelvic soft tissue. 10. Tumor involvement of the pelvic peritoneum is PRESENT. 11. Metastatic involvement of the EXTRAPELVIC PERITONEUM is PRESENT. 12. Metastatic involvement of the omentum is PRESENT. 13. The maximum dimension of tumor implants outside the true pelvis is. >2 cm. 15. Metastatic involvement of the endometrium is ABSENT. 16. Regional lymph node metastases CANNOT BE EVALUATED. 17. The total number of regional lymph nodes examined is 0. 18. The total number of metastatically-involved regional lymph nodes cannot be evaluated. 19. DETAILED STAGING INFORMATION: Based on the above information, the PRIMARY TUMOR is. classified as: TNM Scheme. FIGO Scheme. Definition. T3c. IIIC. Macroscopic peritoneal. metastasis beyond true pelvis measuring > 2 cm in greatest dimension,. THE REGIONAL LYMPH NODES are classified as: NX (Nodal status cannot be assessed). THE STATUS OF DISTANT TUMOR SITES is classified as : MX (Status cannot be assessed). 20. The FINAL AJCC/UICC/FIGO STAGE IS: AJCC/UICC/FIGO. X. Insufficient data to assign stage. Amendments. Reason: This case is being amended to correct the Microscopic description field.",train,
2177,TCGA-WT-AB44.B7EB0E0B-46C5-43C0-A78D-FB094290765A,"SURG PATH #: SPECIMEN CLASS: ALT ID #: SEX: F. DATE RECEIVED: DATE OF PRINTING: Material Received: A: left breast SLN #1 time out. B: left breast SLN #2 time out. C: left breast SLN #3 time out. D: left breast SLN #4 time out. E: left breast lumpectomy time out. F: additional anterior left breast tissue. History: year-old female with history of invasive lobular carcinoma of the breast. Final Diagnosis: A. Lymph node (1), ""left breast SLN #1"", biopsy: There is no evidence of malignancy in one lymph node. (0/1). Deeper sections and a pancytokeratin immunostain are negative in support of the above diagnosis. B. Lymph node (1), ""left breast SLN #2"", biopsy: There is no evidence of malignancy in one lymph node. (0/1). Deeper sections and a pancytokeratin immunostain are negative in support of the above diagnosis. C. Lymph node (1), ""left breast SLN #3"", biopsy: There is no evidence of malignancy in one lymph node. (0/1). Deeper sections and a pancytokeratin immunostain are negative in support of the above diagnosis. D. Lymph node (1), ""left breast SLN #4"", biopsy: There is no evidence of malignancy in one lymph node. (0/1). Deeper sections and a pancytokeratin immunostain are negative in support of the above diagnosis. E. Breast, ""left breast lumpectomy"", lumpectomy: Invasive lobular carcinoma, moderately differentiated. See comment. Lobular carcinoma in-situ and atypical lobular hyperplasia. Previous biopsy site changes. F. Breast, ""additional anterior left breast tissue"", excision: Microscopic focus of invasive lobular carcinoma. See comment. Lobular carcinoma in-situ and atypical lobular hyperplasia. Date of Printing: SURG PATH #: ALT ID #: Comment: INVASIVE CARCINOMA OF THE BREAST. Specimen Type: Lumpectomy. Laterality: Left. Tumor Site: 1:00, 6 cm FTN. Histologic Type: Invasive lobular carcinoma. Size of Invasive Component: 1.5 cm in greatest dimension in the main lumpectomy. 0.3 cm in greatest dimension in the separately. submitted ""additional anterior left breast tissue"". Tumor Multicentricity: Yes. Surgical Margins: The carcinoma is focally 1.5 mm from the anterior margin and focally 1.75 mm from the inferior margin in. the. main lumpectomy (Specimen E); all other margins are greater than 0.2 cm away. In specimen F (""additional anterior left breast. tissue"") which is unoriented, carcinoma is present at one shave margin/tissue edge while all other margins are 0.2 cm or greater. away. Histologic Grade (Nottingham Histologic Score): II/III. Tubule Formation: 3. Nuclear Grade: 2. Mitotic Count (40x objective): 1. Total Nottingham Score: 6/9. Ductal Carcinoma In-situ (DCIS): Absent. Lobular Carcinoma In-situ (LCIS): Present. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Not identified. Tumor Necrosis: Absent. Nipple Involvement: Not applicable. Skin Involvement: Not applicable. Lymph Node Sampling: Sentinel lymph node(s) only. Total number of involved nodes/total nodes found: 0/4. Non-neoplastic Breast Tissue: Focal atypical ductal hyperplasia. Fibrosis and prior biopsy site changes. Prognostic markers: Ordered on prior biopsy. See. for addendum. Time between tumor removal and placement into formalin < 1 hour: Yes. Fixation Time between 6-48 hours: Yes. Pathologic Staging: pT1c snNo(i-). Primary Tumor (Invasive Carcinoma) (pT). pT1c: Tumor 10 mm but d20 mm in greatest dimension. Regional Lymph Nodes (pN). Modifier (required only if applicable). (sn): Only sentinel node(s) evaluated. If 6 or more sentinel nodes and/or nonsentinel nodes are removed, this modifier. should not be used. pNO (i-): No regional lymph node metastases histologically, negative IHC. Distant Metastasis (M). Not applicable. The pathologic stage assigned here should be regarded as provisional, as it reflects only current pathologic data and does not. incorporate full knowledge of the patient's clinical status and/or prior pathology. In Specimen F, immunohistochemical stain for smooth muscle myosin supports the diagnosis. Attestation: By this signature, I attest that I have personally formulated the final interpretation expressed in this report and that the above diagnosis is based. upon my examination of the slides and/or other material indicated in this report. Interpreted by: Date of Printing: SURG PATH #: ALT ID #: Resident. Gross Description: A. Received in formalin labeled with the patient's name ""left female breast sentinel lymph node #1 out at. are two tan-pink. lymph nodes measuring 0.9 x 0.9 x 0.6 cm and 1.4 x 1.3 x 0.6 cm. The smaller lymph node is inked black. Both lymph nodes are. serially sectioned and submitted entirely in cassette A1. B. Received in formalin labeled with the patient's name ""female left breast sentinel lymph node #2 time out. "" is a 2.3 x 1.8 x. 0.6 cm aggregate of yellow-tan fibroadipose tissue that is palpated to reveal two possible lymph nodes measuring 1.2 x 0.8 x 0.4. cm and 1.5 0.7 x 0.5 cm. The smaller lymph node is inked black. Both lymph nodes are serially sectioned and submitted. entirely in cassette B1. C. Received in formalin labeled with the patient's name and ""female left breast sentinel lymph node #3 time out. "" is a 3.2 x. 1.7 x 0.9 cm aggregate of yellow-tan fibroadipose tissue that is palpated to reveal two possible fymph nodes measuring 0.5x 0.5. x. 0.3 cm and 1.0 x 0.6 x 0.4 cm. The smaller lymph node is inked black. Both lymph nodes are serially sectioned and. submitted. entirely in cassette C1. D. Received in formalin labeled with the patient's name and ""left female breast sentinel lymph node #4 out at. "". is a 2.2 X 1.1. x 0.8 cm aggregate of yellow-tan fibroadipose tissue that is palpated to reveal one possible lymph node measuring 0.4 x 0.3 x 0.3. cm. The specimen is serially sectioned and submitted entirely in cassette D1. E. Received fresh labeled with the patient's information and ""female left breast lumpectomy"" is a 35 gm lumpectomy specimen. measuring 7.0 x 5.5 x 1.0 cm. The specimen has already been inked by the surgeon as follows: Orange - Lateral. Yellow - Medial. Red - Superior. Blue - Inferior. Green - Anterior. Black - Posterior. The specimen is serially sectioned from lateral to medial into twelve slices. In slices 6 through 8, there is a 1.2 x 0.7 x 0.6 cm firm. white well circumscribed mass that is: 0.1 cm from the anterior margin. 1.8 cm from the posterior margin. 1.5 cm from the superior margin. 2.2 cm from the inferior margin. 2.0 cm from the lateral margin. 1.6 cm from the medial margin. The remainder of the breast parenchyma is yellow-white adipose tissue. The specimen is entirely submitted as follows: E1. Slice #1 (lateral margin). E2. Slice #2. E3-4. Slice #3 bisected. E5-7. Slice #4 trisected. E8-9. Slice #5 bisected. E10-12. Slice #6 trisected. E13-14. Slice #7 bisected. E15-17. Slice #8 trisected. E18-20. Slice #9 trisected. E21-22. Slice #10 bisected. E23-24. Slice #11 bisected. E25. Slice #12 (medial margin). The specimen was removed from the patient at. and placed in formalin at. on and not removed from formalin until. F. Received in formalin labeled with the patient's name and ""additional anterior left breast tissue"" is a 2.7 x 1.9 x 1.0 cm piece of. yellow lobular adipose tissue. The outer surface is inked black. The specimen is serially sectioned to reveal a yellow. homogeneous cut surface with no discrete lesion or abnormalities identified. The specimen is entirely submitted in cassettes. Date of Printing: SURG PATH #: ALT ID #: F1-F3. The breast was removed from the patient at. , and placed in formalin immediately in the OR and not removed from. formalin until. on today's date. If immunohistochemical stains and/or in situ hybridization are cited in this report, the performance characteristics were determined by the. in compliance with CLIA'88. regulations. Some of these tests rely on the use of ""analyte specific reagents"" and are subject to specific labeling requirements by the FDA. Known. positive and negative control tissues demonstrate appropriate staining. This testing was developed by the. It has not been cleared or approved by the FDA. The FDA has determined that such clearance or approval. is not necessary. Date of Printing:",train,1.5 cm
2228,TCGA-LL-A5YL.17B51CA5-E325-4EA0-AFED-C6D0FD5A40EF,"AGE/SX: ROOM. REG DR: BED: DIS: TLOC: COLL. TIME IN FORMALIN: 4:16. hrs. CLINICAL INFORMATION: Pre-Op Diagnosis: Right breast CA. Remarks: Specimen (s) : A. Right breast tissue stitch axillary tail. B. Right axillary node x2. C. #1 sentinel node right breast. D. IS level 3 node stitch marks highest level node. E. Axillary contents. MICROSCOPI DIAGNOSIS. A. RIGHT BREAST, TOTAL MASTECTOMY: INVASIVE LOBULAR CARCINOMA. INVASIVE CARCINOMA MEASURES AT LEAST 4.5 CM IN GREATEST DIMENSION (pT2). NOTTINGHAM COMBINED HISTOLOGIC GRADE 2 OF 3. TUBULE FORMATION SCORE 3 OF 3. NUCLEAR PLEOMORPHISM SCORE 2 OF 3. MITOTIC COUNT SCORE 1 OF 3. SURGICAL MARGINS OF RESECTION FREE OF INVASIVE LOBULAR CARCINOMA. FOCI OF LOBULAR CARCINOMA IN SITU. FOCI OF DUCT CARCINOMA IN SITU. INTERMEDIATE NUCLEAR GRADE, NOT EXTENSIVE. SEE COMMENT FOR SURGICAL PATHOLOGY CANCER CASE SUMMARY CHECKLIST. B. RIGHT AXILLARY LYMPH NODES X2, EXCISION: METASTATIC BREAST CARCINOMA IN TWO OF TWO LYMPH NODES. C. SENTINEL LYMPH NODE #1, EXCISION: NEGATIVE. NO EVIDENCE OF METASTATIC CARCINOMA IN THIS SPECIMEN. D. LEVEL 3 AXILLARY LYMPH NODES, REGIONAL RESECTION. NEGATIVE. NO EVIDENCE OF METASTATIC CARCINOMA IN SIX HIGHEST LEVEL 3 LYMPH NODES. E. RIGHT AXILLARY LYMPH NODES, REGIONAL RESECTION: METASTATIC BREAST CARCINOMA IN ONE OF 14 AXILLARY LYMPH NODES. COMMENT(S). SURGICAL PATHOLOGY CANCER CASE SUMMARY CHECKLIST - CAP APPROVED. Procedure: Total mastectomy. RUN DATE. RUN TIME. RUN USER: SPEC #: COMMENT (S). Lymph Node Sampling : Sentinel lymph node(s). axillary dissection. Specimen Laterality: Right. Histologic Type of Invasive Carcinoma : Invasive lobular carcinoma. Tumor Size: Greatest dimension of largest focus of invasion : 45. mm. Histologic Grade (Nottingham) : Glandular/Tubular Differentiation: Score 3. Nuclear Pleomorphism: Score 2. Mitotic Rate: Scors 1. Overall Grade Grade 2. Ductal Carcinoma In Situ: DCIS is present; negative for extensive intraductal. component (EIC). Architectural Patterns: Cribriform, solid. Nuclear Grade Grade II. Necrosis: Present, focal. Lobular Carcinoma In Situ: Present. Invasive Carcinoma: Margins uninvolved by invasive. Margins: carcinoma. Distance from closest margin : 1 0mm. DCIS: Margins uninvolved by DCIS. Distance from closest margin > 10 mm. Lymph Nodes: Number of sentinel lymph nodes examined: 1. Total number of lymph nodes examined (sentinel and. nonsentinel) : 23. Number of lymph nodes with macrometastases (>2 mm) : 3. Number of lymph nodes with micrometastases (>0.2 mm. to 2 mm and/or 200 cells) : 0. Number of lymph nodes with isolated tumor cells. (50.2 mm and <200 cells) : 0. Number of lymph nodes without tumor cells. identified 20. Extranodal Extension : Not identified. Method of Evaluation : Hematolxylin and eosin, level 1. Lymph-Vascular Invasion. Not identified. Dermal Lymph-Vascular Invasion. Not identified. Pathologic Staging: Primary Tumor: pT2. Regional Lymph Nodes: pN1a. Distant Metastasis: Not applicable. Ancillary Studies: ER: Positive (92% of tumor cells with nuclear. positivity); strong. PR: Negative. HER2: Positive (score 3+). In Situ Hybridization for HER2 Not amplified. RUN DATE : RUN TIME: Specimen Inquiry. RUN USER: SPEC #: GROSS DESCRIPTION: The specimen is submitted in five containers. A. The first specimen submitted in the fresh state is labeled ""right breast tissue"" The. specimen is the right breast, total mastectomy specimen Suture marks the axillary tail of. the breast. There is an ellipse of white skin containing the nipple. This measures 9 x 4.5. cm The breast itself measures 23 x 22.5 x 6.5 cm. There is a firm mass palpable beneath. the surface at approximately the 11 o'clock position The overlying superficial margin. adjacent to the skin is marked with black ink and the deep margin beneath this is marked. with blue ink. On cut section the mass measures approximately 4.5 x 3 x 3 cm. The edges. are quite difficult to discern and are more easily palpated than visualized In the center. of the specimen there is a small focus of hemorrhage consistent with previous biopsy. . portion of this mass is set aside for tissue banking per protocol. The mass extends to. within approximately 1 cm of the overlying superficial margin at approximately 11 O'clock. at its closest point. It is located well above the deep margin which is approximately 7 cm. beneath the mass. Cut sections through the remainder of the breast tissue reveals some. rubbery white parenchymal breast tissue and abundant yellow fat. There. are. other. nodules or mass is identified. Sections are submitted as follows: A1. nipple. A2-5 -. mass in breast. A6. mass in breast with adjacent tissue. A7-9 -. non-neoplastic appearing breast tissue. B. The. second specimen is received in the fresh state in the operating room and represents. two axillary lymph nodes, one measuring 2 x 1.5 x 1 cm and the other measuring 1 x 0.7 x. 0.7. cm. The cut sections are hard. A section of each is examined by frozen section. These are submitted in block B1, frozen section control. Additional section of each is. submitted in block B2. C. The. third specimen initially in the fresh state is labeled ""sentinel node #1"" and is a. piece of yellow fat measuring 2.5 x 2 x 1 cm with a 1 cm round moderately firm lymph node. which is bisected and submitted in toto in block C1. D. The fourth specimen is labeled ""level 3 axillary nodes"" The specimen is a piece of. yellow fatty tissue measuring 9 x 3 x 1.! cm with a suture marking the highest level 3. lymph node. There are five additional small lymph nodes. The highest node is submitted in. block D1 and the other five lymph nodes are submitted in block D2. E. The fifth container is labeled ""right axillary contents"" The specimen is yellow fatty. tissue measuring 10 x 9 x 2.5 cm. Within the fatty tissue are several nodules consistent. with. lymph nodes. The largest of these measures 2 cm in diameter and on cut section is. partially replaced by very hard white tissue. A section of each node is. submitted. in. blocks E1 through E4. MICROSCOPIC DESCRIPTION. The slides are examined and evaluated. RUN DATE. RUN TIME. Specimen Inquiry. RUN USER. SPEC #: INTRAOPERATIVE CONSULTATION. OPERATING ROOM CONSULTATIONS : . Portions of the breast mass are processed for tumor tissue banking per protocol. B. FROZEN SECTION DIAGNOSIS OF RIGHT AXILLARY LYMPH NODES X2: METASTATIC CARCINOMA IN TWO LYMPH NODES. PHOTO DOCUMENTATION. Image. Image. Image. Image. Image. Image. (signature on file).",train,4.5 CM;45. mm
2252,TCGA-R6-A8WC.F8CD8721-D488-428E-9CBE-6F07FF1EF14F,"DIAGNOSIS. (A) ESOPHAGUS, DISTAL, TUMOR, BIOPSY: INVASIVE, MODERATELY DIFFERENTIATED ADENOCARCINOMA. No distinctive-type of Barrett mucosa identified. GROSS DESCRIPTION. (A) DISTAL ESOPHAGEAL TUMOR - Multiple light gray and pink fragments of soft tissue (0.8 x 0.3 x 0.3 cm in aggregate). Entirely submitted in A. BIOMARKER TESTING. Tumor block: A1. CLINICAL HISTORY. Esophageal carcinoma. SNOMED CODES. ""Some tests reported here may have been developed and performance characteristics determined by. . These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by: END OF REPORT-.",train,0.8 x 0.3 x 0.3 cm
2304,TCGA-D8-A73U.7BA4658F-3343-4176-BDCD-620A1001A032,"Gender: F. Clinical diagnosis (suspicion) Cancer of the left breast. Date of admission: Material: 1) Material: Left breast. Method of collection: total organ resection. Histopathological diagnosis: Invasive lobular carcinoma of the left breast (NHG2, pT2). (8520/3 T-04030). . codes according to ICD-O-3 or SNOMED. Macroscopic description: Left breast, sized 21.2 x 12.3 x 5.4 cm, removed without axillary tissues and with a skin flap of 18.2 x 8.3 cm. Weight: 436g. Tumour sized 4x2,2x1,6cm found on the boundary of upper quadrants, placed 2.8 cm from the upper boundary,. 1.4cm from the base and 1.0cm from the skin. Microscopic description: Invasive ductal carcinoma (classical type) - NHG 2 (3+2+1: 0 mitoses/ 10 HPF - visual area: 0.55mm: 0.55mm). The. nipple without pathological lesions. Glandular tissue showing parenchyma atrophy. Results of intraoperative examination: Estrogen receptors found in 75% of neoplastic cell nuclei. Progesterone receptors found in 75% of neoplastic cell. nuclei. HER2 protein stained with. HER-2/neu (4B5) Rabbit Monoclonal Antibody. Negative reaction in invasive cancerous cells ( Score = 1+). The expression of proliferating nuclear antigen Ki 67 in 15 % cellular nuclei.",train,4x2;2x1;6cm
2380,TCGA-FI-A3PV.0EBA5D54-65AC-4F79-ACE9-29FB1F924E3A,"Suraical Pathology Report. service:Gynecology. (Age: Other Related Clinical Data: DIAGNOSIS: UTERUS, ENDOMETRIUM, TOTAL ABDOMINAL HYSTERECTOMY. - PAPILLARY SEROUS ADENOCARCINOMA. - ADENOCARCINOMA IS CONFINED TO THE ENDOMETRIUM. - NO LYMPHVASCULAR SPACE INVASION IS IDENTIFIED. UTERUS, CERVIX, TOTAL ABDOMINAL HYSTERECTOMY. - PAPILLARY SEROUS ADENOCARCINOMA INVOLVING ENDOCERVICAL. GLANDS. UTERUS, MYOMETRIUM, TOTAL ABDOMINAL HYSTERECTOMY. - LEIOMYOMATA WITH CALCIFICATION AND HYALINIZATION. LARGEST 6.2 CM. OVARY, RIGHT, OOPHORECTOMY. NO HISTOPATHOLOGIC ABNORMALITY. - PARAOVARIAN SOFT TISSUE WITH ORGANIZING THROMBUS. - NO FALLOPIAN TUBE IDENTIFIED. LYMPH NODES, RIGHT PELVIC, EXCISION. - NO CARCINOMA IDENTIFIED IN FIVE LYMPH NODES (0/5). LYMPH NODES, LEFT PELVIC, EXCISION. - NO CARCINOMA IDENTIFIED IN FIVE LYMPH NODES (0/5). LYMPH NODES, LEFT PERIAORTIC, EXCISION. - NO CARCINOMA IDENTIFIED IN FOUR LYMPH NODES (0/4). LYMPH NODES, RIGHT PERIAORTIC, EXCISION. - NO CARCINOMA IDENTIFIED IN TWO LYMPH NODES (0/2). Intraoperative Consultation: An intraoperative non-microscopic consultation was obtained and interpreted as: ""called to pick-up uterus, cervix, right ovary and tube' consisting of a 600. gram uterus, measuring 15 cm (from fundus to os) x 8 cm (cornu to cornu) x 10. cm. (anterior to posterior). The right ovary is attached and no definitive tube is. identified intraoperatively. opened to show a 5 cm wide x 7 cm long endometrial. cavity with tumor in the fundic area. Tumor and normal (serosa) taken for. Shown to surgeon. Remainder for permanents,"". Microscopic Description and Comment: Microscopic examination substantiates the above cited diagnosis. History : The patient is a year old woman with endometrial cancer. Operative. procedure: Total abdominal hysterectomy with right salpingo-oophorectomy and. pelvic lymph node dissection. specimen(s) Received: A: CERVIX, UTERUS, AND RIGHT TUBE AND OVARY. B: RIGHT PELVIC LYMPH NODE. C: LEFT PELVIC LYMPH NODE. D: LEFT PERI AORTIC LYMPH NODE. E: RIGHT PERI AORTIC LYMPH NODE. Gross Description. The. specimens are received in five containers of formalin, each labeled. The first container is labeled ""cervix, uterus, right tube and. ovary. It contains a 600 gram, 15 x 10 x 8 cm previously opened uterus which. has a shiny light brown serosal surface without focal lesions and is obviously. distorted by abundant myometrial nodules. The cervix measures 2.0 x 1.9 cm. and. has a shiny white-tan ectocervical mucosa without focal lesions. The. transformation zone is grossly unremarkable and the endocervical canal measures. 3.8 cm in length and also has a shiny brown, unremarkable mucosa. The. endometrial cavity measures 7.0 cm long x 5 cm wide x 0.5 cm in depth and has a. finely folded light brown endometrium with a fungating, soft and irregular tan. mass over the most superior aspect of the posterior wall and over the fundus and. most superior aspect of the anterior wall. There is no gross involvement of the. lower uterine segment. Numerous sections through the tumor show it to be. exophytic without obvious invasion into the underlying myometrium which is. markedly distorted. It has a maximal thickness of 3.6 cm and has numerous white. whorled nodules (> 10) throughout with several underlying the endometrial tumor. mass and ranging from 0.4 up to 6.2 cm in maximum dimension. On sectioning. there is no evidence of necrosis, hemorrhage, or cystic change. Several of. these nodules have yellow-browr gritty apparent calcification. The attached. right ovary is lobulated and light tan and measures 3.4 x 2.5 x 1.5 cm. It has. a variegated tan cut surface without masses or focal lesions. Examination. and. numerous sections though the surrounding lobulated broad ligament soft tissue. show dilated veins with central brown thrombi but no obvious fallopian tube. Labeled A1, A2 - anterior cervix and lower uterine segment, respectively; A3. anterior endomyometrium with tumor (partial thickness) A4, A5 - posterior. cervix and lower uterine segment, respectively; A6 - posterior endometrium tumor. (partial thickness) : A7 - full thickness posterior endometrium with tumor; A8,. A9. continuous fuli thickness sections over posterior endomyometrium with tumor. (top to bottom); A10 - full thickness anterior endometrium with tumor; A11,. A12. - myometrial nodules; A13 - right ovary; A14 - paraovarian soft tissue. Jar. 3. The second container is labeled ""#2, right pelvic lymph node. It contains. four. pieces of lobulated yellow fibroadipose tissue, measuring 9.5 x 6.5 x 3.8 cm in. aggregate which are dissected to show numerous large and fat replaced tan-brown. lymph nodes ranging from 0.4 up to 3.5 cm. Labeled B1 to B3 - single lymph. node. in each cassette, sectioned; B4 - two small lymph nodes; B5 to 87 - entire. largest single lymph node. Jar 1. The third container is labeled ""#3, left pelvic lymph node.' It contains. four. pieces of lobulated yellow and tan fibroadipose tissue which is dissected to. show numerous tan-brown lymph nodes without gross sclerosis, some of which are. quite large, measuring from 0.4 up to 2.4 cm in maximum dimension. Labeled C1. four small Tymph nodes; C2, C3- a single large node, sectioned; C4, C5 - another. single large node, sectioned; C6 - single smller node, bisected. Jar 1. The fourth container is labeled ""#4, left peri-aortic lymph node.' It contains. four pieces of lobulated yellow and brown fibroadipose tissue which are. dissected to show several tan-brown Tymph nodes without gross sclerosis ranging. from 0.4 up to 1.2 cm in maximum dimension. Labeled D1 - three individual Tymph. nodes; D2 - single larger node, bisected. Jar 1. The fifth container is labeled '#5, right periaortic lymph node. It contains. four pieces of lobulated yellow and tan fibroadipose tissue measuring 3. 8 x 3.1. x 0.9 cm in aggregate which are dissected to show two tan lymph nodes without. gross sclerosis measuring 0.5 and 1.1 cm, respectively. Labeled E1 - single. smaller node; E2 -single larger node, bisected. 1ar. 1. synopsis. SYNOPTIC REPORTING FORM FOR MALIGNANT ENDOMETRIAL TUMORS. 1. A NEOPLASM IS: Present. 2. THE HISTOLOGIC DIAGNOSIS IS: Adenocarcinoma, serous papillary type. 3. THE MAXIMUM TUMOR SIZE IS 3.6 cm. 4. THE LENGTH OF THE UTERINE CAVITY IS. 7.0 cm. 6. THE NUCLEAR GRADE OF THE TUMOR IS: NIII. 7. INVASIVE TUMOR IS: Absent (intraendometrial tumor only). 8. THE TUMOR INVADES TO A DEPTH OF 0 mm WITH. A MYOMETRIAL THICKNESS OF 20 mm "". 9. THE ENDOCERVIX IS: Involved by tumor in its mucosal aspect only. 10. LYMPHATIC INVASION BY TUMOR IS: Absent. 11. VASCULAR INVASION BY TUMOR IS: Absent. 12. RESIDUAL NON-NEOPLASTIC ENDOMETRIAL TISSUE: Shows atrophy. 13. THE MYOMETRIUM: Shows the presence of leiomyomas. 14. THE RIGHT OVARY: Is free of tumor. 15. THE LEFT OVARY: Is not evaluable. 16. THE RIGHT FALLOPIAN TUBE. Is not evaluable. 17. THE LEFT FALLOPIAN TUBE: Is not evaluable. 18. THE VAGINAL CUFF OF EXCISION IS: Not evaluable. 19. TUMOR INVASION OF ADJACENT STRUCTURES IS: Absent. 20. METASTASIS TO THE OMENTUM AND PERITONEUM IS: NOT evaluable. 21. ""T"" DATA- THE TUMOR IS: TNM Categories. FIGO Stages. 2a. IIA. Endocervical glandular involvement only. 22. THE REGIONAL LYMPH NODES: Are free of tumor in 16 nodes. 23. ""N"" DATA- - THE REGIONAL LYMPH NODES ARE: (Free of metastases). 24. ""M"" DATA- - DISTANT METASTASES ARE: MX (Not evaluable). 25. THE OVERALL PATHOLOGIC AJCC STAGE OF THE TUMOR IS: Stage X. Insufficient data to assign a stage. The pathologic stage assigned here should be regarded as provisional, and may. change after integration of clinical data not provided with this specimen. surgical Pathology Report. SURGICAL PATHOLOGY REPORT - CONSULT. service:Inside/outside. (Age : Other Related Clinical Data: DIAGNOSIS. UTERUS, ENDOCERVIX, CURETTINGS (. DETACHED CLUSTERS OF CARCINOMA CELLS. ENDOCERVICAL EPITHELIUM WITH NO HISTOPATHOLOGIC ABNORMALITY. UTERUS, ENDOMETRIUM, CURETTINGS. - PREDOMINANTLY BLOOD CLOT WTTH DETACHED CLUSTERS OF CARCINOMA CELLS. UTERUS, CERVIX, BIOPSY. - BLOOD CLOT WITH DETACHED ATYPICAL CELLS. - ACUTE AND CHRONIC CERVICITIS, MTID. UTERUS, CERVIX, THIN PREPARATION. - POSITIVE FOR MALIGNANCY, CONSISTENT WITH CARCINOMA. Microscopic Description and Comment. The cytologic features are consistent with a poorly differentiated. adenocarcinoma. The site of origin, endometrial, endocervical or extrauterine. cannot be ascertained in these samples. History. The patient is a year old woman with postmenopausal bleeding. Operative. procedure: Pap smear as well as endocervical and endometrial curettings, and. cervical biopsies. Material( (5) Received. Received are seven slides labeled. (6) and. (1) accompanied by a. corresponding pathology report.",train,6.2 cm;3.6 cm
2436,TCGA-93-A4JN.BA9DB454-6107-4F98-8646-89129230D602,"FINAL CORRECTED REPORT DATED. REPLACES ALL PREVIOUS VERSIONS. Final, Corrected. CORRECTED REPORT. Cardiothoracic Surgery. Takart. Accessioned: DIAGNOSIS: LUNG, ""PARIETAL PLEURAL DEPOSIT,"" BIOPSY (INCLUDING FS1). - ADENOCARCINOMA. - HYALINIZED GRANULOMAS. - SEE COMMENT. LYMPH NODE, LEVEL 7, BIOPSY. - NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). - HYALINIZED GRANULOMA. - NO FUNGAL FORMS OR MYCOBACTERIAL SPECIES IDENTIFIED ON GMS, AFB OR FITE STAINS. LYMPH NODE, LEVEL 11, BIOPSY. - NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). - HYALINIZED GRANULOMA. LYMPH NODE, LEVEL 11, BIOPSY (INCLUDING FS2). - NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). - HYALINIZED GRANULOMA. LUNG. LINGULA, RESECTION (INCLUDING FS3). - ADENOCARCINOMA (3.2 CM). INVASIVE AND POORLY DIFFERENTIATED. - TUMOR INVADES INTO  THE VISCERAL PLEURA (T2aN0Mia . STAGE IV). - ARTERIAL INVASION IDENTIFIED. - NON-TUMORAL LUNG WITH HYALINIZED GRANULOMAS. . SEE SYNOPSIS AND COMMENTS. By the signature. ! attest that the above diagnosis is based ypon my gersonal. examination of the sides(and/or other material in the diagrosis). "". Page of 4. Intraoperative Consultation: An intraoperative non-microscopic consultation was obtained and interpreted as: ""Brought to the frozen section area is. 'lingula,' which consists of a pink-red wedge of lung, measuring 13 x 12.5 x 3 cm. Staple line removed and inked. black. Sectioned to show a light brown-tan soft mass measuring 3.2 x 2.7 cm, located approximately 0.5 cm from the. nearest inked margin. Portion frozen as FS3. Tissue taken for tuberculosis test. Rest for permanents,"" by. FS1: Pleural deposit, blopsy. - ""Hyalinized granulomas, focal small basophilic nests, question tumoriets."" by. FS2: Level 11 lymph nodes. - ""Hyalinized granulomas, focally necrotizing. no evidence of malignancy,"" by. FS3: Lingula. excision. ""Adenocarcinoma, inked margin free of tumor,"" by. Microscopic Description and Comment: Sections of the submitted lingula"" (part E) show an invasive, poorly differentiated adenocarcinoma (3.2 cm) which has. an infiltrative and poorly circumscribed border, involving the visceral pleura (PL2). The tumor invades into but not. through the visceral pleura (blockE7). All surgical resection margins are free of tumor. Of note, multiple intra-arterial. invasions with tumor cells colonizing the endothelial wall are also seen. A provisional primary tumor staging is provided. as T2a based on the staging information from the ""lngula"" specimen. Additional sections of the specimen ""pleural deposit"" (part A) show focal small basophilic nests of tumor cels with. some features of neuroendocrine differentiation. Small amount of mature adipose tissue is also present. At deeper. level, some of these areas also showed tubular and acinar architecture. These tumor cells are positive for TTF-1 and. are negative for synaptophysin and chromogranin, confirming their malignant nature. Per discussion with. we understand that the submitted ""pleural deposit"" (part A) was acquired. from distant parletal pleural site (M1a). This report is ammended to Include this information and to upstage. the lesion to STAGE IV. Numerous granulomas are seen (part B, part C, part D, part E). GMS, FITE, AFB are performed on the lymph node. specimen acquired from level 7 (part B) and the results are negative. also reviewed select sections and concurs with final diagnosis. History: The patient is. who presents with a pre-operative diagnosis of lung mass. Pre-operative biopsy show. no evidence of maagnancy in multiple lymph nodes. Operative procedure: Video-assisted lingulectomy. Specimen(s) Received: A: PLEURAL DEPOSIT. B: LYMPH-NOOE, LEVEL-1. C: LYMPH NODE, LEVEL 11. D: LYMPH NODE, LEVEL 11. E: LINGULA. Gross Description;. The specimens are received in five formalin-filled containers, each labaled with the patient's name. The first container is additionally labeled ""pleural deposit; FS1. It contains a green tissue cassette PST,. which holds multiple minute brown-tan frozen section tissue remnants, measuring 0.5 x 0.3 x 0.1 cm in aggregate. Wrapped. Labeled A1 (FS1). Jar 0. The second container is labeled ""level 7 lymph nodes. It contains a pink-tan lymph node candidate. measuring 2 x. 1. x 1 cm in greatest dimension. Bisected to show no grossly identifiable lesion. Labeled B1. Jar. 0. The third container is labeled ""level 11 lymph node."" It contains one single pink-brown lymph node candidate,. measuring 0.9 x 0.8 x 0.6 cm. Bisected. Labeled C1. Jar 0: The fourth container is labeled ""level 11 lymph node; FS2."" It contains a green tissue cassette labeled ""FS2,"" which. holds two pieces of brown-pink frozen section tissue remnants, measuring 1 x 1.2x0.3 cm and 1 x 1.2 x 0.3 cm each. Labeled D1 (FS2). Jar 0. The fifth container is labeled ""linguia; FS3 it contains a green tissue cassette labeled ""FS3,"" which holds a 1.8 x. 1.2 x 0.2 cm pink-tan frozen section tissue remnant. Labeled E1 (FS3). Also present within the container is a. previously inked and sectioned lingula lobectomy specimen. weighing 78.5 g. and measuring 13 x 12.5 x 3 cm. A. staple line is present at the site of resection. The staple line is removed and its underlying parenchymal resection. margin is inked black. Sectioned to show a 3.2 x 2.7 x 2.5 cm tumor mass, which is located approximately 0.5 cm. from the nearest inked parenchymal resection margin (sampled in E3) and is located 1.2 from the bronchial resection. margin. The pleural surface overlying the tumor shows puckering that measures 0.5 cm in the greatest dimension. The pleural surface in this area is inked blue. The uninvolved area of lung is further sectioned to show brown-tan,. spongy, unremarkable parenchyma. Upon further inspection, a 0.2 cm white-yellow, pearly lesion is present at the. periphery of the pleural surface (sampled in E8). Labeled E2 - bronchial and vascular resection margin; E3 . tumor. in. relation to the nearest inked parenchymal resection margin; E4 - tumor in relation to the pleural puckering; E5 -. additional tumor with pieural puckering; E6 - additional tumor with black inked parenchymal resection margin; E7 -. more tumor with pleural puckering; E8 - 0.4 cm pearly pleural nodule; E9 - grossly uninvolved lung. Jar 2. SYNOPTIC REPORTING FORM FOR LUNG CARCINOMA. The provided tumor staging also includes the information acquired from the patients prior biopsy specimen. NEOPLASM. A neoplasm is present. HISTOPATHOLOGIC TYPE. The histologic classification of the tumor is adenocarcinoma, acinar (usual) type. HISTOLOGIC GRADE (G). The grade of the tumor is poorly differentiated (G3). TUMOR SIZE. The maximum dimension of the tumor is 3.2 cm. LYMPHATIC INVASION. Lymphatic invasion by tumor is absent (LO). VENOUS INVASION. Venous invasion by tumor is absent (V0). ARTERIAL INVASION. Arterial invasion by tumor is present. PLEURAL INVOLVEMENT. Pleural invoivement is present; tumor invades through visceral pleura, without invoivement of parietal pleura (PL2). SAMPLED SPECIMEN MARGINS. The sampled surgical margins are uninvolved by tumor. NON-NEOPLASTIC TISSUE. The non-neoplastic lung tissue shows granulomatous inflammation. PRIMARY TUMOR (T). Tumor > 3 cm but <= 7 cm or tumor with any of the following features (T2 tumors with these features are classified as. T2a if <= 5 cm) (T2). Invades visceral pleura (PL1 or PL2). Tumor > 3 cm but <= 5 cm in greatest dimension (T2a). REGIONAL LYMPH NODES (N). No regional lymph node metastasis histologically, no examination for ITC (pNo). DISTANT METASTASIS (M). Separate tumor nodules in contralateral lobe; tumor with pleural nodules or malignant pleural or pericardial effusion. (M1a). STAGE GROUPING. The overall international stage is T2a/NO//M1a (Stage IV). The pathologic stage assigned here should be regarded as provisional, and may change after integration of clinical. data not provided with this specimen. Corrections. Corrected: Previous Signout Date: Comment: This case was corrected to change the synoptic report. Corrected: Previous Signout Date: Comment: This case wes corrected to change the synoptic report. Surgical Pathology report is available.",train,3.2 CM;3.2 cm;3.2 cm;3.2 x 2.7 x 2.5 cm
2482,TCGA-06-A6S1.0BAB6F0A-77A8-4D16-B4E6-1AC173521399,"Client: (Age: ) Location: Gender: F Accnt: Phy Location: Clinical History. woman has had bowel and urinary incontinence and leg weakness with L5-S1 spine. degeneration. for about six to eight months. the patient has experienced headache and expressive. aphasia. On imaging, there are multifocal lesions, some interconnected, in both cerebral hemispheres, more. numerous on the. right side. The masses are irregularly enhancing. Operative Diagnoses. Brain tumor. Operation / Specimen. A: Brain,right frontal tumor, excision biopsy. B: Right frontal tumor, excision biopsy. Pathologic Diagnosis. A, B. Brain, right frontal, craniotomy: 1. Glioblastoma, WHO grade 4. 2. Negative immunostain for mutant IDH1-R132H protein. 3. Negative for codeletion of chromosomal arms 1p and 19q. 4. KI-67/ MIB-1 proliferation index: up to 23%. Senior. Senior Staff Pathologist. Procedures/Addenda. PCR for EGFR variant III mutation. Interpretation. POSITIVE - EGFRvIII mutation is detected. Results-Comments. TEST DESCRIPTION: Testing performed on RNA extracted from paraffin tissue block. (A3). H and E slide was examined and no microdissection was needed. The epidermal growth factor receptor (EGFR) is an attractive molecular target in glioblastoma because it. is amplified,. overexpressed, and/or mutated in up to 40% to 50% of patients. Epidermal growth factor receptor variant. III. (EGFRvIII) is an oncogenic, constitutively active mutant form of EGFR that is commonly expressed in. glioblastoma. Cell culture and in vivo models of glioblastoma have demonstrated EGFRvIII as defining prognostically. distinct. subgroups of glioblastomas. Additionally, the presence of EGFRvIII has been shown to sensitize tumors. to EGFR. tyrosine kinase inhibitors when the tumor suppressor protein PTEN is intact. RNA is extracted from. formalin fixed,. paraffin embedded tissue samples and reverse transcribed to cDNA. The cDNA is then amplified using. standard PCR. technique for DNA templates. PCR products are detected by gel electrophoresis. The limit of detection of. this assay. has been determined to be approximately 5 mutant cells in 100 normal cells. FDA Comment: The above data are not to be construed as the results from a stand alone diagnostic test. This test. was developed and its performance characteristics determined by the. as required. by CLIA '88 regulations. It has not been cleared or approved for specific uses by the U.S. Food and Drug. Administration (FDA). The FDA has determined that such clearance or approval is not necessary. These. results are. provided for informational purposes only, and should be interpreted only in the context of established. procedures. and/or diagnostic criteria. Senior Staff Pathologist. MGMT Promoter Methylation. Interpretation. NEGATIVE: No evidence of methylated MGMT promoter is detected. Results-Comments. Testing performed on DNA extracted from paraffin tissue block. (A3). H and E slide was examined and no microdissection was needed. TEST DESCRIPTION: Patients with glioma containing a methylated MGMT promoter have been shown to. benefit. from therapy with alkylating agents. Assessment of MGMT promoter methylation status involves bisulfite. treatment of. DNA followed by real-time PCR amplification. of methylated and unmethylated DNA. sequences. The. analytic sensitivity of this assay was determined by serial dilution of methylated positive control DNA into. unmethylated DNA, and was assessed to be 1% of methylated DNA in the background of unmethylated. DNA. Factors. such as the presence of >50% non-neoplastic cells in the sample, or extensive tissue necrosis, may. preclude the. detection of methylated MGMT promoter sequences. FDA COMMENT: The above data are not to be construed as the results from a stand alone diagnostic. test. This test. was developed and its performance characteristics determined by the. as required. by CLIA '88 regulations. It has not been cleared or approved for specific uses by the U.S. Food and Drug. Administration (FDA). The FDA has determined that such clearance or approval is not necessary. These. results are. provided for informational purposes only, and should be interpreted only in the context of established. procedures. and/or diagnostic criteria. Senior Staff Pathologist. Loss of Heterozygosity 1p, 19q Assay (LOH). Interpretation. POSITIVE: Allelic loss on chromosome arm 19q is detected. Allelic loss on chromosome arm 1p is not detected. Informative loci are: D1S548, D1S1592, D19S412, D19S606, D19S1182. Results-Comments. Testing performed on DNA extracted from tumor paraffin block. (A3). DNA extracted from a. corresponding blood specimen was used as a normal reference control. H and E slide was examined and no microdissection was needed. TEST DESCRIPTION: Allelic loss is assessed by PCR assay in Normal DNA (baseline)/ Tumor DNA. pairs using 3. markers at both 1p and 19q. The 3 markers on 1p are D1S548, D1S1592, and D1S552 (with D1S468,. D1S1612, and. D1S496 as backup markers) and the 3 markers on 19q are D19S219, D19S412, and PLA2G4C (with. D19S606 and. D19S1182 as backup). All markers are microsatellites (2 or 4 nt repeats) except PLA2G4C which is a. minisatellite (26. nt repeat) polymorphism. The markers were selected based on heterozygosity score, amplicon size, and. ease of. interpretation. The backup markers are used if the first line markers at that chromosome arm are. uninformative or. otherwise ambiguous in their interpretation. LOH at all informative loci on each chromosomal arm. represents the. typical finding in oligodendrogliomas with 1p and 19q deletion. FDA COMMENT: The above data are not to be construed as the results from a stand-alone diagnostic. test. This test. was developed and its performance characteristics determined by the. as required. by CLIA 88 regulations. It has not been cleared or approved for specific uses by the U.S. Food and Drug. Administration (FDA). The FDA has determined that such clearance or approval is not necessary. These. results are. provided for informational purposes only, and should be interpreted only in the context of established. procedures. and/or diagnostic criteria. TECHNICAL SENSITIVITY: The presence of >15% non-neoplastic cells in the sample may preclude the. detection of. allelic loss. Senior Staff Pathologist. Intra-Operative Consultation. A. Brain,right frontal tumor, excision biopsy: 1. Sparsely cellular, few gemistocyte astrocytes. No lymphoma or inflammation. Touch preparation. smears. performed at. and results reported to the Physician of Record. 2. Diffuse proliferation of gemistocyte-like astrocytes (C/N diffuse astrocytic neoplasm, high grade, R/O. other. No. lymphoma). Frozen section performed at. and results reported to the Physician of. Record. Senior. Gross Description. A. ""Brain, right frontal tumor,"" received fresh, one fragment of cerebral tissue, 2.3 x 2.3 x 1.3 cm. Semi. firm, pasty,. poor cortical-white matter interphase, creamy-white. Serially sectioned. Half of specimen submitted, A1-. A4, frozen. tissue A5. B. ""Right frontal tumor,"" excision biopsy: CONTAINER LABEL: right frontal tumor. FIXATIVE: Formalin. NO. PIECES: several gray tan fragments. SIZE/VOL: 2.2 x 1.8 X 0.8 cm., 1.25. grams. CASSETTES: 1, 2 NS. ICD-9(s): 323.9323.9. B: EGFRvIII: LOH 1p19q: MGMT: Histo Data. Part A: Brain,right frontal tumor, excision blopsy. Stain/cnt Block Ordered Comment. H&E x 1 1. TPS H&E x 1 1. H&E x 1 2. x 13. Run IDH1, please. EGFR vill-curls x 13. H&E x 13. LOH-curls x 13. LOH-curls x 13. MGMT-curls x 13. MIB1-DA x 1 3. H&E x 1 4. FS H&E x 1 5. H&E x 1 5. Part B: Right frontal tumor, excision blopsy. Stain/cnt Block Ordered Comment. H&E x 1 1. H&E x 12.",train,2.3 x 2.3 x 1.3 cm;2.2 x 1.8 x 0.8 cm
2630,TCGA-DH-5141.15a0f3ec-2bdc-4fb9-ae65-e1c38277ff11,"THIS IS AN ADDENDUM REPORT. Surgical Pathology Consultation / Department of Pathology. Case Type: CLINICAL HISTORY: gentleman with rhinorrhea in. MRI revealed tumor, which pathology revealed oligodendroglioma. Had left-sided stroke (illegible) month postop. Began having headaches. recently and had MRI done revealing a right frontal lesion. GROSS DESCRIPTION: Received the following specimens in the Department of Pathology, labeled. with the patient's name and. A. ""Tumor"". B. ""Tumor"". C. ""Tumor"". A. The specimen is received without fixative and consists of two pieces. of beige to gray-tan soft tissue, that measure 0.6 x 0.3 x 0.2 cm and 0.5. x 0.3 x 0.2 cm, respectively. A portion of the specimen is submitted for. frozen section; the frozen section diagnosis is ""Infiltrating glioma,. oligodendroglioma not excluded; grade deferred to permanents, per. The frozen tissue is resubmitted in FSA1, and the remaining. tissue is submitted in A2, for permanent processing. B. The specimen is received unfixed and consists of a 32.5 gm portion. of apparent cerebral cortex and underlying subcortical white matter,. measuring 3.5 x 5.0 x 2.8 cm, with a 1.E x 1.5 cm ragged, hemorrhagic. component. Deep surfaces appear cauterized. Sections reveal effacement. of the gray-white junction, especially adjacent to the ragged hemorrhagic. region, and a pale tan-yellow tan discoloration of the subcortical. tissue. Representative sections are submitted in B1-B6, for permanent. processing. The specimen is received unfixed and consists of an 8.0 gm portion. of apparent cerebral cortex and underlying subcortical white matter,. measuring 4.2 x 3.5 x 1.4 cm. Sections reveal a better-defined. gray-white junction and minimal tan discoloration in white matter. Representative sections are submitted in C1-C4, for permanent processing. DIAGNOSIS: A. ""Tumor"", biopsy: Oligodendroglioma, with anaplastic foci. (see comment). B. ""Tumor"", excision: Oligodendroglioma, with anaplastic. foci (see comment). C. ""Tumor"", excision: Oligodendroglioma, with anaplastic. foci (see comment). Comment: This infiltrating oligodendroglioma appears to have caused a. ""vacuolar"" degeneration in large areas of involved white matter. (GFAP-immunoperoxidase), and has diffusely infiltrated overlying cortex. Perhaps of greater concern, however, are deeper areas with increased. cellular density and nuclear atypia, in which Ki - -67-immunostain focally. labels up to 20% of nuclei, apparently representing areas of anaplastic. ""transformation"". ""I, or my qualified designee, have performed the gross examination and. description and I have personally reviewed the gross description and. specimen preparations referenced herein, and have personally issued this. report. "". Resident/Prosector/Pathologist: Note: Test systems have been developed and their performance. characteristics determined by. Some tests. have not been cleared or approved by the U.S. Food and Drug. Administration. The FDA has determined that such clearance is not. necessary. These tests are used for clinical purposes and should not be. regarded as investigational or for research. This laboratory is certified. under the Clinical Laboratory Improvement Amendments of. as. qualified to perform high complexity clinical laboratory testing. ADDENDUM: FLUORESCENCE IN SITU HYBRIDIZATION (FISH) WAS PERFORMED ON REPRESENTATIVE. PARAFFIN-EMBEDDED TUMOR TISSUE (VYSIS) . IN THIS CASE, DELETIONS OF BOTH. 1P AND 19Q WERE IDENTIFIED. RECENT CLINICAL STUDIES HAVE SUGGESTED THAT. COMBINED LOSS OF CHROMOSOME 1P AND 19Q IN OLIGODENDROGLIAL BRAIN TUMORS. MAY BE ASSOCIATED WITH PROLONGED SURVIVAL AND ENHANCED RESPONSE TO. CHEMOTHERAPY (REFS 1-5). REFERENCES.",train,
2656,TCGA-IK-8125.77a2c310-8f8b-4e45-92d8-52379e34f11f,"DEPARTMENT OF PATHOLOGY AND LABORATORY MEDICINE. Date Coll: Accession No. : SPECIMEN. A. Brain tumor. B. Brain tumor. C. Brain tumor. CLINICAL NOTES. CLINICAL HISTORY: Left frontal brain tumor. FROZEN SECTION DIAGNOSIS. FSA) Left frontal - At least anaplastic astrocytoma (WHO grade. III) . Final grade deferred to permanent sections. FSB) Brain tumor - Predominantly q. clude rare. microscopic involvement by tumor. GROSS DESCRIPTION. A. Received fresh for frozen section, labeled ""brain tumor"". are irregularly shaped fragments of hemorrhagic tissue that. measure 1.5 X 1.2 X 0.6 cm. in dimension. Half of the spe. is. frozen and the remainder is taken for permanent section. B. Received fresh for frozen section, labeled ""br. umor"". is an irregularly shaped fragment of tan-white tissue that. measures 0.2 X 0.2 X 0.2 cm. in dimension. The tissue is entirely. frozen. C. The specimen is received fresh, labeled ""brain. tumor-routine"" and consists of multiple pieces of pink to. soft yellow tissue me. X 1.0 cm. The tissue is. entirely submitted. MICROSCOPIC DESCRIPTION. Microscopic sections of the left frontal brain tumor. reveals a malignant diffuse glioma. The tumor does have. diffuse high grade astrocyti. S suggested by the. patient's prior core biopsy. The current material,. however, does have what appe. godendroglial. differentiation suggesting the lesion is actually a mixed glioma. For tha. con. up. to the. reviewe. sen. d. categorized it as an anaplastic oligoastrocytoma WHO grade III. They. will be doing a FISH study for the 1P/19Q deletion which is seen in. oligodendrogliomas. That result will be reported separately. DIAGNOSIS. A, B, C. Brain, left frontal, resection: A.",train,1.5 x 1.2 x 0.6 cm
2746,TCGA-DU-A76O.64ED6980-61B9-4F1C-B7EE-B3459BD7E398,"Client: Gender: M Accnt: Phy Location: Clinical History. -old man has past history of left leg amputation for cartilaginous tumor (Ollier's disease), and. has several. intra axial, intracranial tumors consistent with low histological grade gliomas. Patient experiences. medically. intractable complex partial epilepsy. Operative Diagnoses. Medically intractable complex partial epilepsy. Operation / Specimen. A: Para sagittal, biopsy. B: Inferior parietal, biopsy. Pathologic Diagnosis. A. Brain, parasagittal, excision: 1. Low histological grade glioma, consistent with diffuse astrocytoma (WHO grade 2). 2. IDH1-R132H mutation: Positive. 3. MIB-1 proliferation index: > 9%. 4. 1p, 19q LOH: Negative. 5. MGMT: Low positive. B. Brain, inferior parietal, excision: 1. Neoplastic glial infiltrate, sparse. 2. Architectural features: Uncertain. See Microscopy Description and Comment. Comment. Part A. This specimen is portions of cerebrum that are moderately infiltrated by a glial neoplastic proliferation that. has a. mixed oligo astrocytic phenotype, with uniform round/ovoid nuclei frequently surrounded by halos. However, the. neoplastic cells are devoid of the 1p, 19q deletion characteristic of oligodendrogliomas. Mitotic figures are. found with. great difficulty, and there is not microvascular proliferation or tumor necrosis. The MIB-1 proliferation. index is greater. than 9% (as normal native cells are entered in the total nuclear count; the index is probably no more than. 15%). The findings are interpreted as those of a low histological grade glial neoplasm that has molecular. features of. astrocytoma. The elevated cycling activity may portend a heightened aggressive potential. Part B. This specimen is three small fragments of cerebral cortex in which, because of the small size and. orientation of the. fragments, it is difficult to evaluate the cortical architectural features. Furthermore, the IDH1 stain. demonstrates a. somewhat sparse sprinkling of the cortex by neoplastic glial cells, which interferes even more with. evaluation of the. distribution of normal cells. There is not obvious architectural distortion, dysmorphic neuronal element, or. balloon. cells. The findings are interpreted as a glial neoplasm sparsely infiltrating the cerebral cortex; and non. conclusive of cortical. dysplasia. The features in both specimens may be correlated with clinical, imaging, electrophysiological, and. operative findings. for their interpretation and patient's follow up. Senior Staff Pathologist. Consultant: Senior Staff Pathologist. Procedures/Addenda. Loss of Heterozygosity 1p, 19q Assay (LOH). Interpretation. NEGATIVE: Allelic loss on chromosome arm 1p and chromosome arm 19q is NOT detected. Informative loci are: D1S1592, D1S552, D19S412, D19S606, D19S1182 and PLA2G4C. Results-Comments. Testing performed on DNA extracted from tumor paraffin block. (A1). DNA extracted from a. corresponding blood specimen was used as a normal reference control. H and E slide was examined and no microdissection was needed. TEST DESCRIPTION: Allelic loss is assessed by PCR assay in Normal DNA (baseline)/ Tumor DNA. pairs using 3. markers at both 1p and 19q. The 3 markers on 1p are D1S548, D1S1592, and D1S552 (with D1S468,. D1S1612, and. D1S496 as backup markers) and the 3 markers on 19q are D19S219, D19S412, and PLA2G4C (with. D19S606 and. D19S1182 as backup). All markers are microsatellites (2 or 4 nt repeats) except PLA2G4C which is. a. minisatellite (26. nt repeat) polymorphism. The markers were selected based on heterozygosity score, amplicon size, and. ease of. interpretation. The backup markers are used if the first line markers at that chromosome arm are. uninformative or. otherwise ambiguous in their interpretation. LOH at all informative loci on each chromosomal arm. represents the. typical finding in oligodendrogliomas with 1p and 19q deletion. FDA COMMENT: The above data are not to be construed as the results from a stand-alone diagnostic. test. This test. was developed and its performance characteristics determined by the. as required. by CLIA 88 regulations. It has not been cleared or approved for specific uses by the U.S. Food and Drug. Administration (FDA). The FDA has determined that such clearance or approval is not necessary. These. results are. provided for informational purposes only, and should be interpreted only in the context of established. procedures. and/or diagnostic criteria. TECHNICAL SENSITIVITY: The presence of >15% non-neoplastic cells in the sample may preclude the. detection of. allelic loss. Senior Staff Pathologist. MGMT Promoter Methylation. Interpretation. LOW POSITIVE: Methylated MGMT promoter is detected. Results-Comments. Testing performed on DNA extracted from tumor paraffin block. (A1). H and E slide was examined and no microdissection was needed. TEST DESCRIPTION: Patients with glioma containing a methylated MGMT promoter have been shown to. benefit. from therapy with alkylating agents. Assessment of MGMT promoter methylation status involves bisulfite. treatment of. DNA followed by real-time PCR amplification. of methylated and unmethylated DNA. sequences. The. analytic sensitivity of this assay was determined by serial dilution of methylated positive control DNA into. unmethylated DNA, and was assessed to be 1% of methylated DNA in the background of unmethylated. DNA. Factors. such as the presence of >50% non-neoplastic cells in the sample, or extensive tissue necrosis, may. preclude the. detection of methylated MGMT promoter sequences. FDA COMMENT: The above data are not to be construed as the results from a stand alone diagnostic. test. This test. was developed and its performance characteristics determined by the. as required. by CLIA '88 regulations. It has not been cleared or approved for specific uses by the U.S. Food and Drug. Administration (FDA). The FDA has determined that such clearance or approval is not necessary. These. results are. provided for informational purposes only, and should be interpreted only in the context of established. procedures. and/or diagnostic criteria. Senior Staff Pathologist. Gross Description. A. Para sagittal, biopsy: CONTAINER LABEL: para sagittal. FIXATIVE: Formalin. NO. PIECES: 5. SIZE/VOL: 2-4 mm. tan brain tissue CASSETTES: 1. B. Inferior parietal, biopsy: CONTAINER LABEL: inferior parietal. FIXATIVE: Formalin. NO. PIECES: 2. SIZE/VOL: 3-4 mm. CASSETTES: 1. Microscopic Description. IMMUNOHISTOCHEMISTRY: Part A: The GFAP demonstrates a rather delicate gliofibrillary background. The tumor cells are heavily. and. uniformly reactive with IDH1. With the MIB-1 there is a proliferation index of more than 9%, since the. normal native. nuclei are included in the total cell count. Part B: The IDH1 evinces a sparse sprinkling of positive glial neoplastic nuclei sprinkled throughout the. cerebral. cortex. The GFAP demonstrates absence of reactive astrocytes. The CD163 depicts slight dendritic. microglial. unrest, probably associated with previous mechanical manipulation. The NeuN and NFP highlight a thin,. tangentionally sectioned cerebral cortex that overall has reasonable well preserved layering, without overt. disorganization or dysmorphism. ICD-9(s): 191.0 191.0. Billina Fee Code(s): A: B: LOH 1p19q: MGMT: Histo Data. Part A: Para sagittal, biopsy. Stain/cnt Block Ordered Comment. mGFAP-DA x 1 1. H&E x 1 1. IDH1-sld x 1 1. LOH-curls x 1 1. MGMT-curls x 1 1. MIB1-DA x 1 1. Part B: Inferior parietal, biopsy. Stain/cnt Block Ordered Comment. CD163 Vector x 1 1. mGFAP-DA x 1 1. H&E x 1 1. IDH1-sld x 1 1. NeuN x 1 1. NF2F11 x 1 1. Rct 3 H&E x 1 1.",train,
2801,TCGA-KN-8437.9f926dde-901c-4611-aee6-3ecde5a7c165,"Previous. 05-44224M RT: SUPERIOR TURBINATE & ANTERIOR NASAL. biopsies: SEPTUM. 04-43867M allograft renal biopsy. 02-23164M ALLOGRAFT RENAL BIOPSY/is. 01-27641M TX KIDNEY BX/sr. (and more). DIAGNOSIS. Right kidney, radical nephrectomy: Chromophobe renal cell carcinoma. see svnontic report. Kidney: Nephrectomy, partial or radical Synopsis. MACROSCOPIC. Specimen Type: Right radical nephrectomy. Focality: Unifo cal mass. Tumor Site. Greatest dimansien: 3.0.m. MICROSCOPIC. ic Type: Histologic Grade: G1: Nuclei round, uniform, approximately 10 microns; nucleoli. inconspicuous or absent. EXTENT OF INVASION. Primary Tumor: pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney. Regional Lymph Nodes: pNX: Cannot be assessed. Lymph Nodes: None submitted. Distant metastasis: pMX: Cannot be assessed. Margins: Margins uninvolved by invasive carcinoma. Adrenal gland: Not present. Venous invasion: Absent. Comments: Colloidal iron stain shows focal granular cytoplasmic staining consistent with the. above diagnosis. The tumor arises in an end stage kidney. Clinical: Right renal mass. Gross: The specimen is received fresh labeled with the patient's name. the medical record number and ""right kidney"", and consists of a. laporascopic radical nephrectomy specimen. The kidney with attached perinephric fat weighs. VI gianto. NUI ILLINIOU to auru ure specifical. a well circumscribed tan and brown nodule measuring 3.0 x 3.0 X 1.5 cm. The nodule abuts the. renal capsule but no invasion into perinephric fat is noted. Small cysts are noted within the. cortex. The remainder of the kidney is grossly unremarkable. The renal mass is sectioned and. a portion is taken for tissue bank. No adrenal gland is present. The specimen is represented. as follows: A=vascular margin, B=ureter margin, C-F=tumor in tumor relation to kidney and. perinephric fat, F=cystic areas and cortex and samples of cortex and medulla, G=section of. grossly unremarkable perinephric fat.",train,3.0.m
2876,TCGA-DD-AAVV.5F24D049-6BE5-403B-9E5A-399921814C68,"DIAGNOSIS: Liver, right, posterior sectionectomy: Hepatocellular carcinoma, S6. 1) Post-chemoembolization status: absent. 2) Size of tumor; 4x2.8x2.2cm. 3) Gross type: multinodular confluent type. 4) Satellite nodule: present. 5) Histologic type: trabecular. 6) Cell type: classic cell group. 7) Edmondson and Steiner's histologic grade: The worst differentiation: 4. The major differentiation: 3. 8) Fatty change: absent. 9) Hemorrhage/peliosis: present (2%). 10) Tumor necrosis: present (5%). 11) Vascular invasion(microscopic): present. 12) Capsule formation: absent. 13) Septal formation: present. 14) Involvement of a major branch of the portal vein: absent. 15) Involvement of a major branch of the hepatic vein: absent. 16) Bile duct invasion: present. 17) Serosal invasion: present (Glisson's capsule) (Fibrous adhesion). 18) Surgical margin: clear (safety margin: 3cm). 19) Intrahepatic metastasis: present. 20) Multicentric occurrence: absent. 21) Pathologic stage: AJCC (pT2),. (pT4). 22) Related biopsy: none. 23) Additional pathologic findings. a) Chronic hepatitis, HBV-associated. with minimal lobular activity. mild porto-periportal activity. periportal fibrosis. b) Cirrhosis: absent. c) Dysplasia: absent. d) Bile duct adenoma, 0.15mm in size.",train,4x2.8x2.2cm;0.15mm
2877,TCGA-B0-5081.f33bac8a-d76c-45e7-a7d5-ae93a45f8cf8,"FINAL DIAGNOSIS. KIDNEY, RIGHT, LAPAROSCOPIC RADICAL NEPHRECTOMY -. A. RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE, FUHRMAN NUCLEAR GRADE II/IV, 5.5 CM IN. GREATEST DIMENSION. B. DIRECT INVASION OF THE RENAL VEIN IS IDENTIFIED, GROSSLY AND MICROSCOPICALLY. C. TUMOR SHOWS NO EVIDENCE OF INVASION OF RENAL SINUS OR PERINEPHRIC ADIPOSE TISSUE (See. comment). D. ALL SURGICAL MARGINS ARE FREE OF TUMOR. E. URETERITIS CYSTICA is PRESENT. F. ADRENAL GLAND IS NOT IDENTIFIED. G. PATHOLOGIC STAGE: pTNM = pT3b NX MX.",train,5.5 CM
2889,TCGA-AA-3532.82516932-0618-4e40-9b7f-bcc09639e261,"Diagnosis / Diagnoses: Resectate of the colon under inclusion of a moderately differentiated adenocarcinoma of. the colorectal type, of maximum 2.5 cm in size, with infiltration of the pericolic fatty. tissue. Tumor-free regional lymph nodes. Tumor-free mesenteric resection margin. Tumor-free large intestinal resection margins. Tumor stage: pT3 pNO (0/35) pMX; G2, L0, V0, locally R0.",train,2.5 cm
2948,TCGA-G3-A6UC.08415C4C-C645-4911-BA53-6E562E562FD4,"CONFIDENTIAL. Demographics (for. verification purposes). Sex: M. Collected Date/Tir. Received Date/Time. Specimen Description. A. Gallbladder at. B. Liver segment 6 at. Clinical Information. Cirrhosis secondary to ETOH with likely HCC. Diagnosis. A. Gallbladder: Cholelithiasis. B. Liver segment 6: Chronic hepatitis, mild. Cirrhosis, micronodular. Hepatocellular carcinoma, moderately differentiated, solid variant,. 2.5 cms in the greast dimension, with metastases to the portal veins. and intrahepatic metastases. Tumor 0.3 cm away from the resection margin. Verified: Gross Description. Received are specimen containers A to B. All requisitions and specimen containers are. labelled with the patient's name,. The cassettes and AP identifiers are. labelled with the Surgical Number. A. Specimen is received fresh. The container is designated ""A. Gallbladder"". The. specimen consists of a congested intact gallbladder measuring 11.0 x 3.5 x 3.5 cm. The. serosal surface is smooth and glistening. Opening reveals the gallbladder to be filled. with green bile. Also found in the gallbladder are five black irregular calculi ranging. from 0.4 cm up to 1.5 cm in greatest dimension. The mucosal surface is dark green, rough. and the gallbladder wall averages between 0.1 to 0.2 cm in thickness. Found at the neck. and near the cystic duct are two firm palpable nodules within the adipose tissue, the. first measuring 1.0 cm, the other 1.5 cm in greatest dimension. Sections are as follows: A1. - three sections of gallbladder. A2. - the smaller node bisected. A3. - the larger node bisected. B. Specimen is received fresh. The container is designated ""Liver segment 6"". The. specimen consists of a portion of liver weighing 50.8 g and measuring 6.5 x 5.0 x 2.5 cm. The liver capsule is nodular and the surgical resection margin has been inked blue. Sectioning reveals a green circumscribed mass measuring 2.5 x 2.3 x 2.5 cm. Adjacent. to. the green circumscribed mass is a hemorrhagic circumscribed mass measuring 1.0 x 1.0 x. 1.0 cm. The green mass comes within 0.3 cm of the blue painted surgical resection margin. and the hemorrhagic mass 0.1 cm to the blue painted surgical resection margin. The green. mass comes with less than 0.1 cm of the liver capsule and the hemorrhagic mass comes. within 0.7 cm of the liver capsule. Sections are as follows: B1. - section of the green mass and its relationship to the liver capsule. B2. - section of the green mass and its relationship to the blue painted surgical. resection margin. B3. - hemorrhagic mass with a portion of the adjacent green mass and the relationship. to the blue. painted surgical margin. B4. - further section of hemorrhagic mass and relationship to blue painted surgical. resection margin. Please note that upon sectioning of the hemorrhagic mass, it is found to have a. cut surface. which is granular and the substance easily pulls out of the. circumscribed area, query blood. vessel. B5. - representative section of liver parenchyma. Encounter Number. Patient Location.",train,2.5 cms
3045,TCGA-VM-A8CB.581F6861-4408-48DF-BBAB-62707C31090B,"Temporary Copy. case. Patienal. Collectee. Clinical History. none given. Diagnosis. 1. ""LEFT FRONTAL LESION"", (BIOPSY) : - HIGH GRADE GLIOMA MOST CONSISTENT WITH ANAPLASTIC OLIGODENDROGLIOMA. 2. ""LEFT FRONTAL LESION"", (RESECTION) : - HIGH GRADE GLIOMA MOST CONSISTENT WITH ANAPLASTIC OLIGODENDROGLIOMA (WHO GRADE. III). I certify that I personally conducted the. diagnostic evaluation on the above specimens. and have rendered the above diagnosis (es) : For questions regarding this case, call. Frozen Section Diagnosis. Frozen section diagnosis per. 1FA: ""High grade glioma"". Gross Description. Two containers are received labeled with the patient's name and medical record. number. Specimen one is received fresh for frozen section labeled ""left frontal lesion"". The specimen is a 1.8 x 1.2 x 0.4 cm portion of pink-tan soft tissue. Half of this. tissue is submitted for frozen section. Submitted in total in cassette 1FA, and. 1A. Specimen two is received in formalin labeled ""left frontal lesion"", is a 46.60 g. portion of pink-tan focally hemorrhagic brain tissue. The tissue is 9.0 x 7.5 x. 3.0 cm in aggregate. Sectioning shows a grey to dusky pink glistening cut surface. No discrete nodules are identified. Representative sections submitted in cassette. 2A-2D. Microscopic Examination. Temporary Copy. Race 20f 2. Dase. o. logation. Performed. Synoptic Report. No AJCC/UICC TNM Staging System. Protocol web posting date: Protocol effective date: Specimen type/procedure: Open biopsy. Resection. Specimen handling: Frozen section. Unfrozen for permanent paraffin sections. other. Specify: Received in formalin for permanent sections. Specimen size: Greatest dimension 9.0 cm. Additional dimension: 7.5 x 3.0 cm. Laterality: Left. Tumor site: Brain, cerebrum. Left frontal. Histologic type and grade: oligodendroglial tumors. Histologic Grade: Anaplastic oligodendrogliom (WHO grade III). Margins: Cannot be assessed. Ancillary studies: None performed. Comments: Specimen will be sent in consultation to the. at. division of neuropathology. Addendum Report. Temporary Copy. Page 10 1. Colected. pocauer. Addendum Discussion. Outside consultation diagnosis from. is as. follows: DIAGNOSIS: BRAIN, LEFT FRONTAL LESION, BIOPSY (PART 1) AND RESECTION (PART 2) ,. - ANAPLASTIC OLIGODENDROGLIOMA, WHO GRADE III (SEE COMMENT). Comment: Evaluation of the 1p and 19q status of this neoplasm will be performed through. laboratories; the results of this testing will be issued in a separate report. ORIGINAL DIAGNOSIS REMAINS UNCHANGED. I certify that I personally conducted the. diagnostic evaluation on the above specimen (s). and have rendered the above diagnosis (es) : Addendum Report. Temporary Copy. Gase. rocation. Addendum Discussion. 1p/19q FISH. Fluorescence in-situ hybridization (FISH) analysis for deletions of 1p and/or 19q. are performed on sections from block ""2A"". Calculated 1p/1q ratio = 0.49 (<0.74 is deleted). Calculated 19q/19p ratio = .055 (<0.88 is deleted). The results are interpreted as deleted for 1p and 19q. This assay was read by Dr. A result of a deleted 1p and 19q suggests a favorable prognosis. A solitary 1p. deletion suggests an intermediate prognosis. A 19q solitary deletion may suggest a. favorable prognosis in a smaller subset of tumors. The lack of either 1p and/or. 19q deletion (s) is considered a poor prognostic indicator and may be associated. with decreased disease-free survival and overall survival. I certify that I personally conducted the. diagnostic evaluation on the above speciment (s). and have rendered the above diagnosis (es) :",train,
3061,TCGA-CG-4465.76cc9b66-f915-4038-9d9c-bc152d28cd87,"Diagnosis: Distal partial gastric resection with tumor-free oral resection margin and inclusion of an. ulcerated poorly differentiated adenocarcinoma or gastric carcinoma of diffuse (so-called. signet ring cell carcinoma), located in the prepyloric antrum in the region of the greater. curvature, with infiltration of all parietal layers, encroachment on the transverse colon, several. regional lymph node metastases, omentum metastases and peritoneal spread also in the region. of the distal resection margin and in the region of one of the resection margins of the. transverse colon resection material. pT4 L1 V0 R2 pN3 21/27 pM1).",train,
3082,TCGA-L5-A4OX.47B52FFF-17E4-4A00-ADDF-D7837E4FBAA0,"PREVIOUS DIAGNOSIS INQUIRY. 2. SEX: M. PROCEDURE: SPHS. A. year-old with esophageal cancer arising in Barrett's. PROCEDURE: SPGD. 1. ""Esophagogastrectomy"". Received in format in in a large container is a. esophagogastrectomy specimen comprised of 8.5 cm long, 5 cm circumference. distal esophagus with 5 cm x 12 cm circumference proximal stomach with. attached perigastric adipose ranging up to 5 cm. Adventitia and serosal. surface is grossly unremarkable. No perforations. Esophageal mucosa is. wrinkled grey at most proximal 3 cm with a 6 cm length of saimon colored. Barrett's mucosa extending to the gastroesophageal junction with a 3.3 x 2.5. cm ulcer with heaped-up borders at the gastroesophageal junction. Ulcer. extends through the esophageal mucosa to a maximum depth of 1.0 cm (grossly. abutting but not penetrating muscularis propria). Gastric mucosa wrinkled, tan. with normal folds. No ulcers or other masses. Several lymph nodes identified. in perigastric adipose tissue. 1A. Neoplasm at greatest depth and with respect to proximal. 18. Lesion with respect to distal. 1C and D. Proximal and distal including gastroesophageal junction. respectively. each). 1E. Barrett's mucosa to proximal esophagus. 1F. Barrett's mucosa to gastroesophageal junction. 1G. Multiple tymph nodes. 1H. Two lymph nodes, one inked blue. Each bisected. 11. One grossly positive lymph node. Trisected. 1J. One grossly positive Lymph node. Sectioned. 2. Cervical esophagus margin"". Received in formal in in a small container is a. 1.8 cm long, 1 cm internal diameter segment of esophagus with intact. adventitial lining and wrinkled grey mucosa. One stapled and open margin. Sampled at open end. 3. ""Esophageal Lymph pode"" Recaived in formalin in a smait containen is. 1.2. cm anthracotic lymph node. Bisected. PROCEDURE: SPMI. ESOPHAGEAL, CARDIAC AND GASTROESOPHAGEAL JUNCTION CARCINOMA: PREVIOUS DIAGNOSIS INQUIRY. 3. SEX: M. Type of carcinoma: Adenocarcinoma. If adenocarcinoma, it is arising in: Barrett's mucosa. Depth of invasion: Muscularis propria. Number of positive lymph nodes: 3/15. Extranodal metastasis: Unknown. Pattern of invasion: Expansile. Esophageal and gastric resection margins involved: No. Deep resection margin involved: No. TNM classification: T2 N1 Mx. PROCEDURE: SPOX. 1. Esophagus and proximal stomach, resection: Invasive adenocarcinoma. arising in Barrett's mucosa, extending focally into superficial muscularis. propria. Resection margins negative. Angiolymphatic invasion present. Metastatic adenocarcinoma present in 3 of 15 lymph nodes. Incidental. esophageal leiomyoma. Please see template for details. 2. Cervical esophageal margin, resection: Esophagus, negative for neoplasm. 3. Esophageal lymph node, excision: 1 lymph node, negative for neoplasm. 1,. the signing staff pathologist, have personally. examined and interpreted the slides from this case. END OF PREVIOUS DIAGNOSIS INOUIRY.",train,
3088,TCGA-AX-A2HF.5454BF58-3D26-4D61-B0A8-30A06ECD0E60,"DOS: Female. FIN: ADMITTED: PT LOCATION,. ADMITTING PROVIDER: DISCHARGED: PT TYPE: Surgical Pathology Report - Final. RECEIVED DATE/TIME. Clinical Information. Endometrial cncer. Diagnosis. A. Left saipirigo-oophorectomy: Ovary: Fibrothecoma (4.5 cm). Fallopian tube: without diagnostic abnormality. B. Total abdominal hysterectomy with right salpingo-oophorectomy: Uterus and cervix (71 grams): Uterine serous carcinoma with focal clear cell features, FIGO 3, see summary. Other findings: Cervix: squamous atrophy. Focal necrotizing vasculitis. Endometrium (background): Inactive. Myometrium: focal necrotizing vasculitis, see comment. Serosa: small peritoneal inclusion cyst. Right ovary and fallopian tube: without diagnostic abnormality. SUMMARY FOR ENDOMETRIAL NEOPLASMS: Specimen(s) submitted and Procedure(s): uterus, cervix, bilateral fallopian tubes, bilateral ovaries, omentum and. regional lymph nodes; total abdominal hysterectomy with bilateral salpingo-oophorectomy, omentectomy,. regional lymph node dissections. Specimen intgrity: intact, bivalved. Histologic type: serous with focal clear cell features. Histologic grade: high grade, FIGO 3. Tumor size: 2.5 cm. Myometrial invasion: present, outer half, see comment. Depth of irivasion: 8 mm. Myometrial thickness: 14 mm. Involvement of cervix: not appreciated. Lower uterine segment involvement: not appreciated. Lymphatic vascular space involvement: not appreciated. Extent of involvement of other organs: none. Margins: free of tumor. Summary, cytology: negative, see separate report(s). Summary, lymph node dissections: DOS. SEX: Female. FIN: Surgical Pathology Report - Final. COLLECTED DATE/TIME. RECEIVED DATE / TIME. All regions: Total positive/total removed: (0/36). Pelvic lymph nodes: Total positive/total removed: (0/27). Para-aortic lymph nodes: Total positive/total removed : (0/9). Additional pathologic findings: as above. Summary, Anciliary studies requested/obtained: study(les) obtained on fresh tissue. Summary, Clinical history: see electronic medical record. Distant metastasis(es): unknown. AJCC 7th edition Pathologic Staging: pT1b pNO pMX FIGO IB grade 3. C. J. Regional lymph node resections: No evidence of tumor in a total of thirty six lymph nodes (0/36), as follows: C. Left external illac lymph node: (0/8). D. Left obturator lymph nodes: (0/3). E. Left common lymph nodes: (0/3). F. Left perlaortic lymph nodes: (0/5). G. Right external Illac lymph nodes: (0/5). H. Right obturator lymph nodes: (0/4). I. Right common lymph nodes: (0/4). J. Right periaortic lymph nodes: (0/4). K. Omentectomy: No evidence of tumor. Pathologist/Electronically signed: Report verified at: Comment. Focal areas exhibit a tubal pattern with cytoplasmic clearing consistent with focal features of clear cell carcinoma (slide. B9). Depth of invasion is difficult to measure because the tumor focus is polypoid. At it's closest point (slide B13), tumor is. approximately B mm from serosa. In an adjacent section (on the same slide), the myometrium is 14 mm thick, so depth of. invasion is calculated as 8 mm in a 14 mm thick myometrium. Rarely vasculitis identified in the gyn tract is associated with systemic disorders or symptoms. Surg Path Intraoperative Frozen Section. A. FS: Left ovary: Fibroma. Reported to Dr. with read back. M.D. Specimen. A. Left fallopian tube and ovary. B. Uterus, right tube and ovary. C. Left external iliac lymph node. 7. DOS: -male. FIN: Surgical Pathology Report - Final. COLLECTED DATE/TIME. RECEIVED DATE/TIME. D. Left obturator lymph nodes. E. Left common lymph nodes. F. Left periaortic lymph nodes. G. Right external iliac lymph nodes. H. Right obturator lymph nodes. I. Right common lymph nodes. J. Right perialortic lymph nodes. K. Omentum. Gross Description. A. Received tresh for frozen section diagnosis properly labeled with the patient's name and labeled ""left fallopian tube. and ovary"" is  4.5 x 2.5 x 2 cm tan-gray, glistening ovary. The specimen is sectioned to reveal striated, homogenous cut. surfaces. A pprition is submitted for frozen section diagnosis. Attached to the ovary is a 4 cm in length by 0.5 cm in. diameter fimbriated fallopian tube. The serosa appears tan-brown, and smooth. The specimen is sectioned to reveal a. complete pinpoint lumen. A portion of tube is submitted fresh for research. Cassette summary: 1. Frozen section of ovary. 2-3. Ovary. 4. Fallopian tube. B. Received fresh properly labeled with the patient's name and labeled ""uterus, right tube and ovary"" is a 71 g previously. opened uterus with attached right adnexa. The uterus measures 7.5 cm from cervix to fundus, 4 cm from comu to cornu,. and 3 cm from anterior to posterior. The serosa appears pink-brown, smooth, and unremarkable. The cervix appears. tan-gray, focally hemorrhagic, glistening, measures 3.8 cm in diameter, with a 0.3 cm slitlike os. A portion of attached. vaginal mucosa is present on the posterior surface measuring 2.5 x 0.8 x 0.5 cm. The upper endocervical canal is. remarkable for multiple cystic structures filled with gelatinous material ranging in size from 0.3-1.5 cm in greatest. dimension. These cysts appear to have a smooth inner lining. The endometrial cavity measures 3 cm from comu to. cornu, 3.5 cmifrom cervix to fundus, 0.3 cm in thickness, and is remarkable for a friable, fungating, polypoid mass. measuring 2.5 x 2.5 x 2.5 cm located primarily on the right side, and extending into the lower uterine segment. Upon. sectioning, the mass is located 0.8 cm from the serosal surface and 0.4 cm from the upper endocervical canal on the. anterior aspect, and is located 7 cm from the serosa surface, and a 0.3 cm from the upper endocervical canal on the. posterior aspect. The attached right fimbriated fallopian tube measures 5 cm in length, 0.5 cm in diameter, with a serosa which appears. purple-tan, and smooth. The tube is sectioned to reveal a complete pinpoint lumen. The attached yellow-tan, cerebriform. ovary measures 2 x 1 x 0.8 cm, and is sectioned to reveal tan-gray, smooth cut surfaces. Portions of tumor are submitted. fresh for. study. The anterior is inked blue, the posterior and right adnexa are inked black. Cassette summary: 1. Vaginal mucosa. JVI. DOS: 1. ale. FW: Surgical Pathology Report - Final. COLLECTED DATE/TIME. RECEIVED DATE / TIME. 2. Cervix anterior. 3. Upper endocervical canal anterior. 4. Cervix posterior. 5. Upper endocervical canal posterior. 6. Represented sections of the cystic structures within upper endocervical canal. 7-8. Full-thickness section bisected of mass on anterior. 9-10. Full-thickness section bisected of mass on anterior. 11. Endomyometrium anterior. 12-13. Full thickness sections of mass on posterior. 14. Endomyometrium posterior. 15. Left parametria. 16. Right parametria. 17. Fallopian tube. 18. Ovary. C. Received in formalin properly labeled with the patient's name and labeled ""left external illac lymph node are multiple. portions of fibroadipose tissue which aggregate to 5 cm in greatest dimension. Upon dissection multiple pink-tan, firm. Ivmph nodes are identified ranging in size from 1-2 cm in greatest dimension. All possible lymph nodes are submitted. Cassette summary: 1. 2 candidate nodes bisected, one inked blue. 2. 2 candidate nodes bisected, one inked blue. 3. 3 candidate nodes. 4. 1 candidate node bisected. D. Received in formalin properly labeled with the patient's name and labeled ""left obturator lymph node"" is a portion of. fibroadipose tissue measuring 5.5 x 3x1 cm. Upon dissection multiple tan-brown, firm candidate nodes are identified. ranging In size from 0.5-3 cm in greatest dimension. All possible lymph nodes are submitted. Cassette summary: 1. 2 candidate nodes. 2-3. 1 candidate node sectioned. E. Received in formalin properly labeled with the patient's name and labeled ""left common lymph nodes"" are multiple. portions of fibroadipose tissue which aggregate to 3 cm in greatest dimension. Upon dissection 3 tan-brown, firm,. candidate lymbh nodes are identified ranging in size from 0.7-1 cm in greatest dimension. All possible lymph nodes are. submitted. Cassette summary: 1. 2 candidate nodes. 2. 1 candidate node bisected. DOS: Female. FIN: Surgical Pathology Report - Final. COLLECTED DATE. RECEIVED DATE / TIME. K. Received in formalin properly labeled with the patient's name and labeled ""omentum"" is a portion of fibroadipose tissue. which aggregate to 14 x 12 x 5 cm. The specimen is sectioned to reveal 95% yellow, lobulated, glistening adipose tissue,. and 5% brown fibrous tissue. No masses or areas of interest are identified grossly. Microscopic Description. A nicroscopiciexamination has been performed and is reflected in the above diagnosis(es). QC. }. DOS: SEX: Female. FIN: Surgical Pathology Report - Final. COLLECTED DATE/TIME. RECEIVED DATE/TIME. F. Received in formalin properly labeled with the patient's name and labeled ""left periaortic lymph nodes"" are multiple. portions of fibroadipose tissue which aggregate to 4.5 cm in greatest dimension. Upon dissection multiple pink-tan, firm. lymph nodes are identified ranging in size from 1.2-2 cm. All possible lymph nodes are submitted. Cassette summary: 1-4. 1 candidate node each, bisected. 5. 2 candidate nodes bisected, one inked blue. G. Received in formalin properly labeled with the patient's name and labeled ""right external illac lymph nodes"" are. multiple portions of fibroadipose tissue which aggregate to 6 cm in greatest dimension. Upon dissection multiple. pink-tan,. firm lymph nodes are identified ranging in size from 1-3 cm in greatest dimension. All possible lymph nodes. are. submitted. Cassette summary: 1. 1 candidate node bisected. 2. 1 candidat node bisected. 3. 2 candidat nodes. 4-5. 1 candidate node bisected. H. Received in formalin properly labeled with the patient's name and labeled ""right obturator lymph nodes"" are multiple. portions of fibroadipose tissue which aggregate 4.5 cm in greatest dimension. Upon dissection multiple tan-brown,. firm. candidate nodes are identified ranging in size from 0.5-3.5 cm in greatest dimension. All possible lymph nodes are. submitted. Cassette summary: 1. 2 candidat nodes. 2. 1 candidate node. 3-4. 1 candidate node bisected. I. Received in formalin properly labeled with the patient's name and labeled ""right common lymph nodes"" are multiple. portions of fibroadipose tissue measuring 5 x 2 x 0.5 cm. Upon dissection multiple tan and brown, firm lymph nodes are. identified range in size from 0.5-2.5 cm in greatest dimension. All possible lymph nodes are submitted. Cassette summary: 1. 2 candidate node. 2. 1 candidate node bisected. 3. 1 candidat node bisected. J. Received in formalin properly labeled with the patient's name and labeled ""right periaortic lymph nodes"" is a portion of. fibroadipose tissue measuring 3.5 x 2x 1 cm. Upon dissection multiple tan-brown, firm lymph nodes are identified ranging. in size from 0.5-1.5 cm in greatest dimension. All possible lymph nodes are submitted. Cassette summary: 1. 2 candidate nodes. 2. 2 candidate nodes. 3. 1 candidate node bisected.",train,4.5 cm;2.5 cm
3102,TCGA-S9-A7IQ.2E181A31-FB43-4A8C-87E2-F34AA6B14784,Morphology shows both astrocytic and oligodendroglial differentiation. No evident mitotic. activity. Proliferation index 2%. Diagnosis. Oligoastrocytoma WHO grade II.,train,
3126,TCGA-P5-A731.F22D0DFD-A361-4735-B391-82975EA64AE5,Clinical diagnosis: Brain tumor. Gross description: The material presented by grayish soft-elastic pieces of right frontal and. temporal lobes. Microscopic description: Received material is represented mainly by brain tissue with the adjacent. small areas of oligoastrocytoma. WHO Grade II with a large number of. calcifications. Final diagnosis: Oligoastrocytoma: Grade II.,train,
3133,TCGA-BR-6852.c6ac5892-9d86-4b22-862e-02588657b004,"Segment of the stomach with the. Adenocarci. tumor of 12 X 8 cm, with fatty tissue. noma, G3,. infiltration. with. Greater and lesser omentum lymph. perigastric. nodes are soft, hyperemic. fat. Omentum is hyperemic. infiltration. Fifteen. dissected. lymph. nodes. demonstra. te sinus. histiocytos. is, reactive. changes of. the. follicles. Omentum: fibrosis,. focal. lymphoid. infiltration. Surgical. margins. along the. esophagus. are free of. metastase. S. Tumor Features: Exophytic (polypoid),. STOMACH TISSUE CHECKLIST. Tumor Extent: Perigastric fat , Venous. Invasion: Absent, Margins: Absent,. Specimen type: Subtotal gastrectomy. Treatment Effect: Tumor site: Stomach. Tumor size: 8 X 0 X 12 cm. Tumor features: Exophytic (polypoid). Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Subserosa. Lymph nodes: 0/15 positive for. metastasis (Greater and lesser omentum. 0/15). Lymphatic invasion: Not specified. Venous invasion: Absent. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not. specified. Comments: None.",train,8 X 0 X 12 cm;12 X 8 cm
3215,TCGA-KO-8416.a1c0eb6f-5aba-4b11-8303-434e976e89d6,"MODIFIED REPORT - REVIEW ADDENDUM SECTION. ADDENDUM. DIAGNOSIS. RIGHT KIDNEY AND ADRENAL: RENAL CELL CARCINOMA, CHROMOPHOBE TYPE (SEE COMMENT). COMMENT. The purpose of this addendum report is to classify this renal carcinoma based on the immunohistochemical pattern. The tumor is. positive for cytokeratin 7 and CD117 and shows weak diffuse cytoplasmic positivity for CD10. DIAGNOSIS. (A) RIGHT KIDNEY AND ADRENAL: RENAL CELL CARCINOMA (8.5 CM IN MAXIMUM DIMENSION), FUHRMAN GRADE 3 (SEE COMMENT). TUMOR IS CONFINED TO THE KIDNEY. INVASION OF INTRAPARENCHYMAL HILAR VESSELS IS PRESENT. Extraparenchymal hilar vessels are free of tumor. Margins of resection are free of tumor. Chronic interstitial nephritis and glomerulosclerosis in kidney adjacent to tumor. Unremarkable adrenal gland. COMMENT. Immunohistochemical stains are pending and the results will be reported in a supplemental report. GROSS DESCRIPTION. (A) RIGHT KIDNEY AND ADRENAL - A radical nephrectomy specimen (19.0 X 12.0 X 7.0 cm), including the right kidney (13.0 X. 5.5 X 3.0 cm), segment of the renal artery, the renal vein and ureter (14.0 cm in length and averaging 0.4 cm in diameter) in the. adrenal gland (6.0 X 2.0 X 1.5 cm). There is an 8.5 X 8.5 X 6.5 cm well circumscribed tumor arising from the anterior surface of the kidney, involving the upper. and. middle. pole. The. tumor pushes into the perinephric adipose tissue and extends to within 0.2 cm from the inked Gerota's fascia. in an area marked by Dr. as abutting the colon. The tumor is centrally cystic (approximately 60% of the tumor). This cyst is. filled with brown opaque fluid. The wall of the tumor consists of lobulated brown, friable tissue which is surrounded by a thickened. fibrous capsule. The tumor pushes into but does not appear to invade the renal sinus and does not appear to invade the. perinephric adipose tissue or the renal vein. The adjacent kidney parenchyma is unremarkable. No additional masses are identified. The pelvicalyceal system is. smooth and devoid of any lesions. No lymph nodes are identified in the hilum of the kidney. Cross sections of the right adrenal. gland show unremarkable cortex and medulla. Portions of the tumor have been submitted for possible electron microscopy, on hold. The tumor and normal renal. parenchyma are submitted for research purposes. INK CODE: Blue - Gerota's fascia/area marked by surgeon as adherent to colon. SECTION CODE: A1-A3, closest approach mass to inked Gerota's fascia/area marked by surgeon as adherent to colon,. frozen section; A4, vascular and ureter margins; A5, representative of adrenal gland; A6-A13, representative of tumor (A6-A8 with. relationship to renal sinus; A9-A10, with relationship to nonneoplastic kidney; A11-A12, with relationship to perinephric adipose. tissue; A13, additional representative section); A14, A15, no-neoplastic kidney. FS/DX: MARGIN FREE OF TUMOR. 1.",train,8.5 CM;8.5 X 8.5 X 6.5 cm
3222,TCGA-DX-A3UB.D8B3F485-3154-457E-ACC2-0DCAC3AA4433,"Clinical Diagnosis & History: Bleeding secondary to jejunal mass. Specimens Submitted: 1: SP: Proximal jejunum. DIAGNOSIS: 1. SMALL BOWEL, PROXIMAL JEJUNUM: RESECTION: - SMOOTH MUSCLE NEOPLASM, CONSISTENT WITH A LOW GRADE LEIOMYOSARCOMA,. OF JEJUNUM, SEE NOTE. - THE TUMOR INVOLVES TRANSMURAL SMALL BOWEL WALL WITH EXTENSION TO THE. MUCOSAL SURFACE WITH EROSION AND IS PRESENT <1 MM FOR THE SEROSAL SURFACE. - THE TUMOR MEASURES 2.7 CM IN GREATEST DIMENSION. - THE TUMOR EXHIBITS A NODULAR AND INFILTRATING GROWTH PATTERN. - NO TUMOR NECROSIS IS NOTED. - THE ESTIMATED MITOTIC ACTIVITY IS 2-3/10 HPF. - NO VASCULAR INVASION IS IDENTIFIED. SURGICAL MARGINS OF RESECTION ARE FREE OF TUMOR. - THE UNINVOLVED SMALL BOWEL MUCOSA IS UNREMARKABLE. NOTE: IMMUNOSTAINS REVEAL THAT THE TUMOR CELLS ARE POSITIVE FOR DESMIN. AND SMA; THEY ARE NEGATIVE FOR S100, CD34, AND CD117. THE ESTIMATED. PROLIFERATIVE INDEX (MIB-1) IS UP TO 10%. THIS CASE HAS BEEN REVIEWED WITH. IN CONSULTATION. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1.) The specimen is received fresh labeled ""proximal jejunum"" and consists. of an unoriented portion of small bowel measuring 9.0 cm in length and 7.6. cm in circumference. There is a tan-white firm fungating tumor measuring. 2.7 x 2.2 x 1.8 cm located 3.7 cm from one resection and 2.5 cm from the. other resection end. The tumor penetrates the bowel wall and is present on. the serosal surface. This area is inked black. TPS is taken. Gross. photographs are taken. The entire tumor is submitted. The remaining specimen. is representatively submitted. Summary of sections: M1 - one shaved margin. M2 opposite shaved margin. T tumor. D - normal duodenum. Summary of Sections: Part 1: SP: Proximal jejunum. Block. Sect. Site. PCs. 1. D. 1. 1. M1. 1. 1. M2. 1. 5. 5.",train,2.7 CM;2.7 x 2.2 x 1.8 cm
3230,TCGA-CN-A641.C9680CF7-9A89-4318-8799-951091DAA0BE,"Pathology R. Report Typ. Date of Ev. M. Authored by. Hosp/Group. Record Status. FINAL DIAGNOSIS: PART 1: LEFT NECK LEVELS II, III AND IV, DISSECTION. A. METASTATIC SQUAMOUS CELL CARCINOMA, UP TO 1 CM, IN THREE OF. THIRTY-SEVEN LYMPH NODES (3/37). B. EXTRACAPSULAR EXTENSION IS PRESENT. PART 2: LYMPH NODES, RIGHT NECK LEVELS IIA AND IIB, DISSECTION. THIRTY-ONE BENIGN LYMPH NODES (0/31) . PART 3: LARYNX AND BASE OF TONGUE, TOTAL LARYNGECTOMY AND BASE OF. TONGUE. RESECTION. A. SUPRAGLOTTIC INVASIVE KERATINIZING SQUAMOUS CELL CARCINOMA,. 5.4. CM, MODERATELY DIFFERENTIATED, INVOLVING BASE OF TONGUE, HYOID BONE,. GLOTTIS,. AND PYRIFORM SINUSES. B. THYROID CARTILAGE IS FREE OF CARCINOMA. C. VASCULAR INVASION IS ABSENT. D. PERINEURAL INVASION IS PRESENT. E. ALL MARGINS ARE FREE OF CARCINOMA. F. TWO BENIGN LYMPH NODES (0/2) . G. STOMA WITH REACTIVE CHANGES. H. BENIGN THYROID TISSUE. I. pT4a N2b. By Pathologist: My signature is attestation that I have personally reviewed the. submitted. material (s) and the final diagnosis reflects that evaluation. GROSS DESCRIPTION: The specimen is received fresh in three parts. Part 1 is labeled with the patient' S name, initials XX, medical record. number. and ""left neck dissection levels 2, 3, 4"". It consists of an. unoriented. selective left neck dissection (12.8 X 4.9 x 1.1 cm) and shows yellow. fibroadipose tissue and several prominent lymph nodes ranging in size. from 0.1. to 2.0cm. There is an area of firm, tan-brown skeletal muscle (1.9 X. 1.5 x. 0.3 cm). In level 2A there is one prominent lymph node (2.2 X 1.9 X 0.3 cm). Additional. lymph node candidates - 0.2-0.9 cm. In level 2B there are two prominent lymph nodes (1.9 X 0.4 X 0.1 cm and. 2.5 x. 0.7 X 0.3 cm), both bisected. Additional lymph node candidates - 0.1- -. 1.6 cm. In level 3 there is one prominent lymph node (1.2 X 0.9 x 0.1 cm),. bisected. Two additional lymph node candidates - 0.4 -0.7 cm. In level 4 there are lymph node candidates, 0.1 -0.7 cm. Section code: 1A- Level 2A, one lymph node. 1B - 1C- Level 2A, nine lymph nodes. 1D- Level 2B, one lymph node, bisected. 1E- Level 2B, one lymph node, bisected. 1F -1G- Level 2B, eight lymph nodes. 1H- Level 3, one lymph node, bisected. 1I- Level 3, two lymph nodes. 1K-1L- Level 4, thirteen lymph nodes. 1J- Representative sections of muscle. Time in formalin: 22 hours. Part 2 is labeled with the patient' S name, initials XX, medical record. number. and ""right neck, short stitch level 2A, long stitch level 2B"". It. consists of. an oriented selective right neck dissection (12.1 X 3.2 1.5 cm) and. shows. yellow fibroadipose tissue and several prominent lymph nodes. In level 2A there are two prominent lymph nodes (2.0 x 1.5 x 0.4 cm and. 2.0 x. 1.3 x 0.5 cm) both are bisected. There are nineteen smaller lymph nodes. ranging in size from 0.1 -0.7 cm in greatest dimension. In level 2B there is one prominent lymph node (2.0 X 1.2 x 0.3 cm),. bisected. There are nine smaller lymph nodes ranging in size from 0.1-1.0 cm in. greatest. dimension. Time in formalin: 22 hours. Section code: 2A- Level 2B, one lymph node, bisected. 2B 2D- - Level 2C- Level 2A, 2B, lymph node, bisected bisected. nine lymph nodes. one. 2E- Level 2A, one lymph node,. 2F - -2H- Level 2A, nineteen lymph nodes. Part 3 is labeled with the patient's name, initials XX, medical record. number. and ""total laryngectomy and base of tongue resection"". It consists of. a total. laryngectomy specimen (SI-7.8 cm, AP-7.4 cm, W-6.6 - cm) that includes. attached. base of tongue (5.8 X 4.7 X 2.6 cm), right and left pharyngeal tissue,. posterior cricoid tissue, anterior compartment soft tissue and. tracheostomy. stoma with attached skin (1.3 1.3 X 0.9 cm). There is a light tan,. friable,. ulcerated, circumferential mostly supraglottic tumor (5.4 X 5.3 X 2.2. cm). extending 1.0 cm into the left glottic region. It involves the left. false. vocal cord and abuts the right true vocal cord, right and left pyriform. sinus,. anterior commissure, hyoid bone and base of tongue. The tumor is. located 0.9. cm from the left laryngeal margin and 0.2 cm from the base of tongue. deep. margin. The tumor does not grossly involve the thyroid or cricoid. cartilage. One candidate lymph node (0.4 cm) is dissected from the anterior. compartment. soft tissue. The tracheal stoma is uninvolved by tumor. INK CODE: Red deep margin. Green hyoid bone region. Blue base of tongue. Black anterior surface. CASSETTE CODE: 3AFS Deep margin, designated by surgeon, shave. 3BFS Left lateral pharyngeal margin, shave. 3CFS Right lateral pharyngeal margin, shave. 3D Tracheal margin, shave. 3E Hyoid bone with tumor. 3F-3G Base of tongue, shave margin. 3H Posterior cricoid region, shave margin. 3I Anterior compartment, shave. 3J Deep base of tongue, additional shave margin. 3K Representative section of right pyriform sinus. 3L. Representative section of left pyriform sinus. 3M Anterior commissure. 3N Right true and false vocal cords. 30 Left true and false vocal cords. 3P Thyroid cartilage and adjacent grossly normal tissue. 3Q Stoma, submitted entirely. 3R Base of tongue with tumor at deepest level of involvement. (perpendicular. section). 3S One lymph node, level VI. Time in formalin: 22 hours. DICTATED BY: INTRAOPERATIVE CONSULTATION: 3AFS: DEEP MARGIN (SHAVE) (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR PRESENT. 3BFS: LEFT LATERAL PHARYNGEAL MARGIN (SHAVE) (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR PRESENT. 3CFS: RIGHT LATERAL PHARYNGEAL MARGIN (SHAVE) (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR PRESENT. MICROSCOPIC: Microscopic examination substantiates the above diagnosis. The following statement applies to all immunohistochemistry, Insitu. Hybridization Assays (ISH & FISH) , Molecular Anatomic Pathology, and. Immunofluorescent Testing: The testing was developed and its performance characteristics. determined by. the. Department of Pathology, as required by. the CLIA. '88 regulations. The testing has not been cleared or approved for the. specific use by the U.S. Food and Drug Administration, but the FDA has. determined such approval is not necessary for clinical use. Tissue. fixation. ranges from a minimum of 2 to a maximum of 84 hours. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (""CLIA"") as qualified to perform high-complexity. clinical. testing. Pursuant to the requirements of CLIA, ASR's used in this. laboratory. have been established and verified for accuracy and precision. Additional. information about this type of test is available upon request. CASE SYNOPSIS: SYNOPTIC DATA - LARYNX RESECTIONS. TYPE OF LARYNGECTOMY: Total. TUMOR LATERALITY: Bilateral. ATTACHED STRUCTURES: Pyriform sinus, Base of tongue, Thyroid, Skin. TUMOR LOCATION/SEGMENT: Supraglottic. TUMOR SIZE: Maximum dimension: 5.4 cm. HISTOLOGIC TYPE OF TUMOR: Squamous cell carcinoma. HISTOLOGIC GRADE: Moderately differentiated. STRUCTURES INVOLVED BY TUMOR: Anterior commissure, False cord,. Ventricle,. Epiglottis, Vallecula-base of tongue, Pyriform sinus, Other: hyoid bone. LYMPH NODES: Lymph nodes positive, Right: 0. Total number of right sided lymph nodes examined: 31. Lymph nodes positive, Left: 3. Total number of left sided lymph nodes examined: 37. Site of 'other' lymph nodes: level VI. Lymph nodes positive, 'other': 0. Total number of 'other' lymph nodes examined: 2. EXTRACAPSULAR SPREAD OF LYMPH NODE METASTASES. INTRA-PERINEURAL INVASION: Present. VASCULAR INVASION: SURGICAL MARGIN INVOLVEMENT: Free (2 mm or more). I STAGE, PATHOLOGIC: Supraglottis, pT4a. N STAGE, PATHOLOGIC: pN2b. M STAGE, PATHOLOGIC: pMX. PATIENT HISTORY: CHIEF COMPLAINT/ PRE-OP/ POST-OF DIAGNOSIS: Supraglottic carcinoma. PROCEDURE: Total laryngectomy. SPECIFIC CLINICAL QUESTION: Not answered. OUTSIDE TISSUE DIAGNOSIS: Not answered. PRIOR MALIGNANCY: Not answered. CHEMORADIATION THERAPY Not answered. ORGAN TRANSPLANT: Not answered. IMMUNOSUPPRESSION Not answered. OTHER DISEASES: Not answered. CYTOGENETIC TESTS: Not answered. HISTO TISSUE SUMMARY/SLIDES REVIEWED: Part 1: Left Neck Dissection Levels 2-4. Stain/. Block. H&E x 1. A. H&E x 1. B. H&E X 1. C. H&E X 1. D. H&E X 1. E. H&E X 1. F. H&E X 1. G. H&E X 1. H. H&E X 1. H&E X 1. H&E X 1. K. H&E X 1. Part 2: Right Neck. Stain,. Block. H&E X 1. A. H&E X 1. B. H&E X 1. C. H&E x 1. D. H&E X 1. E. H&E X 1. F. H&E X 1. G. H&E X 1. H. Part 3: Total Laryngectomy and Base of Tongue Resection. Stain,. Block. H&E X 1. E. H&E X 1. F. H&E x 1. G. H&E X 1. H. H&E X 1. H&E X 1. H&E X 1. K. H&E X 1. L. H&E X 1. M. H&E X 1. N. H&E X 1. O. H&E X 1. P. H&E X 1. H&E X 1. R. H&E X 1. S. H&E X 1. T. H&E X 1. H&E X 1. H&E X 1. AFS. H&E X 1. BFS. H&E X 1. CFS. H&E X 1. DDR.",train,5.4. CM;5.4 X 5.3 X 2.2. cm;5.4 cm;1 CM
3240,TCGA-L5-A8NH.54F5151E-0008-40D7-9BD6-67AA7AC4E804,"OPER DATE: REQ DOC: PROCEDURE: -year-old male with distal esophageal mass showing high grade dysplasia. changes suspicious for invasive cancer. Combined hiatal hernia. 1.5 cm left. basilar lung nodule, common bile duct dilatation and 2-3 cm left renal (esion. suspicious for renal cell carcinoma. ERCP in. showed ampullary. adenoma. PROCEDURE: 1. ""Left thoracic inlet tracheoesophageal groove"". 1.9 x 1.7 x 0.6. cm. lobulated, firm, white nodule. Bisected. 1A. Frozen section control. 18. Remainder. 2. ""Retroportal lymph node"". Two tan-brown soft tissue fragments, measuring. 1.3 x 1.0 x 0.5 cm and 1.2 x 0.7 x 0.5 cm. Both bisected and submitted in. cassettes 2A-B. PREVIOUS DIAGNOSIS INQUIRY. 3. REPORT DATE: PATIENT NBR: SEX: M. ADM DATE: SIRTHDATE: OPER DATE: REQ DOC: 3. ""Gallbladder"". A 12.0 cm gallbladder, 4.5 cm in diameter with pink-purple,. unremarkable serosal surface. The gallbladder is filled with amber bile and. has a velvety, red-brown, unremarkable mucosa. Representative pieces from. mucosa and cystic duct submitted in cassette 3. 4. ""Esophagus and proximel stomach"". An 8.0 cm esophagus, 2.3 cm in diameter. with attached 5.4 cm proximal stomach, closed at both ends with staple. lines. The esophageal mucosa is flattened, pink-gray with a 3.5 x 1.6 cm. fungating, partially ulcerated, tan-brown lesion, 3.3 cm from the proximal. margin of resection. At the level of the gastroesophageal junction, there is. another 2.2 x 1.6 cm fungating, tan-brown (esion, 2.5 cm from the distal. margin of resection. Both Lesions are raised 1.2 cm from the mucosal surface. of the specimen. Deep radial margin inked black. The mucosal lesions extend. grossly to the level of the muscularis, but do not penetrate into the. surrounding fat. It appears that the lesions may be connected at a level deep. to the mucosa. Distal margin of resection inked blue. The surrounding. fibroadipose tissue contains multiple lymph nodes, the largest of which. appears grossly involved. 4A-B. Proximal mucosal lesion with deepest extension. 4C-D. Distal mucosal lesion with deepest extension. 4c contains interface. between proximal and distal lesions. 4E. Distal margin of resection. 4F. Uninvolved gastric and esopnageal mucosa. 4G-H. Largest lymph node. 41-J. Two bisected Lymph nodes each. One node has been inked blue in each. case. 4K-L. Four lymph nodes each. 5. Cervical esophageal margin"". A 1.3 cm segment of esophagus, 2.0 cm in. diameter, closed at one end with a staple line. Cross section submitted in. one cassette. FROZEN SECTION REPORT: 1A. Lymph node with metastatic adenocarcinoma. have reviewed and interpreted the frozen section. material at the time it was requested. Permanent sections confirm frozen section report. PROCEDURE: ESOPNAGEAL, CARDIAC AND GASTROESOPHAGEAL JUNCTION CARCINOMA: Type of carcinoma: Adenocarcinoma. If adenocarcinoma, is it arising in: G-E junction otherwise not specified. PREVIOUS DIAGNOSIS INQUIRY. REPORT DATF. 4. PATIENT NBR: SEX: M. BIRTHDATE: ADM DATE: OPER DATE: REQ DOC: Depth of invasion: Muscularis propria. Number of positive lymph nodes, the total number sampled is irrelevant: 6. Extranodal metastasis: Unknown. Pattern of invasion: Infiltrative. Esophageal and gastric resection margins involved: No. Deep resection margin involved: No. TNM classification: T1N1MX. PROCEDURE: 1. Lymph node, ""left thoracic intet trachecesophageal groove, excision: One. lymph node positive for metastatic carcinoma (1/1). 2. Lymph node, ""retroportal lymph node"", excision: Two Lymph nodes negative. for neoplasm (0/2). 3. Gallbladder, resection: Chronic cholecystitis. 4-5. Esophagus, resection: Invasive adenocarcinoma, poorly differentiated,. 5.7 cm, abutting the muscularis propria. Lymphatic invesion present. Margins. negative. Please see template. 1,. D., the signing staff pathologist, have personally. examined and interpreted the slides from this case. Code:",train,1.9 x 1.7 x 0.6. cm;5.7 cm
3298,TCGA-BH-A18F.771497E1-473E-421A-A149-CFA58E95B728,"CHIEF COMPLAINT/ PRE-OPI POST-OP DIAGNOSIS: 1.2-cm mass posterior 12 o'clock right breast. Core blopsy Invasive ductal. carcinoma. LMP DATE: Not provided. PROCEDURE. Right segmental mastectomy/sentinel lymph node biopsies. SPECIFIC CLINICAL QUESTION: Not provided. OUTSIDE TISSUE DIAGNOSIS: No. PRIOR MALIGNANCY No. CHEMORADIATION THERAPY: No. OTHER DISEASES No. ADDENDA: Addendum. There a few satellite nodules ranging in size from 0.5-2 mm, which measure 0.5-1.2 cm from the main dominant nodule. These. satellite nodules are the nodules that are seen closest to the margins, as reported. FINAL DIAGNOSIS: PART 1: BREASTRIGHT/SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA (see comment). B. NOTTINGHAM GRADE 3 (TUBULE FORMATION 3, NUCLEAR PLEOMORPHISM 3, MITOTIC ACTIVITY 3;. TOTAL SCORE 9/9). C. THE INVASIVE TUMOR MEASURES 1.1 CM IN GREATEST DIMENSION (ON SLIDE IK). D. NO DUCTAL CARCINOMA IN-SITU (DCIS) IS IDENTIFIED. E. NO LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. F. RESECTION MARGINS ARE NEGATIVE FOR INVASIVE CARCINOMA; INVASIVE CARCINOMA MEASURES. LESS THAN 1 MM FROM THE ANTERIOR AND INFERIOR MARGINS, 1 MM FROM THE MEDIAL MARGIN, AND. 1.5 MM FROM THE POSTERIOR MARGIN. G. SKIN, NEGATIVE FOR TUMOR. H. ATYPICAL DUCTAL HYPERPLASIA. I. CALCIFICATIONS ASSOCIATED WITH INVASIVE CARCINOMA. J. FIBROCYSTIC CHANGES WITH DUCTAL EPITHELIAL HYPERPLASIA ANO COLUMNAR CELL ALTERATIONS. K. CHANGES CONSISTENT WITH PRIOR BIOPSY SITE. THE INVASIVE TUMOR CELLS ARE NEGATIVE FOR ESTROGEN AND PROGESTERONE RECEPTORS AND. ALSO NGATIVE FOR HER-2/NEU (SCORE 0). AS PER PREVIOUS REPORT. PART 2: AXILLA, RIGHT, CYST EXCISION -. EPIDERMAL INCLUSION CYST. PART 3: LYMPH NODE, RIGHT AXILLARY, SENTINEL #1, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 4: LYMPH NODE, RIGHT AXILLARY, SENTINEL #2, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 5: LYMPH NODE, RIGHT AXILLARY, SENTINEL #3, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). COMMENT: The triple negative invasive tumor was reported to be positive for basal markers, as per previous report (I. Although the mass grossly measured 1.4 cm by gross examination, the tumor is best estimated to be 1.1 cm. based on the microscopic measurement from slide 1K. CASE SYNOPSIS: SYNOPTIC . PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Segmental. Clock position:12 oclock. SIZE OF TUMOR: Maximum dimension invasive component: 11 mm. MULTICENTRICITY/MULTIFOCALTY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS, Other Type(s): Basal-like phenotype confirmed by IHC. on biopsy. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation 3. Mitotic activity score. 3. Total Nottingham score: 9. Nottingham grade (1, 2, 3): 3. ANGIOL YMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: Yes, malignant zones. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 0.5 mm. LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 3. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: SKIN INVOLVED (ULCERATION): NON-NEOPLASTIC BREAST TISSUE: ADH, FCD, Other: ductal epithelial hyperplasia, columnar cell alterations. T STAGE, PATHOLOGIC: pTic. N STAGE, PATHOLOGIC: pNO. M STAGE: Not applicable. ESTROGEN RECEPTORS: negative. PROGESTERONE RECEPTORS: negative. HER2/NEU: 0.",train,11 mm;1.1 cm;1.1 cm
3323,TCGA-EJ-A7NN.4027496E-5E84-4502-BD86-980339AD9896,"[D:4027496E-5E84-4502-BD86-980339AD9896. FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT PELVIC, EXCISION -. A. METASTATIC TUMOUR IS PRESENT IN THREE OUT OF TWELVE LYMPH NODES (3/12) EXAMINED. B. LARGEST METATSTATIC FOCUS MEASURES 0.4CM. C. EXTRACAPSULAR EXTENSION IS NOT IDENTIFIED. PART 2: LYMPH NODES, LEFT PELVIC, EXCISION -. NO EVIDENCE OF NEOPLASIA IN THIRTEEN (0/13) LYMPH NODES EXAMINED. PART 3: PROSTATE AND BILATERAL SEMINAL VESICLES, RADICAL PROSTATECTOMY -. A. INVASIVE MODERATELY DIFFERENTIATED ADENOCARCINOMA, ACINAR TYPE, GLEASON SCORE 4 +3 - 7. WITH TERTIARY GLEASON PATTERN 5. B. THE CARCINOMA INVOLVES BOTH THE RIGHT AND LEFT LOBES AND HAS A GREATEST NODULAR. DIAMETER OF 1.9CM (slide 3U). c. THE CARCINOMA INVOLVES 25-30% OF THE EXAMINED PROSTATE VOLUME. D. THE CARCINOMA SHOWS ESTABLISHED EXTRACAPSULAR EXTENSION. E. THE EXTRACAPSULAR EXTENSION IS SEEN IN THE MID AND BASE OF RIGHT POSTERIOR REGION (slides. 3V AND 3W). F. CARCINOMA INVOLVES BILATERAL SEMINAL VESICLES. G. CARCINOMA FOCALLY INVOLVES THE SURGICAL RESECTION MARGINS IN THE REGION OF RIGHT. POSTERIOR APEX AND BASE (slides 3U, 3W) AND THE SOFT TISSUE MARGIN AT THE BASE OF RIGHT. SEMINAL VESICLE AND VASDEFERENS (slides 3A, 3B). H. PERINEURAL INVASION IS IDENTIFIED (slides 3V, 3W, 3X). ANGIOLYMPHATIC INVASION IS IDENTIFIED (slide 3A, 3C). J. MULTIFOCAL HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA IS IDENTIFIED. K. PATHOLOGIC TNM STAGE: PT3b N1 MX. L. TNM HISTOLOGIC GRADE = G3-4. M. BENIGN PROSTATIC HYPERTROPHY AND CHRONIC PROSTATITIS ARE NOTED. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY PROSTATE TUMORS. CLINICAL DATA: PSA value: 9.77. INVASIVE CA IDENTIFIED?: TUMOR HISTOLOGY: Adenocarcinoma NOS. PRIMARY GLEASON GRADE: 4. SECONDARY GLEASON GRADE: 3. GLEASON SUM SCORE: 7. GLEASON 4/5 PERCENTAGE: 60%. WEIGHT OF PROSTATE: 40.82gm. TUMOR SIZE: Maximum dimension: 1.9 cm. LOBE LATERALITY: Right and Left Lobes. PERCENT OF SPECIMEN INVOLVED BY TUMOR: > 25%. MULTIFOCAL DISEASE: HIGH GRADE PIN: Yes - multifocal. EXTRAPROSTATIC EXTENSION: Yes - Established (> 0.8mm). PERINEURAL INVASION: ANGIOLYMPHATIC INVASION: SEMINAL VESICLE INVASION: SURGICAL MARGIN INVOLVEMENT: Widespread tumor involvement at margin. LYMPH NODES EXAMINED: 25. LYMPH NODES POSITIVE: 3. EXTRANODAL EXTENSION: SIZE OF NODAL METASTASIS: 4mm. T STAGE, PATHOLOGIC: pT3b. N STAGE, PATHOLOGIC: pN1. M STAGE, PATHOLOGIC: pMX. HISTOLOGIC GRADE: G3-4, Poorly differentiated/undifferentiated.",train,1.9CM;1.9 cm
3338,TCGA-F6-A8O3.79D96BBD-E399-4928-A86A-FF5086045841,"Gross Description: Tumors is located in Brain, Frontal Lobe, with 6x5x5cm in size, soft and brown-white. surface, moderately-margin. Microscopic Description: Tumor is increased cellularity and hemogenous. Nuclei are round and irregular. and hyperchromatic. Mitotic figures are present. Tumor cells have moderate, eosinophilic or clear. cytoplasm around a central spherical nucleus. Tumor tissue intervenes in thin vascular and invades into. begnin brain tissue. Tumor is necrotic. Vasculae are hyperplastic. Diagnosis Details: Oligodendroglioma, grade Il. Comments: Formatted Path Reports: Brain tumor checklist. Diagnosis: Oligodendroglioma of the brain. Tumor location: Brain, Frontal Lobe. Tumor grade: Poorly differentiated. Tumor size: 6x5x5cm. Diagnosis details: None. Comments: None.",train,6x5x5cm;6x5x5cm
3376,TCGA-OL-A66N.CDB6A529-DE8B-48F6-A569-D07251D139C3,"UTD:CDB6A529-DE8B-48F6-A569-D07251D139C3. FINAL PATHOLOGIC DIAGNOSIS. A. Left breast, modified radical mastectomy: - Invasive lobular carcinoma, SBR grade II, see pathologic parameters and. comment. - Lobular carcinoma in situ, classic type. - Metastatic carcinoma in thirteen of fifteen lymph nodes (13/15); biopsy. site present in one node. Breast Pathologic Parameters. 1. Invasive carcinoma: A. Microscopic measurement: 6.6cm (slices 5-11); 20% cellularity. See. comment. B. Composite histologic (modified SBR) grade: II. - Architecture: 3. - Nuclear grade: 2. - Mitotic rate: 1. C. Associated lobular carcinoma in situ (LCIS): - Within main mass and extending away. 2. Excisional biopsy margins: Widely (>1cm) free of tumor. 3. Blood vessel and lymphatic invasion: Absent. 4. Nipple and skin: unremarkable. 5. Axillary lymph nodes: Positive (13/15). - Size of largest metastatic deposit: 1cm. - Extranodal extension: present, largest focus 2mm (multifocal). 6. Special studies (see. - ER: Moderate to strong expression in 80% of invasive tumor nuclei. - PR: No expression of invasive tumor nuclei. - HER2 antigen (FISH): Non-amplified (ratio: 1.10). 7. pTNM (AJCC, 7th edition, 2010): pT3, N3, MX. Clinical History: The patient is a. year-old female with breast cancer undergoing left breast. modified radical mastectomy. Comment. The tumor exhibits 20% cellularity. Although extensive hyalinization is present. in the tumor bed, this feature was also seen on the pre-treatment biopsy. Hence,. response to chemotherapy is difficult to assess. Of note, no significant. treatment response is seen in the lymph nodes. Specimens Received: A: Left breast modified radical mastectomy. Gross Description: A. The specimen is received in a single container labeled with the patient's. name, medical record number, and additionally identified as, 'left breast. modified radical mastectomy'. Received fresh and placed in formalin is a 1,276.6. gm modified radical mastectomy specimen. The specimen is received oriented with. a suture designating left axillary tail. The specimen measures 26.5 cm from. superior to inferior, 27.5 cm from medial to lateral, and 5 cm from anterior to. posterior. There is an attached 9.5 X 9 x 2.5 cm axillary tail. On the. anterior surface is a 23.5 X 13 cm tan-white ellipse of skin with a 6 x 5 cm. areola and a 1.1 X 1 cm flattened nipple. The nipple-areolar complex reveals no. evidence of ulceration or retraction. The specimen is inked as follows: superior edge - blue;. inferior edge - green;. posterior - black. The specimen is serially sectioned from medial to lateral into 21 slices to. reveal a firm, bulging, scallop tan-white to pink 8.5 X 6.5 X 4.2 cm mass in. slices 5-13. The mass is 0.7 cm from posterior margin (black) and 0.5 cm from. anterior skin. A biopsy tract filled with gel is present in places 6-7, with. clip present in slice 7. The remainder of the specimen consists of. approximately 5% dense gray-white fibrous breast parenchyma and 95% lobulated. yellow adipose tissue. No additional masses or nodules are grossly identified. Sectioning through the axillary tail reveals multiple tan-brown, rubbery lymph. nodes ranging from 0.6 X 0.4 X 0.4- 2 X 0.9 x 0.5 cm in greatest dimension. Breast specimens are fixed for at least 6 hours in 10% NBF and no more than 72. hours. Block summary: A1: mass closest approach to posterior margin (black), slice 13. A2: mass, slice 12. A3: mass, slice 11. A4: mass, slice 10. A5: mass, slice 9. A6: mass closest approach to skin, slice 8. A7: mass biopsy tract, slice 7. A8: mass biopsy tract, slice 6. A9: mass, slice 5. A10: medial to lesion,slice 4. A11: medial to lesion, slice 14. A12: medial to lesion, slice 15. A13: upper-inner quadrant, slice 5. A14: upper-outer quadrant slice 12. A15: lower-outer quadrant slice 9. A16: lower-inner quadrant slice 4. A17: nipple. A18: skin subjacent to nipple. A19-A23: one lymph node candidate bisected in each cassette. A24: three lymph node candidates. A25: one lymph node candidate. A26: three lymph node candidates. A27-A29: one lymph node candidate bisected in each cassette. MD. PhD.",train,6.6cm
3379,TCGA-FE-A231.8B8522CD-C9E7-4762-99F9-D597B35ABF03,"From: Page:4/13. Specimen Description. Accession # : Med. Rec # : Clinical History. Thyroid cancer. Final Pathologic Diagnosie. A. Lymph node, anterior right neek: Metastatic papillary thyroid carcinoma in one lymph node (1/1). B. Soft tissue, right inferior neck: Benign lymph node with extensive brown pigment deposition,. consistent with hemosiderin (0/1); no parathyroid tissue is identified. Right thyroid lobe: Papillary thyroid carcinoma (See SYNOPTIC REPORT). Metastatic papillary thyroid carcinoma in seven of seven lymph. nodes (7/7). D. Right anterior Level III lymph nodes: Metastatic papillary thyroid carcinoma in two of two lymph nodes. (2/2). Right central neck tissue: One benign lymph node (0/1). F. Right Level III and IV lymph nodes. Metastatic papillary thyroid carcinoma in five of fifteen lymph. nodes (5/15). G. Soft tissue, right inferior neck: Portions of a lymph node with extensive brown pigment. deposition, consistent with hemosiderin (0/1) : no parathyroid tissue is. identified. H. Left thyroid lobe: Nodular goiter with focal chronic inflammation. One benign lymph node (0/1). I. Superior central lymph nodes: Metastatic papillary thyroid carcinoma in one lymph node (1/1). Print this Page. Specimen Description. Submitting. Clinical History. Thyroid cancer. Final Pathologic Diagnosis. A. Lymph node, anterior right neck: Metastatic papillary thyroid carcinoma in one lymph node (1/1). B. Soft tissue, right inferior neck: Benign lymph node with extensive brown pigment deposition,. consistent with hemosiderin (0/1) i no parathyroid tissue is identified. C. Right thyroid lobe: Papillary thyroid carcinoma (See SYNOPTIC REPORT). Metastatic papillary thyroid carcinoma in seven of seven lymph. nodes (7/7). D. Right anterior Level III lymph nodes: Metastatic papillary thyroid carcinoma in two of two lymph nodes. (2/2). E. Right central neck tissue: One benign lymph node (0/1). F. Right Level III and IV lymph nodes: Metastatic papillary thyroid carcinoma in five of fifteen lymph. nodes (5/15). G. Soft tissue, right inferior neck: Portions of a lymph node with extensive brown pigment. deposition, consistent with hemosiderin (0/1) ; no parathyroid tissue is. identified. H. Left thyroid lobe: Nodular goiter with focal chronic inflammation. One benign lymph node (0/1). I. Superior central lymph nodes: Metastatic papillary thyroid carcinoma in one lymph node (1/1). Synoptic Report. SYNOPTIC REPORT FOR THYROID CANCER: Specimen type: Total thyroidectomy. Tumor location: Right thyroid. Tumor size: 9.4 cm. Histologic type: Papillary thyroid carcinoma. Tumor grade: Grade 2 of 3. Lymphatic/vascular invasion: positive. Capsular invasion: Negative. Tumor extent: Confined to the thyroid: yes. Multifocal: negative. Invasion of thyroid cartilage or hyoid bone: Negative. Infiltration of adjacent structures: Negative. Margins. For partial or subtotal resection: uninvolved. Lymph nodes: Total number examined: 31. Sites/laterality: Right side and superior central. Number positive: 16. Number negative: 15. Extranodal extension: negative. Additional pathologic findings: nodular goiter. Special studies: none. pTNM: pT3 pN1b pMx. Comments: The findings from the previous FNA have been noted. The above synoptic report complies, in slightly modified form, with the. guidelines of the Coliege of American Pathologists Protocols and the AJCC. Cancer Staging Manual, 7th edition, 2010, for the reporting of cancer. specimens. INTRAOPERATIVE CONSULTATION DIAGNOSIS. AF1. Anterior lymph node right neck: (FROZEN SECTION PERFORMED). One lymph node with metastatic papillary thyroid carcinoma. BF1. Possible right inferior parathyroid: (FROZEN SECTION PERFORMED). Not parathyroid. Examining pathologist. SPECIMEN (S) RECEIVED. A: Lymph node, excision. B: Parathyroid gland, BX. C: Thyroid resection total or lobe. D: Lymph node, dissection. E: Lymph node, dissection. F: Lymph node, dissection. G: Parathyroid gland, BX. H: Thyroid resection total or lobe. I: Lymph node, dissection. GROSS DESCRIPTION: The specimens are received in nine properly labeled containers with the. patient' s name and accession number, two of which are submitted for frozen. section. A. The specimen is designated ""anterior lymph node right neck"" and. consists of a 1.7 x 1.2 x 1.0 cm aggregate of soft tissue in which there is. a 1.3 x 1.0 x 0.6 cm lymph node. The specimen is resubmitted as received. from frozen section in cassette AF1. TE 1. B. The specimen is designated ""possible right inferior. parathyroid"" and consists of a 0.4 x 0.2 x 0.2 cm piece of soft tissue. The. specimen is resubmitted as received from frozen section in cassette BF1. TE. 1. C. The specimen is designated ""right thyroid lobe"" and consists of. a 317.6 gram hemithyroidectomy that is 13.4 cm from superior to inferior,. 9.4 cm from medial to lateral and 6.5 cm in the anteroposterior dimension. The outer surface of the hemithyroid is diffusely nodular and numerous. grossly positive lymph nodes are identified in the perithyroidal soft. tissue. The isthmic resection edge is inked orange and the outer surface of. the specimen is inked blue. The cut surface of the mass is solid tan-white. and has foci of both hemorrhage and necrosis. The greatest dimension of the. mass is 9.4 cm. The mass diffusely approaches the inked outer surface of. the thyroid. In the perithyroidal soft tissue, seven lymph nodes are. identified, six of which are grossly positive for tumor. The largest. grossly positive lymph node is 2.5 cm in greatest dimension. (. Summary of Cassettes: C1-2, isthmic resection edge, perpendicular;. C3-6, representative sections of mass to inked outer surface; C7, necrotic. and hemorrhagic portion of mass to inked outer surface; C8, one lymph node;. C9, representative section of the largest grossly positive lymph node; C10,. representative sections of three grossly positive lymph nodes; C11,. representative sections of two grossly positive lymph nodes. D. The specimen is designated ""right anterior level 3 lymph nodes"". and consists of a 4.7 x 2.3 x 1.0 cm aggregate of tan-yellow soft tissue. that contains two lymph nodes that are 2.9 x 1.5 x 1.0 and 2.5 x 1.3 x 1.0. cm respectively. The lymph nodes are grossly positive for tumor involvement. (confirmed by touch preparation) ; one representative section of each lymph. node is submitted for microscopic examination. Summary of Cassettes: D1, representative section of one grossly. positive lymph node; D2, representative section of second grossly positive. lymph node. Note: Each grossly positive lymph node is submitted in its plane of. greatest dimension. E. The specimen is designated ""right central neck tissue"" and. consists of one sheet of tan-yellow soft tissue that is 4.2 x 3.5 x 0.4 cm. No lymph nodes are grossly identified. The entire specimen is submitted for. microscopic examination. TE 2. F. The specimen is designated ""right level 3 and 4 lymph nodes"". and consists of an unoriented piece of soft yellow adipose tissue that is. 6.2 x 5.7 x 1.9 cm. Multiple possible lymph nodes are identified that range. from 0.2 to 1.8 cm in greatest dimension. Only adipose tissue remains in. the container. RS 4. Summary of Cassettes: F1, six possible lymph nodes; F2, five possible. lymph nodes; F3, three possible lymph nodes; F4, one possible lymph node,. bisected. G. The specimen is designated ""possible right inferior. parathyroid"" and consists of a less than 0.05 gram aggregate of red-brown. soft tissue that is 0.7 x 0.3 x 0.2 cm. The specimen is submitted in its. entirety for microscopic examination in cassette G1. TE 1. H. The specimen is designated ""left thyroid lobe"" and consists. of. an 11.0 gram hemithyroidectomy that is 5.4 cm from superior to inferior,. 3.6 cm from medial to lateral and 1.3 cm in the anteroposterior dimension. The isthmic resection margin is inked orange and the outer surface of the. thyroid is inked blue. The specimen is serially sectioned to reveal. homogeneous beefy red parenchyma with no focal masses or lesions. RS 4. Summary of Cassettes: H1, isthmic resection edge, shaved; H2-4,. representative sections of left thyroid lobe. I. The specimen is designated ""superior central lymph nodes"" and. consists of one piece of tan-white soft tissue that is 2.4 x 1.4 x 0.8 cm. Two firm possible lymph nodes are identified that are 0.4 and 1.4 cm in. greatest dimension respectively. TE 2. Summary of Cassettes: 11, one possible lymph node; 12, one possible. lymph node, bisected. Lab Use Only: Gross description by: Top of Page.",train,9.4 cm
3403,TCGA-UY-A78K.5A6AB084-6B3E-4C9F-9DD6-E055376EF290,"SOURCE: A. Right ureteral margin (FS). B. Left ureteral margin (FS). C. Left pelvic lymph nodes. D. Bladder, resection, partial or total. E. Anterior peri-vesicular fat. F. Superior common iliac artery lymph nodes (ES). G. Additional left pelvic nodes. H. Left common iliac lymph nodes. I. Right pelvic lymph nodes. J. Final left ureteral margin. K. Final right ureteral margin. DIAGNOSIS: A. Right ureteral margin, excision: Sections of ureter with no. evidence of dysplasia or carcinoma. Left ureteral margin, excision: Sections of ureter with. evidence of dysplasia or carcinoma. C. Left pelvic lymph nodes, excision: Urothelial carcinoma,. metastatic to one regional lymph node, with extracapsular extension. (1/1). D. Bladder, prostate and seminal vesicles, radical. cystoprostatectomy: Bladder: -Invasive urothelial carcinoma, high grade (WHO grade. 3/3), 0.4 cm in diameter. -Ureteral and urethral margins negative for tumor. -Polypoid cystitis. -Non specific granulomatous inflammation. See comment. Prostate: -Urothelial carcnoma, metastatic. -Benign nodular hyperplasia. -Chronic inflammation. Seminal vesicles: No evidence of carcinoma. E. Anterior perivesicular fat, excision: Mature fibroadipose. tissue. F. Superior common iliac artery lymph nodes, excision: Orothelial. carcinoma metastatic to two of two regional lymph nodes (2/2). G. Left pelvic lymph nodes, excision: Thirteen regional lymph nodes. with no evidence of metastatic carcinoma (0/13). H. Left common iliac lymph nodes, excision : Urothelial carcinoma. metastatic to three of five regional lymph nodes (3/5) . I. Right pelvic lymph nodes, excision: Urothelial carcinoma. metastatic to three of nine regional lymph nodes (3/9) . Final left ureteral margin, excision: Ureter with no evidence of. dysplasia or carcinoma. K. Final right ureteral margin, excision: Urothelial dysplasia,. high grade, no carcinoma identified. CLINICAL DATA: The patient is a +year-old man with invasive high grade bladder cancer. diagnosed on biopsy. He undergoes radical prostatectomy and cystectomy, with. biopsies for frozen section. GROSS DESCRIPTION: The specimen is received in eleven parts, each labeled with the patient's name. and medical record number. Part A is received fresh and is additionally labeled ""#2 right ureteral. margin."" It consists of one soft, pink-tan, irregular, unoriented tissue. fragment, measuring 0.6 x 0. x 0.4 cm, that is inked at one end. The specimen. is entirely submitted for frozen section diagnosis as FS1, with the frozen. section remnant submitted in cassette A1. Part B is received fresh and is additionally labeled ""#3 left ureteral margin.'. It consists of one soft, pink-tan, irregular, unoriented tissue fragment,. measuring 1.3 x 0.8 x 0.5 cm, that is inked at one end. The specimen is. entirely submitted for frozen section diagnosis as FS2, with the frozen section. remnant submitted in cassette B1. Part C is received in formalin and is additionally labeled ""#1. Left pelvic. lymph nodes.' It consists of a single piece of yellow-red, fibrofatty soft. tissue, measuring 3 x 1 x 0.5 cm. The specimen is bisected and entirely. submitted in cassettes C1 and C2. Part D, additionally labeled ""#4 bladder, consists of a radical. cystoprostatectomy, including bladder, ureters, prostate and seminal vesicles. The bladder measures 18 x 12 x 4.5 cm, the wall averages 2.5 cm in thickness. The bladder mucosa is pale tan and shows two ulcerations, one in the trigone. and one in the dome measuring, respectively, 1.5 and 1 cm in diameter, the. bladder wall underlying these areas is indurated and dusky. The surrounding. uninvolved mucosa is mostly polypoid. Grossly no tumors are identified in the. mucosa and bladder wall. The ureters are patent. The prostate measures 4.5 x 4. x 2.5 cm, the cut surface reveals nodularity of both lobes, no tumor is. identified grossly. The right ureter measures 8.5 cm in length and 0.5 cm in. diameter. The left ureter measures 10 cmin length and 0.3 cm in diameter. The. urethra measures 4.5 cm in length. The right seminal vesicle measures 1 cm x. 0.5 cm in average diameter. The left seminal vesicle measures 2 cm x 0.5 cm in. average diameter. The posterior surface of the specimen is inked black,. anterior-right is inked green, and anterior-left is inked blue. Representative. sections are submitted as follows: Cassette D1: Left ureteral margin,. inked yellow. Cassette D2: Right ureteral margin, inked yellow. Cassettes D3-D4: Urethral margin from base of prostate. Cassette D5-9: Trigone. Cassette D10: Left prostate. Cassette D11: Left. prostate plus seminal vesicle. Cassette D12: Right prostate. Cassette D13: Right prostate plus seminal vesicle. Cassettes D14-D17: Potential lymph nodes. Cassettes D18-21: Trigone ulceration. Cassette. D22-24. Dome ulceration. Cassettes D26-28: Nodular area of right. prostate. Note: urethra is included in D27-28, which contain a bisected. piece. Part E is additionally labeled ""#5 anterior peri-vesical fat."" It consists. of. two pieces of yellow-red fibrofatty tissue, measuring 1 x 0.5 x 0.2 cm in. aggregate. The specimen is entirely submitted in cassette E1. Part F is received fresh and is additionally labeled ""#8 superior common iliac. artery lymph nodes.' It consists of two soft, pink-tan, irregular, unoriented. tissue fragments, measuring 4.0 x 2.0 x 0.6 cm in aggregate. A representative. section is submitted for frozen section diagnosis as FS3. with the frozen. section remnant submitted in cassette F1. The remainder of the specimen is. serially sectioned and submitted in cassette F2. Part G, additionally labeled ""6 - additional left pelvic lymph nodes, "" consists. of multiple red-yellow fragments of soft, fatty tissue, measuring - 4.0 x 2.5. x 0.5 cm in aggregate. The largest portion measures - 7.0 x 3.0 x 0.5 cm. This latter specimen is cut into thirds. The small fragments are submitted as. cassettes G1-G3, and the largest fragment cut into thirds is submitted as. cassettes G4-G6. Part H is additionally labeled ""7 - left common iliac lymph nodes. "". It. consists of three portions of red-yellow, fibrofatty tissue, measuring 1.5 x. 0.5 x 0.5 cm in aggregate. The specimen is submitted in toto in cassette H1. Part I, additionally labeled ""9 - right pelvic lymph nodes, "" consists of. multiple fragments of red-yellow, fibrofatty tissue, measuring 6.0 x 4.0 x 0.9. cm in aggregate. The specimen is submitted in toto in cassettes I1-I5. Part J, additionally labeled ""10 - final left ureteral margin, "" consists of a. single portion of red-yellow, tubular tissue, measuring 4.0 x 0.8 cm in. diameter, with a staple. The staple is removed, and a cross section from the. stapled end is submitted as cassette J1. A cross sections from the unstapled. side is submitted in cassette J2. Part K, additionally labeled ""11 - final right ureteral margin,"" consists of. two pieces of red-yellow, fibrofatty tissue, measuring 2.0 x 2.0 x 0.5 cm in. aggregate, with an attached staple. The staple is removed, and the adjacent. cross section is submitted in cassette K1. A representative cross section of. the unstapled portion as well as a sample of white-yellow soft tissue are. submitted in cassette K2. COMMENTS: Bladder Tumor Synoptic Comment 1. Tumor type: Urothelial carcinoma, papillary. with squamoid features. 2. Tumor grade: Grade 3/3 (2003 WHO. classification) 3. Tumor size: 0.4 cm (D8). 4. Extent of tumor in. bladder: 0.4 cm focus of invasive tumor in outer half of the muscularis. propria (D8) 5. Lymphatic/vascular invasion: Not present. 6. Epithelial. abnormalities in bladder: Polypoid cystitis and nonspecific granulomatous. inflammation (post transurethral resection of bladder tumor) see note below. 7. Extension of tumor into organs adjacent to bladder: Prostate. 8. Surgical margins: Urethral margin: Negative. Right ureter margin: High grade. urothelial dysplasia. Left ureter margin: Negative. Perivesical margin: Negative. 9. Lymph nodes: Nine of 30 lymph nodes contain metastatic tumor. (9/30); the largest metastatic deposit measures 2.0 cm in greatest dimension. (C2) i there is focal extranodal tumor growth (C1). 11. AJCC/UICC stage: pT2bN2MX. The bladder mucosa, submucosa and muscularis propria of the dome and trigone. show an intense nonspecific granulomatous inflammatory reaction with foreign. body giant cells and focal necrotizing palisading granulomas (C8) These. findings are consistent with the patient's recent history of transurethral. resection of his bladder tumor, at these sites. The bladder mucosa is. otherwise benign with polypoid type chronic inflammation and focal hyperplasia,. with no residual carcinoma or dysplasia. There is a microscopic focus of high. grade urothelial carcinoma located in the outer half of the muscularis propria. of the trigone. A 0.3 cm focus of high grade urothelial carcinoma is present. in the periurethral prostate.",train,0.4 cm;0.4 cm;0.4 cm
3407,TCGA-C5-A1BJ.9F012D5B-DF59-43C3-96FC-4E6EE55BDAD6,"PATHOLOGX. MR No. : Hosp. No. : Service: GYNECOLOGY. 7. BLADDER, SITE NOT SPECIFIED, BIOPSY. - SQUAMOUS METAPLASIA (SEE COMMENT). - CYSTITIS CYSTICA. UTERUS, CERVIX, BIOPSY. - INVASIVE SQUAMOUS CELL CARCINOMA. By this signature, I attest that the. above diagnosis is based upon my. personal examination of the slides. (and/or other material indicated in. the diagnosis), and that I have. revrewed and approved this report. M.D. M.D. SPECIMEN(S) SUBMITTED. Part 1: BLADDER. Part 2: CERVIX. HISTORY. The patient is- a year old woman with cervical cancer and. irregular bleeding. Clinical diagnosis: Cervical cancer. Operative procedure: EUA, cysto. GROSS. The specimens are received in two containers of formalin, each. labelled with the. The first container is labelled. ""bladder biopsy. It contains seven. fragments of tan-gray, soft,. mucosal tissue measuring 1.2 x 1.0 x 0.2 ca. in aggregate. Inked and wrapped. The second container is labelled ""cervical biopsy. It contains. two fragments of pink-gray, soft, mucosal tissue measuring 1.5 x. 0.7 x 0.5 cm. in aggregate.",train,
3439,TCGA-L5-A8NW.AB0A2162-96C9-47E9-B7BC-0E9640A7115A,"OPER DATE: REQ DOC: PROCEDURE: A. year-old male presented with dysphagia. Distal esophageal adenocarcinoma. Transhiatal esophagectomy. PROCEDURE: 1. ""Thoracic esophagus A 5.0 cm segment of esophagus, 2.5 cm in diameter. At. the distal end of the specimen, there is a 3.0 cm portion of proximal stomach,. 5.5 cm in circumference. Esophagus has been opened to reveal a 3.4 x 3.2 cm. raised, exophytic lesion at the gastroesophageal junction, which occupies 3.2. of a total 5.4 cm circumference. This Lesion protrudes 0.4 cm from the. surrounding mucosa. There are two tan tongues of possible Barrett's mucosa,. 1.6 x 0.7 cm and 0.5 x 0.5 cm. These are at the proximal end of the previously. described Lesion. The remaining esophageal mucosa is wrinkled, gray without. grossly visible lesions. The associated gastric mucosa is rugated tan, without. Lesions. Radial margins inked black. The (esion is 3.0 cm from the proximal. margin of the specimen and 2.5 cm from the distal margin. Serial longitudinal. cuts reveal that the lesion appears to extend into the underlying muscularis. propria. It has firm gray-white cut surfaces. A search through the associated. fibroadipose reveals multiple possible lymph nodes. 1A.-c. Full longitudinal sections of lesion and adjacent possible Barrett's. mucosa. The deepest extension is inked in cassette 1A. 1D.&E. Grossly uninvolved esophageal and gastric mucosa, respectively. 1F.-1. Possible Lymph nodes. 1J. One bisected possible lymph node. 2. Cervical esophagus A 3.8 cm length of esophagus, 2.5 cm in diameter and. closed at one end with a staple line. The associated mucosa has no grossly. visible lesions. One representative cross-section submitted in cassette #2. 3. ""Mediastinal Lymph node"" A 3.5 x 3.0 x 1.2 cm fragment of lobular, yellow. fibroadipose, containing multiple possible lymph nodes. PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 4. PATIENT NBR: SEX: M. ADM DATE: BIRTHDATE: OPER DATE: REQ DOC: 3A.&B. One bisected lymph node each. 3c. Three possible lymph nodes. 4. ""Periesophageal lymph node A 2.6 x 2.5 x 1.1 cm fragment of lobular, tan. fibroadipose, containing multiple possible Lymph nodes. 4A. One bisected lymph node. 4B. Possible lymph nodes. 5. ""Gastrohepatic ligament A 5.0 x 3.0 x 1.8 cm fragment of lobular, yellow. fibroadipose, containing two possible lymph nodes. 5A. Possible lymph nodes. 58. Fibroadipose. PROCEDURE: ESOPHAGEAL, CARDIAC AND GASTROESOPHAGEAL JUNCTION CARCINOMA: Type of carcinoma: Adenocarcinoma. If adenocarcinoma, is it arising in: GE junction otherwise not specified. Depth of invasion: Muscularis propria. Number of positive Lymph nodes, the total number sampled is irrelevant: 6/18. Extranodal metastasis: Unknown. Pattern of invasion: Infiltrative. Esophageal and gastric resection margins involved: No. Deep resection margin involved: No. TNM classification: T2 N1 MX. PROCEDURE: 1.&2. Thoracic esophagus, resection: Invasive adenocarcinoma, extending into. muscularis propria. Margins negative. Three of ten lymph nodes surrounding. gastroesophageal junction positive for metastatic adenocarcinoma. See. template. 3. Mediastinal Lymph nodes, biopsy: One of five lymph nodes positive for. metastatic adenocarcinoma. PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE. 5. PATIENT NBR: SEX: M. BIRTHDATE: ADM DATE: OPER DATE: REQ DOC: 4. Paraesophageal lymph nodes, biopsy: Two of three lymph nodes positive for. metastatic adenocarcinoma. 5. Gastrohepatic Ligament, biopsy: Unremarkable fibroadipose tissue, No tymph. nodes. I. the signing staff pathologist, have personal ly. examined and interpreted the slides from this case. Code:",train,
3446,TCGA-ZF-A9RL.EC382266-E28D-4F67-B363-84425688F82F,"SPECIMEN. Bladder TURT. CLINICAL DETAILS. Previous G3 pTa bladder tumour. Now 2 lesions. 1 papillary at bladder neck and 1 at the dome of the bladder. MACROSCOPY. Four pieces of tissue, the largest 6 mm. MICROSCOPY. Please note only one specimen received. Grade: 3 poorly differentiated. Growth pattern: Papillary. Type: Transitional cell carcinoma. Muscularis propria: Present. Stromal invasion: The basal part of the tumour is fragmented, with individual cells appearing to. invade the superficial part of the lamina propria; this may be artefactual but. early stromal invasion cannot be excluded. Vascular channel invasion: Not identified. Background urothelium: Flat urothelium is present which is not dysplastic. SUMMARY. Bladder, transitional cell carcinoma G3, equivocal stage. Pathologists -. DR.",train,
3469,TCGA-AG-3878.1c22a9d6-937c-4d7b-9564-892999e0d4f6,"Diagnosis. This concerns sections of a moderately differentiated rectal carcinoma (colic. adenocarcinoma in rectal position) with infiltration of the muscularis (pT2), without clear. vascular infiltration (L0 V0), as well as free lymph nodes. Tumor classification: ICDO-DA M-8140/3. G2. pT2, L0, V0, pNO.",train,
3542,TCGA-CJ-4897.508e7910-02fc-4b42-8b89-b4df86faa878,"Surgery Date: DIAGNOSIS. (A) RIGHT KIDNEY AND ADRENAL: RENAL CELL CARCINOMA, CONVENTIONAL (90% CLEAR CELLS AND 10% EOSINOPHILIC CELLS),. FUHRMAN'S NUCLEAR GRADE 3. TUMOR EXTENDS INTO THE PERINEPHRIC ADIPOSE TISSUE. TUMOR INVADES THE ADRENAL GLAND. (SEE COMMENT). TUMOR INVADES THE RENAL VEIN. THE TUMOR MEASURES 13.5 CM IN MAXIMUM DIMENSION. Vascular, ureteral and soft tissue margins, free of tumor. COMMENT. The. tumor extends into the perinephric adipose tissue compressing the adrenal gland. In addition, the tumor focally invades the adrenal. gland by direct extension. GROSS DESCRIPTION. (A). RIGHT. KIDNEY. AND ADRENAL - A nephrectomy specimen (25.5 x 16.5 x 9.0 cm) including compressed adrenal gland (6.0 x 3.0 x 0.1. cm) and ureter (8.0 x 0.5 cm). A 13.5 x 9.0 x 0.5 cm solid and cystic, yellow-red, heterogeneous tumor is present. The tumor is mainly located within the upper lobe,. extending to the mid third and lower pole of the kidney. The tumor has myxoid, degenerative-looking areas, as well as hemorrhagic and. necrotic foci. The tumor involves the perinephric fat, bulging out from the kidney and extending up to the adrenal gland, which is. grossly compressed by the tumor. The tumor involves the renal sinus but does not extend to the pelvicalyceal system. A tumoral. thrombus. is. present intraluminally within the renal vein, 1.0 cm away from the vein margin. The soft tissue margins appear to be free of. tumor. Portions of the tumor are submitted for possible electron microscopic studies and for tissue bank. The uninvolved kidney parenchyma is unremarkable. INK CODE: Black - soft tissue margin. SECTION CODE: A1, renal vein, renal artery and ureter margins; A2-A7, tumor in relation to adrenal gland; A8-A12, tumor in relation. to. perinephric fat (A11 and A12 include tumor within the perinephric fat); A13, tumor within the renal sinus; A14, tumor in relation to the. pelvicalyceal system; A15, A16, tumor within renal vein, in relation to pelvicalyceal system; A17, tumor with renal vein; A18, tumor within. vein with adjacent renal parenchyma; A19, tumor with renal parenchyma; A20, nontumoral kidney parenchyma. CLINICAL HISTORY. Right renal mass. SNOMED CODES. T-71000, T-B3000, M-83123. 1.",train,13.5 CM;13.5 x 9.0 x 0.5 cm
3568,TCGA-ET-A39S.2E9B4821-BC11-4BE9-9420-01B5C16B3270,"SPECIMEN TAKEN: FINAL DIAGNOSIS. THYROID (TOTAL THYROIDECTOMY): SPECIMEN TYPE: Total thyroidectomy. TUMOR SITE: Left lobe. HISTOLOGIC TYPE: Papillary carcinoma. TUMOR SIZE: 1.0 CM greatest dimension. FOCALITY: Unifocal. LYMPH NODES: All TWO (2) lymph nodes are negative for tumor. EXTENT OF INVASION. PRIMARY TUMOR: pT1: Tumor size <2 cm, limited to thyroid. REGIONAL LYMPH NODES: pNO: No regional lymph node metastases. DISTANT METASTASIS: pMx: Cannot be assessed. MARGINS: Margins are uninvolved. Distance of invasive carcinoma from nearest margin: <1 mm (anterior and posterior). VENOUS/LYMPHATIC INVASION: Absent. ADDITIONAL PATHOLOGIC FINDINGS: None identified.",train,1.0 CM
3633,TCGA-BR-7901.d3b5ad77-4461-4bd9-8791-09d03e212a51,"Gross Description. Microscopic Description. Stomach and lower part of the. Adenocarcinoma (cardia-esophageal. esophagus. In the cardia part of. junction); G2; adjacent fatty tissue. the stomach -- plate-like tumor. invasion; tumor spreads into the wall. of 8 X 6 cm in size. Tumor. adjacent lymph node. Fifteen lymph. spreads to the esophagus,. nodes are examined, two lymph. invade into the fat tissue. Cardia- nodes demonstrate metastases. esophagial lymph nodes are rosy. Omentum and surgical margins are. colored, dense. Omentum is. tumor free. hyperemic. Separately taken. lymph node is black colored,. soft. Diagnosis Details. Comments. Tumor Features: Ulcerated,. Tumor Extent: Perigastric fat ,. Venous Invasion: Absent,. Margins: Absent, Treatment. Effect: Laterality. Procure. ment. STOMACH TISSUE CHECKLIST. Specimen type: Total gastrectomy. Tumor site: Gastroesophageal junction. Tumor size: 6x0x8cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Moderately differentiated. Tumor extent: Subserosa. Lymph nodes: 2/15 positive for metastasis. (Greater and lesser omentum 2/15). Lymphatic invasion: Not specified. Venous invasion: Absent. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: None.",train,8 X 6 cm;6x0x8cm
3643,TCGA-B5-A0K3.2D78431C-7385-4BD3-B597-85E613D89BF6,"CLINICAL HISTORY: Malignant neoplasm of corpus uteri. Laparoscopic total hysterectomy, BSO, and. lymph node sampling. GROSS EXAMINATION: A. ""Uterus, cervix, bilateral tubes and ovaries (AF1-3)"" received is a 280. gram, 10.6 x 6.8 x 5.5 cm partially morcellated uterus. The specimen is. unoriented and contains one portion of the cervix (posterior cervix) which is. detached from the specimen. The endocervical canal (2.5 x 1 cm) is white-tan. and has an herringbone pattern. The endometrial canal (not able to be. measured) has a friable, soft endometrium which begins roughly 2.5 cm from. the. lower uterine segment. Sectioning reveals a 0.6 cm endometrium overlying a 2. cm myometrium. The friable endometrium does not appear to invade the. myometrium. There are multiple (greater than 20) white, whorled lesions in. the myometrium, the largest of which measures 2 x 2 x 1.9 cm. Sectioning. of. these white, whorled lesions does not reveal any hemorrhage or necrosis. The. right tube (partially morcellated) and measures 3 cm in length x 0.6 cm in. diameter and has an unattached fimbriae. Sectioning reveals an unremarkable. tube. The right ovary (2.5 x 1.2 x 1 cm) is white, cerebriform, and is. grossly unremarkable. The left tube is also interrupted but measures 2.5 cm. in length x 0.6 cm in diameter. Sectioning reveals an unremarkable tube and. fimbriae. The left ovary (2. 6 x 1.3 x 0. cm) is white, cerebriform, and upon. sectioning contains several corpora albicantia. The serosal surface is, in. areas where it is not morcellated, smooth, tan, and grossly unremarkable. BLOCK SUMMARY: A1-2- (AF1-2) full-thickness posterior endomyometrium. A3-. endomyometrium (AF3). A4-. anterior cervix. A5-. posterior cervix. A6-. anterior lower uterine segment. A7-. posterior lower uterine segment. A8-. posterior endomyometrium. A9-A10- anterior endomyometrium with deepest invasion and leiomyoma. A11- representative section of endometrium. A12- right tube and fimbriae. [D:2078431C-7385-4BD3-B597-85E613D898F6. A13- right ovary. A14- left tube and fimbriae. A15- left ovary. A16-A17- posterior endomyometrium bisected. A18-A19- anterior endomyometrium, bisected. A20- leiomyoma with overlying endometrium. B. ""Posterior vaginal cuff"", received is a 3.5 x 2 x 1.5 cm aggregate of. fibrofatty tissue which is unoriented. The entire specimen is. C. ""Left pelvic nodes"", received is a 5 x 2.5 x 1 cm aggregate of fibroadipose. tissue, which is dissected for lymph nodes and submitted as follows: BLOCK SUMMARY: C1-. three lymph node candidates. C2-. two lymph node candidates, one blue and bisected. C3-. one lymph node candidate, bisected. C4-. two lymph node candidates, bisected, one inked blue. C5-6-. one lymph node candidate, bisected. C7-. remaining fibroadipose tissue. D. ""Right external iliac lymph node"", received is a 3.2 x 2.2 x 1.8 cm. aggregate of fibroadipose tissue which is dissected for lymph nodes and. submitted as follows: BLOCK SUMMARY: D1- two lymph node candidates. D2- two lymph node candidates, one bisected, inked blue. D3- remaining fibroadipose tissue. E. ""Right obturator nodes"", received is a 5.8 x 4.2 x 1.4 cm aggregate of. fibroadipose tissue which is dissected for lymph nodes and submitted as. follows: BLOCK SUMMARY: E1- three lymph node candidates. E2-. two lymph node candidates. E3- one lymph node candidate, bisected. E4- one lymph node candidate, bisected. E5-6- remaining fibroadipose tissue. F. ""Right aortic lymph node (low)"", received is a 3.8 x 2 x 0.6 cm aggregate. of fibroadipose tissue which is dissected for lymph nodes and submitted as. follows: BLOCK SUMMARY: F1- three lymph node candidates. F2- three lymph node candidates. F3- remaining fibroadipose tissue. G. ""Right aortic lymph node (high)"". received is a 1.5 x 1 x 0.5 cm aggregate. of fibroadipose tissue which is submitted in its entirety in block G1. H. ""Left aortic lymph node"", received fresh and placed in formalin. at. 3:00 pm is a 3 x 1.5 x 0.8 cm aggregate of fibrofatty tissue which is. dissected for lymph nodes and submitted as follows: BLOCK SUMMARY: H1- three lymph node candidates. H2- remaining fibroadipose tissue. INTRA OPERATIVE CONSULTATION: A.- ""Uterus, cervix, bilateral tubes and ovaries"": AF1-2- (full-thickness. posterior endomyometrium) -. polyp with atypical. hyperplasia, no invasive. carcinoma is seen on two. sections (Dr. AF3- endometrioid. adenocarcinoma FIGO 2 of 3,. no invasion seen (Dr. MICROSCOPIC EXAMINATION: Microscopic examination is performed. IMMUNOHISTOCHEMICAL FINDINGS: The immunoperoxidase tests reported herein were developed and their. performance characteristics were determined by the. Some of them may not be cleared or approved by. the U.S. Food and Drug Administration. The FDA has determined that such. clearance or approval is not necessary. These tests are used for clinical. purposes. They should not be regarded as investigational or for research. This. laboratory is certified under the Clinical Laboratory Improvements Amendments. of 1988 (CLIA) as qualified to perform high complexity clinical testing. PATHOLOGIC STAGE: PROCEDURE: HYSTERO-SALPINGO-OOPHORECTOMY DISSECTION. PATHOLOGIC STAGE (AJCC 6th Edition) : pT1b pNO pMX. NOTE: Information on pathology stage and the operative procedure is. transmitted to this Institution's Cancer Registry as required for. accreditation by the Commission on Cancer. Pathology stage is based solely. upon the current tissue specimen being evaluated, and does not incorporate. information on any specimens submitted separately to our Cytology section,. past pathology information, imaging studies, or clinical or operative. findings. Pathology stage is only a component to be considered in determining. the clinical stage, and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon's operative report. DIAGNOSIS: A. ""UTERUS, CERVIX, BILATERAL TUBES AND OVARIES (AF1-AF3) "": UTERUS: 280 GRAMS. ENDOMETRIUM: TUMOR SITE: DIFFUSE. HISTOLOGIC TYPE: ENDOMETRIOID ADENOCARCINOMA, WITH FOCAL PAPILLARY. SEROUS DIFTERENTIATION, SEE COMMENT. FIGO GRADE: 3. TUMOR SIZE: 2.1 CM (SINGLE SLIDE MAXIMUM MEASUREMENT). MAXIMUM DEPTH OF MYOMETRIAL INVASION: 0.2 CM, IN A 2.0 CM THICK WALL. LYMPHATIC/VASCULAR INVASION: POSSIBLY PRESENT, SEE COMMENT. ADJACENT NON-NEOPLASTIC ENDOMETRIUM: ENDOMETRIAL POLYP WITH GENERALLY. INACTIVE ENDOMETRIUM. REMAINING MYOMETRIUM: LEIOMYOMATA. CERVIX: NEGATIVE FOR TUMOR. SEROSA: NEGATIVE FOR TUMOR. SPECIMEN MARGINS: NOT INVOLVED. RIGHT AND LEFT FALLOPIAN TUBES: NEGATIVE FOR CARCINOMA. RIGHT OVARY: BENIGN BRENNER TUMOR (1 CM), NEGATIVE FOR CARCINOMA. LEFT OVARY: NEGATIVE FOR CARCINOMA. B. ""POSTERIOR VAGINAL CUFF"": NEGATIVE FOR CARCINOMA. C. ""LEFT PELVIC NODES"" (DISSECTION) : ELEVEN LYMPH NODES, NEGATIVE FOR CARCINOMA (0/11) . D. ""RIGHT EXTERNAL ILIAC LYMPH NODES"" (DISSECTION) : SIX LYMPH NODES, NEGATIVE FOR CARCINOMA (0/6) . E. ""RIGHT OBTURATOR NODES"" (DISSECTION) : TEN LYMPH NODES, NEGATIVE FOR CARCINOMA (0/10) . F. ""RIGHT AORTIC LYMPH NODE (LOW) (DISSECTION) : SEVEN LYMPH NODES, NEGATIVE FOR CARCINOMA (0/7) . G. ""RIGHT AORTIC NODE (HIGH) "": BENIGN NERVE AND GANGLION. NEGATIVE FOR CARCINOMA OR LYMPH NODES. H. ""LEFT AORTIC LYMPH NODE"" (DISSECTION) : FOUR LYMPH NODES, NEGATIVE FOR CARCINOMA (0/4), SEE COMMENT. COMMENT: The adenocarcinoma in part A has areas of definitive endometrioid. differentiation, but in many areas is very poorly differentiated, not. exhibiting a definite endometrioid pattern. Some areas are consistent with. papillary serous carcinoma. Immunoperoxidase stain for p53 on block All'is. diffusely and strongly positive, consistent with serous tumor. Only. superficial myometrial invasion. is seen. The tumor does involve the lower. uterine segment, but not the cervix. All of the grossly visible tumor has been. submitted (tumor size was grossly difficult to determine) There are foci. of. tumor cells within vascular lumens, but not directly attached to the vessel. wall, which is suggestive of, but not definite for, vascular invasion. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es).",train,2.1 CM;1 CM
3664,TCGA-A2-A4RY.2D6815B5-7704-4D67-93D1-78EDD924F131,"Specimen. ) Status: Sp type: SURGICAL P. M.D. PREOPERATIVE DIAGNOSIS. BREAST CANCER, BENIGN MAMMARY DYSPLASIA. OPERATION PERFORMED. DOCTOR (S) : PROCEDURE: MASTECTOMY MODIFIED RADICAL/TOTAL MASTECTOMY. TISSUE REMOVED. A. RIGHT AXILLARY LYMPH NODE LEVEL 2. B. RIGHT AXILLARY LYMPH NODE LEVEL 3. C. LEFT MASTECTOMY STITCH AT. D. RIGHT MODIFIED RADICAL MASTECTOMY STITCH AT. GROSS DESCRIPTION. RECEIVED IN 4 PARTS. PART A RECEIVED LABELED. RIGHT AXILLARY LEVEL 2 LYMPH. NODES IS A NODULAR PORTION OF YELLOW FATTY TISSUE MEASURING 3.7 X 2.2 X. 0.7 CM IN GREATEST DIMENSION. FOUR FIRM OVOID STRUCTURES ARE IDENTIFIED. MEASURING FROM 0.4 TO 1 CM IN GREATEST DIMENSION. THE LARGER NODES ARE. EACH SECTIONED AND GROSSLY POSITIVE. ONE-HALF OF EACH OF THESE IS. SUBMITTED ALONG WITH THE UNSECTIONED SMALLER NODE LABELED A. THE. REMAINING NODAL TISSUE IS SUBMITTED PER CLINICAL BREAST CARE PROJECT. RESEARCH PROTOCOL LABELED P1-P3. PART B RECEIVED LABELED. RIGHT AXILLARY LEVEL 3 LYMPH. NODE IS A FIRM 0.8 CM IN GREATEST DIMENSION NODULE AND AN IRREGULAR. PORTION OF NODULAR YELLOW FATTY TISSUE MEASURING 6 X 1.5 X 0.7 CM. FIVE. FIRM OVOID STRUCTURES ARE IDENTIFIED IN THIS PORTION OF FATTY TISSUE. THREE OF THE NODULES ARE SUBMITTED UNSECTIONED LABELED B1. ONE-HALF. FROM 2 SEPARATE GROSSLY POSITIVE NODES ARE SUBMITTED IN B2 WITH THE. REMAINING TISSUE FROM THESE 2 NODES SUBMITTED AS P4. THE LARGEST NODE. MEASURING 1.4 CM IN GREATEST DIMENSION IS GROSSLY FOCALLY POSITIVE. THIS. IS SUBMITTED BISECTED AS B3. PART C RECEIVED LABELED. LEFT MASTECTOMY STITCH AT 12. O'CLOCK IS A 1310 GRAM SIMPLE MASTECTOMY MEASURING 23 CM FROM MEDIAL TO. LATERAL, 23.5 CM FROM SUPERIOR TO INFERIOR, AND UP TO 5.5 CM FROM. Specimen. Sp type: GICAL P. M.D. GROSS DESCRIPTION. ANTERIOR TO DEEP. THE NIPPLE IS UNREMARKABLE WITHIN A 14 x 5 CM SKIN. ELLIPSE. A SUTURE DENOTES 12 O'CLOCK. THE ANTERIOR ASPECT IS MARKED. WITH BLUE INK, THE DEEP MARGIN WITH BLACK. SECTIONING REVEALS THE. CENTRAL 50% OF THE SPECIMEN TO CONSIST OF DENSE TAN FIBROUS TISSUE. THIS. IS SURROUNDED BY A PERIMETER OF YELLOW FATTY TISSUE. NO MASSES ARE. IDENTIFIED. REPRESENTATIVE SECTIONS ARE SUBMITTED AS. FOLLOWS: C1--NIPPLE, C2--CENTRAL DEEP MARGIN, C3 AND 4--UPPER OUTER QUADRANT, C5. AND 6--UPPER INNER QUADRANT, C7 AND 8--LOWER INNER QUADRANT, C9 AND. 10--LOWER OUTER QUADRANT. ADDITIONALLY WITHIN THE CONTAINER AND. INCLUDED THE WEIGHT ARE ADDITIONAL MULTIPLE IRREGULAR FRAGMENTS OF. YELLOW-RED FATTY TISSUE IN AGGREGATE MEASURING 10 X 10 x 2.3 CM. SECTIONING REVEALS BLAND YELLOW FATTY TISSUE AND REPRESENTATIVE SECTIONS. ARE SUBMITTED LABELED C11 THROUGH 13. NOTE: MIRROR IMAGE SECTIONS OF THE NIPPLE ARE SUBMITTED AS P15 AND. MIRROR IMAGE SECTIONS TO C3, C5, C7, AND C9 ARE SUBMITTED FROZEN IN OCT. PER CLINICAL BREAST CARE PROJECT RESEARCH PROTOCOL. PART D RECEIVED LABELED. RIGHT MODIFIED RADICAL. MASTECTOMY STITCH AT 12 O'CLOCK IS A 1460 GRAM RIGHT MODIFIED RADICAL. MASTECTOMY. THE MASTECTOMY PORTION MEASURES 24.5 CM FROM MEDIAL TO. LATERAL, 26 CM FROM SUPERIOR TO INFERIOR, AND UP TO 6.5 CM FROM ANTERIOR. TO POSTERIOR. THE AXILLARY PORTION MEASURES 10 x 9 x 2.5 CM. THE. ANTERIOR MARGIN IS MARKED BLUE. THE DEEP IS MARKED BLACK. THE NIPPLE. IS UNREMARKABLE AND SITS IN THE MORE SUPERIOR PORTION OF THE SKIN. ELLIPSE. THE SKIN ELLIPSE MEASURES 14 x 5.5 CM. THE 12 O'CLOCK SUTURE. IS JUST TO THE MEDIAL SIDE OF THE AREOLA. THE AXILLARY TAIL IS REMOVED. AND RED INK IS PLACED IN THIS AREA TO INDICATE THAT IT IS NOT TRUE. MARGIN. UPON A QUICK PALPATION OF THE AXILLARY TAIL THREE ARE 3. PROMINENT STRUCTURES. THE 1ST IS A 0.8 CM IN GREATEST DIMENSION LYMPH. NODE WHICH IS GROSSLY NEGATIVE AND IS SUBMITTED BISECTED AS D1. THE 2ND. IS A 2.5 CM GROSSLY NEGATIVE NODAL STRUCTURE SUBMITTED BISECTED AS D2. THE 3RD STRUCTURE IS A 3.8 CM IN GREATEST DIMENSION GROSSLY POSITIVE. LYMPH NODE OF WHICH ONE FULL CROSS SECTION IS SUBMITTED IN D3 AND 4. A. COIL CLIP IS IDENTIFIED AND THE AREA OF THE CLIP IS SUBMITTED IN D5. THIS IS THE SAME NODE AS D3 AND 4. PORTIONS OF THIS LARGEST NODE ARE. ALSO SUBMITTED IN P5 AND 6. SECTIONING REVEALS THE CENTRAL PORTION OF. THE BREAST TO CONSIST OF DENSE TAN FIBROUS TISSUE AND THIS EXTENDS TO AN. ILL-DEFINED GRAY-TAN MASS AT 9 O'CLOCK WHICH MEASURES 5.5 CM FROM MEDIAL. TO LATERAL, 8 CM FROM SUPERIOR TO INFERIOR BY PALPATION, AND 4.5 CM FROM. ANTERIOR TO POSTERIOR. GROSSLY IT IS 1 CM FROM BOTH THE ANTERIOR AND. DEEP MARGIN. SECTIONS ARE SUBMITTED AS FOLLOWS: D6--NIPPLE, D7 THROUGH. D9--SECTIONS OF DEEP MARGIN BENEATH LESION, D10 THROUGH D14--A CONTINUOUS. SECTION OF THE LESION FROM SUPERIOR TO INFERIOR WHERE THE RED ENDS ARE. Specimen. eq#: SP type: SURGICAL P. .D. GROSS DESCRIPTION. THE AREA WHERE THE ONE STRIP WAS SEPARATED FROM THE ADJACENT SECTION,. 015--SECTION OF THE FAR LATERAL PORTION OF THE GROSS LESION, D16--SECTION. FROM THE FAR MEDIAL PORTION OF THE GROSS LESION, D17--TISSUE DEEP TO THE. 5 CROSS SECTIONS, 018--TISSUE ANTERIOR TO TE 5 CROSS SECTIONS,. D19--RANDOM SECTION OF LESION FROM THE MIDPORTION, D20--RANDOM TUMOR. INFERIOR-EDG D21--UPPER INNER QUADRANT 2. CM.EROM GROSS TUMOR,. D22--UPPER OUTER QUADRANT 3 CM FROM GROSS TUMOR, D23--LOWER OUTER. QUADRANT 3 CM FROM GROSS TUMOR, D24--LOWER INNER QUADRANT 5 CM FROM GROSS. TUMOR. FURTHER EXAMINATION OF THE AXILLARY TAIL: EIGHTEEN (18) ADDITIONAL. NODAL STRUCTURES ARE IDENTIFIED. THESE ARE SUBMITTED AS FOLLOWS: D25-6. NODES NOT SECTIONED, D26--ONE-HALF OF 2 GROSSLY POSITIVE LYMPH NODES. PLUS 1 GROSSLY FAT REPLACED LYMPH NODE, BISECTED, D27--4 NODES, EACH. BISECTED, D28--2 NODES, EACH BISECTED, D29--3 NODES, EACH BISECTED. SECTIONS PER CLINICAL BREAST CARE RESEARCH PROTOCOL ARE SUBMITTED FROM. THE LYMPH NODE WITH THE CLIP LABELED P5 AND P6; TWO OF THE GROSSLY. POSITIVE LYMPH NODES IN CASSETTE D26 AS P16; AND SECTIONS OF THE TUMOR. AS P7 THROUGH P14 WITH MIRROR IMAGE SECTIONS FROZEN IN OCT OF P7, P8,. p9, AND 013 AS WELL AS TISSUE FROZEN IN OCT AS MIRROR IMAGE TO THE. NIPPLE (D6) AND OF THE RANDOM QUADRANT SECTIONS (D21 THROUGH D24). COMMENT: THIS SPECIMEN EXCEEDS THE MAXIMUM CAP/ASCO. GUIDELINE OF 48 HOURS FORMALIN FIXATION. PATH PROCEDURES. PROCEDURES: 88305/2, 88307, 88309, A BLK, B BLK/3, C BLK/13, D BLK/29. FINAL DIAGNOSIS. PART A RIGHT AXILLARY LEVEL 2 LYMPH NODE SAMPLING: METASTATIC. CARCINOMA CONSISTENT WITH LOBULAR CARCINOMA OF PRIMARY BREAST ORIGIN. INVOLVING 4 OF 4 LYMPH NODES WITH THE TUMOR REPLACING 80-90% OF THE. CELLS IN EACH NODE AND THE LARGEST FOCUS OF TUMOR SPANNING A DISTANCE OF. APPROXIMATELY 9 MM. PART B RIGHT AXILLARY LEVEL 3 LYMPH NODE SAMPLING: METASTATIC 6/16 LN (level 3). Specimen: eceived: ) Status: aq#. Sp type: SURGICAL P. M.D. FINAL D1AGNOSIS. CARCINOMA IDENTIFIED IN 6 OF 6 LYMPH NODES. PART C LEFT MASTECTOMY: SKIN AND FATTY BREAST TISSUE WITH FOCAL. FIBROCYSTIC CHANGES PRESENT. NO EVIDENCE OF MALIGNANCY OR ATYPIA. PART-D RIGHT MODIFIED RADICAL MASTECTOMY: MULTICENTRIC IN SITU AND. INFILTRATING LOBULAR CARCINOMA OF THE PLEOMORPHIC TYPE, NUCLEAR GRADE. 2-3 OF 3 WITH A LOW MITOTIC INDEX WITH DOCUMENTED MICROSCOPIC EVIDENCE. OF TUMOR SPANNING A DISTANCE OF AT LEAST 78 MM IN A SUPERIOR TO INFERIOR. DIRECTION. THE TUMOR WAS 8 MM FROM THE CLOSEST DEEP MARGIN. METASTATIC. CARCINOMA IDENTIFIED IN 8 OF 20 AXILLARY LYMPH NODES WITH THE LARGEST. FOCUS OF TUMOR SPANNING A DISTANCE OF 20 MM AND FOCAL MICROSCOPIC. PERINODAL SOFT TISSUE INVASION PRESENT. M.D.",train,78 MM
3803,TCGA-BH-A0BW.14CE78F3-8FB4-476D-A09C-AE87F7919D77,"FINAL DIAGNOSIS: PART 1: SENTINEL LYMPH NODE #1, LEFT AXILLA, DISSECTION -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1) (SEE COMMENT). PART 2: SENTINEL LYMPH NODE #2, LEFT AXILLA, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1) (SEE COMMENT). PART 3: SENTINEL LYMPH NODE #4, LEFT AXILLA, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1) (SEE COMMENT). PART 4: SENTINEL LYMPH NODE #5, LEFT AXILLA, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1) (SEE COMMENT). PART 5: SENTINEL LYMPH NODE #3, LEFT AXILLA, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1) (SEE COMMENT). PART 6: PALPABLE LYMPH NODE #1, LEFT AXILLA, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 7: NON-SENTINEL LYMPH NODE, LEFT AXILLA, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 8: PALPABLE LYMPH NODE #2, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 9: BREAST. LEFT, SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA, 2.0 CM (GROSS), NOTTINGHAM GRADE 3 (COMBINED NOTTINGHAM. SCORE: 9/9; TUBULE FORMATION 3/3, MITOTIC ACTIVITY 3/3, NUCLEAR PLEOMORPHISM 3/3). B. DUCTAL CARCINOMA IN SITU, NUCLEAR GRADE 3, SOLID WITH COMEDO NECROSIS AND ASSOCIATED. MICROCALCIFICATIONS, ADMIXED WITH INVASIVE TUMOR AND COMPRISES 10% OF TUMOR MASS. C. LYMPHOVASCULAR INVASION IS NOT IDENTIFIED. D. MARGINS FREE. E. ATYPICAL DUCTAL EPITHELIAL HYPERPLASIA. F. FIBROADENOMATOID NODULE. G. DUCTAL EPITHELIAL HYPERPLASIA. H. PATHOLOGIC STAGE (see comment). CASE JINUPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. SIZE OF TUMOR: Not specified. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: Maximum dimension invasive component: 2.0 cm. TUMOR TYPE (invasive component): NOTTINGHAM SCORE: Ductal adenocarcinoma, NOS. Nuclear grade: 3. Tubule formation: 3. Mitotic activity score: 3. Total Nottingham score: 9. ANGIOLYMPHATIC INVASION: Nottingham grade (1, 2, 3): 3. DERMAL LYMPHATIC INVASION: CALCIFICATION: Not applicable. TUMOR TYPE, IN SITU: Yes, malignant zones. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Solid, DCIS admixed with invasive carcinoma. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 8. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain, Keratin stain. NON-NEOPLASTIC BREAST TISSUE: ADH. T STAGE, PATHOLOGIC: N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: PROGESTERONE RECEPTORS: previously performed. HER2/NEU: previously performed. zero or 1+.",train,2.0 CM;2.0 cm
3835,TCGA-VD-A8KI.7F74C718-5BFD-466A-B03F-B61B587D92EC,"printed: Clinical Consultant & Location. Unit No. SPECIMEN. Right eye (enucleation). CLINICAL DETAILS. Right choroidal melanoma. See diagram. MACROSCOPIC DESCRIPTION. An intact right eye. Dimensions: Axial 24mm, Horizontal 24mm, Vertical 23mm. Cornea: Horizontal 12mm, Vertical 12mm. Optic nerve. Length 9mm, Diameter 4mm. Pupil: normal, regular. On description, on infero postero is a dark pigmented nodule. ??? 6mm x 4mm height (3mm from optic nerve). On trans-illumination, - there is a dark shadow in ? side of. the globe - 22 x 21mm and developed in the optic nerve. insertion. Plane of section: vertial. Intraocular description: On sectioning a dome shaped pigmented choroidal mass. measuring LBD 15mm, height 12mm. Tumour size. LBD 15mm, Height 12mm. MICROSCOPY. Histologically, the enucleated eye demonstrates a normal. anterior segment with an unremarkable cornea, a deep. anterior chamber and open angles. The iris leaves are. unremarkable. The ciliary muscles are moderately atrophic. orinted: HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. There is mild hyalinisation of the ciliary processes. The. lens shows moderately advanced cataractous changes. In the posterior segment, at the level of the equator, a. choroidal melanoma can be seen. This is dome-shaped with a. large accompanying exudative retinal detachment. The retina. overlying the tumour is atrophic with degenerative changes,. and focally there is retinal invasion. The tumour is partially pigmented and consists of a mixture. of cells, both epithelioid and spindle cells, with a slight. dominance of the latter. The epithelioid cell component is. approx. 40%. The melanoma cells are immunoreactive for. MelanA, SOX-10 and HSP-27 (score 2). The number of mitoses is approx. 5/40 high power fields. The. microvasculature of the melanoma is prominent, but closed. loops are not present in the tissue planes evaluated. Occasional ""vascular lakes"" can be observed; in these tumour. cells can be see located within the lumen. The lymphocytic. infiltrate within tumour is minimal. Macrophages are. scattered throughout the tumour in moderate density. There is a large extraocular growth, which has arisen at two. sites, transclerally. These are 3mm and 1mm in diameter,. respectively. The larger is encapsulated only by a very thin. layer of connective tissue. The optic nerve is tumour free, and demonstrates mild. atrophic changes. The examined vortex veins are free of. tumour. DIAGNOSIS. Choroidal melanoma of mixed cell type with extraocular. melanoma growth. COMMENT. Molecular genetic examination of DNA extracted from the. tumour cells will be performed using multiplex-ligation. dependent probe amplification (MLPA), looking at chromosomes.",train,15mm;15mm
3837,TCGA-AC-A6IW.302E69E0-39F0-4CDB-97F9-A6CDDB3D7233,"Provider Group : Date of Service: Date Received: A copy of this renant will be faxed to: FINAL SURGICAL PATHOLOGY REPORT. Diagnosis: A. - C.) LEFT BREAST, ADDITIONAL ANTERIOR MARGIN, AND LEFT AXILLARY SENTINEL. LYMPH NODE. SIMPLE MASTECTOMY (INCLUDING RE-EXCISION OF. ANTERIOR MARGIN) AND SENTINEL NODE BIOPSY: - Invasive ductal carcinoma, Nottingham grade 3. [D:302E69E0-39F0-4CDB-97F9-A6CDDB307233. - Size: 2.6 cm in greatest dimension. - Location: 11:00. - No in situ component identified. - Margins: - Invasive carcinoma is widely free of all margins (at least 1 cm away). - Additional anterior margin consists of benign skin and subcutaneous tissue. - No lymphovascular invasion identified. - Two sentinel lymph nodes, negative for carcinoma (0/2). - Uninvolved breast parenchyma with focal fibroadenomatoid changes. - Benign skin and nipple with small intraductal papilloma. COMMENT: Breast carcinoma biomarker studies will be repeated on a representative. section of tumor (block A7) due to the focal weak to strong reactivity for ER and PR in. <1% tumor cells seen previously on core biopsy. The results will follow in an. addendum. PATHOLOGIC TUMOR STAGING SYNOPSIS: Type and grade (invasive): Invasive ductal carcinoma, Nottingham grade 3. Type and grade (in situ): N/A. Primary tumor: pT2. Regional lymph nodes: pNo(i-)(sn). Distant metastasis: N/A. Stage: IIA. Lymphovascular invasion: Not identified. Margin status: R0, negative. Printed: This report continues. Page 1/6. FINAL SURGICAL PATHOLOGY REPORT. Invasive Breast Cancer Tumor Staging Information. AJCC Cancer Staging Handbook, 7th Ed., and CAP Protocol (revised June 2012). Previous pathology specimens. Printed: This report continues. Page 2/6. SPECIMEN IDENTIFICATION. Simple mastectomy with re-excision of anterior. Procedure/specimen type: margin. Left breast. Laterality: Sentinel lymph node biopsy. Lymph node sampling: INVASIVE CARCINOMA TUMOR CHARACTERISTICS. Invasive ductal carcinoma. Histologic type: 11:00. Tumor site: 2.6 cm in greatest dimension. Tumor size: Unifocal. Tumor focality: 3 of 3 (Nottingham score 9 of 9). Histologic grade (Nottingham Score): 3 of 3. Tubule formation: 3 of 3. Nuclear pleomorphism: 3 of 3. Mitotic rate: Not identified. Lymphovascular invasion: Benign skin and nipple. Macroscopic and microscopic extent of tumor: Not identified. DUCTAL CARCINOMA IN SITU (DCIS): MARGINS. Widely free of all margins (at least 1 cm away). Invasive carcinoma: LYMPH NODES. 2 (sentinel nodes). Total lymph nodes examined. 0. Number of lymph nodes involved. N/A. Size of largest metastatic deposit: N/A. Extranodal extension: PATHOLOGIC STAGING: pT2. Primary Tumor (pT): Regional lymph nodes (pN): pNo(i-)(sn). N/A. Distant metastasis (pM): IIA. AJCC Stage: ANCILLARY STUDIES: Negative (less than 1% positive cells, weak. Estrogen receptor: intensity). Negative (less than 1% positive cells, strong. Progesterone receptor: intensity). Negative (score 0). HER2: High (70% positive cells). Ki-67: This report continues. Printed: - Page 3. Page 3/6. FINAL SURGICAL PATHOLOGY REPORT. Source of Specimen: A. Breast;left. B. Sentinel lymph node;left axillary. C. Breast;left additional anterior margin. Clinical History/Operative Dx: Malignant neoplasm of breast (female, left). Intraoperative Diagnosis: B. Left axillary sentinel lymph node. : No tumor cells identifier. Gross Description: A. Part A is designated as left breast - stitch = lateral. Initially received in the fresh state for possible. is an 862 gram left simple mastectomy, 26.8 cm medial-lateral, 20.8 cm. inferior-superior, and 4.0 cm posterior-anterior. The overlying ellipse of wrinkled, tan-brown skin is 26.3 x. 13.0 cm with a medial-inferior orientated, darkened brown, wrinkled areola, 4.8 cm in diameter with a. prominent 1.3 cm nipple. A double suture marks the lateral apex of the skin. A palpable mass is. appreciated in the upper inner quadrant (approximating 11:00). The surgical margins are now. differentially inked as follows: Superior superficial: Blue,. Inferior superficial: Orange,. Posterior: Black. Included within the container are two unoriented strips of wrinkled, tan-brown skin measuring 11.7 X 2.7 x. 0.7 cm and 10.3 X 2.4 X 1.3 cm each. Printed: This report continues. Page 4/6. FINAL SURGICAL PATHOLOGY REPORT. The breast is serially sectioned perpendicularly through the medial-lateral long axis to reveal a. well-demarcated, soft to rubbery, light gray, lobulated tumor mass measuring upwards of 2.6 x 2.5 x 2.3. cm (slabs 6-7, from medial). This tumor is placed grossly 1.0 cm from the superior superficial, 2.4 cm from. the deep and greater than 5.0 cm from the inferior superficial, most medial and most lateral surgical. margins. Along the medial periphery of the lesion is an embedded twisted radiologic marker. The remaining cut sections of the breast demonstrates admixed yellow-tan fibrofatty tissue without. additional discrete nodularity. No lymph node tissue is appreciated along the lateral periphery. Sectioning. through the remaining two strips of skin demonstrate unremarkable fibrofatty cut surfaces. Representative. sections are submitted. Cassette summary: A1) nipple,. A2) medial and lateral extension of skin,. A3) upper inner quadrant, slab 3,. A4) upper inner quadrant, slab 5, adjacent to tumor,. A5) upper inner quadrant, tumor and superior superficial surgical margin, slab 6,. A6-A7) upper inner quadrant, tumor and superior superficial surgical margin, contiguous sections, slab 6,. A8) upper inner quadrant, deep margin adjacent to tumor, slabs 6-7,. A9) upper inner quadrant-central superior, adjacent to tumor, slab 8,. A10-A11) lower inner quadrant, slabs 4 and 6, respectively,. A12-A13) lower outer quadrant, slabs 9 and 11, respectively,. A14-A15) upper outer quadrant, slabs 9 and 11, respectively,. A16-A17) representation of separate strips of skin and subcutaneous fat, two pieces each. B. Part B is left axillary sentinel lymph node. (frozen section). Initially received in the fresh state for. frozen section/touch prep analysis is a 6.0 X 3.0 x 1.0 cm pad of yellow-tan fatty soft tissue. Initial. sectioning reveals a single fatty pink and tan lymph node candidate, 2.0 cm in greatest dimension. Two. touch preparation slides are forwarded for microscopic evaluation. Further examination of the fat reveais. possible additional lymph node tissue up to 1.0 cm in greatest dimension. The largest lymph node is. entirely submitted for routine histology with a sentinel node protocol performed in B1 and B2, and the. additional/residual lymph node tissue candidacy is submitted in B3 and B4 for routine histology. C. Part C is additional anterior margin - left. Initially received in the fresh state is a 15 gram elliptical. excision of wrinkled tan-brown skin and subcutaneous fat, 11.1 x 2.6 x 1.5 cm. The margins are submitted. unoriented; the possible outer margin is now marked blue and the remaining surgical margins are marked. black. Sectioning demonstrates glistening, admixed yellow-tan fibrofatty tissue without discrete nodularity. or grossly unusual areas of change suggestive of residual or invasive tumor component. Representative. section are submitted for microscopic evaluation in C1-C5 (six pieces. Microscopic Description: A. - C.) Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. The sentinel nodes (part B) were evaluated by H&E levels and. cytokeratin immunostain. Controls are appropriate. Printed: This report continues. Page 5/6. FINAL SURGICAL PATHOLOGY REPORT. Printed: END OF REPORT (FINAL). Page 6/6.",train,2.6 cm;2.6 cm;2.6 x 2.5 x 2.3. cm
3849,TCGA-08-0359.C95BD6B5-0C33-4567-AD43-352283E6377F,"FINAL PATHOLOGIC DIAGNOSIS. A. Brain, left occipital, biopsy: Glioblastoma multiforme, WHO grade IV. B. Brain, left occipital, biopsy: Glioblastoma multiforme, WHO grade IV. Intraoperative Diagnosis. FS1. (A) Brain, left occipital tumor, biopsy: WHO glioblastoma multiforme, grade IV. Tissue section and. cytologic preparation. Gross Description. The specimen is received fresh in two parts, each labeled with the patient's name and medical record. number. Part A is additionally labeled ""left occipital tumor."" It consists of a single irregular, unoriented fragment of. tan-red, gelatinous, soft tissue, measuring 0.8 x 0.5 x 0.3 cm. A small portion of the specimen is used for. cytological preparation as TP1. One-half of the specimen is submitted for frozen section diagnosis as FS1,. with the frozen section remnant submitted in cassette A1. The remaining half of the specimen is submitted. in cassette A2. Part B is additionally labeled ""tumor."" It consists of a portion of brain tissue and tumor, measuring 8.5 x. 7.0 x 3.2 cm. Extensive areas of necrosis are identified. Representative sections of the tumor and the. brain-tumor interface are submitted in cassettes B1 through B9, with cassette B10 containing uninvolved. brain. Clinical History. The patient is a. year-old woman with a left occipital tumor, suspicious for glioblastoma multiforme. Diagnosis based on gross and microscopic examinations. Final diagnosis made by attending pathologist. following review of all pathology slides.",train,8.5 x. 7.0 x 3.2 cm
3852,TCGA-CV-7415.dab06915-e50b-42f4-a6c8-de0dbdd4b6f7,"DIAGNOSIS. (A). LEFT PYRIFORM SINUS: INVASIVE MODERATELY DIFFERENTIATED SQUAMOUS CARCINOMA. PHARYNGEAL PLEXUS OF VAGUS NERVE: Segment.of-nerve,--no tumor present. (C). TOTAL LARYNGOPHARYNGECTOMY, BILATERAL NECK DISSECTIONS, EXCISION OF LEFT. NECK SKIN, LEFT THYROIDECTOMY: INVASIVE MODERATELY DIFFERENTIATED SQUAMOUS CARCINOMA OF THE. LEFT PYRIFORM SINUS EXTENDING INTO THE LEFT ARYEPIGLOTTIC FOLD,. ESOPHAGUS, LEFT PARAGLOTTIC SPACE, LEFT PARATRACHEAL/PARA-. ESOPHAGEAL SOFT TISSUE AND LEFT THYROID. VASCULAR/LYMPHATIC INVASION PRESENT. Surgical margins, free of tumor. METASTATIC SQUAMOUS CARCINOMA IN 11 OF 53 LEFT CERVICAL LYMPH. NODES (11/53), 1/2 SUBMANDIBULAR/SUBMAXILLARY, LEVEL 2;. 5/7 SUBDIGASTRIC, LEVEL 3; 3/8 MIDJUGULAR, LEVEL 4; 1/7. LOWER JUGULAR, LEVEL 5; 0/8 UPPER POSTERIOR CERVICAL, LEVEL. 6;. 0/7 MID POSTERIOR CERVICAL, LEVEL 7; 0/5 LOWER POSTERIOR. CERVICAL, LEVEL 8; 1/9 SUPRACLAVICULAR/SCALENE, LEVEL 9. LYMPH NODES. (SEE COMMENT). METASTATIC SQUAMOUS CARCINOMA IN 5 OF 29 RIGHT CERVICAL LYMPH. NODES (5/29) (0/5 SUBMANDIBULAR/SUBMAXILLARY, LEVEL 2; 2/4. SUBDIGASTRIC, LEVEL 3; 1/1 MIDJUGULAR, LEVEL 4; 0/4 LOWER. JUGULAR, LEVEL 5; 1/2 UPPER POSTERIOR CERVICAL, LEVEL 6; 1/5. MID POSTERIOR CERVICAL, LEVEL 7; 0/8 LOWER POSTERIOR CERVICAL,. LEVEL 8 LYMPH NODES. (SEE COMMENT). METASTATIC SQUAMOUS CARCINOMA IN 1 OF 2 PERITHYROIDAL LYMPH. NODES, LEVEL 10 (1/2). Right and left submandibular glands, no tumor present. Segment of left jugular vein, no tumor present. Segment of left vagus, no tumor present. One parathyroid gland, no tumor present. skin with marked solar elastosis and subcutaneous tissue of. the anterior neck with marked acute inflammation. (D) NEW ESOPHAGEAL MARGIN: Portion of esophagus, no tumor present. COMMENT. The tumor in the left pyriform sinus is 9.5 cm in greatest. dimension. The largest lymph node involved by metastatic tumor is 2.5 cm in. largest dimension and located in the left subdigastric area. Approximately. 50% of it is replaced by metastatic tumor. However, many of the other lymph. nodes involved by metastatic tumor are almost completely replaced by the. metastasis. there is extranodal extension measuring at Teast 3.0 mm. SPECIMEN. (A) LEFT PYRIFORM SINUS: PHARYNGEAL PLEXUS OF VAGUS NERVE: TOTAL LARYNGOPHARYNGECTOMY, BILATERAL NECK DISSECTIONS, EXCISION OF LEFT. NEW ESOPHAGEAL MARGIN: SNOMED CODES. T-55300, M-80703,T-C4200,M-80703.",train,9.5 cm
3861,TCGA-RS-A6TO.6F3960E4-4E90-4CFD-B318-61C96F3F5281,"Clinical Diagnosis & History: Malignant lesion. Right lower gingiva. Specimens Submitted: 1: Anterior lip mucosa margin; excision (fs). 2: Right lateral margin buccal mucosa; excision (fs). 3: Left lateral margin buccal mucosa; excision (fs). 4: Posterior margin floor of mouth; excision (fs). 5: Right genial glossus margin; excision (fs). 6: Right neck, level 2B; excision. 7: Right neck, level 1A; excision. 8: Right neck, level 1B; excision. 9: Right neck, level 2A; excision. 10: Right neck, level 3; excision. 11: Left lateral margin, buccal mucosa #2; excision. 12: Left neck level 1B; excision. 13: Right anterior mandible; composite resection. DIAGNOSIS: 1. Anterior lip mucosa margin; excision (fs) : Benign squamous mucosa, with ulceration and reactive atypia. 2. Right lateral margin buccal mucosa; excision (fs) : - Squamous mucosa with focal mild dysplasia. 3. Left lateral margin buccal mucosa; excision (fs) : - Squamous cell carcinoma in situ present on frozen section slide only. 4. Posterior margin floor of mouth; excision (fs) : - Squamous mucosa with mild dysplasia. 5. Right genial glossus margin; excision (fs) : - Benign skeletal muscle. 6. Right neck, level 2B; excision: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 5. 7. Right neck, level 1A; excision: Lymph Node Dissection: Metastatic squamous cell carcinoma. Number of lymph nodes examined: 7. Number of lymph nodes with metastatic disease: 2. Size of the largest lymph node involved by tumor: 0.5cm. Size of the largest metastatic focus : 0.2 cm. Extranodal extension is identified. 8. Right neck, level 18; excision: Lymph Node Dissection: Metastatic squamous cell carcinoma. Number of lymph nodes examined: 13. Number of lymph nodes with metastatic disease: 2. Size of the largest lymph node involved by tumor: 1.4cm. Size of the largest metastatic focus : 1.4 cm. Extranodal extension is not identified. Benign salivary gland with lymphocytic sialadenitis is also. present. 9. Right neck, level 2A; excision: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 12. 10. Right neck, level 3; excision: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 13. 11. Left lateral margin, buccal mucosa #2; excision: - Benign squamous mucosa. 12. Left neck level 1B; excision: Lymph Node Diasection: Benign lymph nodes. Number of lymph nodes examined: 11. Benign salivary gland also present. 13. Right anterior mandible; composite resection: Tumor Type: Invasive squamous cell carcinoma. Keratinizing. Histologic Grade: Moderately differentiated. Tumor Size: Greatest diameter is 3.0 cm. Maximal thickness 1. 8cm. Tumor Location: Lower gingiva. Tumor Invasion: Tumor extends through bone. Tumor Necrosis: Not identified. Vascular Invasion: Not identified. Perineural Invasion: Identified. Pattern of Invasion: Invasive islands. Tumor Multicentricity: Not identifed. In situ carcinoma: Not identifed. Non-Neoplastic Mucosa: Exhibits chronic inflammation. Surgical Margins: Invasive carcinoma is present at the following margin(s) : deep. margin, lateral side. Bone Invasion: Involves medullary space. Bone Margins: Benign. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), . AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1. The specimen is received fresh for frozen section consultation labeled. ""Anterior lip mucosal margin"" and consists of a tan mucosa tissue measuring. 0.6 x 0.2 x 0.1 cm. The specimen is entirely submitted for frozen section. Summary of sections: FSC - frozen section control. 2. The specimen is received fresh for frozen section consultation labeled. ""Right lateral margin, buccal mucosa"" and consists of a tan mucosa tissue. measuring 1.0 x 0.2 x 0.2 cm. The specimen is entirely submitted for frozen. section. Summary of sections: FSC - frozen section control. 3. The specimen is received fresh for frozen section consultation labeled. ""Left lateral margin, buccal mucosa"" and consists of a tan mucosa tissue. measuring 0.8 x 0.2 x 0.2 cm. The specimen is entirely submitted for frozen. section. Summary of sections: FSC - frozen section control. 4. The specimen is received fresh for frozen section consultation labeled. ""Posterior margin, floor of mouth"" and consists of a tan mucosa tissue. measuring 0.3 x 0.2 x 0.2 cm. The specimen is entirely submitted for frozen. section. Summary of sections: FSC - frozen section control. 5. The specimen is received fresh for frozen section consultation labeled. ""Right genial glossus margin"" and consists of a red soft tissue measuring. 1.0 x 0.4 x 0.3 cm. The specimen is entirely submitted for frozen section. Summary of sections: FSC - frozen section control. 6) The specimen is received fresh and is labeled ""Right neck- level 2B"". It. consists of a 3.5 x 2.5 x 1.7 cm portion of adipose tissue, which upon. sectioning displays 5 possible tan-red firm lymph nodes ranging from 0.3 x. 0.3 x 0.3 cm to 0.7 x 0.6 x 0.3 cm. All identified lymph nodes are. submitted. Summary of sections: LN- lymph nodes (5). 7) The specimen is received fresh and is labeled ""Right neck- level 1A"". It. consists of a 3.0 x 1.8 x 1.3 cm portion of adipose tissue, which upon. sectioning displays 10 possible tan-red firm lymph nodes ranging from 0.2 x. 0.1 x 0.1 cm to 1.0 x 0.5 x 0.3 cm. All identified lymph nodes are. submitted. Summary of sections: LN- lymph nodes (10). 8) The specimen is received fresh and is labeled ""Right neck- level 1B"". It. consists of a 5.8 x 4.5 x 3.6 cm portion of adipose tissue with attached 3.7. x 2.5 x 1.0 cm submandibular gland. The specimen is dissected to 19 possible. tan-red lymph nodes and one grossly positive lymph node ranging from 0.2. x. 0.2 x 0.1 cm to 1.6 x 1.4 x 0.8 cm. All identified lymph nodes and. additional representative sections of the remaining specimen are submitted. Summary of sections: SMG submandibular gland. LN - lymph nodes. GPLN- grossly positive lymph node, representative. 9) The specimen is received fresh and is labeled ""Right neck- level 2A"". It. consists of a 4.1 x 3.4 x 2.0 cm portion of adipose tissue, which upon. sectioning displays 11 possible tan-red firm lymph nodes ranging from 0.2 x. 0.2 x 0.1 cm to 1.2 x 0.6 x 0.4 cm. All identified lymph nodes are. submitted. Summary of sections: LN- lymph nodes (9). BLN- bisected lymph nodes (2). 10) The specimen is received fresh and is labeled ""Right neck- level 3"". It. consists of a 6.0 x 1.5 x 1.0 cm portion of adipose tissue, which upon. sectioning displays 15 possible tan-red firm lymph nodes ranging from 0.2 x. 0.1 x 0.1 cm to 0.7 x 0.3 x 0.3 cm. All identified lymph nodes are. submitted. Summary of sections: LN- lymph nodes (15). 11) The specimen is received fresh, labeled ""Left lateral margin-buccal. mucosa # 2"", and consists of a gray-tan irregular portion of mucosal lined. soft tissue measuring 1.2 x 0.4 x 0.2 cm. The specimen is inked and entirely. submitted. Summary of sections: --undesignated. 12) The specimen is received fresh, labeled ""Left neck level 1B"" and. consists of a 4.8 x 2.0 x 1.4 cm fragment of adipose tissue with attached. 3.4 x 3.2 x 0.8 cm grosaly unremarkable salivary gland. Sectioning the. adipose tissue reveals a tan, soft, ovoid, tan-pink lymph nodes, ranging. from 0.3 to 1.2 cm in greatest dimension. The largest lymph node is bisected. and one half is submitted to the TPS and the remaining half is submitted for. permanent. The remaining lymph nodes are entirely submitted and the. remaining specimen is representatively submitted. Summary of sections: LN whole lymph nodes. BLN -- bisected lymph nodes. RHN -- remaining half of lymph node submitted to TPS. SG salivary gland. 13) The specimen is received fresh labeled ""right anterior composite. resection of mandible, suture marks anterior"" and consists of a resected. portion of mandible with attached soft tissue and a mucosal surface. measuring 7.2 x 3.5 x 3.2 cm in overall dimension. The mandible measures. 7.2 x 2.2 x 1.9 cm. The soft tissue measures 6 x 3.5 3.1 cm with a mucosal. surface measuring 5.2 cm (anterior to posterior) x 3.5 cm (lateral/buccal to. medial/gingival) The mucosa is purple grey with a central ulcerated lesion. measuring 3 x1.8 cm, grossly located from the mucosal margins as follows: 0.9 cm-anterior, 0.6 em-lateral/buccal, 1.5 cm- posterior and 0.6 cm-medial. The lesion is 1.1 cm from the anterior bone margin and 1.6 cm from the. posterior bone margin. The specimen is inked anterior-purple,. lateral/buccal-green, posterior-orange, medial-blue, deep-black. Upon. sectioning the lesion has underlying invasive component, grosaly extending. to a depth of 1 cm, 0.2 cm from the nearest (lateral) margin. The lesion. grosaly extends into the underlying bone. A representative section of the. lesion to the bone is submitted following decalcification. Perpendicular. sections of the anterior and posterior margins are submitted; the remaining. lesion is blocked out and submitted sequentially from anterior to posterior. in its entirety. The bone margins are shaved. Gross photographs are taken. Tumor sampled for TPS. Representative sections are submitted. Summary of sections: ABM - anterior bone margin, shaved. PBM -- posterior bone margin shaved. LB -- lesion to bone. AM -- anterior mucosal and soft tissue margin (perpendicular). PM -- posterior mucosal and soft tissue margin (perpendicular). L -- lesion (submitted sequentially from anterior to posterior). Summary of Sections: Part 1: Anterior lip mucosa margin; excision (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 2: Right lateral margin buccal mucosa; excision (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 3: Left lateral margin buccal mucosa; excision. Block. Sect. Site. PCs. 1. fsc. 1. Part 4: Posterior margin floor of mouth; excisior. Block. Sect. Site. PCs. 1. fsc. 1. Part 5: Right genial glossus margin; excision. Block. Sect. Site. PCs. 1. fsc. 1. Part 6: Right neck, level 2B; excision. Block. Sect. Site. PCs. 2. LN. 5. Part 7: Right neck, level 1A; excision. Block. Sect. Site. PCs. 2. LN. 10. Part 8: Right neck, level 1B; excision. Block. Sect. Site. PCs. 1. GPLN. 1. 4. LN. 19. 1. SMG. 1. Part 9: Right neck, level 2A; excision. Block. Sect. Site. PCs. 2. BLN. 4. 2. LN. 9. Part 10: Right neck, level 3; excision. Block. Sect. Site. PCs. 3. LN. 15. Part 11: Left lateral margin, buccal mucosa #2; excision. Block. Sect. Site. PCs. 1. U. 1. Part 12: Left neck level 1B; excision. Block. Sect. Site. PCs. 1. BLN. 2. 2. LN. 12. 1. RHN. 1. 1. SG. 1. Part 13: Right anterior mandible; composite resection. Block. Sect. Site. PCs. 1. ABM. 1. 1. AM. 1. 12. L. 12. 1. PBM. 1. 1. PM. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue. sample examined at the time of the intraoperative. consultation. 1. FROZEN SECTION DIAGNOSIS: Ulcerated squamous mucosa with atypia. PERMANENT DIAGNOSIS: Same. 2. FROZEN SECTION DIAGNOSIS: Squamous mucosa with moderate. dysplasia. PERMANENT DIAGNOSIS: Same. 3. FROZEN SECTION DIAGNOSIS: In situ squamous cell carcinoma. PERMANENT DIAGNOSIS: Same. 4. FROZEN SECTION DIAGNOSIS: Squamous mucosa with mild dysplasia. PERMANENT DIAGNOSIS: Same. 5. FROZEN SECTION DIAGNOSIS: Benign skeletal muscle. PERMANENT DIAGNOSIS: Same.",train,3.0 cm;1. 8cm
3890,TCGA-CR-5249.f17b05fc-b033-42f9-984f-6bf20fc5c1ce,"DIAGNOSIS: 1) TONSIL, RIGHT, TONSILLECTOMY BASALOID SQUAMOUS CELL CARCINOMA, 2.2CM. IN GREATEST EXTENT (SEE COMMENT). COMMENT: These findings correspond to AJCC stage II (pT2, pNn/a). CLINICAL DATA. Clinical Features/Dx: unspecified. Operation: unspecified. Operative Findings: unspecified. Operative Diagnosis: unspecified. Tissue Submitted: 1) right tonsil. GROSS DESCRIPTION: 1) SOURCE: Tonsil, Right. Received fresh is a single fragment of red-pink tissue, measuring 3.5 x2.7 X 1.5 cm. The. mucosal surface is lobulated, jagged, and irregular. The cauterized surface is inked entirely in blue and is sectioned to. reveal a mass of white, irregular tissue, measuring 2.2 X 2.0 X 1.5 cm. The surrounding tissue is pink-tan and normally. lobulated. A small portion of tumor is submitted for research. Representative sections are submitted. Summary of. sections: 1A-B, 1/1. Slides and report reviewed by Attending Pathologist. ADDENDUM REPORT. The following report contains additional information that supplements the previously issued report. ADDENDUM FINDINGS: DIAGNOSIS:1) TONSIL, RIGHT, TONSILLECTOMY: BASALOID SQUAMOUS CELL CARCINOMA, 2.2CM IN. GREATEST EXTENT; NEGATIVE FOR LYMPHOVASCULAR INVASION; EDGES OFTHE SPECIMEN. NEGATIVE FOR MALIGNANCY (SEE COMMENT). COMMENT: These findings correspond to AJCC stage II (pT2, pNn/a). Slides and report reviewed by Attending Pathologist.",train,2.2CM;2.2CM
3894,TCGA-RW-A7D0.E3FD9EF7-2F86-47D6-90ED-B912F333C419,"PREVIOUS DIAGNOSIS INQUIRY. 1. SEX: F. ADM DATE: OPER DATE: PROCEDURE: SPHS. year-old female with pheochromocytoma. Operative Procedure: Left posterior. approach. Retroperitoneal adrenalectomy. Fresh. PROCEDURE: SPGD. 1. ""Left adrenal gland. Received is a 60 gram adrenal specimen (8.0 x 4.5. x. 4.0 cm). Previously inked blue. Cross sectioning reveals a 4.5 x 4.0 x 3.0 cm. encapsulated mass within the adrenal gland. The mass is partially solid and. cystic with hemorrhagic and necrotic areas. 1A. Section of solid area of mass. 1B. Section of hemorrhagic/necrotic area. 1C. Section of hemorrhagic area. 1D. Section of solid area. 1E. Section of mass and normal adrenal gland. 1F. Section of normal adrenal gland. (1 each). PROCEDURE: SPDX. 1. Left adrenal gland, excision: Pheochromocytoma (4.5 cm). Margins negative. 1,. , the signing staff pathologist, have personally. examined and interpreted the slides from this case. Code: END OF PREVIOUS DIAGNOSIS INQUIRY.",train,4.5 cm
3899,TCGA-EW-A6SD.9FB40DC5-BED9-420E-B334-4D0BE8B8BCF5,"F. Pathologic Interpretation: A. LEFT BREAST LUMPECTOMY: INVASIVE DUCTAL CARCINOMA, poorly differentiated, Nottingham grade 3 (3+3+3=9), 2.1 cm in greatest. dimension. Resection margins are free of tumor; closest is inferior, 0.1 cm. B. LEFT AXILLARY CONTENTS: METASTATIC DUCTAL CARCINOMA to two out of twenty-six lymph nodes (2/26) with extranodal. extension. C. ADDITIONAL LEFT AXILLARY CONTENTS LEVEL 2-3: No malignancy seen in five lymph nodes (0/5). Surgical Pathology Cancer Case Summary. Specimen: Partial breast. Procedure: Excision without wire-guided localization. Lymph Node Sampling: Axillary dissection (partial or complete dissection). Specimen Integrity: Single intact specimen (margins can be evaluated). Specimen Laterality: Left. Tumor Size: Size of Largest Invasive Carcinoma: Greatest dimension of largest focus of invasion over 0.1 cm: 2.1 cm. Additional dimensions: 1.7 x 1.7 cm. Tumor Focality: Single focus of invasive carcinoma. Macroscopic and Microscopic Extent of Tumor: Skin: Skin is not present. Skeletal Muscle: No skeletal muscle present. Ductal Carcinoma in Situ (DCIS): DCIS is present. Architectural Patterns: Solid. Nuclear Grade: Grade III (high). Histologic Type of Invasive Carcinoma: Invasive ductal carcinoma (no special type or not otherwise specified). Histologic Grade: Nottingham Histologic Score: Glandular (Acinar)/Tubular Differentiation. Score 3: < 10% of tumor area forming glandular/tubular structures. Nuclear Pleomorphism. Score 3: Vesicular nuclei, often with prominent nucleoli, exhibiting marked variation in size and. shape, occasionally with very large and bizarre forms. Mitotic Count. Score 3. Overall Grade. Grade 3. Margins: Margins uninvolved by invasive carcinoma. Distance from closest margin: 1 mm (inferior). Margins uninvolved by DCIS. Lymph Nodes: Number of sentinel lymph nodes examined: 0. Total number of lymph nodes examined (sentinel and nonsentinel): 31. Number of lymph nodes with macrometastases (> 0.2 cm): 2. Largest metastatic deposit: 3.0cm. Extranodal Extension: Present. Method of Evaluation of Sentinel Lymph Nodes: Hematoxylin and eosin (H&E), one level. Pathologic Staging (pTNM): Primary Tumor (pT): pT2: Tumor > 20 mm but 50 mm in greatest dimension. Regional Lymph Nodes (pN): pN1a: Metastases in 1 to 3 axillary lymph nodes, at least 1 metastasis greater than 2.0 mm. Distant Metastasis (pM): Not applicable. Ancillary Studies: Estrogen Receptor: Performed on another specimen: Results: Less than 1% immunoreactive cells present. Progesterone Receptor: Performed on another specimen: Results: Less than 1% immunoreactive cells present. HER2/neu Immunoperoxidase Studies: Performed on another specimen: Results: Positive (Score 3+). Clinical History: None Provided. Operation Performed. Left Breast Lumpectomy. Pre Operative Diagnosis: Breast Cancer. Specimen(s) Received/Processing Information: Fee. Codes: A: LEFT BREAST LUMPECTOMY H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E,. Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x. 1. B: LEFT AXILLARY CONTENTS H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E,. Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1,. H&E, Initial x 1. C: ADDITIONAL LEFT AXILLARY CONTENTS LEVEL 2-3 H&E, Initial x 1, H&E, Initial x. Gross Description: A. Received in formalin is a yellow tan fibrotic adipose tissue fragment weighing 86 grams and measures 8.0 x. 7.0 x 4.0 cm. The specimen is oriented with a long stitch lateral, short superior and double stitch. Inked as. follows: Superior in Blue - deep black, anterior yellow, inferior green, lateral orange and medial red. Cross. sections of the specimen shows a firm pale tan well circumscribed mass measuring 2.1 x 1.7 x 1.7 cm. It is. within 1 mm from inferior resection margin, all additional margins are uninvolved by tumor. The mass shows. a metallic clip (previous biopsy site). No additional lesions are grossly present. Sections submitted as. follows: Cassette #1-4. Representative section of the mass with relations to the inferior margin (almost in toto). (Cassette #1) -largest dimension of the mass, (Cassette #4) previous biopsy site. Cassette# 5. Superior margin. Cassette# 6. Deep margin. Cassette# 7. Anterior margin. Cassette#8. Lateral margin. Cassette #9. Medial resection margin. B. Received in formalin are multiple yellow tan fibrotic adipose tissue fragments measuring 15.0 x 13.0 x 4.0. cm in aggregate. Twenty-six lymph nodes were grossly identified measuring up to 3.0 x 2.0 cm in greatest. dimension. The two largest lymph nodes show a metastatic tumor. Sections submitted as follows: Cassette #1. Representative section from one large lymph node. Cassette #2. Representative section from the second largest lymph node. Cassettes# 3&4. One lymph node in toto per cassette. Cassettes#5-10. Four lymph nodes in toto per cassette. C. Received in formalin is a yellow tan fibrotic adipose tissue fragment. It measures 10. 0 x 6.0 x 2.0 cm in. aggregate. The five lymph nodes are grossly identified measuring up to 0.4 x 0.3 cm in greatest dimension. Sections submitted as follows: Cassette #1. Two lymph nodes in toto. Cassette# 2. Three lymph nodes in toto.",train,2.1 cm;1.7 x 1.7 cm
3907,TCGA-19-5955.cc6d5233-b9dc-4551-b3bc-6b7b2b2c2c7b,"FINAL DIAGNOSIS. A., B. RIGHT TEMPORAL LOBE OF BRAIN, TUMOR, BIOPSY AND REMOVAL: -- GLIOBLASTOMA MULTIFORME (WHO GRADE IV). By the signature on this report, the individual or group listed as making the Final Interpretation/Diagnosis certifies that they have. reviewed this case. Intraoperative Consultation: A: Microscopic and touch imprint diagnosis: Glioblastoma multiforme. Clinical History: R brain tumor. Specimens Submitted As: A:R TEMPORAL NEOPLASM. B:RIGHT TEMPORAL NEOPLASM. Gross Description: A: Received fresh for intraoperative evaluation labeled with the patient's name, hospital number and. ""right temporal neoplasm"" are two irregular fragments of white-pink soft tissue, 0.9 X 0.5 x 0.4 cm and. 0.7 X 0.5 X 2.4 cm. A touch prep is performed on a portion of this tissue. A portion of this tissue is. submitted for frozen section. The specimen is submitted entirely in two cassettes. B: Received fresh, labeled with the patient's name and number, and ""right temporal neoplasm"", are two. irregular fragments of opaque white to pink tan, soft, cerebriform tissue measuring in aggregate 2.3 X. 1,9 X 0.4 cm. A portion of the specimen is submitted to. The remaining tissue is submitted. entirely in one cassette.",train,
3950,TCGA-D8-A147.380639A2-E89C-4495-8168-82120617129F,"page 1/1. copy No. Examination: Histopathological examination. Patier. PESEL: Gender: F. Material: Partial organ resection - lesion from the left breast - lower outer quadrant. Expected time of examination: Clinical diagnosis: Cancer of the right breast, typical quadrant marking. Macroscopic description: Part of the breast sized 8.8 x 8.3 x 2.4 cm with a skin flap of 5.8 x 2.3 cm, marked typically, with an X-ray. image. Tumour cross section sized 1.7 x 1.5 x 2.3 cm. Margins: to the base 0.1 cm; do the skin surface 0.6 cm;. to the sternum 2.2 cm, to the axilla 3.6 cm, to the shoulder 2.3 cm, lower 4.3 cm. Microscopic description: Carcinoma ductale invasivum: NHG3 (3+3+3: 18 mitoses /10 HPF - diam. 0.55mm), pT2. Solitary DCIS focuses. found beneath the tumour (solid type with medium atypia, no necrosis) placed 0.5 cm from the incision line. Histopathological diagnosis: Resectio partalis mammae dextrae: Carcinoma ductale invasivum et ductale in situ (NHG3, pT2). Results of immunohistochemical examination: Estrogen receptors in neoplastic cell nuclei not found. Progesterone receptors in neoplastic cell nuclei not found. HER2 protein stained with HercepTest by DAKO. Negative reaction in invasive cancerous cells ( Score = 0).",train,1.7 x 1.5 x 2.3 cm
3966,TCGA-DK-A3X1.45B099D5-2E5F-4B70-9B17-D37BC5CA0D40,"Urology. Clinical Diagnosis & History: year old with pT2 urothelial cell carcinoma, status post 2 courses of BCG. Specimens Submitted: 1: SP: Uterus, cervix, bilateral tubes and ovaries anterior vaginal wall, bladder, perivesical lymph nodes. 2: SP: Right distal pelvic lymph nodes. 3: SP: Left pelvic lymph node. 4: SP: Left distal pelvic lymph nodes. 5: SP: Right distal ureter. 6: SP: Left distal ureter. DIAGNOSIS: 1. SP: Uterus, cervix, bilateral tubes and ovaries anterior vaginal wall, bladder, perivesical lymph nodes: Tumor Type: Invasive urothelial carcinoma, NOS. Histologic Grade: High grade. Pattern of growth of the Non-Invasive component: In situ component not identified. Pattern of growth of the Invasive component: Infiltrating. Tumor Multicentricity: Not identified. Bladder Local Invasion: Perivesical soft tissues. Extravesical Tumor Extension: Ureters uninvolved. Vascular Invasion: No definite vascular invasion present. Perineural Invasion: Not identified. Surgical Margins: Free of tumor. See also parts 5 and 6. Non-Neoplastic Mucosa: Exhibiting chronic cystitis. Exhibiting foreign body reaction. Female Genital Organs: The endometrium shows endometrial polyp. The myometrium shows mural leiomyomas. The left fallopian tube shows simple serous cysts. The right ovary shows hilus cell and stromal hyperplasia. The left ovary shows stromal hyperplasia. Remaining genital organs are unremarkable. Perivesical Lymph Nodes: LN Not involved 0/1. The Pathologic Stage is (AJCC. pT3 (Invasion of perivesicle soft tissue). 2. SP: Right distal pelvic lymph nodes: Lymph Nodes: Not involved. Number of nodes examined:2. 3. SP: Left pelvic lymph node: Lymph Nodes: Not involved. Number of nodes examined:8. 4. SP: Left distal pelvic lymph nodes: Lymph Nodes: Not involved. Number of nodes examined:8. 5. Right distal ureter; excision: - Ureter with focal mild atypia. 6. Left distal ureter; excision: - Benign ureter. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1) The specimen is received fresh, labeled ""uterus, cervix, bilateral tubes and ovaries, anterior vaginal wall, bladder and perivesical. lymph nodes"". It consists of a cystectomy-hysterectomy and bilateral salpingo-oophorectomy specimen measuring 11 cm from. superior to inferior, 12cm laterally and 5cm from anterior to posterior. The bladder measures 13 x 11cm, the uterus measures 5 x. 4.6 x 2.8 cm, the right ovary measures 2.2x 1.0 x 0.9 cm, the right fallopian tube measures 5,4 x 0.7 cm, the left ovary measures. 2.7 x 1.3 x 0.9 cm, and the left fallopian tube measures 4 x 0.7 cm. The portion of vaginal cuff measures 5.5 x 2.0 cm. The distal. urethral margin and the vaginal cuff margin are shaved and submitted. The ureteric stumps are buried in the specimen, measure. approximately 2 cm and show probe-patent lumen. The specimen is inked black for posterior, blue for anterior and the bladder is. opened anteriorly to reveal a friable fungating mass measuring 3.3 x 2.4 cm located in the dome focally extending to trigone. The. distance from the left and the right ureteric orifices are 5.2 cm and 5.3 cm respectively. On sectioning, the tumor extends to a depth. of 2.0 cm, and appears to extend into the perivesical fat grossly reaching to the subserosa. The remaining bladder mucosa shows. flat. mucosa. without. additional lesion. Discrete perivesical lymph nodes are not identified. The uterus is bivalved to reveal multiple. fibroids ranging from 0.5 to 1.5 cm and endometrial polyp measuring 2x 1.2 x 0.2 cm. The ovaries and fallopian tubes are. unremarkable. Tissue is submitted for. Gross photograph is taken. Representative sections are submitted. Summary of sections: UTHM - urethral margin. RUM - right ureter margin. LUM -left ureter margin. L-lesion. RUO -right ureteric orifice. LUO -left ureteric orifice. LP-left posterior wall. LA-left anterior wall. RP-right posterior wall. RA-right anterior wall. TRI -trigone. EMM -endomyometrium. CX-cervix. V - vagina, full thickness to include bladder mucosa. DVM -distal vaginal margin. RTO -right tube and ovary. LTO-left tube and ovary. LN - possible lymph node. 2). The specimen is received fresh labeled ""Right distal pelvic lymph nodes"" and consists of 2 pink tan firm lymph nodes. measuring 0.7 x 0.6 cm and 2.0 x 1.0 cm in greatest dimension. The larger lymph node is inked black and bisected. All identified. lymph nodes are submitted. Summary of sections: LN - lymph nodes. 3). The specimen is received fresh labeled ""Left pelvic lymph nodes"". It consists of multiple lymph nodes ranging from 0.2 x 0.2. cm up to 3 x 1.8 cm. The lymph nodes are serially sectioned at 3 mm intervals and submitted. Summary of sections: LN-lymph nodes. BLN-bisected lymph node. LN1-lymph node number one. LN2-lymph node number two. LN3-lymph node number three. 4). The specimen is received fresh, labeled ""Left distal pelvic lymph node"" and consists of multiple pink tan firm lymph nodes. ranging from 0.2 x 0.2 cm up to 3.5 x 1 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes. BLN- bisected lymph node. 5). The specimen is received in formalin labeled ""Right distal ureter unclipped is a margin."" It consists of a segment of ureter. measuring 5 cm in length and 0.4 cm in diameter. The attached adipose tissue measures up to 1.5 cm in thickness. There is a. clip. on one end of the specimen. The specimen is serially sectioned from the clipped to the non-clipped end and submitted. entirely. Summary of sections: MC-margin with clip. SS-serial sections from clipped to non-clipped end. margin without clip. 6). The specimen is received in formalin labeled ""Left distal ureter unclipped is a margin."" It consists of a segment of ureter. measuring 3.5 cm in length and 0.4 cm in diameter. The attached adipose tissue measures up to 1.5 cm in thickness. There is. a. clip on one end of the specimen. The specimen is serially sectioned from the clipped to the non-clipped end and submitted. entirely. Summary of sections: MC-margin with clip. SS-serial sections from clipped to non-clipped end. MWC-margin without clip. Summary of Sections: Part 1: SP: Uterus, cervix, bilateral tubes and ovaries anterior vaginal wall, bladder, perivesical lymph nodes. Block. Sect. Site. PCs. 1. CX. 2. 1. dnm. 1. 2. emm. 2. 6. L. 6. 1. la. 2. 1. LN. 1. 1. lof. 2. 1. Ip. 2. 1. lum. 1. 1. luo. 1. 1. ra. 2. 1. rof. 2. 1. rp. 1. 1. rum. 1. 1. ruo. 1. 1. tri. 1. 1. uthm. 1. V. 1. Part 2: SP: Right distal pelvic lymph nodes. Block. Sect. Site. PCs. 1. In. 1. Part 3: SP: Left pelvic lymph node. Block. Sect. Site. PCs. 1. bIn. 1. 1. In. 1. 2. In1. 2. 2. In2. 2. 2. In3. 2. Part 4: SP: Left distal pelvic lymph nodes. Block. Sect. Site. PCs. 1. BLN. 1. 1. LN. 1. Part 5: SP: Right distal ureter. Block. Sect. Site. PCs. 1. mc. 1. 1. mwc. 1. 1. SS. 1. Part 6: SP: Left distal ureter. Block. Sect. Site. PCs. 1. MC. 1. 1. MWC. 1. 1. SS. 1.",train,2.0 cm
3996,TCGA-D9-A3Z4.48B52D74-74EA-43BE-918A-4A4E3BDB76B7,": xxx. Examination result. Clinical diagnosis (suspicion): Skin melanoma on the right arm. Date of admission: (urgency: Standard). Material: 1) Material: skin of the arm, Method of collection: Lesion resection. Histopathological diagnosis: Malignant melanoma of the skin with ulceration. 12 mm, diameter 24 mm. pT4b, pN3. Macroscopic description: A flap of skin with subcutaneous tissue sized: 1 8 x 8 x 2 cm. Tumour sized 2.4 x 2.4 x 1 cm on the skin,. brown-coloured, ulcerous, placed 1 cm from the base and 2 cm from the side edge. Small satellite tumours on the skin from 0.1 to 0,6 cm (side margin 0.6 cm, from the base 0.4 cm). Proliferation sized 3 x 1.7 x 3.5 cm in the subcutaneous tissue, reaching the base. Microscopic description: Malignant melanoma of the skin. Clinical data and histology suggestive of a primary lesion - nodular type. Level V according to. thickness of 12 mm acc. to. the largest tumour size is 24 mm. A faint. lymphocitary proliferation at the foot of the lesion, no signs of regression. Ulceration and satellite lesions. No. remnants of the pre-existing naevus. Minimum margin of healthy tissues to the side of the surgical specimen: 0.3 cm Minimum margin of healthy tissues. from the base of the surgical specimen: 0 cm.",train,2.4 x 2.4 x 1 cm;24 mm;24 mm
4026,TCGA-VQ-AA6G.03985625-8D3E-4D02-97B4-C349D272107C,"PRIMARY SITE: Stomach (Cardia). ""Product of esophagogastrectomy"": Moderately differentiated invasive and ulcerated adenocarcinoma of Laurn's intestinal type. Neoplasia size: 5.0 x 4.0 x 1.4cm. Location: cardia. Depth of infiltration: up to subserosa. Sanguineous vascular invasion: not detected. Lymphatic vascular invasion: present. Perineural invasion: not detected. Adjacent gastric mucosa: moderate chronic inactive gastritis. Esophageal adjacent mucosa: moderate chronic esophagitis. Surgical margins free of neoplastic involvement. 19 lymph nodes were dissected from peri-gastric fat, all free of tumor (0/19), distributed as. follows: - Chain 1 - right paracardic: 0/2. - Chain 2 - left paracardic: 0/3. Presence of neoplastic infiltration in the. adipose tissue. - Chain 3 - lesser curvature: 0/5. - Chain 7 - left gastric artery: 0/2. - Chain 9 - celiac trunk: 0/3. - Chain 110 - inferior paraesophageal: 0 4. ""Greater omentum"": . Free of neoplasia. ""Esophageal margin"": . Free of neoplasia.",train,5.0 x 4.0 x 1.4cm
4038,TCGA-FU-A23L.717358E4-EB69-4232-B0AE-36C7058531A9,"Hospital of Origin: QC Pathologist: FINAL PATHOLOGIC DIAGNOSIS: A. Lymph nodes, left pelvic, excision: No neoplasm identified in three lymph nodes. B. Lymph nodes, right pelvic, excision: No neoplasm identified in three lymph nodes. Aterus, cervix, bilateralovaries and fallopian tubes,. C. hysterectomy with bilateral salpingo-oophorectomy: Invasive squamous cell carcinoma. -. Grade: Moderate to poorly differentiated. Location: Circumferential involvement of the cervix with. extensive involvement of the lower uterine segment and. extension into the uterine corpus. Size: Approximately 3.8 cm by gross evaluation. Tumor involves the deep stroma of the cervix and lower. uterine segment. Depth of deepest invasion is approximately 1.8 cm. Tumor invades into the adipose connective tissue outside of. the uterus. Lymphovascular space invasion not identified. Surgical margin status: Carcinoma in situ closely approximates the anterior and. posterior cervical margin. Invasive squamous cell carcinoma involves the deep. connective tissue cauterized surface. No tumor identified in the separately submitted left and. right paracervical tissue. Lymph nodes: No tumor identified in three lymph nodes of the left. paracervical soft tissue. No neoplasm identified in two lymph nodes of the right. paracervical soft tissue. PTNM stage (AJCC 2010): pT2a1 NO. Endometrium -. Atrophy. Myometrium -. Multiple leiomyomas with areas of hyalinization and. calcification; adenomyosis. Bilateral ovaries -. No neoplasm identified. Bilateral fallopian tubes -. No neoplasm identified. D. Specimen submitted as ""right uterine artery"",. excision: Benign adipose tissue and arterial vessel with no neoplasm. identified. COMMENTS: Selected slides have been reviewed by D. who. agrees with the diagnosis. CLINICAL HISTORY: Preoperative Diagnosis: of cervix. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Left pelvic lymph node - FS. B. Right pelvic lymph node - FS. C. Uterus, cervix and bilateral tubes and ovaries. D. Right uterine artery. CODES: PROCEDURAL DEMOGRAPHICS: Accession Date/Time: GROSS DESCRIPTION: A. Received in a single container labeled. and. #1 left pelvic lymph node is a 6.2 x 5.3 x 1.1 cm. aggregate. of fibroadipose tissue bearing multiple irregular tan-yellow. firm tissues consistent with probable lymph node ranging. from 0.5 x 0.3 x 0.2 cm. to 3.5 x 1.8 x 0.7 cm. The. specimen is sectioned and representative sections are. submitted for frozen section. The frozen section residue is. submitted in block 1. Additional representative sections. are submitted, to include the lymph nodes in their entirety. as labeled: block 2--four whole probable lymph nodes;. blocks 3-8 one lymph node hisected in each; blocks 9 and. 10--one lymph node serially sectioned. The blocks are. labeled. B. Received in a single container labeled. and. #2 right pelvic lymph node is a 6.3 x 5.5 x 1.1 cm. aggregate of fibroadipose tissue bearing multiple irregular. tan-yellow firm tissues consistent with probable lymph node. ranging from 1.3 X 0.6 x 0.5 cm. to 2.5 x 1.1 x 0.4 cm. The. specimen is sectioned and representativ sections are. submitted for frozen section. The frozen section residue is. submitted in block 1. Additional representative sections. are submitted, to include the ly. h nodes in their entirety. as labeled: block 2--three whc. ,robable lymph nodes;. block 3--two whole probable lymph nodes; blocks 4-7 one. lymph node bisected in each. The blocks are labeled. C. Received in a single container labeled ,. ! and. #3 uterus, cervix and bilateral tubes and ovaries is a 244. gram previously opened hysterectomy specimen consisting of a. 7.8 x 6.8 x 3.4 cm. uterine body and an attached 4.4 x 4.2 x. 3.8 cm. cervix. There is a rim of gray-white mucosa. surrounding the ectocervix. The serosa is smooth and tan-pink. The ectocervix is. smooth, focally hemorrhagic and gray-white with a 0.7 cm. slit like os. The endocervical canal is tan and 3.6 cm. in. length. The cut surface of the cervix consists of a 3.8 x. 2.5 cm. gray-white to yellow lesion with a thickness of 2.1. cm. The lesion appears to abut the inked margin. The. lesion involves all four quadrants. The lesion possibly. extends into the lower uterine segment. The identifiable endometrial cavity is 1.8 cm. from cornu to. cornu and 2.4 cm. in length. The endometrium is tan and. averages 0.1 cm. in thickness. The myometrium is. trabeculated, tan-pink and averages 1.9 cm. in thickness. There are four intramural whorled gray-white dense nodules. ranging from 0.5 cm. to 3.9 cm. in greatest dimension. No. areas of hemorrhage or necrosis are identified in the. nodules. One of the nodules is diffusely hardened and. yellow. There are four irregular tan-yellow to white firm tissues in. the left paracervical soft tissue ranging from 0.6 x 0.5 x. 0.3 cm. to 1.1 x 0.7 x 0.3 cm. No obvious lymph nodes or. lesions are identified in the right paracervical soft. tissue. Also received in the same container is a 3.1 x 1.5 x 1.1 cm. ovary with an attached 3.3 x 0.4 cm. fimbriated fallopian. tube. The outer surface of the ovary is lobulated and tan. The cut surface is tan with gray-white corpora albicans. The fallopian tube has a tan-pink serosa and a pin point. lumen. There is also a 2.5 x 1.3 x 0,8 cm. ovary with a detached. 1.4 x 0.3 cm. fimbriated fallopian tube. The outer surface. of the ovary is lobulated and tan. The cut surface is tan. with gray-white corpora albicans. The fallopian tube has a. tan-pink serosa and a pin point lumen. The specimen is inked, serially sectioned and representative. sections are submitted as labeled: block 1--cervix 12 to. 3:00; 2--cervix 3 to 6:00; 3--cervix 6 to 9:00; 4--cervix 9. to 12:00; 5--anterior lower uterine segment; 6--posterior. lower uterine segment; 7--anterior endomyometrium with. serosa; 8--posterior endomyometrium; block 9--two myometrial. nodules; block 10--largest myometrial nodule; blocks 11-12. hardened myometrial nodule, following decalcification; block. 13--three whole firm tissues from left paracervical soft. tissue; 14--one firm tissue from left paracervical soft. tissue, bisected; blocks 15-16 right paracervical soft. hed fallopian tube; block. tissue; 18--ovary block and 17--ovary detached with fallopian tube. The blocks are. labeled Also received in the same container for is a green and yellow. cassette labeled. and. D. Received artery is a 3.5 x 1.8 x 0.6 cm. aggregate blocks of. in a single container labeled. right fibroadipose uterine tissue which is submitted in toto in 1-2. labeled. INTRA-PROCEDURE CONSULTATION: FSA: ESB: No No tumor tumor identified identified (0/3). (0/3). Both diagnoses are per Dr. XR Chest Bedside. EXAMINATION: CHEST-BEDSIDE. CPT: RIS Order: COMPLETED: FULL RESULT: Indication: Short of breath. Comparison: I. Findings: AP chest was performed. Heart size is normal. No adenopathy ist;. evident. Minimal basilar atelectasis or infiltrate is present. There is. no pneumothorax present. There is no pleural fluid present. The osseous. structures appear intact. Mildly dilated loops of bowel are seen beneath. the diaphragm. IMPRESSION: Mild basilar atelectasis or infiltrate. Otherwise, no significant change. in the appearance of the lungs. a. INES.",train,
4042,TCGA-B0-5703.8695872f-42db-44b9-a326-464bc1d0f411,"PRE-OP DIAGNOSIS: Left kidney cancer. POST-OP DIAGNOSIS: Same. PROCEDURE: Laparoscopic left nephrectomy. FINAL DIAGNOSIS: KIDNEY, LEFT, LAPAROSCOPIC LEFT NEPHRECTOMY -. A. RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE. B. FUHRMAN NUCLEAR GRADE IS 3. C. THE GREATEST DIAMETER OF THE NEOPLASM IS 5.5 cm. D. THE NEOPLASM IS CONFINED WITHIN THE RENAL CAPSULE. E. NO INVASION OF THE RENAL VEIN IS IDENTIFIED. F. NO EVIDENCE OF ANGIOLYMPHATIC INVASION IS IDENTIFIED. G. ALL SURGICAL MARGINS ARE FREE OF THE NEOPLASM. H. THE NON-NEOPLASTIC KIDNEY IS UNREMARKABLE. I. TNM STAGE: pT1b NX MX. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY KIDNEY TUMORS. SPECIMEN TYPE: Other: Laparoscopic nephrectomy. LATERALITY: Left. TUMOR SITE: Lower pole. FOCALITY: Unifocal. TUMOR SIZE: Greatest dimension: 5.5 cm. Additional dimensions: 5.3 x 4.5 cm. MACROSCOPIC EXTENT OF TUMOR: Tumor limited to kidney. HISTOLOGIC TYPE: Clear cell (conventional) renal carcinoma. HISTOLOGIC GRADE (Fuhrman Nuclear Grade): G3. PATHOLOGIC STAGING (pTNM): pT1b. pNX. Number of regional lymph nodes examined: 0. pMX. MARGINS: Margins uninvolved by invasive carcinoma. ADRENAL GLAND: Not present. VENOUS (LARGE VESSEL) INVASION (V): Absent. LYMPHATIC (SMALL VESSEL) INVASION (L): Absent.",train,5.5 cm;5.5 cm;5.3 x 4.5 cm
4103,TCGA-UD-AABZ.FA7A0AF7-06C4-4F15-B3B6-8B9E39D526B2,"Printed. Sex: M. Date of Service: CLINICAL HISTORY: ? Mesothelioma ? Mucinous adenocarcinoma ? Lymphoma. Normal. MACROSCOPIC: File. 1. Left chest wall: Nodular piece of solid grey-white tissue. measuring 25mm x 20mm x 10mm. Slightly shiny cut surface (FS, A-D,. Notes. Requirer. 1r). 2. Left lingula: A wedge shaped section of lung tissue measuring 60mm. Motified. x 20mm x 10mm. A staple margin is seen at one edge. The pleural. surface shows a diffuse firm area of white thickening measuring 60mm x. Patrent. 10mm. The cut surface shows the lung parenchyma to be replaced by firm. Will Ca!. white tissue. FROZEN SECTION REPORT: Make. Appointm. 1. INVASIVE MALIGNANCY. Provisional diagnosis mesothelioma vs. adenocarcinoma. Await paraffin and IPOX for definite diagnosis. Prescripti. MICROSCOPIC: On Corte. 1. Paraffin sections confirm an infiltrating malignant epithelioid. Treatmer. neoplasm- with luminal formation. There are ragged nests and. infiltrating glandular type structures present with some focal areas of. Check "". Doctor. necrosis lying within a fibroblastic stroma. Some areas show a. sheet-like - growth pattern and large nested areas of growth also seen. The tumour appears predominantly infiltrative however there is also. Normal. some surface atypical proliferation with papillary pattern also. File. present. Notes. 2. Sections show infiltrating malignant tumour with overall similar. Require. appearance to that described in specimen 1. The tumour involves the. pleural surface and has breached the visceral pleural and extends into. Patrent. Notifiet. the underlying pulmonary parenchyma. Growth is on a broad front. Focal surface overlying fibrin exudation seen. There is also extension. Pauen. in small vascular spaces along the septae. Focally there is a visceral. Will Ca. pleural atypical papillary proliferation of mesothelial cells. Special. Make. stains of infiltrating tumour show mucin stains are negative without. Appointit. definite intracytoplasmic neutral mucin positivity. Immunoperoxidase. stains show infiltrating tumour CALRETININ positive, TTF- 1 negative,. Cotlec. Prescript. CAM 5.2 positive, CK 7 positive, CK20 patchy weak to moderate. positivity, EMA positive with cytoplasmic and rim positivity, AE 1/3. On Corr. positive, PSA negative, CD15 negative, CEA negative, CK5/6 patchy. Trezime. moderate positivity. Check "". Docto. M. Printed. M. Sex: M. - 3 -. Normal. File. CONCLUSION: 1. & 2. Left chest wall - and left lingula: MALIGNANT MESOTHELIOMA. Required. (nodular and diffuse growth pattern). Noilfied. Will Cart. Make. Appointment. Prescription. On Correct. Treatment. Check with. Docior. M.",train,
4110,TCGA-QU-A6IO.6450E3BE-55E8-4A6C-AA40-86B74F30458B,"Pathology Examination. Birthdate. Pathology. #. Male. Report to: Gross Description by: SPECIMEN SUBMITTED: RT & LT OBTURATOR NODES/PROSTATE. Procedure date. Tissue received. Report Date. Diagnosed by. Previous biopsies: PROSTATE BX'S. SKIN SCALP. DIAGNOSIS: A. (Right obturator lymph node, A-C): Lymph node with no malignancy identified. B. (Left obturator lymph node D-F): Lymph node with no malignancy identified, see note. C. (Prostate, G-X): Adenocarcinoma, see synoptic report. Note: Although multiple lymph node profiles present on the slides of the left obturator lymph node. specimen, the number of individual nodes represented by these profiles is not clear. Prostate Gland: Radical prostatectomy Synopsis. MICROSCOPIC. Histologic Type: Adenocarcinoma. Histologic Grade -- Gleason Pattern. Primary pattern: Grade 3. Secondary pattern: Grade 3. Total Gleason Score: 6. Tumor quantitation. # Positive Stides. Total Slides. Left. 3. 5. Left apex. 2. 3. Right. 3. 5. Right apex. 3. 3. EXTENT OF INVASION. Primary Tumor: pT2c: Bilateral disease. Regional Lymph Nodes: pNO: No regional lymph node metastasis. Lymph Nodes. Number examined: see Comments. Number involved: see Comments. Margins. Tumor extends to the inked capsular margin of the left lobe (slides U and V). The bladder. margin and inked apical margins are free of tumor. Extraprostatic extension: Absent. Seminal vesicle invasion (invasion of muscular wall required): Absent. Perineural invasion: Present. Comments: There is one right obturator lymph node and that shows no evidence of malignancy. Sections of the left obturator lymph node specimen reveal multiple lymph node profiles, but is not. clear how many nodes are represented by these profiles. However all of these sections are free of. tumor. Clinical: Carcinoma of prostate on needle biopsy. Gross: The specimen is received fresh in three parts, all labeled. and the medical. record number. Part 1 is additionally labeled ""right obturator lymph node"" and consists of a 3.5 x 3.0 x 1.0 cm fatty. tissue excision weighing 4 grams. The specimen is sectioned to reveal 1.0 x 1.0 x 1.0 possible. lymph node with a tan white granular cut surface. The remainder of the specimen is unremarkable. fatty tissue. The specimen is represented as follows: A = large node bisected, B-C = adjacent soft. tissue. Part 2 is additionally labeled ""left obturator lymph node"" and consists of a 4.3 x 2.5 x 1.0 cm fatty. tissue excision, weighing 4 grams. The specimen is represented as follows: D= one large possible. node bisected, E-F = soft tissue. Part 3 is additionally labeled ""prostate"" and consists of a 59 gram prostate specimen measuring. 5.5 X 5.2 X 4.5 cm with a right seminal vesicle measuring 2.5 X 2.0 X 1.0 cm and a left seminal. vesicle measuring 2.5 x 2.0 x 1.0 cm. The specimen has been oriented by the surgeon with a stitch. in the right seminal vesicle. The right vas deferens is 3 cm in length with an average diameter of. 0.4 cm, the left vas deferens is 2.2 cm in length with an average diameter of 0.4 cm. The specimen. is inked with the right side in black and the left side in blue and is serially sectioned from apex to. the base. There is diffuse nodularity in the apex measuring 2 cm in greatest diameter. There is. additionally in the posterior apex a firm rubbery nodule measuring approximately 0.8 cm in largest. dimension. in the right mid apex there is a firm white nodule measuring 0.4 cm in greatest. dimension. In the left mid prostate there is a palpable nodule measuring approximately 0.2 cm. There is additionally some diffuse nodularity posteriorly in the mid base to base region. The. specimen is represented as follows: G = right seminal vesicle and vas deferens, H = left seminal. vesicle and vas deferens, I = shaved left base prostate, J = shaved right base of prostate, K-M =. left apex, N-P = right apex, Q = left and right posterior apex, R = right posterior mid apex, S = left. posterior mid prostate, T = left posterior mid base, U = right posterior mid base, V = left base, W =. left and right base, X = right mid prostate. By his/her signature above, the senior physician certifies that he/she personally conducted a gross and/or microscopic examination of the described. specimens(s) and rendered or confirmed the diagnosis(es) related thereto. Immunohistochemistry test(s), if applicable, were developed and their performance characteristics were determined by. They have not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined. that such clearance or approval is not necessary. These tests are used for clinical purposes. They should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA - 88) as qualified to perform high complexity clinical. laboratory testing.",train,
4112,TCGA-61-1995.5ea6d43b-376d-43cb-873f-c33ec814a95d,"FINAL DIAGNOSIS: PART 1: RIGHT ADNEXA, RIGHT SALPINGO-OOPHORECTOMY -. A. HIGH GRADE POORLY DIFFERENTIATED SEROUS PAPILLARY CARCINOMA INVOLVING RIGHT OVARY AND. RIGHT FALLOPIAN TUBE. B. FOCAL LYMPHOVASCULAR INVASION IDENTIFIED. C. PELVIC CYTOLOGY. IS POSITIVE MALIGNANT CELLS. D. FIGO TUMOR STAGE: IV. PART 2: LEFT ADNEXA, LEFT SALPINGO-OOPHORECTOMY -. A. HIGH GRADE POORLY DIFFERENTIATED SEROUS PAPILLARY CARCINOMA INVOLVING LEFT OVARY. B. LEFT FALLOPIAN TUBE, UNREMARKABLE,. PART 3: UTERUS, WITHOUT ADNEXA (162 GRAMS) AND ANTERIOR BLADDER PERITONEUM, TOTAL ABDOMINAL. HYSTERECTOMY AND EXCISION -. A. METASTATIC HIGH GRADE POORLY DIFFERENTIATED SEROUS PAPILLARY CARCINOMA INVOLVING. ANTERIOR BLADDER PERITONEUM, UTERINE SEROSA AND ADJACENT MYOMETRIUM. B. CERVIX WITH LYMPHOVASCULAR INVASION BY METASTATIC HIGH GRADE POORLY DIFFERENTIATED. SEROUS PAPILLARY CARCINOMA. C. WEAKLY PROLIFERATING ENDOMETRIUM. D. ADENOMYOSIS. PART 4: SIGMOID MESENTERY NODULE, EXCISION -. HIGH GRADE POORLY DIFFERENTIATED SEROUS PAPILLARY CARCINOMA. PART 5: RIGHT PELVIC PERITONEUM, EXCISION -. HIGH GRADE POORLY DIFFERENTIATED SEROUS PAPILLARY CARCINOMA. PART 6: RIGHT PERICOLIC GUTTER TUMOR, EXCISION -. HIGH GRADE POORLY DIFFERENTIATED SEROUS PAPILLARY CARCINOMA. PART 7: APPENDIX, APPENDECTOMY -. HIGH GRADE POORLY DIFFERENTIATED SEROUS PAPILLARY CARCINOMA INVOLVING APPENDICEAL. SEROSA AND PERIAPPENDICEAL TISSUE. PART 8: PERIAORTIC LYMPH NODES, DISSECTION -. TWO LYMPH NODES POSITIVE FOR HIGH GRADE POORLY DIFFERENTIATED SEROUS PAPILLARY. CARCINOMA (2/2). PART 9: OMENTUM, OMENTECTOMY -. HIGH GRADE POORLY DIFFERENTIATED SEROUS PAPILLARY CARCINOMA. PART 10: DIAPHRAGMATIC NODULE, EXCISION -. HIGH GRADE POORLY DIFFERENTIATED SEROUS PAPILLARY CARCINOMA. PART 11: MESENTERIC NODULE, EXCISION -. HIGH GRADE POORLY DIFFERENTIATED SEROUS PAPILLARY CARCINOMA. SYNOPTIC - PRIMARY OVARIAN TUMORS INCLUDING BORDERLINE TUMORS. TUMOR LOCATION: Bilateral. PROCEDURE: TAH with salpingo-oophorectomy. TUMOR SIZE: Maximum dimension: 17.5 cm. TUMOR TYPE: Papillary serous carcinoma. HISTOLOGIC SILVERBERG GRADE: Poorly differentiated (8-9 pts). ARCHITECTURAL PATTERN: Solid (3). CYTOLOGIC ATYPIA: Marked (3). MITOTIC COUNTS / 10hpf: > or = 25 (3). HISTOLOGIC GRADE (serous tumors): High grade. VASCULAR INVASION: TUMOR CAPSULE: Intact. SURFACE IMPLANTS: Invasive. SURFACE IMPLANT SITE: Uterus, Fallopian Tubes, Omentum, Peritoneal metastasis beyond the pelvis. SURFACE IMPLANT SIZE: > 2 cm. MALIGNANT CELLS IN ASCITES OR. PERITONEAL WASHING: LYMPH NODES EXAMINED: Total number of lymph nodes examined: 2. LYMPH NODES POSITIVE: Number of positive lymph nodes, Right: 2. Number of positive lymph nodes, Left: 0. EXTRANODAL EXTENSION: T STAGE, PATHOLOGIC: T STAGE, PATHOLOGIC. T STAGE, PATHOLOGIC continued. pT3c. N STAGE, PATHOLOGIC: pN1. M STAGE, PATHOLOGIC: pM1. FIGO STAGE: IV.",train,17.5 cm
4140,TCGA-BP-4176.104bb086-299d-4aa3-a07b-27066d1d036f,"Clinical Diagnosis & History: with right renal mass. Specimens Submitted: 1: SP: Kidney, right, nephrectomy. DIAGNOSIS: 1. SP: Kidney, right, nephrectomy. Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. Fuhrman Nuclear Grade: Nuclear grade II/IV. Tumor Size: Greatest diameter is 4.5 cm. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Unremarkable. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT1 Tumor <= 7.0 cm in greatest dimension limited to the kidney. Gross Description: 1). The specimen is received fresh for frozen section diagnosis, labeled, ""Right kidney"". It consists of a 26.0 X 12.0 x 6.5 cm. nephrectomy specimen with abundant attached perinephric fat. The specimen is bivalved revealing a 10.0 x 6.0 x 5.0 cm kidney. with a 4.5 x 4.5x3.5 cm circumscribed yellow mass within the renal cortex mid-pole and extending into the adjacent perinephric. fat. Gross hemorrhage is identified. The mass does not extend into the pelvi-calyceal system. The renal vein is grossly. uninvolved by tumor. The adrenal gland is not present within the specimen. The specimen is serially sectioned. for. lymph. node. identification and no lymph nodes are grossly identified. The remaining renal parenchyma is serially sectioned at 0.5 cm intervals. and does not reveal any other grossly obvious lesions. TPS and photographs are taken. Summary of Sections: FSC - frozen section control. MARG - vascular and ureteral margins. NL - representative normal. MASS - multiple sections of mass. Summary of Sections: Part 1: SP: Kidney, right, nephrectomy (fs) (pjm/Img). Block. Sect. Site. PCs. 1. fsc. 1. 1. marg. 1. 6. mass. 6. 1. nl. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: RENAL CELL CARCINOMA, CONVENTIONAL. PERMANENT DIAGNOSIS:SAME.",train,4.5 cm
4153,TCGA-HC-7738.374827be-3cc2-4da8-a815-40539e441ccd,"FINAL SURGICAL PATHOLOGY REPORT. Diagnosis: PROSTATE, RADICAL PROSTATECTOMY: - Prostatic adenocarcinoma, Gleason score 3 + 4 =. 7. - Multifocal, largest focus 1.7 cm. - Involves right and left prostate. - No extraprostatic extension identified. - Perineural invasion present. - Surgical margins free of tumor. PATHOLOGIC TUMOR STAGING SYNOPSIS: Type and grade: Prostatic adenocarcinoma, Gleason score 3 + 4 = 7. Primary tumor: pT2c. Regional lymph node: pNX. Distant metastasis: pMX. Pathologic stage: IIB. Lymphovascular invasion: Not identified. Perineural invasion: Present. Margin status: R0, negative. FINAL SURGICAL PATHOLOGY REPORT. Prostate Tumor Staging Information. (data derived from current specimen, staging in accordance with or modified from AJCC Cancer Staging. Handbook, 7th Ed, and CAP protocol,. Procedure: Radical prostatectomy. Specimen type: Prostatectomy. Prostate size/weight: 52 grams, 4.5 X 4.0 X 3.5 cm. Tumor Features: Tumor site: Right and left prostate lobes. Tumor size: Multifocal, largest focus 1.7 cm. Tumor quantification: 5% of prostate gland. Histologic type: Prostatic adenocarcinoma. Histologic grade (Gleason pattern): Primary pattern: 3. Secondary pattern: 4. Tertiary pattern: N/A. Total Gleason score: 7. Lymphovascular invasion: Not identified. Perineural invasion: Present. Extraprostatic extension: Not identified. Seminal vesicle invasion: Not identified. Treatment effect: N/A. Lymph Nodes: N/A. Margin Evaluation: Distance to closest margin: 0.1 cm from left lateral margin. Other margins: 0.2 cm from right lateral and posterior margins. Pathologic tumor staging descriptors: Primary tumor (pT): pT2c. Regional lymph nodes (pN): pNX. Distant metastasis (pM): pMX. Margin status (R): R0, negative. Pathologic stage: IIB. Additional findings: High-grade prostatic intraepithelial neoplasia. Comment: N/A. FINAL SURGICAL PATHOLOGY REPORT. Source of Specimen: Prostate. Clinical History/Operative Dx: Malignant neoplasm prostate. Gross Description: The specimen is labeled prostate and is received in formalin. It consists of a prostatectomy specimen. weighing 52 grams. The prostate gland measures 4.5 x 4 X 3.5 cm and weighs 52 grams. It includes a 2.3. X 1.2 X 1 cm portion of right seminal vesicle, a 1 cm segment of right vas deferens, a 1.2 cm segment of. left vas deferens, and a 2 X 1.7 X 0.8 cm left seminal vesicle. The right anterior surface of the prostate is. inked blue, the left anterior surface is inked green, and the posterior surface is inked black. The prostatic. apex, bladder neck, and seminal vesicles/vasa are trimmed. The prostate is divided into right and left. halves and is sectioned from apex to bladder neck. In the apical third of the right prostate, there is a 0.7. cm circumscribed area of firm yellowish discoloration suggestive of neoplasm. There is very patchy, small,. yellowish discoloration of the corresponding portion of the left apical prostate. The prostatic gland. parenchyma is otherwise tan and shows bulging yellow nodularity in the periurethral region bilaterally. Also in the specimen container are three cylindrical fragments of pale tan tissue suggestive of portions of. vasa varying from 1.1-1.8 cm in length and up to 0.4 cm in diameter. Representative sections are. submitted. Section summary: A1) right prostatic apex, A2) left prostatic apex, A3) right bladder neck, A4). left bladder neck, A5) surgical margin right vas deferens, right seminal vesicle, A6) surgical margin left vas. deferens, left seminal vesicle, A7-A22) prostate, apex-bladder neck, A23) sections of separate tissue. Microscopic Description: Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered.",train,1.7 cm;1.7 cm;0.7. cm
4201,TCGA-44-3396.6a7ec9e8-ea86-4c3b-9d0e-9564e41311b5,"SPECIMEN. A. Pericardial reflection node. B. Right upper and middle lobe. C. Lymph node level 11. D. Lymph node 4R. E. Lymph node 2R. F. Lymph node level 9. CLINICAL NOTES. Non-small cell lung cancer. FROZEN SECTION DIAGNOSIS. A) Lymph node, pericardial reflection node, excision - Metastatic. non small cell carcinoma. GROSS DESCRIPTION. A. Received fresh for frozen section labeled ""pericardial. reflection node"" are irregularly shaped fragments of tan tissue. that. measure 0.6 X 0.6 x 0.4 cm in aggregate dimension. The tissue is. entirely frozen. B. Received fresh, subsequently fixed and inflated with. formalin labelled ""bilobe right upper and middle lobe"" is. a. 14.0 X 12.0 x 5,7 cm portion of lung which is grossly consistent. with the upper and middle lobe of the right lung. The pleural is. violaceous smooth glistening with black stippling present showing a. 3.0 cm umbilication at the fissure of the middle and upper lobe. This focus is inked and the specimen is sectioned to show a large. white-gray firm mass which is 5.5 x 5.0 X 3. cm. The tumor is. contiguous with the umbilication and is also present at the base of. the middle lobe. There are staples present at this area. This. area. is inked and on sectioning shows no discrete tumor invading the. stapled tissue. The remainder of the parenchyma is red-brown and. fleshy, Few hilar nodes are grossly identified. The tumor comes. within 1.5 cm of the bronchial margin. Representative sections of. GROSS DESCRIPTION. the specimen are submitted as follows: BLOCK SUMMARY 1 - brochial and vascular margins; 2-5 -. representative section of tumor to umbilication and normal; 6 -. representative section of tumor to base at stapled aspect of middle. lobe; 7 - tumor to bronchus; 8 - representative normal; 9-10. possible hilar lymph node (block 10 is bisected) . RS-10. C. Received fresh subsequently fixed in formalin labeled. ""lymph node level 11"" is a 1 X 0.5 X 0.4 cm black red. irregular soft tissue fragment which is entirely submitted in one. cassette. AS-1. D. Received fresh subsequently fixed in formalin labeled. 'lymph node 4R"" are two red black pink irregular soft. tissue fragments which are 0.6 cm each in greatest dimension. The. specimens are entirely submitted in one cassette. AS-1. E. Received fresh subsequently fixed in formalin labeled. ""lymph node 2R"" are multiple pink yellow black irregular. soft to hard tissue fragments which have an aggregate measurement. of. 2.2 X 1.5 x 0.7 cm. The specimens are entirely submitted in one. cassette. AS-1. F. Received fresh subsequently fixed in formalin labeled. ""lymph node level 9"" is a 2 x 0.7 x 0.3 cm pink black. irregular soft tissue fragment which is entirely submitted in one. cassette. AS-1. MICROSCOPIC DESCRIPTION. Histologic type : Adenocarcinoma. Histologic grade: Poorly differentiated. Primary tumor (pT) : The tumor measures 5.5 cm. in dimension and is. present within less than 0.2 cm. of the bronchial margin of. excision, PT2. Margins of resection: Invasive carcinoma is present in soft tissue. MICROSCOPIC DESCRIPTION. of the lung within 0.2 cm. of the bronchial margin of excision. Direct extension of tumor: Tumor shows multifocal areas of. extension up to and focally into the pleural but is not identified. on the pleural surface. Vessel invasion: Present. Regional lymph nodes (pN) : Tumor shows involvement of hilar lymph. nodes which appears to be direct extension, although metastases can. not be excluded. Metastatic carcinoma is identified in a. pericardial reflection node, pN2 . Distant metastasis (pM) : pMx. 14x1, 3x5, 5x1. DIAGNOSIS. A. Lymph node, pericardial reflection node, excision - One lymph. node positive for metastatic carcnoma (1/1) . B. Lung, right upper and middle lobe, excision - Invasive poorly. differentiated adenocarcinoma (see tumor characteristics in. the lung resection template in the microscopic description) . C. Lymph node, level 11, excision - One lymph node negative for. metastatic carcinoma (0/1). D. Lymph node, level 4R, excision - Two lymph nodes negative for. metastatic carcinoma (0/2). E. Lymph node, level 2R, excision - Fragments of lymph node. negative for metastatic carcinoma. F. Lymph node, level 9, excision - One lymph node negative for. metastatic carcinoma (0/1). --- End Of Report ---. E. Received fresh subsequently fixed in formalin labeled. ""level 5"" is a 1.5 X 1.0 X 0.7 cm. black pink tan. irregular. rubbery tissue fragment. The specimen is bisected to show a white. firm rubbery nodule which is entirely submitted in one cassette. AS-1. F. Received fresh and subsequently fixed in formalin. labeled ""level 4 is a 0.5 x 0.3 X 0.3 cm pink-red. irregular. soft tissue fragment which is entirely submitted in one cassette. AS-1. MICROSCOPIC DESCRIPTION. A. The following template applies to the left lower lobe. wedge resection: Histologic type : Adenocarcinoma. Histologic grade : Poorly differentiated. Primary tumor (pT) : 1.7 cm (pT1). Margins of resection Uninvolved. Venous (large vessel) invasion: Not identified. Arterial (large vessel) invasion: Not identified. Lymphatic (small vessel) invasion: Not identified. MICROSCOPIC DESCRIPTION. Regional lymph nodes (pN) : See specimen E below. Distant metastasis (pM) : Cannot be evaluated by this specimen. (pMX). Other findings: None. B. The following template applies to the left upper lobe. wedge resection: Histologic type: Adenocarcinoma. Histologic grade : Poorly differentiated. Primary tumor (pT) : 1.8 cm (pT1). Margins of resection: Uninvolved. Direct extension of tumor: Tumor invades the visceral pleura. Venous (large vessel) invasion: Not identified. Arterial (large vessel) invasion: Not identified. Lymphatic (small vessel) invasion: Not identified. Regional lymph nodes (pN) : See specimen E below. Distant metastasis (pM) : Cannot be evaluated by this specimen. (pMX). Other findings: None. C. The level 7 lymph node demonstrates no evidence of. metastasis in one node. D. The level 6 lymph node demonstrates two lymph nodes. with. no evidence of metastatic disease. E. The level 5 lymph node demonstrates metastatic poorly. differentiated carcinoma involving one lymph node. The size of the. metastasis is 1.5 cm. F. The level 4 lymph node demonstrates no evidence of. metastasis in one lymph node. MICROSCOPIC DESCRIPTION. 14x2, 4x2, 3x4. DIAGNOSIS. A. Lung, left lower lobe, wide resection: - Poorly differentiated adenocarcinoma, 1.7 cm, surgical. margins uninvolved. B. Lung, left upper lobe, wedge resection: - Poorly differentiated adenocarcinoma, 1.8 cm, surgical. margins uninvolved. C. Level 7 lymph node, resection: - No evidence of metastasis to one lymph node (0/1). D. Level 6 lymph node, resection: - No evidence of metastasis to two lymph nodes (0/2). E. Level 5 lymph node, resection: - Metastatic adenocarcinoma involving one lymph node, size of. metastasis 1.5 cm. F. Level 4 lymph node, resection: - No evidence of metastasis to one node (0/1).",train,5.5 cm;1.7 cm;1.8 cm;1.7 cm;1.8 cm
4286,TCGA-FD-A3N5.9E5D7033-E1B3-47A8-9526-D45B3113A54C,"Gender: Male. Race: Unknown. Report Date: FINAL PATHOLOGIC DIAGNOSIS. A. Right pelvic lymph nodes; dissection: - Nine lymph nodes, no tumor present (0/9). B. Left pelvic lymph nodes; dissection: - Seven lymph nodes, no tumor present (0/7). (See comment). C. Bladder, prostate, seminal vesicles, vas deferens; cystoprostatectomy: - Urothelial carcinoma, high grade, with extensive squamous differentiation. and. keratin production, invasive into muscularis propria. No lymphovascular invasion present. - Margins of resection (soft tissue,. prostatic urethra, right and left ureter),. no tumor present. - Extensive chronic lymphoplasmacytic inflammatory response and follicular. hyperplasia. in the extravesical adipose tissue. - See pathologic parameters and comment. - Prostate with high grade prostatic intraepithelial neoplasia (PIN). - Bilateral seminal vesicles and vasa deferentia, no tumor present. D. Urethral margin; resection: - Segment of prostatic urethra, no tumor present. Urothelial Carcinoma Pathologic Parameters. 1. Tumor type: Urothelial carcinoma with extensive squamous. differentiation. 2. Grade of tumor: High grade. 3. Depth of invasion: Muscularis propria, outer half. 4. Tumor distribution: Solitary, 7.0 x 3.5 x 3.0 cm. Involving right wall, anterior wall, posterior wall and dome. 5. Ureteral margins: Negative6. Distal urethral margin: Negative. 7. Soft tissue margin: Negative. 8. Lymph nodes: Sixteen lymph nodes, no tumor present (0/16). 9. pTNM: pT2b, NO, MX. Effective. I this Checklist utilizes the 7th edition TNM staging. system for Bladder of the American Joint Committee on Cancer (AJCC) and the. Comment. Part B5: The sections show a lymph node with fibrosis and plasmacytic. infiltrate. The immunohistochemical stain Cam5.2 is positive in rare dendritic. cells. Part C: The majority of tumor shows extensive squamous differentiation with. keratin production (99%). M.D. Interpretation performed by the Attending Pathologist and reviewed with the. Resident/Fellow,  M.D., Ph.D. M.D. Clinical History: The patient is a. year-old male with bladder cancer who undergoes. prostatectomy and ileal conduit. Specimens Received: A: Right pelvic lymphnodes. B: Left pelvic lymphnodes. C: Bladder, prostate, seminal vesicles, vas deferens. D: Urethral margin. Gross Description: The specimen is received in four containers, each labeled with the patient's. name and medical record number. A. The first container is additionally designated ""1. right pelvic lymph. nodes"". Received fresh and placed in formalin is a 5.0 x 4.0 x 3.0 cm aggregate. of fibrofatty tissue which is dissected to reveal multiple tentative lymph nodes. range in size from 0.5 to 2.5 cm. The lymph nodes are entirely submitted as. follows: A1-A5: one node, bisected in each cassette. A6: four lymph nodes. B. The second container is additionally designated ""2. left pelvic lymph. nodes"". Received fresh and placed in formalin is a 6.5 x 4.5 x 2.0 cm aggregate. of fibrofatty tissue which is dissected to reveal multiple tentative lymph nodes. range in size from 0.5 to 3.0 cm. The lymph nodes are entirely submitted as. follows: B1-B2: largest node, bisected. B3: one lymph node, bisected. B4: one lymph node, bisected. B5: four lymph nodes between sponges. B6: adjacent fibrous tissue. C. The third container is additionally designated ""3. bladder, prostate,. seminal vesicles, vas deferens"". Received fresh and placed in formalin is a 303. gram, 14.5 x 9.5 x 3.0 cm cystoprostatectomy specimen with attached mesenteric. fat. The bladder measures 9.0 x 8.0 x 3.0 cm. The right ureteral stump. measures 0.5 cm and the left 0.3 cm. Both demonstrate patent lumina. The. prostate measures 4.5 x 4.3 x 4.0 cm. The right seminal vesicle measures 4.5. x. 3.5 x 2.0 cm. The right vas deferens measures 8.5 x 1.0 cm. The left seminal. vesicles measures 4.0 x 3.0 x 1.5 cm. The left vas deferens measures 4.5 x 1.0. cm. The right half of the prostate and bladder is inked blue and the left half. is inked black. The prostate is opened anteriorly along the urethra and. continues superiorly through the bladder in a Y-shaped incision. The prostate. is serially sectioned from apex to base to reveal a firm white 0.6 cm nodule. grossly abutting the black inked margin. The remainder of the prostate is. unremarkable. The seminal vesicles are markedly dilated and filled with a. yellow-green gelatinous fluid. The bladder demonstrates a 7.0 x 3.5 x 3.0 cm. fungating friable yellow-tar mass grossly involving the right wall, anterior. wall, posterior wall and the dome of the bladder. Serially sectioning reveals. tumor invasion into the muscularis propria to a depth of 3.0 cm extending to. within 0.5 cm of the inked margin. The remainder of the bladder mucosa is. tan-brown, edematous and glistening with a uniform 0.3 cm wall thickness. The. bilateral ureteral orifices are identified and probe patent. Representative. sections are submitted as follows: C1: urethral margin. C2: right ureteral margin, between sponges. C3: left ureteral margin, between sponges. C4: prostatic apical margin. C5-C11: representative prostate. C12: seminal vesicles and vasa deferentia. C13-C18: mass from inferior to superior. C19: right ureteral orifice. C20: left ureteral orifice. C21: dome. C22: anterior wall. C23: posterior wall. C24: left wall. C25: trigone. D. The fourth container is additionally designated ""4. urethral margin"". Received fresh and placed in formalin is an unremarkable-oriented 1.5 x 1.0 x. 0.5 cm portion of tissue which is focally cauterized. The specimen is serially. sectioned and entirely submitted in cassette D1. , M.D.",train,7.0 x 3.5 x 3.0 cm;3.0 cm
4306,TCGA-XP-A8T8.3CA9BE22-CEFC-4970-A4FC-95D235386C84,"Nature of material: Esophagus. ANATOMOPATHOLOGIC RESULT. MACROSCOPY. Received 3 vials, identified as follows: Vial 1 (Esophagus): Received in formalin, surgical specimen represented by the esophagus. and proximal stomach, previously opened at its greatest diameter, weighing 79 grams. The. esophagus measures 11.5 X 2.2 X 1.5 cm while the stomach measures 7.5 cm in length and 3.1. cm in diameter, lying stapled at its distal end. The outer surface of the esophagus is grayish and. rough without drilling or infiltration areas. Its wall is whitish and shows thickening in its middle. third, where is observed infiltrating and ulcerated mucosal lesion with 2.1 cm in length. The. lesion is 4.1 cm distant from closer surgical margin (distal). The stomach segment displays. brown and smooth serous. To the cuts, the mucosa is brown and wrinkled, without macroscopic. lesions. The dissection of the fat adjacent to the viscera shows nodular, gray and fibroelastic. structures, with higher measures ranging from 0.3 to 0.9 cm. - Vial 2 (Lymph node): nodular, gray and fibroelastic structure, with smooth outer surface and. absence of macroscopic lesion to the cuts, measuring 0.8 X 0.5 X 0.3 cm. - Vial 3 (Liver): brown tissue fragment, hardened and rectangular, measuring 0.5 X 0.3 X 0.3 cm. MICROSCOPY. Description dispensable. DIAGNOSTIC. Product of esophagectomy and partial gastrectomy: -Well-differentiated squamous cell carcinoma, focally ulcerated in the middle third of the. esophagus, associated with extensive in-situ component. -Predominance of areas with squamous cell carcinoma in situ, being that the neoplasm has. macroscopic measure 2.2 X 2.1 cm. -Macroscopic shape: ulcerated and infiltrative. -Degree of infiltration: submucosa. -Discrete desmoplastic stromal reaction. -Absence of lymphoid aggregates in the peritumoral stroma. -Absence of vascular infiltration. -Absence of perineural infiltration. -Free surgical margins. -Metastasis in 1 of 10 evaluated lymph nodes (1/10). -Gastric mucosa of body/fundus standard with moderate chronic inflammatory process, focally. active. Positive resence for Helicobacter pylori in small quantity. -Pathological staging pT1b pN1. Product of liver biopsy: -Steatohepatitis stage 3, with moderate steatosis (40% of the fragment). PARTICIPANTS OF APPRAISAL REPORT. - ISSUER. - REVIEWER.",train,2.2 X 2.1 cm
4310,TCGA-D8-A1XL.762963FB-3D8C-4616-8C8C-0CD3E45FD243,"page 1 / 2. conv No. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: 1. lesion excision - from the left breast outer upper quadrant. Unit in charge: Central C. Expected time of examination: 5 working days. Clinical diagnosis: and left axillary nodes in one block. Results of immunohistochemicarexaminanon: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell. nuclei. HER2 protein stained with HercepTestM by DAKO. Score = 2+, FISH verification recommended. Macroscopic description: Partial resection of breast - outer upper quadrant. Breast segment sized 8.4 x 7.4 x 2.6 cm with a 2.8 x 6.8 cm skin flap and axillary tissue sized 8 x 9 x 2, no RTG. Tumour cross section sized 3.0 x 1.8 x 2.9 cm. Margin: to the base 0.1 cm, to the front skin surface 0.2 cm, to the sternum 3.5 cm, to the axilla 2.2 cm, to the shoulder 1.3 cm,. lower 0.8 cm. Microscopic description: Carcinoma ductale invasivum NHG3 (3 + 2 + 3/19 mitoses/10 HPF - visual area of 0.55 mm). Largest dimension of the lesion 3.0 cm. Minimum margin at the base side < 0.05 cm. The other margins as in macroscopic description. Lymph nodes: Metastases carcinomatosae in lymphonodis (No II / XIII). Infiltratio carcinomatosa capsulae lymphonodorum et telae adiposae perinodalis. Histopathological diagnosis: Carcinoma ductale invasivum NHG3, pT2, pN1a. Invasive ductal carcinoma of the left breast. Compliance validated t. Examination: Intraoperative examination. page 2 / 2. Fyamination No.: Results of immunohistochemical. examination: RESULT OF HER2/neu GENE AMPLIFICATION with the FISH method by Path Vysion HER2 DNA Probe Kit. HER-2 GENE AMPLIFICATION NOT FOUND.",train,3.0 x 1.8 x 2.9 cm;3.0 cm
4312,TCGA-R8-A6MK.0E083D5C-1EE1-4BDA-9D6E-93420C3BAE39,"M. (178.0cm 86.2kg BSA: 2.06m. MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A) RIGHT FRONTAL BRAIN MASS. OLIGODENDROGLIOMA, GRADE 2 (WHO). (B) RIGHT FRONTAL BRAIN MASS -. OLIGODENDROGLIOMA, GRADE 2 (WHO). Entire report and diagnosis completed by. COMMENT. A 1p/19q analysis will be performed. GROSS DESCRIPTION. (A) RIGHT FRONTAL BRAIN MASS FOR RESEARCH - The specimen consists of a piece of cerebral cortex and underlying white. matter. measuring. 5.0 x 5,0 x 3.0 cm. On cut surface is a delineated gray-white junction seen in the majority of the specimen. However, a portion shows an obscure gray-white junction. This portion is submitted for frozen section and smear in cassette A1. An additional representative section is submitted in cassettes A2-A10. Specimens are also sent for research studies. FS/DX: LOW-INTERMEDIATE GRADE INFILTRATING GLIOMA. (B) RIGHT FRONTAL BRAIN MASS - The specimen is received fresh in one container labeled with the patient's name, medical. record. number. and. designation as right frontal brain mass. The specimen consists of two irregular fragments of yellow to white-tan. tissue. One. fragment measures 3.2 x 2.4 x 0.7 cm and the other fragment measures 2.7 x 2.4 x 0.8 cm. The cut surface of the. specimen. is. white to yellow-tan and homogeneous, no focal lesions are identified. The entire specimen is submitted for histologic. examination. SECTION CODE: B1-B3, larger fragment of the specimen submitted entirely; B4-B6, the smaller fragment of specimen. submitted entirely. SNOMED CODES. T-A2000, M-94503. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". Released by: Start of ADDENDM. Page: 2. M. (178.0cm 86.2kg BSA: 2.06m. ADDENDUM. Real time PCR was performed for markers on chromosomes 1p and 199 and shows loss at both chromosomal arms. Combined. 1p/19q loss has been shown to correlate with the oligodendroglial lineage and may predict a more favorable response to adjuvant. therapy compared with tumors showing intact 1p/19q. Entire report and diagnosis completed by. Released by: END OF REPORT-.",train,
4371,TCGA-A7-A26I.CCE33A95-774E-4242-B2A1-05FF002ED1D9,"Date Coll: SPECIMEN. A. Left axillary sentinel node. B. Left breast mass. Long stitch anterior, short stitch superior. CLINICAL NOTES. PRE-OP DIAGNOSIS: Left breast cancer. CLINICAL HISTORY: year-old white female with breast cancer. POST-OP DIAGNOSIS: Left breast cancer. GROSS DESCRIPTION. A. Received fresh labeled ""left axillary sentinel nodes"". are two slightly rubbery tan-white-pink tissues in keeping. with lymph nodes measuring 0. and 1.0 cm. in greatest dimension. The specimens are bisected and entirely submitted independently in. two blocks (one bisected tissue per cassette). B. Received fresh within a TranSpec container labeled. 'left breast mass"" is a 7.3 cm. (medial to lateral) x 6.5. cm. (superior to inferior) x 3.7 cm. (anterior to posterior), soft,. lobulated tan gold-white portion of fibroadipose tissue with two. sutures as stated previously. The margins are inked as follows: Anterior - blue, posterior - black, superior - green, and inferior. orange. The specimen is sectioned from medial to lateral. There is. a central, moderately well-circumscribed, 3.2 cm. (medial to. lateral) x 2.5 cm. (superior to inferior) x 2.4 cm. (anterior to. posterior), firm tan white tumor mass with several central. associated cylindrical tan white structures in keeping with cyte of. prior needle core biopsy. A portion of tumor and a portion of. normal parenchyma are submitted for tissue procurement as requested. The tumor appears to focally extend to within 0.3 cm. of both the. anterior and posterior inked margins. The cut surfaces throughout. the remainder of the specimen consist predominantly of glistening. lobulated golden yellow adipose tissue with a minimal amount of. interspersed dense tan-white fibrous tissue. No additional. abnormality is noted. Representative sections are submitted in. a. sequential manner from medial to lateral in 10 blocks as labeled. BLOCK SUMMARY: 1 - Representative perpendicular sections medial. margin cap; 2-9 sequential sections; 10 - representative. perpendicular sections lateral margin cap. MICROSCOPIC DESCRIPTION. A. Microscopic examination involved the evaluation of the. four H&E stained sections of each of the tissue blocks. Also pan cytokeratin AE1/AE3 immunohistochemical stains were. evaluated of each tissue block and no metastatic tumor was. identified in any of the examined sections (0/2) (snpNO). B. Microscopic examination of the left breast lumpectomy. specimen reveals: Invasive Carcinoma: Present. Histologic type: Infiltrating ductal. Histologic grade: Elston's SBR grade 2. Overall grade: 2. Architectural score: 2. Nuclear score: 2. Mitotic score: 2. Greatest dimension (pT) : 3.2 cm. in greatest dimension (pT2). Specimen margins: The resection margins are negative for. carcinoma with the closest resection margins being superior and. anterior where invasive tumor is 2 mm. from the resection. margin. Tumor is 3 mm from the posterior resection margin. Vessel invasion: Not identified. Calcification: Present. Ductal carcinoma in situ: Present. Histologic pattern: Solid with cancerization of lobules. Nuclear grade: High grade. Central necrosis: Absent. % DCIS of total tumor (if mixed) : Less than 10%. Extensive intraductal component (present/absent) : Absent. Specimen margins: DCIS is 2 mm from the anterior and superior. margins and 3 mm from the posterior margin. Calcification: not identified. Description of non-tumorous breast: Fibrosis, apocrine metaplasia. and microcysts with sclerosing adenosis. Prognostic markers, Umpon been reported previously on the core. biopsy see. 4x2, 20x1. DIAGNOSIS. A. Left axillary sentinel lymph nodes, biopsy: Two lymph nodes negative for metastatic tumor (0/2). B. Left) breast, lumpectomy: Invasive ductal carcinoma, Elston's SBR grade 2, tumor size. 3.2 cm. Associated high grade solid ductal carcinoma in-situ. Invasive and in-situ carcinoma are 2 mm from the resection. margins designated superior and anterior and 3 mm from the. resection margin designated posterior. No lymphovascular space invasion identified. See microscopic description. (Electronic Signature). End Of Report ---.",train,3.2 cm;3.2 cm
4403,TCGA-B5-A1N2.CB8D6955-D74A-4A05-ACC3-F0DE49CC60A9,"CLINICAL HTCTORY: Per. serous carcinoma uterus. GROSS EXAMINATION: A. ""Right common iliac node"", received fresh for frozen and later placed in. formalin at. on. is a 3 x 1.5 x 0.3 cm lymph node. Representative sections submitted for frozen as AF1, frozen section remnant. submitted in block A1. Remaining lymph node is submitted in block A2. B. ""Uterus, cervix, bilateral tubes and ovaries"", received fresh and placed in. formalin at. on. is a 390 gram (post fixed weight), 14.5 x 2 x 7.5. cm uterus with a 2.2 cm in diameter cervix with a 1 cm patent os. The serosa. is pink-tan with eight subserosal nodules, ranging from 0.3 to 3.6 cm in. greatest dimension. A 1.1 x 0.9 x 0.3 cm pedunculated subserosal nodule is. present. The serosa is inked black. A 0.5 x 0.3 x 0.2 cm cyst is seen in the. anterior endocervical canal, 1.3 cm away from the ectocervix. The surrounding. tissue of the cervix is inked blue. A 10.2 x 8.5 cm area of irregularity is noted in the endometrial cavity,. centered in the fundus of the uterus and involving right and left cornu. The. majority of the lesion overlies the 6.2 x 8.5 x 4.5 cm submucosal diffusely. calcified white whorled like nodule. The lesion extends to 4.7 cm away from. the anterior ectocervix. On cut surface the endometrium is 0.2 cm in. thickness and the myometrium is 1.6 cm in thickness. The lesion grossly. extends into the inner third of the myometrium. A 3.8 x 2.2 x 2.8 cm. endometrial polyp is seen adjacent to the right cornu. The polyp is 0.5 cm. away from the primary lesion. Further sectioning reveals three intramural. white whorled like nodules ranging from 0.5 through 1.4 cm in greatest. dimension. A 1.1 x 0.9 x 0.7 cm calcified submucosal nodule is seen in the. posterior segment of the uterus. The right fallopian tube is 8.5 cm in length x 0.6 cm in diameter, sectioning. reveals no masses or lesions. The right ovary is 3.5 x 2.4 x 1.3 cm with a. 1.5. x 1.1 x 0.9 cm simple cyst. Sectioning reveals yellow lobulated cut. surface with a simple uniloculated cyst with no excrescences. The left. fallopian tube is 8.3 cm in length and 0.8 cm in diameter, sectioning reveals. no masses or lesions. The left ovary is 3 x 1.6 x 0.5 cm. The cut surface is. yellow-tan and lobulated with no grossly evident masses or lesions. BLOCK SUMMARY: B1-. pedunculated nodule on the serosa. B2-. anterior endocervical canal and lower uterine segment. B3-. representative section of cyst in the anterior lower uterine segment. B4-. posterior lower uterine segment and endocervical canal. B5-6-. representative full thickness sections of the lesion. B7-10- representative sections of the lesion. B11-. lesion with respect to anterior lower uterine segment. B12-. representative full thickness of normal anterior segment of the uterus. B13-. representative full thickness section of posterior segment of uterus. B14-. representative sections of right fallopian tube and ovary with cyst. B15-. representative sections of left fallopian tube and ovary. B16-. representative section of intramural nodules. B17-. representative section of subserosal nodule. B18-. representative section of endometrial polyp. INTRA OPERATIVE CONSULTATION: A. ""Right common iliac node"":AF1 (representative) -metastatic carcinoma present. MICROSCOPIC EXAMINATION: Microscopic examination is performed. PATHOLOGIC STAGE: PROCEDURE: HYSTERECTOMY, BILATERAL SALPINGO-OOPHORECTOMY, LYMPH NODE BIOPSY. PATHOLOGIC STAGE (AJCC 7th Edition) : pT3a pN1 pMX. NOTE: Information on pathology stage and the operative procedure is. transmitted to this Institution's Cancer Registry as required for. accreditation by the Commission on Cancer. Pathology stage is based solely. upon the current tissue specimen being evaluated, and does not incorporate. information on any specimens submitted separately to our Cytology section,. past pathology information, imaging studies, or clinical or operative. findings. Pathology stage is only a component to be considered in determining. the clinical stage, and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon's operative report. DIAGNOSIS: A. ""RIGHT COMMON ILIAC NODE"" (BIOPSY) : METASTATIC ADENOCARCINOMA IN ONE LYMPH NODE (1/1/). SIZE OF METASTASIS: 0.6 CM AT LEAST. FOCAL EXTRACAPSULAR EXTENSION IS PRESENT. B. ""UTERUS, CERVIX, BILATERAL TUBES AND OVARIES"" (HYSTERECTOMY AND BILATERAL. SALPINGOOOPHORECTOMY) : UTERUS, 390 GRAMS: CARCINOMA OF THE ENDOMETRIUM: TUMOR SITE: DIFFUSE. HISTOLOGIC TYPE: SEROUS ADENOCARCINOMA. FIGO GRADE: NOT APPLICABLE. TUMOR SIZE: 10.2 CM IN GREATEST DIMENSION. MAXIMUM DEPTH OF MYOMETRIAL INVASION: SEE COMMENT. LYMPHATIC/VASCULAR INVASION: PRESENT, EXTENSIVE. ADJACENT NON-NEOPLASTIC ENDOMETRIUM: ENDOMETRIAL POLYP. REMAINING MYOMETRIUM: ADENOMYOSIS. MULTIPLE BENIGN LEIOMYOMAS, UP TO 6.2 CM. CERVIX: CARCINOMA INVOLVES ENDOCERVICAL MUCOSA. CERVICAL STROMA FREE OF CARCINOMA. SEROSA: FREE OF CARCINOMA. SPECIMEN MARGINS: NOT INVOLVED. RIGHT OVARY: CARCINOMA PRESENT WITHIN OVARIAN STROMA. BENIGN BRENNER TUMOR, 0.9 CM. LEFT OVARY: NO CARCINOMA IDENTIFIED. BENIGN BRENNER TUMOR, 0.9 CM. FALLOPIAN TUBES, RIGHT AND LEFT: NO PATHOLOGIC DIAGNOSIS. COMMENT: The maximum depth of definitive tumor tissue invasion is. approximately 2 mm in a 1.6 cm thick myometrium. Carcinoma is extensively. present within the outer half of the myometrium, but at this depth the tumor. appears to be confined within vascular spaces. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es).",train,0.9 CM;10.2 CM;0.9 cm;6.2 CM
4436,TCGA-B0-4823.690f1249-5e3c-4c07-951e-7168dc0da62a,"FINAL DIAGNOSIS. KIONEY, RIGHT, HAND-ASSISTED LAPAROSCOPIC RADICAL NEPHRECTOMY -. A. RENAL CELL CARCINOMA, CLEAR CELL (CONVENTIONAL) TYPE, MODERATELY DIFFERENTIATED, FUHRMAN. GRADE 2/4 (3.5 CM.). B. THE TUMOR DOES NOT INVADE THE RENAL CAPSULE NOR THE RENAL VEIN. C. ALL SURGICAL RESECTION MARGINS ARE NEGATIVE FOR MALIGNANCY. D. FOCAL CHRONIC TUBULAR INTERSTITIAL DISEASE IN THE RENAL PARENCHYMA. E. RIGHT ADRENAL GLAND WITH NODULAR HYPERPLASIA, WITH NO EVIDENCE OF MALIGNANCY. F. TNM STAGE: pT1A, NX, MX. Final Diagnosis. RECEIVED 17 SLIDES. LABELED ""RIGHT KIDNEY MASS, FINE NEEDLE ASPIRATION"": A. EXTREMELY SCANT SPECIMEN INSUFFICIENT FOR DEFINITIVE DIAGNOSIS. (see comment). B. RARE ATYPICAL CLEAR CELLS NOTED. (see comment). C. Rare glomeruli and tubular cells noted. Comment: Twelve smears, 3 Thinprep slides, and 2 cell block slides were reviewed. The aspirate is very scant and predominantly consists of blood. One (slide 1C2) of the cell block slides show rare atypical clear cells with some scattered hemosiderin pigment. However,. the paucity of the atypical cells precludes a definitive diagnosis. Rare glomeruli and benign tubular cells are also. identified. Repeat sampling is recommended for a definitive diagnosis.",train,3.5 CM
4450,TCGA-W5-AA38.DE95FEF2-B511-434D-8136-C6B7EF3C0507,"SLIDE DISPOSITION: DIAGNOSIS: A. Liver, portion of segment VIII, wedge resection: Subcapsular. fibrosis with associated acellular debris (2.8 X 1.8 X 0.8 cm) . Negative for tumor. B. Liver, additional portion of segment VIII, wedge resection: Poorly-differentiated cholangiocarcinoma forming a 1.4 X 1.2 x 1.1. cm mass. The surgical resection margin is negative for tumor (free. by 0. cm). This final pathology report is based on the gross/macroscopic. examination and the frozen section histologic evaluation of the. specimen(s) Hematoxylin and Eosin (H&E) permanent sections are. reviewed to confirm these findings. Any substantive changes. identified on permanent section review will be reflected in a. revised report. GROSS DESCRIPTION: A. Received fresh labeled ""liver, portion of segment VIII"" is a. 10.92 gram, 3.8 X 2.9 x 2.2 cm liver wedge specimen. A 2.8 x 1.8. X. 0.8 cm necrotic mass is present, located 0.4 cm from the closest. surgical resection margin, which is inked black and submitted. perpendicularly. Representative sections are submitted. Grossed by. B. Received fresh labeled ""liver, additional portion of segment. VIII"" is a 9.19 gram, 3.7 x 2.3 x 1.9 cm liver wedge specimen. A. single 1. 4 x 1.2 x 1.1 cm tan-white mass is present, located 0.6 cm. from the closest surgical resection margin, which is submitted. perpendicularly. Representative sections are submitted. Grossed by. BLOCK SUMMARY: Part A: Liver-portion of segment. 8. 1 Liver segment 8-1. 2 Liver segment 8-2. 3 Liver segment 8-3. 4 Liver segment 8-4. 5 Liver segment 8-5. Part B: Liver-additional portion segment 8. 1 Liver segment 8 normal. 2 Add liver seg 8 mass. 3 Add liver seg 8 capsule.",train,1.4 X 1.2 x 1.1. cm
4463,TCGA-EK-A2H0.AEDD5CA3-2E0A-414F-AA38-CCF5229EC7F2,"PAGE: 1. 5 LOC: U#. AGE/SX: RM/BED: REG DR: TLOC: DIS : SPEC #: Obtained: CLINICAL HISTORY : LEFT EXTERNAL ILIAC (EVALUATE FOR SUCCEED). SPECIMEN/PROCEDURE: 1. LYMPH NODE - RIGHT OBTURATOR I. 2. LYMPH NODE - RIGHT EXTERNAL ILIAC. 3. LYMPH NODE - RIGHT COMMON ILIAC. 4. LYMPH NODE - RIGHT EXTERNAL ILIAC. 5. LYMPH NODE - RIGHT OBTURATOR. 6. CERVIX - BIOPSY TUMOR. 7. LYMPH NODE - LEFT EXTERNAL ILIAC. 8. LYMPH NODE - LEFT OBTURATOR. 9. LYMPH NODE - LEFT COMMON ILIAC. 10. LYMPH NODE - LEFT PARA-AORTIC. 11. LYMPH NODE - LEFT EXTERNAL ILIAC. IMPRESSION: 1). RIGHT OBTURATOR LYMPH NODE: Six lymph nodes are negative for tumor (0/6). 2). RIGHT EXTERNAL ILIAC LYMPH NODE: One lymph node are negative for tumor (0/1) . 3). RIGHT COMMON ILIAC LYMPH NODE: Seven lymph nodes are negative for tumor (0/7). 4). RIGHT EXTERNAL ILIAC LYMPH NODE: Three lymph nodes are negative for tumor (0/3). 5). RIGHT OBTURATOR ILIAC LYMPH NODE: Two lymph nodes are negative for tumor (0/2). 6). CERVICAL BIOPSY TUMOR: Squamous cell carcinoma, large cell keratinizing with stromal invasion. 7). LEFT EXTERNAL ILIAC LYMPH NODE: Seven lymph nodes are negative for tumor (0/7). 8). LEFT OBTURATOR ILIAC LYMPH NODE: Page: 2. SPEC #: IMPRESSION (continued). Two lymph nodes are negative for tumor (0/2). 9). LEFT COMMON ILIAC LYMPH NODE: One lymph node is negative for tumor (0/1). 10) LEFT PARAAORTIC ILIAC LYMPH NODE: Two lymph nodes are negative for tumor (0/2). 11) LEFT EXTERNAL ILIAC LYMPH NODE: Four lymph nodes are negative for tumor (0/4). Dictated. Entered: COMMENT: Thirty-five lymph nodes are negative for tumor. Entered: SPECIAL STAINS/PROCEDURES. Mucicarmine stain is negative. GROSS DESCRIPTION: 1). Received labeled with the patient's name and ""right obturator"" is a 2.5 x 2.0 x 0.9 cm. portion of yellow gold to pink tan fibroadipose tissue dissected for possible lymph. nodes. Six possible lymph nodes identified ranging from 0.3 cm to 1.5 cm in greatest. dimension and submitted as follows: CASSETTE SUMMARY. Cassette 1A: Five possible lymph nodes. Cassettes 1B-1C: One lymph node bisected. 2). Received labeled with the patient's name and ""right external iliac"" is a pink to pale. tan apparent lymph node with a small amount of adherent yellow gold adipose tissue. The specimen is 1.0 x 1.0 x 0.9 cm. The adherent adipose tissue is dissected free. The lymph node is bisected. Received labeled with the patient's name and ""right common iliac"" is a. 2.2 x 2.0 x 1.0 cm aggregate of pink to pale tan to yellow gold portions of. fibroadipose tissue dissected for possible lymph nodes. Received are seven pink to. pale tan tissue fragments ranging from 0.6 cm to 2.0 cm in greatest dimension. These. fragments are submitted as follows: SPEC #: GROSS DESCRIPTION (continued). CASSETTE SUMMARY. Cassette 3A: Five possible lymph nodes. Cassette 3B: Two possible lymph nodes. 4). Received labeled with the patient's name and ""right external iliac"" are three portions. of yellow gold to pink tan fibroadipose tissue ranging from 1.0 cm to 2.2 cm in. greatest dimension. The specimen is dissected for possible lymph nodes. Three. possible lymph nodes identified ranging from 0.5 to 1.4 cm in greatest dimension and. submitted as follows: CASSETTE SUMMARY. Cassette 4A: Two possible lymph nodes. Cassette 4B: One lymph node bisected. 5). Received labeled with the patient's name and ""right obturator"" is a 3.2 x 2.0 x 1.0 cm. aggregate of yellow gold to pink tan fibroadipose tissue dissected for possible lymph. nodes. Two possible lymph nodes identified ranging from 0.8 cm to 2.0 cm in greatest. dimension and submitted as follows: CASSETTE SUMMARY. Cassette 5A: One lymph node entirely submitted. Cassette 5B: One lymph node bisected. Received labeled with the patient's name and ""cervical biopsy tumor"" is a pale pink. tan hemorrhagic tissue fragment, 1.1 x 0.7 x 0.4 cm. The specimen is entirely. submitted in cassette #6. 7). Received labeled with the patient's name and ""left external iliac"" is a. 4.4 x 3.0 x 1.2 cm aggregate of pink to pale tan to yellow gold portions of. fibroadipose tissue dissected for possible lymph nodes. Five possible lymph nodes. identified ranging from 0.5 cm to 1.7 cm in greatest dimension and submitted as. follows: CASSETTE SUMMARY. Cassette 7A: Three possible lymph nodes. Cassette 7B: One lymph node trisected. Cassettes 7C-7D: One lymph node serially sectioned, entirely submitted. 8). Received labeled with the patient's name and ""left obturator"" is a portion of yellow. gold to pink tan fibroadipose tissue, 3.2 x 2.0 x 0.5 cm. The specimen is dissected. for possible lymph nodes. Two possible lymph nodes identified ranging from 0.8 cm to. 3.5 cm in greatest dimension and submitted as follows: CASSETTE SUMMARY. Cassette 8A: One possible lymph node. ?age: 4. SPEC #: Continued). GROSS DESCRIPTION: (continued). Cassettes 8B: One lymph node trisected. 9). Received labeled with the patient's name and ""left common iliac"" is a. 2.0 x 1.7 x 0.4 cm portion of yellow gold to pink tan fibroadipose tissue dissected. for possible lymph nodes. One lymph node identified, 1.0 x 0.4 x 0. cm. The. specimen is bisected and entirely submitted in cassette #9. 10). Received labeled with the patient's name and ""left para-aortic"" are two portions of. yellow gold to pink tan fibroadipose tissue ranging from 1.0 cm to 1.5 cm in greatest. dimension dissected for possible lymph nodes. Two possible lymph nodes identified. ranging from 0.5 cm to 0.7 cm in greatest dimension and submitted as follows: CASSETTE SUMMARY. Cassette 10: Two possible lymph nodes. 11) Received labeled with the patient's name and ""left external iliac"" are two portions of. yellow gold to pink tan fibroadipose tissue ranging from 1.7 cm to 2.1 cm in greatest. dimension dissected for possible lymph nodes. Two possible lymph nodes identified. ranging from 0.7 cm to 1.1 cm in greatest dimension and submitted as follows: CASSETTE SUMMARY. Cassette 11A: One lymph node bisected. Cassette 11B: One lymph node trisected. Dictated y. Entered: COPIES TO: CPT Codes : MUCICARMINE-88313/3999050, CERVICAL BIOPSY (1)/88305/3997100,. LYMPH NODE BIOPSY (M)/88305/3998021/2, LYMPH NODE, REGIONAL RESECT/88307/3998030/8.",train,1.1 x 0.7 x 0.4 cm
4498,TCGA-BR-4184.3893d873-2a7f-4bbd-943a-fea998d34fd3,"STOMACH TISSUE CHECKLIST. Specimen type: Partial gastrectomy. Tumor Site: Body, greater curvature. Tumor configuration: Exophytic (polypoid). Tumor size: 8.0 x 7.0 X 2.5 cm. Histologic type: Adenocarcinoma. Histologic grade: Moderately differentiated. Extent of invasion: Serosa (visceral peritoneum). Lymph nodes: 1 of 8 lymph nodes positive for metastasis. Margins - Proximal margin: Not specified. Distal margin: Not specified. Omental (radial) margin: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not. specified. Perineural invasion: Not specified. Additional pathologic findings: Not specified. Comments: None. STOMACH TISSUE CHECKLIST. Specimen type: Partial gastrectomy. Tumor Site: Body, greater curvature. Tumor configuration: Exophytic (polypoid). Tumor size: 8.0x7.0x2.5cm. Histologic type: Adenocarcinoma. Histologic grade: Moderately differentiated. Extent of invasion: Serosa (visceral peritoneum). Lymph nodes: 1 of 8 lymph nodes positive for metastasis. Margins - Proximal margin: Not specified. Distal margin: Not specified. Omental (radial) margin: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not. specified. Perineural invasion: Not specified. Additional pathologic findings: Not specified. Comments: None.",train,8.0 x 7.0 X 2.5 cm;8.0x7.0x2.5cm
4517,TCGA-38-A44F.FC3ACA4F-AA49-47F4-9BA3-7B18C56F64AD,"GA-38-A44F-01A-PR. Diagnosis: A: Lung, right upper lobe, wedge resection. Tumor histologic type (WHO) : invasive lung adenocarcinoma,. acinar predominant (mixed acinar and micropapillary subtypes). Tumor histologic grade (WHO) : moderate to poorly differentiated. Tumor size: 3.2 cm maximum tumor size by gross examination. Focality: unifocal. Other structures involved: none. In situ carcinoma: not identified. Extent of invasion: Venous: not identified. Arterial: not identified. Lymphatic: not identified. Perineural: not identified. Pleura: not identified. Surgical margins: negative. Lymph nodes: no tumor seen in one lymph node in this specimen. (0/1). Size of largest metastasis: not applicable. Extracapsular extension of tumor in lymph nodes: not applicable. Findings in nontumorous lung: emphysematous changes, multifocal. bronchiolar metaplasia and focal fibrous remodeling. AJCC PATHOLOGIC TNM STAGE: pT2a pNO. NOTE: This pathologic stage assessment is based on information. available at the time of this report, and is subject to change. pending clinical review and additional information. B: Lymph node, Station 4, removal. - Benign fibroadipose soft tissue; no lymph nodes identified; no. tumor seen. Comment: Molecular studies have been ordered on a representative section. of the tumor to be reported separately by. Clinical History: year-old. with right upper lobe mass. Gross Description. Received are two appropriately labeled containers. Container A is additionally labeled ""right upper lobe wedge.' "" It. holds a 51.8 gram, 11.0 X 4.0 X 2.8 cm wedge of lung. There is. an 11.0 cm staple line along one edge which is removed and the. exposed parenchyma is inked green. The pleura is notable for an. area of tan/white discoloration, roughly 2.1 X 1.6 cm which is. inked blue. This area comes to within 0.5 cm of the green inked. stapled parenchymal margin. Within the wedge there is a 3.2 X. 2.4 x 1.5 cm tan, firm, somewhat circumscribed mass with central. cavitations. The mass is 0. 4 cm from the green inked stapled. parenchymal margin, abuts the pleura, but does not appear to. grossly invade through it, and is surrounded by tan firm lung. tissue. A portion of the mass and normal is submitted to Tissue. Procurement. The remainder of the parenchyma is tan/brown and. spongy. Block summary: A1, A2 - mass with respect to green inked parenchymal margin,. perpendicular and overlying pleura. A3 - additional section of mass with respect to pleura. A4 - mass and adjacent lung parenchyma. A5 - lung parenchyma away from mass. Container B is additionally labeled ""Station 4 lymph nodes. "" It. holds a 2.6 X 1.5 X 0.5 cm fragment of yellow firm fibrofatty. tissue. No lymph nodes are palpated within the tissue which is. bisected and submitted in blocks B1-B2,.",train,3.2 cm
4518,TCGA-BB-7870.3b8038fc-940b-4bda-b275-6c8fca428c9f,"LAB RESULTS. SURG PATH REPORT. 1st Specimen collected on. FINAL DIAGNOSIS. 1. RIGHT PYRIFORM (RESECTION) : SQUAMOUS MUCOSA, NEGATIVE FOR TUMOR. 2. INFERIOR MARGIN (RESECTION) : SQUAMOUS MUCOSA, NEGATIVE FOR TUMOR. 3. RIGHT VALLECULAE (RESECTION) : SQUAMOUS MUCOSA, NEGATIVE FOR TUMOR. 4. LEFT PYRIFORM (RESECTION) : SQUAMOUS MUCOSA, NEGATIVE FOR TUMOR. 5. LEFT VALLECULAE (RESECTION) : SQUAMOUS MUCOSA AND UNDERLYING. LYMPHOID TISSUE, NEGATIVE FOR TUMOR. 6. TONGUE BASE (RESECTION) : SQUAMOUS MUCOSA, NEGATIVE FOR TUMOR. 1. RIGHT NECK LEVEL 2 (RESECTION) : SIXTEEN (16) LYMPH NODES WITH. BENIGN LYMPHOID HYPERPLASIA, NEGATIVE FOR TUMOR. SEE NOTE. NOTE: has reviewed a representative lymph node node. from this section, and agrees with the diagnosis of benign lymphoid. hyperplasia. 8. RIGHT NECK LEVEL 3 (RESECTION) : EIGHT (8) LYMPH NODES AND. ASSOCIATED FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 9. RIGHT NECK LEVEL 4 (RESECTION) : FIVE (5) LYMPH NODES AND. ASSOCIATED FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 10, LEFT NECK LEVEL 2 (RESECTION) : TEN (10) LYMPH NODES WITH BENIGN. LYMPHOID HYPERPLASIA, NEGATIVE FOR TUMOR. SEE NOTE. NOTE: has reviewed a representative lymph node node. from this section, and agrees with the diagnosis of benign lymphoid. hyperplasia. 11. LEFT NECK LEVEL 3 (RESECTION) : THIRTY-ONE (31) LYMPH NODES AND. ASSOCIATED FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 12. LEFT NECK LEVEL 4 (RESECTION) : THIRTEEN (13) LYMPH NODES AND. ASSOCIATED FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 13. LARYNX (TOTAL LARYNGECTOMY) : SPECIMEN TYPE: Resection (laryngectomy) : TUMOR SITE: LARYNX: Supraglottis. TUMOR: Greatest dimension 3.2. HISTOLOGIC TYPE: Squamous cell carcinoma, conventional. HISTOLOGIC GRADE: G3: Poorly differentiated. PRIMARY TUMOR (pT) : SUPRAGLOTTIS: pT4a: Tumor invades through thyroid cartilage. Unofficial lab results - do not file in patient chart. Contact medical records for official chart copy. UNLESS OTHERWISE NOTED ON THE DETATL PAGE ALL LAB RESULTE PEREORMED AT: REGIONAL LYMPH NODES (pN) : ALL AERODIGESTIVE SITES EXCEPT. NASOPHARYNX. pNO: No regional lymph node metastasis. IXTRA-CAPSULAR EXTENSION OF NODAL TUMOR. Absent. DISTANT METASTASIS (pM) : pMx: Cannot be assessed. MARGINS INVOLVED BY TUMOR: Right lateral and right superior mucosal margins (specimen. margin). Left superior mucosal margin (specimen margin) . For true. margin status please see Parts 1-6. VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION: Absent. PERINEURAL INVASION: Absent. ADDITIONAL PATHOLOGIC FINDINGS: Carcinoma in situ and chronic inflammation. Attached fragment of benign thyroid tissue. NOTE: This case was shown at the daily Quality Assurance Conference. Unofficial lab results - do not file in patient chart. Contact medical records for official chart copy. UNLESS OTHERWISE NOTED ON THE DETAIL PAGE, ALL LAB RESULTS PERFORMED AT:",train,
4542,TCGA-24-2024.4189cfa0-00c3-42fb-91b9-d2f4b4887061,"OF SURGICAL PATHOLOGY. Address: : Hosp. No. : DIAGNOSIS. OVARY, RIGHT, SALPINGO-OOPHORECTOMY - POORLY DIFFERENTIATED. PAPILLARY SEROUS ADENOCAROINOMA (SEE COMMENT). OVARY, RIGHT, ""TUMOR, 11 EXCISION - POORIYDIFFERENTIATED PAPTLLARY. SEROUS ADENOCARCINOMA. OVARY, LEFT, SALPINGO-OOPHORECTOMY . METASTATIC PAPILLARY SEROUS. CARCINOMA IN PARA-OVARIAN ADHESIONS. - SEROUS CYSTADENOMA. FALLOPIAN TUBE, LEFT, SALPINGO-OOPHORECTOMY - METASTATIC PAPILLARY. SEROUS ADENOCARCINOMA IN PERITUBAL TISSUE. APPENDIX, APPENDECTOMY - METASTATIC PAPILLARY SEROUS. ADENOCARCINOMA INVOLVING THE SEROSAL SURFACE OF APPENDIX. OMENTUM, OMENTECTOMY - METASTATIC PAPILLARY SEROUS ADENOCARCINOMA. UTERUS, CERVIX, TOTAL ABDOMINAL HYSTERECTOMY. - MILD ACUTE AND CHRONIC INFLAMMATION. UTERUS, ENDOMETRIUM, TOTAL ABDOMINAL HYSTERECTOMY. - INACTIVE ENDOMETRIUM (SEE COMMENT). UTERUS, MYOMETRIUM, TOTAL ABDOMINAL HYSTERECTOMY. - LEIOMYOMAS, HYALINIZED, LARGEST. MEASURING 1.9 CM IN GREATEST DIMENSION. - ADENOMYOSIS. UTERUS, SEROSA, TOTAL ABDOMINAL HYSTERECTOMY - METASTATIC. PAPILLARY SEROUS ADENOCARCINOMA IN SEROSAL ADHESIONS. --1--. OF SURGICAL PATHOLOGY. SPECIMEN (S) SUBMITTED. Part 1: RIGHT OVARY. Part 2: RIGHT OVARY TUMOR. Part 3: LEFT OVARY. Part 4- UTERUS, CERVIX. Part 5: MESO-APPENDIX. Part 6: OMENTUM. HISTORY. The patient is a. with an ovarian neoplasm with. tumor extending CO omencum on CT BCAN, Increased CA 125. Rule. out ovarian carcinoma. Operative procedure: Examination under. anesthesia, laparotomy, total abdominal hysterectomy, bilateral. aalpingo-oophorectomy, omentectomy, An intraoperative. non-microscopic consultation was obtained and interpreted as: ""Right ovary, ovary measuring 10 x 7 x 6 cm with a 6 x 3 cm area. on the external surface with smooth serosa. The surface ie. replaced by a friable papillary tumor. The majority of the. specimen is cystic and contains brown-gray liquid with numerous. papillary lesions in the wall. Tumor removed in ER for. "". GROSS. The-specimens are received-in six containers of formalin; each. labeled with the patient'e name. The first container is labeled. ""uterus, cervix"" and contains a uterus with cervix weighing 184. grams and measuring 11 x 7.2 x 5.! cm in greatest dimensions. Externally, the uterine Berosa is irregular at the regione of the. peritoneal reflection. The reat of the serosa appears. hemorrhagic. The uterus is distorted by multiple myomas giving it. a. multinodular architecture. The OB is slit - measuring 1. 1. cm in greatest dimensions. The cervical canal measures 4 em in. length. No nodularities or papillary areas are recognized. The. endometrial cavity measures 3.7 x 1.3 em in greatest dimensions. There appears to be a polypoid structure been on the posterior. superior wall of the endometrium. This polypoid structure. measures 1.2 x 0.7 cm. The myometrium has a maximum thicknese. that measures 3 cm. It is distorted by multiple myomas ranging in. - 2 - -. UF SURGICAL PATHOLOGY. GROSS (continued). size from 0.3 to 1.9 cm. These myomas do not appear to show any. evidence of cystification, necrosis, or hemorrhage. Some of these. are hyalinized and calcified. Occasional subserosal myomas are. also recognized. Labeled: C1, anterior cervix; C2, posterior. cervix; E1, polypoid area; E2, anterior endomyometrium; E3. posterior endomyometrium; M1 and M2, leiomyomas. Jar 2. The second container is labelled ""right ovary. 11 It contains a. previously sectioned ovary measuring 10 X 7 x 6 cm and weighing 99. grams. The external Burface is blue-tan and glistening in areas,. but a large area of the surface shows a papillary friable mass. measuring -5.5 x 4 cm. No distinct fallopian tube is recognized. The opened surface of the ovary ehows a thickened wall in multiple. areas with a unilocular cystic structure having multiple papillary. friable excrescences. The cut surface in areas showe a somewhat. cystic underlying friable tissue. Sections taken and labelled as. follows RO1-RO8, cyst wall; RO7 and RO8, papillary areas from the. external surface. Jar 2. The third container ie labelled ""right ovary tumor. "" It contains. a large fragment measuring 3 x 3.5 x 1.2 cm in greatest. dimensions. This fragment is extremely friable having a papillary. configuration. Labelled RO9 and RO10. Jar 1. The fourth container is labelled ""left ovary. "" It contains a. ovary with attached fallopian tube. The ovary measures 3 x 2. x. 1.1 cm. in greatest dimensione. Externally, each. shows. multinodular white-yellow configuration with a irregular papillary. area seen on one external aspect. The fallopian tube attached. measures 5 cm in length having a diameter of 0.9 cm and appears. free of tumor. The cut surface of the ovary shows a large cystic. cavity filled with serous fluid, unilocular having a emooth. lining. Sectione taken and labelled: L01, ayet of the ovary; L02,. fallopian tube; L03, papillary area, Jar 1. The fifth container is labelled ""nesoappendix. It containe an. appendix with attached yellow periappendiceal fat and separate. fragment in the same container of yellow fibrofatty tissue. The. appendix measures 7 cm in length having a diameter of 0.5 cm in. the upper third and 0.6 cin in the middle third and 0.9 cm in the. - 3. OF SURGICAL PATHOLOGY. GROSS (continued). lower third. There appears to be a hemorrhagic nodular area been. in the lower third of the appendix. The attached fibrofatty. fragment measures 3.5 x 1.5 x 0.2 cm. It appears unremarkable. The separately submitted fibrofatty fragment measures 3.5 x 1.5. x. 0-9-cm- Taken and labelled as follows: Al, appendix; A2, ft. Jar 1. The sixth container is labelled ""omentum. It contains a large. fragment of hemorrhagic yellow lobular cmental tissue measuring 13. x 9 x 2.5 cm in greatest dimensions. The omentum is completely. covered in ~70% of the area by a papillary friable tumor,. Representative section taken and labelled B. Jar 2. COMMENT. Poorly differentiated papillary serous adenocarcinoma completely. replaces the right ovary and is present on the eurface of the. right ovary. The right fallopian tube is not identified and may. have been completelyreplaced by adenocarcinoia. Small implante of. papillary serous adenocarcinoma are present in peritubal tissue in. the left fallopian tube and within adhesions in the left ovary. Metastatic papillary serous adenocarcinoma also involves the. serosal surface of the appendix and the omentum. The endometrium. is atrophic. The polypoid lesion described grossly represents a. hyalinized submucosal leiomyoma. Numerous hyalinized leiomyomas. and adenomyosis are present in the myometrium: The serosal. surface of the uterus also contains metastatic papillary gerous. carcinoma. SYNOPTIC REPORTING FORM FOR MALIGNANT OVARIAN NEOPLASMS. la. A neoplasm ie PRESENT. 2. The HISTOLOGIC DIAGNOSIS is: Serous adenocarcinoma. 3. The LOCATION( (s) OF THE PRIMARY TUMOR (s) is/are: Right and left ovary. 5. The NUCLEAR (BRODERS'' ) GRADE of the tumor is : G3. poorly-differentiated. 6. Tumor IS identified on the ovarian surface (s) -. Tumor DOES invade the mesovarium. - 4 - -. or SURGICAL PATHOLOGY. COMMENT (continued). 8. Invasion of adjacent fallopian tube CANNOT BE EVALUATED. 9. Tumor DOES invade the pelvic soft tissue. 10. Tumor involvement of the pelvic peritoneum is PRESENT. Metastatic involvement of the EXTRAPELVIC peritoneum. CANNOT BE EVALUATED. 12. Metastatic involvement of the omentum is PRESENT. 14. Metastatic involvement of the uterine serosa is PRESENT. 15. Metastatic involvement of the endometrium is ABSENT. 16. Regional lymph node metastabes CANNOT BE EVALUATED. 17. The total number of regional lymph nodes examined is 0. 19. DETAILED STAGING INFORMATION: Based on the above information, the PRIMARY TUMOR is. classified as: TNM SCHEME. FIGO SCHEME. DEFINITION. T3a. IIIC. Macroscopic peritoneal. metastasis beyond true pelvis. measuring greater than 2 cm in. greatest dimension, OR. Regional lymph node metastasis. OR Metastasis to capsule of. liver. THE REGIONAL LYMPH NODES are classified as: NX (Nodal status cannot be asseased). THE STATUS OF DISTANT TUMOR SITES is classified as: MX (Status cannot be asseased). 20. The FINAL AJCC/FIGO STAGE requires clinical correlation. {End of Report).",train,1.9 CM;3 x 3.5 x 1.2 cm
4627,TCGA-HM-A4S6.B4118FB2-3A61-44B4-BC2F-020EB53542A1,"Final Surgical Pathology Report. Procedure. Diagnosis. A. Uterus, cervix, resection: Invasive squamous cell carcinoma, poorly differentiated, 6.5 cm. Squamous cell carcinoma in situ focally extends to the cervical cuff. margin, (6-9 o'clock). Lymphovascular space invasion by carcinoma identified. Uterus, endometrium, resection: No pathologic diagnosis. Uterus, myometrium, resection: No pathologic diagnosis. Ovaries, right and left, resection: No pathologic diagnosis. Fallopian tubes, right and left, resection: No pathologic diagnosis. B. Right pelvic lymph nodes, resection: Metastatic carcinoma in 1 of 6 lymph nodes (1/6). C. Right periaortic lymph nodes, resection: No evidence of metastasis in 4 lymph nodes (0/4). D. Left pelvic lymph nodes, resection: Metastatic carcinoma in 1 of 1 lymph node (1/1). E. Left periaortic lymph nodes, resection: No evidence of metastasis in 2 lymph nodes (0/2). Microscopic Description: Microscopic examination performed. A. Histologic type: Invasive squamous cell carcinoma of the cervix. Histologic grade Poorly differentiated. Primary tumor (pT) TNM (FIGO) : 6.5 cm, pT1b2. FIGO IB2. Margins of resection: Distance of tumor to closest margin: Less than 0.5 mm from inked. circumferential margin. Presence of carcinoma in situ at distal margin: Squamous carcinoma. in situ is present in the cervical cuff margin between 6 and 9:00. Vascular invasion: Present. Regional lymph nodes (pN) : Metastatic carcinoma is present in one right. and one left pelvic lymph node,. N1. Distant metastasis (pM) : Cannot be evaluated by the specimen, pMX. Other findings None. B. The right pelvic lymph nodes demonstrate metastatic carcinoma in. 1. of 6 nodes. C. The right periaortic lymph nodes demonstrate no evidence of. metastasis 4 lymph nodes. D. The left pelvic lymph nodes demonstrate metastatic squamous cell. carcinoma in 1 of 11ymph node. E. The left periaortic lymph nodes demonstrate no evidence of. metastasis in 2 lymph nodes. Specimen. A. Uterus, cervix, tubes and ovaries, right parametrium. B. Right lymph nodes, pelvic. C. Right periaortic lymph node. D. Left pelvic lymph nodes. E. Left periaortic lymph node. Clinical Information. Cervical carcinoma. Intraoperative Consultation. AFS1,AFS2,AFS3 - uterus, cervix, resection: Invasive Squamous Cell. Carcinoma. Gross Description. A. Received fresh labeled ""uterus, cervix, tubes and ovaries, right. parametrium"" is a 249 g, 8.5 x 5.3 x 4.7 cm symmetrical uterine corpus. with attached, markedly expanded, 6.5 cm cervix and bilateral adnexa. The serosa is smooth to scaberous tan-pink-red. A scant amount of soft. tan-pink-gold parametrial tissue is present along the right and left. lateral aspects. The cervix measures 5.5 cm from right to left and 5.3. cm from anterior to posterior. The anterior surface is inked blue and. the posterior surface is inked black. The annular 5.3 cm ectocervix. ranges from smooth tan-white to glistening white-pink in keeping with. tumor. A thin rim of wrinkled tan-white vaginal mucosa circumferences. the ectocervical margin. The specimen is opened along the lateral. aspects to show a circumferential soft tan-white cervical tumor. A. portion of the tumor and a portion of normal are submitted for tissue. procurement as requested. A frozen section is performed. On. sectioning, the tumor has a maximal thickness of 3 cm (invasive. thickness), however tumor replaces the entire 6.5 cm cervix. Carcinoma. extends to within less than 0.1 cm of the inked posterior surface. The. triangular 4.5 x 3.2 cm uterine cavity is lined by flat tan-pink-red. endometrium averaging 0.2 cm. The myometrium is smooth tan-pink and. measures up to 2.3 cm. A single, 0.8 cm tan-white intramural leiomyoma. is present anteriorly (see block 15). The rubbery tan-pink right and. left ovaries average 2.8 x 1.8 x 1.2 cm. The stroma of both ovaries is. pale tan with identifiable corpora albicantia. A few cystic structures. measuring up to 0.7 cm are present within the left ovary. The. centrally discontinuous tan-pink right and left fallopian tubes average. 6.5 cm in length and range from 0.4-0.7 cm in diameter. RS 20. Summary: 1 - 12-3 o'clock cervical cuff, 2 - 3 - 6 o'clock cervical. cuff, 3 - 6 - 9 S'clock cervical cuff, 4 - 9 - 12 cervical cuff, 5 and. 6 - 12 o'clock cervix/Lus, 7 and 8 - 3 o'clock cervix/Lus, 9 and 10. o'clock - 6 o'clock cervix/Lus, 11 and 12 - 9 o'clock cervix/Lus, 13. and 14 - posterior cervix tumor to closest inked surface, 15 - anterior. endomyometrium, 16 - posterior endomyometrium, 17 - right adnexa, 18 -. left adnexa, 19 - right parametrium, 20 - left parametrium. B. Received fresh labeled ""right lymph nodes, pelvic"" is a 7.7 x 6.5 x. 3.2 cm aggregate of soft tan gold adipose tissue. Several soft to. slightly rubbery tan-pink-gold tissues in keeping with lymph nodes. measuring up to 3.3 cm in greatest dimension are recovered. The. lymphoid tissues are entirely submitted in 9 blocks. Summary: 1 - 2 lymph nodes, 2 through 5 - 1 bisected lymph node per. cassette, 6 through 9 - largest lymph node. C. Received fresh labeled ""right periaortic lymph node"" is a 2.7 x 1.7. x 0.4 cm aggregate of soft, lobulated tan gold adipose tissue which. appears to contain 3 soft tan-pink tissues in keeping with lymph nodes. measuring up to 0.7 cm. The lymphoid tissues are submitted in toto in. one block. D. Received fresh labeled ""left pelvic lymph nodes"" is a 5.9 x 5.5 x. 2.2 cm aggregate of soft, lobulated tan gold adipose tissue. A single,. ovoid, 2.1 cm soft to slightly rubbery tan-pink-gold tissue in keeping. with lymph node is recovered. The lymphoid tissue is bisected and. entirely submitted in 2 blocks. E. Received fresh labeled ""left periaortic lymph node"" is a 2.1 x 2.0. x. 0.8 cm aggregate of soft tan gold adipose tissue. No definitive. lymphoid tissues are recovered. AS1. i. D.te Reviewe. /.",train,6.5 cm;6.5 cm;3 cm;0.8 cm
4628,TCGA-BB-4217.002080fa-fbde-47c1-940e-6086c14de03b,"LAB RESULTS. RG PATH REPORT. LECTION DATE/TIME. 1st Specimen collected en. FINAL DIAGNOSIS. 1). LEFT TONGUE BASE (EXCISION) : SQUAMOUS MUCOSA. NEGATIVE FOR. TUMOR. 2) RIGHT POSTERIOR PHARYNGEAL WALL (EXCISION} : SQUAMOUS MUCOSA. NEGATIVE FOR TUMOR. 3) NASOPHARYNGEAL MARGIN (EXCISION) : SQUAMOUS MUCOSA. NEGATIVE FOR. TUMOR. -1). SOFT PALATE UVULA (EXCISION) : ULCERATED SQUAMOUS MUCOSA WITH. POCAL HIGH GRADE DYSPLASIA. SEE NOTE. NOTE: The focal high grade dysplasia is seen only on the frozen. section. 5) 2ND NASOPHARYNGEAL MARGIN (EXCISION) : SQUAMOUS MUCOSA WITH. CHRONIC INFLAMMATION. NEGATIVE FOR TUMOR. 6) LEFT EUSTACHIAN TUBE (EXCISION) : SQUAMOUS MUCOSA. NEGATIVE FOR. TUMOR. 1) 2ND SOFT PALATE (EXCISION) : SQUAMOUS MUCOSA. NEGATIVE FOR TUMOR. a) TUMOR AT NASOPHARYNX (EXCISION) : INFILTRATING POORLY. DIFFERENTIATED KERATINIZING SQUAMOUS CELL CARCINOMA. ADDITIONAL NASOPHARYNX (EXCISION) : RESPIRATORY MUCOSA WITH. :ONIC INFLAMMATION. NEGATIVE FOR TUMOR. 10) SOFT TISSUE RIGHT LINGUAL ARTERY (EXCISION) : BENIGN. FIBROCONNECTIVE TISSUE. NEGATIVE FOR TUMOR. :1). ADDITIONAL SOFT PALATE (EXCISION) : SQUAMOUS MUCOSA AND MINOR. SALIVARY GLAND. NEGATIVE FOR TUMOR. 2) LYMPH NODES, RIGHT NECK (DISSECTION) : TWO OF ELEVEN (2/11). LYMPH NODES POSITIVE FOR SQUAMOUS CELL CARCINOMA, ONE NODE SHOWS. EXTRACAPSULAR EXTENSION. :3) LYMPH NODES, RIGHT NECK LEVEL IV (DISSECTION) : ONE OF EIGHT. (1/8) LYMPH NODES POSITIVE FOR SQUAMOUS CELL CARCINOMA. EXTRACAPSULAR. EXTENSION IS PRESENT. 14) LYMPH NODES, LEFT NECK (DISSECTION) : THREE (3) LYMPH NODE AND. ASSOCIATED FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. LYMPH NODES, LEVELS II AND III (DISSECTION) : ONE OF SEVEN (1/7). LYMPH NODES POSITIVE FOR SQUAMOUS CELL CARCINOMA WITH EXTENSION INTO. SOFT TISSUE FORMING A NODULE OF SQUAMOUS CELL CARCINOMA. (5.0 CM). :6) LYMPH NODES, LEFT NECK LEVEL IV (DISSECTION): TWO OF SEVENTEEN. (2/17) LYMPH NODES POSITIVE FOR SQUAMOUS CELL CARCINOMA. :7) LARYNX (LARYNGOPHARYNGECTOMY) : SPECIMEN: caryngopharyngectomy. TUMOR SITE: Posterior pharyngeal space. Unofficial lab results - do not file in patient chart. Contact medical records for official chart copy. INLESS. NOTED. rus. ORMED AT: ;TOLOGIC TYPE: Squamous cell carcinoma (keratinizing). TUMOR SIZE: a cm greatest dimension. HISTOLOGIC GRADE: poorly differentiated. LYMPH NODES: Metastatic carcnoma in 6 of 51 lymph nodes: Ipsilateral,. Contralateral. Specify largest positive node: 5 cm. EXTRANODAL EXTENSION: Present. EXTENT OF INVASION. PRIMARY TUMOR. pT4: Tumor invades nasopharynx (see part 8). REGIONAL LYMPH NODES: pN2c: Metastasis in bilateral or contralateral lymph nodes, none. !arger than 6 cm in greatest dimension. DISTANT METASTASIS: oMx: Cannot be assessed. MARGINS. Margins are uninvolved. Distance of invasive carcinoma from nearest margin: 1 mm. Specify margin: Soft tissue. VENOUS/LYMPHATIC INVASION: asent. PERINEURAL INVASION: Present. NOTE: This case was reviewed with. who concurs with the. diagnosis. Reported bv: Unofficial lab results - do not file in patient chart. Contact medical records for official chart copy. UNLESS OTHEROTSE NOTED ON TUR DETATI pace ALI DEDFORMED AT:",train,5.0 CM
4680,TCGA-XR-A8TG.B6CBB321-E73F-4A24-8557-E10E94B2B8C6,"Nature of material: Liver. Biopsy number: ANATOMOPATHOLOGIC RESULT. MACROSCOPY. Received 2 vials, identified as follows: -Liver: liver fragment, wedge-shaped, measuring 7.5 X 6.0 X 1.5 cm and weighing 61.0. g. Its external surface shows capsule with opaque and rough appearance due to the. presence of multiple micro undulations. It shows a softened and whitish lesion of. circular shape with a larger diameter 2.5 cm, 1.0 cm away from the surgical resection. margin. The remaining portions of hepatic parenchyma show hardened, brownish and a. cirrhotic pattern. -Gallbladder: gallbladder, previously opened in its longer axis, measuring 7.5 x 3.5 X 1.0. cm. It is accompanied by the cystic duct stump, measuring 1.5 cm long and 0.6 cm in. diameter. Its outer surface is smooth and greenish-brown. The wall is gray and. homogeneous, while the mucosa shows velvety appearance and yellowish coloring,. with polypoid aspect folds. It was not observed stones. MICROSCOPY. Description associated with the diagnosis. DIAGNOSTIC. Product of partial hepatectomy and cholecystectomy: -Hepatocellular carcinoma of multinodular pattern with well differentiated (grade II of. Edmonson-Steiner - in 40% of the lesion) and poorly differentiated (grade IV of. Edmonson-Steiner - in 60% of the lesion) areas. The lesion shows solid, trabecular and. small cells morphologic pattern, with higher measure of 2.5 cm and focally infiltrating. liver capsule. -Vascular invasion and angiolymphatic embolization undetected. -Adjacent hepatic parenchyma with micronodular cirrhosis, associated with moderate. necroinflammatory activity. C virus infection, according to clinical data. -Free surgical margins. -Gallbladder with tiny and polypoid projections in mucosa, associated with xanthomized. macrophage accumulation (cholesterol polyps): Morphological features are compatible. with cholesterolosis. No signs of malignancy, in the gallbladder. -Pathological staging (TNM - 7th ed.): pT1 pNx. PARTICIPANTS OF APPRAISAL REPORT. - ISSUER. - REVIEWER.",train,
4686,TCGA-HZ-A77Q.D550175A-9593-4283-94D5-91268C8D7799,"Surgica) Report. Specimen. Description. Hospitar. Hospital ID: Age/Sax. Attending Physiciar. Performing Physici. Hospital of Origir. QC Pathologist: FINAL PATHOLOGIC DIAGNOSIS: A. gallbladder, chalecystectomy: Chronic cholecystitie. B. peri-portal lymph node, excision: One lymph node, negative for metastatic disease. Frozen section diagnosis confirmed. C. perigastric lymph node, excision: One lymph node, negative for metastatic disease. Frozen.section diagnosis confirmed. D. distel margin of pancreas, blopay: Severe chronic pancreatitis, malignancy not Identified. Frozen section diagnosis confirmed. E. pancreas and duodenum, Whipple: Tumor Characteristics: 1. Histologic-type: Adenocarcinoma. 2. Histologio grade: 2, moderately differentisted. 3. Tumor site: Pancress with extension into ampulla. 4. Tumor size: 2.8 x 2.2 x 1.7 CM. 5. Microscopic tumor extension: a. Tumor invades: Ampulia. 6. Treatment effect: Not ridentified. 7. Lymphovascular space invasion: Not identified. 8. Perineural invasion: Not identified. Surgical Margin Status: 1. Margins uninvolved by invasive carcinoma: Uncinate. process, bile duct. pancreatic resection, posterior and. superior soft tissue. a. Distance of invasive carcinoma from closest margin: .i CM. b. Specify margin (if possible): Anterior and inferior. soft tissue margins. 2, Margin(s) involved by invasive carcinoma: None. Lymph Node Status: }. Total number of lymph nodes received: 19. 2. Total number of fymph nodes involved: Une. Othe: 1. pTNM stage: p T3N1. es. 2. Other significant findings: Chronic pancrealitis. COMMENTS: CLINICAL HISTORY: Preoperative Diagnosis: Pancreatic cancer. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Gallbladder. B. Periportal lymph node frozen section. C. Perigastric frozen section. D. Distal margin of pancreas. E. Pancreas/duodenum stitch in deep margin/inked pancreatic. transection margin. CODES: 88304. 88305. 88331. 88305. 88331. 88305. 88331. 88309. PROCEDURAL DEMOGRAPHICS: Accession Date/Time: GROSS DESCRIPTION: A. Received in formalin labelec. and '#1. gallbladder' is a 6.7 x 3.2 x 1.9 cm Intact galibladder with. a 0.2 em eystic duet. The serosa is smooth and tan-green. The mucosa is velvety and tan-green. The lumen contains. green bile. The bile and formalin are filtered through a. fine mesh structure and no choleliths are identified in the. lumen or the specimen container. The wall thickness averages. 0.1 cm. The specimen is sectioned and representative. sections are submitted in one rassatto. B. Received labeled. '#2 periportal lymph. node' is a 2.3 x 1.8 x 0.5 cm irregular tan firm tissue. consistent with a probable lymph node. The cut surface. consists of lobulated tan soft tssue. The specimen is. bisected and submitted in its entirety for frozen section. and the frozen section residue is submitted in blocks 1 and. 2 labeled. C, Received labeled. and '#3 perigastric. lymph node' is a 0.7 x 0,5 x 0.2 cm irregular tan firm. tissue consistent with a probable lymph node with attached. adipose tissue which is submitted in toto for frozen section. and the frozen section residue is submitted in one cassette. labeled. D. Received lapereu. and '#4 distal margin of. pancreas is a 2.1 x 1.7 x 0.3 cm irregular tan-yellow. lobulated soft tissue, which is submitted in toto for frozn. section and the frozen section residue is submitted in one. E Received in formalin labeled. pancreas/duodenum stitch in deep margin, Ink marking. pancreatic resection margin' is a Whipple specimen. consisting of a 8.9 cm segment of stomach with a minimal. amount of allached mesentery, a 13.6 cm segment of duodenum,. a 4.8 x 2.5 x 2.0 cm portion of pancreas and a 1.2 cm. segment of common bile duct. There is a very minimal amount. of attached fibroadipose tissue on the duodenum and. pancreas. There is a suture designating the deep margin and. Ink on the pancreatic resection margin. The outer surface of the pancreas is shaggy and tan. The cut. surface of the pancreas consists of a 2.8 x 2.2 x 1.7 cm. ill-defined slightly cystic gray-white mass, 2.2 cm and 2.0. cm from the pancreatic resection margin and common bile duct. margin, respectively. The lesion abuts the uncinate process,. anterior, posterior and interior pancreatic soft tissue. margins and is 2.2 cm from the superior pancreatic soft. tissue margin. The lesion appears to involve the ampulla of. Vater, but does not involve the duodenal mucosa. The remainder of the cut surface of the pancreas consists of. lobulated tan-yellow soft lissue, No additional lesions are. identified. The gastric serosa is smooth and tan-pink. The mucosa is. tan-pink with the normal folda. No mucosal messes are. identified. The inner circumference averages 8.8 cm and the. wall thickness averages 0.5 cm. The duodenal serosa is smooth to shaggy and tan-pink. The. mucosa is tan-pink with the normal folds. No mucosal masses. are Identified. The inner circumference ranges from 5.2 cm. to 11.2 cm and the wall thickness averages 0.2 cm. There are multiple irregular tan-firm tissues consistent. with probable lymph nodes ranging from 0.2 x 0.2 x 0.1 cm to. 1.8x 0.5 x 0.6 em,. Also received in the same container is a 2.0 x 1.4 x 0.7 cm. tan firm tissue consistent with probable lymph node. The cut. surface is tan-yellow. The specimen is inked, sectioned and representative sections. are submitted as labeled: block 1, gastric and duodenal. margins (en face); block 2, pancreatic resection-margin (en. face); block 3, common bile duct (en face); block 4, ampulla. of Vater, block 5, tesion to uncinate process. (perpendicular); block 6, lesion to anterior pancreatic soft. tissue; block 7; lesion to posterior pancreatic soft tissue;. block 8, lesion to inferior pancreatic soft tissue; block 9,. lesion; block 10, superior pancreatic soft tissue (. perpendicular); block 11, uninvolved pancreatic parenchyma;. block 12, pylorus; blocks 13 and 14, five whole perigastric. probable lymph nodes in each; blocks 15 and 16, two whole. peripancreatic probable lymph nodes in each; block 17; one. peripancreatic lymph node, trisected; block 18, one. peripancreatic lymph node, serially sectioned; blocke 19 and. 20, peripancreatic and duodenal adipose tissue, entirely. submitted: block 21; additional tissue, bisected. The blocks. labeled. Also received in the same. container IS a blue, yellow and green cassette labeled. for: '. INTRA-PROCEDURE CONSULTATION: FROZEN SECTION DIAGNOSES: Part B: Tumor not identified. Part C: Tumor not identified. Both of those diagnoses are. Part D: Negative for tumor.",train,2.8 x 2.2 x 1.7 CM
4814,TCGA-FG-7634.b6184ded-a667-44ea-a0d3-32ec6df38516,"Intraoperative Consultation: A: Microscopic: Glioma. Addendum. Addendum Diagnosis. Fluorescence in situ hybridization, performed at. , demonstrates loss of both chromosomes. 1p and 19q. A copy of this report is on file in the Department of Pathology. Clinical History: I frontal neoplasm. Specimens Submitted As: A:LEFT FRONTAL NEOPLASM. Gross Description: Received fresh for intraoperative consultation, labelled with the patient's name and hospital number, and ""left frontal. neoplasm"", are multiple, pink-tan, soft tissue fragments, 1 X 0.4 x 0.2 cm in aggregate. Representative sections are. submitted for frozen section and touch imprint. The remainder of tissue is submitted entirely for permanents. Summary of Cassettes: A. 1FS. 2. permanents.",train,
4860,TCGA-DU-8165.611a4975-123d-470e-afa7-4a17dbea7a9d,"Accession # : Med: Rec. : Phone Number: Gender: F. Client: : CLINICAL HISTORY. woman experienced recent onset seizure, and on imaging. has a. 1.5 cm, left anterior temporal lobe lesion with cystic component and. peripheral enhancement. OPERATIVE DIAGNOSES. Possible brain tumor left temporal lobe. Operation/Specimen: A: Brain tumor, biopsy. PATHOLOGICAL DIAGNOSIS: Brain, site not specified, excisional biopsy: Anaplastic. oligodendroglioma. See Microscopy Description and Comment. COMMENT. The sections contain portions of cerebrum that are heavily. infiltrated/effaced. by a neoplastic proliferation of glial cells that have astrocyte-like. phenotype, but with rather uniform round nuclei and frequently with. perinuclear halos. There is brisk mitotic activity, with a high MIB-1. proliferation index of about 30%. There is prominent endothelial. hyperplasia,. and focal microvascular cellular proliferation. There is no tumor. necrosis. The features are those of an anaplastic oligodendroglioma. Results of molecular testing are reported below. PROCEDURES/ADDENDA. PCR for EGFR variant III mutation. Interpretation. NEGATIVE - No evidence of EGFRVIII mutation is detected. Results-Comments. TEST DESCRIPTION: Testing performed on RNA extracted from. H and E slide was examined and no microdissection was needed. The epidermal growth factor receptor (EGFR) is an attractive molecular. target. in glioblastoma because it is amplified, overexpressed, and/or mutated. in up. to 40% to 50% of patients. Epidermal growth factor receptor variant. III. (EGFRvIII) is an oncogenic, constitutively active mutant form of EGFR. that is. commonly expressed in glioblastoma. Cell culture and in vivo models of. glioblastoma have demonstrated EGFRVIII as defining prognostically. distinct. subgroups of glioblastomas. Additionally, the presence of EGFRVIII has. been. shown to sensitize tumors to EGFR tyrosine kinase inhibitors when the. tumor. suppressor protein PTEN is intact. RNA is extracted from formalin. fixed,. paraffin embedded tissue samples and reverse transcribed to cDNA. The. cDNA is. then amplified using standard PCR technique for DNA templates. PCR. products. are detected by gel electrophoresis. The limit of detection of this. assay has. been determined to be approximately 5 mutant cells in 100 normal. cells. FDA Comment: The above data are not to be construed as the results. from a. stand alone diagnostic test. This test was developed and its. performance. characteristies determined by the. laboratory as. required by CLIA '88 regulations. It has not been cleared or approved. for. specific uses by the U.S. Food and Drug Administration (FDA) The FDA. has. determined that such clearance or approval is not necessary. These. results are. provided for informational purposes only, and should be interpreted. only in. the context of established procedures and/or diagnostic criteria. MGMT Promoter Methylation. Interpretation. NEGATIVE: No evidence of methylated MGMT promoter is detected. Results-Comments. Testing performed on DNA extracted from tumor paraffin block. H and E slide was examined and no microdissection was needed. TEST DESCRIPTION: Patients with glioma containing a methylated MGMT. promoter. have been shown to benefit from therapy with alkylating agents. Assessment of. MGMT promoter methylation status involves bisulfite treatment of DNA. followed. by real-time PCR amplification (MethyLight) of methylated and. unmethylated DNA. sequences. The analytic sensitivity of this assay was determined by. serial. dilution of methylated positive control DNA into unmethylated DNA, and. was. assessed to be 1% of methylated DNA in the background of unmethylated. DNA. Factors such as the presence of >50% non-neoplastic cells in the. sample, or. extensive tissue necrosis, may preclude the detection of methylated. MGMT. promoter sequences. FDA COMMENT: The above data are not to be construed as the results. from a. stand alone diagnostic test. This test was developed and its. performance. characteristics determined by the. laboratory as. required by CLIA '88 regulations. It has not been cleared or approved. for. specific uses by the U.S. Food and Drug Administration (FDA) The FDA. has. determined that such clearance or approval is not necessary. These. results are. provided for informational purposes only, and should be interpreted. only in. the context of established procedures and/or diagnostic criteria. Loss of Heterozygosity 1p, 19q Assay (LOH). Interpretation. POSITIVE: Allelic loss on chromosome arm 1p is detected. Loss of one allele noted in one marker on chromosome arm 19q. suggestive of. partial deletion (D19S1182). Informative loci are: D1S1592, D1S1612, D1S552, D19S219, D19S606 and. D19S1182. Results-Comments -. Testing performed on DNA extracted from tumor paraffin block. DNA extracted from a corresponding blood specimen was used as a normal. reference control. H and E slide was examined and no microdissection was needed. TEST DESCRIPTION: Allelic loss is assessed by PCR assay in Normal DNA. (baseline), / Tumor DNA pairs using 3 markers at both 1p and 19q. The 3. markers. on 1p are D1S548, D1S1592, and D1S552 (with D1S468, D1S1612, and. D1S496 as. backup markers) and the 3 markers on 19q are D19S219, D19S412, and. PLA2G4C. (with D19S606 and D19S1182 as backup) All markers are microsatellites. (2 or 4. nt repeats) except PLA2G4C which is a minisatellite (26 nt repeat). polymorphism. The markers were selected based on heterozygosity score,. amplicon size, and ease of interpretation. The backup markers are used. if the. first line markers at that chromosome arm are uninformative or. otherwise. ambiguous in their interpretation. LOH at all informative loci on each. chromosomal arm represents the typical finding in oligodendrogliomas. with 1p. and 19q deletion. FDA COMMENT: The above data are not to be construed as the results. from a. stand-alone diagnostic test. This test was developed and its. performance. characteristics determined by the. laboratory as. required by CLIA $ 88 regulations. It has not been cleared or approved. for. specific uses by the U.S. Food and Drug Administration (FDA) The FDA. has. determined that such clearance or approval is not necessary. These. results are. provided for informational purposes only, and should be interpreted. only in. the context of established procedures and/or diagnostic criteria. TECHNICAL SENSITIVITY: The presence of >15% non-neoplastic cells in. the sample. may preclude the detection of allelic loss. INTRA-OPERATIVE CONSULTATION. A. Brain tumor, biopsy: Glial neoplasm, with abnormal vessels and. mitoses, high. histological grade (astrocytic?? R/O oligodendroglioma???. Touch. preparation smears performed at. and results. reported to. the Physician of Record. GROSS DESCRIPTION. A. Brain tumor, biopsy. CONTAINER LABEL: tumor frozen and permanent. FIXATIVE: Formalin. NO. PIECES: several pale gray tan fragments. SIZE/VOL: 12 x 9 x 3 mm. in aggregate. CASSETTES: 1-FS remnant, 2-4-remainder. NS. MICROSCOPIC DESCRIPTION. IMMUNOHISTOCHEMISTRY: The GFAP demonstrates prominent. gliofibrillogenesis by. the neoplastic cells. The synaptophysin and NFP demonstrate overall. tumor. nodules partially surrounded by strands of cerebral tissue, within. which there. may be NeuN-positive scattered non-neoplastic neurons. The p53. protein is. strongly over expressed by virtually all neoplastic cells. With the. MIB-1. there is a proliferation index of about 30% throughout the tumor. The. CD34. depicts a rich microvasculature with hyperplasia and microvascular. cellular. proliferation. ICD-9(s) : 239.6 239.6. Histo Data. Part A: Brain tumor. biopsy. Stain/cnt. Block. Comment. FS H/E x 1. 1. H/E x 1. 1. TPS H/E X 1. 1. CD34-DA x 1. 2. EGFR vIII-curls x 1. 2. mGFAP-DA X 1. 2. H/E X 1. 2. LOH-curls X 1. 2. MGMT-curls X 1. 2. MIB1-DA X 1. 2. NeuN X 1. 2. NF2F11 X 1. 2. P53D07 x 1. 2. Synap-DA x 1. 2. H/E X 1. 3. H/E X 1. 4.",train,
4864,TCGA-05-4433.eeae318d-a517-48b6-9a21-5c72dc4bd510,"Main diagnosis/diagnoses: Peripheral bronchopulmonary, histologically mucinous adenocarcinoma with very. predominant bronchioloalveolar differentiation and spread and a small component showing. destructive, infiltrative growth and localization in S10. TNM classification on the basis of this material pT2 pNO pMX R0 stage IB. C34.3 M 8255/3. Comment/supplementary remark: There is no evidence of the carcinoma having infiltrated the visceral pleura. The resection. margin of the bronchus and vessels and all the removed lymph nodes are also tumor-free.",train,
4896,TCGA-16-1047.E45EE1FB-3821-4F46-A033-8A292A5B0884,"(Age: Visit # : Resulted : Gender: F. Facility: SPECIMEN (S) RECEIVED. 1. BRN: RIGHT FRONTAL PARIETAL TEMPORAL LESION. DIAGNOSIS. Brain, right frontal parietal temporal region : Glioblastoma (WHO grade. IK. CLINICAL HISTORY. RIGHT BRAIN TUMOUR. GROSS DESCRIPTION. The specimen container, labeled with the patient 1 S name and as ""right. frontal parietal temporal lesion"". contains a piece of pinkish white. tissue, received in 10% buffered formalin. In aggregate this measures 0.6. x 0.5 x 0.3 cm and weighs less than 1 gm. 1A - specimen submitted in. toto. MICROSCOPIC DESCRIPTION. Sections show an infiltrating glial tumour of predominantly astrocytic. derivation. Numerous mitotic figures are present. There is abundant. microvascular proliferation. Areas of necrosis are not present in the. specimen.",train,
4899,TCGA-AA-3866.546e3d57-4548-4776-af98-a46df3160a72,"Diagnosis/ Diagnoses. 1. Mechanically altered liver tissue with sections of a regressively changed cyst with. partially dystrophic wall calcification. 2. Subcapsular liver tissue with circumscribed, clearly regeneratory, nodular. hyperplasia and moderate steatosis. 3. Resected ileocolic sample with a moderately differentiated adenocarcinoma of the. colorectal type, measuring max 4 cm, with infiltration of the tunica muscularis. propria up to the border of the perimuscular fatty tissue. Tumor-free local lymph. nodes. Tumor-free small and large intestine resection margins. Tumor-free. mesenteric resection margin. Complete, scarred obliteration of the appendix with a. condition following previous appendicitis. The tumor stage is: pT2, pNO (0/23), pMX; G2, LO, V0, R.",train,4 cm
4908,TCGA-14-2555.0589c710-33e8-4c4b-98ea-41b47635085d,"Document Date: Modified. Date Collected: Date Received: PT: SUPPLEMENTAL REPORT. SUPPLEMENTAL DIAGNOSIS: The diagnoses are unchanged. COMMENT: MGMT GENE AMPLIFICATION. DNA was isolated from a paraffin embedded block of the brain tumor biopsy. DNA methylation patterns in the CpG island of the MGMT gene. ) was determined by chemical. (bisulfite) modification of unmethylated, but not methylated, cytosines to. uracil and subsequent PCR using primers specific for either methylated or the. modified unmethylated DNA. The. PCR products were analyzed in duplicate parallel runs by capillary gel. electrophoresis. The sensitivity of the assay based on DNA dilution studies. is at least 1:1000. The analyzed region of the MGMT promoter is UNMETHYLATED. INTERPRETATION: MGMT (06 methylguaine DNA methyltransferase) is a DNA repair gene. Methylation. of the promotor leads to gene silencing and loss of MGMT expression. a recent. study that tested the methylation status of the same region of the MGMT. promoter in glioblastomas found that MGMT promoter methylation was an. independent favorable prognostic factor and was associated with a survival. benefit in patients treated with temozolamide and radiotherapy. e. This test was not requested, performed or reported at. Hospital Department of Pathology. The test was requested by. n. The test was performed and. results reported by. 1, Department of Pathology,. Results are included with this Surgical Pathology report so that all available. information on this tumor may be accessed at one site. DIAGNOSIS: 1. RIGHT TEMPORAL BRAIN LESION, RESECTION, FS1A, TP1A: - GLIOBLASTOMA, WHO GRADE IV. - SEE COMMENT. 2. RIGHT TEMPORAL BRAIN LESION, RESECTION: - GLIOBLASTOMA, WHO GRADE IV. - SEE COMMENT. 3. DURA, RESECTION: - SECTION OF DURA WITH UNDERLYING GLIOBLASTOMA, WHO GRADE IV. - SEE COMMENT. Pa. COMMENT. This malignant neoplasm stains positively for GFAP and a stain for CD34. highlights the highly proliferative blood vessels of this neoplasm. Tumor. necrosis is identified, fulfilling the criteria for glioblastoma, WHO grade. IV. Immunohistochemistry for neurofilament shows neoplastic cells invading. neurofilament positive axons, FISH analysis for EGFR gene status will be. performed and a separate report will be issued. Tissue will be sent for MGMT. analysis and a separate report will be issued. SPECIMEN: 1. Right temporal brain lesion. 2. Right temporal brain lesion. 3. Dura. CLINICAL HISTORY/OPERATIVE FINDINGS: None provided. GROSS DESCRIPTION: Specimen #1 is received fresh for intraoperative consultation and is labeled. with the patient's name and medical record number and as ""right temporal brain. lesion."" The specimen consists of red and white brain tissue that is soft in. consistency which measures 2.5 x 1.5 X 0.4 cm. A representative section is. taken for frozen section diagnosis and the cryoblock is transferred to. cassette ""FS1A."" The rest of the specimen is submitted in cassette ""1B."". Dictated by Dr. Specimen #2 is received in formalin and is labeled with the patient's name and. medical record number and as ""right frontal brain lesion. The specimen. consists of multiple fragments of brown and white brain tissue measuring 3.0 X. 2. X 0.6 cm in aggregate. Representative sections are submitted in cassettes. ""2A"" and ""2B. "" Dictated by. Specimen #3 is received in formalin and is labeled with the patient's name and. medical record number and as ""dura. "" The specimen consists of one piece of. fibrous soft tissue, measuring 4.5 X 2.1 x 0.3 cm. Representative sections. are submitted in cassette ""3A.' Dictated by. INTRAOPERATIVE CONSULTATION: FS1A, TP1A: RIGHT TEMPORAL BRAIN LESION, BIOPSY (FROZEN SECTION, TOUCH. PREPARATION) : GLIOBLASTOMA. Frozen Section results were communicated to the surgical team and. were repeated back by. MICROSCOPIC DESCRIPTION: Microscopic examination performed. SPECIAL STAINS : GFAP. DONE. CD34. DONE. NF. DONE. FISH. DONE. FISH. DONE. 2 (Continued. FLUORESCENCE IN SITU HYBRIDIZATION. SPECIMEN: Brain, right temporal brain lesion. CLINICAL HISTORY/REFERRING DIAGNOSIS: Glioblastoma, WHO grade IV. GROSS DESCRIPTION: Paraffin block, labeled 2A. TEST PERFORMED/PROBES USED: EGFR gene locus specific probe (7p12). Chromosome 7 alpha satellite DNA specific probe (7p11. 1-7q11.1) -. POSITIVE for EGFR gene amplification. nuc ish amp (EGFR) [193/200]. INTERPRETATION: Flourescence in situ hybridization was performed using the above listed DNA. probes (Abbott Molecular, Inc. ) The probes were simultaneously hybridized to a. section of the formalin-fixed paraffin-embedded tissue submitted for. evaluation. Of 200 interphase nuclei analyzed, 96% of cells were POSITIVE for EGFR gene. amplification. Positive and negative controls were appropriate. Correlation. with clinical and other laboratory parameters is suggested. COMMENT. The results of this test should not be used alone as the sole basis for. diagnosis and/or treatment. These results may, however, prove useful when. used in conjunction with other diagnostic procedures and clinical evaluations. Use of these results, in this manner, can be considered to fall within the. scope of practice of medicine. This test was developed and its performance. characteristics determined by the. It has been. cleared or approved by the U.S. Foud anda brug.",train,
4945,TCGA-CV-A45Y.622179CF-B6E7-4854-B9D6-9D0AE5028AE4,"Sex: M. Case type: Surgical History. Case imported from legacy computer system. The format of this report does not match the original case. For cases prior to. the section ""SPECIMEN"" may have been added. SUPPLEMENTAL REPORT. DIAGNOSIS: (B) TOTAL LARYNGECTOMY: SQUAMOUS CARCINOMA IN THYROID CARTILAGE. Entire report and diagnosis completed by: Report released by: DIAGNOSIS. (A) LARYNX BIOPSY: INVASIVE POORLY DIFFERENTIATED SQUAMOUS CARCINOMA. (B). TOTAL LARYNGECTOMY AND BILATERAL NECK DISSECTION: INVASIVE POORLY DIFFERENTIATED SQUAMOUS CARCINOMA, PRESENCE OF. LYMPHATIC AND PERINEURAL INVASION INVOLVING RIGHT AND LEFT. FALSE VOCAL CORD, RIGHT AND LEFT TRUE VOCAL CORDS, VENTRICLES,. PRESENCE OF SUBGLOTTIC EXTENSION ON THE LEFT SIDE MEASURING. 7.0'MM. TUMOR INVADING PERICHONDRIUM. Margins of excision free of tumor. Ten right lymph nodes, no tumor. TWO left lymph nodes, no tumor. (C) LEFT LYMPH NODES: Three lymph nodes, no tumor. (D) RIGHT EPIGLOTTIC FOLD MARGIN: Squamous mucosa, no tumor. Entire report and diagnosis completed by: Report released by: GROSS DESCRIPTION. (A) LARYNX - Three portions of tan-pink-purple soft tissue ranging from 0.4 to. 0.2 cm in greatest dimension. Submitted for frozen section examination as A. FS/DX: INVASIVE SQUAMOUS CELL CARCINOMA. Sex: M. Case type: Surgical History. (B) TOTAL LARYNGECTOMY AND BILATERAL NECK DISSECTION - A total laryngectomy. and attached fibroadipose tissue with overall measurements of 9.0 x 6.0 x 5.5. cm. An ulcerated friable mass involving the right transglottic and the. midline and glottic and subglottic lesion on the left measuring 4.5 x 3.0 x. 1.0 cm. The mucosal margin appears grossly uninvolved. Small fragments of. soft tissue (1.5 x 1.5 cm) on the right and on the left were identified, and. the lymph node was submitted separately on the right and left neck dissection. The specimen is submitted entirely from right to Teft in cassettes B2-B14 for. the laryngeal cancer; B15-817, right lymph node: 818, section of thyroid;. B19-B21, Tymph nodes from the left side. (c) LEFT LYMPH NODES - Received are three pink-tan lymph nodes ranging from. 0.9 x 0.8 x 0.6 to 1.9 x 1 x 0.7 cm. Entirely submitted in C1 through C3, one. lymph node each. (D) RIGHT EPIGLOTTIS FOLD MARGIN - A single portion of tan-pink soft tissue. (1.2 x 0.2 x 0.2 cm). Submitted in toto for frozen section examination as. D. FS/DX: MUCOSA, NO TUMOR PRESENT. SNOMED CODES. M-80703 T-24100.",train,
4983,TCGA-29-1703.c8397af0-67d2-4e69-993b-7349657e9953,"CLINICAL HISTORY: Pelvic mass, abdominal/pelvic swell NOS. (montal mining with bilateral. adnexal masses, Post menopausal. GROSS EXAMINATION: A. ""Omentum (AF1)"". received fresh for frozen section. A 320.0 gram, 15.5 x. 11.5 x 2.5 cm portion of tan-yellow, firm fibroadipose tissue with diffuse. adhesions and white-tan adherent exudate is received. The specimen is. serially sectioned to exhibit a tan-yellow, firm, cut surface throughout, i.e. tumor size greater than 2 cm. A representative section has been previously. frozen as AF1 and the frozen section remnant is entirely submitted in block. A1. An additional representative section is submitted in block A2. B. ""Right tube and ovary"", received fresh and placed in formalin. A 101.0. gram, 8.0 x 5.8 x 3.7 cm ovary with an adherent 5.5 cm long fimbriated. fallopian tube. The surface of the ovary is focally disrupted and is serially. sectioned to exhibit a 4.5 x 3.8 x 2.8 cm thin walled cyst filled with a. yellow-tan, waxy, sebaceous material, and a small amount of white-tan mucinous. material. A 2.2 x 1.4 x 1.2 cm tan, friable nodule is attached to the cyst. wall. No additional masses or papillary excrescenses are grossly. identified. The remainder of the parenchyma is replaced by a white-tan, firm. tissue and multiple thin walled cysts up to 2.0 cm, one of which is lined by. papillary excrescenses. BLOCK SUMMARY: B1- mass adjacent to sebaceous-filled cyst. B2- cyst with papillary excrescenses. B3- representative section of adherent fallopian tube. B4- representative section of friable nodule. C. ""Anterior cul-de-sac"", received fresh and placed in formalin. Received is. a 3.8 x 2.0 x 0.8 cm aggregate of multiple fragments of tan-yellow. fibroadipose tissue, representative of which are submitted in block C1. D. ""Left tube and ovary"", received fresh and placed in formalin. A 50.0 gram,. 6.5 x 5.0 x 2.2 cm ovary with an attached and focally embedded fimbriated. fallopian tube is received. The surface of the ovary is disrupted and rough. with multiple adhesions. The ovary is serially sectioned to exhibit a firm,. white-tan cut surface with multiple cysts up to 2.2 cm in greatest dimension,. one of which is lined by papillary excrescenses. No normal ovarian tissue is. grossly identified. The fallopian tube is 5.2 cm long with an average. diameter of 0.4 cm. BLOCK SUMMARY: D1- cyst with papillary excrescenses. D2- representative section of white-tan solid tissue. D3- representative section of embedded fallopian tube. E. ""Uterus and cervix"", received fresh and placed in formalin. Received is a. 56.0 gram, 8.5 x 5.0 x 3.5 cm uterus with attached cervix. The serosa is. covered with multiple adhesions and multiple, firm, white-tan adherent. nodules. The white-tan, smooth and glistening ectocervix has a 0,7 cm patent. os which opens into a 2.0 cm long tan, trabeculated endocervical canal. The. 3.4 x 1.5 cm endometrial cavity is lined by a tan, smooth endometrium. The. 0.1 cm endometrium overlies a 1.3 cm myometrium remarkable for a 1.3 cm in. greatest dimension, white, well-circumscribed, whorled nodule with a bulging. rage 2015. cut. surface. Representative sections of cervix are submitted in Block E1-2. and representative sections of endomyometrium are submitted in blocks E3-4. F. ""Left cul-de-sac"", received fresh and placed in formalin. Received is a. 5.2 x 4.5 x 1.6 cm fragment of tan-yellow fibroadipose tissue which is focally. indurated. Sectioning reveals a white-tan, firm cut surface with yellow,. lobulated adipose tissue. A representative section is submitted in Block F1. G. ""Rectosigmoid colon"", received fresh and placed in formalin. Received is. a. 16.0 cm long unoriented segment of large intestine that ranges in. circumference from 2.5 cm up to 5.5 cm. The serosa is diffusely covered. with. adhesions and multiple focal areas of induration. The lumen is focally. stenotic and surrounded by indurated, yellow, lobulated adipose tissue. The. mucosa is pink-tan and grossly unremarkable. Sectioning exhibits areas of. white-tan, firm tissue deep to the mucosa, which corresponds to the areas of. induration on the serosa. BLOCK SUMMARY: G1-. stapled margin. G2-. open margin. G3-4-. representative sections of mucosa in relation to white-tan, firm. tissue. H. ""Posterior wall of bladder"", received fresh and placed in formalin. Received is a 2.7 x 2.7 x 0.7 cm aggregate of multiple fragments of gray-tan. tissue which is entirely submitted in block H1. I. ""Left pelvic side wall"", received fresh and placed in formalin. Received. is a 4.5 x 2.5 x 1.0 cm fragment of firm, tan-yellow fibroadipose tissue which. is sectioned to exhibit a white-tan, firm cut surface with a minimal amount of. yellow, lobulated adipose tissue. A representative section is submitted in. Block I1. J. ""Small bowel nodules"", received fresh and placed in formalin. Received is. a 2.0 x 1.0 x 0.4 cm aggregate of multiple fragments of firm, gray-tan tissue. which is entirely submitted in block J1. K. ""Omentum"", received fresh and placed in formalin. Received is a 5.0 x 3.5. x 1.5 cm aggregate of two fragments of tan-yellow fibroadipose tissue with. focal adhesions. Sectioning exhibits a white-tan, firm cut surface with a. small amount of fibroadipose tissue. A representative section is submitted in. block K1. L. ""Supragastric nodule"", received fresh and placed in formalin. Received is. a 3.5 x 2.3 x 0.9 cm fragment of tan-yellow fibroadipose tissue. Sectioning. exhibits a white-tan, firm cut surface with a small amount of fibroadipose. tissue. A representative section is submitted in block L1. M. ""Transverse colon nodule"", received fresh and placed in formalin. Received. is a 1.5 x 0.8 x 0.6 cm fragment of tan-gray tissue, which is sectioned and. submitted entirely in block M1. N. ""Left high pericolic gutter"", received fresh and placed in formalin. Received is a 3.3 x 3.0 x 1.1 cm fragment of tan-gray, firm fibroadipose. tissue. Sectioning exhibits a white-tan, firm cut surface with a small amount. of fibroadipose tissue. A representative section is submitted in block N1. o. ""Colon"", received fresh and placed in formalin. Received is a 3.0 x 0.5 x. 0.5 cm fragment of tan-gray tissue with a 3.0 cm long stapled line. The. stapled line is removed and the remaining soft tissue is entirely submitted in. block 01. P. ""Proximal donut"", received fresh and placed in formalin. Received is a 1.2. cm annular fragment of gray-tan tissue with a 0.5 cm in diameter central. defect which is bisected and entirely submitted in block P1. Q. ""Distal donut"", received fresh and placed in formalin. Received is a 1.2. x. 1.2 x 1.0 cm fragment of gray-tan tissue with a tan, glistening mucosa which. is remarkable for a 0.5 cm in diameter defect. The specimen is bisected and. entirely submitted in block Q1. INTRA OPERATIVE CONSULTATION: A. ""Omentum"": AF1- adenocarcinoma. MICROSCOPIC EXAMINATION: Microscopic examination is performed. PATROLOGIC STAGE: PROCEDURE: Hysterectomy, bilateral salpingo-oohphorectomy, omentectomy,. partial colectomy, multiple biopsies. PATHOLOGIC STAGE (AJCC 6th Edition) : pT3c pNX pMX. NOTE: Information on pathology stage and the operative procedure is. transmitted to this. as required for. accreditation by the. Pathology stage is based solely. upon the current tissue specimen being evaluated, and does not incorporate. information on any specimens submitted separately to our Cytology section,. past pathology information, imaging studies, or clinical or operative. findings. Pathology stage is only a component to be considered in determining. the clinical stage, and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon's operative report. DIAGNOSIS: SUMMARY DIAGNOSIS: SEROUS ADENOCARCINOMA OF THE RIGHT AND LEFT OVARIES,. INVOLVING BILATERAL FALLOPIAN TUBES, UTERINE SEROSA, OMENTUM, RECTOSIGMOID. COLON, AND MULTIPLE ADDITIONAL PERITONEAL SITES AS LISTED BELOW. DETAILED DIAGNOSES BY SITE: A. ""OMENTUM"" (OMENTECTOMY) : METASTATIC SEROUS ADENOCARCINOMA. TUMOR SIZE: GREATER THAN 2 CM. B. ""RIGHT TUBE AND OVARY"" (SALPINGO-OOPHORECTOMY) : MODERATELY DIFFERENTIATED PAPILLARY SEROUS ADENOCARCINOMA OF THE OVARY. TUMOR SIZE: 8 CM. FIGO GRADE: 2 OF 3. SURFACE INVOLVEMENT: PRESENT. REMAINDER OF OVARY WITH MATURE CYSTIC TERATOMA (4.5 CM), SEE COMMENT. FALLOPIAN TUBE: POSITIVE FOR SEROUS CARCINOMA. COMMENT: Adjacent to the tumor in the ovary is a mature cystic teratoma. (dermoid cyst) The epithelium in the dermoid is unremarkable and there is no. evidence that the carcinoma arose from the dermoid. C. ""ANTERIOR CUL-DE-SAC"" (BIOPSY) : SEROUS ADENOCARCINOMA. D. ""LEFT TUBE AND OVARY"" (SALPINGO-OOPHORECTOMY) : MODERATELY DIFFERENTIATED PAPILLARY SEROUS ADENOCARCINOMA OF THE OVARY. TUMOR SIZE: 6.5 CM. FIGO GRADE: 2 OF 3. rage 40 ). SURFACE INVOLVEMENT: PRESENT. FALLOPIAN TUBE: POSITIVE FOR SEROUS CARCINOMA. E. ""UTERUS AND CERVIX"" (HYSTERECTOMY) : UTERUS WITH SEROSAL IMPLANTS OF SEROUS ADENOCARCINOMA. ENDOMETRIUM: NO PATHOLOGIC DIAGNOSIS. MYOMETRIUM: LEIOMYOMA. CERVIX: NO PATHOLOGIC DIAGNOSIS. F. ""LEFT CUL-DE-SAC"" (BIOPSY) : SEROUS ADENOCARCINOMA. G. ""RECTOSIGMOID COLON"" (RESECTION) : SEGMENT OF COLON WITH EXTENSIVE INVOLVEMENT BY SEROUS ADENOCARCINOMA. H. ""POSTERIOR WALL OF BLADDER"" (BIOPSY) : SEROUS ADENOCARCINOMA. I. ""LEFT PELVIC SIDEWALL"" (BIOPSY) : SEROUS ADENOCARCINOMA. J. ""SMALL BOWEL NODULES"" (BIOPSY) : SEROUS ADENOCARCINOMA. K. ""OMENTUM"" (OMENTECTOMY) : SEROUS ADENOCARCINOMA. L. ""SUPRAGASTRIC NODULE"" (BIOPSY) : SEROUS ADENOCARCINOMA. M. ""TRANSVERSE COLON NODULE"" (BIOPSY) : SEROUS ADENOCARCINOMA. N. ""LEFT HIGH PERICOLIC GUTTER"" (BIOPSY) : SEROUS ADENOCARCINOMA. o. ""COLON"" (EXCISION) : COLON WITH ACUTE SEROSITIS. NEGATIVE FOR MALIGNANCY. P. ""PROXIMAL DONUT"" (EXCISION) : COLON WITH ACUTE AND ORGANIZING SEROSITIS. NEGATIVE FOR MALIGNANCY,. rage 5 of. Q. ""DISTAL DONUT"" (EXCISION) : COLON WITH ACUTE AND ORGANIZING SEROSITIS. NEGATIVE FOR MALIGNANCY. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es).",train,2 cm;2 CM;8 CM;6.5 CM
5073,TCGA-57-1993.55495e3a-6052-4fb1-b8a9-10b54dcdfbea,"SPECIMEN INF. DIAGNOSIS. DIAGNOSIS: A. Right oophorectomy: Serous adenocarcinomal. Grade; III. Tumor show near total replacement of specimen. Size: 10.6 cm in greatest dimension. Lymphovascular space invasion: Not identified. Right fallopian tube - Focal mucosal and serosal involvement by serous adenocarcinoma. B. Omentum, excision: Metastatic serous adenocarcinoma. C. Ovary, left oophorectomy: Serous adenocarcinoma. Grade: III. Focal calcified fibrous nodule with adjacent necrotic tissue. Tumor shows near total replacement of ovary. Size: 9.1 cm in greatest dimension. Lymphovascular space invasion present. Left fallopian tube ""not identified grossly or histologically. D. Peritoneum, left gutter, biopsy: Metastatic adenocarcinoma. E. Peritoneum, right gutter, biopsy: Metastatic adenocarcinoma. F. Diaphragm, biopsy: Melastatic adenocarcinoma. G. Sigmoid mesenteric implant, biopsy: Metastatic adenocarcinoma. H. Uterus, hysterectomy: Uterine cervix. Microscopic focus of high grade serous carcinoma. at transition zone. Multiple foci of metastatic tumor within intravascular space and submucosal connective tissue. Benign endocervical polyp. Endometrium -. Endometrial polyp. Background atrophy. Myometrium -. Foci of metastatic adenocarcinoma within vessels and connective tissue. Multiple hyalinized leiomyomas. Uterine serosa -. Foci of metastatic adenocarcinoma. DIAGNOSIS. pTNM stage: T3NXMX. COMMENTS: This case has been reviewed by Dr. vho agrees with the diagnosis. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Postoperative Diagnosis: Symptoms/Radiologia Findings: SPECIMENS: A. Right ovary. B. Omentum. C. Left ovary. D. Left gutter. E. Right gutter. F. Biopsy of diaphragm. G. Sigmoid mesenteric implant. H. Uterus. SPECIMENDATA. GROSS DESCRIPTION: A. Part A received in formalin labeled. and #1 is a 10.6 x 10.1 x 4.4 cm irregular to ovoid, shaggy tan pink to red purple membranous. tissue, with an attached 2.8 x 0.6 cm tubular tissue. The cut surface of the tissue consists of a 10.8 cm cyst. The remainder of the cut surface consists. tan pink to gray white consistent with probable fallopian tube. Also. in the same container is a 4.6 x 3.1 x 1.5 cm irregular gray white soft tissue, consistent with possible ovary. The outer surface is lobulated. shaggy and gray white. The cut surface is gray white. The specimen is serially sectioned and representative sections are submitted for frozen section and the frozen section residue is submitted in block 1. Additional representative sections are submitted as labeled: membranous tissue block 8 tubular tissue attached to membranous tissue. blocks 9 and 10 additional tissue. The blocks are labeled. Also received in the same container are three orange cassettes labeled A C. and D and a green and yellow cassette labeled. for genomic research study. B. Part B received in formalin labeled. ind #2 omentum is a 15.8 x 12,1 x 3.2 cm aggregate of fibroadipose tissue, consistent with. omentum. The cut surface consists of predominantly yellow lobulated adipose tissue, with a minimal amount of gray white fibrous tissue. There are. several firm gray white areas on the cut surface. The specimen is serially sectioned and representative sections are submitted in one cassette labeled. C. Part C received in formalin labeled. and #3 left ovary is a 9.1 x 4.7 x 2.6 cm irregular, shaggy tan red soft tissue. The cut surface. consists of focally gritty gray white to tan soft tissue. There is a 1.1 x 0.6 x 0.5 cm hard nodule within the cut surface. No ovarian stroma is identified. A. fallopian tube is not identified. The specimen is serially sectioned and representative sections are submitted in six cassettes, with the hard nodule. submitted in cassette 6, following decalcification. The cassettes are labeled. D. Part D received in formalin labeled. and #4 left gutter is an 8.4 x 3.6 x 0.4 cm irregular gray white to tan red membranous tissue, with. attached adipose tissue. The specimen is serially sectioned and representative sections are submitted in one cassette labeled. E. Part E is received in formalin labeled. nd #5 right gutter is a 7.4 x 5.2 x 1.1 cm irregular, granular gray white to tan red membranous. tissue, with attached adipose tissue. The specimen is serially sectioned and representative sections are submitted in one cassette labeled. F. Part F received in formalin labeled. ind #6 biopsy diaphragm is a 2.7 x 1.8 x 0.5 cm aggregate of gray white to red soft tissue, which is. serially sectioned and submitted in its entirety in one cassette labeled. G. Part G received in formalin labeled. ind #7 sigmoid mesenteric implant is a 1.3 x 1.1 x 0.4 cm irregular, gritty gray white soft tissue,. vith attached adipose tissue, which is serially sectioned and submitted in its entirety in one cassette labeled. H. Part H received in formalin labele. and #8 uterus is a 52 gram previously opened hysterectomy specimen, consisting of a 4.7 x 4.3 x. 2.6. cm. uterine body and a 2.4 x 1.8 x 1.5 cm cervix. The specimen can not be oriented. The serosa is shaggy and tan pink to red. The exocervix is. smooth and gray white with a 0.1 cm circular os. The endocervical canal is glistening tan and 1.6 cm in length. There is a 0.6 x 0.5 cm endocervical. polyp. The identifiable probable endometrium is glistening tan and averages 0.1 cm in thickness. There is a 1.2 cm cystic gray white possible. endometrial polyp. The myometrium is trabeculated, tan pink, and averages 1.3 cm in thickness. There are multiple intramural whorled gray white. dense nodules, ranging from 0.4 to 1.8 cm in greatest dimension. No areas of hemormhage or necrosis are identified in the nodules. The largest nodule. has a gritty. hard gray white to yellow cut surface. The specimen is serially sectioned and representative sections are submitted as labeled: blocks 1. and 2 anterior and posterior cervix block 3 endocervical polyp, entirely submitted blocks 4 and 5 endomyometrium to include probable endometrial polyp. in its entirety block 6 myometrial nodules block 7 largest myometrial nodule, following decalcification block 8 serosa. The blocks are labeled. NTRA-OPERATIVE CONSULTATION: FSA: 'Adenocarcinoma: Favor ovarian primary' per Dr. . i.",train,10.6 cm;9.1 cm
5087,TCGA-05-4430.0c8a524e-3241-4cde-8d22-1330aaf8c603,"Main diagnosis/diagnoses: Peripheral bronchopulmonary, histologically mixed-cell adenocarcinoma of the left lower. lobe of the lung with a predominant acinar and small large-cell solid component, a. bronchioloalveolar pattern of spread in the tumor periphery and main localization in S6. TNM classification on the basis of this material pT2 pNO pMX R0, stage IB. C34.3; M 8255/3. Comment/supplementary remark: The carcinoma has infiltrated the visceral pleura. The resection margin of the bronchus and. vessels and all the lymph nodes removed are tumor-free.",train,
5147,TCGA-BP-4760.4701f631-c963-4b33-8e6d-9431c0d7bdd5,"Clinical Diagnosis & History: Two left renal masses. Specimens Submitted: 1: SP: Tumor interpolar region left kidney. 2: SP: Lower pole tumor, left kidney. 3: SP: Cyst wall interpolar region left kidney. 4: SP: Left perinephric fat- lower pole. 5: SP: Supra tumor interpolar region. 6: SP: Left renal sinus fat. 7: SP: Left lower pole fat. DIAGNOSIS: 1). KIDNEY, INTERPOLAR REGION, LEFT, PARTIAL NEPHRECTOMY: - RENAL CELL CARCINOMA, CONVENTIONAL CLEAR CELL TYPE, NUCLEAR GRADE II/IV. - THE TUMOR GREATEST DIAMETER IS 2.0 CM. - THE TUMOR IS CONFINED WITHIN THE RENAL CAPSULE. - ALL SURGICAL MARGINS ARE FREE OF TUMOR. - THE NON-NEOPLASTIC KIDNEY IS UNREMARKABLE. 2). KIDNEY, LOWER POLE, LEFT, PARTIAL NEPHRECTOMY: - RENAL CELL CARCINOMA, CONVENTIONAL CLEAR CELL TYPE, CYSTIC, NUCLEAR GRADE II/IV. - THE TUMOR GREATEST DIAMETER IS 2.6 CM. - THE TUMOR IS CONFINED WITHIN THE RENAL CAPSULE. - ALL SURGICAL MARGINS ARE FREE OF TUMOR. - THE NON-NEOPLASTIC KIDNEY IS UNREMARKABLE. 3). KIDNEY, INTERPOLAR REGION CYST WALL, LEFT, EXCISION: - FRAGMENTS OF MULTILOCULAR CYSTIC RENAL CELL CARCINOMA. 4). KIDNEY, LOWER POLE, PERINEPHRIC FAT, LEFT, EXCISION: - BENIGN FIBROADIPOSE TISSUE. 5). KIDNEY, LEFT, SUPRA TUMOR, INTERPOLAR REGION, EXCISION: - BENIGN FIBROADIPOSE TISSUE. 6). KIDNEY, LEFT, RENAL SINUS FAT, LEFT, EXCISION: - BENIGN FIBROADIPOSE TISSUE. 7). KIDNEY, LOWER POLE, FAT, LEFT, EXCISION: - BENIGN FIBROADIPOSE TISSUE. 1). The specimen is received fresh for frozen section, labeled ""Tumor interpolar region left kidney"". It consists of a 4.0 x 2.0. x 1.5 cm partial nephrectomy specimen. The cut surface reveals a 2.0- x 1.5 X 1.4 cm circumscribed multilobulated, tan-yellow to. gray-white mess adjacent to 1,0 cm segment of normal kidney parenchyma. The outer surface Is inked bleck. A. specimen. is. submitted for frozen section. A specimen is also submitted for. Representative sections are submitted. Summary of Sections: FSC - frozen section control. T - multiple sections of tumor including cepsule and normal kidney. 2). The specimen is received fresh for frozen section, labeled ""Lower pole tumor, left kidney"". It consists of a 2.5 x 2.0 x 1.5. cm tan-pink nodule. The specimen is inked and soctioned revealing a circumscribed, partly cystic mass with tan-pink, friable. cut. surface and minimal rim of normal kidney. Representative sections are submitted,. is also taken for this. Summary of Sections: FSC - frozen section control. T - multiple sections of tumor. 3). The specimen is received fresh for frozen section, rabeled Cyst well interpolar region left kidney"". It consists of two soft. tissues measuring 2.1 x 2.0 x 3.0 cm in aggregate. The entire specimen is submitted for frozen section. Summary of Sections: FSC - frozen section control. 4). The specimen is received In formalin, labeled ""Left perinephric fat-lower pole"". Il consists of a 5.0 X 4.0 x 2.0 cm. aggregate of tan-yellow lobulated fatty tissue. No masses are identified or palpated. Representative sections are submitted. Summary of Sections: PNF - perinephric fat. 5). The specimen is received in formalin, labeled ""Supra tumor interpolar region"". It consists of an 8.0 X 2,0 x 1.0 cm. tan-yellow lobulated fally tissue with probable palpable lymph nodes. All lymph nodes are submitted. Summary of Sections: PLN - possible lymph nodes. BLN - bisected lymph nodes. 6). The specimen is received in formalin, lebeled ""Left renal sinus fat"". It consists of a 6.0 x 4.0 x 2.0 cm aggregate of. tan-yellow lobulated fally tissue. Representative sections are submitted. Summery of Sections: RSF - renal sinus fat. 7). The specimen is received in formalin, labeled ""Left lower pole fat"". It consists of a 7.0 x 6.0 x 2.5 cm aggregate of. lobulated fibrofatty tissue, No messes are grossly palpated. Representative sections are submitted. Summary of Sections: LPF - lower pole fat. Summary of Sections: Part 1: SP: Tumor interpolar reglon left kidney. Block. Sect. Site. PCs. 1. fsc. 1. 5. t. 5. Part 2: SP: Lower pole tumor, left kidney. Block. Sect. Site. PCs. 1. fsc. 1. 5. 5. Part 3: SP: Cyst wall interpolar region left kidney. Block. Sect. Site. PCs. 1. fsc. 1. Part 4: SP: Left perinephric fat- lower pole. Block. Sect. Site. PCs. 3. pnf. 3. Part 5: SP: Supra tumor interpolar region. Block. Sect. Site. PCs. 2. bln. 2. 5. pln. 5. Part 6: SP: Left renal sinus fat. Block. Sect. Site. PCs. 4. rsf. 4. Part 7: SP: Left lower pole fat. Block. Sect. Site. PCs. 4. lpf. 4. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: RENAL CORTICAL NEOPLASM. INKED MARGIN FREE. PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS: RENAL CORTICAL NEOPLASM, INKED MARGIN BENIGN. PERMANENT DIAGNOSIS: SAME. 3). FROZEN SECTION DIAGNOSIS: CYSTIC RENAL CORTICAL LESION SUSPICIOUS FOR RENAL CORTICAL. CARCINOMA. PERMANENT DIAGNOSIS: SAME,.",train,2.0 CM;2.6 CM;4.0 x 2.0. x 1.5 cm
5165,TCGA-DD-A11C.35CD5B20-BF61-4D28-AC7F-2CDC959382CD,"TISSUE DESCRIPTION: .1 A2 B1 C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12 C13 C14. C15. Right lobe liver (2890.0 grams, 24.3 x 22.0 x 13.3 cm), a. pericholedochal lymph node (2.1 x 1.1 x 0.8 cm) , and gallbladder. (9.2 x 4.4 x 2. 1 cm) . DIAGNOSIS: Liver, right lobe, resection: Grade 3 (of 4) hepatocellular. carcinoma forming a 22.0 x 15.3 x 12.8 cm mass in the right lobe of. noncirrhotic liver. The surgical margins are free of tumor by a. minimum of 1.1 cm. A large (10.3 x 7.4 x 5.5 cm) subcapsular. hematoma is also present. Lymph node, pericholedochal, excision: A single pericholedochal. lymph node is negative for tumor. Gallbladder, cholecystectomy: Mild chronic cholecystitis with. cholesterolosis and a single benign cystic duct lymph node are. identified. TISSUE DESCRIPTION: A1 A2 B1 C1 C2 C3 C4 C5 C6 C7 CB C9 C10 C11 C12 C13 C14. C15. Right lobe liver (2890.0 grams, 24.3 x 22.0 x 13.3 cm), a. pericholedochal lymph node (2.1 x 1.1 x 0.8 cm), and gallbladder. (9.2 x 4.4 x 2.1 cm) . DIAGNOSIS: Liver, right lobe, resection: Grade 3 (of 4) hepatocellular. carcinome forming a 22.0 x 15.3 x 12.8 cm mass in the right lobe of. noncirrhotic liver. The surgical margins are free of tumor by a. minimum of 1.1 cm. A large (10.3 x 7.4 x 5.5 cm) subcapsular. hematome is also present. Lymph node, pericholedochal, excision: A single pericholedochal. lymph node is negative for tumor. Gallbladder, cholecystectomy Mild chronic cholecystitis with. cholesterolosis and a single benign cystic duct lymph node are. identified.",train,22.0 x 15.3 x 12.8 cm;22.0 x 15.3 x 12.8 cm
5167,TCGA-4A-A93W.709348FB-E674-4720-B651-901E74E65449,"Sex: F. Account: Date Collected: Date Received: Clinical Data: Right renal mass. FINAL PATHOLOGIO DIAGNOSIS. 1. Right kidney (14 grams), partial nephrectomy: Papillary renal cell carcinoma. 2. Right kidney (deep margin): Papillary renal cell carcinoma; new margin free of tumor. SYNOPTIC REPORT. Tumor site: Right kidney. Histologic type: Papillary renal cell carcinoma. - Sarcomatoid features: Not identified. Histologic (Fuhrman) grade: G2. Tumor size: 3.6 cm. Tumor focality: Unifocal. Extent of tumor: Tumor is limited to kidney. Parenchymal margin: Negative for malignancy (1.0 cm from tumor). Angiolymphatic invasion: Not identified. Surgical Pathology Staging: pT1a NX. Pathologist, Electronic Signature. SPECIMEN(S) SUBMITTED: GROSS DESCRIPTION. 1. Right renal mass: In formalin labeled ""right renal mass"" is a 14 gram, 4 x 3.3 x 3.3 cm partial nephrectomy specimen. There is a 3.6 cm lobulated pale tan-red mass present. The mass abuts and elevates the renal capsule; however, no. invasion into or through the capsule is noted. The mass is grossly present, however, at the deep parenchymal resection. margin. The perinephric fat is inked black, with the parenchymal margin inked blue. Representative sections submitted. in four cassettes, A through D. 2. Deep margin: in formalin labeled ""deep margin"" is a 3.3 x 1.3 x 1.2 cm portion of renal parenchyma, with an attached. portion of lobulated pale tan-red tumor and an additional 2.5 x 2.5 X 1.3 cm aggregate of loose tumor fragments. The. tumor is grossly 1 cm from what appears to be the true deep margin, which is inked blue. Representative sections. submitted in two cassettes, A and B. CPT CODE(S): ICD-9 CODE(S): FACILITY: SURGICAL PATHOLOGY REPORT - CONTINUED. Result ID: 88307,88305.",train,3.6 cm;2.5 x 2.5 X 1.3 cm
5201,TCGA-24-2281.363dc00f-480d-4a3f-8950-80a6bc0b7dd8,"J Location. Receiv. Accessioned: Physician (s) : Other Related Clinical Data: DIAGNOSIS: OVARY, RIGHT, OOPHORECTOMY. - POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA. - SEE SYNOPTIC. FALLOPIAN TUBE, RIGHT, SALPINGECTOMY. - POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA BY DIRECT EXTENSION. OVARY, LEFT, OOPHORECTOMY. - POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA. - FOCAL LYMPHVASCULAR SPACE INVASION BY ADENOCARCINOMA IS IDENTIFIED. FALLOPIAN TUBE, LEFT, SALPINGECTOMY. - NO HISTOPATHOLOGIC ABNORMALITY. SOFT TISSUE, ANTERIOR CUL-DE-SAC, BIOPSY. - UNREMARKABLE FIBROADIPOSE TISSUE. SOFT TISSUE, POSTERIOR CUL-DE-SAC, BIOPSY. - UNREMARKABLE FIBROADIPOSE TISSUE. SOFT TISSUE, LEFT PELVIC SIDEWALL, BIOPSY. - UNREMARKABLE FIBROADIPOSE TISSUE. SOFT TISSUE, RIGHT PELVIC SIDEWALL, BIOPSY. - UNREMARKABLE FIBROADIPOSE TISSUE. SOFT TISSUE, RIGHT GUTTER, BIOPSY. - UNREMARKABLE FIBROADIPOSE TISSUE. SOFT TISSUE, LEFT GUTTER, BIOPSY. - UNREMARKABLE FIBROADIPOSE TISSUE. LYMPH NODES, LEFT PELVIC, DISSECTION. - NO EVIDENCE OF MALIGNANCY IN EIGHT LYMPH NODES. LYMPH NODES, RIGHT PELVIC, DISSECTION. - NO EVIDENCE OF MALIGNANCY IN SIX LYMPH NODES. LYMPH NODES, RIGHT COMMON PERIAORTIC, DISSECTION. - NO EVIDENCE OF MALIGNANCY IN TWO LYMPH NODES. LYMPH NODES, LEFT COMMON PERIAORTIC, DISSECTION. - NO EVIDENCE OF MALIGNANCY IN TWO LYMPH NODES. OMENTUM, OMENTECTOMY. - FOCAL ENDOSALPINGIOSIS. - NO EVIDENCE OF MALIGNANCY IN ONE INCIDENTAL LYMPH NODE. By this signature, I attest that the above diagnosis is. based upon my personal. examination of the slides (and/or other material indicated in the. diagnosis). Peport Electronically Reviewed and Signed Out By. Intraoperative Consultation: An intraoperative non-microscopic consultation was obtained and interpreted as: ""Called to pick up 'right tube and ovary, consisting of a 3.5 x 2.7 x 2.5 cm. ovary with smooth serosal surface, and solid cystic areas. Solid component. measures 2.5 x 1.5 x 1.4 cm, and 2 x 1.5 x 1. cm (two nodules) with papillary. cut surface. Unremarkable fallopian tube measures 6 x 0.8 cm. A section is cut. for frozen section (FS1) Rest for permanents, by. A second intraoperative non-microscopic consultation was obtained and. interpreted as: Called to pick up 'left tube and ovary, consisting of a 3 x. 2. cm pink-white ovary with pink smooth surface and portion of unremarkable. fallopian tube. Ovarian cut surface is tan-white. Tumor and fallopian tube for. tumor bank. No frozen. All for permanents,"" by. FS1: Right ovary. - Serous papillary carcinoma. MICTOSCODIC Description and Comment: Microscopic examination substantiates the above cited diagnosis. History: The patient is a. with bilateral adnexal masses; her CA125 is. greater than 100. Operative procedure: EUA, exploratory laparotomy, bilateral. salpingo-oophorectomy. Specimen (s) Received: A: OVARY AND TUBE, RIGHT. B: OVARY AND TUBE, LEFT. C: ANTERIOR CUL-DE-SAC. D: POSTERIOR CUL-DE-SAC. E: LEFT PELVIC SIDEWALL. F: RIGHT PELVIC SIDEWALL. G: RIGHT GUTTER. H: LEFT GUTTER. I: LYMPH NODE, LEFT PELVIC. J: LYMPH NODE, RIGHT PELVIC. K: LYMPH NODE, RIGHT COMMON PERIAORTIC. L: LYMPH NODE, LEFT COMMON PERIAORTIC. M: OMENTUM. Gross Description. The specimens are received in thirteen formalin-filled containers, each labeled. The first container is labeled ""right tube and ovary. "". contains a previously-opened ovary that weighs 19.17 grams, along with the. attached fallopian tube. The measurements are consistent with those in the. intraoperative consultation. Also in the container is a frozen section cassette. labeled ""FS1, N with tan-white tissue measuring 2.1 x 2 x 0.2 cm. Submitted as. A1. Additional sections submitted in A2 to A4. A5 - fallopian tube. The second container is labeled ""left tube and ovary, It contains a 15.07 gram. tubo-ovarian complex. The ovary measures 2.5 x 2 x 1.6 cm. The fallopian tube. is adhesed to the ovary, and measures 2.2 x 0.6 cm. The surface of the ovary is. irregular. Labeled B1 to B4 - ovary; B5 - ovary and fallopian tube. The third container is labeled ""anterior cul-de-sac.) It contains a white-tan. fragment of fatty tissue measuring 1.2 x 1.2 x 1 cm. The fourth container is labeled ""posterior cul-de-sac. It contains a soft. tissue fragment measuring 1.1 x 0.2 x 0.2 cm. The fifth container is labeled ""left pelvic sidewall. It contains a 1 x 0.3 x. 0.3 cm tan tissue. The sixth container is labeled ""right pelvic sidewall. It contains a 1 x 0.5 x. 0.3 cm yellow-tan fatty tissue. The seventh container is labeled ""right gutter. It contains a 1 0.4 x 0.4 cm. fatty tissue: The eighth container is labeled ""left gutter. It contains two yellow-tan. fragments of tissue measuring 0.4 x 0.3 x 0.2 cm each. The ninth container is labeled left pelvic lymph nodes. It contains fatty. tissue measuring, in aggregate, 6 x 5 x 2 cm. Labeled I1 to I5 - one. putative. lymph node bisected each; I6 - multiple single lymph nodes. The tenth container is labeled ""right pelvic lymph nodes. It contains. fibrofatty tissue measuring -7 x 5 x 1 cm. Labeled J1 to J5 - single putative. lymph node bisected; J6 - individual single lymph node. The eleventh container is labeled ""right common peri-aortic lymph node. It. contains a single 3 x 2 x 1 cm yellow fatty tissue. Entire tissue appears to be. a putative single lymph node. Serially sectioned. The twelfth container is labeled ""left common peri-aortic lymph node.' It. contains two fatty fragments of tissue measuring 1.5 x 1.5 x 0.6 and 1.5 x 1 x. 0.3 cm. Labeled L1 - smaller fragment bisected; L2 - larger fragment in. multiple sections. The thirteenth container is labeled ""omentum."" It contains a 100-gram omentum. measuring 15 x 5 x 1 cm. There are no papillary projections, or tumor nodules. noted on the omental surface. Labeled M1 to M5. Jar 2. SYNOPTIC REPORTING FORM FOR MALIGNANT OVARIAN NEOPLASMS. HISTOPATHOLOGIC TYPE. The histologic diagnosis is serous adenocarcinoma. TUMOR LOCATION. The locations of the primary tumor (s) are the right and left ovary (synchronous. primary tumors). HISTOLOGIC GRADE. The histologic grade is poorly differentiated (G3). TUMOR INVASION. Tumor does invade the adjacent fallopian tube/peritubal soft tissue. TUMOR INVOLVEMENT. Tumor involvement of the pelvic peritoneum/soft tissue is absent. PRIMARY TUMOR (T). Based on the above information, the primary tumor is classified as extension. and/or implants on uterus and/or tubes (T2a/IIA). REGIONAL LYMPH NODES (N). The regional lymph nodes are classified as no regional lymph node metastasis. (NO). The total number of regional lymph nodes examined is 19. DISTANT METASTASIS (M). The status of distant tumor site cannot be assessed (MX). STAGE GROUPING. The Final AJCC/UICC/FIGO stage has insufficient data to assign stage (Stage X). The pathologic stage assigned here should be regarded as provisional, and may. change after integration of clinical data not provided with this specimen. The performance characteristics of some immunohistochemical stains, fluorescence. in-situ hybridization tests and immunophenotyping by flow cytometry cited in. this report (if any) were determined by the. as part of an ongoing quality assurance and 111. compliance with federally mandated regulations drawn from the. Some of these tests rely on the. use of ""analyte specific reagents"" and are subject to specific labeling. requirements by the US Food and Drug Administration. determined that such clearance or approval is not necessary. This test is used. for clinical purposes. It should not be regarded as investigational or for. research. Nevertheless, federal rules concerning the medical use of analyte. specific reagents require that the following disclaimer be attached to the. This test was developed and its performance characteristics determined by. the.",train,
5206,TCGA-06-0137.608435f3-0b6e-4191-b678-c023e8936906,"Surnical Pathology Report. CLINICAL HISTORY. with right parieto-occipital glioblastoma in. Currently, recurrence. OPERATIVE DIAGNOSES. Not Given. Operation/Specimen: A: Brain, biopsy. B: Brain, resection. PATHOLOGICAL DIAGNOSIS: A and B. Brain, right parieto-occipital, excision: Glioblastoma. See comment. COMMENT. The specimens are fragments of cerebrum containing a neoplastic proliferation. of astrocytes with nuclear anaplasia, mitotic figures, microvascular. proliferation and necrosis. There are zones of pseudosarcoma, and the neurons. present are interpreted as entrapped. PROCEDURES/ADDENDA. Interpretation. MIB-1 PROLIFERATION INDEX 19%. Results-Comments. IMMUNOHISTOCHEMISTRY: The GFAP depicts sparse glial fibrillogenesis by the. tumor cells in the more cellular zones, a little more abundant in the looser. areas. With the MIB-1, there is a proliferation index of about 19% in the. more active areas. [NTRA-OPERATIVE CONSULTATION. Brain, biopsy, touch prep and smears: Malignant tumor (c/w glioma). GROSS DESCRIPTION. A. Received fresh, 2 fragments, 0.8 cm. across in aggregate. Semi firm,. tannish-grey. In total, Ai and A2. B. Reeived fresh, 2 fragments, 1.7 cm. across, in aggregate. Semi-firm,. tannish-white. In total, B1 and B2. ICD-9(s): 191.3.191 3. Histo Data. Part A: Brain. biopsy. Block. Comment. mGFAP-DA x 1. 1. H/E x 1. 1. MIB1-DA X 1. 1. Part B: Brain. resection.",train,0.8 cm
5217,TCGA-EX-A69L.6B157876-04F4-49D6-BACB-87F8E2B921CE,"Diagnosis: A: Lymph nodes, right pelvic, regional resection. - No evidence of metastatic disease in ten lymph nodes (0/10). - Follicular lymphoid hyperplasia. B: Lymph nodes, left pelvic, regional resection. - No evidence of metastatic disease in twelve lymph nodes (0/12). - Follicular lymphoid hyperplasia. C: Cervix, uterus and parametrium, radical hysterectomy. Histologic type: Invasive non-keratinizing squamous cell. carcinoma. Histologic grade: moderate to poorly differentiated. Tumor focality/site (quadrant (s) of cervix) invasive carcinoma. 6-3 o'clock clockwise (3 quadrants). CIN3 at 5 o' clock. Tumor size: (greatest dimension) 4.0 cm. Extent of invasion: Depth: 1.6 cm Wall thickness: 2.3 cm. Percent 70%. (See sections C6 and C7). Horizontal extent: 2.7 cm. Lymphovascular space invasion: none identified. Parametrial soft tissue involvement : -no evidence of tumor. involvement in the right or left parametrium. -3 benign right parametrial lymph nodes and 1 benign left. parametrial lymph node (0/4). Vaginal cuff involvement negative, margins clear. Surgical margins: clear. Invasive: carcinoma comes within 0.5 cm of the anterior cervical. soft tissue margin at 12 o' clock in section C7 (closest margin). Intraepithelial: widely free. Regional lymph nodes (see other specimens) : Total number involved: 0. Total number examined: 26. Additional pathologic findings : Endometrium. - Proliferative phase. Myometrium. - Leiomyomata, no significant atypia, mitotic activity, or tumor. necrosis identified. AJCC Pathologic Stage: pT1b1 pNO pMx. Note: This staging information is based on the pathologic. specimen and may be incomplete. A comprehensive review of all. available clinical information is recommended to determine final. staging. Clinical History: -year-old with Stage 1B cervical cancer. Gross Description: Received are three appropriately labeled containers. Container A is additionally labeled ""right pelvic lymph node. It consists of a 4.3 X 2.6 X 1.5 cm portion of adipose tissue. that is dissected for lymph node candidates of which nine are. identified ranging from 0.4 cm in greatest dimension up to 4.3 x. 1.5 X 1.2 cm in greatest dimension. Block summary: : A1 - five lymph nodes. A2 - two lymph nodes. A3 - one lymph node, serially sectioned. A4-A6 - one lymph node, serially sectioned. Container B is additionally labeled ""left pelvic lymph node. It. consists of a 6. 1 X 2.1 X 1.4 cm portion of adipose tissue that. is dissected for lymph node candidates of which eleven are. identified ranging from 0.4 cm in greatest dimension up to 4. 1 X. 1.3 X 0.4 cm in greatest dimension. Block summary : B1 - four lymph nodes. B2-B7 - - each contains one lymph node, serially sectioned. B8-B9 - - one lymph node, serially sectioned. Container C is additionally labeled ""uterus, cervix,. parametrium."". Specimen fixation: formalin. Specimen type: radical hysterectomy with attached bilateral. parametrium. Adnexa: absent. Weight: : 345 grams. Shape: distorted pyriform. Dimensions: Height : 10.5 cm. Anterior to posterior width: 5.2 cm. Breadth at fundus : 7.1 cm. Serosa: pink/tan, smooth and glistening with two homogeneous. white whorled rubbery nodules (1.0 X 1.0 X 0.6 cm and 7.1 X 4.7. X 4. 6 cm), each of which bulges on cut section; Anterior. cervix=blue, posterior cervix=black. Cervix: Ectocervix: 4. 1 cm in diameter; smooth and gray, of which. approximately 75% of the anterior ectocervix is eroded by tumor;. the posterior ectocervix has a focus of abutting tumor but is. intact, smooth and glistening. Tumor size: 4.0 .x 2.7 X 1.5 cm (protruding into the canal). Tumor site: Tumor involves from 6 o' clock up through 3 o' clock. (clockwise fashion) with 3-5 o' clock uninvolved by mass; the. mass is soft, tan/yellow, well circumscribed and partially. friable but is without hemorrhage or necrosis; the mass. partially erodes the anterior ectocervix and grossly abuts the. posterior ectocervix, extends 1.2 cm into the stroma, 0.3 cm. from the anterior cervical soft tissue margin, 0.9 cm from the. posterior cervical soft tissue margin, 1.4 cm from the anterior. lower uterine segment, 1.1 cm from the posterior lower uterine. segment, and 0.8 cm closest to the vaginal mucosal margin (at. 12 o' clock). Endocervix: involved by mass except from 3-5 o' clock. Other features: none. Endometrium: Length of endometrial cavity: 3.9 cm. Width: 3.8 cm. Endometrial surface: red/brown, slightly granular (less than 0. 1. cm thick). Other findings: none. Myometrium: Thickness of wall: 2.5 cm. Other findings: The myometrium is tan, trabeculated and contains. approximately 10 homogenous white whorled rubbery nodules up to. 3.5 X 3.5 X 3.0 cm in greatest dimension, all of which. bulge on cut section. Vagina: The vaginal mucosa measures 4.7 cm in diameter X 1.3 cm. wide x 0. 1 cm thick and is tan, smooth and glistening and. unremarkable. Urinary bladder: n/a. Rectum: n/a. Digital picture: not taken. Tissue give to tissue procurement: Tumor is given to the Tumor. Procurement foundation. Block summary : C1 - vaginal mucosal margin, en face from 12 to 3 o' clock. C2 - vaginal mucosal margin, en face, from 3 to 6 o' ' clock. C3 - vaginal mucosal margin, en face, from 6 to 9 o' clock. C4 - vaginal mucosal margin, en face, from 9 to 12 o' clock. C5 - perpendicular of mass at 9 o' clock with vaginal mucosa. C6-C8 - cervix, 12 o' clock, longitudinal section from. ectocervix through the anterior lower uterine segment, one piece. trisected (C6 contains mass eroding through ectocervix, C7 has. vaginal mucosa and cervical soft tissue, C8 is anterior lower. uterine segment with intramural nodule). C9 - perpendicular of mass at 3 o' clock. C10 - perpendicular of cervix at 5 o' clock. C11-C13 - cervix at 6 o' clock, one full length longitudinal. section from ectocervix towards posterior lower uterine segment,. one piece, trisected (C11 has mass with ectocervix and vaginal. mucosa, C12 is mass within endocervical canal, C13 is posterior. lower uterine segment). C14 - perpendicular cervix at approximately 8 o' clock with mass. C15-C16 - anterior corpus, full thickness, bisected, with. subserosal nodule. C17-C18 - posterior corpus, full thickness, bisected with. intramural nodule. C19-C21 - intramural nodules. C22-C24 - largest subserosal nodule. C25-C29 - right lateral parametrial soft tissue, serially. sectioned. C30-C34 - left parametrial soft tissue, serially sectioned.",train,4.0 cm;4.0 .x 2.7 X 1.5 cm;1.6 cm
5309,TCGA-Y8-A8S0.3D3C8809-0309-484B-9E1E-98A0A5613E85,"Research Gross Description. male with left renal mass. Research Dx. CASE SUMMARY FOR NEPHRECTOMY FOR RENAL CELL CARCINOMA: Procedure: Laparoscopic partial nephrectomy. Specimen laterality: Left. Tumor site: Inferolateral cortex. Tumor size: 1 x 1 x 0.7 cm. Tumor focality: Unifocal. Macroscopic extent of tumor: Tumor limited to the kidney. Histologic type: Papillary renal cell carcinoma, type I. Sarcomatoid features: Not identified. Tumor necrosis: Not identified. Histologic grade (Fuhrman Nuclear Grade): 2. Microscopic tumor extension: Tumor limited to the kidney. Margins: Negative for carcinoma(tumor extends to within 0.5 mm of the parenchymal margin. Lymph-Vascular invasion: Not identified. Pathologic staging (pTNM): Primary tumor: pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney. Regional lymph nodes: pNX: Unable to assess. Distant metastasis: pM: Not applicable. Pathologic findings in nonneoplastic kidney: No significant histologic abnormalities. Other tumors and/or tumor-like lesions: None identified. AJCC Staging (7th edition) pT1a pNX pM: Not applicable. Research QC. Tumor T1: 100% tumor nuclei. 0% necrosis. 0% normal. Normal N1: 100% benign kidney. Research Specimen. Specimen Process Time. Blood draw time: Plasma frozen time. Serum frozen time: Buffy coat frozen time: Tissue: Cold ischemia start time: Formalin fixation start time. Frozen start time: Total cold ischemia time: Formalin fixation stop time: Total formalin fixation time: 1. Specimen Weight. Normal. 1-112 mg. Tumor. 1-135 mg_. Specimen Size. Plasma x 3. Serum x 1. Buffy coat X 1. Cryovials X 2. Normal X 1. Tumor x 1. Metastatic x 0. FFPE X 2. Normal x 1. Tumor x 1 (. -no FS). Metastatic x 0. Study. Patient Consent.",train,1 x 1 x 0.7 cm
5384,TCGA-80-5611.42e15634-a742-4e7c-a795-e5fe6fd7b9aa,"A description for each data field can be found in the 'Data description worksheet (yellow tab). tion Details. Histology and staging. TUMOUR. FF. LUL lung mass. Adenocarcinoma. 0. 11. RESECT. LUL. 3.20. 03. III. T2,NOS. MO.",train,
5401,TCGA-LG-A9QC.AD8045A1-61EA-4713-9C8D-9AF200DB1424,"DATE OBTAINED: DATE RECEIVED: SUBMITTING MD: DIAGNOSIS. #1-CHOLECYSTECTOMY: MILD CHRONIC CHOLECYSTITIS. #2-LIVER, RIGHT LOBE, RESECTION: HEPATOCELLULAR CARCINOMA. Tumor type: Hepatocellular Carcinoma. Number of tumors: One main tumor mass, with multiple surrounding satellite lesions. Tumor size: 9 cm. Location (R or L lobe): Right lobe. Tumor Necrosis: Present, incomplete. Worst Tumor differentiation: Grade 2. Infiltrative pattern: Absent. Vascular Invasion: Present. Hepatic capsule: No extrahepatic invasion. Local extension: Absent. Margins: Negative. Multifocality: Satellite lesions present, multiple, up to 1.5 cm diameter. Other findings: Adjacent hepatic parenchyma with areas of hemorrhage, hemosiderin. deposition, reactive changes, and mild portal chronic inflammation. ypTNM: pT1 pNx. #3-DIAPHRAGM, PARTIAL RESECTION: SEGMENT OF SKELETAL MUSCLE CONSISTENT WITH DIAPHRAGM. WITH SURFACE FIBROUS ADHESIONS AND FOCAL GRANULATION TISSUE. NEGATIVE FOR MALIGNANCY. #4-SEGMENT OF OMENTUM: BENIGN ADIPOSE TISSUE WITH FOCAL FIBROSIS, NEGATIVE FOR. MALIGNANCY. COMMENT. 88309, 88304, 88305, 88329B, 88311. Clinical Diagnosis and History: Liver cancer. Tissue(s) Submitted: 1: GALLBLADDER. 2: RIGHT LOBE OF LIVER. 3: SECTION OF DIAPHRAGM. 4: SEGMENT OF OMENTUM. Gross Description: Specimen #1 is received in formalin, labeled gallbladder, and consists of an 8.5 x 3.5 x 1.4 cm intact gallbladder with attached pink. cystic duct exhibiting a 0.5 cm in diameter lumen. The serosa is gray-pink and smooth. Opening reveals approximately 15-20 CC of. amber viscous bile. The wall averages 0.1 cm. The mucosa is tan-red and velvety. No choleliths are identified. Representative. sections are submitted labeled 1A. Specimen #2 is received fresh for intraoperative consultation, labeled right lobe of liver (tissue removal time. ), and. consists of a 1,289-gram, 16 x 13.5 x 9.5 cm right lobe of liver exhibiting a focally retracted and nodular capsule associated with a. foci of adhesions. The resection margin is inked blue and the specimen is serially sectioned to reveal a 9.1 x 9 X 6.8 cm lobulated. mass exhibiting a variegated yellow-tan to hemorrhagic (approximately 20%) cut surface. The mass comes to within 1.6 cm of the. blue inked resection margin. The above is related to the surgeon intraoperatively. The remaining parenchyma appears gross. unremarkable, exhibiting a homogeneous mahogany surface. Representative normal and tumor are triaged per a depth and. protocol. Representative sections are submitted as follows: 2B: tumor to closest blue inked resection margin. 2C-2E: representative sections of tumor with blue inked capsular adhesions/calcifications and hemorrhage (after decalcification). 2F-21: additional representative sections of variegated cut surface. 2J: representative sections of normal liver parenchyma. 2K-2O: periphery of tumor, question satellite lesions. 2P-2T: Question vascular invasion of tumor. Specimen #3 is received in formalin labeled section of diaphragm and consists of a 1.5 X 0.5 x 0.5 cm tan white tissue fragment. exhibiting a focally granular cut surface. The tissue is bisected and entirely submitted labeled 3A. Specimen #4 is received is received fresh labeled segment of omentum and consists of a 10.0 x 7.5 X 1.8 cm lobulated portion of. omentum exhibiting focal cautery and erythema. Sectioning reveals no gross nodules. Representative sections are submitted. labeled 4A-4B. Intraoperative Consult Diagnosis. 2A/. SURGICAL MARGIN GROSSLY NEGATIVE 1.6CM FROM THE TUMOR.",train,9 cm
5422,TCGA-A2-A25D.BE63B06A-E3E0-4E00-9B9F-5E7DE8852E07,"TO. Patient: : Specimen #: Race: WHITE. Physician (s): SPECIMEN: A: RIGHT OUTER BREAST LUMPECTOMY. B: HIGHEST RIGHT AXILLARY LYMPH NODE. C: RIGHT AXILLARY LYMPH NODE DISSECTION. FINAL DIAGNOSIS: A. BREAST, RIGHT OUTER, LUMPECTOMY: - TUMOR TYPE: INVASIVE LOBULAR CARCINOMA, PLEOMORPHIC TYPE (SEE. COMMENT). NOTTINGHAM GRADE: POORLY DIFFERENTIATED (G3). NOTTINGHAM SCORE: 8/9 (Tubules= 3, Nuclei= 3, Mitoses= 2) . - TUMOR SIZE (GREATEST DIMENSION) : 3.2 CM (MEASURED GROSSLY) . - TUMOR FOCALITY: SINGLE FOCUS OF INVASIVE CARCINOMA. - TUMOR SIDE (QUADRANT) : RIGHT OUTER. - VENOUS/LYMPHATIC INVASION: PRESENT. - MARGINS: POSITIVE. TUMOR EXTENDS TO THE ANTERIOR AND INFERIOR INKED TISSUE EDGES. - LOBULAR CARCINOMA IN SITU: NOT IDENTIFIED. - LYMPH NODES: TWENTY-THREE (23) LYMPH NODES POSITIVE FOR METASTATIC. CARCINOMA (SEE PARTS ""B"" AND ""C""). - ESTROGEN RECEPTORS: POSITIVE (95% NUCLEI STAINING, REFER TO. - PROGESTERONE RECEPTORS: NEGATIVE (0% STAINING. REFER TO. - HER 2 NEU by IHC: NEGATIVE, 1+ (REFER TO. - AJCC PATHOLOGIC STAGE (7TH EDITION) : pT2 N3a. B. AXILLARY LYMPH NODE, RIGHT (""HIGHEST"") BIOPSY: - ONE (1) LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA (SEE COMMENT). SIZE OF LARGEST METASTATIC DEPOSIT: 0.9 CM. EXTRACAPSULAR EXTENSION: FOCALLY PRESENT. C. AXILLARY LYMPH NODES, RIGHT, DISSECTION: - TWENTY-TW (22) OF TWENTY-THREE (23) LYMPH NODES POSITIVE FOR. METASTATIC CARCINOMA (SEE COMMENT). SIZE OF LARGEST METASTATIC DEPOSIT: 2.1 CM. EXTRACAPSULAR EXTENSION: PRESENT. Specimen #: FINAL DIAGNOSIS (continued) : Comment : The lymph node metastases seen in parts ""B"" and ""C"". demonstrate multiple foci of extracapsular extension and in most cases. represent near complete replacement of the underlying nodal architecture. This case received prospective peer review. CLINICAL DIAGNOSIS AND HISTORY: female with medical diagnosis of breast cancer (invasive. mammary adenocarcinoma, right breast breast; positive right axillary node) . PRE-OPERATIVE DIAGNOSIS: None provided. POST-OPERATIVE DIAGNOSIS: None provided. GROSS DESCRIPTION: A: Received fresh, labeled with the patient's name. and designated, ""Right Outer Breast Lumpectomy"" and consists of an. irregular portion of soft tissue oriented with a single suture - anterior;. double - lateral; and short - superior. The specimen measures 10.5. cm. superior to inferior; 7.0 cm medial to lateral; and 3.0 cm anterior to. posterior. The specimen is inked as follows: superior = blue; inferior =. green; medial = red; lateral = yellow; anterior = orange; and posterior =. black. Serial sections reveal a poorly-defined, firm tan-white mass. measuring 3.2 x 2.5 x 2.0 cm. The mass approaches the closest margin as. follows: 0.2 cm inferior; 0.5 cm deep and anterior; and 1.0 cm medial. The remainder of the specimen is composed of lobulated, yellow-tan adipose. tissue admixed with a minimal amount of fibrous tissue and is otherwise. unremarkable. Representative sections are sequentially submitted from. superior to inferior as follows A1 - superior margin; A2-A4- adjacent. normal; A5-A7- mass with deep and anterior margins; A8- - mass; A9-A10- mass. with deep margin; All-A13- - mass with deep, anterior and medial margin;. A14-A16- - mass with lateral, inferior and anterior margin; A17-A19- mass. with deep and inferior margins. Matched sections of A4 and A6-A8 - are submitted in OCT and Paraffin per. Specimen #: GROSS DESCRIPTION (continued) : CBCP protocol. Time in formalin: 28 hours. B: Received in formalin, labeled with the patient's name. and designated, ""Highest Right Axillary Lymph Node"" and consists. of an irregular fragment of tan-yellow adipose tissue measuring 1.5 x 1.0. x 0.5 cm. Blunt dissection reveals an ovoid fragment of tan, soft tissue. representing possible lymph node measuring 1.5 cm in greatest dimension. Sectioning of the possible lymph node reveals a tan-white, firm cut. surface. C: Received in formalin, labeled with the patient's name. ind designated, ""Right Axillary Lymph Node Dissection"" and. consists of an irregular fragment of tan-yellow, lobular adipose tissue. measuring 10.0 x 6.0 x 3.0 cm. The specimen is blunt dissected to reveal. 22 roughly ovoid fragments of tan-white, firm tissue representing possible. lymph nodes ranging from 0.4 to 4.3 cm in greatest dimension. Sectioning. of the possible lymph nodes reveals a tan-white, firm cut surface with. focal areas of hemorrhage. Sections are submitted as follows: C1- five. possible lymph nodes; C2- representative sections of four possible lymph. nodes; C3- - representative sections of four possible lymph node; C4-. representative sections of three possible lymph nodes; C5 - representative. sections of two possible lymph nodes; C6- representative sections of two. possible lymph nodes; C7- - representative section of one possible lymph. node; C8- - one whole possible lymph node, bisected.",train,3.2 CM
5427,TCGA-2G-AAHT.7ACA59FF-57F3-46E5-A01B-85F1E18674BE,"Direct diai. Summary pathology report. Left orchidectomy; seminoma; diameter 9.0 cm; no angio-invasion; no invasion of tunica. albuginea; epididymis, rete testis and spermatic cord not present in the available slides. = date of orchidectomy): pathologist.",train,
5436,TCGA-CZ-4857.fc5d937e-280d-47ee-a6ce-4eb7b1b6430f,"Report Status. Type Surgical Pathology. Specimen Type: Kidney, partial or total resection. Procedure Date: Resident: Pathologia. PATHOLOGIC DIAGNOSIS: RIGHT KIDNEY, /NEPHRECTOMY: RENAL CELL CARCINOMA, CLEAR CELL TYPE (9.2 cm), Furman grade 3 of 4. Tumor does not invade Gerota's fascia. Tumor extends into the wall but not through the renal vein. Vascular and ureteral margins negative for tumor. No lymphovascular invasion is identified. Two (2) lymph nodes; no tumor present. REGIONAL LYMPH NODES, BIOPSY: One (1) lymph node; no tumor present. CLINICAL DATA: History: with pain and hematuria. R kidney mass and possible lung. nodules. Operation: Nephrectomy. Clinical Diagnosis: As above. TISSUE SUBMITTED: #1) R. kidney. #2) Regional lymph nodes. GROSS DESCRIPTION: The specimen is received fresh, in two parts, each labeled with the patient?s. name and unit number. Part A, labeled ""#1. R. kidney"", consists of a right radical nephrectomy. specimen (976.5 grams, 28.6 x 10.8 x 6.7 cm), to include right kidney (16.3 x. 8. x 5.5 cm), ureter (8.0 cm in length x 0.4 cm in diameter), renal vein at. hilum (0.5 cm in length x 1.2 cm in diameter), renal artery (3.5 cm in length x. 0.4 cm in diameter), additional clip vascular structure (11 cm in length x 0.3. cm in diameter - consistent with a vein), Gerota's fascia (12.5 x 7.0 x 0.1 cm). and abundant attached perinephric fat. There is a golden yellow/red/tan,. partially encapsulated nodular focally hemorrhagic centrally necrotic mass (9.2. x 7.7 x 5.7 cm) within the upper pole, focally impinging upon the renal capsule. and closely opposed black-inked Gerota's fascia, focally appears to impinge the. renal vein, coming to within 1.2 cm of the renal vein, 2.8 cm from the renal. artery margin, and grossly appears to abut but invade the renal pelvis coming. to within 8 cm of he ureteral margin. Representative sections of the tumor are. submitted to cytogenetics and electron microscopy for future studies. A 0.4 x. 0.3 x 0.3 cm white firm nodule is identified within a medullary pyramid along. the anterior/lateral aspect of within the mid pole of the kidney, 1.1 cm. lateral and inferior to the aforementioned mass. The remaining renal. parenchyma displays a well-defined cortico-medullary junction with no other. gross lesions. Two brown/pink rubbery nodules (1.3 cm and 1.5 cm in greatest. dimension are identified within the perihilar soft tissue. Representative. cortex is submitted for future electron microscopy, immunofluorescence studies. and to the tissue bank for special studies. Tumor is also submitted to the. tissue bank (T1, T2 and T3) . Micro A1: ureteral, arterial and venous margins, en face, 4 frags,. Micro A2: ""T1"", 1 frag,. Micro A3: ""T2"", 1 frag,. Micro A4: ""T3"", 1 frag,. Micro A5-6: renal mass at deepest extension, in relationship to Gerota's. fascia, 2 frags,. Micro A7-8: renal mass at possible invasion into vein and relationship with. pelvis, 2 frags,. Micro A9: random tumor, 1 frag,. Micro A10-11: additional white firm nodule in relationship to mass, 2 frags,. Micro A12: cortico-medullary junction, 1 frag,. Micro A13: bisected nodules (? lymph node) 2 frags,. Micro A14: bisected perihilar nodule (? lymph node) , 2 frags,. Part B, labeled ""#2. regional nodes"", consists of an unoriented portion of. yellow/tan fatty soft tissue (6.5 x 4.2 x 2.0 cm). Sectioning reveals a large. gray/pink/yellow matted firm probable lymph node (5.4 x 3.3 x 2.0 cm). The. tissue is bisected and one-half of the entire matted lymph node is submitted. Micro B1-6: large matted lymph node (one-half of specimen) 6 frags,. By his/her signature below, the senior physician certifies that he/she. personally conducted a microscopic examination (""gross only"" exam if so stated). of the described specimen (s) and rendered or confirmed the diagnosis (es). related thereto. Resident Review by. Ginal Diagnosis by. Report Status: Type Cytogenetics. PATIEN. Cvtogeneticist. KARYOTYPE: T1:92,XXYY, der (1) x2, del (3) (p12) x2 (1). T3: 46,XY. METAPHASES COUNTED: 16. ANALYZED: 6. SCORED: 10. BANDING: GTG. INTERPRETATION: Three different specimens from the same tumor were received. Specimen #1: only 1 metaphase cell was obtained, and contains a deletion of the. short arm of chromosome 3, a characteristic finding in renal cell carcinoma,. clear cell type. Specimen #2: No metaphases were obtained, and therefore the cytogenetic. analysis could not be performed. Specimen #3: No cytogenetic aberrations were identified. COMMENTS. Mosaicism and small chromosome anomalies may not be detectable using the. standard methods employed. Chromosome analysis was performed at a level of 400. bands or greater. INDICATION FOR TEST: ? RCC.",train,9.2 cm
5441,TCGA-CV-7413.75b017a7-c3e9-4eb1-8fd7-99b419889861,"DIAGNOSIS : (A) ANTERIOR MANDIBLE: MODERATELY DIFFERENTIATED SQUAMOUS CARCINOMA INVADING ANTERIOR. MANDIBLE, RESECTION MARGINS FREE OF TUMOR. DIAGNOSIS. (A). CHIN INCLUDING ANTERIOR MANDIBLE AND OVERLYING SKIN AND BASE OF TONGUE,. RESECTION: INVASIVE, MODERATELY DIFFERENTIATED SQUAMOUS CARCINOMA INVOLVING. SKIN, SUBCUTANEOUS TISSUE AND FLOOR OF MOUTH, RESECTION MARGINS. FREE OF TUMOR. Sections of bone pending decalcification. (B) RIGHT LINGUAL NERVE: Peripheral nerve, no evidence of carcinoma. LYMPH NODES, RIGHT MIDDLE JUGULAR: Lymph nodes, no evidence of metastatic disease. COMMENT. Perineural and lymphovascular invasion are not seen. SPECIMEN. (A). CHIN INCLUDING ANTERIOR MANDIBLE AND OVERLYING SKIN AND BASE OF TONGUE,. RIGHT LINGUAL NERVE: LYMPH NODES, RIGHT MIDDLE JUGULAR: SNOMED CODES. T-11180, M-80703.",train,
5557,TCGA-IB-7897.4c894664-b029-462a-9ef2-a7c859a11272,"HISTOPATHOLOGY REPORT. ORIGINAL REPORT. SPECINEN: A. Gallbladder. B. Node of. importance. c. Whipple's specimen. CLINICAL HISTORY: Pancreatic cancer. DIAGNOSIS: A. GALLBLADDER,. CHRONIC CHOLECYSTITIS. B. NODE OF IMPORTANCE, BIOPSY: MESTASTASTATIC PANCREATIC ADENOCARCINOMA. C. DUODENUM AND HEAD OF PANCREAS, WHIPPLE'S SURGERY: MODERATELY DIFFERENTIATED INFILTRATING DUCTAL ADENOCARCINOMA. MAXIMUM DIAMETER 3.. 5 CM, WITH FOCAL EXTRAPANCRHATIC CANCER ADJACENT. TO PYLORIC LYMPH NODES, ABUTTING ON PAINTED RESECTION MARGIN,. PANCREATIC INTRAEPITHELTAL NEOPLASIA (PANIN 1B/2) LOCATED AT THE NECK. RESECTION MARGIN IN LARGER PANCREATIC DUCTS. 2 OF 17 LYMPH NODES POSITIVE FOR MISTASTATIC. ADENOCARCINOMA. INCIDENTAL PANCREATIC HAMARTOMA/EETEROTOPIA IN DUCIDENAL WALL. HISTOPATHOUOGV REPORT. GROSS DESCRIPTION: A. The specimen consists of a 7.0 x 3.! x 1.5 em gallbladder with a grey. congested serosa. The thickness of the wall ranges from 0.2 to 0.3 cm. The. mugosal surface is green and velvety, No stones are identified. The cystio. duot is patent, Three representative sections are submitted in cassette A,. B. The specimen consists of an irregular fragment of soft tissue measuring. 1.1 x 1.0 x 0.3 cm. Bisected and submitted in toto in cassette B,. c. The specimen consists of a 21.0 cm of duodenum with a proximal segment of. pancreas measuring 4.5 x 4.6 x 2.5 cm. The common bile duot is patent and its. resection margin is taken enface. There is a 3.! x 1.2 x 2.6 am firm mass. oddupying all the tissue located above the common bile duot, This mass is. located at 0.2 am from the surface in contaot with the mesenteric blood. vessels and 0,4 cm from the anterior surface of the pancreas. Located at the. mucosal surface at 3.8 om and 7.4 em from the proximal resection, there are. two. sections are submitted as follows: 01. common bile duct margin enface. C2. pancreatic distal margin enface. C3,. proximal resection margin (stomach). C4,. distal resection margin (duodenum). C5-7,. uncinate process, blood vessels ' and distal margins (black, blue and. orange colors respectively). tumor and duodenal mudosa. C11. preserved pancreatid tissue and preserved duodenum mucosa. yellow nodular lesions at the duodenal mucosa. C13. distal stomach lymph nodes. 014-15,. common bile dudt area lymph nodes. 016,. panoreatic head lymph nodes. C17. duodenal lymph node, trisected. duodenal Jymph nodes, uncut. MICROSCOPIC DESCRIPTION: The slides from specimen C show a malignant neoplasm composed by a. proliferation of large epithelial cella with hyperchromatic, irregular nuclei. forming primiti.ve duotal structures surrounded by a dense, collagenized. HISTOPATHOLOGY REPORT. MICROSCOP.C DESCRIPTION: stroma. The uncinate and other main resection margins are clear of malignant. dells but there is extranodal invasive carcinoma around the pyloric nodes. that touches the painted outer surface of the specimen. Two of the pyloria. nodes have metastatic cander. 15 other nods are negative. The resection margin at the neck of the panoreas is clear of carcnoma, but. there are some atypical changes compatible with PAN IN 1B and 2 present in the. pancreatic duot at this margin.",train,3.. 5 CM
5561,TCGA-UY-A78O.139E5F15-194A-451A-83D7-919C657C08A3,"Anatomic Site:Right Ureter (FS). Left Ureter (FS). Bladder (FS on urethra). Distal right ureter (FS). Right pelvic lymph nodes (FS). Final urethral margin. Left pelvic lymph nodes. Final left ureter. Clinical Diagnosis/History. The patient is a. -year-old woman. No further clinical history is provided. A recent consult. indicates a transurethral bladder tumor resection showing invasive high-grade. urothelial carcinoma with invasion of the. muscularis propria. Gross Description: The specimen is received in eight parts, each labeled with the patient's name. and medical record number. Parts A through E are. received fresh. Parts F-H are received in formalin. Part A is additionally labeled ""right ureter (frozen) "" It consists of a. single segment of ureter, measuring 2.8 cm in length. and 1.2 cm in greatest diameter. The specimen is oriented by a black stitch. and verbally by the surgeon. Gross tumor extends. from the distal end of the ureter. The proximal margin is submitted en face. for frozen section diagnosis as FS1, with the. frozen section remnant submitted in cassette A1. The remaining ureter is. entirely submitted as follows: Cassette A2: Proximal half of remaining ureter. Cassette A3: Distal half of remaining ureter. Part B is additionally labeled ""left ureter (frozen) "" It consists of one. fragment of pink-red ureter, measuring 0.5 x 0.4 x. 0.3 cm. The specimen is entirely submitted for frozen section diagnosis. as. FS2, with the frozen section remnant submitted in. cassette B1. Part C is additionally labeled ""bladder. It consists of a specimen, weighing. 271 gm and measuring 22 x 13 x 3.5 cm. Present. within the specimen is a bladder, with a stent protruding through the left. ureter. In addition, there is included the left. fallopian tube and ovary. There is a small portion of the vaginal cuff. posterior to the urethra. The small stub of the left. ureter measures 0.3 cm in length and 0.2 em in diameter and is grossly normal. The remnant fragment of right ureter measures. 1.5 cm in length and 0.9 cm in diameter, and there is gross tumor at the. proximal end. An en face margin of the urethra is. submitted for frozen section diagnosis as FS3, with the frozen section remnant. submitted in cassette C1. The right-anterior. half of the bladder is inked green, the left-anterior half is inked blue, and. the posterior is inked black. The specimen is. then opened anteriorly through the remaining urethra to reveal a yellow-tan,. friable mass, measuring 3 x 2 x 1.8 cm, near the. right ureter opening and posterior bladder wall. Within the posterior aspect,. there is an area of potential bladder wall. involvement by the tumor, with possible tumor within 0.1 cm of the posterior. surgical resection margin. No other focal lesions. are identified. The left fallopian tube measures 5.5 cm in length and 0.4 cm. in average diameter. The fimbriae are lush, and. cross sections are grossly normal. The left ovary measures 2.5 x 1.2 x 0.9 cm. and has a grossly normal parenchyma. The. perivesicular fat is extensively searched for lymph nodes, with two candidate. lymph nodes identified. Representative sections. are submitted as follows: Cassette C1: Remnant from FS3. Cassette C2: Right and left ureter margins. Cassette C3: Left fallopian tube and ovary. Cassette C4: Normal bladder. Cassette C5: Tumor at posterior bladder. Cassette C6: Tumor at posterior bladder. Cassette C7: Mass at right ureter. Cassette C8: Mass at candidate remnant urethra. Cassette C9: Two candidate lymph nodes and candidate right. fallopian tube. Part D is additionally labeled ""distal right ureter, long stitch = proximal. end."" It consists of a single red-tan, tubular. structure, measuring 4.3 cm in length and 1.4 cm in greatest diameter. The. lumen measures 0.4 cm in diameter. A long stitch. marks the proximal margin, and a short stitch marks the distal margin. An en. face cut of the proximal margin is submitted for. frozen section diagnosis as FS4, with the frozen section remnant submitted in. cassette D1. The remaining specimen is entirely. submitted as follows: Cassette D2: Remaining proximal one-third. Cassette D3: Remaining mid one-third. Cassette D4: Remaining distal one-third. Part E, additionally labeled ""right pelvic lymph nodes, consists of soft,. red-yellow, fibro-fatty tissue measuring 8 x 5.5 x 1. cm and weighing 26 gm. Multiple prominent lymph node candidates are. identified. Representative sections from two lymph node. candidates are submitted for frozen section diagnosis 5. The first frozen. section remnant is submitted in cassette E1, with the. remainder of the lymph node candidate submitted in cassette E2. The second. frozen section remnant is submitted in cassette E3,. with the remainder of the lymph node candidates submitted in cassettes E4-E5. Following fixation, the remainder of the lymph. node candidates are submitted as follows: Cassette E6: One lymph node, bisected. Cassette E7: One lymph node candidate, bisected. Cassette E8: One lymph node candidate, bisected. Cassette E9: TWO lymph node candidates, bisected and differentially. inked. Cassette E10: Three small lymph node candidates, bisected, two. differentially inked. Cassette Ell: Multiple small lymph node candidates, submitted whole. Part F, additionally labeled ""4 - final urethral margin,"" consists of one. firm, yellow-brown, irregular, unoriented tissue. fragment measuring 2.2 x 1.8 x 0.4 cm. The specimen is sectioned and entirely. submitted in cassette F1. Part G, additionally labeled ""7 - left pelvic lymph nodes, "" consists of. multiple soft, yellow, irregular, unoriented,. fibroadipose tissue fragments measuring 9 x 5 x 3.5 cm in aggregate and. containing multiple lymph node candidates ranging from. 0.3 to 3.1 cm in greatest diameter. The lymph node candidates are submitted. as follows: Cassette G1: Intact lymph node candidates. Cassette G2: Two bisected lymph node candidates, inked in. different colors. Cassettes G3-G5: Single lymph node candidate, trisected. Cassettes G6-G9: Single lymph node candidate, sectioned into four sections. Part H, additionally labeled ""8 - final left ureter, "" consists of one soft,. tan-white, irregular, unoriented, fibrous tissue. fragment measuring 1 x 0.7 x 0.2 cm. The specimen is trisected and entirely. submitted in cassette H1. The immunoperoxidase stain (s) reported above were developed and their. performance characteristics determined by the. They have not been cleared or approved by the. U. S. Food and Drug Administration. The FDA has. determined that such clearance or approval is not necessary. These tests are. used for clinical purposes. They should not be. regarded as investigational or for research. This laboratory is certified. under the Clinical Laboratory Improvement Amendments. of 1988 (""CLIA"") as qualified to perform high-complexity clinical testing. Diagnosis Comments: Bladder Tumor Synoptic Comment. 1. Tumor type: Urothelial (transitional cell). 2. Tumor grade: High grade. 3. Tumor size: 3 cm. 4. Extent of tumor in bladder: Invasion into outer half of muscularis. propria. 5. Lymphatic/vascular invasion: None identified. 6. Epithelial abnormalities in bladder: Carcinoma in situ. 7. Extension of tumor into organs adjacent to bladder: Ureter, right. 8. Surgical margins: Urethral margin: Free of tumor. Right ureter margin: Final margin free of tumor. Left ureter margin: Final margin free of tumor. Perivesical margin: Negative, closest margin is 0.2 cm, posterior, slide. C5. 9. Lymph nodes: No tumor (0/24) . 10. Other pathologic findings in bladder: Olceration and chronic. inflammation. 11. AJCC/UICC stage: pT2bNOMX. 12. Additional margin: The distal end of Part A (right ureter) is involved by. high grade invasive carcinoma (slide A3) into the. muscularis propria; however the proximal specimen margin (slide A1). demonstrates chronic inflammation of the lamina propria with. atypia of the urothelial mucosa with we regard as reactive atypia. In Part D. (labeled final proximal margin of the right. ureter) the proximal specimen margin (slide D1) is negative for dysplasia or. carcinoma. However the distal end of this specimen. (slide D4) reveals nuclear atypia of urothelial carcinoma in situ. Because of. the intense chronic inflammation, distinguishing. reactive vs dysplastic changes are difficult. Immunohistochemical stain for. p53 was performed on slide D3 where the inflamed. urothelium have atypical, round, slightly enlarged nuclei and prominent. nucleoli. The stains highlights scattered positivity. Thus based on the morphology and results of the immunohistochemical stain, the. atypical changes on slide D3 are regarded as. reactive. Dr. has reviewed select portions of Parts A and D. and concurs. Level section on C9 confirms the. diagnosis. Interoperative Diagnosis: FS1 (A) Right ureter, proximal margin, biopsy: Chronic ureteritis with. atypia, favor dysplasia. FS2 (B) Left urater, biopsy: No tumor seen. FS3 (C) Distal urethra, biopsy: No tumor seen. FS4 (D) Right ureter, proximal margin, biopsy: No tumor seen. 14. FS5 (E) Right pelvic lymph nodes, biopsy: Representative section of two. lymph node candidates, no tumor seen. Final Diagnosis: A. Right ureter, distal, resection: 1. Proximal specimen margin with chronic ureteritis and atypia; see comment. 2. Distal end of ureter with high grade invasive urothelial carcinoma into. muscularis propria. B. Left ureter, distal, biopsy: No dysplasia or carcinoma. C. Bladder and left fallopian tube and ovary, cystectomy and. salpingo-oophorectomy: 1. Bladder with invasive high grade urothelial carcnoma, into outer one-half. of muscularis propria; see comment. 2. No tumor in one lymph node (0/1). 3. Left fallopian tube and ovary with no significant pathologic abnormality. D. Right ureter, final proximal margin, biopsy: Proximal specimen margin with. no dysplasia or carcinoma. E. Lymph nodes, right pelvic, dissection: No tumor in seventeen lymph nodes. (0/17). F. Urethra, ""final margin, biopsy: No dysplasia or carcinoma. G. Lymph nodes, left pelvic, dissection: No tumor in six lymph nodes (0/6). H. Left ureter, final margin, biopsy: No dysplasia or carcinoma.",train,3 cm
5588,TCGA-UF-A7JD.8B218C4E-A9AB-486A-9A8E-B3001C98F86A,"PRIMARY SITE: Buccal mucosa. 1 - ""Neck lymph nodes - Right"": Eighteen lymph nodes with no evidence of metastatic carcinoma (0/18). - Salivary gland fragments with congestion, uninvolved by neoplasia. 2 - ""Neck lymph nodes"": - Two of seven lymph nodes involved by metastatic carcinoma (2/7), with capsular. involvement. 3 - Anterior margin uninvolved by neoplasia. 4 - ""Retromolar lesion surgical excision specimen"": - Poorly differentiated squamous cell carcinoma, ulcerated, measured 4.1 cm, 1.4 cm. deep, with necrosis sites. - Lymphovascular invasion: present. - Perineural invasion: present. - Osseous tissue involved by carcinoma. - Intense peritumoral desmoplasia. - Scarce peritumoral lymphocitary infiltrate. - Deep margin involved by carcinoma. - Other surgical margins uninvolved by carcinoma.",train,4.1 cm;1.4 cm
5598,TCGA-77-8150.d19c8493-374a-4b6a-9975-5f220c77834b,"Histopathology Report. SEE SUPPLEMENTARY REPORT BELOW. HISTORY. Frozen section. Squamous cell carcinoma. Trunchus intermedius. MACROSCOPIC. Six specimens received: 1: The specimen is unlabelled and consists of a fragment of tissue measuring 6. X 4 x 3 mm. [BIT, 1A]. FROZEN SECTION DIAGNOSIS: No evidence of malignancy. Phoned to. 2: The specimen is labelled ""(R) lung' and consists of a right lung measuring. 220 mm superior to inferior, 160 mm anterior to posterior and 90 mm medial to. lateral. The upper and lower lobes are formed well. The right middle lobe is. quite rudimentary and the horizontal fissure is only very poorly formed. The. pleural surface is quite ragged particularly over the right lower lobe. A. piece of redundant pleura is present at the inferolateral aspect of this lobe. Several discrete areas of firm induration can be palpated over the medial. surface of the right lower lobe. The pleural surface of the right upper lobe. is much smoother, however the lung itself is quite firm in the inferior aspect. of the right upper lobe and a firm mass can be palpated in the right lower lobe. close to the hilar region. On sectioning of the lung the right upper lobe is. largely free of pathology. In the right lower lobe numerous perihilar lymph. nodes can be seen and a firm tumour mass measuring 43 x 25 x 20 mm. It has an. endobronchial component approaching to within 7 mm of the bronchial resection. margin and appearing to completely obstruct the right lower lobe bronchus. The. right lower lobe is nearly completely replaced by pneumonia and large amounts. of tenacious pus are noted throughout this lobe of lung. [2A-B, bronchial. resection margin, 2A is the upper lobe bronchus, 2B is the lower lobe bronchus;. 2C-H, peribronchial lymph nodes; 21, endobronchial tumour; 2J-L, tumour close. to resection margin; 2M, lower lobe lung including pneumonia; 2N, bullous area. of lung from the upper lobe; 20, normal lung and subpleural lymph node from the. upper lobe; 2P, area of attached redundant pleura from the lower lobe]. 3: The specimen is labelled 'No. 3 lymph node' and consists of a piece of. nodal tissue measuring 15 x 19 X 10 mm. [Bisected and BIT, 3A]. 4: The specimen is labelled 'No. 7 plus 8 lymph node' and consists of nodal. tissue measuring 35 X 15 x 20 mm. [Sectioned and BIT, 4A-C]. 5: The specimen is labelled 'No. 9 lymph node and consists of a piece of nodal. Histopathology Report. tissue measuring 20 X 15 x 10 mm. [Bisected and BIT, 5A]. 6: The specimen is labelled 'No. 10 lymph node' and consists of a piece of. nodal tissue measuring 15 X 10 X 10 mm. [Bisected and BIT, 6A]. MICROSCOPIC. 1: Paraffin sections confirm the frozen section diagnosis of no evidence of. malignancy. The biopsy includes bronchial cartilage and seromucinous glands. and surrounding fibroadipose tissue. 2: Sections show a moderately differentiated squamous cell carcinoma that is. forming a polypoid endobronchial mass and is invading through the bronchial. wall and into the adjacent lung and hilar fibroadipose tissue. Pleural. invasion is not identified. There is no blood vessel invasion and no lymphatic. permeation is seen. Perineural permeation is identified and this extends. closely to (0.3 mm) a hilar soft tissue margin. The lesion is well clear of. the bronchial resection margin. At the bronchial resection, squamous. metaplasia is identified. There is involvement of peribronchial lymph nodes. within the region of the tumour. Distal to the tumour, there is evidence of. obstructive pneumonitis with mild bronchiectasis. The uninvolved lung shows. mild respiratory bronchiolitis, peribronchial dust deposition and emphysema. Elastic pulmonary arteries show mild atheroma. The attached pleural adhesion. appears fibrotic. Within the peribronchial lymph nodes, there are silicotic. nodules together with prominent sinus histiocytosis. Focally the histiocytes. are forming poorly developed granulomata. The granulomata may be in response. to the tumour however, a rare granuloma contains central necrosis and special. stains for micro-organisms will be undertaken. A large silicotic nodule is. present in the subpleural lymph node. 3: Sections of the lymph nodes show reactive changes only. There is no. evidence of malignancy. 4: Sections of the lymph nodes show reactive changes only. There is no. evidence of malignancy. 5: Sections of the lymph nodes show reactive changes only. There is no. evidence of malignancy. 6: Sections of the lymph nodes show reactive changes only. There is no. evidence of malignancy. SUMMARY. 1-6: Right lung and lymph nodes: A: Moderately differentiated squamous cell carcinoma; 43 mm in maximal. dimension. Histopathology Report. B: Perineural permeation identified but no blood vessel or lymphatic invasion. present. C: No pleural invasion identified; clear of bronchial margin but close to. hilar soft tissue margin (0.3 mm). D: Peribronchial lymph node metastases. E: T3N1. F: Non-neoplastic lung: Emphysema and mild respiratory bronchiolitis. SUPPLEMENTARY REPORT. 1: No microorganisms are identified within the lymph node granulomata with. special stains (Grocott and Ziehl-Neelsen). SUPPLEMENTARY REPORT. 2: A further section of the tumour has been examined [2Q]. The tumour appears. confined to the bronchus in this sectioned and there is no involvement of the. hilar margin. The section containing the close nerve is said to be in the. region of the frozen section. c.c. Lung Cancer Registry.",train,43 x 25 x 20 mm;43 mm
5604,TCGA-UW-A7GI.EEB0E26D-3BF2-4D38-8D94-4251A03344D4,"Diagnosis: A: Left kidney, nephrectomy. - Renal cell carcinoma, chromophobe type, eosinophilic variant, tumor size 3.5 cm. in greatest dimension, nuclear grade 2 (of 4), tumor confined to kidney, surgical. margins free of tumor. - Renal vein, artery and ureter with no tumor seen. - Portion of adrenal gland with no tumor seen. B: Left adrenal gland, mass removal. - Adrenal myelolipoma, tumor size 14 cm in greatest dimension. Comment: None. Clinical History: year-old male with left adrenal mass. Gross Description: Received are two appropriately labeled containers. Container A: Specimen fixation: formalin. Type of specimen: nephrectomy. Size and weight of specimen: 500 grams, 14.5 x 10.0 x 4.8 cm. Presence/absence of adrenal gland: questionably present, an area of yellow/orange. discoloration is present in the perirenal adipose tissue, but not definitive for an. adrenal gland. Tumor description: circumscribed, yellow/tan, soft, and partially encapsulated. Tumor size: 3.5 X 3.5 X 3.0 cm. Presence/absence of multicentricity: absent, one focus is identified. Confinement/Non-confinement to kidney: the tumor grossly appears to contain. questionable areas of extracapsular extension into the surrounding fat. Extent of invasion: Perirenal adipose tissue: questionably involved. Renal vein: tumor does not grossly involve. Ureter: tumor does not grossly involve. Surgical margins: Perirenal adipose tissue: extends to within 0.8 cm of the closest black inked. deep soft tissue margin. Renal vein: negative. Renal artery: negative. Ureter:negative. Description of kidney away from tumor: has a pink/tan, smooth, and grossly. unremarkable cut surface, with distinct corticomedullary junctions; the cortex contains two linear. incisional defects, containing suture material, one located on each pole. Lymph nodes (hilar): none. Tissue submitted for special investigations: none. Block Summary: A1 - vascular and ureteral margins. A2 - tumor at closest approach to black ink. A3,A4 - tumor at area of questionable extracapsular extension. A5,A6 - additional representative tumor. A7 - additional representative normal kidney. A8 - representative section of area with adipose tissue containing an. orange/yellow discoloration (possible portion of adrenal gland). Container B is additionally labeled ""left adrenal mass."" It holds a 1010 gram, 14.2. X 13.2 x 7.0 cm ovoid, circumscribed, soft tan/gray mass, containing areas of. disrupted surface. A 10.0 x 1.0 cm area contains an orange/yellow minimal amount of. adherent portion of tissue, consistent with adrenal gland. Sectioning reveals a. soft, yellow/tan, focally hemorrhagic and focally necrotic cut surface. This mass. diffusely abuts the blue inked surgical margin. The area underlying the. yellow/orange surface has a red/brown, hemorrhagic cut surface, with a small,. approximately 0.5 x 0.1 cm rim of orange yellow tissue, consistent with adrenal. gland. B1-B5 - representative sections. B6 - sections of area containing yellow/orange possible adrenal gland. Light Microscopy: Light microscopic examination is performed by Dr. Specimen A: Histologic tumor type/subtype: renal cell carcinoma, chromophobe type, eosinophilic variant. Histologic grade (if applicable): 2 (of 4). Tumor size (greatest dimension): 3.5 cm. Extent of tumor invasion: Capsular invasion/perirenal adipose tissue: negative. Renal vein: negative. Ureter: negative. Blood vascular: negative. Lymphovascular: negative. Histologic assessment of surgical margins: Perirenal adipose tissue: free of tumor. Renal vein: free of tumor. Renal artery: free of tumor. Ureter: free of tumor. Adrenal gland: no tumor seen. Separately submitted specimen B shows a 14 cm. myelolipoma of the adrenal gland. Lymph nodes: not identified. Other significant findings: none.",train,3.5 cm;14 cm;3.5 X 3.5 X 3.0 cm;3.5 cm;14 cm
5620,TCGA-DD-A73C.FE051CD7-9C34-4A45-934C-DD8BB00C717A,"Female. DIAGNOSIS: A. Liver, segments II and III, partial hepatectomy: Hepatocellular. carcinoma, well differentiated (grade 1 of 4), forming a dominant,. 14.5 x 10.5 x 10.0 cm mass with multiple satellite masses (see parts. C, E, F) . The tumor is confined to the liver. The resection margin. is negative for tumor (tumor free margin, 0.5 cm) Macroscopic. large vessel (venous) invasion is absent. Microscopic (small. vessel) invasion is absent. No regional lymph nodes are identified. The surrounding non-neoplastic hepatic parenchyma shows no. significant diagnostic abnormality (see comment). Pathologic staging based on available surgical pathology material. (AJCC 7th edition) : pT3a. Comment: The sections of the large mass present in segments II and. III (part A) demonstrate a well differentiated neoplasm with bland. cytology that shows loss of the normal reticulin network and. dispersion of the neoplastic cells by an intercellular material. suggestive of mucin. The reticulin network is preserved in the. surrounding liver parenchyma. A glypican 3 stain is negative in the. neoplastic cells and is noncontributory. The separately submitted. wedge resections from segment VI, segment VIII, and segment IVB show. smaller nodules with similar histologic features. No defined lesion. is identified in the liver segment VII. The overall features including loss of the reticulin network and the. multifocality suggest, although the cytologic features are bland and. well differentiated, that this represents a well differentiated. hepatocellular carcinoma. Case seen with. Additional reticulin stains will be performed on parts C and E as. well as a mucicarmine stain performed on part A. These stains will. be reported in an addendum, when available. B. Gallbladder, cholecystectomy: Mild chronic cholecystitis. C. Liver, segment VI, resection: Well differentiated. hepatocellular carcinoma, forming a 1.2 x 1.: x 0.8 cm nodule, 0.9. cm from the surgical resection margin. D. Liver, segment VII, resection: Hepatic tissue with cautery. effect. No definitive lesion is identified. E. Liver, segment VIII, resection: Well differentiated. hepatocellular carcinoma, forming a 1.0 x 1.0 x 0.9 cm nodule, 0.1. cm from the surgical resection margin. F. Liver, segment IVB, resection: Well differentiated. hepatocellular carcinoma, forming a 1.1 x 1.0 x 0.6 cm nodule,. abutting the inked surgical resection margin. Interpreted by: ADDENDUM: Reticulin stains are performed on two of the satellite nodules. (blocks C1 and E1) The stains show convincing loss of the. reticulin framework in both nodules, adding further support for the. diagnosis of hepatocellular carcinoma with multiple satellite. nodules. Given the mucinous character of the cut tumor surface, a mucicarmine. stain is performed on a representative tumor block (A2) . There is. a. faint pink blush in the dilated sinusoids, but no intracellular. mucin is identified. Some hepatocellular carcinomas can overexpress. mucin-related proteins (particularly MUC1) i that could possibly. account for both the gross and histochemical findings.",train,14.5 x 10.5 x 10.0 cm;1.2 x 1.: x 0.8 cm; 1.0 x 1.0 x 0.9 cm;1.1 x 1.0 x 0.6 cm
5640,TCGA-VM-A8C9.572BF80A-ECDD-4EAF-A28D-7BFB0137A598,"Surg Path Fina Report. Temporary Copy. o 2. case. Clinical History. Left temporal tumor. Diagnosis. 'LEFT TEMPORAL TUMOR"", (RESECTION) : - DIFFUSE ASTROCYTOMA, WHO GRADE II. I certify that I personally conducted the. diagnostic evaluation on the above specimens. and have rendered the above diagnosis (es) : For questions regarding this case, call. Resident. Gross Description. A single specimen is received in formalin labeled with the patient's name, medical. record number and ""#1 left temporal tumor"". The specimen consists of three,. unoriented tan-white to gray tissue fragments, grossly consistent with brain tissue. measuring 3.0 x 2.5 x 1.0 cm. The specimen is serially sectioned to reveal no. focal lesions. Submitted entirely in cassettes 1A-1B. Microscopic Examination. Sections show foci of increased cellularity within gray and white matter. The foci. have infiltrative borders and are composed of cells with irregularly shaped nuclei. and moderate amounts of eosinophilic cytoplasm. Frequent pleomorphic,. hyperchromatic, and occasional multinucleated cells are present. No significant. mitotic figures, necrosis or vascular proliferation with hyperplasia is identified. Immunohistochemical stains are performed with appropriately reactive positive and. negative controls and show the neoplastic cells to be positive for GFAP and. negative for synaptophysin and NeuN. Synoptic Report. No AJCC/UICC TNM Staging System. Protocol web posting date: Protocol effective date: Specimen type/procedure: Resection. Specimen handling: Unfrozen for routine permanent paraffin sections. Specimen size: Greatest dimension: 3.0 cm. Laterality: Left. Tumor site: Brain/cerebrum: Left temporal lobe. surg Path-Fina Repor. emporary Gopy. Ratiene. Histologic type and grade: Diffuse astrocytoma (WHO grade II). Histologic Grade : WHO grade II. Ancillary studies: Immunohistochemistry. GFAP - positive. NeuN - negative. Synaptophysin - negative. Additional pathologic findings: None. Critais. Dragnoris Discresanty. Pomari Tumer Site Discreponicy. QUALIFIED /. Weif. BTh Reviewed 10/2/2013.",train,3.0 x 2.5 x 1.0 cm
5655,TCGA-06-0650.de2d8135-1c15-4475-be37-232d9779e908,"CLINICAL HISTORY. with recent onset seizures has right frontal. heterogeneously. intra axial tumor, with hemorrhage, vasogenic edema, and mass. effect. OPERATIVE DIAGNOSES. Not Given. B: Brain, right frontal tumor, excision biopsy. operation/Specimen: A: Brain, right frontal tumor, excision biopsy. PATHOLOGICAL DIAGNOSIS: frontal, excision Glioblastoma. MIB-1. proliferation. A and B. Brain, right. index: 30%. See Comment. COMMENT contain portions of a neoplastic proliferation a high proliferation of small glial. The cells, specimens with nuclear anaplasia, cellular proliferation mitotic figures, and necrosis, very and zones with of tumor. necrosis index, microvascular with pseudopalisading There are zones of hemorrhage, prominent. thrombosis of vessels. The predominantly phenotype from of astrocytic. malignant this high oligodendrogliomas. These histological small cell grade glioblastomas glioma Determining (WHO grade are the difficult LOH IV) status is to of. tell this patient apart may better characterize the neoplasm. PROCEDURES/ADDENDA. MGMT Promoter Methylation. Interpretation. POSITIVE - Methylated MGMT promoter is detected. Results-Comments. Testing was done on block. TEST DESCRIPTION: Bisulfite treatment of DNA followed by PCR amplification of. both methylated and unmethylated MGMT promoter sequences, with products. detected by gel electrophoresis. FDA COMMENT: The above data are not to be construed as the results from a. stand-alone diagnostic test. This test was developed and its performance. characteristics determined by the. Laboratory as. required by CLIA. regulations. It has not been cleared or approved for. specific uses by the U.S. Food and Drug Administration (FDA) The FDA has. determined that such clearance or approval is not necessary. These results are. provided for informational purposes only, and should be interpreted only in. the context of established procedures and/or diagnostic criteria. INTRA-OPERATIVE CONSULTATION. A. Brain, right frontal tumor, excision biopsy, touch prep and smears : High. histological grade glioma, C/W glioblastoma. Frozen section performed. at. and results reported to the Physician of. Record. GROSS DESCRIPTION. A. Received fresh, several fragments, 1.2 cm. In aggregate. Soft, tannish-brown,. with small blood clot. In total, A1 and A2. B. SPECIMEN: Right frontal tumor. FIXATIVE: Formalin. GENERAL: A 3.0 x 2.0 x 1.0 cm., 1.36 gm. aggregate of several irregularly. shaped red to gray-tan fragments of brain tissue. SECTIONS: B1, B2 all submitted. MICROSCOPIC DESCRIPTION. IMMUNOHISTOCHEMISTRY: The GFAP demonstrates focal sparse gliofibrillogenesis. by the neoplastic cells. The neoplastic cells do not over express the p53. protein. With the MIB-1 there is a proliferation index of about 30% in the. more active areas. ICD-9 (s) : 191.1 191.9. nisto Data. Part A: Brain, right frontal tumor, excision biopsy. Stain/cnt. Block. Comment. FS H/E X 1. 1. H/E x 1. 1. H/E x 1. 2. Part B: Brain right frontal tumor, excision biopsy. Stain/cnt. Block. Comment. mGFAP-DA x 1. 1. Please repeat at normal. and lower dilution. Thanks. mGFAP-DA x 1. 1. H/E x 1. 1. MGMT X 1. 1. MIB1-DA x 1. 1. P53D07 X 1. 1. H/E X 1. 2.",train,
5693,TCGA-C5-A2LZ.EF2D354D-F959-45B3-AA5C-170E00AF3F45,"(Age: Date Received: Patient !ype. H3A. D. UTERUS, CERVIX, BIOPSY. - SQUAMOUS CELL CARCINOMA, MODERATELY IFFERENTIATED. (SEE DESCRIPTION),. By this signature, l/attest that the. above diaghosis is based upon my. personal examination of the slides. (and/or other material indicated in. the diagnosis), and that I have. reviewed and approved this report. HISTORY. The patient is a year oil woman who underwent cervical biopsy. GROSS. Submitted by Dr. ior review is one slide labeled. accompanied by a correscandirg pathology report. material orikinater r on.",train,
5695,TCGA-B8-4143.208d6d5e-c6bf-481b-9564-44beca8b1fe7,"Diagnosis: Left kidney, radical nephrectomy. - Renal cell carcinoma, clear cell type, tumor size 10 cm. in greatest dimension, nuclear grade 3 (of 4), extending. through capsule of kidney into perirenal adipose tissue,. involving lumen of renal vein with tumor present at margin. of renal vein. - Adrenal gland with no tumor seen. - Two perirenal lymph nodes with no tumor seen (0/2) . Comment: None. Clinical History: with a left renal mass now undergoes left nephrectomy. Gross Description: Received is one appropriately labeled container. Specimen fixation: formalin. Type of specimen: radical nephrectomy. Size and weight of specimen: 17 X 9 X 8.5 cm, 610 gm. Presence/absence of adrenal gland: present with no gross. abnormality noted. Tumor description: Predominantly solid yellow and tan/white. mass with a gelatinous appearance and irregular borders. Tumor size: approximately 10 X 6 X 5.8 cm. Presence/absence of tulticentricity: absent. Confinement/Non-confinement to kidney: appears to be. confined within the renal capsule and there is perirenal. fat around the tumor. Extent of invasion: Perirenal adipose tissue: tumor grossly does not involve. the perirenal adipose tissue. Renal vein: tumor is present in lumen of renal vein and is. present at margin. Ureter: not involved. Other organs: the adrenal gland does not appear to be. involved. Surgical margins: Perirenal adipose tissue: negative. Renal vein: positive. Renal artery: negative. Ureter: positive. Description of kidney away from tumor: unremarkable. Lymph nodes (hilar) : there is one large hilar possible. lymph node which is bisected. Tissue submitted for special investigations: A portion of. the tumor and the non-tumorous kidney are given to tissue. Block Summary: A1-A2 - sections of the hilum. A3 - possible hilar lymph node bisected. A4 - adrenal gland. A5-A14 - representative sections of the tumor. A15 - non-tumorous - renal parenchyma. Light Microscopy: Light microscopic examination is performed. Histologic tumor type/subtype: renal cell carcinoma, clear. cell type. Histologic grade (if applicable) : 3 (of 4). Tumor size (greatest dimension) : 10 cm. Extent of tumor invasion: Capsular invasion/perirenal adipose tissue: capsular. penetration identified with involvment of perirenal. adipose tissue. Renal vein: involved with tumor. Ureter: not involved. Lymphovascular: not involved. Adjacent organs: not involved. Histologic assessment of surgical margins. Perirenal adipose tissue: margins negative. Renal vein: involved at margin. Renal artery: not involved. Ureter: not involved. Adrenal gland: not tumor seen. Lymph nodes: no tumor seen in 2 perirenal lymph nodes.",train,10 cm;10 X 6 X 5.8 cm;10 cm
5696,TCGA-HT-7481.879a7f04-519f-44c0-bad3-32c637ab5955,"path report. Microscopic. Sections demonstrate a glial neoplasm that diffusely infiltrates both gray and white matter. In. the gray matter, there is prominent perineuronal satellitosis as well as subpial surface spread. Tumor cells have round nuclei with few apparent cytoplasmic processes. Many demonstrate. perinuclear halos. There is little cytologic atypia. No mitotic figures are seen. There is no. microvascular proliferation or necrosis. Addendum discussion: Numerous MIB-1 reactive cells are present throughout the specimen. A labeling index of 21% is. calculated. This is indicative of a markedly proliferative glial neoplasm. Despite this, no mitotic. figures are identified on the. stain and only a rare mitotic figure was indentified on the. immunohistochemistry. Consequently, the tumor must be classified as low grade/grade II. Nevertheless, the very high MIB-1 labeling index suggests more aggressive behavior. Close. clinical follow-up is indicated. Final Addendum Diagnosis: Oligodendroglioma, low grade, WHO grade II.",train,
5796,TCGA-76-6191.d91aa8ca-fe4b-4f2e-89a7-c56d6fe176e1,"ADDENDED. FINAL DIAGNOSIS: 1. Left temporal lobe brain tumor : GLIOBLASTOMA, WHO GRADE iv. SEE. MICROSCOPIC DESCRIPTION. 2. Left temporal lobe brain tumor : GLIOBLASTOMA, WHO GRADE iv. This diagnostic report has been personally interpreted by the signatory. of record. Addendum. IMMUNOHISTOCHEMICAL STAINS. GFAP: POSITIVE STAINING OF TUMOR CELLS. KI67: AREAS OF THE TUMOR SHOW ON SLIDE 2A POSITIVE NUCLEAR STAINING OF. GREATER THAN 30% OF TUMOR CELL NUCLEI. P53: POSITIVE STAINING OF ONLY A VERY FEW CELLS WITHIN THE TUMOR. SPECIMEN (SLIDE 2A). Microscopic Description: The tumor is composed of pleomorphic glial cells. Mitotic figures are. identified in tumor cells. The features of Glioblastoma including. areas of pseudopalisading necrosis are best seen on the actual frozen. tissue sections. Frozen Section Diagnosis: 1. Left temporal lobe brain tumor : Gliob lastoma. Frozen section. diagnosis by. Clinical History and Diagnosis: Left temporal lobe brain tumor. Source of Specimen: 1: Left temporal lobe brain tumor. 2: Left temporal lobe brain tumor. Gross Description: 1. Left temporal lobe brain tumor : Received fresh for frozen are. multiple fragments of tan-red soft tissue measuring 0.9 X 0.7 X 0.2 cm. in aggregate dimension. Touch preps are prepared and approximate ly 50%. of the specimen is submitted for frozen sectioning one cassette. The. remainder is submitted for permanents in one additional cassette. 2. Left temporal lobe brain tumor : Received in formalin in a specimen. container labeled with the patient's name and ""#2 left temporal lobe. brain tumor"" are 2 fragments of tan-white soft tissue measuring 1.9 X. 0.6 X 0.3 cm in aggregate. The specimen is entirely submitted in one. cassette. Histology Laboratory. H&E. Immunohistochemistry Notes. 1. Quantification of immunohistochemistry assay for ER and PR studies. is by the method of Battiafora et.al. Applied Immunohistochemistry,. 2. Hercept Test (DakoCytomation) Formalin fixed, paraff in embedded. Interpretation follows the manufacturer' S recommendation. Documented by. EGFR pharmDx Clone 2-18C9 Formalin fixed, paraffin embedded. Interpretation follows the manufacturer' S recommendation. Doucmented by. 3. Analyte Specific Reagent (ASCR) Disclaimer. The use of one or more. reagents in the above tests is regulated as an analyte specific reagent. (ASR). These tests were developed and their performance characteristics. determined by the. They have not been cleared by the US Food and Drug Administration. The FDA has determined that such clearance or approval is not. necessary.",train,1.9 X. 0.6 X 0.3 cm
5801,TCGA-EB-A42Z.71C108F9-92F6-4DB0-BD3B-6E3DC8427E03,"Laterality:Malignant melanoma. Path Report:SKIN TISSUE CHECKLIST. Specimen type: Surgical resection. Tumor site: Skin. Tumor size: 3 x 3 X 1 cm. Tumor features: Ulcerated, Pigmented. Satellite nodules: Not specified. Histologic type: Malignant melanoma. Histologic grade: Poorly differentiated. Lymph nodes: 1/10 positive for metastasis (Right inguinal lymph node 1/10). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Breslow depth 10mm. Comments: None.",train,3 x 3 X 1 cm
5802,TCGA-14-3476.04ff03b7-631f-4c5f-8cdf-874817f2afe5,"Document Date: Modified. SUPPLEMENTAL REPORT. SUPPLEMENTAL DIAGNOSIS: Previous diagnosis remains unchanged. See. Molecular Diagnostics. Reprot. results for Block 1A. COMMENT : This test was not requested, performed or reported at. The test was requested by. The test was performed and. reported by Center for. Results are included with this Surgical Pathology report so that. all available. information on this tumor may be accessed at one site. MGMT GENE AMPLIFICATION. DNA was isolated from a paraffin embedded block of the brain tumor. biopsy. DNA methylation patterns in the CpG island of the. MGMT gene. was determined. by chemical. (bisulfite) modification of unmethylated, but not methylated,. cytosines to. uracil and subsequent PCR using primers specific for either. methylated or the. modified unmethylated DNA. The. PCR products were analyzed in duplicate parallel runs by capillary. gel. electrophoresis. The sensitivity of the assay based on DNA. dilution studies. is at least 1:1000. The analyzed region of the MGMT promoter is UNMETHYLATED. INTERPRETATION: MGMT (06 methylguaine DNA nethyltransferase) is a DNA repair gene. Methylation. of the promotor leads to gene silencing and loss of MGMT. expression. a recent. study that tested the methylation status of the same region of the. MGMT. promoter in glioblastomas found that MGMT promoter methylation was. an. independent favorable prognostic factor and was associated with a. survival. benefit in patients treated with temozolamide and radiotherapy. and Benefit from. Temozolomide. in Glioblastomas. DIAGNOSIS: 1. RIGHT FRONTAL BRAIN LESION, RESECTION, FS1A, TP1A: - GLIOBLASTOMA WITH OLIGODENDROGLIOMA COMPONENT, WHO GRADE IV. - SEE COMMENT. 2. RIGHT FRONTAL BRAIN LESION, RESECTION: - GLIOBLASTOMA WITH OLIGODENDROGLIOMA COMPONENT, WHO GRADE IV. - SEE COMMENT. COMMENT: This glioblastoma has an element of oligodendroglioma within it,. comprising. approximately 20% of neoplastic cells. Perhaps more. morphologically. impressive is the high degree of angiogenesis and the extensive. reactive. stromal component associated with it. In the majority of this. stromal. reaction, the matrix has a myxoid appearance whereas in others of. the stroma. has a more highly spindled and collagen-rich. These stromal. elements are. interpreted as a reactive process associated with the angiogenesis. because of. the geographic association of these two processes. FISH analysis. of EGFR and. 1p/19q have been ordered and the results will be issued in a. separate. report. Tissue has been sent for MGMT analysis and the results. will be issued. in a separate report. SPECIMEN: 1. Right frontal brain lesion. 2. Right frontal brain lesion. CLINICAL HISTORY/OPERATIVE FINDINGS: Right craniotomy. Brain tumor. GROSS DESCRIPTION. Two specimens are received, each labeled with the patient's name. and medical. record number. Specimen #1 is received fresh for intraoperative consultation and. is labeled. as ""right frontal brain lesion."" The specimen consists of multiple. fragments. of pink-tan, soft tissue measuring in aggregate, 0.8 x 0.8 x 0.6. cm. Representative sections are submitted for frozen section diagnosis. and the. contents of the cryoblock are transferred to cassette ""FS1A. "" A. touch prep is. also performed. The remainder of the specimen is submitted in. cassette. ""1B.'. Specimen #2 is received in formalin and is labeled as ""right. frontal brain. lesion. "" It consists of multiple fragments of brain with adherent. hemorrhage. measuring 4.0 X 3.8 X 2.3 cm in aggregate. The entire specimen is. submitted. in cassettes ""2A"" through ""2G."" Dictated by. INTRAOPERATIVE CONSULTATION: FS1A, TP1A: RIGHT FRONTAL BRAIN LESION, BIOPSY (FROZEN SECTION,. TOUCH. PREPARATION) : GLIOBLASTOMA. Frozen Section results were communicated to the surgical. team and. were repeated back by. MICROSCOPIC DESCRIPTION: Microscopic examination performed. SPECIAL STAINS: FISH. DONE. FISH. DONE. FISH. DONE. FISH. DONE. FISH. DONE. FISH. DONE. FLUORESCENCE IN SITU HYBRIDIZATION. SPECIMEN : Brain, right frontal lesion. CLINICAL HISTORY/REFERRING DIAGNOSIS: Glioblastoma with oligodendroglioma component, WHO grade IV. GROSS DESCRIPTION: Paraffin block 1B. TEST PERFORMED/PROBES USED: EGFR gene locus specific probe (7p12). Chromosome 7 alpha satellite DNA specific probe (7p11.1-7q11.1). Probe for chromosome 1p36. Probe for chromosome 1q25. Probe for chromosome 19p13. Probe for chromosome 19q13. NEGATIVE for EGFR gene amplification. nuc ish 7cen (D7Z1x2-10), 7p12 (EGFRx2-10) [200/200]. NEGATIVE for chromosome 1p36 deletion. nuc ish (TP73 x 2), (ANGPTL X 2) [170/200]. NEGATIVE for chromosome 19q13 deletion. nuc ish (ZNF443 X 2), (GLTSCR x 2) [166/200]. INTERPRETATION: Flourescence in situ hybridization was performed using the above. listed DNA. probes. The probes were simultaneously. hybridized to a. section of the formalin-fixed paraffin-embedded tissue submitted. for. evaluation.",train,
5803,TCGA-3A-A9IL.530378DE-962E-4E7F-A75A-42A5BE91712C,"Submittion Ph,. Intracp Patholeg:at: Performing Phymiciani. HIETORY: YEAR-OLD FEMALE NITH HISTORY OF PITUITARY ADENCIA EXCIEION, PAPATHYROID ADENOMA. PRECPERATIVE. MASS AT HEAD CF FANCREAS. EPECIMEN. Me CALE-BLADDER, LIVER BIOPSY PS. B. PANCREATIC DUODENESTOMY 4FS. FINAL DIADNCSIE: A. LIVER, CALLBLADDER FOSSA, BIOPSY: Liver parenciyma with aream of necromia and grant cell fore:gn body resction. No viable tumor is identified. a. PANCREATIC DUODENECTOMY: Pancrestic neuroendoerine. tumar,. ISee key pathologic findings). KEY PATHOLOGICAL FINDINGS. Epezimen type: Whipple procedure. Tumor site: Read of pancreas. type: Pancreatic tumor. Tumar differantiatiane. Kell differentiated. Tumor Tacality. Twa tumaz poduies. Tumor configusation: Nodulor. Tunor mire: 1.3 - and 0,5 em in greatent dimension, respectively. Other organse. Duadenum, and distal portion of stonach. Extent of invanion: Pancream and up to of duodemut. Le invasion: Present. Perineural invasion: Not identifaed. Mitotic autivity: 2/50. Margina: Free c! tumor, however the tumor is at Ims. of. the. retraperitoneal. resection margin. Lymph noder: Mecastatic pascrestic. tumor to five of nine regional lymph aodes involved by tumor 145/91. Distant. Liver with no evidence of viable tumor, Additional. pathologic findinga: Focal acute pancreation, Pathclogic. stage: NA. I. M.D. the attending pathologist, perocnally revieved the entire. pathlory case and rendered the final Electronically Signed out by. OTHER RELATED CLINICAL LATA: NA. INTRACPERATIVE. FROZEN CECTION DIAGNOEIE. FEA. CALLELADDER, LIVER BIOPEY. FEAL. Benign liver tiasue. No viable tumor seen. FEE. PANCREATIC DOCDENECTOMY. FEBI. Parenchymal renection margin im negative. FEB2. Bile duct margin 5 segative. FEB3: Smaller tumor im neuroeniogrine tumor. 7E34. Large timor im neurcendocrine tumor. CONDENT: This frezen aection was cumminicated to and acknowledged by. I,. M.D., have performed the intrapperative. conmultation and incued the above diagnoses. GROCE DESCRIPTION: A. Specimen A is received Exenh labeled :allbladdex fosms, liver bicpay."" The. specimen consists of an irregular, uncriented fragment CE tan cod-brown rubbery. measuring 0.4 x 0.4 x 0.2 cm, which is submitted entirely for section. as. D. Specimen a is received freak labeled pancreatic all margins on. rozen aection, mingle long in pancreatic margin, double long in. mingle abort is bile duct margim- The apecimen conniata of ducdenum 19.6 en. in length and up to 3.5 en in sircumferecce at the stapled distal remection. margia), diatal pertion of atomach 115,0 along lesser curvature, 15.0 em along. the greater curvature, and 13.0 em in circumfexence et the ptapled proximal. resectica margin), pancreatic head 17.0 x 6.0  2.5 =m) There is 11. of. adipose tissue et graster and lemmer cimextium attached to the grester and leaser. curvature of the stcmach reppectively. The peroma, of tha atomach in tan-pick,. glistening, mildly connested. The outer surface of the ducdemum is phaggy. with amall amount of attacked fibroadipose tissue. The apecimea ia aziented. according to the surgeon'a depignation and inked on follows: Proximal resection margin of the atomach opened and inked black. Distal resection margin of the duodenum opened and inked blue. Euperior aspect of the papcrestic head inked black. Anterion aspect of the pancrestic heard and uncinate proceda inked greeri. Uncinate reascion margin inked blue. Petroperitansal resection sargin inked crange. Tangential section of the pareschymal resectica margin ct the pancreatic hend da. mubitter for Frozen section as FEBT. Tangential section of the bide duct mary: for fromen section as PSB2. Representative sectiona DE the maller and. larger tumora submitted fcr frozen mection as PEB3 and PER4 respectively. On. accioming, the pancrestic head reveals 2 tumor zodules. The tamor nodule number. 1. measures up to 1,3 em in greatent dimensica and in 0.3 em from the closest anterior. margin of pancreatic head, 0.3 cm from the dicdenal wall, 1.4 cm frcm the common. bile duct, 0.8 cm from the clonest resection maryin, and 4.0 em. from the parenchymel resection margin of the pancreatic head. The cut surface of. the nodule mumber in tham pink wichcue evidence of necrosia. axx. hemorrhage. The tumor nedule number 2 measuren up to a.s em in dumension. and in 0.2 em from the clesent anterice ampect of pancreatic headi. This tumor la. 1.0 em from the cloment uncinate procesa resection margin, 1.5 em from the vall of. main pancreatic duet, 2.5 em from the wall ef common biie duat; and 1.7 from the. duodenal wall. The remaining parenchyms of the head DE gancreas in tan pale-yellow. to tan-pink, lobulated, and grosmly unremarkable. The main pancrectic duet and. comman bile duet ar# grocaly usremarkable. The ampalla of Vater in al inbtly. promiment and grously unsemarkable. The the stomach is tan-pink,. plisteming, focally erythematoum, and exhibita preservation of rugae. The mucoma of. the duodestum in tan-pick, macth, glistening, and ham the intestisal folds. The peripheral margina of pancrestic head compoaed =E tan pale-yellew, soft,. lebulated adipoge tinsue, which ia ranging from 0.1 to 0.5 em in thckneas. A. single possible lymph node 1a identified with: fibroadipose tionue of the superior. ampect of the pancreatic head. Five grossly recognizable lymph nodes are dentified. within fibroadipone ticaue of retroperitoneal aspect of pancreatic head, ranging. frem 0.1 to 1.2 cm in greatent dimencion. The biggest Tymph sode in groasly. positive for malignancy. No lymph nodes are identified within fibroadipcse tiasue. af anterior aspect of pancreatic head. No lymph noden are identified within adipone. tupaue c pertion of greater cmentum. No lymph nodes are identified attached to the. lesner curvature c5 the stomach and duodenum. Representative dection of the. specimen submitted to the procurement laboratory. The digital picture c. the. specimen is taken. Representative secticas of the specimen aze submitted in 19. cassettes, ar-a19, as ollows: 21-93: Tangential section of he proximal resection sargin of. the stonach. 84: Tangential nection of the distal resection margio c! the. ducdenum. BS: Ampulla of Vater. Ares of junceios between main pancreatic duet and common. bile duet. 97-26: Tumor number with clomeat anterior aspect of. pancreatio head. Tumor number 1 with clomest duodenal wall. 810,. Tumor number 1 with ciccest common bilm duet wall. all. Tangential section of uncinate process resection margin. 012-813: Bemaining tumor number 2 with closest anterior ampest. of panscestic hesd. 204,. Two lymph nodea, grester periteneal aspect of pancreatio bead. 315: One lyeph node, retropezitcneal ampect. al6: Twa lymph nodes, retroperitoment ampect. 017-910: The remaining retexperitopeal resection margin of the. pancreatio head, perpendiculas sectiona. One lymph node, superior mapect OF pancreation head.",train,
5844,TCGA-K1-A42W.4CD0465A-2CA0-4AB4-AA4A-AD940A53CB49,"FINAL DIAGNOSIS: PART 1: DISTAL PANCREAS, RESECTION -. A. SEEIOMYOSARCOM; INTERMEDIATE GRADE (3.5 CM), INVOLVING PANCREATIC PARENCHYMA (see. comment). B. PANCREATIC MARGIN IS FREE OF TUMOR. C. PANCREATIC PARENCHYMA WITH FOCAL CHRONIC PANCREATITIS AND LOW GRADE PaniN. D. FOUR BENIGN LYMPH NODES (0/4). E. PATHOLOGIC STAGE: pT1b NO Mx. PART 2: SPLEEN, SPLENECTOMY -. A. SPLEEN WITH NO SIGNIFICANT ABNORMALITY. B. THREE BENIGN LYMPH NODES (0/3). PART 3: LYMPH NODE, HEPATIC ARTERY, EXCISION -. TWO BENIGN LYMPH NODES (0/2). COMMENT: The neoplasm is composed of pleomorphic spindled cells arranged in fascicles with focal necrosis (approximately 5%). and mitoses of 21 per 50 high power fields. The tumor is strongly immunoreactive for actin and desmin and Ki67. decorates approximately 20% of the tumor nuclei. CD34 highlights the vasculature. S100, AE1/3, DOG1, CKit and. HMB45 are negative. These results together with the morphology support an intermediate grade leiomyosarcoma. The. tumor may represent a primary intra-abdominal/ retroperitoneal leiomyosarcoma and has been staged as such in this. report. Alternatively, the tumor may represent a metastasis. A uterine primary may be considered. Clinical and. radiographic correlation is suggested. has also reviewed part 2 in this case. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY SOFT TISSUE TUMORS. SPECIMEN TYPE: Radical resection. TUMOR SITE: pancreas. TUMOR DEPTH: Deep: Intra-abdominal. Deep: Retroperitoneal. TUMOR SIZE: Greatest dimension: 3.5 cm. Additional dimensions: 3.1 cm. PRERESECTION TREATMENT: No therapy. HISTOLOGIC TYPE (WHO classification of soft tissue tumors): leiomyosarcoma. RESULTS OF ANCILLARY STUDIES: see comment. MITOTIC RATE: 6 /10 high-power fields. MACROSCOPIC NECROSIS: Absent. MICROSCOPIC NECROSIS: Present: Extent: 5%. GRADE: System used: r. Grade: Grade 2. PATHOLOGIC STAGING (pTNM): pT1b. pNO. Number regional lymph nodes examined: 9. Number regional lymph nodes involved: 0. pMX. MARGINS: Margins uninvolved by sarcoma. MICROSCOPIC VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION: Absent. PERINEURAL INVASION: Absent. Reason for the Exam: PANCREATIC MASS. EXAMINATION PERFORMED: CT ABDOMEN WITH AND WITHOUT CONTRAST. CLINICAL INDICATION: Pancreatic mass with pathology consistent with spindle cell carcinoma. TECHNIQUE: Helical 2. .5mm images were obtained from the lung apices through the. pelvis following the uneventful IV administration of 125cc of Isovue. 370. Post-contrast images were obtained during arterial and venous. phases per pancreatic mass protocol. COMPARISON: None. FINDINGS: Lung: There is mild emphysema; otherwise lungs are clear. There is no. effusion or pneumothorax. Heart size is normal with no effusion. No. enlarged thoraic lymph nodes are noted. Abdomen: There is a 3x3cm hypo-attenuating and hypovascular lesion. inproximal body of pancreas. The lesion is round and is well. demarcated with has lower attenuation than the rest of pancreas on. all phases. There is no finding of invasion to adjacent organs or. vascular structures. The remainder of the pancreas is normal with no. additional focal lesion, atrophy or ductal dilatation. There is a small hypoattenuating lesion in segment 8 of liver,. measuring 1.3cm. The lesion is hypoattenuating on the unenhanced and. arterial phases; on the portal phase, there is the suggestion of. subtle discontinuous nodular peripheral enhancement, favoring a. benign etiology (such as sclerosed hemangioma) The liver is. otherwise normal. The hepatic vessels are patent. The spleen and. adrenal glands are unremarkable. There is a 7mm hypoattenuating. lesion in the midpole of the left kidney which is too small to. characterize. The kidneys are otherwise normal. There is no. intra-abdaminal fluid collection or enlarged lymph nodes. The stomach. and loops of small and large bowel are normal in course and. appearance. Pelvis: The rectum, sigmoid, appendix, uterus and adnexa and bladder. are unremarkable. There is no intrapelvic fluid collection or. enlarged lymph nodes. No osseous abnormalities are identified. IMPRESSION: CHEST: 1. MILD EMPHYSEMA; NO FINIDNGS OF METASTASIS. ABDOMEN: 1. 3X3CM WELL-DEFINED HYPOVASCULAR MASS WITHIN THE PROXIMAL BODY OF. PANCREAS CORRELATING TO PATIENT'S KNOWN SARCOMA; THERE IS NOFINIDNG. OF INVASION INTO VASCULAR STRUCTURES OR ADJACENT ORGANS. 2. SMALL HYPOATTENUATING LESION IN SEGMENT 8 OF THE LIVER IS FAVORED. TO BE DUE TO A BENIGN ETIOLOGY WITH DIFFERENTIAL CONSIDERATIONS. INCLUDINGSCLEROSED HEMANGIOMA VERSUS CYST. FOLLOW-UP CT CAN ASSESS. STABILITY. PELVIS: 1. UNREMARKABLE PELVIC CT. CLINICAL HISTORY: -year-old female status post laparoscopic distal pancreatectomy and. splenectomy for pancreatic leiomyosarcoma on. COMPARISON: TECHNIQUE: 2 5mm axial images of the chest, abdomen, and pelvis were obtined. with 125 CC of Isovue-370 intravenous contrast and Readi-Cat oral. contrast in the portal venous phase. Coronal and Bagittal reformats. were also provided. . FINDINGS: CHEST: ""The visualized thyroid gland and great vessels are unremarkable. A. 3. nm subpleural right lower lobe nodule is \table since. representing a benign lesion. The lungs ar, clear without suspicious. pulmonary nodules, consolidation, or pleural effusion. There are no. enlarged thoracic lymph nodes. The heart size is normal with no. pericardial effusion. ABDOMEN: The suspicious hypodense lesion in segment has enlarged, measuring. .3cm from 1.1cm previously. Several new hypodense lesions including. segment 4A 1.3cm focus and 2.4x2.7cm segment 6 lesion are new and. concerning for metastases. The nonenhancing segment 4A lesion likely. representing a hepatic cyst isunchanged. The spleen, distal pancreas,. and gallbladder are surgically absent. There is no evidence of. disease recurrence in the surgical bed. The adrenal glands and right. kidney are unremarkable. A lower pole posterior left renal cyst is. unchanged. The small and large bowel are normal in caliber without. focal wall thickening. There is no free fluid, free air, or enlarged. lymph nodes in the abdomen or pelvis. Mild atherosclerotic calcifications are seen in a normal caliber. abdominal aorta. A 5 cm fat containing umbilical hernia is unchanged. PELVIS: The urinary bladder, uterus, ovaries, and rectum are unremarkable. Sigmoid diverticulosis is seen with no CT evidence of diverticulitis. No osteoblastic or lytic lesions are identified in the chest,. abdomen, or pelvis. IMPRESSION: CHEST: 1. No metastatic disease in the chest. ABDOMEN: 1. Development of multiple hypodense lesions compatible with. metastatic disease in segments 4A, 6, and 7 with the largest. measuring 2.4x2.7cm in segment 6. 2. No evidence of local disease recurrence or enlarged lymph nodes. 3. Unchanged fat containing umbilical hernia. PELVIS: 1. No acute abnormalities in the pelvis. 2. Sigmoid diverticulosis. CLINICAL HISTORY: Date of Event. Liver lesion. History of leiomyosarcoma of pancreas. SOURCE-OF SPECIMEN: LIVER, US-GUIDED FINE NEEDLE ASPIRATION. Addendum. The liver FNA was reviewed at. (outside accession number. and interpreted as ""Positive for malignant cells, Metastatic high. grade leiomyosarcoma which is in agreement with the original diagnosis. rendered in this case. The outside pathology report is archived and available. from the. athology Department upon request. FINAL DIAGNOSIS: LIVER, US-GUIDED FINE NEEDLE ASPIRATION: SATISFACTORY FOR INTTERPRETATION. POSITIVE FOR MALIGNANT CELLS. METASTATIC LEIOMYOSARCOMA (SEE COMMENT). LXP/LXP. COMMENT: The FNA contains a spindle cell neoplasm with myxoid change. Immunostains. performed on scant cell block material show that the tumor cells are positive. for desmin and cladesmon which supports the above diagnosis. The cell block. contains insufficient tumor material to evaluate actin and 8100 stains.",train,3.5 CM;3.5 cm;3.1 cm
5854,TCGA-WT-AB41.FDB00212-9782-4ACE-AD59-019384297A2F,"SURG PATH #: SPECIMEN CLASS: ALT ID #: SEX: F. DATE RECEIVED: DATE OF PRINTING: Material Received: A: left axillary sentinel lymph node #1 blue. B: C: D: left left breast axillary total sentinel mastectomy lymph node #2 blue Site e50.9. 8 o'clock additional medial short superior, long anterior, clip true margin. E: 8 o'clock additional inferior short anterior, long lateral clip true margin. F: 8 o'clock additional anterior short superior, long lateral, clip true margin. G: 8 o'clock additional posterior short superior, long lateral, clip true margin. H: additional skin left breast blue at 3:00. History: year old female with a clinical history of breast cancer. Final Diagnosis: A. Lymph node, ""left axillary sentinel lymph node #1 blue"", biopsy: Micrometastatic mammary carcinoma (0.23 mm) identified on permanent and pancytokeratin immunostained sections. only. See comment. B. Lymph node, ""left axillary sentinel lymph node #2 blue"", biopsy: There is no evidence of malignancy (0/1). Deeper sections and a pancytokeratin immunostain are negative in support of the above diagnosis. C. Breast, ""left breast total mastectomy"", mastectomy: Invasive ductal carcinoma, moderately differentiated, nuclear grade 2, two foci (measuring 1.2 cm and 1.8 cm in greatest. dimension respectively). See comment. D. Fibroadipose tissue, ""8 o'clock additional medial short superior, long anterior, clip true margin"", reresection: No diagnostic abnormalities. There is no evidence of malignancy. E. Fibroadipose tissue, ""8 o'clock additional inferior short anterior, long lateral clip true margin"", reresection: No diagnostic abnormalities. There is no evidence of malignancy. F. Fibroadipose tissue, ""8 o'clock additional anterior short superior, long lateral, clip true margin"", reresection: No diagnostic abnormalities. There is no evidence of malignancy. G. Skeletal muscle and adipose tissue, ""8 o'clock additional posterior short superior, long lateral, clip true margin"", reresection: Date of Printing: SURGICAL PAIHOLOGY REPORT. SURG PATH #: ALT ID #: No diagnostic abnormalities. There is no evidence of malignancy. H. Skin, ""additional skin left breast blue at 3:00"", reresection: No diagnostic abnormalities. There is no evidence of malignancy. Comment: INVASIVE CARCINOMA OF THE BREAST. Specimen Type: mastectomy. Laterality: left. Tumor Site: lower inner quadrant at 8:00 and mid outer quadrant at 3:00. Histologic Type: Invasive ductal carcinoma. Size of Invasive Component: 1.2 cm in greatest dimension (8:00) and 1.8 cm in greatest dimension (3:00). Tumor Multicentricity: Present (2 foci as noted above). Surgical Margins: Final margins are negative for carcinoma. In the mastectomy, the 8:00 focus is within 0.1 cm of the inferior,. medial. and anterior margins and within 0.2 cm of the deep margin; however the separately submitted additional medial, inferior,. anterior and posterior margins (specimens D through G) are negative for carcinoma. Histologic Grade (Nottingham Histologic Score): II/III. Tubule Formation: 3. Nuclear Grade: 2. Mitotic Count (40x objective): 1. Total Nottingham Score: 6/9. Ductal Carcinoma In-situ (DCIS): Present, focal, intermediate nuclear grade, without necrosis. Lobular Carcinoma In-situ (LCIS): Absent. Lymph-Vascular Invasion: Present, focal. Perineural Invasion: not identified. Tumor Necrosis: not identified. Nipple Involvement: not identified. Skin Involvement: not identified. Lymph Node Sampling: Sentinel lymph node(s) only. Total number of involved nodes/total nodes found: 1 micrometastasis out of 2 nodes. Size of largest metastasis: 0.23 mm. Extranodal extension: not identified. Fixation to one another: Non-neoplastic Breast Tissue: not identified. Treatment Effect (Response to Presurgical Neoadjuvant Therapy): In the Breast: In the Lymph Nodes: Prognostic markers: See. for addendum. on prior biopsy. Fixation Time between 6-48 hours: Yes. Pathologic Staging: pT2N(sn) 1miM(not applicable). Primary Tumor (Invasive Carcinoma) (pT). pT1: Tumor <20 mm in greatest dimension. pT1c: Tumor >10 mm but <20 mm in greatest dimension. Regional Lymph Nodes (pN). (sn): Only sentinel node(s) evaluated. If 6 or more sentinel nodes and/or nonsentinel nodes are removed, this modifier. should not be used. pN1mi: Micrometastases (greater than 0.2 mm and/or more than 200 cells, but none greater than 2.0 mm). Distant Metastasis (M). Not applicable. Date of Printing: SURG PATH #: ALT ID #: The pathologic stage assigned here should be regarded as provisional, as it reflects only current pathologic data and does not. incorporate full knowledge of the patient's clinical status and/or prior pathology. The final diagnosis has been communicated via electronic mail to. Attestation: By this signature, I attest that I have personally formulated the final interpretation expressed in this report and that the above diagnosis is based. upon my examination of the slides and/or other material indicated in this report. Interpreted by: Gross Description: A. Received fresh labeled with the patient's name and ""left axillary sentinel lymph node #1 blue"" is an irregular portion of red-tan. fibroadipose tissue. The tissue is palpated to reveal one possible lymph node measuring 2.8 x 2.5 x 1.3 cm. The specimen. is. serially sectioned and submitted entirely in cassettes A1FS and A2FS for frozen and permanent diagnosis. B. Received fresh labeled with the patient's name and ""left axillary sentinel lymph node #2 blue"" is an irregular portion of red-tan. fibroadipose tissue. The tissue is palpated to reveal one possible lymph node measuring 2.5 x 1.8 x 1.0 cm. The possible lymph. node is serially sectioned and submitted entirely in cassette B1FS for frozen and permanent diagnosis. C. Received fresh labeled with the patient's name and ""left breast total mastectomy short superior/long lateral"" is a 650 gram. simple mastectomy specimen measuring 20.5 x 18 x 3.5 cm. There is a short stitch marking superior and a long stitch marking. lateral. The breast is serially sectioned to reveal a 1.2 x 1.2 x 0.8 cm tan-pink stellate mass that is 22.5 cm from the lateral margin,. abutting the medial margin, 8.4 cm from the superior margin, abutting the inferior margin, 0.2 cm from the superficial margin, and. 0.2 cm from the deep margin. The mass is located in the lower inner quadrant at approximately 8:00. The deep resection margin. is inked black and the superficial resection margin is inked blue. The medial margin of the mass is inked orange and the inferior. margin of the mass is inked green. A second tan-white stellate mass measuring 1.8 x 1.5 x 1.4 cm is located 6.5 cm from the. lateral margin, 13.6 cm from the medial margin, 13.6 cm from the superficial margin, 8.3 cm from the inferior margin,. 2.4 cm from the superficial margin/skin and 3.7 cm from the deep margin. The mass is located in the mid outer portion of the. specimen at approximately 3:00. The remainder of the breast parenchyma is yellow-white and unremarkable. The specimen. contains a tan-brown skin ellipse measuring 7.2 x 4.5 cm. The nipple measures 1.4 x 1.3 x 0.6 cm. There is no dimpling or skin. retraction identified. The breast is placed in formalin at. The specimen is submitted as follows: C1. Lower inner quadrant mass to medial margin. C2-C4. Remainder of lower inner quadrant mass (to superficial, deep and inferior margin). C5-C6. Second mass to deep margin (bisected). C7-C8 Second mass to superficial margin/skin (bisected). C9-C14 Remainder of second mass. C15. Representative section from upper inner quadrant. C16. Representative section from lower inner quadrant. C17. Representative section from lower outer quadrant. C18. Representative section from upper outer quadrant. C19. Nipple (serially sectioned). C20. Skin. D. Received in formalin labeled with the patient's name and ""8:00 additional medial, short superior, long lateral, clip true"" is a 2.6. x. 1.9 x 1.0 cm lumpectomy specimen, with a short suture designating superior, a long stitch designating anterior, and clips. designating the true (medial) margin. The specimen is received as follows: Anterior orange. Posterior - black. True (medial) - green. Lateral blue. The specimen is serially sectioned from superior to inferior to reveal a tan-yellow, glistening cut surface. No discrete lesions are. identified. The specimen is submitted entirely from superior to inferior in cassettes D1 through D4. The breast was placed. in. formalin at. Date of Printing: SURG PATH #: ALT ID #: E. Received in formalin labeled with the patient's name and ""8:00 additional inferior short anterior, long lateral, clip true margin"" is. a 3.0 x 2.3 x 1.1 cm lumpectomy specimen, with short suture designating anterior, long suture designating lateral, and clips marking. the true margin. The specimen is inked as follows: Anterior - orange. Posterior - black. Superior blue. True (inferior) - green. The specimen is serially sectioned from medial to lateral to reveal a yellow-gold, glistening cut surface. No discrete lesions are. identified. The specimen is submitted entirely from medial to lateral in cassette E1 through E4. The breast is placed in formalin. at. F. Received in formalin labeled with the patient's name and ""8:00 additional anterior short superior, long lateral, clip true margin"". is a 3.2 x 1.7 x 0.3 cm lumpectomy specimen, with short sutures designating superior, a long stitch designating lateral, and clips. designating the true (inferior) margin. The specimen is inked as follows: True (anterior) - orange. Posterior black. Medial green. Lateral blue. The specimen is serially sectioned from superior to inferior to reveal a yellow, glistening cut surface. No discrete lesions are. identified. The specimen is submitted entirely from superior to inferior in cassettes F1 through F3. The breast is. placed. in. formalin at. G. Received in formalin labeled with the patient's name and ""8:00 additional posterior short superior, long lateral, clip at true. margin"" is a 2.1 x 1.9 x 0.6 cm lumpectomy specimen with short sutures designating superior, a long set of sutures designating. lateral, and clips designating the true margin. The specimen is inked as follows: Anterior - orange. True (posterior) - black. Medial green. Lateral blue. The specimen is serially sectioned from superior to inferior to reveal a tan-pink to tan-brown cut surface. No discrete lesions are. grossly identified. The specimen is submitted entirely from superior to inferior in cassettes G1 through G3. The specimen. is. placed in formalin at. H. Received in formalin labeled with the patient's name and ""additional skin left breast blue at 3:00"" is a 5.0 x 5.0 cm C-shaped. portion of tan-brown skin and subcutaneous tissue with an attached strip of brown skin measuring 13.9 x 0.3 x 0.5 cm. The skin. on the specimen was inked blue in the OR and designates 3:00. The remainder of the specimen is inked as follows: 12 to 3:00 orange. 3 to 6:00 purple. 6 to 9:00 blue. 9 to 12:00 - green. Deep-black. The specimen is serially sectioned from 12 to 6:00, and no discrete lesions are identified. Also received within the container are. two irregular portions of tan-brown skin and subcutaneous tissue measuring 1.4 x 0.6 x 0.6 cm and 8.6 x 0.3 x 0.5 cm. This tissue. is serially sectioned and no discrete lesions are identified. The specimen is submitted as follows: H1. Representative sections from the 12 to 3:00 margin. H2-H4 -. Representative sections from the 3 to 6:00 margin. H5. Representative sections from the 6 to 9:00 margin. H6. Representative sections from the 9 to 12:00 margin. H7-H8 -. Representative sections from the additional skin and underlying soft tissue. Intraoperative Consultation: A1FS, A2FS, lymph node, ""left axillary sentinel lymph node #1 blue"": Negative for carcinoma. Date of Printing: SURG PATH #: ALT ID #: B1FS, lymph node, ""left axillary sentinel lymph node #2 blue"": Negative for carcinoma. If immunohistochemical stains and/or in situ hybridization are cited in this report, the performance characteristics were determined by the. in compliance with CLIA'88. regulations. Some of these tests rely on the use of ""analyte specific reagents"" and are subject to specific labeling requirements by the FDA. Known. positive and negative control tissues demonstrate appropriate staining. This testing was developed by the. It has not been cleared or approved by the FDA. The FDA has determined that such clearance or approval. is not necessary. Date of Printing:",train,1.2 cm;1.8 cm;1.2 cm;1.8 cm;0.23 mm
5902,TCGA-BP-4162.38b98d39-b206-4a74-8311-5950f14e5bc3,"Clinical Diagnosis & History: 5 cm right renal tumor. Specimens Submitted: 1: SP: Right kidney. 2: SP: Paracaval lymph nodes. 3: SP: Gallbladder. DIAGNOSIS: 1). KIDNEY, RIGHT; NEPHRECTOMY: - RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE. NUCLEAR GRADE II/IV. THE PATTERN OF GROWTH IS ACINAR. THE. TUMOR GREATEST DIAMETER IS 4.5 CM. THE TUMOR IS CONFINED. WITHIN THE RENAL CAPSULE. NO INVASION OF THE RENAL VEIN IS. IDENTIFIED. ALL SURGICAL MARGINS ARE FREE OF TUMOR. THE. NON-NEOPLASTIC KIDNEY SHOWS BENIGN CYSTS. 2). LYMPH NODES, PARACAVAL; EXCISION: - THREE LYMPH NODES NEGATIVE FOR CARCINOMA (0/3). 3). GALLBLADDER; CHOLECYSTECTOMY: - CHRONIC CHOLECYSTITIS AND CHOLELITHIASIS. Gross Description: 1) The specimen is received fresh, labeled ""Right kidney"". It. consists of a nephrectomy specimen. The entire specimen weighs. 330 grams and measures 13 X 7 x 4 cm. Sectioning reveals a 4.5. cm circumscribed yellow somewhat friable tumor towards the upper. pole. The tumor measures 4.5 cm in maximal dimension and is. confined within the kidney. Multiple cysts are identified in the. kidney with the largest measuring 4 cm towards the upper pole. The cysts are lined by smooth glistening lining and contains. clear fluid. The uninvolved kidney appears unremarkable with. prominent cortical medullary junction. The tumor does not extend. into the renal pelvic. There is no evidence of invasion of renal. vein grossly. Representative sections are submitted. Summary of Sections : T - tumor. TK - tumor with kidney. TC - tumor with capsule. C - representative sections of cyst. K - uninvolved kidney. GF - Gerota's fascia. UM - ureteric margin. VM - vascular margin. HF - hilar fat. 2) The specimen is received in formalin, labeled ""Paracaval. lymph nodes"". It consists of fatty tissue with multiple lymph. nodes with the largest measuring 2 cm. All lymph nodes are. submitted. Summary of Sections : LNB - bisected lymph nodes. LN - multiple lymph nodes. 3) The specimen is received in formalin, labeled ""Gallbladder"". It consists of a gallbladder measuring 7 x 3.5 x 2 cm. The. specimen has previously been opened to reveal multiple black. irregular gallstones measuring from 2.0 to 0.5 cm. The. gallbladder wall measures 0.3 cm in thickness. The mucosa is. green and granular with no gross lesions. Representative sections. are submitted. Summary of section: U - undesignated. Summary of Sections: Part. Sect. SiteBlocks Pieces All. C. 2. M. GF. 1. M. HF. 2. M. K. 1. M. 2. M. TC. 1. M. TK. M. UM. 1. M. VM. M. 2. LN. 2. LNB. 1. 3. 3. U. 3.",train,5 cm;4.5 CM;4.5. cm;4.5 cm
5908,TCGA-EM-A3FL.BFC4CD62-F17E-4F0B-8766-389A882167FE,"Facility: Specimen(s) Received. 1. Parathyroid: left upper parathyroid qs. 2. left hemi- thyroid stitch upper pole. Diagnosis. 1. No pathological diagnosis: Parathyroid (left upper) blopsy. 2. Multifical papillary carcinoma, dominant follicular variant, 1.5 cm; arising in follicular nodular disease and chronic. lymphocytic thyroiditis: Thyroid (left) hemithyroidectorny specimen. Comment. There is a unifocal 1.5 cm papillary carcinoma transformation in the dominant lesion. Synoptic Data. Procedure: Left hemithyroidectomy. Fresh. Specimen Integrity: Intact. Specimen Size: Left lobe: 4.3 cm. 3.3 cm. 2.3 cm. Isthmus +/- pyramidal lobe: 3.0 cm. 1.7 cm. 1.2 cm. Specimen Weight: 23.5 g. Tumor Focality: Multifocal, ipsilateral. DOMINANT TUMOR. Tumor Laterality: Left lobe. Tumor Size: Greatest dimension: 1.5cm. Histologic Type: Papillary carcinoma, follicular variant. Papillary carcinoma, oncocytic or oxyphilic variant. Follicular architecture. per TSS, follicular variant > 99%. Classical cytomorphology. Oncocytic or oxyphilic cytomorphology. Histologic Grade: Not applicable. Margins: Margins uninvolved by carcinoma. Tumor Capsule: None. Tumor Capsular Invasion: Not identified. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Not identified. Extrathyroidal Extension: Not identified. SECOND TUMOR. Tumor Laterality: Left lobe. Isthmus. Tumor Size: Greatest dimension: 0.7cm. Additional dimensions: 0.2 cm. Histologic Type: Papiliary carcinoma, follicular variant. Papillary carcinoma, microcarcinoma (occult, small or microscopic) variant. Papillary carcinoma, oncocytic or oxyphilic variant. Follicular architecture. Classical cytomorphology. Oncocytic or oxyphilic cytomorphology. Histologic Grade: Not applicable. Margins: Margins uninvolved by carcinoma. Tumor Capsule: None. Tumor Capsular Invasion: Not identified. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Not identified. Extrathyroidal Extension: Not identified. TNM Descriptors: m (multiple primary tumors). Primary Tumor (pT): pT1b: Tumor more than 1 cm but not more than 2 cm in greatest dimension, limited to. the thyroid. Regional Lymph Nodes (pN): pNX: Regional lymph nodes cannot be assigned. Number of regional lymph nodes examined: 0. Number of regional lymph nodes involved: 0. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: Adenomatoid nodule(s) or Nodular follicular disease. Thyroiditis, other: chronic lymphyoctic thyroiditis. Ancillary Studies: Type: IHC. Results: The 1.5 cm focus (slide no 2E) is negative for Galectin-3 and is focally. positive for cytokeratin 19. Few cells are positive for HBME-1 with an apical and. membranous pattern. Pathologic Staging is based on AJCC/UICC TNM,. Edition. Gross Description. 1. The specimen labeled with the patient's name and as ""Parathyroid: Left upper parathyroid QS"" consists of a piece of. reddish tissue that weighs 0.007 g and measures 0.4 x 0.2 x 0.1 cm. It is frozen for intraoperative consultation. 1A. frozen section block resubmitted. 2. The specimen labeled with the patient's name and as ""left hemi-thyroid stitch upper pole"", consists of a left. hemithyroidectomy specimen that weighs 23.5 g. The lobe measures 4.3 cm SI x 3.3 cm ML x 2.4 cm AP and the isthmus. measures 3.0 cm SI x 1.7 cm ML x 1.2 cm AP. No parathyroid glands and no lymph nodes are identified grossly. The. external surface is painted with blue dye. The upper to lower pole of the lobe contains a well delineated nodule that. measures 4.1 cm SI x 3.1 cm ML x 2.3 cm AP. The remainder of the thyroid tissue is unremarkable. Sections of nodule. and normal tissue are stored frozen. The remainder of the specimen is submitted as follows: 2A-J. lobe, superior to inferior. 2K-M isthmus. Quick Section utagnosis. QS-1A: Parathyroid tissue identified: Parathyroid (left upper) biopsy. Dr. Microscopic Description. The 1.5 cm focus (slide no 2E) is negative for Galectin-3 and is focally positive for cytokeratin 19. Few cells are positive. for HBME-1 with an apical and membranous pattern. The rest of dominant lesion is negative for HBME-1, cytokeratin 19. and Galectin-3.",train,1.5 cm;1.5 cm;0.7cm;1.5cm;0.2 cm
5957,TCGA-F5-6813.1e211347-b80e-439f-813b-4ec3b89e7d73,LARGE INTESTINE TISSUE. CHECKLIST. Specimen type: Excision of tumor. Specimen size: Not specified. Tumor site: Rectus abdominus. Tumor size: 5 X 5 X 1 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Moderately. differentiated. Tumor extent: Perirectal tissues. Lymph nodes: 12/12 positive for. metastasis (Pararectal 12/12). Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not. specified. Comments: None.,train,5 X 5 X 1 cm
5971,TCGA-C5-A1BE.0A21AE44-27DF-4F41-BAB5-209A25087C0A,"Gynecology. F. DIAGNOSIS: UTERUS, CERVIX, RADICAL HYSTERECTOMY. - MODERATELY DIFFERENTIATED NON-KERATINIZING SQUAMOUS CELL CARCINOMA, 5 CM IN. GREATEST DIMENSION. . SQUAMOUS CELL CARCINOMA INVADES TO A DEPTH OF 14 MM (TOTAL WALL THICKNESS 15 MM). SQUAMOUS CELL CARCINOMA IS PRESENT LESS THAN 1 MM FROM THE INKED MARGIN IN THE. ANTERIOR LOWER UTERINE SEGMENT. - EXTENSIVE LYMPHATIC AND VASCULAR SPACE INVASION IS IDENTIFIED. PARAMETRIA, RADICAL HYSTERECTOMY. - NO CARCINOMA IDENTIFIED. - FOCAL ENDOSALPINGIOSIS. - VESSELS WITH COMPLEX ATHEROSCLEROSIS. LYMPH NODES, PARAMETRIAL SOFT TISSUE, RADICAL HISTERECTOMY. - NO CARCINOMA IDENTIFIED IN THREE LYMPH NODES (0/3). VAGINA, RADICAL HYSTERECTOMY. - NO CARCINOMA OR DYSPLASIA IDENTIFIED. UTERUS, ENDOMETRIUM, TOTAL ABDOMINAL HYSTERECTOMY. - IN SITU AND INVASIVE SQUAMOUS CELL CARCINOMA EXTENSIVELY INVOLVING ENDOMETRIUM. - ENDOMETRIAL POLYPS, WITH INVOLVEMENT BY SQUAMOUS CELL CARCINOMA IN SITU. - INACTIVE ENDOMETRIUM. UTERUS. MYOMETRIUM, RADICAL HYSTERECTOMY. - LEIOMYOMATA, LARGEST 0.9 CM. - SQUAMOUS CELL CARCINOMA BY DIRECT EXTENSION. OVARY, RIGHT, SALPINGO-OOPHORECTOMY. - NO HISTOPATHOLOGIC ABNORMALITY. FALLOPIAN TUBE, RIGHT, SALPINGO-OOPHORECTOMY. - NO HISTOPATHOLOGIC ABNORMALITY. OVARY, LEFT. SALPINGO-OOPHORECTOMY. - NO HISTOPATHOLOGIC ABNORMALITY.",train,5 CM;0.9 CM
5995,TCGA-KL-8330.1e3df59f-dd7c-4718-be8b-ce7c0adce23c,"Clinical Diagnosis & History: vith right renal mass. Specimens Submitted: 1: SP: Right kidney & adrenal gland. 2: SP: Right paracaval nodes. DIAGNOSIS: 1). KIDNEY AND ADRENAL GLAND, RIGHT; RADICAL NEPHRECTOMY: - RENAL CELL CARCINOMA, CHROMOPHOBE TYPE. - THE TUMOR GREATEST DIAMETER IS 18 CM. - THE TUMOR IS CONFINED WITHIN THE RENAL CAPSULE. - NO INVASION OF THE RENAL VEIN IS IDENTIFIED. - ALL SURGICAL MARGINS ARE FREE OF TUMOR. - THE NON-NEOPLASTIC KIDNEY IS UNREMARKABLE. - THE ADRENAL GLAND IS UNREMARKABLE. 2). LYMPH NODES, RIGHT PARACAVAL; EXCISION: - EIGHT BENIGN LYMPH NODES (0/8). IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Special Studies: Special Stain. Comment. RECUT. RECUT. RECUT. 1). The specimen is received fresh, labeled ""Right Kidney and Adrenal Gland"". It consists of a kidney, adrenal gland and. tumor. The specimen measures 19 cm (superior-inferior) x 14.5 cm (anterior-posterior) x 17.2 cm (lateral). The specimen weighs. 1,800 grams. The adrenal gland is disrupted and measures 8.7 x 3.1 x 0.7 cm. The ureter measures 6.5 x 0.6 x 0.4 cm. The. tumor measures 18 x 15 X 13.5 cm. The adrenal gland appears to be uninvolved by tumor. On the cross section, tumor has a. centrally located scar and appears to be light mahogany in color. There are some areas of hemorrhagic. The tumor arises from. the superior pole of the kidney and appears to be well-demarcated. The kidney measures 9.5 x 7.5 x 6 cm. Gross photographs. and. are taken. The tumor does not involve the kidney pelvis and it has a thin, fibrous membrane around it. The tumor is. very friable. Representative sections are submitted. Summary of Sections: MA - ureteral vascular margins and representative sections of adrenal gland. C - section of tumor with capsule. K - section of uninvolved kidney. P - section of kidney pelvic. T - sections of the tumor. 2). The specimen is received in formalin, labeled ""Right Paracaval Nodes"". It consists of a 4.0 x 2.5 x 1.5 cm aggreate of. fibrofatty tissue fragments with multiple lymph nodes dissected ranging from 0.9 to 2.8 cm in greatest dimension. The largest two. lymph nodes are bisected and each is submitted in a separate cassette. The remainder of the lymph nodes are entirely submitted. Summary of Sections: BLN1 - first bisected lymph node. BLN2 - second bisected lymph node. LN - remainder of the lymph nodes. Summary of Sections: Part 1: SP: Right kidney & adrenal gland. Block. Sect. Site. PCs. 1. C. 1. 1. K. 1. 1. MA. 4. 1. P. 1. 7. T. 7. Part 2: SP: Right paracaval nodes. Block. Sect. Site. PCs. 1. BLN1. 2. 1. BLN2. 2. 2. LN. 4.",train,18 CM;18 x 15 X 13.5 cm
6005,TCGA-CZ-4865.b44898d2-5b0e-4f20-ba5f-ee1e10bb156b,"Report Status: Amend/Adder. Type: Surgical Pathology. Specimen Type: Kidney. partial or total resection. Procedure Date: PATHOLOGIC DIAGNOSIS: SPECIMEN LABELED LEFT KIDNEY' (475 gm) : RENAL CELL CARCINOMA, /clear cell type (3.0 cm). Fuhrman nuclear grade II of IV. Tumor is confined to the kidney and does not involve perihilar or. perinephric adipose tissue. Artery, vein and ureter resection margins are negative for tumor. No lymphovascular invasion is identified. Simple cyst (10 cm). Non-neoplastic renal parenchyma will be evaluated by the Renal Pathology. Service and the results will be reported in an addendum. B. SPECIMEN LABELED ""RETROPERITONEAL LYMPH NODES"": Fibroadipose tissue with no tumor present. No lymphoid tissue identified (the specimen was entirely submitted for. histologic analysis). AJCC Classification (6th Edition) : Tla NX MX. CLINICAL DATA: History: 70 yo female, incidental L renal mass RCC by bx. PMH: COPD, breast ca. Operation: L radical nephrectomy. Clinical Diagnosis: Renal cell ca L kidney. TISSUE SUBMITTED: A/1. L kidney. B/2. Regional retroperitoneal lymph nodes. GROSS DESCRIPTION: The specimen is received fresh, in two parts, each labeled with the patients. name and unit number. Part A, ""1. L kidney"", consists of 475g nephrectomy specimen, consisting of a. left kidney (18.2 x 9.0 x 5.9 cm) including a thin-walled cyst (10 x 9.5 x 5.9. cm) in the lower pole (lined by smooth walls and filled with a thin, serous. fluid). the ureter (6.0 cm length, 0.3 cm diameter) the renal artery (1.2 cm. length, 0.9 cm diameter), and the renal vein (0.5 cm length, 1.1 cm diameter). The specimen has been previously inked and bivalved, revealing a circumscribed,. tan/yellow, focally hemorrhagic mass (3.0 x 2.6 x 2.5 cm) in the upper/mid. kidney abutting the renal pelvis. The mass is 1.2 cm from the renal vein. resection margin, 1.0 Cm from the renal artery resection margin, 8.3 cm from. the ureteral resection margin, and 0.3 cm from the closest black-inked deep. margin. (hilar fat) The mass does not appear to grossly invade the renal. pelvis. The remaining renal parenchyma is unremarkable. The corticomedullary. junction is distinct. A representative section of tumor has been submitted to. Cytogenetics, the Tissue Bank, and for quick-fix, and a representative section. of normal tissue has been submitted to the Tissue Bank (cortex and medulla). for EM (cortex), and for IF (cortex). Micro A1: vascular ureteral margins, multi frag. Micro A2: quick-fixed section of tumor, 1 frag,. Micro A3: tumor and renal vein, 1 frag,. Micro A4: tumor and closest deep margin (inked black), 1 frag,. Micro A5: tumor and renal pelvis, 1 frag,. Micro A6: lower pole cyst wall, cyst w/respect to uninvolved renal. parenchyma, 3 frag,. Part B, ""2. retroperitoneal lymph nodes"", consists of multiple fragments of. soft tan/yellow adipose tissue (4 x 3.5 x 1.2 cm in aggregate) . There. are no. palpable lymph nodes. The specimen is entirely submitted. un an. Micro B1-B2: multi frag/cass,. By his/her signature below, the senior physician certifies that he/she. personally conducted a microscopic examination (""gross only"" exam if so stated). of the described specimen (s) and rendered or confirmed the diagnosis (es). related thereto. ADDENDUM. RENAL PATHOLOGY EVALUATION OF KIDNEY PARENCHYMA: LEFT KIDNEY, NEPHRECTOMY: SIMPLE CYSTS (approximately 5 up to 10 cm), MOST LIKELY RESULTING FROM. URINARY OBSTRUCTION AND RETENTION, WITH COMPRESSION-RELATED CHANGES OF. THE ADJACENT KIDNEY PARENCHYMA. MILD CHRONIC CHANGES OF THE KIDNEY PARENCHYMA, INCLUDING. FOCAL GLOBAL AND SEGMENTAL GLOMERULOSCLEROSIS, MILD (98 OF GLOMERULI). ,. MOST LIKELY SECONDARY TO FUNCTIONAL ADAPTATIONS FROM NEPHRON LOSS. TUBULAR ATROPHY AND INTERSTITIAL FIBROSIS, MILD (10-15% OF CORTEX). - ARTERIAL AND ARTERIOLAR SCLEROSIS, MODERATE. (SEE NOTE). PAPILLARY ADENOMA (0.1 cm). NOTE: Mild chronic changes are present in the kidney parenchyma, not including the. loss of nephrons from cyst and tumor-related compression. Because these. changes are a result of functional adaptations to nephron loss from any. glomerular, tubular, interstitial, vascular, or mass-replacing process, a. similar degree of chronic damage would be expected in the contralateral kidney. Incidental note is made of a papillary adenoma. The kidney parenchyma has been reviewed by. Renal Pathology. MICROSCOPIC DESCRIPTION: Sections of formalin-fixed paraffin-embedded tissue (block A6) were evaluated. using HE, PAS, Jones silver methenamine, and AFOG (trichrome) stains. The sample consists of cortex and medulla. There are 157 glomeruli present. away from the cyst wall, of which 12 are globally sclerosed and 2 are. segmentally sclerosed. Extensive glomerulosclerosis is present adjacent to the. cyst wall; the parenchyma in this area also shows compression-related changes. and entrapped tubules, vessels with smooth muscle hypertrophy, and glomeruli. The remaining glomeruli show no significant expansion of the mesangial areas. There are no discernible craters or spikes, but a few double contours of the. glomerular capillary wall basement membranes are seen. Approximately 10-15% of. the cortical parenchyma shows tubular atrophy and interstitial fibrosis. Arteries and arterioles exhibit a moderate degree of sclerosis. GROSS DESCRIPTION. Additional sections were submitted to further characterize the nature. cyst wall. Micro. Non-neoplastic kidney and cyst wall, 1 frag each,. [Clinical history: Breast cancer, severe COPD, creatinine 0.6-1.1). Report Status: Final. Type: Cytogenetics. Cytogeneticist. KARYOTYPE: 46, XX, +X, der (3) t (3;8) (p2?1;q2?3) -8 (10]. METAPHASES COUNTED: 10. ANALYZED: 7. SCORED: 3. BANDING: GTG. INTERPRETATION: All metaphases contained clonal aberrations including loss of the short arm of. chromosome 3, which is a characteristic finding in renal cell carcinoma, clear. cell type. COMMENTS: Mosaicism and small chromosome anomalies may not be detectable using the. standard methods employed. Chromosome analysis was performed at a level of 400. bands or greater. INDICATION FOR TEST: ? RCC.",train,3.0 cm;0.1 cm
6056,TCGA-IQ-7631.6ba769f5-1902-4a99-80b6-3b297f578e99,"PAGE 10. SPEC #: CLINICAL HISTORY- -. PRE-OP DX: Not provided. PROCEDURE: Not provided. RELEVANT CLINICAL HX: Not provided. GROSS DESCRIPTION: A. Received fresh and labeled ""Upper lip margin clip superior (skin)"" is a soft tissue. fragment which measures 1.4 X 0.3 x 0.1 cm. Clip margin inked in blue. Specimen. submitted in toto in one cassette for frozen section. B. Received fresh and labeled ""Inferior margin clip superior (skin) "" is a soft tissue. fragment measuring 0.5 x 0.3 x 0.2 cm. Clip margin inked in blue. Specimen submitted. in toto in one cassette for frozen section. C. Received fresh and labeled ""Inferior lateral margin clip superior (skin)"" is a soft. tissue fragment which measures 1.3 X 0.5 X 0.2 cm. Clip margin inked in blue. Submitted in toto in one cassette for frozen section. D. Received fresh and labeled ""Lower lip margin clip superior (skin)' is a soft tissue. fragment which measures 1.3 X 0.3 X 0.2 cm. Clip margin inked in blue. Submitted in. toto in one cassette for frozen section. E. Received fresh and labeled ""Mental margin clip superior (skin) is a soft tissue. fragment which measures 1.0 x 0.7 X 0.2 cm. Clip margin is inked in blue. Submitted in. toto in one cassette for frozen section. F. Received fresh and labeled ""Upper cheek margin (skin) "" is a soft tissue fragment which. measures 1.3 X 0.3 x 0.2 cm. Clip margin inked in blue. Submitted in toto for frozen. section in one cassette. G. Received fresh and labeled ""Nasolabial margin (skin) clip posterior"" is a soft tissue. fragment which measures 1.5 x 0.3 X 0.2 cm. Clip margin inked in blue. Submitted in. toto in one cassette for frozen section. H. Received fresh and labeled ""Right lower alveolar ridge"" is a soft tissue fragment. measuring 2.0 X 0.3 x 0.2 cm. Submitted in toto in one cassette for frozen section. Received fresh and labeled ""Right lower gingival labial mucosa margin"" is a soft. tissue fragment which measures 1.2 X 0.7 X 0.2 cm. Submitted in toto in one cassette. This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. and. return the report to us by mail. PAGE 11. SPEC #: GROSS DESCRIPTION (Continued). for frozen section. Received fresh and labeled ""Lower lip margin clip at oral commissure"" is a soft tissue. measuring 1.3 X 0. X 0.2 cm. Clip margin inked in blue. Submitted in toto in one. cassette for frozen section. K. Received fresh and labeled ""Upper lip mucosal margin"" is a soft tissue fragment which. measures 1.2 x 0.5 X 0.2 cm. Submitted in toto in one cassette for frozen section. Received fresh and labeled ""Anterior buccal margin clip anterior"" is a soft tissue. fragment measuring 1.3 x 0.6 x 0.3 cm. Clip margin is inked in blue. Submitted in toto. in one cassette for frozen section. M. Received fresh and labeled ""Posterior buccal margin clip posterior"" is a soft tissue. fragment measuring 1.5 x 0.5 x 0.3 cm. Clip margin inked in blue. Submitted in toto in. one cassette for frozen section. N. Received fresh and labeled ""Retromolar trigone"" is a soft tissue fragment which. measures 1.1 x 1.0 x 0.3 cm. Submitted in toto in one cassette for frozen section. o. Received fresh and labeled ""Retromandibular mucosa margin"" is a soft tissue fragment. which measures 1.0 X 0.3 x 0.2 cm. Submitted in toto in one cassette for frozen. section. P. Received fresh and labeled ""Posterior buccal fat"" is a fibroadipose tissue which. measures 2.5 x 1.5 x 0.4 cm. Representative section submitted for frozen and no. lesions grossly identified. Sections submitted as follows: Cassette #1FS: Frozen section. Cassette #1: Remaining tissue submitted in toto. Received fresh and labeled ""Lower right mandible periosteal margin"" is a soft tissue. fragment which measures 0.9 X 0.1 x 0.1 cm. Submitted in toto in one cassette for. frozen section. R. Received in formalin and labeled ""Buccal resection, buccal mucosa and cheek skin,. lower lip, mental skin suture superior"" is a specimen with skin mucosa and. fibroadipose tissue which measures 5.5 x 5.0 x 3.0 cm. The skin measures 4.0 X 3.0 X. 0.1 cm. A surgical scar on the skin surface measures 2.0 cm in length X 0.1 X 0.1 cm. The mucosa measures 5.0 X 3.0 X 0.1 cm. The external surface of the mucosa is nodular. with small focal ulceration which is less than 0.1 cm. Specimen is inked as follows: This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. and. return the report to us by mail. PAGE 12. SPEC #: GROSS DESCRIPTION: superior, blue; inferior, green; anterior, red; posterior, black. Sectioning reveals a. poorly defined nodular tumor which is tan to white. Tumor appears 0.5 cm from the. anterior margin, 1.0 cm from posterior margin, less than 0.1 cm from the inferior. margin, 1.0 cm from the superior margin. The tumor extends to the mucosal margin. It. is 1.0 cm from skin. The tumor measures 2.5 x 2.5 X 3.0 cm. Sections submitted as. follows: Cassette #1: Anterior margin, two fragments. Cassette #2: Posterior margin, two fragments. Cassette #3: Inferior margin. Cassette #4: Superior margin. Cassette #5: Tumor in relation to mucosal margin and ulcerated area and also shows. relationship of tumor to skin. Cassettes #6&7: Composite section of tumor with surrounding fat. Cassettes #8&9: Composite section of tumor. Cassette #10: Representative section of brown area extending from tumor. S. Received in formalin and labeled ""Right buccal fat pad"" are multiple fragments of. adipose tissue which measures 4.0 X 2.0 x 1.0 cm in aggregate. No lesions grossly. identified. No lymph nodes. Specimen submitted in toto in cassettes #1-4. Received in formalin and labeled ""Left neck dissection level 1B"" is a fibroadipose. tissue which measures 5.0 X 4.0 x 2.5 cm. Salivary gland is present which measures 4. 6. x 2.5 X 2.0 cm. Largest lymph node measures 2.3 x 0.5 x 0.5 cm. Sections submitted as. follows: Cassette #1: Largest lymph node bisected. Cassette #2: Two possible lymph nodes. Cassette #3: Representative section of salivary gland. U. Received in formalin and labeled ""Left neck dissection level 2A"" is a fibroadipose. tissue which measures 6.0 X 4.0 x 2.5 cm. Largest lymph node measures 2.0 X 1.0 X 0.5. cm. Sections submitted as follows: Cassette #1: Four lymph nodes. Cassette #2: Four possible lymph nodes. Cassette #3: Four possible lymph nodes. Cassette #4: Four possible lymph nodes. Cassette #5: One lymph node bisected. Cassette #6: One lymph node bisected. Cassette #7: One lymph node bisected. This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. and. return the report to us by mail. PAGE 13. SPEC #: GROSS DESCRIPTION: Cassette #8: One lymph node. V. Received in formalin and labeled ""Right neck dissection level 2B"" is a fibroadipose. tissue which measures 3.5 x 1.0 X 1.0 cm. Largest lymph node measures 0.6 x 0.5 X 0.3. cm. Sections submitted as follows: Cassette #1: One lymph node. Cassette #2: Remainder of fibroadipose tissue in toto. W. Received in formalin and labeled ""Right neck dissection levels 1A, 1B, 2A, 3, 4"" is a. fibroadipose tissue which measures 8.0 X 5.5 X 4.0 cm. Specimen is unoriented. Salivary gland is identified which measures 4.5 x 2.5 X 2.0 cm. Largest. lymph. node. measures 1.7 X 1.0 x 0.6 cm. Sections submitted as follows: Cassette #1: Largest lymph node bisected. Cassette #2: One lymph node bisected. Cassette #3: One lymph node bisected. Cassette #4: One lymph node bisected. Cassette #5: One lymph node bisected. Cassette #6: Six possible lymph nodes. Cassette #7: Six possible lymph nodes. Cassette #8: Five possible lymph nodes. Cassette #9: Six possible lymph nodes. Cassette #10: One lymph node bisected and representative section of salivary gland. x. Received in formalin and labeled ""Left forearm subcutaneous mass"" are small fragments. of pale tan/white tissue which measures 1.5 X 1.3 X 1.0 cm in aggregate. Submitted in. toto in one cassette. Y. Received fresh and labeled ""Right thyroid lobe with isthmus"" is a right thyroid lobe. with isthmus. Specimen weighs 13.82 grams and measures 4.3 X 2.5 x 2.5 cm. Isthmus. measures 1.0 X 0.5 X 0.5 cm. External surface is smooth and has no lesions. It is. inked in black. There is a nodule in the right lobe which extends from the superior. pole through the mid pole which is well circumscribed and measures 3.0 x 2.5 x 2.0 cm. It is yellow and colloid in appearance. There is a small nodule in the isthmus which. measures 1.0 X 0.5 X 1.0 cm. It is yellow and well circumscribed. Representative. section of large nodule submitted for frozen section. Isthmus margin submitted for. frozen section. Remainder of specimen is placed in formalin for permanent. There are. some calcifications in the nodule. Remainder of thyroid gland is beefy red brown and. unremarkable. Thyroid submitted in toto. Sections submitted as follows: This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. and. return the report to us by mail. PAGE 14. SPEC #: GROSS DESCRIPTION: Cassette #1FS Margin at isthmus. Cassette #2FS: Representative section of nodule. Cassettes #1-3: - Nodule in superior pole of right lobe. Cassettes #4-7: Nodule in middle pole right lobe. Cassettes #8&9: Nodule in normal thyroid gland tissue and inferior pole right lobe. Cassettes #10&11: Isthmus with nodule in toto. Cassette #11: Two lymph nodes submitted with isthmus. OPERATING ROOM CONSULT. A) Upper lip margin, clip superior, Skin. Skin. no malignancy Seen. B) Inferior margin, clip superior, Skin. Same as A. C) Inferior lateral margin, Clip Superior, Skin. Same as A. D) Lower lip margin, clip superior, Skin. Same as A. E) Mental Margin, clip superior, Skin. Same as A. F) Upper cheek margin, Skin. Same as A. G) Naso Labial margin, Skin, Clip Posterior. Same as A. H) Right lower alveolar ridge. No malignancy seen. I) Right lower gingival labial mucosa margin. Same as H). J) Lower lip margin. Clip at oral commisure. Same as H). K) Upper lip mucosal margin. Same as H) . L) Anterior buccal margin. Clip anterior. Same as H). M) Posterior Buccal Margin. Clip Posterior. Same as H). N) Retromolar trigone. This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. and. return the report to us by mail. PAGE 15. SPEC #: OPERATING ROOM CONSULT. Same as H). O) Retromandibular mucosal margin. Same as H). P) Posterior Buccal Fat. Same as H). Q) Lower right mandible periosteal margin. Same as H). Y) Right thyroid lobe with ishmus. Representative section: -Follicular lesion. -Defer final diagnosis for complete sampling and permanent sections. This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. and. return the report to us by mail. REG DR: Copies to: Submit Dr: This is a corrected report. Any previous versions are stored internally and are available if necessary. SPECIMEN ID: A. SKIN - Upper lip margin, clip superior. Skin.,. B. SKIN - Inferior margin clip superior, Skin. C. SKIN - Inferior lateral margin, clip superior, Skin,. D. SKIN - Lower lip margin, clip superior, skin,. E. SKIN - mental margin clip superior, skin, F. SKIN - upper cheek margin, skin,. G. SKIN - Nasolabial margin, skin, clip posterior,. H. SOFT TISSUES OF HEAD AND NECK - Right lower alveolar ridge. I. SOFT TISSUES OF HEAD AND NECK - Right lower gingival labial mucosa margin. J. LIP, NOS - lower lip margin, clip at oral comminsure.,. K. LIP, NOS - upper lip mucosal margin,. L. SOFT TISSUES OF HEAD AND NECK - Anterior Buccal margin clip anterior,. M. SOFT TISSUES OF HEAD AND NECK - Posterior Buccal Margin Clip Poterior,. N. SOFT TISSUES OF HEAD AND NECK - Retromolar trigone,. o. SOFT TISSUES OF HEAD AND NECK - Retromandibular mucosal margin,. P. ADIPOSE TISSUE - posterior buccal fat,. Q. SOFT TISSUES OF HEAD AND NECK - Lower right mandible periosteal margin,. R. SOFT TISSUE - BUCCAL RESECTION, BUCCAL MUCOSA AND CHEEK SKIN, LOWER LIP,. S. SOFT TISSUE - RIGHT BUCCAL FAT PAD, T. NECK, NOS - LEFT NECK DISSECTION. LEVEL. IB,. U. NECK, NOS - LEFT NECK DISSECTION LEVELS 2A,. V. NECK, NOS - RIGHT NECK DISSECTION LEVEL 2B,. W. NECK, NOS - RIGHT NECK DISSECTION LEVELS 1A, 1B, 2A, 3, 4,. X. SOFT TISSUE - LEFT FOREARM SUBCUTANEOUS MASS,. Y. THYROID GLAND - Right thyroid lobe with ishmus. This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. and. return the report to us by mail. SPEC #: SPECIMEN ID: (Corrected Result). Edit Date: Edit Reason: DIAGNOSIS EDIT/CLARIFICATION. A. UPPER LIP MARGIN, CLIP SUPERIOR, SKIN: Skin, no malignancy seen. B. INFERIOR MARGIN, CLIP SUPERIOR, SKIN: Skin, no malignancy seen. C. INFERIOR LATERAL MARGIN, CLIP SUPERIOR, SKIN: Skin, no malignancy seen. D. LOWER LIP MARGIN, CLIP SUPERIOR, SKIN: Skin, no malignancy seen. E. MENTAL MARGIN, CLIP SUPERIOR, SKIN: Skin, no malignancy seen. F. UPPER CHEEK MARGIN, SKIN: Skin, no malignancy seen. This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. and. return the report to us by mail. SPEC #: FINAL DIAGNOSIS. (Corrected Result). G. NASOLABIAL MARGIN, SKIN, CLIP POSTERIOR: Skin, no malignancy seen. H. RIGHT LOWER ALVEOLAR RIDGE: No malignancy seen. RIGHT LOWER GINGIVAL LABIAL MUCOSA MARGIN: No malignancy seen. J. LOWER LIP MARGIN, CLIP AT ORAL COMMISSURE: No malignancy seen. K. UPPER LIP MUCOSAL MARGIN: No malignancy seen. L. ANTERIOR BUCCAL MARGIN, CLIP ANTERIOR: No malignancy seen. M. POSTERIOR BUCCAL MARGIN, CLIP POSTERIOR: No malignancy seen. N. RETROMOLAR TRIGONE: No malignancy seen. This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. and. return the report to us by mail. SPEC #: FINAL DIAGNOSIS. (Corrected Result). o. RETROMANDIBULAR MUCOSAL MARGIN: No malignancy seen. P. POSTERIOR BUCCAL FAT: No malignancy seen. LOWER RIGHT MANDIBLE PERIOSTEAL MARGIN: No malignancy seen. R. BUCCAL RESECTION, BUCCAL MUCOSA AND CHEEK SKIN, LOWER LIP: This case was reviewed and discussed at the weekly. In my. opinion, the buccal mucosa carcinoma is best characterized as a low to intermediate. grade mucoepidermoid carcinoma. The case was discussed with. Tumor size 2.0 cm (by microscopic estimate) . No perineural or lymphovascular invasion seen. Margins negative for tumor (see frozen section A through Q above). S. RIGHT BUCCAL FAT PAD: Benign adipose tissue and salivary gland tissue. No evidence of malignancy. T. LEFT NECK DISSECTION, LEVEL 1B: This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. and. return the report to us by mail. SPEC #: FINAL DIAGNOSIS. (Corrected Result). Lymph nodes (2) ; negative for tumor. Benign salivary gland tissue; negative for tumor. U. LEFT NECK DISSECTION LEVELS 2A: Lymph nodes (17) ; negative for tumor. V. RIGHT NECK DISSECTION LEVEL 2B: Lymph nodes (4) i negative for tumor. W. RIGHT NECK DISSECTION LEVELS 1A, 1B, 2A, 3, 4: Lymph nodes (25) ; negative for tumor. Salivary gland tissue; no evidence of malignancy,. X. LEFT FOREARM SUBCUTANEOUS MASS: Angiolipoma. Y. RIGHT THYROID LOBE WITH ISTHMUS: Multiple follicular colloid nodules consistent with goiter with focal chronic. inflammation. No evidence of malignancy. This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. and. return the report to us by mail. SPEC #: FINAL DIAGNOSIS. (Corrected Result). A. UPPER LIP MARGIN, CLIP SUPERIOR, SKIN: Skin, no malignancy seen. B. INFERIOR MARGIN, CLIP SUPERIOR, SKIN: Skin, no malignancy seen. C. INFERIOR LATERAL MARGIN, CLIP SUPERIOR, SKIN: Skin, no malignancy seen. D. LOWER LIP MARGIN, CLIP SUPERIOR, SKIN: Skin, no malignancy seen. E. MENTAL MARGIN, CLIP SUPERIOR, SKIN: Skin, no malignancy seen. F. UPPER CHEEK MARGIN, SKIN: Skin, no malignancy seen. G. NASOLABIAL MARGIN, SKIN, CLIP POSTERIOR: Skin, no malignancy seen. H. RIGHT LOWER ALVEOLAR RIDGE: This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. and. return the report to us by mail. SPEC #: FINAL DIAGNOSIS. No malignancy seen. I. RIGHT LOWER GINGIVAL LABIAL MUCOSA MARGIN: No malignancy seen. J. LOWER LIP MARGIN, CLIP AT ORAL COMMISSURE: No malignancy seen. K. UPPER LIP MUCOSAL MARGIN: No malignancy seen. L. ANTERIOR BUCCAL MARGIN, CLIP ANTERIOR: No malignancy seen. M. POSTERIOR BUCCAL MARGIN, CLIP POSTERIOR: No malignancy seen. N. RETROMOLAR TRIGONE: No malignancy seen. o. RETROMANDIBULAR MUCOSAL MARGIN: No malignancy seen. This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. and. return the report to us by mail. SPEC #: FINAL DIAGNOSIS. P. POSTERIOR BUCCAL FAT: No malignancy seen. LOWER RIGHT MANDIBLE PERIOSTEAL MARGIN: No malignancy seen. R. BUCCAL RESECTION, BUCCAL MUCOSA AND CHEEK SKIN, LOWER LIP: Invasive well differentiated squamous cell carcinoma. Tumor size 2.0 cm (by microscopic estimate) . No perineural or lymphovascular invasion seen. Margins negative for tumor (see frozen section A through Q above). S. RIGHT BUCCAL FAT PAD: Benign adipose tissue and salivary gland tissue. No evidence of malignancy. T. LEFT NECK DISSECTION, LEVEL 1B: Lymph nodes (2) ; negative for tumor. Benign salivary gland tissue; negative for tumor. U. LEFT NECK DISSECTION LEVELS 2A: Lymph nodes (17) ; negative for tumor. This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. and. return the report to us by mail. SPEC #: FINAL DIAGNOSIS. V. RIGHT NECK DISSECTION LEVEL 2B: Lymph nodes (4) i negative for tumor. W. RIGHT NECK DISSECTION LEVELS 1A, 1B, 2A, 3, 4: Lymph nodes (25) ; negative for tumor. Salivary gland tissue; no evidence of malignancy. x. LEFT FOREARM SUBCUTANEOUS MASS: Angiolipoma. Y. RIGHT THYROID LOBE WITH ISTHMUS: Multiple follicular colloid nodules consistent with goiter with focal chronic. inflammation. No evidence of malignancy. This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. and. return the report to us by mail.",train,2.5 x 2.5 X 3.0 cm;2.0 cm;2.0 cm
6063,TCGA-A6-2681.ec4bb62b-edf5-4051-8240-4e9d89fd928f,"SPECIMEN. Right colon. CLINICAL NOTES. PRE-OP DIAGNOSIS: Cancerous cecum. GROSS DESCRIPTION. Received fresh labeled ""right colon"" is a previously. unopened 31 cm. segment of proximal right colon with. attached 28 cm. of distal ileum surfaced by smooth tan-pink serosa. with a copious amount of attached mesentery, mesocolon, and. unremarkable omentum. An unremarkable, 3.2 cm. appendix averaging. 0.6 cm. in diameter is present. The proximal and distal margins. measure 4.2 and 7.0 cm. in circumference respectively. On opening. there is a well-circumscribed, 2.8 X 2.5 cm. rubbery tan pink-red. tumor mass within the cecal pouch, 2 cm. distal to the ileocecal. valve. A portion of tumor and a portion of normal mucosa are. submitted for tissue procurement as requested. On sectioning, the. tumor has a maximal thickness of 0. cm., approaching the. muscularis. and extending to within 0.5 cm. of the inked free radial serosal. surface. The ileal mucosa and uninvolved colonic mucosa is. otherwise unremarkable glistening tan-pink with regular folds and. the walls average 0.5 cm. in thickness. A few uncomplicated. diverticula are evident throughout the colonic segment. Several. soft tan pink tissues in keeping with lymph nodes measuring up to 1. cm. in greatest dimension are recovered from the attached mesentery. and mesocolon. Representative sections are submitted in fifteen. blocks as labeled. RS-15. BLOCK SUMMARY: 1 - Proximal and distal margins; [11-01] -. entire. lesion;. 6 - ileum; 7 - ICV; 8 - random colon; 9 - appendix; 10,11 - eight. whole lymph nodes per cassette; 12 - seven whole lymph nodes; 13-15. - one bisected lymph node per cassette. GROSS DESCRIPTION. MICROSCOPIC DESCRIPTION. Histologic type: Adenocarcinoma. Histologic grade: Moderately-differentiated. Primary tumor (pT3) : Carcinoma extends through the muscularis. propria into the subserosal fat. Proximal/distal/radial margins: Negative. Vascular invasion: Not identified. Regional lymph nodes (pN) : twenty-three negative lymph nodes. (0/23). Non-lymph node pericolonic tumor: Not identified. Other findings : unremarkable appendix, ileum. Diverticulosis. 5. DIAGNOSIS. Colon, terminal ileum, appendix, right hemicolectomy: Adenocarcinoma, moderately-differentiated, with invasion through. the muscularis propria into the subserosal fat (pT3). Margins of excision: Negative. Vascular invasion: Not identified. Twenty-three negative lymph nodes 10/231.",train,2.8 X 2.5 cm;0. cm
6080,TCGA-24-1603.b5ea4cb8-5f2a-4a6d-88ed-f36c1b12e3f9,"an. Sax/Rade: MS No. : Hosp. No. : Taken/Beceived: OVARY, 1.EPm, EXCISTOK - POORLY ADEKOCARCEMOMA. MIXED PAFILLARY SEROUS ARD TYPE. ovany, siche, - POOPLY. MIZED PAPILLARY SEROUS AND TYPE. FAELOPIAN RIGHT, EXCISION - NO DEFINITE FALLOPIAI TUBE. IDENTIFIED. FALLOFIAN ruse, IErm, EXCISION - NO ABNORMALITY. UTERUS, CERVSK, /EXCISION, - NO ARNORMALITY. UTERUS, ENDOMETRIUM, EXCISION - INACTIVE. UTERUS, MYOMETRIUM, EXCISTOR - POORLY DIPPERENTIATED ADENOCAROSNOMA,. METASTATIC, SEROSAL IMPLANTS. - ADENOMYOSIS. CMENTUM, EXCISION - POORLY DIFPERENTIATED ADENOOABOINOKA,. METASTATIC, CONSISTENT wrth OVARIAN PRIXARY. ( SEE SYNOPTIC REPORT). SPECTMEN isi SUBMITTED. Part 1: PS1-CVARY, -. Par 2: ES-OVARY, - LEFT. RE. Part 3: RICHT ADNEXA AND UTERUS. Faxt & OMENTUM. HISTORY. The patient is 2. with bilateral admexal masses. operativo procedure: TOT&A abdominal hysterectomy with bilateral. salpingo - and omentectomy. be. RD. dross (continuad). from anterios and pocteries corvix; Est and E2: sections from. anterior and postorior encometriua; F1: dection from putative. right fellopian tobe; M1 and M2, section from myometriam to the. tumor on the cerosa sections from the large globular. cystic tuker mass. The fourth costainer is labelled omentum"" and consisto of 2 slab. of omestal Pst. measuring 19.0 1. 9.0 7 1.0 on. Multiple. groy-uhite, noft tissue nodulas are identified, the lezgest oz. which masumes 1.2 x 1.2 3 $ .0 cm. OMMENT. Sections from both right and left ovaries show a poorly. differentated adencarsinoma with features of both papillary. serous and endometricid carcinoma. Borta ovaries are almost. completely replaced by the tumor and show tumor both on the. surface and within the stroma. The tumer ds repredented by lerge. neste, and papillary. structured concisting of large cells. with it high ratio, large hyperchromatic. nucled; and a high mitotic rate approaching approximately es. mitoses in 20 high power fields including abnonmal forms. Sectione from the cervix are unremarkable Sectione from the. endomatrium show an inactive endometxium. The myometrium Dear the. serosa showo a small area of adenomyocio. Large netactatio. implants of tumor are present on the serosa of the uteras covering. approximately 76% of the surface area. The left tallopiam tube. shows no histopathologio abnormality while no definite fallopian. tube is identified on the right adde, It is possible that the. artached fallopian tube on the lett side has been replaced. completely by the tumor. Metastatio tumor implanto are prasent in. further detailo. na. SYNOPTIC REPORTING FORM FOR MALIGNANT OVARIAN NEOPLASKS. A neoplasm ic PRESENT, bilaterally. The histolocid DIAGNOSIS is: Mixed serous adenccarcinoma and endometrial type. The LOCATION(S) OF THE PRIMARY TUMOR(S) is/are: Right and left ovary (synchronous primary tumors). The FIGGO CRADE of the tamor is: ITI (Tumor composed of greater than 50% colid celledar. nests). 5. The RUCLEAR (BRODERS' ) GRADE 61 the tumor 13:",train,
6082,TCGA-DC-6160.52adeca8-253e-432d-a349-2eadf318a1aa,"Addendum. Clinical Diagnosis & History: Diagnosed with rectal carcinoma at 15 cm on. rectal carcinoma. Specimens Submitted: 1: SP: Rectum and rectosigmoid. 2: SP: Additional sigmoid. 3: SP: Proximal ring. 4: SP: Distal ring. DIAGNOSIS: 1). COLON, RECTUM AND RECTOSIGMOID, SEGMENTAL RESECTION: - THREE (3) FOCI OF ADENOCARCINOMA, MODERATELY DIFFERENTIATED, OF. SIGMOID AND RECTOSIGMOID. - THE TUMORS MEASURE 2.9 X 1.8 X 0.8 CM, 0.4 x 0.4 x 0.2 CM, AND 0.7 X. 0.5 X 0.2 CM, RESPECTIVELY. - GROSS CONFIGURATIONS ARE POLYPOID. - PREEXISTING TUBULAR ADENOMA IS IDENTIFIED. - TWO SMALLER TUMORS INVADE INTO THE SUBMUCOSA (pT1) . - THE LARGEST TUMOR INVADES INTO MUSCULARIS PROPRIA (pT2). - NO VASCULAR INVASION IS IDENTIFIED. - NO PERINEURAL INVASION IS IDENTIFIED. - SURGICAL MARGINS ARE FREE OF TUMOR. - ADDITIONAL HYPERPLASTIC POLYP IS IDENTIFIED. THE UNINVOLVED COLONIC MUCOSA IS UNREMARKABLE. - LYMPH NODES: NUMBER OF METASTASES:0 NUMBER EXAMINED: 8 (0/8). (ADDITIONAL LYMPH NODES ARE BEING EXAMINED AND AN ADDENDUM REPORT WILL. FOLLOW) . 2). COLON, ADDITIONAL SIGMOID, SEGMENTAL RESECTION: - HYPERPLASTIC POLYP. - UNREMARKABLE COLONIC MUCOSA. - ONE BENIGN LYMPH NODE (0/1). 3). COLON, PROXIMAL RING, EXCISION: - UNREMARKABLE COLONIC MUCOSA. 4. COLON, DISTAL RING, EXCISION: - UNREMARKABLE COLONIC MUCOSA. I. ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) , AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. 1. Gross Description: 1) The specimen is received fresh labeled ""rectum and rectosigmoid"". It. consists of a rectosigmoid colon that measures 12.0 cm in length by 7.0 cm. in circumference at the distal resection margin. The serosal surface is pink. and smooth. The radial resection margin is inked black and the specimen is. opened to reveal a pink-tan papillary tumor measuring 2.9 cm in length by. 1.8 cm in width by 0.4 cm, located 3.5 cm from the distal resection margin. There is a smooth sessile polyp measuring 0.4 x 0.4 x 0.2 cm, located 0.7 cm. from the tumor, and 5.0 cm from the closest (distal) resection margin. There. is a second pink-tan smooth sessile polyp measuring 0.6 x 0.4 x 0.2 cm,. located 1.2 cm from the tumor, and 3.2 cm from the distal resection margin. (arbitrarily designated P2) There is a third pink-tan smooth sessile polyp. measuring 0.7 x 0.5 x 0.2 cm, 1.0 cm distal to the tumor, and 1.8 cm from. the distal resection margin (arbitrarily designated P3) . The three polyps. are blocked out and entirely submitted. The tumor is sectioned to reveal a. well defined pink-white extension to depth of 0.8 cm grossly not involving. the underlying fat, and 1.2 cm from the inked radial resection margin. Representative sections of the tumor are submitted. Remaining mucosa is. otherwise grossly unremarkable. The specimen is submitted for lymph nodes. and possible lymph nodes are submitted. TPS is taken. Representative. sections are submitted. Summary of sections: PM - proximal margin. DM distal margin. RM -- radial margin. T-- tumor. P1, P2, P3polyps submitted from proximal to distal. T tumor. U - undesignated. LN. lymph nodes. RM- radial margin. 2) The specimen is received fresh labeled ""Additional sigmoid"" and consists. of a previously opened portion of bowel measuring 5.6 cm in length by 5.3 cm. in circumference. There is attached pericolic fat extending 6.2 cm in. length. The mucosa reveals a central pink-tar smooth sessile polyp. measuring 0.5 x 0.4 x 0.2 cm, 2.8 cm from the nearest unoriented resection. margin. The polyp is blocked out entirely submitted. The remaining mucosa is. otherwise grossly unremarkable. Representative sections including margins. are. submitted. The specimen is submitted for lymph dissection, and all. identified lymph nodes are submitted. Summary of sections: M1-margin one. M2-opposing margin. P-polyp. U - undesignated. LN - lymph nodes. 3) The specimen is received in formalin, labeled ""proximal ring"" and. consists of a silver metal anastomotic pin measuring 7.5 x 2.8 x 1.5 cm. At. the center of the pin, a plastic piece is noted. A ring of pink tan soft. tissue is attached measuring 2.0 x 1.8 x 0.5 cm. The mucosal surface. is. pink tan and focally hemorrhagic and the serosal surface is pink tan and. smooth. Several sutures and staples are noted. The sutures and staples are. removed and the soft tissue is entirely submitted. Summary of sections: - undesignated. 4) The specimen is received in formalin, labeled ""distal ring"" and consists. of a ring of pink tan soft tissue measuring 1.8 x 1.8 x 0.7 cm. Multiple. sutures and staples are attached. The mucosal surface is pink tan and. focally hemorrhagic. The sutures and staples are removed and the soft tissue. is entirely submitted. Summary of sections: U --undesignated. Summary of Sections: Part 1: SP: Rectum and rectosigmoid. Block. Sect. Site. PCs. 5. ADD. 9. 1. BLN. 2. 2. DM. 2. 6. LN. 12. 1. P1. 1. 1. P2. 1. 1. P3. 1. 2. PM. 2. 1. RM. 1. 3. T. 3. 1. U. 1. Part 2: SP: Additional sigmoid. Block. Sect. Site. PCs. 4. add. 8. 1. LN. 4. 2. M1. 2. 2. M2. 2. 1. U. 1. Part 3: SP: Proximal ring. Block. Sect. Site. PCs. 2. u. 2. Part 4: SP: Distal ring. Block. Sect. Site. PCs. 2. u. 2. Procedures/Addenda: Addendum. Addendum Diagnosis. PART #1 COLON, RECTUM AND RECTOSIGMOID, RESECTION: EIGHT ADDITIONAL LYMPH NODES ARE IDENTIFIED; THE FINAL LYMPH NODE COUNT IS. 0/16, pNO.",train,15 cm;2.9 X 1.8 X 0.8 CM;0.4 x 0.4 x 0.2 CM;0.7 X. 0.5 X 0.2 CM;2.9 cm;1.8 cm;0.4 cm
6087,TCGA-DH-5142.d6bad55b-31f4-416a-8775-e3439c0f6918,"SPECIMEN(S) SUBMITTED/PROCEDURES ORDERED: CLINICAL HISTORY: male, here for left side craniotomy for tumor. GROSS DESCRIPTION: Received the following specimens in the Department of Pathology, labeled with. the patient's name and. A. Brain tumor. B. Brain tumor. A. The specimen is received fresh and consists of a dome-shaped portion of edematous beige to gray-. tan homogenous tissue that is 3.2x2.5x2.0cm. A representative portion is submitted for frozen. section. Frozen section diagnosis is ""Infiltrating glioma, most likely astrocytic, with features suspicious. for anaplasia,"" by Dr. The frozen tissue is submitted in cassette FSA1, and representative tissue. is submitted in cassettes A2-A4. A representative portion is submitted for the. B. The specimen is received fresh and consists of a 3.6 X 3.3 x 0.9 cm portion of homogenous beige to. gray-tan soft tissue with focal areas of yellow to white softening. A representative portion is submitted. in cassettes B1-B4, and a portion is submitted to. DIAGNOSIS: A. ""Brain tumor"": Anaplastic astrocytoma (WHO Grade III) (see comment). B. ""Brain tumor"": Anaplastic astrocytoma (WHO Grade III). COMMENT: This highly infiltrative astrocytoma shows evidence of anaplastic transformation as well as. areas of diffuse low grade histology. Areas of increased cellularity and pleomorphism are. especially striking in slides A3 and A4. A conspicuous gemistocytic appearance of the tumor cells is. apparent throughout (GFAP-immunoreactive). Although only a few mitotic figures are apparent in this. well sampled glioma, the Ki-67 labeling index is around 9 % (range: 6-13%) in highly cellular areas. These. results support the diagnosis. ""I or my qualified designee, have performed the gross examination and. description and I have personally reviewed the gross description and specimen preparations referenced. herein, and have personally issued this report."". Resident/Prosector/Pathologist: Note: Test systems have been developed and their performance characteristics determined by. Some tests have not been cleared or approved by the U.S. Food and Drug. Administration. The FDA has determined that such clearance is not necessary. These tests are used for. clinical purposes and should not be regarded as investigational or for research. This laboratory is. certified under the Clinical Laboratory Improvement Amendments of. a qualified to. perform high complexity clinical laboratory testing.",train,
6089,TCGA-BC-A69H.AE56DFF8-AF71-4217-A491-8F78543E186D,"Diagnosis. A: Liver, segments 4-8, resection. Number of tumors: one. Tumor histologic type: poorly differentiated carcinoma, favor. hepatocellular carcinoma (see comment). Histologic grade: poorly differentiated, grade 4 of 4. (Edmondson-Steiner classification). Tumor size: 11 cm. Tumor location: right hepatic lobe. Tumor necrosis: focal (approximately 10% by gross. examination). Vascular invasion: present, extensive. Perineural invasion: not identified. Capsular invasion: not identified. Satellite lesions: not identified. Margins: Parenchymal margin: negative but extremely close (0.13 mm). (possibly superseded by specimen B). Vascular margins : negative. Bile duct margins: negative. Lymph nodes: none identified. Background liver: moderate macrovesicular steatosis. (approximately 40%). focal ballooning degeneration of. hepatocytes, and at least bridging fibrosis (see comment). Additional findings: none. AJCC Pathologic TNM stage: pT2 pNX. NOTE: This pathologic stage assessment is based on information. available at the time of this report and is subject to change. pending clinical review and additional information. B: Liver, segment 4B, excision. - No carcinoma identified. - Moderate macrovesicular steatosis. Comment : Immunostains are performed on a section of tumor (block A5) . The. malignant cells are positive for cytokeratin AE1/AE3, CK8/18,. and HepParl. MOC-31 shows patchy moderate staining. CD10 is. negative. The immunophenotype shows overlapping features between. hepatocellular carcinoma and cholangiocarcinoma; however, given. the strong HepPar1 staining, a poorly differentiated. hepatocellular carcinoma is favored. Special stains are performed on a section of background liver. (block A9) . A trichrome stain shows bridging fibrosis with areas. suggestive of possible early nodule formation. There is a single. focus of minor centrilobular perisinusoidal fibrosis. A. reticulin stain shows no significant hepatic plate expansion. An. iron stain shows mild to moderately increased iron staining. within hepatocytes (grade 2 of 4) and increased iron staining. within Kupffer cells. A PAS-D stain shows no PAS positive. cytoplasmic inclusions. Clinical History: year-old male with a clinical diagnosis of hepatocellular. carcinoma. Gross Description: Received are two appropriately labeled containers. Container A: Specimen Type: lobectomy, right. Specimen Weight: 850 grams. Measurement : 18 X 13 X 11 cm. Orientation: The specimen is oriented anatomically. The cut. surface is inked blue. The specimen is received with a stitch in. the center of the cut surface, which is inked red. Capsule: focally thinned where the mass abuts over a region 4.5. X 4.5 cm near the dome; the capsule is brown and smooth. Mass: An 11.2 X 8.6 X 7.2 cm yellow/tan, poorly circumscribed. mass is present. The mass has a central scar and focal. hemorrhage. Less than 10% of the mass is necrotic. The mass. abuts but does not penetrate through the capsule. Less. than 1 mm from the blue inked surgical margin. Adjacent liver tissue: brown and grossly unremarkable without. nodularity or fibrosis. Major portal vein/ hepatic vein: not involved. Gallbladder: not present. Block summary: A1 - vascular margins, cut surface. A2 - vascular margins, capsule. A3 - mass in closest approach to blue inked surgical margin. A4 - mass in relation to capsule. A5- - - representative sections of mass. A9 - sections of grossly unremarkable liver taken away from mass. Container B is additionally labeled ""liver, Segment 4B. "" It. holds a 28.4 gram, 7.2 X 2.7 X 2.6 cm approximately wedge-shaped. piece of liver. One surface is a tan smooth serosal surface, and. the remaining two surfaces are cut parenchymal surfaces. One of. the cut surfaces is designated by the surgeon with the stitch. at the definitive margin. The definitive margin is inked blue,. and the opposite surface is inked black. Serial sectioning. reveals a tan firm parenchymal surface without masses, cysts or. other lesions. Block summary: B1-B2 - one full thickness section, bisected. B3-B4 - - one full thickness section, bisected. B5-B6 - - additional representative sections of blue inked. representative margin.",train,11 cm
6114,TCGA-DE-A4MC.FAD65DE3-2C89-4A88-AB39-6B9B9BC0954C,"Diagnosis. A: Thyroid, total thyroidectomy. Tumor histologic type: papillary. Tumor size: 2.8 cm. Tumor growth pattern: circumscribed. Tumor focality: unifocal, right superior pole. Extent of invasion: Capsular Invasion: not encapsulated. Lymphovascular: not identified. Blood vascular: not identified. Extra thyroidal extension: present (A1, A3). Surgical margins: - Not involved, focally to 1 mm of the anterior and posterior. margins of the right superior pole. Status of thyroid gland away from tumor: nodular hyperplasia. Lymph nodes: submitted separately. AJCC Stage: pT3 pN1b. NOTE: This pathologic stage assessment is based on information. available at the time of this report, and is subject to change. pending clinical review and additional information. B: Lymph node, right neck level 3, excision. - Metastatic papillary thyroid carcinoma (1/1), 7mm diameter,. without extracapsular extension. Clinical History: -year-old female with malignant thyroid neoplasm. Gross Description: Specimen A is labeled ""total right thyroid, stitch superior"". Specimen fixation: Formalin. Type of specimen: Total thyroidectomy. Size and weight of specimen: 24.4 grams, composed of a 4.8 x 2.2. X 2.3 cm right lobe, 4.2 X 1.7 X 1.7 cm left lobe, central. contiguous isthmus and a 2.2 x 0.8 X 0.5 cm pyramidal lobe. Orientation: Anterior/blue, posterior/black, and isthmus/yellow. The specimen is sectioned from superior towards inferior. Tumor location: Right superior pole. Focality: Unifocal. Dominant tumor: Yes. Tumor description: Solid white/tan with a gritty cut surface and. irregular borders. Tumor size: 2.8 X 1.9 X 1.7 cm. Confinement/non-confinement: : Appears confined to the thyroid. although it expands the right superior pole anteriorly with. focally adherent cauterized fibrous tissue. Distance of tumor to surgical margins: Focally abuts the. anterior blue inked margin and the posterior black inked margin. as well as the superior pole of the right thyroid. Appearance of thyroid gland away from tumor: Dark red/brown and. unremarkable with the exception of a 0.6 cm gelatinous cyst in. the left upper pole, lined by smooth glistening borders. The. isthmus and pyramidal lobe are grossly unremarkable. Parathyroids: Not identified. Tissue submitted for special investigations: Tumor is given to. tissue procurement. Lymph nodes: Submitted separately. Digital photograph taken: No. Block Summary: Inking: Anterior/blue, posterior/black isthmus/yellow. A1 - Perpendicular sections of right superior pole. A2 - Next section, right superior pole. A3 - Next section. A4-A5 - Inferior edge of tumor. A6 - Representative sections from pyramidal lobe. A7-A8 - - Representative sections from left lobe. Specimen B is labeled ""right neck lymph node level 3"" and is a. 1.2 X 0.9 X 0. 4 cm firm gray/tan lymph node candidate with a. small amount of attached fat and is serially sectioned to reveal. a solid tan/gray cut surface, B1,.",train,2.8 cm;2.8 X 1.9 X 1.7 cm
6158,TCGA-B8-5163.4e7cfbab-7e98-4e75-9eef-6ad8316a38f5,"Diagnosis: Right kidney, radical nephrectomy. Histologic tumor type/subtype: renal cell carcinoma, clear cell subtype; see comment. Histologic grade (if applicable): Fuhrman grade 3 of 4. Tumor size (greatest dimension): 5.5 cm. Extent of tumor invasion: Capsular invasion/perirenal adipose tissue: tumor focally invades capsule; perirenal adipose tissue is negative for. carcinoma. Gerota's fascia: negative for carcinoma. Renal vein: positive for carcinoma. Ureter: negative for carcinoma. Venous (large vessel): positive for carcinoma. Lymphatic (small vessel): positive for carcinoma. Histologic assessment of surgical margins: Perirenal adipose tissue: negative for carcinoma. Gerota' S fascia: negative for carcinoma. Renal vein: positive for carcinoma. Renal artery: negative for carcinoma. Ureter: negative for carcinoma. Adrenal gland: not present. Lymph nodes: none identified. Other significant findings: Mild glomerulosclerosis and interstitial fibrosis. AJCC Staging: pT3a. pNx. This staging information is based on information available at the time of this report, and is subject to change. pending clinical review and additional information. Comment: Immunohistochemical stains are performed and demonstrate the tumor is negative for Hales colloidal iron, CK7,. CD117, and RCC while being positive for vimentin and with equivocal staining for E-cadherin. The histologic and. immunohistochemical findings are most consistent with renal cell carcinoma, clear cell subtype. Clinical History: with a clinical diagnosis of a renal tumor. As, the patient has a large right upper pole renal mass that extends to the. left renal vein and into the inferior vena cava. Gross Description: Received is one appropriately labeled container. Specimen fixation: formalin. Type of specimen: radical. Side of specimen: right. Size and weight of specimen: The weight is 930 grams; the specimen measures 26.5 x 16.0 x 9.5 cm overall; the. kidney measures 9.2 x 6.0 X 5.0 cm. Orientation: The perirenal adipose tissue has been previously inked blue. Presence/absence of adrenal gland: absent. Tumor description/site: Anatomic site: renal cortex; upper pole; The pole varies from yellow to red to dark brown. with focal cysts and necrosis evident. The tumor is encapsulated and extends to the hilar areas and through the renal. vein. Tumor size: 5.5 x 4.7 X 4.0 cm. Presence/absence of multicentricity: absent. Confinement/non-confinement to the kidney: The tumor is predominantly confined to the cortex of the kidney and. is seen extending into and through and the lumen of the renal vein. Extent of invasion: Perirenal adipose tissue: tumor does not grossly involve. Gerota' S fascia: tumor does not grossly involve. Renal vein: positive for gross tumor. Ureter: does not grossly involve. Other organs: n/a. Surgical margins: Perirenal adipose tissue: negative, 0.5 cm at closest approach. Renal vein: positive, A portion of polypoid tumor grossly extends through the lumen and measures 2.5 X 1.5 X 1.0. cm,. Renal artery: negative, 0.3 cm at closest approach. Ureter: negative, 1.5 cm at closest approach. Description of kidney away from tumor: The remainder of the kidney appears red to tan in color with no other. lesions or masses identified; The average cortical measurement is 0.8 cm and the average medullary measurement. is 1.2 cm. Lymph nodes (hilar): none identified. Other significant findings: none. Tissue submitted for special investigations: yes. Digital photograph taken: no. Block summary: (Inking: blue=perirenal fat). Al - ureter and artery margin. A2 - tumor and perirenal fat, closest approach. A3-A7 - tumor with capsule. A8 - central tumor. A9 - tumor with overlying perirenal fat, additional section. A10-A11 - perpendicular section through tumor extension into renal vein (at hilum). A12 - hilum, en face. A13 - hilum, perpendicular sections. A14 - normal kidney and urothelium. A15 - ureter, additional. Grossing Pathologist: Light Microscopy: Light microscopic examination is performed. Appropriate internal and/or external positive and negative controls have been evaluated. Some of the. immunohistochemical reagents used in this case may be classified as analyte specific reagents (ASR). These were. developed and have performance characteristics determined by the. These reagents have not been cleared or approved by the US Food and Drug. Administration (FDA). The FDA has determined that such clearance or approval is not necessary. These tests are. used for clinical purposes. They should not be regarded as investigational or for research. This laboratory is. certified under the Clinical Laboratory Improvement Amendments of. (CLIA-88) as qualified to perform high. complexity clinical laboratory testing.",train,5.5 cm;5.5 x 4.7 X 4.0 cm;2.5 X 1.5 X 1.0. cm
6161,TCGA-BH-A0E2.29EDE507-90BA-4ABE-B3EF-559EBA4CCD56,"P.25/33. DIAGNOSIS: BREAST, RIGHT, MODIFIED RADICAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA WITH ASSOCIATED CALCIFICATIONS. B. NOTTINGHAM GRADE 3 (TUBULE FORMATION: 3, NUCLEAR PLEOMORPHISM: 3, MITOTIC ACTIVITY: 3; TOTAL. SCORE: 9/9). C. INVASIVE TUMOR MEASURES 2.5 X 2.3 X 2.0 CM. D. DUCTAL CARCINOMA IN SITU (DCIS), NUCLEAR GRADE 3, SOLID, CRIBRIFORM MICROPAPILLARY AND CLEAR. CELL TYPES WITH COMEDONECROSIS AND ASSOCIATED CALCIFICATIONS. E. THE DUCTAL CARCINOMA IN SITU (DCIS) CONSTITUTES 50% OF THE TOTAL TUMOR VOLUME AND IS. PRESENT ADMIXED WITH THE INVASIVE COMPONENT. F. THE DUCTAL CARCINOMA IN SITU (DCIS) IS PRESENT IN 12/22 SLIDES. G. NO LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. H. RESECTION MARGINS ARE NEGATIVE FOR CARCINOMA. DUCTAL CARCINOMA IN SITU (DCIS) IS 4.0 MM. FROM THE NEAREST ANTERIOR MARGIN, THE INVASIVE CARCINOMA IS GREATER THAN 1.0 CM FROM ALL. MARGINS. I. THE NIPPLE IS INVOLVED BY DUCTAL CARCINOMA IN SITU. J. SKIN IS NEGATIVE FOR TUMOR. K. NON-NEOPLASTIC BREAST: INTRADUCTAL PAPILLOMA AND FIBROCYSTIC CHANGES WITH. FIBROADENOMATOID NODULES,. L. BIOPSY SITE CHANGES WITH FAT NECROSIS. M. METASTATIC CARCINOMA INVOLVING FOUR OF TWENTY-SIX LYMPH NODES (4/26). N. THE LARGEST METASTATIC FOCUS MEASURES 2.0 CM. O. EXTRACAPSULAR EXTENSION IS IDENTIFIED AND MEASURES 1 MM. P. THE INVASIVE TUMOR CELLS TESTED POSITIVE FOR ESTROGEN AND WEAKLY POSITIVE FOR. PROGESTERONE RECEPTORS AND NEGATIVE FOR HER-2, AS PER PREVIOUS PATHOLOGY REPORT. LASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Modified radical mastectomy. Lower outer quadrant. SIZE OF TUMOR: MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: Maximum dimension invasive component: 2 5 cm. TUMOR TYPE (invasive component): NOTTINGHAM SCORE: Ductal adenocarcinoma, NOS. Nuclear grade: 3. Tubule formation: 3. Mitolic activity score: 3. Total Nottingham score: 9. Nottingham grade (1, 2, 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION;. Yes, malignant zones. TUMOR TYPE, IN SITU: Cribriform. Solid. Micropapillary. Comedo. DCIS admixed with invasive carcnoma. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Percent of tumor occupled by in situ component 50 %. SURG MARGINS INVOLVED BY IN SITU COMPONENT: PAGET'S DISEASE OF NIPPLE: Distance of in silu disease to closest margin: 40 mm. LYMPH NODES POSITIVE: 4. LYMPH NODES EXAMINED: 26. METHOD(S) OF LYMPH NODE EXAMINATION: H/E levels. SIZE OF NODAL METASTASES: Diameter of largest lymph nodo metastasis: 20 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: SKIN INVOLVED (ULCERATION): NON-NEOPLASTIC BREAST TISSUE: Papillonia, FCD, Other: Fibroadenomatoid nodules. T STAGE, PATHOLOGIC: N STAGE, PATHOLOGIC: pN2a. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTRONE RECEPTORS: positive. HER2/NEU:",train,2.5 X 2.3 X 2.0 CM;2 5 cm;4.0 MM
6217,TCGA-D6-A6EQ.E3C55935-DC6F-40F9-B529-E0D39775AD9C,"Gender: M. Examination result No. Surgery and Laryngological Oncology Dept. Clinical diagnosis (suspicion) Laryngeal carcinoma. Date of admission: Material: 1) Material: larynx. Please mark surgical margins - lower (trachea). Method of collection: Collection of. specimens for laboratory examination. Histopathological diagnosis. Invasive keratinising squamous cell carcinoma (G3) of the larynx. Incision lines free of neoplastic lesions. pT3. (8071/3 T-24100). . codes according to (CD-O-3 or SNOMED. Macroscopic description: Surgical specimen sized 9.5 x 7.0 X 3.5cm, including larynx with the hyoid bone and part of the trachea 1.5 cm in. length. Tumour found in the glottal region, sized 4.5 x 2.5 x 1.2cm invading the subglottal region, glottis, supraglottal. region, aryepiglottic fold on the left side. Results of intraoperative examination: Margins at the side of 1 wire and 2 wires (top) cancerous lesions. Final reply to be given after the analysis of paraffin specimens. Pathologist: I.",train,4.5 x 2.5 x 1.2cm
6230,TCGA-BC-A10S.A0F69833-CBDD-492D-9564-AE8FB2F9CE3B,"CLINICAL INFORMATION. The patient is with a history of hepatocellular carginomg. undergoes resection of the left liver lobe. GROSS DESCRIPTIONS. One appropriately labeled, formalin-filled, container is received. It holds a 362 gram, 13.5 x 10.5 x 5.0. cm. tan/gray liver lobe with an 8.0 x 7.5 x 5.0 intact tumor mass protruding from the surface. There is a. roughly spherical defect in the base of the specimen where tumor was given to tissue procurement. The. surgical margin has been inked black. The cut tumor surface demonstrates central regions of. yellow/orange necrosis and hemorrhage. The tumor appears well circumscribed and its closest distance. to the surgical margin is 1.2 cm. No other masses are identified in the hepatic parenchyma. Representative. sections are submitted as per block summary. BLOCK SUMMARY. 1-5 tumor. 6 - uninvolved parenchyma. 7-8 - surgical margin. LIGHT MICROSCOPY. Light microscopic examination is performed. Sections show a well circumscribed and apparently encapsulated tumor nodule composed of enlarged. hyperchromatic hepatocytes arranged predominantly in a trabecular pattern. There is both a micro-. trabecular as well as a macro-trabecular pattern. Focal pseudo-acinar structures are also. seen. There are focal areas of tumor necrosis and hemorrhage. Focal changes suspicious for. lymphovascular space invasion are observed in the capsule(section #8). There was a single nodule of. tumor without any apparent satellite lesions. The tumor appears to be well differentiated and does not. involve in the surgical margins. The adjacent liver tissue has a normal hepatitic architecture without. significant fibrosis. Steatosis was also absent. DIAGNOSIS. LIVER MASS, LEFT LOBE, PARTIAL HEPATITIC RESECTION. - HEPATOCELLULAR CARCINOMA, WELL DIFFERENTIATED, PREDOMINANTLY. TRABECULAR PATTERN, 8.0 CM IN GREATEST DIMENSION. - SURGICAL MARGINS CLEAR.",train,8.0 CM;8.0 x 7.5 x 5.0
6261,TCGA-BR-6458.f8162f79-5a2d-4b69-877b-f7e796dc57b1,STOMACH TISSUE CHECKLIST. 11. Specimen type: Subtotal gastrectomy. Tumor site: Fundus. Tumor size: 0 X 0 X 8.5 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Subserosa. Lymph nodes: 1/15 positive for metastasis (Greater and lesser. omentum 1/15). Lymphatic invasion: Not specified. Venous invasion: Absent. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.,train,0 X 0 X 8.5 cm
6346,TCGA-VR-A8ER.E984A958-58F7-42DD-9B75-51147814701B,"PRIMARY SITE: Esophagus. 1. Specimen: thoracic and abdominal esophagus and proximal stomach. Procedure: Esophagogastrectomy. Tumor site: distal esophagus and stomach. Tumor size (greatest dimension): 7,8 cm. Histologic type: Squamous cell carcinoma, ulcerated. Histologic grade: G2 moderately differentiated. Microscopic tumor extension: tumor invades mucosa, submucosa, muscularis propria. and adventitia. Lymph-vascular invasion: not identified. Perineural invasion: not identified. Margins: Proximal margin: uninvolved by carcinoma. Distal margin: uninvolved by carcinoma. Circumferential (radial margin): involved by invasive carcinoma. Regional lymph nodes from lesser curvature with conglomerate: Number examined: 08. Number positive for neoplasia: 03. 2. Lymph nodes of the hepatic artery: Number examined: 06. Number positive for neoplasia: 00. 3. Margin of the stomach: Uninvolved by carcinoma.",train,7.8 cm
6392,TCGA-A4-A7UZ.B67F4143-2D87-4682-B17B-23C6D99D02B0,"M. Path Report. ACCESSION NO. : Final Diagnosis(es): (A) Left kidney and adrenal gland, radical nephrectomy: 1) Papillary renal cell carcinoma (5.5 cm), Type 2,. Fuhrman grade 3 of 4 (see Synoptic Report). 2) Tumor focally invades renal sinus. 3) Separate tumor focus located in proximal ureter (0.7. cm). 4) Pathologic stage: pT3a N1 MX. 5) Adrenal gland with no pathologic abnormality. (B) Left adrenal gland, completion adrenalectomy: 1) Benign adrenal gland. 2) No malignancy identified. (C) Lymph nodes, para-aortic, excision: 1) Metastatic papillary renal cell carcinoma involving two. of two lymph nodes (2/2). 2) Extracapsular extension identified. (D) Lymph nodes, para-aortic, excision: 1) Metastatic papillary renal cell carcinoma involving ten of. sixteen lymph nodes (10/16). 2) Extracapsular extension identified. 3) Vascular invasion present. (E) Lymph nodes, interaortocaval, excision: 1) Metastatic papillary renal cell carcinoma involving two. of two lymph nodes (2/2). 2) Vascular invasion present. (F) Ureter, left distal, ureterectomy: Benign ureter, negative. for malignancy. Synoptic Report: Laterality: Left. Specimen Procedure: Radical nephrectomy. Tumor Site: Middle,. Tumor Size: 5.5 x 5.0 x 4.5 cm. Tumor Focality: Multifocal (kidney and ureter). Macroscopic Extent of Tumor: Limited to kidney. Histologic Type: Papiliary renal cell carcinoma. Sarcomatoid Features: Not identified. Tumor Necrosis: Present, 5%. Histologic Grade (Fuhrman Nuclear Grade): Grade 3, Type 2. Microscopic Extent of Tumor: Renal sinus, focal. Lymphvascular Invasion: Present. Margins: Ureteric: Negative. Vascular: Negative. Soft Tissue: Negative. Regional lymph nodes: Printed from. Page: 1 of 6. M. Number examined: 20. Number positive: 14. Pathologic Staging: pT3a N1 MX. Pathologic Findings in Non-Neoplastic Kidney: Mild, patchy,. interstitial, chronic inflammation. Immunohistochemistry: RCC: Positive. PAX-8: Positive. CD10: Positive. CK5: Negative. p63: Negative. Comments: The morphologic features and immunohistochemical profile. supports the diagnosis of papillary renal cell carcinoma. Although spread into the ureter is unusual for renal cell. carcinoma, the main kidney mass and tumor within the ureter. share the same immunohistochemical profile and morphologic. appearance, representing the same tumor. This case has been reviewed and the diagnosis agreed upon by. consulting departmental surgical pathology staff. The gross description and all microscopic slides have been. reviewed and interpreted by the undersigned pathologist'. Specimen(s) Receiveu. A: Left kidney and adrenal gland. B: Left adrenal gland. C: Para-aortic lymph nodes. D: Para-aortic lymph nodes. E: Part of interaorta caval. F: Distal ureter, left. Clinical History: Left kidney cancer. Intraoperative Consultation: FSA1-FSA2: Left kidney mass: Carcinoma, favor urothelial (2. blocks). FSC1-FSC2: Paraaortic lymph node: Metastatic carcinoma, favor. papillary renal cell carcinoma (2 blocks). Gross Description: (A) (left kidney and adrenal gland). Specimen components and dimensions: Received fresh for frozen. section analysis is a kidney and perinephric fat measuring 29.0. Printed from: Page: 2 of 6. M. x 23.0 x 6.0 cm. The specimen weighs 1,270 gm. The kidney. itself measures 12.0 x 6.5 x 5.0 cm. The attached adrenal gland. measures 4.5 x 1.5 x 1.0 cm. The attached ureter measures 5.5. cm in length and has an average diameter of 0.4 cm. The kidney. has been shelled out of the perinephric fat and bivalved by the. surgeon. The perinephric fat is inked black. The capsular. surface of the kidney is tan-brown. There are multiple small. white granular lesions ranging in size from 0.1 to 0.5 cm on the. surface. A portion of the tumor appears to be pushing the. capsule out and this area measures 4.5 x 3.0 x 2.6 cm. It does. not appear to be grossly invading through the capsule. Size, appearance and location of tumor: Bivalving the specimen. reveals a tan-white to pink friable mass (5.5 x 5.0 x 4.5 cm). present within the center of the kidney. There is an additional. small tan-pink nodule (0.7 x 0.5 x 0.4 cm) at the proximal. ureter. A representative section of the smaller mass is. submitted in FSA1. A representative section of the large tumor. is submitted in FSA2. Renal capsule/Renal sinus: The tumor appears to be extending. the capsule, but does not appear to grossly invade through the. capsule into the perinephric fat. The tumor appears to abut the. renal sinus; however, no gross invasion is identified. The. small mass on the ureter does not appear to grossly invade into. the ureter. Renal vein: Not clearly identified. Other findings: None. Uninvolved tissues: The adrenal gland appears golden yellow. with small punctate hemorrhage areas present. The uninvolved. renal parenchyma appears tan-brown. The medulla is tan-pink. The average cortical thickness is 0.9 cm. The uninvolved ureter. serosa is tan-pink, smooth and glistening. The uninvolved. ureter mucosa is tan-white and striated. Lymph nodes: Five potential lymph nodes are identified in the. hilum fat ranging in size from 0.4 to 1.1 cm. The larger nodes. are firm and suspicious for tumor involvement. Blocks submitted: FSA1-FSA2 - representative tumor (large mass and smaller. ureteral mass, respectively). A3 - representative shave margin of all vascular structures. identified. A4 - entire small lesion found on the ureter and cross sections. A5-A6 - representative sections of the tumor and its. relationship to the sinus fat. A7 - representative section of the tumor and its relationship to. the renal pelvis and sinus fat. A8 - representative section of the tumor and its relationship to. the uninvolved renal parenchyma. A9-A10 - representative section of the tumor and in its. relationship to the capsule where it protrudes. A11 - representative section of perinephric fat. Printed from: Page: 3 of 6. M. A12 - representative section of grossly uninvolved renal. parenchyma and uninvolved ureter. A13 - five potential lymph nodes intact. A14 - adrenal gland. (B) (left adrenal giand) Received in formalin is a portion of. adrenal gland measuring 5.5 x 3.5 x 3.5 cm. The adrenal gland. is golden yellow with red hemorrhagic tissue within the center. Serial sectioning of the adrenal gland demonstrates no grossly. identified masses. Representative sections are submitted in. cassettes B1-B3. (C) (para-aortic lymph nodes) Received fresh for frozen. section is tan-red tissue measuring 5.0x 2.5 x 2.0 cm. Three. firm lymph nodes are identified ranging in size from 1.2 to 4.0. cm. the smallest lymph node is inked black and submitted intact. along with one representative section of the middle-sized lymph. node in FSC1. A representative section of the largest lymph. node is submitted in FSC2. The remainder of the middle-sized. lymph node is serially sectioned and submitted entirely in. cassette C3. The largest lymph node is serially sectioned and. submitted in cassettes C4-C6. (D) (para-aortic lymph nodes) Received in formalin are two. fragments of tan-red fibroadipose tissue measuring 7.0 x 10.5 x. 4.0 cm. There are multiple surgical clips and sutures present. Additionally present are fragments of a vascular structure. Sixteen potential lymph nodes are identified which are firm and. rang in size from 0.4 to 6.0 cm. Blocks are submitted as. follows: D1 - representative sections of the vascular structures. identified within the specimen. D2 - six potential lymph nodes intact. D3 - three potential lymph nodes intact. D4 - one matted lymph node bisected. D5 - one potential lymph node bisected. D6-D8 - one lymph node serially sectioned. D9-D10 - one lymph node serially sectioned. D11-D14 - one lymph node serially sectioned. D15-D16 - representative sections of one lymph node. D17-D19 - representative sections of the largest lymph node. (E) (part of interaortocaval) Received in formalin is one. fragment of tan-pink fibroadipose tissue measuring 5.5 x 5.5 x. 3.0 cm. Two large firm matted lymph nodes are identified. ranging in size from 3.0 x 5.5 cm. Blocks are submitted as. follows: E1-E2 - representative sections from the smaller matted lymph. node. E3-E5 - representative sections of the larger matted lymph node. (F) (distal ureter, left) Received in formalin is a portion of. ureter measuring 5.0 cm in length and having a diameter ranging. from 0.6 to 0.5 cm. There is a stapled and suture on one end of. the ureter. This end of the ureter is inked blue. The ureter. Printed from: Page: 4 of 6. M. is serially sectioned. Blocks are submitted as follows: F1 - the inked blue margin which was the one with a staple and. suture on it as well as the opposite margin. F2 - the remainder of the specimen serially sectioned. Microscopic Description: Complete microscopic evaluation has been performed. Appropriately reacting controls have been performed and. evaluated for all stains on this case as required. Histopathology has a list of IH antibodies that are regulated as. analyte specific reagents (ASR's). These assays were developed. and their performance characteristics determined by the. They. have not been cleared by the US Food and Drug Aaministration. The FDA has determined that such clearance or approval is not. necessary for the ASR's. These tests are not investigational. and are used in standard clinical care. In cases where. Immunohistochernistry testing is performed, the following. antibodies and their respective clones may be used to determine. therapy for the patient: EFGR(3c6), ER(SP1), PR(1E2),. Her2neu(4B5), CD117(Poly) CD20(L26) Ki67(30-9). Uniess otherwise stated in the report, all tissue tested for. ERPR by IHC, Her2 by IHC and/or HER2 by FISH have been fixed as. per C.A.P. requirements for a minimum of 6 hours and a maximum. of 48 hours. ER, PR, Ki-67, p53 are reported as a semi-quantitative. percentage of positively stained nuclei. Her-2/neu and EGFR are. scored as follows: No staining at all is scored as (0), weak,. incomplete membrane staining in any proportion of cells is. scored as (1+), less than strong but complete staining in any. proportion of cells or complete strong staining in less than 30%. of cells is scored as (2+), and strong complete staining in more. that 30% of cells is scored as (3+). All studies are performed. on tissue fixed in 10% neutral buffered formalin and embedded in. paraffin unless otherwise stated in the report. Printed from: Page: 5 of 6.",train,5.5 cm;0.7. cm;5.5 x 5.0 x 4.5 cm;5.5 x 5.0 x 4.5 cm;0.7 x 0.5 x 0.4 cm
6407,TCGA-49-AAR4.8982CE18-FA5A-4882-AAC4-F2AC6ED60C49,"INTERPRETATION AND DIAGNOSIS: 1,2. LEFT UPPER LOBE AND LEFT UPPER LOBE #2: SPECIMEN TYPE: Wedge resection and completion lobectomy. TUMOR SITE: Left upper lobe. HISTOLOGIC TYPE: Adenocarcinoma, Nos. TUMOR SIZE: Greatest dimension: 3.0 cm. LOCATION, SIZE AND HISTOLOGIC TYPE OF. ADDITIONAL SEPARATE TUMOR NODULES, IF ANY. None identified. HISTOLOGIC GRADE: G2: Moderately differentiated. LYMPH NODES : Metastatic carcinoma in 2 of 17 lymph nodes (see parts 4&6). DIRECT EXTENSION OF TUMOR: Visceral pleura (supported by Movats stain). EXTENT OF INVASION. PRIMARY TUMOR: pT2: Tumor invades visceral pleura. REGIONAL LYMPH NODES: pN2: Metastasis in ipsilateral mediastinal or subcarinal lymph nodes. DISTANT METASTASIS: pMX: Cannot be assessed. MARGINS : Margins uninvolved by invasive carcinoma. VENOUS/ARTERIAL (LARGE VESSEL) INVASION: Indeterminate. LYMPHATIC (SMALL VESSEL) INVASION: Indeterminate. ADDITIONAL FINDINGS. Respiratory bronchiolitis. 3. LYMPH NODE, STATION 9 (EXCISION) : ONE (1) LYMPH NODE, NEGATIVE. FOR TUMOR. 4. LYMPH NODE, LEVEL 10 (EXCISION) : METASTATIC ADENOCARCINOMA. INVOLVING ONE (1) OF ONE (1) LYMPH NODE. 5. LYMPH NODE, LEVEL 12 (EXCISION) : ONE (1) LYMPH NODE, NEGATIVE. FOR TUMOR. 6. LYMPH NODE, L4 (DISSECTION) : METASTATIC ADENOCARCINOMA INVOLVING. ONE (1) OF FIVE (5) LYMPH NODES. 7. LYMPH NODE, LEVEL 7 (EXCISION) : ONE (1) LYMPH NODE, NEGATIVE FOR. TUMOR. 8. LYMPH NODES, L9 (DISSECTION) : TWO (2) LYMPH NODES AND ASSOCIATED. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 9. LYMPH NODE, LEVEL 5 (EXCISION) : ONE (1) LYMPH NODE, NEGATIVE FOR. TUMOR. GROSS DESCRIPTION. PART #1: FS: LEFT UPPER LOBE. Resident Pathologist: FROZEN SECTION DIAGNOSIS: Left upper lobe: Non-small cell carcinoma. The specimen is received fresh labeled. and designated. left upper lobe. It consists of a 63.7 gms, 13.5 x 5 x 4.2 cm wedge. shaped lung tissue. The margin is closed with staples. The staples. are removed and the margins are inked black. The pleural surface has a. 2.5 cm area of stellate puckering with a firm area of lung parenchyma. suspicious for tumor below it. The pleura is inked black. Upon serial. sectioning, there is a 3 x 1.7 x 1.5 cm white tan poorly circumscribed. stellate subpleural mass, that is 0.3 cm from the stapled margin. The. mass does not appear to involved the pleural surface. A representative. section of the mass is submitted for frozen section. The remaining. lung is red brown and non-crepitant. Representative sections are. submitted with approximately 80% of the tumor submitted. SUMMARY OF SECTIONS: 1. - FSC. - 1. M. - A-D. - 1. (PUCKERED PLEURA WITH SUBPLEURAL MASS). - E. - 1. (PERPENDICULAR TUMOR CLOSEST TO RESECTION. MARGIN). 2. - F-G. 1 EA. (NON-INVOLVED LUNG). 8. - -TOTAL- 8. PART #2: FS: LEFT UPPER LOBE #2. Resident Pathologist: FROZEN SECTION DIAGNOSIS: Left upper lobe #2: Bronchial margin and one (1) lymph node,. negative for tumor. The specimen is received fresh labeled. and deignated. left upper lobe #2. It consists of a 320 gms, 15 x 12 x 4 cm. completion lobectomy specimen. The lung is diffusely non-crepitant. The pleura is slightly hemorrhagic and mottled with anthracotic. pigmentation. No mass is palpated within this portion of specimen. Additionally, no pleura puckering is identified. There is a stapled. margin consistent with the area from where the initial wedge. resection was taken. There is a 1.2 cm portion of bifurcating. bronchus present which appears patent. No tumor is identified within. the lumen. A shave of this bronchi are taken. Multiple red brown. hilar lymph nodes are are identified ranging in size from 0.5 to 1.4. cm. None of these appear grossly positive. The entire pleural margin. is inked black. Upon serial sectioning, the lung has a uniform. congested red brown with focal emphysematous changes and diffuse. anthracotic pigmentation. The hilar vessels are remarkable. No. masses or lesions are identified. Representative sections are. submitted. SUMMARY OF SECTIONS : 1. - FSC - 1. 1. - A. - 3. 2. - -B-C. 1. EA. ( PERPENDICULAR OF GROSSLY NORMAL LUNG). INCLUDING MARGIN OF WEDGE RESECTION). M. -D-F. 1 EA. (ADDITIONAL LEFT UPPER LOBE LUNG). - G. - 2. (ONE POTENTIAL HILAR LYMPH NODE BISECTED). - H. - 4. (ONE POTENTIAL HILAR LYMPH NODE). - I. - 2. (ONE POTENTIAL HILAR LYMPH NODES, ? POS. BISECTED). 10. - TOTAL - 17. PART #3: STATION 9. Resident Pathologist: The specimen is received fresh labeled. and designated. station 9. It consists of one unoriented fragment of yellow, to red. brown fibrofatty tissue measuring 0.4 x 0.4 x 0.2cm. Upon dissection. two potential lymph nodes are identified with a red brown color. One. measures 4 x 0.2 x 0.2 cm. and the other lymph nodes measuring 0.2. x 0.2 x 0.2 cm. Neither lymph nodes appear grossly positive. The. specimen is submitted in its entirety. SUMMARY OF SECTIONS : 1. -A. 2. 1. -TOTAL - 2. PART #4: LEVEL 10. Resident Pathologist: The specimen is received fresh labeled. and designated. level 10. It consists of one unoriented nodular fragment of yellow red. tan fibrofatty tissue measuring 2.5 x 1.2 x 0.8 cm. Upon lymph node. dissection, one tan white to tan black lymph node is identified. The lymph node appears to have a diffuse anthracotic pigment within it. and. multiple firm nodular areas consistent with metastatic tumor. has harvested a portion of the tumor for tumor bank. The lymph. node measures 1.9 X 1.6 x 1 cm. The specimen is serially sectioned and. submitted in its entirety. SUMMARY OF SECTIONS: 1. - A. - 2. 1. - B. 2 (ONE POSITIVE LEVEL 10 NODE SERIALLY SECTIONED). 2. - -TOTAL - 4. PART #5: LEVEL 12. Resident Pathologist: The specimen is received fresh labeled. and designated. level 12. It consists of one unoriented and severely cauterized. fragment of yellow red to black fibrofatty tissue measuring 0.! 5 x 0.4. x 0.4 cm. Grossly one potential lymph node measuring 0.4 cm in. greatest dimension is identified. The specimen is submitted in its. entirety. SUMMARY OF SECTIONS. - A. - 1 (ONE POTENTIAL LEVEL 12 LYMPH NODE). - -TOTAL- - 1. PART #6: L4. Resident Pathologist: Th specimen is received fresh labeled. and designated. L4. It consists of multiple fragments of yellow tan to red brown,. black fibroadipose tissue measuring in aggregate 1.5 X 1 x 0.5 cm. Grossly, upon dissection, six potential lymph nodes are identified. measuring in size from 0.2 x 0.4 cm in greatest dimension. Multiple. lymph nodes have a black pigmentation consistent with anthracosis. However, none of the nodes appears grossly positive. The specimen is. submitted in its entirety in lens paper. SUMMARY OF SECTIONS: 1. - A. - 6 (SIX POTENTIAL L4 NODES). - TOTAL - 6. PART #7: LEVEL 7. Resident Pathologist: The specimen is received fresh labeled. and designated. level 7. It consists of one unoriented soft yellow pink tan to dark. red black fibroadipose tissue measuring 1.3 x 0.8 x 0.4 cm. Upon lymph. node dissection, one potential lymph node is identified consistent. it has a dark red black parenchyma consistent with anthracosis. The. node does not appear grossly positive. The specimen is submitted in. its entirety. SUMMARY OF SECTIONS: PART #8: L9. Resident Pathologist: The specimen is received fresh labeled. and designated. L9. It consists of a one unoriented fragment of yellow tan red to. dark red to black fibroadipose tissue measuring 1.5 x 1 x 0.4 cm. Upon dissection, one potential lymph node is identified. SUMMARY OF SECTIONS: 1. - A. - 1. (ONE NODE BISECTED). - B. - 3. (SMALLER POTENTIAL NODE AND SOFT TISSUE). 2. - TOTAL - 5. PART #9: LEVEL 5. Resident Pathologist. The specimen is received fresh labeled. and designated. level 5. It consists of one unoriented fragment of dark red brown to. black tissue measuring 1.0 x 0.5 x 0.5 cm. The potential lymph node. does not appear grossly positive. The specimen is bisected to reveal. a soft fleshy tan to red brown variegated parenchyma. The entire. specimen is submitted. SUMMARY OF SECTIONS : 1. A. - 2. 1. - TOTAL - 2. printed.",train,3.0 cm
6432,TCGA-BQ-5892.7b3d8d0a-6422-42c4-8bf2-d57a18d2d729,"Ref. Physiciam: Clinical Diagnosis & History: Left renal mass >6 cm. Specimens Submitted: 1: SP: Kidney, left, total nephrectomy. 2: SP: Lymph nodes, preaortic and para-aortic, dissection. 3: SP: Adrenal gland and suprahilar lymph node, left, excision. 4: SP: Lymph nodes, left hilar, dissection. DIAGNOSIS: 1. SP: Kidney, left, total nephrectoiny: Tumor Type: Renal cell carcinoma - Unclassified type. Angiomyolipoma, 1 cm in greatest dimension. SEE COMMENT. Fuhrman Nuclear Grade: High nuclear grade. Tumor Size: Greatest diameter is 6,5 cm. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: Not identified. Surgical Margins: Free of tumor. The renal artery exhibits moderate atherosclerotic changes with stenosis at the margin. Non-Neoplastic Kidney: Mild arterionephrosclerosis and benign simple cortical cysts (PAS stain supports). Adrenal Gland: See part 3. Lymph Nodes: See parts 2 & 4. Staging for renal cell carcinomaloncocytoma: p T1 Tumor <= 7,0 cm in greatest dimension limited to the kidney. COMMENT: The tumor exhibits predominat papillary features with focal solid and clear cell morphology Tumor cells have large. eosinophilic to clear cytoplasm and pleomorphic nuclei with open chromatin and occasional nuleoli. 8y immunostains, the tumor. was reactive with CD10 and CA-IX but negative for AE1:AE3, EMA, CK7 and racemase. Staining for TFE3 and TFEB (for. translocation renal cell carcinomas) was also negative. This overlapping morphology and immunoprofile does not allow for placing. this tumor in any of the well recognized categories and is thus deignated UNCLASSIFIED TYPE. The morphology along with the. presence of an angiomvolinoma however is cominiscent of tamors that we encountered in patients with tuberous sclerosis. This. case was reviewed at. 2. SP: Lymph nodes, preaortic and para-aortic, dissection: Lymph Nodes: Not involved. Number of nodes examined:17. Segment of benign ureter. 3, SP: Adrenal gland and suprahilar lymph node, left, excision: Benign adrenal gland and periadrenal adipose tissue. No lymph nodes identified. 4. SP: Lymph nodes, left hilar, dissection: Lymph Nodes: Not involved. Number of nodes examined:4. Some of the and ISH tests were developed and their performance characteristics were determined by the Department of Pathology They have. not been cleared or approved by the US Food and Drug Administration The FDA has determined that such clearance of approval is not necessary These tests are. hould not be regarded as investigational or for research. This latoratory is certified under the Clinical Laboratory improvement. S qualified to perform high complexity clinical laboratory testing. IATTEST THAT THE ABOVE DIAGNOSIS is BASEI UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL). AND THAT THAVE. REVIEWED AND APPROVED THIS REPORT. Special Studies: Special Stain. Comment. CA-1X. CD10. AE1:AE3. EMA. CK7. CD117. RACEMASE. IMM H&E. IMM RECUT. PAS. NEG CONT. HMB-45. A103-1. HMB-45. A103-1. IMM RECUT. NEG CONT. IMM RECUT. NEG CONT. Gross Description: 1) The specimen is rece Uney and consists of a kidney with attached ureter, renal vessels and perinephric. fat weighing 812 9 in total measuring 22 x 13 x 8 cm overall. The kidney measures 12.2 x 9 x 4 cm. The attached ureter. measures 7 cm in length and 0.6 cm in diameter. The attached renal vein measures 2 cm in length and 1 cm in diameter. The. renal vessels and ureter margins are grossly unremarkable. An adrenal gland is not identified. The kidney is inked black and. bivalved to reveal a hemorrhagic golden yellow and red tumor at mid portion measuring 6.5 x 6 x 4.5 cm. Sections through the. remainder of the kidney reveal a pink brown parenchyma, with a well-defined cortico-medullary junction. There is a second nodule. in. the lower pole measuring 1 X 0.6 x 0.6 cm showing a tan gray cut surface. The cortex measures 1 cm and the calyces appear. normal. No lymph nodes are identified in the perinephric fat. The specimen is photographed. Representative sections are. submitted for TPS and for permanent sections. Summary of sections: UM ... ureteral margin, VM- vascular margin, T- tumor, TSF tumor with sinus fat. RP  renal pelvis representative sections, K -- representative sections kidney, T2- second cortical nodule. 2). The specimen is received in formalin, labeled preaortic and para-aortic lymph nodes and consists of multiple pink tan firm. lymph nodes ranging from 0.5 to 3.8 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN -- lymph nodes, BLN -- bisected lymph nodes, QLN -- quadrisected lymph node. 3) The specimen is received fresh labeled as Left adrenal gland suprahilar lymph node' and consists of a fragmented piece of. adipose tissue measuring 9 x 7.5 x 1.5 cm, containing an adrenal gland measuring 6 x 3.5 X 1 cm The cut section of adrenal. reveals a golden yellow cortex and dark brown medulla, which is grossly unremarkable. The specimen is representatively. submitted as follows. Summary of Sections: A- adrenal, F-fat. 4). The specimen is received in formalin, labeled hilar lymph node, left and consists of four pink tan firm lymph nodes ranging. from 0.5 lo 1 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - - lymph nodes, BLN -- bisected lymph node. Summary of Sections;. Part 1: SP: Kidney, left, total nephrectomy. Block. Sect. Sito. PCs. 2. k. 2. 2. 2. 7. t. 7. 3. 12. 3. 5. tsf. 5. 1. um. 1. 1. vm. Part 2: SP: Lymph nodes, preaortic and para-aortic, dissection. Block. Sect. Site. PCs. 3. BLN. LN. 13. 4. QLN. 4. Part 3: SP: Adrenal gland and suprahilar lymph node, left, excision. Block. Sect. Site. PCs. ad. 2. 3. f. 3. Part 4: SP: Lymph nodes, left hilar, dissection. Block. Sect. Site. PCs. 1. BLN. 2. 2. LN. 3.",train,1 cm;6.5 cm;6.5 x 6 x 4.5 cm
6441,TCGA-CR-7367.5353c2cd-aa3e-4d76-9aa5-8609310c904d,"DIAGNOSIS: 1) MARGIN, LEFT ANTERIOR TONGUE, EXCISION: NEGATIVE FOR MALIGNANCY. 2) MARGIN, LEFT BASE OF TONGUE, EXCISION: NEGATIVE FOR MALIGNANCY. 3) MANDIBLE, TONGUE, SUPERIOR NECK, RADICAL RESECTION: INVASIVE. WELL-DIFFERENTIATED KERATINIZING SQUAMOUS CELL CARCINOMA, 8.5 CM IN. GREATEST EXTENT, INVOLVING THE SKIN AND FLOOR OF MOUTH WITH EROSION INTO. THE MANDIBLE AND MUCOSAL ULCERATION; PERINEURAL INVASION PRESENT,. NEGATIVE FOR DEFINITIVE LYMPHOVASCULAR. INVASION; TONSIL UNINVOLVED;. TUMOR EXTENDS TO LESS THAN 0.1 CM FROM THE SUPERIOR LATERAL RESECTION. MARGIN; HOWEVER, ALL INKED RESECTION MARGINS NEGATIVE FOR TUMOR (SEE. COMMENT). 4) LYMPH NODE, LEVEL 2 POSTERIOR, EXCISION: 7 LYMPH NODES, NEGATIVE FOR. MALIGNANCY. 5) LYMPH NODE, LEFT NECK LEVEL 2,3 EXCISION: 1 OF 6 LYMPH NODES INVOLVED. BY SQUAMOUS CELL CARCINOMA, MICROSCOPIC FOCUS PRESENT WITHIN A 1.5 CM. LYMPH NODE (NEGATIVE FOR EXTRANODAL EXTENSION). 6) LYMPH NODE, LEFT LEVEL 4, EXCISION: 8 LYMPH NODES, NEGATIVE FOR. MALIGNANCY. 7) LYMPH NODE, POSTERIOR LEVEL 3, EXCISION: 7 LYMPH NODES, NEGATIVE FOR. MALIGNANCY. 8) LYMPH NODE, LEFT NECK LEVEL 4, EXCISION: 2 LYMPH NODES, NEGATIVE FOR. MALIGNANCY. COMMENT: These findings correspond to AJCC 6th edition pathologic stage I. V A (pT4aN1M n/a). CLINICAL DATA. Clinical Features/Dx: unspecified. Operator: Operation: unspecified. Operative Findings: unspecified. Operative Diagnosis: unspecified. Tissue Submitted: 1) left anterior tongue margin, 2) left base of. tongue margin, 3) left composite. jaw-neck-tongue, 4) level 2 posterior, 5) left. neck levels 2-3, 6) left neck level 4, 7). posterior level 3, 8) left neck level 4 lymph. nodes. GROSS DESCRIPTION: 1) SOURCE: Left Anterior Tongue Margin. The specimen labeled, ""left anterior tongue margin,"" is received fresh. and is comprised of a 0.2 X 0.1 X 0.1 cm piece of mucosal tissue. The. specimen is entirely submitted for frozen section. Summary of sections: 1AFSC, entirely submitted, 1/1. 2) SOURCE: Left Base of Tongue Margin. The specimen labeled, ""left base of tongue margin,"" is received fresh. and is comprised of a 2.8 X 1.0 X 0.4 cm strip of mucosal tissue with. underlying soft tissues. The specimen is submitted entirely for frozen. section. Summary of sections: 2AFSC, entirely submitted, 1/1. 3) SOURCE: Left Composite, Jaw-Neck-Tongue. The specimen labeled, ""left composite resection, tongue, jaw, neck,"" is. received fresh and is comprised of a mandibular resection extending from. the right mandible anterior to the mental foramen, to the left angle of. the mandible. Attached is the base of the tongue, floor of mouth, and a. significant portion of soft tissue from the left anterior lateral. chin/superior neck. The left tonsil is attached. The specimen measures. 11.0 cm superficial to deep (anterior to posterior), 10.0 cm superior to. inferior, and 6.5 cm medial to lateral. The overlying skin is pink-tan,. hair-bearing, and possesses an ulcerated mass, measuring 8.5 X 5.8. surface centimeters. The specimen is inked as follows on the resection. surfaces: anterior-yellow, posterior-green, superior-red,. inferior-black, lateral-blue, medial-orange. The left palatal tonsil is. present attached to the specimen, and measures 2.6 X 1.3 X 2.2 cm. The. specimen is sectioned to show the mass lesion extending deep into the. specimen to a depth of 5.5 cm and is comprised of a soft, white-tan. parenchyma with an infiltrative border. This process surrounds and. apparently invades the mandibular bone. The process comes within 0.3 cm. of the lateral superior resection margin (blue). The tonsil is appears. free of this process. A portion of the tumor is retained for research. purposes. Representative tumor is retained in RPMI, glutaraldehyde, and. frozen at - -80 degrees for possible future studies. Representative. sections are submitted. Appropriate sections are decalcified. Summary of sections: 3A, anterior medial bony margin en face, 1/1; 3B,. posterior bony margin en face, 1/1; 3C, lateral margin, 2/1; 3D,. inferior margin, 1/1; 3E, inferior margin, 1/1; 3F, deep margin, 2/1;. 3G, medial margin, 2/1; 3H, superior margin, 1/1; 3I, tonsillar margin,. 1/1; 3J, anterior (superficial) margin, 2/1; 3K, possible hypoglossal. nerve margin versus tendon, 1/1; 3L, floor of mouth (red ink in floor of. mouth is not true margin, red ink on tongue muscle is true margin), 1/1;. 3M-N, mandibular involvement, 2/2; 30, skin, 1/1; 3P, tonsil, 1/1; 3Q,. representative sections, 2/1. 4) SOURCE: Level 2 Posterior. Received fresh is a 3.5 X 2.5 X 1.3 cm portion of partially. circumscribed, yellow-tan, lobular, adipose tissue with a nodularity. noted on palpation. The dissected lymph nodes range in size from 0.4 cm. up to the largest, 1.1 cm in greatest length. The lymph nodes are. submitted in total. Summary of sections: 4A, two lymph nodes, each bisected, 4/1; 4B, three. lymph nodes, one bisected, 4/1. 5) SOURCE: Left Neck Level 2, 3. Received fresh labeled, ""left neck level 2, 3,"" is a 4.5 X 2.5 X 1.8 cm. portion of yellow-tar fibrofatty tissue, with a nodularity noted on. palpation. The specimen is dissected for lymph nodes. The dissected. lymph nodes range in size from 1.4 cm in greatest dimension up to 3.0 cm. in greatest dimension. The lymph nodes are submitted entirely. Summary of sections: 5A, two lymph nodes, each bisected, 4/1; 5B, one. lymph node, bisected, 2/1; 5C-D, one lymph node, bisected, 1/1 each. 6) SOURCE: Left Level 4. Received fresh labeled, ""left level 4,"" is a 5.0 X 4.0 X 1.4 cm portion. of partially circumscribed, yellow-gray, fibrofatty tissue, with a. nodularity noted on palpation. The dissected lymph nodes range from 0.3. cm up to the largest, 1.4 cm in greatest dimension. The lymph nodes are. submitted. Summary of sections: 6A, three lymph nodes, two bisected, 5/1; 6B, three. lymph nodes, two bisected, 5/1; 6C, four lymph nodes, 4/1. 7) SOURCE: Posterior Level 3. Received fresh labeled, ""posterior level 3,"" is a 3.0 X 3.0 X 1.2 cm. portion of partially circumscribed, yellow-tan, lobular, fibrofatty. tissue, with a nodularity noted on palpation. The dissected lymph nodes. range in size from 0.3 to 0.6 cm in greatest dimension. The lymph nodes. are submitted. Summary of sections: 7A, four lymph nodes, 4/1; 7B, three lymph nodes,. 3/1. 8) SOURCE: Left Neck Level 4 Lymph node. Received fresh labeled, ""left neck level 4 lymph node,"" is a 3.5 X 2.0 X. 1.2 cm portion of partially circumscribed, yellow-tan, lobular, adipose. tissue, with a nodularity noted on palpation. Serial sectioning shows a. red-brown cut surface, grossly consistent with a portion of muscle, and. a single lymph node, 2.0 X 1.2 X 1.0 cm. The lymph node is bisected and. submitted in total. Summary of sections: 8A, 2/1. 2. Slides and report reviewed by Attending Pathologist. SURGICAL PATHOLOGY INTRAOPERATIVE CONSULTATION. 1) SOURCE: Left Anterior Tongue Margin. FROZEN SECTION DIAGNOSIS: BENIGN. 2) SOURCE: Left Base of Tongue Margin. FROZEN SECTION DIAGNOSIS: BENIGN. The following special studies were performed on this case and the. interpretation is incorporated in the diagnostic report above: 1xDECALCIFICATION. SNOMED: T-51000,T-51000,M-80703,.",train,8.5 CM
6451,TCGA-BH-A1F5.F70DE761-F081-4F4C-AD22-9A166CF78CA8,"PATIENT HISTORY: The patient is a. -old female. Date of last menstrual period: Not given. PRE OP DIAGNOSIS: Breast cancer. POST OP DIAGNOSIS: Same. PROCEDURE: Right sentinel node biopsy, right segmental mastectomy. FINAL DIAGNOSIS: PART 1: RIGHT SENTINEL LYMPH NODE #1, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR TUMOR (0/1). PART 2: RIGHT NON-SENTINEL LYMPH NODE #2, BIOPSY -. FIBROADIPOSE TISSUE, NO LYMPH NODE IDENTIFIED. PART 3: RIGHT NON-SENTINEL LYMPH NODE #1, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR TUMOR (0/1). PART 4: RIGHT NON-SENTINEL LYMPH NODE #3, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR TUMOR (0/1). PART 5: RIGHT SENTINEL LYMPH NODE #2, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR TUMOR (0/1). PART 6: RIGHT SENTINEL LYMPH NODE #3, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR TUMOR (0/1). PART 7: RIGHT BREAST, BIOPSIES X4-. A. ONE OUT OF 4 LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA (1/4). B. BENIGN FIBROADIPOSE TISSUE (see comment). PART 8: RIGHT BREAST, SEGMENTAL MASTECTOMY -. A. INFILTRATING DUCT CARCINOMA. 1.4 CM IN GREATEST DIMENSION AS MEASURED ON THE SLIDE,. NOTTINGHAM SCORE 7/9 (TUBULES 3, NUCLEI 3, MITOSIS 1) ASSOCIATED WITH MICROCALCIFICATIONS. B. LYMPHOVASCULAR INVASION IDENTIFIED. C. DUCTAL CARCINOMA IN SITU, SOLID AND CRIBRIFORM TYPE, NUCLEAR GRADE 2 ASSOCIATED WITH. MICROCALCIFICATIONS AND COMPRISING LESS THAN 5% OF TUMOR. D. SURGICAL MARGINS NEGATIVE. E. INFILTRATING DUCT CARCINOMA APPROACHES ANTERIOR MARGIN WITHIN 0.3 CM. F. CHANGES CONSISTENT WITH PREVIOUS CORE BIOPSY SITE. G. TUMOR IS ESTROGEN RECEPTOR POSITIVE, PROGESTERONE RECEPTOR POSITIVE AND HER-2/NEU. NEGATIVE AS PER PREVIOUS CORE BIOPSY REPORT. H. UNREMARKABLE SKIN. I. FIBROCYSTIC CHANGES. COMMENT: One lymph node in specimen number 7 contains micrometastatic carcinoma that measures less than 0.2 cm in diameter.",train,1.4 CM
6473,TCGA-D1-A17R.51598364-A609-4EBC-8500-53042C9E79E9,"DIAGNOSIS: A. Uterus, bilateral ovaries, and fallopian tubes;. hysterectomy. and bilateral salpingo-oophorectomy: FIGO grade II (of. III). endometrial adenocarcinoma, endometrioid type, is. identified forming. a mass (4.4 x 3.9 x 1.2 cm), located in the posterior. uterine wall. The tumor invades 0.1 cm into the myometrium (total wall. thickness. 2.2 cm) . The tumor does not involve the endocervix or. cervix. Lymphovascular space invasion is not identified. The. margins are. negative for tumor. The cervix, bilateral ovaries,. fallopian tubes. and appendix are unremarkable. [AJCCpT1bNOMX]. B. Lymph nodes, right pelvic, biopsy: Multiple (5) right. pelvic. lymph nodes are negative for tumor. C. Lymph nodes, left pelvic, biopsy: Multiple (6) left. pelvic. lymph nodes are negative for tumor. This final pathology report is based on the. ross/macroscopic. examination and frozen section histologic evaluation of. the. specimen (s) . GROSS DESCRIPTION: A. Received fresh labeled ""uterus, bilateral fallopian. tubes and. ovaries"" is a 190.0 gram uterus with attached bilateral. tubes and. ovaries and an unremarkable cervix. The uterine serosa is. smooth. There is a 4.4 x 3.9 x 1.2 cm polypoid mass in the fundus. of the. endometrial cavity with 2.2 cm myometrial thickness. There are no. leiomyomas. There is a 3.0 x 2.0 x 1.2 cm right ovary. with a smooth. outer surface and a solid cut surface with a 7.0 x 0.8 cm. right. fallopian tube. There is a 4.2 x 2.8 x 1.7 cm left ovary. with a. ragged outer surface and cystic. There is a solid cut. surface with. a 6.5 x 0.8 cm left fallopian tube. Representative. sections are. submitted. B. Received fresh labeled ""right pelvic lymph nodes"" is a. 10.0 x. 7.0 X 2.0 cm aggregate of adipose and lymphatic tissue. All. lymphatic tissue submitted. C. Received fresh labeled ""left pelvic lymph nodes"" is a. 6.0 x 4.0. X. 0.9 cm aggregate of adipose and lymphatic tissue. All. lymphatic. tissue submitted. BLOCK SUMMARY. Part A: Uterus, bilateral fallopian tubes and ovaries. 1 Endometrial mass 1. 2 Endometrial mass 2. 3 Endometrial mass 3. 4 Endometrial mass. 4. 5 Lt tube and ovary. 6 Rt tube and ovary. 7 Lower uterine segment. 8 Cervix 6:00. 9 Endometrial mass 5. Part B: Right Pelvic Lymph Nodes. 1 Rt pelvic LNs- - 1 (B1). 2 Rt pelvic LNs - 1 (B2). 3 Rt pelvic LNs - lof2 (B3). 4 Rt pelvic LNs-2of2 - (B3). 5 Rt pelvic LNs-2(B4). Part C: Left Pelvic Lymph Nodes. 1 Lt pelvic LN5 (C1). 2 Lt pelvic LN5 (C2). 3 Lt pelvic LN2 (C3). 4 Lt pelvic LN2 (C4). 5 Lt pelvic LN1 (C5).",train,4.4 x 3.9 x 1.2 cm
6504,TCGA-QR-A703.0702773F-DD32-4CC2-A20C-EDC9877A6673,"DIAGNOSIS: Right adrenal mass (excision): Pheochromocytoma with areas. suggestive of diverged differentiation. NOTE: Immunohistochemistry studies were performed and were positive for. Chromogranin, Synaptophysin and S-100 and negative for C-Kit and NFTP. The case was reviewed by. The immunoperoxidase tests performed here were developed and their. performance characteristics determined by the Specialized Diagnostics. Unit of the Laboratory of Pathology, They have not been cleared or. approved by the U.S. Food and Drug Administration. The FDA has also. determined that such clearance or approval is not necessary: This. laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (CLIA) as qualified to perform high complexity. clinical laboratory testing. CLINICAL INFORMATION: Brief Clinical History: pt with VHL Requestor. Requestor Phone/Pager: Specimen Taken For. Protocol: 01 - Yes. Allocate Order to Protocol: PROCEDURE: Operative Findings: Large right renal mass Post-Operative. Diagnosis: pheochromocytoma Pre-Operative Diagnosis: Pheochromocytoma. SPECIMENS SUBMITTED: 1. ADRENAL MASS, RIGHT. GROSS DESCRIPTION: Received is a single formalin filled container. labeled with the patient's name, medical record number and ""right. adrenal mass"". The specimen consists of an 8.7 x 6.1 X 3.6 cm red/brown. nodular piece of tissue with a ribbon of golden-appearing tissue. measuring 2.2 X 0.4 cm, grossly consistent with normal adrenal. The. specimen weighs 90.5 grams. Further examination of the specimen reveals. that the main tumor mass is 6.7 x 6.0 x 3.5 cm with an additional rim of. tissue grossly resembling normal adrenal measuring 7.2 cm in length x. 0.6 cm. The external surface is entirely inked in black and the. specimen is bisected to reveal a variegated brown, tan and yellow cut. surface with area of deep red measuring 2.8 cm in greatest dimensions. Central portions of the tumor measuring 5.0 x 3.0 X 1.0 cm in aggregate. are procured for. A central portion of tumor, measuring. 1.5 X 0.5 x 0.3 cm, is procured for. Small sections of grossly. normal-appearing adrenal measuring 0.6 x 0.3 x 0.3 cm are procured for. for. The procurement was done by. on. , the specimen is received as noted above. and representative sections are submitted in white cassettes for. permanent processing as follows: Conficential Patient Information, Unanthorized IS by th: I Privacy Act or. Do not file in Medical Record. tumor with capsule. tumor with relation to normal. normal,. area of hemorrhage and firm white area. Gross dictated by. No consultants. #. #. Paticat Information, Unauthorized disclosure is prohibitad or the Privaci Act of 1979. Do not file in Medical Record.",train,6.7 x 6.0 x 3.5 cm;5.0 x 3.0 X 1.0 cm;1.5 X 0.5 x 0.3 cm
6516,TCGA-DJ-A13M.F7271934-A7FC-4BF5-A45A-5296AD308007,"Clinical Diagnosis & History: year old female with left thyroid mass, FNA consistent with atypical cells. Specimens Submitted: 1: SP: Thyroid, Total thyroidectomy. 2: SP: Delphine node. DIAGNOSIS: 1. SP: Thyroid, Total thyroidectomy: Tumor Type: Papillary carcinoma, follicular variant. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Left lobe. Tumor Size: Greatest diameter is 2.0 cm. Tumor Encapsulation: Completely surrounded. Capsular Invasion: Focal invasion. Single focus of capsular invasion. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Tumor Multicentricity: Separate focus of papillary microcarcinoma, encapsulated, non-invasive in right lobe (0.7 cm). Non-Neoplastic Thyroid: Bjing.Typer. Clinical Diagnosis & History: year old female with left thyroid mass, FNA consistent with atypical cells. this. Specimens Submitted: 1: SP: Thyroid, Total thyroidectomy. 2: SP: Delphine node. DIAGNOSIS: 1. SP: Thyroid, Total thyroidectomy: Tumor Type: Papillary carcinoma, follicular variant. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Left lobe. Tumor Size: Greatest diameter is 2.0 cm. Tumor Encapsulation: Completely surrounded. Capsular Invasion: Focal invasion. Single focus of capsular invasion. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Tumor Multicentricity: Separate focus of papillary microcarcinoma, encapsulated, non-invasive in right lobe (0.7 cm). Non-Neoplastic Thyroid: Exhibits noduler hyperpiasia. Parathyroid Glands: Not identified. - Four benign lymph nodes (0/4). 2. SP: Lymph node, Delphine; Excision: -One benign lymph node (0/1). IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL). AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The is received fresh, labeled ""Total thyroid"" and consists of a thyroid weighing 24 g. The right external lobe measures surface is 5,5 x. specimen the left lobe measures 4.3 x 2.3 x 2.3 cm and the isthmus measures 2.0 x 2.0 x 1.0 cm. The inked blue. 2.0 x 2.0 cm, thin fibrous capsule. The posterior surface of the specimen is inked black, and the anterior identified is in the. covered by reveals a a 1.5 x 1.1 x 1.0 cm yellow tinged fluid filled cyst with a 1.2 cm papillary excrescence, nodules identified right in the lobe. The cyst Sectioning through the remaining tissue reveals a 2,0 x 2.0 x 1.4 cm encapsulated yellow-tan tumor sections. Sectioning wall lining is white and trabecular. There are two 0.3 cm in greatest dimension white-tan firm in the left lobe. right lobe. the anterior and posterior capsule. The remaining thyroid parenchyma is red tan and beefy. Representative sectioned and entirely of. abutting the specimen are submitted for TPS, and a photograph has been taken. The remaining tissue is serially. submitted. Summary of sections: C-- cyst. T-left lobe tumor. RN--right lobe nodules. RL right lobe. LL left lobe. I - isthmus. 2). The specimen is received fresh, labeled ""Delphine node"" and consists of yellow-pink portion of soft tissue measuring 0.5 x 0.3 x. 0.1 cm. The specimen is entirely submitted. Summary of sections: U-undesignated. Summary of Sections: Part. 1: SP: Thyroid, Total thyroidectomy. Block. Sect. Site. PCs. 4. C. 5. 3. I. 4. 6. LL. 8. 7. RL. 13. 2. RN. 4. 4. 6. Part 2: SP: Delphine node. Block. Sect. Site. PCs.",train,2.0 cm;0.7 cm;2.0 cm;0.7 cm;2.0 x 2.0 x 1.4 cm
6532,TCGA-E9-A1N9.39D6D1DE-2CAE-470F-836B-926242F46E67,BREAST TISSUE CHECKLIST. Specimen type: Radical mastectomy. Specimen size: Not specified. Tumor site: Breast. Tumor size: 3.2 X 2.5 X 1.5 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal and lobular carcinoma. Histologic grade: Tumor extent: Not specified. Lymph nodes: 0/8 positive for metastasis (Regional 0/8). Right) lower. Extracapsular invasion of the lymph nodes: Not specified. outer. Margins: Not specified. quasrant. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.,train,3.2 X 2.5 X 1.5 cm
6580,TCGA-BA-6873.9a6d5caf-f8b1-4db8-8b85-e36153b21bad,"Diagnosis: A: Tongue base mucosa, biopsy. - No tumor seen. B: Posterior ventral tongue, biopsy. - No tumor seen. C: Lower mouth mucosa, biopsy. - No tumor seen. D: Base of tongue B, biopsy. - No tumor seen. E: Midline ventral tongue mucosa, biopsy. - No tumor seen. F: Lymph node, left neck Level 1, biopsy. - Metastatic squamous cell carcinoma in 1 of 9 lymph nodes. (1/9) ; maximum size of metastasis 1.0 cm; extracapsular. extension identified. - Benign salivary gland tissue present. G: Lymph node, left neck Level 2, biopsy. - Metastatic squamous cell carcinoma in 1 of 2 lymph nodes. (1/2) ; maximum size of metastasis 0.9 cm; extracapsular. extension identified. H: Lymph node, left neck Level 3, biopsy. Metastatic squamous cell carcinoma in 1 of 37 lymph nodes. (1/37) ; maximum size of metastasis 0.2 cm; negative for definite. extracapsular extension. I: Tongue, left hemiglossectomy. Tumor histologic type/subtype: invasive moderately. differentiated keratinizing squamous cell carcinoma. Primary site: tongue. Size: 5.4 cm by gross examination. Extent of invasion: Angiolymphatic invasion present. Perineural Invasion: present. Bone invasion: not applicable. Carcinoma in situ : not identified. Surgical Margins: All surgical margins negative for definite. involvement by carcinoma; the anterior tip is close but negative. for definite carcinoma (see comment) . Lymph nodes: Total lymph node count for all specimens is 3 of 48. involved by metastatic squamous cell carcinoma, separately. submitted in specimens F, G and H. Size of largest metastasis: 1.0 cm. Extra-capsular extension: focally present in specimens F and G. Other significant findings: The carcinoma is deeply invasive. into the skeletal muscle within the hemiglossectomy The tumor. extends far anteriorly, very close to the anterior tip. In the. anterior tip, the carcinoma is present beneath an intact surface. squamous mucosa. AJCC PATHOLOGIC TNM STAGE: pT4a pN2b. NOTE: This pathologic stage assessment is based on information. available at the time of this report, and is subject to change. pending clinical review and additional information. Comment: The frozen section diagnoses are confirmed. The surgical resection margins are free of definite involvement. by tumor. The tumor does extend deeply into the muscle of the. hemiglossectomy specimen and extends far anteriorly. An anterior. tip section was taken and submitted en face initially which. revealed a focus of submucosal invasive squamous cell carcinoma. This section is subsequently bisected and submitted as. perpendicular sections revealing the invasive carcinoma to be. present beneath an intact anterior surface squamous mucosa. The. inked true margins in the anterior tip section are negative for. definite tumor. Intraoperative Consult Diagnosis : A frozen section was requested by. FSA1 : Tongue base mucosa, biopsy. - Chronic inflammatory infiltrate. No tumor seen. FSB1 : Posterior ventral tongue, biopsy. - No tumor seen. FSC1: Lower mouth mucosa, biopsy. - No tumor seen. FSD1: Base of tongue, B, biopsy. - No tumor seen. FSE1: Midline ventral tongue mucosa, biopsy. - No tumor seen. Frozen Section Pathologist: MD. Clinical History: with left sided tongue lesion; biopsy showed. moderately differentiated squamous cell carcinoma. Gross Description: Received are nine appropriately labeled containers. Containers. A-E are received fresh for frozen section. Container A holds a 1 X 0.4 X 0.4 cm red/tan soft tissue. fragment; block FSA1, NTR. Container B holds a 0. 0.5 X 0.3 cm red/tan soft tissue. fragment; block FSB1,. Container C holds a 0. 0.3 X 0.3 cm red/tan soft tissue. fragment; block FSC1,. Container D holds a 0. 0.3 X 0.3 cm red/tan soft tissue. fragment; block FSD1,. Container E holds a 1. 0.3 X 0.3 cm red/tan soft tissue. fragment; block FSE1,. Container F is additionally labeled ""left neck, Level 1."" It. holds an 8.3 X 6.1 X 2.0 cm unoriented aggregate of brown/tan. fibroadipose tissue. There is 10.7 gram (4.9 X 2.9 X 1.7 cm). gland. The outside surface is inked entirely in blue. Nine lymph node candidates, ranging in size from 3.4 X 1.9 X 1.1. cm to 0.5 X 0.4 X 0.2 cm are identified. The largest node on. sectioning is white and firm with areas of hemorrhage. The. submandibular gland on sectioning is tan and lobulated. Block summary: F1 - largest node, representative sections. F2 - largest node, representative sections. F3, F4 - second largest node, serially sectioned and entirely. submitted. F5 - one lymph node, bisected. F6 - three lymph node candidates. F7 - three lymph node candidates. F8 - submandibular gland, representative sections. F9 - submandibular gland, representative sections. Container G is additionally labeled ""left neck, Level 2."" It. holds a 5.0 X 4.6 X 2.0 cm aggregate of brown/tan fibrofatty. tissue. There are three lymph node candidates palpated ranging. in size from 2.1 X 1.1 X 1.0 cm to 0.5 X 0.2 X 0.2 cm. On. sectioning the largest node has a white/tan firm area. On. sectioning, the second largest node is homogeneously pink/tan. Block summary: G1 - largest node, representative sections. G2 - second largest node, serially sectioned. G3 - second largest node, serially sectioned. G4 - smallest node. Container H is additionally labeled ""left neck Level 3.' It. holds a 9.3 X 4.5 X 2.0 cm aggregate of brown/ tan fibrofatty. tissue. The are twenty lymph node candidates palpated ranging in. size from 2.8 X 1.9 X 0.7 cm to 0.3 X 0.3 X 0.3 cm. On. sectioning, the largest node is hemorrhagic. Block summary: H1, H2 - largest node, serially sectioned, entirely submitted. H3 - second largest node, bisected and entirely submitted. H4 - three lymph node candidates. H5 - three lymph node candidates. H6. - three lymph node candidates. H7 - four lymph node candidates. H8 - five lymph node candidates. Container I is additionally labeled ""left hemiglossectomy, long. stitch/lateral, short/anterior. "" It holds a 6.5 X 3.6 X 3.0 cm. segment of tongue with long stitch designating lateral and short. stitch designating anterior. The inking scheme is blue=lateral,. green=medial, black=deep. The surface of the tongue is patchy,. white with areas of firm micronodularity measuring 4.5 X 2.5 cm. in the lateral anterior segment. The remaining surface is. unremarkable. On sectioning, the tumor occupies approximately. 70% of the total specimen. The tumor is white/tan and firm with. areas of hemorrhage. The tumor is 2.5 cm medial to lateral, 2.1. cm from the tongue surface to deep margin, 5.4 cm anterior to. posterior. The tumor grossly extends to the blue inked surface. which is representative of ulcerated tumor at the mucosal. surface and not a true margin, and also extends close to the. black inked deep margin. The tumor extends to within 0.4 cm of. the closest green inked medial margin. The tumor extensively. involves the lateral mucosal surface with extensive ulceration. The tumor is white-tan and firm and extends far into the. anterior aspect of the specimen, very close to the anterior tip. of the resection specimen. The remaining uninvolved tongue is. tan-brown with a whorled muscular appearance. Block summary: Il - anterior tip, initially submitted en face, subsequently. bisected as perpendicular margin specimen. I2 - posterior tip, en face. I3 - representative sections of tumor with all margins. I4 - tumor with closest green inked medial margin. I5 - tumor with closest blue inked lateral margin. I6 - tumor with closest black inked deep margin. I7 - mass with closest overlying tongue surface.",train,5.4 cm;2.5 cm;2.1. cm;5.4 cm
6595,TCGA-CM-6675.5dbfd78d-0f01-401c-8e64-934db33a89da,"Clinical Diagnosis & History: RLQ tenderness, CT scan revealed mass at hepatic flexure at colon and mass. at segment 7. Colonoscopy revealed mass of colon. Biopsy shown increased. lymphoplasmacytic infiltration at lamina propria. Carcinoma of hepatic. flexure with liver mass. Specimens Submitted: 1: Lymph node, base of superior mesentery artery, excision. 2: Lymph node, middle colic, excision. 3: Colon, right, nemi-colectomy. DIAGNOSIS: 1. Lymph node, base of superior mesentery artery, excision. -Metastatic moderately differentiated adenocarcinoma in one of two lymph. nodes (1/2). 2. Lymph node, middle colic, excision. -One benign lymph node (0/1). 3. Colon, right, hemi-colectomy: Tumor Type: Adenocarcinoma. Histologic Grade: Moderately differentiated. Tumor Location: Cecum. Tumor Size: Length is 8 cm. Width is 6 cm. Maximal thickness is 1.8 cm. Tumor Budding: Extensive. Increased Tumor Infiltrating Lymphocytes: Absent. Precursor Lesions: Not identified. Deepest Tumor Invasion: Subserosal adipose tissue and/or mesenteric fat. Gross Tumor Perforation: Not identified. Lymphovascular Invasion: Identified. Large Venous Invasion: Not Identified. Perineural Invasion: Identified. Surgical Margins: Free of tumor. Polyps/Mucosa Dysplasia (away from the carcinoma) : Not Identified. Non-Neoplastic Bowel: Unremarkable. Appendix: Not identified. Lymph Nodes: Number with metastasis: 12. Total number examined: 72. Tumor deposits in pericolorectal soft tissue: Identified. Identified; number:1. Tumor Staging (AJCC 7th Edition) : pT3 (Tumor invades through the muscularis propria into. pericolorectal tissues). Lymph Node Stage (AJCC 7th Edition) : N2b (Metastasis in seven or more regional lymph nodes). Note: Results of immunohistochemical staining for DNA mismatch repair. proteins are as follows: MLH1 Staining present in tumor. MSH2: Staining present in tumor. MSH6: Staining present in tumor. PMS2: Staining present in tumor. Conclusion:Immunohistochemical staining for the tested DNA mismatch repair. proteins is retained in the tumor. Some of the immunohistochemistry and ISH tests were developed and their. performance characteristics were determined by the Department of Pathology. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is. not necessary. These tests are used for clinical purposes. They should not. be regarded as investigational or for research. This laboratory is certified. under the Clinical Laboratory Improvement Amendments of. (CLIA -. as. qualified to perform high complexity clinical laboratory testing. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) , AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1. The specimen is received fresh for frozen section labeled ""base of. superior mesenteric artery lymph node"" are two lymph nodes each measure 0.5. cm greatest dimension. The lymph nodes are entirely submitted for frozen. section. Summary of sections: FSC-frozen section control. D. 2. The specimen is received fresh for frozen section labeled ""middle colic. lymph node"" is a 1.0 cm lymph node. The lymph node is bisected and entirely. summit of the frozen section. Summary of sections: FSC-frozen section control. 3) The specimen is received fresh, labeled ""Right hemi-colectomy"" and. consists of a segment of terminal ileum, cecum and ascending colon. The. terminal ileum measures 14 cm in length and 3 cm in circumference at the. proximal resected margin. The remaining colon measures 40 in length with a. circumference of 6 cm at the distal resected margin. The appendix is not. present. The intestinal serosa is pink tan and smooth. Focally hemorrhagic. lobulated yellow tan adipose tissue spans the length of the specimen. measuring up to 5 cm in thickness. The specimen is opened to reveal a. circumferential mass lesion measuring 6 cm in length and 8 cm in width. The. mass is located in the cecum, 23 cm from the proximal margin and 15 cm from. the distal margin. Sectioning shows that the tumor invades the fat. The. depth of invasion is 1.8 cm grossly. Right underneath the mass is a 4 x 2.5. x 2 cm conglomerate of five nodules with yellow/white cut surface (distance. from tumor surface to the deepest portion of the conglomerate is 4.8 cm). The remaining mucosa is unremarkable. The specimen is submitted for lymph. node dissection. The attached adipose tissue is thoroughly examined and all. identified lymph nodes are submitted. Representative sections of the. specimen are submitted for permanent sections and for TPS. Summary of sections: P - proximal margin shave. D - distal margin shave. T - tumor. RS representative sections. LN - lymph nodes. BLN - bisected lymph nodes. C - conglomerate of 5 nodes, representative section. Summary of Sections: Part 1: Lymph node, base of superior mesentery artery, excision. Block. Sect. Site. PCs. 1. FSC. 1. Part 2: Lymph node, middle colic, excision. Block. Sect. Site. PCs. 1. fsc. 1. Part 3: Colon, right, hemi-colectomy. Block. Sect. Site. PCs. 5. BLN. 5. 1. C. 1. 1. D. 1. 10. LN. 20. 1. P. 1. 1. RS. 1. 6. T. 6. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1. Frozen Section Diagnosis: Base of superior mesentery artery lymph node. Positive for metastatic adenocarcinoma. Permanent Diagnosis: SAME. 2. Frozen Section Diagnosis: Middle colic lymph node. Benign. Permanent Diagnosis: SAME.",train,8 cm;6 cm;1.8 cm
6606,TCGA-QT-A5XM.43F2E29C-B8D4-41D5-9B3E-B36F1A2CF1D8,"Diagnosis : A: Adrenal gland, left, robotic laparoscopic adrenalectomy. Histologic tumor type: Pheochromocytoma. Tumor size (greatest dimension) : 3.4 cm, gross measurement. Tumor gland weight: Estimated 18 g (estimated, see comment). Specimen integrity: Disrupted. Specimen size: 119 g, 13 X 7 X 4 cm. Specimen laterality: Left. Invasive properties: Capsule: Not identified. Extra-adrenal tissues: Not identified. Lymphovascular: Not identified. Blood vascular: Not identified. Histologic assessment of surgical margins : Not involved by tumor. Status of adrenal gland away from tumor: Unremarkable. Lymph nodes: Number of lymph nodes involved: N/A. Number of lymph nodes examined: 0. Comment: Immunohistochemical staining for Ki-67 - revealed a labelling. index of <1%. Tumor gland mass is estimated. Precise measurement was not. possible without disrupting margins. Estimated tumor mass is. approximately 7 g. Clinical History. year-old male with an adrenal mass. Per. he has a 3.5. cm mass in the left adrenal gland. Urine and serum metanephrines. are both elevated, consistent with a clinical diagnosis of. pheochromocytoma. Gross Description: Received is one appropriately labeled container, additionally. labeled ""adrenals.'. Specimen fixation: formalin. Type of specimen: adrenalectomy. Size and weight of specimen: Overall: 119.4 grams, 13 X 7 X 4. cm; Adrenal gland 7.6 X 4.0 X 1.8 cm. The adrenal represents. approximately 15% of the entire mass of the specimen. Structures attached to adrenal gland, if applicable: periadrenal. adipose tissue. Orientation: The specimen is received markedly disrupted with. the periadrenal adipose tissue absent over a 3.0 X 1.5 cm area. The adrenal gland underlying this region has a 2.6 cm linear. disruption which has been sutured closed. The periadrenal. adipose tissue and exposed adrenal gland are inked blue on the. side of this disruption. The periadrenal adipose tissue is. inked black on the non-disrupted side. However, given the. disruption, themarginal tissue is poorly adherent to the adrenal. gland, compromising assessment of margins. Tumor description: brown, well circumscribed and grossly. necrotic, emerging from and restricted to the medulla. Tumor weight: Tumor, immediately adjacent normal adrenal gland. and immediately adjacent periadrenal adipose tissue weighs. 14. 6 grams (after removal of distant adrenal gland and non-. marginal periadrenal adipose tissue. Tumor represents. approximately 50% of the mass of this tissue). Tumor size: 3.4 X 2.0 X 1.6 cm. Confinement/Non-confinement to the adrenal gland: Grossly. appears confined, however, disruption of the surgical margins. comprises assessment of confinement. Distance of tumor from surgical margins: 1 mm to the closest. black inked periadrenal resection margin (non-disrupted side) i. less than 1 mm to the closest blue inked periadrenal resection. margin (disrupted side). Appearance of adrenal gland away from tumor: Golden yellow/tan. cortex, ranging in thickness from less than 1 mm to 1 mm, with a. brown central medulla. No additional masses or hemorrhage. Lymph nodes: none identified. Tissue submitted for special investigations Tumor is submitted. to Tissue Procurement. Digital photograph taken: not taken. Block summary: (Inking: olack=non-disrupted side, blue=disrupted side). A1-A10 - mass, entirely submitted; Closest blue inked margin in. A3; closest black inked margin in A6. A11-A12 - representative sections of uninvolved adrenal gland. Uninvolved adrenal and periadrenal adipose remains in formalin.",train,3.4 cm;3.4 X 2.0 X 1.6 cm
6653,TCGA-BF-A5EQ.AE7A4A09-97F1-43C5-BD47-89FDE4EC8678,Component. Type of. Histological. of treatment. Tissue. Clinical. Tumor. Specimen. Specimen. Number of. Amount/per. Grade. TNM Stage. TNM Stage. TNM Stage. Treatment. Tumor cell. Clinical. Specimen. Specificati. Container. Procurem. description. (Chemo. Ethrucity. Anatomical Site. Index. (Race). Diagnosis. Matrix. containera. container. (source). (T). (N). (M). type. %. Format. Site #. (Source). Horm Th. label. on. ent. Details). 4. 0. 0. none. n/a. 75. Caucasian. Male. Melanoma. Skin. Primary. Tumor. Tissue. OCT. block. 1. 200. mg. Melanoma. n/a. (White). blood. Caucasian. Male. Melanoma. Blood. n/a. Normal. Blood. frozen. tube. 1. 4. ml. n/a. n/a. n/a. n/a. n/a. none. n/a. n/a. draw. (White). Criteria.,train,
6743,TCGA-95-A4VK.0B713E19-EE67-4C3B-8319-4C69019C00D0,"This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures. regarding patient information. Any unauthorized use, disclosure. or reproduction of this information is strictly prohibited. Anat Path Reports. Anat Path Reports. Document Date: Modified. Histology. Document Contains Addenda. APRPT (Verified). Acc #: Pulmonary Big. F. Client: Submitting. Phys: Amended Surgical Pathology Report. ADDENDUM PRESENT. Addendum Diagnosis. Lung, Right Upper Lobe, EGFR Analysis (block. NEGATIVE for detectable EGFR alteration. Addendum Comment. For the complete report from. please refer to the. section of the lab result flowsheet. in the. This analysis was performed by. ) and was not performed at. The results are being reported here for. convenience and as supplemental information only. The final diagnosis as reported below remains unchanged. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures. regarding patient information. Any unauthorized use. disclosurc. or reproduction of this information is strictly prohibited. Anat Path Reports. Final Pathologic Diagnosis. A. LYMPH NODE, R10/SUMP, EXCISION, A1FS: - METASTATIC CARCINOMA INVOLVING ONE OF ONE LYMPH NODE (1/1). B. LUNG, RIGHT UPPER LOBE, LOBECTOMY: ADENOCARCINOMA, PREDOMINANTLY MICROPAPILLARY PATTERN WITH LESSER PROPORTIONS OF. ACINAR AND LEPIDIC (AKA BAC) PATTERNS OF GROWTH. - THE TUMOR IS MODERATELY DIFFERENTIATED AND MEASURES 6 X 5.1 X 4.1 CM. - LYMPHOVASCULAR INVASION IS IDENTIFIED. - NO PERINEURAL INVASION IS IDENTIFIED. - NO VISCERAL PLEURAL INVASION IS IDENTIFIED (CONFIRMED WITH AN ELASTIC STAIN). - BRONCHIAL AND VASCULAR MARGINS ARE NEGATIVE FOR CARCINOMA. - THE UNINVOLVED LUNG PARENCHYMA SHOWS NO SIGNIFICANT PATHOLOGIC CHANGES. - TWO PERIBRONCHIAL LYMPH NODES ARE NEGATIVE FOR CARCINOMA (0/2). - SEE SYNOPTIC. C. LYMPH NODES, RIGHT 10 SUMP, EXCISION: - METASTATIC CARCINOMA INVOLVING TWO OF TWO LYMPH NODES (2/2). D. LYMPH NODES, LEVEL 4, EXCISION: - METASTATIC CARCINOMA INVOLVING FIVE OF FIVE LYMPH NODES (5/5). E. LYMPH NODES, 4R, EXCISION: - ONE LYMPH NODE IS NEGATIVE FOR CARCINOMA (0/1). F. LYMPH NODES, R7, EXCISION: - ONE LYMPH NODE NEGATIVE FOR CARCINOMA (0/1). G. LUNG, RIGHT LOWER LOBE, WEDGE RESECTION: - BENIGN LUNG TISSUE WITH MILD EMPHYSEMATOUS CHANGES. Comment. Per. both parts D and G are from the RIGHT side. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures. regarding patient information Any unauthorized use. disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Addendum / Signed Out. Amendments. Reason: Wrong Site by MD. Synoptic Worksheet. B. Right upper lobe, bronchus is marked with stitch: Specimen: Lobe(s) of lung: RIGHT UPPER LOBE. Procedure: Lobectomy. Specimen Integrity: Intact. Specimen Laterality: Right. Tumor Site: Upper lobe. Tumor Focality: Unifocal. Histologic Type: Adenocarcinoma, mixed subtype. Histologic Grade: G2: Moderately differentiated. Tumor Size: Greatest dimension: 6.0 cm. Additional dimension: 5.1 cm. Additional dimension: 4.1 cm. Visceral Pleura Invasion: Not identified. Tumor Extension: Not applicable. Bronchial Margin: Uninvolved by invasive carcinoma. Involvement by squamous cell carcinoma in situ (CIS) not applicable. Vascular Margin: Uninvolved by invasive carcinoma. Parenchymal Margin: Not applicable. Parietal Pleural Margin: Not applicable. Chest Wall Margin: Not applicable. Other Attached Tissue Margin: Not applicable. All Margins Uninvolved By Invasive Carcinoma: Distance of invasive carcinoma from closest margin: 10 mm. Margin closest to invasive carcinoma:: bronchial. Treatment Effect: Not applicable. Lymph-Vascular Invasion: Present. Extranodal Extension: Not identified. TNM Descriptors: Not applicable. Primary Tumor (pT): pT2b: Tumor greater than 5 cm, but 7 cm or less in greatest dimension. Regional Lymph Nodes (pN): pN2: Metastasis in lipsilateral mediastinal and/or subcarinal lymph node(s). Nodes examined: 12. Nodes involved: 8. Distant Metastasis (pM): Not applicable. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures. regarding patient information. Any unauthorized use, disclosure. or reproduction of this information is strictly prohibited. Anat Path Reports. Clinical History. Right VATS, lobectomy. Right upper lobe lung mass. Specimen(s) Received. A: R10 lymph node/sump lymph node. B: Right upper lobe, bronchus is marked with stitch. C: R10 sump lymph node. D: Level 4 lymph node. E: 4R lymph node. F: R7 lymph node. G: Right lower lobe wedge. Gross Description. The specimen is received fresh for intraoperative consultation, labeled with the patient's name, medical record number and. designated ""R10/sump lymph node."" It consists of a single lymph node measuring 1.8 x 1.1 x 0.8 cm. The lymph node is. submitted entirely for frozen section diagnosis in cassette ""A1FS."" A touch prep is performed. Dictated by. Specimen B is received fresh in a container labeled with the patient's name and medical record number and as ""FS3 right upper. lobe."" The specimen consists of a lobe of lung measuring 13.8 x 9.5 x 4.5 cm and weighing 160 grams. Multiple stapled. margins are present on the specimen and a stitch is present for orientation. Multifocally abutting the pleura is a multilobulated. firm partly mucoid mass measuring 6.0 x 5.1 x 4.1 cm. This mass extends to the stapled parenchymal margin of resection and. extends to within 1.0 cm of the bronchial and vascular margins of resection. The lung adjacent to and distal to this mass. appears slightly mottled. No other lesions are identified within the lung. Tissue is submitted for Tumor Bank. The pleural. overlying the mass is inked black and the parenchymal margin of resection is inked blue after removal of the staple line. The. bronchial margin is shaved and submitted for frozen section diagnosis in cassette ""B1FS."" Representative sections of the. remainder of the specimen are submitted as stated below. Dictated by. Specimen C is received in formalin, labeled with the patient's name, medical record number and as ""right 10 sump lymph node."". The specimen consists of multiple fragments of dark colored soft tissue measuring in aggregate, 0.7 x 0.5 x 0.3 cm. The. specimen is submitted entirely in lens paper in cassette ""C1."" Dictated by. Specimen D is received in formalin, labeled with the patient's name, medical record number and as ""level 4 lymph node (per. specimen is from the right side)."" The specimen consists of multiple fragments of fibroadipose tissue measuring in. aggregate, 4.2 x 2.9 x 0.5 cm. Multiple lymph nodes are identified in the specimen ranging in size from 0.3 to 1.7 cm. The. specimen is submitted as stated below. Dictated by. Specimen E is received in formalin, labeled with the patient's name, medical record number and as ""4R lymph node."" The. specimen consists of a single lymph node measuring 1.2 x 0.7 x 0.5 cm. The specimen is bisected and submitted entirely in. cassette ""E1."" Dictated by Dr. Specimen F is received in formalin, labeled with the patient's name, medical record number and as ""R7 lymph node."" The. specimen consists of a single fragment of soft tissue measuring 0.9 x 0.6 x 0,4 cm. The specimen is submitted entirely in. cassette ""F1."" Dictated by Dr. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures. regarding patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Specimen G is received in formalin, labeled with the patient's name, medical record number and as ""right lower lobe wedge. (per. this specimen is from the right side)"" The specimen consists of a wedge of lung measuring 5.8 x 2.6 x 1.8 cm. There are two intersecting staple lines on the specimen, one measuring 5.5 cm, the other measuring 2.8 cm. There is a 0.7 cm. crescent shaped defect in the serosa, and the serosa is otherwise unremarkable. No lesions are identified in the lung. parenchyma. Representative sections are submitted in cassettes ""G1"" through ""G3."" Dictated by Dr. CASSETTE SUMMARY: A1FS: One lymph node, bisected. B1FS: Bronchial margin. B2: Vascular margins. B3: Three possible parabronchial lymph nodes submitted whole. B4: Representative mucoid mass. B5: Mass and parenchymal margin of resection. B6: Mass and pleura. B7: Mass, pleura and surrounding lung. B8: Mass and surrounding lung. B9: Mass and segmental bronchus. B10: Lung parenchyma distant from mass. D1: One lymph node, trisected. D2: One lymph node, bisected. D3: Three lymph nodes, submitted whole. Intraoperative Consult Diagnosis. A1FS, A1TP: R10 LYMPH NODE/SUMP LYMPH NODE (FROZEN SECTION AND TOUCH PREPARATION): LYMPH. NODE. WITH METASTATIC ADENOCARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. on. B1FS: RIGHT UPPER LOBE (FROZEN SECTION): BRONCHIAL MARGIN IS BENIGN. Frozen section results were communicated to the surgical team and were repeated back by -. on. Microscopic Description. Microscopic examination performed. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures. regarding patient information Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports.",train,6 X 5.1 X 4.1 CM;6.0 cm;5.1 cm;4.1 cm
6750,TCGA-AK-3461.eb8e79cd-445c-498d-ad22-ca225c0254aa,"Clinical History/Diagnosis: Left Renal Mass. Source of Specimen(s): Left Kidney resection with Adrenal gland. Gross Description: Received in one part. Source of Tissue: 1. Labeled #1, ""left kidney and adrenal"". Gross Description: Received fresh labeled,. left kidney and adrenal"". It consists of a kidney with surrounding. perinephric fat weighing a total of 844 grams and measuring 22 x 16 X 8.5. cm. The attached ureter measures 9.5 cm in length and 0.3 cm in. diameter. The ureter is opened to show a smooth tan-pink mucosa with no. papillary structures noted. The specimen is bisected to show a 10.5 X 6.5. x 4 cm kidney. A well-demarcated, golden-yellow firm 3.5 x 3 x 3 cm. nodule is identified at the superior pole and comes within less than 0.1. cm of the renal capsule. Grossly the tumor appears confined to the kidney. and does not appear to infiltrate the surrounding perinephric fat. The. remaining renal parenchyma is tan-pink, soft with no other discrete masses. present. The attached adrenal measures 4.5 x 2.5 x 2 cm. The adrenal is. sectioned to show a soft golden-yellow cut surface. No obvious discrete. masses are present. Representative sections are submitted in 1A-1F. Designation of Sections: 1A- ureteral and vascular margins, 1B-1C- tumor. with closest radial margin inked blue, 1D-1E- tumor with adjacent normal. kidney, 1F- adrenal gland. Final Diagnosis: Left kidney and adrenal: Renal cell-carcinoma, conventional (clear cell) type,. nuclear. grade II/IV. The 3.5 cm carcinoma is confined to the kidney. Angiolymphatic invasion is not identified. - Surgical resection margins are free of carcinoma. Adrenal gland with no diagnostic abnormalities recognized. pTNM: T1a Nx Mx. FCGTL: Chromo15, Chrom45, Interp. Procedures/Addenda. FC Cytogenetics Solid. Results-Comments. CYTOGENETIC ANALYSIS REPORTS. DIAGNOSIS: Left Renal Mass. KARYOTYPE: Normal. karyotype: 46,XY[18]. Two additional cells had nonclonal changes. One metaphase contained an. extra copy of chromosome 14. Another metaphase was a broken tetraploid. cell. RESULTS: The renal mass was harvested after twelve and fourteen days in. culture. The chromosomes from twenty metaphases were counted and. analyzed, and four of these metaphases were karyotyped by G-banding. Eighteen cells had a modal chromosome number of 46 and appeared to have a. normal karyotype. Two cells had nonclonal changes. One of these. metaphases contained an extra copy of chromosome 14. Another metaphase. was a broken tetraploid cell. The significance of a single abnormal cell. is unclear. It may represent an emerging or undetected clonal cell. population, technical artifact, or random event. The normal results may. reflect an overgrowth of normal interstitial tissue rather than tumor.",train,3.5 cm
6769,TCGA-2Y-A9H0.33EB4235-F58D-4AB6-8944-F2B59374A5F0,"x. Submitting Phyarcians: Patnolog:at. Intrap Pathologist: Performing PbyEician: CLINICAL HISTORY: LEFT UEPATOCELLULAR CA. PRECPERATIVE DIAGNOSIS: MEPATOCELIALAR. SPECIMEN TYPA(S) #. A: CELIAC LN, FS (1). E: NODULE RT LOBE OF LIVER, F9 121. C: CALLPLADDER. D: LT LOPE LIVER. E: LT EEPATIC VEIN STUMP. F: LT VEIN MARGIN, FS. FIMAL DIAGNOSTS: LYMPH NODE, CELINC, BIOPSY: Negative for malignancy. E. LIVER, RIGHT LOBE NODULE,. Negative ror malignancy,. callalADDER, RESECTION: Chronte cholecystitis. D. DIVER, LEFT LOBE, PRSECTION: Well iirrerentiated hepatodellutar carcinoma. See Key Pathologicil Findings. LEFT HEPATIC VEIN STUM2: Negative for malignancy. LEFT VEIN MARGIN: Negative for malignancy. KEY PATHOLOGICAL FINDINGS: KEY PATHOLOCICAL FINDINGS. Gpecimen type: partial resection. Tumor configuration: satellite nodulea. Cumor size: 8 am in ciximua dimension. Hiatologic type: hepatocellular carcicoza. Histologic grade: vell-dirTerentiated. Tumor necrosis: Preaent. Extent of invasion: Invades hepatic vein. Perizieural invasion: Absent. Parenchyman margin: Negative. Bile duet marg:n: Not asseased. Other margina;. Not applicable. Venous (Carge invasion: Present. Lymph nodes: 0/1. Pathologic stage: T3NOMX. I. the atcending pathologist, personally reviewed the ectire. pathlogy case and readered the rinal diageOBis. Electronically Signed out by. OTHER RELATED CLINICAL DATA: NA. INTRAOPERATIVE DIAGNOSIS: FSA: CELIAC LYMPH NODE: Lymph node with no evidence or malignancy. FSP: NODULE RIGHT LORE CP LIVER: M:10 portal inflammation. No carcinoma identitied. PEP: FINAL VEIN MARGIN: Fibrosis and chrente) inflimmation. No evidence of calignancy,. have performed the intraoperative. consultations and iasued the above diagnoses. GROSS DESCRIPTION: A. Specimen A ia labeled celia lymph pode, FSt. Received fresh la a tan-brown. lymph node measuring 2.6 x 1.6 x 0.8 The specimen is bisected and balt or the. specimen 15 frozen, The :rozen section residue te submitted in cassette FSA. The. remaining tiasue 1a aubnitted in cassette A. B. Specimen a is labaled nodule right Tobe of liver, PS. Received fregh are two. tan-brown cylindrical fragments of sort tiasue measuring fros 0.8 up to 1.5 em in. length each with an average diateter of 0.1 on The apecimen 18 frozen In it's. entirety and the frozen section residue is subnitted in cassette PSB. Specimen C is labeled gallbladder"". Received freah le an oblong ;atibladder. measuring 10.0 x 3.5 x 1,3.cm. The serosal surface is green-tn and unremarkable. Thare are multiple lymph nodes attached to the gillbladder, The cyat:C duct 18. identifted and Deasures 1.7 ca in length. The apecimen 18 opented to reveal a. green-tan trabeculir mucosa. The specimen 138 3 wall thicknesa or 0.8 cm. NO. lesiona or calcult are grosaly appreciated. Representative Bections are surzitted. as follows: Cl: dalibladder, neck, tundus, and cystic tuct margin. C2: Four single lyzph podes. D. Specimen D is Tabeled :eft Tobe liver Received trean. is a. hepatolobectomy weighing 716.0 gin, 18.5 3.5 x 6.0 cm. The capsule 3: the liver 18. diatorted by multiple white-tan nodules measuring from 1.5 up Lo 9.0 cm in greatest. dimension. The hepatic vein appeara to be involved by tumor. The resection zargin. 18 inked black and the apecimen is serially sectioced to reveal a 7.5 X5 x 4 em. tumor mass composed or confluent nodules with satellite nodules throughout the. parenchyes. The nodules are white-tan aort, necrotic, hemorrhagic cut surface. The. nodules are located 1,4 em from the closeat inked resectd The uninvelved. liver parenchyma la tan-brown and unrecarkable. Representative sections are. submitted to the Tiasue Procurement Laboratory, Representative aections are. submitted 38 follows: D1;. Tumor in relation to the hepatic vein and artery. Tumor in relation to the inked resected margin. D31. Section of the tumor in relation to the capsuie. D4: Uninvolved liver parecchyma. E,. Specimen E is labeled left thepatic vein atump' - Recetved treah 1a the lert. hepatic vein stuxp measuring 3.0 x 1.0 x 0.4 The specimen has a aingle atapled. margio line. The specisen Le received Laked on ane s:de. The Inked cargin. designates the true margin. The margin is reinked blue and sucmitted in toto. In. caszette E. F. Specimen F 18 labeled Frinal vein margin-liver, Received fresh 13 3. red-brown Irregular fragment or sort cessuring 1.5 x 0.8 x0.3 em. The. specimed 18 frozen in ite entirety and the frozen section residue 18-Bubmitted in. cassette A.",train,
6815,TCGA-HI-7171.0bdd67bb-5cf4-4972-9ab6-9878c351857f,"Sex: M. Source of Specimen(s). 1: Left pelvic Lymph Node. 2: Right pelvic Lymph Node. 3: Prostate and Seminal Vessicles. Gross Description: Received in three parts. Source of tissue: 1. Labeled #1, ""left pelvic lymph nodes"". Gross Description: Received fresh labeled "", left. pelvic lymph nodes"" consists of a 6 x 3 x 1.5 cm aggregate of yellow. lobulated, hemorrhagic fat. Multiple lymph nodes are dissected out of the. fat ranging from 2 x 2 x 0.4 cm up to 3.5 x 1.5 x 0.4 cm. The lymph nodes. are entirely submitted in cassettes 1A-IC for microscopic evaluation. Source of tissue: 2. Labeled #2, ""right pelvic lymph nodes"". Gross Description: Received fresh labeled"",. right pelvic lymph nodes"" consists of a 4 x 3 x 1 cm aggregate of yellow. lobulated, hemorrhagic fat. Two lymph nodes are dissected out of the fat. measuring 1 x 1 x 0.3 cm and 2.5 x 1 x 0.4 cm. The lymph nodes are. entirely submitted in cassettes 2A for microscopic evaluation. Source of tissue: 3. Labeled #3, ""prostate and seminal vesicles"". Gross Description: Received fresh labeled'. prostate and seminal vesicles"" consists of a 58 gram, 5 x 4.5 X 4 cm. red-brown, hemorrhagic prostate with intact capsule, patent urethra and. bilateral seminal vesicles and vas deferens. The right seminal vesicle. measures 2 X 1 X 0.7 cm, the right vas deferens measures 4 x 0.5 cm, the. left seminal vesicle measures 4 X 2 x 1 cm, and the left vas deferens. measures 5 X 0.5 cm. The right side is inked yellow and the left side is. inked black and the specimen is sectioned revealing tan-pink, rubbery to. firm cut surfaces with multiple brown, small to medium calculi. Sectioning of the seminal vesicles and vas deferens reveals tan-red cut. surfaces and fluid-filled spaces. Representative sections are submitted. as designated for microscopic evaluation. Designation of Sections: 3A right apex. 3B left apex. 3C right base. 3D left base. 3E-3F right anterior mid. 3G-3H right posterior. superior. 3I-3J left anterior mid. 3K-3L left posterior superior. 3M. right seminal vesicle and vas deferens. 3N left seminal vesicle and vasdeferens. Please note the specimens are placed in formalin at. Final Diagnosis: 1. Left pelvic lymph nodes: - No tumor seen in five lymph nodes (0/5). 2. Right pelvic lymph nodes: - No tumor seen in two lymph nodes (0/2). 3. Prostate and seminal vesicles, radical prostatectomy: - Prostatic adenocarcinoma, Gleason's score 9 (5+4). - Tumor involves both lobes. Tumor involves the apex on the right side, extending into the. surrounding muscles and nerves, but the inked margin is negative. - Angiolymphatic invasion is not identified. - Perineural invasion is identified. - Extracapsular extension is identified. - Tumor involves right posterior inked margin. - Left and right seminal vesicles positive for tumor. - Tumor involves 80% of tissue examined. - pT3b NO Mx.",train,
6828,TCGA-G9-6498.0F610D96-54E9-4E40-B3D4-19554C782057,"SPECIMENS: A. PROSTATE. B. PROSTATE MARGIN. SPECIMEN(S): A. PROSTATE. B. PROSTATE MARGIN. GROSS DESCRIPTION: A. PROSTATE. Received fresh labeled with matching patient identifiers is a resected prostate gland weighing 48 9 and. measuring 4.5-cm from right to left, 4.8-cm from anterior to posterior, and 3.5-cm from apex to base,. The exernal capsule is red, smooth and intact. The apex and base are removed from the specimen. yielding a new weight of 23 g. The specimen is serially sectioned from apex to base, Cut section shows. firm, tan fibrous parenchyma. No lesions or nodules are grossly appreciated. The right and left seminal. vesicle measure 2.3 x 1.5 x 0.5, and 2.9 x 1.7 x 0,5 cm respectively. Both are bisected show beige tan. cystic tissue. The right and left vas measure 3.1 x 0.2, and 1.9 x 0.2 cm, respectively. Both. are. sectioned to show firm tan tube structure. A portion of the specimen is submitted for tissue. procurement. The remainder is entirely submitted for microscopic evaluation. Cassettes are submitted. as follows: A1-A2: Right apex. A3: Left Apex. A4: Level 1 right anterior. A5: Level 1 right posterior. A6: Level 1 left anterior. A7: Level 1 left posterior. A8; Level 2 capsule, right side. A9: Level 2 capsule, left side. A10-A11: Right lateral base. A12: Right base. A13-A14: Right base with proximal urethral margin. A15-A16: Left base with proximal urethral margin. A17-A18: Left base. A19-A20: Left lateral base. A21: Right seminal vesicle, right vas. A22: Left seminal vesicle, left vas. B. PROSTATE MARGIN. Received in formalin in a container labeled with matching patient Identifiers is a fragment of pink tan. unoriented soft tissue measuring 0.7 x 0.3 x 0.1 cm. The entire specimen is submitted In cassette B1. DIAGNOSIS: A. PROSTATE, PROSTATECTOMY: - PROSTATIC ADENOCARCINOMA, GLEASON SCORE 3 + 4 = 7. - TUMOR INVOLVES RIGHT AND LEFT LOBES AND - 15% OF THE PROSTATE. - TUMOR IS PRESENT AT THE INKED RIGHT APICAL AND RIGHT. ANTERIOR MARGINS, WITH PERIPROSTATIC FAT INVOLVEMENT. BILATERAL SEMINAL VESICLES AND BLADDER BASE, NO TUMOR SEEN,. B. PROSTATE MARGIN, EXCISION: - PROSTATIC TISSUE, NO TUMOR SEEN. SYNOPTIC REPORT - PROSTATE GLAND. right and left lobes from apex to mid. WHO CLASSIFICATION. Epithelial tumors. Adenocarcinoma 8140/3. Multicentricity: Gland Involvement: 15%. Gleason Grade/Sum:: Grade 3+4, Sum 7. High Grade PIN Present: Perineural Invasion: Yes. Vascular/Lymphatic Invasion: Seminal Vesicle Invasion: Periprostatic Fat Involved: Details: right apex and right anterior. Bladder Neck Involved: Margins Involvement: Yes. see above. Linear Distance: Diffuse (>10mm or Multifocal). Frozen Performed: Lymph Nodes: Negative. Other Pathologic Findings: BPH. Pathological Staging (pTNM): T 3a. N: X. M X. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: Prostate cancer.",train,
6884,TCGA-2Y-A9HA.C07BBEDC-59CE-41B9-9D47-EDFD8AEB26B9,"Final Diagnosis. A. LIVER, LIVER SEGMENT 6, SEGMENTAL RESECTION: Hepatocellular carcinoma, moderately differentiated. Tumor size: 1.7 cm. Margin of resection is free of tumor (tumor is at least 8 mm away from the inked,. cauterized deep margin of resection). Uninvolved liver with chronic hepatitis, mildly active with transition to cirrhosis (modified. ISHAK stage 3 of 4), compatible with hepatitis C. See Key Pathological Findings. B. LIVER, LIVER SEGMENT 8, SEGMENTECTOMY: Hepatocellular carcinoma, moderately differentiated. Tumor size: 1.5 x 1.4 x 1.3 cm. Margin of resection: see part C. See Key Pathological Findings. C. LIVER, SEGMENT 8 NEW MARGIN, RESECTION: Liver with chronic hepatitis, mildly active with transition to cirrhosis (modified. ISHAK stage 3 of 4), compatible with hepatitis C, negative for carcinoma. the attending pathologist, personally reviewed all. slides and / or materials and rendered the final diagnosis. Electronically. Ancillary Studies. Special stains Trichrome, Reticulin, Iron, and PAS-D were performed with adequate controls on block. A8 and were reviewed. Key Pathological Findings. A: Liver, Resection. Specimen: Liver. PROCEDURE: Partial hepatectomy. Minor hepatectomy (less than 3 segments). TUMOR SIZE: Greatest dimension: 1.7 cm. TUMOR FOCALITY: Multiple (specify location): segment 6 and segment 8. HISTOLOGIC TYPE: Hepatocellular carcinoma. HISTOLOGIC GRADE: GII: Moderately differentiated. TUMOR EXTENSION (select all that apply): Tumor confined to liver. PRIMARY TUMOR (pT): pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm. REGIONAL LYMPH NODES (pN): pNX: Cannot be assessed. DISTANT METASTASIS (pM): pMX: Cannot be assessed. MARGINS: Parenchymal margin uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 8 mm. VENOUS (LARGE VESSEL) INVASION (V): Absent. ADDITIONAL PATHOLOGIC FINDINGS: Hepatocellular dysplasia. Cirrhosis/fibrosis. Hepatitis (specify type): Hepatitis C. Specimen(s) Received. A. LIVER SEGMENT 6. B. LIVER SEGMENT 8. C. LIVER SEGMENT 8 NEW MARGIN. Clinical History. LIVER CANCER. Preoperative Diagnosis. Liver cancer. Gross Description. A. The specimen is received fresh, labeled ""liver segment 6"" and consists of an unoriented,. resected segment of liver, 65.5 g, and 6.9 x 6.0 x 4.5 cm. The capsule is intact and pitted. No lesion. is grossly seen. The deep margin is cauterized and inked blue. The cut surfaces exhibit a golden. yellow, circumscribed, circular, spongy mass (1.7 cm diameter) which is 1 cm from deep margin and. does not involve the capsule. The lesion does not grossly involve vasculature. Necrosis (5%) is. noted, with no hemorrhage identified. Normal liver parenchyma is coarsely lobulated and congested. No satellite lesions are noted. Representative sections are submitted in A1-A8 as labeled: A1: Mirror image section of liver lesion for Tissue Procurement. Laboratory. A2-A3: Liver lesion nearest deep margin. A4: Liver lesion with vasculature. A5-A6: Liver lesion with necrosis. A7: Tumor random. A8: Normal liver parenchyma. The tissue is submitted for Tissue Procurement Laboratory. B. The specimen is received fresh, labeled ""liver segment 8"" and consists of an unoriented,. ovoid, resected segment of liver, 10.1 g, 3.7 x 2.8 cm, excised to a depth of 2 cm. The capsule is. intact, smooth and glistening. The margin of resection is inked blue. The cut surfaces exhibit a pale. gray-tan, solid, circumscribed, intraparenchymal lesion, 1.5 x 1.3 X 1.4 cm. The lesion is 3 mm deep. from capsule and extends to the deep margin. Punctate necrosis, indicative of biopsy site is noted,. with no hemormhage identified. The remaining parenchyma is normal, with no satellite lesion noted. Representative sections, including the entire lesion are submitted in B1-B5 as labeled: B1-B2: Liver lesion nearest deep margin. B3-84: Liver lesion with potential biopsy site. B5: Normal liver parenchyma. The specimen is not submitted for Tissue Procurement Laboratory. C. The specimen is received fresh, labeled ""liver segment 8 new margin; ink-true margin"" and. consists of an oriented, irregular resected liver fragment, 1.6 g, 2.8 x 2.1 cm, excised to a depth of 1.1. cm. The specimen is markedly cauterized and the deep margin is re-inked blue. A capsule is not. identified. The cut surfaces exhibit smooth, coarsely lobulated, tan-red parenchyma, with no lesion. grossly seen. Necrosis is not identified. The specimen is submitted entirely in C1-C3. The specimen is not submitted for Tissue Procurement Laboratory.",train,1.7 cm;1.5 x 1.4 x 1.3 cm;1.7 cm
6887,TCGA-31-1950.4ed80cbd-e56d-4d09-b8ac-2b6535346b73,"Specimen Type: 1: OVARIES. 2: Omentum. Clinical Details: No details given. Macroscopic Description: 1) Ovaries: Two ovaries received, the larger ovary on external examination appears partly solid and partly. cystic and measures 12 X 13 X 11cm and weighs more than 1500gms. On external. examination there are irregular nodular and solid areas on the ovarian surface, these appear. to be areas of capsular breach. The external surface is inked black. An attached fallopian. tube is identified and measures 8cm in length and 0.5cm in diameter. On slicing the larger. ovary it is partly solid and partly cystic, there are abundant papillary excrescences and. formations on the inner ovarian cyst lining and the solid areas are white and firm. The smaller. partly cystic ovary measures 7.7 X 5.5 X 3cm and the attached fallopian tube measures 4cm in. length and 0.7cm in diameter. On the external surface of the smaller ovary there are large,. solid/papillary areas and areas of irregularity. On slicing the ovary the inner surface shows. papillary excrescences and is irregular. The smaller ovary weighs 205. .8gms. BLOCKS;. 1A: Larger ovary, area of capsular breach: ,1pc. 1B: Larger ovary with irregular external surface: 1,2pcs. 1C-F: Larger ovary, cyst wall with solid internal projections: 1pc in each. 1G-H: Larger ovary, cyst wall with internal solid areas: 1pc in each. 1K: Larger ovary: solid area larger cyst: 1, ,1pc. 1L: RS larger cyst wall: 1,2pcs. 1M: RS solid area: 1, 1pc. 1N: TS fallopian tube larger cyst: 1,2pcs. 1P-Q: Smaller ovary, irregular/solid papillary areas: 1pc in each. 1R: TS fallopian tube smaller ovary, including 0.4cm cyst ? paratubal: 1,2pcs. 1S: Smaller ovary, solid area: 1,1pc. 1T: Smaller ovary, cyst wall: 1,3pcs. 1U: Smaller ovary, cyst wall: 1,2pcs. 1V: Smaller ovary, solid area: 1, 1pc. 2) Omentum: A piece of omentum measuring 23 X 5 X 1cm. On slicing the omentum white nodules are. identified (query representing tumour), the largest measuring 2 X 0.7 X 1.5cm. There are in. addition multiple smaller nodules. BLOCKS: 2A: RS largest omental nodule: 1,2pcs. 2B-C: RS other omental nodules: 2pcs in each. 2D: RS separate omental nodules: 1, ,1pc. 2E-F: Background omentum: 1pc in each. Microscopic Description: 1) Ovaries: Both ovaries show a dense infiltration of moderately atypical glandular cells forming complex. papillary and cystic structures. There is stratification of the cells lining these structures. The. cells are pleomorphic, hyperchromatic and show numerous mitotic figures. There is invasion. into the underlying stroma, with areas of necrosis and haemorrhage. Psammoma bodies are. seen. The tumour extends through the inked capsular surface margins. Both fallopian tubes. show no evidence of tumour invasion. The appearances are those of a moderately. differentiated serous papillary cystadenocarcinoma. 2) Omentum: The omentum shows infiltration of the omental fat by atypical glandular cells forming papillary. structures, both in the nodular areas, as well as in the background omentum. The. appearances are similar to the cells in the ovarian specimens. The tumour in the largest. nodule measures up to 19.7 mm. The peritoneal fluid contains malignant cells. Final Diagnosis: 1-2) OVARIES, TUBES AND OMENTUM: GRADE 2 SEROUS PAPILLARY CYSTADENOCARCINOMA OF THE OVARIES, IN. BOTH OVARIES, EXTENDING THROUGH THE CAPSULAR SURFACE, WITH. METASTASIS IN THE OMENTUM. T3b Nx Mx (FIGO STAGE IIIC).",train,2 X 0.7 X 1.5cm;19.7 mm
7022,TCGA-AX-A1C5.6F79B83A-90B4-45DF-8542-A6BC2F93470D,"FIN: SEX: Female. Attending. Consulting: Surgical Pathology Final. Collected Date: Verified Date: Diagnosis. A. Uterus, cervix, bilateral ovary and fallopian tube; total hysterectomy (198 gms) and bilateral. salpingo-oophorectomy: Endometrioid endometrial adenocarcinoma. FIGO grade III/III. pT3a Tumor involves uterine serosal surface, parametria and bilateral ovaries. - lower uterine segment and cervix involved. - extensive angiolymphatic invasion present. - bilateral fallopian tubes with paratubal cyst (right side); negative for tumor. - left ovary with extensive involvement by tumor. - right ovary with surface involvement by tumor. - 2 lymph nodes positive for tumor (2/3) - Parts C and E. - omentum negative for tumor - Part G. - minimum pathologic stage pT3a N1 Mx. B. Cul de sac, biopsy: Positive for tumor. C. Lymph node, right pelvic, excisional biopsy: Positive for tumor. (1/1). D. Lymph node, left pelvic, excisional biopsy: Negative for tumor.(0/1). E. Lymph node, right periaortic, excisional biopsy: Positive for tumor. (1/1). F. Submitted as left periaortic lymph node, biopsy: Mature adipose tissue. Surgical Pathology Final. Collected Date: Verified Date: No lymphoid tissue present. Negative for tumor. G. Omentum, biopsy: Negative for tumor. Comment. A: Endometrium, Hysterectomy, Macroscopic. SPECIMEN TYPE: Radical hysterectomy (includes parametria). TUMOR SITE: Specify location(s), if known: uterus. TUMOR SIZE: Greatest dimension: 9 cm. Additional dimensions: 6 x 3.2 cm. HER ORGANS PRESENT: Right ovary. Left ovary. Right fallopian tube. Left fallopian tube. A: Endometrium, Hysterectomy, Microscopic. HISTOLOGIC TYPE: Endometrioid adenocarcinoma, not otherwise characterized. HISTOLOGIC GRADE: G3: More than 50% nonsquamous solid growth. MYOMETRIAL INVASION: Invasion present. Specify depth of invasion: 22 mm. Specify myometrial thickness: 22 mm. PRIMARY TUMOR (pT): pT3a [IIIA]: Local and/or regional spread as specified in T3a, T3b, and FIGO IIIA and IIIB: Tumor. involves serosa, parametria, and/or adnexa (direct extension or metastasis. REGIONAL LYMPH NODES (pN): pN1 [IIIC): Regional lymph node metastasis. Number examined: 3. Number involved 2. DISTANT METASTASIS (pM): pMX: Cannot be assessed. Surgical Pathology Final. Collected Date: Verified Date: MARGINS: Involved by invasive carcinoma. Specify margin(s): posterior uterine serosal. VENOUS/LYMPHATIO (LARGE/SMALL VESSEL) INVASION (V/L): Present. ADDITIONAL PATHOLOGIC FINDINGS: None identified. This case was also reviewed by Dr. who agrees with the above diagnosis. (Electronic Signature). Clinical History. Endometrial carcinoma. Specimen. A) Uterus, bilateral ovaries/fallopian tubes, cervix. B) Pelvic cul-de-sac biopsy. C) Right pelvic lymph node. D) Left pelvic lymph node. E) Right paraaortic. F) Left paraaortic. G) Omentum. Gross Description. The specimens are received fresh in seven containers, each designated with the patient's name. Part A is designated ""uterus, bilateral tubes and ovaries, and cervix"". The specimen consists of a total. hysterectomy specimen to include a uterus with attached cervix and attached bilateral adnexa. The left. fallopian tube with fimbriae is 2.5 cm in length and 0.3 cm in diameter. The ovary is tan-gray, 2.5 cm in greatest. dimension. Bivalving reveals a tan cut surface with normal ovarian architecture present. The right fallopian. tube with fimbriae is 5 cm in length and 0.5 cm in diameter. The ovary is tan-gray, 2.5 cm in greatest. dimension. Serially sectioning reveals a tan-gray cut surface. Surgical Pathology Final. Collected Date: Verified Date: The uterus with cervix is 198 g, approximately 11.5 x 8.6 x 5.7 cm. The serosa is tan-pink with a moderate. amount of hemorrhagic adhesions. The paracervical/parametrial margin is inked black. The cervix is tan-pink,. 3.5 X 3.0 x 1.5 cm. Upon bivalving, the endocervical canal is 1.5 cm and the endometrial cavity is entirely. replaced by tan-gray mass extending. and involving the lower uterine cavity, 2.5 cm from the squamocolumnar. junction. Sectioning the anterior endometrium/myometrium and mass, the mass is 1.2 cm in thickness, it. involves 50% of the myometrium, 1.2 cm from the serosa. Sectioning the posterior endometrium/myometrium. and mass, the mass extends to and there is serosal involvement, the mass is approximately 3.2 cm in depth. There also appears to be parametrial involvement (black ink). Tissue was taken according to the. and. protocol. The specimen is submitted as per code of sections. CODE OF SECTIONS: A1. Left fallopian tube and ovary. A2. Right fallopian tube and ovary. A3. Anterior cervix. A4-A5. Anterior endometrium/myometrium, mass, deepest invasion. A6. Right parametrial margin. Posterior cervix. -A10. Posterior endometrium/myometrium, mass, deepest invasion (serosal. involvement). A11. Parametrial margin involvement. Part B is designated ""pelvic cul-de-sac"". The specimen consists of a portion of yellow-gray to red membranous. tissue, 1.2 cm in greatest dimension. The specimen is entirely submitted in a single cassette. Part C is designated ""right pelvic lymph node"". The specimen consists of a portion of tan-gray to yellow. rubbery tissue, 2.5 x 1.5 x 0.7 cm. The specimen is entirely submitted in a single cassette. Part D is designated ""left pelvic lymph node"". The specimen consists of lobulated adipose tissue, 4.5 x 3.0 x. 1.5 cm. Sectioning reveals a lymph node with possible tumor involvement, 2.5 X 2.0 x 1.5 cm. The entire. lymph node is submitted in cassettes D1-D3. Part E is designated ""right paraaortic"". The specimen consists of lobulated adipose tissue with tangray. rubbery tissue, 2.0 x 1.5 x 1.0 cm. Sectioning reveals a possible tumor bisected and entirely submitted in a. single cassette. Part F is designated ""left paraaortic"". The specimen consists of a portion of lobulated adipose tissue, 1.0 x 1.0. x 0.4 cm. The specimen is submitted as received in a single cassette. Surgical Pathology Final. Collected Date: Reccived Date: Verified Date: Part G is designated ""omentum"". The specimen consists of an apron of omentum, 22 X 12 X 4 cm. Sectioning,. there are no implants identified. The cut surface is lobulated adipose tissue. Representative portions are. submitted in cassettes G1-G2.",train,9 cm;6 x 3.2 cm
7064,TCGA-D1-A0ZO.13826E23-2184-4D03-B67C-B312BF4FA87E,"adenocarcinams, endometrivid, NOS 8380)3. DIAGNOSIS: A. Uterus, bilateral ovaries, and fallopian tubes;. hysterectomy and. bilateral salpingo-oophorectomy: Endometrial. adenocarcinoma,. endometrioid type, FIGO grade 1 (of 3) is identified. forming a mass. (3.5 X 3.0 X 1.0 cm) in the uterine fundus (both posterior. and. anterior) . The tumor invades 0.6 cm into the myometrium. (total. myometrial thickness, 2.0 cm). The tumor does not involve. the. endocervix. Lymphovascular invasion is not identified. The. background endometrium shows complex hyperplasia with. atypia. The. vaginal cuff margin is negative for tumor [AJCC pT1bNXMX]. The. bilateral ovaries and fallopian tubes show no diagnostic. abnormalities. B. C. Lymph nodes, right and left pelvic, excision: Multiple left. pelvic lymph nodes (11 right and 7 left) are negative for. tumor. This final pathology report is based on the. gross/macroscopic. examination and frozen section histologic evaluation of. the. specimen(s) . A. Received fresh labeled ""uterus, right and left. fallopian tubes. and ovaries"" is a 100.0 gram uterus with attached. bilateral tubes. and ovaries and an unremarkable cervix. The uterine. serosa is. smooth There is a 3.5 X 3.0 x 1.0 cm mass in the fundus. of the. endometrial cavity with 1.5 cm myometrial thickness. There are. multiple (3) intramural leiomyomas (ranging in size from. 0.4 cm to. 1.0 cm in greatest dimension) . There is a 2.5 X 1.1 X 0.8. cm right. ovary with a smooth outer surface and a cut. surface with a 6.5 X 0.6 cm right fallopian tube. There. is a 2.0 X. 1.2 X 0.7 cm left ovary with a smooth outer surface and a. solid cut. surface with a 6.5 X 0.7 cm left fallopian tube. Representative. sections submitted. B. Received fresh labeled ""right pelvic lymph nodes"" is a. 5.0 X 4.0. X 1.0 cm aggregate of adipose and lymphatic tissue. All. 1 ymphatic. tissue submitted. C. Received fresh labeled ""left pelvic lymph nodes"" is a. 5.3 X 4. - 1. X 1.5 cm aggregate of adipose and lymphatic tissue. All. 1 ymphatic. tissue submitted. GROSS DESCRIPTION: A. Received fresh labeled ""uterus, right and left. fallopian tubes. and ovaries"" is a 100.0 gram uterus with attached. bilateral tubes. and ovaries and an unremarkable cervix. The uterine. serosa is. smooth There is a 3.5 X 3.0 X 1.0 cm mass in the fundus. of the. endometrial cavity with 1.5 cm myometrial thickness. There are. multiple (3) intramural leiomyomas (ranging in size from. 0.4 cm to. 2.0 cm in greatest dimension) . There is a 2.5 X 1. 1. X 0.8 cm right ovary with a smooth outer surface and a. solid. cut surface with a 6.5 X 0.6 cm right fallopian tube. There. is a 2.0 X 1.2 X 0.7 cm left ovary with a smooth outer. surface and a. solid cut surface with a 6.5 X 0.7 cm left fallopian tube. Representative sections submitted. B. Received fresh labeled ""right pelvic lymph nodes"" is a. 5.0 X 4.0. X 1.0 cm aggregate of adipose and lymphatic tissue. All. lymphatic. tissue submitted. C. Received fresh labeled ""left pelvic lymph nodes"" is a. 5.3 X 4.1. X 1.5 cm aggregate of adipose and lymphatic tissue. All. 1 .ymphatic. tissue submitted. BLOCK SUMMARY: Part A: Uterus, right and left fallopian tubes and. ovaries. 1 Cervix. 2 Lower uterine segment. 3 Tumor. 4 Tumor. 5 Tumor. 6 Tumor. 7 Serosa. 8 Right fallopian tube. 9 Left fallopian tube. 10 Right ovary. 11 Left ovary. 12 Tumor. 13 Tumor. 14 Normal endometrium. Part B: Right Pelvic Lymph Nodes. 1 Right pelvic Ins 1. 2 Right pelvic lns 1. 3 Right pelvic lns 1. 4 Right pelvic lns 2. 5 Right pelvic lns 2. 6 Right pelvic lns1. Part C: Left Pelvic Lymph Nodes. 1 Left pelvic lns 3. 2 Left pelvic Ins 2. 3 Left pelvic Ins 3. 4 Left pelvic lns 2. 5 Left pelvic Ins 1.",train,0.4 cm;1.0 cm;2.0 cm
7065,TCGA-HC-7213.8b2f0b23-7a12-432a-b209-37e57a2f112b,"Hospital of Origin: QC Pathologist: FINAL PATHOLOGIC DIAGNOSIS: A. Right and left pelvic lymph nodes; excision: No metastatic carcinoma identified in four lymph nodes. (0/4). B. Prostate; radical prostatectomy: Tumor Characteristics: 1. Histologic type: Prostatic adenocarcinoma. 2. Prostate size: 4.5 x 4.5 X 4.0 cm, 42.5 grams. 3. Tumor quantitation: Tumor involves approximately 25-30%. of the prostate gland volume. 4. Gleason grade: a. Primary pattern: 4/5. b. Secondary pattern: 5/5. c. Total Gleason score: 9/10. 5. Extraprostatic extension: Focally present primarily. associated with peripheral nerve in the soft tissue. 6. Seminal vesicle involvement: Bilateral. 7. Lymphovascular space invasion: Not identified. 8. High grade PIN: Present. 9. Treatment effect: Not identified. Surgical Margin Status: Surgical margins including apical (less than 0.1 cm),. bladder neck, and inked prostatic margin negative for tumor. Lymph Node Status: 1. Total number of lymph nodes received: Four, see. specimen A. 2. Total number of lymph nodes containing metastatic. carcinoma: Zero (0/4). Other: pTNM stage: pT3b NO. COMMENTS: CLINICAL HISTORY: Preoperative Diagnosis: Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Right and left pelvic lymph nodes. B. Prostate. PROCEDURAL DEMOGRAPHICS: Accession Date/Time: GROSS DESCRIPTION: The specimen is received in two formalin filled containers. labeled with the patient's name. A. Additionally labeled #1 and contains a 5.5 x 3.5 X 2.0 cm. aggregate of yellow-tan fibrofatty soft tissue. On. palpation, four firm fatty possible lymph nodes are. identified ranging from 0.2 up to 3.0 cm in greatest. dimension. They are entirely submitted in cassettes A1-4. labeled. designated as follows: 1--wwo whole. possible lymph nods; 2-one whole possible bisected lymph. node; 3-4--one whole possible bisected lymph node. B. Additionally labeled #2 and contains. a 42,5. gram, 4.5 x 4.5 x 4.0 cm prostate received with attached. bilateral adnexa having overall dimensions of 5.0 x 3.0 x. 2.0 cm. The capsule is pink-tan smooth to shaggy. The. specimen is inked as follows: right side - blue; and left. side - black. The base and apical margins are coned and. serially sectioned. The remainder of the gland is serially. sectioned from apex to base to reveal a pink-tan focally. cystic cut surface with diffuse periurethral nodularity. A. 3.5 X 3.0 X 2.5 cm yellow-tan nodular, glistening mass is. present within the right base and partially surrounds the. right seminal vesicle. This mass abuts the inked soft tissue. margin. Representative sections are submitted in cassettes. B1-22 labeled. designated as follows: 1--right. prostate/seminal vesicle junction; 2-left prostate/seminal. vesicle junction; 3-4-apical margin, perpendicular;. 5-6--base margin, perpendicular; 7-10-mass to inked soft. tissue margin and right seminal vesicle; 11-13--right. anterior prostate, apex to base; B14-16--right posterior. prostate, apex to base; 17-19-left anterior prostate, apex. to base; 20-22-left posterior prostate, apex to base. Additionally, a yellow and green cassette are submitted for. Genomics research each labeled.",train,
7077,TCGA-DD-A11D.8D1A74F7-E6C3-4557-917A-CA7273929ADF,"TISSUE DESCRIPTION: A1 B1 B2 B3 B4. Right lobe liver (1,585 grams; 21.0 x 16.0 x 9.0 cm) and gallbladder. (8.5 x 2.0 x 2.0 cm). DIAGNOSIS: Liver, right lobe, resection: Grade 2 (of 4) hepatocellular. carcinoma forming a 4. x 3.8 x 3.7 cm mass located 3.0 cm from the. surgical margin. The uninvolved liver shows moderate cirrhosis. Gallbladder, cholecystectomy: Gallbladder without diagnostic. abnormalities. A single benign cystic duct lymph node is. identified. TISSUE DESCRIPTION: A1 B1 B2 B3 B4. Right lobe liver (1, 585 grams; 21.0 x 16.0 x 9.0 cm) and gallbladder. (8.5 x 2.0 x 2.0 cm). DIAGNOSIS: Liver, right lobe, resection: Grade 2 (of 4) hepatocellular. carcinoma forming a 4.4 x 3.8 x 3.7 cm mass located 3.0 cm from the. surgical margin. The uninvolved liver shows moderate cirrhosis. Gallbladder, cholecystectomy: Gallbladder without diagnostic. ebnormelities. A single benign cystic duct lymph node is. identified.",train,4. x 3.8 x 3.7 cm;4.4 x 3.8 x 3.7 cm
7105,TCGA-CU-A3YL.A1AF7975-132E-469A-B4C8-A0A3F19EA0D0,"Addenda Present. Accession # : Diagnosis: A: Urethra, proximal margin, biopsy. - No in situ or invasive carcinoma identified. B: Lymph nodes, right pelvic, dissection. - Five lymph nodes with no malignancy identified (0/5). C: Lymph nodes, left pelvic, dissection. - Two lymph nodes with no malignancy identified (0/2). D: Bladder and prostate, cystoprostatectomy. Tumor histologic type: papillary urothelial carcinoma. Tumor histologic grade (WHO classification) : high grade. Macroscopic tumor size (greatest dimension) : 8.5 cm. Microscopic extent of invasion: tumor invades the lamina propria. of the. bladder, prostatic ducts and prostatic stroma. Tumor site/focality of tumor: solitary; tumor involves bladder. and. prostate. Angiolymphatic space invasion: not identified. Associated epithelial lesions: urothelial carcinoma in situ. involves the bladder and. prostatic ducts bilaterally. Ureters: uninvolved. Histologic assessment of surgical margins: : Ureter, right: negative. Ureter, left: negative. Urethra: negative. Paravesicular soft tissue: negative. Prostate, right and left: negative. Lymph nodes : Seven lymph nodes with no malignancy identified. (0/7;. specimens A and B). Other findings : prostatic glandular atrophy; PIN4. immunohistochemical. stain pending on block D7 to rule out prostatic adenocarcinoma. (results will be. reported in an addendum). AJCC PATHOLOGIC TNM STAGE: pT4a pNO. NOTE: This pathologic stage assessment is based on information. available at the. time of this report, and is subject to change pending clinical. review and. additional information. Intraoperative Consult Diagnosis: An intraoperative consultation is requested by Dr. in. at. on. FSA1: : Urethral margin, biopsy. - Focal urothelial atypia, favor reactive, cannot completely. exclude low grade. dysplasia. - Dr. concurs. Drs. a. Frozen Section Pathologist: , MD. Clinical History: yoar-old. with a history of invasive high grade. urothelial carcinoma with. focal micropapillary features and urothelial carcinoma in situ. of the prostate. Gross Description: Received are four appropriately labeled containers. Container A holds a 1.5 X 0.7 X 0.4 cm partially cauterized. red/tan soft tissue. fragment, FSA1,. Container B is additionally labeled ""right pelvic lymph nodes. "". It holds. multiple brown/tan, fatty, lobulated soft tissue fragments which. measure 7.2 x. 4.5 X 1.7 cm in aggregate. Dissection reveals multiple lymph. node candidates,. the largest of which is 1.6 x 1.0 X 0.7 cm. Block summary: B1 - largest lymph node candidate, bisected. B2 - one lymph node candidate, bisected. B3 - two lymph node candidates. B4 - one lymph node candidate, bisected. Tissue remains in formalin. Container C is additionally labeled ""left pelvic lymph nodes. "". It holds multiple. tan lobulated fatty soft tissue fragments which measure 5.2 X. 4.0 X 1.8 cm in. aggregate. Dissection reveals two lymph node candidates which. measure 1.8 X 1.4. X 0.6 cm and 0.7 X 0.5 X 0.5 cm, respectively. Block Summary: C1,C2 - serial sections of largest lymph node candidate. C3 - one lymph node candidate, bisected. Fat remains in formalin. Container D is additionally labeled ""bladder and prostate. "". Specimen fixation: formalin. Type of specimen (s) received: radical cystoprostatectomy. Size of overall specimen: 15 cm superior to inferior, 13 cm. right to left, 8 cm. anterior to posterior. Size of urinary bladder 8 X 8 X 5 cm. Size of additional organs: The prostate is 4.2 X 3.2 X 3.0 cm. Orientation: Right=blue, left=black, and distal urethral. margin=yellow. Tumor size: 8.5 x 7.5 X 3.5 cm. Tumor description exophytic, papillary friable nodule;. Sectioning through the. tumor reveals a friable cut surface which appears to. be superficial. The underlying muscle wall appears intact as. does the. perivesicular fat. Tumor location: The tumor occupies the majority of the. urothelium sparring a. small portion of the posterior and left wall. The tumor. ends inferiorly at the prostatic urethra orifice. Distance of tumor to margins: Gross tumor is 2.2 cm from the. distal prosthetic. urethral margin. Other mucosal lesions none. Description of other organs or structures: Sectioning through. the prostate. reveals minimal periurethral nodularity and ill-defined white. indurated discoloration in the right posterior/lateral lobe. Digital photograph taken: not taken. Tissue submitted for special investigation: Tumor is given to. Block summary: (Inking: right=blue, left=black, distal urethral margin=yellow). D1 - en face right ureter margin. D2 - en face left ureter margin. D3 - en face distal urethral margin. D4-D5 - - representative section from right prostate. D6-D7 - - representative sections from left prostate. D8 - right ureterovesicular junction. D9 - left ureterovesicular junction. D10 - trigone/bladder neck with underlying seminal vesicle. tissue. D11 - section of dome. D12 - right wall. D13 - left wall. D14 - posterior wall. D15 - additional section of left wall. D16 - vas deferens margin of resection. D17 - representative section of blue and black inked deep soft. tissue margin. Procedures/Addenda: Addendum. Addendum. Immunohistochemical stains for PIN4. show an. intact basal cell layer, supporting the interpretation of benign. prostatic glands.",train,8.5 cm;8.5 x 7.5 X 3.5 cm
7185,TCGA-KM-8439.174672ef-6475-44c2-9934-8726b8e5e98e,"DIAGNOSIS: 1. Renal, tumor #1, left, partial nephrectomy: Renal cell carcinoma, chromophobe type. 2. Renal, tumor #4, left, partial nephrectomy: Renal cell carcinoma, chromophobe type. 3. Renal, tumor #5, left, partial nephrectomy: Renal cell carcinoma, chromophobe type. 4. Renal, tumor #2, left, partial nephrectomy: Renal cell carcinoma, chromophobe type. 5. Renal, tumor #3, left, partial nephrectomy: Renal cell carcinoma, chromophobe type. 6. Renal, tumor #6, left, partial nephrectomy: Renal cell carcinoma, chromophobe type. 7. Renal, tumor #7, left, partial nephrectomy: Renal cell carcinoma, chromophobe type. 8. Renal, tumor #8, left, partial nephrectomy: Renal cell carcinoma, clear cell type, Fuhrman nuclear grade. Il / III. Renal cell Carcinoma, Chromophobe type. See note. 9. Renal, tumor #9, left, partial nephrectomy: Renal cell carcinoma, clear cell type, Fuhrman nuclear grade. Il / III. Renal cell carcinoma, Chromophobe type. See note. NOTE: In specimens 8 and 9, two grossly and morphologically different tumor masses are identified; one is a. clear cell RCC and the other one an RCC chromophobe type. Immunoperoxidase and in-situ hybridization tests performed here and used for diagnosis were developed and their performance. characteristics determined by the. They have not been cleared or approved by the U.S. Food and Drug. Administration. The FDA has also determined that such clearance or approval is not necessary. This laboratory is certified under the Clinical. Laboratory Improvement Amendments of. (CLIA) as qualified to perform high complexity clinical laboratory testing. CLINICAL INFORMATION: Brief Clinical History: yo. male with bilateral renal tumors and no known family history of renal. cancer, attention. PROCEDURE: Pre-Operative Diagnosis: renal tumors Post-Operative Diagnosis: renal. tumors Operative Findings: diffuse involvement of left kidney with. renal tumors; minimal normal parenchyma observed on intraoperative. sonogram. SPECIMENS SUBMITTED: 1. TUMOR, Left kidney # 1 (1FS). 2. TUMOR, Left kidney # 4 (2FS). 3. TUMOR, Left kidney # 5 (3FS). 4. TUMOR, Left kidney # 2. 5. TUMOR, Left kidney # 3. 6. TUMOR, Left kdieny # 6. 7. TUMOR, Left kidney # 7. 8. TUMOR, Left kidney # 8. 9. TUMOR, Left kidney # 9. INTRAOPERATIVE CONSULTATION: 1. ""Tumor #1 left kidney"". 1FS diagnosis: Oncocytic neoplasm, favoring oncocytoma. 2. ""Tumor #4 left kidney"". 2FS diagnosis: Oncocytic neoplasm. 3. ""Tumor #5 left kidney"". 3FS diagnosis: Oncocytic neoplasm. These findings were reported by. GROSS DESCRIPTION: Received fresh from the OR is a specimen labeled with the patient's name, medical record number, and further. specified as: 1. ""tumor #1 left kidney"". It is an ovoid red to pink nodular tissue fragment measuring 2 x 1.5 X 0.8 cm. It is. trisected revealing a pink-tan homogeneous cut surface. The central slice is frozen as ""1FS"". Received in. the Gross Pathology Lab is a specimen matching the above description. The portion submitted as frozen. section is transferred to an orange cassette labeled 1FS. A second of the trisected pieces is submitted in. cassette labeled. or permanent processing. 2. ""tumor #4 left kidney"". It consists of a red to tan 2.5 x 1.8 x 1 cm tissue fragment. It was trisected and the. middle section is submitted as 2FS. Received in the Gross Pathology Lab is a specimen matching the. above description. The section submitted for frozen is transferred to an orange cassette labeled 2FS for. permanent processing. Representative further sections are taken and submitted in cassettes 2A and 2B. 3. ""tumor #5 left kidney"". It consists of a red-tan 5 X 5 X 3.5-cm tissue fragment. It was bisected to reveal a. red to tan hemorrhagic cut surface. Representative sections are frozen as 3FS. Received in the Gross. Pathology Lab is a specimen matching the above description. The frozen specimen was transferred to an. orange cassette labeled 3FS for permanent processing. Cassettes 3A-3G contains representative. sections of the tumor. 4. ""tumor #2 left kidney"". It is a dome-shaped red to pink nodular tissue fragment measuring 2 x 1.4 x 0.7. cm. It is bisected revealing a homogeneous tan to pink cut surface with central hemorrhage. Approximately 60% of the tissue is procured for UOB. Gross photographs are taken and the remainder of. the specimen is placed in formalin and submitted to Pathology for permanent processing. In the Gross. Pathology Lab a specimen matching the above description is received. It is entirely submitted in a. cassette labeled. or permanent processing. 5. ""Tumor #3 left kidney"". It is a dome-shaped red to pink nodular tissue fragment measuring 1.8 X 1.4 X 0.5. cm. It is bisected revealing a hemorrhagic maroon/red cut surface. Approximately 50% of the tissue is. procured for UOB. Gross photographs are taken and the remainder of the specimen is placed into. formalin and submitted to Pathology for permanent processing. Received in the Gross Pathology Lab is a. specimen matching the above description. A representative section is submitted in a cassette labeled. or permanent processing. 6. ""Tumor #6 left kidney"". The specimen is a spherical pink to red nodular tissue fragment measuring 4.8 x. 4.8 x 4.7 cm. It is bisected revealing a focally disrupted tan to pink nodular tissue fragment that is. homogeneous. The surface is tan to pink and fleshy. Approximately 30% of the tissue is procured for. UOB. Gross photographs are taken and the remainder of the specimen is placed into formalin and. submitted to Pathology for permanent processing. Received in the Gross Pathology Lab is a specimen. matching the above description. Representative sections are submitted in cassettes 6A-6E. Cassette 6A. contains a portion of adjacent tissue that has a distinct smooth creamy texture compared to the rest of the. lesion. 7. ""Tumor #7 left kidney"". The specimen consists of 2 fragments that are red to tan soft tissue and 1 yellow. to pink soft tissue fragment measuring from 2.5 to 4.5 cm in greatest dimension. The largest fragment is. bisected revealing a variegated maroon to pink hemorrhagic cut surface measuring 4.5 X 3.5 x 3. Approximately 50% of tissue from the largest fragment is procured for UOB. Gross photographs are. taken and the remainder of the specimen is placed into formalin and submitted to Pathology for. permanent processing. Received in the Gross Pathology Lab is a specimen matching the above. description. Representative sections are taken and submitted in cassettes labeled 7A-7F for permanent. processing. 8. ""Tumor #8 left kidney"" is a focally disrupted ovoid pink to tan nodular tissue fragment measuring 5.5 X 5 X. 3.5 cm. It is bisected revealing a tan-pink fleshy cut surface with a well-circumscribed yellow to tan. spherical nodule, 1.2 cm in greatest diameter, at the periphery. Approximately 50% of the tissue,. spherical tan nodule, and 20% of the rest of the specimen are procured. The remainder of the specimen. is placed into formalin and submitted to Pathology for permanent processing. Received in the Gross. Pathology Lab is a specimen matching the above description. Representative sections of the specimen. are taken and submitted in cassettes 8A-8E. Please note that 8E contains a representative section of the. nodule described. 9. ""Tumor #9 left kidney"". It is a binodular pink to tan tissue fragment overall measuring 2 x 1.5 x 1.5 cm. One nodule is well-circumscribed and solid homogeneous and tan measuring 1.3 cm. The other is ill-. defined, hemorrhagic, and variegated maroon to tan and measuring 1.2 cm. Approximately 50% of tissue. is procured for UOB. Gross photographs are taken and the remainder of the specimen is placed into. formalin and submitted to Pathology for permanent processing. Received in Pathology is a specimen. matching the above description. The two fragments are submitted in white cassettes labeled 9A and 9B. AZR1. dentification. 4 of 5. NIH-2772 (7/97). P.A. 09-25-0099. File in Section 3: Tissue Examination.",train,
7190,TCGA-MY-A913.E17EECA7-26DE-4456-94B2-6B5A9F4931AD,"Med Rec. #: Report Name: : Surg Path Case - STATUS: Final. ES NOTE. Collect/Perform: Department: Physician who Performed Procedure: Requesting Physician: Attending Pathologist : DIAGNOSIS: Cervix, biopsy: - Fragments of invasive poorly differentiated squamous carcinoma. - Orientation precludes measurement of depth of invasion. COMMENT: There is a copious amount of sampled tigsue, almost all of which. is composed of. tumor. A p63 stain is strongly positive supporting the diagnosis. CLINICAL INFORMATION: Cervical cancer. GROSS DESCRIPTION: The specimen is received fresh labeled ""cervical biopsy . It consists of a. 2 x 0.7 x 0.4 cm. irregular portion of tan rubbery tissue. One aspect demonstrates apparent. tan smooth mucosa. The tissue is inked and serially sectioned. The cut. surfaces are tan and smooth. Also received are two tan rubbery tissue. fragments measuring 0.5 x 0.4 x 0.2 cm in aggregate. The specimen is. entirely submitted in three cassettes as follows: 1A-1B- largest portion of tissue, sectioned. 1C separately received tissue fragments. The following special studies were performed on this case and the. interpretation is incorporated in the diagnostic report above: Report Name: I certify that I personally conducted the diagnostic evaluation of the. above specimen (s) and have rendered the final diagnosis (es). Note: The histology, immunochemistry and in situ hybridization components. for this case were performed at. The Attending Pathologist reviewed this case and made the diagnosis. Where applicable, immunohistochemistry and in situ hybridization teats were. developed and the performance characteristics determined by the. have not been cleared or approved by the US Food and Drug Administration. and the results should be correlated with other clinical and laboratory. data. Appropriate controls were performed for all immunohistochemistry; in. situ hybridization and histochemical tests.",train,
7201,TCGA-EL-A3GR.F2945CC2-AEE4-45F7-A640-4174EB0D37FD,"Sex: F. Case type: Surgical Case. DIAGNOSIS. (A) THYROID, TOTAL THYROIDECTOMY: PAPILLARY THYROID CARCINOMA (3.0 X 2.0 CM) INVOLVING THE RIGHT LOBE OF THE THYROID. EXTRATHYROIDAL EXTENSION PRESENT. Margins of resection free of tumor. VASCULAR INVASION IDENTIFIED. METASTATIC PAPILLARY CARCINOMA IN SIX OF SEVEN EXAMINED PERITHYROIDAL LYMPH NODES (6/7). (B) TISSUE DESIGNATED RULE OUT PARATHYROID, EXCISION: Parathyroid tissue present. (C) RIGHT PARATRACHEAL LYMPH NODES, NODE DISSECTION: METASTATIC PAPILLARY CARCINOMA IN NINE OF TWELVE EXAMINED LYMPH NODES (9/12); NO. EXTRACAPSULAR EXTENSION PRESENT. (D) RIGHT BUCCAL LESION, EXCISION: One benign lymph node with no tumor present (0/1). Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) TOTAL THYROIDECTOMY - A total thyroidectomy specimen consisting of a right lobe (5.0 x 2.5 x 2.0 cm), unremarkable. isthmus (2.0 x 2.0 x 0.5 cm) with possible pyramidal lobe, and left lobe (3.0 x 2.0 x 1.0 cm). The cut surface of the right lobe shows a well defined, soft, papillary lesion (3.0 x 2.0x 2.0. cm). involving. the. middle. and. the lower third of the lobe. The cut surface of the isthmus and the left lobe are unremarkable. SECTION CODE: A1-A5, tumor, right lobe; A6-A8, remnant of unremarkable left lobe; A9, possible pyramidal lobe; A10,. isthmus, in toto; A11, left lobe, in toto. Sampling of the tumor and unremarkable thyroid parenchyma was performed for the tumor bank. (B) RULE OUT PARATHYROID - A 0.3 x 0.3 x 0.2 cm pink fragment of soft tissue. Specimen is submitted in toto in B for frozen. section. Also prepared are two touch preps. FS/DX: PARATHYROID TISSUE. (C). RIGHT PARATRACHEAL DISSECTION - An irregular fragment of fibrous adipose tissue measuring 4.0 x 2.5x0.8 cm. The. specimen is serially sectioned and ten lymph nodes are identified ranging from (0.3 x 0.3 x 0.2 to 1.0 x 0.8 x 0.4 cm). SECTION CODE: C1, four lymph nodes; C2, four lymph nodes; C3, two lymph nodes. (D) RIGHT BUCCAL LESION - A yellow-pink node measuring 0.8 x 0.4 x 0.4 cm. The specimen is entirely submitted in D. COOLEY, CHERYL. Sex: F. Case type: Surgical Case. CLINICAL HISTORY. Papillary thyroid cancer. SNOMED CODES. T-B6000, M-80503, M-80506. ""Some tests reported here may have been developed and performance characteristics determined by. hase tests have not been specifically cleared or approved. by the U.S. Food and Drug Administration."". Released by:",train,3.0 X 2.0 CM
7273,TCGA-28-1746.2abf3d8f-18f6-493d-89b8-3e2a5f37f84e,"bepartment of Pathology & Laboratory Medicine. Addendum - Please See End of Report. Reason for Addendum #1: Additional studies/stains/opinion(s). DIAGNOSIS: A, G, H. BRAIN, RIGHT TEMPORAL, EXCISIONAL BIOPSY: Glioblastoma multiforme, WHO grade IV. B. BRAIN, RIGHT TEMPORAL, EXCISIONAL BIOPSY: Glioblastoma multiforme, WHO grade IV. Proportion of the tumor - 95%. Proportion of necrosis - 10%. C. BRAIN, RIGHT TEMPORAL, EXCISIONAL BIOPSY: Glioblastoma multiforme, WHO grade IV. Proportion of the tumor - 100%. Proportion of necrosis - 30%. D. BRAIN, RIGHT TEMPORAL, EXCISIONAL BIOPSY: Glioblastoma multiforme, WHO grade IV. Proportion of the tumor - 100% of cortex and white matter infiltrated by the tumor. Proportion of necrosis - 0%. E. BRAIN, RIGHT TEMPORAL, EXCISIONAL BIOPSY: Glioblastoma multiforme, WHO grade IV. Proportion of the tumor - 100%. Proportion of necrosis - 25%. F. BRAIN, RIGHT TEMPORAL, EXCISIONAL BIOPSY: Glioblastoma multiforme, WHO grade IV. Proportion of the tumor - 100%. Proportion of necrosis - 0%. COMMENT: A high percentage of tumor cells (greater than 20%) immunostaining for MGMT has been reported to be associated. with a relatively diminished response to Temodar. Hence, the low 5% result in. this case suggests a likelihood of this tumor being responsive to Temodar. Recent studies have shown that co-expression of EGFRvIII and PTEN as detected by immunostaining was. significantly correlated with a clinical response of glioblastomas to EGFR kinase inhibitors. Hence the loss of PTEN in this case suggests a diminished probability of response to. EGFR-kinase inhibitors. Patient Case(s): Page UI ,. PATIENT NOTIFIED OF RESULTS. DR: NURSE: Addendum - Please See End of Report. Recent studies indicated an adverse prognostic significance of increased expression of laminin beta 1 and decreased. expression of laminin beta 2 predicting a worse survival of patients with gliomas. between laminin-8 and glial tumor grade, recurrence, and patient survival. Accordingly, elevated expression of beta 1 and suppressed expression of beta 2 in this tumor predict more. aggressive behavior. Retained expression of PTEN was found to be associated with a more favorable prognosis in patients with high. grade gliomas. Molecular subclasses of high-grade glioma. predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. Presence of activated (phosphorylated p42/44 Mitogen-Activated Protein Kinase (pMAPK) has been shown to be. associated with a relative resistance of glioblastoma multiforme to radiation therapy. Prognostic Associations of Activated Mitogen-Activated Protein Kinase and Akt Pathways in. Glioblastoma. Correspondingly, presence of a large fraction of cells immunonegative to pMAPK antibody in this case suggests a. likelihood of this tumor being responsive to radiation therapy. The use of these tests in guiding therapy has limitations. Review of the relevant literature and clinical correlation. is. advised. These test results do not obligate or preclude use of the relevant therapeutic agents. IDC2a: Selected slides were reviewed in consultation with. HISTORY: Temporal tumor. MICROSCOPIC: Sections disclose necrotizing malignant neoplasm featuring striking microvascular proliferation and composed of. diffuse infiltration of hyperchromatic elongate astrocytic nuclei showing numerous mitotic figures. The tumor. displays extensive infiltration with focal extension to the pia. IMMUNOSTAINS: MGMT (G3): 3%. PTEN (G3): Loss (I+). pMAPK (G3): 10% of tumor nuclei and 15% of tumor cell cytoplasm is positive. Laminin beta-1 (8/411) (G3): Upregulated (3+ in endothelial cells). Laminin beta-2 (9/421) (G3): Focal loss (0-1+ staining in endothelial cells). GROSS: A. RIGHT TEMPORAL TUMOR FS. Labeled with the patient's name, labeled ""right temporal"", and received fresh in the Operating Room for frozen. section consultation and subsequently fixed in formalin is a 1.5 x 2.1 x 0.4 cm aggregate of multiple pink-tan soft. tissue fragments ranging from 0.1 to 1.1 cm in greatest dimension. Entirely submitted. A1. Frozen section remnant - 1. A2. Remaining tissue - multiple. B. RIGHT TEMPORAL. Labeled with the patient's name, labeled ""right temporal"", and received in formalin is a 0.9 x 0.4 x 0.3 cm pink-tan. soft tissue fragment. Entirely embedded. Addendum - Please See End of Report. Slide key: B1. Frozen section remnant - 1. C. RIGHT TEMPORAL. Labeled with the patient's name, labeled ""right temporal"", and received in formalin is a 0.5 x 0.4 x 0.2 cm pink-gray. soft tissue fragments. Entirely embedded. CI. 1. D. RIGHT TEMPORAL. Labeled with the patient's name, labeled ""right temporal"", and received in formalin is a 0.4 X 0.2 x 0.3 cm gray-tan. soft tissue fragment. Entirely embedded. Slide key: DI. I. E. RIGHT TEMPORAL. Labeled with the patient's name, labeled ""right temporal"", and received in formalin are two soft pink-tan tissue. fragments measuring 0.4 x 0.2 x 0.1 cm and 0.5 x 0.4 x 0.1 cm. Entirely embedded. E1. 2. F. RIGHT TEMPORAL. Labeled with the patient's name, labeled ""right temporal"", and received in formalin is a 0.5 X 0.4 X 0.1 cm pink-gray. soft tissue fragment. Entirely submitted. F1. 1. G. RIGHT TEMPORAL/PERMANENT. Labeled with the patient's name, labeled ""right temporal"", and received in formalin is a 4.2 x 3.5 x 1.5 cm aggregate. of multiple pink-gray soft tissue fragments with focal areas of hemorrhage on their surfaces. The segments range in. size from 0.1 cm to 2.4 cm in greatest dimension. Entirely embedded. Slide key: G1. 4. G2. 3. G3. Multiple. G4. 3. H. RIGHT TEMPORAL. Labeled with the patient's name, labeled ""right temporal tumor"", and received in formalin is a 3.5 x 4.0 X 1.8 cm. aggregate of multiple pink-tan soft tissue fragments ranging from 0.5 to 3.2 cm in greatest dimension. Along the. outer surfaces of the fragment are focal areas of hemorrhage. Entirely embedded. HI. 4. H2. 2. H3. 4. H4. 2. Gross dictated by. OPERATIVE CALL. OPERATIVE CONSULT (FROZEN): PART A. RIGHT TEMPORAL FS: Glioblastoma. Addendum - Please See End of Report. If this report includes immunohistochemical test results. please note the following: Numerous imunuohistochemical tests were developed and their performance characteristics determined by. Il of Pathology and Laboratory Medicine. Those immuohistochemical tests have not been cleared or approved by the. U.S. Food and Drug Administration (FDA), and FDA approval is not required. I have personally examined the specimen. interpreted the results. reviewed the report and signed it electronically. FADDENDUM. FISH (FLUORESCENCE IN SITU HYBRIDIZATION) for EGFR. Number of cells analyzed: 40. Ratio of EGFR/CEP: 1.1. Percentage of cells with >4 copies of EGFR: 72.5%. Amplification: NO. High Level of Polysomy: YES. INTERPRETATION: 1. Samples are interpreted as Positive if : a. EGFR to CEP 7 signal ratio is > 2.0 in > 10% of analyzed cells. b. When high level of polysomy (> four copies of EGFR in > 40% of cells) is present. 2. Samples are interpreted as Negative if EGFR to CEP 7 signal ratio is < 2.0 or in the absence of high. level of polysomy (> four copies of EGFR). 3. Samples are considered inconclusive, requiring consult with the pathologist, when EGFR to CEP 7. signal ratio is > 2.0 in < 10% of analyzed cells or when high level of polysomy (> four copies of. EGFR) is present in < 40% of cells. These cases also need to be co-read. Addendum - Please See End of Report. REFERENCES. I have personally examined the specimen. interpreted the results. reviewed the report and signed it electronically.",train,3.5 x 4.0 X 1.8 cm
7309,TCGA-58-8392.d98ba859-91e2-4de1-bb61-b925d77e33de,"Pathology Report-Summary: Material: Lung, left, upper lobe: 19.0 X 17.0 X 5.5 cm. Tumor: 4.8 X 4.2 X 3.8 cm. Diagnosis: Squamous Cell Carcinoma (NOS), partially basaloid. pT2a, pNO (0/23), pMx, G3. Supplementary examination: EGFR mutation analysis (sanger sequencing, Ex 18 - 21). EGFR mutation positive. p.L856R (c.2573T>G).",train,4.8 X 4.2 X 3.8 cm
7315,TCGA-RC-A7SH.F862582D-03E2-41AB-85C8-B637C2573E74,"(Ver ified). A-D. Liver, right lobectomy: HEPATOCELLULAR CARCINOMA. Tumor number : one. Satellite nodule: no. Gross type: nodular with per inodular extension. Size(on) : 7.5x6.5x4.0cm. Differentiation: The worst differentiation: Edmondson grade IV. Differentiation: The major differentiation: Edmondson grade III. Histologic type : Macrotrabecular, Microtrabecular, Pseudoglandular. Cell type: Hepatic. Clear. Tumor necrosis : no. Hemorrhage : yes ( less than 5%). Fatity change : no. Fibrous capsule : partial. Infiltration of capsule : yes. Septum formation : yes. Surgical margin invasion : no(margin of the clearance 5.5 cm). Serosa invasion: no. Portal vein invasion : no. Bile duct invasion : no. Hepatic vein invasion : no. Hepatic artery invasion : no. Microvesse| invasion : yes. Intrahepatic metastasis : no. Multicenteric occurrence : no. T stage : pT2. N stage: No metastasis in all 1 Tymph node(pNO). [ 0/1: per ipor tal vein (0/1)]. Non-tumor liver. Chronic hepatitis : yes. Etilogy : HBV. Grade, lobular : minimal. Grade, portoperiportal : none. Stage(tibrosis) : septal. Cirrhosis : no. Dysplastic nodule : no. (Verified). Ductal epithelial dysplasia : no. Other liver disease : no. Gallbladder : No pathologic abnormality. Falciforin Ligament: No pathologic abnormality. < Immunohistochemical stain results >. Iron (block A11) : Negative. Cytokeratin 7 (block A11): Positive in bile ducts. Cytokeratin 19(block A5): Negative. Cytokeratin 7 (block A5): Focal positive. Hepatocyte (block A5): Positive. A. The speciment received in formali consists of a lobectomy of liver. measuring. 16x12x8cm and weighing 800gm. The external surface shows a huge capsular. mass. The parenchyme resection margins are clear. The vascular resection. margin also clear. On section, there is an nodular mass with perinodular. extension. measuring 7.5x6.5x4cm. The mass is 5.5cm apart from parenchyme. resection margin. The remaining parenchyme shows cirrhotic change. Representative sections are embedded. (A1-Periportal vain lymph node. A2 to 8- tumor one plane, A9 and 10- tumor with capsuie. A11- background liver). B. The specimen. received in formalir consists of a gallbladder. measuring 8cm. in length and 3cm in diameter. The capsular surface is unremarkable. The wall measures 0. .2cm in maximal thickness. The mucosa is greenish velvety. There is no stone or polyo Representative sections are embedded in. one cassette. C. The specimen received in formalin consists of compartmentalized Tymph nodes. All Tymph nodes found are entirely embedded. (C-LN). 0. The soecimen received in formalin consists of a Tump of adipose tissue. clinically labeled as ""falciform higament"" measuring 4x3xicm. On serial section. there is no definite mass. Representat ive sections are embedded in a cassette. H&E(14). MT(1), RTC(1). D-PAS(1). Tron(1). Cytokeratin 7(7). Cytokeratin 19(1). tron (1). (Ver if fied).",train,7.5x6.5x4.0cm
7376,TCGA-DV-5568.6102167a-dc99-4515-bb5c-e545b592c309,"DIAGNOSIS: 1. Kidney, right, ""tumor #1"" (excision): Cyst with fibrosis. 2. Kidney, right, ""tumor #2"" (excision): Renal cell carcinoma, clear cell type, Furhman nuclear grade II. 3. Kidney, right, ""tumor #3"" (excision): Renal cell carcinoma, clear cell type, Furhman nuclear grade II. 4. Kidney, right, ""tumor #4"" (excision): Fibrous tissue. 5. Kidney, right, ""tumor #5"" (excision): Renal cell carcinoma, clear cell type, Furhman nuclear grade II. 6. Kidney, right, ""tumor #6"" (excision): Renal cell carcinoma, clear cell type, Furhman nuclear grade II. 7. Kidney, right, ""tumor #7"" (excision): Renal cyst lined by atypical cells. 8. Kidney, right, ""tumor #8"" (excision): Renal cyst lined by atypical cells. 9. Kidney, right, ""tumor #9"" (excision): Renal cell carcinoma, clear cell type, Furhman nuclear grade. II. 10. Kidney, right, ""tumor #10"" (excision): Renal cell carcinoma, clear cell type, Furhman nuclear grade II. 11. Kidney, right, ""tumor #11"" (excision): Renal cell carcinoma, clear cell type, Furhman nuclear grade II. 12. Kidney, right, ""tumor #12"" (excision): Fibrous tissue and renal parenchyma. 13. Kidney, right, ""tumor #13"" (excision): Renal cell carcinoma, clear cell type, Furhman nuclear grade II. NOTE: CLINICAL INFORMATION: Brief Clinical History: history of VHL, bilateral renal massess. Specimen Taken For Protocol: Yes Allocate Order to Protocol: PROCEDURE: SPECIMENS SUBMITTED: 1. KIDNEY, RIGHT, Tumor. 2. KIDNEY, RIGHT, Tumor. 3. KIDNEY, RIGHT, Tumor. 4. KIDNEY, RIGHT, Tumor. 5. KIDNEY, RIGHT, Tumor. 6. KIDNEY, RIGHT, Tumor. 7. KIDNEY, RIGHT, Tumor. 8. KIDNEY, RIGHT, Tumor. 9. KIDNEY, RIGHT, Tumor. 10. KIDNEY, RIGHT, Tumor. 11. KIDNEY, RIGHT, Tumor. 12. KIDNEY, RIGHT, Tumor. 13. KIDNEY, RIGHT, Tumor. GROSS DESCRIPTION: Received are 13 containers labeled with the patient's name, medical record. number, and further specified as: 1. ""Tumor #1 right kidney"". The specimen consists of a cystic soft tissue mass that has been opened to. reveal a smooth cavity that appears loculated. The specimen measures 1.5 X 1.2 x 1.0 cm. The. specimen is serially sectioned and representative sections are submitted in white cassette labeled. for permanent processing. 2. ""Tumor #2 right kidney"". The specimen consists of a red-tan soft tissue mass measuring 1.3 x 1.0 X 1.0. cm. 75% of the tumor is procured for the UOB Lab. The remaining specimen is sent to Surgical. Pathology. In Surgical Pathology, the specimen received matches the above description. The cut. surface of the tumor reveals a yellow solid tumor mass. The specimen is sectioned and entirely. submitted in white cassette labeled. for permanent processing. 3. ""Tumor #3 right kidney"". The specimen consists of a 0.8 x 0.5 x 0.2 cm soft tissue mass. 50% of the. tumor is procured by the. The remaining tissue is sent to Surgical Pathology. In Surgical. Pathology, the specimen received matches the above description. The specimen is entirely submitted in. white cassette labeled. for permanent processing. rage 2 of 4. 4. ""Tumor #4 right kidney"". The specimen consists of a red-tan soft tissue mass measuring 0.5 x 0.5 x 0.3. cm. The specimen is entirely submitted in white cassette labeled. for permanent. processing. 5. ""Tumor #5 right kidney"". The specimen consists of a red-tan soft tissue mass measuring 1.5 X 1.5 x 1.2. cm. Approximately 60% of the tumor is procured for the. The remaining specimen is sent to. Surgical Pathology. In Surgical Pathology, the specimen received matches the above description. The. cut surface of the tumor reveals a yellow solid tumor nodule. The specimen is serially sectioned and. entirely submitted in white cassette labeled. for permanent processing. 6. ""Tumor #6 right kidney"". The specimen consists of a red-tan soft tissue mass measuring 0.8 x 0.8 X 0.5. cm. Approximately 50% of the specimen is procured by the. The remaining specimen is sent to. Surgical Pathology. In Surgical Pathology, the specimen received matches the above description. The. specimen is entirely submitted in white cassette labelec. for permanent processing. 7. ""Tumor #7 right kidney"". The specimen consists of a red-tan soft tissue mass measuring 1.0 X 1.0 x 0.5. cm. The specimen is entirely submitted in white cassette labeled. for permanent. processing. 8. ""Tumor #8 right kidney"". The specimen consists of a red-tan soft tissue fragment measuring 0.6 x 0.2 X. 0.2 cm. The specimen is entirely submitted in white cassette labeled. for permanent. processing. 9. ""Tumor #9 right kidney"". The specimen consists of a 1.0 X 0.8 x 0.6 cm soft tissue fragment. Approximately 60% is procured for the The remaining specimen is sent to Surgical Pathology. In Surgical Pathology, the specimen received matches the above description. The specimen is entirely. submitted in white cassette labeled. for permanent processing. 10. ""Tumor #10 right kidney"". The specimen consists of a red-tan soft tissue mass measuring 3 x 3 x 3 cm. Approximately 75% is procured by the. The remaining specimen is sent to Surgical Pathology. In Surgical Pathology, the specimen received matches the above description. The cut surface of the. tumor reveals a yellow necrotic cut surface. The specimen is serially sectioned and representative. section is submitted in white cassette labeled. for permanent processing. 11. ""Tumor #11 right kidney"". The specimen consists of a red-tan soft tissue mass measuring 1 x 1 X 1 cm. Approximately 50% of the tumor is procured by the. The remaining specimen is sent. to. Surgical Pathology. In Surgical Pathology, the specimen received matches the above description. The. specimen is serially sectioned to reveal a yellow-red cut surface. The specimen is entirely submitted in. white cassette labeled. for permanent processing. 12. ""Tumor #12 right kidney"". The specimen consists of a red-tan soft tissue mass measuring 0.6 X 0.5 X 0.4. cm. Approximately 50% of the tumor is procured by the. The remaining specimen is sent to. Surgical Pathology. In Surgical Pathology, the specimen received matches the above description. The. specimen is entirely submitted in white cassette labeled. for permanent processing. 13. ""Tumor #13 right kidney"". The specimen consists of a red-tan soft tissue mass measuring 1.7 x 1.2 X 1.2. cm. Approximately 50% of the tumor is procured for the. The remaining specimen is sent to. Surgical Pathology. In Surgical Pathology, the specimen received matches the above description. The. specimen is serially sectioned to reveal a yellow-red cut surface. Representative sections are submitted. in white cassette labeled. for permanent processing. No consultants.",train,1.5 X 1.2 x 1.0 cm;1.3 x 1.0 X 1.0. cm;0.8 x 0.5 x 0.2 cm;0.5 x 0.5 x 0.3. cm;1.5 X 1.5 x 1.2. cm;0.8 x 0.8 X 0.5. cm;1.0 X 1.0 x 0.5. cm;0.6 x 0.2 X. 0.2 cm;1.0 X 0.8 x 0.6 cm;3 x 3 x 3 cm;1 x 1 X 1 cm;0.6 X 0.5 X 0.4. cm;1.7 x 1.2 X 1.2. cm
7387,TCGA-A2-A04R.6A97C809-91BB-4E35-9E12-F5F2A58C9D35,"Specimen # : F. Race: BLACK. AMENDED. SPECIMEN: A: LEFT SENTINEL LYMPH NODE B: LEFT BREAST TISSUE. FINAL DIAGNOSIS: A. LYMPH NODE, LEFT SENTINEL, EXCISION: - NEGATIVE FOR MALIGNANCY BY IMMUNOHISTOCHEMISTRY. B. BREAST, LEFT, LUMPECTOMY: - INFILTRATING DUCTAL CARCINOMA, MODERATELY DIFFERENTIATED BY COMBINED. HISTOLOGIC CRITERIA. - MAXIMUM TUMOR DIMENSION = 2.0 CM. - ASSOCIATED DUCTAL CARCINOMA IN SITU, NUCLEAR GRADE 2 WITH NECROSIS. - SURGICAL MARGINS ARE NEGATIVE FOR TUMOR. MICROCALCIFICATIONS IDENTIFIED IN THE DUCTAL CARCINOMA IN SITU. AND THE INFILTRATING CARCINOMA COMPONENTS. ESTROGEN RECEPTOR POSITIVE (80% nuclear staining). PROGESTERONE RECEPTOR: POSITIVE ( 90% nuclear staining). (SEE COMMENT) . AMMENDMENT 2: FOLLOWING INTRADEPARTMENTAL REVIEW, RESULTS OF HER2 STUDIES. ARE REVISED. HER2 BY IMMUNOHISTOCHEMISTRY: WEAKLY POSITIVE (2+). HER2 BY FISH: NOT AMPLIFIED (1. 1). COMMENT: Estrogen and progesterone receptors were evaluated by immunohistochemical. methods. A positive test is defined as easily discernable nuclear. staining in more than 58 of the tumor cells. The specimen was evaluated for HER-2/Neu (c-erbB2) overexpression by. immunohistochemical methods (DAKO Hercep Test) . Staining is interpreted. on a scale of 0 to 3+ with positivity defined as 2+ or greater. Specimens. with a weakly positive (2+) Hercep Test are further evaluated by. Specimen #. FINAL DIAGNOSIS (continued) : fluorescence in situ hybridization (PathVysion FISH assay) to detect. presence or absence of Her-2/neu - gene amplification. CLINICAL DIAGNOSIS AND HISTORY: -year-old. female with T1NOMO infiltrating ductal. carcinoma of left breast on physical exam and core biopsy. GROSS DESCRIPTION: A. LEFT SENTINEL LYMPH NODE received fresh, labeled with the patient's. name, designated ""LEFT SENTINEL LYMPH NODE"" consists of a 2.0 cm x 0.7 cm. x 0.4 cm soft, tan tissue fragment. Bisected. 1CF. B. LEFT BREAST TISSUE received fresh, labeled with the patient's name,. designated ""LEFT BREAST TISSUE"" consists of a piece of fibrofatty tissue,. measuring 9.7 cm anterior to posterior, 6.8 cm medial to lateral, and 5.0. cm superior to inferior. The overlying ellipse of brown skin, with a 0.4. cm linear incision, measures 2.6 cm x 0.8 cm. Ink code: Red=lateral,. yellow=medial, black=posterior, blue=superior, and green=inferior. The. specimen is sectioned anterior to posterior revealing a 2.0 cm tumor, with. ell-defined margins and white, gritty cut surface, 0.4 cm from the. nearest margin superior. The remaining tissue is mostly fatty with a few. patches of white fibrous tissue. One section of skin, one section of. grossly normal fibrous tissue, and two sections of tumor are submitted for. the CBCP protocol (matching paraffin section=B1, B2, and B3-B4,. respectively) . Slide key: B1: Representative skin. B2: Grossly normal fibrous tissue. B3-B4: Tumor. B5-B6: Anterior margin. B7: Representative fibrous tissue. B8-B9: Tumor. B10-B12: Section of B3. B13-B14: Representative sections. B15-B16: Section of B4. B17: Representative sections. B18-B22 Posterior. margin. 22CF.",train,2.0 CM;2.0 cm
7429,TCGA-B8-4153.3ce87474-7776-467a-b209-79972b785698,"Diagnosis: Kidney, left, laparoscopic radical nephrectomy. Histologic tumor type/subtype: renal cell carcinoma, clear. cell type. Histologic grade (if applicable) : Fuhrman grade 3 of 4. Tumor size (greatest dimension) : 5 cm. Extent of tumor invasion: Capsular invasion/perirenal adipose tissue: negative for. carcinoma. S fascia: negative for carcinoma. Renal vein: negative for carcinoma. Ureter: negative for carcinoma. Venous (large vessel) : positive for renal cell carcinoma. (A8). Lymphatic (small vessel) : negative for carcinoma. Sinus adipose tissue: positive for renal cell carcinoma. Adjacent organs: negative for carcinoma. Histologic assessment of surgical margins: Perirenal adipose tissue: negative for carcinoma. Gerota' S fascia: negative for carcinoma. Renal vein: negative for carcinoma. Renal artery: negative for carcinoma. Ureter: negative for carcinoma. Adrenal gland: Negative for carcinoma. Lymph nodes: none identified. Other significant findings: simple renal cyst. AJCC Staging : pT3a. pNx. pMx. This staging information is based on information available. at the time of this report, and is subject to change. pending clinical review and additional information. Clinical History: The patient is who presents with left renal mass. Gross Description: Specimen fixation: Formalin. Type of specimen: Laparoscopic radical nephrectomy. Side of specimen: Left. Size and weight of specimen: 800 grams; overall 26 X 13. X. 11.5 cm; kidney 11 X 8 X 6 cm; adrenal 4.5 X 1.5 cm. Orientation: The external surface of the specimen is inked. blue, the adrenal gland is dotted with yellow ink. Presence/absence of adrenal gland: Present. Tumor description/site: The tumor involves the renal. cortex, medulla, and pelvis, with a pushing border into the. perirenal adipose tissue (there is no infiltrating tumor. beyond the capsule into the perirenal fat) ; the tumor has. an overall central location that does not favor either the. superior or inferior poles; the tumor is orange/yellow,. ell-circumscribed, and firm to palpation; areas of. hemorrhage and necrosis are identified. Tumor size: 5 X 4.5 X 4.0 cm. Presence/absence of multicentricity: The tumor is unifocal. Confinement/non-confinement to the kidney: The tumor has a. pushing border but does not invade through the renal. capsule (the tumor is close to the blue inked surgical. margin of resection). Extent of invasion: Perirenal adipose tissue: Negative. Gerota' S fascia: Negative. Renal vein: Negative. Ureter: Negative. Other organs: The tumor does not involve the adrenal gland. Surgical margins: Perirenal adipose tissue: Negative. Renal vein: Negative. Renal artery: Negative. Ureter: Negative. Description of kidney away from tumor: The remainder of the. normal kidney demonstrates a normal cortex to medulla ratio. and is unremarkable. Lymph nodes (hilar) : No hilar lymph nodes are appreciated. Other significant findings: None. Tissue submitted for special investigations: Normal and. neoplastic tissue are submitted to tissue procurement for. special investigation. Digital photograph taken: None taken. Block Summary: A1 - Distal vascular margins and ureter. A2 - Tumor with close approach to blue surgical ink and. extension from cortex into perirenal fat. A3 - Additional section of tumor and perirenal fat. A4 - Section of tumor near interface of medulla and renal. pelvis. A5 - Representative section of tumor with adjacent cortex. and perirenal fat. A6 - Representative section of adrenal gland. A7 - Representative section of large vessel with hemorrhage. and adjacent kidney/tumor. A8 - Additional representative section of tumor near. interface of medulla and pelvis. A9 - Section of uninvolved kidney with simple cyst.",train,5 cm;5 X 4.5 X 4.0 cm
7469,TCGA-XC-AA0X.B22BD117-8DF0-47FF-BE25-9FE2DA916DB6,"Female. Admission Date: Discharge Date: Collected Date/Time: Received Date/Time: Final Diagnosis. A. LUNG, RIGHT LOWER LOBE, LOBECTOMY: - INVASIVE AND IN SITU SQUAMOUS CELL CARCINOMA, 1.3 CM, SEE SYNOPTIC REPORT. - FOUR LYMPH NODES NEGATIVE FOR MALIGNANCY (0/4). B. LYMPH NODES, LEVEL 7, RESECTION: THREE LYMPH NODES NEGATIVE FOR MALIGNANCY (0/3). C. LYMPH NODES, LEVEL 10, RESECTION: FOUR LYMPH NODES NEGATIVE FOR MALIGNANCY (0/4). D. LUNG, RIGHT MIDDLE LOBE, WEDGE RESECTION: - LUNG WITH EMPHYSEMATOUS CHANGES, ALVEOLAR HEMORRHAGE. E. LYMPH NODES, R4, RESECTION: - ONE LYMPH NODE NEGATIVE FOR MALIGNANCY (0/1). F. LYMPH NODE, R2, RESECTION: - ONE LYMPH NODE NEGATIVE FOR MALIGNANCY (0/1). (Electronic signature). Verified: Synoptic Report. SPECIMEN: Lung. PROCEDURE: Lobectomy. SPECIMEN INTEGRITY: Intact. Print Date/Time: Distribute to: Patient T locations: Collected Date/Time: Received Date/Time: SPECIMENLATERALITY: Right. TUMOR SITE: Lower lobe. TUMOR SIZE: Greatest dimension: 1.3 cm. TUMOR FOCALITY: Unifocal. HISTOLOGIC TYPE: Squamous cell carcinoma. HISTOLOGIC GRADE: G2: Moderately differentiated. VISCERAL PLEURA INVASION: Not identified. TUMOR EXTENSION: Tumor involves main bronchus 2 cm or more distal to the carina. BRONCHIAL MARGIN: Cannot be assessed. VASCULAR MARGIN: Cannot be assessed. PARENCHYMAL MARGIN: Uninvolved by invasive carcinoma. PARIETAL PLEURAL MARGIN: Not applicable. CHEST WALL MARGIN: Not applicable. TREATMENT EFFECT: Not applicable. LYMPH-VASCULAR INVASION: Not identified. PRIMARY TUMOR (pT): pTla: Tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of. invasion more proximal than the lobar bronchus (ie, not in the main bronchus); or. REGIONAL LYMPH NODES (pN): pNO: No regional lymph node metastasis. Number examined: 13. Number involved: 0. DISTANT METASTASIS (pM): Not applicable. Source of Specimen. A. Right Lower Lobe. B. Level 7. C. Level 10. Print Date/Time: Collected Date/Time: Received Date/Time: D. Right Middle Lobe. E. R4. F. R2. Clinical Information. PRE-OP DIAGNOSIS: Lung cancer. POST-OP DIAGNOSIS: Same. TYPE OF PROCEDURE: Bronchoscopy, right VATS. Rmoval right lower lobe. Gross Description. Specimen is received in 6 parts: A. The specimen is labeled ""RIGHT LOWER LOBE"" and is received unfixed. It consists of a lobe of the lung measuring 15 x 12 x 8. cm and weighing 280 g. The pleural surface is pink-purple and smooth and shows multiple anthracotic markings. The bronchial and. vascular margins are stapled shut. The soft tissue margin of resection measuring 2 cm, 4 cm, 4.5 cm and 5 cm. A 1.3 x 1.2 x 1.2 cm an ill-defined gray-tan mass is identified 2 cm away from the bronchial margin of resection and 3 cm away from. the closest pleural surface. Pleural surface closest to the mass is covered with smooth surface without any papillary excrescences. and. is. inked. Remaining portion of the lung shows dark red tan congested parenchyma without other lesions. At the hilum 0.7 x 0.7 x 0.5. cm and 0.6 x 0.6 x 0.5 cm lymph nodes are identified. Representative sections are submitted as follows: A1 = bronchial and vascular margin of resection. A2 = soft tissue margin of resection. A3-A5 = mass, entirely submitted. A 6 = random section of the lung. A7 = 2 lymph nodes. A8 = closest pleural surface to the mass. B. The. specimen is labeled ""LEVEL VII"" and is received in formalin. It consists of 3 black tan lymph nodes ranging from 0.5 x 0.5 x. 0.3 - 0.6 x 0.5 x 0.3 cm. Entirely submitted in cassette B1. C. The. specimen is labeled ""LEVEL X"" and is received in formalin. It consists of 4 black tan lymph nodes measuring 0.5 x 0.4 x 0.2-. 0.8 x 0.5 x 0.3 cm. Entirely submitted in cassette C1. D. The. specimen is labeled ""RIGHT MIDDLE: LOBE"" and is received in formalin. It consists of a wedge shaped piece of lung tissue. measuring 3.5 x 1 x 0.7 cm which 3.5 cm stapled margin of resection. In the center portion 1 x 0.7 x 0.5 cm irregular fragmented area. is noted which is 0.3 cm away from the stapled margin of resection which is inked red. Entirely submitted in cassettes D1-D2. E. The specimen is labeled ""R4"" and is received in formalin. It consists of a single black lymph node measuring 2 x 0.7 x 0.6 cm. Sectioned and entirely submitted in cassette E1. F. The specimen is labeled ""R2"" and is received in formalin. It consists of a single black tan lymph node measuring 0.7 x 0.5 x 0.5. Print Date/Time: Collected Date/Time: Received Date/Time: cm. Sectioned and entirely submitted in cassette F1. Special Stains/Slides. TTF-1: negative in tumor cells. Napsin A: negative in tumor cells. p63: positive in tumor cells. INTERPRETATION: Squamous cell carcinoma. Immunohistochemical studies were performed on formalin fixed, paraffin-embedded tissue (Block A3) with adequate positive and. negative control sections. The performance characteristics of these antibodies were determined by the. They have not been cleared or approved by the U.S. Food and Drug Administration The FDA has determined that such. clearance or approval is not necessary. These tests are used for clinical purposes. They should not be regarded as investigational or for research. This laboratory is. certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88) as qualified to perform high-complexity clinical laboratory testing. 14 H&E. 3ihc. Tissue Code.",train,1.3 CM;1.3 cm
7476,TCGA-A2-A3XW.A4621FE7-E898-40BA-B45E-3DC9EF607F37,"Specimen #: (Age: Racer. SPECIMEN: A: RIGHT BREAST B: SENTINEL NODE #1 RIGHT AXILLA. C: NON SENTINEL LYMPH NODE RIGHT AXILLA. D: SENTINEL NODE #2 RIGHT AXILLA. E: NON-SENTINEL NODE #2 RIGHT AXILLA. FINAL DIAGNOSIS: A. BREAST, RIGHT, MASTECTOMY: - -TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA, NO SPECIAL TYPE. - NOTTINGHAM GRADE: MODERATELY DIFFERENTIATED (G2). - NOTTINGHAM SCORE: 7/9. (Tubules=3, Nuclei=2, Mitoses=2 i mitotic count 8 per 10 HPF at. 40x power, Slide A5). - TUMOR SIZE (GREATEST DIMENSION) : 3.0 CM (Gross measurement) . - TUMOR NECROSIS: FOCALLY PRESENT IN INFILTRATING COMPONENT. - MICROCALCIFICATIONS PRESENT IN CARCINOMA AND BENIGN BREAST TISSUE. - VENOUS / LYMPHATIC INVASION: PRESENT, EXTENSIVE. - MARGINS : NEGATIVE. - DISTANCE OF INFILTRATING TUMOR FROM THE NEAREST MARGIN IS 2.5 MM,. FROM THE DEEP MARGIN (Slide A8) . SEE COMMENT. - INTRADUCTAL COMPONENT: PRESENT. -DUCTAL CARCINOMA IN SITU WITH APOCRINE FEATURES, HIGH NUCLEAR GRADE. (G3) CRIBRIFORM AND SOLID TYPES WITHOUT DEFINITE NECROSIS. - LYMPH NODES: SEE PARTS B-E. - NIPPLE INVOLVEMENT: PRESENT WITHIN THE STROMA. - SKIN INVOLVEMENT ABSENT. - MULTICENTRICITY ABSENT. - ESTROGEN RECEPTORS : POSITIVE (95-100% Nuclear staining, per. - PROGESTERONE RECEPTORS POSITIVE (10% Nuclear staining, per. - HER2 by IHC: NEGATIVE (1+; per. - HER2 BY FISH: NOT PERFORMED. - PATHOLOGIC STAGE: pT2 N1a Mx. - ADDITIONAL PATHOLOGIC CHANGES: -FIBROCYSTIC CHANGES INCLUDING STROMAL FIBROSIS, MICROCYSTS AND. APOCRINE METAPLASIA. - NODULAR SCLEROSING ADENOSIS. - MODERATE-FLORII USUAL DUCTAL HYPERPLASIA. FOR OFFICIAL USE ONLY - PERSONAL DATA - PRIVACY ACT OF. Specimen #: FINAL DIAGNOSIS (continued) : - -FIBROADENOMATOID CHANGE. -COLUMNAR CELL CHANGE WITHOUT ATYPIA. B. LYMPH NODE, RIGHT AXILLA (#1), , SENTINEL BIOPSY: -ONE LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA. -LARGEST METASTATIC FOCUS : 1.5 CM. -MICROSCOPIC FOCUS (0.8 MM) OF EXTRANODAL EXTENSION BY CARCINOMA. IDENTIFIED. -SEE COMMENT. C. LYMPH NODE, RIGHT AXILLA, NON-SENTINEL BIOPSY;. -ONE OF TWO LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA. -LARGEST METASTATIC FOCUS = 1.1 CM. -NEGATIVE FOR EXTRANODAL EXTENSION BY CARCINOMA. D. LYMPH NODE, RIGHT AXILLA (#2) SENTINEL BIOPSY: -ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA BY H AND E AND. IMMUNOHISTOCHEMISTRY. -SEE COMMENT. E. LYMPH NODE, RIGHT AXILLA (#2) NON-SENTINEL BIOPSY. -TWO LYMPH NODES, NEGATIVE FOR METASTATIC CARCINOMA BY H AND E. Comment: Part A - The tumor that is closest to the margin is present. within a lymphatic space. Parts B and D are examined per the. sentinel node protocol, with four. step sections and intervening sections examined by immunohistochemistry. for pancytokeratin (x2) Control stains are reviewed. CLINICAL DIAGNOSIS AND HISTORY: yo. diagnosed with right breast cancer. PRE-OPERATIVE DIAGNOSIS: right breast cancer. FOR OFFICIAL USE ONLY - PERSONAL DATA - PRIVACY ACT OF. FOR OFFICIAL USE ONLY - PERSONAL DATA - PRIVACY ACT O!. Specimen #: POST-OPERATIVE DIAGNOSIS: none provided. GROSS DESCRIPTION: A: Received fresh, labeled with the patient's name,. and. designated ""Right Breast, long-lateral, short-superior, double-deep. stitches"" consists of a 344 gm mastectomy specimen oriented with short. stitch superior, long stitch lateral. The specimen measures 20.0 cm. superior to inferior, 18.0 cm medial to lateral, and 3.0 cm anterior to. posterior. The darkly pigmented superficial skin ellipse measures 9.5 x. 3.5 cm and displays a 1.0 cm centrally located, flat nipple free of. discharge. The deep margin is inked black and the superficial margin is. inked blue. Serial sections reveal a centrally located, well-defined mass. measuring 3.0 cm (superior to inferior) x 2.5 x 2.5 cm. The mass is. subjacent to (and continuous with) the nipple and comes to within 1.3. cm. of the deep margin. The cut surface is pink-white, firm and gritty with. peripheral congestion. The fibrous tissue surrounding the mass is markedly. dense and diffusely nodular, suggestive of an additional focal lesion. The. remainder of the specimen is composed moderately of dense fibrous tissue. admixed with lobulated, yellow-tan adipose tissue. No lymph nodes are. identified. Representative sections are submitted. Cassette Summary: A1- nipple with subjacent mass; A2 - mass with deep. margin; A3-A5- mass; A6- mass with skin; A7-A8- deep margin to tumor,. central breast; A9- lower mid, adjacent (inferior) to tumor; A10- margin. of A9; A11- - central breast, adjacent (medial) to tumor; A12- margin of. A11; A13- - upper outer quadrant, 4.5 cm from tumor; A14- margin of A13. A15- lower outer quadrant, 4.5 cm from tumor; A16- lower inner quadrant. with deep adjacent to tumor; A17- upper inner quadrant adjacent to. tumor;. Matched sections of A1, A3-A7, A9, A11, A13 and A15-A17 are submitted in. OCT for. protocol. B: Received fresh, labeled with the patient's name,. and. designated ""Sentinel Node #1 Right Axilla"" consists or a 1.5 x 1.2 x. 0.7. cm possible lymph node. The lymph node is bisected to reveal a firm,. tan-white cut surface. The specimen is submitted in cassette B1. A. matched section of section of B1 is submitted in OCT for. protocol. C: Received fresh, labeled with the patient's name,. and. designated 'Non-Sentinel Lymph Node Right Axilla"" consists of two possible. lymph nodes measuring 1.5 x 1.0 x 0.5 cm and 0.5 cm in greatest dimension. The cut surface of the larger possible lymph node is pink-white and firm. The lymph nodes are submitted as follows: Cassette Summary : C1- one lymph node; C2 - one lymph node bisected. A matched section of C1 is submitted in OCT for. protocol. FOR OFFICIAL USE ONLY - PERSONAL DATA - PRIVACY ACT OF. FOR OFFICIAL US# ONLY - PERSONAL DATA - PRIVACY ACT o. Specimen #: GROSS DESCRIPTION (continued) : D: Recei 1 in formalin, labeled with the patient's name. designated ""Sentinel Node #2 Right Axilla"" consists of one. irregular shaped fragment of yellow lobular adipose tissue measuring 1. 5. cm in greatest dimension. Sectioning reveals one possible lymph node. measuring 0.6 cm in greatest dimension. Specimen submitted in its. entirety. E: Received fresh, labeled with the patient's name. and. designated ""Non-Sentinel Node #2"" consists of two possible lymph nodes. measuring 2.0 x 1.0 x 0.7 cm and 0.7 cm in greatest dimension. Sectioning. of both possible lymph nodes reveals a pink-tan unremarkable cut surface. The lymph nodes are entirely submitted as follows: Cassette Summary: E1-E2- one lymph node; E3 - one lymph node bisected. A matched section of E2 is submitted in OCT for. protocol. FOR OFFICIAL USE ONLY - PERSONAL DATA - PRIVACY.",train,3.0 CM
7547,TCGA-BF-A9VF.FDBA635C-E51D-4E19-8084-ED2EF54FAC0B,"Male. Clinical diagnosis: Melanoma. Gross description: The material presented - skin, left leg, lower thigh region, surgical resection. Microscopic description: Received material is malignant melanoma with features of mixed epitheloid and. spindle cell melanoma. Grade 3, Clark II- III, Breslow 0,79mm, Tumor content. 80% with 5 % stroma present. Final diagnosis: Mixed epitheloid and spindle cell melanoma. Confidential.",train,
7555,TCGA-BR-4361.90734fa8-e5ff-46fe-9260-c565ab3e2836,STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor Site: Not specified. Tumor configuration: Ulcerating. Tumor size: 11. cm in diameter. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Extent of invasion: Liver. Lymph nodes: 2. nodes negative for malignancy. Margins - Proximal margin: Not specified. Distal margin: Not specified. Omental (radial) margin: Not. specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Additional pathologic. findings: Not specified. Comments: None.,train,11. cm
7607,TCGA-06-0649.81ba5108-b92b-4d5c-ab65-134afc0d3173,"AMENDED. CLINICAL HISTORY. with possible stroke and seizures, has. heterogenously enhancing left temporal tumor with edema and mass effect. OPERATIVE DIAGNOSES. Not Given. Operation/Specimen: A: Brain, Left temporal, biopsy. B: Brain, left temporal tumor, biopsy. PATHOLOGICAL DIAGNOSIS: A and B. Brain, left temporal, excisional biopsies: Glioblastoma. See Comment. COMMENT. The specimens are fragments of an astrocytic neoplastic proliferation that. focally infiltrates and extensively effaces the brain tissue. The neoplasm. has nuclear anaplasia, mitotic figures, microvascular cellular proliferation. with necrosis and thrombosis, and zones of tumor necrosis, i.e. a. glioblastoma. Special stains to better characterize the neoplasm have been requested and. results will be reported as an addendum. AMENDMENTS. Amended: Reason: Report, Dictation, Typographical Error. The case was signed out before the gross was transcribed. Previous Signout Date: PROCEDURES/ADDENDA. Immunohistology. Interpretation. Brain, Immunohistochemistry: MIB-1 proliferation index "". See Results and Comment (below). Results-Comments. IMMUNOHISTOCHEMISTRY: The GFAP depicts gliofibrillogenesis by the neoplastic. cells. The tumor cells do not over express the p53 protein. With the MIB-1. there is a proliferation index of about 23% in the more active areas. Comment: The results are those of a glioblastoma. INTRA-OPERATIVE CONSULTATION. A. Brain, touch prep and smears: High histological grade glioma. glioblastoma) . GROSS DESCRIPTION. A. ""Brain, Left temporal, biopsy, received fresh, four fragments, 0.6 cm. across in aggregate. Semi firm, glistening, tannish-grey. In total, A1. B. SPECIMEN: Left temporal tumor. FIXATIVE: None. GENERAL: Several fragments of tan rubbery brain parenchyma with red clotted. blood, 3 cm in loose aggregate. SECTIONS: B1-B3 all submitted. ICD-9 (s) : 225.0 225.0. Histo Data. Part A: Brain, Left temporal, biopsy. Stain/cnt. Block. Comment. FS H/E X 1. 1. mGFAP-DA x 1. H/E x 1. 1. MIB1-DA x 1. 1. P53D07 X 1. 1. H/E x 1. 2. Part B: Brain, left temporal tumor, biopsy. Stain/cnt. Block. Comment. H/E X 1. 1. H/E x 1. 2. H/E X 1. 3.",train,
7658,TCGA-WB-A81H.1BBE4ED0-1371-41F5-912D-B75054C25C48,"Short descriptive translation of the pathology review reported by the. Pathoanatomical review. Date report: Material: right adrenal. This is a soft tan and necrotic tumor with a diameter of 5 cm with focal areas of more solid,. white to gray tissue. Histologically, this is a pleomorph tumor in part composed of zellballen where single giant. cells are present. A capsule is not found. Immunohistochemically, the tumor exhibits a diffuse staining for synaptohpysin and. chromogranin. Focally, the AE1/3 stains positive. Single sustentacular cells are identified by. positive staining for S100. Only the adjacent adrenal parenchyma stains positive for MART1. and inhibin. With Ki67, a proliferation index of 5% is found. Final diagnosis: pheochromocytoma.",train,5 cm
7709,TCGA-86-6851.519253c3-7e47-4c66-9149-65e622f1ba29,"86-6851. A. Labeled left upper lobe lesion. Sections show a. Received fresh for intraoperative. poorly differentiated. consultation is a previously incised and. invasive. diffusely ragged wedge of lung. adenocarcinoma with. measuring 7 X 3 X 2.2 cm. There are 2. both. firm gray and brown lesion measuring. acinar and solid. 1.0 and 1.4 cm in greatest dimension. growth patterns. The. tumor extends to the. B. Labeled left upper lobe bronchial. subpleura. margin. Received fresh for. Immunohistochemica. intraoperative consultation is a 150 g lobe. stains are performed. of lung measuring approximately. with appropriate. 15 X 10 X 4 cm. the pleural surface is tan. control reactions. to red and smooth to slightly. to confirm this. wrinkled with two staple lines adjacent to. histologic impression. the hilum measuring 3.8 and 13. The malignant cells. cm in length. The larger passes through a. are positive for. 2.5 X 2.2 cm firm white-tan to. cytokeratin 7, TTF-1,. red mass that comes to within 2.0 cm of. Napsin-A while. the bronchial margin. Immediately. negative for. adjacent to the bronchial margin is a 1.5. cytokeratin 5/6. The. cm gray-white lymph node grossly. malignant cells show. positive for metastatic tumor. The. rare focal positivity. bronchial margin and adjacent lymph. for p63. An elastin. node. stain shows. are sampled for frozen section. The. no convincing. background lung is tan to red and. penetration of the. spongy with no other nodules or masses. visceral pleural elastic. lesions. Another hilar lymph node is. layer by the. not identified. tumor. LUNG CARCINOMA CHECKLIST. LUNG TISSUE. 1. Tumor type: Adenocarcinoma. CHECKLIST. 2. Histologic grade: Poorly. differentiated. Specimen type: 3. Tumor location: Left upper lobe. Lobectomy. 4. Tumor size: 2.5 X 2.2 cm. Tumor site: Lung. 5. Angiolymphatic invasion: Yes. Tumor size: 2.5 X 2.2. 6. Bronchial margin: The bronchus. cm. is free of tumor. However, a. Histologic type: peribronchial lymph node at the. Adenocarcinoma. resection margin contained. Histologic grade: metastatic tumor. Poorly differentiated. with extranodal extension into. Tumor extent: Not. peribronchial soft tissues. specified. 7. Parenchymal margin: Involved. Other tumor nodules: by carcinoma. Not specified. 8. Vascular margins: Free of tumor. Lymph nodes: 1/7. 9. Pleural involvement: Subpleural. positive for metastasis. 10. Lymph nodes: One of two. (Regional 1/7). peribronchial lymph nodes positive. Lymphatic invasion: for. Present. metastatic tumor (1/2). One benign. Venous invasion: para-aortic lymph node (0/1). Four. Present. benign hilar lymph nodes (0/4). Margins: Involved. 11. Size of largest metastatic. Evidence of neo-. deposit: 1.3 cm. adjuvant treatment: 12. TNM: pT1b, pN1, pMX. Not specified. Additional pathologic. findings: Not specified. Comments: None.",train,7 X 3 X 2.2 cm;2.5 X 2.2 cm;2.5 X 2.2
7739,TCGA-T2-A6WZ.B7760635-A828-4040-AA36-21FA18D4CD4F,"Dept. MRN : Encounter. #: Department: Surgical Pathology Request. (Order. Result Narrative. ADDENDUM. ADDENDUM REPORT. ) : THIS ADDENDUM REPORT SUPERSEDES THE REPORT ISSUED. THE DIAGNOSIS IS UNCHANGED. An immunohistochemical study for EGFR demonstrates moderate to strong labeling of. nearly all tumor cells with an H score of 220 (5% at 0 , 0% at 1+, 65% at 2+, 30%. at 3+). one of our. pathologists, has also reviewed this. additional study and she concurs with the above assessment. FINAL DIAGNOSIS. A) Left tongue, pharynx and neck zones 1, 2 and 3 soft tissue, near total. glossectomy, partial pharyngectomy, left neck dissection: Left tongue and oral pharynx, glossectomy and pharyngectomy. Invasive well to moderately-differentiated squamous cell carcinoma (7 cm). involving the left posterolateral tongue, pharynx and soft palate; tumor extends. to the right/midline lingual specimen margin (see parts B-F and J for separately. submitted and final margins). Left neck zones 1, 2, 3, dissection: Zone 1: Five lymph nodes, negative for carcinoma (0/5). - Zone 2: One lymph node, negative for tumor (0/1). - Zone 3: Metastatic squamous cell carcinoma (0.41 cm) involving one of six lymph. nodes (1/6). - Squamous cell carcinoma abutting but not invading the submandibular gland. capsule. B) True midline tongue margin, excision: - Negative for carcinoma. C) Left true vallecula margin, excision: - Negative for carcinoma. D) True midline pharyngeal margin, excision: - Negative for carcinoma. E) Left true superior tonsil margin, excision: - Negative for carcinoma. F) Medial posterior mobile tongue, excision: - Negative for carcinoma. G) Right neck soft tissue, dissection: - Zone 1: Six lymph nodes, negative for carcinoma (0/6). - Zone 2a Ten lymph nodes, negative for tumor (0/10). - Zone 2b: Twenty lymph nodes, negative for carcinoma (0/20). - Zone 3: Eight lymph nodes, negative for carcinoma (0/8). - Zone 4: Six lymph nodes, negative for carcinoma (0/6). H) Teeth, #22, 24 and 25, extractions: - Three teeth without significant histopathologic changes. I) Additional left posterior neck, zones 2 and 3, dissection: - Zone 2b: Nineteen lymph nodes, negative for carcinoma (0/19). - Zone 3: Metastatic squamous cell carcinoma (0.46 cm) involving one of eight. lymph nodes (1/8) with focal extranodal extension. J) Additional right anterior tongue margin, excision: - Negative for carcinoma. COMMENTS. The results of studies for HPV and EGFR will be reported as an addendum. one of our. surgical pathologists, has also. reviewed slides from this case and she concurs with the above diagnosis. was notified of our findings by secure electronic mail. CLINICAL HISTORY. The patient is a. -year-old male with biopsy-proven left base of tongue squamous. cell carcinoma. DIAGNOSTIC SUMMARY. - Specimen: Portions of tongue, oropharynx and soft palate, left and right neck. lymph nodes and teeth. - Procedure: Near total glossectomy, partial pharyngectomy, partial palatectomy,. left neck dissection (1-3), right neck dissection (1-3) and teeth extractions. - Specimen Laterality: Left and midline tongue, right and left neck tissue. - Tumor Site: Oropharynx including left posterolateral tongue, posterior pharynx. and soft palate. - Tumor Focality: Single focus. - Tumor Size: 7 cm. - Histologic Type: Squamous cell carcinoma. - Histologic Grade: G1-2 (Well to moderately-differentiated. - Margins: Though carcinoma involves the midline/right lingual margin in the main. resection specimen (part A) , separately submitted lingual margins (parts B, F and. J) are uninvolved by carcinoma. - Lymph-Vascular Invasion: Not identified. - Perineural Invasion: Present. - Lymph Nodes, Extranodal Extension: Focally present. - Pathologic Staging for Oropharynx Lesion (pTNM). - - Primary Tumor: pT3 (Tumor > 4 cm in greatest dimension or extension to the. lingual surface of epiglottis). - - Regional Lymph Nodes: pN2b (Metastasis in multiple ipsilateral lymph nodes,. none >6 cm). - - 89 lymph nodes examined, 2 involved. - - Distant Metastasis (pM) : Not applicable. GROSS DESCRIPTION. A) Received fresh, labeled. and designated ""left near-. total glossectomy and partiar pharyngectomy Tert neck dissection zones 1, 2, 3"" ,. is a glossectomy, pharyngectomy, neck dissection specimen. The tongue is 9.5 cm. anterior to posterior, 4.5 cm left to right and 3.4 cm superior to inferior. The. pharyngectomy specimen is 6.8 cm anterior to posterior, 3.0 cm left to right and. 3.9 cm superior to inferior. The neck dissection is 8.0 x 6.1 x 3.4 cm. The. specimen is oriented per the specimen container as follows: Single stitch superior tonsil margin, double long stitch left vallecula, double. short stitch neck dissection zone 3. There is another single stitch that is. oriented in person by a member of the surgical team as a prominent lymph node in. zone 1A on the left side. The specimen is inked as follows: Right side of tongue margin = red. Base of tongue margin = blue. Inferior portion of tongue margin = black. Vallecula margin = orange. Posterolateral oropharynx margin = green. Superior tonsillar margin = yellow. Floor of mouth margin = orange. Lateral oropharynx margin = black. Gross photographs are taken. The neck dissection tissue is removed and the resultant exposed tissue is inked. yellow. The tongue, left floor of mouth and left oropharynx contain a large. ulcerated mass with deep furrows and papillary structures. This irregular. ulcerated mass measures 7 x 4.5 cm. The ulcerations extend 1.8 cm into the. tongue from the surface. The lesion is 1.4 cm from the right tongue margin, 0.8. cm from the anterior floor of mouth margin, 0.9 cm from the superior tonsillar. margin, 2.3 cm from the posterolateral oral pharynx margin, 1.6 cm from the. vallecula margin, and 1.4 cm from the base of tongue margin. Small portions. of. tissue have been taken from the lesion as well as uninvolved tongue for tissue. banking. The tongue is serially sectioned to reveal a white, fibrotic,. spiculated lesion that extends to within 0.4 cm of the deep margin. Representative sections are submitted as follows: (A1) Tumor to right tongue margin. (A2) Tumor to base of tongue margin. (A3) Tumor to vallecula margin. (A4) Tumor to posterolateral oral pharynx margin. (A5) Tumor to superior tonsillar margin. (A6) Tumor to anterior floor of mouth margin, includes inked surface denoting. where the neck dissection was removed (yellow ink not a surgical margin). (A7-A10) Right side of tongue shave margin from anterior to posterior (en face). (A11) Remaining inferior portion of right side of tongue shave margin (en face). (A12-A13) Tumor. (A14) Tumor to deep margin. (A15) Sutured 1A left lymph node, bisected. (A16) Remaining tissue of zone la. (A17) Remaining tissue of zone la. (A18) Two candidate lymph nodes, zone 1b. (A19) Zone 1b after removing from oropharynx, trisected (yellow ink not a. surgical margin). (A20-A23) Remaining tissue, zone 1b. (A24) Submandibular gland. (A25-A30) Anterior zone 2, anterior to posterior. Zone 3: (A31) One lymph node, bisected. (A32) One lymph node, bisected. (A33) One lymph node, bisected. (A34) One lymph node, bisected. (A35-A50) Remaining tissue. Received fresh for frozen section diagnosis, labeled. are five specimens. B) Designated ""true midline tongue margin, "" is a portion of red-brown tissue. measuring 1.2 x 0.8 x 0.3 cm. The specimen is submitted entirely for frozen. section diagnosis and resubmitted for permanent section diagnosis in cassette. (FSB1). C) Designated ""left true vallecula margin, "" is a portion of red-brown soft tissue. measuring 1.9 x 0.6 x 0.3 cm. The specimen is submitted entirely for frozen. section diagnosis and resubmitted for permanent section diagnosis in cassette. (FSC1). D) Designated ""true midline pharyngeal margin, "" is a portion of red-brown soft. tissue measuring 1.6 x 1.4 x 0.3 cm. The specimen is submitted entirely for. frozen section diagnosis and resubmitted for permanent section diagnosis in. cassette (FSD1). E) Designated ""left true superior tonsil margin, "" is a portion of pink-white soft. tissue measuring 2.2 x 1 x 0.3 cm. The specimen is submitted entirely for frozen. section diagnosis and resubmitted for permanent section diagnosis in cassette. (FSE1). F) Designated ""medial posterior mobile tongue, "" is a portion of pink-white soft. muscular tissue measuring 1.4 x 0.7 x 0.4 cm. The specimen is submitted entirely. for frozen section diagnosis and resubmitted for permanent section diagnosis in. cassette (FSF1). In formalin, labeled. are four specimens. G) Designated ""right neck dissection, "" is a 12.5 x 7.0 x 3.0 cm neck dissection,. which is oriented per the specimen container as follows: single stitch = zone 1,. double long stitch = zone 2b, double short stitch = zone 4. (G1) Lymph node, bisected, zone 1. (G2) Lymph node, bisected, zone 1. (G3) Four candidate lymph nodes, zone 1. (G4) Three candidate lymph nodes, zone 1. (G5-G6) Representative sections of submandibular gland, zone. 1. (G7-G10) Remaining tissue, zone 1. (G11-G12) Two candidate lymph nodes, bisected; a larger and a smaller, zone 2a. (G13) Five candidate lymph nodes, zone 2a. (G14-G18) Residual tissue, zone 2a. (G19) One lymph node, bisected, zone 2b. (G20) Three candidate lymph nodes, zone 2b. (G21-G24) Remaining tissue, zone 2b. (G25) One lymph node bisected and inked black, and two candidate lymph nodes,. zone 3. (G26) Remaining tissue, zone 3. (G27) Four candidate lymph nodes, zone 4. (G28) Remaining tissues, zone 4. H) Designated ""teeth #22, 24 and 25, n are three teeth, ranging from 1.8 x 0.6. x. 0.6 cm to 2.0 x 0.6 x 0.3 cm. The smallest tooth is fractured longitudinally. with a pink, firm material in the core of the tooth. The specimen is submitted. in its entirety, after decalcification, as follows: (H1) Previously fractured tooth. (H2-H3) Remaining two teeth. I) Designated ""additional left posterior neck dissection, zones 2 and 3, "" is a. 0.8 x 6.5 x 1.5 cm neck dissection. It is oriented per the specimen container as. follows: single stitch = zone 2b, double stitch = zone 3. The specimen is. submitted in its entirety as follows: (I1-I2) Lymph node, bisected, zone 2b. (I3-I4) Remaining tissue, zone 2b. (I5-I6) Two lymph nodes bisected, the larger and a smaller, zone 2b. (I7-I8) One lymph node bisected, zone 2b. (I9) Four candidate lymph nodes, zone 2b. (I10) Five candidate lymph nodes, zone 2b. (I11-I12) Remaining tissues, zone 2b. (I13) Three lymph nodes, the largest is bisected, zone 3. (I14) Three lymph nodes, the largest is bisected, zone 3. (115-I16) Remaining tissues, zone 3. J) Designated ""additional right anterior tongue margin, "" is a 3.5 x 0.8 x 0.6 cm. tongue tissue. No orientation is provided. The specimen is submitted in its. entirety in cassettes (J1-J2). INTRAOPERATIVE DIAGNOSIS. FSB1: Negative for malignancy. FSC1: Negative for malignancy. FSD1: Negative for malignancy. FSE1: Negative for malignancy. FSF1: Negative for malignancy. Intra-Operative Diagnosis Reviewed and Interpreted By: I certify that (1) all services on this form were rendered and are hereby. approved for billing, (2) all specimens/slides have been examined / reviewed, (3). the medical record has been documented for these services, and (4) the rendering. of the services and the documentation in the medical record are in accordance. with. guidelines. Final Diagnosis Reviewed and Interpreted by: Pathology Resident. Some tests used in this case were developed in and their performance. characteristics determined by the. The procedures and reagents have been validated. by evaluation of both negative and positive controls. This testing has not been. cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has. determined that such clearance or approval is not necessary. Test results are. used for clinical purposes. They should not be regarded as investigational or for. research. The. is accredited by the. College of American Pathologists and is certified under the Clinical Laboratory. Improvement Amendments of 1988 (CLIA-88) as qualified to perform high complexity. clinical laboratory testing. ""I certify that (1) all services on this form were rendered and are hereby. approved for billing, (2) all specimens/slide have been examined / reviewed, (3). the medical record has been documented for these services, and (4) the rendering. of the services and the documentation in the medical record are in accordance. with. guidelines. Lab and Collection. Surgical Pathology Request on. Result History. SURGICAL PATHOLOGY REQUEST on. Specimen Information. Specimen #. Received Date and Time. Surgical Pathology Request. year old. Provider Not In System. Provider Status. Surgery Report. Lab Printout. Open Hard Copy Result Report. Surgical Pathology Request). View Order Information. Dept. MRN : Encounter. #: Department: Lab Collection Information. Lab IDs. Specimen #. Surgical Pathology Request. Date and. Authorizing: System, Provider. Time: Lab. Not In. Department: Diagnoses. Oral-mouth cancer. 145.9. Smoking hx. V15.82. Alcohol abuse. 305.00. Squamous cell carcinoma of lateral tongue. 141.2. Squamous cell cancer of retromolar trigone. 145.6. Release Date/Time. Start Date/Time. End Date/Time. Comments. Frequency. Duration. Priority. ONCE. 1 occurrence. Routine. Normal. Authorizing Provider. System, Provider Not In. System, Provider Not In. Attending Provider(s). Admitting Provider. View Order Information. There are no specimens. Reprint Requisitions. Surgical Pathology Request.",train,7 cm;7 cm
7749,TCGA-SX-A7SO.37B70EEA-86D4-4373-820D-F42F046B8B02,"Result Date: Encounter. info: Clinic Number: DIAGNOSIS: A. Ascending and proximal transverse colon, appendix: Specimen: Terminal ileum, cecum, ascending and transverse colon. Procedure: Right hemi- and transverse colectomy. Tumor site: Ascending colon, 12 cm from ileocecal valve. Tumor size: 3.0 cm in greatest dimension. Tumor histologic type: Adenocarcinoma. Histologic grade: Moderately differentiated (grade 2 of 3) . Microscopic tumor extension: Invasive adenocarcinoma, extends into. the submucosa. No evidence of carcinoma penetrating into the. underlying muscularis propria. Margins: Proximal small bowel and distal colonic margins; negative. for tumor. Distance to mesorectal margin: Not applicable. Lymph-vascular invasion: Not identified. Perineural invasion: Not identified. Tumor deposits (discontinuous extramural extension) : Not present. Macroscopic completeness of mesorectum (if applicable) : Not. applicable. Lymph nodes: A total of twenty-two regional lymph nodes, negative. for metastatic adenocarcinoma (0/22). Response to treatment: Not applicable. Additional findings: Separate inflammatory polyp, 0.6 cm in. greatest dimension, distal to the main tumor mass. Appendix, with. fibrous obliteration. Pathologic staging: pT1, pNO. Ancillary testing: Not performed. Block (s) containing malignancy suitable for further testing: Block. A5. B. Left kidney tumor: Procedure/laterality: Left partial nephrectomy. Histologic type: Papillary renal cell carcinoma, with eosinophilic. cytoplasm. Nuclear grade (Fuhrman, 1-4) : 2 of 4. Tumor size: 7.0 cm in greatest dimension. Tumor site: Upper pole. Tumor focality: Unifocal. Sarcomatoid features: Not present. Tumor necrosis: Not present. Microscopic tumor extension : Extension into perinephric tissue Not present. Extension beyond Gerota's fascia: Not present. Extension into renal sinus: Not present. Extension into renal vein: Not present. Extension into collecting system: Not present. Extension into adrenal gland (if applicable) : Not applicable. Surgical margins: Fatty soft tissue margins; negative for tumor. Lymph-vascular invasion: Not identified. Lymph nodes: None present. Pathologic findings in nonneoplastic kidney: No specific pathologic. features. Pathologic staging: pT1b, pNX. Biorepository sample (if applicable) : Representative section of. tumor and normal kidney are shown on block B6. Block (s) containing malignancy suitable for additional testing: B4. DIAGNOSIS COMMENT: Selected slides of the colectomy and nephrectomy specimens reviewed. with. CLINICAL INFORMATION: Hepatic flexure cancer and left kidney renal cell carcinoma. SPECIMEN (S) : A:Ascending and proximal transverse colon, appendix. B:Lt kidney tumor. PRELIMINARY INTRAOPERATIVE DIAGNOSIS: Intraoperative Pathologist (s) : A. Ascending proximal transverse colon and appendix, gross. consultation: Margins grossly clear. Tumor identified (approximately. 3. cm). Relatively flat polyp identified more distally. B. Left kidney tumor, frozen section diagnosis: Papillary renal. cell carcinoma, no sarcomatoid features. GROSS DESCRIPTION: A. Received fresh labeled and ""ascending and. proximal transverse colon, appendix. Specimen: Terminal ileum, cecum, ascending and transverse colon. Procedure: Right hemi- and transverse colectomy. Dimensions: 5.5 cm of terminal ileum and 50 cm of large bowel. Tumor site: Ascending colon, 12 cm distal to ileocecal valve. Tumor configuration: Flat, granular, pink-tan. Tumor size: 3 x 2.5 X 0.5 cm. Tumor distance to nearest margin: Proximal, 17 cm. Distance to mesorectal margin (if applicable) : Not applicable. Macroscopic completeness of mesorectum: Not applicable. Tumor extension into fat: Not grossly identified. Tumor extension to inked free surface: No. Tumor perforation: No. Tumor deposits in fat: No. Additional mass/polyp (s) : Yes; 0.6 x 0.4 x 0.3 cm situated 8 cm. distal to the main tumor. Lymph nodes: Twenty-three possible lymph nodes from 0.2 cm to 0.8. cm. Gross notes: Additional findings: A grossly unremarkable 5 x 0. 6-cm appendix. encased by slightly hemorrhagic fat. Block key for specimen A: A1) sample of each surgical margin;. A2-A5) entire main tumor; A6) polyp; A7) appendix; A8) eight lymph. nodes; A9) four lymph nodes; A10) eight lymph nodes; A110 three. lymph nodes. B. Received fresh labeled and ""left kidney tumor.'. Procedure: Partial nephrectomy. Specimen laterality: Left. Tumor site: Upper pole. Tumor size: 7 x 5 x 5 cm. Tumor focality: Unifocal. Gross extent of tumor: Extension into perinephric tissue: : Absent. Extension beyond Gerota's fascia: Absent. Extension into renal sinus: Absent. Extension into renal vein: Absent. Extension into collecting system: Absent. Adrenal gland: Not identified. Gross notes: Gross tumor characteristics: Soft, gray-brown, predominately. solid. Kidney weight: 325 g with fat, 135 g without fat. Specimen dimensions: Overall 11 x 8 x 7 cm. Distance to margin: 0.3 cm grossly from parenchymal margin. Lymph nodes: None identified. Inking details: The parenchymal margin and the Gerota's fascia. surface are inked blue. Biorepository sample submitted: Yes, see block key. Block key for specimen B: B1) Frozen section sample of tumor;. B2-B4) additional samples of tumor; B5) inked fatty soft tissue. margin; B6) mirror images of biorepository sample (normal and. tumor). Support for the diagnosis in this case may have included the. use of Immunohistochemistry tests that were developed and whose. performance characteristics were determined by. They have not been cleared. or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not. necessary. These tests should not be regarded as investigational. or for research. This laboratory is certified under the Clinical. Laboratory Improvement Amendments of 1988 ('CLIA') as qualified. to perform high complexity clinical laboratory testing.",train,3.0 cm;7.0 cm;3. cm;3 x 2.5 X 0.5 cm;7 x 5 x 5 cm
7753,TCGA-DB-A64S.31AB0B8C-9300-4508-B653-CB898986E68F,"Final Diagnosis: A-C. Brain, right frontal #1-#3, biopsies: Low grade oligoastrocytoma (WHO grade II), astrocytic predominant. Special Stains: Neurofilament: The tumor demonstrates an infiltrative pattern of growth. p53: Moderate to high labeling. Ki67/MIB-1: Low to moderate labeling index. Fluorescence in situ hybridization (FISH) studies for 1p19q deletion have been ordered on paraffin sections and. will be performed by the. For interpretation, see Synthesis in Labs under Genetics. Interpreted by: Preliminary Frozen Section Consultation: A. Brain, right frontal #1, smears: Low-grade glial lesion with oligodendroglial features. Hold over for. ALL EMBEDDED. continued next page. classification on permanent sections. Intraoperative cytologic smear(s) interpretation performed by: Gross Description: A. Received fresh labeled ""right frontal brain"" is a 2.5 x 2.3 x 0.7 cm portion of brain. Smears prepared. All. submitted. Grossed by. B. Received fresh labeled ""deep right frontal white matter - brain"" is a 2.5 x 1.6 x 0.4 cm aggregate of neural. tissue. Smears prepared. All submitted for permanent sections only. Grossed b. C. Received fresh labeled ""right frontal lesion #2 - brain"" is a 1.6 x 0.6 x 0.3 cm aggregate of neural tissue. Smears prepared. All submitted for permanent sections only. Grossed by. Block Summary: Part A: Right frontal lesion - brain. 1 Rt frontal lesion 1. 2 Rt frontal lesion 2. 3 Rt frontal lesion 3. 4 Rt frontal lesion 4. Part B: Deep right frontal white matter - brain. 1 Deep rt frontal brain 1. 2 Deep rt frontal brain 2. 3 Deep rt frontal brain 3. Part C: Right frontal lesion #2 - brain. 1 At frontal lesion #2-1. 2 Rt frontal lesion #2-2. ALL EMBEDDED. Page of 2. caseis.",train,
7757,TCGA-CG-5725.c7c5deac-897c-4f52-98f2-720567515b85,"Diagnosis(es): Total gastrectomy specimen with an ulcerated carcinoma of the esophagogastric junction of. maximum diameter 6.5 cm localized subcardially in the area of the posterior wall on the. greater curvature side, of the histological type of a poorly differentiated adenocarcinoma. Invasive tumor dissemination within all gastric wall layers as far as the adjacent perigastric. fatty tissue and with lymphatic tumor spread. Oral and aboral resection margin and greater omentum tumor-free. Antrum and corpus with non-florid, moderate chronic gastritis, foveolar hyperplasia and. focal intestinal metaplasia, and partial mucosal atrophy. No evidence of Helicobacter. pylori. Twenty-four regional lymph nodes tumor-free with uncharacteristically reactive. changes. Therefore tumor stage pT2b pNO (0/23).",train,6.5 cm
7778,TCGA-P3-A6T6.4BBD0CEB-259B-44F7-A1E4-C4D6CCDE5849,"CLINICAL DATA: Maxillary cancer. Per. patient is a history of squamous cell. carcinoma of the maxilla. GROSS DESCRIPTION: A). Received fresh in a container labeled ""... for intraoperative. consultation"" designated ""right buccal margin"" is a 2 X 0. 4 X 0.2 cm portion. of pink-tan soft tissue. The specimen is inked blue. The specimen is. bisected and then submitted entirely for frozen section, and following frozen. section evaluation, the residue is submitted entirely in cassette AFS1. B). Received fresh in a container labeled ""..."", designated ""right. maxillary tumor"" is a 5.6 cm ML x 4.2 cm AP x 3.6 cm SI portion of maxillary. bone, hard and soft palate, floor of ethmoid sinus, and single tooth. The. anterior soft tissue and bony margin is inked blue, the lateral bone and soft. tissue margin is inked black, the posterior soft tissue and bone margin is. inked orange, and the medial soft tissue margin is inked green. The mucosa. of the palate is tan-pink and focally hemorrhagic with a focal area (2.1 X. 2.0 cm) that is granular and has an irregular appearance with dark brown. discoloration. Margins are taken for the anterior, lateral, medial, and. posterior soft tissue margins, and then the specimen is serially sectioned. from medial to lateral to reveal a 2.0 x 2.1 x 2.6 cm, white, firm, ill-. defined mass that is eroded through the maxillary bone. After serial. sections through the mass are taken, the remaining specimen consists of two. thin bones, and a tooth. Cassette list: B1 - anterior soft tissue margin;. B2 - lateral soft tissue margin; B3 - posterior soft tissue margin; B4 -. medial soft tissue margin; B5 - posterior portion of the mass; B6 -. representative section through the mass; B7 - additional representative. section through the mass; B8 - additional section through the mass. The bony. anterior, posterior, and lateral margins are submitted for decalcification. prior to further processing, and then submitted in cassettes B8-B10. C). Received fresh in a container for frozen labeled ""..., deep margin"" are. fragments of dark red soft tissue admixed with fragments of bone measuring. 4.5 X 1.5 X 1 cm in aggregate dimension. Representative sections of soft. tissue are submitted for frozen. Frozen section residue is submitted in. block CFS1. D). Received fresh in a container for frozen labeled ""..., posterior margin"". are 2 dark red fragments of soft tissue measuring 1.5 X 1 X 0.2 cm in. aggregate dimension. The specimen is entirely submitted for frozen. Frozen. section residue is submitted in block DFS1. E) Received fresh in a container for frozen labeled "".... lingual nerve"" is a. 0.5 cm tan, irregular soft tissue which is marked with blue ink and entirely. submitted for frozen. Frozen section residue is submitted in block. F). Received fresh in a container for frozen labeled ""..., superior margin"" is. a 1.2 X 0.8 x 0.2 cm tan, irregular soft tissue which is marked with blue ink. and entirelv submitted for frozen. Frozen section residue is submitted in. block. G). Received fresh in a container for frozen labeled "".... lateral margin"" is. a 0.8 X 0.5 x 0.1 cm tan, irregular soft tissue which is marked with black. ink and entirely submitted for frozen. Frozen section residue is submitted. in block. H). Received fresh in a container for frozen labeled ""..... anterior margin"" is. a 0.6 x 0.2 x 0.1 cm tan, irregular soft tissue which is marked with orange. ink and entirelv submitted for frozen. Frozen section residue is submitted. in block. I). Received fresh in a container for frozen labeled ""..., deep margin"" is a. 0.5 X 0.5 x 0.1 cm tan, irregular soft tissue which is marked with blue ink. and entirely submitted for frozen. Frozen section residue is submitted in. block. Received fresh in a container for frozen labeled ""..., medial margin"" is a. 1.2 cm tan, irregular soft tissue which is marked with black ink and entirely. submitted for frozen. Frozen section residue is submitted in block. K). Received fresh in a container for frozen labeled "".... posterior deep. margin"" is a 0.7 x 0.7 x 0.2 cm tan, irregular soft tissue which is marked. with black ink and entirely submitted for frozen. Frozen section residue. is. submitted in block. L). Received fresh in a container for frozen labeled ""..., deep medial. margin"" is a 1 x 0.6 X 0. cm tan, irregular soft tissue which is marked with. orange ink and entirely submitted for frozen. Frozen section residue is. submitted in block. M). Received in a container of formalin labeled ""..., right maxillary. mucosa"" are multiple hemorrhagic, rubbery fragments of soft tissue admixed. with a portion of cartilage. Specimen measures 2 x 2 x 0.5 cm in aggregate. dimension. Soft tissue minus the cartilage is entirely submitted in cassette. M1. N) Received in a container of formalin labeled ""., tooth #5"" is a 2.2 x 0.6. X 0.2 cm premolar designated as ""#5."" There is silver amalgam on the. lateral side of the crown. No soft tissue is received. Specimen is reviewed. by Dr. Gross only. O). Received fresh in a container for frozen labeled ""..., new medial. mucosa margin"" is a 0.8 X 0.5 X 0.1 cm tan, irregular soft tissue which is. marked with black ink and entirely submitted for frozen. Frozen section. residue is submitted in block. P). Received fresh in a container for frozen labeled ""..., new superior. margin"" is a 1 X 0.3 X 0.3 cm tan, irregular soft tissue which is marked with. blue ink and entirely submitted for frozen. Frozen section residue is. submitted in block. Q). Received fresh in a container for frozen labeled ""..... new deep margin"" is. a 0.6 cm tan, irregular soft tissue which is marked with black ink and. entirely submitted for frozen. Frozen section residue is submitted in block. R) Received fresh in a container for frozen labeled ""..... palate"" is a 0.6 cm. tan, irregular soft tissue which is marked with blue ink and entirely. submitted for frozen. Frozen section residue is submitted in block. S). Received in a container of formalin labeled ""..., repeat medial. resection"" are a few variegated, hemorrhagic, rubbery portions of soft tissue. measuring 2. 6 x 2 x 0.5 cm in aggregate dimension. There are congested,. friable cut surfaces. No obvious masses are identified. Specimen is. entirely submitted in 2 cassettes. Received in a container of formalin labeled ""..... medial maxillary. wall"" is a 2 X 1.5 x 0.2 cm tan, firm, irregular fragment of cartilage with a. scant amount of attached apparent bone. Specimen is sectioned and has dark. red cut surfaces and no masses are appreciated. The specimen is entirely. submitted in cassette T1 following decalcification. INTRAOPERATIVE CONSULTATION: AFS) No carcinoma identified (cautery artifact present). CFS) Deep margin positive for carcinoma. DFS) Posterior margin positive for carcinoma. EFS) Lingual nerve positive for carcinoma. FFS) Superior margin positive for carcinoma; bone involved. GFS) Lateral margin negative. HFS) Anterior margin negative. IFS). Deep lateral margin negative. JFS) Medial margin positive for carcinoma. KFS) Posterior deep margin positive for carcinoma. LFS) Deep medial margin negative. OFS) New medial mucosal margin negative. PFS) New superior margin negative. QFS) New deep margin negative. RFS) Palate negative. FINAL DIAGNOSIS: A). Right buccal margin, excision: Squamous mucosa with no evidence of in. situ or invasive carcinoma. B) Right maxillary tumor, maxillectomy : Poorly differentiated invasive. squamous cell carcinoma with the following features: 1. 2.6 cm. 2. Extent: Carcinoma erodes through the maxillary bone. 3. Margins: a. Carcinoma involves the orange-inked posterior specimen margin, the. green-inked medial specimen margin and the black-inked lateral specimen soft. tissue margins; see comment. b. The anterior soft tissue margin is negative for carcinoma. C. Carcinoma involves the medial maxillary bone margin (hard palate) ;. anterior maxillary bone margin and bones. of the maxillary sinus are negative for carcinoma. 4. Extensive lymphovascular invasion is identified. 5. Focal perineural invasion is present. 6. The minimum pathologic stage is pT4a, pNx, pMx (AJCC,2002, 6th edition). C, D, E, F, J, ,K) Mucosa, sites as designated, biopsies: Multiple designated. margins positive for poorly differentiated squamous cell carcinoma,. including: 1. Deep margin. 2. Posterior margin. 3. Lingual nerve. 4. Superior margin. 5. Medial margin. Posterior deep margin. G, H, I,L,M,O,P,Q-T) Mucosa, sites as designated, biopsies: Multiple. designated mucosal margins with no evidence of in situ or invasive carcinoma,. including: 1. Lateral margin. 2. Anterior margin. 3. Deep lateral margin. 4. Deep medial margin. 5. Right maxillary mucosa. 6. New medial mucosal margin. 7. New superior margin. 8. New deep margin. 9. Palate. 10. Repeat medial resection. 11. Medial maxillary wall. N). Tooth #5, extraction (gross only) : Tooth with silver amalgam and. gross diagnostic alterations. COMMENT: Evaluation of the maxillectomy specimen (B) was supplemented by. intraoperative evaluation of multiple surgical margins by frozen section. Although several specimen margins are positive (see above) final surgical. margins should be based on a correlation of all examined specimens in the. surgical context. Procedures used to establish the diagnosis: Routine.",train,5.6 cm ML x 4.2 cm AP x 3.6 cm
7812,TCGA-ET-A25J.EC2F28C3-6E69-4BCD-B08A-54FD4B2F9603,"1) TOTAL THYROID (THYROIDECTOMY): SPECIMEN TYPE: Total thyroidectomy. TUMOR SITE: Right lobe. Site : thyroid C739. HISTOLOGIC TYPE: Papillary carcinoma. TUMOR SIZE (LARGEST NODULE): Greatest dimension: 2.5 cm. FOCALITY: Unifocal. LYMPH NODES (ALL PARTS): Metastatic carcinoma in 2 of 18 lymph nodes. EXTENT OF INVASION (STAGING) PRIMARY TUMOR: pT2: Tumor >2.0 cm but less than or equal to 4.0 cm limited to thyroid. REGIONAL LYMPH NODES: pN1a: Nodal metastasis to Level VI (pretracheal, paratracheal,. prelaryngeal/Delphian) nodes. DISTANT METASTASIS: pMx: Cannot be assessed. MARGINS: Margins are uninvolved. VENOUS/LYMPHATIC INVASION: Absent. ADDITIONAL PATHOLOGIC FINDINGS: One benign parathyroid gland. GROSS DESCRIPTION. PART #1: TOTAL THYROID. Dictated: The specimen is received fresh labeled with the patient's name, xxxx, and designated. ""Total Thyroid, Stitch Marks Right Thyroid Tumor."" The specimen consists of a grossly. identifiable thyroid measuring 7.4 x 5.3 x 2.0 cm and weighing 16.37 grams. The anterior. is inked orange and the posterior inked black. Serial sectioning reveals a 2.5 x 2.4 x 1.5. cm tumor in the right middle lobe, with a tan to white focally hemorrhagic and necrotic. appearance. The specimen is serially sectioned and submitted in its entirety. There is also. a 1.1 x 1.1 x 1.0 cm piece of fibroadipose tissue. Blunt dissection reveals seven (7). potential lymph nodes. The remainder of the fat is submitted. in its entirety. SUMMARY OF SECTIONS : 1 A. -3 (LEFT INFERIOR MARGIN). 1 B - 2 (LEFT, SERIALLY SECTIONED FROM INFERIOR TO SUPERIOR). 1 C. -2. (LEFT LOBE). 1 D. 4. (LEFT SUPERIOR MARGIN). 1 E. M. (ISTHMUS). 1 F. - -6. (RIGHT INFERIOR MARGIN). 1 G. 2. (RIGHT LOBE). 1 H. -2. (RIGHT LOBE). 1 I. - 2. (RIGHT INFERIOR TUMOR). 1 J. - 2. (RIGHT TUMOR). 1 K. - M (RIGHT LOBE SUPERIOR ASPECT OF TUMOR AND SUPERIOR. MARGIN). 1 L. - 7 (SEVEN POTENTIAL LYMPH NODES). 1 M - M (REMAINING FAT). 13 - TOTAL - MULTIPLE.",train,2.5 cm;2.5 x 2.4 x 1.5. cm
7852,TCGA-DD-A4NR.93133C58-B1BF-4A5C-8EFC-AE17EC6A0B64,"REVISED REPORT (Addendum/Procedure included). TISSUE DESCRIPTION: A1 A2 A3 A4 A5. Portion of liver segment VIII (110 grams, 8.5 x 8.5 x 6.0 cm) . DIAGNOSIS: Liver, segment VIII, excision: Grade 3 (of 4) hepatocellular. carcinoma, usual type, forming a 5.0 x 4.5 x 4.0 cm mass. The tumor. is located in segment VIII. The hepatic capsule is free of tumor. The surgical margins are free of tumor, the clearance being 1.6 cm. grossly. Extratumoral vascular invasion is not identified. The. tumor is not encapsulated, infiltration of parenchyma being of. pushing type. Non-neoplastic liver will be reported in an addendum. ADDENDUM: The non-neoplastic liver is consistent with primary biliary. cirrhosis stage 4 (of 4) . Iron is negative for hemosiderosis. Trichrome stain highlights bridging fibrosis with regenerative. nodules.",train,5.0 x 4.5 x 4.0 cm
8002,TCGA-AC-A3YJ.0F890724-8554-4B2B-B4EC-6B9B24C757D8,"MRN #: SPECIME. DIAGNOSIS. DIAGNOSIS: A. Right sentinel lymph nodes, one lymph node: No evidence of metastatic carcinoma. Confirms frozen section diagnosis and confirmed by negative staining for pancytokeratin. B. Right breast mastectomy: Multiple areas of invasive papillary carcinoma. Largest area size 3 cm. Architectural score: 1 of 3. Nuclear score: 2 of 3. Mitotic score: 1 of 3. Total score: 4 of 9 = grade 1. Additional areas of in situ and invasive papillary carcinoma located in other quadrants of the breast. The largest area of confluent carcinoma measures 0.8 cm. No evidence of skin of nipple involvement. Overlying skin contains a large seborrheic keratosis. Deep margin of excision is free of carcinoma. TNM: T2pNO(i-)MX. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Right modified radical mastectomy with sentinel node mapping with frozen section. Adenocarcinoma, with papillary subtype. (Papiliary carcinoma). ER positive, PR positive. Postoperative Diagnosis: Symptoms/Radiokogic Findings: SPECIMENS: A. Sentinel node right, count 4600 with frozen section. B. Right breast tissue 1453 grams. SPECIMEN DATA. GROSS DESCRIPTION: The specimen is received in two containers labeled with the patient's name . A. Container A is received fresh for frozen section, additionally labeled 'right sentinel node' and contains a 2.5 x 2.0 x 1.0 cm aggregate of yellow-tan. fibrofatty soft tissue. On palpation, a 1.3 cm firm fatty nodule is identified consistent with possible lymph node. The nodule is bisected and entirely. submitted for frozen section. The residual is entirely resubmitted for permanent section in cassette A labeled. B. Container B is received with formalin additionally labeled 'right breast tissue' and consists of a 1439.4 gram, 27.5 x 19.0 x 6.5 cm simple mastectomy. specimen partially surfaced by pink-tan wrinkled skin which bears a central 1.5 x 1.0 x 0.2 cm slightly raised nipple. Orientation is not offered or possible. Located 0.7 cm from the skin edge and 7.8 cm from the nipple is a 1.3 x 0.8 x 0.5 cm gray-brown raised skin lesion. Additional skin lesions are not. identified. The deep margin is inked and the specimen is serially sectioned to reveal a 2.8: x 1.5 x 1.0 cm cystic lesion containing pink-tan friable soft. tissue, along with a radiographic clip. This lesion resides 4.5 cm from the skin surface and 2.2 cm from the inked deep margin. Multiple additional pink-. tan rubbery lesions are identified diffusely scattered throughout the specimen and involve all four quadrants. The largest of these remaining lesions is. 3.0 x 1.8 x 1.8 cm and approaches to within 0.4 cm of the inked deep margin. The uninvolved areas are comprised of yellow-tan adipose tissue admixed. with moderate amounts of interspersed gray-white fibrous tissue. Discrete axillary tail is not present, however, five firm fatty possible lymph nodes are. identified along one edge of the specimen. These possible lymph nodes range from 1.0 up to 1.4 cm in greatest dimension. Also received in the same container are two portions of pink-tan wrinkled skin with yellow-tan subcutaneous fibroadipose tissue. These tissues are 8.0 x. 2.0 x 1.3 cm and 16.0 x 3.0 x 2.0 cm.The cut surfaces are yellow-tan fibrofattywith no discrete lesions. Representative sections are submitted in. cassettes B1 through 13 labeled. esignated as follows: 1, nipple; 2, skin lesion, entirely; 3 and 4, radiographically located lesion; 5 and 6,. largest additional lesion to inked usep margin, perpendicular; 7 through 10, additional representative lesions from all four quadrants; 11, two whole. possible lymph nodes; 12, two whole possible bisected lymph nodes (one inked): 13. one whole possible bisected lymph node. Additionally, a yellow,. green and blue cassette are submitted for genomics research each labeled. ININA-OPERATIVE CONSULTATION: FROZEN SECTION DIAGNOSIS: Part A: No neoplasm identified (0/1) per Dr.",train,3 cm;0.8 cm
8008,TCGA-K6-A3WQ.16F848AA-C14C-45F7-A756-414615853761,"Results Viewer. Encounter Num. COPY ONLY DO NOT FILE. of specimon. A. USERUO, CERVTX, BILATERAL FALLOPIAN TUBES & OVARIES FOR. GROSS-. B. VAGINAL CUFF TISSUE-. C. SIGMOID SURFACE TISSUE-. D. CUL-DE-SAC TISSUE-. F. LEFT ADENEXAL TISSUE-. F. RIGIT SIDE WALL TISSUE-. G. RIGHT PELVIC LYMPII NODES-. H. LEFT PELVIC LYMPH NODE-. 1. RICHT STDE WALL TISSUE #2-. J. OMENT'IM-. FINAL DIAGNOSIS: A. UTERUS, CERVIX, BILATERAL FALLOPIAN TUBES & OVARIES FOR. GROSS-. ENDOMETRIAL CARCINOMA. HISTOLOGIC TYPE: SEROUS TYPE, ADMIXED WITH CLEAR CELL AND 100% indometrial carcinoma,. ENDOMETRIOTD COMPONENTS. GRADE: 3/3. DEPTE OF INVASION: 14 MM. NEARLY 959 OF MYCMETRIUM. ICD-0-3. THICKNESS: 15 MM. AT TUMOR GITE. INVAGION OF CERVICAL STROMAL: PRESENT. Pre. Results Viewer. INVASION OF VAGINA: NOT SEEN IN PART ""B"". INVASIVE IMPLANTS, SEEN TN UTERINE SEROSA, BILATERAL ADNEXAE,. CUL-DE-SAC, RIGHT SIDE WALL (PARTS ""F"" AND ""I""), AND PERICOLIC. SOFT TISSUE (PART ""C""). METASTATIC CARCINOMA ALSO NOTED IN OMENTUM. TUMOP. SIZE: 3.5 CM IN GREATEST DIMENSION. TNM STAGE (AJCC, Edition) : pT3b, pN1, pM1. (SMALI VESSEL) INVASION: PRESENT. LYMPH NODE (S) INCLUDED IN ALL PARTS: NUMBER INVOLVED : 1. NUMBER EXAMINED: 2. SPECIMEN TYPE: HYSTERECTOMY AND BILATERAL. LEENGO-OOPHORECTOMY. SIZE OF UTERUS: 6 x 4.5 x 3 CM. ADENOMYOSIS. NO TUMOR SEEN AT RESECTION MARGINS OF THE SPECIMEN. B. VAGINAL CUFF TISSUE-. FIBROUS TISSUE, INFLAMED WITH CAUTERY ARTIFACT. C. SIGMOID SURFACE TISSUE-. INVASIVE CARCINOMA AS SEEN IN PART ""A"". D. CUL-DE-SAC TESSUE-. INVASIVE CARCINOMA AS SEEN IN PART ""A"". F. LEFT ADENEXAL TISSUE-. INVAGIVE CARCINOMA AS SEEN IN PART ""A"". : RIGHT SIDE WALL TISSUE-. INVASIVE CARCINOMA AS SEEN IN PART ""A"". G. RIGHT PELVIC LYMPH NODES-. LYMPH NODE, NEGATIVE FOR TUMOR. H. OFFT PELVIC LYMPH NODE-. LYMPH NODE with MICROME/TASTASIS. NO EXTRANODAL INVASION GEEN. CFE NOTE. NOTE: THE MICROMETASTASIS CONSISTS OF P.ARE MINUTE CLUSTERS OF. TUMOR CELLS. ON IMMUNOSTAINING, THE TUMOR CELIS ARE POSTTIVE FOR. KERATINS. Appropriate positive controls were stained along side sections. from this case, The control tissue was examined and judged to. be technically acceptable. Prep. Results Viewer -. 1. 1< THE STDE WALL TISSUE #2-. INVASIVE CARCINOMA AS SEEN IN PART ""A"". OMENTUM. INVASIVE CARCINOMA AS SEEN IN PART ""A"". signed Others. Brocen Section. A. DLERUS, CERVIX, BILATERAL FALLOPIAN TUBES AND OVARIES, GROSS. EKAM: -:- CM FRIABLE PAPILLATION OCCUPYING THE ENTIRE ENDOMETRIAL. VAVITY AND INVADING INTO THE MYOMETRIUM (>50%) ;. SCIORTENED CERVIX (S/P LEEP), NO TUMOR SEEN GROSSLY IN THE. CERVIK. SECTIONS OF TUMOR AND CERVIX TAKEN FOR RESEARCH STUD'. Frozen soction performed by Lr. Case Clinical Information. PAPILLARY SEROUS UTERINE CANCER. Gross Description. A. Received in formalin labeled ""uterus, cervix, bilateral. cuces and ovaries"" is a hysterectomy specimen with attached. bilateral adnexae, weigning a total of 80 grams. The uterus. 5 em Licm Cundus to exocervix, 3 cm como to comm and. 4.5 cm anterior to posterior. The right fallopian tube measures. 1 X 0.5 am. The right ovary is yellow/tan and cystic in. apceatance and measures 2.5 x 2 x 1.5 cm. The left fallopian. unbe measures 1.5 % 0.5 cm. The left ovary is yellow/tar firm. and mensures 2 & 1.1 x 1 cm. The exocervix measures 1.5 % 1.2 X. 1....m. The utorus has been previously bivalved to show .). endocervical canal measuring 1.5 x 0.1 cm. endemetria caviry has been previously sectioned and is. remerKab. is for a gray/tan, Triable papillary mass meaturing ?.. The mycmetrium is 0.5 em in thickness. Sect the endomyometrium shows chat the. resion invotues of the myoretrium. The right fallopian. : sectally sectioned showing an unremarkable riupoint. Prepared. Results Viewer. Tumen. The right ovary is serially sectioned to show a cyst. with a clear fluid. No excrescence or papillation is grossly. identified. The left fallopian tube is serially sectioned to. show an unremarkable pinpoint lumen. The left ovary is serially. sectioned to show3 a gray/tan atrophic parenchyma. The boecimen. is. represented as follows: cervix is coned, radially sectioned. and submitted as 12-3:00 in Al, 3-6:00 in A2-A3, 6-9:00 ir. A1,. 9-12:00 in A5-A6; anterior lower uterine segment in A7; anterior. endomyometrium and tumor at its deepest. invasion in A8-A11;. posterior lower uterine segment in A12; posterior endomyometrium. and tumor at its deepest invasion in A13-A16; right fallopian. tabe, ovary and imbria in A17; and left fallopian tube, ovary. and fimbria in Ala. B. Received in formalin labeled with the patient's name and. ""vaginal cuff tissue"" is a gray/tan tissue fragment measuring 1. x 1) em. Wrapped and entirely submitted in B1. C. Received in formalin labeled with the patient's name and. ""sigmoid surface tissue"" is d gray/tan, fibrous Lissue Eragment. measuring 3 x 2 cm. Entirely submitted in C1-C3. D. Received in formalin labeled with the patient's name and. ""cul-de-sac"" are gray/tan fibrous tissue fragments measuring =. x. 1.5 cm. Sectioned. Entirely submitted in D1-D2. E. Received in formalin Labeled with the patient's name and. ""left adnexal tissue"" is a gray/tan, friable tissue fragment. measuring 2 2. 1.2 cm. Entirely submitted in E1. :- Received in formalin labeled with the patient's name and. ""right side wall"" is a gray/brown, fibrous and hemorrhagic. tissue measuring 0.9 1 0.7 cm. Entirely submitted in Fl. G. Recoived in formalin labeled with the patient's name and. ""right pelvic lymph nodes"" is a yellow/tan fibroadipose tianue. measuring 0.7 2 0.5 cm consistent with lymphoid tissue. Bisected, wrapped and entirely submitted in G1. IL. Received in formalin labeled with the patient's name and. ""loit polvic lymph node"" is a yellow/tar fibroadipose tinaue. heasuring 1.5 % 0. cm consistent with lymph node. One lymph. node is grossly identified measuring 0.7 x 0.4 cm. Bisected,. wlapped and entirely submitted in H1. I. Received in formalin labeled with the patient's name and. ""right side wall #2"" is a yellow/tan, fibrous and homorrbagic. fragment measuring 1.5 x 1 cm. Entirely submitted in 11. I. Received in tormail labeled with the patient's name and. ""omontum"" is a yollow/tan, fixm and fibroadipose tissue. measuring 20 y 4 x 2 cm. Sectioned to show three gray/tan. redules. The largest measures 3 x 2 cm; the smallest, 1.5 x 1. em consistent with metastatic disease. Represented in J1-J2. Prepared. procequre. A. AA ROUTINE the X1 BLOCK. 1. A. AA BONTINE BAF 31 BLOCK. 2. HUE x1. A. AA BOOTENE HIF X1 BLOCK. 3. H&S X1. A. AA ROUTINE H&E X1 BLOCK. 4. RAE x1. A. AA ROUTINE H&E X1 BLOCK. 5. A&E X1. A. AA ROUTINE H&E X1 BLOCK. 6. H&E x1. A. AA ROUTINE HAE X1 BLOCK.7. H&E X1. A. AA ROJTINE H&E X1 BLOCK. 8. H&E X1. A. AA ROUTINE H&E X1 BLOCK.9. HaE 31. A. AA ROVTINE HIEE X1 BLOCK. 10. HICE XI. A. AA HAF. X1 BLOCK. 11. H&E X1. A. AA HSE x1 BLOCK.12. 1163 x1. A. AA ROTPINE H&E X1 BLOCK. 13. H&E X1. A. AA ROUPINE H&E X1 BLOCK.14. x1. A. AA ROUTING HICE X1 BLOCK.15. its X1. in. AA ROUTINE IME X1 BLOCK. 16. HTEE 31. A. AA POUTTNE HAF X1 BLOCK.17. H&E K1. A. AA ROVEINE H&E X1 BLOCK. 18. H4E 21. B. AA ROUTINE HaE 31 BLOCK. HSE X1 A RECUTS. c. AA ROUTINE H&E X1 BLOCK. L. HSE 71. C. All ROUTINE H&E X1 BLOCK. 2. STAE y1. : AA ROUTINE lixE X1 BLOCK. 3. H&P K1. Results Viewer -. Page  old. D. AA ROUPINE H&E X1 BLOCK. 1. HSS X1. D. AA ROUTINE HsE X1 BLOCK. 2. H&E X1. E. AA ROUTINE H&E X1 BLOCK. HAE X1. "". AA ROUTINE I&E X1 BLOCK. HAE 31. i; AA ROUTINE H&E X1 BLOCK. HiE X1. 11. AA ROUTINE HuE X1 BLOCK. H&E X1 AE1/AE3. L. AA ROUPINE HAE X1 BLOCK. J. AA ROUTINE H&E X1 BLOCK. 1. x1. J. AA ROUTINE IISE X1 BLOCK. 2. H&E x1. Prepared f.",train,3.5 CM
8010,TCGA-KM-A7QC.D3E87845-70EA-4641-BDCE-6961254E5108,"MEDICAL RECORD. PROCEDURE DATE: SEX: F. SIGN-OUT DATE: ATTENDING: REQUESTING: CONTACT NO: (MD). ROOM: COPIES TO: DIAGNOSIS: 1. Lymph node, paraaortic (excision): Reactive lymph node. No tumor seen. 2. Kidney, left base ""mass"" (excision): Necrotic debris. 3. Kidney, left, deeper base ""mass"" (excision): Kidney parenchyma. No tumor seen. 4. Kidney and adrenal, left, morcellated (nephrectomy-morcellated): Renal cell carcinoma, chromophobe type,. ""Furhman nuclear grade II with extensive necrosis and acute and chronic inflammation. Diffuse interstitial. nephritis. Vascular and ureteral margins free of tumor. Focal ureteritis. No capsular invasion seen. Adrenal gland. No tumor seen. NOTE: Kidney Nephrectomy Summary Table Macroscopic. Specimen Type: Nephrectomy - morcellated. Laterality: Left. Tumor Size: 4 cm. Focality: Unifocal. Macro Extent of Tumor: Confined to kidney. Microscopic. Histologic Type: Renal cell carcinoma, chromophobe type,. Histologic Grade;. Furhman nuclear grade Il. - age 1 of 3. MEDICAL RECORD. Date or Report: Extent of Invasion. Primary Tumor(pT): pT1a. Regional Lymph Nodes(pN): pNO. Distant Metastisis(pM): pMx. Margins: Vascular, ureteral and inked surgical margins free of tumor. CLINICAL INFORMATION: Brief Clinical History: female wiht left renal mass. Specimen Taken For Protocol: Allocate Order to Protocol: PROCEDURE: Operative Findings: left upper pole mass Post-Operative Diagnosis: left renal mass Pre-Operative Diagnosis: left renal mass. SPECIMENS SUBMITTED: 1. ROUTINE + 6FS, Peri-aortic lymph node (1FS). 2. SERIAL 5 + 6FS, Left kidney mass (2FS). 3. ROUTINE + 3FS, Left kidney mass (3FS). 4. KIDNEY, Left adrenal morgellated. INTRAOPERATIVE CONSULTATION: 1. 1FS Diagnosis: Lymph nodes, no definitive tumor seen on frozen section. The Frozen Sections were performed by. 2FS Diagnosis: Fragments of probable epithelioid tumor cells with coagulative necrosis; definitive characterization. deferred to permanent. 3FS Diagnosis: Portion of renal cortical tissue with focal mild interstitial inflammation, no definitive tumor seen on. frozen sections. The Frozen Sections were performed by. GROSS DESCRIPT Received are 4 formalin-filled containers labeled with the patient's name, medical record. number, and further described as follows: 1. ""Paraaortic lymph node"". The specimen is a tan to red/brown soft tissue fragment measuring 1.6 x 1.2 x 0.2. cm. The specimen is frozen in toto as 1FS. In Surgical Pathology, the specimen is entirely transferred into an. orange cassette labeled. for permanent processing. MEDICAL RECORD. Nam. 2. Left kidney mass base"". The specimen is multiple (3) tan tissue fragments measuring 0.2 x 0.2 x 0.1 cm in. aggregate. The specimen is frozen in toto. In Surgical Pathology, the specimen is transferred into an orange. cassette labeled. for permanent processing. 3. ""Left kidney mass deeper base"". The specimen is a piece of red/brown tissue measuring 1.0 x 0.5 x 0.4 cm. The specimen is frozen in toto as 3FS. In Surgical Pathology, the specimen is entirely transferred to an orange. cassette labeleo. for permanent processing. 4. ""Kidney and adrenal - morcellated"" Received is a specimen labeled ""left kidney and adrenal morcellated"" The. specimen consists of a simple nephrectomy specimen three pieces measuring 16 x 10 x 5 cm in aggregate. The. adrenal gland is identified. The ureteral and vascular structures are identified by surgical staples. The specimen. is inked black and bisected revealing a 4 cm diameter tumor mass with a tan-yellow, soft, necrotic cut surface. 50% of the tumor is procured for. Representative normal is procured for Research. Procurement. was performed by. on. to. The vascular/ureteral margins are submitted. in white cassettes. 4A-C. The most distal end of the ureter is submitted in white cassette. 4D. Sections of the most inferior aspect of the tumor and kidney. inferior aspect of the tumor (most adjacent to. the kidney) are submitted in white cassettes. A section of adrenal gland is submitted in 4G. Representative sections of fat are submitted in 4H. A representative section of normal kidney renal parenchyma. is submitted in 4I. Representative sections of the tumor are also submitted in 4J-4Q for permanent processing. Gross dictated by. No consultants.",train,4 cm;4 cm
8025,TCGA-38-7271.7eb95f4d-3fb0-4312-89d1-4d5ec9f4f677,"Diagnosis: A, B: Lung, right upper lobe lesion, wedge biopsy. - Adenocarcinoma, moderately differentiated, 2.5 cm diameter,. consistent with lung primary, without pleural invasion, surgical. margins not involved. Intraoperative Consult Diagnosis: n section was requested by Dr. in OR. on. at. FSA1 : Right upper lobe mass, wedge biopsy. - Adenocarcinoma, moderately differentiated. - Defer to special stains to exclude metastasis. Drs. at. Frozen Section Pathologist: M.D., PhD. Clinical History. The patient is a. - +year-old female with a right upper lobe lung. mass. CIS: PMHx. for grade 3, ductal breast. inoma (ER. weak, PR negative, HER2 score 0) diagnosed in. eviewed. here as OS06-) . Positive smoking history prior. Gross Description: Received are two appropriately labeled containers. Container A: Received for frozen section is an 8.0 X 4.5 X 3.0. cm wedge of lung. There is an .11-defined, slightly firm and tan. nodule at the resection edge. This measures 2.5 X 1.8 X 0.5 cm. The tissue beneath the stapled tissue is submitted in blocks A1. and A2. Representative sections of the nodule are submitted in. blocks A3 and A4. A portion of the nodule is frozen as FSA1. Container B is additionally labeled ""right lung, upper lobe. wedge. "" The specimen is received as a 54.9 gram aggregate of two. pieces of lung tissue. The first piece measures 4.3 X 1.7 X 0.9. cm. The larger piece measures 8.5 X 8.0 X 2.9 cm. Blue ink has. been applied to the area of previous wedge biopsy. There is an. area of defect in between the two pieces, representing the. initial wedge biopsy. Within the lung tissue, there is a. subpleural hard white/firm mass, 3.5 X 3.0 X 3.0 cm in greatest. gross dimensions. Sections of normal lung and the large mass. were submitted for Tissue procurement. The staple lines are. removed and the tissue beneath is submitted in blocks B1 and B2. B3-B5 - - representative sections through tumor. Light Microscopy : Light microscopic examination is performed by Dr. The frozen section diagnosis is confirmed. Sections show a gland-forming carcinoma, without mucinous. differentiation. Features favor lung over breast primaries. To. clarify lineage, immunohistochemistry was performed, and shows. immunoreactivity for TTF-1 and HER2, with no reactivity for. GCDFP or ER. This immunophenotype supports lung primary.",train,2.5 cm
8064,TCGA-56-7221.9c136f18-c53c-45f8-b20f-850086ee0f55,"Pre-Op Diagnosis. Right lung cancer. Post-Op Diagnosis. Same. Clinical History. Nothing indicated on requisition. Gross Description: Six parts. Container labeled. 1 - level 9 lymph node"" are two. nodular portions of gray tan to black tissue from 1.0 x 0.5 x 0.3 cm. and 1.1 x 0.6 x 0.3 cm. The specimen is entirely submitted in a. single cassette. Container labeled. 2 - level 7 lymph node"" are 1.2 x. 1.0 x 0.4 cm of gray yellow to brown black fleshy and fatty tissue. fragments entirely submitted in a single cassette. Container labeled. 3 - level 10 lymph node"" are three. irregular fragments of soft fleshy gray black tissue from 0.6 x 0.2. x 0.2 cm to 0.6 x 0.4 x 0.3 cm. The specimen is entirely submitted. in a single cassette. Container labeled. 4 - right lung lower lobe"" is a. previously partially inked partially sectioned portion of. recognizable pulmonary parenchyma grossly consistent with right. lower lobe. The specimen as received weighs 180 grams and measures. 13.8 x 8.2 x 5.1 cm. The margin of resection is bifurcation of the. tertiary bronchi. This is surrounded by a few mottled fleshy gray. brown to black nodules up to 1.1 cm in greatest dimension. The. pleura is wrinkled and gray tan. Noted on the anterior aspect near. the base is a previously inked portion of pleura with moderate. anthracotic streaking. This is previously sectioned to reveal an. underlying 3.5 3.3 x 2.6 cm lobulated nodular fibrotic lesion with. a markedly necrotic gray tan cut surface. The lesion is seen at its. nearest point 0.2 cm from the anterior inked pleura, 0.2 cm from the. medial pleura, and 0.1 cm from the basal pleura. The lesion does. not grossly appear to extend through the pleura in any of these. areas. The lesion is noted at its nearest point 4.3 cm from the. nearest bronchial margin. A bronchial connection is grossly. identified. The remaining parenchyma is spongy and tan pink with. moderate anthracotic streaking. No additional gross lesions are. identified. Also received in the same container are two tissue. cassettes each labeled. Representative sections are. submitted labeled as follows: A - shaved bronchial margin and. peribronchial nodules, B - lesion to anterior pleura, C - lesion to. medial pleura, D - lesion to basal pleura, E - lesion with bronchial. connection, F - representative lesion, G - random uninvolved. parenchyma. Container labeled. 5 - level 8 lymph node"" are 2.9 x. 2.1 x 1.5 cm of fragmented lobulated fleshy gray black tissue. fragments which are sectioned and entirely submitted in four. cassettes. Container labeled. 6 - level 4 lymph node"" are 2.1. x. 1.6 x 0.7 cm of gray yellow fleshy and fatty tissue fragments which. are entirely submitted in a single cassette. Microscopic Description: The slides labeled. are examined. See diagnosis. Final Diagnosis. Lymph node, level 9 (biopsy): Anthrasilicosis and mild reactive sinus histiocytosis, no. metastatic carcinoma identified within one (0/1) lymph node. PAS. 4. Lymph node, level 7 (biopsy): Anthrasilicosis and mild reactive sinus histiocytosis, no. metastatic carcinoma identified within four (0/4) lymph nodes. PAS 4. Lymph node, level 10 (biopsy): Anthrasilicosis and mild reactive lymphoid hyperplasia, no. metastatic carcinoma identified within three (0/3) lymph nodes. PAS 4. Lung, right lower lobe (lobectomy): Tumor characteristics: Histologic type: Large cell carcinoma consistent with squamous. cell carcinoma with areas of necrosis (see comment). Location of tumor: Right lower lobe near base. Size: 3.5 x 3.3 x 2.6 cm in greatest dimension. Grade: Poorly differentiated. Pleural invasion: Not identified. Lymphovascular space invasion: Yes. Surgical margin status: Tumor distance from bronchial margin: 4.3 cm. Tumor distance from parenchymal (stapled) margin: Not. applicable. Tumor distance from pleural surface: Less than 1 mm (see. comment). Lymph node status: Total number of bronchial lymph nodes examined: 3. Total number of lymph nodes containing metastatic carcinoma: o. (0/3). See above and below diagnoses for remaining lymph nodes. PAS 9. Other findings: Area of subpleural fibrosis. PAS 4. Emphysematous changes. PAS 4. Lymph node, level 8 (biopsy): Multiple fragments of lymph nodes demonstrating anthrasilicosis,. reactive sinus histiocytosis, no metastatic carcinoma. identified (see comment). Lymph nodes demonstrating granulomas (see comment). PAS 6. Lymph node, level 4 (biopsy): Anthrasilicosis and reactive sinus histiocytosis, no metastatic. carcinoma identified within two (0/2) lymph nodes. PAS 4 SPC-A. CPT: 88309, 88305 x5, 88312 x2. Stage: pT2NO. Comments. Sections show a poorly differentiated large cell carcinoma with. squamous differentiation (poorly differentiated squamous cell. carcinoma). This extends to within less than 1 mm of the pleural. surface, but does not invade the pleura. A focus of lymphovascular. space invasion is identified. Lymph nodes from level 8 were. received multiply fragmented and it is impossible to ascertain an. accurate node count. No metastatic carcinoma is identified. Occasional granulomas are present from the level 8 lymph nodes,. specimen #5. An acid fast and GMS stain are performed which. demonstrate no acid fast bacilli (with appropriate positive. control). No fungal organisms are identified (with appropriate. positive control). Clinical correlation and follow up is. recommended. At the request of the undersigned pathologist, these slides have. been additionally reviewed by Dr. who concurs with the. diagnosis. This test has been finalized at the. Campus.",train,3.5 x 3.3 x 2.6 cm
8170,TCGA-74-6584.315ce84d-6870-4a44-bf59-e5b1ba0d94bb,"Encounter Date: Results: PATHOLOGYNON GYN. CYTOLOGY. Lab. SURGICAL PATHOLOGY Case Number: Procedures/Addenda Present. CLINICAL INFORMATION: Neoplasm of unspecified nature of brain. ICD-9 code: 239.6. INTRAPROCEDURAL CONSULTATION: A. Right brain tumor (frozen section): High-grade malignant neoplasm. consistent with glioblastoma multiforme. GROSS DESCRIPTION: A. Received fresh, labeled. and designated ""A. right. brain tumor"", is a 1.0x1.0x0.2cm aggregate of pink-tan hemorrhagic soft. tissue fragments. A frozen section was performed on one aspect of the tissue. and is submitted in AFS, The remaining tissue was submitted in one cassette. B. Received fresh on. is approximately 30 CC of clear light. orange fluid, labeled. (B)"". Prepared are one cellblock and. one ThinPrep slide. C. Received fresh, labeled. and designated ""C. CUSA. contents"", is a 6.2x3.0x1.3cr aggregate of pink-tan hemorrhagic soft tissue. fragments, which are entirely submitted in three cassettes. D. Received in formalin, labeled. and designated ""D. connective dura"", is a 1.3x1.0x0.1cm fragment of hemorrhagic dura, which. is. entirely submitted in one cassette. E. Received fresh, labeled. and designated ""E. right brain. tumor"", is a 3.5x2.5x0.9 cm aggregate of hemorrhagic pink-tan soft tissue. fragments. Specimen is submitted in its entirety in two cassettes. MICROSCOPIC DESCRIPTION: The immunohistochemical tests reported were developed and performance. characteristics determined by. They have not been. cleared or approved by the U.S. Food and Drug Administration. The FDA has. determined that such clearance or approval is not necessary. These tests may. be used for clinical purposes. They should not be regarded as. investigational or for research use only. is certified. under the Clinical Laboratory Improvement Amendments of. (CLIA) as. qualified to perform high complexity clinical laboratory testing. FINAL PATHOLOGIC DIAGNOSIS: Encounter Date: A. RIGHT BRAIN TUMOR: C. CUSA CONTENTS: E. RIGHT BRAIN TUMOR: Glioblastoma, WHO grade IV/IV, with the following features: -Degree of cellularity: High. -Microvascular proliferation: present. -Necrosis: present. Mitotic activity: high, at least 20 per 10 high power fields. Other features: MGMT studies (PCR and immunohistochemistry) and FISH. studies are pending. -Please see comment section. B. CYST ASPIRATE (including evaluation of cellblock): -Proteinaceous fluid. D. CONNECTIVE DURA: -Fibrous connective tissue consistent with dura showing infiltrating. glioblastoma. COMMENT: In addition to the usual features of glioblastoma, there is a region of small. clustered cells in part E reminiscent of neuronal or primitive. neuroectodermal differentiation. Immunostains reveal delicate synaptophysin. positivity and decreased GFAP expression compared to the opposite findings. in. the high-grade glial component. These changes are supportive of focal. primitive neuronal differentiation. P53 immunostains show staining in both. components. In part D, the glioblastoma invades the apparent dura. Foci suggestive of. vascular invasion by tumor were raised and immunostains to GFAP and CD31. applied to further characterize the tumor. The tumor is GFAP positive and the. dura is richly vascular. The suspected areas are not represented in the. sections studied, however, and the question of vascular invasion cannot be. confirmed. PROCEDURESIADDENDA: ICC- IMMUNOHISTOCHEMISTRY Date Ordered: Date Complete: Interpretation. At the request of. representative sections of the tumor (E) were. submitted for MGMT Immunohistochemistry. The result is approximately 50% of. the tumor is positive. Endothelial cells serve as a positive internal. control. Results-Comments. E. RIGHT BRAIN TUMOR, IMMUNOHISTOCHEMISTRY RESULTS: -TUMOR IS POSTIVE FOR MGMT BY IMMUNOHISTOCHEMISTRY. (APPROXIMATELY 50%). MGMT by PCR. Date Complete: Interpretation. {Not Entered}. Results-Comments. E. RIGHT BRAIN TUMOR, MGMT Methylation Assay Result: Gene Methylation NOT detected. Please see full report from. for additional details accession. Lab Inquiry. View Complete Results. Dept Phone: Description. Encounte. Department. Encounter. PATHOLOGY / NON GYN CYTOLOGY. Patient Patient Name Sex. Information. Admitted Date. CSN. Released By. Department. Information.",train,1.0x1.0x0.2cm;3.5x2.5x0.9 cm
8237,TCGA-AA-3982.98bb6188-7493-47af-a8da-99929e1ea542,"This is an unequivocal finding in the sense of an adenocarcinoma of the colon with extensive. necrosis and poor differentiation (thus corresponding to G3) with penetration of all parietal. layers and vascular infiltration (thus corresponding to pT3, L1, V1) with free resection margins. in the mucosal region with a regular mucosa, submucosa and muscularis and free resection. margins in the mesenchymal region and three lymph node metastases (corresponding to pN1). In addition, there were diverticular formations. Tumor classification: ICDO-DA-M. G3. pT3. L1, V1. pN1 (3 of 13 lymph nodes).",train,
8292,TCGA-OL-A5S0.EDF80CFD-4115-48E9-BF76-DDE957A97AEB,"FINAL PATHOLOGIC DIAGNOSIS. A. Breast, right, modified radical mastectomy: - Invasive ductal carcinoma, grade III/III, 5.0 cm in greatest dimension,. present 1.0 mm from posterior inked surgical margin, other margins widely free. (see pathologic parameters and comment below). Ductal carcinoma in-situ, high grade, solid type with associated central. necrosis and calcifications, surgical margins negative. - Previous biopsy site identified. - Metastatic carcinoma involving two of twelve lymph nodes (2/12). B. Breast, right, deep margin re-excision: - Skeletal muscle and fibroadipose tissue, negative for carcinoma. C. Breast, right 'additional tissue under superiomedial skin flap,' excision: - Breast and fibroadipose tissue, negative for carcinoma. D. Skin, right 'chest wall at corner of incision,' excision: - Skin and fibroadipose tissue, negative for carcinoma. Breast Pathologic Parameters. 1. Invasive carcinoma: A. Gross measurement: 5.0 cm. B. Composite histologic (modified SBR) grade: III/III. C. Associated intraductal carcinoma in situ (DCIS). - High grade, solid type with associated central necrosis and. calcifications. - Within main mass. 2. Surgical margins: Free of tumor. - DCIS 3.0 mm from closest margin (posterior). - Invasive carcinoma 1.0 mm from closest margin (posterior) on mastectomy,. separately submitted deep margin re-excision (specimen B) negative for carcinoma. - Additional margins widely free. 3. Blood vessel and lymphatic invasion: Present. 4. Nipple: Uninvolved. 5. Skin: Uninvolved. 6. Skeletal muscle: Focally involved. 7. Axillary lymph nodes: Metastatic carcinoma involving two of twelve lymph. nodes (2/12). - Size of largest metastatic deposit: 1.1 cm. - Extranodal extension: Present (2.0 mm). 8. Special studies . - ER: Weak expression in 30% of invasive tumor nuclei. - PR: No expression in invasive tumor nuclei. - Ki-67: 50% proliferation rate. - Her2/neu antigen (FISH): Amplified (ratio: 3.8). 9. pTNM (AJCC, 7th edition, 2010): pT2, N1a, MX. Clinical History: The patient is a. year-old female with right breast invasive ductal carcinoma. with axillary nodal metastases who undergoes right modified radical mastectomy. Comment. The 5.0 cm mass identified on gross examination is comprised of both invasive. and in-situ carcinoma with extensive necrosis and calcifications. Specimens Received: A: Right breast and axillary contents. B: Additional deep margin. C: Additional tissue under superiomedial skin flap. D: Skin at corner of incision; r chest wall. Gross Description: The specimens are received in four containers each labeled with the patient's. name and medical record number. A. The first container is additionally identified as, 'right breast and. axillary contents'. Received fresh and placed in formalin is a 730 g simple. mastectomy specimen. The specimen is oriented with a double short suture. designating the superior aspect and a double long suture designating the lateral. aspect. The breast measures 23 cm from medial to lateral, 21 cm from superior. to inferior, and 4.5 cm from anterior to posterior. On the anterior surface is. 20 X 8.5 cm ellipse of skin with a 4.2 X 4.0 cm areola and a 1.3 X 1.3 X 0.5 cm. nipple. The nipple-areolar complex reveals no evidence of ulceration or. retraction. There is an attached 6.5 X 5.5 X 1.5 cm portion of apparent axillary. tail on the lateral aspect of the specimen. There is an attached 4.5 X 1.8 X 0.2. cm skeletal muscle consisting of pectoralis at the deep margin at junction of. upper-outer quadrant and lower-outer quadrant in slice3-5 The specimen is. inked as follows: anterior-superior - blue;. anterior-inferior - green;. posterior - black. The specimen is serially sectioned from lateral (slice #1) to medial (slice #11). to reveal a 5.0 X 3.8 X 3.5 cm pink-tan, firm mass (lesion #1) extending from. upper-outer quadrant to lower-outer quadrant in slices 3-7. The mass is 1.6 cm. from the anterior-inferior margin and abuts the posterior margin. Surrounding. the mass is a 10x7x4 cm ill-defined, pink area composing of dilated ducts. and fibrotic tissue in slices 4-9 and the most prominent in slice 7-8. The. ill-defined area (lesion #2) extends towards anterior aspect and is 0.6 cm from. the closest anterior margin and 2.0 cm from the closest posterior margin. The. remainder of the specimen consists of approximately 10% dense gray-white fibrous. breast parenchyma and 90% lobulated yellow adipose tissue. No additional masses. or nodules are grossly identified. Within the axillary tail are identified. several lymph node candidates measuring from 0.3-2.5 cm in greatest dimension. Block summary: A1: Lesion #1, slice 3. A2: Lesion #1, slice 4. A3: Lesion #1 abutting posterior margin, slice 5. A4: Lesion #1, slice 6. A5: Lesion #1, slice 7. A6: Lesion #2, slice 4. A7: Lesion #2, slice 5. A8: Lesion #2, slice 6. A9: Lesion #2, slice 7. A10: Lesion #2, slice 8. A11: Lesion #2, slice 9. A12: Representative adjacent medial to lesion #2, slice 10. A13: Representative adjacent lateral to lesion #2, slice 3. A14: upper-outer quadrant slice 2. A15: lower-outer quadrant slice 1. A16: upper-inner quadrant slice 11. A17: lower-inner quadrant slice 10. A18: nipple. A19: skin. A20: One lymph node. A21-A23: 4 lymph node candidates, each cassette. A24-A26: One lymph node, serial section. B. The second container is additionally identified as, 'additional deep margin;. underlying palpable tumor : Received in formalin is a 3.9 g, 4.2 X 2.2x0.8 cm. yellow-tan, soft tissue fragment with one short stitch designating as new true. deep margin (inked blue) and attached clips on original margin (inked black). The specimen is serially sectioned and entirely submitted as B1-B5. C. The third container is additionally identified as, 'additional tissue under. superiomedial skin flap'. Received in formalin is an unoriented 2.3 g, 4.8 X 1.2. x 1.1 cm portion of yellow-tan fibroadipose tissue, which is serially sectioned. and entirely submitted C1-C2. D. The fourth container is additionally identified as, 'skin at corner of. incision; right chest wall'. Received fresh and placed in formalin is an. unoriented V-shaped ellipse of wrinkled, tan-brown skin measuring 4.5 X 1.5 cm. adjunct with 3.2 X 1.5 cm excised to a depth of 1.3 cm. The specimen is serial. sectioned and review grossly unremarkable parenchyma. The representative section. is submitted as D1. Tissue fixed for at least 6 hours in 10% NBF and no more than 72 hours.",train,5.0 cm;5.0 cm;5.0 cm;4.2 x 2.2x0.8 cm
8352,TCGA-V4-A9EE.780F5B34-05FF-44A1-B9F4-062D737246FD,"Right eye enucleation. Macroscopy. The eyeball measures 25 mm of diameter before fixation, with a posterior segment of optic. nerve of 6 mm. At the section, at the lateral and posterior part of the eyeball, slightly distant. from the ciliary body, distant from the intraocular emergence of the optic nerve, a tumor is. found which is massively protruding in the vitreous cavity. It measures 16 mm main line for. 12 mm of maximum thickness and is partly cystic. The anterior chamber is free. Samples have. been made for cryopreservation and cytogenetic studies. Two samples have been made for. cryopreservation and the specimen has been then included entirely after fixation. Microscopy. The tumor seen macroscopically correspond to a malignant proliferation made nearly only. with medium or large epithelioid cells, with large eosinophilic cytoplasm sometimes loaded. with melanin pigment. The nuclei are irregular in shape and size sometimes monstrous. They. are often strongly nucleolated.A few mitotic figures are observed. The tumor proliferation,. stuck to the internal face of the sclera, infiltrates the most internal sheaths on less than one. third of its thickness. The tumor proliferation stays distant to the ciliary body which is free as. well as the iris and the anterior chamber. At the posterior part it stays distant to the. intraocular emergence of the optic nerve which is free on its entire course( pre and post. laminar, optic foramen meningeal sheaths and cut end) no extrasclrale extension was. observed. Conclusion. Choroidal melanoma with epitheloid cells measuring 16 mm main line by 12 mm maximal. thickness. The tumor proliferation infiltrates the internal part of the sclera on less than one third.No extra. ocular extension was seen. The ciliary body, the iris and the anterior chamber as well as the optic nerve on its entire. course (pre and post laminar, optic foramen, meningeal sheaths and cut end) are free.",train,16 mm;12 mm;16 mm;12 mm
8402,TCGA-DU-7015.15dbad7b-e2ae-42b0-92a1-5ccfc3090c2d,"PATHOLOGICAL DTAGNOSTS: A,B. RIGHT TEMPORAL LOBE, BIOPSY: OLIGODENDROGLIOMA (WHO GRADE 2). (MIB-. 1: 4%) . Operation/Specimen: Right temporal tumor lobe. Clinical History and Pre-Op Dx: None provided. GROSS PATHOLOGY: A. Multiple 0.5 to 1.2 cm tissue fragments. INTRAOPERATIVE CONSULTATION, Frozen section diagnosis Glioma. All. submitted in 1 and 2. B. SPECIMEN: Right temporal tumor lobe. FIXATIVE: Saline. GENERAL: Multiple fragments of tan-gray soft tissue, smooth and. shiny 1.5 x 1 X 0.3 cm. SECTIONS: X1 - all submitted. MICROSCOPIC: Frozen section diagnosis is confirmed. This tumor is an. oligodendroglioma involving the white matter and cortex. The tumor is. moderately cellular with mild nuclear pleomorphism. Mitotic figure is. rare. Vascular endothelial hyperplasia and tumor necrosis are not. present. This tumor is classified as oligodendroglioma WHO grade 2.",train,1.5 x 1 X 0.3 cm
8420,TCGA-DK-AA6M.C1106CFA-9382-4748-927C-E46BA18D4991,"F. Urology. Clinical Diagnosis & History: year old female, history of TCC in. , TCC Ta HG, after 6x BCG, now with bladder tumor. Specimens Submitted: 1: Bladder, right lateral wall, TURB. DIAGNOSIS: 1. Bladder, right lateral wall, TURB: Tumor Type: Invasive urothelial carcinoma, NOS. with sarcomatoid and anaplastic features. Histologic Grade: High grade. Pattern of growth of the non-invasive component: Flat (in situ carcinoma). Local Invasion: Muscularis propria. Vascular Invasion: Not identified. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1. The specimen is received in. labeled ""right lateral wall"", and consists of multiple pieces of tan soft tissue. measuring 3.0 x 2.0 x 0.7 cm in aggregate. The specimen is entirely submitted in two cassettes. Summary of Sections: Part 1: Bladder, right lateral wall, TURB. Blocks Block Designation. PCs. 2. 2.",train,
8446,TCGA-E2-A1L6.F23523C7-B6E9-4205-BD36-D76E9EE9C453,"SPECIMENS: A. SENTINEL LYMPH NODE 1 LEFT AXILLA. B. SENTINEL LYMPH NODE 2 LEFT AXILLA. C. SENTINEL LYMPH NODE 3 LEFT AXILLA. D. LEFT BREAST. DIAGNOSIS: A. SENTINEL LYMPH NODE #1 LEFT AXILLA, EXCISION: - METASTATIC ADENOCARCINOMA, IDENTIFIED IN ONE LYMPH NODE (MICROMETASTASES,. 1.8 MM IN GREATEST DIAMETER). B., C. SENTINEL LYMPH NODES #2-3, LEFT AXILLA, EXCISION: - TWO LYMPH NODES, NEGATIVE FOR MALIGNANCY (0/2). D. LEFT BREAST, MASTECTOMY: - WELL DIFFERENTIATED INFILTRATING DUCTAL CARCINOMA, (1.5. CM IN GREATEST DIAMETER, SBR GRADE 1). - MULTIFOCAL INTERMEDIATE GRADE DUCTAL CARCINOMA IN SITU (CRIBRIFORM,. MICROPAPILLARY, AND PAPILLARY PATTERNS). - PROLIFERATIVE TYPE FIBROCYSTIC CHANGES. - ATYPICAL DUCTAL HYPERPLASIA. - ATYPICAL LOBULAR HYPERPLASIA. - CHANGES CONSISTENT WITH PREVIOUS BIOPSY SITE, UPPER INNER. QUADRANT, WITH ORGANIZING HEMATOMA. - THREE ADDITIONAL LYMPH NODES, NEGATIVE FOR TUMOR (0/3). SEE. COMMENT. SPECIMEN(S): A. SENTINEL LYMPH NODE 1 LEFT AXILLA. B. SENTINEL LYMPH NODE 2 LEFT AXILLA. C. SENTINEL LYMPH NODE 3 LEFT AXILLA. D. LEFT BREAST. CLINICAL HISTORY: year old with left breast ca. GROSS DESCRIPTION: A. SENTINEL LYMPH NODE 1 LEFT AXILLA. Received fresh for touch prep evaluation labeled with the patient name designated ""A - sentinel lymph. node #1 left axilla"" is a beige-tan lymph node measuring 1.6 x 1.2 x 0.7 cm. The specimen is bisected,. touch preps are performed. The entire specimen is submitted in a cassette labeled A1. B. SENTINEL LYMPH NODE 2 LEFT AXILLA. Received fresh for touch prep evaluation labeled with the patient name designated ""B - sentinel lymph. node #2 left axilla"" is a fragment of yellow beige soft tissue measuring 2.2 x 1.8 x 0.5 cm. A tan lymph. node is identified and measures 0.6 x 0.5 X 0.4 cm. The lymph node is bisected, touch preps are. performed. The entire specimen is submitted in cassette labeled B1. C. SENTINEL LYMPH NODE 3 LEFT AXILLA. Received fresh for touch prep evaluation labeled with the patient name designated ""C - sentinel lymph. node #3 left axilla"" is a tan lymph node measuring 1.3 x 0.9 x 0.5 cm. The specimen is bisected, touch. preps are performed. The entire specimen is submitted in a cassette labeled C1. D. LEFT BREAST. Received fresh for tissue procurement labeled with the patient name designated ""D - left breast"" is a. mastectomy specimen weighing 228 grams measuring 15.3 x 15.0 X 3.0 cm. The axilla measures 5.0 x. 3.5 x 1.0 cm. The specimen is received with orientation, a black suture indicating the axillary tail. The. specimen is inked as follows: posterior deep margin, black; anterior, blue. The overlying ellipse of. beige-tan skin measures 8.0 x 2.5 cm. The light beige areola measures 2.0 cm in diameter. The. everted nipple measures 0.9 cm in diameter. The specimen is serially sectioned from medial to lateral. Cut section shows a firm, granular beige-tan mass in the lower outer quadrant approaching the deep. margin at a distance of 0.2 cm. The mass measures 1.5 x 1.3 x 1.2 cm and is located 4.5 cm from the. axilla. Extending from the area of the mass through the central portion and to the medial, beige-tan. fibrous parenchyma is demonstrated. In the upper inner quadrant there is a hemorrhagic well-. circumscribed area measuring 2.4 x 1.6 x 1.0 cm. This area approaches the deep margin at a distance. of 0.2 cm and is located 4.8 cm from the lesion. A portion of the specimen is submitted for tissue. procurement. Representative sections are submitted as follows: D1-D4: sections of the lesion and overlying posterior margin lower outer quadrant. D5-D9: representative sections of central fibrous tissue. D10-D17: the entire hemorrhagic area in the upper inner quadrant. D18-D20: representative sections from the upper outer quadrant. D21-D23: representative sections from the lower inner quadrant. D24-D25: sections of nipple. D26: representative section of skin. D27-D30: possible axillary lymph nodes. COMMENT: Re-examination of the original touch-prep examined at the time of the intra-operative consultation again. was interpreted as no evidence of malignant cells on this slide. The permanent sections from the lymph. node however, show a micrometastases, (1.8 mm). Gross examination of the breast reveals an ill. defined mass in the lower outer quadrant measuring 1.5 x 1.3 x 1.0 cm in greatest extent. In addition, in. the upper inner quadrant there is a hemorrhagic area measuring 2.4 x 1.6 x 1 cm. BREAST CANCER TEMPLATE: Specimen type: Mastectomy. Needle localization: Laterality: Left. INVASIVE TUMOR: Present. Multifocal: Histologic type: Ductal. Tumor Size (cm): 1.5 x 1.3 x 1.2 cm. Tumor site: Lower outer quadrant. Grade, Tubular: 2. Grade, Nuclear: 2. Grade, Mitotic: 1. Modified Scarff Bloom Richardson grade: I. Necrosis: Absent. Invasion Vasc/Lymphatic: None identified. DCIS COMPONENT: DCIS Quantity: Estimated 20%. DCIS Type: Cribriform, micropapillary and. papillary. DCIS Location: DCIS is associated with the. invasive tumor with separate foci. seen away from the invasive. tumor in the central region of the. breast. Nuclear grade: Intermediate. Necrosis: None identified. Location of Ca++: DCIS and benign epithelium. Margins: Negative. Distance from closest margin: DCIS extends to within 2 mm of. carcinoma extends to within 3 mm. of the deep margin. Specimens Involved. Specimens: D: LEFT BREAST. HER2 Status Results, Immunohistochemistry Evaluation. SPECIMEN. Surgical Excision. Block Number: Block. D4. TEST RESULTS. Interpretation: Negative. Intensity: 1+. % Tumor Staining: 40%. FISH ORDERED. METHODOLOGY. Methodology: Fixation Type and Length: Tissue was fixed in 10% neutral buffered formalin. ) for no less than 8 and no longer than 24 hours. Antibody and Assay Methodology: Rabbit anti-human HER2, HerceptestTM (FDA-approved test kit),. Control. Slides Examined: External kit-slides provided by manufacturer (cell lines with high, low and negative. HER2 protein expression), and in-house known HER2 amplified control tissue were evaluated along. with the test tissue. These control slides run along side of this patient's sample showed appropriate. staining. Adequacy of Specimen: Adequate, well preserved, clear-cut invasive carcinoma identified for. HER2 evaluation. Scoring Criterion and Scoring System: IHC Level of Expression(Score) /Tumor Cell Membrane Staining Pattern. Negative (0)/Absence of Staining. Negative (1+)/Faint Incomplete membrane Staining, >10% of Cells. Equivocal (2+)/Weak complete membrane Staining, >10% of Cells. Positive (3+)/Strong complete membrane Staining, >10% of Cells. Equivocal Category for HER2 IHC results: A HER2, 2+ staining result that is interpreted as equivocal. may not indicate gene amplification. A FISH test for HER2 gene amplification will be ordered for all. HER2 IHC 2+ results. COMMENT. HER2 analysis was performed on this case by immunohistochemistry utilizing the FDA approved. HercepTest (TM) test kit following the manufacturer's instructions listed in the package insert. This. assay was not modified, and adherence to all instruction and guidelines were strictly followed. Interpretation of the HER2 immunohistochemical staining characteristics is guided by published results. in the medical literature (4), information provided by the reagent manufacturer and by internal review of. staining performance within Pathology Department. HER2 TEST VALIDATION. This HER2 immunohistochemical assay has been validated according to the recently revised. recommendations and guidelines from the NCCN HER2 testing in Breast Cancer Task Force, and the. jointly issued recommendations and guidelines from ASCO and the CAP (5). 80 randomly selected. breast cancer samples were tested for HER2 by IHC as outline above and interpreted as, negative. (score 0/1+) equivocal (score 2+) and positive (score 3+) without knowledge of the previous reported. results. These cases were also blindly read using two different FISH assay as amplified or non-amplified and. the HER2/CEP17 ratios were recorded. After analyzing these results, there was 100% concordance. between the IHC and FISH results for cases that were interpreted as either positive or negative by IHC. 9 of the 80 cases were interpreted as equivocal by IHC and of these 3/9 (33%) were non-amplified by. FISH and 6/9 (66%) were found to be amplified. The Pathology Department Immunohistochemistry laboratory takes full responsibility for this tests. performance and has programs in place to regularly monitor the proficiency and the interpretation of. HER2 assays. The laboratory also participates in external quality assurance HER2 programs including. the CAP proficiency testing program. REFERENCE. 1. Carlson RW, Anderson BO, Burstein HJ, et al., NCCN breast cancer clinical practice guidelines in. oncology. J Natl Compr Canc Netw. 2005;3:238-289. Lobular Neoplasia: Atypical lobular hyperplasia. Lymph nodes: Sentinel lymph nodes and axillary. lymph nodes one positive, (1/6). Micrometastases (1.8 mm in. greatest diameter, negative for. extranodal extension). Non-neoplastic areas: Atypical ductal hyperplasia,. atypical lobular hyperplasia,. columnar cell change with foci of. BREAST TUMOR BIOMARKERS TEMPLATE. Immunohistochemistry for ER/PR and Her-2 have been ordered on block D4, and the results will be. issued as an addendum. Pathologic Stage : pT1c pNimi. This assay can be used to select invasive breast cancer patients for hormone therapy (1). ER and PR analysis was performed on this case by immunohistochemistry utilizing the ER (ER 1D5,. 1:100) and PR (PGR 136, 1:100) antibody provided by. following the manufacturer's instructions. listed in the package insert. This assay was not modified, and adherence to all instruction and. guidelines were strictly followed. Interpretation of the ER/PR immunohistochemical staining. characteristics is guided by published results in the medical literature (1), information provided by the. reagent manufacturer and by internal review of staining performance within the Pathology Department. 1. Harvey JM, et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding. assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 17:1474-. 1481, 1999. ADDENDUM: BREAST ER/PR -1. Specimens Involved. Specimens: D: LEFT BREAST. SPECIMEN. Type: Surgical Excision. Block Number: D4. HORMONE RECEPTOR STATUS. Laboratory: Estrogen Receptor: Positive. Allred Score: 8 = Proportion score 5 + Intensity score 3. Progesterone Receptor: Positive. Allred Score: 8 = Proportion Score 5 + Intensity Score 3. The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the. proportion score (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of. cells staining, 4 = 31-60% of cells staining, 5 = 60% of cells staining) to the intensity score (1 = weak. intensity of staining, 2 = intermediate intensity of staining, 3 = strong intensity of staining), with a scoring. range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score of. less than or equal to 2. Methodology: Fixation Type and Length: Tissue was fixed in 10% neutral buffered formalin. for no less than 8 and no longer than 24 hours. Antibody and Assay Methodology: Mouse anti-human ER and PR,. 2. Carlson RW, Brown E, Burstein HJ, et al., NCCN Task Force Report: adjuvant therapy for breast. cancer. J Natl Compr Canc Netw. 2006;4:S1-S26. 3. Romond EH, Perez EA, Bryant J, et al. Trastuzumab plus adjuvant chemotherapy for operable. HER2-positive breast cancer. N Eng J Med 2005;353(16):1673-84. 4. Leong ASY, Formby M, Haffajee Z, et al. Refinement of immunohistologic parameters for Her2/neu. scoring validation by FISH and CISH. Appl Immunohistochem Mol Morphol. 2006;14:384-389. 5. Wolff AC, Hammond EH, Schwartz JN, et al., American Society of Clinical Oncology/College of. American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Recepto 2. Testing in Breast Cancer. Arch of Path and Lab Med 2007; 131:18-43. Microscopic/Diagnosuc Dictation: PATHOLOGIST,. Microscopic/Diagnostic Dictation: PATHOLOGIST. Final Review: PATHOLOGIST,. Final: PATHOLOGIST,. Addendum:,. Addendum Review: PATHOLOGIST. Addendum Final: PATHOLOGIST. Addendum: PATHOLOGIST, 0: Addendum Review: PATHOLOGIS. Addendum Final: PATHOLOGIST, (.",train,1.5. CM;1.5 x 1.3 x 1.2 cm;1.5 x 1.3 x 1.2 cm
8452,TCGA-05-4398.37d9ee69-f24e-4dda-a283-078243db1fa8,"Main diagnosis/diagnoses: Locally advanced, peripheral bronchopulmonary, histologically mixed adenocarcinoma of the. right upper lobe of the lung with a predominant large-cell, polymorphocellular and partly. clear-cell solid component, with bronchioloalveolar growth pattern in the tumor periphery and. very small acinar part, mainly located in S1 and satellite focus in S3. TNM classification pT4 pN3 L1 V1 R0, stage IIIB. C 34.1 M 8255/3. Comment/supplementary remark: The main tumor shows a large cicatricial area and has invaded small blood vessels located in. the tumor and also lymph nodes. There are lymph node metastases in samples 1.) to 4.), 6.) to. 8.) and 10.). The visceral pleura and resection margins of the bronchus and vessels of the. main preparation and also the lymph nodes of samples 5.) to 9.) are tumor-free.",train,
8461,TCGA-CG-4438.cdf1fd9e-640d-478b-af18-e4084b97940b,"Diagnosis/diagnoses: Total gastrectomy preparation with the inclusion of an extensive, widespread, ulcerated,. poorly differentiated adenocarcinoma (intestinal type) with a maximum diameter of 9 cm and. extending as far as the pylorus with infiltration of the perigastric fatty tissue and. circumscribed penetration of the overlying serosa. Thirteen regional lymph node metastases. Tumor-free oral resection margin covered with unremarkable squamous epithelium and also. tumor-free aboral resection margin covered with characteristic duodenal mucosa. Tumor-free. omentum. Tumor stage: pT3 pN2 (14/58) pMX;.",train,9 cm
8526,TCGA-26-1799.946926e0-e570-4349-acff-922f546129fa,"Surgical Pathology Consultation / Department of Pathology. SPECIMEN(S) SUBMITTED/ PROCEDURES ORDERED: A. Brain mass (88307). A. Frozen Section Charge (88331). B. Brain mass (88307). CLINICAL HISTORY: blood pressure in 200s. Brain mass at left. temporal lobe. GROSS DESCRIPTION: Received the following specimens in the Department of. Pathology, labeled with the patient's name and hospital #: A. Brain mass. B. Brain mass. A. The specimen is received fresh, labeled ""brain mass,"" and consists. of a 1.0 X 0.8 X 0.6 cm portion of tan to beige soft tissue. A. representative portion is submitted for frozen section. Frozen section. diagnosis is, ""Malignant glioma."" By Dr. The frozen section. tissue is submitted entirely for permanent processing in cassette FSA1. and the remaining tissue is submitted in cassette A2. B. The specimen is received fresh, labeled ""brain mass, and consists. of a 4.5 X 4.0 X 1.6 cm irregular ovoid portion of cortical gray matter. and underlying subcortical white matter. Sectioning reveals partially. lodged gray and white interface. No discrete masses are seen. Representative portion of tissue is submitted for. Tumor Bank. The. remaining tissue is submitted in cassettes B1-B7. DIAGNOSIS: A. Brain mass: Glioblastoma multiforme (WHO Grade IV astrocytoma). B. Brain mass: Glioblastoma multiforme (WHO Grade IV astrocytoma). ""I, or my qualified designee, have performed the gross examination and. description and I have personally reviewed the gross description and. specimen preparations referenced herein, and have personally issued this. report."". Resident/Prosector/Pathologist: ICD9 Codes: 191.9. Note: Test systems have been developed and their performance. characteristics determined by. [edical Laboratories. Some tests. have not been cleared or approved by the U.S. Food and Drug. Administration. The FDA has determined that such clearance is not. necessary. These tests are used for clinical purposes and should not be. regarded as investigational or for research. This laboratory is certified. under the Clinical Laboratory Improvement Amendments of. as. qualified to perform high complexity clinical laboratory testing.",train,
8559,TCGA-DD-AACT.0A9193A6-4600-44F8-88AD-264F8F2D7B4E,"CLINICAL DIAGNOSIS: HCC. Specimen : liver. Gross Photo : 0. GROSS: Specimen: Liver: 20.5 x 9.5 x 3.5 cm, 226.5 gm (unfixed). Operation: Left lateral segmentectomy. Lesion: A well-defined, oval, lobulated mass. Size: 6.0 X 4.0 x 4.0 cm. Cut surface: Yellowish tan with bile-pigmented (necrosis: no). Gross type: Expanding nodular. Resection margin: Not involved grossly (safety margin: 0.6 cm). Others: Satellite nodule: No. Remaining parenchyma: Unremarkable. Portal vein invasion: No. Gross photo: Present. Blocks. T1-4, tumor and surrounding tissue X 4. L, remaining parenchyme of liver X 1. RM, resection margin of liver x 1. MICROSCOPIC: Hepatocellular carcinoma: Yes. The worst differentiation II. The major differentiation II. Histologic type: Trabecular. Cell type: Hepatic (95%) and clear (5%). Fatty change: No. Fibrous capsule formation: No. Capsular infiltration: No. Septum formation: Yes. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: No. Microvessel invasion: No. Intrahepatic metastasis: No. Multicentric occurrence: No. Non-tumor liver pathology. 1. Chronic hepatitis: Yes. 1-1. Etiology: HBV. 1-2. Grade, lobular: Mild. 1-3. Grade, portoperiportal: Minimal. 1-4. Stage (fibrosis): Periportal. 1-5. Cirrhosis: No. 2. Dysplastic nodule: No. 3. Ductal epithelial dysplasia: No. 4. Other liver diseases: No. NOT reported. Gross: liver,ectomy,hepatocellular carcinoma. T56000, P10, M81703. DIAGNOSIS: Liver, left, lateral segmentectomy: Hepatocellular carcinoma. Suggestion :",train,6.0 X 4.0 x 4.0 cm
8596,TCGA-99-AA5R.5541B103-6FD2-4767-B914-8A5B58E86D0A,"LUNG MALIGNANT. LUNG UNINVOLVED. BLOOD. SERUM. PLASMA. BUFFY-COAT. Case: : Collected date: Result date: Clinical Information. The patient is a. year old [black]-female with a lung nodule. Frozen Section Diagnosis. MFS1: Left lower lobe, resection: - Adenocarcinoma. (Per. Gross Description. The specimen is received in thirteen containers each labeled with the patient's name and medical record. number. The first container is labeled ""level IX lymph node"". Received is an anthracotic fragment of tissue measuring 1.5. x 0.8 x 0.3 cm. It is serially sectioned and entirely submitted. The second container is labeled ""#2 - level VIII. lymph node"". Received is an anthracotic tan-yellow fragment of. tissue measuring 0.5 x 0.4 x 0.2 cm, submitted in total. The third container is labeled ""#3 - level VII lymph node"". Received is an anthractic tan-gray fragment of soft. tissue measuring 0,8 x 0.6 x 0.4 cm, trisected and submitted in total. The fourth container ,is labeled ""#4 - level XI lymph node"". Received is an anthracotic fragment of tissue. measuring 0.2 x 0.2 x 0.1 cm, submitted in total. The fifth container is labeled ""# 5 - level V lymph node"" Received is an anthracotic tan- gray fragment of soft. tissue measuring 1.0 x 0.7 x 0.5 cm, bisected and submitted in total. The sixth container is labeled ""#6 - level VI lymph node"". Received is a tan-yellow and focally anthracotic. fragment of tissue measuring 0.6 x 0.3 x.0.3 cm, submitted in total. The seventh container is labeled ""#7 - level XI lymph node"". Received is an anthracotic fragment of tissue. measuring 0.4.x.0.4, x 0,3 cm, submitted in total. The eighth container is labeled ""#8 - lvel X lymph node"". Received is an anthracotic fragment of tissue. measuring 0.7 x 0.4 x 0.3 cm, submitted in total,. The ninth container is labeled ""#9 - level XIII lymph node"". Received is an irregularly shaped anthracotic. fragment of tissue measuring 1.0 x 0,7 x 0.3 cm, trisected and submitted in total,. The tenth container is labeled ""#10 - level XI lymph node"". Received are two anthracotic fragments of tissue. ranging from 0.2 up to 0,5 cm, submitted in total. The eleventh container is labeled ""#11 - level. X lymph node"". Received is a single anthracotic fragment of tissue. measuring 1.0 x 0.6 X 0.5 cm, bisected and submitted in total,. The twelfth- container is labeled ""#12 - level X lymph node"". Received is an irregularly shaped anthracotic. fragment of tissue measuring 1.2 x 0.6 x 0.4 cm that is trisected and submitted in total. /. The thirteenth container is labeled ""#13 - left lower. lobe"". Received is a lobectomy specimen consistent with the. left lower lobe measuring 18,0 x 9.0 x 3.3 cm in greatest dimensions, The pleural surface is tan-pink and shows. moderate to severe anthracotic pigmentation: There is a staple line noted across the hilum of the lung revealing. unremarkable bronchial and vascular structures, The brnchi are lined by tan-pink glisteing mucosa without. distinct gross lesion. Located 2.5 cm from the bronchial resection margin; there is an intramural tan gritty nodule measuring 1.2 cm in. greatest dimensions. This nodule is surrounded by red-brown spongy pulmonary parenchyma. A representative. section of this nodule is submitted for frozen section as MFS1. The remaining lung reveals spongy and. moderately anthracotic pulmonary parenchyma and reveals no other mass lesion. There are no other gross. lesions identified, The remaining tumor is submitted for permanent section while a portion of tumor is submitted. for frozen. Block Summary. A1- Level IX lymph node. B1-Level VIII lymph node. C1-Level VIHymph node. D1-(Level XI lymph node,. E1-Level V Jymph node. F1-Level VI lymph node. G1-Level XI lymph node. H1-Level X lymph riode. 11- Level XIII lymph node,. J1- Level XI lymph node. K1-Level X lymph node. L1-Level X lymph node,. M1- Left lower Jobe mass,. M2- Bronchial and vascular. shave margins left lower lobe. M3- Small peribronchiolar, lymph nodes. M4- Remainder of left lower lobe mass,. M5- Uninvolved prenchyma. Mieroscopic Description. A microscopic examination has been performed. Diagnosis. (A) Lymph node, level IX, excision: - Negative for malignancy. (B) Lymph node, level VIII, excision: - Negative for malignancy. (c) Lymph node, level VII, excision: - Negative for malignancy. (D) Lymph node, level XI, excision: - Negative for malignancy. (E) Lymph node, level V, excision: - Negative for malignancy. (F) Lymph node, level VI, excision: - Negative for malignancy. (G) Lymph node, level XI, excision: - Negative for malignancy. (H) Lymph (node, level X, excision: 7 Negative for malignancy. (I) Lymph node, level XIII, excision: - Negative for malignancy. (J) Lymph node, level XI, excision: - Negative for malignancy. (K) Lymph node, level X, excision: - Negative for malignancy. (L) Lymph: node, level X, excision: - Negative for malignancy. (M) Lung, left lower lobe, lobectomy: - Adenocarcinoma (1.2 cm), moderately differentiated. - Pleura. is not involve by tumor. - Surgical margin negative for malignancy. - Three peribronchial lymph nodes negative for malignancy (0/3). (Electronically signed by). Verified: Synoptic Report. SPECIMEN: Lobe(s) of lung: left lower-lobe. PROCEDURE; Lobectomy. SPECIMEN INTEGRITY: Intact. SPECIMEN LATERALITY:Left. TUMOR SITE: Lower lobe. TUMOR SIZE: Grealestidimension:.: 1,2.cm. TUMOR FOCALITY: Unifocal. HISTOLOGIC TYPE:Adenocarcinama. HISTOLOGIC GRADE: G2: Moderately differentiated. VISCERAL PLEURA INVASION: Not identified. TUMOR EXTENSION: Not identified. BRONCHIAL MARGIN: Uninvolved by invasive carcinoma. VASCULAR MARGIN: Uninvolved by invsive carcinoma. PARIETAL PLURAL MARGIN: Uninvolved by invasive carcinoma. LYMPH NODES: Present. PRIMARY TUMOR (pT): pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura,. without bronchoscopic evidence of invasion more proximal than the lobar bronchus (ie, not in the main. bronchus); or. REGIONAL LYMPH NODES (pN): pNO: No regional lymph node metastasis.",train,1.2 cm;1.2 cm
8600,TCGA-IN-A6RL.BBD38294-0174-48C8-8A3F-2B5FABC536A6,"FINAL DIAGNOSIS: PART 1: LYMPH NODE, LEVEL 7 NEAR BRONCHUS INTERMEDIUS, BIOPSY -. NO TUMOR PRESENT IN ONE LYMPH NODE (0/1). PART 2: LYMPH NODE, LEVEL 7 NEAR CARINA, BIOPSY -. NO TUMOR PRESENT IN ONE LYMPH NODE (0/1). PART 3: LYMPH NODE, LEVEL 7 NEAR LEFT MAIN BRONCHUS, BIOPSY -. NO TUMOR PRESENT IN ONE LYMPH NODE (0/1). PART 4: LYMPH NODE, PERIESOPHAGEAL, BIOPSY -. A. BENIGN FIBROADIPOSE TISSUE. B. NO LYMPH NODE IDENTIFIED. PART 5: SOFT TISSUE, PERIESOPHAGEAL -. A. BENIGN FIBROADIPOSE TISSUE. B. NO TUMOR PRESENT. PART 6: ESOPHAGUS, ESOPHAGECTOMY -. A. MODERATELY DIFFERENTIATED ADENOCARCINOMA, 3.5 CM, INVASIVE INTO BUT NOT THROUGH THE. MUSCULARIS PROPRIA, LOCATED AT THE GASTROESOPHAGEAL JUNCTION. B. ANGIOLYMPHATIC AND PERINEURAL INVASION PRESENT. C. MARGINS FREE OF TUMOR; TUMOR IS 0.1 CM FROM THE CIRCUMFERENTIAL (ADVENTITIAL) MARGIN. D. PATHOLOGIC STAGE: pT2 pN2. E. ADDITIONAL FINDINGS: a. HIGH-GRADE COLUMNAR EPITHELIAL DYSPLASIA ASSOCIATED WITH THE INVASIVE. ADENOCARCINOMA. b. NO DEFINITIVE BARRETT'S MUCOSA IDENTIFIED. F. GASTRIC MUCOSA OTHERWISE WITHOUT SIGNIFICANT ABNORMALITY. PART 7: ANASTOMOTIC RINGS, RESECTION -. NO TUMOR PRESENT. PART 8: FINAL GASTRIC MARGIN, RESECTION -. NO TUMOR PRESENT. PART 9: GASTROESOPHAGEAL FAT, RESECTION-. A. METASTATIC ADENOCARCINOMA IN THREE OF EIGHTEEN LYMPH NODES (3/18). B. NON-NECROTIZING FIBROTIC GRANULOMAS INVOLVING ONE ANTHRACOTIC LYMPH NODE. C. RESULTS OF GROCOTT AND AFB STAINS WILL BE REPORTED IN AN ADDENDUM. PART 10: LYMPH NODE, SUBCARINAL NEAR AZYGOUS, BIOPSY -. NO TUMOR PRESENT IN ONE LYMPH NODE (0/1). PART 11: LYMPH NODE, PERIGASTRIC, BIOPSY -. METASTATIC ADENOCARCINOMA IN ONE OF ONE LYMPH NODE (1/1). PART 12: LYMPH NODE, LEVEL 7, BIOPSY -. NO TUMOR PRESENT IN ONE LYMPH NODE (0/1). PART 13: LYMPH NODE, SUBCARINAL ""ON ESOPHAGUS"", BIOPSY -. NO TUMOR PRESENT IN ONE LYMPH NODE (C. PART 14: LYMPH NODE, SUBCARINAL, BIOPSY. NO TUMOR PRESENT IN ONE LYMPH NODE (0/1). PART 15: LYMPH NODE, NEAR GASTRIC CURVE, BIOPSY -. METASTATIC ADENOCARCINOMA IN ONE OF ONE LYMPH NODE (1/1) WITH EXTRACAPSULAR EXTENSION. PART 16: LYMPH NODE, GASTRIC FAT, BIOPSY -. NO TUMOR PRESENT IN ONE LYMPH NODE (0/1). PART 17: LYMPH NODE, FAT PAD, BIOPSY -. NO TUMOR PRESENT IN ONE LYMPH NODE (0/1). COMPREHENSIVE THERANOSTIC SUMMARY. IMMUNOHISTOCHEMISTRY: Her2: EQUIVOCAL (2+). IN SITU HYBRIDIZATION / FISH: HER2 (ERBB2) amplification: NEGATIVE. Addendum. Part 9: Grocott and AFB stains are negative for fungal and mycobacterial organisms. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY ESOPHAGEAL TUMORS. MACROSCOPIC. SPECIMEN TYPE: Esophagectomy. TUMOR SITE: Tumor midpoint centered on esophagogastric junction. TUMOR SIZE: Greatest dimension: 3.5 cm. Additional dimensions: 2.0, 1.0 cm. MICROSCOPIC. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: G2. PATHOLOGIC STAGING (pTNM). pT2. pN2. Number of lymph nodes examined: 29. Number of lymph nodes involved: 5. pM Not applicable. PRIOR TREATMENT: No prior treatment. MARGINS. Proximal margin uninvolved by invasive carcinoma. Distal margin uninvolved by invasive carcinoma. Circumferential (adventitial) margin uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 1 mm. Specify margin: Circumferential. ANGIOLYMPHATIC INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: High grade dysplasia. SPECIAL PROCEDURES: In Situ Procedure. Interpretation. HER2 FISH STUDIES PERFORMED ON THE ADENOCARCINOMA ARE NEGATIVE. # Cells Analyzed: 63. Ratio HER2/CEP17: 1.28. SNR: 2.9. CNR: 2.2. % Hyperdiploid: 21(33.3%). HER2 IMMUNOPEROXIDASE STUDIES PERFORMED ON THE ADENOCARCINOMA ARE EQUIVOCAL. IHC score: 2+. INTERPRETATION GUIDELINES AND PROBE/CLONE INFORMATION: FISH: Probe: HER2. DNA Probe. Probe Description: The. HER2. DNA probe is a 190 Kb. directly labeled fluorescent DNA probe. specific for the HER2. gene locus. The CEP 17 DNA probe is a 5.4 Kb. directly labeled. fluorescent DNA probe specific for the alpha satellite DNA sequence at the centromeric region of chromosome 17. The probes are pre-mixed and pre-denatured in hybridization buffer. Interpretation: HER2 negative: HER2 gene/chromosome 17 ratio less than 2.0. HER2 positive: HER2 gene/chromosome 17 ratio greater than 2.0. Results should be considered along with other clinical information. has modified the suggested manufacturer protocol for HER2 FISH testing. The modifications have been tested and validated. The modifications are as follows: Slides are deparaffinized in. Tissue is. digested in protease 31 minutes; Tissue and probe are co-denatured at 90 C for 12 minutes; Paraffin pretreatment reagents and. control slides are prepared in house. Amplified, non-amplified, and internal (centromere 17) controls were used in the testing. The. laboratory takes responsibility for the test performance. FISH analysis was manually performed and quantitatively assessed by analysis of a minimum of 60 cells using the HER2. and the CEP17. probes. IHC: anti-HER-2/neu (4B5) Rabbit Monocional Primary Antibody. Tumors are considered POSITIVE if they show HER2 protein over-expression (3+) by IHC. IHC scoring for HER2 in gastric and GE junction cancer by type of diagnostic specimen: SCORE SURGICAL SPECIMEN-STAINING PATTERN. NEGATIVE. 0. No reactivity or membranous reactivity in <10% of tumor cells. 1+. Faint/barely perceptible membranous reactivity in 10% of tumor cells;cells are reactive only in part of their membrane. EQUIVOCAL. 2+. Weak to moderate complete, basolateral or lateral membranous reactivity in 10% of tumor cells. POSITIVE. 3+. Strong complete, basolateral or lateral membranous reactivity in 10% of tumor cells. BIOPSY SPECIMEN-STAINING PATTERN. NEGATIVE. 0. No reactivity or no membranous reactivity in any (or <5 clustered) tumor cells. 1+. Tumor cell cluster ( 5 cells) with a faint/barely perceptible membranous reactivity irrespective of percentage of tumor. cells stained. EQUIVOCAL. 2+. Tumor cell cluster ( 5 cells) with a weak to moderate complete, basolateral or lateral membranous reactivity irrespective. of percentage of tumor cells stained. POSITIVE. 3+. Tumor cell cluster ( 5 cells) with a strong complete, basolateral or lateral membranous reactivity irrespective of. percentage of tumor cells stained.",train,3.5 CM;3.5 cm;2.0;1.0 cm
8635,TCGA-G3-A5SM.791E29AD-22A6-402E-978C-69407C6B748F,"Note: If you do not see ""END OF PRINTED REPORT"" at the bottom of th. the report YOU DO NOT HAVE THE ENTIRE REPORT. Please try prin. CONFIDENTIAL. Relevant. information. Demographics. (for verification. Date of Birth: purposes). Sex: M. Collected Date/Time. Received Date/Time. Specimen Description. A. Gallbladder. B. HCC tumor left lobe. C. Deep margin. D. Final margin liver lobe left. Clinical Information. Infectious patient:Yes - Hep +. Cirrhosis, hepatocellular carcinoma?. Diagnosis. A. Gallbladder, Cholecystectomy: Gallbladder with no pathologic abnormality. B. Liver, (Left Lobe), Wedge Resection: - Hepatocellular carcinoma, Grade III/IV. The tumor measures 2.7 cm in maximal dimension. Carcinoma is present at the cauterized/inked parenchymal margin. in this specimen (see comment). Focal small vessel invasion is seen within the tumor itself. No perineural invasion identified. Cirrhosis of the surrounding liver parenchyma. C. Liver, (Deep Margin), Excision: - Negative for hepatocellular carcinoma. D. Liver, (Final Margin) , Excision: - Negative for hepatocellular carcinoma. Verifier. Gross Description. Received are specimen containers A in n. roquisitions and specimen containers are. labelled with the patient's name,. The cassettes and AP identifiers are. labelled with the Surgical Number. A. The specimen is designated ""Gallbladder"" The specimen is received fresh and is. subsequently placed into formalin and consists of a gallbladder that measures 10.0 x 4.0. x 4.0 cm. Opening the gallbladder reveals approximately 10 ml of dark green bile. The. serosa of the gallbladder appears unremarkable as does the mucosal surface. There are no. stones present. A section of mucosa is submitted in cassette A1. B. The specimen is designated ""HCC tumor left lobe"". The specimen is received fresh and. is subsequently placed into formalin and consists of a piece of liver that weighs 43.8. g. and measures 4.0 x 4.5 x 4.0 cm. There is a solitary firm, tan nodule present at the. inked margin of the specimen and this nodule measures 2.7 x 2.7 x 2.5 cm. The surrounding. liver parenchyma is cirrhotic. Random sections of the tumor are submitted in cassettes. B1 to B5. B6 contains uninvolved cirrhotic liver parenchyma. C. The specimen is designated ""Deep margin"". The specimen consists of a small fragment. of firm brown tissue that measures 1.0 x 0.8 x 0.2 cm. It is submitted in toto in. cassette C1. D. The specimen is designated ""Final margin liver lobe left"". The specimen consists of a. firm brown friable tissue that measures 1.1 x 1.0 x 0.2 cm. This is submitted in toto in. cassette D1. Pathclogist Comment. Although tumor is present at the inked margin in specimen ""B"", the final resection. margins (specimens ""C"" and ""D"") are free of tumor. Number. Encounter. Number. Patient Location. - END OF PRINTED REPORT -. Criteria. is. Temor Site Diser epancy. Drive may Ht tory. Primary Notad. asei. (UALIFI'S /. = wer Initiais. BIH atc Per wid 1.16.13.",train,2.7 cm
8662,TCGA-AO-A0JL.C2976F78-89AF-4461-8D22-BFEBC0504722,"clinical Diagnosis & History: %/O female with left breast mass. Mammo showed 2 lesions in UOQ left. breast. Core biopaies IDC and DCIS. Proceeding to MRM. Specimens Submitted: 1: SP: Left breast with level 1 and low level 2 axillary contents. 2: SP: Additional level 2 left axillary contents. 3: SP: Left level 2 and level 3 axillary contents. DIAGNOSIS: 1). BREAST WITH LEVEL I AND LOW LEVEL II AXILLARY CONTENTS, LEFT;. MODIFIED RADICAL MASTECTOMY AND AXILLARY LYMPH NODE DISSECTION: - TWO SEPARATE TUMOR NODULES: ONE IS LOCATED IN THE UPPER OUTER. QUADRANT AND SHOWS AN INVASIVE DUCTAL CARCINOMA, POORLY DIFFERENTIATED. (HISTOLOGIC GRADE III/III, NUCLEAR GRADE III/III), MEASURING 3.9 CM IN. LARGEST DIMENSION GROSSLY. THE SECOND IS LOCATED IN THE UPPER AND LOWER OUTER QUADRANTS AT 3:00 AND IS. COMPOSED OF PREDOMINANTLY DUCTAL CARCINOMA IN SITU (DCIS) WITH SEVERAL FOCI. OF INVASIVE DUCTAL CARCINOMA, POORLY DIFFERENTIATED AND SIMILAR TO ABOVE,. RANGING IN SIZE FROM LESS THAN 0.1 CM TO ABOUT 0.4 CM. - THE DUCTAL CARCINOMA IN SITU (DCIS) IS OF THE SOLID AND CRIBRIFORM TYPES. WITH HIGH NUCLEAR GRADE, EXTENSIVE NECROSIS AND FOCALLY INVOLVES A LARGE. LACTIFEROUS DUCT OF THE NIPPLE. - CALCIFICATIONS ARE PRESENT IN THE IN SITU AND INVASIVE CARCINOMA, AND IN. BENIGN BREAST PARENCHYMA. - VASCULAR INVASION IS PRESENT. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY EITHER INVASIVE OR IN SITU. CARCINOMA IS IDENTIFIED. - NO SKIN INVOLVEMENT BY CARCINOMA IS IDENTIFIED. - THE REMAINING BREAST TISSUE SHOWS PREVIOUS BIOPSY SITE AND MILD. FIBROCYSTIC CHANGES. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF POSITIVE. LYMPH NODES IN RELATION TO THE TOTAL NUMBER OF LYMPH NODES EXAMINED) : THERE IS EXTRANODAL TUMOR EXTENSION (>2 MM). - RESULTS OF IMMUNOHISTOCHEMICAL STAINS ARE AS FOLLOWS: ER: 0% NUCLEAR STAINING. PR: 0% NUCLEAR STAINING. HER-2/NEU (HERCEPTEST) : NEGATIVE (STAINING INTENSITY OF 1+). 2). AXILLARY CONTENTS, LEFT ADDITIONAL LEVEL II; DISSECTION: TWELVE BENIGN LYMPH NODES (0/12). 3). AXILLARY CONTENTS, LEFT LEVELS II AND III; DISSECTION: - THREE BENIGN LYMPH NODES (0/3). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Comment. ER-C. PR-C. HER2-0. NEG CONT. IMM RECUT. NEG-HER2. Gross Description: 1). The specimen is received fresh labeled, ""Left breast with level 1 and. low level 2 axillary contents, stitch marks axillary contents and consists. of a breast with attached axillary tail. The breast measures 37.0 x 26.0. x. 6.7 cm with overlying skin ellipse measuring 36.5 x 18.0 cm. Situated on. the skin surface is an everted nipple measuring 1.4 x 1.2 x 0.1 cm and. areola measuring 4.8 x 4.5 cm. The skin shows no visible scars. A suture. demarcates the axillary tail which measures 11.0 x 4.0 x 3.5 cm. The. posterior surface of the breast is inked black and the specimen is serially. sectioned to reveal a white tan firm ill-defined mass in the upper outer. quadrant measuring 3.9 x 3.7 x 3.3 cm, located 1.5 from the deep margin. There is a biopsy site identified in the lower outer quadrant, corresponding. to the three o'clock position, measuring 2.0 x 2.0 x 1.5 cm. The remaining. breast tissue shows predominantly yellow lobulated adipose tissue admixed. with white-tan fibrous soft tissue with no other gross identifiable lesions. The axillary tissue is dissected to reveal several grossly positive lymph. nodes, measuring up to 4.5 cm. Representative sections of the mastectomy. specimen and all identified axillary lymph nodes are submitted (the large. grossly positive lymph nodes are representatively submitted). Tissue. is. taken for TPS. Summary of sections: N - nipple. NB - nipple base. s skin. D - deep margin. T tumor. BX - separate biopsy site. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. LN - individual lymph nodes. 2). The specimen is received in formalin, labeled ""Additional level 2. left axillary contents"" and consists of an axillary dissection measuring 7 x. 4.5 x 0.8 cm. The specimen consists of soft yellow-tan lobulated tissue. with several pink-tan lymph nodes identified on cut section ranging from 0.2. cm to 1.8 cm in greatest dimension. The specimen is submitted for lymph. node digest dissection. Summary of sections: LN - lymph nodes. 3). The specimen is received in formalin, labeled ""Left level 2 and level. 3 axillary contents"" and consists of an unoriented axillary dissection. measuring 7.5 x 4.7 x 1.8 cm. The specimen consists of yellow tan lobulated. tissue, which on sectioning reveals several pink-tan lymph nodes ranging. from 0.2 cm to 2.3 cm in greatest dimension. The specimen is submitted for. lymph node dissection. Summary of sections: LN - lymph nodes. Summary of Sections: Part 1: SP: Left breast with level 1 and low level 2 axillary contents. Block. Sect. Site. PCs. 3. BX. 3. 1. D. 1. 2. LIQ. 2. 4. LN. 4. 2. LOQ. 2. 1. N. 1. 1. NB. 1. 1. s. 1. 3. T. 3. 2. UIQ. 2. 2. 2. Part 2: SP: Additional level 2 left axillary contents. Block. Sect. Site. PCs. 4. LN. 4. 2art 3: . SP: Left level 2 and level 3 axillary contents. Block. Sect. Site. PCs. 2. LN. 2.",train,3.9 CM;0.1 CM;0.4 CM
8677,TCGA-AX-A064.F760DFF2-7A11-4465-8581-397ABAA76BE4,"RUN DATE : I. RUN TIME: : ;pecimen Inquiry. CrIENT. LOC: U# : AGE/SX: RM/BED: REG DR: No PCP/Family Physician. TLOC: DIS: SPEC #: Obtained: CLINICAL HISTORY : ENDOMETRIAL CANCER. SPECIMEN/PROCEDURE : 1. UTERUS - UTERUS, TUBES AND OVARIES. 2. LYMPH NODE - RIGHT PARA-AORTIC. 3. LYMPH NODE - LEFT PARA-AORTIC. 4. LYMPH NODE - RIGHT COMMON ILIAC. 5. LYMPH NODE - RIGHT PELVIC. 6. LYMPH NODE - LEFT PELVIC. 7. LYMPH NODE - LEFT COMMON ILIAC. 8. LYMPH NODE - RIGHT PELVIC. IMPRESSION: 1). UTERUS, TUBES AND OVARIES, SALPINGO-OOPHORECTOMY AND HYSTERECTOMY. Endometrial adenocarcinoma, endometrioid type, FIGO grade II, nuclear grade 2. involving posterior and anterior uterus wall and extending to posterior cervical. mucosa, with myometrium invasion. All resection margins are free of the tumor. Ovaries bilateral, without tumor involvement. Fallopian tube, bilateral, without involvement. Small leiomyoma of myometrium, 0.8 cm. 2). LYMPH NODE, RIGHT PARA-AORTIC, DISSECTION: Fibrovascular tissue without tumor identified. No lymph nodes identified. 3). LYMPH NODES, LEFT PARA-AORTIC, DISSECTION: Five lymph nodes with metastasis (0/5). 4). LYMPH NODES, RIGHT COMMON ILIAC, DISSECTION: Three lymph nodes without metastasis (0/3). LYMPH NODES, RIGHT PELVIC, DISSECTION: Thirteen lymph nodes without metastasis (0/13). 6). LYMPH NODES, LEFT PELVIC, DISSECTION: Eleven lymph nodes without metastasis (0/11). LYMPH NODE, LEFT COMMON ILIAC, DISSECTION: Page: 2. SPEC #: Continued). CMPRESSION: (continued). One lymph node without metastasis (0/1) . 8). LYMPH NODE, RIGHT PELVIC, DISECTION: One lymph node without metastasis (0/1). ENDOME'TRIAL CARCINOMA CHECKLIST. MACROSCOPIC. SPECIMEN TYPE. tyoterectomy and salpingo-oophorectomy. TUMOR SITE. Specify location (s), if known Posterior and anterior cavity of uterus. TUMOR SIZE. Greatest dimension: 2.5 x 1.5 x 1.8 cm. OTHER ORGANS PRESENT. Right ovary. Left ovary. Right fallopian tube. Left fallopian tube. MICROSCOPIC. (ISTOLOGIC TYPE. Endometrioid adenocarcinoma, not otherwise characterized. HISTOLOGIC GRADE. G2: 6% to 50% nonsquamous solid growth. MYOMETRIAL INVASION. Myometrial invasion present. Maximal depth of myometrial invasion: 2 mm. Thickness of myometrium in area of maximal tumor invasion: 1. 7cm. The 8 of myometrial involvement: 12%. EXTENT OF INVASION. PRIMARY TUMOR (pT). TNM (FIGO). pT2a (IIA) : Endocervical glandular involvement only. REGIONAL LYMPH NODES (pN). TNM (FIGO). pNO: No regional lymph node metastasis. Page: 3. SPEC #: IMPRESSION : (continued). Number examined: 34. DISTANT METASTASIS (pM). TNM (FIGO). pMX: Cannot be assessed. MARGINS. Uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 1.1 cm. (Specify margin : Cervical radial margin. VENOUS/LYMPILATIC (LARGE/SMALL VESSEL) INVASION (V/L). Absent. ADDITIONAL PATHOLOGIC FINDINGS. None identified. Pat] ^logic TNM (AJCC 6th Edition) : pT2a NO MX. Entered: SPECIAL STTAINS/PROCEDURES: Immunohistochemical stains are performed with appropriate positive and negative control on. section 1A. CD10: Marked reduced at the tumor with myometrium invasion. GROSS DESCRIPTION: Received fresh with the patient's name and ""uterus, cervix, tubes and ovaries"", is a. 67. gram specimen with uterus (7.0 x 5.3 x 3.5 cm), left ovary (2.5 x 1.6 x 0.9 cm) and. fallopian tube (5.2 x 0.5 cm), and right ovary (3.0 x 1.6 x 0.7 cm) and fallopian tube. (4.0 x 0.7 cm). The serosal surface of the uterus is pink to dark-red, glistening and. is grossly unremarkable. The cervix is covered by dark red fibromuscular tissue. The. ectocervix is dark pink, smooth and glistening. The uterus is bivalved revealing an. exophytic soft friable, yellow-tan polypoid lesion, 2.5 x 1.5 x 1.8 cm located at. posterior and anterior middle portion of the endometrial cavity. The remaining. endometrial canal, 3.0 x 2.6 cm has a red-tan glistening herringbone mucosa. Multiple. cuts are made through the myometrium, 1.5 cm maximum thickness, revealing yellow-pink. finely trabeculated myometrium and a 1.0 x 0.8 x 0.6 cm yellow-tan ell-circumscribed. intramural nodule. The endocervical canal is a yellow to dark red, glistening. herringbone mucosa that is grossly unremarkable. The endocervix has a smooth, yellow. Page: 4. SPEC #: GROSS DESCRIPTION: (continued). cut surface. The external surface of the ovaries are yellow-tan, finely nodular with. a solid yellow-white cut surface that is grossly unremarkable. The bilateral. fallopian tubes are dark red to pink, glistening with distal fimbriated ends and a. yellow unremarkable cut surface. The specimen is representatively sampled and. submitted as follows: CASSETTE SUMMARY: Cassette 1A,18: Full thickness sections, posterior uterus with lesion in two. cassettes. Cassette 1C: Full thickness section, posterior uterus with well-circumscribed. nodule. Cassette 1D,1E: Full thickness sections, posterior uterus with lesion. Cassette 1G-1K: Representative full thickness sections, anterior uterus. Cassette 1L: Representative section, midportion, posterior cervix. Cassette 1M: Representative section, midportion, anterior cervix. Cassette 1N: Left ovary and fallopian tube, representative section. Cassette 1P: Right ovary and fallopian tube, representative section. 2). Received in formalin, labeled ""right para-aortic lymph node"" and with the patient's. name, is an aggregate of irregular portions of yellow-tan lobulated adipose tissue,. 1.5 x 1.2 x 0.5 cm. The specimen is dissected for lymph nodes, there are two tan. ovoid lymph nodes identified, 0.3 x 0.2 x 0.2 cm and 0.7 x 0.5 x 0.3 cm. All lymph. nodes identified are submitted in cassette #2. 3). Received in formalin, labeled ""left para-aortic lymph nodes"" and with the patient's. name, is an aggregate of irregular portions of yellow-tan lobulated adipose tissue,. 1.5 x 1.5 x 0.5 cm. The specimen is dissected for lymph nodes, there are five tan. ovoid lymph nodes identified, ranging from 0.3 x 0.2 x 0.2 cm to 0.8 x 0.5 x 0.4 cm. All lymph nodes identified are submitted as follows: CASSETTE SUMMARY: Cassette 3A: Four lymph nodes. Cassette 3B: One lymph node, bivalved. 4). Received in formalin, labeled ""right common iliac lymph node"" and with the patient's. name, are two irregular unoriented portions of yellow-tan lobulated adipose tissue,. 0.8 x 0.4 x 0.4 cm and 1.5 x 1. o x 0.8 cm. The specimen is dissected for lymph. nodes, there are three tan ovoid lymph nodes identified, ranging from 0.4 x 0.3 x 0.2. cm to 1.3 x 0.6 x 0.4 cm. All lymph nodes identified are submitted as follows: CASSETTE SUMMARY: Cassette 4A: Two lymph nodes. Cassette 4B: One lymph node, bivalved. 5). Received in formalin, labeled ""right pelvic lymph nodes"" and with the patient's name,. is an aggregate of irregular portions of yellow-tan lobulated adipose tissue, 4.0 x. 4.0 x 1.0 cm. The specimen is dissected for lymph nodes, there are thirteen irregular. pale tan to tan glistening ovoid lymph nodes identified, ranging from 0.3 x 0.2 x 0.2. Page : 5. SPEC #: GROSS DESCRIPTION: (continued). cm to 1.3 . x 0.9 x 0.4 cm. All lymph nodes identified are submitted as follows : CASSETTE SUMMARY: Cassette 5A: Five lymph nodes. Cassette 5B: Five lymph nodes. Cassette 5C: Two lymph nodes, bivalved, one inked green. Cassette 5D: One lymph node, bivalved. Received in formalin, labeled ""left pelvic lymph nodes"" and with the patient's name,. is an aggregate of irregular portions of yellow-tar lobulated adipose tissue, 5.0 x. 3.0 x 1.0 cm. The specimen is dissected for lymph nodes, there are eight tan ovoid. lymph nodes identified, ranging from 0.4 x 0.3 x 0.2 cm to 1.2 x 0.8 x 0.5 cm. All. lymph nodes identified are submitted as follows: CASSETTE SUMMARY: Cassette 6A: Five lymph nodes. Cassette 68: Two lymph nodes, bivalved, one inked green. Cassette 6C: One lymph node, bivalved. Received in formalin, labeled ""left common iliac lymph nodes"" and with the patient's. name, are three irregular unoriented portions of yellow-tan lobulated adipose tissue,. ranging from 1.2 x 0.5 x 0.3 cm to 1.5 x 0.8 x 0.5 cm. The specimen is dissected for. lymph nodes, there are no obvious lymph nodes identified. The specimen is entirely. submitted in one cassette. 8). Received labeled with the patient's name and ""right pelvic lymph node"". Received is a. 1.7 x 1 x 0.5 cm portion of yellow gold to pink tan fibroadipose tissue. The specimen. is dissected for possible lymph nodes. One lymph node is identified that is, 2 x 0.8. x. 0.4 cm. Entirely submitted in cassette 8. Entered: COPIES TO: No PCP/Family Physician. Page: 6. SPEC #: the. CPT Codes : LYMPH NODE BIOPSY (M) /. LYMPH NODE, REGIONAL RESECT/. SOFT TISSUE, LIPOMA/ADIPOSE. UTERUS W/WO ADNEXAE, TUMOR-8. IHC. ICD9 Codes: Resident Physician: I have personally reviewed the material. (specimen/slide) and approve this final report.",train,0.8 cm;2.5 x 1.5 x 1.8 cm
8681,TCGA-M8-A5N4.DA73BF07-6A4B-472E-8164-486504B8A516,Sample Type TUMOUR. Diagnosis. ductal adenocarcinoma. Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis. Type of Procedure. RESECT. Site of Tissue/Primary (Histology). pancreas. Tumour Size (cm). 3.3999999999999999. Histology. ductal adenocarcinoma. Grade/Differentiation. II. Pathological T. T3. Pathological N. Clinical M. M0. Histology Comments. pancreatic head. Sample Type BUFFY. Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis.,train,3.4000000000000000
8730,TCGA-QR-A70K.89446519-CC95-4244-9BCF-F37619D3618E,"DIAGNOSIS: 1. Retroperitoneal mass (1FS): Splenunculus. 2. Adrenal mass, right, excision: Pheochromocytoma. See Note. NOTE: No vascular or capsular invasion seen. A lymph node search was. performed in periadrenal adipose tissue and no lymph nodes were. identified. synaptophysin neoplastic negative S100 for stains chromogranin sustentacular and. The cells are positive. and for inhibin. cells. This staining pattern is consistent with a pheochromocytoma. Immunoperoxidase and in-situ hybridization-tests-performer here and. used for diagnosis were developed and their nerformance characteristics. determined by the Laboratory of Pathology,. They have not been. cleared or approved by the U.S. Food and Drug Administration. The FDA. has also determined that such clearance or approval is not necessary. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (CLIA) as qualified to perform high complexity. clinical laboratory testing. CLINICAL INFORMATION: Brief Clinical History: Pheochromocytoma. Specimen Taken For Protocol: 01 - Yes Allocate Order to Protocol: PROCEDURE: Operative Findings: Large 10 X 9 X8 cm right adrenal mass. and a 2 X. 1. .5cm left splenule Post-Operative Diagnosis: Pheochromocytoma. Pre-Operative Diagnosis: Pheochromocytoma. SPECIMENS SUBMITTED: 1. RETROPERITONEAL MASS, Left (1FS). 2. ADRENAL GLAND, RIGHT. INTRAOPERATIVE CONSULTATION: Received fresh from the OR with the. patient's name, medical record number, date of birth, and further. specified as ""left retroperitoneal mass"" is an intact spherical nodule,. maroon and smooth in color, 1.5 cm in diameter and is focally attached. to pink-yellow adipose tissue separately measuring 1.2 x 0.8 x 0.8 cm. Diagnosis (1FS): Spleen. The intraoperative consultation was performed. GROSS DESCRIPTION: Received fresh are 2 specimens, each in. containers labeled with the patient's name, medical record number, and. further specified as follows: Received fresh from the OR in a container labeled with the patient's. name, medical record number, and further. Patient Information. Unandrorized disclosure is prohibited Federal Prinni Actor 16,74. Do not file in Medical Record. Received are 2 formalin-filled containers labeled with the patient's. name, medical record number, and date of birth. These specimens are. further specified as follows: 1. ""Left retroperitoneal mass"" are 2 fragments of tissue that. appear in consistency and color to be that of splenic tissue. The. first fragment is irregular, lobulated, 3 cm splenic tissue. fragment that is placed into a white cassette labeled. Another 2-cm fragment of what appears to be splenic. tissue is placed into a white cassette labeled. This. tissue also corresponds to the specimen that was examined as a. frozen section. The whole contents of the section examined during. the intraoperative frozen section consultation are transferred. from a green cassette labeled. to an orange cassette labeled. 2. ""Right adrenal for esection-and-permanent"" is a focally. disrupted red ovoid nodular tissue fragment measuring 10 x 9 x. 8. cm, and weighing 429 grams. It is focally covered by adipose. tissue and the cortex of the adrenal gland that is evident. There. is a 1 x 0.4-cm focal surgical defect on the external surface with. pink-tan soft friable tumor fragments that appear to be tumor. It. is bisected revealing a heterogeneous red-tan soft friable and. rubbery cut surface with hemorrhage. The center of the mass has a. rubbery to crumbly maroon-red necrotic center comprising 50% of. the nodule. Gross photographs are taken. Approximately 60% of. the viable portion of the nodule is procured for research with the. majority going to I. and a 4-mm piece of tissue to. Ine remainder of the specimen is placed into. tormalin and submitted to Pathology for permanent. Procurement. was performed by. on. Received in pathology is the above mentioned mass that is cut in a. perpendicular fashion from the lateral to the medial side in order. to improve fixation. The areas of necrotic tissue that appear to. be consistent with a tumor are apparent on the lateral surface of. the mass. On gross examination, there does appear to be normal. adrenal gland which appears on one of the lateral surfaces and. appears 4 cm in greatest diameter. The external surface of the. entire mass has been inked black. Serial sections through the. portion of the mass that appears to have adrenal gland in addition. to tumor are sectioned and placed into cassettes. represents the most lateral portion of the identified adrenal. gland and serial sections are 1 cm apart and towards the medial. aspect of the mass. The first section in does not appear to. have any adrenal tissue on gross examination, however, the next. section that will be placed in. does appear to have. normal adrenal tissue. The irregular mass is serially sectioned. and placed into white cassettes labeled. This. area appears to be lateral to normal adrenal tissue. This portion. of the mass is approximately 6 cm and extends from what appears to. be the end of normal adrenal tissue all the way to the edge of the. mass. Again, the capsule is inked black. A well-circumscribed. white-tan lesion is located within the realm of a much more dark. Contidencial Parient Information, Unaurhorized disclosure is prohibited by the Premay Act it. JobID: Do not file in Medical Record. reddish brownish homogeneous material that encompasses most of the. mass, This lesion is placed entirely into the white cassette. The most lateral portion of the mass is placed into. white cassette labeled. Surrounding adipose tissue. with the possibility of harboring lymph nodes are placed into. white cassettes labeled. An additional 1.5 cm. white lesion that is well-circumscribed and within the larger mass. that is very homogeneous and tan-brown in color is sectioned and. placed into white cassette labeled. Gross Description dictated by. Additional. Gross Description dictated by : No consultants. Accessioned: Final Report Signed Out: <Resident Signature>. Date Report Signed: Princi t. Information prohibit by de Federal Print"" ill of 19 %. JobID: Requested By: I -. Do not file in Medical Record.",train,10 X 9 X8 cm;2 X. 1. .5cm
8732,TCGA-AX-A3GI.A803E376-399C-4841-A6AE-E82B99CD57B7,"Result date: ;PECIMEN DESCRIPTION. ;PECIMEN DESCRIPTION. Surgical Fathology Report. Pathology #: Site/Client: (Age: Gender: F. FINAL PATHOLIGIC DIAGNOSES. A. UTERUS, CERVIX, BILATERAL FALLOPIAN TUBES AND OVARIES, TOTAL. ABDOMINAL HYSTERECTOMY AND BILATERAL SALPINGO-OOPHORECTOMY: ENDOMETRIAL SEROUS ADENOCARCINOMA. TUMOR SIZE: . CM IN MAXIMUM DIMENSION. TUMOR INVADES UP TO 3.8 CM OUT OF 3.9 MYOMETRIAL THICKNESS. TUMOR INVOLVES CERVIX AND LEFT OVARY. ANGIOLYMPHAT:C INVASION IS IDENTIFIED. ADDITIONAL PATROLOGIC FINDINGS: - UTERUS: LEIOMYOMATA WITH DEGENERATIVE CHANGES. - RIGHT FALLOPIAN TUBE WITH WALTHARD REST. - RIGHT OVAR` WITH SMALL SEX CORD-STROMAL TUMOR, CONSISTENT WITH. FIBROTHECOMA (1.5 CM IN MAXIMUM DIMENSION). PLEASE SEE COMMENT AND SYNOPTIC REPORT (SDR CHECKLIST) BELOW. B. LYMPH MODE, LEFT PELVIC, DISSECTION: METASTATIC CARCINOMA INVOLVING TWO OUT OF TWO LYMPH NODES WITH. EXTRANODAL EXTENSION (2/2). C. LYMPH NODE, RIGHT PELVIC, DISSECTION: METASTATIC CARCANOMA INVOLVING TWO OUT OF THREE LYMPH NODES WITH. EXTRANODAL EXTENSION (2/2). ) Report. D. LYMPH NODE, RIGHT PERIAORTIC, DISSECTION: METASTATIC CARCINOMA INVOLVING THREE OUT OF FOUR LYMPH NODES WITH. EXTRANODAL EXTENSION (3/4). PATHOLOGIC STAGE AND CASE SUMMARY. pN2 (FIG0 11IC2). COMMENT. Sections of the left ovary show a proliferation of bland-looking spindle. ceils arranged into interlacing fascicles. Some of these cells show a. clear cytoplasm. No pleomorphism, necrosis or cytologic atypia seen. Ocrasional ritoses are noted. By immunohistochemical staining, these. neoplastic cells are positive for calretenin and inhibin. These findings. are consistent with fibrothecoma. A: UTERUS/CERVIX/ TUBES AND OVARIES BILATERALLY. SPECIMEN: Uterus, bilateral ovaries. and fallopian tubes. PROCEDORE: Specify- Total abdominal. hysterectiomy and bilateral salpingioophorectomy. LYMPH NODE SAMPLING: Performed, pelvic lymph. nodes and right periaortic lymph node dissection. SPECIMEN INTEGRITY: Intact hysterectomy. apecimen. TOMOR SITE: Specify- anterior and. posterior aspects of endometrial cavity. TOMOR SIZE: Greatest dimension- 9 cm. ADDITIONAL TUMOR DIMENSIONS: - 7.5 x 3.8 cm. HISTOLOGIC TYPE: Serous adenocarcinoma. HISTOLOGIC GRADE: Not applicable. MYOMETRIAL INVASION: Present, >- 50% myometrial. invasion. DEPTH OF MYCMETRIAL INVASION: - 3.8 cm. MYOMETRIAL THICKNESS: - 3.9 cm. INVOLVEMENT OF CERVIX: Invasion of cervical. stromal connective tissue. OTHER ORGANS INVOLVEMENT, EXTENT: See seperate organs below. RIGHT OVARY: Not involved. LEFT OVARY: Involved. RIGHT FALLOFIAN TUBE: Not involved. LEFT FALLOPIAN TUBE: Not involved. VAGINA: Not applicable. RIGHT PARAMETRIOM: Not applicable. LEFT PARAMETRIUM: Not applicable. OMENTUM: Not applicable. RECTAL WALL: Not applicable. BLADDER WALI : Not applicable. PELVIC WALL: Not applicable. HGADDER MUCCSA AND/OR BOWEL MUCOSA: Not applicable. OTHER ORGANS: Not applicable. PERITONEAI ASCITIC FLOID: See cyology report, case#-. NK111-(103.104,105) -. MARGINS: Uninvolved by invasive. carcinama. DISTANCE FROM CLOSEST MARGIN: - 2 mm. SPECIFY CLOSEST MARGIN: - anterior paracervical. soft tissue margn. LYMPH-VASCOIAR INVASION: Present. PATHCLOGIC STAGING (ptN) : - pT3a, pN2 (FIGO IIIC2). PELVIC LYMPH NODES: Number examined- 5. PELVIC LYMPH NODES INVOIVED: Number- 4. PARA-AORTIC LYMPH NODES: Number examined- 4. PARA-AORTIC NODES INVOLVED: Number- 3. OTHER LYMPH NODES: Not sampled. OTHER NODES INVOLVED: Not applicable. DISTANT METASTASIS (pM) : Not applicable. SPEC1FY METASTASIS SITE(S) : Not applicable. ADDITIONAL PATHOLOGIC FINDINGS. Specify- fibrothecoma of. left ovary. ANCILLARY STUDIES: Specify- immunostains , see. diagnosis comment. CLINICAL BISTORY: Not specified. COMMENT (S) : - none. All tests performed by. Pathologists,. SPECIMEN(S). A: UTERUS/CERVIX/ TUBES AND OVARIES BILATERALLY. B: LEFT PELVIC LYMPH NODE, DISSECTION. C: RIGHT PELVIC LYMPH NODE, DISSECTION. D: RIGHT PERIAORTIC LYMPH NODE. PROCEDURE. EXPLORATORY LAPAROTOMY TUMOR DEBULKING PELVIC NODE DISSECTION. PREOPERATIVE DIAGNOSIS. UTERINE CANCER. POSTOPERATIVE DIAGNOSIS. OTERINE CANCER. GROSS DESCRIPTION. A. Received firesh Labeled uterus, fallopian tubes, ovaries and cervix,. is a 650 q total hysterectomy specimen. The uterus measures 15 cm from. the cervix to fundus, 11.5 cm from cornu to cornu and 9.5 cm from. anterior 10 posterior. The serosal surface is bosselated with three. subserosa! nodules ranging in maximum dimension from 0.7 to 2 cm, the. largest one measures 2 x 1.2 x 1 am and is located on the anterior. surface. The subserosal nodules have tan white firm cut surfaces. The. remaining surface io pink-tan and smooth. The cervix measures. 4. em in length x 2.5 cm in diameter. The cervical DS is slit-like and. measures i). } cm in diameter. The anterior surface is inked yellow and. the posterior surface is inked black for microscopic evaluation. The. uterus is opened to reveal hemorrhagic fluid and a tan-pink/red friable. mass occupy no all the endometrial cavity on both anterior and posterior. aspects. The endometrial cavity measures 9 cm in length x 7.5 cm in. width. The mass grossly appears involving the lower uterine segment and. not involving the cervix. The mass is about 1.4 cm from the anterior. paracervica soft tissue margin and approximately 4 cm from the cervical. os. The masa grossly appears involving the superficial myometrium with. a. maximum depth of invasion approximately 1 cm out of 5 cm thickness of. the anterior endomyometrium. The mass has a maximum depth of invasion. on the posterior aspect of approximately 1.5 cm out of 4 cm. endomyometr.um thickness. Multiple tan-white firm intramural nodules. are ident: fied ranging in maximum dimension from 0.5 cm to 5 cm, the. largest one measures 5 x 4 x 3.5 cm and is located on the posterior. side. Some of these nodules are calcified. The endomyometrium ranges in. thickness forom 1.5 to 5.2 cm. The right fallopian tube measures 6.5 cm. in length x approximately 0.6 cm in diameter. The serosal surface is. pink-tan and smooth. Serial sectioning reveals a pinpoint lumen. The. right ovary measures 3 x 2 x 1 cm and it is serially sectioned to reveal. a tan-yellow nodule measuring 1.5 x 1.1 x 0.8 cm. The left fallopian. tube measures 7 cm in length x approximately 0.6 cm in diameter. The. serosal surface is pink-tan and smooth. The fallopian tube is serially. sectioned to reveal a pinpoint lumen. The left ovary measures 3 x 2 x. 1. cm. The left ovary is serially sectioned to reveal unremarkable. tan-pink cut surfaces. Representative sections of the specimen are. submitted as follows: Cassettes 1- the anterior cervix,. Cassettes 2 and 3- the anterior lower uterine segment,. Cassette 4- the closest tumor to the anterior paracervical soft tissue. margin,. Cassettes 5-6- anterior endomyometrium full thickness,. Cassettes 7-8- anterior endomyometrium full thickness,. Cassette 9- anterior endomyometrium full thickness,. Cassette 10- two reps of the anterior endomyometrium full thickness,. Cassette 11- posterior cervix,. Cassettes 12-13- posterior endocervix to posterior lower uterine. segment,. Cassettes 14-15- posterior endomyometrium,. Cassette 16- posterior endomyometrium full thickness,. Cassette 17- posterior endomyometrium full thickness,. Cassettes 18 and 19- representative sections of the posterior. endomyomet.rium full thickness,. Cassette 21- the tumor to the closest posterior paracervical soft tissue. margin,. Cassettes 20 and 22- representative sections of the largest intramural. nodule,. Cassette 23- - representative sections of the other nodules including the. subserosal podules. Cassettes 24-26- the right fallopian tube, submitted entirely,. Cassettes 27-28- the right ovary, submitted entirely,. Cassettes 29-31- the left fallopian tube, submitted entirely,. Cassettes 32-33- the left ovary, submitted entirely. B. Received fresh labeled left pelvic lymph node are three soft. yellow-pink tragments of adipose tissue aggregating to 3.2 x 3 x 1 cm. Within the fat there are two tan-pink possible lymph nodes measuring 0.7. and 1.7 cm in greatest. dimension. The smallest fragment of tissue is. bisected revealing a smooth walled cyst containing clear serous fluid. The specimen is submitted as follows: Cassette B1- cyst bisected,. Cassette B2- one possible lymph node, bisected,. Cassette B3- remainder of soft tissue. C. Received fresh labeled right pelvic lymph node are two yellow-tan. lobular fragments of adipose tissue measuring 1.9 x 1.5 x 1 cm and 2.5. x. 2 x 1.5 cm. Within the fat there are three brown-tan possible lymph. nodes which range from 1.2 to 2.5 cm in greatest dimension. The. specimen is submitted entirely as follows: Cassette C1- one possible lymph node, bisected,. Cassette C2- one possible lymph node, bisected,. Cassette C3- one possible lymph node bisected,. Cassette C4- remainder of soft tissue. D. Received fresh labeled right periaortic lymph node are two. tan-yellow lobular fragments of adipose tissue aggregating to 3.5 x 3 x. 1 cm. Within the fat there are three tan-pink, slightly firm possible. lymph nodes which measure 1 x 0.7 x 0.5 cm, 1.7 x 1.3 x 1, and 3 x 1.7 x. 1. cm. The largest possible lymph node is bisected revealing solid and. cystic, tan-yellow, slightly gritty tissue. The specimen is submitted. entirely as follows: Cassette D1- smallest possible lymph node, bisected with remainder of. soft tissue,. Cassette D2-03- one possible lymph node, trisected, divided between two. cassettes,. Cassettes D4-D5- largest possible lymph node, bisected, divided between. two cassettes. CPT CODE (S; : A: 83309, 88342, 88342. B: 88307. C: 88307. This test was developed and its performance and characteristics. determined by the. It has not been cleared. or approved by the U.S. Food and Drug Administration (FDA). . The FDA has. determined hat mich clearance or approval is not necessary. This test. is used for clinical purposes. It should not be regarded as. investigational or for research. This laboratory is certified under the. Clinical Laboratory Improvement Amendments of 1988 (CLIA-88) as. qualified to perform high complexity clinical laboratory testing. Unless indi cated as evaluated by gross examination only, all slides have. been reviowed By the signing Pathologist. Completed Action List: A. Perform b:",train,1.5 CM;9 cm;7.5 x 3.8 cm
8759,TCGA-BG-A0M6.39EC3673-5B31-403B-8328-9DEA5FF7CD1A,"FINAL DIAGNOSIS: PART 1: ADNEXUM, RIGHT, RIGHT SALPINGO-OOPHORECTOMY -. A. OVARY WITH SMALL INCLUSION CYST. B. UNREMARKABLE FALLOPIAN TUBE. PART 2: ADNEXUM, LEFT, LEFT SALPINGO-OOPHORECTOMY -. A. OVARY WITH METASTATIC ADENOCARCINOMA. B. UNREMARKABLE FALLOPIAN TUBE. PART 3: UTERUS (276 GRAMS), TOTAL ABDOMINAL HYSTERECTOMY -. A. POORLY-DIFFERENTIATED ADENOCARCINOMA OF ENDOMETRIUM, PAPILLARY SEROUS TYPE, FIGO. GRADE 3. B. NEOPLASM INVADES 100% OF MYOMETRIUM POSTERIORLY WITHOUT SEROSAL EXTENSION. C. NEOPLASM INVOLVES 100% OF ENDOMETRIAL SURFACE. D. LYMPHOVASCULAR INVASION IDENTIFIED. E. PATHOLOGIC STAGE pT3a pN1 pMX, FIGO STAGE 3C. F. LEIOMYOMA, 4.5 CM. PART 4: CERVIX, TOTAL ABDOMINAL HYSTERECTOMY -. A. PAPILLARY SEROUS ADENOCARCINOMA EXTENDING INTO ENDOCERVICAL GLANDS AND DEEPLY. INVOLVING CERVICAL STROMA. B. NEOPLASM EXTENDS TO DEEP MARGIN OF RESECTION POSTERIORLY. C. ECTOCERVICAL MARGIN OF RESECTION APPEARS FREE OF NEOPLASM. PART 5: OMENTUM, OMENTECTOMY - -. UNREMARKABLE ADIPOSE TISSUE, NO NEOPLASM IDENTIFIED. PART 6: ABDOMINAL PERITONEUM, LEFT, BIOPSY A-. UNREMARKABLE ADIPOSE TISSUE, NO NEOPLASM IDENTIFIED. PART 7: ABDOMINAL PERITONEUM, LEFT, BIOPSY B-. SOFT TISSUE, NO NEOPLASM IDENTIFIED. PART 8: PELVIC PERITONEUM, LEFT, BIOPSY -. SOFT TISSUE, NO NEOPLASM IDENTIFIED. PART 9: ANTERIOR CUL-DE-SAC, BIOPSY -. FIBROADIPOSE TISSUE, NO NEOPLASM IDENTIFIED. PART 10: PELVIC PERITONEUM, RIGHT, BIOPSY -. SOFT TISSUE, NO NEOPLASM IDENTIFIED. PART 11: ABDOMINAL PERITONEUM, RIGHT, BIOPSY A -. SOFT TISSUE, NO NEOPLASM IDENTIFIED. PART 12: ABDOMINAL PERITONEUM, RIGHT, BIOPSY B -. SOFT TISSUE, NO NEOPLASM IDENTIFIED. PART 13: LYMPH NODE, LEFT PELVIC, DISSECTION -. TWO LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/2). PART 14: LYMPH NODES, LEFT PELVIC, DISSECTION -. TWO LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/2). PART 15: LYMPH NODES, LEFT COMMON ILIAC, DISSECTION -. TWO OF FOUR LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA (2/4), ONE WITH EXTRACAPSULAR. EXTENSION. PART 16: LYMPH NODES, LEFT PERIAORTIC, DISSECTION -. ONE OF THREE LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA (1/3). PART 17: LYMPH NODES, RIGHT PELVIC, DISSECTION -. TWO OF SEVEN LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA (2/7), ONE WITH EXTRACAPSULAR. EXTENSION. PART 18: LYMPH NODES, RIGHT PELVIC, DISSECTION -. ONE LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA (1/1). PART 19: LYMPH NODES, RIGHT PERIAORTIC, DISSECTION -. TWO OF TWO LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA (2/2). PART 20: APPENDIX, APPENDECTOMY -. FIBROUS OBLITERATION OF DISTAL APPENDICEAL LUMEN. NO NEOPLASM IDENTIFIED. CASE SYNOPSIS: SYNOPTIC - PRIMARY UTERINE ENDOMETRIAL TUMORS: HYSTERECTOMY SPECIMENS. TUMOR TYPE: Serous adenocarcinoma. HISTOLOGIC GRADE (epithelial neoplasm) [combined architectural and nuclear]: Poorly differentiated (FIGO 3). ARCHITECTURAL GRADE: Poorly differentiated. NUCLEAR GRADE: Grade 3. TUMOR SIZE: Maximum dimension: 6.5 cm. PERCENT OF ENDOMETRIAL SURFACE INVOLVEMENT: Anterior endomyometrium: 100 %, Posterior endomyometrium: 100 %. DEPTH OF INVASION. Greater than 1/2 thickness of myometrium. STRUCTURES INVOLVED: Endocervical glands, Cervical stroma, Adnexa. ANGIOLYMPHATIC INVASION: OTHER: (epithelial, smooth muscle, others), Leiomyoma. LYMPH NODES POSITIVE: Number of lymph nodes positive:: 8. LYMPH NODES EXAMINED: Total number of lymph nodes examined: 21. LYMPH NODE GROUPS INVOLVED: Pelvic lymph nodes, Right, Common iliac lymph nodes, Left, Para-aortic lymph nodes,. Right, Para-aortic lymph nodes, Left. EXTRANODAL EXTENSION: T STAGE, PATHOLOGIC: pT3a. N STAGE, PATHOLOGIC: pN1. M STAGE, PATHOLOGIC: pMX. FIGO STAGE: IIIC.",train,4.5 CM;6.5 cm
8816,TCGA-EW-A1IY.7C003A4F-DC30-43D0-AC61-ACE6BA118BEE,"F. Pathologic Interpretation: A. Sentinel node #1. -One lymph node, no malignancy seen (0/1). - Immunostains are in progress. B. Sentinel node #2. -One lymph node, no malignancy seen (0/1). - Immunostains are in progress. C. Sentinel node #3. -One lymph node, no malignancy seen (0/1). - Immunostains are in progress. D. Non-sentinel lymph node: - Two lymph nodes, no malignancy seen (0/2). E. Right breast mass, 1 short stitch superior, 1 long stitch lateral, lumpectomy: - Inflitrating ductal carcinoma, intermediate nuclear grade, 2.0 cm in greatest dimension. - Focal ductal carcinoma in situ, cribriform type, intermediate nuclear grade with necrosis. - Margins are free of tumor. - Lymphovascular invasion is not seen. - AJCC pT2NOMx. - See tumor summary. - Other areas of the breast show fibrocystic changes with microcalcifications. - Skin with scar and foreign material (gel foam) deposition. - Changes of (previous biopsy site. - Focal changes of previous therapy effect noted on non-neoplastic breast tissue and a small portion of tunior. - Immunostains are in progress. F. Deep margin blue true deep: - Skeletal muscle, no malignancy seen. G. Internal mammary sentinel node. 2nd intercostal. - One lymph node, no malignancy seen (0/1). - Immunostains are in progress. Tumor Summary: Specimen Type: Excision. Lymph Node Sampling: Sentinel lymph nodes and one non-sentinel node. Specimen Size: Greatest dimension: 7.2 cm. Additional dimensions: 6.1 x 2.5 cm. Laterality: Right. Tumor Site: Not specified. Size of Invasive Component: Greatest dimension: 2.0 cm. Additional dimensions: 1.8 x 1.5 cm. Histologic Type: Invasive ductal carcinoma. Histologic Grade: Tubule Formation: Moderate 10% to 75% (score = 2). Nuclear Pleomorphism: Marked variation in size, nucleoli, chromatin clumping. etc (score =3). For a 40x objective with a field area of 0.152 mm2: 0 to 5 mitoses per 10 HPF (score =1). Total Nottingham Score: Grade II: 6-7 points. Pathologic Staging (pTNM). Primary Tumor: pT2. SURGICAL PATHOL Report. Regional Lymph Nodes: pNO. Number examined: 6. Number involved: 0. Distant Metastasis: pMX. Margins: Uninvolved by invasive carcinoma. Distance from closest margin: 2.0 mm. Specify which margin: Posterior (deep), see comment. Venous/Lymphatic Invasion: Absent. Microcalcifications: Present in non-neoplastic tissue. ""Electronically Signed Out By. NOTE: Some immunohiatochemice/ antibodies are analyte specific reagents (ASRs) validated by our laboratory (Her 2, Parvo, H. pylort, HBcore). These ASRs are clinically indicatora that do. not require FDA approval. These clones are used: IDS=ER, POR 636=PR, A485-HER2. H-11=EGFR, CCH2/OOG9=CMV, F39.4. 1=AR and HPV by ISH. AS Immunohietochern) stains are used. with formaho or molecular fired, paraffin embedded tisaue. Detection is by LSAB. The results are read by a pathologier as positive or negative. As the attending pathologiet, / attest that 1: (i) Examindo the relevant. proparation(a) for the specimen(s); and (4) Rendered he diagnoais(es). Procedures/Addenda. Addendum. Date Complete: Addendum Diagnosis. A, B, C, G. Immunohistochemistry for keratin is negative (Blocks A1, A2, B1, B2, C1 and G1). E. Tumor cells are positive for ER and PR and negative for HER2-neu (block E7). Intraoperative Consultation. AFS. Sentinel node #1. touch prep and FS: Negative for tumor. BFS. Sentinel node #2. FS: Negative for tumor. CFS. Sentinel node #3. FS: Negative for tumor. FFS. Deep margin blue true deep FS: Skeletal muscle, no malignancy seen. Clinical History: Patient is a. year old female with history of right breast cancer. Pre Operativo Diagnosis: SURGICAL PATHOL Report. Right breast cancer. Specimen(s) Received: A: sentinel node #1. touch prep and FS. B: sentinel node #2. 1 FS. C: sentinel node #3. FS. D: non-sentinel lymph node. E: right breast mass, 1 short stitch superior, 1 long stitch lateral fresh. F: deep margin blue true deep FS. G: Internal mammary sentinel node. 2nd intercostal (. Gross Description: A. Received fresh and labeled ""sentinel node #1. touch prep and FS' consists of a lymph node, 1.5 cm in greatest. dimension. Specimen bisected and submitted in toto in two cassettes as follows. 1. Half on lymph node for frozen. 2. The rest of lymph node for permanent. B. Received fresh and labeled ""sentinel node #2 (. consists of irregular shaped, yellow-tan, adipose tissue fragment,. 1.4 x 0.7 x 0.2 cm. Specimen submitted in toto in two cassettes. 1. One section from frozen. 2. The reminder of the specimen for permanent. C. Received fresh and labeled ""sentinel node #3. consists of irregular shaped, pale-tan, soft tissue fragment, 0.4 x 0.3. x 0.2 cm. Specimen bisected and submitted in toto in one cassette for frozen. D. Received in formalin and labeled ""non-sentinel lymph node"" consists of two irregular shaped, yellow-tan, sof tissue. fragment, 1.4 x 0.8 x 0.3 cm and 1.0 x 0.5 x 0.2 cm. Examination of the specimen reveal two possible lymph nodes, 1.3. cm and 0.8 cm in greatest dimension. Specimen submitted in toto In two cassettes as follows. 1. Large lymph node bisected. 2. Small lymph noe bisected. E. Received fresh and labeled ""right breast mass, 1 short stitch superior, 1 long stitch lateral"" consists of an irregular by. shaped, fibro-adipose tissue fragments measuring 7.2 x 6.1 x 2.5 cm and weighing 35.3 grams. Attached to the anterior. aspect of the specimen there is a very thin ellipse of skin, 2.8 cm by 0.2 cm. For gross purpose the specimen is inked as. follows: Anterior resection the skin surrounding the skin in yellow, superior resection margin is inked blue, inferior. resection margin is inked green, medial resection margin is inked red, lateral resection margin is inked orange and. posterior resection margin is inked black. Multiple cross sections reveal an ill-circumscribed, gray-white, hard and gritty. mass, 2.0 x 1.8 x 1.5 cm. The mass is 0.2 cm from deep resection margin (nearest margin), 1.5 cm from the skin surface,. 1.0 cm from medial resection margin, 1.7 cm from lateral resection margin, 2.0 cm from superior resection margin and. 1.8. cm from inferior resection margin. The reminder of the specimen reveals an unremarkable fibro-adipose tissue. The. stroma to fat ratio is 30.70%. Representative sections are submitted as follows. 1. Superior resection margin. 2. Inferior resection margin. 3. Medial resection margin. 4. Lateral resection margin. 5&6. Composed sections of the mass in relation with deep resection margin (nearest margin). 7-9. Additional representative section from the mass. 10. Representative section from skin. 11-14. Representative section from the reminder of the stroma. F. Received fresh and labeled ""deep margin blue true deep"" consists of irregular shaped, yellow-tan, fibro-adipose tissue. fragments, 1.8 x 1.5 x 0.2 cm. The resection margin inked black. Specimen multisected and submitted in toto in one. cassette for frozen. G. Received in formalin and labeled ""internal mammary sentinel node. , 2nd intercostal (. consists of Irregular. shaped, yellow-tan, soft tissue fragment, 0.5 x 0.4 x 0.1 cm. Specimen submitted in toto in one cassette. SURGICAL PATHOL Report. ICD-9(s): 174.8.",train,2.0 cm;2.0 cm
8831,TCGA-ZH-A8Y1.B4025F42-46CB-4D4E-ABB4-DBF701615F14,"Diagnosis: A: Liver lesion, ""Level 5"", excision. - Adenocarcinoma, moderately differentiated, of intrahepatic. bile ducts (primary hepatic cholangiocarcinoma), 4.5 mm. - Carcinoma is less than 1 mm from inked parenchymal margin. - Dysplasia of the intraductal biliary epithelium (see comment). B: Liver, Segment 8, excision. - Adenocarcinoma, moderately differentiated, of intrahepatic. bile ducts (primary hepatic cholangiocarcinoma), at least two. separate foci by gross examination, 0.4 and 0.8 cm. - Inked parenchymal margin (definitive margin) positive for. carcinoma (B2). - Dysplasia of the intraductal biliary epithelium and. intraductal biliary papillary carcinoma in situ, mutlifocal. C: Liver, Segments 2-5, partial hepatectomy. Adenocarcinoma, moderately differentiated, of intrahepatic. bile ducts (primary hepatic cholangiocarcinoma), at least 11.2. cm by gross measurement. - Dysplasia of the intraductal biliary epithelium and. intraductal biliary papillary carcinoma in situ, mutlifocal. - Inked parenchymal margin is extensively positive for invasive. carcinoma (C1). - Bile duct margin is positive for dysplasia (C9). Invasive carcinoma extends into perihepatic fibroadipose. tissue. - Lymphovascular space invasion is identified. - AJCC stage: pT3 pN1 (see comment). D: Lymph nodes, perihepatic, excision. - One of eleven lymph nodes positive for metastatic. adenocarcinoma (1/11). - Size of metastasis is 0.6 cm. - Extracapsular extension identified. Comment: The liver displays a spectrum of intraductal biliary neoplasia. In some bile duct profiles the epithelium is dysplastic without. papillary structure formation. In other bile duct profiles,. intraductal biliary papillomatosis is present as multifocal. papillary lesions. Intraductal papillary carcinoma is. considered to be to be the in situ lesion for the invasive. cholangiocarcinoma, and is related to the pancreatic intraductal. mucinous neoplasm. Dysplasia of the bile duct epithelium without. papillomatosis most likely is part of the same neoplastic. process in this case. The invasive tumor does not have papillary. architecture, and is a conventional gland-forming. adenocarcinoma. Invasive carcinoma is present as large mass. lesions/nodules (mass forming subtype). Extensive peri-ductal invasion (carcinoma spread along intact. biliary tree) is not identified. The tumor is staged as a. pathologic T3 because of invasion into perihepatic fibroadipose. tissue at the round ligament. Clinical History: -year-old female with intrahepatic malignant neoplasm. consistent with cholangiocarcinoma. Gross Description: Received are four formalin-filled containers. Container A is additionally labeled ""Level 5 liver lesion. "" It. holds a 0.8 X 0.7 X 0.4 cm wedge-shaped fragment of gray/tan. liver which is partially covered with a smooth capsule. The. parenchymal surface is inked black and the specimen is. sectioned to reveal a 0.5 X 0.4 X 0.3 cm circumscribed white. subcapsular nodule abutting the black inked parenchymal margin. The specimen is serially sectioned and entirely submitted in. block A1,. Container B is additionally labeled ""Segment 8 liver. "" The. requisition states: stitch marks definitive segment 8 margin. It holds a 3.1 gram, 2.4 X 2.2 X 1.7 cm friable fragment of. liver tissue with two sutures present on one surface. designating definitive margin. This surface is inked black, and. the opposite surface is inked red for identification purposes. The specimen is sectioned perpendicular to the black inked. margin and entirely submitted in blocks B1-B5. Sectioning reveals two white circumscribed nodules which are 0.4. and 0.8 cm in greatest dimension. Each nodule abuts the red. inked margin opposite the sutured margin. The smaller nodule. comes within 0.2 cm of the black inked sutured margin. (B3) , and the larger nodule comes within 0.3 cm of the black. inked sutured margin (B1). Block Summary : B1-B5,. Container C is additionally labeled ""Liver, Segments 2-5. "" It. consists of a 545 gram, 18 X 13 X 5 cm partial hepatectomy. specimen composed of Segments 2-5. The capsule is brown/gray,. focally plaque-like. The parenchymal margin is inked blue. There. is a small amount of attached fat along the inferior edge of. Segment 5. Along the medial edge of the parenchymal margin there. is a 3.4 X 2.9 cm fragment of fibromembranous tissue and. cauterized fat. This area is adherent upon the capsule. Sectioning demonstrates a dominate nodule surrounded by. multiple butting nodules off its edge and within the remainder. of the parenchyma. The dominate nodule is 11.2 X 9.8 X 4.4 cm. The smaller nodule within the parenchyma and subcapsular range. from 0.1 to 4 cm in greatest dimension. The closest approach to. the parenchymal margin (inked black) is 0.2 cm. The tumor has a. solid gritty yellow/tan cut surface with areas of firm,. white tissue at the periphery. The surrounding hepatic. parenchyma is homogeneous tan/gray with no micronodular pattern. identified. Tumor and normal are given to Tissue Procurement. Block Summary: C1 - tumor nodules at closest approach to black inked. parenchymal margin. C2-C3 - fibromembranous tissue adherent near surgical margin. C4-C5 - additional section near adherent fatty tissue at round. ligament insertion. C6 - edge of tumor and large caliber lumina. C7-C8 - additional sections of tumor. C9-C11 - additional sections, en face, from surgical margin,. lumina. Container D is additionally labeled ""perihepatic lymph node.' It. consists of a 3.7 X 2.6 X 1.5 cm aggregate of cauterized. yellow/tan fibrofatty tissue which is dissected for lymph node. candidates. Lymph node candidates up to 3.1 cm in greatest. dimension are identified. Block summary : D1 - four lymph node candidates. D2 - two lymph node candidates. D3 - one bisected lymph node candidate. D4-D5 - - one sectioned lymph node candidate. A small amount of fat remains in formalin.",train,4.5 mm;0.4;0.8 cm;11.2. cm
8855,TCGA-44-3918.da381e6d-f69d-424f-ab84-5c300ca19435,"SPECIMEN. A. Left upper lobe FS. B. Node level 5. C. Node level 1. D. Left upper lobe. E. Node level 7. F. Node level 4. G. Node level 9. CLINICAL NOTES. PRE-OP DIAGNOSIS: Lung mass. FROZEN SECTION DIAGNOSIS. FSA) Left upper lobe - Poorly differentiated adenocarcinoma. GROSS DESCRIPTION. A. Submitted fresh for frozen and tissue procurement. labeled ""left upper lobe"" is a wedge resection of. pulmonary. tissue, which has a small incision previously made within it. The. wedge measures maximally 7 X 4 X 3 cm. Next to the incision site. there is some puckering of the pleura, which overlies a palpable. lung mass. Sutures are removed from the specimen and is then. serially sectioned. Sections through the specimen reveals a. puckered firm tan tumor mass immediately below the pleural surface. measuring maximally 2.2 cm in greatest dimension. Per request, a. portion of tissue is submitted for tissue procurement. A portion. of. tissue is submitted for frozen section. RS-4. B. Received fresh, subsequently fixed in formalin labeled. ""node level 5"" is a 1.2 X 0.5 X 0.5 cm black-red irregular. soft tissue fragment which is bisected and entirely submitted in. one. cassette. AS-1. C. Received in formalin labeled ""node level 1"" is a 1.5 x. 1.5 X 0.6 cm pink black, irregular tissue fragment which. is. GROSS DESCRIPTION. bisected and entirely submitted in one cassette. AS-1. D. Received fresh, subsequently fixed in formalin labeled. ""left upper lobe"" is a 20.0 X 6.5 x 3.5 cm remainder of. lobe. The specimen is partially covered with violaceous smooth. glistening pleura and shows multiple staple lines present. throughout. the specimen. The specimen is sectioned showing a pink-red spongy. cut surface with no discrete gross lesions identified. Multiple. black-red hilar nodes are grossly identified. Representative. sections of the specimen are submitted as follows: BLOCK SUMMARY: 1 - possible hilar lymph node; 2 - vascular and. bronchial margins; 3-4 - representative normal. RS-4. E. Received fresh, subsequently fixed in formalin labeled. ""node level 7"" are two black-red irregular soft tissue. fragments which average 0.8 cm in greatest dimension. The. specimens. are entirely submitted in one cassette. AS-1. F. Received fresh, subsequently fixed in formalin labeled. ""node level 7"" is a 0.5 x 0.4 x 0.4 cm gray-pink-black. irregular soft tissue fragment which is entirely submitted in one. cassette. AS-1. G. Received in formalin labeled ""node level 9"" is a 1.2 X. 0. 7 X 0.5 cm black-gray irregular soft tissue fragment. which is bisected and entirely submitted in one cassette. AS-1. MICROSCOPIC DESCRIPTION. Histologic type: Adenocarcinoma. Histologic grade: Moderate to poorly differentiated. Primary tumor (pT) : Tumor measures maximally 2.2 cm in size and is. confined to the lung (pT1b) . Margins of resection: Bronchial and vascular margins are free of. tumor. MICROSCOPIC DESCRIPTION. Direct extension of tumor: Absent. Venous (large vessel) invasion: Negative. Arterial (large vessel) invasion: Negative. Lymphatic (small vessel) invasion: Negative. Regional lymph nodes (pN) : Hilar lymph nodes and all sampled. mediastinal. lymph nodes are negative for metastatic carcinoma (pNO). Distant metastasis (pM) : Cannot be assessed (pMx) . 5,3x5,14. DIAGNOSIS. A. and D. Lung, left upper lobectomy. Moderate to poorly differentiated adenocarcinoma. The tumor is confined to the lung without involvement of the. visceral pleural surface. Bronchial and vascular margins of resection are free of. tumor. Seven bronchial lymph nodes negative for metastatic carcinoma. (0/7). B. Lymph node, level 5, resection: Negative for malignancy. C. Lymph node, level 1, resection: Negative for malignancy. E. Lymph node, level 7, resection: Negative for malignancy. F. Lymph node, level 4, resection: Negative for malignancy. G. Lymph node, level 9, resection: DIAGNOSIS. Negative for malignancy.",train,2.2 cm;2.2 cm
8925,TCGA-AX-A05U.1F51E982-37A1-40C6-BFAC-782B93D9967F,"RUN DATE: RUN TIME: 3Y: ACCT # : LOC: AGE/SX: RM/BED: REG DR: SPEC #: Obtained: CLINICAL HISTORY. ENDOMETRIAL CA. SPECIMEN/PROCEDURE. 1. LYMPH NODE - PARA AORTIC. 2. LYMPH NODE - RT PARA AORTIC. 3. LYMPH NODE - RT COMMON ILIAC. 4. LYMPH NODE - RT EXTERNAL ILIAC. 5. LYMPH NODE - RT OBTURATOR. 6. LYMPH NODE - LEFT OBURATOR. 7. LYMPH NODE - LEFT EXTERNAL ILIAC. 8. LYMPH NODE - LEFT COMMON ILIAC. 9. UTERUS - CERVIX, BILATERAL TUBES AND OVARIES. IMPRESSION: 1). LEFT PARA-AORTIC LYMPH NODES: Four lymph nodes are negative for tumor (0/4) . 2). RIGHT PARA-AORTIC LYMPH NODES: Seven lymph nodes are negative for tumor (0/7). . 3). RIGHT COMMON ILIAC LYMPH NODES: Two lymph nodes are negative for tumor (0/2). 4). RIGHT EXTERNAL ILIAC LYMPH NODES: Three lymph nodes are negative for tumor (0/3). 5). RIGHT OBTURATOR LYMPH NODES: Three lymph nodes are negative for tumor (0/3) . 6). LEFT OBTURATOR LYMPH NODES: Two lymph nodes are negative for tumor (0/2). 7). LEFT EXTERNAL ILIAC LYMPH NODE: Mature adipose tissue. No lymph node material is identified. 8). LEFT COMMON ILIAC LYMPH NODES: SPEC #: (Continued) Page: 2. IMPRESSION: (continued). Two lymph nodes are negative for tumor (0/2). 9). UTERUS, BILATERAL TUBES AND OVARIES: ENDOMETRIUM: Adenocarcinoma of endometrium, endometrioid type, FIGO grade I, nuclear. grade 2, (3.8 cm.) invading < 50% of the myometrium. The uninvolved endometrium shows complex hyperplasia with and without. atypia as well as disordered proliferative endometrium. MYOMETRIUM: Myometrial invasion measuring 5 mm where the wall measures 21 mm (29%) . No vascular space invasion is identified. Adenomyosis. CERVIX: Chronic cystic cervicitis. No evidence of tumor or dysplasia. Endometriosis involving the deep cervical stroma. OVARIES, BILATERAL: Atrophic pattern with focal hyperthecosis. No tumor is identified. The left ovary has a benign serous cystadenofibroma with dominant cystic. component (2.0 cm). FALLOPIAN TUBES, BILATERAL: No pathologic diagnosis. ENDOMETRIAL CARCINOMA CHECKLIST. ACROSCOPIC. SPECIMEN TYPE. Hysterectomy. TUMOR SITE. Specify location (s), if known: Anterior corpus. TUMOR SIZE. Greatest dimension: 3.8 cm. Additional dimensions: 1.8 x 0.8 cm. OTHER ORGANS PRESENT. Right ovary. Left ovary. Right fallopian tube. Left fallopian tube. MICROSCOPIC. (Continued) Page: 3. SPEC #: IMPRESSION: (continued). HISTOLOGIC TYPE. Endometrioid adenocarcinoma, not otherwise characterized. HISTOLOGIC GRADE. G1: 5% or less nonsquamous solid growth. MYOMETRIAL INVASION. Invasion present. Maximal depth of myometrial invasion: 5 mm. Thickness of myometrium in area of maximal tumor invasion: 21 mm. The & of myometrial involvement: 29%. EXTENT OF INVASION. PRIMARY TUMOR (pT). TNM (FIGO). pTlb (IB) : Tumor invades less than one-half of the myometrium. REGIONAL LYMPH NODES (pN). TNM (FIGO). pNO: No regional lymph node metastasis. Number examined: 23. DISTANT METASTASIS (pM). TNM (FIGO). pMX: Cannot be assessed. MARGINS. Uninvolved by invasive carcinoma. VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION (V/L). Absent. ADDITIONAL PATHOLOGIC FINDINGS. Hyperplasia. Complex (adenomatous). Atypical hyperplasia. Complex (adenomatous). Other (specify) : Adenomyosis, endometriosis. Pathologic TNM (AJCC 6th Edition) : pT1b NO MX. Dictated bv: Entered: SPEC #. (Continued) Page: 4. GROSS DESCRIPTION: 1). Received labeled with the patient's name and ""left para-aortic"" Received is a 2.5 x. 1.7 x 1.5 cm aggregate of yellow gold lobulated adipose tissue. Dissected for. possible lymph nodes. Four possible lymph nodes identified, ranging from 1 to 1.5 cm. in greatest dimension. Submitted as follows: CASSETTE SUMMARY: Cassette 1A: Three possible lymph nodes. Cassette 1B: One lymph node bisected. 2). Received labeled with the patient's name and ""right para-aortic"". Received is a 3.5 x. 4 x 2 cm aggregate of yellow gold hemorrhagic fibroadipose tissue. Dissected for. possible lymph nodes. Five possible lymph nodes identified, ranging from 1.5 to 3 cm. in greatest dimension. Submitted as follows: CASSETTE SUMMARY. Cassette 2A: Three possible lymph nodes. Cassette 2B: One lymph node bisected. Cassette 2C: One lymph node bisected. 3). Received labeled with the patient's name and ""right common iliac"". Received is a 3 x. 1.3 x 0.9 cm portion of yellow gold to pink tan lobulated adipose tissue. Dissected. for possible lymph nodes. Two possible lymph nodes identified, ranging from 1.5 to. 2.1 cm in greatest dimension. Submitted as follows: CASSETTE SUMMARY: Cassette 3A: One lymph node bisected. Cassette 3B: One lymph node bisected. 4). Received labeled with the patient's name and ""right external iliac"". Received is a. 4.7 x 1.6 x 1 cm portion of yellow gold lobulated adipose tissue. Dissected for. possible lymph nodes. Three possible lymph nodes identified, ranging from 0.9 to 3.5. cm in greatest dimension. Submitted as follows: CASSETTE SUMMARY: Cassette 4A: Two possible lymph nodes. Cassette B,4C: One lymph node bisected. 5). Received labeled with the patient's name and ""right obturator"". Received is a 4.7 x. 3.5 x 1.4 cm aggregate of yellow gold with lobulated adipose tissue. Dissected for. possible lymph nodes Three possible lymph nodes identified, ranging from 1 to 3 cm. in greatest dimension. Submitted as follows: CASSETTE SUMMARY: Cassette 5A: One lymph node bisected. Cassette 5B: One lymph node bisected. Cassette 5C: One lymph node bisected. SPEC #: (Continued) Page: 5. GROSS DESCRIPTION: (continued). 6). Received labeled with the patient's name and ""left obturator"" Received is a 4.2 x. 2.5 x 1.5 cm aggregate of yellow gold hemorrhagic fibroadipose tissue. Dissected for. possible lymph nodes. Three possible lymph nodes identified, ranging from 1 to 3 cm. in greatest dimension. Submitted as follows: CASSETTE SUMMARY: Cassette 6A: Two possible lymph nodes. Cassette 6B: One lymph node bisected. Received labeled with the patient's name and ""left external iliac"". Received is a 4.5. x 3.5 x 1.6 cm aggregate of yellow gold lobulated adipose tissue. Dissected. for. possible lymph nodes. No lymph nodes are grossly identifiable. Specimen is. representatively submitted in cassettes 7A-7C. 8). Received labeled with the patient's name and ""left common iliac"" Received is a 3 x. 2.5 x 1 cm aggregate of yellow gold hemorrhagic tissue fragments. Two possible lymph. nodes identified, ranging from 1 to 2 cm in greatest dimension. CASSETTE SUMMARY: Cassette 8A: One lymph node bisected. Cassette 8B: One lymph node bisected. 9). Received fresh, labeled with the patient's name, number and ""uterus, cervix, bilateral. tubes and ovaries"", is a hysterectomy and bilateral salpingo-oophorectomy specimen. consisting of uterus (10.0 x 7.5 x 6.5 cm), right ovary (4.0 x 3.0 x 1.5 cm), right. fallopian tube which appears to be previously ligated and measures 2.2 cm in length. and 0.5 cm in diameter at the proximal end and 2.5 cm in length and 0.5 cm in diameter. at the distal end, left ovary (3.0 x 1.8 x 1.5 cm), and left fallopian tube which. appears to be previously ligated and measures 2.5 cm in length and 0.5 cm in diameter. at the proximal end and 2.2 cm in length and 0.7 cm in diameter at the distal end. The uterus is abnormally enlarged with multiple nodules ranging from 1.5 cm to 5.5 cm. in maximum dimension and the serosal surface of the uterus has an irregular contour. with red-tan focally hemorrhagic surface. The ectocervix is flattened, pink-tan with. an external os measuring 1.8 cm. Upon opening the specimen the endocervical canal is. 3.0 cm, irregular, pink-tan and otherwise unremarkable. There is a 3.8 x 1.8 x 0.8 cm. pink-tan polypoid lesion in the endometrial cavity attached to the anterior. endometrium. The endometrial cavity is 6.0 x 2.5 cm, focally hemorrhagic and. approximately 40% of the lumen is occupied by the tumor. The posterior endomyometrium. is mostly free of tumor and is pink-tan with focal hemorrhages. The tumor grossly. does not extend to the endocervical canal and is 4.5 cm away from the external os. anteriorly. The myometrium is white-tan to pink and measures 1.5 cm to 2.5 cm. in. thickness. Upon sectioning the posterior myometrium has a white-tan whorled. leiomyoma, 5.5 x 5.0 x 4.8 cm. The anterior myometrium shows the tumor invading. approximately 0. cm at the area of 2.5 cm myometrial thickness. There is a 1.0 x 0.9. SPEC #: (Continued) Page: 6. GROSS DESCRIPTION: (continued). x 0.5 cm yellow-tan fleshy polypoid mass in the posterior endometrial cavity, located. at the superior margin which upon sectioning does not appear to involve the. myometrium. The external surface of the right ovary is pink-tan, cerebriform and unremarkable. The right fallopian tube is previously ligated, however unremarkable. The external. surface of the left ovary is pink-tan, cerebriform with a 2.0 x 1.0 x 0.5 cm firm. polypoid lesion extending from the lateral surface. Upon sectioning the ovarian. stroma is white-tan, homogeneous and unremarkable with the polyp showing yellow-tan. gelatinous material. Specimen is representatively sectioned and submitted as follows. The specimen is a part of research and accordingly normal tissue and tumor were. submitted for research. CASSETTE SUMMARY: Cassette 9B: Right ovary and fallopian tube. Cassette 9C: Left ovary. Cassette 9D: Polypoid extension from the left ovarian surface and left. fallopian tube. Cassette 9E: Anterior ectocervix. Cassette 9G: Anterior lower uterine segment. Cassette 9H,9J: Representative section of the anterior endomyometrium with tumor. (at the level of maximum invasion). Cassette 9K: Posterior cervix. Cassette 9L: Posterior lower uterine segment. Cassette 9M: Posterior endomyometrium. Cassette 9N: Posterior endomyometrium with polypoid lesion. Cassette 9P,90: Representative sections of the largest leiomyoma. Entered: COPIES TO: Undefined Provider. SPEC #: (Continued) Page: 7. CPT Codes: : LYMPH NODE, REGIONAL RESECT/. SOFT TISSUE, LIPOMA/ADIPOSE (1). UTERUS W/WO ADNEXAE, NOT TUMOR OR PROLAPSE. ICD9 Codes:",train,3.8 cm;3.8 cm;5.5 x 5.0 x 4.8 cm;1.8 x 0.8 cm
8976,TCGA-A7-A4SE.C0C49D41-AA66-435B-9312-FAD8E2DC3305,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Breast, left, segmental mastectomy: Invasive ductal carcinoma,. grade 3, size 2.8 cm in greatest dimension; negative margins of. excision. B. Sentinel lymph node #1, biopsy: Two negative lymph nodes (0/2) . C. Sentinel lymph node #2, biopsy: One negative lymph node (0/1) . D. Breast, medial to left segmental mastectomy, biopsy: Negative for. malignancy or atypia. E. Breast, inferior to left segmental mastectomy, biopsy: Negative. for malignancy or atypia. F. Breast, posterior to left segmental mastectomy, biopsy: Skeletal. muscle; negative for malignancy or atypia. G. Breast, lateral to left segmental mastectomy, biopsy: Negative. for malignancy or atypia. H. Breast, superior to left segmental mastectomy, biopsy: Negative. for malignancy or atypia. Microscopic Description: Invasive Carcinoma. Histologic type: Ductal. Histologic grade: 3. Overall grade: 9/9. Architectural score: 3. Nuclear score: 3. Mitotic score: 3. Greatest dimension (pT) : 2.8 cm. Specimen margins: Negative. Vessel invasion: Not identified. Calcification: Present. Ductal carcinoma in situ: Histologic pattern: Solid. Nuclear grade: 3. Central Necrosis: Present. 8 DCIS of total tumor (if mixed) : 1%. Extensive intraductal component (present/absent) : Absent. Specimen margins: Negative. Calcification: Negative. Description of non-tumorous breast: Fibrocystic changes, with ductal. hyperplasia of usual type, a minute fibroadenoma, and apocrine. metaplasia, with calcification. Comments: Sentinel lymph nodes negative, confirmed by negative. cytokeratin immunostaining of blocks BFS1 and CFS2. Cytokeratin. staining was also performed on one block from part E, to exclude. involvement by carcinoma. Prior biopsy site identified. Extensive. central tumor necrosis is present. Prognostic markers: See core biopsy report,. 4x8, 14x2, 15x2, 20x3. [A few of the antibodies used in our laboratory may be classified as. analyte specific reagents. These antibodies are monitored and. controlled in our laboratory and their performance for in vitro. diagnosis is well described in the medical literature. They have not. been cleared or approved by the FDA.: Specimen. A. Left Breast. B. Left axillary sentinel lymph node #1, hot, blue,. C. Left axillary sentinel lymph node #2, not hot, not blue, but. palpable. D. Medial to segmental mastectomy left breast. E. Inferior to segmental mastectomy left breast. F. Posterior to segmental mastectomy left breast. G. Lateral to segmental mastectomy left breast. H. Superior to segmental mastectomy left breast. Clinical Information. Left breast cancer. Intraoperative Consultation. B) Left axillary sentinel node #1: Two negative lymph nodes (0/2). C) Left axillary sentinel node #2, biopsy: One negative lymph node. (0/1). Gross Description. A. Received unfixed for tissue procurement, labeled left breast. segmental mastectomy single long lateral, double long anterior, is. a 100 gram breast segmental excision that is 9 cm from anterior to. posterior, 7.5 cm medial to lateral, and 3 cm from superior to. inferior. The superior surface is inked black, and a section is. submitted for tissue procurement as requested. An additional. section of uninvolved fatty tissue is submitted from the posterior. aspect, for procurement. Additional sections after fixation. The. superior surface is inked black, medial green, lateral yellow,. inferior blue. There is a tan, firm, lobulated mass lesion in the. mid-portion of the specimen, 3.0 x 2.0 x 1.7 cm. This is 3 mm from. the green-inked medial margin (closest margin). All other margins. are grossly greater than 1 cm from the mass. Representative. sections: 1 Anterior margin, 2 adjacent section with margin, 3/4/5. contiguous tumor, possible biopsy cavity in 5, 6/7/8 contiguous,. 9-10 random medial and lateral, possible close margin, 11-14. additional posterior sections, with last section = posterior. margin. B. Received unfixed for frozen section, labeled left axillary. sentinel node #1, are 2 adjacent and attached lymph nodes, 0.9 cm. in greatest dimension each, bisected and entirely submitted in. blocks B1 and B2. C. Received unfixed for frozen section, labeled left axillary. sentinel node #2, is a single lymph node, 1.4 x 1.3 x 1.0 cm,. bisected and entirely submitted in 2 blocks. D. Received fresh and subsequently fixed in formalin labeled ""medial. to segmental mastectomy left breast ""is a 5.2 x 3.5 x 1.5 cm yellow. lobular fatty tissue fragment which has a suture designating the. new medial border. The surface is inked and the specimen is. sectioned to show yellow lobular fatty cut surface with minimal. fibrous tissue present. No discrete residual tumor is grossly. identified. The specimen is entirely submitted labeled 1 through. 10. E. Received fresh and subsequently fixed in formalin labeled. ""inferior to segmental mastectomy left breast ""is a 4.3 x 2.7 x. 2.2. cm yellow lobular fatty tissue fragment which has a suture. designating new inferior border. The surface is inked and the. specimen is sectioned to show yellow lobular fatty cut surface with. minimal fibrous tissue present. No residual tumor is grossly. identified. The specimen is entirely submitted labeled 1 through 9. F. Received fresh and subsequently fixed in formalin labeled. ""posterior to segmental mastectomy left breast ""is a 3.2 x 2.5. x. 1.0 cm yellow lobular fatty tissue fragment which is partially. covered with skeletal muscle. There is a suture designating the new. posterior margin. The surface is inked and the specimen is. sectioned to show a yellow lobular fatty cut surface with scanty. fibrous tissue present. The specimen is entirely submitted in 5. cassettes. G. Received fresh and subsequently fixed in formalin labeled ""lateral. to segmental mastectomy left breast ""is a 4.3 x 3.5 x 1.5 cm yellow. lobular fatty tissue fragment. There is a suture designating the. new lateral border. The surface is inked and the specimen is. sectioned to show yellow lobular fatty cut surface with minimal. fibrous tissue present. No residual tumor is grossly identified. The specimen is entirely submitted in 9 cassettes. H. Received fresh and subsequently fixed in formalin labeled. ""superior segmental mastectomy left breast ""is a 4.3 x 2.2 x 1.0. cm. yellow lobular fatty tissue fragment which has a suture designating. the new superior border. This is inked and the specimen is. sectioned to show yellow lobular fatty cut surface with scanty. fibrous tissue present. The specimen is entirely submitted in 4. cassettes.",train,2.8 cm;2.8 cm
8981,TCGA-L6-A4EQ.E74C0B3F-6261-4C59-8A1F-6DD5975637D2,"Clinical Center. Birth Date: AP Supplemental Report. SUPPLEMENTAL. SUPPLEMENTAL. REASON FOR THE SUPPLEMENTAL REPORT: To clarify the location of the. lesions. Diagnosis remains unchanged. DIAGNOSIS: 1. Lymph node, delphan lymph node, biopsy: Metastatic carcinoma to. lymph node (1/1). 2. Thyroid, total thyroidectomy: Papillary thyroid carcinoma, conventional type,(3.5cm), isthmus. Hurthle cell neoplasm, favor Hurthle cell adenoma. (left lobe). See note: Multinodular goiter. The original report is as follows: DIAGNOSIS: 1. Lymph node, delphan lymph node, biopsy: Metastatic carcinoma to. lymph node (1/1). 2. Thyroid, total thyroidectomy: i,. Papillary thyrold carcinoma, conventional type,(3.5cm), left. lobe. ii. Hurthle cell neoplasm, favor Hurthle cell adenoma. (isthmus). See. note: iii. Multinodular goiter. NOTE: The Hurthle cell neoplasm shows no evidence of fibrous capsule and. capsular or vascular invasion. This lesion stains positive for. thyroglobulin and negative for Calcitonin. Dr. is informed by Dr. of presence of micrometastasis in. lymph node on. Immunoperoxidase and in-situ hybridization tests performed here and used. for diagnosis were developed and their performance characteristics. determined by the Laboratory of Pathology, They have not been. cleared or approved by the U.S. Food and Drug Administration. The FDA. has also determined that such clearance or approval is not necessary. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (CLIA) as qualified to perform high complexity. clinical laboratory testing. (Other). Do not file in Medical Record. Clinical Center. Birth Date: Clinical_History:__thyrold. cancer, papillary Specimen Taken For. Protocol: 01 - Yes. PROCEDURE: Pre-Operative Diagnosis: papillary thyroid ca. Post-Operative. Diagnosis: same Operative Findings: isthmus nodule,. left lobe nodule. SPECIMENS SUBMITTED: 1. SERIAL 5 + 3FS, Delphan lymph node (1FS). 2. THYROIDECTOMY, TOTAL. INTRAOPERATIVE CONSULTATION: 1FS: ""Delphan lymph node, rule out metastatic thyroid cancer"". 1FS Diagnosis: Lymph node with fibrotic tissue, no tumor seen. -The frozen section is performed by Dr. and Dr. - Dr. is informed by Dr. of presence of micrometastasis in. lymph node on. GROSS DESCRIPTION: Two specimens are received fresh with the. patient's name, medical record number, and further specified as follows: 1. ""Delphan lymph node, rule out metastatic thyrold cancer"". It. consists of a yellow-tan soft tissue fragment measuring 0.8 x 0.7 x 0.4. cm. Entirely frozen. In Surgical Pathology, the specimen matched the. above description and the specimen is transferred to cassette. 2. ""Total thyroid gland, long stitch right superior, short left. superior"". It is a total thyroidectomy weighing 42.7 grams (post. procurement). Gross photographs are taken. The right lobe measures 3 x. 2.5 x 1.5 cm. The left lobe 6.5 x 3 x 1.5 cm. Isthmus measures 4 x 4 x. 1.5 cm. A solid lesion measuring 3.5 x 3.2 x 2.2 is identified in the. left lobe, while a cystic lesion 3.3 x 2.5 x 2 cm in deflated state is. identified in isthmus. Approximately 1 x 1 cm of tissue is procured for. Dr. from each lesions. Procurement was performed by Dr. in OR and. on. Also 0,5 cm of each tumor and 0.5 x 1 x 1 cm of normal tissue in the. right lobe is also procured for Dr. The right anterior. aspect of the gland (right lobe and isthmus) is inked blue, the left. anterior aspect of the gland (left lobe) is inked red, and posterior. aspect of the gland is inked black. Approximately 0.8 x 0,6 x 0.3 cm of. normal-appearing thyroid tissue from the right lobe is procured In TPPF. for the normal tissue bank by. on. a.m. The remainder of the specimen is placed in formalin and submitted. for Pathology for permanent processing. In Surgical Pathology, the. specimen matched the above description and is entirely submitted. The. external capsule of the gland is grossly uninvolved by aforementioned. two lesions. The superior aspect of left lobe is grossly uninvolved. with a beefy-red cut surface and is submitted in cassettes 2A and 2B. Do not file in Medical Record. Clinical Center. I. Birth Date: ty. from superior. to inferior. The solid lesion in the inferior aspect of. left lobe is yellow-tan and well-circumscribed with multiple focal. punctate hemorrhage and multiple nodular lesion measuring around 0.5 x. 0.6 cm but no necrosis or depressed scar. The solid lesion is submitted. from left upper aspect to left lower aspect in cassette 2C-2J and right. upper to right lower aspect in 2K-2O. The cystic lesion in the isthmus. is gray-tan with a finely papillary and granular appearance and focal. punctate hemorrhage. A calcified spot around 0.8x 0.6x 0.6 cm is. identified in the right middle aspect of the cystic lesion. The isthmus. is submitted from left upper aspect to left lower aspect in 2P-2R and. right upper to right lower in. Pright aspect of isthmus and. left aspect of right lobe from left to right. right lobe from. superior to inferior. 2GG: superior aspect of very right end of right. lobe. 2HH: inferior aspect of the very right end of right lobe. No consultants. #. (Other). Do not file in Medical Record.",train,3.5cm;3.5cm
8992,TCGA-B0-4813.0b904450-5c80-4e14-9918-1949fa7c15fa,"FINAL DIAGNOSIS: PART 1: KIDNEY, RIGHT, NEPHRECTOMY -. A. RENAL CELL CARCINOMA (6.5 CM), CONVENTIONAL (CLEAR) CELL TYPE. B. THE CARCINOMA EXTENDS INTO RENAL VEIN FORMING AN ADDITIONAL 5,0-cm MASS. C. FUHRMAN GRADE: 3 OF 4. D. NO EXTENSION THROUGH THE RENAL CAPSULE IS NOTED. E. ANGIOLYMPHATIC INVASION SEEN MICROSCOPICALLY. F. HISTOPATHOLOGICAL STAGING: pT3b, Nx, Mx. PART 2: VEIN, VENA CAVA, RESECTION MARGIN, EXCISION -. RENAL CELL CARCINOMA, INVOLVING THE VEIN WALL. COMMENT: Part 1: Additional margin from the distal ureter is submitted. Results will be issued as an addendum.",train,6.5 CM;5.0-cm
9014,TCGA-24-2288.a8d48a3e-3f22-44ec-8cbd-2ad8bb43bb45,"MRN : Accessioned: Patient Typo: DIAGNOSIS: OVARY AND FALLOPIAN TUBE, LEFT, SALPINGO-OOPHORECTOMY. PAPILLARY SEROUS CARCINOMA POORLY DIFFERENTIATED, INVOLVING OVARY AND FALLOPIAN. TUBE. OVARY AND FALLOPIAN TUBE, RIGHT, SALPINGO-OOPHORECTOMY. PAPILLARY SEROUS CARCINOMA, POORLY DIFFERENTIATED INVOLVING OVARY AND FALLOPIAN. TUBE WITH EXTENSIVE LYMPHOVASCULAR SPACE INVASION. OMENTUM, OMENTECTOMY (FS). - METASTATIC CARCINOMA. OMENTUM, OMENTECTOMY. - METASTATIC CARCINOMA. SMALL INTESTINE, RESECTION. - METASTATIC CARCINOMA, MULTIPLE NODULES INVOLVING MESENTERY AND SMALL INTESTINE. WALL. - METASTATIC CARCINOMA PRESENT IN 5 OF 5 MESENTERIC LYMPH NODES (5/5). SOFT TISSUE, VENTRAL HERNIA, HERNIORRHAPHY. - METASTATIC CARCINOMA, SOFT TISSUE AND DERMAL INVOLVEMENT. By this signature, 1 attest that the above diagnosis is based upon my personal. examination of the slides(and/or other material indigated in the diagnosis). '. Diagnosis Comment. SYNOPTIC REPORTING FORM FOR MALIGNANT OVARIAN NEOPLASMS. 1. A neoplasm is PRESENT. 2. The HISTOLOGIO DIAGNOSIS is: Serous adenocarcinoma. 3. The LOCATION(S) OF THE PRIMARY TUMOR(S) is/are: Right and left ovary (synchronous primary tumors). 4. The FIGO GRADE of the tumor is: III (Tumor composed of >50% solid cellular nests). 5. The NUCLEAR (BRODERS') GRADE of the tumor is: G3 (Poorly-differentiated). 6. Tumor IS identified on the ovarian surface(s). 7 Tumor DOES invade the mesovarium. 8. Tumor DOES invade the adjacent fallopian tube (bilaterally). 9. Tumor invasion of pelvic soft tissue CANNOT BE EVALUATED. 10. Tumor involvement of the pelvic peritoneum is PRESENT. 11. Metastatic involvement of the EXTRAPELVIC PERITONEUM is PRESENT. 12. Metastatic involvement of the omentum is PRESENT. 13. The maximum dimension of tumor implants outside the true pelvis is 8.0 cm. 14. Metastatic involvement of the uterine serosa CANNOT BE EVALUATED. 15. Metastatic involvement of the endometrium CANNOT BE EVALUATED. 16. Regional lymph node metastases CANNOT BE EVALUATED. 17. DETAILED STAGING INFORMATION: Based on the above information, the PRIMARY TUMOR is. classified as: TNM Scheme. FIGO Scheme. Definition. T3c. IIIC. Macroscopic peritoneal metastasis beyond true pelvis measuring > 2 cm. in. greatest dimension. THE REGIONAL LYMPH NODES are classified as: NX (Nodal status cannot be assessed). THE STATUS OF DISTANT TUMOR SITES is classified as: MX (Status cannot be assessed). 18. The FINAL AJCC/UICC/FIGO STAGE IS: AJCC/UICC/FIGO. Insufficient data to assign stage. The pathologic stage assigned here should be regarded as provisional, and may change after integration of clinical. data not provided with this specimen. Intraoperative Consultation: An intraoperative non-microscopic consultation was obtained and interpreted as: ""Called to O.R. to pickup 'omentum."". It consists of a 7 X 3 X 2.0 cm glistening fleshy white mass. A representative section is submitted for FS1. An. additional portion is submitted for tumor bank. The remainder is placed in formalin. Microscopic Description and Comment: Microscopic examination substantiales the above cited diagnosis. History: The patient is a. with enlarged uterus and ovarian and omental masses. A previous cervical biopsy. showed poorly differentiated carcinoma (S99-10--). Operative Procedure: Exploratory laparotomy; omentectomy;. bilateral salpingo-oophorectomy; ventral hernia repair; small bowel resection. Specimen(s) Received: A: OMENTUM (FOR FS). B: OMENTUM, ROUTINE. C: SMALL BOWEL. D: LEFT OVARY. E: RIGHT OVARY AND TUBE,. F: HERNIA SAC. Gross Description;. The specimens are received in six formalin-filled containers labeled with the patient's name. in addition, the first. container is labeled ""omentum (FS1). It holds a previously sectioned white, firm, well-demarcated mass measuring 7. x 5 X 2.5 cm, in aggregate, and a cassette labeled ""FS"" holding a section of tumor measuring 3 x 1.5 x 0.2 cm. On. multiple sections, the tum or shows colid, focally necrotic, homogeneous cut surfaces. Labeled A1 - FS; A2 and A3. additional sections of tumor. The second container is labeled ""omentum."" It contains fragments of fatty tissue with attached vessels, consistent with. omentum, measuring 10 x 5x3 cm. Multiple white, firm nodules, ranging in size from 0.2 to 3 cm, are scattered on. the omental surface. All these nodules show firm, white, solid and partially cyslic and hemorrhagic cut surfaces. Labeled B1 - sections of two different nodules. The third container is labeled ""small bowel."" It contains several adhesed loops of small intestine centered around a. large solid white, fleshy omental mass. The length of the small intestino is difficult to appreciate due to the degree of. distortion; it is - -100 cm in length. The Jumen is even and -2.5 cm in diameter. In the area encroached by tumor, the. lumen of the intestine appears narrowed to a diameter of 1 cm. However, the intestine is lined by unremarkable. mucosa throughout its length, with no evidence of intraluminal tumor, The tumor surrounds the intestinal loop,. involves the mosentery with multiple additional white nodules, ranging in sizo from 0,5 to 3 cm, studding the peritoneal. surface. Tumor nodules are also present at the stapled mesenteric resection margin. The main tumor measures 10. cm in groatest dimension. Labeled C1 and C2 - intestine with serosal tumor; C3 - stapled resection margins of the. intestine; C4 - mesenteric lymph nodes/tumor nodules. The fourth container is labeled ""left ovary."" It contains a 7.5 x 5 x 4 cm solid ovoid firm white mass with irregular. surface. A portion of the surface is represented by a thin-walled white cyst. The mass is bisected to show solid white,. soft cut surfaces with areas of necrosis. The above described cyst contains necrotic, yollow fluid. There is no. recognizable residual ovarian tissue. Also, no fallopian tube is identified grossly. Labeled D1 to D3 - sections of the. tumor (including cyst). The fifth container is labeled ""right ovary."" Il holds an ovary with attached fallopian tube. The ovary is 4 x 3 2 cm and. the fallopian tube is 5 em in length and 0.5 cm in average diametor, and includes the proximal third of the fallopian. .ube as well as the fimbriated end. The ovary appears to be entirely replaced by a multinodular firm solid white tumor. In addition, multiple tumor nodules ranging in size from 0.2 to 1 cm are present on the tubo-ovarian ligament and. serosa overlying the fallopian tube, including the fimbriated end of the tube. Labeled E1 - ovarian tumor (including. tubo-ovarian ligament); E2 - fallopian tube (transverse sections and fimbriated end). Dann n ,. scar. measuring portion of this sac shows ring-like attached serosa. The sixth container 21 X 6 x5cm. is labeled A ""hemia sac, skin, tumor."" It holds a sac-like portion of skin with. well as The an additional serosal surface 8 x 7 x of 4 the cm hernia nodule sac of firm shows extensive a serosal structure thickening consistent on a plaque-like with markedly area distended of 8 X 4 umbilical as. The described skin is putative tan, umbilical scar. In addition, multiple solid tumor, small involving firm tumor the nodules serosa are and scattered fat adjacent to the above cm,. dermis. Also, the largest tumor and nodule of the shows sac show solid, multiple extensively tumor nocrotic nodules cut infiltrating through on the serosa surface. into the. sections of the largest wrinkled nodule and shows extensive areas of hyperkoratosis. No tumors are seen on the the skin serosal surface. Cross. Labeled homorrhagic F1 degeneration. Jar 2. The tumor is present in the subcutaneous fat underlying surfaces the with skin areas of the of cystic hernia and sac. and F2.",train,8.0 cm;10. cm;3 x 1.5 x 0.2 cm
9024,TCGA-BA-5557.afdefdb5-7366-46e6-b6c8-088a36f3428f,"SURGICAL PATHOLOGY REVISED REPORT. Addenda Present. Diagnosis: A: Tooth #30, anterior buccal gingiva, biopsy. - Squamous mucosa with chronic inflammation and dystrophic calcification. - No carcinoma identified. B: Deep retromolar trigone, biopsy. - Benign squamous mucosa. - No carcinoma identified. C: Right anterior tongue pilar, biopsy. - Benign salivary gland and soft tissue. - No carcinoma identified. D: Left palate, biopsy. - Benign squamous mucosa. - No carcinoma identified. E: Deep posterior tongue, biopsy. - Benign skeletal muscle and adipose tissue. - No carcinoma identified. F: Deep midline tongue, right, biopsy. - Benign skeletal muscle and adipose tissue. - No carcinoma identified. G: Soft tissue, anterior neck fat, removal. - Benign parathyroid gland. - No carcinoma identified in four lymph nodes (0/4). H: Lymph nodes, right neck, Level 3, removal. - No carcinoma identified in eight lymph nodes (0/8). I: Lymph nodes, right neck, Level 4, removal. - No carcinoma identified in nine lymph nodes (0/9). J: Lymph nodes, right neck, Level 1, removal. - No carcinoma identified in five lymph nodes (0/5). - Benign salivary gland. K: Lymph nodes, right neck, Level 2, removal. - Metastatic squamous cell carcinoma with necrosis and focal cystic change involving one of eight lymph nodes (1/8) measuring 1.1 cm in. greatest dimension. - No extracapsular extension identified. L: Tongue, right hemiglossectomy. Tumor histologic type: Squamous cell carcinoma. Histologic grade: Moderately differentiated, keratinizing. Tumor size: 2.0 in greatest dimension. Greatest depth of invasion 1.6 cm into muscle of tongue. Extent of invasion: Angiolymphatic invasion: Not identified. Perineural invasion: Not identified. Bone invasion: N/A. Carcinoma in situ: Present. Likely primary site: right tongue. Surgical Margins: Negative, both the margins on this specimen as well as the separately submitted margins from parts A -. F. Lymph nodes: Carcinoma identified in one of 34 lymph nodes (1/34)see specimens G-K. Size of largest nodal metastasis (greatest dimension): 1.1 cm (specimen K). Presence/absence of extranodal extension: Absent. Other significant findings: None. AJCC PATHOLOGIC TNM STAGE: pT1 pN1 NOTE: This pathologic stage assessment is based on information available at the. time of this report, and is subject to change pending clinical review and additional information. Intraoperative Consult Diagnosis: A frozen section was requested by Dr. FSA1: Tooth #30, anterior buccal gingiva, biopsy. - No carcinoma identified. - Focal chronic inflammation noted. FSB1: Deep retromolar trigone, biopsy. - Squamous mucosa and salivary gland tissue; no carcinoma identified. FSC1: Right anterior tonsillar pillar, biopsy. - Salivary gland tissue; no carcinoma identified. FSD1: Left palate, biopsy. - Squamous mucosa with chronic inflammation; no carcinoma identified. FSE1: Deep posterior tongue biopsy. - Skeletal muscle; no carcinoma identified. FSF1: Deep midline tongue, right, biopsy. - Skeletal muscle; no carcinoma identified. Frozen Section Pathologist: Gross Description: Received are twelve appropriately labeled containers. Containers A-F are received fresh for frozen section. Container A holds two fragments of red/tan soft tissue measuring 2 x 2 x 2 mm in aggregate. (Block FSA1,. Container B holds a 0.7 X 0.5 X 0.2 cm cauterized red/tan soft tissue fragment. (Block FSB1,. Container C holds a 0.8 X 0.6 X 0.5 cm red/tan soft tissue fragment. (Block FSC1,. Container D holds a 0.4 x 0.3 x 0.3 cm white/tan soft tissue fragment. (Block FSD1,. Container E holds a 0.3 X 0.2 X 0.3 cm white/tan soft tissue fragment. (Block FSE1,. Container F holds a 0.6 x 0.4 x 0.4 cm red/tan soft tissue fragment. (Block FSF1,. Container G is additionally labeled ""anterior neck fat."" It holds multiple fragments of yellow lobulated adipose tissue measuring 1.7 X 1.5 X. 0.5 cm in aggregate. The fragments are submitted in block G1,. Container H is additionally labeled ""right neck, Level 3."" It holds a 3.6 x 2.2 x 1.5 cm fragment of yellow firm tissue. The outer surface is. smooth. Sectioning reveals four lymph node candidates ranging from 0.5 to up to 1.5 cm. Additionally, there are fragments of red/brown. grossly unremarkable muscle. The lymph nodes are sampled in three cassettes; blocks H1-H3, per block summary. Block summary: H1 - multiple lymph node candidates. H2 - one lymph node candidate, trisected. H3 - three lymph node candidates. Container I is additionally labeled ""right neck, Level 4."" It holds a 4.1 x 2.8 X 1.5 cm fragment of yellow firm tissue. The outer surface is. smooth. Within the specimen there are multiple lymph node candidates ranging from less than 0.5 cm to 1.5 cm. The lymph node candidates. are sampled in four cassettes; blocks I1-I4, per block summary. Block summary: Il - multiple lymph node candidates. I2-I3 - one lymph node candidate, serially sectioned. I4 - two lymph node candidates. Container J is additionally labeled ""right neck, Level 1."" It holds an 18.7 gram, 5.7 x 3.3 x 1.8 cm fragment of yellow lobulated tissue. The. outer surface is smooth. Sectioning reveals multiple lymph node candidates ranging from 1.0 x up to 1.5 cm. Additionally, a portion of. the. tissue is yellow, lobulated and grossly resembles salivary gland tissue. The specimen is sampled in four cassettes; blocks J1-J4. Block summary: J1 - one lymph node candidate, serially sectioned. J2. - two lymph node candidates, one bisected and not inked; the other not bisected and inked blue. J3 - one lymph node candidate, bisected and section of salivary gland tissue. J4 - one lymph node candidate, trisected. Container K is additionally labeled ""right neck, Level 2."" It holds a 6.0 X 2.8 x 1.8 cm fragment of yellow firm tissue. The outer surface. is. smooth. Sectioning reveals multiple lymph node candidates ranging from 0.5 cm to up to 2.5 cm. The largest lymph node candidate has a. cystic center. The cyst is filled with yellow flocculent purulent material. The lymph nodes are sampled in four cassettes; blocks K1-K4, per. block summary. Block summary: K1 - one lymph node candidate, serially sectioned. K2 - multiple lymph node candidates. K3 - one lymph node candidate, serially sectioned. K4 - representative section from largest lymph node candidate to include cyst. Container L: Specimen fixation: formalin. Specimen Type: partial glossectomy. Size of specimen: 6.7 cm from anterior to posterior, 5.3 cm from medial to lateral, 3.0 cm from superior to inferior. Orientation: The specimen was received with short stitch=medial, long stitch=anterior. Inking: anterior=yellow, posterior=green, medial=blue, lateral=red, deep inferior=black. Tumor description: On the surface of the mucosa, a 2.0 X 1.1 cm tan ulcerated, ill-defined lesion is present. The lesion is covered. with red/brown blood clot and located on the mucosa of the tongue within the lateral posterior aspect. Extent of tumor: extends into the underlying tongue muscle. Presence/absence of bone involvement: n/a. Distance of tumor to surgical margins: 0.5 cm from deep/inferior,1.0cm from red inked lateral, 1.5 cm from blue inked medial, less. than 1.0 cm from green inked posterior and greater than 2.5 cm from yellow inked anterior. Description of remaining tissue: Also present on the lateral aspect is a fragment of yellow lobulated tissue grossly consistent with. salivary gland tissue. The remainder of the cut surface of the tongue is tan/brown and firm. Tissue submitted for. tumor submitted to the. Block summary: L1 - tumor with respect to deep inferior margin, perpendicular. L2 - tumor with respect to salivary gland tissue and lateral margin, perpendicular. L3 - tumor with respect to surrounding tongue muscle and deep margin, perpendicular. L4 - perpendicular sections through posterior margin. L5 - additional sections from lateral margin perpendicular. L6 - uninvolved tissue, anterior. Light Microscopy: Light microscopic examination is performed by Dr. Attending Pathologist: I have personally conducted the evaluation of the above specimens and have. rendered the above diagnosis(es). Procedures/Addenda: Addendum. Stains for HPV and P16 were requested at ENT conference. Immunostain for high risk HPV is negative. P16 stain is interpreted as negative. 2+ staining in approximately 50% of the tumor cells is seen. For p16 stain to be considered positive diffuse strong staining in >70% of the. tumor cells should be present.",train,2.0;2.0 X 1.1 cm
9038,TCGA-FX-A2QS.55148DBE-D662-4930-8B29-15905F0A459D,"Patient Location: Date of Service: Date Received: Room. Bed: Date Re. Itema were attached to this order: FINAL SURGICAL PATHOLOGY REPORT. Diagnosis: A. KIDNEY, LEFT, RADICAL NEPHRECTOMY: - DEDIFFERENTIATED LIPOSARCOMA. - ARISES FROM PERINEPHRIC ADIPOSE TISSUE. - 11.5 CM IN MAXIMUM DIMENSION. - MARGIN STATUS: NEGATIVE. - CONTAINED WITHIN GEROTA'S FASCIA. - 0.005 CM FROM THE FASCIAL SURFACE. - LYMPHOVASCULAR INVASION: NOT IDENTIFIED. - ADRENAL GLAND UNINVOLVED BY TUMOR. PATHOLOGIC STAGING SUMMARY: - Primary tumor: pT2b (deep tumor, 11.5 cm In greatest dimension). - Regional lymph nodes: pNX (none submitted for evaluation). - Distant metastasis: pMX. - Pathologic stage: III. - Margin status: R0 (contained within Gerota's fascia, 0.005 cm from fascial surface). COMMENT: This case was forwarded to. in. consultation. The diagnosis of dedifferentiated liposarcoma is reflective of their. Interpretation. Dr. notifled of the consultant's diagnosis at approximately. on. Printed: This report continues (FINAL). FINAL SURGICAL PATHOLOGY REPORT. Tumor Staging Information. (data derived from current specimen, staging in accordance with or modified from AJCC Cancer Staging. Handbook, 7th Ed, and CAP protocol,. Radical nephrectomy. Procedure: TUMOR FEATURES: Perinephric adipose tissue, associated with left kidney. Tumor site: (abuts but does not invade kldney). Greatest dimension: 11.5 cm. Tumor size: Additional dimensions: 9.5 x 7.5 cm. Deep, retroperitoneal. Macroscopic extent of tumor: Dedifferentiated liposarcoma. Histologic type: 30 per 10 high power fields. Mitotic rate: Present. Necrosis: Approximately 40%. Extent: 3. Histologic grade: RO (NEGATIVE). MARGINS: 0.005 cm from anterior surface of Gerota's fascia. Distance from closest margin: Not identified. Lymphovascular invasion: PATHOLOGIC STAGING: pT2b (deep tumor, 11.5 cm in greatest dimension). Primary tumor: Regional lymph nodes: pNX. pMX. Distant metastasis: III. Tumor stage: R0 (closest margin, anterior surface of Gerota's fascia,. Margin status: 0.005 cm). Pre-resection treatment: No therapy. Chronic interstitial nephritis. Additional findings: Hyaline arteriolar sclerosis. i, MD, Pathologist. Signec. This report continues. Printed: FINAL SURGICAL PATHOLOGY REPORT. Source of Specimen: A. Left kidney nephrectomy. Clinical History/Operative Dx: Left renal mass. Gross Description: A. The specimen is labeled left kidney and is received without fixative. It consists of a nephrectomy. specimen which together with perinephric fat weighs 865.0 grams. The specimen measures 19.5 cm from. superior to inferior, 11.0 cm from medial to lateral and 8.5 cm from anterior to posterior. Along the. medial superior edge of the perinephric fat there is a 4.8 x 2.0 x 0.7 cm portion of adrenal gland. On. sectioning the adrenal gland is partially autolyzed and there is a very small 0.2 cm focus of pale tan. discoloration of the adrenal cortical tissue centrally. The anterior surface as well as the superior portion of. the kidney Is bulging and distorted. Over the anterior surface there is a 10.0 x 8.5 cm portion of thin. delicate membranous tissue consistent with Gerota's fascia. Gerota's fascia is inked black. At the hilum. the renal artery and renal vein are identified. The vesseis are opened and there is no gross evidence of. intraluminal tumor. Extending from the hilum is a thin and delicate portion of ureter which is 7.0 cm in. length and has a maximum diameter of 0.3 cm. The ureter is opened and the urothellum is tan-white,. smooth and unremarkable. The kidney is bivalved to reveal an upper pole tumor mass which at its. periphery is translucent and tan-white, centrally dull yellow-tan and possibly infarcted. The tumor mass. measures 11.5 x 9.5 x 7.5 cm. With gentle manipulation, the tumor mass appears to attach itself to the. renal capsule at the superior pole and does not, except for a small focus, appear to be attached to the. cortical surface of the kidney. Serial sections of the tumor reveal It Is in the perinephric fat and abuts. Gerota's fascia along the anterior surface. Tumor approaches to within 0.4 cm of the adrenal gland. Tumor is present at the perirenal fat at the hilum. The uninvolved kidney shows fatty infiltration of the. hilum and a well delineated cortical medullary junction. The cortical thickness is 0.6 cm. No other renal. parenchymal masses are identified. Dissection of the perinephric fat reveais no obvious lymph nodes. Representative sections are submitted. Sections summary: (A1) surgical margin renal artery, renal vein. and ureter, (A2) adrenal gland with possible tumor implant, (A3) sections of tumor and renal capsule. adherent to superior pole of kidney, (A4) tumor adherent to cortical surface of superior pole,(A5) tumor. abutting Gerota's fascia and tumor and closest approach to adrenal gland, (A6-A7) representative. sections of tumor, (A8) tumor and renal peivic adipose tissue, (A9) uninvolved kidney. (DS). Microscopic Description: A. Sections of the kidney tumor show a spindle cell neoplasm, with marked nuclear pleomorphism,. nuclear hyperchromasia, coarse chromatin, scattered multinucleated cells, numerous mitoses, and areas. of necrosis. The neoplastic cells are positive for CD34, Vimentin, and focally for smooth muscle actin. The cells are negative for OSCAR keratin, PAX-8, smooth muscle myosin, S100, CD31, CAM6.2, Desmin,. Melan-a, HMB45, and muscle specific actin, All staining controls are appropriately reactive. Printed;. This report continues (FINAL). FINAL SURGICAL PATHOLOGY REPORT. B. See reference lab report. Printed: This report continues (FINAL).",train,11.5 CM;11.5 cm;11.5 cm;11.5 cm;11.5 x 9.5 x 7.5 cm;9.5 x 7.5 cm
9070,TCGA-OL-A66P.979468F0-6B4A-4759-9CA2-7BA1D1441BC2,"FINAL PATHOLOGIC DIAGNOSIS. A. Right axillary sentinel node #1, biopsy: - One lymph node, negative for metastatic carcinoma (0/1). (H&E and. cytokeratin AE1/AE3). B. Right axillary sentinel node #2, biopsy: - One lymph node, negative for metastatic carcinoma (0/1). (H&E and. cytokeratin. AE1/AE3). C. Superior mastectomy flap, excision: - Benign fibroadipose tissue with focal fat necrosis. D. Right breast, simple mastectomy: - Two foci of invasive ductal carcinoma, SBR Grade II, see breast. pathologic parameter. - Ductal carcinoma in-situ, intermediate nuclear grade, solid and apocrine. types. - Microscopic focus of atypical ductal hyperplasia. - Previous biopsy sites identified. - Margins of excision are negative for invasive and in-situ carcinoma. - Intraductal papilloma (9 mm) with extensive hyalinization, see comment. - Hyalinized 6 mm nodule with osseous metaplasia. - Columnar cell change. - Fibroadenomatous changes. - Apocrine metaplasia. - Sclerosing adenosis. - Duct ectasia. E. Inferior flap, right breast excision: - Benign fibroadipose tissue with microscopic focus of breast parenchyma,. distant from. the new true margin. F. Medial flap, right breast excision: - Benign fibroadipose tissue. Breast Pathologic Parameters. 1a. Invasive carcinoma: (1 o'clock lesion). A. Gross measurement: 2.1 X 1.9 cm. B. Composite histologic (modified SBR) grade: II. - Architecture: 3. - Nuclear grade: 2. - Mitotic rate: 1. C. Associated intraductal carcinoma in situ (DCIS): - Within main mass (forming less than 5% of tumor volume). 1b. Invasive carcinoma (12 o'clock lesion): 0.9 X 0.8 cm. Composite histologic (modified SBR) grade II. - Architecture: 3. - Nuclear grade: 2. - Mitotic rate: 1. Associated intraductal carcinoma in situ (DCIS): None. 2. Intraductal carcinoma: A. Microscopic measurement: Admixed with 1 o'clock lesion. B. Type: Solid, Apocrine. C. Nuclear grade: Intermediate. D. Associated features: None. 3. Excisional biopsy margins: Free of tumor. - DCIS more than 10 mm from anterior-superior (closest) margin. Invasive carcinoma more than 5 mm from anterior-superior (closest) margin. 4. Blood vessel and lymphatic invasion: Suspicious. 5. Nipple: unremarkable. 6. Skin: uninvolved. 7. Skeletal muscle: absent. 8. Axillary lymph nodes: Negative (0/2). 9. Special studies (ER, PR repeated on mastectomy): 1 o'clock lesion. - ER: No expression, 0% of invasive tumor nuclei. - PR: No expression, 0% of invasive tumor nuclei. - HER2 antigen (FISH) (biopsy. Not amplified (ratio: 1.14). - Ki-67 (Performed on previous biopsy. : 35%. Special studies (ER, PR repeated on mastectomy): 12 o'clock lesion. - ER: No expression, 0% of invasive tumor nuclei. - PR: No expression, 0% of invasive tumor nuclei. - HER2 antigen (FISH)(biopsy. : Not amplified (ratio: 1.13). - Ki-67 (Performed on previous biopsy. ): :30%. 10. pTNM (AJCC, 7th edition, 2010): pT2(m), NO(sn), MX. Effective. this Checklist utilizes the 7th edition TNM staging. system for breast of the American Joint Committee on Cancer (AJCC) and the. International Union Against Cancer (UICC). Clinical History: The patient is a. year-old female with multicentric right breast invasive. ductal carcinoma undergoing simple mastectomy and sentinel node biopsies. mammogram showed a hypoechoic mass at 1:00 in the right breast, 4. cm from the nipple, measuring 20 mm in maximum diameter. A smaller round. hypoechoic mass measuring 8 mm in maximum diameter was additionally identified. at 12:00 in the right breast, 4 cm from the nipple. Clips wereplaced in the. central aspect of both lesions. Comment. D. Immunohistochemical stains for cytokeratin 5/14 were performed on block D7. and support intraductal hyperplasia, usual type. Immunohistochemical stains for. p63 and mycin heavy chain were performed on D10 and support an intraductal. papilloma. All immunohistochemical controls were appropriate. Specimens Received: A: Right axillary sentinal. node #1. B: Right axillary sentinal. node #2. C: Superior mastectomy flap. D: Right breast. E: Inferior flap right breast. F: Medial flap right breast. Gross Description: The specimens are received in six containers each labeled with the patient's. name and medical record number. A. The first container is additionally identified as, 'right axillary sentinel. node #1'. Received fresh for intraoperative consultation is a portion of rubbery. yellow-tan tissue measuring 2.5 X 2.3 X 0.8 cm. The specimen is bisected and. entirely frozen, and the frozen section diagnosis by Dr. is 'no tumor'. The. frozen section remnants are entirely submitted in A1 FS and A2 FS. B. The second container is additionally identified as, 'right axillary sentinel. node #2'. Received fresh for intraoperative consultation is a portion of. yellow-tan and blue-tinged tissue measuring 1.5 X 1.0 x 0.8 cm. The specimen is. bisected and entirely frozen, and the frozen section diagnosis by Dr. is. 'no tumor'. The frozen section remnant is entirely submitted in B1 FS. C. The third container is additionally identified as, 'superior mastectomy. flap'. Received fresh and placed in formalin is a 26.5 gram, 10.3 x 4 x 0.9 cm. portion of lobulated yellow fibroadipose tissue. There is a stitch on one aspect. of the specimen designating the final anterior margin. The aspect of the. specimen with the stitch is inked black. The specimen is serially sectioned to. reveal grossly unremarkable lobulated yellow fibroadipose tissue. Representative. sections are submitted in C1-C5. D. The fourth container is additionally identified as, 'right breast'. Received fresh and placed in formalin is a 593.6 g simple mastectomy specimen. The specimen is oriented with a double short suture designating the superior. aspect and a double long suture designating the lateral aspect. The breast. measures 24.5 cm from medial to lateral, 18 cm from superior to inferior, and. 3.5 cm from anterior to posterior. On the anterior surface is a 21.5 X 13.5 cm. brown ellipse of skin with a 5.5 x 3.8 cm areola and a 1.2 X 1.1 x 0.5 cm raised. nipple. The nipple-areolar complex reveals no evidence of ulceration or. retraction. The specimen is inked as follows: anterior-superior - blue;. anterior-inferior - green;. posterior - black. The specimen is serially sectioned from medial to lateral into 20 slices (slice. 1 = medial, nipple in slice 10) to reveal a well-circumscribed lobulated tan. mass measuring 2.1 x 1.9 X 1.5 cm in the superior aspect of slices 7 and 8. The. mass is 1.3 cm from the posterior (black) margin, 1.3 cm from the anterior. superior (blue) margin, and 0.9 cm from the anterior skin. In slice 8, 1.8 cm. superior to the first mass, is a 0.9 x 0.8 X 0.8 cm rubbery mass that is located. 1 cm from the posterior (black) margin and 0.8 cm from the anterior superior. (blue) margin. A clip is identified in slice 8 within the second mass. There are. 2 additional nodular areas in the breast. The first measures 0.9 X 0.8 x 0.7 cm. and is located in the inferior aspect of slice 11, 1.6 cm from the posterior. (black) margin. The second nodular area measures 0.5 X 0.4 X 0.4 cm and is found. in the inferior aspect of slice 15, 1 cm from the posterior (black) margin. The. remainder of the specimen consists of approximately 25% dense gray-white fibrous. breast parenchyma and 75% lobulatedyellow adipose tissue. No additional masses. or nodules are grossly identified. Block summary: D1: mass #1, slice 7. D2: mass #1, slice 7, including deep margin. D3: mass #1, slice 8, including closest to anterior superior margin. D4: masses #1 and #2, slice 8. D5-D6: mass #2, slice 8, including closest to anterior superior and deep margins. (submitted in tandem). D7: medial to mass #1, slice 6. D8: inferior to mass #1, slice 8. D9: lateral to masses #1 and #2, slice 9. D10: nodular area #1, slice 11. D11: breast parenchyma between nodular areas #1 and #2, slice 13. D12: nodular area #2, slice 15. D13: lateral to nodular area #2, slice 16. D14: upper-outer quadrant slice 14. D15: lower-outer quadrant slice 14. D16: upper-inner quadrant slice 4. D17: lower-inner quadrant slice 5. D18: nipple. D19: skin, slice 8. E. The fifth container is additionally identified as, 'inferior flap right. breast stitch marks final anterior margin'. Received fresh and placed in. formalin is a 6.5 g, 4.7 x 3.2 x 0.6 cm portion of lobulated yellow fibroadipose. tissue. On one aspect of the specimen is a stitch designating the final anterior. margin. The aspect of the specimen with the stitch is inked black. The specimen. is serially sectioned to reveal grossly unremarkable lobulated yellow. fibroadipose tissue. Representative sections are submitted in E1-E5. F. The sixth container is additionally identified as, 'medial flap right breast. stitch marks final anterior margin'. Received fresh and placed in formalin is a. 3.5 g, 4.7 X 1.4 X 0.7 cm portion of lobulated yellow fibroadipose tissue. There. is a stitch on one aspect of the specimen designating the final anterior margin. The aspect of the specimen with the stitch is inked black. The specimen is. serially sectioned to reveal grossly unremarkable lobulated yellow fibroadipose. tissue. The specimen is entirely submitted in F1-F4. Tissue fixed for at least 6 hours in 10% NBF and no more than 72 hours. MD, PhD. Intraoperative Consult Diagnosis: A1 FS and A2 FS: 'no tumor', by Dr. B1 FS: 'no tumor', by Dr.",train,9 mm;2.1 X 1.9 cm;0.9 X 0.8 cm;20 mm
9095,TCGA-HU-A4H5.FAA7C711-71B3-47A5-95C1-2A8005E6AA76,"Stomach, total gastrectomy: Advanced gastric carcinoma. Muc2(-)/Muc5AC(+)/Muc6(+)/CD10(++)/cERB2(-),GI(I) type). 1. Location : upper third, Center at fundus and posterior wall. 2. Gross type : Borrman type 1 (fungating). 3. Histologic type : papillary adenocarcinoma (pap). 4. Histologic type by Lauren : intestinal. 5. Growth pattern: mixed expanding and infiltrative growth pattern. 6. Size : 6.5x5.0cm. 7. Depth of invasion : invades proper muscle (pT2). 8. Resection margins and anvil ring : free from carcinoma. safety margins: distal 21.0cm, proximal 4.5cm. 9. Lymph node metastasis : no metastasis in 73 regional lymph nodes (pNO). (lesser curvature 0/32, greater curvature 0/37, #14v 0/0, LN 0/4). 10. Lymphatic invasion : not identified. 11. Venous invasion : not identified. 12. Perineural invasion : not identified. 13. Associated finding: peritumoral lymphocytic infiltration, moderate. 14. Other finding: jejunum - no tumor. # Immunohistochemistry : CD10, MUC2, MUC5ac, MUC6, C-erb B2.",train,6.5x5.0cm
9154,TCGA-EM-A4FK.EF94D807-0D05-49D5-B5B3-A9731D861BF8,"Facility: Specimen(s) Received. 1. Thyroid: Right subtotal stitch superior. Diagnosis. Papillary carcinoma, oncocytic variant 2.6 cm right; nonspecific chronic thyroiditis: Thyroid, right hemithyroidectomy. specimen. Comment. This case has been seen in consultation with. and he agrees with the interpretation and diagnosis. Synoptic Data. Procedure: Right hemithyroidectomy. Fresh. Specimen Integrity: Intact. Specimen Size: Right lobe: 5.0 cm. 2.6 cm. 2.0 cm. Isthmus +/- pyramidal lobe: 2.5 cm. 1.6 cm. 0.8 cm. Specimen Weight: 16.9 g. Tumor Focality: Unifocal. DOMINANT TUMOR. Tumor Laterality: Right lobe. Tumor Size: Greatest dimension: 2.6cm. Additional dimension: 2.2 cm. Additional dimension: 1.9 cm. Histologic Type: Papillary carcinoma, oncocytic or oxyphilic variant. Follicular. architecture per TSS, follicular varient = 100%. Other architecture: focal solid and trabecular growth. Oncocytic or oxyphilic cytomorphology. Histologic Grade: Not applicable. Margins: Margins uninvolved by carcinoma. Tumor Capsule: Partially encapsulated. Tumor Capsular Invasion: Not identified. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Not identified. Extrathyroidal Extension: Not identified. TNM Descriptors: Not applicable. Primary Tumor (pT): pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid. Regional Lymph Nodes (pN): pNX: Regional lymph nodes cannot be assigned. Number of regional lymph nodes examined: 0. Number of regional lymph nodes involved: 0. Distant Metastasis (pM): Not applicable. Additional Patholgic Findings: Thyroiditis, focal (nonspecific). Pathologic Staging is based on AJCC/UICC TNM, 7th Edition. Gross Description. 1. The specimen labeled with the patient's name and as ""right subtotal thyroid, stitch superior"", consists of a right. hemithyroidectomy specimen that is oriented with a stitch, superior and weighs 16.9 g. The lobe measures 5.0 cm SI x. 2.6 cm ML x 2.0 cm AP and the isthmus measures 2.5 SI x 1.6 cm ML x 0.8 cm AP. The external surfaces have fibrous. adhesions and are painted with liquid bluing. No parathyroid glands and/or lymph nodes are identified grossly. The right. lobe contains a lower pole well delineated, tan and focally hemorrhagic nodule(s) that measure 2.6 cm SI x 2.2 cm ML x. 1.9 cm AP. The remainder of the thyroid tissue is grossly normal. Sections of nodule and normal tissue are stored. frozen. The remainder of the specimen is submitted as follows: 1A-M lobe, superior to inferior. 1N-P isthmus. Page Fof.",train,2.6cm;2.2 cm;1.9 cm;2.6 cm
9172,TCGA-YL-A9WK.B963A02D-0AE8-494C-A522-376AFABA374A,PROSTATE AND PELVIC/OBTURATOR LYMPH NODES; RADICAL PROSTATECTOMY: TUMOR PROCUREMENT: HISTOLOGIC TYPE. ACINAR ADENOCARCINOMA. HISTOLOGIC GRADE (PRIMARY ATTERN+SECONDARY PATTERN = GLEASON SCORE): 4+5=9. TERTIARY PATTERN NOT PRESENT. PERCENTAGE OF DIFFERENT GLEASON PATTERNS. NOT REPORTED. TUMOR LOCATION. ANTERIOR. RIGHT. LEFT. POSTERIOR. RIGHT. LEFT. EXTRA-PROSTATIO EXTENSION. PRESENT. NON-FOCAL. SITE OF EXTRA-PROSTATIC EXTENSION. POSTERIOR. RIGHT. LEFT. SEMINAL VESICAL INVASION. PRESENT. BOTH. SURGICAL MARGINS. INVOLVED BY INVASIVE CARCINOMA. POSTERIOR. RIGHT. LEFT. NATURE OF POSITIVE MARGINS. NOT REPORTED. EXTENT OF POSITIVE MARGINS. MULTIFOCAL. MILLIMETRIC EXTENT OF POSITIVE MARGINS: NOT REPORTED. GLEASON GRADE OF CARCINOMA PRESENT AT THE POSITIVE MARGINS. NOT REPORTED. LYMPHOVASCULAR INVASION. ABSENT. PERINEURAL INVASION. PRESENT. TUMOR VOLUME. PROPORTION OF PROSTATE INVOLVED BY CARCINOMA: 30%. TREATMENT EFFECT ON CARCINOMA. NOT APPLICABLE. LYMPH NODES. LEFT PELVIC. NUMBER OF NODES INDENTIFIED: 1. NUMBER OF NODES INVOLVED BY METASTASIS: 0. ADDITIONAL PATHOLOGIC FINDINGS. HIGH-GRADE PROSTATIC INTRA-EPITHELIAL NEOPLASIA. BASAL CELL HYPERPLASIA. ATROPHY. PATHOLOGICAL STAGING. pT3b. pNO. pMX.,train,
52,TCGA-BH-A0HA.E6C20D27-63E5-4FFF-96BF-E8BD71296925,"FINAL DIAGNOSIS: PART 1: BREAST, RIGHT, TOTAL MASTECTOMY -. A. B. INVASIVE LARGEST DUCTAL TUMOR (MASS CARCINOMAS #1): NOTTINGHAM (3). GRADE Il (TUBULE FORMATION 3, NUCLEAR PLEOMORPHISM. 2, SECOND LARGEST TUMOR (MASS #2): NO TINGHAM GRADE II (TUBULE FORMATION 3, NUCLEAR. MITOTIC ACTIVITY 1; TOTAL SCORE 6/9). c. PLEOMORPHISM 3, MITOTIC ACTIVITY 1; TOTAL SCORE 7/9). D. SMALLEST TUMOR (MASS #3): NOTTINGHAM GRADE II (TUBULE FORMATION 3, NUCLEAR. PLEOMORPHISM 2, MITOTIC ACTIVITY 1; TOTAL SCORE 6/9). is. INVASIVE TUMORS MEASURE 1.3 CM (SLIDE 1D), 0.8 CM. AND 0.5 CM l. E. DUCTAL CARCINOMA IN-SITU (DCIS), NUCLEAR GRADE 2, SOLID PATTERN. G. F. DCIS CONSTITUTES 10% OF THE TOTAL TUMOR MASS AND IS PRESENT ADMIXED WITH AND AWAY. FROM THE INVASIVE COMPONENT. H. LOBULAR CARCINOMA IN-SITU (LCIS) IS ALSO IDENTIFIED. I. NO LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. J. RESECTION MARGINS ARE NEGATIVE FOR CARCINOMA. K. INVASIVE CARCINOMA IS 0.5 CM FROM THE NEAREST ANTERIOR MARGIN. L. DUCTAL CARCINOMA IN-SITU IS 0.5 CM FROM THE NEAREST ANTERIOR MARGIN. M. NIPPLE IS NEGATIVE FOR TUMOR. N. NON-NEOPLASTIC BREAST TISSUE SHOWS NON-PROLIFERATIVE FIBROCYSTIC CHANGES. O. BIOPSY SITE CHANGES. P. INVASIVE TUMOR CELLS (MASS #1) TESTED POSITIVE FOR ESTROGEN AND PROGESTERONE. RECEPTORS AND NEGATIVE FOR HER-2 AS PER PREVIOUS PATHOLOGY REPORT. PART 2: LYMPH NODE, RIGHT, SENTINEL NODE #1, BIOPSY -. NO METASTATIC MAMMARY CARCINOMA IDENTIFIED IN ONE LYMPH NODE (0/1). PART 3: BREAST, RIGHT, SENTINEL NODE #2, BIOPSY -. NO METASTATIC MAMMARY CARCINOMA IDENTIFIED IN TWO LYMPH NODES (0/2). PART 4: LYMPH NODE, RIGHT, SENTINEL NODE #3, BIOPSY -. NO METASTATIC MAMMARY CARCINOMA IDENTIFIED IN ONE LYMPH NODE (0/1). PART 5: BREAST, LEFT, TOTAL MASTECTOMY -. A. NIPPLE WITH NO EVIDENCE OF PAGET'S DISEASE. B. BENIGN BREAST PARENCHYMA WITH NON-PROLIFERATIVE FIBROCYSTIC CHANGES. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Simple mastectomy. Site: breast, NOS C50-9 3/0/11 her. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 1.3 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR AGGREGATE SIZE: Sum of the sizes of multiple invasive tumors: 2.6 cm. TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: TUMOR TYPE, IN SITU: Solid. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 5 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of in situ disease to closest margin: 5 mm. PAGET'S DISEASE OF NIPPLE: LYMPH NODES POSITIVE: o. LYMPH NODES EXAMINED: 4. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: pT1c. N STAGE, PATHOLOGIC: pNO(i-). M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: zero or 1+.",val,1.3 CM;0.8 CM;0.5 CM;1.3 cm;2.6 cm
81,TCGA-D1-A15W.1C938760-9492-4F4E-87CE-85CE3C15BBCA,"I Surgical Pathology. TISSUE DESCRIPTION: A1 B1 B2 B3 B4 B5 B6 B7 B8 B9 B10 B11 C1 C2 C3. C4 C5 D1 D2. D3 D4 D5 D6 E1 E2 E3 E4 E5. Uterus, right ovary (2.0 X 1.5 X 0.9 cm) with 5.9 cm. segment of. right fallopian tube, and left ovary (1.9 X 1.8 X 0.9 cm). with 7.3. cm segment of left fallopian tube together weighing 95.0. grams,. separately submitted tissue from the pelvic peritoneum. (biopsy, 1.4. x 1.0 X 0.2 cm), right and left pelvic lymph nodes and. left. para-aortic nodes. DIAGNOSIS: Uterus, bilateral ovaries, and fallopian tubes; total. abdominal. hysterectomy and bilateral salpingo-oophorectomy: Invasive FIGO. grade I (of III) endometrial adenocarcinoma, endometrioid. type. forming a mass (8.5 X 2.6 x 1.1 cm) invading 0.7 cm into. the 1.8 cm. myometrial thickness. Tumor locally involves the lower. uterine. segment. The cervix is uninvolved. Ovary, right, oophorectomy: Focus of endometriosis. Ovary, left, oophorectomy : Without diagnostic. abnormality. Fallopian tubes, right and left, salpingectomies : Without. diagnostic abnormality. Soft tissue, pelvic peritoneum, biopsy : Inflamed. fibroconnective. tissue. Lymph nodes, right pelvic, lymphadenectomy: Multiple (11. external. iliac, 4 common iliac, 1 internal iliac and 3 obturator). are. negative for tumor. Lymph nodes, left pelvic, lymphadenectomy: A single left. pelvic. obturator (of 9) is positive for metastatic. adenocarcinoma. Multiple. (1 external iliac, 4 common iliac, 1 internal iliac) are. negative. for tumor. Lymph nodes, left para-aortic, lymphadenectomy: Multiple. (8) left. para-aortic lymph nodes are negative for tumor.",val,
84,TCGA-29-1688.cb2bd608-b9d4-497e-9058-2269dc86b5b3,"CLINICAL HISTORY: Ovarian carcinoma. GROSS EXAMINATION: A. ""Right tube and ovary"". In formalin. Received is an ovoid-shaped, tan. hemorrhagic soft tissue measuring 9.5 x 6.5 x 2.5 cm. in greatest dimensions. There are multiple various-sized cystic structures on the serosa. The. largest measures 1.5 x 1.5 x 1.0 cm. Part of the serosa is smooth and. glistening. Multiple surgical clips are present. There is a small amount. of. attached soft tissue, probably the adnexa. The mucosal surface consists of. multiple various-sized hemorrhagic cystic structures. Some of which are. filled serous fluid and blood clots. Blocks are submitted as follows: Blocks A1, A2 - Representative sections of the ovary. Block A3 - Representative sections of the presumed adnexa. Block A4 - More sections of the ovary. B. ""Left ovary"". In formalin. Received is a pale-white ovoid soft tissue. measuring 5.5 x 3.5 x 2.0 cm. in greatest dimensions. There are multiple. various-sized cystic structures on the serosal surface and the largest one. measures 0.4 x 0.4 x 0.3 cm. Otherwise, the surface is smooth and glistening. On cross-sections, the cysts are filled with serous fluid. Representative. sections are submitted as Blocks B1 and B2. C. ""Peritoneal nodules. Fresh. Received is an aggregate of yellow, firm,. fatty soft tissue measuring 12.5 x 8.5 x 3.0 cm. They consists of multiple. various-sized indurated nodules measuring from 2.5 x 1.6 x 1.2 cm. to 0.4 x. 0.3 x 0.2 cm. Representative sections of the specimen are submitted as. Blocks C1 through C4. D. ""Tumor"". In formalin. Received is a plaque-like, tan, hemorrhagic. nodular structure which weighs 1810 grams and measures 35.0 x 27.0 x 5.5 cm. in greatest dimensions. On the surface, there are numerous small blood clots. and tumor nodules in various sizes, The latter is fused in a conglomerate. plaque structure. Serial sections reveal mostly solid tumor, mixed with. blood clots and rather homogenous in nature. Representative sections are. submitted as Blocks D1 through D7. E. ""Appendix"". In formalin. Vermiform appendix and attached soft tissue. measuring 6.0 x 3.0 x 0.1 cm. The attached soft tissue is yellow,. hemorrhagic and nodular in nature. Cross-sections reveal a pale white. infiltrates consistent with tumor. Representative sections are submitted as. Blocks E1 and E2. F. ""Spleen"". In formalin. Received is a bean-shaped, gray-pink spleen. measuring 12.0 x 6.2 x 3.5 cm. It weighs 110 grams, The capsule is rather. smooth and glistening over the superior surface; however, the ventral surface. is centrally covered with fatty tissues and possibly intermixed with nodule. structures. They are mostly situated in the hilum area. Serial sections. reveal beefy-red surfaces; no infarcts or suspicious tumor infiltrates. Sections are submitted as follows: Block F1 - Representative section of the spleen,. including the nodules. Block F2 - More sections of the spleen, including the nodules and capsule. Block F3 - Additional section of the spleen. G. ""Omentum"". In formalin. Received is an aggregate of yellow, fatty soft. tissue measuring 17.0 x 9.5 x 3.5 cm. in greatest dimensions. The serosal. surfaces are covered by numerous various-sized tumor nodules and some of them. are arranged in a plaque-like fashion. Most of them are less than 0.8 cm. in. greatest dimension. However, serial sections reveal nodules measure up to. 2. x 1.0 x 0.8 cm. Representative sections are submitted as Blocks G1. through G5. DIAGNOSIS: A. ""RIGHT TUBE AND OVARY"": INVASIVE MODERATELY DIFFERENTIATED SEROUS CYSTADENOCARCINOMA WITH VASCULAR. CHANNEL INVASION. NO TUBAL TISSUE DETECTED. B. ""LEFT OVARY"": OVARIAN TISSUE WITH INVASIVE MODERATELY DIFFERENTIATED SEROUS. CYSTADENOCARCINOMA. C. ""PERITONEAL NODULES"": OMENTAL TISSUE WITH MULTIPLE DEPOSITS OF SEROUS CYSTADENOCARCINOMA. D. ""TUMOR"": OMENTAL TISSUE WITH MULTIPLE DEPOSITS OF SEROUS CYSTADENOCARCINOMA. E. ""APPENDIX"": APPENDIX WITH FIBROUS LUMINAL OBLITERATION. MESOAPPENDIX WITH DEPOSITS OF SEROUS CYSTADENOCARCINOMA. F. ""SPLEEN"": SPLEEN (110 GRAMS) WITH MULTIPLE CAPSULAR SURFACE DEPOSITS OF SEROUS. CYSTOADENOCARCINOMA. G. ""OMENTUM"": OMENTAL TISSUE WITH DEPOSITS OF SEROUS CYSTADENOCARCINOMA. ADDENDUM 1: Immunostaining for carcinoembryonic antigen (CEAN) is performed on sections. from Block A1 (""right ovary"") and G1 (""omentum""). The immunostaining is done. using DAKO rabbit anti--human CEA which is ""the purified immunoglobulin. fraction of rabbit antiserum (DAKO product A115) The histological sections of. ovary contains abundant adenocarcinoma for evaluation. The tumor cells stain. focally for carcinoembryonic antigen. The cells that stain positively are. scattered throughout the tumor, and I estimate that the positively staining. cells comprise only 1 to 2% of the population. The positively staining cells. exhibit mildly intense staining. There are focal areas within the tumor where. there is a greater percentage of cells which stain positively (approximately. 1/3 of the tumor cells are positive), but this is compensated for by other. areas in which none of the tumor cells stain positively. Overall, there is. insignificant expression of CEA by the tumor. The histological sections from the omentum also contain abundant tumor. There. is no significant staining of the tumor cells for carcinoembryonic antigen. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es).",val,
209,TCGA-56-A4ZJ.94A1F143-A043-4277-8DD7-E248DF53C1C0,"Pre-Op Diagnosis. Right lower lobe squamous cell cancer. Post-Op Diagnosis. Same as above. Clinical History. Nothing indicated. Gross Description: Four parts. Received in formalin labeled "". 1 - level 9 lymph. node right lung"" is a 1.1 x 0.8 x 0.3 cm irregular black soft tissue. consistent with probable lymph node, which is bisected and submitted. in its entirety in one cassette. Received in formalin labeled. 2 - level 10 lymph. node right lung"" are three irregular granular black soft tissues. consistent with probable lymph node ranging from 0.5 x 0.4 x 0.2 cm. to 1.1 x 0.7 x 0.3 cm, which are submitted in toto in one cassette. Received labeled. 3 - right lower lung lobe"" is a. 185 gram, 19.4 x 10.5 x 3.2 cm lower lung lobe with an attached 0.8. cm segment of bronchus. The pleura is smooth to wrinkled and. tan-pink to gray-purple with black anthracotic areas. There is a 3.1. cm linear staple line adjacent to the hilum. No additional. parenchymal staple lines are identified. There is a 1.4 x 1.1 cm. slightly ill-defined umbilicated area of pleura 2.2 cm from the. hilum. The cut surface of this area consists of a 1.8 x 1.5 x 1.2 cm. well circumscribed tan nodule, 3.4 cm from the bronchial margin and. 3.8 cm from the staple line. The remainder of the cut surface. consists of spongy tan-red parenchyma. There are two tan-white. nodules measuring 0.1 cm and 0.2 cm in greatest dimension which abut. the pleura near the periphery of the specimen. The nodules are 3.6. cm from each other. No additional parenchymal lesions are. identified. No obvious intraparenchymal or hilar lymph nodes are. identified. The specimen is inked, serially sectioned and. representative sections are submitted as labeled: A - bronchial and. vascular margins (en face) ; B - pleural margin (perpendicular) i C-F. - lesion, entirely submitted; G - larger nodule, entirely submitted;. H - smaller nodule, in toto. Also received in the same container is. a blue, yellow and green cassette labeled. genomic. research study. Received in formalin labeled. 4 - level 4 lymph. node right lung"" is a 2.8 x 1.7 x 0.5 cm irregular fibroadipose. tissue bearing three irregular black firm tissues consistent with. probable lymph node ranging from 1.1 x 0.5 x 0.3 cm to 1.2 x 0.8 x. 0.5 cm. The specimen is sectioned and representative sections are. submitted, to include the lymph nodes in their entirety, as labeled: A-C - one lymph node, bisected in each. Microscopic Description: See diagnosis. Final Diagnosis. Lymph node, right lung, level 9, excision: Reactive hyperplasia, negative for malignancy, one node. Lymph node, right lung, level 10, excision: Reactive hyperplasia, negative for malignancy, three nodes. Lung, right lower lobe, lobectomy: Tumor characteristics: Specimen integrity: Intact, margins can be evaluated. Specimen laterality: Right side. Histologic type: Squamous cell carcinoma, non-keratinizing. Histologic grade: 2 (moderately differentiated). Tumor site: Right lower lobe. Tumor focality: Unifocal. Tumor size: 1.8 x 1.5 x 1.2 cm. Visceral pleural invasion: Not identified. Lymphovascular space invasion: Not identified. Tumor extension: Not identified. Treatment effect: Not identified (no specific history provided). Surgical margin status: Tumor distance from bronchial margin: 3.4 cm. Tumor distance from stapled margin: 3.8 cm. Tumor distance from pleural surface: 0.1 cm. Lymph node status: Total number of lymph nodes received (includes all four parts of. this case) : 10. Total number of lymph nodes containing metastatic carcinoma: 0. Other significant findings: Two small subpleural fibrous nodules are present consistent with. areas of scarring. pTN stage: pTla, NO PAS 9 SPC-NP. Comments. The history of ""back lower lobe squamous cell carcinoma"" is noted. There is however no prior material identified in our files for. review and comparison. The two small subpleural nodules identified grossly, separate from. the malignancy, are both areas of fibrosis containing some. histiocytes and reactive alveolar lining cells, possibly. representing areas of resold pneumonia. At the request of the undersigned pathologist, these slides have. been additionally reviewed by Dr. who concurs with the. diagnosis.",val,
500,TCGA-VS-A959.10A6CADD-C99B-4A34-9D5D-02AD37C1AB80,"PRIMARY SITE: Cervix. ""Uterine cervix biopsy"": Invasive poorly differentiated squamous cell carcinoma.",val,
655,TCGA-LD-A66U.5FF5CE63-2A8F-4117-A384-A57EED6473D8,"Amended. DATE OBTAINED: DATE RECEIVED: SUBMITTING MD: MD. DIAGNOSIS. 1. SUPERFICIAL RIGHT AXILLARY BREAST TISSUE, EXCISION: SMALL FOCUS OF INVASIVE LOBULAR. CARCINOMA (0.6MM) PRESENT AT THE EDGE OF ONE FRAGMENT, WITH SURROUNDING ADIPOSE. TISSUE; RARE BENIGN BREAST ACINI; SEE COMMENT. 2. RIGHT AXILLARY SENTINEL LYMPH NODE #1: ONE LYMPH NODE POSITIVE FOR MICROMETASTASIS. (0.6 MM); SEE COMMENT. 3. RIGHT AXILLARY SENTINEL LYMPH NODE #2: ONE LYMPH NODE POSITIVE FOR MULTIPLE FOCI OF. MICROMETASTASIS (LARGEST 1.5MM), CONFIRMED BY CYTOKERATIN STAIN; NO EXTRANODAL. EXTENSION. 4. RIGHT BREAST, MASTECTOMY: INVASIVE LOBULAR CARCINOMA. SIZE (INVASIVE): 3.5 cm. LATERALITY: Right. TUMOR FOCALITY: Unifocal. LESIONAL SITE: 10:00. HISTOLOGIC TYPE: Invasive lobular carcinoma, classical and pleomorphic types. NUCLEAR GRADE: II and III of III. HISTOLOGIC GRADE: N/A. (invasive lobular carcinoma). IN-SITU COMPONENT: LCIS. (Classical and focal pleomorphic types; NG II, focal III). LYMPH NODE SAMPLING: Positive (2/15), largest 3mm; no extranodal involvement; see specimens #2, #3 & #6. AJCC CATEGORIES: Stage IIB. pTNM: pT2. pN1mi. cTNM: cT2. cN1. cM0. INTEGRITY/ORIENTATION: Intact specimen with designated margins. MARGINS (invasive lobular): Focal positive superior/anterior margin (see final margin in #1);. Other margins negative (>3mm). LYMPHOVASCULAR INVASION: Present. MICROCALCIFICATIONS: Not identified. NIPPLE/SKIN: Negative skin and nipple. SKELETAL MUSCLE: Present, focal, negative for tumor. OTHER: Focal sclerosing adenosis, columnar cell changes and usual mild hyperplasia. 5. LEFT BREAST, PROPHYLACTIC MASTECTOMY: BENIGN BREAST WITH SMALL PAPILLOMATOSIS,. SCLEROSING ADENOSIS AND MILD USUAL DUCTAL HYPERPLASIA; NO ATYPIA; NEGATIVE SKIN AND. NIPPLE. 6. RIGHT AXILLARY CONTENTS, DISSECTION: THIRTEEN NEGATIVE LYMPH NODES (0/13). COMMENT. #1: There is one small focus of invasive carcinoma at the edge of a fragment (0.6mm, confirmed by negative calponin and p63. immunostain), with severe cautery artefact, which was not seen on frozen section. The tumor is surrounded by fatty tissue, and. thus would be regarded as negative final margin for specimen #4. #2: There is single focus of micrometastasis in the SLN #1. This focus is only present in slide 2B CTD2, and not on other levels,. frozen smears and cytokeratin immunostained slides. 88307x5, 88305, 88331, 88332, 88333x2, 88342x3. Clinical Diagnosis and History: Right breast cancer 10 o'clock. cT2,cNI,cMo, clinical stage 2B. Tissue(s) Submitted: 1: SUPERFICIAL RIGHT AXILLARY BREAST TISSUE. 2: RIGHT AXILLARY SENTINEL LYMPH NODE #1. 3: RIGHT AXILLARY SENTINEL LYMPH NODE #2. 4: RIGHT BREAST LONG STITCH LATERAL SHORT STITCH SUPERIOR. 5: LEFT BREAST LONG STITCH LATERAL SHORT STITCH SUPERIOR. 6: RIGHT AXILLARY CONTENTS. Gross Description: Specimen #1 is received fresh for intraoperative consultation, labeled with the patient's name and superficial right axillary breast. tissue, and consists of a 2.7 x 1.7 x 0.6 cm tan-yellow lobulated adipose tissue which is entirely submitted for frozen section. analysis labeled 1AFS-1BFS. Specimen #2 is received fresh for intraoperative consultation, labeled with the patient's name and right axillary sentinal lymph node. #1, and consists of a single tan-pink, nodular tissue consistent with lymph node measuring 1.3 x 0.7 x 0.5 cm. The specimen is. serially sectioned and two intraoperative smears are performed. The specimen is entirely submitted labeled 2A-2B. Specimen #3 is received fresh on a blue surgical towel for intraoperative consultation, labeled with the patient's name and right. axillary sentinal lymph node #2, and consists of a single tan-pink, nodular tissue consistent with lymph node measuring 1.0 x 0,5 x. 0.5 cm. The specimen is serially sectioned and an intraoperative smear is prepared. The specimen is entirely submitted labeled. 3A-3B. Specimen #4 is received fresh for formalin, labeled with the patient's name and right breast, long stitch lateral, short stitch superior,. and consists of a 520 gram, 18 (superior to inferior) by 17 (medial to lateral) by 4 (anterior to posterior) cm right mastectomy. specimen. A short suture designating superior, and a long suture designating lateral are present. A 14 x 4.5 x 0.3 cm white-tan,. unremarkable ellipse of skin is identified containing a 1.3 x 1.1 x 0.3 cm unremarkable, everted nipple. The areola measures 3.5 x. 2.5 cm. The specimen is differentially inked as follows: superior/anterior - blue, inferior/anterior - green, posterior/deep - black. and. serially. sectioned from lateral to medial to reveal a 3.5 x 2.5 x 1.1 cm firm, tan-pink, irregular mass at the 10 o'clock position. This mass is focally 0.2 cm from the posterior, 0.2 cm from the superior/anterior, and greater than 4 cm from the inferior margins. The mass is present in multiple sections and is seen to extend more centrally. No other lesions are grossly identified. The. surrounding breast parenchyma consists of white, fibrous tissue (60%) and tan lobular adipose tissue (40%). Time in formalin: 14:20. Representative sections are submitted as follows: 4A-4B: Mass closest to superior/anterior and deep margins, contiguous section. 4C: Mass to deep margin. 4D: Mass to superior/anterior margin. 4E: Mass to deep margin. 4F-4G: Tumor without margin. 4H: Mass to deep. 41: Tumor without margin. 4J: Inferior margin closest to tumor. 4K-4L: Fibrous tissue immediately medial to mass. 4M: Fibrous tissue in central breast. 4N: Fibrous tissue in medial most breast. 40: Nipple and skin section closest to mass. 4P: Outer upper quadrant. 4Q: Outer lower quadrant. 4R: Inner upper quadrant. 4S: Inner lower quadrant. Specimen #5 is received fresh for formalin, labeled with the patient's name and left breast, long stitch lateral, short stitch superior,. and consists of a 550-gram, 20 (superior to inferior) by 15.9 (medial to lateral) by 5.4 (anterior to posterior) product of left. mastectomy. An unremarkable, tan ellipse of skin is identified measuring 13.3 x 4.2 x 0.2 cm. The everted nipple measures 1 x. 0.9 cm and resides within a 4 x 2.9 cm areola. The specimen is differentially inked as follows: superior/anterior - blue,. inferior/anterior - green, posterior/deep - black and serially sectioned from medial to lateral to reveal no distinct mass but areas. consistent. with. fibrocystic changes containing blue domed cysts averaging 0.3 cm in greatest dimension. The surrounding breast. parenchyma consists of tan-yellow lobulated adipose tissue (60%) and white, fibrous areas (40%). No other lesions are grossly. identified. Time in formalin: Representative sections are submitted as follows: 5A: Nipple. 5B: Outer upper quadrant. 5C: Inner upper quadrant. 5D: Inner lower quadrant. 5E: Outer lower quadrant. 5F-5L: Fibrous areas. 5M: Superior margin to fibrous area. 5N: Deep margin to fibrous area. 50: Inferior margin to fibrous area. Specimen #6 is received fresh on a blue surgical towel, labeled with the patient's name and right axillary contents, and consists of. multiple tan-pink, nodular tissues consistent with lymph nodes ranging from 0.5 to 2 cm in greatest dimension. All grossly. identifiable lymph nodes are submitted as follows: 6A-B: One lymph node, bisected, each cassette. 6C-6D: One lymph node, bisected. 6E-F: One lymph node, bisected, each cassette. 6G-H: Intact lymph nodes. Intraoperative Consult Diagnosis. 1A-1B/FSDX: BENIGN BREAST TISSUE AND FAT; NO MALIGNANCY. 2A/GDX/SMDX: NEGATIVE LYMPH NODE (0/1). 3A/GDX/SMDX: POSITIVE LYMPH NODE (1/1). Amendments. Amended: Reason: Further review of case. SLN #2 should be counted as multiple micromet. Previous Signout Date:",val,
720,TCGA-G3-A25W.F92FE7A0-15D4-45FD-BB39-E3022E30EB77,"Laboratory Services. PHN: ACB: Telephone: Encounter: Received Date/Time: Specimen Description. A. Gallbladder. B. Liver. C. Tumor thrombus - left hepatic vein. Clinical Information. Hepatocellular carcinoma. Diagnosis. A. Gallbladder, cholecystectomy: -Normal gallbladder with no pathologic abnormality. B. Liver, partial hepatectomy: -Moderately differentiated hepatocellular carcinoma. -Solitary, 11.0 cm in greatest dimension, 0.8 cm from the resection. margin. -Background liver negative for cirrhosis or significant steatosis. C. Tumor thrombus, left hepatic vein: PHN: ACB: Surc. Received Date/Time: - -Hepatocellular carcinoma with necrosis. Verified: Synoptic Report. B: Liver, Resection, Microscopic. HISTOLOGIC TYPE: Hepatocellular carcinoma. HISTOLOGIC GRADE: GII: Moderately differentiated. PRIMARY TUMOR (pT): pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm. REGIONAL LYMPH NODES (pN). DISTANT METASTASIS (pM). MARGINS: Parenchymal margin uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 0.8 mm. Specify margin: Parenchymal resection margin. Bile duct margin cannot be assessed. VENOUS (LARGE VESSEL) INVASION (V): Present. ADDITIONAL PATHOLOGIC FINDINGS: None identified. Gross Description. Received are specimens A to C. All requisitions and specimen containers are labelled with the patient's name. The cassettes and AP identifiers are labelled with the Surgical Number. PHN: ACB: Surgicali Pathology Report. Received Date/Time: A. The specimen Is labelled as ""gallbladder"" and consists of a cholecystectomy specimen, measuring 6.0 x 2.5 x 2.5 cm. The gallbladder contains green bile and no stone. The gallbladder surface attached to the liver was sampled and. submitted in A1. Representative sections of the rest of the gallbladder wall are submitted in A2. B,. specimen is labelled as ""Liver"" and consists of a partial hepatectomy specimen weighing 723 grams that has been. previously. inked with silver nitrate. The resection margin has been painted black. The specimen measures approximately. 18.0 x 13.0 x 8.0 cm. Serial sectioning through the specimen shows that 95% of the specimen is occupied by a relatively. circumscribed, soft, tan mass lesion. The mass lesion measures 11.0 cm in greatest dimension. The cut surface is. hemorrhagic with possible necrosis. Grossly, the mass lesion is approximately 0.8 cm to the liver resection margin. Sections are submitted as follows: B1. Representative section of tumor with closest liver resection margin, which is painted. black. B2-B6. Multiple representative sections of the mass lesion. B7,88. Representative sections of the hemorrhagic and possible necrotic area. B9,810. Representative sections of the uninvolved background liver parenchyma. C. The specimen consists of one fragment of white solid mass lesion. It is submitted in toto in cassette C. Microscopic Description. The main tumor consists of nests and cords of malignant hepatic cells with enlarged nuclei and prominent nucleoli. Globular eosinophilic inclusions are seen in many hepatocytes. There are foci of hemorrhage and necrosis present.",val,
835,TCGA-L5-A8NV.430218E3-EEB1-47CA-B907-4AA14D8A13EC,"PREVIOUS DIAGNOSIS INQUIRY. 2. REPORT DATE. PATIENT NBR: SEX: M. ADM DATE: BIRTHDATE: OPER DATE: REQ DOC: PROCEDURE: rear-old male with long history of reflux. Recent onset dysphagia/weight. loss. Evaluation indicates adenocarcinoma. No chemo or x-ray therapy. PROCEDURE: 1. ""Esophagus. "" A 13.0 x 7.0 x 2.5 cm specimen comprised of 7 cm of distal. esophagus and 6 cm of proximal stomach. Received opened longitudinally. At the. GE junction there is a somewhat nodular thickening of the mucosa, 1.5 x 1.5. cm. Maximum depth of lesion 1.3 cm. Remainder of the GE junction shows slight. irregularity and possible ulceration. Distal and proximal staple lines. removed. Deep inked black. 1A-B. Distal stomach resection margin. 1C. Proximal uninvolved esophagus, proximal end inked black. 1D-G. Sections through major portion of Lesion. 1H-J. Lymph node dissection. 2. ""Cervical esophageal margin."" A 3.2 x 2.0 x 2.0 cm length of esophagus. closed at one end with staple line. 2A. Stapled end. 28. Non-stapled end. PROCEDURE: ESOPHAGEAL, CARDIAC AND GASTROESOPHAGEAL JUNCTION CARCINOMA: Type of carcinoma: Adenocarcinoma. If adenocarcinoma, is it arising in: GE junction. Depth of invasion: Omental surface. Number of positive lymph nodes, the total number sampled is irrelevant: 0. Extranodal metastasis: Unknown. Pattern of invasion: Infiltrative. Esophageal and gastric resection margins involved: No. Deep resection margin involved: Yes. PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 3. PATIENT NBR: SEX: M. BIRTHDATE: ADM DATE: OPER DATE: REQ DOC: TNM classification: T2NOMx. PROCEDURE: 1. Esophagus, resection: Moderately to poorly differentiated adenocarcinoma. arising from the gastroesophageal junction (1.5 cm). Tumor penetrates. muscularis propria and reaches the omentum surface. Distal gastric margin. negative for neoplasm. Four lymph nodes negative for neoplasm. See template. 2. Cervical esophageal margin, resection: Negative for neoplasm. 1,. he signing staff pathologist, have personally examined and. interpreted the slides from this case. Code: END OF PREVIOUS DIAGNOSIS INQUIRY.",val,
851,TCGA-DJ-A2PX.763C06CF-4DC5-4A5A-B698-224A9E5693A2,"eck. Neck. Clinical Diagnosis & History: FNA left lobe. Specimens Submitted: 1: Total thyroid. DIAGNOSIS: 1. Total thyroid: Tumor Type: Papillary carcinoma, follicular variant. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Left lobe. Tumor Size: Greatest diameter is 1.2 cm. Tumor Encapsulation: Completely surrounded. Capsular Invasion: Focal invasion. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Tumor Multicentricity: Not identified. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. Exhibits chronic lymphocytic thyrolditis. Parathyroid Glands: Not identified. Lymph Nodes: Four benign lymph nodes (0/4). LATTEST THAT THE ABOVE DIAGNOSIS is BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT THAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: b. 1. The specimen is received fresh labeled ""total thyroid"" and consists of a thyrold weighing 18.0 g. The right lobe measures 5.5. x. 3.0 x 0.9 cm, the left lobe measures 4 x 2x1 cm and the isthmus measures 2 x 1.5 x 0.6 cm. The external surface is covered by a. thin fibrous capsule. The posterior surface of the specimen is inked black, and the anterior is inked blue. Sectioning of the left. lobe reveals a 1.2 CM light brown nodule with central cystic degeneration, located at the upper pole of the left lobe and abutting the. thyroid capsule. Sections through the right lobe reveal red tan and beefy thyrold parenchyma with a vague nodularity (gelatinous. fleshy nodules). The isthmus is red tan and beefy. Representative sections of the specimen (left lobe nodule) are submitted for. TPS. The remaining tissue is serially sectioned and representatively submitted. Summary of sections: N - nodule, entirely submitted. LL left lobe. RL right lobe. IS isthmus. Summary of Sections: Part 1: Total thyroid. Block. Sect. Site. PCs. 1. IS. 1. 1. LL. 1. 2. N. 2. 2. RL. 2.",val,
1229,TCGA-A5-A2K3.D38D2FD4-78EF-4F49-976E-529055A6D9A9,"WUID:D38D2FD4-78EF-4F49-976E-529855A6D9A9. Copies To: DIAGNOSIS: A. RIGHT PELVIC LYMPH NODES, EXCISION: No tumor identified in two lymph nodes (0/2). B. LEFT COMMON ILIAC AND PRECAVAL LYMPH NODE, EXCISION: No tumor identified in seven lymph nodes (0/7). C. LEFT PELVIC LYMPH NODE, EXCISION: No tumor identified in seven lymph nodes (0/7). D. LEFT COMMON ILIAC LYMPH NODE, EXCISION: No tumor identified in one lymph node (0/1). E. CERVIX, UTERUS, TUBES AND OVARIES, TOTAL ABDOMINAL HYSTERECTOMY. WITH BILATERAL SALPINGO-OOPHORECTOMY: Endometrial adenocarcinoma, high-grade, see note. Grade III of III. Tumor size: Microscopic foci of residual endometrial adenocarcinoma. No myometrial invasion is identified. Extensive lymphovascular space invasion is identified. All inked surgical margins are free of tumor. Parametrium is free of tumor. Pathologic stage: pT1a NO Mx FIGO IA. Chronic cervicitis. - Adenomyosis. Leiomyomas (5,0.3 to 1.7 cm with foci of hyalinization). Bilateral ovaries and fallopian tube without malignancy. See note. NOTE: The adenocarcinoma is higb-grade and does not fit the typical histologic features of an. endometrioid adenocarcinoma or a serous carcinoma. However given the high nuclear grade and. extensive lymphovascular space invasion a component of high-grade serous adenocarcinoma is. favored. Intradepartmental consultation obtained. HISTORY: Uterine cancer. MICROSCOPIC: Patient Case(s): Page of }. NOTIFIEDOR RESULTS. NURSE: part. Sce diagnosis. GROSS: A. RIGHT PELVIC LYMPH NODE. Labeled with the patient's name, labeled ""right pelvic lymph node"", and received in formalin is a 2.2 x 2.0 x 0.7 cm. aggregate of soft yellow adipose tissue. One lymph node is identified, measuring 0.4 x 0.2 x 0.2 cm. Entirely. submitted. A1. Multiple. B. LEFT COMMON ILIAC AND PRECAVAL LYMPH NODES. Labeled with the patient's name, labeled ""left common iliac and precaval lymph nodes"", and received in formalin is. a 3.1 x 2.6 x 0.5 cm aggregate of soft yellow adipose tissue. Two definitive lymph nodes are identified, measuring. 1.1 x 0.5 x 0.4 cm and 0.5 x 0.4 x 0.3 cm. Entirely submitted. B1. Two lymph nodes - 2. B2. Additional adipose tissue - multiple. C. LEFT PELVIC LYMPH NODE. Labeled with the patient's name, labeled ""left pelvic lymph node"", and received in formalin is a 3.0 x 1.5 x 0.6 cm. aggregate of soft yellow adipose tissue. Three lymph nodes are identified, ranging from 0.5 to 1.1 cm. Entirely. submitted. CI. Three lymph nodes - 3. C2. Additional adipose tissue - multiple. D. LEFT COMMON ILIAC LYMPH NODE. Labeled with the patient's name, labeled ""left common iliac lymph node"", and received in formalin is a 2.5 x 1.1 x. 0,4 cm aggregate of soft yellow adipose tissue. One lymph node is identified, measuring 0.5 x 0.4 x 0.2 cm. The. lymph node and adipose tissue are entirely submitted. D1. Multiple. E. CERVIX UTERUS TUBES AND OVARIES. Labeled with the patient's name, labeled ""cervix uterus tubes and ovaries"", and received fresh in the Operating. Room for intraoperative consultation and subsequently fixed in formalin is a 75 gram specimen consisting of a. previous incised uterus with attached bilateral fallopian tubes and ovaries. The uterus measures 9.7 cm from fundus. to ectocervical margin, 4.8 cm from comu to comu and a maximum of 3.8 cm from anterior to posterior. The. ectocervix measures 3.5 cm and has a diameter of 2.8 cm. The external os measures 0.7 cm. The left ovary. measures 1.8 x 1.1 x 0.6 cm. The left, fimbriated fallopian tube is 4.0 cm long, 0.5 cm in diameter and has a patent. lumen up to 0.1 cm in diameter. The right ovary measures 2.5 x 0.8 x 0.6 cm. The right, fimbriated fallopian tube. is 4.5 cm long has a diameter of 0.5 cm and a patent lumen up to 0.1 cm in diameter. The endometrial cavity. measures 3.9 cm in length and a maximum of 2.5 cm in width. The myometrium has a thickness of 1.8 cm. The endometrial cavity shows to focal areas of thickening, one on the anterior surface measuring 0.4 x 0.3 x 0.1 cm. and one on the posterior surface measuring 0.3 x 0.2 x 0.1 cm. Sectioning of these lesions reveals them to be. confined to the endometrial cavity with no obvious invasion. Also noted are approximately 5.0 leiomyomata. located intramurally, submucosally, and subserosally. Sectioning of all nodules reveais a firm white whorled. appearance with no areas of hemorrhage or necrosis. They range in size from 0.3 to 1.7 cm in greatest dimension. The exocervix, the external os and endocervical canal are grossly unremarkable. The uninvolved portion of. endometrial cavity is covered by tan-pink hemorrhagic mucosal surface without additional gross lesions. The serosa. shows no gross abnormalities. The bilateral ovaries and fallopian tube are grossly unremarkable. Ink key: Anterior cervix - blue. Posterior cervix - black. Slide key: E1. Left ovary - 2. E2. Left fallopian tube - 3. E3. Right ovary and fallopian tube - 4. E4. Anterior cervix - I. E5. Posterior cervix - 1. E6. Anterior lower uterine segment - 1. E7. Anterior uterine fundus - \. E8, E9. Anterior uterine corpus with polypoid lesion - 1 each. E10. Posterior lower uterine segment - !. E11. Posterior uterine fundus - 1. E12-E14. Posterior uterine corpus with polypoid lesion - I each. E15. Leiomyomas - 2. Gross dictated by. , M.D. OPERATIVE CALL. OPERATIVE CONSULT (GROSS): E. CERVIX, UTERUS, TUBES AND OVARIES, GROSS ONLY: Focal endometrial thickening with some myometrial invasion (demarcation between endometrium and. myometrium is inapparent). Fibroids and right hydrosalpinx. Cervix and bilateral ovaries show no apparent focal lesions. Tissue procured for research. M.D.). If this report includes immunohistochemical test results. please note the following: Numerous immunohistochemical lests were develoned and their performance characteristics determined. Those immunohistochemical tests have not been cleared or approved by the. U.S. Food and Drug Administration (FDA), and FDA approval is not required. I have personally examined the specimen. interpreted the results. reviewed the report and signed it electronically.",val,
1246,TCGA-ED-A627.104D5D1C-E6E3-4806-9E6C-4C949865F713,"Gross Description: Microscopic Description: Diagnosis Details: Comments: Formatted Path Reports: LIVER TISSUE CHECKLIST. Specimen type: Hepatectomy. Tumor size: 7.5 X 7.5 X 7.5 cm. Focality: Not specified. Histologic type: Hepatocellular carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: CD10+, Hepar+, AFP+. Comments: None.",val,
1305,TCGA-D1-A2G5.741AB1D9-493E-4659-BC2E-BF77A7E1CC14,"REVISED REPORT (Revised information underlined) ICD-0-3 -. TISSUE DESCRIPTION: B1 B2 B3 B4 B5 B6 B7 C1 C23C4C5C67C8 C9. C10 C11 D1. D2 D3 D4 D5 D6 D7 D8 D9 D10 D11 D12 D13 E1 E2 E3 F1 G1 H1. Il. Uterus, right ovary (2.0 X 1.9 X 1.3 cm) with 8.8 cm. segment of. right fallopian tube, and left ovary (3.2 X 2.1 X 1.3 cm). with 8. 5. cm segment of left fallopian tube together weighing 200.0. grams. previously submitted tissue from the abdomen (skin and. subcutaneous. tissue without umbilicus, 2305.0 grams) i right and left. pelvic lymph. nodes; right and left para-aortic lymph nodes above and. below the. inferior mesenteric artery; right gonadal vessels (10.2 cm. in. length). DIAGNOSIS: Uterus, hysterectomy : FIGO grade III (of III) endometrial. adenocarcinoma, endometrioid type, forming an 8.4 X 3.5 x. 2.4 cm. polypoid mass filling the endometrial cavity. The tumor. infiltrates. 0.4 cm into the myometrium (total myometrial thickness,. 2.0 cm). Angiolymphatic invasion is not identified. Multiple (2). intramural. leiomyomata (2.3 cm and 1.2 cm in greatest dimension) are. identified. The cervix is uninvolved by tumor. Ovary and fallopian tube, right and left, salpingo-. oophorectomy: Without diagnostic abnormality. Lymph nodes, right pelvic, excision: A. single (1 of 5). right. external iliac lymph node is positive for a microscopic. focus of. metastatic adenocarcinoma. Multiple right pelvic lymph. nodes (2 internal iliac, 3 common iliac, 9 obturator) are. negative. for tumor. Lymph nodes, left pelvic, excision: Multiple left pelvic. lymph. nodes (4 external iliac, 2 internal iliac, 5 common iliac,. 7. obturator) are negative for tumor. Lymph nodes, right and left para-aortic, lymphadenectomy : Multiple. para-aortic lymph nodes above the inferior mesenteric. artery (5. right, 5 left) are negative for tumor. Multiple para-. aortic lymph. nodes (3 additional right, 2 right below the inferior. mesenteric. artery) are negative for tumor. Gonadal vessel, right, excision: The right gonadal vessel. is. negative for tumor. Skin and subcutaneous tissue, abdomen, excision: Skin and. subcutaneous tissue without umbilicus (2305.0 grams). identified. grossly. AMENDMENTS: (Previous Signout Date: Revision Description: On deeper permanent sections,. a. single (1 of. 5) right external iliac lymph node shows a microscopic. focus of. metastatic adenocarcinoma. Original Diagnosis. Uterus, hysterectomy : FIGO grade III (of III) endometrial. adenocarcinoma, endometrioid type, forming an 8.4 X 3.5 x. 2.4 cm. polypoid mass filling the endometrial cavity. The tumor. infiltrates. 0.4 cm into the myometrium (total myometrial thickness,. 2.0 cm). Angiolymphatic invasion is not identified. Multiple (2). intramural. leiomyomata (2.3 cm and 1.2 cm in greatest dimension) are. identified. The cervix is uninvolved by tumor. Ovary and fallopian tube, right and left, salpingo-. oophorectomy. Without diagnostic abnormality. Lymph nodes, right pelvic, excision: Multiple right. pelvic lymph. nodes (5 external iliac, 2 internal iliac, 3 common iliac,. 9. obturator) are negative for tumor. Lymph nodes, left pelvic, excision: Multiple left pelvic. lymph. nodes (4 external iliac, 2 internal iliac, 5 common iliac,. 7. obturator) are negative for tumor. Lymph nodes, right and left para-aortic, lymphadenectomy: Multiple. para-aortic lymph nodes above the inferior mesenteric. artery (5. right, 5 left) are negative for tumor. Multiple para-. aortic lymph. nodes (3 additional right, 2 right below the inferior. mesenteric. artery) are negative for tumor. Gonadal vessel, right, excision: The right gonadal vessel. is. negative for tumor. Skin and subcutaneous tissue, abdomen, excision: Skin and. subcutaneous tissue without umbilicus (2305.0 grams). identified. grossly.",val,
1325,TCGA-EA-A3QD.C5F8BF41-F7A7-4870-890E-861D2DE51DBE,"Laterality: Path Report:CERVIX TISSUE CHECKLIST. Specimen type: Hysterectomy, bilateral salpingo-oophorectomy. Tumor site: Cervix. Tumor size: 2.6x2.5x0.98 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Poorly differentiated. Tumor extent: Lesion less than 4.0 cm. Lymph nodes: 1/6 positive for metastasis (Pelvic 1/6). Lymphatic invasion: Present. Venous invasion: Present. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",val,
1428,TCGA-DX-A8BO.CD89E7C9-AADE-4A80-876F-225A392B47FE,"Clinical Diagnosis & History: Right leg mass. Specimens Submitted: 1: Right leg mass sarcoma ???. 2: Lateral fascial margin right leg. DIAGNOSIS: 1. Right leg mass sarcoma; excision: - High grade spindle and pleomorphic sarcoma consistent with malignant. fibrous histiocytoma/ undifferentiated high grade pleomorphic sarcoma. - Tumor measures 9 x 6 x 4 cm. - Tumor involves dermis, subcutis and extends to fascia. Necrosis is present about 15%. - Tumor extends focally to the deep margin of resection and is located. 0.1 cm from the lateral resection margin (Please see part 2). Tumor does not. involve attached periosteum and portion of bone, All other margins are. negative. Note: Immunostains show that the tumor cells are negative for SMA, myogenin,. desmin, S-100 and HMB45. 2. Lateral fascial margin right leg: - Benign fibro-adipose tissue. Some of the immunohistochemistry and ISH tests were developed and their. performance characteristics were determined by the. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is. not necessary. These tests are used for clinical purposes. They should not. be regarded as investigational or for research. This laboratory is certified. under the Clinical Laboratory Improvement Amendments of 1988 (CLIA - 88) as. qualified to perform high complexity clinical laboratory testing. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), , AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1) The specimen is labeled ""right leg mass ?? sarcoma"", long stitch lateral,. short stitch superior. Received fresh is an ellipse of skin measuring 11 x 7. x 3.5 cm. The skin surface is tan to white to alightly hemorrhagic. Two. stitches are identified, designated by the surgeon as above. The specimen is. yellow inked Black-deep, blue-lateral, homogeneous tan/yellow, red-superior,. as follows: green-medial,. -inferior. Serial sectioning reveals a. partially cystic and hemorrhagic mass measuring 9 x 6 x 4 cm. It appears to. be within 1 mm from the deep and lateral margin. TPS is submitted and photos. are taken. Representative sections are submitted as follows: Summary of sections: IM--inferior margin. TD- tumor to deep margin. TL-tumor to lateral margin. TM-tumor to medial margin. TS- tumor in relation to skin. TC- tumor in cystic and hemorrhagic areas. TF-tumor in relation to fat. T- tumor. NS- normal skin. SM- superior margin. 2). The specimen is received in formalin labeled Lateral fascial margin. right leg."" It consists of an elongated piece of brown-tan soft tissue. measuring 4.0 x 0.5 x 0.5 cm. The specimen is sectioned and submitted. entirely. Summary of sections: U - undesignated. Summary of Sections: Part 1: Right leg mass sarcoma ???. Block. Sect. Site. PCs. 1. im. 1. 1. ns. 1. 1. sm. 1. 4. 4. 1. tc. 1. 2. td. 2. 1. tf. 1. 2. tl. 2. 2. tm. 2. 2. ts. 2. Part 2: Lateral fascial margin right leg. Block. Sect. Site. PCs. 1. u. 1.",val,
1471,TCGA-FY-A3R6.912F801B-814F-4FA4-9216-F62E875AAA7F,"Report for. TEST: Surgical Pathology. Collected Date & Time: Result Name. Reference Range. SURGICAL P. Location: Discharge Location. (Age : Service: Surgery. Physician (s) : Specimen (s) Received. A: Total thyroid. B: Tip of possible left inferior parathyroid. C: Level six lymph nodes. D: Left level two lymph nodes. E: Left modified radical neck dissection. Pathologic Diagnosis. Total thyroid (A) : Multifocal papillary carcinoma involving the left. thyroid lobe and left portion of thyroid isthmus (largest focus. 2.2 cm) with numerous (<10) microscopic foci and remaining. thyroid lobe all measuring <1 mm in greatest dimension. Tumor confined to the thyroid, negative for extrathyroidal. extension. Margins of surgical resection negative for tumor. involvement. Negative for lymphovascular and perineural invasion. Background of lymphocytic thyroiditis. Tip of possible left inferior parathyroid (B) : Normocellar parathyroid tissue. Level 6 lymph nodes (C) : Metastatic papillary carcinoma involving two of three. lymph nodes (largest metastatic focus 2.0 cm, negative for. extranodal extension). Level 2 lymph nodes (D) : Metastatic papillary carcinoma involving one of four. lymph nodes (0.5 cm metastatic focus, negative for extranodal. extension). Left modified radical neck dissection (E) : Metastatic papillary thyroid carcinoma involving two. of 23 lymph nodes (2.5 cm and 2.0 cm metastatic foci with. extranodal extension present in both nodes). SURGICAL PATHOLOGY CANCER CASE SUMMARY CHECKLIST: THYROID GLAND. RESECTION: Procedure: Total thyroidectomy. Received: In formalin. Specimen Integrity: Intact. Specimen Size: Right lobe: 4.5 x 2.0 x 1.4 cm. Left lobe: 4.0 x 1.8 x 1.8 cm. Isthmus: 1.0 x 0.2 x 0.2 cm. Left neck dissection: 9.0 x 5.5 x 1.3 cm. Specimen Weight: 14 grams. Tumor Focality Multifocal, ipsilateral. Dominant Tumor: Tumor Laterality: Left lobe. Tumor Size: 2.2 cm. Histologic. Variant: Type: Papillary follicular and per TSS, Follicular. carcinoma,. classical. Architecture: Classical and follicular. Cytomorphology: Classical. Histologic Grade: Grade 1, well-differentiated. margins, uninvolved by carcinoma. Tumor Capsule: Not present. Tumor Capsular Invasion: Not applicable. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Not identified. Extrathyroidal Extension: Not identified. Second Tumor: Tumor Laterality: Left lobe. Tumor Size: >10 foci of microscopic tumor surrounding. larger nodule, all measuring <1 mm in greatest dimension. Histologic Type: Variant: Follicular variant, papillary carcinoma. Architecture: Follicular. Histologic Grade: Well-differentiated. Grade 1. Margins: Uninvolved by carcinoma. Tumor Capsule: Not present. Tumor Capsular Invasion: Not applicable. Lymph-Vascular Invasion: Not present. Perineural Invasion: Not present. Extrathyroidal Extension: Not present. Additional Pathologic Findings: Lymphocytic thyroiditis,. benign Hurthle cell nodules and numerous microscopic foci of. tumor (>10) present in the left thyroid lobe and focally in the. left side of the thyroid isthmus (all measuring <1 mm in greatest. dimension). Ancillary Studies: Not performed. Clinical History: Defer to clinical correlation as to. whether this patient has a history of radiation exposure or. family history of thyroid neoplasia. PATHOLOGIC STAGE: pT2(m), pN1b (number of lymph nodes. examined 30, total number of positive lymph nodes 5), pMX. NOTE: Information on pathology stage and the operative procedure. is transmitted to this Institution' S Cancer Registry as required. for accreditation by the Commission on Cancer. Pathology stage. is based solely upon the current tissue specimen being evaluated. and does not incorporate other relevant data. Pathology stage is. only a component to be considered in determining the clinical. stage and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon'. S. operative report. Primary Pathologist: Clinical History. Papillary thyroid cancer. Intraoperative Consultation. B. Tip of possible left inferior parathyroid: Parathyroid. tissue (microscopic evaluation). Gross Description. A. The specimen is received fresh labeled ""total thyroidectomy"". and consists of a 14 g total thyroid resection. There is a. suture designating the pole of the left lobe of the thyroid. The. surface is shaggy and gray-purple. The right lobe which is inked. blue is 4.5 x 2.0 x 1.4 cm. The left lobe which is inked black. is 4.0 x 1.8 x 1.8 cm. The isthmus which is inked yellow is 1.0. x 0.2 x 0.2 cm. The specimen is serially sectioned to reveal a. multinodular ill-defined firm tan-brown lesion that encompasses. the majority of the left lobe of the thyroid and approximates 2.2. x 1.5 x 1.3 cm. There are additional nonsuspicious. well-circumscribed soft tan-brown nodules identified in the. isthmus and the right lobe that measure up to 0.4 cm. The. majority of the right lobe has a firm red-brown cut surface. Representative sections are submitted as A1-A6 entire left lobe. lesion; A7 isthmus and right lobe with nodules; A8 and A9 right. lobe with remaining nodules. This specimen is reviewed with. A portion of the lesion is submitted for. studies. B. The specimen is received fresh for frozen section labeled. ""possible tip of left inferior parathyroid"" and consists of two. irregular tan-pink soft tissue fragments that are 10 mg and. average 0.2 cm. The are frozen and submitted in their entirety. in cassette B1FS. C. The specimen is received in formalin labeled ""level 6 lymph. nodes"" and consists of two firm tan-gray grossly positive lymph. nodes that are 1.5 and 2.0 cm. Two representative sections. from. each lymph node are submitted as C1 one lymph node, and C2. other lymph node. D. The specimen is received in formalin labeled ""left level 2. lymph nodes"" and consists of four firm tan-gray lymph nodes that. range from 0.5 to 2.5 cm. Their cut surfaces are firm tan-gray. and grossly positive. They are submitted entirely as D1 one. bisected lymph node, D2 two whole lymph nodes; D3 one bisected. lymph node. E. The specimen is received in formalin labeled ""left modified. radical neck dissection"" and consists of a 9.0 x 5.! x 1.3 cm. irregular indurated tan-yellow portion of fibroadipose tissue. There is a double suture designating the lowest level 4 and a. single suture designating the lateral level 5. The specimen is. divided into a superior half (with level 4) and an inferior half. (with level 5). There is no attached salivary gland identified. Identified within the inferior half of the specimen is a. prominent vessel that is 1.5 cm in length and 0.4 cm in diameter. There is no gross evidence of tumor involvement. There are two. enlarged, grossly positive lymph nodes identified within level 4. There are a few additional firm tan-gray lymph nodes identified. that range from 0.2 to 0.6 cm. Also noted separate from the. oriented tissue are two irregular, indurated tan-yellow portions. of fibroadipose tissue that measure 4 cm in aggregate. Within. the tissue there are several firm tan-gray lymph nodes that range. from 0.2 to 1. cm. Representative sections are submitted in. nine cassettes. Cassette summary: E1 section from one grossly positive lymph. node, level 4; E2 section from one grossly positive lymph node,. level 1; E3 three whole lymph nodes, level 4; E4 cross-sections. of vessel, level 5; E5 two whole lymph nodes, level 5; E6 five. whole lymph nodes, level 5; E7 one bisected lymph node and. additional tissue; E8 five whole lymph node in additional. tissue; E9 five whole lymph nodes in additional tissue. Microscopic Description. Microscopic examination has been performed on all slides. The. pathologic diagnosis encompasses the essential microscopic. findings of this case. Interpretation performed at.",val,
1601,TCGA-13-0893.0648E74B-766C-4AB7-BEEE-D45895413E5E,"V3.00 110614. Instructions: The TCGA Missing Pathology Report Form should be completed for cases for which a pathology report is not. available. General Pathology Report Information. #. Data Element. Entry Alternatives. Working Instructions. Provide the tumor type of the case. 1. Tumor type: Indicate to which BCR location the case was originally sent. BCR specimen originally sent. NCH. 2. to: IGC. Biospecimen Core Resource (BCR). 3. Date specimen received at. BCR: ICD-0-3 Histology Code: Provide the histology code for the sample from the Case. Quality Control Form (CQCF) and the overall case (patient. For Specimen: (CQCF). diagnosis, if different). 4. For Case: (patient. diagnosis, if available. elsewhere). ICD-0-3 Site Code: Provide the site code for the sample from the Case Quality. Control Form (CQCF) and the overall case (patient diagnosis, if. different). For Specimen: (CQCF). 5. For Case: (patient. diagnosis, if available. elsewhere).",val,
1651,TCGA-EB-A97M.4EFD3127-7414-49F4-838A-D1050EDDEE31,"Gross Description: There is a fragment of skin 8x4 cm in its size with pigmented mass 2x1,5 cm in its. size with invasion into fatty tissue. Microscopic Description: Malignant melanona (pigmented), in cells of nevus, with ulcerating. Clarks is IV,. Breslow is 15 mm. Diagnosis Details: Tumor Features: Ulcerated, Tumor Extent: More than 4 mm with or without. ulceration, Venous Invasion: Absent, Margins: Absent, Treatment Effect: Comments: Formatted Path Reports: SKIN TISSUE CHECKLIST. Specimen type: Excision of skin lesion. Tumor site: Skin, trunk. Tumor size: 1.5x0x2cm. Tumor features: Ulcerated, Pigmented. Satellite nodules: Not specified. Histologic type: Malignant melanoma. Histologic grade: Undifferentiated. Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: No. Additional pathologic findings: Clark's level IV, Breslow is 15 mm. Comments: None.",val,
1661,TCGA-23-1032.6E8A5413-EB7E-49D8-8E11-8CA6A912ED50,"PATH # : A/S: F. Rec: : Col: DIAGNOSIS: OMENTUM, ANTERIOR ABDOMINAL WALL, PELVIC TUMOR,. LESSER SAC TUMOR, OMENTUM, FALCIFORM LIGAMENT, MESOCOLIC TUMOR,. RIGHT GUTTER TUMOR, RIGHT HEPATIC FLEXURE, PERITONEAL TUMOR, RIGHT. COLON TUMOR, CUL-DE-SAC TUMOR, RECTOSIGMOID TUMOR, ANTERIOR RECTAL. WALL, BLADDER PERITONEUM TUMOR, AND SIGMOID TUMOR (TUMOR. DEBULKING): - Metastatic high grade Mullerian-derived papillary serous. carcinoma. - Specimens include fibroadipose, adipose, and fibromuscular. tissue infiltrated by carcinoma. - Some of the tissues are mesothelial lined. Focal skeletal muscle (specimen #3, pelvic tumor) and. bladder muscularis (specimen #19, bladder peritoneum tumor). are also noted. 6. LIVER (WEDGE RESECTION): - Liver with metastatic papillary serous carcinoma. 13. APPENDIX (APPENDECTOMY) : - Appendix with metastatic papillary serous carcinoma involving. serosa and mesoappendix. - Mucosa and muscularis propria with no evidence of carcinoma. 14. RIGHT OVARY AND FALLOPIAN TUBE (SALPINGO-OOPHORECTOMY) : - Papillary serous carcinoma involving: - Ovary (12 cm) with extensive parenchymal and surface. involvement. - Paratubal and paraovarian soft tissues. - Fallopian tube is compressed by tumor but no mucosal. involvement is identified. 15. UTERUS, LEFT FALLOPIAN TUBE (?) AND OVARY (SUPRACERVICAL. HYSTERECTOMY, LEFT SALPINGO-OOPHORECTOMY): : - Papillary serous carcinoma involving: - Ovary (6 cm) with extensive parenchymal and surface. involvement. - Paraovarian soft tissues. - Uterine serosa. - Fallopian tube not identified. - Atrophic endometrium with a few cystic glands. - Subserosal calcified leiomyoma (0.45 cm). - Scant endocervical mucosa at inferior cervical resection. margin. 21. RECTOSIGMOID COLON (SEGMENTAL RESECTION) : - Metastatic papillary serous carcinoma involving colonic. serosa and pericolic fat. - Mucosa and muscularis propria with no evidence of carcinoma. - No tumor seen at surgical margins. - Two pericolic lymph nodes with no evidence of metastatic. carcinoma (0/2). 22. LEFT ILIAC LYMPH NODE (EXCISION) : - One lymph node with no evidence of metastatic carcinoma (0/1). 23. ""RIGHT PELVIC LYMPH NODE' (EXCISION) : - Benign adipose tissue; no lymph node present. NOTE: The adenocarcinoma is similar in all specimens with features. of a Mullerian-derived papillary serous carcinoma characterized by. high nuclear grade with architectural patterns including. papillations, gland formations, cysts, solid nests, and. micropapillations. Some of the tumor cella exhibit cytoplasmic. vacuolization. Many psammoma bodies, foci of necrosis and acute. inflammation, a desmoplastic stromal reaction, and focal. lymphovascular invasion are also noted. Some of the specimens show. a. surface exudate with fibrin, histiocytes, leukocytes, mesothelial. cells, and tumor cells. The patient's prior left breast carcinoma. is reviewed,. and it does not resemble the current ovarian and abdominal tumor,. which is consistent with a new primary. HISTORY: Ascites, diverticulitis, left breast carcinoma. MICROSCOPIC: See Diagnosis. GROSS: 1: OMENTUM. Labeled 'amentum', received fresh in the Operating Room with tissue. taken for clonogenic studies and the remainder fixed in formalin,. is an 18 x 7 x 4.5 cm portion of yellow lobulated fatty tissue. The portion of tissue is almost completely replaced by a white-tan. firm and focally cystic mass. Cut sections through the mass reveal. white-tan, focally hemorrhagic and focally yellow solid areas and. also cysts filled with clear and mucoid material. Representative. sections are submitted. A. Solid and cystic area - 1. B. Cystic area - 1. 2: ANTERIOR ABDOMINAL WALL. Labeled ""anterior abdominal wall' and received in formalin is a 3 x. 1 x 1 cm portion of white-tan, focally hemorrhagic soft tissue. c. Multiple. 3: PELVIC TUMOR. Labeled 'pelvic tumor' and received in formalin are eight fragments. of white-tan, focally hemorrhagic soft tissue ranging from 1.2 to. 5.5 cm and aggregating to 7.5 x 7.5 x 2.5 cm. Representative. sections are submitted. D. 3. 4: LESSER SAC TUMOR. Labeled ""lesser sac tumor"" and received in formalin is a 4.5 x 3.0. x 1.5 cm aggregate of multiple white-tan, firm portions of tissue. Representative sections are submitted. E. 4. 5: OMENTUM. Labeled 'omentum and received in formalin are two 22 x 7 x 4 cm. and 22 x 8 x 4 cm portions of fibrofatty and focally hemorrhagic. soft tissue. Both portions of tissue are almost completely. replaced by white-tan, focally hemorrhagic mass. Representative. sections are submitted. F. 2. LIVER TUMOR. Labeled 'liver tumor' and received in formalin is a 2.5 x 2.5 x 1.0. cm portion of tan-brown and cauterized soft tissue. Cut sections. through the tissue reveal a 1.0 x 1.0 x 1.0 cm white-tan firm. nodule and brown-tan soft tissue at the periphery of the nodule. Representative section. G. 1. FALCIFORM LIGAMENT. Labeled falciform ligament' and received in formalin is a 4.7 x. 2.0 x 1.0 cm portion of pink-tan soft tissue. There are multiple. white-tan firm nodules identified within the soft tissue. The. nodules range from 0.2 to 1.5 cm. Representative sections are. submitted. H. 2. 8: MESOCOLIC TUMOR. Labeled 'mesocolic tumor and received in formalin are five. portions of white-tan cauterized soft tissue. Portions of tissue. range from 0.5 to 1.2 cm. Entirely submitted. I. 6. 9: RIGHT GUTTER TUMOR. Labeled right gutter tumor"" and received in formalin is an 8.5 x. 4.0 x 1.5 cm portion of yellow lobulated fibrofatty tissue. Almost. the entire specimen is replaced by multiple white-tan firm nodules. ranging from 0.2 to 0.5 cm. Representative sections are submitted. J. 5. 10: RIGHT HEPATIC FLEXURE. Labeled ""right hepatic flexure' and received in formalin is an 8.0. x 3.0 x 0.7 cm portion of yellow fatty tissue with a 3.5. x 3.0 cm area of multiple white-tan firm nodules adhesed to the. fatty tissue. Representative sections are submitted. K. 3. 11: PERITONEAL TUMOR. Labeled 'peritoneal tumor' and received in formalin is a 4.0 x 3.0. x 1.2 cm irregular portion of tan, hemorrhagic soft tissue. A. portion of tissue is entirely replaced by white-tan firm nodular. mass. Representative sections are submitted. L. 2. 12: RIGHT COLON TUMOR. Labeled right colon tumor' and received in formalin is a 1.2 x 1.0. x 0.5 cm portion of white-tan firm tissue. Entirely submitted. M. 2. 13: APPENDIX. Labeled appendix' and received in formalin is a 6.5 cm in length,. 0.7 cm in average diameter appendix with a 1.3 cm in width attached. periappendiceal fat. Appendiceal serosa is brown-tan and focally. hemorrhagic with multiple white-tan firm nodules. Periappendiceal. fat is also partially replaced by white-tan firm nodules. Cut. section through the appendix reveals a 0.2 cm in thickness white. appendiceal wall and up to 0.5 cm in diameter lumen. The appendix. is filled with feculent material. Tumor does not grossly invade the. appendiceal wall. Representative sections are submitted. N. 5. 14: RIGHT OVARY. Labeled 'right ovary' and received in formalin is a 12 x 10 x 6 cm. distorted ovary. The surface is variegated with focally. hemorrhagic areas and multiple fibrous adhesions. Cut section. through the ovary reveals yellow-tan hemorrhagic variegated soft. and focally necrotic mass. There is a 9.0 cm in length, 1.0 cm in. diameter fallopian tube attached to the ovary. A fimbriated end is. not identified. Cut sections through the fallopian tube reveal a. 0.2 cm in thickness wall and up to 0.4 cm lumen. Representative. sections are submitted. o-s. 1 each. 15: UTERUS, LEFT TUBE AND OVARY. Labeled ""uterus, left tube and ovary and received in formalin is a. supracervical hysterectomy with attached adnexa. The uterus and. ovary weigh 70 grams. The uterus measures 4.5 cm superior to. excisional cervical margin, 5.0 cm cornu to cornu, and 2.0 cm. anterior to posterior. The uterine serosa is pink-tan with. multiple serous adhesions which contain multiple white-tan and firm. nodules. There is also a 1.0 cm in diameter white-tan firm serosal. nodule. The uterus is incised on both sides. Cut section reveals a. 3.5 cm in length, up to 1.5 cm in width uterine cavity. The. endometrium is pink-tan, grossly unremarkable, and ranges in width. from 0.1 to 0.2 cm. The myometrium is pink-tan, grossly. unremarkable, and measures up to 1.5 cm in thickness. The attached. left adnexa measures 6 x 3.5 x 1.5 cm consisting of a variegated,. focally hemorrhagic mass. The fallopian tube is not definitively. identified. There is a smaller 3.0 x 1.5 x 1.0 cm white-tan firm. mass which is loosely attached to the already described mass. Representative sections are submitted. T. Posterior lower uterine segment - 1. U. Anterior lower uterine segment - 1. V. Anterior corpus - 1. W. Posterior corpus. x. Posterior lower uterine segment and serosal adhesions - 2. Y-AA. Ovarian and tubal mass - 1 each. BB. Smaller firm mass - 2. ADDITIONAL SECTION. MM. Possible fallopian tube - 4. 16: CUL DE SAC TUMOR. Labeled 'cul de sac tumor' and received in formalin is a 9.5 x 7.5. x 3.5 cm aggregate of white-tan firm tumor and clotted blood. Representative sections are submitted. cc. 2. 17: RECTAL SIGMOID TUMOR. Labeled ""rectal sigmoid tumor' and received in formalin is a 4.5 x. 2.5 x 0.5 cm irregular portion of tan, focally hemorrhagic soft. tissue. There is a 1 x 1 cm white-tan firm area at one surface of. the tissue. Representative sections are submitted. DD. 3. 18: ANTERIOR RECTAL WALL. Labeled 'anterior rectal wall' and received in formalin are four. portions of white-tan soft tissue ranging from 0.7 to 1.5 cm. Entirely submitted. EE. Multiple. 19: BLADDER PERITONEUM AND TUMOR. Labeled bladder peritoneum and tumor' and received in formalin are. five portions of yellow lobulated fatty tissue almost entirely. replaced by white-tan and firm tumor nodules which range from 0.2. to 2.0 cm. Representative sections are submitted. FF. 3. 20: SIGMOID TUMOR. Labeled sigmoid tumor' and received in formalin are two 2.0 and. 1.0 cm portions of white-tan soft tissue. Entirely submitted. GG. 2. 21: RECTAL SIGMOID COLON. Labeled ""rectal sigmoid colon and received in formalin is a 4.5 cm. in length, 5 cm in opened circumference segment of colon with a 5.5. cm in width portion of attached pericolonic fat. The serosa is. pink-tan and smooth with multiple small white-tan nodules attached. to the serosa and in the pericolonic fat. The wall measures 0.3 cm. in thickness and is grosaly unremarkable. The mucosal folds are. grossly unremarkable and no lesions are identified. Representative. sections are submitted. HH. Serosal nodule. II. Margins. JJ. Pericolonic fat with nodules - Multiple. 22: LEFT ILIAC LYMPH NODE. Labeled 'left iliac lymph node' and received in formalin is a 0.9 x. 0.4 x 0.3 cm lymph noae. Entirely submitted. KK. 2. 23: RIGHT PELVIC LYMPH NODE. Labeled ""right pelvic lymph node' and received in formalin are two. 1.0 x 0.9 x 0.9 cm portions of fatty lobulated tissue. No grossly. identifiable lymph node is present. Entirely submitted. LL. Multiple. Gross dictated by. OPERATIVE CONSULT (GROSS) : 1. OMENTUM: -Three pieces, each 1.5 cm in greatest dimension were taken for. the extreme drua resistance testing. Special Studies: None. See Also: I,. the pathologist of record, have. personally examined the specimen, interpreted the. results, reviewed this report and signed it electronically.",val,
1917,TCGA-ET-A3BP.111885BE-27BA-4EDA-9AAE-53308A6BE629,"SPECIMEN TAKEN: FINAL DIAGNOSIS. LEFT THYROID (TOTAL THYROIDECTOMY): SPECIMEN TYPE: Total thyroidectomy. TUMOR SITE: Isthmus, Left lobe. HISTOLOGIC TYPE: Papillary carcinoma, conventional type. FOCALITY: Multifocal: 2.5 cm - left lobe; 1.2cm - isthmus. LYMPH NODES: Metastatic carcinoma in 2 of 3 perithyroidal lymph nodes. EXTENT OF INVASION. PRIMARY TUMOR: pT2: Tumor >2 cm, limited to thyroid. REGIONAL LYMPH NODES: pN1a: Nodal metastasis to regional lymph nodes. DISTANT METASTASIS: pMx: Cannot be assessed. MARGINS: Margins are uninvolved. Distance of invasive carcinoma from nearest. margin: <1 mm (posterior margin). VENOUS/LYMPHATIC INVASION: Present.",val,
2085,TCGA-CN-4727.806c5b39-7a57-4f61-8630-3850850754a0,"Accession Date: Attending Physician: Procedure Physician/Conias In. Specimen Class: Bench Designate: PATIENT HISTORY: CHIEF COMPLAINT/PRE-OP/POST-OP DIAGNOSIS: Respiratory distress. PROCEDURE: Tracheostomy, Total laryngectomy, Bilateral neck dissection. SPECIFIC CLINICAL QUESTION: Not answered. OUTSIDE TISSUE DIAGNOSIS: Not answered. PRIOR MALIGNANCY: Not answered. CHEMORADIATION: Not answered. ORGAN TRANSPLANT: Not answered. IMMUNOSUPPRESSION: Not answered. OTHER DISEASES: Not answered. ADDENDA: Addendum. The results of ancillary studies are as follows: P16 mmunohistochemistry: negative. HPV in-situ hybridization: negative. EGFR immunohistochemistry: 1+ membranous staining. My signature is attestation that I have personally reviewed the submitted material(s) and the above diagnosis reflects that evaluation. FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT NECK DISSECTION LEVELS 2-4, BIOPSY -. A. SIXTEEN LYMPH NODES, NO SQUAMOUS CELL CARCINOMA PRESENT (0/18). B. METASTATIC PAPILLARY THYROID CARCINOMA INVOLVING TWO OF SIXTEEN LYMPH NODES (2/16). C. NO EXTRACAPSULAR SPREAD PRESENT. PART 2: LYMPH NODES, LEFT NECK DISSECTION LEVELS 2-4, BIOPSY -. TWENTY-ONE LYMPH NODES, NO TUMOR PRESENT (d/21). PART 3: LEFT UPPER PHARYNX, BIOPSY -. MILD DYSPLASIA, NO TUMOR PRESENT. PART 4: BASE OF TONGUE, LEFT, BIOPSY -. NO TUMOR PRESENT. PART 5: BASE OF TONGUE, RIGHT, BIOPSY -. NO TUMOR PRESENT. PART 6: UPPER PHARYNX, RIGHT, BIOPSY -. NO TUMOR PRESENT. PART 7: UPPER PHARYNX, RIGHT, BIOPSY -. NO TUMOR PRESENT. PART 8: UPPER PHARYNX, LEFT, BIOPSY -. MILD DYSPLASIA, NO TUMOR PRESENT. PART 9: LARYNX, TOTAL LARYNGECTOMY -. A. INVASIVE SQUAMOUS CELL CARCINOMA, MODERATELY DIFFERENTIATED (3.5 CM), SUPRAGLOTTIC,. INVOLVING THE RIGHT AND LEFT EPIGLOTTIS, FALSE CORDS, AND EXTENDING INTO THE PRE-. EPIGLOTTIC AND PARAGLOTTIC SPACES, AND ANTERIOR SOFT TISSUE (see comment). B. NO THYROID CARTILAGE INVOLVEMENT. C. NO ANGIOLYMPHATIC INVASION OR PERINEURAL INVASION PRESENT. D. MARGINS FREE OF TUMOR. E. PATHOLOGIC STAGE: pT4N0. F. HYPERCELLULAR BONE MARROW WITH TRILINEAGE HEMATOPOIESIS, AND SLIGHTLY LEFT SHIFTED. MYELOID MATURATION. COMMENT: Part 9: Ancillary studies are being performed and the results will be reported in an addendum. My signature is attestation that I have personally reviewed the submitted material(s) and the final diagnosis reflects that evaluation. GROSS DESCRIPTION: The specimen is received fresh, in nine parls, each labeled with the patlent's name, medical record number and initials. Part 1 is received labeled ""right neck, levels 2-4"". It consists of a single, un-oriented plece of fibroadipose tissue measuring 6.0 x. 4.0 x 2.5 cm. Throughout the tissue are numerous tan-lo-white calored lymph nodes, ranging in size from 0.3 to 2.0 cm. The. nodes vary from soft to firm in consistency. Representative sections are submilted for permahent histology as follows: 1A. one large node. IB. 4 nodes. IC. 6 nodes. ID-1E. fibroadipose tissue. Part 2 is received labeled ""left neck, levels 2-4"". It consists of a single, un-oriented piece of fibroadipose tissue measuring 6.5 X 4.7. x 3.0 cm. Throughout the tissue, 17 tan-to-white colored lymph nodes are identified, ranging in size from 0.3 to 2.0 cm. The nodes. vary from soft to firm in consistency. The remainder of the fibroadipose tissue appears unremarkable. Representative sections are. submitted for permanent histology as follows: 2A-2D. nodes. 2E-2G. fibroadipose tissue. Part 3 is received labeled ""left upper pharynx"". It consists of a single piece of soft, tan-white tissue measuring 1.5 x 0.2 x 0.2 cm. Following an intraoperative frozen section, the entire tissue is submitted for permanent histology in a single cassette labeled 3A. Part 4 is received labeled ""left base of tongue"". It consists of a single piece of soft, tan-brown, partially cauterized tissue measuring. 2.0 x 0.6 x 0.3 cm. Following an intraoperative frozen section, the entire tissue is submitted for permanent histology in a single. cassette labeled 4A. Part 5 is received labeled ""right base of tongue"". It consists of two small pieces of soft, tan-white tissue collectively measuring 0.6. X 0.5 x 0.3 cm. Following an intraoperative frozen section, the entire tissue is submitted for permanent histology in a single. cassette labeled 5A. Part 6 is received labeled ""right upper pharynx"". It consists of a single piece of soft, tan-brown, partially cauterized tissue. measuring 1.5 X 0.3 X 0,2 cm. Following an intraoperative frozen section, the entire tissue is submitted for permanent histology in a. single cassette labeled 6A. Part 7 is received labeled ""right hypopharynx"". It consists of a single piece of soft, tan-brown, partially cauterized tissue measuring. 1.2 X 0.5 x 0.1 cm. Following an intraoperative frozen section, the entire tissue is submitted for permanent histology in a single. cassette labeled 7A. Part 8 is received labeled ""left hypopharynx"". It consists of a single strip of soft, tan tissue measuring 3.0 x 0.2 X 0.1 cm. Following. an intraoperative frozen section, the entire tissue is submitted for permanent histology in a single cassette labeled 8A. Part 9 is received labeled ""larynx"". It consists of a complete larynx with attached tongue base, superior trachea and surrounding. soft tissue having an overall measurement of 8.5 x 5.5 X 5.0 cm. The mucosal surface of the epiglottis shows a peripherally. fungating, centrally ulcerating mass lesion that measures 3.5 x 2.8 cm. The lesion Is centered approximately 0.5 cm to the left of. the midline and 3.1 cm from the tlp of the epiglottis. The mass extends inferlorly, apparently involving the left false vocal chord,. obscuring the left ventricle and abutting the superior surface of the left true chord. On the right, the mass appears to extend to the. superior aspect of the false chord, compressing the right ventricle. The right true chord is edematous and expanded. Serial. sections along the mid-sagiltal plane at 3 mm intervals show the mass extending Into the pre-epiglottic space (predominantly on. the left), with extension between the hyoid bone and superlor aspect of the thyrold cartilage. Maximum thickness of the leslon is. approximately 2.0 cm. The lesion appears to invade into the base of the tongue, but remains at least 0.5 cm from the tongue base. margin. The lesion directly abuts the epiglottic cartilage In multiple areas but does not appear to Invade it. At the tip of the. epiglottis is an irregularly shaped area of ulceratlon that measures 0,8 X 0.6 cm, and 1-2 mm in depth. The mucosa overlying the. left pre-epiglottic reglon shows a deep, well-demarcated ulceration that measures 1.0 x 0.6 cm, with a depth of 3 mm. On. sectioning, this ulceration Is contiguous with the invading mass lesion in the underlying pre-epiglottic space. The tracheal mucosa. is glistening, tan, and shows multifocal pinpoint hemorrhage. The soft tissue surrounding the remainder of the speclmen cohsists. of normal appearing muscle and adpose which has been partially cauterized. The entire soft tissue margin of resection is inked,. seven digital images are taken, and representative sections are submitted for histology as follows: 9A. tracheal margin, shave. 9B. epiglottis, tumor and longue base section. gc. tumor, epiglottis, pre-epigiollic space and ulceration. gb. tumor and hyold bone. gE. tumor and left false/true chords. gF. tumor and right false/true chords. gG. soft lissue margin (random). normal trachea. Sections A, D, E, F are submitted for decalcification. This specimen was reviewed with. INTRAOPERATIVE CONSULTATION: 3FS: LEFT UPPER PHARYNX. A. BENIGN. B. MILD-TO-MODERATE.DYSPLASIA,NO TUMOR SEEN. 4FS: LEFT BASE OF TONGUE. A. BENIGN. B. NO TUMOR SEEN. 5FS: RIGHT BASE OF TONGUE. A. BENIGN. B. 6FS: RIGHT UPPER PHARYNX. A. BENIGN. B. MILD DYSPLASIA, NO TUMOR SEEN. 7FS: RIGHT HYPOPHARYNX. A. BENIGN. B. NO TUMOR SEEN. 8FS: LEFT HYPOPHARYNX. A. BENIGN. B ID-TO-MODERATE. DYSPLASIA, NO TUMOR SEEN. MICROSCOPIC: Microscopic examination substantiates the above diagnosis. The following statement applies to all immunohistochemistry, insitu hybridization (ISH & FISH), molecular anatomic pathology, and. immunofluorescence testing: The testing was developed and its performance characteristics determined by the. as. required by the CLIA. egulations. by the U.S. Food and Drug. Administration, but the FDA has determined such approval is not necessary for clinical use. Tissue fixation ranges from a minlmum ol. to a maximum of. This laboratory is certifled under the Clinical Laboratory Improvement Amendments of. as qualified to perform high-. complexity clinical testing. Pursuant to the requirements of CLIA, ASR's used In tills laboratory have been established and verilled for. accuracy and precision. Additional information about this type of test Is available upon request. CASE SYNOPSIS: SYNOPTIC DATA - LARYNX RESECTIONS. TYPE OF LARYNGECTOMY: Total. TUMOR LOCATION: Midline. ATTACHED STRUCTURES: Base of tongue. TUMOR LOCATION/SEGMENT: Supraglottic. TUMOR SIZE: Maximum dimension: 3.5 cm. HISTOLOGIC TYPE OF TUMOR: Squamous cell carcinoma. HISTOLOGIC GRADE: Moderately differentiated. STRUCTURES INVOLVED BY TUMOR: False cord, Epiglottis, Pre-epiglottic space, Paraglottic space, Extralaryngeal. soft tissue. LYMPH NODES POSITIVE: Number of lymph nodes positive:: 0. LYMPH NODES EXAMINED: Total number of lymph nodes examined: 37. EXTRACAPSULAR SPREAD OF LYMPH NODE METASTASES. INTRA-PERINEURAL INVASION: Absent. VASCULAR INVASION: SURGICAL MARGIN INVOLVEMENT: Free (2 mm or more). T STAGE, PATHOLOGIC: Supraglottis, pT4a. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. HISTO TISSUE SUMMARY/SLIDES REVIEWED: Part 1: Right Neck Levels 2-4. Stain/cnt. Block. H&E x 1. A. H&E x 1. B. H&E X 1. C. H&E x 1. D. H&E x 1. E. Part 2: Left Nock 1 availe 2-4. Recelved. Stain/cnt. Block. A. H&E. B. H&E. x. C. H&E. x. D. H&E x 1. E. H&E x 1. F. H&E x 1. G. Part 3: 1 eft Unner Phanunx. Stain/cnt. Block. H&E x 1. Afs. Part 4: Left Base of Tongue. Recelved. Stain/cnt. Block. H&E x 1. Afs. Part 5: Right Base of Tongue. Stain/cnt. Block. H&E x 1. Afs. Part 6: Right. Unner Pharynx. Stain/cht. BIOCK. H&E x 1. Afs. Part 7: Right Unner Pharynx. Stain/cnt. Block. H&E x 1. Afs. Part 8: 1 oft Unner Pharnnx. Stain/cnt. Block. H&E x 1. Afs. Part 9; Larynx. Stain/cht. Block. H&E x 1. B. H&E Recut x 1. C. IHPV x 1. C. cmet x 1. C. IEGFR x 1. C. IBNKNC x 1. C. IBNKNC X 1. C. IBNKNC x 1. C. IBNKNC x 1. C. IBNKNC x 1. C. IBNKNC x 1. C. H&E x 1. C. IISH x t. C. IISH x 1. C. P16 x 1. C. V-EGFR x 1. C. H&E x 1. G. H&E x 1. Decal x 1. H&E x 1. Decal x 1. H&E x 1. Decal x 1. H&E x 1. Decal x I. H&E x 1. ICD-9 Diagnosis Codes: {None Entered}. CONSULTING PATHOLOGIST(S): SPECIAL PROCEDURES: In Situ Procedure. Interpretation. PROBE: LSI EGFR/CEP7 Dual-Color Probe. Cytogenetic Location: 7p12/7p11.1-q11.1. EGFR FISH STUDIES PERFORMED ON THE SQUAMOUS CELL CARCINOMA ARE NEGATIVE. Number of cells analyzed: 60. Ratio EGFRICEP7: 1.53. High Polysomy: 0%. SNR (signal to nucleus ratio): 2.5. Low Polysomy: 16(26.7%). Trisomy: 4(6.7%). Disomy: 40(66.6%). PROBE: c-MET/CEP7. Cytogenetic Location: 7q31.2/7p11.1-q11.1. C-MET FISH STUDIES PERFORMED ON THE SQUAMOUS CELL CARCINOMA ARE NEGATIVE FOR AMPLIFICATION. Number of cells analyzed: 60. Ratio c-MET/CEP7: 1.07. SNR (signal to nucleus ratio): 2.2. Hlgh Polysomy: 0%. Low Polysomy: 0%. Trisomy: 21(35.0%). Disomy: 39(65.0%). My signature is attestation that / have personally reviewed the submitted material(s) and the above dlagnosis reflects that evaluation. EGFR FISH analysis was manually performed and quantitatively assessed by analysis of a minlimum of 60 cells using the EGFR. SpectrumOrange and the CEP7 SpectumGreen probes. C-MET FISH analysis was manually performed and quantitatively assessed by analysis of a minimum of 60 cells using the c-MET. SpectrumOrange and the CEP7 SpectrumGreen (centromeric) probes. EGFR FISH positive: High Polysomy: > four gene copies in > 40% of cells. Gene Amplification: Ratio gene/chromosome more than two or > 15 gene copies in > 10% of cells. EGFR FISH negative: Disomy: two gene copies in more than 90% of the cells. Trisomy: three gene copies in more than 10% of cells. Low Polysomy: > four gene copies in more than 10% but less than 40% of cells. c-MET FISH positive: Gene Amplification: Ratio gene/chromosome more than two or > 15 gene copies in > 10% of cells. c-MET FISH negative: Ratio gene/chromosome less than two or < 15 gene copies in VI 10% of the cells. References:",val,
2134,TCGA-AZ-6608.75a5b0f7-23f0-41de-b863-9029a57ff12d,"PATIENT HISTORY: CHIEF FCOMPLAINT/PRE-OP/POST-OP DIAGNOSIS: Sigmoid colon mass. PROCEDURE: Sigmoid colon resection. SPECIFIC CLINICAL QUESTION: Not answered. OUTSIDE TISSUE DIAGNOSIS: Not answered. PRIOR MALIGNANCY: Not answered. CHEMOTHERAPY: Not answered. ORGAN TRANSPLANT: Not answered. IMMUNOSUPPRESSION: Not answered. OTHER DISEASES: Not answered. FINAL DIAGNOSIS: SIGMOID COLON, SEGMENTAL COLECTOMY -. A. ULCERATED, POLYPOID, INVASIVE, MODERATELY DIFFERENTIATED, COLONIC ADENOCARCINOMA, 3 CM,. PRESENT IN THE SIGMOID COLON 3 CM FROM THE PROXIMAL AND 5.5 CM FROM THE DISTAL RESECTION. MARGINS. B. CARCINOMA INVADES DEEPLY INTO, BUT NOT THROUGH THE MUSCULARIS PROPRIA. C. PRESUMED ANGIOLYMPHATIC INVASION (see diagnosis G). D. ONE SMALL TUBULAR ADENOMA. E. ALL SURGICAL RESECTION MARGINS, SUBSEROSAL AND SEROSAL SURFACE ARE BENIGN. F. NON-NEOPLASTIC COLONIC MUCOSA WITH NO SIGNIFICANT HISTOPATHOLOGIC ABNORMALITY. G. METASTATIC COLONIC ADENOCARCINOMA IS PRESENT AND LARGELY REPLACES TWO OF TWELVE (2/12). REGIONAL LYMPH NODES. THE LARGER METASTATIC FOCUS MEASURES 0.4 CM. NO EXTRACAPSULAR. EXTENSION IS IDENTIFIED. H. TNM PATHOLOGIC STAGE: T2 N1 MX (see synoptic). CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY COLON, RECTAL, APPENDIX TUMORS. SPECIMEN TYPE: Sigmoidectomy. SPECIMEN LENGTH: 11.5 cm. TUMOR SITE: Sigmoid colon. TUMOR CONFIGURATION: Exophytic (polypoid). TUMOR SIZE: Greatest dimension: 3 cm. Additional dimensions: 3 x 1.7 cm. INTACTNESS OF MESORECTUM: Not applicable. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: Low-grade (well to moderately differentiated). PATHOLOGIC STAGING (pTNM): pT2. pN1. Number of nodes examined: 12. Number of nodes involved: 2. pMX. Treatment: Untreated. MARGINS: Proximal margin uninvolved by invasive carcinoma. Distal margin uninvolved by invasive carcinoma. Circumferential (radial) margin - Not applicable. Mesenteric margin uninvolved by invasive carcinoma. If all margins uninvolved by invasive carcinoma: distance of invasive carcinoma from. closest margin: 30 mm. Margin: Proximal. ANGIOLYMPHATIC INVASION: Present. PERINEURAL INVASION: Absent. TUMOR BORDER CONFIGURATION: Infiltrating. ADDITIONAL TUMOR CHARACTERISTICS: None. ADDITIONAL PATH FINDINGS (check all that apply): Adenoma(s).",val,
2139,TCGA-14-1456.fd1151fa-9611-4d50-a918-07f3e587879b,"Date Collected: Date Received. DIAGNOSIS. 1. BRAIN, LEFT FRONTAL, BIOPSY, FS1A: - GLIOBLASTOMA MULTIFORME. 2. BRAIN, LEFT FRONTAL, EXCISION: - GLIOBLASTOMA MULTIFORME. - SEE COMMENT. COMMENT: This infiltrating astrocytoma discloses focal anaplasia, high. cellularity,. necrosis and microvascular proliferation. These features are. indicative of. glioblastoma multiforme. However, other areas in this tumor appear. to. represent lower grade infiltrating astrocytoma. The infiltrative. nature of. this tumor is confirmed in a neurofilament immunohistochemical. stain. A MIB1. proliferation rate is estimated at approximately 10-15% in the. higher grade. areas of the tumor. SPECIMEN: 1. Left frontal brain lesion. 2. Left frontal brain lesion. CLINICAL HISTORY/OPERATIVE FINDINGS: Craniotomy, brain tumor. Brain tumor. Left frontal craniotomy. GROSS DESCRIPTION: Specimen #1 is received fresh for intraoperative consultation,. labeled with. the patient's name, medical record number and as ""left frontal. brain. lesion."" The specimen consists of multiple pieces of tan-red. tissue measuring. in aggregate 0.7 x 0.7 x 0.3 cm. A representative section is. submitted for. frozen tissue diagnosis, and the contents of the cryoblock are. resubmitted in. cassette ""FS1A."" The remainder of the specimen is submitted in. cassette. ""1B. "" Immunohistochemical stains MIB1 and neurofilament are. ordered on. cassette ""1B."". Specimen #2 is received in formalin, labeled with the patient s. name, medical. record number and as ""left frontal brain lesion. "" The specimen. consists of. numerous fragments of tan-red tissue measuring in aggregate 2.5 x. 2.5 x 0.4. cm. Representative sections are submitted in cassettes ""2A"" and. ""2B. Approximately 75% of the tissue have been submitted. INTRAOPERATIVE CONSULTATION: FS1A: LEFT FRONTAL BRAIN LESION (FROZEN SECTION) : ASTROCYTOMA; GRADING. DEFERRED. MICROSCOPIC DESCRIPTION: Microscopic examination performed. Page 1 (Continued. SPECIAL STAINS: : KI-67. DONE. KI-67. DONE. NF. DONE. NF. DONE.",val,
2143,TCGA-DJ-A2PT.0C47594E-54FF-4DC6-BB4C-FC0861570B22,"Clinical Diagnosis & History: Thyroid papillary carcinoma on FNA right lobe. Specimens Submitted: 1: Right paratracheal nodes (fs). 2: Total thyroid. 3: Pretracheal tissue. 4: Right mediastinal tissue. 5: Left mediastinal tissue. DIAGNOSIS: 1. Right paratracheal nodes (fs): Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 5. 2. Total thyroid: Tumor Type: Papillary carcinoma, tall cell variant. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: site : thyroid, NOS C13.9. Right lobe. Tumor Size: Greatest diameter is 1.5 cm. Tumor Encapsulation: None Identified. Blood Vessel Invasion: Focal Invasion. Extrathyroid Extension: Invades:perithyroidal fibradipose tissue and skeletal muscle. Surgical Margins: Free of tumor. Tumor Multicentricity: Not identified. Adenoma(s) (away from the carcinoma): Not Identified. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. Exhibits chronic lymphocytic thyroiditis. Parathyroid Glands: Not identified. Lymph Nodes: Three fymph nodes negative for metastatic carcinoma are identified (0/3). 3. Pretracheal tissue: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 6. 4. Right mediastinal tissue: Lymph Node Dissection: Benign fibroadipose tissue. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 2. The specimen is received fresh labelled ""total thyroid, stitch marks right thyroid lobe"" and consists of a thyroid weighing 12.5 g. The right lobe measures 3.5x2x1.5 Cm, the left lobe measures 4x3x1 cm and the isthmus measures 1.2x1x0.6 Cm. The external. surface is covered by a thin fibrous capsule. The posterior surface of the specimen is inked black, and the anterior is inked blue. Sectioning reveals overall multinodular thyroid tissue with one prominent nodule with white tan cut surface on the right lobe. measuring 1.5x1.2x1.0 cm. Sections through the remaining tissue reveal beefy red parenchyma. The remaining thyroid. parenchyma is red tan and beefy. Representative sections of the specimen are submitted for TPS. The remaining tissue is serially. sectioned and representatively submitted. Summary of sections: N nodule. RL right lobe. LL left lobe. IS isthmus. 3) The specimen is received in formalin labeled, ""pretracheal tissue"", and consists of multiple pieces of red and tan soft tissue. measuring 0.9 x 0.6 x 0.2 cm in aggregate. Entirely submitted. Summary of sections: U-- undesignated. 4) The specimen is received in formalin, labeled ""right superior mediastinal tissue"", and consists of two irregular fragments of. pink-tan soft tissue measuring 0.4 and 1.8 cm in greatest dimension. Submitted entirely. Summary of sections: U - undesignated. 5) The specimen is received in formalin, labeled ""left superior mediastinal tissue"", and consists of an irregular fragment of pink-tan. soft tissue measuring 0.5 cm in greatest dimension. Entirely submitted. Summary of sections: U- undesignated. Summary of Sections: Part 1: Right paratracheal nodes (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 2: Total thyroid. Block. Sect. Site. PCs. 1. IS. 1. 2. LL. 2. 4. N. 4. 3. RL. 3. Part 3: Pretracheal tissue. Block. Sect. Site. PCs. 1. U. 4. Part 4: Right mediastinal tissue. Block. Sect. Site. PCs. 1. U. 2. Part 5: Left mediastinal tissue. Block. Sect. Site. PCs. 1. U. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative. consultation. 1. Frozen section diagnosis: Right paratracheal nodes (fs): Benign. Permanent diagnosis: same.",val,
2149,TCGA-BK-A6W3.15A94B35-48FD-4F94-94E4-25F8084F8B91,"Final Surgical Pathology Report. Procedure: Diagnosis. Uterus and bilateral adnexa, resection: Cervix: CIN-1, CIN2. Endometrium: Polypoid endometrioid type endometrial adenocarcinoma,. FIGO grade 2. Secretory type endometrium. Myometrium: Probable very superficial myometrial invasion. Ovaries, left and right: No pathological diagnosis. Uterine tubes, left and right: No pathological diagnosis. Parametrium, left and right: No pathological diagnosis. Microscopic Description: Histologic type: Endometrioid type endometrial adenocarcinoma. forming an exophytic polyp with adjacent secretory type. endometrium. Histologic grade: FIGO II. The tumor is greater than 5% but less. than 50% solid. There is micro-focal increased nuclear. grade (e.g. block A16). Myometrial invasion: Focal probable very superficial myometrial. invasion K< 10%). Vascular invasion: Absent. Endometrial hyperplasia: Absent. Lower uterine segment: Negative for malignancy. Uterine cervix: Transformation zone CIN 1 and CIN 2 are present. CIN2 is present at the ectocervical epithelial edge of the. specimen in block RR2. Parametrium: Negative for malignancy. pTNM: Tla. MSI testing: Ordered on block A16. Other findings: None. Specimen. Uterus, cervix, bilateral tubes and ovaries. Clinical Information. Patient with grade 1 endometrial adenocarcinoma on biopsy. ASCUS Pap, for TAH BSO. Intraoperative Consultation. A. Uterus and bilateral adnexa, resection: Polypoid endometrial adenocarcinoma. Grade deferred to permanent sections. No definite myometrial invasion seen. Gross Description. The specimen is received unfixed labeled uterus, cervix, bilateral. tubes and ovaries and consists of a uterus and bilateral attached. adnexa weighing 142.8 g. The uterus measures 10.5 by 5.5 by 5 cm. The. ectocervix is white and measures 3 by 2.7 cm. The external os measures. 1.4 X 0.1 cm. The left ovary is white and yellow with some purplish. cortical cysts. The specimen measures 2 point 2 x 2 by 1.2 cm. There is. adjacent pink uterine tube measuring 3 cm in length and 0.7 cm in. diameter. The right ovary is white with some cortical cysts. The ovary. measures 3.2 by 2.3 x 1.5 cm. There is some adjacent red soft tissue. that might be 2 segments measure 2 and 1.5 cm in length and are up to 1. cm in diameter. The uterus is opened with a single incision at the 3:00. lateral side. There is a polypoid tumor and uterine cavity measuring. 2.2 by 2.2 by 2.4 cm. Portions of polyp and underlying posterior. myometrium are taken for frozen section diagnosis as requested (3. blocks) . Additional sections after fixation. Block summary: 1-3 left ovary, uterine tube and parametrium; 4-6 right. ovary, uterine tube and parametrium; 7-11 anterior cervix and. endomyometrium; 12-17 posterior cervix and endomyometrium. RR1-8. cervix.",val,
2355,TCGA-BR-6454.e3b99d2c-c5bf-4705-a9ed-15ebe007d53c,"Case ID. Subject. STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Stomach. Tumor size: 8 X 5 X 1.7 cm. Tumor features: None specified. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Adjacent structures (specify) -. Esophagus, lesser omentum. Lymph nodes: 0/5 positive for metastasis. (Regional 0/5). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: None.",val,
2390,TCGA-BR-7197.d8d0b7e5-98c6-404d-921e-f4ab8ebf7c28,"Gross Description. Microscopic. Diagnos. Comme. Subject ID. Description. is. nts. Details. Stomach segment with. Adenocarcinoma,. the plate-like tumor of. with subserosa. 6 X 5.5 cm in size, with. infiltration. entire wall layers. Morphological. invasion. features of the. Greater and lesser. tumor structure. curvature lymph nodes. may suggest its. are hyperemic. neuroendocrinal. Omentum is without. origin. changes. Fifteen dissected. lymph nodes. demonstrate. reactive changes. Omentum is. without changes. Lateralit. Procure. y. ment. STOMACH TISSUE CHECKLIST. NA. Specimen type: Subtotal gastrectomy. Tumor site: Pylorus. Tumor size: 5.5 X 0 X 6 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Tumor extent: Subserosa. Lymph nodes: 0/15 positive for. metastasis (Greater and lesser omentum. 0/15). Lymphatic invasion: Not specified. Venous invasion: Absent. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not. specified. Comments: None.",val,
2460,TCGA-06-0188.8cdb3fca-ac62-497e-9402-5bb50f97df4f,"CLINICAL HISTORY. experienced epileptic uncal fits (foul chemical taste. and anxiety). , and has enhancing tumor in right temporal lobe extending to the. uncus. OPERATIVE DIAGNOSES. Not Given. Operation/Specimen A: Brain, resection. B: Brain, right temporal, resection. PATHOLOGICAL DIAGNOSIS: A. Brain, site not specified, excisional biopsy: Glioblastoma. MIB-1. proliferation index: 22%. B. Brain, right temporal, resection Anaplastic astrocytoma MIB-1. proliferation index: 5%. See comment. COMMENT. Part A is portions of cerebral cortex infiltrated by a glial neoplastic. proliferation with frequent getalstocytes, easily found mitotc figures; is. MIB-1 proliferation index of 22%, and focal microvascular cellular. proliferation with focal vascular karyorrhexis, i.e. a glioblastoma. Part B is portions of cerebrum with focal white matter areas infiltrated by an. astrocytoma with mitotic figures, but absent microvascular proliferation or. necrosis, i.e. an anaplastic astrocytoma. PROCEDURES/ADDENDA. MGMT Promoter Methvlation. Interpretation. NEGATIVE - No evidence of methylated MGMT promoter is detected. esults-Comments. Submitted, block A1. TEST DESCRIPTION: Bisulfite treatment of DNA followed by PCR amplification of. both methylated and unmethylated MGMT promoter sequences, with products. detected by gel electrophoresis. FDA COMMENT: The above idata are not to be construed as the results from a. stand-alone diagnostic test. This test was developed and its performance. characteristics determined by the. laboratory as. required by CLIA. regulations. It has not been cleared or approved for. specific uses by the J.S. Food and Drug Administration (FDA) The FDA has. determined that such clearance or approval is not necessary. These results are. provided for informational purposes only, and should be interpreted only in. the context of established procedures and/or diagnostic criteria. INTRA-OPERATIVE CONSULTATION. Brain, touch prep and smears: Glioma, high grade. Part. GROSS DESCRIPTION. A. Received fresh, three fragments, 0.7 cm. in aggregate. Semi firm, tan. In. total, Al and A2. B. SPECIMEN: Right temporal brain tumor. FIXATIVE: None. GENERAL: Two, 1.4 x 0.6 X 0.5 cm. and 4.0 x 2.5 x 1.7 cm., fragments of red. to gray-tan brain tissue, having a combined weight of 7.26 gm. SECTIONS: B1 - small fragment, entirely submitted, B2-B7 - larger fragment,. serially sectiond and entirely submitted. MICROSCOPIC DESCRIPTION. IMMUNOHISTOCHEMISTRY The GFAP demonstrates prominent glial fibrillogenesis. by the neoplastic cells. In part A, about 10% of the cells over express the. p53 protein, a phenomenon absent in part B. The CD34 depicts microvascular. cellular proliferation in specimen A. With the MIB-1 there are proliferation. indices of 22% and 58 in specimens A and B, respectively. These immuno profiles support the diagnosis of high histological grade. astrocytoma. ICD-9 (s) : 191 2 191 2. Histo Data. Part A; Brain. resection. Stain/cnt. Block. Comment. CD34-DA X 1. 1. EGFR x 1. 1. mGFAP-DA x 1. 1. H/E X 1. 1. MIB1-DA X 1. 1. P53D07 x 1. 1. H/E X 1. 2. H/E X 1. 3. Part B: Brain right temporal, resection. Stain/cnt. Block. Comment. H/E X 1. 1. H/E x 1. 2. H/E x 1. 3. H/E X 1. 4. H/E x 1. 5. H/E X 1. 6. MIB1-DA X 1. 6. P53D07 X 1. 6. H/E x 1.",val,
2480,TCGA-AJ-A2QK.01A114A2-098F-4AAD-9010-54910FB89B4A,"I. Sex: Female. MRN #: Ref Phy. SPECIMEN INFORMATION. Acct / Reg #. DIAGNOSIS. DIAGNOSIS: A. Omentum, biopsy: Tumor not identified. B. Left paraaortic lymph nodes, excision: Two lymph nodes, negative for metastatic disease. Frozen section diagnosis confirmed. C. Left paraaortic lymph nodes, excision: Three lymph nodes, negative for metastatic disease. D. Right paraaortic lymph nodes, excision: Three lymph nodes, negative for metastatic disease. E. Left pelvic lymph nodes, excision: Ten lymph nodes, negative for metastatic disease. F. Right pelvic lymph nodes, excision: Eight lymph nodes, negative for metastatic disease. G. Uterus, bilateral adnexa, hysterectomy with bilateral salpingoophorectomy: Cervix: Tumor Characteristics: 1. Histologic type: Endometrioid adenocarcinoma. 2. Histologic grade: 3. 3. Tumor site: Endometrium. 4. Tumor size: 5.0 x 2.7 cm. 5. Myometrial invasion: Tumor extends 0.7 cm into a 2.8 cm thick myometrium. 6. Involvement of cervix Not seen. 7. Extent of involvement of other organs: Not identified. 8. Lymphovascular space invasion: Focally present. Surgical Margin Status: 1. Margins uninvolved: Cervix, serosa, parametria. 2. Margins involved: None. Lymph Node Status: Number of lymph nodes received: See above. Other: 1. Other significant findings: a. Myometrium leiomyomata. b. Attached ovary with focus of stromal hyperthecosis. c. Separate ovary and bilateral fallopian tubes without evidence of malignancy. 2. PTNM stage: pT1aNO (FIGO IA). COMMENTS: Appropriately controlled immunochemical stains performed on blocks G3 show the following results: P53 - Focally positive in lesional cells. WT-1 - Negative in lesional cells. Cytokeratin 7 - Positive in lesional cells. Cytokeratin 20 - Negative in lesional cells. CDX2 - Negative in lesional cells. Inhibin - Negative in lesional cells. Additional controlled immunostains were performed on block G16 with the following results: Cytokeratin 7 - Negative in cellular proliferation. Cytokeratin 20 - Negative in cellular proliferation. CDX2 - Negative in cellular proliferation. P53 - Negative in cellular proliferation. WT-1 . Negative in cellular proliferation. Inhibin - Positive in cellular proliferation. Findings consistent with stromal hyperthecosis. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Omentum biopsy. B. Left paraaortic lymph nodes. C. Left paraaortic lymph nodes. D. Right paraaortic lymph nodes. E. Left pelvic lymph nodes. F. Right pelvic lymph nodes. G. Uterus, cervix, bilateral tubes and ovaries. SPECIMEN DATA. GROSS DESCRIPTION: A. The first container A is labeled. omentum biopsy. The specimen consists of a piece of yellow tan fibroadipose tissue measuring 1.5. x 1.0 x 0.5 cm. The specimen is bisected. There are no nodules grossly identified. The specimen is entirely submitted in a single cassette. B. The second container B is labeled. left paraaortic lymph nodes #2. The specimen consists of two probable lymph nodes measuring. 1.0 x 1.0 x 0.5 cm and 1.5 x 1.2 x 0.5 cm. The smaller piece has been inked. Each of the lymph nodes have been bisected. The lymph nodes are. entirely submitted in cassette. C. The third container C is labeled. left parasortic lymph node. The specimen consists of a portion of fibroadipose tissue measuring. 6.0 x 3.5 x 1.0 cm. Sectioning reveals three probable lymph nodes measuring from 0.5 to 1.8 cm. The lymph nodes are entirely submitted in cassettes. as follows: one probable node bisected-1; one probable node bisected-2; one probable node-3. D. The fourth container D is labeled. right parasortic. The specimen consists of a portion of flibroadipose tissue measuring 5.0 x 4.0 x. 1.5 cm. Sectioning reveais three probable lymph nodes measuring from 0.7 to 3.0 cm in greatest dimension. The fymph nodes are entirely submitted in. cassettes. 3 follows: two probable nodes-1; one probable node sectioned-2 to 5. E. The fifth container E is labeled. left pelvic lymph nodes. The specimen consists of a portion of fibroadipose tissue measuring 11.0 x. 7.0 x 3.0 cm. Sectioning reveais eleven probable lymph nodes measuring from 0.7 up to 2.5 cm. The lymph nodes are entirely submitted in cassettes. as follows: one probable node bisected-1 two probable nodes-2; one probable node bisected-3 and 4; one probable lymph node. orsecteu-3 anu u, one probable lymph node bisected-7 and 8; one probable tymph node bisected-9; one probable lymph node bisected-10; one. probable lymph node bisected-11 and 12; one probable lymph node bisected-13 and 14. F. The sixth container F is labeled. right pelvic lymph nodes. The specimen consists of a portion of fibroadipose tissue measuring 10.0. x 7.5 x 4.0 cm. Sectioning reveals seven prooable nodes measuring from 0.9 up to 4.2 cm. The lymph nodes are entirely submitted, with the. exception of the largest lymph node, in cassettes. as follows: one probable lymph node bisected-1; one probable lymph node. bisected-2; one probable lymph node bisected-3; two symph nodes-4; one probable lymph node-5; one probable lymph node sectioned-6 to. 9; representative sections from the largest lymph node-10 to 13. G. The seventh container G is labeled. uterus, cervix, bilateral tubes and ovaries. The specimen consists of a previously bisected. uterus with attached cervix, attached left adnexa and separately submitted right adnexa. The serosal surface of the uterus is gray to brown tan with. slight hemorrhage and adhesions. The serosa has been inked. Sections from the parametrium have been taken. The cervix measures 4.5 cm in length. and 3.5 cm in diameter. The ectocervix is gray to brown tan with hemorrhage. The endocervical canal is light tan and reveais normal mucosal folds. There are no masses identified. The endometrial cavity measures 6.0 cm in length and 4.0 cm in diameter. The lining is gray to brown tan and. hemorrhagic revealing a brown tan shaggy polypoid mass measuring 5.0 x 2.7 cm that is within 2.1 cm of the lower uterine segment. On sectioning the. mass extends into the underlying myometrium approximately 0.7 cm into a 2.8 cm myometrium. The myometrium is gray tan trabecular. There are. white tan whorled intramural masses identified measuring up to 0.9 cm. On sectioning there is no evidence of hemormhage or necrosis. The attached. ovary measures 3.0 x 2.0 x 1.0 cm. The surface is gray tan cribriform. On sectioning the cut surface is yellow to gray tan displaying corpus albicans. measuring up to 0.5 cm. The corresponding fallopian tube measures 3.0 cm in length and 0.3 cm in diameter. The surface is gray to brown tan. On. sectioning the fallopian tube appears grossly unmarkable. The separately submitted ovary measures 4.0 x 1.5 x 0.5 cm. The surface is gray tan. cribriform. On sectioning the cut surface is yellow to gray tan. There are corpus albicans measuring up to 0.5 cm identified. The corresponding. fallopian tube measures 8.0 cm in length and 1.0 cm in diameter. The surface is gray to brown tan. On sectioning the lumen is dilated measuring up to. 0.7 cm containina serosanquineous fluid. No other lesions are identified. Received with the specimen are three cassettes, one green, one blue, one. yellow, labeled. The. yellow one is adrlitional heled 16. green one additionally labeled 17, and the blue one additionally labeled 18. Representative sections are submitted in cassettes. as follows: anterior cervix-1; posterior cervix-2; full thickness sections from the. mass bisected as follows: one cross section-3 and 4; one cross secuon-5 and 6; one cross section-7 and 8; one cross section-9 and 10; polypoid attached. portion of the mass-11; lower uterine segment-12; left parametrium-13; right parametrium-14; sections from the myometrial masses-15;. ovary-16; corresponding tube-17; separately submitted ovary-18 corresponding tube-19.",val,
2504,TCGA-97-7938.c1b81542-c8ad-43d1-a963-1584868e7fe7,"SPECIMENS: 1. LEVEL 9 LYMPH NODES. 2. LUNG, RIGHT UPPER LOBE. 3. LEVEL 7 LYMPH NODES. 4. LEVEL 4 LYMPH NODES. 5. ADDITIONAL RIGHT UPPER LOBE MARGIN. 6. RIB. SEE ADDENDUM. Reason For Addendum #1: Molecular Studies. DIAGNOSIS: 1. LYMPH NODES, LEVEL 9: BIOPSY. - FRAGMENTS OF BENIGN ANTHRACOTIC LYMPH NODE, NEGATIVE FOR. CARCINOMA. 2. LUNG, RIGHT, UPPER LOBE: RESECTION. - ADENOCARCINOMA (1.5 CM), PREDOMINANTLY BRONCHIOLOALVEOLAR. (LEPIDIC), WITH A 0.9 CM FOCUS OF INVASIVE ADENOCARCINOMA OF ACINAR. AND MICROPAPILLARY PATTERNS. BRONCHOVASCULAR MARGIN, NEGATIVE FOR CARCINOMA. - FIBRONECROTIZING GRANULOMAS, SPECIAL STAINS NEGATIVE FOR FUNGI. AND. ACID FAST ORGANISMS (SEE COMMENT). - PLEURAL FIBROSIS. - BENIGN ANTHRACOTIC LYMPH NODES (0/2). 3. LYMPH NODES, LEVEL 7: BIOPSY. - FRAGMENTS OF BENIGN ANTHRACOTIC LYMPH NODE, NEGATIVE FOR. CARCINOMA. 4. LYMPH NODES, LEVEL 4: EXCISION. - BENIGN ANTHRACOTIC LYMPH NODE, NEGATIVE FOR CARCINOMA. 5. LUNG, RIGHT, UPPER LOBE, ADDITIONAL MARGIN: RESECTION. - NO CARCINOMA IDENTIFIED. - CARCINOID TUMORLET IN THREE FOCI (SPANNING 3 MM, 3 MM AND 2. MM). 6. RIB: RESECTION. SEGMENT OF RIB WITH NO DIAGNOSTIC ABNORMALITY, NEGATIVE FOR. CARCINOMA. Specimens: 1: LEVEL 9 LYMPH NODES. 2: LUNG, RIGHT UPPER LOBE. 3: LEVEL 7 LYMPH NODES. 4: LEVEL 4 LYMPH NODES. 5: ADDITIONAL RIGHT UPPER LOBE MARGIN. 6: RIB. LUNG: Resection. SPECIMEN. Procedure: Lobectomy. Specimen Integrity: Intact. Specimen Laterality: Right. Tumor Site: Upper lobe. Tumor Focality: Unifocal. TUMOR. Histologic Type: Adenocarcinoma. EXTENT. Tumor Size: Greatest dimension (cm). 1.5cm. Additional Dimension (cm): 1.5cm X 1cm. Visceral Pleura Invasion: Not identified. Tumor Extension: Not identified. MARGINS. Bronchial Margin. Bronchial Margin Involvement by Invasive Carcinoma: Uninvolved by. invasive carcinoma. Vascular Margin: Uninvolved by invasive carcinoma. Parenchymal Margin: Uninvolved by invasive carcinoma. ACCESSORY FINDINGS. Treatment Effect: Not applicable. Lymph-Vascular Invasion: Not identified. SPECIAL STUDIES. Epidermal Growth Factor Receptor (EGFR) Analysis Results (specify. method): To follow. KRAS Mutational Analysis (specify results): Positive for a p.G12C (c.34G>T) mutation in codon 12 of the KRAS. gene (see below). STAGE (pTNM). Primary Tumor (pT): pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung. or visceral pleura, without bronchoscopic evidence of invasion more. proximal than the lobar bronchus (i.e., not in the main bronchus);. or Superficial spreading tumor of any size with its invasive. component limited to the bronchial wall, which may extend proximally. to the main bronchus. Regional Lymph Nodes (pN). pN0: No regional lymph node metastasis. Distant Metastases (pM): Not applicable. ADDITIONAL NON-TUMOR. Additional Pathologic Finding(s): Inflammation (specify type). Necrotizing granuloma. interstitial fibrosis. Comment(s): The adenocarcinoma is positive for TTF-1. The carcinoid tumorlets. stain positively with. Correlation with microbiology. results suggested. Case reviewed in department consensus. conference. CLINICAL HISTORY AND PRE - OPERATIVE DIAGNOSIS: Lung cancer. MACROSCOPIC DESCRIPTION: The specimen is received in six parts, each labeled with the. patient's name. 1. Part one is received in saline, labeled 'level 9 lymph node'. It. consists of two irregular fragments of tan soft tissue measuring 0.8. X 0.5 X 0.2 cm and 0.6 X 0.4 X 0.2 cm. Entirely submitted in one. cassette. 2. Part two is received fresh, labeled 'right upper lobectomy'. It. consists of a portion of right upper lobe of lung, measuring 15.6 X. 3.8 cm. The staple line measures 15.5 cm. The staple line is shaved. and the pleura around the staple line is inked in green. The pleural. surface is pink tan glistening and reveals a thickened, bossellated. area with fibrous thickening. The bronchial margin measures 1.5 cm. and the vascular margin 1.2 cm. Beneath the thickened pleura there. is a firm gray area, measuring 1.5 X 1.5 X 1.0 cm, located 4.5 cm. from the staple line margin. Also noted a second separate firm gray. white area, measuring 1.5 cm in greatest dimension which upon. pressure exudes cheesy material. This mass is located 1 cm from the. staple line margin, also multiple anthracotic lymph nodes, ranging. from 0.2 cm to 0.5 cm identified from the hilar area. Representative. sections are submitted. 3. Part three is received in saline, labeled 'level 7 lymph node'. It consists of three irregular fragments of tan soft tissue. measuring 1.5 X 0.7 X 0.3 cm, 1.5 x 1 X 0.2 cm and 0.5 X 0.5 X 0.2. cm. Entirely submitted in two cassettes. 4. Part four is received in saline, labeled 'level 4 lymph node'. It consists of a 0.7 X 0.4 x 0.1 cm irregular portion of tan soft. tissue. Entirely submitted in one cassette. 5. Part five is received in saline, labeled 'additional right upper. lobe margin'. It consists of a 6.5 X 4.5 X 2.5 cm triangular-shaped. wedge of lung tissue, with a 6.5 cm long stapled line along one. edge, and two stapled lines along an adjacent edge measuring 3 cm. and 4 cm respectively. The specimen is photographed. The 6.5 cm. long stapled edge is inked black; the 3 cm long stapled edge. (adjacent to the 6.5cm long one) is inked blue; and the 4 cm long. stapled edge is inked green. The black and blue inked stapled lines. are at acute angles. The staples are trimmed off and the specimen. is serially sectioned, revealing no focal lesions or masses. Representative sections are submitted. 6. Part six is received in formalin, labeled 'rib'. It consists of. a 1.4 X 1.4 X 0.6 cm segment of rib with red marrow. Entire. specimen is submitted in one cassette, after decalcification. SUMMARY OF SECTIONS: 1A entirely submitted. 2A vascular margin. 2B bronchial margin. 2C-2J firm area. 2K staple line margin. 2L-2M second mass close to the staple line margin. 2N anthracotic lymph nodes. 3A-3B entirely submitted. 4A entirely submitted. 5A-5E representative sections. 6A rib, after decalcification. SPECIAL PROCEDURES: Decalcification, AFB, GMS, Chromogranin, TTF1. RESULTS: Positive for a p.G12C (c.34G>T) mutation in codon 12 of. the KRAS gene. INTERPRETATION: Mutations in the KRAS gene are reported to. correlate with poor prognosis and resistance to tyrosine kinase. inhibitor therapies in patients with non-small lung cancer. COMMENT: KRAS mutations occur in 15-30% of non-small-cell lung cancer (NSCLC). patients and are strongly associated with adenocarcinoma and smoking. history. This assay analyzes codons 12 and 13 in exon 2 of the KRAS gene;. based on the current literature, approximately 98% of mutations are. expected to occur in these codons. The analytical sensitivity of. the assay is approximately 10%; thus mutations present in a low. percentage of cells may not be detected. This test is validated for use in identifying KRAS codon 12 and. codon 13 mutations in fresh, frozen, or formalin-fixed paraffin. embedded tissue. In particular the test performance has been. established in samples of colorectal cancer and non-small cell lung. carcinoma which harbor these mutations, although several other. tissues are also known to harbor KRAS mutations (e.g. tumors of. pancreas, bile duct, ovary, appendix, etc.). METHOD/LIMITATION: Tissue sections are reviewed by a pathologist and relevant tumor is. selected for analysis. DNA is isolated from the sample, quantified. and amplified by polymerase chain reaction (PCR) using primers to. exon 2 of the KRAS gene. PCR products are subjected to single. nucleotide primer extension to detect mutations at codons 12 and 13;. primer extension products are analyzed using capillary gel. electrophoresis and fluorescence detection. False positive or. negative results may occur for reasons that include genetic variants. or somatic heterogeneity of the tissue sample. REFERENCES: This test was developed and its performance characteristics. determined by. It has not been cleared or approved by the. US Food and Drug Administration. The FDA has determined that such. clearance or approval is not necessary. This test is used for. clinical purposes. It should not be regarded as investigational or. for research. The laboratory is regulated under the. as qualified to. perform high complexity clinical testing. This particular test is. not considered a stand alone test and should be only used in the. context of other diagnostic tests or clinical work-up related to. treatment decisions. and its logo are trademarks of. and used by. a wholly-owned. subsidiary of. under license. and. are operated independently from. Final Diagnosis performed by. ADDENDUM #1: EGFR Mutation Analysis. Genzyme Specimen #. Body Site: Lung. Clinical Data: Adenocarcinoma. RESULTS: No mutation detected. INTERPRETATION: No mutations were identified; however 18-20% of. patients with non-small-cell lung cancer and without identifiable. mutations are reported to be responsive to EGFR tyrosine kinase. inhibitor therapies. COMMENT: This assay analyzes exons 18-21 of the EGFR tyrosine. kinase domain; based on the current literature, the vast majority of. mutations are expected to occur in these exons. The analytical. sensitivity of the assay is 10-20%, thus mutations present in a low. percentage of cells may not be detected. Most data published to date pertain to gefitinib. Similar data have been seen in studies using erlotinib (Tarceva(r)). This test is validated for non-small cell lung carcinoma. The. clinical significance and utility of this test in other tumor types. is unknown. METHOD/LIMITATION: Tissue sections are reviewed by a pathologist and relevant tumor is. selected for analysis. DNA is isolated from the samples, quantified. and amplified by polymerase chain reaction (PCR) using primers to. exons 18-21 of the EGFR gene. PCR products are analyzed by. bi-directional direct DNA sequencing using capillary electrophoresis. and fluorescence detection. False positive or negative results may. occur for reasons that include genetic variants or somatic. heterogeneity of the tissue sample. REFERENCES: DISCLAIMER: This test was developed and its performance characteristics. determined by. The laboratory is regulated under. the. as. qualified to perform high complexity clinical testing. This. particular test is not considered a stand alone test and should be. used only in the context of other diagnostic tests or clinical. work-up related to treatment decisions. and its logo are trademarks of. and used by. a wholly-owned. subsidiary of. under license. and. are operated independently from. Addendum performed by. The electronic signature attests that the named Attending. Pathologist has evaluated the specimen referred to in the signed. section of the report and formulated the diagnosis therein. This report may include one or more immunohistochemical stain. results that use analyte specific reagents. The tests were developed and their performance characteristics. determined by. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is not. necessary.",val,
2555,TCGA-Q2-A5QZ.5CDCBD3A-060E-4F28-9328-F1367B8572F1,"MEDICAL CENTER. LABORATORY. PAGE: 1. Specimen Inquiry. ACCT # : LOC: U# : AGE/SX: SPEC # : CLINICAL HISTORY : RIGHT RENAL MASS. SPECIMEN/PROCEDURE: 1. KIDNEY - RIGHT. IMPRESSION. RIGHT KIDNEY, RIGHT NEPHRECTOMY: Papillary renal cell carcinoma, type II, Fuhrman nuclear grade 3, with focal. renal capsule invasion. (Please see tumor checklist). Margins of resection, free of tumor. KIDNEY: NEPHRECTOMY, PARTIAL OR RADICAL CASE SUMMARY. PROCEDURE. Radical nephrectomy. SPECIMEN LATERALITY. Right. TUMOR SITE. Middle. TUMOR SIZE (largest tumor if multiple). Greatest dimension: 5.3 cm. Additional dimensions: 5.2 x 4.8 am. TUMOR FOCALITY. Unifocal. MACROSCOPIC EXTENT OF TUMOR. Tumor abutting the renal capsule with possible extension into perinephric tissue (beyond. renal capsule). HISTOLOGIC TYPE. Papillary renal cell carcinoma. SARCOMATOID FEATURES. Not identified. TUMOR NECROSIS (any amount). Present. HISTOLOGIC GRADE (FUHRMAN NUCLEAR GRADE). G3 : Nuclei very irregular, approximately 20 m; nucleoli large and prominent. (Continued) Page: 2. SPEC #: IMPRESSION: (continued). MICROSCOPIC TUMOR EXTENSION. Tumor extension into perinephric tissue (beyond renal capsule). MARGINS. Margins uninvolved by invasive carcinoma. LYMPH-VASCULAR (excluding renal vein and its muscle containing segmental branches and inferior vena cava (. INVASION. Absent. PATHOLOGIC STAGING (pTNM). PRIMARY TUMOR (pT). pT3a: Tumor invades perirenal and/or renal sinus fat but not beyond Gerota's fascia. REGIONAL LYMPH NODES (pN). No nodes submitted or found. DISTANT METASTASIS (pM). Not applicable. PATHOLOGIC FINDINGS IN NONNEOPLASTIC KIDNEY. Significant Tubulointerstitial pathologic alterations disease (specify type) : Chronic interstitial nephritis. Pathologic TNM (AJCC 7th edition) : pT3a. NX M. COMMENT. Case reviewed by. SPECIAL Immunohistochemical STAINS/PROCEDURES stains were performed with appropriate positive and negative controls. Pancytokeratin: Positive in tumor cells with likely perinephric tissue invasion. CD31: No difinite evidence of intravascular tumor invasion seen. GROSS DESCRIPTION: fresh, labeled with the patient's name, medical record number and (9.5 ""right x 7.8 x. kidney"" 1. Received is a 302 gram perirenal right radical fat measuring nephrectomy in thickness specimen including from 1.0 to kidney 2.0 cm. No adrenal by 0.3 6.8. cm) and is surrounding identified. Extending from the renal pelvis is a ureter (2.5 cm and in renal length artery (1. gland cm in in diameter diameter), by renal 0.4 cm vein in diameter). (0.5 cm in There length is by a 0.3 5.3 cm x 5.2 in diameter), x 4.8 cm pale-white tumor with. cm. SPEC #: (Continued) Page: 3. GROSS DESCRIPTION : (continued). focal areas of hemorrhage, located in the mid-portion of the kidney. The tumor abutts the. perirenal fat without penetrating the renal capsule. The tumor also does not involve renal. sinus fat or the renal pelvis. The remainder of the renal cortex is tan/brown with a. well-defined cortical medullary junction. The pelvis and calyces are covered by smooth. glistening mucosa. The adipose tissue is thinly sectioned and no lymphnodes are identified. A portion of the tumor is taken for TCGA research. Devitalization time: Freeze time: Ink code: black-outer surface of specimen. CASSETTE SUMMARY: CASSETTE 1A: renal artery, vein and ureter. CASSETTE 1B-1E: tumor abutting perirenal fat. CASSETTE 1G, 1H: tumor adjacent to renal sinus\. CASSETTE 1J: tumor with kidney parenchyma. CASSETTE 1K: normal kidney. CASSETTE 1L, 1M: additional sections of tumor with kidney parenchyma. Entered. COPIES TO: CPT Codes : IHC CD31-88342, KIDNEY, PART/TTL RESECTION TUMOR/88307, IHC KERATIN COCKTAIL-88342,. NEG MAB CONTROL/2. ICD9 Codes : 189.0. Resident Physician: I have personally reviewed the material. ( specimen/slide and approve this final report. END OF REPORT tt.",val,
2790,TCGA-FG-A4MX.E88FF565-EFD8-4E5D-87BC-A7210DE9F29C,"FINAL DIAGNOSIS: A. Right frontal mass: Diffuse astrocytoma (WHO grade 2). Feature S suggest anaplastic change. See. note. B. Tumor cyst wall: Scattered astrocytoma cells within white matte. C. Right frontal mass: Diffuse astrocytoma (WHO grade 2). See note. D. Tumor cyst wall: Scattered astrocytoma cells within white matte. E. Middle - right frontal mass: Scattered astrocytoma cells within white matter. F. Deep cyst wall: Cortex and white matter with cyst wall lined by moderately cellular, viable tumor. (15% of total tissue). Adjacent white matter with only scattered glioma cells. G. Anterior cyst wall: Cyst wall lined by moderately cellular, viable tumor (10% of total tissue). The. adjacent white matter shows no definite tumor (intraoperative smear G reviewed, and shows no. tumor). H. Deep to cyst wall: Fragments of white matter with mild hypercellularity and few atypical cells. No. cellular tumor. Technical Performing Location;. For. questions regarding this case: I. Deep to cyst wall: White matter with cyst wall lined by moderately cellular, viable tumor. Comment: This astrocytoma diffusely infiltrates white and gray matter. In some areas, especially the cyst. wall, the cells are associated with prominent microcystic change. Tumor cells have moderately. pleomorphic astrocytic nuclei, some naked and others with gemistocytic cytoplasm; other areas have a. more round, monotonous pattern suggestive of an oligodendroglioma component. Immunostain for p53 is. diffusely positive, however, arguing against an oligodendroglioma. Perineuronal satellitosis is seen. No. evidence of an underlying grade 1 tumor is seen (i.e. no EGBs, Rosethal fibers or noninfiltrative areas). No mitoses are present. Though the cellularity and pleomorphism are in some areas pronounced, no. mitoses, vascular endothelial proliferation or necrosis are present. Immunostain for MIB-1 (slide C3). shows a nuclear labeling rate of up to 6% (rates of greater than 3% are considered likely to represent. anaplastic change by Burger et al., Surgical Pathology of the Nervous System and its Coverings, 4th. ed.). Thus the tumor is WHO grade 2, but is likely to represent early anaplastic change. Molecular testing for. MGMT, 1p19q are in progress. BRAIN: Resection. MACROSCOPIC. Specimen Type. X Resection. Specimen Size. Greatest dimension: 4.3 x 4 x up to 2.7 cm. Tumor Site. X. Cerebrum: right frontal. Tumor Size. X. Cannot be determined. MICROSCOPIC. Histologic Type. X. Astrocytoma, diffuse. Histologic Grade. X. WHO Grade 2. Margins. X. Cannot be assessed. Additional Studies. X Molecular testing (specify): See above. Frozen Section Diagnosis: A. Right frontal mass. - Infiltrating glioma, features of an oligodendroglioma. (16 minutes) (. B. Tumor cyst wall I. - Glioma. (17 minutes). D. Foci of tumor present. (10 minutes). F. (white matter, SMF1): Glioma present. (cortex, SMF2): No tumor seen. (10 minutes). G. Anterior cyst wall. - Benign. I. Deep cyst wall 1. - Tumor present. Gross Description: A. Received fresh labeled with the patient's name,. and ""right frontal mass,"" is an. aggregate of tan-white tissue, fragments ranging from 0.3 cm to 0.6 cm in greatest dimension,. which are entirely submitted in. B. Received fresh labeled with the patient's name,. and ""tumor cyst wall,"" is a 1.0. x 0.3 x 0.2 cm fragment of tan-white tissue, which is trisected and entirely submitted in. C. Received fresh, labeled with patient's name,. and ""right frontal mass,"" is a 22. gram, 4.3 x 4 x up to 2.7 cm piece of irregular gray-tan brain tissue. The specimen is step. sectioned to reveal gray-tan-white cut surface. A portion of the tissue is taken for brain bank. Representative sections (about 30% of the total specimen) are submitted in cassette 1. D. Received fresh, labeled with patient's name,. and ""tumor cyst wall,"" is a 1.1 x. 0.7 x 0.2 cm irregular piece of gray-white soft tissue which is trisected and entirely submitted in. cassette. E. Received fresh, labeled with patient's name,. and ""middle - right frontal mass,"". is a 1.1 x 0.4 x 0.1 cm piece of irregular gray-white soft tissue which is entirely submitted in. cassette. F. Received fresh, labeled with patient's name,. ' and ""deep cyst wall,"" is a 2.3. gram, 3 x 2.2 x up to 0.8 cm piece of irregular gray-white soft tissue which is cross sectioned to. reveal gray-tan cortex with gray-white white matter. The specimen is entirely submitted in. cassettes. G. Received fresh, labeled with patient's name,. and ""anterior cyst wall,"" is a 0.6. gram, 2 x 1.1 x up to 0.4 cm piece of irregular white-tan soft tissue which is step sectioned and. entirely submitted in cassettes. H. Received fresh, labeled with patient's name,. and ""deep to cyst wall,"" is a 0.2. gram, 1 x 0.6 x 0.2 cm aggregate of multiple fragments of gray-white soft tissue which is entirely. submitted in cassette. I. Received fresh, labeled with patient's name,. and ""deep to cyst wall,"" is a 0.1. gram, 1 x 0.5 x 0.1 cm piece of irregular gray-white soft tissue which is sectioned and entirely. submitted in cassette. Microscopic Description: 20 H&E; p53 immunostain, MIB1, semiquant. I have reviewed all diagnostic slides and have edited the gross and/or microscopic portion of this report. as part of my pathologic assessment and final diagnosis. Amended Molecular Analysis Report. Test Performed. MGMT Methylation Assay. Specimen Type. Paraffin Block. Gene Methylation DETECTED. Methylation of the MGMT (O(6)-methylguanine-DNA methyltransferase) gene was detected using methylation specific PCR technologies. Methylation Score: 5.67. unmethylated <2.00. methylated >=2.00. Background. MGMT (O(6)-methylguanine-DNA methyltransferase) is a DNA repair enzyme that is involved in the repair of damage caused by a variety of. DNA crosslinking compounds, including alkylating agents. Increased methylation of the MGMT gene promoter region causes diminished or. silenced expression of the gene, making cells more sensitive to DNA damage. This relationship has been shown for glioblastomas and. alkylating agents such as Temodar(R)(temozolomide). Approximately 40% to 45% of glioblastoma multiforme (GBM) tumors exhibit MGMT gene methylation. Retrospective studies have shown that. detection of MGMT promoter methylation in tumor samples is associated with an increased likelihood of a favorable response to temozolomide. Methodology. DNA is isolated from formalin-fixed, paraffin-embedded (FFPE) specimen. Molecular analysis of the MGMT gene is performed by methylation-. specific PCR and detected on ABI7900. The MGMT and beta-Actin copy numbers will be used to calculate the ratio of MGMT/beta-Actin. x1000. Molecular-based testing is highly accurate, but as in any laboratory test, rare diagnostic errors may occur. Results of this test are for Investigational Purposes Only. The performance characteristic of this assay have been determined by. The. result should not be used as a diagnostic procedure without confirmation of the diagnosis by another medically established diagnostic product. or procedure. Comments. Block ID: Reference. 1. Vlassenbroeck I. et al. Validation of Real-Time Methylation-Specific PCR to Determine 0(6)-Methylguanine-DNA Methyltransferase Gene. Promoter Methylation in Glioma. J. Molecular Diagnostics 10; 4:332-337. 2008. 2. Hegi M. et al. MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma. New England J Medicine 352; 10:997-1003. 2005. 3. Brandes A. et al. MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant. Radiochemotherapy in Newly Diagnosed Glioblastoma Patients. J. Clinical Oncology 26; 13:2192-2197. 2008. 4. Hau P. et al. MGMT Methylation Status: The Advent of Stratified Therapy in Glioblastoma. Disease Markers 23:97-104. 2007. Director Review: DISCLAIMER: Testing performed at. Revision Reason: AMENDED REPORT. (Previously reported. This amended report is issued to correct a typographical error in the original report. The sentence in the Result. section has been changed from ""Methylation of the MGMT (O(6)-methylguanine-DNA methyltransferase) gene was. not detected using methylation specific PCR technologies."" to ""Methylation of the MGMT (O(6)-methylguanine-DNA. methyltransferase) gene was detected using methylation specific PCR technologies."" There are no other changes. to. the original report. This document contains private and confidential health information protected by state and federal law. If you received this document in error,. Chromosome studies performed by FISH on paraffin blocks of tumor (. -1 showed the following: Chromosome 1p intact. Chromosome 19q intact. Immunostain for IDH1. is positive.",val,
2860,TCGA-44-6775.cd641541-f607-49de-8f57-fa54b0561721,"Date Coll: SPECIMEN. A. R4 lymph node. B. Level 10 lymph node. C. Right lobe stitch marks probably. D. R4 lymph node. E. Level 7 lymph node. CLINICAL NOTES. FROZEN SECTION DIAGNOSIS. A) R4 lymph node, biopsy: Negative for carcinoma. GROSS DESCRIPTION. A. The specimen is received unfixed labeled ""R4 lymph. node"" and consists of multiple pieces of red and black soft. tissue measuring 1.8 X 1.7 X 0.3 cm. in aggregate. The entire. n is submitted for frozen section diagnosis as requested. B. Specimen is received unfixed labeled ""level 10 lymph. node. "" Specimen is received unfixed and consists of two. pieces of pink and red soft tissue measuring 2 X 0.7 X 0.4 cm in. aggregate. AS-1. C. The specimen is received unfixed labeled ""right lobe"". and consist of 175 gram lung lobe with a stapled margin. The specimen measures 12 X 8.5 X 6 cm. The pleural surface has a. clefted appearance and there is a central firm area by palpation. On cut section there is a central firm white mass, the white area. measures 4 by approximately 3 cm. In cross sectional dimension, a. portion of this area may be peritumoral change. A portion of. n is taken for research purposes. Sections after fixation. Block summary: 1-bronchial and vascular margin of resection, 2-next. level of bronchus and vessels, 3-4 tumor, 5, pulmonary margin, 7-11. tumor. D. Specimen is received unfixed labeled ""R4 lymph node"". and consists of a piece of black and red soft tissue. measuring 1 x 0.4 X 0.7 cm. AS-1. E. Specimen is received unfixed labeled ""level 7 lymph. node"" and consists of multiple pieces of red and black soft. tissue occupying approximately 2.5 mL in volume. AS-2. MICROSCOPIC DESCRIPTION. A. Multiple lymph node pieces are negative for malignancy. B. There is no evidence of malignancy in either of 2 lymph nodes. C. Tumor type: Adenocarcinoma. Tumor grade: 2. Mitotic Index: 12 mitoses/10 HPFs (1 HPF = 0.19 sq mm). Tumor size: 4 cm. Bronchial resection margin: Negative for malignancy. Pulmonary margin of resection: Negative for malignancy. Pleura: Negative for malignancy. Vascular invasion: Absent. Attached lymph nodes: There is no evidence of malignancy. in. one peribronchial lymph node. pTNM Stage: T2a. Non-tumorous lung: Unremarkable. D. A single lymph node is negative for malignancy. E. Multiple lymph node pieces are negative for malignancy. 3x4, 4,14. DIAGNOSIS. A. Lymph node, R4, biopsy: Negative for malignancy. B. Lymph node, level X, biopsy: There is no evidence of malignancy. in either of 2 lymph nodes. C. Lung, right lobe, resection: Moderately well-differentiated. adenocarcinoma. D. Lymph node, R4, biopsy: A single lymph node is negative for. malignancy. E. Lymph node, level VII, biopsy: Negative for malignancy. End Of Report ---.",val,
2955,TCGA-CV-7091.1a77fe57-e3ae-4897-824b-ef8a1b7e5fc8,"Case imported from legacy computer system. The format of this report does not match the original  case. For cases prior to. the section ""SPECIMEN"" may have been added. SUPPLEMENTAL REPORT. DIAGNOSIS: COMPOSITE RESECTION ANTERIOR MANDIBLE: POORLY DIFFERENTIATED SQUAMOUS CARCINOMA INVADING BONE. Mandibular margins of resection free of tumor. Entire report and diagnosis completed by: DIAGNOSIS. (A) LEFT NECK CONTENTS, LEVELS I, II, III: Fourteen lymph nodes free of tumor (0/14). Salivary gland with fibrosis and inflammation consistent with. radiation effect. (B) RIGHT NECK CONTENTS, LEVELS I, II, III: Eleven lymph nodes free of tumor (0/11). Salivary gland free of tumor. ANTERIOR LABIAL MARGIN: Squamous mucosa, no tumor present. COMPOSITE RESECTION ANTERIOR MANDIBLE, FLOOR OF MASS, VENTRAL TONGUE: INVASIVE SQUAMOUS CELL CARCINOMA, POORLY DIFFERENTIATED. Tumor thickness 1.4 cm. LYMPHOVASCULAR INVASION PRESENT. Perineural invasion not identified. Margins of resection free of tumor. Sections of mandible are pending for decalcification. (E). LEFT GINGIVAL LINGUAL SULCUS: Squamous mucosa, no tumor present. (F). LEFT LINGUAL MARGIN: Squamous mucosa, no tumor present. ANTERIOR LINGUAL MARGIN: Squamous mucosa, no tumor present. RIGHT LINGUAL MARGIN: Squamous mucosa, no tumor present. RIGHT GINGIVAL LINGUAL SULCUS: Squamous mucosa, no tumor present. TEETH: Multiple teeth, gross diagnosis only. Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) CONTENTS LEFT LEVEL I, II, III NECK - specimen received in three. containers. LEVEL 1 - A portion of fibromuscular tissue, 5.0 X 4.5 X 1.5 cm. A. portion of salivary gland, 2.5 X 1.5 x 1.0 cm, is present. No tumor is. identified in the salivary gland tissue. Multiple lymph nodes, 0.2-1.0 cm in. greatest dimension, are identified, grossly negative. SECTION CODE: A1, representative section from salivary gland tissue; A2,. one bisected lymph node; A3, one bisected lymph node; A4, three lymph nodes;. A5, three lymph nodes; A6, one bisected lymph node. LEVEL 2: A portion of fibromuscular tissue, 3.0 X 2.0 X 1.2 cm. One. possible lymph node, 0.5 cm in greatest dimension, is identified. The. remainder of the tissue consists predominantly of fibroadipose tissue and. vessels. Negative for tumor. SECTION CODE: A7, one possible lymph node; A8 and A9, remainder of level. 2 in toto. CONTENTS OF LEFT NECK LEVEL 3: A fragment of fibroadipose tissue, 6.0 X. 1.0 X 0.5 cm. Six lymph nodes, 0.3-1.5 cm, are identified. No tumor is. identified. SECTION CODE: A10, one bisected lymph node; A11, one bisected lymph. node; A12, one bisected lymph node; A13, multiple lymph nodes. (B) CONTENTS RIGHT NECK - Specimen received in three containers. LEVEL 1: Fibroadipose tissue and salivary gland tissue in toto, 5.7 x 4.0. X 1.7 cm. The salivary gland measure 2.7 x 1.8 x 1.5 cm. Grossly negative. for. tumor. Five lymph nodes, 0.9 cm up to 1.7 cm in greatest dimension, are. identified; all grossly negative for metastasis. SECTION CODE: B1, representative section from salivary gland; B2, one. bisected lymph node; B3, one bisected lymph node; B4, one bisected lymph node;. B5, one bisected lymph node; B6, one bisected lymph node. CONTENTS RIGHT NECK LEVEL 2: A fragment of fibroadipose tissue and. muscular tissue, 4.0 X 2.7 x 0.9 cm. Three lymph nodes are identified at this. level measuring from 1.2 up to 2.3 cm in greatest dimension. All lymph nodes. are grossly negative for metastasis. SECTION CODE: B7 and B8, largest lymph node, bisected; B9, one bisected. lymph node; B10, one bisected lymph node. CONTENTS RIGHT NECK LEVEL 3: A portion of fibroadipose tissue, 6.0 X 1.0. X 0.6 cm. Three lymph nodes, 0.9 cm-1.5 cm, are identified. All lymph nodes. are grossly negative for metastasis. SECTION CODE: B11, one bisected lymph node; B12, one bisected lymph. node; B13, one bisected lymph node. (c) ANTERIOR LABIAL MARGIN - A slenuer strip (4.7 X 0.3 X 0.3 cm). without any orientation. Entirely frozen for intraoperative consultation in. c. FS/DX: BENIGN SQUAMOUS MUCOSA AND SOFT TISSUE, NO TUMOR PRESENT. FS/DX: BENIGN SQUAMOUS MUCOSA AND SOFT TISSUE, NO TUMOR PRESENT. (D) COMPOSITE RESECTION ANTERIOR MANDIBLE, FLOOR OF MOUTH, VENTRAL TONGUE - A. composite resection specimen (6.0 X 6.0 x 6.0 cm) consisting of anterior. mandible (6.0 X 6.0 X 2.5 cm), floor of mouth and ventral tongue (3.0 X 2.0 X. 2.0 cm). There is an ulcerating, tan-gray, firm tumor involving the medial floor. of mouth obliterating the Tingual frenulum and eroding anteriorly through the. mandible to involve the alveoli of the two first incisors and the left second. incisor. The tumor protrudes into the vestibular gingiva and is located. within 0.5 cm of the anterior gingival margin and 1.5 cm of the deep soft. tissue margin. All resection margins appear grossly uninvolved. The. remaining teeth, mandible, tongue, and soft tissues of the floor of mouth are. unremarkable without discrete Tesions. SECTION CODE: D1-D12, representative of tumor. The involved dental. alveoli are submitted to the bone lab for decalcification and sectioning. LEFT GINGIVAL LINGUAL SULCUS - A 1.3 cm slender strip of mucosa, entirely. frozen in E. FS/DX: NO TUMOR PRESENT. (F). LEFT LINGUAL MARGIN - A 3.2 cm Slender strip of mucosa, entirely frozen. in F. FS/DX: NO TUMOR PRESENT. ANTERIOR LINGUAL MARGIN - A 2.7 CM slender strip of mucosa, entirely. frozen in G. FS/DX: NO TUMOR PRESENT. . RIGHT LINGUAL MARGIN - A 2.1 CIII STEnder strip of mucosa, entirely frozen. in H. FS/DX: NO TUMOR PRESENT. RIGHT GINGIVAL LINGUAL SULCUS - A 1.3 cm slender strip of mucosa,. entirely frozen in I. FS/DX: NO TUMOR PRESENT. TEETH - Multiple teeth and fragments of teeth including incisors,. premolars, canines and molars some of which have amalgam. No sections taken,. gross documentation only. SNOMED CODES. M-80703 r-11180.",val,
2997,TCGA-AC-A3EH.3094774B-B764-4D60-BFF3-48FEF39F4BEA,"Sex: Female. DIAGNOSIS. DIAGNOSIS: Breast, right, axillary contents; modified radical mastectomy and axillary node dissection: Tumor Characteristics: 1. Histologic type: Pleomorphic lobular carcinoma, confirmed by negative e-cadherin stain. 2. Size: 10.0 x 10.0 x 7.2 cm. 3. Tumor focality: Unifocal. 4. Elston modification of Bloom-Richardson grade: a. Architectural score: 3/3. b. Nuclear score: 2/3. C. Mitotic score: 1/3. d. Total score: 6/9 = Grade: II. 5. In situ component: Not identified. 6. Lymphovascular space invasion: Present. 7. Skin involvement Not identified. 8. Microcalcifications: Present and associated with invasive carcinoma. Surgical Margin Status: 1. Deep surgical margin free of tumor by 2.5 cm as measured grossly. Lymph Node Status: 1. Total number of lymph nodes received: 12. 2. Total number of lymph nodes containing metastatic carcinoma: 3. Size of largest metastasis: 2.5 cm. 4. Extracapsular extension of tumor: Present. Other: 1. pTNM stage: pT3 N2. CLINICAL INFORMATION: CLINICAL HISTORY: Preoperative Diagnosie: Right MET. Postoperative Diagnosis: Symptams/Radiologic Findings: SPECIMENS: Right breast and axillary contents. at. SPECIMEN DATA. GROSS DESCRIPTION: The specimen is received. right breast and axillary contents the specimen consists of a portion of fibroadipose breast tissue and overlying. skin that measures 18.0 by 8.0 cm and weighs 1,529 gm. The skin surface measures 23.0 x 13.8 cm is light tan wrinkled there is a scar within the outer. quadrant measuring 3.0 cm that is 9.2 cm in the nipple there is slight ecchymosis noted within the upper outer quadrant. No other lesions are identified. The. nipple. is. eccentrically. placed appears grossly unremarkable. Sectioning reveais a firm gray-tan lobular mass that measures 10.0 x 10.0 x 7.2 cm. that is centrally located it is within 2.5 cm of the deep margin of resection the surrounding breast tissue reveais yellow-tan fatty fibroadipose tissue with. areas. of. gray fibrous tissue. Attached to the specimen is a portion of axillary contents measuring 10.0 x 6.0 x 3.0 cm there are twelve possible lymph. nodes that measure from 0.3 to 2.7 cm. Received with the specimen is a separate piece of skin and underlying subcutaneous tisaue 14.0 x 4.0 x 1.5. cm. sectioning cut surface is yellow-tan fatty fibroadipose tissue lesions not identified grossly. Received with specimen are three cassettes labeled. with. a. yellow. one. additionally. labeled -16 green one additionally labeled - 17 and the blue one additionally labeled - 18. Representative. sections are submitted in cassettes labeled. las follows: Nipple - block 1; Deep margin overlying mass - block 2; Sections from the mass -. blocks 3-8; Random sections from the upper inner quadrant - block 9; Lower inner quadrant - block 10; Lower outer quadrant - block 11; Upper outer. quadrant - block 12; Six probable nodes - block 13; Two probable nodes each bisected - block 14; One probable node bisected block 15; One probable. node. trisected - block 16-18; One probable node bisected - block 19; One probable lymph node sectioned - blocks 20-23; Sections from separately.",val,
3081,TCGA-55-A4DF.25E84F93-E9AF-4A09-B3A9-86C5AC80BD4A,"PROCEDURE DATE: REPORT DATE: 10 Consultation. FS DIAGNOSIS: #1: ""No neoplasm consistent with organizing pneumonia"" reported to. Dr. positive patient ID, by Dr. Campus. #2: ""Adenocarcinoma"" reported to Dr. positive patient. ID, by Dr. Pre-Op Diagnosis. Right lower and upper lobe mass. Post-Op Diagnosis. Same as above. Clinical History. Nothing indicated. Gross Description: Five parts. Container labeled. 1 - right lower lobe wedge #1"". is a previously sectioned wedge shaped portion of recognizable. pulmonary parenchyma with a closed staple line as the margin of. resection. The specimen as received weighs 4.3 grams and on. reconstruction measures approximately 4.5 x 1.6 x 1.4 cm. The. pleura is wrinkled gray red. The cut surface is rubbery to spongy. and pink red without discrete gross mass lesion. The portion. submitted for frozen section is reported as ""no neoplasm consistent. with organizing pneumonia"" reported to. positive. patient ID, by. The frozen residue is submitted labeled. A. The remaining tissue is sectioned and submitted labeled B-D. Container labeled. 2 - right lower lobe wedge #2"". is a previously sectioned partially fragmented wedge shaped portion. of recognizable pulmonary parenchyma weighing as received 22 grams. and on reconstruction measures approximately 5.7 X 4.2 x 3.0 cm. the closed staple line is the margin of resection. The pleura is. wrinkled gray pink with an eccentric 2.5 X 2.5 cm plaque like area. of tan gray discoloration and umbilication noted 0.8 cm from the. nearest staple line margin. This is sectioned to reveal a well. defined lobulated gritty gray tan fibrotic lesion with focally. anthracotic gritty gray tan fibrotic cut surface measuring 2.7 x 2.5. x 2.0 cm. This grossly extends to but not through the pleura. The. remaining parenchyma is spongy and pink red. The portion submitted. for frozen section is reported as ""adenocarcinoma"" reported to Dr. ositive patient ID, by Dr. In addition, there. are three tissue cassettes within the specimen container labeled. The frozen residue is submitted labeled A. The. remaining lesion and surrounding tissue is submitted labeled B-H. Representative remaining parenchyma is submitted labeled I-J. Container labeled. 3 - right upper lobe wedge"". has a 15 gram wedge shaped portion of recognizable pulmonary. parenchyma with a closed staple line as the margin of resection. The specimen is 6.0 x 3.0 x 2.1 cm. The pleura is slightly wrinkled. pink red with marked anthracotic streaking and a few areas of. apparent plaque like thickening up to 0.8 cm which are poorly. defined. On sectioning in the central portion of the specimen there. is an intraparenchymal 1.0 x 0.9 x 0.7 cm lobulated gray tan. fibrotic nodular lesion noted 0.4 cm from the nearest staple line. margin. This has a gritty gray tan fibrotic cut surface. The. remaining parenchyma is spongy congested and markedly anthracotic. streaked with moderate honeycombing. The specimen is step sectioned. and entirely submitted in 10 cassettes. Container labeled. 4 - level 4 lymph node"" are. 1.6 X 1.0 x 0.3 cm of gray brown to black fleshy tissue fragments. which are entirely submitted in a single cassette. Container labeled. 5 - level 7 lymph node"" are. 4.0 x 2.2 x 1.1 cm partially fragmented lobulated portion of fleshy. gray black tissue with a slightly mottled fleshy gray black cut. surface. This is received along with 1.2 x 0.9 x 0.4 cm of similar. irregular tissue fragments. The largest portion is sectioned and. submitted labeled A-E while the smaller portion is entirely. submitted labeled F. Microscopic Description: Sections of specimen #2 show a large cell malignant neoplasm that in. areas shows prominent gland formation. These glandular area blend. into more solid nests of neoplastic cells. These are supported by a. dense fibrous stroma and alternate with areas of necrosis. The. neoplasm extends into the pleural but not onto the pleural surface. Sections of the neoplasm within the right upper lobe specimen #3. show a large cell malignant neoplasm with a distinctly different. growth pattern. In this neoplasm the cells form sheets that have. irregular borders. The cells have a moderate amount of eosinophilic. cytoplasm and enlarged pleomorphic nuclei. Sections of the lymph node specimens show no areas of metastatic. carcinoma. Immunohistochemical stains are performed on the neoplasm in the. right lower lobe specimen and right upper lobe specimen. The right. lower lobe specimen shows the neoplasm to be positive for CK7 and. negative for CK20. Some of the cells are strongly positive for. TTF1. These are in the more glandular areas. The more solid areas. are negative for this marker. The more solid areas do express. positivity for CDX-2 where the glandular areas tend to be negative. for this marker. The cells are negative for p63. This staining. pattern would support this being an adenocarcinoma of pulmonary. origin. It is unclear why some of the cells mark with the. colorectal marker CDX-2. This same panel performed on the right. upper lobe specimen show the neoplastic cells to be negative for. both CK7 and CK20. The cells are negative for CDX-2 and TTF1. The. cells are strongly positive for p63. This staining pattern would. support this being a squamous carcinoma that is very poorly. differentiated. The immunohistochemical control slides stain. appropriately. Final Diagnosis. Right lung lower lobe wedge biopsy #1 with frozen section: Negative for carcinoma. Alveolar changes focally with pneumocyte hyperplasia consistent. with organizing pneumonia. and atelectasis. Frozen section diagnosis is confirmed. Lung, right lower lobe wedge biopsy #2 with frozen section: Tumor characteristics: Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor size: 2.7 x 2.5 x 2.0 cm. Tumor focality: Single focus of right lower lobe. Visceral pleural invasion: Yes (PL1). Lymphovascular space invasion: Not identified. Tumor extension: Not identified. Treatment effect: Not identified. Surgical margin status: Tumor distance from bronchial margin: Not applicable. Tumor distance from stapled margin: 0.8 cm. Lymph node status: See specimens four and five. Lung, right upper lobe, wedge biopsy: Histologic type: Poorly differentiated squamous carcinoma (see. above comments). Histologic grade: Poorly differentiated. Tumor site: Right upper lobe. Tumor focality: Right upper lobe, single focus. Tumor size: 1.0 x 0.9 x 0.7 cm. Visceral pleural invasion: Not identified. Lymphovascular space invasion: No. Tumor extension: No. Treatment effect: Not identified. Surgical margin status: Tumor distance from bronchial margin: Not applicable. Tumor distance from parenchymal stapled margin: 0.4 cm. Tumor distance from pleural surface: 0.8 cm (as measured on. histologic sections). Lymph node status: See specimens four and five. Lymph node level 4, excisional biopsy: Negative for tumor (0/1). Lymph node level 7, excisional biopsy: Negative for tumor (0/1). Pathology stage: Comments. The tumor morphology present in specimen three shows focal areas. with morphology compatible with a poorly differentiated. adenocarcinoma. The possibility of focal squamous differentiation. cannot be completely excluded.",val,
3107,TCGA-BQ-5880.4e539a50-675d-401e-9138-efb5b9111d01,"Clinical Diagnosis & History: 79 y/o male with left renal mass. Specimens Submitted: 1: SP: Kidney, Left, Total nephrectomy: 2: SP: Lymph nodes, Left suprahilar and hilarand left adrenal, resection. 3: SP: Lymph nodes, Para-arotic, excision. DIAGNOSIS: 1. SP: Kidnoy, Left, Total nephrectomy: Tumor Type: Renal coll carcinoma . Papillary type. Type 2. Fuhrman Nuclear Grade: Nuclear grade III/IV. Tumor Size. Greatest diameter is 7.5 cm,. Local Invasion (for renal cortical types): Extends through renal capsule but confined within Gerota's fascia. Renal Vein Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Chronic inflammation. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT3a Tumor invades the adrenal gland or perinephric tissues but not beyond Gerota's fascia. 2. Lymph nodes, left suprahilar and hilar and left adrenal, resection: - Renal cell carcinoma, papillary type involving perirenal adipose tissue. - Unremarkable adrenal gland. 3 SP: Lymph nodes, Para-arotic, excisioni. lymph Nodes: Number of nodes examined: T1. Number of metastatic nodes:6. The largest metastatic node is 3.5cm. Perinodal (extracapsular) extension identified. TATTEST THAT THE ABOVE DIAGNOSIS is BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (ANDIOR OTHER MATERIAL), AND THAT THAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1) The specimen is received fresh labeled ""left kidney"" and consists of a kidney with attached ureter, renal vessels and perinephric. fat weighing 285 9 in total. The kidney measures 10.0 x 6.5 x 4.5 cm. The attached ureter measures 2,5 cm in length and 0.5 cm. in diameter. The attached renal vein measures 0.8 cm in length and 0.7 cm in diameter. The renal vessels and ureter margins are. grossly unremarkable. An adrenal gland is not identified grossly. The kidney is inked black and bivalved to reveal an ill-defined. bright-yellow tumor, located at mid portion of kidney and protruding out and involving the perinephric fat, measuring 7.5 x 5.5 x 5.0. cm. Sections through the remainder of the kidney reveal a pink brown parenchyma, with a well-defined cortico-medullary junction. The cortex measures 1.0 cm and the calyces appear normal. No lymph nodes are identified in the perinephric fat. Representative sections are submitted for TPS and for permanent sections. Summary of sections: UVM -- ureteral and vessel margins. T-. tumor. THF tumor with hilar fat. TSF -- tumor with sinus fat. TK -- tumor with adjacent kidney. RP renal pelvis representative sections. K -- representative sections kidney. F-hilar fat. 2) The specimen is received fresh labeled ""Left suprahilar, and hilar lymph node and left adrenal"". It consists of a segment of. yellow-tan fatty lobular tissue containing the adrenal gland and adjacent encapsulated, seemingly intact red-brown mass. The. overall dimensions of the specimen are 14.5x5: x 3 cm. The adrenal measures 4.5 x 1.2 x 1.0 cm, and on cut section shows. unremarkable yellow orange appearance. The red-brown mass measures 4 4x3 cm, is located directly adjacent to the adrenal. gland, but does not show any definite involvement of the gland. The outer surface of the mass is inked black. On cul section of. the mass, it shows cystic, markedly friable dark red hemorrhagic appearance filled with hemorrhagic material No lymph nodes are. grossly identified. Representative sections are submitted A sample of the mass is given to TPS. The specimen has been. photographed. Summary of sections: ADR-adrenal. M-Mass. ADRM-adrenal and mass. 3). The specimen is received in formalin labeled Para-aortic lymph nodes. It consists of multiple lymph nodes ranging from 0.3. x 0.3 cm up to 3.5 x 2.5 cm in greatest dimensions. Cut section of one of the largest lymph nodes shows mottled yellow orange lo. black appearance. Representative sections of this and one of the lymph node are submitted. The largest lymph node is. quadrisected to show predominantly yellow-tan fally lobular appearance with focal firm white-tan areas. After the largest lymph. node is quadrisected, each of the sections is bisected. The remainder of the lymph nodes are entirely submitted. Summary of sections: A-section of largest lymph node, bisected. B- section of largest lymph node, bisected. C-section of largest lymph node, bisected. D-section of largest lymph node, bisected. RS1-representative sections of one of the largest lymph nodes. RS2- representative section of one of the largest lymph nodes, bisected. LN - lymph nodes. BLN1 - bisected lymph node 1. BLN2 - bisected lymph node 2. BLN3 - bisected lymph node 3. Summary of Sections: Part 1: SP: Kidney, Left, Total nephrectomy: Block. Sect. Site. PCs. 1. 1. 1. k. 1. 1. 1. 5. 5. 1. thf. 1. 1. tk. 1. 1. itsf. 1. 1. uvm. 1. Part. 2: SP: Lymph nodes, Left suprahilar and hilar and left adrenal, resection. Block. Sect. Site. PCs. 3. adr. 3. 1. adrm. 5. m. 5. Part 3: SP: Lymph nodes, Para-arotic, excision. Block. Sect. Site. PCs. 2. a. 2. 2. b. 2. 1. bIn 1. 1. 1. bln2. 1. 1. bln3. 1. 2. c. 2. 2. d. 2. 1. In. 1. 2. rs1. 2. 2. rs2. 2.",val,
3238,TCGA-CR-6488.72d1836c-dd9f-4354-9a6b-6bcfe7d71c84,"DIAGNOSIS: 1) VENTRAL TONGUE MARGIN, EXCISION: SQUAMOUS MUCOSA, NEGATIVE FOR. MALIGNANCY. 2) FLOOR OF MOUTH MARGIN, EXCISION: SQUAMOUS MUCOSA, NEGATIVE FOR. MALIGNANCY. 3) TONGUE, DORSAL ANTERIOR MARGIN, EXCISION: SQUAMOUS MUCOSA, NEGATIVE FOR. MALIGNANCY. 4) TONGUE, DORSAL POSTERIOR MARGIN, EXCISION: SQUAMOUS MUCOSA, NEGATIVE FOR. MALIGNANCY. 5) TONGUE, LEFT, HEMIGLOSSECTOMY: MODERATELY-DIFFERENTIATED SQUAMOUS CELL. CARCINOMA, 2.5 CM IN GREATEST EXTENT, PERINEURAL INVASION PRESENT,. EXTENDING TO WITHIN 0.3 CM OF MEDIAL MARGIN AND 0.4 CM OF DEEP MARGIN, ALL. SURGICAL MARGINS NEGATIVE FOR TUMOR; SEE COMMENT AND SUMMARY FINDINGS. 6) LYMPH NODES, LEFT NECK, LEVEL 1B, EXCISION: 8 LYMPH NODES, NEGATIVE FOR. MALIGNANCY (0/8); BENIGN SALIVARY TISSUE. 7) LYMPH NODES, LEFT NECK, LEVEL 2 & 3, EXCISION: 14 LYMPH NODES, NEGATIVE. FOR MALIGNANCY (0/14). COMMENT: These findings correspond to AJCC. Edition pathologic Stage II. (pT2, NO, M n/a). Upper Aerodigestive Tract-including Minor Salivary Glands, Lip, Oral. cavity, Nasal Cavity, Paranasal Sinuses, Oropharynx, Nasopharynx, and. Hypopharynx Summary of Findings: Specimen Type: hemiglossectomy. Tumor Site: left tongue. Tumor Size: 2.5 cm in greatest dimension. Laterality: X Left. X. Margin uninvolved by invasive carcinoma extending to within 0.3 cm of. medial margin, 0.4 cm of deep margin. (Specify distance to closest margins). Histologic Type: squamous cell carcinoma. Histologic Grade: moderately differentiated. Pathologic Staging (pTMN). Primary tumor (pT): pT2. Regional Lymph Nodes (pN): pNO. Number examined: 22. Numbered involved: 0. Perineural invasion: (Select one). X Yes. Bony/Cartilage Invasion: (Select one). X. Not evaluable. Lymph-Vascular invasion: (Select one). X. HPV testing ordered: NO (performed on oral cavity and oropharyngeal. squamous cell carcinomas). CLINICAL DATA. Clinical Features: Unspecified. Operator: Operation: Unspecified. Operative Findings: Unspecified. Operative Diagnosis: Unspecified. Tissue Submitted: 1) ventral tongue margin; 2) floor of mouth. margin; 3) dorsal anterior tongue margin;. 4) dorsal posterior tongue margin; 5)left. glossectomy; 6)left neck level 1B; 7)left. neck level 2 & 3. GROSS DESCRIPTION: 1) SOURCE: Ventral Tongue Margin. Received fresh for intraoperative consultation in a container identified. with the patient's name and medical record number is a sample labeled. ""ventral tongue margin."" The sample consists of a 3.0 X 0.4 X 0.2 cm thin. strip of skin. The sample is bisected (inked green where sample is. bisected) and submitted in entirety for frozen section analysis. The tissue. block was fragmented during frozen section analysis and specimen was. refrozen. The remainder of the sample is submitted in entirety for. permanent sections. Summary of sections: 1AFSC, 2/1. 2) SOURCE: Floor of Mouth Margin. Received fresh for intraoperative consultation in a container identified. with the patient's name and medical record number is a sample labeled. ""floor of mouth margin.' The sample consists of a 3.8 X 0.3 X 0.2 cm. portion of skin with associated soft tissue. The sample is bisected (area. where sample is bisected is inked green). The sample is then submitted in. entirety for frozen section analysis and the remainder for permanent. section. Summary of sections: 2AFSC, 4/1. 3) SOURCE: Dorsal Anterior Tongue Margin. Received fresh in a container labeled with the patient's name and ""dorsal. anterior tongue margin"" is a single fragment of pink-tan soft tissue. measuring 4.0 X 0.2 X 0.2 cm and containing a pink-tan mucosal surface. along one edge of the specimen. The specimen is bisected and the cut edges. of each resulting fragment are inked in black. The specimen is submitted in. its entirety for frozen section evaluation in a single cassette. Summary of sections: 3AFSC, 2/1. 4) SOURCE: Dorsal Posterior Tongue Margin. Received fresh in a container labeled with the patient's name and ""dorsal. posterior tongue margin"" is a single fragment of unoriented, pink-tan soft. tissue, which measures 4.5 X 0.2 X 0.2 cm and contains a pink-tan mucosal. surface along one edge of the specimen. The specimen is bisected and the. cut edges of the resulting fragments are inked in black. The specimen is. submitted in its entirety for frozen section evaluation in a single. cassette. Summary of sections: 4AFSC, 2/1. 5) SOURCE: Left Glossectomy. Received fresh in a container labeled with the patient's name and ""left. glossectomy, stitch = anterior"" is a hemiglossectomy specimen measuring 7. cm from anterior to posterior X 5.5 cm from medial to lateral X 3 cm from. superior to inferior. A surgical suture is attached to one aspect of the. specimen, which is consistent anatomically with the anterior aspect. The. overlying mucosal surface of the specimen is pink-tan, smooth, shiny, and. remarkable for an area of central ulceration measuring 1.5 X 1.0 cm. This. area of ulceration overlies a palpable, firm mass exhibiting approximate,. palpable dimensions of 2.5 cm from anterior to posterior X 2.0 cm from. medial to lateral X 1.5 cm from superior to inferior. The opposite surface. of the specimen is red-brown and focally cauterized. The specimen is inked. in the following manner: anterior orange, medial purple, posterior yellow,. lateral blue, and deep black. The specimen is serially sectioned from. anterior to posterior to reveal a heterogeneous, white-tan mass with focal. areas of hemorrhage present immediately inferior to the mucosal surface and. exhibiting maximal dimensions of 2.5 cm transversely X 1.3 cm in maximal. depth X 1.5 cm from anterior to posterior. The mass appears to extend to. within 1.4 cm of the medial surgical margin, 1 cm of the lateral surgical. margin, 1 cm of the deep surgical margin, and appears widely free of the. anterior and posterior margins. Representative sections are submitted for. evaluation. Summary of sections: 5A-5B, perpendicular approach to medial and deep. margins, 1/1 each; 5C, perpendicular approach to lateral margin, 1/1; 5D,. additional approach to lateral margin, 1/1; 5E, representative tumor, 1/1;. 5F, representative perpendicular approach to posterior margin, 1/1; 5G,. representative approach to anterior margin, 1/1. 6) SOURCE: Left Neck Level 1B. Received fresh in a container labeled with the patient's name and ""left. neck level 1B"" is a single unoriented fragment of pink-yellow fibrofatty. tissue, which measures 5 X 4 X 1.5 cm. A thorough lymph node search is. performed, which reveals 4 candidate lymph nodes, the largest of which. measuring 1 cm in greatest dimension, as well as normal-appearing salivary. tissue measuring 4 X 2.5 X 1.5 cm. The salivary tissue is serially. sectioned to reveal a homogenous, pink-tan, lobulated cut surface with no. masses or other lesions appreciated. Representative sections of salivary. tissue as well as all candidate lymph node tissue are submitted for. evaluation. Summary of sections: 6A, representative salivary tissue, 2/1; 6B, 4. candidate lymph nodes, 4/1; 6C, largest candidate lymph node bisected, 2/1. 7) SOURCE: Left Neck Level 2 & 3. Received fresh in a container labeled with the patient's name and ""left. neck level 2 & 3"" is a single, irregular, unoriented fragment of pink-tan. soft tissue, which measures 8 X 5 X 1.0 cm. A thorough lymph node search is. performed, which reveals 12 candidate lymph nodes, the largest of which. measuring 1.5 cm in greatest dimension. All candidate lymphoid tissue is. submitted for evaluation. Summary of sections: 7A-7C, 4 candidate lymph nodes each, 4/1 each. Slides and report reviewed by Attending Pathologist. SURGICAL PATHOLOGY INTRAOPERATIVE CONSULTATION. 1) SOURCE: Ventral Tongue Margin. FROZEN SECTION DIAGNOSIS: BENIGN. 2) SOURCE: Floor of Mouth Margin. FROZEN SECTION DIAGNOSIS: BENIGN. 3) SOURCE: Dorsal Anterior Tongue Margin. FROZEN SECTION DIAGNOSIS: BENIGN. 4) SOURCE: Dorsal Posterior Tongue Margin. FROZEN SECTION DIAGNOSIS: BENIGN. SNOMED: T-53000,T-53000,M-80103,.",val,
3308,TCGA-A5-A0GW.0EE4FD56-D0BA-43E8-A434-CD86B21F21BF,"8380/3 he. GYNS Adm: Ord #=. ASAP /RESULTED. Collect D/T=. Modifiers: (1 of 1). CoPath Specimen. Source: A: Uterus IT\ Cervix. B: Left Pelvic lymph node. C: Left Peri-aortic lymph node. D: Right Pelvic lymph node. E: Right Peri-aortic lymph node. Final Diagnosis. A. Uterus and cervix (hysterectomy, 85 gm). - Polypoid adenocarcinoma, endometrioid type, FIGO grade 2-3,. 1.6 X 1.5 X 1.0 cm. - Tumor shows superficial myometrial invasion involving 78 of. myometrial wall thickness (0.1 cm /1.4 cm). - Tumor does not involve lower uterine segment or cervix. - Highly suspicious for lymphovascular invasion. - Left and right parametrial margins are negative for. malignancy. - Background complex hyperplasia with atypia identified in lower. uterine segment. - Unremarkable ectocervix and endocervix. - Follicular cyst of right ovary. - Hemorrhagic corpus luteum cyst of left ovary. Unremarkable right and left fallopian tubes. B. Left pelvic lymph node (excision) : - Four lymph nodes negative for malignancy (0/4). C. Left periaortic lymph node (excision) : - Three lymph nodes negative for malignancy (0/3) . D. Right pelvic lymph node (excision) : - Fibroadipose tissue, no lymph nodes identified. E. Right periaortic lymph node (excision) : Two lymph nodes negative for malignancy (0/2). RESULTS FOR SELECTED GRID CELL, SUMMARY. Printed. Nam. Loc. CYNS Adm: Clinical History. year-old female with endometrial cancer. Pre Operative Diagnosis. Endometrial cancer. Operation Performed. LSC hysterectomy; BSO + BPPALND. Gross Description. The specimen is received in 5 parts. Part A is labeled ""uterus and cervix"" and consists of a uterus. and cervix with attached adnexa, previously opened, laterally on. the right side. The specimen weighs 85 grams and measures. 10.5 X 7.5 X 4.5 cm in aggregate. The left fallopian tube. measures 3.4 cm in length by 0.5 cm in diameter. The left ovary. measures 2.6 X 2.4 X 1.5 cm and is tan-white with multiple, <. 0.5 cm serous cysts. The right fallopian tube measures 3.2 cm. in length by 0.4 cm in diameter. The right ovary measures 3. 0 X. 2.2 X 1.8 cm and is tan-white with multiple subcentimeter cystic. lesions. The uterus measures 5.5 cm in width, 7.3 cm in length,. and 3.5 cm anterior to posterior. The cervix measures 2.6 cm in. diameter. The endometrial cavity contains a 1.6 X 1.5 X 1.0 cm,. soft, partially necrotic lesion in the anterior half. The. endometrial cavity measures 2.0 X 5.0 X 0.6 cm. The myometrium. measures 1.3 cm in thickness and the endometrium measures 0.2 cm. in thickness. The tumor is located 1.2 cm from the anterior. margin and 1.2 cm from the posterior margin. The specimen is. inked as follows: anterior=red, posterior=black right. parametrium=orange, left parametrium=green. Representative. sections are submitted as follows. Cassette Summary : A1 and A2 right ovary and fallopian tube, representative,. A3 left ovary and fallopian tube, representative,. A4. left parametrial margin,. A5 right parametrial margin,. A6. anterior cervix,. A7 posterior cervix,. A8 anterior lower uterine segment,. A9. posterior lower uterine segment. RESULTS FOR SELECTED GRID CELL, SUMMARY. Printed. LOC: A11 thru A13 tumor and anterior endomyometrium,. A14 posterior endomyometrium and margin. Part B is labeled ""left pelvic lymph node"" and consists of. multiple fragments of fibroadipose tissue, measuring 1.2 X 1.0 X. 0.3 cm in aggregate. The specimen is entirely submitted in. cassettes B1 and B2. Part C is labeled ""left periaortic lymph node"" and consists of. multiple fragments of fibroadipose tissue, measuring 1.1 X 1.1 X. 0.2 cm in aggregate. The specimen is entirely submitted in. cassette C. Part D is labeled ""right pelvic lymph node"" and consists of. multiple fragments of fibroadipose tissue, measuring 1. 1 X 1.0 x. 0.2 cm in aggregate. The specimen is entirely submitted in. cassette D. Part E is labeled ""right periaortic lymph node"" and consists of. multiple fragments of fibroadipose tissue, measuring 1.0 X 1.0 X. 0.2 cm in aggregate. The specimen is entirely submitted in. cassette E. Microscopic Description. A microscopic examination was performed. 1. Admit Date. Discharge Date. Chief Complaint: vaginal cuff abscess/dehissance. LMP: HPI: y/o G0 s/p laparoscopic hysterectomy, BSO,. for. Stage IB, G 2-3 Endometrial adenoca. Patient reports occasional vaginal. spotting. Her pain is well controlled on PO pain medications. She denies. N/V/CP/SOB/F/C. On post-op - exam in clinic today patient noted to have. opening at vaginal cuff draining copious amounts of purulent material. Of note, the patient has a h/o DM and reports that she has not been. checking her BS at home. Past Medical History: DM, CHTN, Hypercholesterolemia. Past Surgical History: TLH, BSO, BPPALND. Past OB/GYN History. 1) G:0 P:0. 2) OB History : n/a. 3) Pap/STD History : no h/o abnormal Pap or STI. 4) Menstrual: as above. 5) Last Pap : as per HPI. 6) Last Mammo: in. benign. 7) BCM: none. Social History: Family History: no cancer. Medications: Allergies: NKDA. ROS: 1) HEENT: negative. 2) Cardiac : negative. 3) Respiratory: negative. 4) GI, Liver: negative. 5) GU: see HPI / GYN Hx. Loc/SvC=/GYIS. Admit Date: Discharge Date: 6) Neuro: negative. 7) Skin: negative. 8) Bleeding Tendencies: negative. 9) Other: negative. Physical Examination: 1) HEENT: WNL. 2) Breast: ND. 3) Chest/Lungs: RRR. CTA bilaterally. 4) Abdomen: soft. NT. ND. no masses. +BS. Steri-strips c/d/i. 5) Extremities: no edema. 6) Neuro: nonfocal. 7) Skin: WNL. 8) LN: no LAD. 9) Pelvic: 10) Vulva: WNL. 11) Vagina: cuff open. copious amounts of purulent discharge. Cultures. sent. Labs: ordered. Imaging: CT Abd/Pelvis ordered. Assessment and Plan: y/o GO. s/p TLH, BSO, PPALND for Stage Ib endometrial adenoCA,. admitted to gyn service for cuff abscess/dehissence. - UA, UCx, cultures of vaginal cuff sent from clinic today. - Will order CT abdomen / pelvis with PO and IV contrast. - CBC with dif. - blood cultures x2; will start on IV Levaquin/Flagyl once blood. cultrues drawn. - DM: will start on diabetic diet with qAC accucheck. - HTN: will re-start home meds of Atenolol and Benazepril. - DVT PPx: patient to complete 2week outpatient course of prophylactic. Admit Date=. LOC/Svc=/GYNS. Discharge Date=. Lovenox during this admission. 1 R1/. R4. DW Onc Fellow. PLEASE SEE ATTENDING ADDENDUM. DISCUSSED WITH DOCTOR: (MD). Text Status=FINAL. Elec Signed By= (Electronic Signature). (MD).",val,
3457,TCGA-F7-A623.DE5FC874-80AE-4DAA-BDB0-62F7B8DE156D,Gross Description: Microscopic Description: Diagnosis Details: Tumor location: Subglottis. Comments: Formatted Path Reports: LARYNX TISSUE CHECKLIST. Specimen type: Laryngectomy. Tumor site: Larynx. Tumor size: 3 x 4x2.5cm. Histologic type: Squamous cell carcinoma. Histologic grade: Well differentiated. Tumor extent: Not specified. Lymph nodes: 2/6 positive for metastasis (Regional 2/6). Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Comments: Tumor location: Subglottis.,val,
3489,TCGA-A2-A25E.B81555D4-78D9-4235-AABE-F852CA6F15B5,"Specimen #: (Age: F Race: Physician (s) : AMENDED. SPECIMEN: LEFT BREAST MASTECTOMY AND AXILLARY CONTENTS. FINAL DIAGNOSIS: A. BREAST, LEFT RADICAL MASTECTOMY: - RESIDUAL INVASIVE DUCTAL CARCINOMA, MODERATELY DIFFERENTIATED BY. COMBINED HISTOLOGIC CRITERIA, PRESENT IN THE AREA OF BIOPSY CAVITY. AND LOWER OUTER QUADRANT. ESTIMATED TUMOR SIZE BASED ON PREVIOUS NEEDLE LOCALIZATION. BIOPSIES AT LEAST 3.0 CM. - SEPERATE TUMOR MASS IN THE UPPER OUTER QUADRANT: INFILTRATING DUCTAL CARCINOMA, POORLY DIFFERENTIATED. TUMOR SIZE: 2.0 CM (GROSS). MARGIN: TUMOR WITHIN 1MM OF SUPERIOR SUPERFICIAL MARGIN. DUCTAL CARCINOMA IN SITU, INTERMEDIATE-GRADE, PREDOMINANTLY SOLID. AND CRIBRIFORM TYPES. DEEP MARGIN: TUMOR (DCIS) EXTENDS WITHIN 1.0 MM OF DEEP SURGICAL. MARGIN IN ONE SECTION (SLIDE A12) . - METASTASIS TO 6/10 AXILLARY LYMPH NODES WITH EXTRA CAPSULAR. EXTENSION. - SKIN AND NIPPLE NEGATIVE FOR CARCINOMA. - FIBROCYSTIC CHANGES. BIOPSY SITE CHANGES. - AJCC STAGE: T2N2MX. COMMENT:The amendment is made to report that there is a seperate tumor. mass in the upper outer quadrant and also the deep margin status. The amendment is made in the absence of the primary pathologist. Specimen #: FINAL DIAGNOSIS (continued) : CLINICAL DIAGNOSIS AND HISTORY: Left breast carcinoma. GROSS DESCRIPTION: Received fresh is a 167 gm modified radical mastectomy specimen with the. following measurements: breast 12.6 x 11.6 x 1.6 cm, overlying ellipse of. nipple-bearing skin 7.2 x 5.5 cm, attached axillary contents 12.5 x 3.5 x. 0.9 cm. Ink code: blue = superior superficial, green = inferior. superficial, black = posterior. The skin is notable for a 2.0 cm well. healed scar near the lateral edge of the ellipse. Examination of the. axilla reveals multiple firm lymph nodes. A seperate mass is present in. the upper outer quadrant measuring 2.0 x 1.4 x 1.4 cm. The breast is then serially sectioned revealing extensive white fibrous. tissue with a 1.2 cm multiloculated biopsy cavity with associated. hemorrhage and fat necrosis in the lower outer quadrant . Sections of the tumor mass and skin and breast samples for. protocol with matching paraffin sections are follows: cassette A1 grossly. normal skin (medial tip). cassettes A2 and A3 2.0 cm tumor mass from upper. outer quadrant, cassette A4 1.7 cm lymph node, high axilla (grossly. positive), cassette A5 1.8 cm grossly normal lymph node, high axilla,. cassette A6 biopsy cavity site, lower outer quadrant, cassette A7 grossly. normal fibrous tissue, lower outer quadrant (approximately 2.0 cm from. biopsy cavity) cassette A8 grossly normal fibrous tissue, upper outer. quadrant, cassette A9 grossly normal fibrous tissue upper inner quadrant,. cassette A10 grossly normal fibrous tissue lower inner quadrant, cassette. A11 representative sections of nipple and scar from skin, cassette A12. biopsy cavity deep margin lateral, cassette A13 biopsy cavity superior. medial, A14 biopsy cavity inferior medial, A15 four additional lymph nodes. from axillary tail, A16 two additional lymph nodes from axillary tail,. cassette A17 one lymph node bisected from axillary tail.",val,
3525,TCGA-DB-A75O.CADF06CC-B405-4CFF-AB8D-92DA06CB345C,"Final Diagnosis: A. C-D. Brain, left frontal mass #1, #2 and CUSA, biopsy: WHO grade III (of IV) fibrillary and gemistocytic. astrocytoma (anaplastic astrocytoma). B. Brain, left temporal cortex, biopsy: WHO grade III (of IV) fibrillary and gemistocytic astrocytoma (anaplastic. astrocytoma). Scen in consultation with. Interpreted by: Preliminary Frozen Section Consultation: A. Brain, left frontal mass #1, smears: Glioma. Hold over to classify and grade. Intraoperative cytologic smears interpretation performed by: continued next page.",val,
3579,TCGA-39-5031.45179ec8-08fe-4e6c-b5b3-e2ef7711b710,"Clinical Diagnosis & History: with left upper lobe lung nodule squamous cell carcinoma. Specimens Submitted: 1: SP: Part of 6th rib. 2: SP: Level 9 lymph node. 3: SP: Level 11 intralobar lymph node. 4: SP: Level 5 lymph node. 5: SP: Level 12 lymph node. 6: SP: Left upper lobe. DIAGNOSIS: 1). RIB, PART OF 6TH; EXCISION: - BENIGN BONE AND BONE MARROW. 2). LYMPH NODE, LEVEL IX; BIOPSY: - ONE BENIGN LYMPH NODE (0/1). 3). LYMPH NODES, LEVEL XI INTRALOBAR; BIOPSY: - THREE BENIGN LYMPH NODES (0/3) . 4). LYMPH NODE, LEVEL V; BIOPSY: - ONE BENIGN LYMPH NODE (0/1). 5). LYMPH NODES, LEVEL XII; BIOPSY: - THREE BENIGN LYMPH NODES (0/3). 6). LUNG, LEFT UPPER LOBE; LOBECTOMY: - SQUAMOUS CELL CARCINOMA, MODERATELY DIFFERENTIATED, OF LEFT UPPER. LOBE. - THE TUMOR GREATEST DIAMETER IS 1.9 CM. - LYMIPHOVASCULAR INVASION IS PRESENT. - NO PERINEURAL INVASION IS IDENTIFIED. - THE BRONCHIAL MARGIN IS FREE OF TUMOR. - THE PLEURA IS FREE OF TUMOR. - A SEPARATE FOCUS OF BRONCHIOLOALVEOLAR CARCINOMA IS IDENTIFIED IN. SECTION AWAY FROM THE MAIN TUMOR, MEASURING 0.5 CM IN GREATEST DIAMETER. - MUL/TIPLE FOCI OF ATYPICAL ADENOMATOUS HYPERPLASIA ARE SEEN. - THE NON-NEOPIASTIC LUNG SHOWS THE FOLLOWING ABNORMALITIES: EMIPHYSEMATOUS. CHANGES, FOCAL ORGANIZING PNEUMONIA AND CARCINOID TUMORLETS. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF METASTATIC. NODES IN RELATION TO THE TOTAL NUMBER OF NODES EXAMINED) : PERIBRONCHIAL: 0/4. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. 1) The specimen is received in formalin, labeled ""Part of sixth rib and. consists of a segment of rib bone measuring 1.1 x 0.9 x 0.5 cm. One end. is. inked in black, and the other is inked in green. The specimen is bisected. and reveals homogeneous red-tan bony cut surface with no discrete. abnormalities grossly noted. The cortical surface appears intact. The. specimen is bisected and submitted entirely, pending decal. Summary of sections: U-undesignated. 2). The specimen is received in formalin, labeled ""Level 9 lymph node"" and. consists of an anthracotic lymphoid fragment measuring 1.3 x 0.8 x 0.3 cm,. which is entirely submitted. Summary of sections: U-undesignated. 3). The specimen is received in formalin, labeled ""Level 11 intralobar. lymph node"" and consists of three anthracotic lymphoid fragments ranging. from 0.2 to 0.8 cm, which are entirely submitted. Summary of sections: U-undesignated. 4). The specimen is received in formalin, labeled ""Level 5 lymph node"" and. consists of a 0.8 cm anthracotic lymphoid fragment, which is entirely. submitted. Summary of sections: U-undesignated. 5). The specimen is received in formalin, labeled ""Level 12 lymph node"" and. consists of three anthracotic lymphoid fragments ranging from 0.4 to 0.9 cm. which are entirely submitted. Summary of sections: U-undesignated. 6.) The specimen is received fresh and is labeled, ""left upper lobe"". consists of a 17 x 10 x 2.5 Cm lung lobe with attached bronchus and blood. vessels straddled by multiple staple lines, which weighs 230 grams following. fixation. The specimen is received with an incision. The attached bronchus. measures 0.6 cm in length. The pleural surface is smooth and glistening. The pleural surface is inked black. Serial sectioning reveals a 1.5 x 1.5. x. 1.2 cm white, tan, stellate tumor. The tumor has irregular borders. The. tumor is situated in the peripheral lung parenchyma, located 5 cm from the. bronchial margin and 1.5 cm from the closest staple line. The tumor is. subpleural with a puckered overlying pleural surface. The tumor grossly. does not involve the bronchus. The bronchial mucosa is smooth and. glistening. Peribronchial anthracotic lymph nodes are identified and are. submitted. The uninvolved lung parenchyma shows congestion. Representative. sections are submitted. TPS is submitted and photographs are taken. Summary of sections: BM -- bronchial margin. VM -- vascular margin. SM -- staple margin. T -- tumor. RA - random lung parenchyma at least 3 cm away from main tumor. RC - random lung parenchyma close to tumor (within 3 cm of main tumor). LN -- lymph nodes. Summary of Sections: Part 1: SP: Part of 6th rib. Block. Sect. Site. PCs. u. 1. Part 2: SP: Level 9 lymph node. Block. Sect. Site. PCs. 1. u. 1. Part 3: SP: Level 11 intralobar lymph node. Block. Sect. Site. PCs. 1. 1. Part 4: SP: Level 5 lymph node. Block. Sect. Site. PCs. 1. u. 1. Part 5: SP: Level 12 lymph node. Block. Sect. Site. PCs. 1. u. 11. Part 6: SP: Left upper lobe. Block. Sect. Site. PCs. 1. BM. 1. LN. 3. RA. 3. 3. RC. 3. 1. SM. 1. 4. 4. 1. VM. 1.",val,
3653,TCGA-JW-A5VI.4ADC462C-2D78-4CAA-B865-5D954A080801,"PATIENT INFORMATION. sex: F. SPECIMEN INFORMATION. Collectno: CONFOENTAL. CUINICALSINFORALATION. CLINICAL INFORMATION: IMAGES. le . sestable any n you spedito mpsil. The freaco "" nat el 703 see o reviges ew "" them rater. DIAGNOSIS. CERVIX (BIOPSY): INVASIVE SQUAMOUS CELL CARCINOMA, NON-KERATINIZING TYPE, MODERATELY TO. POORLY DIFFERENTIATED (GRADE 2-3/3). SEE COMMENTS. COMMENTS: The Invasive equamous colt carcinoma involves all fragments submitted. One tragment showa ulceratod. surface mucoso. overlying Infitrating tumor; adjacent intact herign squamous spithellum shows mild reactive changu's. The. Invasive squamous carcinoma extends to peripneral and dcop mergins In ell fragmente. There is no evidence of unequivocal. capiliary-lymphatio space Involvement. The tumor size approximates an area 1.2 x 0.3cm (latered extent by depth). There is no provious atnormal pap smear available in our flics for review with the current specimen. If this is in errer, contact. the leboratory to request a reviaw. This case was reviened 38 part of ou. These findinge are discursed with. The report is FAXED. Plesse don't. husifate to contsct me at. ou any questions regarding the pathologic findings. SPECIMEN DATA. SPECIMENS: Cervical blopsy. GROSS DESCRIPTION: Tho specimen container is lebs ed with the patient's name end ""cervix"". Roceived in formalin are mu'tiple gray-white. irreguiar. fragments c/ soft rissue colledively measuring 1.5 x 1.0 x 0.4 an. PATIENT INFORMATION. SPECIMEN INFORMATION. SPECIMEN DATA: MICROSCOPIC DESCRIPTION: Completo misrescopic sxamination is performed.",val,
3706,TCGA-E9-A1RB.3BE8EA29-3C5F-4339-9CE7-98994B545848,"OC ID. Gross Description: Breast with the tumor measuring 2.7 x 2.5 cm. Fatty lymph nodes are soft and hyperemic. Microscopic Description: Infiltrating duct carcinoma; G2. Ten examined lymph nodes demonstrate focal fibrosis and lipomatosis. Diagnosis Details: Tumor Features: Unknown, Tumor Extent: T2 tumor size more than 2cm not more than 5 cm, Venous Invasion: Absent,. Margins: Absent, Treatment Effect: Comments: BREAST TISSUE CHECKLIST. Specimen type: Radical mastectomy. Specimen size: Not specified. Tumor site: Central breast. Tumor size: 2.5 x 0x 2.7 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: 0/10 positive for metastasis (Axillary 0/10). Extracapsular invasion of the lymph nodes: Not specified. Margins: Uninvolved. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None. Laterality: Left, upper inner quadrant (central).",val,
3874,TCGA-78-7537.0bb9490c-1fb1-4d36-85a4-435565e9db53,"HISTORY. Tissue taken at lobectomy. MACROSCOPIC. Two specimens received. 1: The specimen is labelled ""right upper lobe"" and consists of a right upper lobectomy which measures. 140 X 120 x 50 mm in maximum dimension. On palpation there is a firm to hard mass located in the. apical segment, predominantly on the posteromedial aspect. The mass measures approximately 60 X 65. X 40 mm in maximum dimension. There is puckering of the overlying pleural surface at the apex. The. pleural surface on the medial aspect of the specimen has a fibrinous-type exudate. On sectioning there. is a solid lobulated tumour which has a yellow greyish-white cut surface. It, in places, has a villous-. like architecture. There is haemorrhage scattered throughout the tumour. The tumour appears to abut. the pleural surface. The tumour appears to lie at least 20 mm from the bronchial resection margin. There is a soft tissue resection margin which has a row of staples and measures 85 mm in length. The. tumour is well clear of this. The surrounding adjacent uninvolved lung parenchyma has a collapsed. appearance. [1A, bronchial resection margin; 1B-F, tumour; 1G, adjacent uninvolved lung. parenchyma; 1H, hilar lymph nodes]. 2: The specimen is labelled ""hilar lymph node"" and consists of four irregular greyish-black pieces of. tissue which measure in aggregate 30 x 20 X 10 mm. [BIT, 2A]. MICROSCOPIC. 1: Sections show a well differentiated adenocarcinoma. The tumour has a prominent. bronchioloalveolar component with a marked papillary pattern. The cells are tall and columnar with. variable cytoplasm ranging from non-mucinous to clear to mucinous. The lesion is subpleural but. definite pleural invasion is not identified. There is no blood vessel invasion and no lymphatic. permeation is seen. No perineural permeation is identified. The lesion is well clear of the bronchial. resection margin. Tumour appears to be present at a diathermied margin, possibly related to pleura in. block 1F. It is difficult to know whether this represents a true margin. No lymph node metastases are. present. The adjacent lung shows evidence of emphysema. Within the random section of lung, there. is. a localised area of necrosis with surrounding fibrosis. Special stains for microorganisms will be. performed. 2: Sections of the lymph nodes show reactive changes only. There is no evidence of malignancy. SUMMARY. Right upper lobe lung and hilar lymph nodes: 1: Well differentiated adenocarcinoma; 65 mm in maximal dimension. 2: No blood vessel, lymphatic or perineural invasion present. 3: No pleural invasion identified; clear of bronchial margin but extends to an area of diathermy (see. report). 4: No lymph node metastases. 5: T2N0MX. 6: Emphysema and necrotic lesion; special stains for microorganisms being performed. SUPPLEMENTARY REPORT. No micro-organisms are identified within the lung granuloma with special stains. T-28000 M-81403 P1-03000.",val,
3959,TCGA-WC-A883.FDE93561-B0B0-495F-8BBD-932EA3B7D02D,"DIAGNOSIS. (A) RIGHT EYE, FNA SAMPLE FOR SEND OUT TESTING ONLY. (B) RIGHT GLOBE: CHOROIDAL MELANOMA, MIXED EPITHELIOID AND SPINDLED, 18 MM BASE. EXTRAOCULAR EXTENSION PRESENT. TUMOR INVADES SCLERA AND CANAL OF SCHLEMM, EXTENDING TO SUBCONJUNCTIVAL SURFACE. Optic nerve negative for tumor. Vortex veins negative for tumor. (See comment). COMMENT. The tumor in the extraocular space near the conjunctiva is entirely covered by conjunctiva/soft tissue ( margins negative). are 1 per 10 high-power fields. The specimen for part A was sent to. for further diagnostic testing by. which will be reported separately W. the scan documents of. GROSS DESCRIPTION. (A) RIGHT EYE, FOR SEND OUT ESTING-pale-gray semitransparent tissue (0.4 X 0.4 X 0.2 cm) within pink-red fluid (0.5. X 0.5 cm) in a sealed container. The specimen is forwarded for send out testing. (B) RIGHT GLOBE - An enucleation specimen consisting of an intact left lobe (21.0 X 20.0 x 21.0 mm) with an attached 13. optic nerve. The cornea is 11.0 x 10,0 mm with a round central 2.0 mm pupil. The iris is pale gray-yellow with possible rim C. hyperpigmentation over approximately one-third peripherally. 1.0 mm from the limbus and adjacent to the area of possible. pigmentation, a black 2.0 mm probable tumor nodule is present on the external surface of the sclera with loosely adherent. conjunctiva covering the entire surface coming to less than 1.0 mm from the resection edge. An irregular intraocular multinodular mass with a base approximately 18.0 mm in greatest dimension extends from t. and comes to 5.0 mm from the optic nerve within the choroidal space. The mass is located between 2.0 and 6 o'clock. Tum. harvested fresh per protocol. The tumor has a maximum height post harvest 4.0 mm and the tumor surface is binodular. A. suggested from the external surface, the region of extraocular extension noted on the sclera covered by cornea is visible ad. to the tumor. The tumor flattens and becomes thickened again in kind of a rolling/ binodular pattern. An artificial lens is in p. SECTION CODE: B1, regions of vortex veins; B2, optic-nerve margin; B3, B4, calottes with tumor (B3 with extraoct. extension and in extraocular tissue harvest); B5, pupil-optic section with tumor. BIOMARKER TESTING. Primary tumor B5. CLINICAL HISTORY. Right eye uveal melanoma. SNOMED CODES. T-AA000, M-87203. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have no. Page: 2. specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by: END OF REPORT-. Ne. / DI. Reviewed 10713.",val,
4031,TCGA-IB-8127.c26dbe28-7e0c-4e51-8f54-c14cf4f16086,"PHN: ACB: Telephone: Encounter: Collected Date: Received Date/Time: Specimen Description. A. Liver biopsy at. B. Gallbladder at. C. Portal lymph nodes at. D. Whipple's specimen at. Clinical Information. Hx: Suspicion of pancreatic adenocarcinoma. Infectious patient: No. Immunocompromised: No. History of neoplasm: No. Diagnosis. A: Liver Biopsy: Benign bile duct hamartoma. Negative for malignancy. B: Gallbladder, Cholecystectomy: Chronic cholecystitis, negative for atypia. Congested cystic duct lymph node, negative for malignancy. C: Portal Lymph Nodes: Reactive changes, negative for malignancy. Chart Request ID. Pathology: Provider - Permanent. Print Date/Time: PHN: ACB: Collected Date: D: Head of Pancreas (Whipple's Resection): Invasive duct carcinoma of the pancreas, with focal extension to. uncinate process margin. Ulceration of the distal common bile duct and ampulla, with. carcinoma invading through duodenal muscularis propria at the. level of the ampulla. Metastatic pancreatic carcinoma in three of 24 peripancreatic lymph. nodes. Synoptic Report. D: Pancreas (Exocrine), Microscopic. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G2: Moderately differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades ampulla of Vater or sphincter of Oddi. Tumor invades peripancreatic soft tissues. MARGINS: Margin(s) involved by invasive carcinoma. Uncinate process (retroperitoneal) margin (nonperitonealized surface of the uncinate process). TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy): Not known. LYMPH-VASCULAR INVASION: Not identified. PERINEURAL INVASION: Not identified. PRIMARY TUMOR (pT): Chart Request ID: Print Date/Time: Pathology: Provider - Permanent. PHN: ACB: Inquil,. Collected Date: pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric. artery. REGIONAL LYMPH NODES (pN): pN1: Regional lymph node metastasis. Number examined: 24. Number involved: 3. DISTANT METASTASIS (pM): Not applicable. Gross Description. Received are specimens A to D. All requisitions and specimen containers are labelled with the patient's name. The cassettes and AP identifiers are labelled with the Surgical Number. A. The specimen consists of a liver biopsy which measures 1.0 X 0.5 X 0.5 cm. All tissue is submitted for QS in one. block. B. The specimen consists of an unopened gallbladder measuring 9.5 cm in length and up to 2.5 cm in transverse. diameter. The outer surface is unremarkable. Sectioning reveals pale green mucoid contents containing small flecks of. yellow calculous debris measuring up to 0.2 cm in size. The mucosa is smooth and velvety. A cystic duct lymph node,. 1.2. cm. in. greatest dimension, is present at the neck of the gallbladder. Representative sections of the neck, body and. fundus are submitted in B1. The cystic duct lymph node is submitted in B2. C. The specimen consists of three fragments of tissue measuring 3.7 cm, 3.0 cm, and 0.9 cm in greatest dimension. respectively. The largest fragment appears to consist of adipose tissue only and no lymph node is recognizable. Two. representative sections are submitted in C1. The second largest fragment consists entirely of a firm yellow lymph node-. like sample. Two sections are submitted in C2 and C3. The smallest fragment is submitted in C4 in its entirety. D. The specimen consists of a pancreaticoduodenectomy specimen in which the distal stomach to distal duodenal. resection margin distance is 23.0 cm. The attached head of pancreas measures approximately 8.0 X 5.0 x 6.0 cm. A. region of the ampulla is distorted by what appears to be a zone of ulceration into an underlying mass in the head of the. pancreas. The distal common bile duct opens at this area and appears to be up to 1.3 cm in diameter. The duodenal wall. around this area appears congested and indurated. Sectioning of the head of the pancreas shows a hard tumor mass. surrounding the common bile duct and measuring 4.5 X 3,5 X approximately 4.0 cm. The carcinoma lies close to the. uncinate process but also appears to encroach on the posterior surgical margin adjacent to the duodenum; this latter area. is painted orange. The uncinate process margin is painted blue. Sections are taken as follows: Pathology: Provider, - Permanent. PHN: ACB: Surqical Pathology Report. Collected Date: D1 - proximal bile duct margin. D2 - pancreatic neck resection margin. D3 - distal duodenal margin, en face. D4 and D5 - ampulla edge (D5 with posterior margin). D6 and D7 - indurated posterior margin. D8 through D12 - tumor with uncinate margin. D13 - tumor in relation to overlying duodenum. D14 - tumor in relation to overlying proximal duodenal mucosa. D15 - proximal, gastric resection margin. D16 and D17 - six possible lymph nodes from distal lesser curve. D18 - three possible lymph nodes in pancreaticoduodenal chain. D19 through D21 - 11 possible lymph nodes at the inferior aspect of the head of pancreas. Frozen Section Diagnosis. A, Liver Biopsy: Bile duct hamartoma. Negative for malignancy. Microscopic Description. A: Sections after routine processing confirm the frozen section diagnosis. A small cluster of bile ducts form a localized. nodule with no cytologic atypia. B: Sections show mild chronic cholecystitis, but no cytologic atypia. The cystic duct lymph node is congested, but no sign. of malignancy is present. C: Fragments of adipose tissue include small nerve trunks. The large lymph node-like fragment is comprised of lymph. nodes showing focal lipogranulomatosis. No sign of metastatic disease is present. D: The head of pancreas is largely replaced by an invasive moderately differentiated pancreatic duct carcinoma. The. tumor shows varying growth patterns ranging from well defined glandular spaces through to irregular tongues and islands. of carcinoma with prominent nuclear pleomorphism. Many areas show clear cytoplasm consistent with mucinous. differentiation. The carcinoma invades to the zone of the ampulla where the surface of the bile duct is large eroded and. Chart Request IC. Print Date/Time: Pathology: Provider - Permanent. PHN: ACB: gical Pathology Renort. Inquiry Numbe. Collected Date: replaced by granulation tissue. The carcinoma elements extend through the muscularis propria of the duodenum at the. level of the ampulla. Carcinoma focally extends to the uncinate process margin, but does not directly involve the posterior. soft tissue margin. Carcinoma focally extends beyond the confines of the pancreas into peripancreatic adipose tissue. Adjacent pancreatic parenchyma shows prominent inflammation and fibrosis. The en face section of the neck of the. pancreas is negative as is the proximal bile duct margin. Eight lymph nodes are incorporated in the sections of pancreas,. one of which shows metastatic pancreatic adenocarcinoma. There are 16 lymph nodes dissected from the peripancreatic. fatty tissue with metastatic duct carcinoma in two, one of which is in the pancreatico-duodena zone and one in a lymph. node along inferior margin. Pathology: Provider - Permanent.",val,
4078,TCGA-XE-A8H1.7C060166-F812-47BB-94DF-E8E4A6800FEC,"Ord #=. RESULTED. Collect D/T=. SURGICAL PATHOL. Modifiers: (1 of 1). Specimen (s) Received. Right testicle. Clinical History. Not stated. Gross Description. Right testicle: Received fresh is a testicle weighing 75 grams and. measuring overall 15 x 5 x 3 cm. The testis measures 6.5 x 5 x 3 cm. The spermatic cord measures 11 x 2 x 0.5 cm. The entire specimen is. inked black. The tumor measures 3 x 2 x 2 cm and is firm tan with. brown area. The remaining parenchyma is unremarkable. The tumor abuts. the tunica albuginea, however, the tunica albuginea is not adherent. to the tumor. Representative sections are submitted as follows: 1 spermatic cord margin. 2 cord adjacent to margin (green) and mid cord section. 3 epididymis. 4-6 tumor. 7 normal. Date of Dictation: Gross Description By: Microscopic Description. Performed. Final Pathologic Diagnosis. Specimen Type Right testicle. - Laterality : Right. - Focality: Multifocal. RESULTS FOR SELECTED GRID CELL, SUMMARY. - -Tumor Size: 3 x 2 x 2 LIII. -Histologic Type: Embryonal carcinoma, pure. (see comment). Intratubular germ cell neoplasia is present (slide 4). - -Tumor is limited to the testis. Tumor does not involve rete testis,. epididymis, perihilar fat, spermatic cord, tunica vaginalis or. scrotal wall. -Lymphovascular Invasion: Present (slide 5). -Margin: Spermatic cord is negative for tumor. -Remaining testicular tissue shows tubular atrophy, and the. epididymis normal and uninvolved by tumor. Comment: Immunohistochemical stain was performed on slide 6 for. pancytokeratin (AE1/AE3), CD30 and PLAP are positive on the critical. cells; the PLAP stain shows membrane staining. Immunohistochemical. stain for hCG is negative for syncytiotrophoblastic elements. Pathologic Tumor Stage : pT2NXMX (Stage IS). Attending Pathologist: Note: Immunohistochemistry testing was developed and its. performance characteristics determined by. It has not been cleared or approved by the. U.S. Food and Drug Administration. The FDA has determined that such. clearance or approval is not necessary. This test is used for. clinical purposes. It should not be regarded as investigation or. research. This laboratory is certified under the Clinical Laboratory. Improvement Amendments of 1988 (CLIA-88) as qualified to perform high. complexity clinical laboratory testing.",val,
4115,TCGA-CX-7082.872be720-140a-4152-84ce-184d1a2cdfe7,"F / Il a / D i a g // O S i S R 0 p 0 l' I. Senior Pathologist: Collected Date/Time: Received Date/Time: Verified Date/Time: Final Pathologic Diagnosis. A) PALATE AND RETROMOLAR TRIGONE (RADICAL TONSILLECTOMY PARTIAL. PALATECTOMY AND RETROMOLAR TRIGONE EXCISION): Invasive keratinizing squamous cell carcinoma, moderately. differentiated. (See synoptic report). Unremarkable tonsillar tissue, negative for malignancy. B) LATERAL BUCCAL MARGIN (BIOPSY): Fibroadipose tissue with smooth muscle, negative for malignancy. C) DEEP PTERYGOID MARGIN (BIOPSY): Fibroadipose tissue with smooth muscle, negative for malignancy. D) DEEP RETROMOLAR TRIGONE MARGIN (BIOPSY): Fibroadipose tissue with submucosal glands, negative for malignancy. E) INFERIOR BUCCAL MARGIN (BIOPSY): Squamous mucosa with cautery artifact, negative for malignancy. F) PALATE MARGIN (BIOPSY): Fibroadipose tissue, negative for malignancy. G) MEDIAL PHARYNGEAL MARGIN (BIOPSY): Squamous mucosa and underlying submucosal glands and smooth. muscle with mild chronic inflammation, negative for malignancy. H) PHARYNGEAL FAT MARGIN (BIOPSY): Salivary gland tissue, negative for malignancy. I) LEVEL 2 (LYMPH NODE DISSECTION): Printed: Page: 1 of 7. F i Il a / P a t h 0 / o y y D i a y II 0 S i S R e p 0 l' t. Senior Pathologist: Collected Date/Time: Received Date/Time: Verified Date/Time: Two benign lymph nodes, negative for malignancy (0/2). J) LEVEL 3 (LYMPH NODE DISSECTION): One benign lymph node, negative for malignancy (0/1). K) MEDIAL LEVEL 5 (LYMPH NODE DISSECTION): Nine benign lymph nodes, negative for malignancy (0/9). L) LEVEL 5 (LYMPH NODE DISSECTION): Two of two lymph nodes positive for metastatic squamous cell. carcinoma (2/2) with extracapsular extension. I attest I have personally reviewed the specimen/slides and agree with the above findings. Resident: Synoptic Report. A: Lip and Oral Cavity. SPECIMEN (Select all that apply): Other (specify): Tonsil, palate, retromolar trigone. Fresh. PROCEDURE (Select all that apply): Resection. Palatectomy. SPECIMEN INTEGRITY: Intact. SPECIMEN SIZE: Greatest dimensions: 4.8 cm. Printed: Page: 2 of 7. F i Il a / P a I h 0 / y Repor t. Senior Pathologist: Collected Date/Time: Received Date/Time: Verified Date/Time: SPECIMEN LATERALITY: Right. TUMOR SITE (Select all that apply): Other (specify): right retromolar trigone. TUMOR FOCALITY: Single focus. TUMOR SIZE: Greatest dimensions: 3.5 cm. Additional dimensions: 1 X 0.3 cm. TUMOR THICKNESS (pT1 AND pT2 Tumors): Tumor thickness: 4 mm. TUMOR DESCRIPTION (Select all that apply): Gross subtype. Ulcerated. HISTOLOGIC TYPE (Select all that apply): Squamous cell carcinoma, conventional. HISTOLOGIC GRADE: G2: Moderately differentiated. MARGINS (Select all that apply): Margins uninvolved by invasive carcinoma. Distance from closest margin: 0.2cm. This measurement takes into account the additional margins (Specimen B. and Specimen C). While some of the margins on Specimen A appear positive, additional margins were taken in. Specimen B through Specimen H. Specify margin(s), per orientation, if possible: Lateral and deep. LYMPH-VASCULAR INVASION: Not identified. PERINEURAL INVASION: Not identified. LYMPH NODES, EXTRANODAL EXTENSION: Present. PATHOLOGIC STAGING (pTNM): PRIMARY TUMOR (pT). pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. REGIONAL LYMPH NODES (pN). pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension. Specify: Number examined: 15. Number involved: 2. DISTANT METASTASIS. Not Applicable. Printed: Page: 3 of 7. Final P a t h 0 / 0 y y D i a y // 0 S i S Repor I. Senior Pathologist: Collected Date/Time: Received Date/Time: Verified Date/Time: ADDITIONAL PATHOLOGIC FINDINGS (Select all that apply): Keratinizing dysplasia. Moderate. Intraoperative Diagnosis. FS B1: Margin negative for tumor. FS C1: Margin negative for tumor. FS D1: Margin negative for tumor. FS E1: Margin negative for tumor. FS F1: Margin negative for tumor. FS G1: Margin negative for tumor,. FS H1: Margin negative for tumor. Clinical History. male. Pre/Post-operative Diagnosis. SCCA right retromolar trigone mass. Gross Anatomic Description. Specimens received in twelve containers. Specimen A: Designated ""radical tonsillectomy, partial palatectomy, retromolar trigone excision"" is received in formalin. labeled with the patient's name, MRN and ""radical tonsillectomy, partial palatectomy, retromolar trigone excision"". Specimen. consists of a single irregular portion of soft tissue with a mucosal surface which measures 4.8 X 2.9 x 0.6 cm in aggregate. The. specimen is oriented. The mucosal surface is tan/ pink with a roughly central portion of ulceration measuring 3.5 X 1 x 0.3. cm. The specimen came with the deep margin previously inked blue. Cut surface reveals firm and somewhat fibrotic area. underlying the ulceration which grossly abuts the deep inked margins. Inking code: Black - lateral; green -medial; Red - superior; Orange - inferior; blue - deep. Section. code: A1 - medial margin, perpendicularly sectioned; A2 - lateral margin perpendicular sections; A3-A8 - sections of. specimen submitted from medial to lateral, entire specimen. Printed: Page: 4 of 7. F i Il a / P a t II o / 0 y ID i a y II o S i S R e [/ 0 l' t. Senior Pathologist: Collected Date/Time: Received Date/Time: Verified Date/Time: Specimen B: Designated ""lateral buccal margin"" is received fresh for intraoperative consultation and frozen section diagnosis. on. labeled with the patient's name and ""lateral buccal margin"". Specimen consists of one piece of tan tissue. measuring 0.2 X 0.5 X 0.3 cm, entirely frozen. Section code: B1 - frozen section control, entire specimen. Specimen C: Designated ""deep pterygoid margin"" is received fresh for intraoperative consultation and frozen section. diagnosis on. labeled with the patient's name and ""deep pterygoid margin"". Specimen consists of one piece of red. tissue measuring 0.7 X 0.5 X 0.2 cm, entirely frozen. Section code: B1 - frozen section control, entire specimen. Specimen. D: Designated ""deep retromolar trigone margin"" is received fresh for intraoperative consultation and frozen section. diagnosis on. labeled with the patient's name and ""deep retromolar trigone margin"". Specimen consists of one piece. of tan tissue measuring 0.6 X 0.4 x 0.2 cm, entirely frozen. Section code: D1 - frozen section control, entire specimen. Specimen E: Designated ""inferior buccal margin"" is received fresh for intraoperative consultation and frozen section diagnosis. on. labeled with the patient's name and ""inferior buccal margin"". Specimen consists of one piece of tan tissue. measuring 0.4 X 0.2 X 0.1 cm, entirely frozen. Section code: E1 - frozen section control, entire specimen. Specimen F: Designated ""palate margin"" is received fresh for intraoperative consultation and frozen section diagnosis on. labeled with the patient's name and ""palate margin"". Specimen consists of one piece of tan tissue measuring 1.3 x. 0.4 x 0.3 cm, entirely frozen. Section code: F1 - frozen section control, entire specimen. Specimen. G: Designated. ""medial pharyngeal margin"" is received fresh for intraoperative consultation and frozen section. diagnosis on. labeled with the patient's name and ""medial pharyngeal margin"". Specimen consists of one piece of. tan tissue measuring 0.7 X 0.5 X 0.3 cm, entirely frozen. Section code: G1 - frozen section control, entire specimen. Specimen H: Designated ""pharyngeal fat margin"" is received fresh for intraoperative consultation and frozen section. diagnosis on. labeled with the patient's name and ""pharyngeal fat margin"". Specimen consists of one piece of pink/. tan tissue measuring 1.3 x 0.7 X 0.4 cm, trisected and entirely frozen. Section code: H1 - frozen section control, entire specimen. Specimen I: Designated ""level 2"" is received in formalin labeled with the patient's name and ""level 2"". Specimen consists. of. a. single portion of soft tan/ yellow bosselated fibroadipose tissue measuring 3.8 X 2.9 X 0.6 cm. Two lymph nodes are. grossly. appreciated ranging from 0.4 cm to 1.0 cm in diameter. Section code: I1 - 12 - one lymph node each bisected. Printed. Page: 5 of 7. F i Il a / P a I II 0 / 0 D i a y Il o S i S Report. Senior Pathologist: Collected Date/Time: Received Date/Time: Verified Date/Time: Specimen J: Designated ""level 3"" is received in formalin labeled with the patient's name and ""level 3"". Specimen consists of. a single portion of soft tan/ yellow bosselated fibroadipose tissue measuring 3.1 X 2.1 X 0.7 cm. One lymph node is identified. measuring 0.8 cm in diameter. Section code: J1 - one lymph node each bisected. Specimen K: Designated ""medial level 5"" is received in formalin labeled with the patient's name and ""medial level 5"". Specimen consists of a single portion of soft tan/ yellow bosselated fibroadipose tissue measuring 2.5 X 1.8 x 0.3 cm. No. lymph nodes are grossly appreciated. Section code: K1-K2 - entire specimen. Specimen L: Designated ""level 5"" is received fresh for Tumor Bank labeled with the patient's name and ""level 5"". Specimen. consists of a single portion of soft tan/ yellow bosselated fibroadipose tissue measuring 4.5 x 2.5 x 0.6 cm. A portion of one. lymph node is given for Tumor Bank. Two lymph nodes are grossly identified ranging from 0.6 cm to 0.8 cm. Section code: L1-one lymph node bisected minus portion given to Tumor Bank; L2 - one lymph node bisected. Printed: Page: 6 of 7. /. // t l' a 0 [/ e l' a. S. R e Il o l' I. Senior Pathologist: Collected Date/Time: Received Date/Time: Verified Date/Time: Intraoperative Diagnosis. FS B1: Margin negative for tumor. FS C1: Margin negative for tumor. FS D1: Margin negative for tumor. FS E1: Margin negative for tumor. FS F1: Margin negative for tumor. FS G1: Margin negative for tumor. FS H1: Margin negative for tumor. Printed: Page: 7 of 7.",val,
4165,TCGA-43-2576.15a1f3eb-1b46-45c4-85f8-0d52710986b3,"SPECIMEN. A. Level 5 lymph node. B. Left upper lobe. C. Level 7. CLINICAL NOTES. PRE-OP DIAGNOSIS: Lung cancer. FROZEN SECTION DIAGNOSIS. A) Lymph node, level 5, excision - Non small cell carcinoma. GROSS DESCRIPTION. A. Received fresh for frozen section labeled ""level 5. lymph node"" is an irregularly shaped fragment of tissue. that measures 2.5 X 2.2 x 1.5 cm in dimension. A representative. section of the tissue submitted for frozen section. The remaining. tissue is entirely submitted for permanent section in a single. cassette. B. Received fresh, subsequently fixed in formalin labeled. 'left upper lobe"" is a 14.5 X 5.5 x 4.0 cm lung specimen. which is partially covered with pink-red smooth glistening pleura. with black stippling present. The specimen shows a umbilication in. the pleura which is 1.2 cm in greatest dimension and comes within. 3.0 cm of the stapled margin. The pleura is inked blue and black. and the specimen is sectioned to show a 3.5 X 2.5 X 2.5. cm. white-tan-gray firm focus grossly consistent with tumor. This. is. contiguous with the umbilication grossly identified on the pleura. and comes within 0.7 cm of the stapled margin (inked blue). Remainder of the cut surface is pink-tan and spongy showing no. other. discrete gross lesions identified. Representative sections of the. specimen are submitted as follows: BLOCK SUMMARY: 1 - representative normal; 2-3 - representative. section tumor to stapled margin; 4-6 - representative section of. GROSS DESCRIPTION. tumor to pleura and normal. C. Received fresh, subsequently fixed in formalin,. labeled. ""level 7"" are two black-red irregular soft tissue. fragments. measuring 0.8 em and 0.6 cm in greatest dimension. Specimens are. entirely submitted in one cassette.",val,
4191,TCGA-06-0876.64d0b1fe-8c45-4352-b557-c7e8d075a26b,"CLINICAL HISTORY. with headache and left-sided weakness has right. parietal mass, necrotic, with peripheral enhancement and edema with mass. effect. OPERATIVE DIAGNOSES. Not Given. Operation/Specimen: A: Brain, Right parietal biopsy. B: Brain, right parietal biopsy. PATHOLOGICAL DIAGNOSIS: A and B. Brain, right parietal, excisional biopsy and excision: 1. Malignant glioma. 2. MIB-1 proliferation index: 6% to 30%. See Comment. COMMENT. The specimen is a portion of cerebrum extensively effaced by a small cell. glial neoplastic proliferation with nuclear anaplasia, brisk mitotic activity,. microvascular proliferation, and zones of tumor necrosis. In part B there is. extensive necrosis. The neoplasm is a high histological grade glioma, consistent with a small cell. glioblastoma. There is a possibility of an oligodendroglial component. Additional testing may further characterize the neoplasm. PROCEDURES/ADDENDA. MGMT Promoter Methulation. Interpretation. POSITIVE: Methylated MGMT promoter is detected. esults-Comments. Testing was done on tissue block. TEST DESCRIPTION: Patients with glioma containing a methylated MGMT promoter. have been shown to benefit from therapy with alkylating agents. Assessment of. MGMT promoter methylation status involves bisulfite treatment of DNA followed. by real-time PCR amplification (MethyLight) of methylated and unmethylated DNA. sequences. FDA COMMENT: The above data are not to be construed as the results from a. stand alone diagnostic test. This test was developed and its performance. characteristics determined by the. laboratory as. required by CLIA. regulations. It has not been cleared or approved for. specific uses by the U.S. Food and Drug Administration (FDA) The FDA has. determined that such clearance or approval is not necessary. These results are. provided for informational purposes only, and should be interpreted only in. the context of established procedures and/or diagnostic criteria. Interpretation. NEGATIVE: Allelic loss on chromosome arm 1p is NOT detected. There is loss of heterozygosity in only one of the markers (PLA2G4C) on. chromosome arm 19q suggestive of partial deletion. Informative loci are: D1S1592, D1S468, D1S496. D19S412, PLA2G4C, D19S606, D19S1182. Results-Comments. TEST DESCRIPTION: Allelic loss is assessed by PCR assay in Normal DNA. (baseline) / Tumor DNA pairs using 3 markers at both 1p and 19q. The 3 markers. on 1p are D1S548, D1S1592, and D1S552 (with D1S468, D1S1612, and D1S496 as. backup markers) and the 3 markers on 19q are D19S219, D19S412, and PLA2G4C. (with D19S606 and D19S1182 as backup) All markers are nicrosatellites (2 or 4. nt repeats) except PLA2G4C which is a minisatellite (26 nt repeat). polymorphism. The markers were selected based on heterozygosity score,. amplicon size, and ease of interpretation. The backup markers are used if the. first line markers at that chromosome arm are uninformative or otherwise. ambiguous in their interpretation. LOH at all informative loci on each. chromosomal arm represents the typical finding in oligodendrogliomas with 1p. and 19q deletion. FDA COMMENT: The above data are not to be construed as the results from a. stand-alone diagnostic test. This test was developed and its performance. characteristics determined by the. laboratory as. required by CLIA ,. regulations. It has not been cleared or approved for. specific uses by the U.S. Food and Drug Administration (FDA) The FDA has. determined that such clearance or approval is not necessary. These results are. provided for informational purposes only, and should be interpreted only in. the context of established procedures and/or diagnostic criteria. TECHNICAL SENSITIVITY: The presence of >15% non-neoplastic cells in the sample. may preclude the detection of allelic loss. INTRA-OPERATIVE CONSULTATION. A. Brain, Right parietal biopsy, touch prep and smears : High histological grade. glioma, astrocytic. Touch preparation smears performed at. and results reported to the Physician of Record. GROSS DESCRIPTION. A. ""Right parietal, "" received fresh, one fragment, 0.9 cm. Across. Semi firm,. glistening, grey. In total, A1. B. ""Right parietal, several fragments, soft, focally hemorrhagic, 2.0 cm. across. in aggregate. In total, B1 and B2. MICROSCOPIC DESCRIPTION. IMMUNOHISTOCHEMISTRY The GFAP demonstrates focal sparse gliofibrillarity,. and focal areas with prominent gemistocytes, some probably reactive,. neoplastic, and some minigemystocyte-like. About 10% of neoplastic cells over. express the p53 protein. With the MIB-1 the proliferation index ranges. between 6% and 30% in the more active areas. ICD-9 (s) : 239,6 239.6. Histo Data. Part A: Brain. Right parietal biopsy. Stain/cht. Block. Comment. mGFAP-DA x 1. 1. H/E x 1. 1. H/E x 1. 1. MGMT x 1. 1. Please, run LOH, 1p, 19q. Thanks. MIB1-DA X 1. 1. NeuN X 1. 1. P53D07 X 1. 1. Synap-DA x 1. 1. TPS H/E X 1. 1. H/E x 1. 2. Part B: Brain. right narietal biopsy. Stain/cnt. Block. Comment. H/E x 1. 1. mGFAP-DA X 1. 2. H/E x 1. 2. MIB1-DA x 1. 2.",val,
4299,TCGA-G5-6233.fd37563d-01d8-4321-96e9-7d61cc616407,"SPECIMENS: A. LOW ANTERIOR RESECTION OF RECTAL CANCER. B. FINAL DISTAL RECTAL MARGIN. SPECIMEN(S): A. LOW ANTERIOR RESECTION OF RECTAL CANCER. B. FINAL DISTAL RECTAL MARGIN. INTRAOPERATIVE CONSULTATION DIAGNOSIS: A- An ulcerative tumor mass, 9 .5 cm, involving the colon circumferentially. 3 cm from the distal. margin of resection called by Dr. to Dr. at 1:00 p.m. GROSS DESCRIPTION: A. LOW ANTERIOR RESECTION OF RECTAL CANCER. Received fresh is a 30-cm closed segment of colon. The serosa is smooth. There is a suture marking. the distal margin; this region is inked black. Specimen is opened; approximately 3 cm from the distal. margin is a 9 X 7.5 X 0.4-cm ulcerated, indurated, circumferential mass with serpentine borders which. invades the mesocolonic fat. A gross diagnosis was conveyed to O. R. The remainder of the mucosa. has numerous diverticuli and 3 polyps, 0.2-0.4 cm. Tissue is procured. Representative sections are. submitted as follows: A1: proximal margin. A2: distal margin. A3-A8: mass and relationship to margins and normal mucosa. A9: diverticulum. A10: possible polyps. A11: normal mucosa. A12: proximal, 6 lymph nodes. A13: proximal, 5 lymph nodes. A14-A16: proximal, 2 lymph nodes each. A17: proximal, 1 lymph node. A18-A19: proximal, 1 lymph node. A20-A24: distal, 6 lymph nodes each. A25-A26: distal, 2 lymph nodes each. A27-A28: distal, 1 lymph nodes each. A29: obstructed mesenteric blood vessel. fat placed in O-Fix for overnight fixation. A30: proximal, 6 lymph nodes. A31: proximal, 5 lymph nodes. A32-A33: proximal, 2 lymph nodes each. A34-A39: distal, 6 lymph nodes each. B. FINAL DISTAL RECTAL MARGIN. Received in formalin is a piece of pink-tan mucosa with surgical staples measuring 2.3 X 1.7 x 0.8 cm. The staples are removed, specimen is bisected, submitted entirely in cassette B1. DIAGNOSIS: A. RECTOSIGMOID COLON, LOW ANTERIOR SEGMENTAL RESECTION: - INVASIVE MODERATELY DIFFERENTIATED COLONIC ADENOCARCINOMA,. 9 X 7.5 X 0.4 CM, INVADING INTO PERIRECTAL ADIPOSE TISSUE. - MARGINS OF RESECTION ARE NEGATIVE FOR CARCINOMA. - 27 OF 72 LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA (27/72). - SEE SYNOPTIC REPORT. B. DISTAL RECTAL MARGIN, EXCISION: - COLON TISSUE WITH NO EVIDENCE OF CARCINOMA. SYNOPTIC REPORT - COLON & RECTUM. Specimens Involved. Specimens: A: LOW ANTERIOR RESECTION OF RECTAL CANCER. Specimen Type: Rectal/rectosigmoid colon (low anterior resection). Tumor Site: Rectum. Tumor Configuration: Infiltrative. Ulcerating. Tumor size: 9cm Additional dimensions 7.5cm X 0.4cm. WHO Classification. Adenocarcinoma 8140/3. Histologic Grade: G2: Moderately differentiated. Extent of Invasion: Adjacent structures. Specific Structures: Perirectal adipose tissue. Margins: Margin(s) uninvolved by invasive carcinoma (Proximal, Distal, Radial). Distance of invasive carcinoma from closest margin: 0.4cm. Venous/Lymphatic Invasion: Present. Perineural Invasion: Present. Additional Pathologic Findings: Diverticulosis. Extent of Resection: R0: Complete resection with grossly and microscopically negative margins. Lymph Nodes: Positive 27 / 72. Extranodal extension: Present. Implants: Present. Implants: in pericolic adipose tissue. Pathological Staging (pTNM): pT 3 N 2 M X. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: Rectal cancer.",val,
4327,TCGA-AK-3445.cbf13e50-41b8-4877-ad8c-d480cdd5077a,"Clinical History/Diagnosis: Left Renal Mass. Source of Specimen(s): Left kidney. Gross Description: Received in one part. Source of Tissue: 1. Labeled # 1, ""left kidney"". Gross Description: Received fresh in a container labeled left kidney"". It consists of a. left radical nephrectomy. specimen weighing 638 grams and consists of a left kidney measuring 11.0 x. 7.5 X 7.0 cm with some attached perinephric fat measuring from 1.4 up to. 4.0 cm from point of attachment. Superior-medially there is some residual. adrenal gland measuring only 1.5 x 0.7 x 0.7 cm and is unremarkable. The. renal pelvis is a 7.0 cm segment of ureter measuring 0.6 cm in diameter. with a pin point lumen. The ureter is opened and is free of lesions or. masses. At the hilum the vessels are unremarkable. Dissection through. the fat discloses no lesions, masses or nodal tissue. The kidney is. bivalved disclosing a central tumor measuring 5.5 X 3.9 X 4.0 cm. The. tumor is pushing on the renal pelvis however no lesion is noted. The. tumor also pushes on the capsule however no gross invasion is identified. in the capsule or fat. The tumor is firm to soft, predominantly. orangish-yellow with some more white fibrotic areas and an appreciable. amount of hemorrhage. The adjacent parenchyma is brownish-red with no. additional lesions or masses and well-defined cortical-medullary. junctions. Representative sections are submitted in 1A-J. Designation of Sections: 1A- vessels and ureter margin, 1B-1C- tumor in. relationship to capsule and fat, 1D- tumor in relationship to renal. pelvis, 1E- tumor in relationship-to adjacent parenchyma, 1F- tumor, 1G-. additional overlying fat, 1H- uninvolved kidney, 1I- adrenal gland, 1J-. perinephric fat at hilum. Final Diagnosis: 1. Left kidney, radical nephrectomy: - Clear cell renal cell carcinoma (5.5 cm). Fuhrman nuclear grade III. Tumor invades into perinephric fat. See note. - Vascular invasion is not identified. - Renal vein, ureteral and perinephric fat (circumferential) margins are. free of tumor. - Benign adrenal gland. Note: Tumor cells are positive for CD10, Pancytokeratin and Vimentin and. are negative for CD117 supporting the diagnosis. pT3 Nx Mx.",val,
4388,TCGA-UF-A71E.881A6334-4EEE-4468-AD5A-5F3E83C911EB,"Colect date: PRIMARY SITE: Floor of mouth. 1 - ""Lymph Nodes - Level 1, 2 and 3 - Right"": - Absence of neoplasia: (0/22). - Submandibular gland uninvolved by carcinoma. 2 - ""Lymph Nodes - Level 1, 2 and 3 - Left"": - Absence of neoplasia: (0/26). - Submandibular gland uninvolved by carcinoma. 3 - ""Shared of right miloioide muscle"". - Absence of neoplasia. 4 - ""Pelvi- mandibulectomy central arch"": - Squamous cell carcinoma basaloid type. - Tumor size: 4,5x3,6x2,3 cm. - Tumor involves floor of mouth, gingiva, tongue and jaw. - Intense stromal desmoplasia. - Perineural invasion: not identified. - Lymph-vascular invasion: present. - Foci of carcinoma in situ. - Margins uninvolved by invasive tumor. 5- "" Ment of subcutaneous"": - Absence of neoplasia.",val,
4438,TCGA-HV-A7OL.ECB0A827-3335-497C-9A5C-352B2042CB98,"CLINICAL DIAGNOSIS: Pancreatic cancer. Specimen : pancreas. GROSS: Specimen status: Fresh. Operation: Pylorus preserving pancreaticoduodenectomy and cholecystectomy. Organs: Small intestine (17.0 cm in length and 3.5 cm in greatest circumference). Pancreas, partial (5.5 x 4.0 x 3.0 cm). Gallbladder (10.0 cm in length, 3,5 cm in diameter, and 0.3 cm in thickness). Lesions: An ill-defined pale tan solid and firm mass (2.0 X 1.8 X 1.5 cm) in pancreatic head. Cut surface: Yellowish tan, firm and granular. Extent: Extension to peripancreatic soft tissue. Resection margins of bile duct, small intestine and pancreas: Free of tumor. Frozen diagnosis. FS1, Bile duct margin: No tumor present. FS2-3, Pancreatic resection margin: Tumor present. FS4, More resected pancreatic resection margin: No tumor present. Gross photo: Present. MICROSCOPIC: Tumor type: Ductal adenocarcinoma. Tumor location: Pancreatic head. Histologic grade: Moderately differentiated. Tumor size: 2.0 X 1.8 X 1.5 cm. Extent: Peripancreatic soft tissue, and muscle and submucosa of small intestine. Lymphovascular invasion: Present. Perineural invasion: Present. Surgical margins: All surgical margins are free from tumor. Lymph node metastasis: Absent (0/19). DIAGNOSIS: Pancreas, head, pylorus preserving pancreaticoduodenectomy: Ductal adenocarcinoma, moderately differentiated, infiltrating. Small intestine, duodenum, pylorus preserving pancreaticoduodenectomy: Direct tumor extension from pancreas. Bile duct, pylorus preserving pancreaticoduodenectomy: No tumor present. Gallbladder, pylorus preserving pancreaticoduodenectomy: Chronic cholecystitis. Lymph node, pylorus preserving pancreaticoduodenectomy: Lymph node, 7: No tumor present (0/1). Lymph node, 8: No tumor present (0/5). Lymph node, 12: No tumor present (0/4). Lymph node, 13: No tumor present (0/3). Lymph node, peripancreatic: No tumor present (0/6). Suggestion :",val,
4549,TCGA-AA-3971.c9868ee7-4cc6-4c5d-aa91-ed744a8fef35,"Diagnosis (diagnoses): Resected colon sample with a centrally ulcerated, moderately differentiated. adenocarcinoma of the colorectal type, measuring a max of 4.8 cm in diameter, with broad. infiltration of the pericolic fatty tissue and two local lymph node metastases immediately. next to the tumor. Tumor-free colon resection margins. Tumor-free mesenteric resection. margin. Otherwise, individual tubular adenomas of the colon mucous membrane with. predominant moderate dysplasia (synonym: mild intraepithelial neoplasia). The tumor stage is: pT2, pNO (0/27) pMX; G2, L0, V0, R0.",val,
4670,TCGA-90-7767.a9d672eb-90b2-4a1a-8540-d2d7370498d9,"Final Pathologic Diagnosis: A. Lung, right, resection: Poorly differentiated squamous cell carcinoma. All margins negative for neoplasm. Carcinoma involving 3 out 11 of lymph nodes (3/11). B. Lymph node, level 7 subcarinal, excision: One lymph node negative for neoplasm (0/1). C. Lymph nodes, upper paratracheal, excision: Three lymph nodes negative for neoplasm (0/3). D. Lymph nodes, lower paratracheal, excision: Thirteen lymph nodes negative for neoplasm (0/13). E. Lymph nodes, level 10, excision: Three lymph nodes negative for neoplasm (0/3). F. Bronchial margin, excision: Negative for malignancy. Frozen section diagnosis confirmed. Lung resection: Specimen: Lung. Procedure: Pneumonectomy. Specimen laterality: Right. Tumor site: Upper lobe. Specimen integrity: Intact. Tumor size: 6 cm (greatest dimension). Tumor focality: Unifocal. Tumor histologic type: Squamous carcinoma. Tumor grade: Poorly differentiated. Visceral pleura invasion: None. Tumor extension: Not applicable. Margins: Bronchial margin: Uninvolved by invasive carcinoma. Vascular margin: Uninvolved by invasive carcinoma. Parietal pleural margin: Not applicable. Chest wall margin: Not applicable. Other attached tissue margin: Not applicable. If all margins uninvolved by invasive carcinoma: Distanceof invasive carcinoma from closest margin: 9 mm. Specify margin: Parenchymal. Treatment effect: Not applicable. Lymph-vascular invasion: present. Pathologic Staging (pTNM): TNM Descriptors: None known. Primary tumor (pT): pT2b. Regional lymph nodes (pN): pN1. Number examined: 31. Number involved: 3. If lymph node(s) involved, specify involved nodal station(s): ipsilateral peribronchial. Distant metastasis (pM): pMX. Notes: Totally, seven lymph nodes are fibrotic or with central necrosis, but there is. no carcinoma. These lymph nodes are located in the peribronchial, level 7 and. lower paratracheal regions. The examination of this case material and the preparation of this report were. Intraoperative Consult Diagnosis: FSF: Bronchial margin: Negative for malignancy. Gross Description: The specimens are received in six formalin filled containers, all labeled with. the patient's name. Part A is additionally labeled ""right lung (for precision). "" The specimen. consists of a right lung with dimensions of 21 X 12 X 6.5 cm. The lung has a. weight of 400 grams. There are multiple stapled vascular structures present at. the hilum. Additionally, there are staple lines within the parenchyma that have. a total length of 13 cm. The surgical staple lines are removed and the. parenchymal margins are inked blue. The pleural surface of the specimen is. gray-purple to tan-white and generally smooth. The pleural surface has been. inked black overlying the area of the mass and a portion of the tissue sent for. precision diagnostic studies. The specimen is remarkable for a firm tan-white. fungating mass within the bronchus of the right upper lobe. Serial sectioning. reveals that the mass has overall dimensions of 6 X 5 x 4 cm. The cut surfaces. of the mass are firm, tan-white and heterogeneous with areas of necrosis and. hemorrhage. The mass appears to fill the majority of the right upper bronchus. and erode through the wall. It comes to within 0.1 cm of the pleural surface. The mass comes to within 0.5 cm of the inked parenchymal margin. The remaining. uninvolved lung is pink-tan to red-brown and spongy. The bronchial spaces are. filled with gray-green mucoid material. Multiple lymph nodes are present. adjacent to the hilar structures. These range in greatest dimension from 0.5 to. 1.3 cm. Cassettes are submitted as follows: A1. vascular margin;. A2-3. mass in right upper bronchus;. A4. mass to nearest parenchymal margin;. A5-6 remaining parenchymal margin taken en face;. A7. mass to pleura;. A8-11 additional representative sections of mass;. A12 uninvolved lung;. A13-15 multiple lymph nodes submitted in toto;. A16. one lymph node bisected. Part B is additionally labeled ""level 7 subcarinal lymph node."" The specimen. consists of a gray-tan irregular tissue with dimensions of 3.8 X 3 X 1 cm. This. may represent a single lymph node or multiple matted lymph nodes. Sectioning. reveals multiple tan-white areas of discoloration within the tissue, as well as. focal calcification. The specimen is serially sectioned and submitted entirely. in cassettes B1-B5 following decalcification. Part C is additionally labeled ""upper paratracheal lymph node.' The specimen. consists of a portion of yellow-tan fibrofatty tissue with dimensions of 3.3 X. 2.3 X 0.6 cm. Multiple probable lymph nodes are identified with greatest. dimensions ranging from 0.3 to 0.6 cm. These nodes are submitted in toto in. cassette C1. Part D is additionally labeled ""lower paratracheal lymph node."" The specimen. consists of a portion of yellow-tan lobulated fibrofatty tissue with dimensions. of 4.2 X 3.1 X 1.5 cm. Palpation and sectioning reveals multiple probable lymph. nodes with greatest dimensions ranging from 0.4 to 3 cm. Sectioning of the. largest of these nodes reveals abundant calcification. Cassettes are submitted as follows: D1-2. multiple whole probable lymph nodes;. D3-5. one lymph node submitted entirely, pending decalcification. Part E is additionally labeled ""level 10 lymph node.' The specimen consists of. two portions of gray-tan fibrofatty tissue with dimensions of 1.6 X 0.7 X 0.3 cm. and 1.5 X 1.2 X 0.5 cm. The smaller tissue is submitted in toto in cassette E1. The larger tissue is bisected and submitted entirely in cassette E2. Part F is additionally labeled ""bronchial margin."" The specimen is received. fresh for frozen section intraoperative consultation. The specimen consists of a. pink-red ring of bronchus that has dimensions of 3.2 X 2.8 X 0.7 cm. This. tissue is submitted for frozen section F. The residual tissue from frozen. section F is bisected and resubmitted in cassettes F1 and F2.",val,
4745,TCGA-B0-4852.562f6883-15ae-4222-a680-6c0d9d63b3bd,"FINAL DIAGNOSIS: KIDNEY, LEFT, RADICAL LAPARASCOPIC NEPHRECTOMY-. A. RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE. B. THE CARCINOMA MEASURES 8.8 CM IN GREATEST DIMENSION AND HAS A FUHRMAN GRADE OF 2 OUT OF 4. C. THE TUMOR IS CONFINED TO THE KIDNEY AND DOES NOT EXTEND INTO THE PERINEPHRIC FAT. D. ALL SURGICAL RESECTION MARGINS ARE FREE OF TUMOR. E. NO EVIDENCE OF ANGIOLYMPHATIO INVASION. F. PATHOLOGIC STAGE T2NxMx. G. UNINVOLVED RENAL PARENCHYMA UNREMARKABLE.",val,
4910,TCGA-A3-A8CQ.42951E48-270A-4DEC-98A4-2D239C009478,"Sex: Female. SPECIMENINFORMATION. Acct / Reg #: DIAGNOSIS. DIAGNOSIS: Left partial nephrectomy with tumor: Carcinoma. Tumor Characteristics: 1. Histologic type: Conventional-clear cell. 2. Tumor site: Left kidney. 3. Tumor focality: Unifocal. 4. Tumor size: 2.5 x 2x 1.5 cm. 5. Macroscopic extent of tumor: Limited to kidney. 6. Microscopic extent of tumor: Limited to kidney. 7. Nuclear grade: Fuhrman grade 2/4. 8. Lymphovascular space invasion: Not identified. 9. Sarcomatoid features: Not identified. Surgical Margin Status: Margins uninvolved, tumor present approximately 0.1 cm from posterior (stitch) margin, tumor abuts capsule. Lymph Node Status: Total number of lymph nodes received: None. Other: 1. Other significant findings: None. 2. pTN stage: pT1a NX. EINICAEINEORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Stitch on posterior margin. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: Left renal tumor/mass. SPECIMENT DATA. GROSS DESCRIPTION: The specimen is received in a single formalin filled container labeled with the patient's name. and ""left renal tumor/mass"" and consists of. a 3.5 x 2.4 x 2.2 cm partial nephrectomy specimen. Red-pink, shaggy renal parenchyma is present on one aspect and it bears a stitch. The opposite. aspect is smooth and encapsulated. The sutured parenchymal aspect is inked blue and the encapsulated aspect is inked blue. The specimen is. sectioned to reveal a 2.5x 2.0x 1.5 cm, well circumscribed, yellow-tan, hemorrhagic and variegated mass that approaches to within 0.1 cm of. the. sutured parenchymal aspect and abuts the encapsulated aspect. The specimen is entirely submitted in cassettes 1-6 labeled. Additionally, a yellow and green cassette are submitted for genomics research, each labeled.",val,
5070,TCGA-SP-A6QI.2022A9E9-FCAD-4B04-A732-4FFDB416B972,"LABORATORY MEDICINE PROGRAM. Facility: Specimen(s) Received. 1. Adrenal: right adrenal gland. Diagnosis. Pheochromocytoma: Adrenal (right) adrenalectomy specimen. Comment. This is an unusual pheochromocytoma. The architecture and cytology mimic a cortical lesion, but the. immunohistochemistry identifies the correct diagnosis. Clinical History. None. Gross Description. The specimen container labeled with the patient's name and as ""right adrenal gland"" contains an adrenal gland with a. mass. The specimen weighs 39.0 grams and measures 9.0 X 4.7 X 2.5 cm. The external surface is painted with silver that. nitrate. After removal of adherent fat, the adrenal weighs 33.5 grams. On section there is a well-delineated mass. measures 3.4 x 3.2 x 3.0 cm and has a solid bright yellow to yellow-orange homogenous cut surface. The remainder of. the adrenal is unremarkable. The specimen is submitted in toto as follows: 1A-M. mass from one end to the other. 1N-X remainder of the adrenal gland. Microscopic Description. DOMINANT LESION: adrenal tumor. SIZE: 9.0 cm maximum dimension. WEIGHT: 33.5 g. ARCHITECTURE: solid nesting and trabecular architecture. CYTOLOGY: round cells with well-defined cell borders, abundant clear to basophilic cytoplasm and no nuclear. pleomorphism. DEGENERATION: none identified. ENCAPSULATION: incomplete capsule. CAPSULAR INVASION: no frank invasion identified. EXTRA-ADRENAL INVASION: not identified. RESECTION MARGINS: not involved. LYMPHOVASCULAR INVOLVEMENT: not identified. OTHER ADRENAL PATHOLOGY: none; no cortical atrophy or hyperplasia and no medullary hyperplasia. LYMPH NODES: none identified. IMMUNOHISTOCHEMISTRY: positive for chromogranin and tyrosine hydroxylase; sustentacular cells stain for S100. protein.",val,
5194,TCGA-4P-AA8J.A1DC1F44-7E95-4C05-BDE4-B0658FAC37D7,"Result Data. Site : Jongue NOS C02.9. Component. Lab. Clinical History. Tongue cancer. Gross Examination. A. ""Right lateral tongue lesion"", received unfixed for frozen section and. placed in formalin on. is a 0.9 X 0.4 x 0.2 cm tan-gray. fragment of soft tissue submitted entirely for frozen section as AF1. The. frozen section remnant is submitted in A1. B. ""Anterior gingival margin"", received unfixed and placed in formalin on. is a 2.1 x 0.2 x 0.2 cm tan-gray, focally hemorrhagic. fragment of soft tissue submitted entirely for frozen section BF1. The frozen. section remnant is submitted in B1. C. ""Deep tongue margin"", received unfixed for frozen section and placed in. formalin on. is a 2.5 X 1.2 x 0.5 cm red-brown fragment of. soft tissue. The specimen is entirely submitted for frozen section as CF1. The frozen section remnant is submitted in C1. D. ""Anterior tongue attachment"", received unfixed for frozen section and. placed in formalin on. is a 0.5 x 0.3 X 0.2 cm tan-red. fragment of soft tissue submitted entirely for frozen section as DF1. The. frozen section remnant is submitted in D1. E. ""Right floor of mouth"", received unfixed and placed in formalin on. is a 2.5 x 0.5 x 0.3 cm tan, elongated, focally hemorrhagic. fragment of mucosal tissue submitted entirely for frozen as EF1. The frozen. section remnant is submitted in E1. F. ""Right posterior tongue margin"", received unfixed for frozen section and. placed in formalin on. is a 3.2 X 0. - x 0.2 cm tan-red,. focally hemorrhagic fragment of soft tissue submitted entirely for frozen. section as FF1. The frozen section remnant is submitted in F1. G. ""Left floor of mouth"", received unfixed for frozen section and placed in. formalin on. is a 1.8 X 0. x 0.2 cm tan-red fragment of. soft tissue submitted entirely for frozen section as GF1. The frozen section. remnant is submitted in G1. H. ""Left posterior tongue margin"", received fresh for frozen section and. placed in formalin at. is a 2.2 x 0.2 X 0.2 cm tan,. elongated strip of soft tissue submitted entirely for frozen section as HF1. The frozen section remnant is submitted in H1. I. ""Right hemiglossectomy, stitch at tip of tongue"", received unfixed and. placed in formalin on. is a right hemiglossectomy specimen,. 6.5 X 4.5 X 3.2 cm in dimension. The surgeon has marked the tip of the tongue. with a black suture. The right half of the deep aspect is marked with black. ink, and the left half of the deep aspect is marked with blue ink. The. peripheral mucosal and tongue resection margins are shaved and submitted in. a. clockwise fashion. Sectioning through the tongue reveals a tan-gray, well-circumscribed tumor. mass which focally ulcerates the mucosal surface of the tongue. The tumor. mass is 1.9 X 1.5 x 1.5 cm in dimension and extends into the attached floor of. mouth. The central aspect displays a central hemorrhagic area. The tumor. comes to 0.1 cm from the deep resection margin of the specimen. Representative. sections are submitted as follows. BLOCK SUMMARY. Il 12-3:00 specimen margin, en face. I2 3-6:00 specimen margin, en face. I3 6-9:00 specimen margin, en face. I4 9-12:00 specimen margin, en face. I5-I6 tumor mass with relationship to deep resection margin. I7-8 tumor mass with relationship to ulcerated tongue mucosa. J. ""Bilateral level 1A"", received unfixed and placed in formalin on. is a 4.5 x 2.1 x 1.5 cm fragment of adipose tissue. All lymph node. candidates are submitted in J1. BLOCK SUMMARY: J1- three intact lymph node candidates. K. ""Right level 1B"", received unfixed and placed in formalin on. is a 4.8 x 3.5 X 2.5 cm fragment of yellow adipose tissue. Sectioning. reveals a central tan, firm and lobulated salivary gland. The surrounding. adipose tissue is dissected for lymph nodes. Sections are submitted as. follows. BLOCK SUMMARY: K1-2- eight intact lymph node candidates. K3-. one lymph node candidate, bisected. K4-5- representative salivary gland. L. ""Right level 4"", received unfixed and placed in formalin on. is a 2.4 x 1.6 x 0.4 cm fragment of yellow adipose tissue. The specimen is. dissected for lymph nodes. All lymph node candidates are submitted as. follows. BLOCK SUMMARY: L1- one lymph node candidate, bisected. L2- two intact lymph node candidates. M. ""Right level 2A"", received unfixed and placed in formalin on. is a tan-gray firm portion of tissue measuring 4.8 x 3.5 X 1.5 cm. Sectioning reveals a large, gray-white indurated nodule which is 3 cm in. greatest dimension. Sectioning of the nodule reveals tumor involvement. All. lymph node candidates and a representative section of the nodule are submitted. in blocks M1-3. BLOCK SUMMARY: M1- three intact lymph node candidates. M2- representative section of large nodular mass. M3- one lymph node, trisected. N. ""Right level 3"", received unfixed and placed in formalin on. is a 6.5 X 4. 1 x 1.2 cm fragment of yellow adipose tissue. The specimen is. dissected for lymph nodes. Sections are submitted as follows. BLOCK SUMMARY: N1- three intact lymph node candidates. N2- six intact lymph node candidates. O. ""Right level 2B"", received unfixed and placed in formalin on. is a 2.2 X 1.3 X 0.8 cm fragment of yellow adipose tissue. The specimen. is entirely submitted in 01-2. P. ""Left level 1B"", received unfixed and placed in formalin on. is a yellow lobulated firm portion of fatty tissue measuring 5.7 x 3.7 x 2.5. cm. Sectioning reveals a tan lobulated salivary gland. No nodules or masses. are noted within the salivary gland. The remaining adipose tissue is. dissected for lymph nodes. Sections are submitted as follows. BLOCK SUMMARY: P1- salivary gland. P2- one lymph node candidate, bisected. P3- three lymph node candidates, intact. P4-5- one lymph node, serially sectioned. Q. ""Left level 4"", received unfixed and placed in formalin on. is a 4 X. 1 X 1 cm fragment of yellow adipose tissue. The specimen is entirely. submitted in Q1-3. R. ""Right level 2A"", received unfixed and placed in formalin on. is a 3.2 x 1.5 x 1.5 cm firm fragment of yellow adipose tissue. Sectioning. reveals two tan firm lymph node candidates, The largest is 2 cm in greatest. dimension. Both are bisected and entirely submitted in R1-2. S. ""Left level 3"", received unfixed and placed in formalin on. is a 5.2 x 3 x 1 cm fragment of yellow adipose tissue. The specimen is. dissected for lymph nodes. All lymph node candidates are submitted in S1-2. T. ""Left level 2B"", received unfixed and placed in formalin on. is a fragment of yellow adipose tissue 2.8 X 1.5 x 0.5 cm. The specimen. is. entirely submitted in T1. Intraoperative Consultation. A. ""Right lateral tongue lesion"" JF1 (total) -reactive lingual tonsillar. tissue. No carcinoma or dysplasia seen (Dr. B. ""Anterior gingival margin"":BF1 (total)-negative for carcinoma or high grade. dysplasia (Dr. C. ""Deep tissue margin"":CF1 (total)-negative for carcinoma (Dr. D. ""Anterior tongue attachment"":DF1 (total)-negative for carcinoma. (Dr. E. ""Right floor of mouth"": EF1 (total) -negative for carcinoma (Dr. F. ""Right posterior tongue margin"": FF1 (total) 1-negative for carcinoma. (Dr. G. ""Left floor of mouth"":GF1 total)-negative for carcinoma (Dr. H. ""Left posterior tongue margin"":HF1 (total)-negative for carcinoma. (Dr. Microscopic Examination. Microscopic examination is performed. Immunohistochemical Findings. An immunohistochemical stain for p16 was performed on block I5, and is. negative. The immunoperoxidase tests reported herein were developed and their. performance characteristics were determined by the. Some of them may not be cleared or approved by. the U.S. Food and Drug Administration. The FDA has determined that such. clearance or approval is not necessary. These tests are used for clinical. purposes. They should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (CLIA) as qualified to perform high complexity clinical. testing. Pathologic Stage. PATHOLOGIC STAGE (AJCC 7th Edition) : pT2 pN2c pMX. NOTE: Information on pathology stage and the operative procedure is. transmitted to this Institution's Cancer Registry as required for. accreditation by the Commission on Cancer. Pathology stage is based solely. upon the current tissue specimen being evaluated, and does not incorporate. information on any specimens submitted separately to our Cytology section,. past pathology information, imaging studies, or clinical or operative. findings. Pathology stage is only a component to be considered in determining. the clinical stage, and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon's operative report. Diagnosis. A. ""RIGHT LATERAL TONGUE LESION"" (BIOPSY) : LINGUAL TONSILLAR TISSUE. NEGATIVE FOR MALIGNANCY. B. ""ANTERIOR GINGIVAL MARGIN"" (BIOPSY) : SQUAMOUS MUCOSA WITH NO EVIDENCE OF MALIGNANCY. C. ""DEEP TONGUE MARGIN"" (BIOPSY) : SKELETAL MUSCLE AND FIBROADIPOSE TISSUE. NEGATIVE FOR MALIGNANCY. D. ""ANTERIOR TONGUE ATTACHMENT"" (BIOPSY) : FIBROADIPOSE AND VASCULAR TISSUE. NEGATIVE FOR MALIGNANCY. E. ""RIGHT FLOOR OF MOUTH"" (BIOPSY) : SQUAMOUS MUCOSA, SALIVARY TISSUE AND SKELETAL MUSCLE. NEGATIVE FOR MALIGNANCY. F. ""RIGHT POSTERIOR TONGUE MARGIN"" (BIOPSY) : SQUAMOUS MUCOSA AND SKELETAL MUSCLE. NEGATIVE FOR MALIGNANCY. G. ""LEFT FLOOR OF MOUTH"" (BIOPSY) : SQUAMOUS MUCOSA AND SKELETAL MUSCLE. NEGATIVE FOR MALIGNANCY. H. ""LEFT POSTERIOR TONGUE MARGIN"" (BIOPSY) : SQUAMOUS MUCOSA AND SKELETAL MUSCLE. NEGATIVE FOR MALIGNANCY. I. ""RIGHT HEMIGLOSSECTOMY"" (HEMIGLOSSECTOMY) : CARCINOMA OF ORAL CAVITY: Specimen: - Procedure: RIGHT HEMIGLOSSECTOMY. - Specimen size: 6.5 x 4.5 x 3.2 CM. - Specimen integrity: SINGLE, INTACT. Tumor features. - Histologic type: SQUAMOUS CELL CARCINOMA, KERATINIZING TYPE. - Grade: GRADE 2 (MODERATELY DIFFERENTIATED). Tumor extent: - Tumor size: 1.9 x 1.5 CM. - Invasion depth: 1.9 MILLIMETERS. - Tumor thickness: 0.8 MILLIMETERS. - Primary location: RIGHT TONGUE. - Focality: UNIFOCAL. - Contiguous invasion: LESS THAN 4 CM (pT2). Accessory : - Lymphvascular invasion: POSITIVE. - Perineural invasion: POSITIVE. HPV status: p16 NEGATIVE. Margins: SPECIMEN MARGINS NEGATIVE FOR TUMOR. J. ""BILATERAL LEVEL 1A"" (LYMPH NODE BIOPSY) : FIVE LYMPH NODES: NEGATIVE FOR CARCINOMA. (0/5). K. ""RIGHT LEVEL 1B"" (LYMPH NODE BIOPSY) : FIVE LYMPH NODES: NEGATIVE FOR CARCINOMA. (0/5). SALIVARY GLAND WITH CHRONIC SIALADENITIS. L. ""RIGHT LEVEL 4"" (LYMPH NODE BIOPSY) : THREE LYMPH NODES: NEGATIVE FOR CARCINOMA. (0/3). M. ""RIGHT LEVEL 2A"" (LYMPH NODE BIOPSY) : ONE OF SEVEN LYMPH NODES: POSITIVE FOR METASTATIC CARCINOMA. (1/7). 3 CM, EXTRACAPSULAR EXTENSION IS PRESENT. N. ""RIGHT LEVEL 3"" (LYMPH NODE BIOPSY) : ONE OF EIGHT LYMPH NODES: POSITIVE FOR METASTATIC CARCINOMA. (1/8). 0.7 CM, EQUIVOCAL FOR EXTRACAPSULAR EXTENSION. O. ""RIGHT LEVEL 2B"" (LYMPH NODE BIOPSY) : FOUR LYMPH NODES: NEGATIVE FOR CARCINOMA. (0/4). P. ""LEFT LEVEL 1B"" (LYMPH NODE BIOPSY) : TWO OF THREE LYMPH NODES: POSITIVE FOR METASTATIC CARCINOMA. (2/3). 0.8 AND 0.9 CM, EXTRACAPSULAR EXTENSION IS PRESENT IN ONE LYMPH NODE. Q. ""LEFT LEVEL 4"" (LYMPH NODE BIOPSY) : TWO LYMPH NODES: NEGATIVE FOR CARCINOMA. (0/2). R. ""RIGHT LEVEL 2A"" (LYMPH NODE BIOPSY) : TWO LYMPH NODES: NEGATIVE FOR CARCINOMA. (0/2). S. ""LEFT LEVEL 3"" (LYMPH NODE BIOPSY) : TWO OF FIVE LYMPH NODES: POSITIVE FOR METASTATIC CARCINOMA. (2/5). 0.9 AND 1.2 CM, EXTRACAPSULAR EXTENSION IS PRESENT IN ONE LYMPH NODE. T. ""LEFT LEVEL 2B"" (LYMPH NODE BIOPSY) : FOUR LYMPH NODES: NEGATIVE FOR CARCINOMA. (0/4). Comment: I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es) . Dr. M.D. Testing Performed By. Lab - Abbreviation. Director. Valid Date Range. Lab and Collection. Surgical Pathology on. Abnormality. Priority. Source. Routine. Authorizing Provider Information. MD. Surgical Pathology (Order. Authorizing: MD. Pathology and Cytology. Department. General. Released By: Release Date/Time. Start Date/Time. End Date/Time. Frequency. Duration. Priority. Once. 1 occurrence. Routine. Encounter. View Encounter. Reprint Requisition. Surgical Pathology (Order #. on. Original Order. Lab. i. Office. Pager/beeper E-mail. Authorizing Provider. MD. There are no order-level documents. No order transmittal information available.",val,
5299,TCGA-CV-7242.01b0a063-11bb-4cbd-9605-50f37cbb71ac,"Case type: Surgical Case. MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A) TOTAL LARYNGECTOMY, BILATERAL NECK DISSECTIONS, LEVEL II, III AND IV AND RIGHT. HEMITHYROIDECTOMY: INVASIVE SQUAMOUS CARCINOMA, MODERATELY DIFFERENTIATED, 2.2 CM INVOLVING RIGHT. TRANSGLOTIO REGION (SEE COMMENT). Tumor Features: Gross: Exophytic. Size: 2.2 cm in largest dimension. Invasion: Present, depth 1.6 cm. Tumor Border: Infiltrative with thick cords > 4 cells. Perineural Invasion: Absent. Vascular Invasion: Absent. Bone / Cartilage Invasion: Pending Decalcification (see addendum). Lymphocyte Infiltration: Mild. Right neck dissection. No tumor present in 16 Lymph Nodes. Level II: Positive Nodes = 0. Total Nodes = 6. Level III: Positive Nodes = 0. Total Nodes = 7. Level IV: Positive Nodes = 0. Total Nodes = 3. Left neck dissection. No tumor present in 27 Lymph Nodes. Level II: Positive Nodes = 0. Total Nodes = 10. Level III: Positive Nodes = 0. Total Nodes = 7. Level IV: Positive Nodes = 0. Total Nodes = 10. Thyroid, no tumor present. (B) POSTERIOR CRICOID: Squamous mucosa, negative for tumor. (C) RIGHT LATERAL PHARYNX: Squamous mucosa, negative for tumor. (D) LEFT LATERAL PHARYNX: Squamous mucosa, negative for tumor. COMMENT. (A). The balance of right transglotic region with subjacent cartilage and bone is pending decalcification (A5-A9). The. results will be reported in a separate addendum. GROSS DESCRIPTION. (A) TOTAL LARYNGECTOMY, BILATERAL NECK DISSECTIONS, LEVEL II, III AND IV AND RIGHT. HEMITHYROIDECTOMY - A total laryngectomy specimen (7.8 X 4.0 X 4.0 cm) with attached soft tissue and muscle (8.0 X 6.0. X 1.2 cm and right thyroid (3.0 X 3.0 X 2.1 cm). There is a polypoid mass in the right transglottic region measuring 2.2 X 1.9 cm. and 1.6 cm in depth. The tumor has homogeneous yellow-tan cut surface with no grossly hemorrhage or necrosis. The mass. abuts the thyroid cartilage and it is 3.0 cm to the tracheal cartilage resection margin. The left transglottic mucosa is grossly. uninvolved by the mass. Sectioning of the right thyroid reveals spongy, brownish mucosa with no lesion grossly seen. Multiple lymph nodes identified in the neck resection soft tissue and are entirely submitted. Normal and tumor are submitted for Tumor Bank. SECTION CODE: A1, tracheal margin; A2, A3, random section of right thyroid; A4, left transglottic region; A5-A9,. right transglottic mass submitted from right to left (A5-A8, submitted after decalcification); A10-A11, left level II, one possible. node bisected in each section; A12-A13, left level II possible lymph nodes, four per each section; A14, left level III, four. possible nodes; A15, left level III, five possible lymph nodes. A16-A18, left level 4, five possible nodes per section, ATy, 4, four possible nodes; A20, right level 2, one. possible node bisected; A21, right level 2, three possible nodes; A22, right level 2, four possible nodes; A23-A25, right level. 3, five possible nodes in each section; A26, right level 4, one possible node; A27, right level 4, one possible node, bisected;. A28, right level 4, one possible node bisected; A29, muscle. (B). POSTERIOR CRICOID - Received is a nink soft tissue (2 X 0.8 X 0.5), entirely submitted for frozen in B. FS/DX: NO TUMOR PRESENT. (C) RIGHT LATERAL PHARYNX - Received is a pink soft tissue (2.4 X 0.9 X 0.5), entirely submitted for frozen in C. FS/DX: NO TUMOR PRESENT. (D) LEFT LATERAL PHARYNX - Received is a pink soft tissue (2 X 0.8 x 0.5), entirely submitted for frozen in D. FS/DX: NO TUMOR PRESENT. CLINICAL HISTORY. Squamous cell carcinoma, larynx. SNOMED CODES. T-C4200, T-24100, M-80706, M-80703, M-43000,. Entire report and diagnosis completed by. ADDENDUM. This modified report is being issued to provide additional information/results. Addendum completed by. DIAGNOSIS. (A) TOTAL LARYNGECTOMY, BILATERAL NECK DISSECTION, LEVELS II, III, IV AND RIGHT HEMITHYROIDECTOMY: INVASIVE SQUAMOUS CARCINOMA, MODERATELY DIFFERENTIATED, ABUTTING CARTILAGE AND BONE. Entire report and diagnosis completed by:",val,
5310,TCGA-EB-A3HV.BA0FAD4F-F42F-4BE2-932B-A2908260130C,"Caterality: Path Report:SKIN TISSUE CHECKLIST. Specimen type: Excision of tumor. Tumor site: Skin. Tumor size: 5.5x4.5x1.3 cm. Tumor features: Raised, Pigmented. Satellite nodules: Not specified. Histologic type: Nodular melanoma. Histologic grade: Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Clark level 4. Gross Description: Microscopic Description: Diagnosis Details:",val,
5528,TCGA-RY-A83Y.EEC58176-5007-4A8F-9BBB-ABE5B1D13772,"Service Date: (Age: ). Male. Soc. Sec. #: Client: FINAL PATHOLOGIC DIAGNOSIS. A. Brain, left parietal lobe, biopsy: Oligodendroglioma, WHO grade II; see comment. B. Brain, left parietal, excision: Oligodendroglioma, WHO grade II; see comment. C. Brain, Cavitron ultrasonic surgical aspiration: Oligodendroglioma, WHO grade II;. see comment. COMMENT: This oligodendroglioma shows typical features, with a moderately cellular proliferation of neoplastic. oligodendroglia showing uniform round nuclei. The mitotic activity is low, with up to 1 mitotic figure/10. HPFs. No necrosis or microvascular proliferation is seen,. A macrophage infiltrate is intermixed with the tumor, and multiple vessels are cuffed by macrophages. Immunohistochemistry for IDH1 and MIB-1 will be performed on block A2 and the results will be. reported in an addendum. In addition, fluorescence in-situ hybridization for 1p19q will be performed on. block A2 at the. and the results will be reported separately. has reviewed select slides of the case and agrees with the diagnosis. Intraoperative Diagnosis. FS1 (A) Brain, biopsy: Infiltrating glioma, favor oligodendroglioma, at least WHO grade II. Tissue. section and cytologic preparation. Gross Description. The specimen is received fresh in three parts, each labeled with the patient's name and medical record. number. Part A, additionally labeled ""L tumor - FS + perm,"" consists of multiple, irregular, friable, tan to pink. glistening tissue fragments (1.2 x 0.8 x 0.3 cm). A representative section is frozen for frozen section. diagnosis 1 and a touch prep is created. The entire specimen is submitted in cassettes as follows: A1: Frozen section 1 remnant. A2: Remaining tissue. Part B, additionally labeled ""tumor,"" consists of one pink, irregular, unoriented soft tissue fragment (1 x. 1 x 0.3 cm). The specimen is submitted intact in cassette B1. Part C, additionally labeled ""CUSA contents,"" consists of multiple soft, pink, irregular, unoriented soft. tissue fragments (5 x 5 x 2 cm in aggregate). Representative sections are submitted in cassettes. C1-C8. All of the remaining tissue is submitted in cassettes C9-C16. Clinical History. The patient is a -year-old man who presented with seizures, and a left parietal mass with a small. area of focal ring enhancement, on Decadron and Keppra. Per. MRI shows an ill-defined, cortically. based T2/FLAIR hyperintense mass involving the left postcentral gyrus and left Inferior parietal lobule. Diagnosis based on gross and microscopic examinations. Final diagnosis made by attending pathologist following review of all. pathology slides. The attending pathologist has reviewed all dictations and preliminary interpretations performed by any resident. involved in the case and performed all necessary edits before signing the final report. Pathology Resident. /Pathologist. Addendum. Date Complete: Addendum Comment. Immunohistochemical studies performed and evaluated at. show that the neoplastic cells are. positive with the antibodies against IDH-1 (R132H mutant) protein (on A2). MIB1 labeling on A2 is estimated at approximately 4%. The immunoperoxidase stain(s) reported above were developed and their performance characteristics determined by the. They have not been cleared or approved by the U. S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They. should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (""CLIA) as qualified to perform high-compiexity clinical testing.",val,
5539,TCGA-B0-5701.61def406-8bc0-4955-b59a-d1d43267c888,"PATIENT HISTORY: PRE-OP DIAGNOSIS: Left renal mass. POST-OP DIAGNOSIS: Same. PROCEDURE: Left nephrectomy. FINAL DIAGNOSIS: PART 1: KIDNEY, LEFT, NEPHRECTOMY. A. RENAL CELL CARCINOMA, CONVENTIONAL CLEAR CELL TYPE, WITH FOCAL SARCOMATOID FEATURES. B. FUHRMAN'S NUCLEAR GRADE IS IV OF IV. C. THE GREATEST DIAMETER OF THE NEOPLASM is 9.5 CM. D. THE NEOPLASM EXTENDS THROUGH THE RENAL CAPSULE, BUT IS CONFINED WITHIN GEROTA'S FASCIA. E. THE NEOPLASM EXTENDS INTO RENAL PELVIS ADIPOSE TISSUE. F. INVASION OF THE RENAL VEIN IS PRESENT. G. ALL SURGICAL MARGINS ARE FREE OF THE NEOPLASM. H. THE NON-NEOPLASTIC KIDNEY REVEALS ARTERIOLOSCLEROSIS, FOCAL GLOBAL AND SEGMENTAL. GLOMERULOSCLEROSIS, AND FOCAL CYSTIC CHANGE. I. THE ADRENAL GLAND IS FREE OF TUMOR, WITH MILD CORTICAL HYPERPLASIA. J. TNM STAGE: pT3b NO MX. PART 2: LYMPH NODES, HILAR, EXCISION -. NO TUMOR SEEN IN FOUR LYMPH NODES (0/4). CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY KIDNEY TUMORS. SPECIMEN TYPE: Radical nephrectomy. LATERALITY;. Left. TUMOR SITE: Middle. Lower pole. FOCALITY: Unifocal. TUMOR SIZE: Greatest dimension: 9.5 cm. Additional dimensions: 6 x 6 cm. MACROSCOPIC EXTENT OF TUMOR: Tumor extension into perinephric tissues. Tumor extension into major veins. HISTOLOGIC TYPE: Clear cell (conventional) renal carcinoma. Sarcomatoid carcinoma arising in renal cell carcinoma. Subtype and % of sarcomatoid element: 5%. HISTOLOGIC GRADE (Fuhrman Nuclear Grade): G4. PATHOLOGIC STAGING (pTNM): pT3b. pNO. Number of regional lymph nodes examined: 4. Number of regional lymph nodes involved: 0. pMX. MARGINS: Margins uninvolved by invasive carcinoma. ADRENAL GLAND: Uninvolved by tumor. VENOUS (LARGE VESSEL) INVASION (V): Present. LYMPHATIC (SMALL VESSEL) INVASION (L): Absent. ADDITIONAL PATHOLOGIC FINDINGS: Glomerular disease (type): FOCAL GLOBAL AND SEGMENTAL. GLOMERULOSCLEROSIS. Other: ARTERIOLOSCLEROSIS.",val,
5714,TCGA-HV-A5A5.CB59EF73-6734-4BE4-8BBB-C24359E66FEF,"CLINICAL DIAGNOSIS: Pancreatic head cancer. Specimen : CBD, Pancreatic head(LN). GROSS: Specimen status: Fresh. Operation: Pylorus preserving pancreaticoduodenectomy. Cholecystectomy. Organs: Small intestine (25.5 cm in length and 2.5 cm in diameter),. pancreas, partial (7.5 x 5.4 x 3.5 cm),. and common bile duct (5.5 cm in length and 1.0 cm in diameter) in contintuity. Gallbladder (8.5 cm in length, 3.4 cm in diameter). [Pancreas]. Lesion: An ill-defined ovoid mass in pancreatic head to ampullary area. Size: 2.5 x 1.8 x 1.5 cm. Cut surface: Pale tan and firm mass. Extent: Extend to duodenal wall. Resection margins: Distal pancreatic resection margin: Free of tumor (safety margin: 2.3 cm). Radial pancreatic margin: Very close to tumor (safety margin: 0.1 cm). Common bile duct resection margin: Free of tumor. Remaining pancreas: Fibrotic change. [Common bile duct]. Eroded and no mass-like lesion. [Duodenum]. Unremarkable. [Gallbladder]. Mucosa: Dark red to mahogany and velvety. Serosa: Pale pink and smooth. Wall: 0.6 cm in thickness. Frozen section diagnosis. FS1-2, proximal bile duct resection margin: No tumor present. FS3, distal pancreatic resection margin: No tumor present. Gross photo: Present. Blocks. T1-8, pancreatic mass X 8. BD, common bile duct x 1. LN1-2, periduodenal lymph nodes x 2. LN3, No. 12 lymph nodes x 1. LN4, No. 13 lymph nodes X 1. FS1-3, frozen permanent x 3. P and D, duodenal resection margin x 2. GB, gallbladder x 1. Microscopic: Tumor type: Ductal adenocarcinoma. Tumor location: Pancreas. Histologic grade: Moderately differentiated. In situ carcinoma: Not identified. Tumor size: 2.5 x 1.8 x 1.5 cm. Direct extension: Tumor extends beyond the pancreas to duodenum and peripancreatic tissue. Lymphovascular invasion: Present. Perineurial invasion: Present. Surgical margins: Radial margin: Close to tumor (safety margin: 0.1 cm). Distal pancreatic resection margin: Free of tumor. Proximal bile duct resection margin: Free of tumor. DIAGNOSIS: Pancreas, head, pylorus preserving pancreaticoduodenectomy: Ductal adenocarcinoma, moderately differentiated, infiltrating. Common bile duct, pylorus preserving pancreaticoduodenectomy: No tumor present. Small intestine, duodenum, pylorus preserving pancreaticoduodenectomy: Direct tumor extension. Gallbladder, cholecystectomy: Chronic cholecystitis. Lymph node, regional, pylorus preserving pancreaticoduodenectomy: Peripancreatic: Direct tumor extension (2/4). Periduodenal: No tumor present (0/9). Lymph node, regional, biopsy: No. 12: No tumor present (0/3). No. 13: No tumor present (0/3). di.",val,
5741,TCGA-AK-3425.3c0dcc29-86cc-44b2-aba9-fb6f704d7c8e,"Source of Specimen(s): A: RENAL TUMOR. B: PARA AORTIC LYMPH NODE LEFT. Other Related Clinical Data: Clinical History/Diagnosis: LT RENAL TUMOR. Specimen(s): 1. RENAL TUMOR. 2. PARA AORTIC LYMPH NODE LEFT. Sunquest Archived Tests: NATURE OF SPECIMEN : RESECTION, FROZEN SECTION. Gross Description: GROSS DESCRIPTION: Received in two parts. SOURCE OF TISSUE: 1. Labeled #1, ""renal tumor"". FROZEN SECTION DIAGNOSIS: 1FS - CLEAR CELL CARCINOMA, PER DR. GROSS DESCRIPTION: Received fresh for frozen section evaluation is a. 1,426. gram nephrectomy having an abundant amount of attached perinephric fat. The. kidney itself is 9.5 x 7.5 x 5.0 cm in greatest dimension having a 4.5 X. 0.2. cm portion of attached ureter, having a lumen, 0.2 cm in greatest. dimension,. which is probe patent to the renal pelvis. The kidney is bivalved to. reveal. red-purple firm renal parenchyma having a well defined corticomedullary. junction. In the mid portion there is a 5.5 x 3.5 x 3.0 cm mass having. golden yellow-tan to red-purple, soft, variegated and nodular cut. surfaces. Representative section of this mass are submitted for frozen section. evaluation and the frozen section residue is submitted in one block. On sectioning through the perinephric fat there is a 4.5 x 2.0 x 0.5 cm. adrenal gland having golden yellow-tan cut surfaces. Representative. sections are submitted in twelve blocks. DESIGNATION OF SECTIONS: 1FS - frozen section renal mass, 1A - ureter and. vascular margins, 1B-1G - renal mass, 1H-1I - inked circumferential. margin,. 1J-1K - random kidney sections, 1L - adrenal gland. SUMMARY OF SECTIONS: FS, A-L - multiple. SOURCE OF TISSUE: 2. Labeled #2, ""para-aortic lymph node left"". GROSS DESCRIPTION: Received fresh are 5.5 x 4.0 X 2.0 cm of yellow-tan. fibroadipose tissue. It contains several palpable lymph nodes, 0.6 to 2.0. cm in greatest dimension. The lymph nodes are entirely submitted in eight. blocks. DESIGNATION OF SECTIONS: 2A-2H (A-B - one lymph node, C - one lymph node,. D. - one lymph node, E-G - one lymph node, H - two single lymph nodes). SUMMARY OF SECTIONS: A-H - multiple. Final Diagnosis: DIAGNOSIS: 1. LEFT KIDNEY, NEPHRECTOMY: - RENAL CELL ADENOCARCINOMA, CLEAR CELL TYPE, INTERMEDIATE. GRADE, 5.5CM,. CONFINED TO THE KIDNEY. - NEGATIVE ADRENAL GLAND. TUMOR DOES NOT INVOLVE RENAL VEIN, CAPSULE OR PERIRENAL FAT. - URETER AND VEIN MARGINS NEGATIVE. 2. LYMPH NODE, PARA-AORTIC, LEFT, EXCISION: - SIX NEGATIVE LYMPH NODES (0/6).",val,
5897,TCGA-DD-A4NA.48C11C04-947E-4954-9687-DF275D897F79,"REVISED REPORT (Revised information underlined). Addendum/Procedure included. DIAGNOSIS: D. Liver, left lobe, resection: Poorly differentiated. hepatocellular carcinoma forming a lobulated mass, 9.6 x 9.5. x 9.3 cm. There is extensive lymphovascular invasion including a. tumor thrombus. The margins are negative for tumor by < 0.1 cm. Multiple (1 caval and 1 hilar) regional lymph nodes are negative for. tumor. A. Lymph nodes, celiac artery, excision: Multiple (3) celiac. artery lymph nodes are negative for tumor. B. Lymph node, hepatic artery, excision: A single (1) hepatic. artery lymph node is negative for tumor. C. Lymph node, pericholedochal, excision: A single (1). pericholedochal lymph node is negative for tumor. Photographed. This final pathology report is based on the gross/macroscopic. examination and frozen section histologic evaluation of the. specimen (s). ADDENDUM: In situ hybridization for albumin is positive. AMENDMENTS: (Previous Signout Date. Revision Description: Removed ""favor bile duct primary"" from the. original diagnosis. Previous Diagnosis. D. Liver, left lobe, resection: Poorly differentiated. hepatocellular carcinoma favor bile duct primary, forming. a lobulated mass, 9.6 x 9.5 x 9.3 cm. There is extensive. lymphovascular invasion including a tumor thrombus. The margins are. negative for tumor by < 0.1 cm. Multiple (1 caval and 1 hilar). regional lymph nodes are negative for tumor. A. Lymph nodes, celiac artery, excision: Multiple (3) celiac. artery lymph nodes are negative for tumor. B. Lymph node, hepatic artery, excision: A single (1) hepatic. artery lymph node is negative for tumor. Lymph node, pericholedochal, excision: A single (1). pericholedochal lymph node is negative for tumor. Photographed. This final pathology report is based on the gross/macroscopic. examination and frozen section histologic evaluation of the. specimen (s) . igning Pathologist. AMENDMENTS: (Previous Signout Date: Revision Description: Special stains support hepatocellular. carcinoma for part D. Diagnosis changed to reflect this. Original Diagnosis. D. Liver, left lobe, resection: Poorly differentiated. adenocarcinoma, favor bile duct primary, forming a lobulated mass,. 9.6 x 9.5 x 9.3 cm. There is extensive lymphovascular invasion. including a tumor thrombus. The margins are negative for tumor by <. 0.1 cm. Multiple (1 caval and 1 hilar) regional lymph nodes are. negative for tumor. A. Lymph nodes, celiac artery, excision: Multiple (3) celiac. artery lymph nodes are negative for tumor. Lymph node, hepatic artery, excision: A single (1) hepatic. artery lymph node is negative for tumor. C. Lymph node, pericholedochal, excision: A single (1). pericholedochal lymph node is negative for tumor. Photographed. This final pathology report is based on the gross/macroscopic. examination and frozen section histologic evaluation of the. specimen (s) .",val,
5903,TCGA-3C-AALK.F43B01E6-E1DB-44B1-8003-93870606346A,"Path No.: Date Obtained: (Age: ). Date Received: F. See Addendum/Procedure. SPECIMEN: A:Subnipple tissue, right breast, excision. B:Lymph node, right axilla sentinel node, biopsy. C:Lymph node, right axilla sentinel node #2, biopsy. D:Breast, right, total mastectomy. E:Skin, right breast, excision. DIAGNOSIS(ES): A. Subnipple tissue, right breast, excision: Nipple ducts with atypical micropapillary hyperplasia. No carcinoma seen. B. Lymph node, right axilla sentinel node, biopsy: Lymph node, bisected and serially sectioned, negative for carcinoma. IHC for cytokeratin is negative. C. Lymph node, right axilla sentinel node #2, biopsy: Lymph node, quadrasected and serially sectioned, single focus of carcinoma seen by light microscopy. and IHC for cytokeratin (focus of < 10 cells, ITC). D. Breast, right, total mastectomy: Infiltrating ductal carcinoma, well differentiated (1+2+1=4/9), spanning 2,0 cm, arising in a background. of ductal carcinoma in situ, intermediate to high grade. Infiltrating ductal carcinoma, separate focus, moderately differentiated (3+3+1=719), spanning 0.6 cm. Extensive ductal carcinoma in situ, solid, cribriform and micropapillary type, with necrosis and. microcalcification, seen on 15 of 26 slides and extending to within 0.1 cm of deep margin. The. micropapillary DCIS is seen in the nipple duct sections. Lobular carcinoma in situ, monomorphic type. Intraductal papillomas and sclerosing adenosis with microcalcification. Fibroadenoma. E. Skin, right breast, excision: Fragments of skin. CLINICAL INFORMATION: Right breast cancer,. GROSS DESCRIPTION;. The specimen is received in five parts. Part A is received fresh from the operating room for frozen section diagnosis in a container labeled with the patient's. name and ""Rt subnipple tissue R/O cancer"". It consists of one piece of red soft tissue measuring 1.1 x 0,9 X 0.3 cm. The specimen is entirely submitted in one cassette labeled AFS. Part B is received fresh from the operating room for frozen section diagnosis in a container labeled with the patient's. name and ""Right axillary sentinel lymph node #1"". It consists of one piece of fatty tissue measuring 3.2 x 1.4 x 0.8 cm. One lymph node is palpated measuring 1.8 cm in greatest dimension. The lymph node is bisected. The specimen is. entirely submitted in four cassettes labeled BFS1-BFS2, B1 and B2. Please note: Three levels and cytokeratin stains. are ordered for the lymph node only. Legend: BFS1-BFS2 = frozen section-lymph node, B1-B2 = remaining tissue. Part C is received fresh from the operating room for frozen section diagnosis in a container labeled with the patient's. name and ""Right axillary sentinel lymph node #2"". It consists of one piece of fatty tissue measuring 2.8 x 1.9 x 1.1 cm. One. lymph node is palpated measuring 2.7 cm in greatest dimension. The lymph node is quadrisected. The specimen. is entirely submitted in five cassettes labeled CFS1-CFS4 and C1. Please note: Three levels and cytokeratin stains are. ordered for the lymph node only. Legend: CFS1-CFS4 = frozen section-lymph node, C1 = remaining tissue. Part D is received unfixed in a container labeled with the patient's name and ""Right breast mastectomy, stitch short. anterior subnipple tissue, stitch long = lateral"". It consists of a right total skin sparing mastectomy specimen measuring. 22.0. x. 14.0. X. 3.5 cm. A short suture is noted indicating the subareolar and a long suture is noted indicating the superior. (as per Dr. the long suture was mistakenly labeled ""lateral""). An underlying mass is palpable located 1.0 cm. from. the. subareolar. The subareolar is inked blue, the superficial margin is inked yellow and the deep margin is inked. black. The axillary tissue measures 2.5 x 1.5 x 0.5 cm. No lymph nodes are palpable within it. The. specimen is serially sectioned at closely spaced intervals, revealing an area of white, cystic parenchyma measuring. 6.0 x 4.0 x 2.5 cm located in the center, 0.5 cm from the deep margin and 0.2 cm from the superficial margin. Within. the cystic parenchyma is a firm, poorly circumscribed, white-tan mass measuring 2.0 x 2.0 x 1.5 cm which comes to. within 0.6 cm from the deep margin and 1.3 cm from the superficial margin. At least four scattered yellow-white nodules. measuring from 0.5 cm to 0.8 cm in diameter are also seen within the cystic parenchyma located 0.3 cm from the. deep. margin and 1.5 cm from the superficial margin and at least 1.0 cm from the mass. The remainder of the specimen is. composed of a moderate amount of breast tissue (60%) and a moderate amount of yellow fatty tissue (40%). Also. received in the container is one irregular piece of soft, fibrofatty, yellow-red tissue measuring 4.0 x 3.0 x 1.0 cm. On cut. surface, no discrete lesions or lymph nodes are identified. Representative sections are submitted in 26 cassettes. labeled D1-D26. Please note: The specimen was placed in formalin at. LEGEND: D1-D2 = Submucosal area. D3-D4 = Mass with adjacent deep margin. D5-D7 = Remaining portion of mass. D8 = Superficial margin closest to mass. D9-D10 = Nodule closest to mass with adjacent surrounding tissue and deep margin. D11 = Remaining portion of nodule with adjacent surrounding tissue. D12-D15 = Surrounding nodules in cystic parenchyma. D16-D17 = Cystic parenchyma. D18-D19 = Upper inner quadrant. D20-D21 = Lower inner quadrant. D22-D23 = Lower outer quadrant. D24-D25 = Upper outer quadrant. D26 = Fibrofatty tissue also received in the container. Part E Is received unfixed in a container labeled with the patient's name and ""Skin from mastectomy R breast"". It. consists of a strip of rubbery, tan-brown skin measuring 11.6 x 0.7 x 0.2 cm. Representative sections are submitted in. one cassette labeled E1. Please note: The specimen was placed in formalin at. INTRAOPERATIVE CONSULTATION: AFS: Benign breast tissue and large ducts. No carcinoma seen. BFS1, BFS2: No carcinoma seen. CFS1, CFS2: No carcinoma seen. CFS3, CFS4: No carcinoma seen. Performed by: Resident: Interpreted by: Attending: MICROSCOPIC DESCRIPTION: TYPE OF SPECIMEN: Right total mastectomy with sentinel node dissection. II. LOCATION OF THE TUMOR: Central. III. TYPE OF NEOPLASM: Carcinoma, Invasive, Ductal - NOS (Nodule 1). Well Differentiated, Total score 4. (Tubule Score 1, Nuclear Grade Score 2, Mitotic Score 1). TUMOR SIZE: The tumor's greatest dimension 2.0 cm. Carcinoma, Invasive, Ductal - NOS (Nodule 2). Moderately Differentiated, Total score 7. (Tubule Score 3, Nuclear Grade Score 3, Mitotic Score 1). TUMOR SIZE: The tumor's greatest dimension 0.6 cm. Ductal carcinoma in situ, nuclear grade 3, widespread 30%. QUANTITATION: Ductal carcinoma in situ is present in 15 of 26 slides of breast. Intraductal solid subtype, cribriform, comedo, micropapillary/. VI. VASCULAR SPACE INVASION: Present in lymphatics. VII. CALCIFICATION: Present in both malignant and benign areas. VIII. NIPPLE: Ducts involved by DCIS. IX. SKIN: Present, uninvolved by cancer. X. ADJACENT BREAST TISSUE: Cystic disease, proliferative with atypia. MARGINS: Tumor distance from closest margin DCIS- <0.1 cm fromm deep margin. XII. AXILLARY LYMPH NODES: Sentinel - 2. XIII. POSITIVE LYMPH NODES: Sentinel - ITC only. XV. PATHOLOGIC STAGING (pTNM) AJCC 7th Edition: Reflects staging only. of the current specimen. Ultimate. staging responsibility rests with the primary physician. pT1c: Tumor more than 1.0 cm but not more than 2.0 cm in greatest dimension. pNO(ITC,i+): No regional lymph node metastasis on H & E histologically, (ie. Individual tumor cells seen,. none greater than 0.2 mm, positive IHC. COMMENT(S): Case shown at. This report has been reviewed electronically and signed on. Interpreted by: Attending: The diagnosis was rendered by the attending pathologist. Receptor Expression Analysis. INTERPRETATION. Test Performed on formalin fixed paraffin embedded section of: mastectomy. The results are for invasive carcnoma #1. Specimen part: D. Slide#. D3. Fixation: adequate. This tumor is considered positive for estrogen receptor expression (21 % of the cells are positive). The. specimen was adequate for evaluation for ER as per ASCO/CAP guidelines 2010. Approximately 75 % of the. carcinoma cell nuclei stain with an immunohistochemical stain utilizing an anti-estrogen receptor antibody. ) with an average intermediate intensity. This tumor is considered positive for progesterone receptor expression (> 1 % of the cells are positive). The. specimen was adequate for evaluation for PR as per ASCO/CAP guidelines 2010, Approximately 80 % of the. carcinoma cell nuclei stain with an immunohistochemical stain utilizing an anti-progesterone receptor antibody. ) with an average strong intensity. Equivocal/indeterminate for HER2 expression. Her-2/neu over-expression has been evaluated, on a formalin fixed. paraffin embedded section, using the. (proprietary kit). Using the ASCO/CAP scoring criteria, the. score is: 2. Invasive carcinoma #2: This tumor is considered positive for estrogen receptor expression (>1 % of the cells are positive). The. specimen was adequate for evaluation for ER as per ASCO/CAP guidelines 2010, Approximately 100 % of the. carcinoma cell nuclei stain with an immunohistochemical stain utilizing an anti-estrogen receptor antibody. SP1) with an average strong intensity. This tumor is considered positive for progesterone receptor expression @ 1 % of the cells are positive). The. specimen was adequate for evaluation for PR as per ASCO/CAP guidelines 2010. Approximately 100 % of the. carcinoma cell nuclei stain with an immunohistochemical stain utilizing an anti-progesterone receptor antibody. 1E2) with an average strong intensity. Positive for HER2 overexpression. Her-2/neu over-expression has been evaluated, on formalin fixed paraffin. embedded sections, using the. (proprietary kit). Using the ASCO/CAP scoring criteria, the. score: 3. This procedure/addenda has been electronically reviewed and signed on. Interpreted by: Attending: Note: Immunochemistry testing performed at. was developed and ils performance characteristics determined by the. These tests were interpreted in conjunction with externel positive and internal negative controis, unless otherwise noted, It has not been cleared or approved by the US. FDA. This test is used for clinical purposes only. It should not be regarded as investigational or for research. END OF REPORTI.",val,
6041,TCGA-AR-A24W.0F2464F7-4108-4700-B2EC-17BC6C432D42,"Breast, right, total mastectomy: Infiltrating ductal carcinoma, Nottingham grade II (of III), [tubules 3/3, nuclei 2/3, mitoses 1/3;. Nottingham score 6/9], forming a 2.1 x 1.4 x 1.1 cm mass located in the central breast (AJCC pT2). Ductal carcinoma. in. situ,. intermediate nuclear grade, comprising approximately 5-25% of tumor volume. Angiolymphatic invasion is present. The non-. neoplastic breast parenchyma shows proliferative fibrocystic changes. Calcifications present in malignant ducts. Biopsy site. changes present. The tumor does not involve the nipple, overlying skin, or underlying chest wall. All surgical resection margins,. including deep margin, are negative for tumor (minimum tumor free margin, 2.1 cm, deep margin). Lymph nodes, right axillary sentinel Nos. 1A, 1B, 1C and 2, sentinel biopsy: Three (of 4) right axillary sentinel lymph nodes are. positive for metastatic carcinoma (>2.0 mm) [AJCC pN1(5n) ]. Extranodal extension is not present. Blue dye is identified in. lymph nodes Nos. 1A and 1B. Lymph node No. 1C does not contain blue dye. Lymph nodes, right axillary, dissection: Multiple (18) right axillary lymph nodes are negative for tumor. Breast, left, total mastectomy: Ductal carcinoma in situ, micropapillary and cribriform types, low nuclear grade without. intraluminal necrosis, involving an area over 5.7 x 2.3 x 1.4 cm [AJCC pTis]. The non-neoplastic breast parenchyma shows. nonproliferative fibrocystic changes. Calcifications are present in malignant ducts. Biopsy site changes are present. Nipple and. skin are without diagnostic abnormality. All surgical resection margins are negative for tumor (minimum tumor free margin, 1.5. cm, deep margin).",val,
6048,TCGA-EL-A3MY.2F9CD81A-D55E-4C8A-8524-9FFA71F3B3C2,"Sex: M. Case type: Surgical Case. MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A) TOTAL THYROIDECTOMY: PAPILLARY THYROID CARCINOMA (1.5 CM) INVOLVING THE LEFT LOBE AND EXTENDING INTO THE. PERITHYROID SOFT TISSUE AND SKELETAL MUSCLE. Two follicular adenomas (0.8 cm), left lobe. Adenomatoid colloid nodule, right lobe. Margins of resection, free. (B) LEFT CRICOTHYROID TISSUE: PAPILLARY THYROID CARCINOMA IN FIBROUS TISSUE. (C) THYROID ARYTENOID: Skeletal muscle and adipose tissue. No tumor present. (D) THYROID CARTILAGE: Pending section for decalcification. Supplemental report will follow. Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) TOTAL THYROIDECTOMY- - A product of total thyroidectomy with marked adhesion and fibrosis with overall measurements. of 8.0x4.5x2.5 cm. The right lobe is nodular, elongated and measures 6.0 x 2.5 x 1.4 cm, and the left lobe is irregular, fibrotic. with marked adhesion and measures 4.5 X 3.0 X 2.5 cm. Multiple nodules are identified ranging in size from 0.4 to 1.7 cm are. noted throughout the gland. The left lobe shows a fibrotic and firm nodule extending from the superior-to-inferior aspect of the. lobe and involves the soft tissue and muscle surrounding the lobe and abutting the posterior aspect of the margin. The. specimen is submitted entirely as follows. The right lobe was sequentially sectioned from superior to inferior under A1-A7, and. the left lobe sequentially sectioned from superior to inferior under A8 to A24. (B) LEFT CRICOTHYROID TISSUE - Two soft tissue fragments measuring 0.5 X 0.5 x 0.2 cm each, entirely submitted for frozen. in B. FS/DX: THYROID NEOPLASM IN FIBROUS TISSUE. (C) THYROID ARYTENOID - A small soft tissue fragment 1.5 x 0.3 X 0.4 cm. Submitted entirely under C. (D) THYROID CARTILAGE - A fragment of cartilage and bone submitted for decal under D. Sex: M. Case type: Surgical Case. ADDENDUM. Addendum completed by. DIAGNOSIS. (D) THYROID CARTILAGE: PAPILLARY CARCINOMA OF THYROID INVOLVING CARTILAGE. Released by:",val,
6193,TCGA-3T-AA9L.DD88E259-D9C9-4408-ACDC-95715ADD7D1E,"-Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Document Date: Acc #: (Age: ). F. Client: Submitting. Phys: Final Surgical Pathology Report. ADDENDUM PRESENT. Addendum Diagnosis. THE DIAGNOSIS REMAINS THE SAME. Addendum Comment. The following special stains and/or immunohistochemical stains were performed: STAIN. Pancytokeratin. The neoplasm is predomimantly lymphocytic, but has expected numbers of weakly staining epithelial cells. Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Final Pathologic Diagnosis. A. INFERIOR MEDIASTINAL MASS, VIDEO-ASSISTED THORACIC SURGERY, A1FS: - THYMOMA, TYPE B1, LYMPHOCYTE RICH (5.0 X 3.0 X 2.0 CM), WITH DEGENERATIVE CYSTIC CHANGES AND. FIBROSIS. - THYMOMA FOCALLY EXTENDS INTO CAPSULE, AND ABUTS THE INKED SURFACE. - SEE SYNOPTIC REPORT. Assisted by: Flow Cytometry / Sigried Out. Addendum / Signed Out. Synoptic Worksheet. A. Inferior mediastinal mass, FS: Specimen: Not specified. Procedure: Other: Right Video-assisted thoracic surgery (VATS). Specimen Integrity: Intact. Specimen Weight: 27.6(g). Tumor Size: Greatest dimension: 5.0 cm. Additional Dimension: 3.0 cm. Additional Dimension: 2.0 cm. Histologic Type: Type B1 thymoma. Tumor Extension: Not identified. Margins: Margin(s) involved by tumor. Margin(s): peripheral. Treatment Effect: Not applicable. Lymph-Vascular Invasion: Not identified. Regional Lymph Nodes: Cannot be assessed. Number examined: 0. Number involved: 0. Pathologic Staging for Thymomas (Modified Masaoka): Stage lla: Microscopic transcapsular invasion. Implants/Distant Metastasis: Cannot be assessed. Additional Pathologic Findings: Fibrosis. Cystic changes in tumor. Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Clinical History. Mediastinal mass. Right VATS. Specimen(s) Received. A: Inferior mediastinal mass, FS. Gross Description. Specimen A is received fresh along with the patient's name, medical record number and as ""inferior mediastinal mass, FS."" The. specimen consists of two fragments of soft tissue mass, the larger one measures 6. 0 x 3.0 x 2.5 cm and weighs 25 gm. The. specimen is already incised when received. The smaller fragment measures 2.5 x 2.0 x 0.5 cm and weighs 2.6 grams. An. ill-defined encapsulated mass lesion is identified in the larger fragment and measures 5.0 x 3.0 x 2.0 cm. The cutting surface of. this lesion showing yellowish and flesh color. A representative section from this ill-defined mass lesion is submitted for. intraoperative consultation as ""A1FS."" Another ill-defined mass lesion is identified in the small fragment which measures 0.5 x. 0.5 x 0.2 cm, the cutting surface of this small ill-defined mass lesion is fish-flesh. The outside surface of the entire specimen is. inked blue. Sections submitted are indicated below. Dictated by. /. CASSETTE SUMMARY: A1FS: A representative section of the mass lesion from the larger fragment (intraoperative consultation). A2-A7: Representative sections of the mass lesion from the larger fragment. A8: Representative sections of the small fragment with the small mass lesion. Intraoperative Consult Diagnosis. A1FS: INFERIOR MEDIASTINAL MASS (FROZEN SECTION): CORTICAL THYMOMA VERSUS LYMPHOMA. Frozen section results were communicated to the surgical team and were repeated back by. In at. out at. Microscopic Description. Microscopic examination performed. Flow Cytometry. Interpretation. Flow cytometric immunophenotyping of the submitted mediastinal mass is performed using antibodies to the listed analytes. sample). The remainder of the sample is comprised of apparent debris and/or nonviable cells. Phenotypic analysis reveals a distinct population of cells with low light scatter properties comprising approximately 98% of the. total sample which express CD2, variable CD3, partial CD4, CD5, CD7, partial CD8, CD38, and CD45. Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Taken together, these findings demonstrate the presence of an immature T-lymphocyte population consistent with thymocytes. Clinical and laboratory correlation recommended. REFERENCES: Blood. 2008 Apr 15;111(8):3941-67. Cytometry B Clin Cytom. 2007;72 Suppl 1:S14-22. Cytometry B Clin Cytom. 2007;72 Suppl 1:S5-13. Assisted by: Clinical History. Mediastinal mass. Specimen - Gross Description. Soft tan tissue measuring 1.0 x 0.7 x 0.4 cm with 10 mL of clear pink fluid identified as ""mediastinal mass"" is received. Analytes Tested. CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD11b, CD11c, CD13, CD14, CD15, CD16, CD19, CD20, CD22, CD23, CD25, CD33,. CD34, CD36, CD38, CD45, CD56, CD103, CD117, FMC7, HLA-DR, Kappa, Lambda. This test was performed at. The results of this test should not be used alone as the sole basis for diagnosis and/or treatment. These results may, however, prove useful when used in conjunction. with. other diagnostic procedures and clinical evaluations. Use of these results, in this manner, can be considered to fall within the scope of the practice of medicine This. test was developed and its performance characteristics determined by. It has not been cleared or approved by the United States Food and. Drug Administration.",val,
6204,TCGA-UZ-A9PP.0A596611-ED33-4CC5-9C27-D2F1C5E0E6AF,"Visit # : Service Date. Male. Soc. Sec. #: Client: FINAL PATHOLOGIC DIAGNOSIS. A. Perinephric fat, excision: Fibroadipose tissue, no tumor seen. B. Superior margin, excision: Fibroadipose tissue, no tumor seen. C. Base margin, excision: No tumor seen. D. Right renal mass, excision: Papillary renal cell carcinoma (chromophil), 3.5cm. diameter, Fuhrman nuclear grade 2, excised. E. Perinephric fat, excision: No tumor identified. renal cell (Chromosited 826013. COMMENT: Kidney Tumor Synoptic Comment. -Histologic type: Renal cell carcinoma, papillary (chromophil) type. -Grade: 2. -Maximum tumor diameter: 3.5 cm. -Capsule/perirenal fat: Tumor does not penetrate the capsule which surrounds the tumor completely; only part of this capsule is. surrounded by fat or renal tissue. -Hilar lymph nodes (number positive/number of nodes): None submitted or found. -Resection margins: ""Superior margin"" and ""Base margin"" are negative for tumor. -Stage: pTlaNxMx. Specimen(s) Received. A:Perinephric fat. B:Superior margin (FS). C:Base margin (FS). D:Right renal mass. E:Perinephric fat. Intraoperative Diagnosis. FS1 (B1) ""Soft tissue,"" superior margin, biopsy: Fibroadipose tissue, no tumor. FS2 (C1) ""Kidney,"" Base margin, biopsy: Renal parenchyma, no tumor. Clinical History. The patient is a. year-old man with a right renal mass, who undergoes resection. Gross Description. The specimen is received in five parts, each labeled with the patient's name and medical record number. Parts A-D are received fresh. Part E is received in formalin. Part A, additionally labeled ""1 - perinephric fat,"" consists of fatty tissue measuring 1.9 x 1.5 x 1.0 cm as a. pile. The specimen is entirely submitted in cassette A1. Part B, additionally labeled ""2 - superior margin,"" consists of fibrofatty tissue with no visible soft tissue. measuring 2.5 x 0.8 x 0.5 cm. The entire specimen is frozen for frozen section 1, with the remnant. submitted in cassette B1. Part C, additionally labeled ""3 - base margin (FS),"" consists of a single segment of normal-appearing kidney. measuring 3.0 x 2.0 x 1.0 cm; it corresponds to a puncture of the renal mass capsule (specimen D). The. deep margin is inked blue by the surgeon; it is re-inked black and then entirely submitted for frozen. sections 2 and 3 and the tissue blocks are subsequently entirely submitted in cassettes C1-C2. Part D, additionally labeled ""right renal mass,"" consists of a 3.5 x 2.5 x 2.0 cm nodule that is inked on 50%. of the surface. There is attached fat, measuring 4.0 x 3.5 x 2.0 cm as a pile. The nodule is incised to reveal. a brown-tan, soft mass that appears to be necrotic. Attached to the nodule is a rim of brown tissue. measuring 3.5 x 1.5 x 0.7 cm. Representative sections of the nodule and the attached brown tissue are. submitted in cassettes D1-D4. The fatty tissue is thoroughly evaluated for candidate lymph nodes and. candidate lymph nodes are submitted in cassette D5. Representative sections of the fat are submitted in. cassette D6. Part E, additionally labeled ""5 - perinephric fat,"" consists of multiple yellow, glistening, irregular, unoriented. adipose tissue fragments measuring 14.0 x 8.0 x 2.5 cm in aggregate. Upon sectioning, the specimen. consists of grossly normal-appearing adipose tissue without areas of thickening. Representative sections. are submitted in cassettes E1-E3. Diagnosis based on gross and microscopic examinations. Final diagnosis made by attending pathologist. following review of all pathology slides. Pathology Resident. athologist.",val,
6255,TCGA-VQ-A91D.F5B634C5-2C5B-40D6-863A-036089FB5AD3,"PRIMARY SITE: Stomach (Body). ""1-Stomach + D2 lymphadenectomy + right extended colectomy: -Invasive ulcerated moderately differentiated adenocarcinoma, Lauren's intestinal type. -Size of neoplasia: 5.0x4.5x4.0 cm. -Invasion level: serosa and adjacent fat tissue, with involvement of omentum and colon. to submucosa, with ulceration of mucosa. -Blood vessel invasion: present. -Lymphatic invasion: present. -Perineural invasion: present. -Adjacent mucosa: inactive discrete chronic gastritis. -Surgical margins (stomach and colon): uninvolved by neopalsia. -Five out of 33 examined perigastric lymph nodes involved by neoplasia (5/33), with. capsular invasion, without conglomerate formation. 2-Perisplenic omentum: -Lymph node uninvolved by neoplasia (0/1). 3-Transverse mesocolon lymph node: -Uninvolved by neoplasia (0/3). 4-Esophageal margin: -Uninvolved by neoplasia. 5- Lymph nodes following standardization: - -Five lymph nodes uninvolved by neoplasia (0/5), distributed as follows: -Chain 8 -- anterior hepatic artery (8a): 0/1. - -Chain 11 - proximal splenic artery (11p): 0/3. -Chain 12 - hepatoduodenal ligament (12a): 0/1."".",val,
6365,TCGA-MQ-A6BS.83140BDC-6F68-411D-A30D-A99FD2112609,"THIS IS A CONFIDENTIAL AND PRIVILEGED COMMUNICATION. PLEASE DISPOSE OF PAPER COPIES APPROPRIATELY. Test Name: RIGHT RIB 8{PLEURA, RIGHT {DIAPHRAGMATIC PLEURA,. RIGHT {RIGHT LOWER LOBE NODULE 1{RT. MIDDLE LOBE NODULE. Test Date: {LEVEL 4 LYMPH NODE, RIGHT {LEVEL 9 LYMPH NODE, RIGHT {LEVEL 7. LYMPH NODE, RIGHT {THORACOSCOPY, PORT SITE 1, RIGHT. (THORACOSCOPY, PORT SITE 2, RIGHT. SPECIMEN NUMBER: SPECIMENS: 1. RIGHT RIB 8. 2. PLEURA, RIGHT. 3. DIAPHRAGMATIC PLEURA, RIGHT. 4. RIGHT LOWER LOBE NODULE 1. 5. RT. MIDDLE LOBE NODULE. 6. LEVEL 4 LYMPH NODE, RIGHT. 7. LEVEL 9 LYMPH NODE, RIGHT. 8. LEVEL 7 LYMPH NODE, RIGHT. 9. THORACOSCOPY, PORT SITE 1, RIGHT. 10. THORACOSCOPY, PORT SITE 2, RIGHT. 11. AZYGOUS VEIN, RIGHT. DIAGNOSIS: 1. RIB #8, RIGHT: EXCISION. - BONE AND BONE MARROW WITH TRILINEAGE MATURATION. 2. PLEURA, RIGHT: EXCISION. - MALIGNANT MESOTHELIOMA, EPITHELIOD TYPE, INFILTRATING ADIPOSE. TISSUE. - FOCAL FOREIGN BODY GIANT CELL REACTION AND BIREFRINGENT MATERIAL. SUGGESTIVE OF TALC PLEURODESIS. 3. DIAPHRAGMATIC PLEURA, RIGHT: EXCISION. - MALIGNANT MESOTHELIOMA, EPITHELIOD TYPE, INFILTRATING ADIPOSE. TISSUE AND SKELETAL MUSCLE. 4. LUNG, RIGHT LOWER LOBE, NODULE #1: WEDGE RESECTION. - MALIGNANT MESOTHELIOMA, EPITHELIOD TYPE, INVOLVING LUNG. PARENCHYMA. - PARENCHYMAL MARGIN NEGATIVE FOR TUMOR. SEE NOTE. NOTE: Immunostains on part 4 (right lower lobe nodule) demonstrate that. the tumor cells are positive for CK5/6, D2-40, WT-1 (weak, focal). and negative for TTF-1. The stain for Calretinin is. non-contributory. This immunoprofile supports the diagnosis of. malignant mesothelioma. 5. LUNG, RIGHT MIDDLE LOBE, NODULE: WEDGE RESECTION. - MALIGNANT MESOTHELIOMA, EPITHELIOD TYPE, INVOLVING LUNG. PARENCHYMA. - PARENCHYMAL MARGIN NEGATIVE FOR TUMOR. 6. LYMPH NODE, LEVEL 4, RIGHT: EXCISION. - FIVE LYMPH NODES, NEGATIVE FOR MESOTHELIOMA (0/5). 7. LYMPH NODE, LEVEL 9, RIGHT: EXCISION. - ONE LYMPH NODE, NEGATIVE FOR MESOTHELIOMA (0/1). 8. LYMPH NODE, LEVEL 7, RIGHT: EXCISION. - THREE LYMPH NODES, NEGATIVE FOR MESOTHELIOMA (0/3). 9. THORACOSCOPY PORT SITE #1, RIGHT: EXCISION. - SKIN WITH MILD DERMAL FIBROSIS. 10. THORACOSCOPY PORT SITE #2, RIGHT: EXCISION. - SKIN WITH MILD DERMAL FIBROSIS AND LYMPHOHISTIOCYTIC. INFILTRATE. 11. AZYGOUS VEIN, RIGHT: EXCISION. - VEIN WITH NO SIGNIFICANT ALTERATIONS. CLINICAL HISTORY AND PRE - OPERATIVE DIAGNOSIS: Mesothelioma. MACROSCOPIC DESCRIPTION: The specimen is received in eleven parts, each labeled with the. patient's name. 1. Part one is received in formalin, labeled 'right rib #8'. It. consists of three fragments of bone ranging from 4 to 8.2 cm in. length. The outer surface is smooth and shows scant attached. fibromuscular tissue. Sectioning reveals an unremarkable marrow. Representative section is submitted in one cassette following. decalcification. 2. Part two is labeled 'pleura, right'. It consists of three. irregular fragments of pleural tissue measuring 31 X 19 X 1 cm. The. parietal pleural surface shows focal adipose tissue. The wall. thickness ranges from 0.1 to 0.6 cm. Multiple small firm nodules. are noted studded on the pleural surface. These nodules range from. 0.2 to 1.5 cm in greatest dimension. Representative sections are. submitted in five cassettes. 3. Part three is received in saline, labeled 'diaphragmatic pleura,. right'. It consists of pleural tissue fragments ranging 14 x 10 X. 1.5 cm. Focally yellow lobulated adipose tissue is attached. The. remainder of the pleura is gray-purple and shows multiple thickened. nodular areas ranging from 0.5 to 2.0 cm in greatest dimension. Cut. surface of these nodules is white, firm. Representative sections of. these nodules are submitted in four cassettes. 4. Part four is received in saline, labeled 'right lower lobe nodule. #1'. It consists of a wedge of lung measuring 6 x 2.5 x 0.8 cm. The staple line is inked. The pleural surface is gray-purple and. shows a well-defined firm tan lesion measuring 1.5 x 1 x 0.4 cm. Representative sections are submitted. 5. Part five is received in saline, labeled 'right middle lobe. nodule'. It consists of a wedge of lung measuring 4.2 x 1.8 x 0.5. cm. The staple line is inked black. The pleural surface is. gray-purple and shows a well-circumscribed pleural based lesion. measuring 1.2 x 0.7 cm. Cut surface of the lesion is tan and. extends into the lung parenchyma. The lesion is 0.7 cm from the. staple margin. Representative sections are submitted. 6. Part six is received in saline, labeled 'level 4 lymph node,. right'. It consists of a portion of fibrofatty tissue measuring 3.5. x 2 x 1.5 cm. Four possible gray-black lymph nodes ranging from 0.8. to 1.2 cm are noted. Entirely submitted in two cassettes. 7. Part seven is received in saline, labeled 'level 9 lymph node,. right'. It consists of a single fragment of tan-brown firm tissue. measuring 0.6 x 0.4 x 0.2 cm. Totally submitted in one cassette. 8. Part eight is received in saline, labeled 'level 7 lymph node,. right'. It consists of two fragments of tissue composed of group of. gray-black lymph nodes measuring 2.5 x 1.5 x 0.5 cm and 3 x 1 x 0.4. cm. The entire specimen is submitted in two cassettes. 9. Part nine is received in saline, labeled ""thoracoscopy port site. #1, right'. It consists of an ellipse of skin measuring 2.2 x 0.5. cm, excised to a depth of 0.5 cm. The skin's surface is tan-white. and shows a linear scar measuring 1.3 cm in length. Representative. sections are submitted in one cassette. 10. Part ten is received in saline, labeled 'thoracoscopy port site. #2, right' It consists of an ellipse of skin measuring 2.5 x 0.5. cm, excised to a depth of 1.5 cm. The skin's surface is tan-pink. and shows a linear scar measuring 1.5 cm in length. The underlying. soft tissue appears unremarkable. Representative section is. submitted in one cassette. 11. Part eleven is received in saline, labeled 'right azygous vein'. It consists of a segment of vein measuring 1.7 cm in length and 0.6. cm in diameter. The outer surface is tan-pink and unremarkable. Representative section is submitted in one cassette. SUMMARY OF SECTIONS: 1A representative. 2A-2E representative. 3A-3D representative. 4A-4B entire firm lesion. 4C unremarkable lung. 4D stapled margin. 5A-5B entire lesion. 5C uninvolved lung. 5D stapled margin. 6A two lymph nodes. 6B two lymph nodes. 7A in toto. 8A-8B in toto. 9A representative. 10A representative. 11A representative. SPECIAL PROCEDURES: Decalcification. Final Diagnosis performed by. The electronic signature attests that the named Attending. Pathologist has evaluated the specimen referred to in the signed. section of the report and formulated the diagnosis therein. This report may include one or more immunohistochemical stain. results that use analyte specific reagents. The tests were developed and their performance characteristics. determined by. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is not. necessary.",val,
6427,TCGA-DX-A8BQ.43D9170A-5213-4ED3-BA97-CA26FCD96A09,"Clinical Diagnosis & History: with left thigh sarcoma, status post excisional biopay here. for re-excision. Specimens Submitted: 1: SP: Posterior left thigh sarcoma. 2: SP: Posterior and lateral nodule left thigh. DIAGNOSIS: 1. SOFT TISSUE, LEFT POSTERIOR THIGH; RESECTION: - HIGH GRADE MALIGNANT FIBROUS HISTIOCYTOMA, STORIFORM AND PLEOMORPHIC TYPE,. INVOVLING SUBCUTANEOUS FIBROADIPOSE TISSUE AND EXTENDING TO DERMIS. TUMOR DIMENSIONS: 6 x 4.5 x 3 CM. - GROSSLY THE TUMOR APPEARS TO HAVE \R\ 30% NECROSIS. -PREVIOUS PROCEDURE RELATED CHANGES. - SURGICAL MARGINS ARE NEGATIVE. 2. SOFT TISSUE, LEFT POSTERIOR AND LATERAL THIGH; EXICSION: -LOBULATED ADIPOSE TISSUE CONSISTENT WITH LIPOMA. - TUMOR DIMENSIONS: 6 x 4 x 2 CM. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1.) The specimen is received fresh, labeled ""posterior left thigh sarcoma, 1. stitch proximal/lateral, 2 stitches distal/medial and consists of an. oriented piece of skin and soft tissue measuring 15.6 x 10 x 4 cm in overall. dimensions. There is an overlying tan-beige skin ellipse measuring15.3 x 2.9. cm with a centrally located sutured scar area measuring 4.5 cm. The specimen. is inked as follows: Proximal yellow, distal blue, lateral orange, medial. red, anterior green and deep black. The specimen is bisected along its. longitudinal axis to reveal a well circumscribed, unencapsulated tan-grey. hemorrhagic mass measuring 6 x 4.5 x 3 cm. Grossly the tumor appears \RI 30%. necrotic. The masa is located the following distances from the respective. margins: 0.3 cm from anteior/skin, 0.5 cm from deep, 6 cm from proximal, 7. cm from distal, 1.5 cm from medial and 3 cm from lateral. Photographs are. taken and a portion of the tumor is submitted for TPS. Representative. sections are submitted. Summary of sections: PM proximal margin. DM distal margin. LM lateral margin. MMT medial margin with tumor. DMT deep margin with tumor. SKT skin with tumor. T tumor. 2.) The specimen is in formalin, labeled ""posterior and lateral nodule left. thigh"" and consists of an unoriented piece of fatty tissue measuring 6 x 4 x. 2 cm. The specimen is entirely inked black and serially sectioned to reveal. a homogenous yellow fatty cut surface with no gross lesions identified. Representative sections are submitted. Summary of sections: U - undesignated. Summary of Sections: Part 1: SP: Posterior left thigh sarcoma. Block. Sect. Site. PCs. 1. AMT. 1. 1. DM. 1. 1. DMT. 1. 1. LM. 1. 1. PM. 1. 1. SKT. 1. 4. T. 4. Part 2: SP: Posterior and lateral nodule left thigh. Block. Sect. Site. PCs. 4. U. 4.",val,
6453,TCGA-DJ-A4V2.02145821-EB2F-4F21-98C7-379353CF81E6,"Clinical Diagnosis & History: Papillary carcinoma of right tracheal right FNA and (+) for papillary. Right thyroid nodule. Rule out malignancy. Specimens Submitted: 1: Right thyroid and isthmus,right hemithyroidectomy. 2: Left thyroid and isthmus, left hemithyroidectomy. DIAGNOSIS: 1. Right thyroid and isthmus,right hemithyroidectomy: Part # 1. Tumor Type: Papillary carcinoma, classical type. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Other Tumor Features: Psammoma bodies. Tumor Location: Right lobe. Tumor Size: Greatest diameter is 3.0 cm. Tumor Encapsulation: PartIally surrounded. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Tumor Multicentricity: Not identified. Adenoma(s) (away from the carcinoma): Not Identified. Non-Neoplastic Thyroid: exhibits chronic inflammation. Parathyrold Glands: Not identified. Lymph Nodes: One benign lymph node (0/1). 2. Left thyroid and isthmus, left hemithyroidectomy: - Nodular hyperplasia. - No parathyroid gland identified. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1. The specimen is received fresh and is labeled ""right thyroid and isthmus"". It consists of a thyroid lobe measuring 5 x 3 x 1.5 cm. (right lobe) with isthmus (1.2 x 1.0 x 0.5 cm) and weighing 16.5 g. The specimen is oriented by a long stitch designating the upper. pole and a short stitch designating the isthmus. The specimen is inked as follows: anterior-blue and posterior-black. The specimen. is serially sectioned revealing a well-circumscribed, well encapsulated nodule with focal areas of necrosis situated in the right lobe. extending from the upper to the mid-portion of the lobe. The nodule measures 3.0 x 2.5 x 1.5 cm. The specimen is entirely. submitted. A representative portion of the nodule has been submitted for TPS. Summary of sections: N - nodule. RL - right lobe. I isthmus. 2. The specimen is received fresh and is labeled ""left thyroid and isthmus"". It consists of a thyroid lobe measuring 4 x 2 x 0.8 cm. (left lobe) with isthmus (1.0 x 1.0 x 0.5 cm) and welghing 5 g. The specimen is oriented by a long stitch designating the upper pole. and a short stitch designating the isthmus. The specimen Is inked as follows: anterior-blue and posterior-black. The specimen is. serially sectioned revealing a tan/red unremarkable cut-surface. The specimen is entirely submitted. Summary of sections: LL left lobe. / - isthmus. Summary of Sections: Part 1: Right thyroid and isthmus, right hemithyroidectomy. Block. Sect. Site. PCs. 1. 1. 10. N. 10. 2. RL. 2. Part 2: Left thyrold and isthmus, left hemithyroldectomy. Block. Sect. Site. PCs. 1. 1. 4. LL. 4.",val,
6508,TCGA-ET-A25L.16B69890-694B-4489-BF48-F1EDC6776C29,"FINAL DIAGNOSIS. 1. THYROID (THYROIDECTOMY). SPECIMEN TYPE: Total thyroidectomy. TUMOR SITE: Left lobe. HISTOLOGIC TYPE: Papillary carcinoma with focal tall cell features. TUMOR SIZE: Greatest dimension: 3.0 cm. FOCALITY: Unifocal. LYMPH NODES: Metastatic carcinoma in 2 of 12 nodes (includes all parts). EXTENT OF INVASION. PRIMARY TUMOR: pT3: Minimal extrathyroidal. extension into left inferior pole parathyroid gland. REGIONAL LYMPH NODES: pN1b: Nodal metastasis to cervical nodes. MARGINS: Involved by invasive carcinoma (posterior surgical margin). VENOUS/LYMPHATIC INVASION: Present. 2. LEFT LEVEL III, IV, AND V (MODIFIED RADICAL NECK DISSECTION): METASTATIC PAPILLARY THYROID CARCINOMA PRESENT IN ONE OF six (1. OF 6) LYMPH NODES (0.9 CM). EXTRANODAL EXTENSION IS PRESENT. NOTE: The carcinoma involves an adjacent parathyroid gland (left inferior pole). PART #1: TOTAL THYROID AND CENTRAL WEDGE DISSECTION. Dictated: The specimen is received fresh labeled with the patient's name, xxxx and is designated. 'total thyroid and central neck dissection'. The specimen has been previously oriented. with a stitch marking the left tumor. The total thyroid weighs 18.7 gm and measures 7.0 x. 5.5 x 2.9 cm The left lobe measures 4.0 x 3.0 x 2.9 cm and the right lobe measures 4.0 x. 3.0 x 1.4 cm. The anterior aspect of the specimen is inked orange, while the posterior. aspect of is inked black. The specimen is serially sectioned to reveal a lesion in the left. lobe measuring 3.0 x 2.0 x 2.0 cm that is harvested by the tissue bank. This mass has a. homogeneous, yellow, firm, gelatinous cut surface and measures. cut off. There. is an attached portion of yellow, fibrofatty tissue along the left inferior thyroid pole. which measures 3.0 x 1.0 x 0.6 cm. An attempt is made to search for lymph nodes. Three possible lymph nodes are identified. SUMMARY OF SECTIONS. 1 A 1. (RIGHT SUPERIOR LOBE). 1 B 1. (RIGHT MIDDLE LOBE). 1 C 1. (RIGHT INFERIOR LOBE). 1 D - 1. (LEFT SUPERIOR LOBE). 1 E 1. (LEFT MIDDLE LOBE). 1 F - 1. (LEFT INFERIOR LOBE). 1 G 1. (ISTHMUS). 2 - H,I - 1 EACH (TUMOR). 1 J - 1. (TUMOR IN RELATION TO NORMAL). 1 - K - MULTIPLE (LN CANDIDATES). 1 - L - MULTIPLE (REMAINDER OF SOFT TISSUE). 12 - TOTAL - M.",val,
6590,TCGA-S9-A6U5.0A1B0FCA-6B68-4BA3-946D-0B05A99ABEC4,Neuropathology. Commentary: Histology and morphology corresponds to astrocytoma WHO grade II. Diagnosis: Astrocvtoma WHO grade II.,val,
6594,TCGA-AJ-A2QM.282D10FF-370D-4252-B1CB-3410A43C8F82,"Sex: Female. MRN #: Ref Phy. SPECIMEN INFORMATION. Acct/Reg #: DIAGNOSIS. DIAGNOSIS: A. Right ovary and fallopian tube, salpingo-oophorectomy: Ovary and fallopian tube without significant pathologic abnormality. B. Left ovary and fallopian tube, salpingo-oophorectomy: Ovarian tissue without significant pathologic abnormality. Fallopian tube tissue not identified. C. Uterus, hysterectomy: Tumor Characteristics: 1. Histologic type: Papillary serous carcinoma. 2. Histologic grade: High grade. 3. Tumor site: Endometrium. 4. Tumor size: 3.2x27cm. 5. Myometrial invasion: Tumor extends 0.6 cm into a 1.4 cm thick myometrium, as measured microscopically (less than one-half). 6. involvement of cervix: Tumor focally present within endocervical mucosa, as well as within stromal tissue. 7. Extent of involvement of other organs: Not identified. 8. Lymphovascular space invasion: Not identified. Surgical Margin Status: 1. Margins uninvolved: Cervix, serosa, bilateral parametria. Lymph Node Status: 1. See below. Other: 1. pTNM stage: pT2, NO (FIGO: ii). D. Right external iliac lymph nodes, excision: Three lymph nodes, negative for metastatic disease. E. Right obturator lymph nodes, excision. Eight lymph nodes, negative for metastatic disease. F. Right lower periaortic and common lymph nodes, excision: Six lymph nodes, negative for metastatic disease. G. Left external iffac tymph nodes, excrsion: Two lymph nodes, negative for metastatic disease. H. Left obturator lymph nodes, excision. Seven lymph nodes, negative for metastatic disease. I Left lower periaortic and common !ymph nodes, excision: Seven lymph nodes. negative for metastatic diseas-. J. Omentum. Negative for malignancy. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Serous carcinoma of the endometrium. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Right ovary and hibe. B. Left ovary and tube. C. Uterus and cervix. D. Right external illac. E. Right obturator. F. Right lower periaortic and common. G. Left external iliad. H. Left obturator. 1. Left lower periaortic and common. J. Omentum. SPECIMEN DATA. GROSS DESCRIPTION: A. The specimen is received labeled. jht ovary and tube. The specimen consists of an ovary with attached fallopian tube. The ovary. measures 2.2 x 0,5 x 0.5 cm. The surface IS yellow to gray-tan. On sectioning, the cut surface is yellow-gray and reveals corpus albicans measuring up. to 0.5 cm identified. There are no lesions grossly identified. The attached fallopian tube measures 3.6 cm in length and 0.2 cm in diameter, and the. surface is gray-tan. On sectioning, there is no material or lesions Identified within the tumen. The fallopian tube appears grossly unremarkable. Representative sections are submitted in cassettes labeled. 3S follows: ovary in total -- 1-2; representative fattopian tube - 3. B. The specimen is received labeled. left ovary and tube. The specimen consists of an ovary measuring 3.0 x 1.0 x 0.5 cm. The surface is. gray-tan. On sectioning there Is corpus albicans identified measuring up to 0.5 cm. There are no lesions grossly identified. The fallopian tube segment is. not grossly identified. The ovary is entirely submitted in two cassettes labeled. 81-2. C. The specimen is received labeled. terus and cervix. The specimen consists of a previously bisected uterus with attached cervix. The. uterus. measures. 4.5. x. 4.5. x. 3.2. cm. and. weighs 46 gm. The serosal surface of the uterus is gray to brown-tan. Sections from the parametrium have been. taken. The cervix measures 3.5 cm in length and 2.5 cm in diameter. The exocervix is gray-tan to brown-tan with hemorrhage. The endocervical canal is. light tan and reveais normal mucosa) folds. There are no lesions identified grossly. The endometrial cavity measures 3,5 cm in length and 3.5 cm in. diameter and reveals a gray-tan, lobular mass measuring 3.2 x 2.7 cm that is within 0.4 cm of the lower uterine segment. On sectioning, the mass. extends into the underlying myometrium approximately 0.7 cm into a 1.4 cm thick myometrium. The myometrium is gray-tan and trabecufar and there. are no lesions grossly identified Received with the specimen are three cassettes, one green. one yellow and one blue, labeled. with the. yellow additionally tabeled -16, the green additionally labeled -17, and the blue additionally labeled -18. Representative sections are suonated in. cassettes labeled. as follows: anterior cervix - 1; posterior cervix - 2; full thickness sections from the lesion - 3-7; lower uterine segment. - 8; left parametrium - 9; rignt parametrium - 10. D. The specimen is received labelec. it external iliac. The specimen consists of a portion of fibroadipose tissue measuring 7.5 x 4.0 x. 1.0. cm. Sectioning. reveals. three. probapie. lymph nodes that measure from 0.6 to 2.0 cm in greatest dimension. The lymph nodes are entirely submitted. in casseltes. & as follows: one probable node - 1; one probable bisected - 2-3; one probable node bisected - 4-5. E. The specimen is received labeled 1. right obturator. The specimen consists of a portion of fibroadipose tissue measuring 4.5 x 3.5 x 1.0. em tectioning reveais eight probable lympn nodes that measure from 0.5 to 1.8 cm. The lymph nodes are entirely submitted in cassettes 39067E,. $ follows: one probable node bisected - 1; three probable nodes - 2; one probable node bisected - 3; two probable nodes - 4; one probable. node bisected - 5; one probable lymph node bisected - 6. F. The specimen is received labeled. ight lower periaortic and common. The specimen consists of portion of fibroadipose tissue, 3.5 x 2.0. x 0.6 cm. Sectioning reveals six probable lymph nodes that measure from 0,3 to 1.6 cm. The lymph nodes are entirely submitted in cassettes labeled. est, as follows: three probable nodes - 1: one probable lymph node, bisected - 2; one probable lymph node, bisected - 3; one probable lymph. usected - 4. G. The specimen is received labeled with the patient's name,. left external iliac. The specimen consists of a portion of fibroadipose tissue. measuring 5.2: 3,5x0.9 cm. Sectionina ravaale tun tymph nodes that measure 1.5 and 3.0 cm in greatest dimension. The lymph nodes are. entirely submitted in cassettes labele. bllows: one probable node bisected - 1; one probable node trisected - 2-4. H. The specimen is received labelec. t obturator. The specimen consists of a portion of fibroadipose tissue measuring 5.2: 4.5  1 5 cm. Sectioning reveals seven probable lymph nodes that measure from 0.7 to 1.8 cm. The lymph nodes are entirely submitted in cassett. 4 as. follows: one probable node, bisected - 1; three probable nodes - 2; one probable node, bisected - 3; one probable fymph, bisecteu - 4. one probable. lymph node, bisected - 5-6. L. The specimen is received labelec. ft lower perlaortic and common. The specimen consists of a portion of fibroadipose tissue measuring. 3.5 x 3.0 x 0.5 cm. Sectioning reveais seven possible lymph nodes that measure from 0,5 to 1.5 cm. The lymph nodes are entireiy submitted in. laheled : is follows: two probable nodes bisected - 1: one probable Ivmph node. bisected - 3 two probable nodes - 3: two. probable nodes - 4. J The apecimen is received tabeled. intum. The specimen consists of a piece of yellow-tan lobular fibreadipose omentum tissue that. measures 520x12.0x 1.5 cm, On sectioning. there are no nodules arossiv identified Representative sactions are submitted in four cassettes labeled.",val,
6610,TCGA-B2-3923.de7a1ead-e27f-44f8-a903-f9e308effbff,"SPECIMEN. Right kidney. CLINICAL NOTES. Renal mass. GROSS DESCRIPTION. Received fresh for tissue procurement labeled ""right. kidney"" is a 1,005 gram, 20 x 11 X 8.5 cm right kidney. with. attached, probe-patent, 7 cm ureter averaging 0.5 cm in diameter. An abundant amount of perirenal adipose tissue is present which is. received predominantly torn from the kidney proper. Multiple. stapled vessels are at the hilum. No adrenal gland appears to be. present. The capsule is smooth to slightly scabrous delicate. tan-pink and strips with relative ease from the underlying cortical. surface. On sectioning, there is a moderately well circumscribed,. calcified necrosed 11.8 x 10.5 x 8.5 cm golden brown tumor mass. which occupies the inferior pole. The tumor appears to extend up. to, but not through the delicate capsular surface. The. aforementioned calcified region of the specimen appears to be. predominantly central. The renal pelvis is flat, glistening. tan-white. The uninvolved renal parenchyma is uniform red-brown. with a moderately well defined corticomedullary junction and a. maximal cortical thickness of 1.2 cm. No additional mass lesions. or. abnormalities are identified. Representative sections are. submitted. in nine blocks as labeled. RS-9. BLOCK SUMMARY 1 - Vascular and ureteral margins; 2-5 - tumor full. thickness to inked capsular surface; 6 - tumor to normal. parenchyma;. 7 - renal pelvis; 8,9 - random normal parenchyma. MICROSCOPIC DESCRIPTION. Sections show a mass lesion composed of nests or broad of. large polygonal cells with abundant cytoplasm, perinuclear. halos, and distinct cell borders. Nuclei are bland, and. calcifications are easily identifiable. Cytoplasm stains. positively. colloidal iron. Findings are consistent with renal cell. carcinoma, chromophobe type. Histologic type Renal cell carcinoma, chromophobe type. Histologic grade (Fuhrman Nuclear Grade) : 2. Primary tumor (pT) : pT2 (size 11.8 cm; confined to kidney). Margins of resection: Negative. Regional lymph nodes (pN) : None submitted. Adrenal gland: Not submitted. Vascular invasion: Negative. Non-neoplastic kidney Unremarkable. 4,18. DIAGNOSIS. Kidney, right, nephrectomy: Renal cell carcinoma, chromophobe type. Size: 11.1 8 cm in greatest dimension (inferior pole) . Margins : negative. Vascular invasion: not identified.",val,
6613,TCGA-D5-5541.1a21e147-900c-4fae-8a60-9a51093287f2,"Examination: Histopathological examination. Material: Multiple organ resection - segment of the large intestine. Clinical diagnosis: Sigmoid colon carcinoma - sigmoidektomia. Macroscopic description: 13.3 cm length of the large intestine with a segment of the mesenterium sized 15 x 10 x 2.5cm. Cauliflower-shaped tumour sized 5.9 x 4.9 x 1.3 cm in the mucosa. The lesion surrounding 95% of. the intestine circumference, located 3.6cm from one of the incision lines, and 6.2 cm from the. opposite one. Microscopic description: Adenocarcinoma tubulopapillare (G2). Infiltratio carcinomatosa telae adiposae pericolicae. Intestine ends free of neoplastic lesions. Metastases carcinomatosae in lymphonodo (No I / VIII). Histopathological diagnosis: Adenocarcinoma tubulopapillare coli. Metastases carcinomatosae in lymphonodo (No 1/VIII). (G2, Dukes C, Astler-Coller C2, pT3, pN1).",val,
6826,TCGA-A2-A4S2.4A5630FF-0ADC-4E69-B22A-02F1F34F61F9,"/F. Acct# : M.D. Specimen: Sp type: SURGICAL P. A.D. PREOPERATIVE DIAGNOSIS. CANCER OF THE RIGHT BREAST AND AXILLARY NODES. A. OPERATION PERFORMED. DOCTOR (S) : PROCEDURE: MASTECTOMY MODIFIED RADICAL. TISSUE REMOVED. A. RIGHT BREAST. B. RIGHT AXILLARY CONTENTS. GROSS DESCRIPTION. RECEIVED IN 2 PARTS. PART A RECEIVED LABELED. RIGHT BREAST DOUBLE BLACK. STITCH 12 O'CLOCK AT NIPPLE IS A 1, 416 GRAM MASTECTOMY MEASURING 28.5 CM. FROM MEDIAL TO LATERAL, 26.5 CM FROM SUPERIOR TO INFERIOR, AND UP TO 6. CM FROM ANTERIOR TO POSTERIOR. A SUTURE DENOTES 12 O'CLOCK. THE NIPPLE. IS FLAT WITH THE SURROUNDING AREOLA MEASURING 6 CM IN DIAMETER. IN THE. UPPER OUTER QUADRANT 6 CM FROM THE NIPPLE THERE IS A 0.3 CM ULCERATION. AT THE MOST LATERAL ELLIPTICAL TIP OF THE SKIN IS A 2ND SMALL ULCERATION. 0.5 CM IN GREATEST DIMENSION. THIS IS 16 CM FROM THE NIPPLE. THE SKIN. ELLIPSE MEASURES 25.6 x 11.5 CM. THERE IS A PALPABLE MASS AT 12. O'CLOCK. ""MRM"" IS WRITTEN ON THE SPECIMEN AT 12 O'CLOCK. THE ANTERIOR. MARGIN IS MARKED BLUE AND THE DEEP IS MARKED BLACK. SECTIONING REVEALS. THE MAJORITY OF THE BREAST TO CONSIST OF BLAND YELLOW FATTY TISSUE WITH. FINE FIBROUS BANDS. THERE ARE BROADER AREAS OF FIBROSIS IN THE MORE. CENTRAL ASPECT OF THE SPECIMEN. IN THE 12-1 O'CLOCK AREA THERE IS A. FIRM GRAY-TAN MASS WHICH IS GREATER THAN 1 CM FROM THE DEEP MARGIN. MEASURING 5.8 CM FROM SUPERIOR TO INFERIOR, 2.5 CM FROM ANTERIOR TO. POSTERIOR, AND 4 CM FROM MEDIAL TO LATERAL. CENTRALLY THERE IS AN. IRREGULAR AREA OF RED-BROWN DISCOLORATION. THIS IS ALSO GREATER THAN. 1. CM FROM THE OVERLYING SKIN. A COIL CLIP IS IDENTIFIED WITHIN THE. LESION. SECTIONS ARE SUBMITTED AS FOLLOWS: A1--NIPPLE, A2--KKIN. ULCERATIONS AND 12 O'CLOCK SKIN MARGIN, A3--DEEP MARGIN TO CENTRAL. LESION, A4--ANTERIOR MARGIN TO CENTRAL LESION, A5 THROUGH A7--A SUPERIOR. TO INFERIOR CROSS SECTION THROUGH THE LESION AT LEVEL OF CLIP, A8--THE. MOST MEDIAL ASPECT OF LESION, A9--MOST LATERAL ASPECT OF LESION, A10 AND. Specimen: Raceived: sp type: SURGICAL P. M.D. GROSS DESCRIPTION. 11--ADDITIONAL SECTIONS OF MASS, A12--UPPER INNER QUADRANT 4 CM FROM. LESION, A13--UPPER OUTER QUADRANT 5 CM FROM LESION, A14--LOWER OUTER. QUADRANT 5 CM FROM LESION, A15--LOWER INNER QUADRANT 4 CM FROM LESION,. A16--TISSUE DEEP TO NIPPLE AT MEDIAL EDGE OF LESION. NOTE:TISSUEIS-SUBMITTED--PER-CLINICAL-BREAST-CARE-PROJECT-RESEARCH-. PROTOCOL OF THE TUMOR LABELED P1-p10 AND MIRROR IMAGE SECTIONS OF THE. NIPPLE (A1) AND THE RANDOM QUADRANT SECTIONS (A12-A15) ARE SUBMITTED. FROZEN IN CCI. PART B RECEIVED LABELED. AXILLARY CONTENTS ARE 4. FRAGMENTS OF YELLOW-PINK FATTY TISSUE TOGETHER MEASURING 10 X 7.5 x 1.5. CM. THE SPECIMEN IS THEN EXAMINED FOR LYMPH NODES. ALONG ONE EDGE. OF. THIS SPECIMEN THERE ARE STRANDS OF RED MUSCLE FIBERS. EXAMINATION. REVEALS 8 NODAL STRUCTURES. THESE ARE SUBMITTED AS FOLLOWS. FOUR (4). OF THESE MEASURE LESS THAN 0.5 CM AND ARE SUBMITTED AS B1. ONE OF THE. LARGER NODES IS GROSSLY POSITIVE, ONE-HALF IS SUBMITTED IN B2, THE. MIRROR IMAGE AS Pll PER THE CLINICAL BREAST CARE PROJECT RESEARCH. PROTOCOL. THE REMAINING 3 LARGE NODES ARE EACH SUBMITTED BISECTED AND. SEPARATELY LABELED B3 THROUGH B5. B6 IS REPRESENTATIVE MUSCLE. A. BIOPSY CLIP IS NOT GROSSLY IDENTIFIED. COMMENT: THIS CASE IS IN COMPLIANCE WITH CAP/ASCO GUIDELINES OF 6-48. HOURS FORMALIN FIXATION TIME. PATH PROCEDURES. PROCEDURES: 88309, A BLK/16, B BLK/6. FINAL DIAGNOSIS. PART A RIGHT BREAST, SIMPLE MASTECTOMY: INTRALOBULAR AND INFILTRATING LOBULAR CARCINOMA WITH SIGNET-RING. CELL DIFFERENTIATION, GRADE II SHOWING NUCLEAR GRADE 2/3 AND LOW. MITOTIC INDEX. LCIS OF THE CLASSIC TYPE SHOWS NUCLEAR GRADE 1. COMPRISING APPROXIMATELY 5% OF THE TUMOR. 2. THE INVASIVE COMPONENT HAS A MAXIMUM GROSS DIMENSION OF 5.8 CM. WITHIN THE CENTRAL PORTION OF THE BREAST WHICH EXTENDS INTO THE. Specimen: Req# : Sp type: SURGICAL P. 1.D. ADDENDUM. METASTATIC CARCINOMA IS IDENTIFIED IN ONE OF FOUR ADDITIONAL AXILLARY. LYMPH NODES INCLUDING EXTENSION OF TUMOR INTO THE EXTRANODAL SOFT. TISSUE (1/4). A SEPARATE AREA HAVING BIOPSY CHANGES IS ALSO PRESENT. Addendum Signed. (signature on file). M.D. M.D. Speciment. tus: Req# : Sp type: SURGICAL P. .D. FINAL DIAGNOSIS. RETICULAR DERMIS UNDERLYING THE NIPPLE SKIN. 3. THE NIPPLE SKIN, SKIN AND BREAST MARGINS OF RESECTION, AND. RANDOM SECTIONS FROM THE REMAINING QUADRANTS ARE FREE OF TUMOR WITH. THE CLOSEST LOCATED 4 MM FROM THE NEAREST INKED DEEP MARGIN (A3) -. 4. LYMPHOVASCULAR INVASION IS IDENTIFIED. 5. FIBROCYSTIC CHANGES INCLUDING SCLEROSING ADENOSIS, MICROCYST. FORMATION AND PATCHY DENSE STROMA. 6. CALCIFICATIONS ARE SEEN WITHIN THE TUMOR AS WELL AS BENIGN PORTIONS. OF THE BREAST. 7. SCLEROTIC INTRADUCTAL PAPILLOMA. 8. BIOPSY CHANGES. ARE IDENTIFIED. 9. SMALL SKIN ULCERATIONS (2) -. PART B RIGHT AXILLA, LYMPH NODE DISSECTION: METASTATIC BREAST. CARCINOMA IS IDENTIFIED IN 4 OF 6 AXILLARY LYMPH NODES EXAMINED (4/6). EXTENSION OF TUMOR INTO THE PERINODAL SOFT TISSUE INVOLVES THE. LARGEST AREA OF METASTATIC TUMOR WHICH MEASURES 1.1 CM IN GREATEST. MICROSCOPIC DIMENSION. A REPRESEN'TATIVE SECTION OF SKELETAL MUSCLE IS. NEGATIVE FOR TUMOR. BIOPSY CHANGES ARE NOT IDENTIFIED GROSSLY OR. MICROSCOPICALLY IN THE NODAL DISSECTION. ADDENDUM. Addendum #1. Entered: THE LATERAL UPPER OUTER QUADRANT IS RE-EXAMINED AND A WING CLIP IS. IDENTIFIED IN AN AREA OF FATTY TISSUE, WITH THE TISSUE ANTERIOR HAVING A. YELLOW-WHITE INDURATION CONSISTENT WITH A PREVIOUS BIOPSY AREA. THE AREA. OF THE CLIP PROPER IS SUBMITTED IN A17 AND 18. THE TISSUE ANTERIOR TO. THIS AREA IS SUBMITTED IN A19 AND 20. LATERAL TO THIS, THERE IS A. GROSSLY POSITIVE NODAL STRUCTURE 0.6 CM IN DIAMETER. THIS IS SECTIONED. AND SUBMITTED IN A21. AN ADDITIONAL POSSIBLE NODE IS SUBMITTED IN A22. AND 23. AN ADDITIONAL POSSIBLE 0.4 CM NODE IS SUBMITTED IN A24.",val,
6933,TCGA-BH-A0H9.584E15EE-1C80-4507-8AD3-558DF06DBDF3,"FINAL DIAGNOSIS: PART 1: BREAST,RIGHT, SEGMENTAL MASTECTOMY, NEEDLE LOCALIZATION -. A. INVASIVE DUCTAL CARCINOMA, NOTTINGHAM GRADE 3 (TUBULE FORMATION 3, NUCLEAR. POLYMORPHISM 3, MITOTIC ACTIVITY 3, TOTAL SCORE 9/9). B. INVASIVE TUMOR MEASURES 2.1 CM IN GREATEST DIMENSION (GROSS MEASUREMENT). C. DUCTAL CARCINOMA IN SITU (DCIS), SOLID PATTERN, NUCLEAR GRADE 3, ADMIXED WITH INVASIVE. CARCINOMA, CONSTITUTING ABOUT FIVE PERCENT (5%) OF TOTAL TUMOR VOLUME. D. RESECTION MARGINS ARE NEGATIVE FOR CARCINOMA; INVASIVE CARCINOMA IS 1.5 MM TO THE. CLOSEST ANTERIOR MARGIN. E. NO DEFINITIVE LYMPHOVASCULAR INVASION NOTED. F. FOCI OF MICROCALCIFICATIONS ASSOCIATED WITH INVASIVE CARCINOMA. G. FIBROCYSTIC CHANGE. H. THE INVASIVE CARCINOMA IS ER POSITIVE, PR POSITIVE, HER2/NEU WEAKLY POSITIVE AND NO. AMPLIFICATION BY FISH ANALYSIS. PART 2: AXILLA #1 SENTINEL LYMPH NODE, RIGHT, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA. SYNOPTIC - PRIMARI INVASIVE ,. LATERALITY: Right. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 2.1 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 3. Mitotic activity score: 3. Total Nottingham score: 9. Nottingham grade (1, 2, 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: Yes, malignant zones. TUMOR TYPE, IN SITU: Solid. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 1.5 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES EXAMINED: 1. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: pT2. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: 2+.",val,
7043,TCGA-AZ-6607.2a744111-dfa5-4fa2-9eb4-20039a7c08f3,"PATIENT HISTORY: PRE-OP DIAGNOSIS: Colon cancer. POST-OP DIAGNOSIS: Same,. PROCEDURE: Sigmoid colon, resection. FINAL DIAGNOSIS: PART BLADDER WALL, EXCISION -. 1: POSITIVE FOR ADENOCARCINOMA, EXTENDING TO CAUTERIZED SPECIMEN EDGES. PARTS 2 A. AND MODERATELY 4: SIGMOID COLON, DIFFERENTIATED SIGMOIDECTOMY ADENOCARCINOMA - (4.5 CM) INVOLVING COLONIC WALL. TRANSMURALLY (see comment). B. AND DISTAL SURGICAL MARGINS FREE OF CARCINOMA. BOTH ANGIOLYMPHATIC AND PERINEURAL INVASION IDENTIFIED. C. PROXIMAL CARCINOMA IS PRESENT ON SEROSAL SURFACE AND AT CAUTERIZED RADIAL EDGE OF SPECIMEN. D. E. METASTATIC ADENOCARCINOMA IN FIVE OF NINETEEN LYMPH NODES (5/19). PART 3: POSITIVE LEFT PELVIC FOR SIDEWALL, ADENOCARCINOMA, BIOPSY - EXTENDING TO CAUTERIZED SPECIMEN EDGES. PART 5: OMENTUM, EXCISION -. POSITIVE FOR ADENOCARCINOMA. COMMENT: The carcinoma extensively involves the colonic wall, from the mucosa to the pericolic adipose tissue, but no definite. precursor lesion is seen in the colonic mucosa. There is extensive, plaque-like extramural/subserosal involvement as. well, with areas of serosal penetration and at least one focus where cauterized carcinoma is present at what appears to. be the radial and/or mesocolic specimen edge. This corresponds to the operative report describing dense tumor. infiltrating the pelvic sidewall over the iliac vessels, through which the surgeon cut. In addition, immunohistochemical. stains reveal the carcinoma to be strongly positive for cytokeratin 7 with only focal positivity for cytokeratin 20. CDX-2. is. completely negative, as are TTF-1 and PSA. CEA and cytokeratin 19 are positive. Positive immunostains for the DNA. mismatch repair proteins MLH-1, PMS-2, MSH-2 and MSH-6 reveal preserved nuclear expression. In summary, the overall. morphological findings and immunohistochemical profile are not typical of a primary colorectal adenocarcinoma. A. possible primary site compatible with the immunomorphological findings is the pancreaticobiliary system. Alternatively,. if another potential primary site cannot be found clinically, this could be a primary peritoneal adenocarcinoma with. extension into the colonic wall. Finally, the lymph node total includes one lymph node confirmed to be negative for. carcinoma by a negative cytokeratin AE1/AE3 immunostain.",val,
7122,TCGA-XJ-A9DQ.CAD1C3A1-9EF6-4253-AEEB-C6D80A07C8E7,"SURG PATH #: SPECIMEN CLASS: ALT ID #: SEX: M. DATE RECEIVED: DATE OF PRINTING: Material Received: A: Prostate. Historv: -year-old male with prostate cancer. Final Diagnosis: A. Prostate, prostatectomy: Prostatic adenocarcinoma, moderately differentiated, Gleason grade 3+3 (score 6), involving the right lobe with. perineural invasion. See comment. Comment: Prostate. Procedure: Prostatectomy. Histologic Type: Prostatic adenocarcinoma. Histologic Grade: Moderately differentiated. Gleason Pattern. Primary Pattern: 3. Secondary Pattern: 3. Total Gleason Score (Primary + Secondary): 6. Proportion (percent) of prostate involved by tumor: 5%. Tumor Multicentricity: Present. Extraprostatic Extension: Absent, however very close in two foci. Seminal Vesicle Invasion: Absent. Margins: Free of tumor (within 1 mm of inked margin). Perineural Invasion: Present. Vascular Invasion: Absent. Additional Pathologic Findings: Stromal hyperplasia. Lymph Nodes: N/A. Pathologic Staging: pT2aNxMx. Primary Tumor (pT). pT2a: Unilateral, involving one-half of 1 side (""lobe"") or less. Regional Lymph Nodes (pN). pNX: Cannot be assessed. Distant Metastasis (pM). Date of Printing: SURG PATH #: ALT ID #: pMX: Distant metastasis cannot be assessed. The pathologic stage assigned here should be regarded as provisional, as it reflects only current pathologic data and does not. incorporate full knowledge of the patient's clinical status and/or prior pathology. Attestation: By this signature, I attest that I have personally formulated the final interpretation expressed in this report and that the above diagnosis is based. upon my examination of the slides and/or other material indicated in this report. Interpreted by: Gross Description: A. Received fresh labeled ""prostate"" is a radical prostatectomy specimen measuring from 4.2 cm from right to left 3.8 cm from. apex to base and 3.0 cm from anterior to posterior. The right seminal vesicle measures 2.2 cm in length and 1.5 cm in diameter. The. right vas deferens measures 1.4 cm in length and 0.4 cm in diameter. The left seminal vesicle measures 2.3 cm in length and. 1.3 cm in diameter. The left vas deferens measures 1.7 cm in length X 0.4 cm in diameter. The external surface is of the prostate. is. tan-white. and. smooth. The right side of the prostate is inked black and the left side is inked blue. The prostate is serially. sectioned. to. reveal. a tan-yellow band in the posterior aspect of the prostate that measures 2.5 x 0.8 x 0.5 cm that comes within 0.1. cm of the closest margin. The remainder of the cut-surfaces is tan-pink, smooth and glistening. The specimen is submitted as. follows: A1. Right bladder neck margin (radially sectioned). A2. Left bladder neck margin (radially sectioned). A3. Right distal urethral margin (radially sectioned). A4. Left distal urethral margins (radially sectioned). A5. Right and left seminal vesicles and vas deferens margin. A6. Section from the right mid-anterior prostate. A7. Section from the left mid-anterior prostate. A8-A17 Entire posterior right lobe, from apex to base. A18-A28 Entire posterior left lobe, from apex to base. Date of Printing:",val,
7206,TCGA-09-2049.17564604-ce57-4087-887a-f97a5b280b26,"FINAL PATHOLOGIC DIAGNOSIS. A. Left ovary, fallopian tube, salpingo-oophorectomy: 1. Ovary with papillary serous carcinoma, high grade; see comment. 2. Fallopian tube with no significant pathologic abnormality. B. Right ovary, fallopian tube, salpingo-oophorectomy: 1. Ovary with serous cystadenoma. 2. Fallopian tube with papillary serous carcinoma obstructing lumen and. hydrosalpinx. C. Omentum, partial omentectomy: Metastatic high grade papillary serous carcinoma. D. Uerus, cervix, abdominal hysterectomy: -Cervix: High grade serous papillary carcinoma of superior cervix. -Endometrium: 1. High grade serous papillary carcinoma involving polyp. 2. Mildly proliferative glands. -Myometrium: 1. Adenomyosis. 2. Leiomyoma. -Serosa: No significant pathologic abnormality. E. Colon, biopsy: 1. Metastatic high grade papillary serous adenocarcinoma, infiltrating peri-colic fat. and portion of intestinal wall. 2. Colonic mucosa with no significant pathologic abnormality. F. Appendix, appendectomy: Appendix with focal intraluminal calcification. No tumor. seen. COMMENT: Ovarian Tumor Synoptic Comment. Type of tumor: Papillary serous carcinoma. Grade of tumor: high grade, delineated as follows: papillary architecture 2 points, nuclear pleomorphism. 2 points, mitoses 3 points for a sum of 8 points = high grade. Site of tumor: Left ovary, (also right fallopian tube, endometrial polyp, superior cervix, perirectal soft. tissue, omentum). Location of tumor: intracystic and surface of ovary. Condition of capsule: not encapsulated. Cut surface: solid and cystic. Necrosis: moderate. Lymphatic/vascular invasion: not identified. Sites of metastasis in pelvis: Left fallopian tube, cervix, endometrial polyp (see comments below);. diameter of largest pelvic metastasis = 1.7 cm, right fallopian tube. Pelvic lymph nodes: None sampled. Sites of metastasis in abdomen: omentum and peri-rectal soft tissue; maximum diameter of largest. abdominal metastasis = 14 cm, omentum. Para-aortic lymph nodes: None sampled. Peritoneal cytology: positive, metastatic papillary adenocarcinoma;. )ther abnormalities: endometrial polyp, adenomyosis. FIGO stage: IIIC. TNM stage: pT3c Nx MO. Additional comments: We favor this to be a primary serous carcinoma of the left ovary with peritoneal. spread to the right adnexa, and intracavitary spread to the endometrial polyp and superior cervix. The. possibility of a primary uterine carcinoma with spread to the ovary seems unlikely given the extensive. involvement of the left ovary with tumor. Multiple synchronous primary serous carcinomas cannot be. excluded yet also seems less likely. has reviewed the slides and concurs. Speciment (s) Received. A:Left Ovary. B:Right Ovary. C:Omentum. E:Colon tissue fragments. F:Appendix, incidental. G:Ovary Blocks-. Intraoperative Diaghosis. FS1 (A) Left ovarv. salpingo-oophorectomy: Papillary serous carcinoma. FS2 (B) (Gross evaluation only) Hydrosalpinx. Specimen not frozen, but left intact for sampling of. nodular near cystic area. FS3 (C) (Gross evaluation only) Omentum: Grossly involved by tumor. Clinical History. The patient is a. with a history of severe glandular atypia on prior endocervical. curettage. who undergoes total abdominal hysterectomy and bilateral. salpingo-oophorectomy, omentectomy, biopsy of colonic implant and appendectomy. Gross Description. The specimen is received in seven parts, each labeled with the patient's name and unit number. Part A, labeled ""left ovary"", consists of a grossly distorted ovary weighing 243 grams and measuring 10 X. 7. x 9 cm. There are multiple papillated masses on the surface. A portion of fallopian tube is identified which. measures 6 cm in length and 1 cm in greatest diameter. Serial sectioning reveals that the nearly the. entire. ovarian mass consists of tan-pink, soft, friable, papillary structure. Cassette A1 contains a frozen section. remnant. Representative sections of the mass are submitted in cassettes A2-A6. Part B, labeled ""right ovary"", consists of an ovary with a portion of fallopian tube weighing 83. 5 grams. and. measuring 7 x 6 x 4.8 cm. The fallopian tube measures 7 cm in length and 2 cm in greatest diameter at. the. portion of hydrosalpinx. A large cyst is associated with the ovary measuring 6.5 cm in greatest diameter. and containing clear serous fluid. The external surfaces are inked in black. The internal surface of the cyst. cavity is smooth. A 1.3 cm nodular area beneath the cyst wall is visible in the region of the adherence of. the. fimbriae to the ovary. Sections through this region reveals a mass which is contiguous with the internal. surface of the fallopian tube obstructing the distal orifice. This mass measures 1.7 cm in greatest. diameter. A section of this area is submitted in cassette B1. Two irregularly-shaped white fibrous-appearing areas. are. also beneath the internal cyst wall; each measuring <1.5 cm in greatest diameter. Representative sections. f this fibrous area as well as a section of normal-appearing fallopian tube are submitted in cassette B2,. art C, labeled ""omentum"", consists of a section of yellow, fatty omental tissue measuring 30 X 15 X 4 cm. The central portion if firm and indurated, with a tan-white mass, which in some regions has a papillated. border. This central area of caking measures 14 cm in greatest diameter. Representative sections are. submitted in cassettes C1-C3. Part D, labeled ""uterus"", consists of a 113 gram, pink-tan uterus which measures 9.5 cm superior to. inferior, 6 cm laterally, and 4.5 cm in anterior posterior dimension. The cervical os measures 1 cm and is. fish mouth. The cut surfaces are inked in black. The endometrial surface is smooth, yellow-tan and focally. hemorrhagic. Two polyps emanate from the anterior left endometrium; one measuring 2.5 cm in greatest. diameter. Small cystic spaces are present within the myometrium which measures 2 cm in greatest. dimension. The spaces measure0.2 cm in greatest dimension. Representative sections are submitted as. follows: Cassette D1: Anterior cervix,. Cassette D2: Posterior cervix. Cassette D3: Anterior endometrium with cystic space and superior polyp. Cassette D4: Anterior endomyometrium. Cassette D5: Anterior lower uterine segment with polyp. Cassette D6: Posterior endometrium. Cassette D7: Section of lower posterior endomyometrium. Cassette D8: Section of superior endomyometrium with serosa. Cassette D9: Section of superior posterior subserosal nodule. Cassettes D10-14: Serial ascending sections of anterior superior cervix through lower uterine segment. Cassettes D15-18: Serial ascending sections of left anterior endometrium with base of polyp. Cassette D19: Anterior endometrial polyp. Part E, received in formalin, labeled ""tissue from colon"", consists of multiple irregularly-shaped, yellow-tan. masses of fatty, firm tissue measuring 5 X 3 X 1.2 cm in aggregate. One specimen appears to contain. cystic. structures associated with the firm, white nodule. Representative sections are submitted in cassette E1. Part F, received in formalin, labeled ""appendix"", consists of a segment of appendix measuring 2 in length. and 0.7 cm in diameter, with an adjacent 2 cm fatty mesentery. The external surfaces are inked black. Representative sections are submitted in cassette F1. Part G, is received as 11, tan research cassettes, each containing tissue for the. The tan cassettes are labeled in sequential order as. These tan cassettes are. subsequently submitted as cassettes G1-G11. Diagnosis based on gross and microscopic examinations. Final diagnosis made by attending. pathologist following review of all nathology clidon.",val,
7737,TCGA-A5-A1OH.AAF1B591-1A0D-48D2-BF59-95B0D605950A,"DIAGNOSIS: A. LEFT TUBE AND OVARY, SALPINGO-OOPHORECTOMY: Fallopian tube with focal tubal intraepithelial carcinoma (See synoptic report). Ovary with corpora albicantia and multifocal reactive lymphoid aggregates. B. RIGHT TUBE AND OVARY, SALPINGO-OOPHORECTOMY: Metastatic adenocarcinoma with lymphatic space invasion, high grade serous. type, from endometrial primary. Mullerian inclusion cysts. Fallopian tube with tubal intraepithelial carcinoma involving fimbriated end. C. UTERUS WITH CERVIX, TOTAL HYSTERECTOMY: Cervix: Endocervical and ectocervical stroma diffusely involved by high grade. serous adenocarcinoma. Lymphatic space invasion present. Endometrium: Uterine papillary serous carcinoma (UPSC) with diffuse involvement of. endometrium with peripheral endometrial intraepithelial carcinoma. Background atrophic changes. Myometrium: Diffusely superficial and deep myoinvasion by high grade serous. adenocarcinoma (full thickness involvement to serosa). Lymphatic space invasion present, extensive. Monckeberg's vascular medial calcifications. Serosa: Involved by high grade serous adenocarcinoma (full thickness involvement. to serosa). Anterior inked margin positive. D. OMENTUM #1, OMENTECTOMY: Metastatic uterine papillary serous carcinoma. Reactive mesothelial hyperplasia. E. OMENTUM #2, OMENTECTOMY: Metastatic uterine papillary serous carcinoma. Reactive mesothelial hyperplasia. SYNOPTIC REPORT: Applies To: Patient Case(s): Copy For : Page 1 or 4. A: LEFT TUBE AND OVARY. B : RIGHT TUBE AND OVARY. C : UTERUS AND CERVIX. D : OMENTUM 1. E: OMENTUM 2. Macroscopic. Uterus. Speclmen Type: Right ovary. Left ovary. Right fallopian tube. Left fallopian tube. Omentum. None. Other Organs Present: Total abdominal hysterectomy and bilateral salpingo-. Procedure: oophorectomy. Intact hysterectomy specimen. Specimen Integrity: No lymph nodes present. Lymph Node Sampling: Microscopic. Serous adenocarcinoma. Histologic Type: G3: Poorly differentiated. Histologic Grade: Corpus. Tumor Site: Fundus. Lower uterine segment. Isthmus. Greatest dimension: 5.2cm. Tumor Size: Dimensions: 5.2 x 5 X 3cm. Tumor extends through the entire uterine wall to serosal. Myometrial Invasion: surface. Invasion of cervical stromal connective tissue. Involvement of Cervix: Extent of Involvement. Left ovary. of Other Organs: Tumor involves serosal aspect. Margins: Present. Lymphovascular Invasion: Pathologic Staging (p TNM [FIGO]) AJCC 7th Edition 2010. pT3a [IIIA]: Tumor involves serosa and/or adnexa (direct. Primary Tumor (pT): extension or metastasis). Regional Lymph Nodes (pN): pNX: Cannot be assessed. Number of pelvic lymph. 0. nodes examined: Number of pelvic lymph. 0. nodes involved: Number of para-aortic. 0. lymph nodes examined: Number of para-aortic. 0. lymph nodes involved: Number of common iliac. 0. lymph nodes examined: Number of common iliac. lymph nodes involved: 0. Distant Metastasis (pM): pM1 [IVB] Distant metastasis. Site(s): Omentum. HISTORY: Pre-op diagnosis: CA endometrial. MICROSCOPIC FINDINGS: See diagnosis. GROSS: A. LT TUBE AND OVARY. Labeled with the patient's name, designated ""It tube and ovary"", and received in formalin is an intact. adnexa. The tortuous fallopian tube measures 4.0 cm in length and ranges from 0.4 cm in diameter to. 0.9 cm in diameter. It has a fimbriated end. The overlying mesosalpinx is smooth and red-purple. Cut. surface demonstrates a patent lumen lined with delicate pink-tan mucosa. The ovary measures 1.4 x 0.8. x 0.5 cm and has a smooth pink-yellow capsular surface. Cut surface demonstrates a single corpus. albicans measuring 0.9 cm in greatest dimension. Representative sections are submitted. A1. Proximal and mid fallopian tube cross sections and entire fimbriated tip - multiple. A2. Half of bisected ovary - 1. A3. Additional tissue - multiple. B. RT TUBE AND OVARY. Labeled with the patient's name, designated ""It tube and ovary"". and received in formalin is an intact. adnexa. The tortuous fimbriated fallopian tube measures 5.5 cm in length and ranges from 0.3 to 0.5 cm. in diameter. The overlying mesosalpinx is smooth pink-tan and unremarkable. The cut surface. demonstrates a patent pinpoint lumen lined with delicate tan papilliferous mucosa. The attached ovary. measures 1.8 x 0.7 x 0.5 cm. The capsular surface is pink and yellow. The cut surface demonstrates. unremarkable ovarian parenchyma. Representative sections are submitted. Slide key: B1. Proximal and mid fallopian tube cross sections and entire fimbriated tip - multiple. B2. Entire bisected ovary - 2. B3. Entirely submitted additional tissue - multiple. C. UTERUS WITH CERVIX. Labeled with the patient's name, designated ""uterus and cervix"", and received fresh for intraoperative. consultation is a uterus and attached cervix. The uterus measures 7.3 cm in length, 5.1 cm cornu to. cornu, and 5.0 cm anterior to posterior. The cervix measures 2.6 cm in length and 3.6 cm in maximum. transverse dimensions. The ectocervix is pink to red and granular. Entirely filling the endometrial cavity. is a large exophytic mass measuring 5.2 x 5.0 x 3.0 cm. The mass grossly extends into the cervix and is. located approximately 1.0 cm from the os on the anterior side and 1.5 cm from the os on the posterior. side. The serosa overlying the uterine corpus is smooth pink-red unremarkable. Approximately 50% of. the mass has a friable red-brown necrotic cut surface. The muscular uterine wall ranges from 0.6 to 1.8. cm. The point of attachment of the mass is on the right wall. The mass invades to the serosal edge on. the right side. The small amount of uninvolved myometrium is rubbery and pink-tan. The uninvolved. endometrium is smooth and pink-tan. Representative sections are submitted. Ink key: Black - Anterior. Blue - Posterior. Red - Cervical end of lower uterine segment. Slide key: C1. Anterior cervix - 1. C2. Anterior lower uterine segment - 1. C3. Posterior cervix - 1. C4. Posterior lower uterine segment - 1. C5-C8. Anterior myometrium with mass and serosa - 1 each. C9, C10. Uninvolved endomyometrium with serosa to mass - 1 each. C11, C12. Posterior myometrium with serosa and mass - 1 each. D. OMENTUM #1. Labeled with the patient's name, designated ""omentum #1"", and received in formalin is a fragment of. finely lobulated yellow adipose tissue consistent with omentum measuring 7.6 x 6.0 x 1.0 cm. Masses. are not identified. Representative sections are submitted. D1. Multiple. E. OMENTUM #2. Labeled with the patient's name, designated ""omentum #2"", and received in formalin is a fragment of. finely lobulated yellow adipose tissue consistent with omentum measuring 7.2 x 4.5 x 1.1 cm. Masses. are not identified. Representative sections are submitted. E1. Multiple. Gross dictated b'. INTRAOPERATIVE CONSULTATION: C. UTERUS AND CERVIX, GROSS EXAMINATION: Bulky necrotic endometrial tumor with gross extrusion/involvement of cervix. NOTE: Portion of tumor given for research purposes (TCGA). A AND B. LEFT AND RIGHT ADNEXA, GROSS EXAMINATION: No gross tumor seen. 1 have personally examined the specimen. interpreted the results, reviewed the report and signed it electronically. If this report includes immunohistochemic. their. performance charactenstics determined b). immunohistochemical tests have not been cleared or approved by the US. Food and Drug Administration (FDA), and FDA approval is not required.",val,
7880,TCGA-23-1113.a7fa848e-2492-4802-9cb2-58ec66fc3dd4,"PATH # : Hospital No. : A/S: Date of Birth: Soc. Sec. No: Attending MD: Copies To: DIAGNOSIS: 1-4. PELVIC NODULE, PELVIC PERITONEUM, UMBILICAL HERNIA, BLADDER. PERITONEUM, BIOPSIES: -Positive for high-grade papillary serous carcinoma. 5-9. UTERUS, CERVIX, RIGHT AND LEFT OVARIES AND FALLOPIAN TUBES,. HYSTERECTOMY WITH BILATERAL SALPINGO-OOPHORECTOMY: -Papillary serous carcinoma, high-grade. -Tumor involves both right and left ovaries, replacing most of. the ovarian parenchyma. -Tumor also involves the right and left fallopian tubes mucosa. with transmural invasion. -Benign endometrial polyp in a background of secretory. endometrium. -The myometrium is unremarkable. -The uterine serosa is unremarkable. -Cervix shows metastatic deposits of papillary serous carcinoma. in the lymphatic spaces and submucosal stroma. 10. APPENDIX, RESECTION: -Metastatic high-grade papillary serous carcinoma involving. periappendiceal soft tissue. 11-17. SIGMOID IMPLANT, TUMOR NODULE, URETERAL SACRAL NODULE,. OMENTUM, LESSER SAC, COLON NODULE, BLADDER NODULE, BIOPSIES: -Positive for high-grade papillary serous carcinoma. HISTORY: Ovarian carcinoma. MICROSCOPIC: See Diagnosis. GROSS: 1. PELVIC NODULE. Labeled with the patient's name, labeled as designated on the. specimen requisition form, and received in formalin are two firm. pink-white portions of tissue measuring 2.8 and 3.0 cm in greatest. dimensions. The cut surfaces display homogeneous, friable,. tan-white tumor with hemorrhage. Representative section. A: 1. 2. PELVIC PERITONEUM. Labeled with the patient's name, labeled as designated on the. specimen requisition form, and received in formalin is a soft. yellow-tan 5.2 x 3.1 x 0.4 cm irregular portion of membranous. tissue. The specimen is studded with firm, white tumor nodules. Representative section. B: 1. 3. UMBILICAL HERNIA. Labeled with the patient's name, labeled as designated on the. specimen requisition form, and received in formalin is a portion of. saccular fibroadipose and fibromembranous tissue, 4.9 x 3.2 x 0.9 cm. in greatest dimensions. On sectioning a cystic area containing. hemorrhage is identified. Representative section. C: 1. 4. BLADDER PERITONEUM. Labeled with the patient's name, labeled as designated on the. specimen requisition form, and received in formalin are two firm. pink-white portions of tissue measuring 1.3 and 2.2 cm in greatest. dimensions. Representative sections. 5. LEFT TUBE AND OVARY. Labeled with the patient's name, labeled as designated on the. specimen requisition form, and received in formalin is a fallopian. tube measuring 3.6 cm in length, and 0.7 cm in average diameter. The tube is diffusely indurated. The fimbriated end is indurated. with firm, white tumor. On sectioning the lumen measures 0.3 cm in. diameter. Attached to the fallopian tube is a 3.9 x 3.6 x 2.8 cm. solid and cystic ovary which on sectioning is completely replaced. by firm, white tumor. Representative sections. E: fallopian tube-2. F-H: ovary-1 each. 6. RIGHT TUBE AND OVARY. Labeled with the patient's name, labeled as designated on the. specimen requisition form, and received in the fresh state in the. Operating Room for frozen section diagnosis and subsequently fixed. in formalin is a fallopian tube measuring 4.3 cm in length, and. 1.2 cm. in average diameter. The tube is diffusely indurated and. distended by firm white tumor. The fimbriated end is identified. grossly. On sectioning the lumen measures 0.4 cm in diameter. Attached to the segment of fallopian tube is a 4.3 x 3.4 x 3.2 cm. cystic and solid ovary which on sectioning is completely replaced. by firm, white tumor. Representative sections. I: frozen-section control#1-2. J: fallopian tube-2. K-M: ovary-1 each. 7. UTERUS. Labeled with the patient's name, labeled as designated on the. specimen requisition form, and received in the fresh state in the. Operating Room for intra-operative gross consultation and. subsequently fixed in formalin is a uterus without attached adnexa. which weighs 270 grams. The uterine corpus is enlarged, measuring. 6.3 cm superior to inferior, 8.4 cm cornu to cornu, and 7.1 cm. anterior to posterior. The serosa is tan red with focal. hemorrhage. The cervix has a length of 4.3 cm and a diameter of. 4.1 cm. There is a 1.5 cm slit-like patent os. The ectocervical. mucosa is tan-pink and smooth without obvious lesions. The. transformation zone is distinct. The endocervical canal is 3.1 cm. in length and is tan and rugose. The endometrial cavity is 5.2 cm. in length, 3.7 cm in width, and is lined by a soft tan, smooth. endometrium with a thickness of 0.2 cm. The endometrium contains. two tan-brown soft polyps measuring 1.0 and 2.4 cm in greatest. dimensions. The myometrium is 2.3 cm in maximum thickness. The. myometrium is grossly unremarkable. Representative sections. N: anterior uterine corpus-1. O: anterior uterine corpus polyp-2. P: anterior cervix-1. Q: posterior uterine corpus-1. R: posterior uterine corpus polyp-1. S: posterior cervix-1. 8. LEFT OVARY TUMOR. Labeled with the patient's name, labeled as designated on the. specimen requisition form, and received in formalin is a firm white. 2.3 x 1.8 x 1.4 cm irregular portion of tissue. Representative. section. T: 1. 9. RIGHT OVARY TUMOR. Labeled with the patient's name, labeled as designated on the. specimen requisition form, and received in formalin is a firm white. 2.8 x 1.7 x 1.6 cm irregular portion of tissue. Representative. section. U: 1. 10. APPENDIX. Labeled with the patient's name, labeled as designated on the. specimen requisition form, and received in formalin is a vermiform. appendix, 5.7 cm long and 0.8 cm in maximum diameter, with attached. fat up to 0.9 cm in width and 1.1 cm in thickness. The external. surface is tan-pink and bosselated with firm white tumor nodules. No exudate is seen. The wall varies in thickness up to 0.2 cm and. is firm and tan-white. There is no gross perforation. The lumen. measures up to 0.3 cm and contains a small amount of hemorrhagic. material. No fecalith is identified. Representative sections. V: 3. 11. SIGMOID IMPLANT. Labeled with the patient's name, labeled as designated on the. specimen requisition form, and received in formalin are five firm. white portions of tissue measuring from 0.6 to 0.9 cm in greatest. dimension. Representative sections. W: 3. 12. TUMOR NODULE. Labeled with the patient's name, labeled as designated on the. specimen requisition form, and received in formalin are six soft. white portions of tissue measuring from 0.5 to 1.0 cm in greatest. dimension. Representative sections. X: 3. 13. URETERAL SACRAL NODULE. Labeled with the patient's name, labeled as designated on the. specimen requisition form, and received in formalin is a firm. pink-white 2.8 x 1.6 x 1.4 cm irregular portion of tissue. Representative section. Y: 1. 14. OMENTUM. Labeled with the patient's name, labeled as designated on the. specimen requisition form, and received in formalin is a 22.5 x 5.8. x 3.4 cm aggregate of indurated adipose tissue with diffuse, firm,. white tumor nodularity. Representative section. Z: 1. 15. LESSER SAC. Labeled with the patient's name, labeled as designated on the. specimen requisition form, and received in formalin is a firm. yellow-white 2.3 x 1. x 0.8 cm irregular portion of tissue. Representative section. A2: 1. 16. COLON NODULE. Labeled with the patient's name, labeled as designated on the. specimen requisition form, and received in formalin are six firm. pink-white portions of tissue measuring from 0.6 to 1.2 cm in. greatest dimension. Representative sections. B2: 2. 17. BLADDER NODULE. Labeled with the patient's name, labeled as designated on the. specimen requisition form, and received in formalin is a firm. pink-white 1.3 x 0.5 x 0.2 cm irregular portion of tissue. Entirely submitted. C2: 1. OPERATIVE CONSULT (FROZEN) : #6. MALIGNANT TUMOR, FAVOR PAPILLARY SEROUS CARCINOMA. nafarrad to noxmanents. OPERATIVE CONSULT (GROSS) : #7. UTERUS WITH ENDOMETRIAL POLYPS:",val,
8508,TCGA-SW-A7EB.096769DA-F6AE-44A3-8002-9694414D4228,"Final Pathology Template. Final Pathology Report Information. 1.1. Tissue Specimen ID Code: 1.2. Date of Excision: 1.3. Tumor Location (anatomic site): Stomach, Antrum. 1.4. Tumor Size: 3,0x 4,0 (cm). 1.5. Lymph Node Status: 1.5.1. Number Nodes Examined: 5. 1.5.2. Number Nodes Positive: 3. 1.5.3. Lymph Node Locations (Involved Nodes): 2 greater curvature,. 3. lesser curvature. 1.6. Metastasis: 1.6.1. Metastasis Present: Unknown. 1.6.2. Number of Mets: 1.6.3. Site(s) Of Metastasis: 1.7. ICD-9 Code for Specimen Diagnosis: C 16.3. 1.8. Final Pathology Details: (Please suppy de-identified copy of original language final pathology report in. addition to information below). 1.8.1 Macroscopic Description: Surgical specimen of stomach,. measuring 12 cm in combination with greater omentum. At. 5.0 cm from the distal resection margin, ulcerative. formation. with regular borders 3.0 x 4.0cm in. dimension, infiltrating the 1/2 gastric wall. Greater. omentum is intact. 5 lymph nodes (2 - greater. curvatures, 3 - lessen curvature) . 1.8.2. Microscopic. Description: Moderately differentiated. adenocarcinoma of stomach, mucinous type, ulcerated,. with areas hyalinosis and lymphoid. Tumor invades all. wall of the stomach. Margins resection is intact. Greater omentum is intact. Lymph nodes status positive: greater curvature (2 from 2) and lesser curvature. (1. form 3). 1.8.3. Comment (if applicable): 1.8.4. Clinical Diagnosis: Gastric cancer of antrum. 1.8.5. Stage: T3 N2 M0, st. IIIA. PROPRIETARY AND CONFIDENTIAL.",val,
8521,TCGA-A7-A0DC.43D912CD-BD3C-4E69-B28B-AB2E173C0BC2,"SPECIMEN. A. Left sentinel lymph node #1. B. Left breast stitch 12 o'clock. C. Left breast, Tail of Spence. D. Left breast, Nodule inferior skin flap - stitch 6 o'clock. E. Right breast double long 12 o'clock single long hard mass 10. b'clock. F. Palpable area right axilla. G. Sentinel node #2, right breast. REPORT REVISED ON. AT. CLINICAL NOTES. PRE-OP DIAGNOSIS: Bilateral breast carcinoma. FROZEN SECTION DIAGNOSIS. A) Lymph node, sentinel node left, excision: One lymph node. negative for metastatic carcinoma (0/1). FFS1, FFS2: Palpable area, right axilla, biopsy - Benign lymph. node. present. GFS: Sentinel node #2, right axilla, biopsy - One lymph node with. no evidence of metastasis. GROSS DESCRIPTION. A. Received fresh for frozen section labeled ""left. sentinel lymph node #1"" is an irregularly shaped fragment. of blue stained tissue that measures 1.3 x 0.6 x 0.4 cm. in. dimension. Tissue is entirely frozen. B. Received fresh, labeled ""left breast stitch 12. o'clock"". is a 26.0 cm. (medial to lateral) x 24.5 cm. (superior to. inferior) x 4.5 cm. (anterior to posterior) diffusely cauterized and. focally blue stained soft, lobulated tan gold-white portion of. fibroadipose tissue in keeping with breast designated as left per. requisition slip and container and oriented by a single suture as. stated previously. A 5.5 cm. (medial to lateral) X 2.3 cm. (superior. GROSS DESCRIPTION. to inferior) portion of dusky tan white skin with a central,. everted, 1.3 X 1.3 x 0.5 cm. nipple is present along the anterior. aspect. The deep margin is inked black and the specimen is. sectioned. There is a roughly spherical, 2.4 cm. clot-filled. biopsy. cavity within the lower inner quadrant. The cavity is present. within 1.2 cm. of the anterior surface (inked blue see block 2) and. 2.8 cm. of the inked deep margin (see block 1). Several. cylindrical. tan white firm structures are evident within the cavity. The. periphery of the cavity is fibrotic with diffuse chalky yellow fat. necrosis. Lateral to the cavity is an ill-defined focus of firm,. tan white fibrous tissue with dilated ductal structures (see blocks. 6 and 7) Within the center of the focus, there appears to be a. stellate 1.0 x 1.0 X 1.0 cm. rubbery tan white lesion which is 0.5. cm. from the inked deep margin (see blocks 7 and 8) - . The remaining. cut. surfaces throughout the specimen consists predominately of. glistening lobulated golden yellow adipose tissue with a moderate. amount of interspersed focally blue stained dense tan white fibrous. tissue. No additional mass lesions are identified. Representative. sections are submitted in fourteen blocks as labeled. RS-14. BLOCK SUMMARY: 1 - Biopsy cavity to inked deep margin; 2 - biopsy. cavity to anterior surface; 3-5 - biopsy cavity to adjacent. parenchyma; 6 - firm area lateral to biopsy cavity; 7-8 - apparent. lesion lateral to biopsy cavity to inked deep margin; 9 - random. upper outer quadrant; 10 - upper inner quadrant; 11 - lower inner. quadrant; 12 - lower outer quadrant; 13 - junction of the four. quadrant; 14 - nipple. C. Received fresh, labeled ""tail of Spence"", is a 5 X 4 X. 1.6. cm. portion of soft, lobulated golden-yellow adipose. tissue. Three soft tan-pink-gold tissues, in keeping with lymph. nodes, measuring up to 1.5 cm. in greatest dimension, are. recovered. The lymphoid tissues are entirely submitted in three blocks, as. GROSS DESCRIPTION. labeled. RS-3. BLOCK SUMMARY: 1 - One whole presumptive node; 2,3 - one bisected. presumptive node per cassette. D. Received fresh, labeled ""nodule inferior skin flap -. stitch 6 o'clock"", is a 3.8 cm. (9 to 3 o'clock) x 0.9 cm. (12 to 6 o'clock) wrinkled tan-white skin ellipse, with a suture. along one aspect, as stated previously. The 12 'clock half is. inked blue and the 6 o'clock half is inked black. There is a. stellate, rubbery, 0.6 X 0.6 x 0.6 cm. tan-white nodular lesion. within the 9 o'clock half of the specimen, which appears to extend. to within less than 0. cm. of the inked 12 o'clock surface. The. specimen is entirely submitted in a sequential manner from 3 to 9. ""clock in four blocks (nodule block 3). E. Received fresh, labeled ""right breast double long 12. o'clock, single long hard mass 10 o'clock"" is 27.0. cm. (medial to lateral) x 23.5 cm. (superior to inferior) X 4.5. cm. (anterior to posterior) diffusely cauterized and focally blue. stained soft, lobulated tan gold-white portion of fibroadipose. tissue in keeping with breast designated as right per requisition. slip and container and oriented by double suture as stated. previously. A 4. 4 cm. (medial to lateral) X 2.5 cm. (superior to. inferior) dusky tan white skin ellipse with a central, everted, 1.0. x 1. 0 X 0.6 cm. nipple is present along the anterior aspect. A. second single suture is present at approximately 9-10 o'clock. The. intact deep margin is inked black and the specimen is sectioned. There is a moderately well circumscribed, 5.0 cm. (superior to. inferior) X 3.4 cm. (medial to lateral) x 3.0 cm. (anterior to. posterior) auti-loculated slightly firm cystic structure subjacent. to the aforementioned single suture at the junction of the upper. and. lower outer quadrants. The cyst focally extends to within 0.3 cm. of the inked deep margin (see blocks 1 and 2) and is 1.5 cm. from. GROSS DESCRIPTION. the anterior surface (subsequently inked blue) . A portion of the. cystic focus and a portion of normal parenchyma are submitted for. tissue procurement as requested. The cut surfaces throughout the. remainder of the specimen consists predominately of glistening. lobulated golden yellow adipose tissue with a moderate amount of. interspersed diffusely cystic tan white fibrous tissue. No mass. lesion or additional abnormalities are identified. Representative. sections are submitted in 16 blocks as labeled. RS-16. BLOCK SUMMARY: 1-2 - Cystic structure to inked deep margin; 3-4 -. cystic structure to inked anterior margin; 5-10 - representative. cystic structure to surrounding parenchyma including firm area. sequentially from lateral to medial; 11 - random upper outer. quadrant; 12 - upper inner quadrant; 13 - lower inner quadrant; 14. lower outer quadrant; 15 - junction of the four quadrants; 16 -. nipple. F. Container F is labeled with the patient's name,. medical. record number and ""palpable area right axilla"". The. specimen consists of a single fragment of fatty tissue measuring 2. X. 1.5. x 1 cm. AS-1. Blocks FS1 and FS2. G. Container G is labeled. ""sentinel node #2 right axilla"". The specimen consists of. a. single lymph node measuring 0.8 X 0.5 X 0.5 cm. ASF, GFF, bisected. This case is being handled by Dr. MICROSCOPIC DESCRIPTION. B. Left Breast. Invasive carcinoma: Histologic type: Ductal. Histologic grade: II. MICROSCOPIC DESCRIPTION. Overall grade: 6/9. Architectural score: 2. Nuclear score: 2. Mitotic score: 2. Greatest dimension (pT) : No less than 1.5 cm (adjacent to. biopsy. cavity). Specimen margins: Negative. Vessel invasion: No definitive invasion identified. Calcification : Present. Nipple (Paget's) : Negative. Invasion of skin or chest wall: Negative. Ductal carcinoma in situ: Histologic pattern: Cribriform and solid. Nuclear grade: 3. Central necrosis: Present. % DCIS of total tumor (if mixed) : 20%. Specimen margins: DCIS is 3 mm from deep margin (two small. foci). Calcification : Present. Description of non-tumorous breast: Small papillomas; fibrocystic. changes with microcalcifications. Comments: Previous core biopsy. reviewed. Carcinoma. is lateral to prior biopsy site. Prognostic markers: See core biopsy report,. D. ""Left breast, Nodule inferior skin flap"". Invasive Carcinoma. Histologic type: Ductal. Histologic grade: II. Overall grade: 6/9. Architectural score: 2. MICROSCOPIC DESCRIPTION. Nuclear score: 3. Mitotic score. 1. Greatest dimension (pT) : 7 mm. Specimen margins: 1.5 mm from resection margin (several areas). Vessel invasion: Negative. Calcification Present. Comments: Skin not directly involved by carcinoma. Focal duct. present containing necrotic debris and calcification, without. definitive ductal carcinoma in-situ identified. Breast Prognostic Marker Report (Part D). Estrogen receptor. 80%. Progesterone receptor:. 0%. Her2/neu by IHC: 0-1+. Interpretation. Estrogen receptor: Positive. Progesterone receptor. Negative. Her2/neu by IHC: Negative. Part E. Right breast. Ductal carcinoma in situ: Outer breast. Histologic pattern: Solid, papillary and micropapillary. Nuclear grade: 2. Central necrosis: Absent. Tumor size (if pure in situ) : 5 cm. Specimen margins: DCIS is focally 2 mm from deep margin and 3. mm. from anterior margin. MICROSCOPIC DESCRIPTION. Calcification Present. Comments: Fibrocystic changes are intermixed within this. complex. mass lesion, the majority of which is composed of ducts involved. by carcinoma in-situ. Invasive carcinoma is not identified. (p63 performed to evaluate) Portions of case also reviewed. by Dr. Nipple: large ducts of nipple involved by ductal carcinoma. in-situ. Breast Prognostic Marker Report (Part E). Estrogen receptor: 100%. Progesterone receptor:.. 0%. Interpretation. Estrogen receptor: Positive. Progesterone receptor. Negative. Prognostic markers were done by mmunohistochemical stain on. paraffin sections from 10% neutral buffered formalin fixed tissue. using. antibodies on a Benchmark automated. stainer. The Her2/neu antibody is clone 4B5 and has been approved by the FDA. as an aid in the assessment of breast cancer patients for whom. Herceptin treatment is considered. This laboratory meets the test validation and quality assurance. requirements of the ASCO/CAP guidelines for Her2 testing for. carcinoma of the breast (Arch Pathol Lab Med 2007;131:18-43) - . MICROSCOPIC DESCRIPTION. [A few of the antibodies used in our laboratory may be classified. as. analyte specific reagents. These antibodies are monitored and. controlled in our laboratory and their performance for in vitro. diagnosis is well described in the medical literature. They have. not been cleared or approved by the FDA. ]. 4x6, 3, 14x3, 15, 20x2, 25x5. REPORT REVISED ON. AT. DIAGNOSIS. A. Left breast, sentinel lymph node #1, biopsy: One negative lymph node (0/1). B. Breast, left, mastectomy: Invasive ductal carcinoma, grade II, size no less than 1.5. cm., with associated ductal carcinoma in-situ, grade 3, with. necrosis. C. Lymph node, Tail of Spence, left breast, regional resection: Three negative lymph nodes (0/3). D. Breast, left, inferior skin flap nodule, excisional biopsy: Invasive ductal carcinoma, grade II, 7 mm., close to. excisional margin. E. Breast, right, mastectomy: Ductal carcinoma in-situ, grade 2, involving 5 cm area and. large ducts of nipple. No invasive carcinoma identified. F. Lymph node, right axilla, biopsy: One negative lymph node (0/1) . G. Sentinel lymph node #2, right axilla, biopsy: One negative lymph node (0/1). REPORT REVISED ON. AT. DIAGNOSIS. MD (Electronic Signature). REVISED REPORT -. Clarification of specimen identification.",val,
8564,TCGA-55-6980.e73aad2d-83d3-46b2-b2e9-cc93c5fbd670,"SEE REPORT. PROCEDURE DATE: SPECIMEN DESCRIPTION: A. INFERIOR PULMONARY LIGAMENI LYMPH NODE. B. RIGHT LOWER LOBE OF LUNG,. C. TRACHEAL LYMPH NODE N2. D. SUBCARINAL LYMPH NODE. PRE-OPERATIVE DIAGNOSIS: Right lower lobe lung nodule. POST-OPERATIVE DIAGNOSIS: Same, pending pathology. CLINICAL INFORMATION. Right lower lobe nodule. INTRAOPERATIVE CONSULTATION: BPC DIAGNOSIS: ""Non-small cell carcinoma; lesion inked black"" by. GROSS DESCRIPTION: A. Received is a brown-black encapsulated lymph node, measuring 1.0 X 0.8 X. 0.3 cm. Sectioning reveals a hyperpigmented cut surface. The specimen is. entirely submitted in one cassette. B. Received in formalin is a previously sectioned lobe of lung, weighing 144. grams and measuring 20.2 X 19.2 X 4.8 cm. The pleura is tan-pink with a. minimal amount of scattered anthracotic pigmentation. There is a staple line,. measuring 7.7 cm, present along the medial aspect of the lobe. The staple. line is located adjacent to the bronchial margin. The bronchial margin is. unremarkable. The bronchi are dissected. There is a minimal amount of mucus. located within the lumen. The hilar vessels are patent with a minimal amount. of fatty streaks. There is a previously sectioned indurated nodle. measuring. 1.5 X 1.5 X 0.8 cm, located 2.6 cm from the hilar margin. The outer surface. is inked black. Sectioning through the lesion reveals an ill-defined. yellow-white cut surface. The lesion does not disrupt the overlying pleura. The surrounding pulmonary parenchyma is pink-red and fleshy. No other lesions. are identified. Three gray-black hyperpigmented lymph nodes are found. surrounding the hilum, measuring up to 0.4 cm in greatest dimension. Representative sections are submitted in seven cassettes as follows: cassette. 1 - bronchial and vascular margins; cassette 2 - staple line margin; cassettes. 3 and 4 - entire lesion: cassette 5 - three intact possible lymph nodes;. cassettes 6 and 7 - random lung parenchyma. Requeste. Date of Service. Performing Facility. Result Provider. Report Name. Surgical Report. DXSTIC. BPC. Received is a tan-pink to white fleshy portion of soft tissue, measuring. 1.2 X 0.9 X 0.3 cm. The specimen is entirely submitted in one cassette. C. Received in formalin is a portion of tan-yellow fibrofatty tissue. measuring 3.8 X 2.2 x:0.3 cm. Sectioning reveals an indurated hyperpigmented. nodule resembling a. lymph node, measuring 0.9 cm in greatest dimension. The. specimen is entirely submitted in two cassettes as follows: cassette 1 - -. bisected lymph node; cassette 2 - remaining soft tissue. D. Received is a portion of tan-yellow fibrofatty tissue, measuring 2.3 X 2.0. X 0.6 cm. Sectioning reveals a hyperpigmented nodule resembling a lymph node,. measuring 0.8 cm in greatest dimension. The specimen is entirely submitted in. two cassettes as follows: cassette 1 - bisected lymph node; cassette 2 -. remaining soft tissue. MICROSCOPIC DESCRIPTION: A. One slide is examined. Sections of the lymph node show sinus. histiocytosis with anthracosis. No metastatic tumor is present. B. Sections on slides B3 and B4 show a subcapsular tumor with the morphology. of well differentiated invasive adenocarcinoma of bronchoalveolar pattern. The tumor occurs in linear arrays of tumor lining the alveolar spaces. There. is a small central scar. No vascular invasion is present. There is no. penetration of the visceral pleura. The rest of the lung shows changes of. mild chronic obstructive pulmonary disease. The bronchial resection margin is. free of tumor. Sections of intrapulmonary lymph nodes on slide B6 show sinus. histiocytosis with anthracosis. No metastatic tumor is present . BPC. One slide is examined. Sections show similar tumor as described above. C. Two slides are examined. Sections. of the lymph node show sinus. histiocytosis with anthracosis. No metastatic tumor is present. D. Two slides are examined. Sections of the lymph nodes show sinus. histiocytosis with anthracosis. No metastatic tumor is present. FINAL DIAGNOSIS: A. LYMPH NODE, INFERIOR PULMONARY LIGAMENT: 1. NO METASTATIC TUMOR. 2. SINUS HISTIOCYTOSIS WITH FOCAL ANTHRACOSIS. RIGHT LUNG, LOWER LOBE, RESECTION: 1. HISTOLOGIC TYPE: ADENOCARCINOMA, BRONCHOALVEOLAR TYPE. 2. HISTOLOGIC GRADE: WELL DIFFERENTIATED. 3. EXTENT OF INVASION: pT1 (MAXIMAL DIAMETER OF TUMOR IS 1.5 CM). 4. MARGINS: NOT INVOLVED. 5. BLOOD/LYMPHATIC VESSEL INVASION: ABSENT. 6. REGIONAL LYMPH NODES: NOT INVOLVED (SEE A, C, AND D). Requeste. Date of Service. Performing Facility. Result Provider. Report Name. Surgical Report. DXSTIC. DISTANT METASTASIS: NOT KNOWN. LYMPH NODE, TRACHEAL, N2: 1. NO METASTATIC TUMOR IN ONE LYMPH NODE. 2. SINUS HISTIOCYTOSIS WITH ANTHRACOSIS. D. LYMPH NODE, SUBCARINAL, EXCISION: 1. NO METASTATIC TUMOR IN ONE LYMPH NODE. 2. SINUS HISTIOCYTOSIS WITH ANTHRACOSIS. A-MALIGNANT.",val,
8932,TCGA-CN-6996.0475c8e9-f3aa-418f-8685-ea32cd6b89c8,"Report Type. Date of Event. F. Authored by. Hosp/Group. Record Status. FINAL DIAGNOSIS: PART 1: RIGHT HEMIGLOSSECTOMY. A. INVASIVE SQUAMOUS CELL CARCINOMA (4.2 CM), MODERATELY. DIFFERENTIATED, KERATINIZING, INVOLVING INTRINSIC TONGUE MUSCLES. B. VASCULAR AND PERINEURAL INVASION IS PRESENT. C. ANTERIOR, POSTERIOR, AND DEEP TONGUE MARGINS ARE FREE OF. CARCINOMA. CARCINOMA EXTENDS TO ANTERIOR AND POSTERIOR FLOOR OF MOUTH MARGINS. (see parts 2-6 for final true margins). D. PATHOLOGIC STAGE: pT3 N2b. PART 2: ANTERIOR FLOOR OF MOUTH MARGIN, RE-RESECTION. NO TUMOR SEEN. PART 3: POSTERIOR FLOOR OF MOUTH MARGIN, RE-RESECTION. NO TUMOR SEEN. PART 4: MEDIAL POSTERIOR FLOOR OF MOUTH/TONGUE, BIOPSY. INVASIVE SQUAMOUS CELL CARCINOMA, BASED ON ORIGINAL FROZEN SECTION. SLIDES. PART 5: NEW POSTERIOR MARGIN. NO TUMOR SEEN. PART 6: DEEP MUSCLE MARGIN. NO TUMOR SEEN. PART 7: RIGHT NECK DISSECTION, LEVELS 1 THROUGH 4. A. METASTATIC SQUAMOUS CELL CARCINOMA, UP TO 3.5 CM, IN FIVE (5) OF. TWENTY-FOUR (24) LYMPH NODES (5/24), INVOLVING LEVELS 1A AND 2. B. EXTRANODAL EXTENSION IS PRESENT. C. VASCULAR INVASION IS PRESENT. By Pathologist: My signature is attestation that I have personally reviewed the submitted. material(s) and the final diagnosis reflects that evaluation. GROSS DESCRIPTION: The specimen is received in seven parts. Part 1 is received fixed labeled with the patient' S name, initials XXX and. ""right hemi-glossectomy."" It consists of a wedge of tan connective tissue,. 5.8 x 3.2 X 1.6 cm, partially covered with an ulcerated gray-white mucosa. Upon cross-sectioning, a 4.2 X 1.6 X 0.9 cm, white, firm lesion is identified. Digital image photographs are taken. Normal tissue and tissue from tumor were. banked for. Head and Neck Tissue Bank. Ink Code: Blue anterior margin. Green posterior margin. Black all other margins. Red banked area. Cassette Code: 1AFS anterior and posterior margin, shave. 1BFS anterior tongue margin, shave. 1CFS posterior tongue margin margin, shave. 1DFS anterior floor of mouth margin, shave. 1EFS posterior floor of mouth margin, shave. 1F-11 representative sections of the tumor. Part 2 is received fixed labeled with the patient' S name, initials XXX and. ""resection anterior floor of mouth.' It consists of a 2.4 X 1.0 X 0.8 cm, tan. connective tissue and gray-white mucosa. A suture marks medial margin (inked. black) and the true margin was identified by the surgeon (inked blue). After. frozen section analysis the specimen is submitted in cassette 2AFS. Part 3 is received fixed labeled with the patient' name, initials XXX and. ""resection posterior floor of mouth."" It consists of 1.0 X 0.5 x 0.6 cm of. tan connective tissue and gray-white mucosa. A suture marks posterior margin. (inked black) and the true margin was identified by the surgeon (inked blue). After frozen section analysis, the specimen is submitted in cassette 3AFS. Part 4 is received fixed labeled with the patient' name, initials XXX and. ""medial posterior floor of mouth/tongue."" It consists of 0.9 x 0.7 X 0.6 cm. of tan, connective tissue and mucosa. A suture marks posterior margin (inked. black) and the true margin was identified by the surgeon (inked blue). After. frozen section analysis, the specimen is submitted in cassette 4AFS. Part 5 is received fixed labeled with the patient' name, initials XXX and. ""new posterior margin."" It consists of 2.2 X 1.3 X 0.8 cm of tan, connective. tissue and mucosa. A suture marks posterior margin (inked black) and the true. margin was identified by the surgeon (inked blue). After frozen section. analysis the specimen is submitted in cassette 5AFS. Part 6 is received fixed labeled with the patient' name, initials XXX and. ""deep muscle margin."" It consists of 1.1 X 0.8 X 0.5 cm of tan, brown,. connective tissue specimen. After frozen section analysis, the specimen is. submitted in cassette 6AFS. Part 7 is received fixed, labeled with the patient's name, initials, XXX and. ""right neck dissection, levels 1-4"". It consists of a tan-yellow, elongated. fibroadipose tissue measuring 15.0 X 7.2 X 2.3 cm with attached submandibular. gland measuring 4.0 X 3.0 x 1.7 cm. The specimen is divided into levels 1A,. 1B, level 2, level 3 and level 4. Three possible lymph nodes are identified. ranging in greatest dimension from 0.8 to 1.3 cm in level 1A. One lymph node. is identified measuring in greatest dimension 1.6 cm in level 1B. Four. possible lymph nodes are identified ranging in greatest dimension from 0.2 to. 3.5 cm in level 2. The largest lymph node is serially cross sectioned. revealing a cystic and necrotic cut surfaces. Eight possible lymph nodes are. identified ranging in greatest dimension from 0.7 to 2.5 cm in level 3. Four. possible lymph nodes are identified ranging in greatest dimension from 0.4 to. 1.6 cm in level 4. The submandibular gland is serially cross sectioned revealing a lobular. tan-yellow unremarkable parenchyma. Cassette code: 7A one lymph node, bisected, level 1A. 7B two lymph nodes, level 1A. 7C one lymph node, level 1B. 7D representative of submandibular gland. 7E 7F representative of largest lymph node, level 2. 7G three possible lymph nodes, level 2. 7H two possible lymph nodes, level 3. 7I 7J three possible lymph nodes in each, level 3. 7K four possible lymph nodes, level 4. 7L three possible lymph nodes, level 4. 7M one possible lymph node (received as a separate fragment from the main. specimen). INTRAOPERATIVE CONSULTATION: PART 1AFS: ANTERIOR AND POSTERIOR MARGINS, SHAVE (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR PRESENT. PART 1BFS: ANTERIOR TONGUE MARGIN, SHAVE (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR PRESENT. PART 1CFS: POSTERIOR TONGUE MARGIN, SHAVE (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR PRESENT. PART 1DFS: ANTERIOR FLOOR OF MOUTH MARGIN, SHAVE (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. MALIGNANT. C. MICROSCOPIC FOCUS OF INVASIVE CLEAR CELL CARCINOMA AND SKELETAL MUSCLE. PART 1EFS: POSTERIOR FLOOR OF MOUTH MARGIN, SHAVE (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. MALIGNANT. C. MICROSCOPIC FOCUS OF INVASIVE SQUAMOUS CELL CARCINOMA. D. SUBMUCOSAL SOFT TISSUE. PART 2AFS: ANTERIOR FLOOR OF MOUTH MARGIN (frozen section) -. A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR PRESENT, NO MUCOSA. PART 3AFS: POSTERIOR FLOOR OF MOUTH (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR PRESENT. PART 4AFS: MEDIAL POSTRIOR FLOOR OF MOUTH/TONGUE (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. MALIGNANT. C. INVASIVE SQUAMOUS CELL CARCINOMA. PART 5AFS: NEW POSTERIOR MARGIN (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR PRESENT. PART 6AFS: DEEP MUSCLE MARGIN (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR PRESENT. MICROSCOPIC: Microscopic examination substantiates the above diagnosis. caa. The following statement applies to all immunohistochemistry, Insitu. Hybridization Assays (ISH & FISH), Molecular Anatomic Pathology, and. Immunofluorescent Testing: The testing was developed and its performance characteristics determined by. the. Department of Pathology, as required by the CLIA. regulations. The testing has not been cleared or approved for the. specific use by the U.S. Food and Drug Administration, but the FDA has. determined such approval is not necessary for clinical use. Tissue fixation. ranges from a minimum of 2 to a maximum of 84 hours. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of. (""CLIA"") as qualified to perform high-complexity clinical. testing. Pursuant to the requirements of CLIA, ASR's used in this laboratory. have been established and verified for accuracy and precision. Additional. information about this type of test is available upon request. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY UPPER AERODIGESTIVE TRACT AND SALIVARY GLAND. TUMORS. SPECIMEN TYPE: Resection: Right hemiglossectomy. TUMOR SITE: Oral Cavity. TUMOR SIZE: Greatest dimension: 4.2 cm. HISTOLOGIC TYPE: Squamous cell carcinoma, conventional. HISTOLOGIC GRADE: G2. PRIMARY TUMOR (pT): pT3. REGIONAL LYMPH NODES (pN): pN2b. Number of regional lymph nodes examined: 24. Number of regional lymph nodes involved: 5. DISTANT METASTASIS (pM): pMX. MARGINS: Cannot be assessed. VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION (V/L): Present. PERINEURAL INVASION: Present. PATIENT HISTORY: CHIEF COMPLAINT/PRE-OP/POST-OP DIAGNOSIS: T3 M2 of right oral/tongue. PROCEDURE: Hemi-glossectomy and neck dissection. SPECIFIC CLINICAL QUESTION: Margins and nodes. OUTSIDE TISSUE DIAGNOSIS: Yes, squamous cell carcinoma. PRIOR MALIGNANCY: No.. CHEMORADIATION THERAPY: No. ORGAN TRANSPLANT: No. IMMUNOSUPPRESSION: No. OTHER DISEASES: No. HISTO TISSUE SUMMARY/SLIDES REVIEWED: Part 1: Right Hemi Glossectomy. Stain/cnt. Block. H&E x 1. F. H&E x 1. G. H&E X 1. H. H&E X 1. I. H&E X 1. AFS. H&E x 1. BFS. H&E X 1. CFS. H&E x 1. DFS. H&E x 1. EFS. Part 2: Anterior floor of mouth. Stain/cnt. Block. H&E x 1. AFS. Part 3: Posterior floor of mouth. Stain/cnt Block. H&E x 1. AFS. Part 4: Medial posterior floor of mouth. Stain/cnt. Block. H&E x 1. AFS. Part 5: New posterior margin. Stain/cnt. Block. H&E X 1. AFS. Part 6: Deep muscle margin. Stain/cnt. Block. H&E X 1. AFS. Part 7: Right Neck Dissection. Stain/cnt. Block. H&E x 1. A. H&E X 1. B. H&E x 1. C. H&E x 1. D. H&E x 1. E. H&E X 1. F. H&E x 1. G. H&E x 1. H. H&E x 1. I. H&E x 1. J. H&E x 1. K. H&E x 1. L. H&E X 1. M. TC1.",val,
8997,TCGA-AP-A1DP.20EEB047-0185-4B65-9A6A-43D6C97307C8,"Specimens Submitted: 1: 8P: Uterus, cervix, bilateral tubes and ovaries. 2: SP: Portion of omentum. 3: SP: Right common iliac lymph node. 4: SP: Right para-aortic lymph node. 5: SP: Left para-aortic lymph node. 6: SP: Right external iliac lymph node. 7: SP: Right obturator lymph node. 8: SP: Right internal iliac lymph node. 9: SP: Left external iliac lymph node. 10: SP: Left hypogastric lymph node. 11: SP: Left obturator lymph node. AMENDED DIAGNOSIS: 1). UTERUS, CERVIX, FALLOPIAN TUBES AND OVARIES; TOTAL HYSTERECTOMY. AND BILATERAL SALPINGO-OOPHORRCTOWY: - ADENOCARCINOMA OF ENDOMETRIUM, ENDOMETRIOID TYPE, NOS, FIGO GRADE II. (6-50% SOLID GROWTH) NUCLEAR GRADK 2. - THE TUHOR INVADES TO LESS THAN OR EQUAL TO HALF or MYOKETRIUM. THE NAXIMAL THICKNESS OF MYONETRIAL INVASION IS 1.3 CN. - THE THICKNESS or THK MYONETRIUM IN THE AREA OF MAXIMAL TUMOR INVASION. IS 2.8 CM. - NO ENDOCERVICAL INVASION 18 IDENTIFIED. - NO VASCULAR INVASION IB IDENTIFIED. - CERVIX: BENIGN SQUAMOUS MUCOSA. - THE ENDOMETRIUM SHOWS THE FOLLOWING ABNORMALITY (IES) : ATROPHY. - THE MYOMETRIUM SHOWS THE FOLLOWING ABNORMALITY (IES) : ADENOMYOSIS AND. LEIOMYOMA (s). - ALL ADNEXAE ARE UNREMARKABLE. OMENTUM; EXCISION: - BENIGN FIBROADIPOSE TISSUE. 3). LYMPH NODE, LEFT COMMON ILIAC; EXICISION: ONE BENION LYMPK NODE (0/1). 4). LYMPH NODE, RIGHT PARA-AORTIC-AORTIC; EXCISION: - FIVE BENIGN LYMPA NODES (0/5). 5). LYMPH NODE, LEFT PARA-AORTIC-AORTIC, EXCISION: - TWO BENIGN LYMPH NODES (0/2) . 6). LYMPH NODE, RIGHT EXTERNAL ILIAC: EXCISION: - THREE BENIGN LYMPH NODES (0/3). 7). LYMPH NODE, RIGHT OBTURATOR; EXCISION: - TWO BENIGN LYMPH NODES. 8). LYMPH NODE, RIGHT EXTERNAL ILIAC, EXCISION: - TNO BENIGN LYMPH. NODES (0/2). 9). LYMPH NODE, LEFT EXTERNAL ILIAC; EXCISION: - THREE BENIGN LYMPH NODES (0/3). 10). LYMPH NODE, LEFT HYPOGASTRIC; EXCISION: - THO BENIGN LYMPH NODES (0/2). - ONE LYHPH NODE HAS FOCAL ENDOSALPINGIOSIS. 11). LYNPH NODE, LEFT OBTURATOR; EXCISION: - FOUR BENION LYMPH NODES (0/4). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION. OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT.",val,
9010,TCGA-B5-A0K8.1E7C9CA2-73AA-4443-A125-D5588F93BEF9,"CLINICAL HISTORY: Malignant neoplasm corpus uteri. Per E-browser: adenocarcinoma diagnosed at. outside hospital. GROSS EXAMINATION: A. ""Uterus, cervix, tubes and ovaries (AF1)"" Unfixed for frozen section and. transferred to formalin at. is a 85 gram, 6 x 6 x 2.2 cm. uterus with bilateral adnexa. The uterine serosa is tan and unremarkable. Sectioning demonstrates a 2.2 x 2. x. 1.1 cm tan-pink, friable mass at the fundus extending into the posterior. endometrium. The mass does not grossly invade the myometrium (1.8 cm thick),. is 1.5 cm from the closest superior endocervix, and is 4.2 cm from the. cervical os. The endometrium is otherwise tan and less than 0.1 cm thick. The. myometrium is unremarkable. The anterior endocervix is remarkable for a 1.1 cm. nabothian cyst. The ectocervical and endocervical mucosa are otherwise. unremarkable. Representative full-thickness section of the endometrial mass at. the fundus is frozen as AF1. The frozen section control is transferred to A1. BLOCK SUMMARY: A2-8. mass entirely submitted (full-thickness sections) from fundus to. posterior endometrium. A9. adjacent uninvolved posterior endomyometrium. A10. anterior endomyometrium. All. posterior cervix. A12. anterior cervix. The right fallopian tube (4.5 x 0. cm) has a tan, unremarkable serosal. surface and an unremarkable cut surface. The right ovary (2.5 x 2 x 0.8 cm). has a yellow, smooth, glistening surface. The cut surface is unremarkable. Representative right fallopian tube and ovary are submitted in block A13. The left fallopian tube (4.5 x 0.5 cm) has a tan, smooth, glistening surface. There are two paratubal cysts up to 0.3 cm in greatest dimension. The cut. surface is unremarkable. The left ovary (2.5 x 1.5 x 0.6 cm) has a yellow,. unremarkable external surface and an unremarkable cut surface. Representative. left fallopian tube and ovary submitted in block A14. B. ""Toot pelvic lymph node"". Unfixed and transferred to formalin at. on. is a 2.5 x 2 x 0.6 cm fragment of yellow fibroadipose tissue. dissected for lymph nodes. Two apparent lymph nodes up to 1 cm in greatest. dimension are identified and submitted in block B1. The remaining fibroadipose. tissue is submitted in block B2. C. ""T.poft pelvic lymph node"". Unfixed and transferred to formalin at. on. is a 3.4 x 2.2 x 0.8 cm aggregate of yellow fibroadipose tissue. dissected for lymph nodes. Three apparent lymph nodes up to 1.2 cm in greatest. dimension are identified and submitted in block C1. The remaining fibroadipose. tissue is submitted in block C2. D. ""Right pelvic lymph node"". Unfixed and transferred to formalin at. on. is a 4.5 x 4 x 1.5 cm aggregate of tan-yellow fibroadipose tissue. dissected for lymph nodes. Apparent lymph nodes up to 2.5 cm in greatest. dimension are identified. BLOCK SUMMARY: D1. one apparent lymph node, bisected. D2. five apparent lymph nodes. D3. remaining fibroadipose tissue. INTRA OPERATIVE CONSULTATION: A. ""Uterus, cervix, tubes and ovaries"" (AF1, tumor with full thickness. myometrium) : Extensive EIN. No invasive carcinoma seen (Dr. MICROSCOPIC EXAMINATION: Microscopic examination is performed. PATHOLOGIC STAGE: PROCEDURE: HYSTERECTOMY, BILATERAL SALPINGO-OOPHORECTOMY, LYMPHADENECTOMY. PATHOLOGIC STAGE (AJCC 6th Edition) : pT1a pNO pMX. NOTE: Information on pathology stage and the operative procedure is. transmitted to this Institution's Cancer Registry as required for. accreditation by the Commission on Cancer. Pathology stage is based solely. upon the current tissue specimen being evaluated, and does not incorporate. information on any specimens submitted separately to our Cytology section,. past pathology information, imaging studies, or clinical or operative. findings. Pathology stage is only a component to be considered in determining. the clinical stage, and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon's operative report. DIAGNOSIS: A. ""UTERUS, CERVIX, TUBES AND OVARIES"" (HYSTERECTOMY, BILATERAL. SALPINGO-OOPHORECTOMY) : UTERUS: 85 GRAMS. ENDOMETRIUM: TUMOR SITE: FUNDUS, POSTERIOR ENDOMETRIUM. HISTOLOGIC TYPE: SEROUS ADENOCARCINOMA. FIGO GRADE: 3. TUMOR SIZE: 2.2 x 2 x 1.1 CM. MAXIMUM DEPTH OF MYOMETRIAL INVASION: MINIMAL INVASION (1 MM) IN A 1.8. CM THICK WALL. LYMPHATIC/VASCULAR INVASION: NEGATIVE. ADJACENT NON-NEOPLASTIC ENDOMETRIUM: ATROPHIC. REMAINING MYOMETRIUM: ADENOMYOSIS. CERVIX: NO PATHOLOGIC DIAGNOSIS. SEROSA: NO PATHOLOGIC DIAGNOSIS. SPECIMEN MARGINS: NOT INVOLVED. RIGHT AND LEFT OVARIES AND FALLOPIAN TUBES: NO PATHOLOGIC DIAGNOSIS. B. ""LEFT PELVIC LYMPH NODE"" (BIOPSY) : THREE LYMPH NODES, NEGATIVE FOR MALIGNANCY (0/3). C. ""LEFT PELVIC LYMPH NODE"" (BIOPSY) : FOUR LYMPH NODES, NEGATIVE FOR MALIGNANCY (0/4) . D. ""RIGHT PELVIC LYMPH NODE"" (BIOPSY) : FIVE LYMPH NODES, NEGATIVE FOR MALIGNANCY (0/5) . I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es) .",val,
9044,TCGA-AO-A0JJ.EB9B6625-6674-4665-9BEE-D4DFD9366A02,"Clinical Diagnosis & History: y/o female with biopsy proven left ILC at. Scheduled for left total. mastectomy and SLN/possible ALND. Specimens Submitted: 1: SP: Sentinel node #1, level 1, left axilla (fs). 2: SP: Sentinel node #2, level 2, left axilla (fs). 3: SP: Sentinel node #3, level 2, left axilla (fs). 4: SP: Sentinel node #4, level 1, left axilla (fs). 5: SP: Left breast (sr). 6: SP: Non-sentinel node level 1, left axilla. 7: SP: Left axillary contents level 1. 8: SP: Left axillary contents level 2 ana tag. DIAGNOSIS: 1). LYMPH NODE, SENTINEL #1 LEVEL I LEFT AXILLA; BIOPSY: - METASTATIC MAMMARY CARCINOMA INVOLVING ONE OF ONE LYMPH NODE (1/1) . - NO EXTRANODAL TUMOR EXTENSION IS PRESENT. 2). LYMPH NODE, SENTINEL #2 LEVEL II LEFT AXILLA; BIOPSY: - ONE BENIGN LYMPH NODE (0/1). 3). LYMPH NODE, SENTINEL #3 LEVEL II LEFT AXILLA; BIOPSY: - ONE BENIGN LYMPH NODE (0/1) . 4). LYMPH NODE, SENTINEL #4 LEVEL I LEFT AXILLA; BIOPSY: - ONE BENIGN LYMPH NODE (0/1). 5). BREAST, LEFT; MASTECTOMY: - INVASIVE LOBULAR CARCINOMA, CLASSICAL TYPE, DIFFUSELY INVOLVING THE. SUBMITTED TISSUE SECTIONS. THE LARGEST DIMENSION OF THE INVASIVE CARCINOMA. CANNOT BE ACCURATELY DETERMINED BECAUSE OF ITS DIFFUSE NATURE, BUT BASED ON. GROSS EXAMINATION IT IS ESTIMATED THAT THR INVASIVE CARCINOMA SPANS AN AREA. OF ABOUT 4.5 CM. - THE BASE OF THE NIPPLE IS ALSO INVOLVED BY INVASIVE LOBULAR CARCINOMA. - LOBULAR CARCINOMA IN SITU (LCIS). - MICROCALCIICATIONS ARE PRESENT IN BENIGN (ENTRAPPED) BREAST PARENCHYMA. - LYMPHOVASCULAR INVASION IS PRESENT. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY CARCINOMA IS IDENTIFIED. SKIN WITH SCAR. , THE REMAINING NON-NEOPLASTIC BREAST TISSUE SHOWS BIOPSY SITE CHANGES AND. FOCAL DUCTAL HYPERPLASIA WITH FOCAL ATYPIA. ONE AXILLARY LYMPH NODE IS POSITIVE FOR METASTATIC MAMMARY CARCINOMA. (1/1) - NO EXTRANODAL TUMOR EXTENSION IS PRESENT. - RESULTS OF IMMUNOHISTOCHEMICAL STAINS ARE AS FOLLOWS: ER: 95% NUCLEAR STAINING WITH STRONG INTENSITY. PR: 70% NUCLEAR STAINING WITH MODERATE TO STRONG INTENSITY. HER-2/NEU (HERCEPTEST) : NEGATIVE (STAINING INTENSITY OF 0). 6). LYMPH NODE, NON-SENTINEL LEVEL I LEFT AXILLA; BIOPSY: - ONE BENIGN LYMPH NODE (0/1). 7). LYMPH NODES, LEFT AXILLARY CONTENTS LEVEL I; DISSECTION: - TWENTY-TWO BENIGN LYMPH NODES (0/22). 8). LYMPH NODES, LEFT AXILLARY CONTENTS LEVEL II; DISSECTION: SIXTEEN BENIGN LYMPH NODES (0/16). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) . AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Commen t. RECUT. ER-C. PR-C. HER2-C. NEG CONT. IMM RECUT. NEG-HER2. RECUT. Gross Description: 1). The specimen is received fresh and is labeled ""Sentinel node #1 level. 1 axilla"" and consists of one lymph node measuring 1.5 x 0.8 x 0.4 cm. Bisected and entirely submitted for frozen section. Summary of sections: FSC - frozen section control. 2). The specimen is received fresh, labeled ""Sentinel node #2 level 2. left axilla"" and consists of one lymph node measuring 0.8 x 0.5 x 0.3 cm. Entirely submitted for frozen section. Summary of sections: FSC - frozen section control. , M.D. 3). The specimen is received fresh, labeled ""Sentinel node #3 level 2. left axilla"" and consists of one lymph node measuring 1.0 x 0.5 x 0.3 cm. Entirely submitted for frozen section. Summary of sections: FSC - frozen section control. , M.D. 4). The specimen is received fresh and is labeled ""Sentinel node #4 level. 1. left axilla"" and consists of a lymph node measuring 1.5 x 0.5 x 0.4 cm. Entirely submitted for frozen section. Summary of sections: FSC - frozen section control. M.D. 5). The specimen is received fresh labeled, ""Left breast, stitch marked. axillary tail"" and consists of a breast with attached axillary tail. The. breast measures 35.5 x 24.0 x 3.8 cm with overlying skin ellipse measuring. 13.5 x 7.5 cm. Situated centrally on the skin surface is an unremarkable. nipple measuring 1.2 x 1.2 x 0.8 cm and areola measuring 3.9 x 3.9 cm. The. skin shows a linear scar measuring 8.0 cm, situated vertically near the. nipple. A suture demarcates the axillary tail which measures 4.5 x 3.5 x. 3.5 cm. Sectioning the breast reveals a biopsy cavity, measuring 4.2 x 3.5. x 4.0 cm with a fibrotic area superior to the cavity. One ill-defined tan. mass is present, measuring 4.5 x 4.5 x 2.7 cm, located lateral to the nipple. in UOQ and 3.5 cm from the deep surgical margin. The remaining breast. tissue shows unremarkable intermingling of fatty and fibrotic areas. The. axillary tissue is dissected to reveal one lymph node, measuring 1.1 x 0.5 x. 0.5 cm. Representative sections are submitted. A portion of tumor is. submitted to. Summary of sections: N - nipple. NB - nipple base. s - skin scar. D - deep margin. T - tumor. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. LNS - lymph node. M.D. 6). The specimen is received in formalin is labeled ""Non-sentinel node. level 1 left axilla"" and consists of a tan soft lymph node measuring 1.0 x. 1.0 x 0.7 cm. Entirely submitted. Summary of sections: LN - lymph node (bisected). , M.D. 7). The specimen is received in formalin and is labeled ""Left axillary. contents level 1"" and consists of multiple lymph nodes and fat measuring 8.0. x 7.0 x 1.1 cm in aggregate. The lymph nodes measure from 0.2 cm to 3.0 cm. in greatest dimension. The lymph nodes are entirely submitted. Summary of sections: BLN1 - bisected lymph node. BLN2 - bisected lymph node. LN - lymph nodes. M.D. 8). The specimen is received in formalin labeled ""Left axillary contents. level 2 and tag"" and consists of multiple lymph nodes and attached fat. measuring 5.0 x 4.0 x 0.6 cm. The lymph nodes measure from 0.3 cm to 0.5 cm. in greatest dimension. The lymph nodes are entirely submitted. Summary of sections: LN - lymph nodes. Summary of Sections: Part 1: SP: Sentinel node #1, level 1, left axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 2: SP: Sentinel node #2, level 2, left axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 3: SP: Sentinel node #3, level 2, left axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 4: SP: Sentinel node #4, level 1, left axilla (fs). Block. Sect. Site. PCs. fsc. 1. Part 5: SP: Left breast. Block. Sect. Site. PC's. 1. dm. 1. 2. lig. 2. 1. Ins. 1. 2. loq. 2. 1. n. 1. 1. nb. 1. 1. sk. 1. 5. t. 5. 2. uiq. 2. 2. uoq. 2. Part 6: SP: Non-sentinel node level 1, left axilla. Block. Sect. Site. PCs. 1. In. 1. Part 7: SP: Left axillary contents level 1. Block. Sect. Site. PCs. 2. blnl. 2. 2. bln2. 2. 6. In. 6. Part 8: SP: Left axillary contents level 2 and tag. Block. Sect. Site. PCs. 3. In. 3. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS. METASTATIC CARCINOMA. PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS. NO CARCINOMA IDENTIFIED. PERMANENT DIAGNOSIS: SAME. 3). FROZEN SECTION DIAGNOSIS. NO CARCINOMA IDENTIFIED. PERMANENT DIAGNOSIS: SAME. 4). FROZEN SECTION DIAGNOSIS. NO CARCINOMA IDENTIFIED. PERMANENT DIAGNOSIS: SAME.",val,
9087,TCGA-CG-4449.05cd8a06-a4a6-4975-af7b-638c92cde38d,"Diagnosis/diagnoses: 1.: Tumor-free lymph nodes. 2.: Total gastrectomy preparation with the inclusion of a moderately differentiated. mucigenous adenocarcinoma (intestinal type) in the prepyloric antrum of the stomach, with a. maximum diameter of 3 cm, with infiltration of the perigastric fatty tissue and a further. moderately differentiated adenocarcinoma (intestinal type), likewise in the antrum, measuring. 1.5 cm in diameter, with circumscribed infiltration of the tunica submucosa. Six regional. lymph node metastases in the region of the greater curvature. Tumor-free esophageal. resection margin covered with characteristic squamous epithelium and tumor-free duodenal. resection margin. Tumor-free omentum. Tumor stage: pT2b (2) pN1 (6/42) pMX;.",val,3 cm;1.5 cm
9092,TCGA-CM-5344.9af94cfc-6eef-4691-9dfb-c0f60cfebdcb,"Clinical Diagnosis & History: old with sigmoid colon cancer. Specimens Submitted: 1: SP: Colon, terminal ileum, appendix; total colectomy. DIAGNOSIS: 1. SP: Colon, terminal ileum, appendix; total colectomy: Tumor Type: Adenocarcinoma. Histologic Grade: Moderately differentiated. Tumor Location: Sigmoid colon. Tumor Size: Length is 3 cm. Width is 4 em. Maximal thickness is 0.3 cm. Tumor Budding: Focal. Increased Tumor Infiltrating Lymphocytes: Absent. Precursor Lesions: Tubular adenoma. Deepest Tumor Invasion: Subserosal adipose tissue and/or mesenteric fat. Gross Tumor Perforation: Not identified. Lymphovascular Invasion: Identified. Large Venous Invasion: Not Identified. Perineural Invasion: Identified. Surgical Margins: Free of tumor. Polyps/Mucosa Dysplasia (away from the carcinoma) : Tubular adenoma; number: 3. Non-Neoplastic Bowel: Extensive melanosis coli. Appendix: Unremarkable. Lymph Nodes: Number with metastasis: 3. Total number examined: 108. Tumor staging (AJCC 7th Edition) : pT3 (Tumor invades through the muscularis propria into. pericolorectal tissues). Lymph Node Stage (AJCC 7th Edition) : N1b (Metastasis in 2-3 regional lymph nodes). NOTE: THE IMMUNOHISTOCHEMICAL STAINING FOR THE TESTED DNA MISMATCH REPAIR. PROTEINS (MLH1, MSH2, MSH6, PMS2) IS RETAINED IN THE TUMOR. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Comment. RECUT. Gross Description: 1) The specimen is received fresh, labeled ""total colectomy"" and consists. of a segment of terminal ileum, cecum with attached appendix, ascending,. transverse, descending and sigmoid colon. The terminal ileum measures 12 cm. in length and 3.5 cm in circumference at the proximal resected margin. The. remaining colon measures 95.5 in length with a circumference of nine cm at. the distal resected margin. The attached appendix measures 8 cm in length. and averages 0.5 cm in diameter The appendiceal and intestinal serosa is. pink tan and smooth. Focally hemorrhagic lobulated yellow tan adipose. tissue spans the length of the specimen measuring up to 2.5 cm in thickness. The specimen is opened to reveal a mass lesion measuring 3 cm in length and. 4. cm in width. The mass is located in the sigmoid colon, 85 cm from the. proximal margin and 7 cm from the distal margin. Sectioning shows that the. tumor invades the muscularis propria and possibly the serosa. The depth of. invasion is 0.3 cm grossly. The remaining mucosa shows two sessile polyp,. measuring 0.5 x 0.5 x 0 .3 and 0.3 x 0.2 x 0.2 cm. The attached adipose. tissue is submitted for lymph node dissection and all identified lymph nodes. are submitted. The colon is extensively sampled with representative sections. submitted for permanent sections and for TPS. Summary of sections: PM - proximal margin shave. DM - distal margin shave. T tumor. P polyps. A - appendix representative sections. RS -representative sections. Summary of Sections: Part 1: SP: Colon, terminal ileum, appendix; total colectomy. Block. Sect. Site. PCa. 1. A. 1. 1. DM. 1. 23. LN. 85. 1. P. 1. 1. PM. 1. 10. RS. 10. 5. 5.",val,3 cm;4 em;0.3 cm
9105,TCGA-KK-A8IA.641BD2CD-8B57-49BB-A2E1-9EB78097B4D6,"MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A) LEFT PELVIC LYMPH NODES: METASTATIC ADENOCARCINOMA IN TWO OF ELEVEN LYMPH NODES WITH EXTRANODAL EXTENSION. (2/11). (SEE COMMENT). (B) RIGHT PELVIC LYMPH NODES: METASTATIC ADENOCARCINOMA IN ONE OF EIGHT LYMPH NODES (1/8). (SEE COMMENT). (C) ""LEFT PERIVESICLE"" LYMPH NODES: Adipose tissue no lymph nodes or tumor present. (D) PROSTATE AND SEMINAL VESICLES: Supplemental report to follow. Entire report and diagnosis completed by. COMMENT. The foci of metastatic carcinoma measure 4.0 mm and 8.0 mm in part A and 4.0 mm in part B. GROSS DESCRIPTION. (A) LEFT PELVIC LYMPH NODES - Received are multiple fragments of fatty tissue measuring in aggregate (9 x 5 x 2 cm). Dissection. reveals multiple possible lymph nodes ranging from 0.4 up to 2.8 cm in their greatest dimension. Possible lymph nodes. are entirely submitted in cassettes. SECTION CODE: A1, three possible lymph nodes; A2, one sectioned possible lymph node; A3, one sectioned possible. lymph node; A4, one sectioned possible lymph node; A5, one sectioned possible lymph node; A6, A7, one sectioned possible. lymph node; A8, A9, one sectioned possible lymph node; A10, A11, one sectioned possible lymph node; A12-A14, one sectioned. possible lymph node. (B) RIGHT PELVIC LYMPH NODES - Multiple fragments of fatty tissue measuring in aggregate 8.5 x 4.5 X 2 cm. Dissection. reveals multiple possible lymph nodes ranging from 0.5 up to 3.3 cm in greatest dimension. Possible lymph nodes are entirely. submitted in cassettes. SECTION CODE: B1, two possible lymph nodes; B2, one sectioned possible lymph node; B3, one sectioned possible. lymph node; B4, one sectioned possible lymph node; B5, one sectioned possible lymph node; B6, one sectioned possible lymph. node; B7-B10, one sectioned possible lymph node. (C) LEFT PERIVESICLE LYMPH NODES - Multiple fragments of fatty tissue measuring in aggregate 2.5 x 2.4 x 0.5 cm. Entirely. submitted in cassette C. (D) PROSTATE AND SEMINAL VESICLES - Supplemental report to follow. CLINICAL HISTORY. Prostatic cancer. SNOMED CODES. T-C4600, M-y1976. Page: 2. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by: Start of ADDENDUM. Page: 3. ADDENDUM. This modified report is being issued to provide additional information/results. Addendum completed by. DIAGNOSIS. (D) PROSTATE AND SEMINAL VESICLES: PROSTATIC ADENOCARCINOMA, GLEASON SCORE 9 (4 + 5). (SEE COMMENT). TUMOR EXTENDING IN MULTIPLE AREAS INTO EXTRAPROSTATIC TISSUE. TUMOR INVADING LEFT SEMINAL VESICLE AND LEFT PERIVESICULAR SOFT TISSUE. FOCAL EXTENSION OF TUMOR TO THE MARGIN OF RESECTION CANNOT BE EXCLUDED. Right seminal vesicle and segments of vasa deferentia, no tumor present. SEE PREVIOUS REPORT FOR DIAGNOSIS OF THE PELVIC LYMPH NODES. COMMENT. The prostate gland contains a single focus of prostatic adenocarcinoma. The tumor is located in the right. anterior, mid anterior, left anterior, left anterolateral, left lateral, left posterolateral, left posterior, mid. posterior, right posterior, right posterolateral and right lateral peripheral zone. It is estimated that the tumor. occupies approximately 70% of the prostatic volume. The tumor focus measures 4.5 X 3.0 cm in the largest. cross-sectional dimension and it is present in three cross sections and extensively in the apex and base. regions. The tumor exhibits extraprostatic extension in the left lateral and left posterolateral aspect of the. prostate, left superior neurovascular bundle region and posterior surface of the prostate at the base level. At the sites of extraprostatic extension, the margin of resection is free of tumor. The tumor extends in the. right posterolateral aspect of the prostate to less than 0.1 mm from the inked surface. Focal marginal. involvement cannot be excluded. The tumor extensively involves the left seminal vesicle including intra and extraprostatic portions. Please refer to the previous report for the diagnosis of the pelvic lymph nodes. GROSS DESCRIPTION. Page: 4. (D) PROSTATE AND SEMINAL VESICLES - A specimen consisting of a prostate, attached right and left. seminal vesicles and attached segments of right and left vasa deferentia. The prostate gland (5.8 X 3.3 X 3.4 cm, 51 grams, post-fixation) has the usual shape. The soft tissue. present along the left posterolateral aspect of the prostate appears more abundant than along the right side. Nodules are palpated on the left and right sides of the prostate. Serial cross sections after fixation. demonstrate areas consistent with tumor in the right posterolateral and left posterolateral peripheral zone of. the three cross sections of the prostate. The seminal vesicles and segments of vasa deferentia are grossly free of tumor. SECTION CODE: D1-D3, right seminal vesicle and segment of right vas deferens from the base. towards the tip; D4-D6, left seminal vesicle and segment of left vas deferens from the base towards the tip;. D7, D8, prostatic base, right border; D9-D12, prostatic base, right posterior border; D13-D22, prostatic base,. central portion; D23, D24, prostatic base, left border; D5-D28, prostatic base, left posterior border; D29-D31,. apex anterior; D32, D33, apex left; D34, D35, apex posterior; D36, D37, apex right; D38-D49, sections of. the three cross sections of the prostate according to specimen radiograph. The anterior aspect of the prostate is inked in green, left surface in red, right surface in yellow and. posterior surface in black. SNOMED CODES. T-92000, M-Y1973. Entire report and diagnosis completed by:",val,4.5 X 3.0 cm
9209,TCGA-AC-A5XS.C4F259BA-7C00-4326-ACB2-924C4AE33E87,"PROCEDURE. Bilateral simple breast mastectomy with sentinel node biopsy left. breast. A. Right breast. B. Left breast with attached sentinel nodes. HISTORY. Left breast cancer. GROSS. A. Received in formalin in a container labeled ""right breast"" is a. mastectomy (22 x 18 x 5 cm). Orientation of the specimen is not. provided. The skin ellipse (20 x 15 cm) has a central unremarkable. nipple and areola. The posterior margin is composed of thin fascia. without attached skeletal muscle. The margins are marked with black. ink. The specimen is serially sectioned. The parenchyma has discrete and. ill-defined areas of soft white fibrous tissue. A suspicious lesion. is not palpated. 1. Nipple and areola. 1NS. 2. Subareolar parenchyma. 2SS. 3-6. Representative sections from four quadrants. B. Received fresh in a container labeled ""left breast"" is a. mastectomy (23 x 17 x 5 cm) with a 7 cm axillary tail. The skin. ellipse (20 x 12 cm) has a central unremarkable nipple and areola. The parenchyma is serially sectioned. The medial hemisphere has a. 2.6 cm in greatest dimension hard gray-white sclerotic neoplasm with. an ill-defined radially infiltrating border measuring approximately. 1 cm from the posterior margin, 2.2 cm from the skin surface and 1. cm from the nearest (inferomedial) radial margin. A representative. portion of the tumor along with normal parenchyma away from the. neoplasm is submitted for TCGA/. The remaining. parenchyma has scattered areas of ill-defined fibrous tissue without. a palpable mass. The axillary tail has numerous fatty lymph nodes. up to 2.5 cm in greatest dimension. 1. Small lymph node. 2-7. Bisected lymph nodes (1 lymph node per cassette). 8-10. Large lymph node. 11. Nipple and areola. 12. Skin and posterior margin nearest neoplasm. 13. Inferomedial quadrant nearest neoplasm. 14-16. Neoplasm. 17. Superolateral quadrant. 18. Inferolateral quadrant. MICROSCOPIC. A-B. Performed. DIAGNOSIS. A. Right simple mastectomy: Nonproliferative breast parenchyma with acellular dense. stromal fibrosis and rare microcalcification. Nipple, free of lesion. CPT 88307. B. Left mastectomy with attached sentinel nodes: Invasive lobular carcinoma, Nottingham grade 1 (previously. diagnosed,. Nipple and skin of posterior margin (nearest neoplasm), free. of lesion. Eight of eight sentinel lymph nodes, free of metastatic. carcinoma. CPT 88309. BREAST CARCINOMA SUMMARY: SPECIMEN: Left breast. PROCEDURE: Left breast with attached sentinel lymph nodes. SPECIMEN INTEGRITY: Intact. SPECIMEN LATERALITY: Left. SPECIMEN SIZE: 23 x 17 x 5 cm. LYMPH NODE SAMPLING: SENTINEL LYMPH NODES: 8 of 8, negative for metastatic. carcinoma. TUMOR SIZE: 2.6 cm. TUMOR FOCALITY: Single focus. SKIN INVOLVEMENT: Negative for cancer. NIPPLE INVOLVEMENT: Negative for cancer. SKELETAL MUSCLE INVOLVEMENT: N/A. DUCTAL CARCINOMA IN SITU (DCIS) : Not present. LOBULAR CARCINOMA IN SITU (LCIS) : N/A. HISTOLOGIC TYPE: Lobular carcinoma. GRADING (NOTTINGHAM) : Tubular Formation Score: 3. Nuclear Pleomorphism Score: 1. Mitotic Rate Score: 1. COMBINED GRADE (NOTTINGHAM) : 1. LYMPHOVASCULAR INVASION: Not seen. MARGIN OF EXCISION: Negative for carcinoma. LYMPH NODES: See above. MICROCALCIFICATION: Not seen. OTHER FINDINGS: N/A. HORMONE RECEPTORS: ER positive. PR positive. HER2: Negative (1+) . PATHOLOGIC. (AJCC Seventh Edition) : pT2 pNO. (Electronic Signature). Completed Action List: on. Type: Sura Path Final Report. Title: Contributor system: SP 1st Addendum Report. SP 1ST ADDENDUM REPORT. ADDENDUM REPORT. E-cadherin immunostain is performed on block B15 to confirm the. lobular nature of the infiltrating mammary carcinoma. The stain is. negative, supporting the diagnosis of invasive LOBULAR carcinoma. Positive and negative tissue controls perform as expected. 88342. (Electronic Signature). Completed Action List: Type: SP 1st Addend. Title: SP 1ST ADDENDUM REPORT. Contributor system:",val,2.6 cm
183,TCGA-FG-A6J1.9421C492-5E69-4641-B4CD-29A4D2C7A4CD,"Gender: F. Result Detail. Pathology Result: Specimen Collected Date: Specimen Received Date: Medical Record Number: Facility: Date Received: FINAL DIAGNOSIS. A. ""TUMOR MARGINS"", BIOPSY: -BLOOD CONTAINING FRAGMENTS OF CEREBRAL CORTEX DEMONSTRATE FOCAL GLIOMATOUS. INFILTRATION. B. ""LEFT INTRACRANIAL TUMOR"", REMOVAL: -OLIGODENDROGLIOMA (WHO GRADE II). Out By. Intraoperative Consultation: Microscopic diagnosis: FSA1: Blood cautery with low grade glioma. Dr. Clinical History: left intracranial tumor. Specimens Submitted As: A:TUMOR MARGINS. B:LEFT INTRACRANIAL TISSUE. Gross Description: A: Received fresh for intraoperative consultation, labeled with the. patient's. name, hospital number and ""margins"", is a segment of tan and red soft. tissue. measuring 3.0 x 1.5 x 1.2 cm. The specimen is bisected and representative. portion is submitted for frozen evaluation and then in one cassette. The. remainder is entirely submitted for permanent evaluation in one additional. cassette. B: Received fresh, labeled with the patient's name and number, are multiple. light tan to pink-tan irregular soft tissue fragments measuring 2.8 x 2.0 x 0.6. of 2. cm in aggregate. Submitted in toto in one cassette. 2 of 2.",test,
321,TCGA-UF-A7JF.F2F30103-A0E4-4377-9132-2DB7C2609064,"PRIMARY SITE: Larynx. I-) ""Biopsy of the left vocal fold"": - Invasive moderately differentiated squamous cells carcinoma. II-) "" Right neck dissection specimen level IV"": - Absence of neoplasia (0/5). III) ""Right neck dissection specimen level III"": - Absence of neoplasia (0/18). IV-) ""Right neck dissection specimen level II"": - Absence of neoplasia (0/8). V-) ""Left neck dissection specimen level II"": - Absence of neoplasia (0/17). VI-) ""Left neck dissection specimen level III"": - Metastatic squamous cell carcinoma in one lymph node (1/7), without capsular. involvement. VII) ""Left neck dissection specimen level IV"": - Absence of neoplasia (0/11). VIII) Product of thyroid and larynx ressection. - Moderately differentiated squamous cell carcinoma, measuring 5.0 x 3.0 cm on the. greatest dimensions, affecting the following structures: Glottic, supraglottic and infraglottic regions on the left. Infraglottic on the right. Piriform sinus on the left. Cricoid, arytenoid and thyroid cartilages. Thyroid isthmus. Soft tissues adjacent to the larynx. Trachea. - Angiolymphatic and perineural invasion not observed. - Left soft tissue margins involved by neoplasia. - Other surgical margins uninvolved by neoplasia. - Right thyroid lobe with no particularities. - Small follicular adenoma on the left thyroid lobe. SUMMARY OF HISTOLOGICAL FINDINGS: - Grade 2 squamous cell carcinoma of the larynx, transglottic on the left and infraglottic. on the right with involvement of the adjacent soft tissues, thyroid and hypopharynx on. the left. - Right lymph nodes: 0/31. - Left lymph nodes: 1/35 without capsular involvement.",test,5.0 x 3.0 cm
370,TCGA-5P-A9K6.6B3A5E0D-BFF2-4386-A9F9-1DB99DEDC3F3,"Papillary Renal Cell Carcinoma, Type I, moderately differentiated. The tumor presents as a multi-focal. one. Stage: pT1a (multifocal), RO. Grade: GII. ICD-0-Code: 8260/3.",test,
518,TCGA-V1-A8MK.B8FB60DC-69C5-421A-90B0-875AE69E27D5,"Service Date: Male. Soc. Sec. #: Client: FINAL PATHOLOGIC DIAGNOSIS. Prostate and seminal vesicles, prostatectomy: 1. Prostatic adenocarcinoma, Gleason score 3+3 = 6; see comment. 2. Seminal vesicles with no tumor. COMMENT: Synoptic Comment for Prostate Tumors. - Type of tumor: Small acinar adenocarcinoma. - Location of tumor: Left posterior midgland, slides A5, A9-A10; left anterior midgland, slides A5,. A7-A8; right posterior apex, slide A2; right posterior midgland, slide A4, A6, A11-A12; right anterior. midgland, silde A4, A6,A13. - Estimated volume of tumor: 4.2 cm cubed (based on tumor area on slides  0.5 cm thick slices). - Gleason score: 3+3. - Estimated volume > Gleason pattern 3: o. - Involvement of capsule: Positive (A6, A11, A12). - Extraprostatic extension: None. - Margin status for tumor: Negative. - Margin status for benign glands: Benign glands present at inked excision margins (A1). - Involvement of seminal vesicle: None. - Perineural infiltration: Positive (A11). - Prostatic intraepithelial neoplasia (PIN): None. - Lymph node status: None present. - AJCC/UICC stage: pT2cNXMX. Specimen(s) Received. A:Prostate and seminal vesicle (fresh). Clinical History. The patient is a. man with prostate cancer, who undergoes robot-assisted laparoscopic. radical prostatectomy. Gross Description. The specimen is received fresh in one part, labeled with the patient's name, unit number and ""prostate. + seminal vesicles fresh,"" and consists of a 36 gm prostate gland with attached seminal vesicle/vas. deferens bundles. The gland measures 3.5 cm from medial-lateral, 3 cm from apex-base, and 3 cm. from anterior-posterior. The exterior of the gland is smooth with a staple line along the anterior. midline, with a red-tan exterior. The seminal vesicle/vas deferens bundles are soft and red-tan. The. left measures 3.5 x 1.5 x 1 cm and the right measures 2.5 x 2 x 1 cm. The right vas deferens measures. 2.5 x 0.5 cm and the left measures 4 x 0.5 cm. A firm mass is palpated along the right posterior. lateral. The right anterior surface of the gland is inked in green, the left anterior surface is inked in. blue, and the posterior surface is inked in black. The apical and bladder margins are removed, and the. remainder of the gland is serially sectioned from apex to base into six slices of 4 mm average thickness. The seminal vesicle/vas deferens bundles are attached to serial slice 6. The serial slices reveal a 0.5. cm area of firm yellow tissue on the right lateral of slice 2. No other lesions are grossly identified. Following further dissection and submission of tissue for possible research evaluation, representative. sections from slices 1-3 are taken for research purposes. The entire gland is submitted as follows: Apical margins. Cassette A1: Left. Cassette A2: Right. Serial slice 1. Cassette A3: Left. Cassette A4: Right. Serial slice 2. Cassette A5: Left. Cassette A6: Right. Left anterior quadrant. Cassette A7: Slice 3. Cassette A8: Slice 5. Left posterior quadrant. Cassette A9: Slice 3. Cassette A10: Slice 5. Right posterior quadrant. Cassette A11: Slice 3. Cassette A12: Slice 5. Right anterior quadrant. Cassette A13: Slice 3. Cassette A14: Slice 5. Bladder margins. Cassette A15: Left. Cassette A16: Right. Prostatic/Seminal vesicle junction. Cassette A17: Left. Cassette A18: Right. Serial slices 4 and 6 are submitted as whole-mount for research purposes. Diagnosis based on gross and microscopic examinations. Final diagnosis made by attending pathologist. following review of all pathology slides.",test,
599,TCGA-55-8091.33902b19-5be6-47ff-81a7-b945ae674a2f,"PROCEDURE DATE: RECEIVED DATE: REPORT DATE: 10 Consultation. FS DIAGNOSES 1 AND 2: ""Negative for neoplasm (reported to Dr. positive patient ID)"" by Dr. campus. Pre-Op Diagnosis. Lung cancer. Post-Op Diagnosis. Same as above. Clinical History. Nothing indicated. Gross Description: Six parts. Container labeled. R lymph node"" has 1.5 x. 1.5 x 0.4 cm of gray-tan to yellow fleshy and fibrofatty tissue. fragments which are submitted for frozen section and reported as. ""negative for neoplasm (reported to. positive patient. ID)"" by Dr. The frozen residue is submitted in a single. cassette. Container labeled. 1. L lymph node"" has a 0.6. x 0.4 x 0.2 cm irregular fragment of soft gray-tan to pink tissue. which is submitted for frozen section and reported as ""negative for. neoplasm (reported to. positive patient ID)"" by Dr. The frozen residue is submitted in a single cassette. Container labeled. - station 11 lymph node"". has a 2.2 x 1.2 x 0.8 cm lobulated fleshy red-brown to black nodule. with a mottled fleshy gray-black cut surface. The sectioned specimen. is entirely submitted in a single cassette. Container labeled. station 12 lymph node"". has a 1.0 x 0.7 x 0.6 cm fleshy tan-pink to brown-black nodule with. a mottled fleshy brown-black cut surface. The bisected nodule is. entirely submitted in a single cassette. Container labeled. right lower lobe"" has a. previously partially sectioned recognizable portion of pulmonary. parenchyma grossly consistent with right lower lobe of lung. The. specimen as received weighs 313 grams and measures 15.2 x 10.5 x 5.5. cm. The margin of resection is a stapled bifurcated tertiary. bronchus. The pleura is smooth and pink-red with moderate. anthracotic streaking. On the lower medial aspect the specimen is. sectioned to reveal a previously partially sectioned 2.0 x 2.0 x 1.6. cm subpleural nodular lesion with a gritty gray-tan fibrotic cut. surface. This grossly extends to but not through the pleural on the. medial aspect and is seen at its nearest point 1.1 cm from the basal. pleura. The lesion is seen at its nearest point 2.8 cm from the. bronchial margin. An apparent bronchial connection is identified. Noted on the lower outer aspect is a subpleural 0.8 x 0.7 x 0.6 cm. subpleural nodular lesion which has a fibrotic cut surface and areas. of calcification. The remaining parenchyma is spongy, slightly. edematous, and tan-pink without additional lesions. Also received in. the same container are three tissue cassettes each labeled. Representative sections are submitted labeled. as follows: A - shaved bronchial margin; B-E - remaining lesion and. surrounding tissue; F - lateral partially calcified nodule; G -. random uninvolved parenchyma. Container labeled. station 7 lymph node"" has. two irregular fragments of soft gray-pink tissue, 0.8 x 0.6 x 0.3 cm. each. Specimen entirely submitted in a single cassette. Microscopic Description: See diagnosis. Final Diagnosis. 4 R lymph node, biopsy with frozen section: Lymph node with anthracotic pigment, negative for neoplasm,. permanent sections confirm the. frozen section diagnosis. 4 L lymph node, biopsy with frozen section: Negative for neoplasm, permanent sections confirm the frozen. section diagnosis. Station 11 lymph node, biopsy: Negative for neoplasm, extensive anthracotic pigment and reactive. changes. Station 12 lymph node, biopsy: Negative for neoplasm. Lung, right lower lobe, lobectomy: Tumor characteristics: Histologic type: Adenocarcinoma, moderately differentiated. Tumor location: Subpleural right lower lung lobe. Tumor size: 2.0 x 2.0 x 1.6 cm. Tumor grade: Moderately differentiated. Pleural invasion: Yes (tumor appears to focally involve overlying. pleura in slide 5D). Lymphovascular space invasion: No. Surgical margin status: Tumor distance from bronchial margin: 2.8 cm. Tumor distance from stapled margin: Not applicable. Tumor distance from pleural surface: Less than 0.5 cm, focally. involving pleura. microscopically. Lymph node status: See specimens 1, 2, 3, 4 and 6. Station 7 lymph node: Negative for tumor. Stage: T2N0. Comments. This test has been finalized at the. Campus. Original report signed out by Dr. REVISION: This revision is made to add the staging to the Diagnosis Section. There is no change in the original diagnosis.",test,
668,TCGA-VD-A8K8.859216F2-7122-4F06-B65E-380D3F22F4ED,"printed. Clinical Consultant & Location. Forenan. Unit No. SPECIMEN. Enucleated left eye. CLINICAL DETAILS. Suspected choroidal melanoma. MACROSCOPIC DESCRIPTION. A left eye. Dimensions: Axial 24mm, Horizontal 23mm, Vertical 23mm. Cornea: Horizontal 12mm, Vertical 12mm. Description: clear. Optic nerve. Length 12mm, Diameter 4mm. Anterior chamber: normal depth. On rans-illumination, a shadow located superiorly measuring. 19 x 18mm. Plane of section: vertical. Intraocular description: On opening he eye a large pigmented choroidal melanoma. measuring 16mm LBD x 12mm in height. Tumour size. BD 16mm, Height 12mm. MICROSCOPY. Histologically, the enucleated eye demonstrates a normal. anterior segment with an unremarkable cornea, a deep. anterior chamber and open angles. The iris leaves are. unremarkable. The ciliary muscles are moderately atrophic. and there is moderate hyalinisation of the ciliary. processes. The lens shows advanced cataractous changes. In the posterior third of the posterior segment, a choroidal. printed: HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. melanoma can be seen. This is dome-shaped with a large. accompanying exudative retinal detachment. The retina. overlying the tumour is atrophic with degenerative changes. The tumour is pigmented and consists of a mixture of cells,. both epithelioid and spindle cells, with a dominance of the. latter. The epithelioid cell component represents 15% of the. tumour cell population. The melanoma cells are immunoreactive. for MelanA and HSP-27 (score 2). The number of mitoses is high approx. 12/40 high power. fields. The microvasculature of the melanoma is prominent, and. closed loops are focally present. Occasional ""vascular. lakes"" can be observed; in these tumour cells can be see. located within the lumen. The lymphocytic infiltrate within tumour is minimal. Macrophages are scattered throughout the tumour in a. moderately density There is no evidence of scleral invasion. or of extraocular growth. The optic nerve is tumour free,. and demonstrates mild atrophic changes. The examined vortex. veins are free of tumour. DIAGNOSI9. Choroid melanoma of mixed cell type. COMMENT. SPECIMEN. 2= Eye. TUMOUR PRESENT. TUMOUR TYPE. 1= Melanoma. CELL TYPE. 3= Mixed. CT LOOPS. 2= Closed loops. NECROSIS. printed: HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. PIGMENTATION. LYMPHOCYTIC INFILTRATION. MITOTIC FREQUENCY. 12 /40 HPF. DIFFUSE MELANOMA. SPREAD. 1= No. CLEARANCE. 2= Adequate. HSP-27 POSITIVITY. 2= 21 -70%. LARGE DIAMETER. 16 mm. THICKNESS. 12 mm. COMMENTS: Molecular genetic examination of DNA extracted from the. tumour cells will be performed using multiplex-ligation. dependent probe amplification (MLPA), looking at chromosomes. 1, 3, 6 and 8. A supplementary report will follow as soon as. these investigations are complete. SUPPLEMENTARY REPORT. In the meantime, molecular genetic analysis of tumour DNA. extracted from the fresh uveal melanoma tissue was performed. using the technique termed multiplex ligation-dependent. probe amplification (MLPA) These investigations were. performed in the. The kit P027 from. which examines for gains or. losses in 31 loci on chromosomes 1, 3, 6 and 8, was used. The DNA concentration was measured using. and the. quality assessed using multiplex-PCR prior to the MLPA. reaction. The DNA concentration was high and of good quality on. assessment. The MLPA reaction was run at least twice on. differing occasions, resulting in similar results. The results of the sequence analysis of the MLPA products is. printed on a separate report. printed: HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. In summary, sequence analysis demonstrated: normal. chromosome 1, monosomy 3, normal chromosome 6 and gains in. chromosome 8. These molecular data require correlation with the clinical. and morphological data for metastatic risk assessment.",test,
850,TCGA-BH-A0DO.C75872B6-2260-41C3-9E21-91E4F52AD7EA,"From. To. P.8/33. RIGHT AXILLA, SENTINEL #1, SENTINEL NODG BIOPSY -. AVILLARY LYMPH NODE. NEGATIVE FOR METASTATIC TUMOR (0/1). FART 2: LYMPH NODE. LEFT AXILLA, SENTINEL #1, SENTINEL NODE BIOPSY -. ONE AXILLARY LYMPH NODE, NEGATIVE FOR METASTATIC TUMOR (0/1). PART 3: LYMPH NODE, LEFT AXILLA, SENTINEL #2, SENTINEL NODE BIOPSY -. ONE AXILLARY LYMPH NODE. NEGATIVE FOR METASTATIC TUMOR (0/1). PART 4: BREAST, LEET, SIMPLE MASTECTOMY. A. INVASIVE DUCTAL CARCINOMA NO SPECIAL TYPE. B. NOTTINGHAM GRADE 3 (TUBULETORMATION: 3, NUCLEAR PLEOMORPHI8M: 3, MITOTIC ACTIVITY: 2; TOTAL. SCORE - a/9). c. THE INVASIVE TUMOR MEASURES APPROXIMATELY 2.0 CM IN LARGEST DIMENSION (FIVE CONTIGUOUS. SECTIONS). D. THE INVASIVE CARCINOMA 18 LOCATED AT THE JUNCTION OF UPPER INNER AND LOWER INNFR. QUADRANTS. E. LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. F. RESECTION MARGINS ARE NEGATIVE FOR CARCINOMA. G. THE NIPPLE 18 NEGATIVE FOR TUMOR. H. THE SKIN IS NEGATIVE FOR TUMOR. I. CALCIFICATIONS ARE ASSOCIATED WITH INVASIVE CARCINOMA AND BENIGN BREAST PARENCHYMA. J. ATYPICAL DUCTAL HYPERPLASIA. K INTRADUCTAL PAPILLOMA. L. THE NON-NEOPLASTIC BREAST SMOWS DUCTAL EFITHELIAL HYPERPLASIA, ADENOSIS AND FIBROCYSTIC. CHANGES. M. PREVIOUS BIOPSY SITE CHANGES. N. THE INVASIVE TUMOR CELLS ARE POSITIVE FOR ESTROGEN AND PROGESTERONE RECEPTORS AND. NEGATIVE FOR HER-2, AS PER PREVIOUS PATHOLOGY REPORT "". PART 5; BREAST, RIGHL SIMPLI MASTECTOMY -. A. INVASIVE DUCTAL CARCINONA NO SPECIAL TYPE. B. NOT TINGRAM GRADE 2 (TUBULE FORMATION: 2. NUCLEAR PLEOMORPHISM: 2. MITOTIC ACTIVITY: 2; TOTAL. SCORE - 8/9). C. THE INVASIVE TUMOR MFASUBEE. D. E. THE DCIS CONSTITUTES -10% OF THE TOTAL TUMOR MASS AND IS PRESENT ADMIXED WITH THE INVASIVE. DUCTAL CARCINOMA IN SITU (DCIS). CRIBRIFORM AND SOLID TYPES WITH MINIMAL NECROSIS. COMPONENT. F. LYMPHOVASCULAR SPACE INVASIN IS IDENTIFIED. G. RESECTION MARGINA ARE NEGATIVE FOR CARCINOMA. H. THE INVASIVE CARCINOMA IS LOCATED AT THE UPPER OUTER QUADRANT. I. THE NIPPLE IS NEGATIVE FOR TUMOR. J. THE SKIN IS NEGATIVE FOR TUMOR. K. ATYPICAL. DUCTAL HYPERPLASIA. L. THE NON-NEOPLASTIC BREAST SHOWS FIBROCYSTIC CHANGES WITH ASSOCIATED. MICROCALCIFICATIONS. M. PREVIOUS BIOPSY SITE CHANGES. N. THE INVASIVE TUMOR CELLS ARE POSITIVE FOR ESTROGEN AND PROGESTERONE RECEPTORS AND. NEGATIVE FOR HER-2, AS PER PREVIOUS PATHOLOGY REPORT. CASE SYNOPSIS: SYNOPTIC -PRIMARY INVASIVE CARCINOMA OF BREAST. LATERAI.ITY: I on. PROCEDURE. Simple mastectoniy. Upper inner quadrant. Lower inner quadrent. SIZE OF TUMOR: Maximum dimension invasive component: 2.0 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal sdenocarcinonia, NOS. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation 3. Mitolic activity score. 2. Total Nottingham scure: 8. Nultingham grade (1. 2. 3). 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: Ycs. benign zonas. Yes. malignant zones. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: LYMPM NODES POSITIVE: o. I. YMPH NODES EXAMINED: 2. METHOD(S) OF LYMPN NODE EXAMINATION: HIVE stoin. SKIN INVOLVED (ULCERATION): NON-NEOPLASTIC BREAST TISSUE: ADH, Papilloma, rco. 1 STAGE, PATHOLOGIC: pTic. N STAGE, PATHOLOGIC: M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: zoro or 1+.",test,
948,TCGA-BP-4327.5e65ef69-17b3-4144-a651-6cf1b511ed4f,"& History: ith right renal tumor. Specimens Submitted: 1: SP: Right kidney. 2: SP: Paracaval lymph nodes. DIAGNOSIS: 1). KIDNEY, RIGHT; RADICAL NEPHRECTOMY: - RENAL CELL CARCINOMA, CLEAR CELL TYPE, NUCLEAR GRADE. II/IV. - THE PATTERN OF GROWTH IS ACINAR. - THE TUMOR'S GREATEST DIAMETER IS 7.5 CM. - THE TUMOR IS CONFINED WITHIN THE RENAL CAPSULE. - NO INVASION OF THE RENAL VEIN IS IDENTIFIED. - ALI, SURGICAL MARGINS ARE FREE OF TUMOR. - THE NON-NEOPLASTIC KIDNEY IS UNREMARKABLE. - THE ADRENAL GLAND IS NOT IDENTIFIED. 2). LYMPH NODES, PARACAVAL; DISSECTION: - SIX BENIGN LYMPH NODES (0/6). Gross Description: 1) The specimen is received fresh, labeled ""Right Kidney"". It. consists of a kidney and perirenal fat measuring 15 x 10 x 7 em. and weighing 400 grams overall. A portion of unremarkable ureter. measures 8 x 0. x 0.3 cm. A portion of unremarkable renal vein. measures 1 em in length and 1 cm in diameter. Adrenal gland is. not identified. The specimen is bivalved showing partly yellow. and partly light tan to brown, focally hemorrhagic and necrotic. tumor measuring 7.5 x 5.5 x 4 cm. The tumor is cortical in. location and has irregular borders with lobulated appearance. The Gerota's fascia around the tumor is inked black. The tumor. protrudes the renal capsule. It is confined within the Gerota's. fascia. The distance from the tumor to the nearest Gerota's. fascia is 0.2 cm and to the renal pelvis 0.3 cm. The renal vein. in uninvolved. The specimen is photographed. Representative. sections are submitted. Fresh tissue is saved for TPS and EM. Summary of Sections: UM - ureteral margin. RVM - renal vein margin. TRC - tumor renal capsule. TP - tumor renal pelvis. TG. - tumor Gerota's fascia. TN. - tumor normal kidney. N. - normal kidney. - additional tumor. 2) The specimen is received in formalin, labeled ""Paracaval. Lymph Nodes"" It consists of two pieces of fibroadipose tissue. measuring 1.5 x 1 x 1 cm and 3 x 2 x 1 cm. Few lymph nodes are. identified that range in size from 0.3 to 0.4 em in largest. dimension. Lymph nodes are submitted in toto. Summary of Sections. LNS - lymph nodes. Summary of Sections : Part. Sect. SiteBlocks Pieces All. N. 1. 2. RVM. 1. 1. 6. 6. TG. 2. 2. TN. 1. TP. 1. 2. TRC. 2. 2. UM. 1. 2. LNS. 1. M. N.",test,
981,TCGA-DQ-7591.0ccae762-78d9-4273-9d99-f431085f22dd,"SP FINAL REPORT Source: HISTORY: History of left neck mass, which on CT showed a mass at the left base of. tongue with left neck adenopathy. Stain for p-16, EGFR and HPV. GROSS: 1. ""Left base of tongue' Received in formalin in a small container is a 0.6 x. 0.7 cm irregular portions of pink-tan soft tissue. MICROSCOPIC DIAGNOSIS: 1. Left base of tongue, biopsy: Invasive, poorly-differentiated,. nonkeratinizing squamous cell carcinoma. See COMMENT. COMMENT. The tumor is diffusely and strongly positive for P16 and EGFR. In situ. hybridization for high-risk HPV is positive. and. I. the signing staff pathologist, have personally. examined and interpreted_ the slides from this case,. This test was develoned and its nerformance charateriszie determined by the. It has not been. cleared or approved by the U.S. FOOD and Drug (The FDA has. determined that such clearance is not necessary. This test is used for. clinical purposes. It should not be regarded as investigational or for. research This laboratory is certified under the Clinical Laboratory. Improvement Amendments of. (CLIA'] as qualified to perform high. complexity testing) -. M. Glose.",test,
1162,TCGA-PK-A5HA.B98EC873-CB6D-4395-A473-C46EC4D2DB00,"LABORATORY MEDICINE PROGKAM. M. Facility: Specimen(s) Received. 1. Adrenal: resection adrenal mass left. 2. Fat. Diagnosis. 1. Adrenal cortical carcinoma: Adrenal. No pathological diagnosis: Lymph node, periadrenal. - (left) adrenalectomy specimen. 2. No pathological diagnosis: Adipose tissue, (site not listed) excisional biopsy. Comment. The morphological and immunohistochemical features are consistent with an adrenocortical carcinoma. Synoptic Data. Neoadjuvant Therapy: Clinical History: Other: left side pain. Tumor Site: Adrenal structure. Adrenal Gland Received: Fresh. Procedure: Adrenalectomy, total. Specimen Integrity: Intact. Specimen Size: Greatest dimension: 7.0 cm. Additional dimension: 6.0 cm. Additional dimension: 5.0 cm. Specimen Laterality: Left. Tumor Size: Greatest dimension: 5.0 cm. Additional dimension: 4.4 cm. Additional dimension: 4.0 cm. Tumor gland weight: 47.3 g. Histologic Type: Adrenal cortical carcinoma. Margins: Margins uninvolved by tumor. Treatment Effect: Not identified. Lymph-Vascular Invasion: Present, small vessel (capillary lymphatic). Perineural Invasion: Not identified. Ancillary Studies: Types: IHC. Results: The tumor is strongly positive for calretinin, synaptophysin and Melan A. (A103). There is variable positivity for LMWK (CAM 5.2), inhibin, CD10. (cytoplasmic) and p53. Stains for EMA, S100, and chromogranin are negative. MIB-1 LI is 20%. TNM Descriptors: Not applicable. Primary Tumor (pT): pT1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion. Regional Lymph Nodes (pN): pNO: No regional lymph node metastasis. Number of Nodes examined: 1. Number of Nodes involved: 0. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: Tumor necrosis. Degenerative changes, Hemorrhage. Pathologic Staging is based on AJCC/UICC TNM, 7th Edition. Clinical History. Left adrenal adenoma. Gross Description. 1. The specimen labeled with the patient's name and as ""resection adrenal gland mass left"" contains an adrenal gland. with surrounding fibroadipose tissue. The specimen measures 7.0 x 6 .0 x 5.0 cm and weighs 70.2 g. The surface is. painted with silver nitrate and the fat is removed. The adrenal gland measures 5.2 x 4.0 x 5.0 cm and weighs 47.3g. On. section, there is a well-circumscribed multilobulated mass that measures 4.4 x 4.0 x 5.0 cm. The cut surface of the tumor. has a variegated light brown to tan color, solid and firm. The rest of the adrenal tissue is unremarkable grossly. The tumor. and normal tissue are stored frozen. The adrenal tissue is submitted as follows: 1A-AG adrenal gland serially sectioned and submitted in toto. 2. The. specimen labeled with the patient's name and as ""fat"" contains a single piece of a grossly unremarkable. fibroadipose tissue that measures 5.5 x 2.2 x 1.7 cm. 2A. representative sections. ;ription. Fuhrman Nuclear Grade: IV. Necrosis: Present, predominantly single cell necrosis. Mitotic activity: >5 mitoses /50 high power fields. Atypical mitosis: Present. Growth pattern: Solid and diffuse. Cell type: Eosinophilic, > %90. Lymphovascular invasion: Present, sinusoidal type. Capsule invasion: Present, focal. Immunohistochemistry: The tumor is strongly positive for calretinin, synaptophysin and Melan A (A103). There is variable. positivity for LMWK (CAM 5.2), inhibin, CD10 (cytoplasmic) and p53. Stains for EMA, S100, and chromogranin are. negative. MIB-1 LI is 20%.",test,
1167,TCGA-EL-A3ZT.F19BB96F-31BF-466F-B1FB-0CBB1EE89A88,"Case type: Surgical Case. DIAGNOSIS. (A). LEFT THYROID LOBE AND ISTHMUS: PAPILLARY THYROID CARCINOMA, CONVENTIONAL TYPE. Location: Left lobe. Multi-focal: No. Size = 2.5 cm. Extrathyroidal extension: Present, extending into fibroadipose tissue. Lymphovascular invasion: Present. Resection Margins: Negative. Background Thyroid: Multinodular adenomatous goiter. Lymph nodes: No lymph nodes present. (B) COMPLETION, RIGHT THYROID LOBE: Multinodular adenomatous goiter, no tumor present. GROSS DESCRIPTION. (A). LEFT THYROID LOBE AND ISTHMUS - A thyroid lobectomy of left lobe (3.5 x 2.0 x 2.0 cm) is nearly entirely replaced by. a soft pink papillary tumor with hyalinized fibrosis surrounding the nodule (2.5 x 1.5 x 0.9 cm) shows an irregular border. outside of the area of fibrosis, but is confined to the thyroid. A portion of skeletal muscle is also present with the specimen. SECTION CODE: A1, representative section for frozen assessment with touch prep; A2-A8, serial sections of the left. lobe and full examination of the interface of nodule with surrounding soft tissue. FS/DX: PAPILLARY THYROID CARCINOMA. (B). COMPLETION, RIGHT THYROID LOBE - A right thyroid lobe measuring 4.4 x 3.0 x 1.0 cm. Serial sectioning revealed. beefy red spongy parenchyma with no grossly identifiable lesion. Representative sections from superior to inferior submitted. in B1-B4. CLINICAL HISTORY. Nodule, left thyroid. SNOMED CODES. T-B6000, M-Y3420, T-B6000, M-80503, M-Y3420,. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been specifically cleared or approved by the U.S. Food and Drug Administration."". Case type: Surgical Case. Entire report and diagnosis completed by:",test,
1207,TCGA-EM-A22L.D48FB953-758B-4515-B244-09DCACD29441,"8340/ 3. F. Facility: Specimen(s) Received. 1. Thyroid: right subtotal hemithyroid stitch upper pole. Diagnosis. Multifocal papillary carcinoma, dominant follicular variant, 2.2 cm: Thyroid. No pathological diagnosis: Lymph node, isthmic. - Right hemithyroidectomy specimen. Synoptic Data. Procedure: Right hemithyroidectomy. Fresh. Specimen Integrity: Intact. Specimen Size: Right lobe: 3.9 cm. 2.3 cm. 1.6 cm. Isthmus +/- pyramidal lobe: 1.7 cm. 1.6 cm. 0.7 cm. Specimen Weight: 8.7 g. Tumor Focality: Multifocal, ipsilateral. DOMINANT TUMOR. Tumor Laterality: Right lobe. Tumor Size: Greatest dimension: 2.2cm. Additional dimension: 2.1 cm. Additional dimension: 1.5 cm. Histologic Type: Papillary carcinoma, follicular variant pn TSS, follocular varient = 100%. Papillary carcinoma, macrofollicular variant. Follicular architecture. Macrofollicular architecture. Classical cytomorphology. Histologic Grade: Not applicable. Margins uninvolved by carcinoma. Margins: Tumor Capsule: Partially encapsulated. Tumor Capsular Invasion: Present, extent minimal. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Not identified. Extrathyroidal Extension: Not identified. SECOND TUMOR. Tumor Laterality: Right lobe. Tumor Size: Greatest dimension: 0.1cm. Histologic Type: Papillary carcinoma, follicular variant. Papillary carcinoma, microcarcinoma (occult, small or microscopic). variant. Follicular architecture. Classical cytomorphology. Histologic Grade: Not applicable. Margins: Margins uninvolved by carcinoma. Tumor Capsule: None. Tumor Capsular Invasion: Not identified. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Not identified. Extrathyroidal Extension: Not identified. TNM Descriptors: m (multiple primary tumors). Primary Tumor (pT): pT2: Tumor more than 2 cm, but not more than 4 cm, limited to. thyroid. Regional Lymph Nodes (pN): pNO: No regional lymph node metastasis. Number of regional lymph nodes examined: 1. Number of regional lymph nodes involved: 0. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: None Identified. Pathologic Staging is based on AJCC/UICC TNM, 7th Edition. Comment. The dominant nodule exhibits multifocal transformation to papillary carcinoma and the extent of. malignancy warrants classification of the entire nodule as papillary carcinoma. There is also a 0.1cm. follicular variant papillary microcarcinoma in the right lobe. The overall morphological features are those. of a low risk papillary carcinoma. Gross Description. The specimen labeled with the patient's name and as ""right subtotal thyroid stitch upper pole"", consists of. a right hemithyroidectomy specimen that weighs 8.7 g. The lobe measures 3.9 cm SI x2.3 cm ML x 1.6. cm AP and the isthmus measures 1.7 SI x 1.6cm ML x 0.7cm AP. No parathyroid gland or lymph nodes. are identified grossly. The mid superior lobe contains one well delineated nodule that measures 2.1 cm SI. X 2.2cm ML x 1.5 cm AP. The cut surface of the nodule has a variegated red-tan color, and has a soft and. flabby consistency. Sections of nodule and normal tissue are stored frozen. The remainder of the. specimen is submitted as follows: 1A-F. lobe, superior to inferior. 1G. isthmus.",test,
1221,TCGA-P5-A72Z.99B1BF7C-E68F-4546-B13B-BF603738796C,"Clinical diagnosis: Brain tumor. Gross description: The material presented by soft gray-whitish pieces from right temporal lobe. Microscopic description: Received material is represented by brain tissue consistent with anaplastic. oligodendroglioma, Ki 67 up to 15%. Final diagnosis: Anaplastic oligodendroglioma: Grade III. Confidential.",test,
1260,TCGA-22-5480.62c5d0aa-1dbd-456a-b16f-cb233be02a88,"DIAGNOSIS: Lung, left upper lobe, lobectomy Grade 4 (of 4) squamous cell carcinoma forming a 2.0 x 2.0 x. 1.5 cm mass located 1.8 cm away from the bronchial margin, which is negative for tumor. histologically, as are multiple (10) intrapulmonary peribronchial lymph nodes and the visceral. pleura. Soft tissue, left hilar region, excision: Grade 4 (of 4) non-small cell carcinoma with. squamous features. Lung, left lower lobe, excision: Intraparenchymal lymph node, negative for neoplasm, but non-. necrotizing granulomatous inflammation is present. The findings of special. stains. for. microorganisms (AR,GMS) will be reported separately in an addendum. Lymph nodes, superior mediastinal, aortic, inferior mediastinal, left lower lobe bronchus,. excision: Multiple superior mediastinal (9 tracheobronchial), aortic (4 aortopulmonary, 3. anterior mediastinal), inferior mediastinal (5 subcarinal, 4 inferior pulmonary ligament). and. (2) left lower lobe bronchus lymph nodes are negative for tumor.",test,
1406,TCGA-BR-4188.03108a9a-1f00-48a4-86ab-81045eb07340,STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor Site: Cardia. Tumor configuration: Ulcerating. Tumor size: 8 X 5 X 1. cm. Histologic type: Signet ring cell carcinoma. Histologic grade: Poorly differentiated. Extent of invasion: Not specified. Lymph. nodes: 2 of 8 positive for metastasis. Margins - Proximal margin: Not specified. Distal margin: Not specified. Omental (radial) margin: Not. specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Additional pathologic. findings: Not specified. Comments: None.,test,
1459,TCGA-R6-A8WG.CAD1CB99-68A3-4BB4-8584-17866244FDE0,"MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A) STOMACH, ""POLYP"" AT HIATAL HERNIA, BIOPSY: Oxyntic/fundic mucosa with chronic inactive gastritis and muscularis mucosae hyperplasia. No tumor, intestinal metaplasia or Helicobacter pylori identified. Deeper levels are examined. (B) ESOPHAGUS, DISTAL, TUMOR, BIOPSY: ULCERATED INVASIVE POORLY DIFFERENTIATED ADENOCARCINOMA UNDERLYING SQUAMOUS MUCOSA. WITH REACTIVE EPITHELIAL CHANGES. COMMENT. Immunohistochemistry performed and reviewed at. shows the neoplastic cells are negative for chromogranin and. synaptophysin. GROSS DESCRIPTION. (A). POLYP. AT HIATAL HERNIA - Multiple light gray and pink fragments of soft tissue (0.7 X 0.3 x 0.3 cm in aggregate). Entirely. submitted in A1. (B). DISTAL ESOPHAGEAL TUMOR - Multiple light gray and pink fragments of soft tissue (1.0 x 0.4 X 0.3 cm in aggregate). Entirely submitted in B1. BIOMARKER TESTING. PRIMARY TUMOR: Block B1. NORMAL: Block A1. CLINICAL HISTORY. Esophageal cancer. SNOMED CODES. ""Some tests reported here may have been developed and performance characteristics determined by. . These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by: Start of ADDENDUM. Page: 2. ADDENDUM. This modified report is being issued to report special studies/IHC/Molecular studies. Addendum completed by. COMMENT. An immunohistochemical stain for Her2-neu. was performed in our lab on a representative. formalin-fixed paraffin-embedded section of distal esophageal adenocarcinoma, Block: B1. Staining. Score. Interpretation. No membranous staining of the invasive tumor cells. 0. Negative. FOOTNOTE: For Her 2: Positive cases are defined as those with strong complete, basolateral, or lateral membranous reactivity in >/= 10% of invasive tumor cells in. resection. specimen or strong complete, basolateral, or lateral membranous reactivity in any invasive tumor cells in biopsy specimen (Score 3+). Negative cases are defined. as. those. with. no staining (Score 0) or faint or barely perceptible membranous staining (Score 1+) of the invasive tumor cells. Equivocal cases are defined as. those with weak to moderate complete, basolateral or lateral membranous reactivity in >/= 10% of invasive tumor cells in resection specimen or weak to moderate. complete, basolateral or lateral membranous reactivity in any invasive tumor cells in biopsy specimen (Score 2+). Reference. Hofmann M, Stoss O, Shi D et al. Assessment of a HER2 scoring system for gastric cancer: results from a validation Study. Histopathology. 2008;52(7):797-805. Entire report and diagnosis completed by: END OF REPORT-.",test,
1583,TCGA-12-3649.65889743-1e73-4812-9909-0711a1b68c2e,"AP Surgical Pathology: Additional Info. CLINICAL HISTORY. Brain tumor. GROSS EXAMINATION: A. ""Brain tissue (AF1) "", received fresh for frozen section is a 2.5 x 1.5 x. 1.2 cm fragment of pink-tan soft tissue. The representative section has been. frozen as AF1 and the frozen section remnant is submitted in block A1. Additional representative sections are submitted in blocks A2, with the. remainder retained in formalin. B. ""Brain tissue"", received fresh and placed in formalin is a 3.7 x 3 X 2 cm. aggregate of pink-tan soft tissue. Sectioning demonstrates a white-pink cut. surface with focal areas of hemorrhage. Representative cross sections are. submitted in blocks B1-3, with the remainder retained in formalin. C. ""Brain tissue"", received fresh and placed in formalin is a 1 x 0.7 x 0.6 cm. aggregate of pink-tan tissue. Representative section is submitted in block. C1, with the remainder retained in formalin. INTRA OPERATIVE CONSULTATION: A. ""Brain tissue"" AF1- glioma, high grade. MICROSCOPIC EXAMINATION: Microscopic examination shows brain infiltrated by a malignant astrocytic. neoplasm characterized by cytologic pleomorphism, mitotic figures,. microvascular changes and pseudopalisading necrosis. On block B3,. subarachnoid infiltration is evident. DIAGNOSIS: A. ""BRAIN TISSUE"" (CRANIOTOMY) : GLIOBLASTOMA (WHO GRADE IV) . B. ""BRAIN TISSUE"" (CRANIOTOMY) : GLIOBLASTOMA (WHO GRADE IV) . C. ""BRAIN TISSUE"" (CRANIOTOMY) : GLIOBLASTOMA (WHO GRADE IV). SUBARACHNOID INFILTRATION EVIDENT. COMMENT: NEUROPATHOLOGIST OF. AND THE ORIGINAL NEUROPATHOLOGIST OF THE FIRST BIOPSY, HAS REVIEWED. THE SLIDES AND CONCURS WITH THE DIAGNOSES RENDERED. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). ADDENDUM 1: Please see Image Cytometry Report. for results of supplementary. 1 of 3. tests. FISH INTERPRETATION SUMMARY: CHROMOSOME 7 CENTROMERE - POLYSOMY (76% OF TUMOR CELLS EXHIBIT POLYSOMY). EGFR - AMPLIFICATION (96% OF TUMOR CELLS EXHIBIT AMPLIFICATION). CHROMOSOME 10 CENTROMERE - CENTROMERE LOSS (36% OF TUMOR CELLS EXHIBIT LOSS). PTEN - ALLELIC LOSS (60% OF TUMOR CELLS EXHIBIT LOSS). 1p36 - INACT (NO LOSS). 1p32 - INTACT (NO LOSS). 19q13 - POLYSOMY (68% OF TUMOR CELLS EXHIBIT A RATIO FOR 19q13/19p13 OF LESS. THAN 1.0). 9p21 - LOSS (58% OF TUMOR CELLS EXHIBIT LOSS). CHROMOSOME 9 CENTROMERE - POLYSOMY (56% OF TUMOR CELLS EXHIBIT POLYSOMY). FOR THE ASTROCYTIC MARKERS, 4 OF 4 MARKERS ARE ABNORMAL AND 9p21 EXHIBITS. LOSS. FOR THE OLIGODENDROGLIAL MARKERS, ALL LOCI ARE INTACT. COMMENT: A MULTIVARIATE SURVIVAL ANALYSIS OF. PATIENTS WITH GLIOBLASTOMAS. REVEALS THAT THE HAZARD OF SHORT SURVIVAL AMONG PATIENTS WITH 0-2 ABNORMAL. MARKERS (OUT OF 4) WAS SIGNIFICANTLY LOWER THAN THAT FOUND WITH PATIENTS WITH. 4 ABNORMAL MARKERS EVEN AFTER ADJUSTMENT FOR AGE EFFECT. BOTH FISH AND IMMUNOHISTOCHEMISTRY FOR PTEN REVEAL SIMILAR FINDINGS INDICATIVE. OF LOSS OF PTEN STATUS. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis(es). ADDENDUM 2: IMMUNOHISTOCHEMICAL LABELING INDEX OF TUMOR CELLS: TISSUE TYPE: BRAIN TISSUE CONTAINING GLIOBLASTOMA (WHO GRADE IV;. VEGF IMMUNOHISTOCHEMISTRY : NEGATIVE (2 X 5% = score 10). PDGFR-A IMMUNOHISTOCHEMISTRY: FOCAL (30%) FOR CYTOPLASMIC AND/OR MEMBRANE. REACTIVITY. PDGFR-B IMMUNOHISTOCHEMISTRY: FOCAL (30%) OR NEGATIVE FOR CYTOPLASMIC AND/OR. MEMBRANE REACTIVITY. LEUCOCYTE COMMON ANTIGEN (LCA) : 25% OF POSITIVE CELLS. PROLIFERATION INDEX INTERPRETATION: HIGH PROLIFERATION INDEX (20% OF TUMOR. CELLS EXHIBIT STAINING) . MGMT - NEGATIVE (10% OF TUMOR CELLS). EGFR wt - POSITIVE (3+ IN 90% OF TUMOR CELLS). 2 of 3. EGFR VIII - NEGATIVE (0% OF TUMOR CELLS). PTEN - LOSS (2+ IN 60% OF TUMOR CELLS). S6 - POSITIVE (2+ IN 30% OF TUMOR CELLS). AKT - NEGATIVE (2+ IN 10% OF TUMOR CELLS). MAPK - POSITIVE (3+ IN 20% OF TUMOR CELLS). Please see. for results of supplementary. tests. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). ADDENDUM 3: HAM 56 staining reveals a focally dense macrophage population consisting of. approximately 25% of cells in regions about areas of necrosis. Remaining. areas are largely negative for macrophages. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). ADDENDUM 5: Please see Image Cytometry Report. for results of supplementary. tests. FISH INTERPRETATION SUMMARY: CKIT - POLYSOMY (89% OF TUMOR CELLS EXHIBIT POLYSOMY). I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). CI ADDENDUM 1: Please see Image Cytometry Report. for results of supplementary. tests. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es) . 3 of 3.",test,
1787,TCGA-IG-A3YA.41B0A7CF-11BD-477C-8315-49985775951B,Path Report:ESOPHAGUS TISSUE CHECKLIST. Specimen type: Excision of tumor. Tumor site: Esophagus. Tumor size: 3 X 3 x 1.2 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Adventitia. Lymph nodes: 0/4 positive for metastasis (Regional 0/4). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.,test,
1812,TCGA-CH-5762.21608393-74f2-4a7b-aaf4-9b02cb7afc94,"Diagnosis. 1. Predominantly poorly differentiated adenocarcinoma of the prostate in the peripheral zone on. both sides with perineural infiltration and invasion of the lymph vessels. Maximum tumor. diameter 2 cm. Right lateral infiltration of the periprostatic fatty connective tissue. Focal. infiltration of the right seminal vesicle. In the apex region on both sides widespread contact with. the color-labeled preparation margin (contact area measuring max. 8 mm). 2. Fatty tissue with 4 tumor-free lymph nodes. 3. Fatty tissue with 3 tumor-free lymph nodes. Summary tumor classification: pT3b, L1, V0, R1; pN0 (0/7); Gleason 4+3 = 7 (Gleason 4: approx. 70%).",test,
1840,TCGA-F5-6814.51379639-fd60-4561-91c8-76941068c36c,Subject. LARGE INTESTINE TISSUE. CHECKLIST. Specimen type: Resection of. rectum. Specimen size: Not specified. Tumor site: Rectum. Tumor size: 15 X 7.5 X 10 cm. Tumor features: None specified. Histologic type: Adenocarcinoma. Histologic grade: Moderately. differentiated. Tumor extent: Pericolonic tissues. Lymph nodes: Not specified. Margins: Not specified. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic findings: Not. specified. Comments: None.,test,
1874,TCGA-EJ-5521.0c816088-3fe4-4646-abaa-94095efd0b26,"PATIENT HISTORY: `The patient is a. vith a history of PSA value of 7.3 which increased from 6.31. The patient also has a. history of. which reveals a Gleason Grade of 3+3=6 on the right lobe. Patient has a past medical. history of dental. PRE-OP DIAGNOSIS: Prostate cancer. POST-OP DIAGNOSIS: Same. PROCEDURE: Radical prostatectomy. FINAL DIAGNOSIS: PART 1: RIGHT PELVIC LYMPH NODES, EXCISION -. ONE BENIGN LYMPH NODE. PART 2: LYMPH NODE, LEFT PELVIS, EXCISION -. ONE BENIGN LYMPH NODE. PART 3: PROSTATE AND BILATERAL SEMINAL VESICLES, RADICAL PROSTATECTOMY -. A. INVASIVE POORLY DIFFERENTIATED ADENOCARCINOMA, GLEASON SCORE 3 + 4 = 7 WITH A DISTINCT. FOAMY MORPHOLOGY. B. THE CARCINOMA INVOLVES PREDOMINANTLY THE RIGHT LOBE AND HAS A GREATEST NODULAR. DIAMETER OF 1.8 CM. C. THE CARCINOMA INVOLVES 15% OF THE EXAMINED PROSTATE VOLUME. D. EXTRACAPSULAR PROSTATIC EXTENSION IS PRESENT IN THE REGIONS OF ANTERIOR RIGHT BASE (SLIDE. 3Q) AND POSTERIOR RIGHT BASE (SLIDE 3Z). E. ALL EXAMINED SURGICAL RESECTION MARGINS ARE FREE OF CARCINOMA. F. EXTENSIVE PERINEURAL INVASION IS SEEN. G. MULTIFOCAL HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN) IS IDENTIFIED. H. BILATERAL SEMINAL VESICLES ARE NOT INVOLVED BY TUMOR. I. NO ANGIOLYMPHATIC INVASION IS IDENTIFIED. J. PATHOLOGIC TNM STAGE: pT3a NO MX. K. TNM HISTOLOGIC GRADE = G3. L. BENIGN PROSTATIC HYPERTROPHY AND CHRONIC MODERATELY ACTIVE PROSTATITIS ARE NOTED. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY PROSTATE TUMORS. CLINICAL DATA: PSA value: 7.3. INVASIVE CA IDENTIFIED?. TUMOR HISTOLOGY: Adenocarcinoma NOS. PRIMARY GLEASON GRADE: 3. SECONDARY GLEASON GRADE: 4. GLEASON SUM SCORE: 7. GLEASON 4/5 PERCENTAGE: 20%. WEIGHT OF PROSTATE: 53.47gm. TUMOR SIZE: Maximum dimension: 1.8 cm. LOBE LATERALITY: Right Lobe. PERCENT OF SPECIMEN INVOLVED BY TUMOR: 5 25%. MULTIFOCAL DISEASE: HIGH GRADE PIN: Yes NOS. EXTRAPROSTATIC EXTENSION: Yes - Established (> 0.8mm). PERINEURAL INVASION: ANGIOLYMPHATIC INVASION: SEMINAL VESICLE INVASION: SURGICAL MARGIN INVOLVEMENT: All surgical margins free of tumor. LYMPH NODES EXAMINED: 2. LYMPH NODES POSITIVE: 0. T STAGE, PATHOLOGIC: pT3a. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. HISTOLOGIC GRADE: G3-4, Poorly differentiated/undifferentiated.",test,
1939,TCGA-19-1789.6a04f636-6851-43f5-974d-97c318e73c3a,"FINAL DIAGNOSIS. A. RIGHT OCCIPITAL NEOPLASM, BIOPSY: -- INFILTRATING GLIOMA. B. RIGHT OCCIPITAL NEOPLASM, BIOPSY NUMBER TWO: -- MALIGNANT ASTROCYTOMA. C. SPECIMEN LABELED SECOND PERMANENT CORE: -- MALIGNANT ASTROCYTOMA. D. SPECIMEN LABELED THREE PERMANENT EDGE: -- GLIOBLASTOMA MULTIFORME (WHO GRADE IV), SMALL CELL VARIANT. Note: Immunohistochemical staining for primitive neuroectodermal differentiation (synaptophysin, neurofilaments) is. negative. E. PERMANENT WHITE MATTER, REMOVAL: CEREBRAL CORTEX AND WHITE MATTER DEMONSTRATING FOCAL HYPERCELLULARITY, CONSISTENT. WITH INFILTRATING GLIOMA. One or more of the reagents used to perform assays on this specimen MAY have contained components considered. to be analyte specific reagents. have not been cleared or approved by the U.S.Food and Drug. Administration. These assays were developed and their performance characteristics determined by the Department. of Pathology at. The assays were performed with appropriate positive and negative. controls. By the signature on this report, the individual or group listed as making the Final Interpretation/Diagnosis certifies that they have reviewed this case. Intraoperative Consult Diagnosis. A. Touch Imprint and Microscopic: Hypercellular tissue. No definite neoplasm identified. B. Touch Imprint and Microscopic: High Grade glial neoplasm. Clinical History: Right occipital neoplasm. Specimens Submitted As: A: RIGHT OCCIPITAL NEOPLASM. B: R OCCIPITAL NEOPLASM. C: 2 PERM CORE. D: 3 PERM EDGE. E: PERM WHITE MATTER. Gross Description: A: Received fresh, for intraoperative consultation, labelled with the patient's name, number and ""1"", are multiple. irregular fragments of tan-pink, soft tissue, 1.4 x 0.6 x 0.6 cm in aggregate. Representative sections are submitted in. cassette A1 for frozen section analysis and the remainder of the specimen is submitted in toto in cassette A2. B: Received fresh, for intraoperative consultation, labelled with patient's name and number, are multiple irregular. fragments of tan-pink neural tissue, 0.6 X 0.4 x 0.3 cm in aggregate. Representative sections are submitted in. cassette B1 for frozen section and permanent analysis and the remainder of the specimen is submitted entirely in. cassette B2. C: Received fresh, post fixed in formalin, labeled with the patient's name, number, and ""2"", are two light tan to white-. tan irregular to wedge-shaped soft tissue fragments measuring 0.9 x 0.7 x 0.7 cm and 1.4 X 1.1 X 0.75 cm. Both. fragments are bisected. On section, the tissue is light tan throughout. Submitted entirely in two cassettes. D: Received fresh, post fixed in formalin, labeled with the patient's name, number, and ""3"", are six light tan to brown. irregular to wedge-shaped soft tissue fragments ranging from 1 x 0.5 x 0.3 cm to 2.7 X 1.5 x 0.5 cm. The two largest. fragments are serially sectioned. On section, the tissue is light tan throughout. Submitted entirely in four cassettes. E: Received fresh, post fixed in formalin, labeled with the patient's name, number, and ""4"", are multiple light tan to. white-tan irregular to wedge-shaped soft fragments of brain ranging from flecks to 4.2 x 2.2 x 1.8 cm. One side of the. largest fragment is smooth and glistening. The two largest fragments are serially sectioned. On section, the tissue is light tan to white tan and lobulated. Submitted entirely in 14 cassettes. Summary of cassettes. D1-D2 largest fragment. D3 2nd largest fragment. D4 remaining tissue. E1-E11 largest fragment. E12-E13 2nd largest fragment. E14 remaining tissue.",test,
1951,TCGA-BP-4789.fc4372a9-ea9b-42be-b7b9-9cf2d0192520,"Additional Copy lo: net. Clinical Diagnosis & History: ith right 3.8 cm renal mass. Specimens Submitted: 1: SP: Kidney, right; partial nephrectomy. DIAGNOSIS: 1. SP: Kidney, right; partial nephrectomy. Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. Fuhrman Nuclear Grade: Nuclear grade II/IV. Tumor Size: Greatest diameter is 3,4 cm,. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: Not identified. Small vessel anglolymphatic invasion also not identifled. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Focal hyalinizing glomerulosclerosis and mild arteriosclerosis. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT1 Tumor <= 7.0 cm in greatest dimension limited to the kidney. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. 1). The specimen Is received fresh for frozen section consultation, labeled ""Right renal mass"" and consists of a partial. nephrectomy measuring 4.5 x 3.7 x 2.9 cm. The resected margin is pink brown, rough, and grossly unremarkable; and has been. inked black. The capsular surtace Is smooth pink-tan with attached adipose tissue, and hes been inked blue. The specimen. is. sectioned to reveal a centrally located fairly well circumscribed partially cystic and partially subcapsular tumor nodule measuring. 3.4 x 2,5 x 2.7 cm, which is located 0,1 cm from the nearest resected margin. On cut section, the solid portion of the nodule. consists of yellow homogenous and focally hemorrhagic soft tissue, and the cystic portion is multilocular, with smooth white tan. fibrous septa are noted, The renal capsule and perinephric fat appear grossly uninvolved. The remaining renal parenchyma is. pink brown and grossly unremarkable. Representative sections of the specimen are submitted for frozen section consultation, to. TPS and for permanent section, and a photograph of the cut sections of the nodule has been taken. Summary of sections: FSC -- frozen section control. RST -representative sections tumor with margin and capsule. Summary of Sections: Part 1: SP: Kidney, right; partial nephrectomy. Block. Sect. Site. PCs. 1. fsc. 1. 5. rst. 5. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: RENAL CORTICAL NEOPLASM, MARGIN NEGATIVE. PERMANENT DIAGNOSIS: SAME.",test,
2108,TCGA-FG-8181.6b2e8993-f8a8-400a-bc49-b283ca7221fe,"Provider Status. Observation Date and Time. Result Narrative. (NOTE). Clinical History. Malignant neoplasm of frontal lobe of brain [191.1]. . Medical History: GERD (gastroesophageal reflux disease) . Optic nerve edema. ADDENDA: Addendum added: Addendum added: Final Pathologic Diagnosis--. A. Left frontal tumor, biopsy: Slides have been referred to. for review and diagnosis. An. addendum will follow. B. Left frontal tumor, excision: Slides have been referred to. for review and diagnosis. An. addendum will follow. C. Left frontal tumor, excision: Slides have been referred to. for review and diagnosis. An. addendum will follow. Signed_By. Addendum Report--. Addendum. See below. Since the pathologists of. specialists in. neuropathology and were the locum tenens on this case during my absence, I. offer no professional opinion on this case except to indicate that the. interpretation of the pathologist of. been. faithfully transferred to this addendum. The original consultation report. is on file in Surgical Pathology. The following is the text of their. Report received from: Consult Service. INTERPRETATION AND DIAGNOSIS: 1) LT FRONTAL TUMOR. ANAPLASTIC INFILTRATING GLIOMA (WHO. GRADE III) . SEE COMMENT. COMMENT: Histologic sections demonstrate an infiltrating glial neoplasm. with increased mitotic activity (up to 5 per 10 high power fields) . Areas. of the tumor demonstrate cells with numerous cytoplasmic processes and. nuclear pleomorphism, while others contain round cells with micronucleoli. and halos. mmunohistochemical stains performed at. demonstrate. strong p53 labeling. MIB-1 labeling index is moderate. Molecular SNP. array studies are negative for 1p/19q loss. The findings support a. diagnosis of anaplastic infiltrating glioma. Given the variable cytologic. features (pleomorphic and round cells) the tumor may be interpreted as an. oligoastrocytoma. Some stains/tests used in rriving at the diagnosis were performed here. using reagents that have not been cleared or approved by the US Food and. Drug Administration These were developed and their performance determined. by thel. ledical Laboratories. Their use does not require FDA. approval. GROSS DESCRIPTION. PART #1: LT FRONTAL TUMOR. Resident Pathologist: NONE ASSIGNED. Received 14 slides. (AF1, AFTP, AF, B1-B5, C1-C6) from. 2/8/12, Received 8 unstained slides. B4). 2/24/12, Received 5 additional unstained slides. B4) . End of Report. lectronically Signed Out By. Addendum. Since the pathologists of. are specialists in. neuropathology and were the locum tenens on this case during my absence,. offer no professional opinion on this case except to indicate that the. interpretation of the pathologist of. has been. faithfully transferred to this addendum. The original consultation report. is on file in Surgical Pathology. The following is the text of their. Addendum from: ADDENDUM. Synaptophysin and Neu-N immunostains performed at. highlight. non-neoplastic brain parenchyma. Some stains/tests used in arriving at the diagnosis were performed here. using reagents that have not been cleared or approved by the US Food and. Drug Administration. These were developed and their performance determined. by the. Laboratories. Their use does not require FDA. approval. INTRAOPERATIVE CONSULTATION DIAGNOSIS: AF1. Left frontal tumor (Frozen section performed) : Consistent with glial neoplasm, possible oligo. Note: Called to Dr. Examining pathologist: MICROSCOPIC: A microscopic examination was not performed. SPECIMEN (S) RECEIVED: NBX. A: Neuropath, Brain, Bx. B: Neuropath Reg. C: Neuropath Reg. GROSS DESCRIPTION: The specimens are received in two properly labeled containers with the. patient' S name and accession number, one of which is a frozen section. A. The specimen is designated ""left frontal tumor"" and consists of. a 0.7 X 0.3 X 0.3 cm portion of tissue. A frozen section was performed and. cassette AF1 is resubmitted as received. B. The specimen is designated ""left frontal tumor"" and consists of. a 3. 9 X 3.8 X 2.8 cm gray-tan to pink soft tumor with focal areas of. hemorrhage. Summary of Cassettes: B1-5, tumor. C. The specimen is designated ""left frontal tumor"" and consists of. a 5.5 X 5.0 X 1. 7 cm aggregate of extremely soft white-tan to pink-tan,. slightly mucinous soft tissue. The cut surface is pink-tan to white-tan. and gelatinous. RS6. Lab Use Only: Lab Use Only: Gross description by : This result is currently not released to. Patient Care Team. Relationship. Specialty. Notifications. Start. End. PCP - General. Family. Medicine.",test,
2214,TCGA-55-7726.094c672b-f6c7-4250-bb17-4d23a48b81c7,"PROCEDURE. Lung, left lower lobectomy. SPECIMEN: A. L9 lymph node. B. left lower lobe lung. C. L10. intralobar. D. L7. HISTORY. Left lower lobe (cancer) (mass) . GROSS. A. Labeled ""L9 lymph node"" is a 0.8 x 0.8 x 0.3 cm rubbery yellow. fat which includes a 0.3 cm in diameter, gray-tan rubbery nodule. B. Labeled ""left lower lobe lung"" is a rubbery salmon-pink resected. left lower lobe of lung, 130 grams and 13.2 x 10.8 x 5 cm. A 2.9. x. 2.4 x 1.3 cm firm tan-gray variegated tumor mass, 1.5 cm from the. bronchial resection margin, puckers but does not penetrate the. pleura of the superior segment. The pleural surface is inked above. the tumor. Resection margins of bronchus and blood vessels are. grossly unremarkable. Parenchyma away from the tumor is gray and. salmon pink, free of additional nodules. Block 1: Frozen section. remnant of bronchial margin. Block 2: Resection margins of. vessels. Blocks 3-5: Tumor. Block 6: Representative lung away from tumor. A. portion of the tumor is submitted for cancer genome study. C. Labeled ""L10 intralobar"" is a 1.2 x 0.8 x 0.3 cm rubbery. tan-yellow node, bisected. 2/1. D. Labeled ""L/7"" is a 0.6 x 0.3 x 0.2 cm rubbery gray-black nodule,. bisected. 2/1. FROZEN SECTION DIAGNOSIS. B. Left lower lobe lung, resection: Bronchial resection margins negative for carcinoma. (Diagnosis to. MICROSCOPIC. A-D. Performed. DIAGNOSIS. A. L9 lymph node, excision biopsy: One lymph node, negative for metastatic carcinoma. CPT 88305. B. Left lower lobe lung, resection: Adenocarcinoma, poorly differentiated (2.9 cm), previously. diagnosed. Intralymphatic tumor invasion. Bronchial and vascular resection margins, free of. malignancy. Tumor-associated scar. Lung parenchyma away from tumor, free of lesion. CPT 88309,88331. C. L10 intralobular lymph node, excision biopsy: One lymph node, negative for metastatic carcinoma. CPT 88305. D. L7 lymph node, excision biopsy: One lymph node, negative for metastatic carcinoma. CPT 88305. SUMMARY OF MALIGNANT NEOPLASM: LUNG. SPECIMEN: lung lobe. PROCEDURE: lobectomy. SPECIMEN INTEGRITY: intact. SPECIMEN LATERALITY. left. TUMOR SITE: lower lobe, superior segment. TUMOR SIZE: 2.9 cm. TUMOR FOCALITY. Unifocal. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: Poorly differentiated. VISCERAL PLEURA INVASION: visceral pleural not involved. MARGINS: Not involved; 1.5 cm to closest. (bronchial) margin. TREATMENT EFFECT: Not applicable. LYMPH-VASCULAR INVASION: Present. LYMPH NODES: Three of 3 lymph nodes, negative for. metastasis. OTHER FINDINGS: Tumor-associated scar. PATH TNM(AJCC 7th ed.) : pT1b pNO Stage IA. COMMENT. Final diagnosis for specimen B corresponds to that given at the time. of frozen section examination. Completed Action List: Type: Title:",test,
2290,TCGA-5P-A9KA.9A0E64A4-CC87-4957-9333-19E1249BFA9C,"Focal Papillary Renal Cell Carcinoma, Type I. Stage: pT1b, pNX, pMX, vo, LO, R1. Grade: GII. ICD-0-Code: 8260/3.",test,
2353,TCGA-AA-A01K.0D66971E-D224-4536-A3BE-B138861D8E7D,"Diagnosis: 1. Chronically fibrosing cholecystitis, with reactive hyperplasia of a local lymph node. 2. Tumor-free fatty tissue. 3. Resected colon with a centrally ulcerated, moderately differentiated. adenocarcinoma of the colorectal type, located 1.5 cm from the aboral resection. margin, and with wide infiltration of the pericolic fatty tissue as well as with four. local lymph node metastases. Tumor-free colon resection margins. Tumor-free. mesocolic resection margin. Also diverticulosis coli. Stage of tumor: pT3 pN2 (4/35) pMX; G2, L1, V0, local R0.",test,
2568,TCGA-GL-A9DC.3FF6A88A-8F78-4733-A980-64F07248700C,"Operative Procedure: Nephrectomy. Pre-Operative Diagnosis: Renal mass. A: Left kidney. B: Peri-aortic lymph node. Final Pathologic Diagnosis: A. Kidney, left, nephrectomy: Tumor histologic type: Papillary renal cell carcinoma, type 1. (Please, see note). Sarcomatoid features (%): 0%. Tumor size: 5 cm (greatest dimension). Other dimensions: 3 X 2 cm. Macroscopic extent of tumor: Tumor limited to the kidney. Focality: Unifocal. Fuhrman grade: 1 of 4. Microscopic extent of tumor: Perinephric fat invasion: Renal sinus invasion: Renal vein involvement: Adrenal gland present: Cancer at resection margin: Pathologic findings in nonneoplastic kidney: Patchy chronic inflammation. Hilar lymph nodes present: Number involved/number present: 0/1. Ancillary Studies: Racemase: Positive. Carbonic anhydrase: Positive. TFE3: Negative. Vimentin: Positive. SDHB: Negative. Cytokeratin 7: Positive. All controls stained appropriately. Pathologic stage (2010). pT1b, pNO, pMX. B. Lymph nodes, periaortic, resection: Fifteen lymph nodes, negative for malignancy (0/15). The examination of this case material and the preparation of this report were. Note: The tumor is predominantly papillary in architecture with cells that mainly have. an abundant cytoplasm that ranges from completely eosinophilic to clear. Although, the morphologic features in general are in favor of papillary renal. cell carcinoma type I, the cytological features of ""clear cells"" are concerning. for clear cell papillary renal cell carcinoma. Immunohistochemical studies. showed that the tumor cells are positive for cytokeratin 7, racemase, carbonic. anhydrase and vimentin and are negative for TFE3 and SDHB. Controls stained. appropriately. The immunohistochemical profile and morphologic features are. consistent with the diagnosis of renal papillary carcinoma type I. Dr. has reviewed the case and. concurs with the diagnosis. Gross Description: Received are two formalin filled containers, each labeled with the patient's. Part A. Specimen components and dimensions: The specimen is the product of a left. nephrectomy, having aggregate dimensions of 15 X 11 x 10 cm and consists of a. kidney having dimensions of 10 x 7 X 5 cm, ureter with length of 5 cm. Adrenal. gland is not present. Size, appearance, and location of tumor: 5 x 3 x 2 cm located in the. mid/superior pole, well encapsulated, inside the capsule the tumor is a friable. tissue, yellow tan- to grey tan in color. It is contained within the kidney. parenchyma boundaries. Renal capsule/renal sinus: The renal capsule strips with ease. Renal vein: The renal vein is free of tumor. Lymph nodes (size, number, & location): Perihilar fibrofatty tissue weighs. 100 grams, it was placed in a fat clearing agent for 30 minutes. Serial. sectioning and palpation does not reveal any obvious lymph nodes. Portions of. fibrous fatty tissue with probable lymph nodes are submitted in cassettes A13-14. for microscopic analysis. Other findings: Multiple cortical cysts that measure from 0.5 cm up to 2 cm in. greatest dimension. Blocks submitted: A1. ureter and vascular margins;. A2-4. tumor to renal capsule;. A5-6. tumor to renal sinus fat;. A7. tumor to collecting system;. A8 tumor;. A9-12 representative sections of the cysts;. A13-14 Perihilar fibrofatty tissue with possible whole lymph nodes. Part B is additionally labeled ""periaortic lymph nodes"" and consists of multiple. portions of fibrofatty tissue that measure in aggregate 3 X 3 X 0.8 cm. Sectioning reveals four possible lymph nodes that range from 0.5 cm up to 2 cm. in greatest dimension. Blocks submitted: B1-2 multiple whole lymph nodes;. B3. one lymph node bisected;. B4. one lymph node bisected;. B5. one lymph node bisected. Microscopic Description: The final diagnosis of each specimen incorporates the microscopic examination. findings. Gender: F.",test,
2650,TCGA-85-8048.623e4187-fd10-4780-94d9-febf2957a922,Requisition. case OpenClinica ID Gross. Microscopic. Diagnosis. Comments. Description. Description. Details. Laterality/lo. Date of excision. cation. LUNG TISSUE CHECKLIST. Left-lower. Specimen type: Lobectomy. Tumor site: Lung. Tumor size: 2 X 3 X 2.5 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Poorly differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: None.,test,
2688,TCGA-DF-A2KS.C6638C17-4F05-491F-86ED-6D7DDB1B8FDE,"Sample Type TUMOUR. Sample Preparation. Fresh Frozen. Site of Primary (Event). Uterine. Site of Tissue. mass on posterior wall. Year of Sample Collection. Age at Sample Collection (yrs). Sample Comments. Days to Procedure Date. 0. Days to Diagnosis. 22. Type of Procedure. Surgical resection. Site of Primary (Histology). Uterus. Bilateral Disease. Tumour Size (cm). 4.2999999999999998. Histology. Endometrioid adenocarcinoma, NOS. Grade/Differentiation. III. Pathological T. T1b. Pathological N. Number of Nodes Sampled. 0. Number of Nodes Positive. 18. Clinical M. M0. Histology Comments.",test,
2762,TCGA-IB-AAUQ.B2B5526A-ADC6-4F65-B5B2-6B0E895968FF,"CONFIDENTIAL. Demographics (for. verification purposes). Sex: M. Collected Date/Time. Received Date/Time. Specimen Description. A. Liver biopsy at. B. Liver biopsy number 2 at. C. Liver biopsy number 3 at. D. Body and tail of pancreas at. Clinical Information. Pancreatitis. Possible pancreatic cancer. Diagnosis. A. Liver, Biopsy: Bile duct hamartoma. Negative for malignancy. B. Liver, Biopsy #2: Benign liver tissue. Negative for malignancy. C. Liver, Biopsy #3: Benign liver tissue. Negative for malignancy. D. Pancreas, Body and Tail, Distal Pancreatectomy: Invasive ductal adenocarcinoma, moderately differentiated with. focal foamy gland pattern, 4.5 x 3.5 x 3.5 cm. Prominent perineural, lymphatic, and venous invasion present. Invasive adenocarcinoma involves retroperitoneal margin and. pancreatic body margin. Thirteen of twenty-one peripancreatic lymph nodes involved by. metastatic adenocarcinoma (13/21) extranodal extension present;. largest tumor deposit 1.2 cm. Please see comment and synontin report. Verified: Synoptic Report. SPECIMEN: Body of pancreas. Tail of pancreas. PROCEDURE: Partial pancreatectomy, pancreatic tail. TUMOR SITE: Pancreatic tail. TUMOR SIZE: Greatest dimension: 4.5. cm. Additional dimensions: 3.5 x 3.5. cm. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G2: Moderately differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades peripancreatic soft tissues. Tumor invades retroperitoneal soft tissue. Tumor invades other adjacent organs or structures. tumor invades wall of splenic vein. MARGINS: Margin(s) involved by invasive carcinoma. Proximal pancreatic margin. Invasive carcinoma involves posterior retroperitoneal surface of pancreas. TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy). No prior treatment. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT) : pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the. superior mesenteric artery. REGIONAL LYMPH NODES (pN) : pN1: Regional lymph node metastasis. Number examined: 21. Number involved: 13. DISTANT METASTASIS (pM) : Not applicable. ADDITIONAL PATHOLOGIC FINDINGS: Pancreatic intraepithelial neoplasia (highest grade: PanIN 2. Chronic pancreatitis. Gross Description. Received are specimen containers A to D. A11 requisitions and specimen containers are. labelled with the patient's name,. The cassettes and identifiers are. labelled with the Surgical Number. A. The specimen consists of liver tissue, measuring 0.3 cm. Submitted in toto in one. cassette. The specimen is received fresh and is subsequently placed into formalin. The container. is designated ""A: Liver biopsy at. The previously frozen tissue is entirely. resubmitted for permanent sections in cassette AQS1. B. The specimen consists of liver tissue, measuring 0.2 cm. Submitted in toto in one. cassette. The specimen is received fresh and is subsequently placed into formalin. The container. is designated ""B: Liver biopsy number 2 at. The previously frozen tissue is. entirely resubmitted for permanent sections in cassette BQS1. C. The specimen consists of liver tissue, measuring 0.8 cm. Submitted in toto in one. cassette. The specimen is received fresh and is subsequently placed into formalin. The container. is designated ""C: Liver biopsy number 3 at. The previously frozen tissue is. entirely submitted for permanent sections in cassette CQS1. D. The specimen is received fresh and is subsequently placed into formalin. The. container is designated ""D: Body and tail of pancreas at. and contains a 12.0 x 6.0. x 3.5 cm portion of pancreatic body and tail. The pancreatic body margin is inked blue,. the distal margin is inked orange, and the radial margin is inked black. The specimen is. bisected longitudinally and is fixed in formalin overnight. Sectioning reveals an ill-. defined, firm, yellow-tan, 4.5 x 3.5 x 3.5 cm mass with a few punctate hemorrhagic areas. The mass is located in the anterior half of the specimen and grossly extends to the. anterior serosa, to within 1.0 cm of the blue-inked pancreatic body resection margin, and. very close (1-2 mm) to the posterior/retroperitoneal margin. The rim of pancreatic. tissue proximal to the mass is soft and tan-colored with a normal lobular configuration. The pancreatic tail tissue distal to the mass (3.5 x 1.0 cm) is attenuated, faintly. nodular, and atrophic-appearing. The pancreatic duct passes through the central. posterior aspect of the mass, and shows no obvious dilation, stricture, or intraductal. mass. Within the peripancreatic fat superior, inferior and posterior to the mass, there. are multiple vell-circumscribed ovoid, firm, white nodules, consistent with lymph nodes,. many of which appear grossly suspicious for metastatic tumor. Representative sections. are submitted as follows: D1. representative perpendicular section of pancreatic body margin closest to. tumor. D2/3. remainder of pancreatic body margin, shaved and submitted en face. D4. single grossly suspicious lymph node, superior to pancreatic mass, sectioned. D5. additional superior margin with possible lymph nodes. D6. single grossly suspicious lymph node located superior to mass, bisected. D7 to 9. additional representative sections of superior portion of tumor with. adjacent grossly. positive lymph nodes. D10 to 12. representative sections of tumor with retroperitoneal margin and grossly. suspicious. retroperitoneal lymph nodes. D13. representative section of atrophic pancreatic tail near retroperitoneum. D14. representative portion of central tumor with large vessel. D15/16. tumor with inferior margin. D17. representative portion of atrophic distal pancreatic tail with distal margin. D18. distal portion of tumor with adjacent possible lymph node. D19. tumor with adjacent anterior serosa. D20. distal peripancreatic fat with three possible lymph nodes (bisected). D21. two additional possible lymph nodes. Frozen Section Diagnosis. A. Liver Biopsy: No evidence of carcinoma. B. Liver Biopsy Number 2: Negative for malignancy. C. Liver Biopsy Number 3: Negative for carcinoma. Pathologist Comment. In case ancillary studies are desired, tumor block information is listed below: Best tumor block: D4. Best normal block: D17. Encounter Number. Patient Location.",test,
2787,TCGA-NF-A4X2.7FC4954E-727C-40F0-8EAF-5C405E7F6B37,"SLIDE DISPOSITION: DIAGNOSIS: A. Uterus, left and right fallopian tubes and ovaries, hysterectomy. and bilateral salpingo-oophorectomy: Malignant mixed Mullerian. tumor with eterologous differentiation (60% glandular, 40% stromal. differentiation) is identified forming a mass, 7.5 x 7.0 x 2.0 cm,. circumferentially involving the uterine cavity. The tumor invades. 2.0 cm into the myometrium (total wall thickness 2.4 cm). The tumor. does not involve the endocervix. Lymphovascular space invasion is. not identified. The margins are negative for tumor. Bilateral. fallopian tubes display severe epithelial atypia. The ovaries are. unremarkable. Seen in consultation with Dr. B. Lymph nodes, right pelvic, excision: Multiple (19) lymph nodes. are negative for tumor. C. Lymph nodes, left pelvic, excision: Multiple (15) lymph nodes. are negative for tumor. D. Lymph nodes, left para-aortic, excision: Multiple (14) lymph. nodes are negative for tumor. E. Lymph nodes, right para-aortic, excision: Multiple (2) lymph. nodes are negative for tumor. with available surgical material [AJCC pT1bNO] (7th edition,. AMENDMENTS: (Previous signout Date: Revision Description: Need to add frozen section diagnosis to part. A. original Frozen Sect-Intraop. A. Uterus, left and right fallopian tubes and ovaries, hysterectomy. and bilateral salpingo-oophorectomy Malignant mixed Mullerian. tumor with heterologous differentiation invading into the outer half. of myometrium and confined to the uterus. Endocervix shows focal. atypical glands suspicious for adenocarcinoma in situ. HOLDOVER to. evaluate on permanent sections. B. Lymph nodes, right pelvic, excision: Multiple (19) lymph nodes. are negative for tumor. c. Lymph nodes, left pelvic, excision: Multiple (15) lymph nodes. are negative for tumor. Frozen section histologic interpretation performed by: D. Lymph nodes, left para-aortic, excision: Multiple (14) lymph. nodes are negative for tumor. Frozen section histologic. interpretation performed by: E. Lymph nodes, right para-aortic, excision: Multiple (2) lymph. nodes are negative for tumor. Frozen section histologic. interpretation performed by: Frozen section histologic interpretation performed by: PRELIMINARY FROZEN SECTION CONSULTATION: A. Uterus, left and right fallopian tubes and ovaries, hysterectomy. and bilateral salpingo-oophorectomy: Malignant mixed Mullerian. tumor with heterologous differentiation invading into the outer half. of myometrium and confined to the uterus. Endocervix shows focal. atypical glands suspicious for adenocarcinoma in situ. The. margins are negative for tumor. Bilateral fallopian tubes and. ovaries are unremarkable. HOLDOVER to evaluate on permanent. sections. See comment. B. Lymph nodes, right pelvic, excision: Multiple (19) lymph nodes. are negative for tumor. c. Lymph nodes, left pelvic, excision: Multiple (15) lymph nodes. are negative for tumor. Frozen section histologic interpretation performed by: D. Lymph nodes, left para-aortic, excision: Multiple (14) lymph. nodes are negative for tumor. Frozen section histologic. interpretation performed by: E. Lymph nodes, right para-aortic, excision: Multiple (2) lymph. nodes are negative for tumor. Frozen section histologic. interpretation performed by: Frozen section histologic interpretation performed by: Comment: Permanent sections revealed severe atypia in. fallopian tubes. GROSS DESCRIPTION: A. Received fresh labeled ""uterus, left and right fallopian tube. and ovary"" is a 195.0 gram disrupted uterus with attached bilateral. tubes and ovaries. The cervix is nearly detached, 4.5 cm from the. ectocervical margin. Multiple portions of a polypoid exophytic mass. measuring 6.5 x 6.4 x 5.0 cm in aggregate are present, separately. There is a 7.5 x 7.0 x 2.0 cm exophytic/polypoid, friable mass. circumferentially involving the endometrial cavity, grossly invading. 2.0 cm. The myometrial thickness is 2.4 cm. There are no. leiomyomas. There is a 2.1 x 1.2 x 0.5 cm right ovary with a. smooth outer surface and a cystic cut surface with a 6.9 x 0.4 cm. right fallopian tube which is unremarkable. There is a 1.9 x 1.7 x. 1.3 cm left ovary with a smooth surface and a solid cut surface with. a 6.8 x 0.4 cm left fallopian tube which is unremarkable. On cut. surface, the left ovary contains a 0.7 x 0.7 x 0.6 cm white yellow. solid nodule. Representative sections are submitted. B. Received fresh labeled ""right pelvic lymph nodes"" is a 4.9 x 4.8. x 1.4 cm aggregate of adipose and lymphatic tissue. Lymph nodes. submitted. c. Received fresh labeled ""left pelvic lymph nodes"" is a 4.4 x 3.3. X 1.5 cm aggregate of adipose and lymphatic tissue. Lymph nodes all. submitted. D. Received fresh labeled ""left para-aortic lymph nodes"" is a 3.2 x. 2.2 x 1.4 cm aggregate of adipose and lymphatic tissue. Lymph nodes. submitted. E. Received fresh labeled ""right para-aortic lymph nodes"" is a 1.9. x. 0.5 x 0.5 cm aggregate of adipose and lymphatic tissue. Lymph. nodes submitted.",test,
2797,TCGA-E9-A1R5.141B770B-22DD-4C87-AFF7-04D85FC9C74A,"OC ID: Gross Description: Lump with the tumour of 1.4 x 1.2 cm in size; fatty tissue lymph nodes demonstrate lipomatosis. Microscopic Description: Infiltrating duct carcinoma; G2. Ten dissected lymph nodes demonstrate hyalinosis, sinus histeocytosis, lipomatosis. Diagnosis Details: Tumor Features: Unknown, Tumor Extent: T1 tumor size 2 cm or less, Venous Invasion: Absent, Margins: Absent, Treatment. Effect: Comments: BREAST TISSUE CHECKLIST. Specimen type: Lumpectomy. Specimen size: Not specified. Tumor site: Upper outer quadrant. Tumor size: 1.2x0x1.4 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: 0/10 positive for metastasis (Axillary 0/10). Extracapsular invasion of the lymph nodes: Not specified. Margins: Uninvolved. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None. Laterality: Right, upper outer quadrant.",test,
2991,TCGA-XD-AAUH.7547A833-EA2B-48ED-B779-D632A6869FA0,"Clinical Information. Obstruction of bile duct. Acute pancreatitis. Diagnosis. A. LIVER CORE BIOPSY: - Liver tissue with features consistent with bile outflow obstruction. - No evidence of malignancy. B. LIVER, WEDGE BIOPSY: - Hyalinized nodule and features of bile outflow obstruction. - No evidence of malignancy. C. COMMON HEPATIC ARTERY LYMPH NODE, BIOPSY: - Three lymph nodes with no evidence of malignancy (0/3). D. PARTIAL PANCREATICODUODENECTOMY: - Invasive moderately to poorly differentiated ductal adenocarcinoma, size: 2.8 cm in maximum. diameter, invading into peripancreatic tissue and wall of small bowel, please see staging summary. - Seven of twenty-two lymph nodes positive for metastatic carcinoma (7/22). - Perineural invasion identified. - Common bile duct, pancreatic duct margin and SMA margin negative for malignancy. - Proximal duodenal margin positive for subserosal ductal adenocarcinoma, distal duodenal margin. negative. E. LYMPH NODE FROM AORTOCAVAL GROOVE, BIOPSY: - Four lymph nodes with no evidence of malignancy (0/5). Pathology Synoptic. Specimen type: Partial pancreaticoduodenectomy. Tumor location: Head of pancreas. Histologic type: Ductal adenocarcinoma. Histologic grade: G2-3. Tumor size and invasion of: Tumor extends beyond the pancreas, but without involvement of. celiac axis or SMA: Yes. Tumor involves celiac axis or SMA: No. Lymphatic invasion: Identified. Large vessel invasion: Not identified. Margins: Common bile duct: Negative. Proximal duodenal: Positive. Distal duodenal margin: Negative. Proximal or distal pancreatic margin: Negative. Peripancreatic soft tissue margin (including retroperitoneal and posterior. pancreatic margin): Negative. Total regional lymph nodes: 30 Number positive: 7. AJCC Pathologic Stage: pT3 N1 (AJCC 7th edition, 2010). Dictated and authenticated by: Performing Location: Gross Description. A. CORE LIVER BIOPSY. Received fresh labeled with the patient name. Description: The specimen consists of two cylinders of tan-brown tissue having lengths of 0.7 and 1.2. cm and diameters of less than 0.1 cm. The specimen is entirely embedded for a frozen section. diagnosis. FROZEN SECTION DIAGNOSIS PERFORMED AT. No evidence. of malignancy. SECTIONS: A1. Frozen section control. B. WEDGE LIVER BIOPSY. Received fresh labeled with the patient name. Description: The specimen consists of three pieces of tan-brown tissue ranging from 0.5-1.0 cm in. greatest dimension, each of which reveals a white-tan nodule measuring up to 0.1 cm in greatest. specimen. The specimen is entirely embedded for a frozen section diagnosis. FROZEN SECTION DIAGNOSIS PERFORMED AT. No evidence. of malignancy. SECTIONS: B1. Frozen section control. C. COMMON HEPATIC ARTERY LYMPH NODE. Received in formalin labeled with the patient name. Description: The specimen consists of an irregular piece of yellow-brown tissue measuring 3.1 cm in. greatest dimension, from which are retrieved three lymph nodes which are submitted in their entirety. SECTIONS: C1. One longitudinally bisected lymph node. C2. One intact lymph node and one inked and longitudinally bisected lymph node. D. PRODUCT OF PARTIAL PANCREATICODUODENECTOMY: Received fresh labeled with the patient name. Specimen received: Product of a partial pancreaticoduodenectomy. Orientation given: Two medium length sutures, one long suture and two long sutures identify the bile. duct, pancreatic neck and SMA margin respectively, per the intraoperative consultation form. Integrity: The pancreatic component is intact; the duodenum is unopened. Size of pancreas: 6.5 X 6.0 x 3.5 cm. Length of duodenum: 19.0 cm. Ducts: Probe patency cannot be demonstrated between the common bile duct and the ampulla. Ampulla: The ampulla is easily probed from the pancreatic duct. Inking scheme: The anterior and posterior surfaces of the pancreas are inked blue and black. respectively. The margins of the common bile duct and the pancreas are inked purple and green. respectively, after the true pancreatic margin is embedded for a frozen section diagnosis. The concavity. created by the portal vein is inked yellow and the SMA margin is inked orange. Tumor site: Within the head of the pancreas. Tumor size: Tumor is estimated to measure 2.8 cm in greatest dimension. Tumor description: White-tan, waxy, poorly circumscribed. Invasion of: The tumor surrounds the common bile duct, compressing it to a diameter of less than 0.1. cm, having a diameter of 1.7 cm at its margin of resection. Distance from margins: The tumor appears to most closely approximate the pancreatic margin of. resection by 0.5 cm, the bile duct margin by 3.0 cm, the anterior blue ink aspect of the pancreas by. apparently less than 0.1 cm, the posterior pancreas by 1.0 cm, the concavity created by the portal vein. by 0.5 cm and the SMA margin by 1.0 cm. Remaining specimen: The small intestinal component has stapled margins of resection, scant serosal. adhesions, an average wall thickness of 0.3 cm and an unremarkable mucosa. Peripheral to the tumor. the pancreas reveals unremarkable cut surfaces, excepting for a 1.1 cm smooth-walled cyst. Lymph nodes: The lymph nodes retrieved from the specimen are submitted in their entirety. Representative sections are submitted with the pancreatic component being submitted proceeding from. the margin towards head. FROZEN SECTION DIAGNOSIS PERFORMED AT. Indicated. margins: All negative for carcinoma. SECTIONS: D1. Frozen section control of common bile duct margin. D2. Frozen section control of pancreatic margin. D3. Frozen section control of SMA margin. D4-5. En face proximal and distal duodenal margins, respectively. D6-7. Longitudinally bisected ampulla. D8-9. Transverse of common bile duct proceeding from margin towards head with adjacent pancreatic. tissue (green ink does not represent a true surgical margin). D10. Approximation of tumor to blue inked anterior pancreatic surface, duodenal wall and green inked. cut surface of pancreas. D11. Approximation of tumor to concavity created by portal vein including pancreatic cyst and. beginning of stricture of common bile duct. D12. Pancreatic cyst, SMA margin and the posterior surface of pancreas. D13. Compressed bile duct and posterior surface of pancreas. D14. Tumor and anterior surface of pancreas. D15. Pancreas, SMA margin, posterior surface and one bisected lymph node. D16. Pancreatic tissue and adjacent duodenal wall, posterior surface of pancreas and compressed. common bile duct. D17. Tumor, anterior surface of pancreas and pancreatic duct. D18. Two inked and longitudinally bisected lymph nodes retrieved from anterior surface of pancreas. D19-20. Eight intact lymph nodes retrieved from inferior aspect of pancreas with four in each cassette. D21. Three intact lymph nodes retrieved from inferior aspect of pancreas. D22. Two longitudinally bisected lymph nodes retrieved from inferior pancreas with one inked orange. D23. One trisected lymph node retrieved from inferior aspect of pancreas. D24-26. One sectioned lymph node retrieved from anterior pancreas adjacent to common bile duct. E. LYMPH NODE FROM AORTOCAVAL GROOVE. Received in formalin labeled with the patient name. Description: The specimen consists of an ovoid piece of tan tissue having a diameter of 2.5 cm from. which are retrieved multiple suspected lymph nodes which are submitted in their entirety. SECTIONS: E1. Four intact suspected lymph nodes. E2-3. One longitudinally trisected lymph node. Microscopic Description. A. CORE LIVER BIOPSY: Microscopic examination is performed and supports the diagnosis above. B. WEDGE LIVER BIOPSY: Microscopic examination is performed and supports the diagnosis above. C. COMMON HEPATIC ARTERY LYMPH NODE: Microscopic examination is performed and supports the. diagnosis above. D. PRODUCT OF PARTIAL PANCREATICODUODENECTOMY: Microscopic examination is performed and. supports the diagnosis above. E. LYMPH NODE FROM AORTOCAVAL GROOVE: Microscopic examination is performed and supports. the diagnosis above. Surg Path Non-Chartable Comment. Diagnosis given directly to surgeon over telephone/speaker phone. (parts Aand B). Tumor QC block on part D.;.",test,
3030,TCGA-G6-A5PC.F9099C73-C2B4-47DF-B4EB-420E9B4353BA,"SPECIMENS: A. LEFT KIDNEY. SPECIMEN(S): A. LEFT KIDNEY. DIAGNOSIS: A. KIDNEY, LEFT, NEPHRECTOMY: - RENAL CELL CARCINOMA, CLEAR CELL TYPE, FURHMAN GRADE 4, MEASURING 6.4-CM,. CONFINED TO RENAL CAPSULE. - URETERAL MARGIN NEGATIVE FOR TUMOR. - ADRENAL GLAND, NO TUMOR SEEN. - ONE HILAR LYMPH NODE NEGATIVE FOR CARCINOMA (0/1). - SEE SYNOPTIC REPORT AND SEE NOTE. NOTE: The tumor has solid and papillary architecture. The cells show clear cytoplasm. Part of the tumor. has high grade nuclei (Furhman grade 4). Theimmunoprofileiscompatible with clear cell carcinoma. phenotype. The patient has tumor metastases to the lung . Dr. concurs. SUMMARY OF MMUNOHISTOCHEMISTRYISPECIAL STAINS. Material: Block A4. Population: Tumor Cells. Stain/Marker:Result: Comment: CYTOKERATIN 7. Negative. PIN-4 HMWCK (CK5 & CK14) Negative. PIN-4 P504S Positive. PIN-4 p63. Negative. CD 10. Positive. The interpretation of the above immunohistochemistry stain or stains is guided by published results in. the medical literature, provided package information from the manufacturer and by internal review of. staining performance and assay validation within the. The use of one or more reagents in the above tests is regulated as an analyte. specific reagent (ASR). These tests were developed and their performance characteristic determined. by the. They have not been. cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such. clearance or approval is not necessary. Special stains and/or immunohistochemical stains were performed with appropriately stained positive. and/or negative controls. SYNOPTIC REPORT - KIDNEY (PARTIAL OR RADICAL). Specimen Type: Radical nephrectomy. With adrenal gland. Laterality: Left. Tumor Site: Not specified. Focality: Unifocal. Tumor Size (largest tumor if multiple): Greatest dimension: 6.4cm. Macroscopic Extent of Tumor: Tumor limited to kidney. WHO CLASSIFICATION. Clear cell renal cell carcinoma 8310/3. Histologic Grade (Fuhrman Nuclear Grade): G4: Nuclei bizarre and multilobated, 20 u or greater, nucleoli prominent, chromatin clumped. Invasion of Vascular/Lymphatic: Absent. Perinephric Tissue Invasion: Absent. Margins: Margins uninvolved by invasive carcinoma. Adrenal Gland: Uninvolved by tumor. Regional Lymph Nodes: Negative 0 / 1. Additional Findings: None identified. Pathological Staging (pTNM): pT 1b N 0 M 1. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. GROSS DESCRIPTION: A. LEFT KIDNEY. Received fresh labeled with patient's identification and ""left kidney"" is an intact kidney with attached. perinephric fat weighing 322 g and measuring 12 X 7 x 5 cm. The adrenal gland is 5.2 x 2.2 x 0.5 cm; it. has a golden orange coloration. The ureter is 8.3 x 0.5 cm. On opening, it is smooth and tan in. coloration. There is a hilar lymph node, 0.4 cm in diameter. The capsular and perinephric fat are inked. black and the kidney is bisected. There is an orange-tan mass, 6.4 x 6.2 x 5.2 cm which extends to. within 0.2 cm of the capsule. It is hemorrhagic and fibrotic and pushes on the renal pelvis resulting in its. dilation. Photograph is taken and tissue is procured; representatively submitted: A1: vasculature margins. A2: bisected hilar lymph node. A3-A5: mass and relationship to capsule and perinephric fat. A6-A7: mass in relationship to renal pelvis. A8: mass and relationship to normal-appearing parenchyma. A9: normal-appearing parenchyma. A10: adrenal gland. A11. Ureter margin. CLINICAL HISTORY: None Given. PRE-OPERATIVE DIAGNOSIS: None Given.",test,
3049,TCGA-AD-A5EJ.7C291BB4-B97B-4EE1-BEB2-3B05FABD24E2,"PROCEDURE DATE: RECEIVED DATE: Pre-Op Diagnosis. Right colon cancer. Post-Op Diagnosis. Same as above. Clinical History. Nothing indicated. Gross Description: Received in a single container labeled. - right colon. and terminal ileum"" is a 23 cm previously opened portion of large. bowel including cecum, as well as 8 cm of attached previously opened. terminal ileum. The specimen is covered by a moderate amount of. pericolic and epiploic adipose tissue in which a 8.4 x 0.8 x 0.8 cm. grossly unremarkable vermiform appendix is identified. The visible. serosa is focally shaggy and tan pink with a few fibrofatty. adhesions. Noted at a point approximately 9 cm from the distal. margin is a 3.3 x 3.2 cm area of indurated umbilication of the. serosa. The specimen has been received after tissue harvest for. genomic study. Within the specimen container are three tissue. cassettes each labeled. The bowel wall is up to. 0.6 cm edematous and fibrotic. The lumen is lined by tan pink mucosa. with preservation of intestinal folds. In the area corresponding to. the umbilication at a point 8.6 cm from the distal margin and 3.8 cm. from the ileocecal valve is a partially sectioned 9.2 x 7.5 cm. plaque like finely granular centrally ulcerated tan pink lesion with. raised rolled borders. This has a gritty gray tan fibrotic cut. surface measuring up to 3.2 cm in thickness. The lesion grossly. extends through the muscularis but is limited by the serosa in the. area away from the pericolic fat. In the area of the pericolic fat. the lesion grossly appears to focally extend through the wall into. the adipose tissue where it is seen at its nearest point. approximately 0.9 cm from the nearest outer surface margin. The. lesion is noted within 0.1 cm of the outer surface in the area of. the serosa. Noted scattered along the length of the bowel are a few. additional tan gray polypoid excrescences up to 0.8 cm which are. unfixed to the underlying muscularis. On sectioning the surrounding. adipose tissue reveals multiple poorly defined fleshy tan pink to. yellow nodules up to 1.5 cm. Representative sections are submitted. labeled as follows: A - proximal margin; B - distal margin; C-G -. representative lesion and surrounding tissue; H - representative. polyps; I - random uninvolved bowel; J - appendix; K-N - individual. pericolic nodules bisected; O-R - whole smaller pericolic nodules. Microscopic Description: The slides labeled. are examined. See diagnosis. Final Diagnosis. Distal ileum, appendix, and right colon (right colectomy): Tumor characteristics: Tumor site: Cecum. Size: 9.2 cm in greatest diameter. Macroscopic tumor perforation: Not identified. Histologic type: Adenocarcinoma. Grade: Moderately differentiated. Microscopic tumor extension: Carcinoma extends through muscularis. propria into subserosal adipose tissue. Margin Status: Proximal margin: No carcinoma identified. Distal margin: No carcinoma identified. Circumferential radial/mesenteric margin: No carcinoma. identified. Distance of tumor from closest margin: 1 mm from the. circumferential radial margin. Treatment effect: Unknown. Lymphovascular space invasion: No unequivocal lymphovascular. space invasion identified. Perineural invasion: Not identified. Presence of mesenteric tumor deposits: Not identified. Lymph Node Status: Total number of lymph nodes examined: 32. Total number of lymph nodes containing metastatic carcinoma: Zero (0/32) PAS 9. Other findings: Scattered foci of lymphoid aggregates. PAS 6. Scattered hyperplastic polyps. PAS 4. Appendix: No carcinoma is identified. PAS 1 SPC-A. Stage: pT3NO. Comments. At the request of the undersigned pathologist, these slides have. been additionally reviewed by Dr. who concurs with the. diagnosis.",test,
3385,TCGA-ND-A4W6.F3CE442E-9166-401C-9E54-4852EC7285F2,"Hospital No: Date of Birth: Date Received: DIAGNOSIS: A. LEFT TUBE AND OVARY: Ovary and fallopian tube with multiple foci of papillary carcinoma,. predominantly in the lumen of vessels. B. RIGHT TUBE AND OVARY: Ovary and fallopian tube with multiple foci of papillary carcinoma,. predominantly in the lumen of vessels. C. UTERUS AND CERVIX: Malignant mixed mullerian tumor of the endometrium infiltrating the entire. thickness of the myometrium with extensive vascular invasion. Cervix: Foci of papillary serous carcinoma within vessels. Leiomyoma with foci of papillary serous carcinoma within vessels. D. RIGHT PARAAORTIC LYMPH NODE: Metastatic papillary serous carcinoma in lymph node extending to perinodal. connective tissue. E. OMENTUM BIOPSY: Adipose tissue, no tumor present. COMMENT: This malignant mixed mullerian tumor is composed of papillary serous. carcinoma, approximately 50%, and sarcoma, with extensive areas of. rhabdomyosarcoma, approximately 50%. All the foci of tumor in the myometrium, cervix,. fallopian tubes and ovaries consist of only papillary serous carcinoma. SYNOPTIC REPORT: Applies To: A : LEFT TUBE AND OVARY. B : RIGHT TUBE AND OVARY. C : UTERUS AND CERVIX. D : RIGHT PERIAORTIC LYMPH NODE. E : OMENTUM BIOPSY. Microscopic. Histologic Type: Malignant mixed mullerian tumor. Tumor Size: Dimensions: 12 X 10 X 8cm. Myometrial Invasion: Greater than 50% myometrial invasion. Patient Case(s): Copy For. PATIENT NOTIFIED OF RESULTS. DR: NURSE: Involvement of Cervix: Invasion of cervical stromal connective tissue. Margins: Uninvolved by invasive carcinoma. Lymphovascular Invasion: Present. Pathologic Staging (p FTNM) AJCC 7th Edition 2010. Primary Tumor (pT): pT3a : Tumor involves serosa and/or adnexa (direct extension or metastasis). Regional Lymph Nodes (pN): pNX: Cannot be assessed. Number of para-aortic lymph nodes examined: 1. Number of para-aortic lymph nodes involved: 1. HISTORY: Vaginal discharge. MICROSCOPIC FINDINGS: See diagnosis. GROSS: A. LEFT TUBE AND OVARY. Labeled. designated ""left tube and ovary"", and received in formalin is an intact adnexa. consisting of a short segment of non-fimbriated fallopian tube measuring 2.6 cm long and 1.2 cm in. diameter intimately attached to a 2.6 x 2.5 x 1.6 cm ovary. The fallopian tube lumen ranges from pinpoint. to 0.4 cm in diameter. The cut surface of the ovary is ill-defined mottled and pink-tan to white. The. overlying capsular surface is disrupted and shaggy. There is attached blood clot and fibrous adhesions. on the mesosalpinx of the fallopian tube. Ink key: black - external surface of adnexa. Representative sections are submitted. Slide key: A1-A3. Fallopian tube with attached ovary - 1 each. B. RIGHT TUBE AND OVARY. Labeled. designated ""right tube and ovary"", and received in formalin is an intact adnexa. consisting of a non-fimbriated segment of fallopian tube measuring 6.4 cm long and average diameter of. 1.5 cm attached to a 2.5 X 2.0 x 1.4 cm ovary. The attached mesosalpinx and fibrovascular paraovarian. tissue measures 4.5 x 2.5 x 1.0 cm. The ovary has a mottled pink-tan to white cut surface. The capsule. is shaggy and granular. The ovary has a patent lumen ranging from pinpoint to 0.2 cm in diameter. The. mesosalpinx has a shaggy surface with attached adhesions. The paraovarian soft tissue is thickened. and edematous. Ink key: black - external surface of adnexa. Representative sections are submitted. Slide key: B1. Fallopian tube cross sections - 2. B2, B3. Bisected presumed non-fimbriated distal end of fallopian tube - 2. B4. Ovary 2. B5. Paraovarian tissue - 2. C. UTERUS AND CERVIX FS. Labeled. designated ""uterus and cervix FS"", and received fresh for intraoperative. consultation is a 1331.5 gram total hysterectomy specimen. It measures 13.4 cm ectocervix to fundus,. 14.0 cm cornu to cornu, and approximately 14.0 cm anterior to posterior. The cervical portion of the. uterus is 3.0 cm long and up to 6.7 cm in maximum diameter. The endometrial cavity is approximately. 12.0 cm long and 10.0 cm wide. The myometrial thickness ranges from 1.4 to 3.5 cm. There is a large fungating mass entirely filling the endometrial cavity (12.0 X 10.0 x 8.0 cm). It is primarily. based in the uterus with extension into both the anterior and posterior lower uterine segments. The mass. is located 4.2 cm from the anterior ectocervix and 1.6 cm from the posterior ectocervix. On the adjacent. myometrium are several separate polypoid masses ranging from 1.0 to 2.2 cm in greatest dimension. The small portions of intervening myometrium range from smooth to pink-tan with an average thickness. of 0.3 cm to bulky solid and tan-white with a thickness of 0.6 cm. The exophytic portions of the mass. range from soft glistening to pink-tan to firm tan-white and whorled. The surface of the exophytic mass is. gray-yellow and necrotic appearing. Approximately 20% to 30% of the mass is necrotic appearing. The. entire mass is superficial with focal probable invasion. In the fundus of the anterior side there is invasive. to 0.4 cm out of a total myometrial thickness of 1.5 cm (less than 50%). In the remaining uterus the mass. is not grossly invasive. Separately received is an aggregate of polypoid necrotic and hemorrhagic mass. measuring 11.0 x 7.0 X 5.0 cm in aggregate. Within the myometrium are approximately 20 to 30 subserosal and intramural nodules ranging from 0.6 to. 5.8 cm in diameter. All of the nodules have a firm tan-white whorled cut surface. Areas of hemorrhage. necrosis are not identified. In one of the middle-sized subserosal nodules are focal calcifications. The. intervening myometrium is pink-tan and rubbery. On the serosal aspect of the uterine corpus are several. small fibrous adhesions. The endocervical canal is dilated with a flat tan-brown faintly granular mucosal. surface. Ink key: Blue - anterior paracervical tissue and uterine corpus serosa. Black - posterior paracervical soft tissue and uterine corpus serosa. Orange - inferior portion of lower uterine segment sections. A representative section is submitted for frozen section, and further submitted for permanent sections. Representative sections are submitted. Gross photographs are taken. Slide key: C1. Anterior cervix - 1. C2. Anterior lower uterine segment with mass - 1. C3-C5. Trisected mass anterior side mid corpus - 1 each. C6, C7. Bisected full thickness section of anterior fundus with soft glistening portion of mass and. probable deepest mass invasion - 1 each. C8-C10. Additional full thickness trisected anterior fundus with soft glistening portion of mass - 1 each. C11, C12. Representative sections of separately received tumor - 1 each. C13. Posterior cervix - 1. C14. Posterior lower uterine segment - 1. C15, C16. Bisected mid portion of posterior uterine corpus with mass - 1 each. C17-C19. Posterior fundus trisected full thickness section with solid firm whorled component of mass - 1. each. C20. Representative posterior leiomyomata - 4. C21. Representative anterior leiomyomata - 4. C22. Frozen section remnant - 1. D. RIGHT PARAAORTIC LYMPH NODE. Labeled. designated ""right paraaortic lymph node"", and received in formalin is a 3.0 x 1.4. X 0.9 cm semifirm candidate lymph node. The cut surface is partially cystic with a solid tan-white tumor. deposit measuring 1.3 cm in greatest dimension. The candidate node is representatively submitted. D1. 4. E. OMENTAL BIOPSY. Labeled. , designated ""omental biopsy"", and received in formalin is a portion of finely. lobulated tan-yellow fibroadipose tissue consistent with omentum measuring 7.0 X 4.0 x 0.6 cm. Mass. lesions are not identified. Representative sections are submitted. E1. Multiple. Gross dictated by. INTRAOPERATIVE CONSULTATION: OPERATIVE CALL. OPERATIVE CONSULT (FROZEN): FSC. UTERUS AND CERVIX: Uterine cavity filled by polypoid mass of tumor. grossly superficially invasive high-grade malignant tumor. I have personallv examined the specimen, interpreted the results, reviewed the report and signed it electronically.",test,
3411,TCGA-26-5134.bc937071-ca55-4002-b4fa-44326be2ac1b,"TUTO TC ANT ADDENDUM REPORT. SPECIMEN (S) SUBMITTED/ PROCEDURES ORDERED. A. Left brain mass. A. KI-67, Nuclear Antigen, Mibl (. A. Glial Fibrill. Acid Prt. A. 1P19q Malignant. Glioma Anaysis (. A. 1P19q Malignant Glioma Analysis, add. ) x 3. A. P53 Protein (88342) A. Frozen Section Charge (-. CLINICAL HISTORY: A. CT. A revealed left temporal lobe mass with some associated edema. GROSS DESCRIPTION: Received the following specimen in the Department of. Pathology, labeled with the patient's name and hospital #. A. Left brain mass. A. The specimen is received fresh, labeled ""brain lesion"" and consists. of two rectangular pieces of cerebral cortex with underlying subcortical. white matter. Each piece of tissue measures 4.2 x 4.0 x 1. cm and 4. 1 x. 3.0 x 1.4 cm. The meningeal surfaces are smooth and beige-tan, with a. fine reticulated vasculature. The resection margin is cauterized and. focally necrotic. Sectioning reveals a clear demarcation between the. gray and white matter layers. No discrete lesion is identified, however,. there is focal discoloration of the white matter. A representative. section of this discolored white matter is submitted for frozen section. Frozen section diagnosis is ""Malignant glioma, per. The. frozen section tissue is submitted for permanent processing in cassette. FSA1. Additional representative sections are submitted in cassettes. A2-A7. DIAGNOSIS: A. ""Left brain mass"": Glioblastoma multiforme with oligodendroglioma component. (WHO Grade IV) (see comment). COMMENT: This high grade glioma features areas of high cellularity,. mitoses, vascular endothelial proliferation and necrosis. The areas of. necrosis with apparent pseudopalisading are best represented in slide. ""A1"". Additional rather circumscribed foci of high grade. oligodendrogliomatous appearance are also seen. In such areas, the Ki-67. labeling index is 20-30% P53 is reactive in about 20% of tumor cell. nuclei. GFAP is reactive in some tumor cells and in reactive-appearing. astrocytes. These results support the diagnosis. bf these results on. ""I, or my qualified designee, have performed the gross examination and. description and I have personally reviewed the gross description and. specimen preparations referenced herein, and have personally issued this. report. "". Resident/Prosector/Pathologist: Note: Test systems have been developed and their performance. characteristics determined by. Some tests. have not been cleared or approved by the US FOOD and Drug Administration. The FDA has determined that such clearance is not necessary. These tests. are used for clinical purposes and should not be regarded as. investigational or for research. This laboratory is certified under the. Clinical Laboratory Improvement Amendments of. as qualified. to perform high complexity clinical laboratory testing. Pathlogist. CHROMOSOMES 1P AND 19Q ANALYSIS: FLUORESCENCE IN SITU HYBRIDIZATION (FISH) WAS PERFORMED ON REPRESENTATIVE. PARAFFIN-EMBEDDED TUMOR TISSUE (VYSIS). IN THIS CASE, NO DELETIONS OF 1P OR 19Q WERE IDENTIFIED. PLEASE REFER TO UF DIAGNOSTIC REFERENCE LABORATORIES REPORT: FOR. FURTHER DETAILS OF THIS ANALYSIS. REFERENCES:",test,
3418,TCGA-IB-AAUO.983120BC-7479-4129-ADBE-D9FAEFC2840E,"CONFIDENTIAL. Demographics (for. verification purposes). Sex: F. Collected Date/Time. Received Date/Time. Specimen Description. A: Node 8 at. B: Periportal lymph node at. C: Proximal bile duct margin at. D: Whipple's specimen at. Clinical Information. Pancreatic cancer. Diagnosis. A. Node 8: Metastatic adenocarcinoma with focal extracapsular extension. B. Periportal Lymph Node: Fibroadipose tissue only. C. Proximal bile duct margin: Inflammatory changes, no neoplasia. D. Whipples specimen: Poorly differentiated ductal carcinoma invasive into duodenum with. perineural, lymphatic and arterial channel invasion, present at the. uncinate resection margin. Four peripancreatic lymph nodes with metastatic adenocarcinoma. Verified: Synoptic Report. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G3: Poorly differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades duodenal wall. MARGINS: Margin(s) involved by invasive carcinoma. Uncinate process (retroperitoneal) margin (nonperitonealized surface of the uncinate. process). TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy) : No prior treatment. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT) : pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension. REGIONAL LYMPH NODES (pN) : pN1: Regional lymph node metastasis. Number examined: 5. Number involved: 5. ADDITIONAL PATHOLOGIC FINDINGS: Chronic pancreatitis. Gross Description. Received are specimen containers A to D all requisitions and specimen containers are. labelled with the patient's name,. The cassettes and. identifiers. are labelled with the Surgical Numper. A: The specimen is received fresh and is subsequently placed into formalin. The. container is designated A node 8. The specimen consists of a single possible fragment of. lymph node that measures 2.8 x 1.3 x 0.6 cm with attached adipose tissue. The specimen. is serially sectioned. The possible lymph node is submitted in A1/2 and the remaining. adipose tissue is submitted in A3. B: Specimen is received fresh. The container is designated B periportal lymph node. The specimen consists of two irregular portions of fibrofatty tissue measuring in. aggregate 4 x 2.5 x 0.5 cm. One piece is submitted in toto in B1, other piece is bisected. and submitted in toto in B2/3. C: The specimen consists of a ring-shaped piece of duct which measures 0.2 cm in length. and 0.9 cm in diameter. Submitted in toto for quick section in one block. Specimen is received fresh. The container is designated C proximal bile duct margin. D: Specimen is received fresh. The container is designated Whipple's The specimen. consists of a segment of duodenum with attached head of pancreas. The bowel measures. approximately 25 cm in length with a circumference which ranges from 4 to 6.5 cm. The. attached head of pancreas measures 6 x 5 x 2.5 cm. The pancreatic body margin is inked. blue, the mesenteric vessel bed margin inked orange, and the uncinate process inked. black. Sectioning the pancreas reveals a firm light tan ill defined mass near the. uncinate process measuring approximately 2.5 x 2.7 x 1.5 cm. Grossly, the mass comes. within 0.1 to 0.2 cm of the black painted uncinate process margin. It is approximately. 2.5 cm away from the blue painted pancreatic body margin. Grossly, the mass comes within. less than 0.1 cm of the external smooth mesothelial surface of the pancreas. The bile. duct is identified and upon opening, contains a stent. The bile duct measures 7 cm in. length and has a circumference of 2.5 cm at the proximal resection margin. The. circumference as it nears the ampulla is 1.5 cm. The mucosa of the bile duct is tan and. is hemorrhagic where the stent is found. The mucosal surface surrounding the ampulla is. firm and indurated. Where the mucosa of the ampulla and the duodenum is firm and. indurated, also corresponds to the location of the tumor which is found in the pancreas. Found in the adipose adjacent to the pancreas, are four possible lymph nodes ranging in. size from 0.7 to 2 cm in greatest dimension. Sections of the specimen as follows: D1. bile duct margin. D2/3. one section of the mass in the pancreas bisected. These sections also. demonstrate the. black painted uncinate process/retroperitoneal margin, as well as the. indurated duodenal. mucosa. D4/5. one section of the mass in the pancreas bisected. This section also shows. the black. painted uncinate process/retroperitoneal margin, as well as the indurated. duodenal. mucosa. three sections of bile duct and ampulla. D8/9. shave section of pancreatic body margin bisected. D10. section of grossly unremarkable pancreas with identifiable pancreatic duct. Also includes. a section of bile duct where the stent was located. D11/12. two further sections of bile duct where the stent was found. D13/14. proximal resection margin of duodenum ? distal portion of stomach bisected. D15. shave section distal margin of duodenum bisected. D16. one possible lymph node bisected. D17. two possible lymph nodes. D18/19. one possible lymph node bisected. Frozen Section Diagnosis. C: Proximal Bile Duct Margin: Low grade dysplasia. Negative for carcinoma. Encounter Number. Patient Location.",test,
3535,TCGA-EM-A3AP.10520066-D640-420F-B717-24B60B3F7465,"Facility: Specimen(e). 1. Thyrold: left hemithyroid stitch upper pole. Diagnosis. Papillary carcinoma, follicular variant, 3.6 cm; mild nodular hyperplasia: Thyroid, left hemithyroidectomy specimen. Synoptic Data. Clinical History: No radiation exposure. Procedure: Left hemithyroidectomy. Fresh. Specimen Integrity: Intact. Specimen Size: Left lobe: 4.3 cm. 3.6 cm. 2.3 cm. Isthmus +/- pyramidal lobe: 2.6 cm. 0.8 cm. 0.6 cm. Specimen Weight: 20.1 g. Tumor Focality: Unifocal. DOMINANT TUMOR. Tumor Laterality: Left lobe. Tumor Size: Greatest dimension: 3.6cm. Additional dimension: 3.2 cm. Additional dimension: 2.1 cm. Histologic Type: Papillary carcinoma,. follicular variant per J35, follicular varient = 100%. Follicular architecture. Classical cytomorphology. Histologic Grade: Not applicable. Margins: Margins uninvolved by carcinoma. Tumor Capsule: Totally encapsulated. Tumor Capsular Invasion: Not identified. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Not identified. Extrathyroidal Extension: Not identified. TNM Descriptors: Not applicable. Primary Tumor (pT): pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid. Regional Lymph Nodes (pN): pNX: Regional lymph nodes cannot be assigned. Number of regional lymph nodes examined: 0. Number of regional lymph nodes involved: 0. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: Adenomatoid nodule(s) or Nodular follicular disease. Thyroiditis, palpation. Pathologic Staging is based on AJCC/UICC TNM, 7th Edition. Gross Descriation. 1. The specimen labeled with the patient's name and as ""left hemithyroid stitch upper pole"", consists of a left hemithyroidectorny. specimen that is oriented with a suture and weighs 20.1 g. The lobe measures 4.3cm SI x 3.6 cm ML x 2.3 cm AP and the isthmus. measures 2.6 SI x 0.8 cm ML x 0.6 cm AP. The external surfaces have fibrous adhesions and are painted with blue dye. parathyroid glands or no lymph nodes are identified grossly. The mid superior lobe contains one well delineated nodule that. measures 3.6 cm SI x 3.2 cm ML x 2.1 cm AP. The cut surface of the nodule has a variegated red-brown color and has a soft and. flabby consistency. The remainder of the thyroid tissue is homogenous and grossly unremarkable. Sections of nodule and normal. tissue are stored frozen. The remainder of the specimen is submitted as follows: 1A-J. lobe, superior to Inferior. 1K. isthmus.",test,
3611,TCGA-BR-8680.90414042-1cda-4da6-b2e6-0dce995a8b8a,"Gross. Microscopic Description. Diagnosis Details. Description. In lesser curvature,. Mucosa is ulcerated. Tumor is. Tubular adenocarcinoma,. there is an ulcerated. invasion into serosa. Tumor is. moderately-differentiated,. tumor, with. composed of tubules containing. infiltrating serosa. 3x3x1cm in size,. necrosis or trabeculae. Glands are. firm and gray. variability in size and shape. Tumor. surface. cells are moderately straitified. Mitotic index is present. Nuclei are. hyperchromatic and irregularly. enlarged and prominent nucleoli. Stroma is invasion of prominent. lymphocytes. Tumor is necrotic. Comments. STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Antrum. Tumor size: 3 X 3 X 1 cm. Tumor features: Ulcerated. Histologic type: Tubular adenocarcinoma. Histologic grade: Moderately differentiated. Tumor extent: Serosa (visceral peritoneum). Lymph nodes: 3/10 positive for metastasis (Adjacent. lymph node 3/10). Lymphatic invasion: Present. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",test,
3615,TCGA-EB-A3Y7.E9D3A87B-37FB-4FAF-854F-373DE709EE14,"Laterality: Tumor Features: Pigmented, Tumor Extent: Tumor 2.01?4mm. with or without ulceration, Venous Invasion: Absent, Margins: Absent, Treatment Effect: Path Report:SKIN TISSUE CHECKLIST. Specimen type: Excision of skin lesion. Tumor site: Skin, facial. Tumor size: 1.5 x 1 x 2 cm. Tumor features: Pigmented. Satellite nodules: Present. Histologic type: Malignant melanoma. Histologic grade: Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Breslow thickness is 4 mm. Comments: None.",test,
3625,TCGA-G7-7502.56ad9f3c-f253-4ff4-a7ef-c89e1f7db059,"SPECIMENS: A. TUMOR BED LEFT PARTIAL NEPHRECTOMY. B. LEFT PARTIAL NEPHRECTOMY. SPECIMEN(S): A. TUMOR BED LEFT PARTIAL NEPHRECTOMY. B. LEFT PARTIAL NEPHRECTOMY. DIAGNOSIS: A. KIDNEY, LEFT, TUMOR BED BIOPSY: - NEGATIVE FOR MALIGNANCY. B. KIDNEY, LEFT, PARTIAL NEPHRECTOMY: - RENAL CELL CARCINOMA, PAPILLARY TYPE. - FUHRMAN NUCLEAR GRADE 2. - TUMOR SIZE: 6.2 X 6 X 5.3 CM. - SURGICAL MARGIN PSITIVE (FOCAL: 1MM). - NO VASCULAR INVASION IDENTIFIED. - TUMOR LIMITED TO THE KIDNEY. SYNOPTIC REPORT - KIDNEY (PARTIAL OR RADICAL). Specimens Involved. Specimens: A: TUMOR BED LEFT PARTIAL NEPHRECTOMY. B: LEFT PARTIAL NEPHRECTOMY. Specimen Type: Partial nephrectomy. Without adrenal gland. Laterality: Left. Tumor Site: Not specified. Focality: Unifocal. Tumor Size (largest tumor if multiple): Greatest dimension: 6.2cm. Additional dimensions: 6cm X 5.3cm. Macroscopic Extent of Tumor: Tumor limited to kidney. WHO CLASSIFICATION. Papillary renal cell carcinoma 8260/3. Histologic Grade (Fuhrman Nuclear Grade): G2: Nuclei slightly irregular, approximately 15 u;. nucleoli evident. Invasion of Vascular/Lymphatic: Absent. Perinephric Tissue Invasion: Absent. Margins: Margin(s) involved by invasive carcinoma. Include: Renal parenchymal margin (partial nephrectomy only). Distance: Ocm. Adrenal Gland: Not present. Regional Lymph Nodes: None sampled. Additional Findings: None identified. Pathological Staging (pTNM): pT 1b N X M X. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. pMX: Cannot be assessed. GROSS DESCRIPTION: A. TUMOR BED LEFT PARTIAL NEPHRECTOMY. Received fresh labeled with the patient's identification and designated ""tumor bed, left partial. nephrectomy"" is a fragment of tan fibrous tissue measuring 0.3 X 0.3 X 0.2 cm. Entirely submitted for. frozen section, FSA. B. LEFT PARTIAL NEPHRECTOMY. Received fresh labeled with the patient's identification and designated ""left partial nephrectomy"" is an. intact, unoriented, partial nephrectomy specimen, 6.5 X 6 X 5.3 cm, with detached fragment of adipose. tissue, 13.2 X 4.5 X 2 cm, collectively weighing 104 g. The parenchymal margin inked black, remainder. of kidney specimen inked blue. The kidney is sectioned to show an encapsulated, golden tan, lobulated,. soft friable mass measuring 6.2 x 6 X 5.3 cm, approaching the parenchymal margin at distance of 0.3. cm. The fragment of adipose tissue is sectioned to show unremarkable cut surface. Gross photographs. are taken. A portion of the specimen is submitted for tissue procurement, representatively submitted: B1-B5: Representative sections, mass and parenchymal margin. B6-B9: Representative sections, mass. B10: Representative sections, detached fragment adipose tissue. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: Left renal mass. FROZEN SECTION INTRAOPERATIVE REPORT: FSA: Soft tissue, tumor bed, biopsy: Fibroadipose tissue defer to permanent. Diagnosis called at. Microscopic/Diagnostic Dictation:., Pathologist,. Final Review:. Pathologist,. Final: Pathologist.",test,
3636,TCGA-R6-A6Y2.4E68B5A8-19BB-4D54-B503-493AF9146B19,"DIAGNOSIS. (A) STOMACH, LESSER CURVATURE ULCER SCAR, BIOPSY: Gastric mucosa with focal active inflammation, fibrosis of the lamina propria and foveolar hyperplasia;. negative for carcinoma. (B) DISTAL ESOPHAGEAL TUMOR, BIOPSY: INVASIVE ADENOCARCINOMA, MODERATELY TO POORLY DIFFERENTIATED. COLUMNAR MUCOSA WITH HIGH GRADE DYSPLASIA. Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) ULCER, SCAR, LESSER CURVATURE - Multiple tan-pink irregular fragments of tissue (1.0 X 0.7 x 0.2 cm in aggregate). Toto in A. (B) DISTAL ESOPHAGEAL TUMOR - Multiple tan-pink irregular fragments of tissue (1.3 X 0.7 x 0.2 cm in aggregate). Toto in B. CLINICAL HISTORY. Esophageal cancer and Barrett esophagus. SNOMED CODES. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". Released by: END OF REPORT-.",test,
3805,TCGA-AO-A12H.2FDFCEB5-74F7-417E-9FD1-ECC81B27803B,"Clinical Diagnosis & History: Palpable right breast mass with core biopsy showing invasive cancer. Specimens Submitted: 2: SP: Sentinel node #1, level 1, right axilla. 2: SP: Sentinel node #2, level 1, right axilla. 3 : SP: Sentinel node #3, level 2, right axilla. 4: SP: Right breast. 5: SP: Sentinel nodes #4 and #5, level 1, right axilla. 6: SP: Non-sentinel nodes right axilla. DIAGNOSIS: 1). LYMPH NODE, SENTINEL #1 LEVEL I RIGHT AXILLA; BIOPSY: - ONE BENIGN LYMPH NODE (0/1). - ADDITIONAL H/E LEVELS AND CYTOKERATIN (AE1:AE3) IMMUNOSTAINS ARE ALSO. NEGATIVE FOR METASTATIC TUMOR. 2). LYMPH NODE, SENTINEL #2 LEVEL I RIGHT AXILLA; BIOPSY: - ONE BENIGN LYMPH NODE (0/1). - ADDITIONAL H/E LEVELS AND CYTOKERATIN (AE1:AE3) IMMUNOSTAINS ARE ALSO. NEGATIVE FOR METASTATIC TUMOR. LYMPH NODE, SENTINEL #3 LEVEL II RIGHT AXILLA; BIOPSY: - ONE BENIGN LYMPH NODE (0/1). - ADDITIONAL H/E LEVELS AND CYTOKERATIN (AE1:AE3) IMMUNOSTAINS ARE ALSO. NEGATIVE FOR METASTATIC TUMOR. 4). BREAST, RIGHT; TOTAL MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, MODERATELY DIFFERENTIATED WITH. SOLID-PAPILLARY GROWTH PATTERN AND MUCINOUS DIFFERENTIATION, MEASURING 2.2. CM IN LARGEST DIMENSION MICROSCOPICALLY. FOCAL DUCTAL CARCINOMA IN SITU (DCIS). SOLID-PAPILLARY, SOLID AND. CRIBRIFORM TYPES WITH LOW TO INTERMEDIATE NUCLEAR GRADE AND MINIMAL. NECROSIS. - NIPPLE, SXIN AND SURGICAL MARGINS ARE NEGATIVE FOR TUMOR. - NO CONVINCING EVIDENCE OF LYMPHOVASCULAR INVASION. - PREVIOUS BIOPSY SITE CHANGES, STROMAL FIBROSIS AND ATROPHY. - IMMUNOHISTOCHEMICAL STAINS WERE PERFORMED ON FORMALIN-FIXED TISSUE. WITH THE FOLLOWING RESULTS FOR INVASIVE CARCINOMA (BLOCK ""T3) : rage 2 or 5. ESTROGEN RECEPTOR (6F11,. 100% NUCLEAR STAINING. WITH STRONG INTENSITY. PROGESTERONE RECEPTOR (1E2;. 5 NUCLEAR STAINING. WITH MODERATE INTENSITY. HER-2/NEU (HercepTest;. NEGATIVE (STAINING. INTENSITY OF 0). 5). LYMPH NODES, SENTINEL #4 AND #5 LEVEL I RIGHT AXILLA; EXCISION: - TWO BENIGN LYMPH NODES (0/2). 6). LYMPH NODES, NON-SENTINEL RIGHT AXILLA; EXCISION: FIVE BENIGN LYMPH NODES (0/5). I ATTEST THAT THE ABOVE DLAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL). AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Comment. RECUT. Gross Description: 1). The specimen is received fresh for frozen section consultation,. labeled ""Sentinel node #1, level one, right axilla"" and consists of a single. pink tan firm lymph node measuring 1.2 cm in greatest dimension. Bisected. and entirely submitted for frozen section. Summary of sections: FSC - frozen section control. 2). The specimen is received fresh for frozen section consultation,. labeled Sentinel node #2, level 1, right axilla"" and consists of a pink tan. firm lymph node measuring 0.5 cm. Entirely submitted for frozen section. Summary of sections: FSC - frozen section control. 1. 3). The specimen is received fresh for frozon section consultation,. labeled Sentinel node #3, level 2, right axilla"" and consists of a single. pink tan firm lymph node measuring 0.8 cm. Bicected and entirely submitted. for frozen section. Summary of sections: FSC - frozen section control. 4). The specimen is received fresh labeled, ""Right breast, stitch marks. axillary tail and consists of a breast measuring 25.2 x 24.6 x 3.2 cm with. overlying ckin ellipse measuring 15.1 x 14.6 cm. Situated centrally on the. skin surface is an everted nipple measuring 1.1 cm and areola measuring 4.1. x 4.2 cm. There is no scar on the skin surface. A suture demarcates the. axillary aspect. The posterior surface of the breast is inked black and the. axillary aspect is inked green. The specimen is serially sectioned to. reveal a 2.5 x 2.2 x 2.3 cm well circunscribed, brown, focally hemorrhagic. mass located at the 11 o'clock axis (upper outer quadrant), 0.9 cm from the. deep margin. A metallic clip is identified adjacent to this lesion. Additionally, a 1.7 x 1.5 x 1.5 cm fibrous area with areas of hemorrhage and. necrosis is present inferior to the 2.5 em mass in the 11 o'clock axis in. the retroareolar region. No other masses or lesions are grossly identified. The cut surfaces are composed of 60% fatty and 40% fibrous ticsue. Sectioning of the axillary aspect reveals no grossly identifiable lymph. nodes. Tissue submitted for TPS. Representative sections are submitted. Summary of sections: N nipple. NB - nipple base. s skin. D deep margin. T tumor. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. RA - retzoareolar fibrous tissue. 5). The specimen is received in formalin labeled, ""Sentinel nodes #4 and. 5, level 1, right axilla"", and consists of two tan lymph nodes measuring 2. cm and 0.8 cm respectively. Both are bisected and entirely submitted. Summary of sections: LLN - larger lymph node (bisected and submitted in two cassettes). SLN - smaller lymph node. 6). The specimen is received in formalin, labeled ""Non-sentinel nodes. right axilla"" and consists of multiple pink tan firm lymph nodes ranging. from 0.2 cm to 2.1 cm in greatest dimension. All identified lymph nodes are. submitted. Summary of sections: LN - lymph nodes. BLN - bisected lymph node. LLN - largest lymph node bisected and submitted in two cassettes. rage 4 or 5. Summary of Sections: Part 1: SP: Sentinel node #1, level 1, right axilla. Block. Sect. site. PCs. 1. FSC. 1. Part 2: SP: Sentincl node #2, level 1, right axilla. Block. Sect. Site. PCs. 1. FSC. 1. Part 3: SP: Sentinel node #3, level 2, right axilla. Block. Sect. Site. PCs. 1. FSC. Part 4: SP: Right breast. Block. Sect. Site. PCs. 1. 1. 1. LIQ. 1. 1. LOQ. 1. 1. N. 1. 1. NB. 1. 2. RA. 2. 1. S. 6. 6. 1. UIQ. 1. UOQ. 1. Part 5: SP: Sentincl nodes #4 and #5, level 1, right axilla. Block. Sect. Site. PCs. LLN. 2. 1. SLN. 1. Part 6: SP: Non-sentinel nodes right axilla. Block. Sect. Site. PCs. 1. BLN. 1. 2. LLN. 2. 1. LN. 1. Intraopezative Consultation: Note: The diagnoses given in this section pertain only to the tissue cample. examined at the time of the intraoperative consultation. ray a or. FROZEN SECTION DIAGNOSIS: SP: SENTINEL NODE #1, LEVEL 1,. RIGHT AXILLA. BENIGN LYMPH NODE. PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS: SP: SENTINEL NODE #2, LEVEL 1. RIGHT AXILLA. RENIGN LYMPH NODE, MAINLY FIBROFATTY WITH SCANTY. LYMPHOID TISSUE. PERMANENT DIAGNOSIS: SAME. 3). SECTION DIAGNOSIS: SP: SENTINEL NODE #3, LEVEL 2,. RIGHT AXILLA. BENIGN LYMPH NODE. PERMANENT DIAGNOSIS: SAME. Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraopezative consultation. 1). FROZEN. CECTION DIAGNOSIS: SP: SENTIMET MODE #1, LEVEL 1,. RIGHT AXILLA. BENIGN LYMPH NODE. PERMANENT DIAGNOSIS: SAME. 2). FROZEM ION DIAGNOSIS: SP: SENTINEL NODE #2, LEVEL 1,. RIGHT AXILLA. : BENIGN LYMPH NODE, MAINLY FIBROFATTY WITH SCANTY. LYMPHOID TISSUE. PERMANENT DIAGNOSIS: SAME. 3). FROVEN. ION DIAGNOSIS: SP: SENTINEL NODE #3, LEVEL 2,. RIGHT AXILLA. BENIGN LYMPH NODE. PERMANENT DIAGNOSIS: SAME.",test,
3960,TCGA-TM-A84R.3182D6DB-4B2D-49B0-A907-5DD62812D470,"CLINICAL DETAILS. Left frontal mass. ?low grade glioma. ?metastasis. ?lymphoma. FROZEN SECTION REPORT. SPECIMEN: ""LEFT FRONTAL MASS FROZEN SECTION"". REPORT: Glioma. No definite high grade features seen but increased cellularity noted. Await. paraffin sections for further grading. PHONED TO: Ext: TIME: SECTIONED BY: Clinical history: see above. Imaging findings: MRI brain. FIRST SEIZURE PRESENTATION. LEFT FRONTAL NON-ENHANCING CYSTIC LESION ON MRI SCAN DONE IN. (FOR INTRAOPERATIVEMRI). Initial sequences demonstrate a large intra-axial mass lesion. within the left frontal lobe measuring up to 7.5 x 3. 3cm in maxinum axial dimension and with "". partially cystic component superiorly. Following sequences demonstrate resection of a large. component of the lesion without apparent complication. Please see Surgeon's report for detuils."". Radiological Size of Lesion: 7.5 x 3.3cm. Contrast enhancement: non enhancing. Current and previous treatment: nil stated. Previous pathology lab number: nil present. Anatomical site: frontal lobe. Intra-axial/extra-axial: intra-axial. Laterality of tumour: left. Specimen type: biopsy. Clinical or differential diagnosis: ?low grade glioma. ?metastasis. ?lymphoma. MACROSCOPIC DESCRIPTION. Two specimens received. 1. ""LEFT FRONTAL MASS FROZEN SECTION"". There are two reddish tan fragments measuring. 5mm and 2mm. First half of largest piece bisceted and embedded in block A and two smears made. H+E and tol blue. le frozen section piece has been kept frozen and residual. tissue embedded in block A. Histopathology Report. Temporary Copy. Case: : 2. ""LEFT FRONTAL MASS HISTOPATHOLOGY"". There is one fragment of pale partially very. soll and haemorrhagie tissue. aggregating to 35 x 20 x 13mm. All embedded from block A-D. MICROSCOPIC REPORT. Specimen 1 and 2 show features of Oligodendroglioma WHO (2007) Grade II. The tumour is infiltrative and is of moderate to dense cellularity. It is composed of mostly round to. oval cells displaying mild nuclear pleomorphism, perinuclear halos and set in a fibrillary. background. Delicate branching vascular network is evident. In some areas, the tumour has a. demarcated pushing edge and the adjacent brain is severely gliotic with many gemistocytic. astrocytes and rosenthal-like fibres are seen (block 2D). There is perivascular lymphocytic cuffing. Therc is adjacent brain cortex and leptomeninges scen in block 2A. Perinuclear satellitosis is not a. feature in this biopsy. Mitotic figures are very infrequent with only two isolated mitosis identified in. all tumour blocks. There is no necrosis or endothelial proliferation. Immunohistochemistry was perfonmed: IDH 1 (R132H): GFAP: p53: EGFR: Ki-67: Microscopic findings: see above. Histological tumour type: Oligodendroglioma. Histological tumour grade: WHO (2007) grade II. Brain invasion (for meningiomas): n/a. Artefacts impacting specimen: nil significant. ANCILLARY TEST FINDINGS. Immunohistochemical stains block: 2A. Immunohistochemical stains result: IDH 1 (R132H): NEGATIVE. Positive antibodies: GFAP (patchy), EGFR (moderate). p53 (20% nuclei). Negative antibodies: IDHI(R132H). Equivocal antibodies: Ki-67 labelling index: 5%. Molecular pathology testing: FISH for 1p/19q and EGFR. IDH sequencing. Research consent: Research block: 2B. Dage 3of .3. Histopathology Report. Temporary Copy. SUMMARY. Specimen 1 and 2, Left frontal mass: - Oligodendroglioma WHO (2007) grade II. - IDHI (R132H) negative on immunohistochemistry. - Supplementary reports with molecular studies to follow. Histopathology Supplementary. Temporary Copy. Case: : SUPPLEMENTARY REPORT. RPAH GLIOMA FISH RESULTS This case was analysed for 1p/199 LOH using. dual. colour probe sets. 1p36,. 1q25 and. 19q13/19p13. Cut-off values: a 1p/lq ratio and. 19q/19p ratio of <-0.80 is taken as indicating LOH. Sixty cells were formally scored with each. probe pair. The case was also hybridised with. EGFR/Ccp7 dual colour FISH probeset to assess EGFR. gene amplification. Chromosome 1. Mean copies 1p per cell: 1.32. Mean copies 1q per cell: 1.92. 1p/lq ratio: 0.687. Interpretation: Ip loss detected by FISII. Chromosome 19. Mean copies 19q per cell: 1.08. Mean copies 19p per cell: 1.87. 194/19p ratio: 0.58. Interpretation: 194 loss detected by FISH. EGFR: Not amplified ( mean copies EGFR/cell= 1.95). COMMENT: Dual 1p/19q loss delected, consistent with oligodendroglial phenotype. No EGFR. anmplification detected. Thuis case was also refererd to. for IDH gene sequencing. They report an IDH2 (R172M) mutation (sce seperate report. SUPPLEMENTARY SUMMARY. Specimen 1 and 2. Left frontal mass: - Oligodendroglioma WHO (2007) grade II. - IDH2 (R172M) mutation detected by external laboratory. - 1p/19q codeletion detected by FISH. - No EGFR amplification. Neuropathology Report. Temporary Copy. CLINICAL HISTORY. Block 2B. Oligodendroglioma with 1p/19q codeletion but negative on IHC for IDHI. (R132H). For sequencing please. SPECIMEN DESCRIPTION. 1 vial of FFPE sections for IDH sequencing. Neuropathology Report. IDH1 and IDH2 MUTATION STATUS. HISTOLOGICAL ASSESMENT: The sample was review by a pathologist and estimated to contain at least 50 % tumour cells. METHOD: Codon 132 of the IDIII gene and codon 172 of the IDII2 gene are amplified and sequenced by pyrosequencing. IDHI: No Mutation Detected. IDH2: MUTATIONDETECTED - R172M. The HGVS nomenclature for this mutation is NM_002168.2(IDI(2): c.515G>T (p.R172M). COMMENTS. This result indicates that the tumour harbours the IDH2(p.R172M) mutation. No IDHI codon 132 mutation was present. Note: All PCR based tests are subject to a low risk of non-amplification of one allele due to primer binding site. single nucleotide polymorphisms (SNP). This can lead to a false negative result. Sample fixation causes DNA degradation which may result in false negative results due to non-amplification of. one allele (allelic drop out) or false positive results due to trans-lesional nucleotide repair during PCR. amplification. SUMMARY. This result indicates that the tumour harbours the IDH2 (p.R172M) mutation.",test,
4054,TCGA-WE-A8K4.1B421DA3-59DD-4246-8D3B-58F4AE13F36B,"Surgical Histology. Surgical Histology. ADDRESS FOR REPORT: HISTOPATHOLOGY REPORT. CASE HISTORY: ?BCC. 8mm punch. MACROSCOPIC: 8 mm punch biopsy. MICROSCOPY: A punch excision of skin showing a benign early trichilemmoma which. appears completely excised. There is no evidence of dysplasia or. malignancy. DIAGNOSIS: 8MM PUNCH EXCISION OF SKIN (RIGHT CHEEK) : TRICHILEMMOMA. Surgical Histology. Surgical Histology. ADDRESS FOR REPORT: Report to Cancer Registry. HISTOPATHOLOGY REPORT. CASE HISTORY: Superficial mass for many years. Ulcerated skin over mass. ? Fat. necrosis in old lipoma. MACROSCOPIC: One core of tissue, 0.9 cm, plus frags. MICROSCOPY: A fragmented needle core biopsy of fibrofatty tissue, which includes. parts of a malignant neoplasm. It is composed of pleomorphic large. epithelioid and spindle-cell shaped cells. They have abundant. eosinophilic (sometimes faintly yellowish) cytoplasm and large. eosinophilic nucleoli. Elsewhere, the tissue shows chronic. iibro-inflammatory changes with focal yellowish brown pigment. (probably blood-derived). There are various possibilities, of which malignant melanoma or. metastatic carcinoma are likely contenders. Are there any clinical. or historical clues?. Please regard this as a provisional and preliminary urgent report. Definitive diagnosis will depend upon immunohistochemical staining. A further report will follow. DIAGNOSIS: CORE BIOPSY OF MASS, RIGHT ARM. SUPPLEMENTARY REPORT: Histochemical and immunohistochemical staining has been undertaken. No definite melanin is recognised within the tumour cells. They are. strongly immunostained in S100 protein, melan A, and HMB-45. preparations. They do not stain for keratins. These observations. imply that the tumour is a malignant melanoma. The history provided. seems odd in that context. DIAGNOSIS: CORE BIOPSY OF MASS, RIGHT ARM: MALIGNANT MELANOMA. REPORT DATE: MALIGNANT MELANOMA MINIMUM DATA SET. LAB NUMBER: PRIVATE PATIENT: ADDRESS FOR REPORT: CLINICAL HISTORY: Melanoma right upper arm. MACROSCOPIC: Large disc of skin 12 x 17 X 3.5 cm. Skin sutured centrally with. underlying firm tumour, 4 cm maximum diameter, which has been. sliced open, disrupted Distance of tumour to margin approximately 4. cm,. minimum 2.0 cm. Deep margin black. Peripheral margin yellow. Closest margin is A and B. A and B continuous. C and D continuous. E and F = random tumour. MICROSCOPIC: Tumour type. Nodular. Growth phase. Vertical. Breslow thickness (mm). 12.00. Mitotic rate (/sq mm). 4. Regression. Absent. Lymphovascular invasion. Absent. Perineural invasion. Absent. Microsatellites. Absent. Coexistent naevus. Absent. Tumour infiltrating lymphocytes. Non-brisk. Completely Excised. Deep margin (mm). 0.3. Circumferential margin (mm). 20.0. Stage. pT4a. COMMENT: Skin sliced open before receipt ulceration can not be. excluded. The possibility of a metastatic lesion should be excluded. clinically. DIAGNOSIS: Skin of Right Arm: Malignant Melanoma. ADDITIONAL REPORT: BRAF immunostain is negative. This case was sent to. for BRAF. testing. BRAF gene analysis using PCR for. Codon 600, Exon of BRAF gene showed no evidence of mutation. Surgical Histology. Surgical Histology. Report to Cancer Registry. HISTOPATHOLOGY REPORT. LAB No: Lab No. Hosp No. CASE HISTORY: Prostate chippings. Catheter in-situ for retention. DRE hard prostate. PSA awaited ?Ca prostate. MACROSCOPIC: Prostate chips weighing 24g. MICROSCOPY: Shows infiltrating adenocarcinoma with more than 90% of the prostate. chips. The features are those of Gleason 4+4=8 with tertiary. pattern 5. DIAGNOSIS: PROSTATE CHIPPINGS: INFILTRATING ADENOCARCINOMA IN MORE THAN 90% OF. TISSUE. pTlb. Consultant Histopathologist. Consultant Histopathologist. REPORT DATE:",test,
4098,TCGA-E8-A415.1592C973-2E73-4A7D-9DF3-7EFD67E67519,"Laterality:Tumor consists of papillae having an fine fibrovascular stalk or. colloid folliculae covered by a single to mutiple layers of cuboidal epithelial cells. Tumor invades in. capsule or vessle or begnin tissue or muscle. The cells tend to maintain their polarity. Nuclei are quite. regular and contain finely dispersed chromatin, or intranuclear grooves. Tumor is fibrous. Path Report:Tumor type:Papillary carcinoma. Tumor size: 1x0.7x0.7cm. Laterality: left. Tumor focality: Unifocal. Invasion of capsule: Yes. Extrathyroidal extension: No.",test,
4298,TCGA-MT-A7BN.BEDF059B-CFDA-4B9C-A9A3-1737D814910B,"SPECIMEN(S): A: Posterior skin. B: Subdermal mass, under flap by external jugular. C: Posterior parotid perifacial node. D: Greature auricular. E: Paratid Superior margin of tumor. F: Right parotidectomy. G: Upper deep margin. H: Lower deep margin. I: Inferior skin margin. J: Anterior skin margin. K: Superior skin margin. L: Ear lobe skin margin. M: Zone 3 lymph node. N: Neck dissection: Lateral zones 2 and 3. O: Anterior zones 2A and 3. P: Submandibular gland, right. FINAL DIAGNOSIS: A. Posterior skin, excision: Squamous mucosa, negative for carcinoma. B. Subdermal mass, under flap by external jugular, excision: - One lymph node, negative for carcinoma (0/1). C. Posterior parotid perifacial node, excision: - One lymph node, negative for carcinoma (0/1). D. Greature auricular, excision: - Fibroconnective tissue, negative for carcinoma. E. Paratid superior margin of tumor, excision: - Benign salivary gland tissue. - No evidence of carcinoma. F. Right parotid, right parotidectomy: - Invasive squamous cell carcinoma, poorly differentiated, greater than 5.0 cm. - Resection margin: Negative for carcinoma. The invasive carcinoma. is 0.1 cm from the closest resection margin. - No squamous cell carcinoma in situ identified. - Benign salivary glands. - See comment. G. Upper deep margin, excision: - Benign salivary gland tissue, negative for carcinoma. H. Lower deep margin, excision: - Benign salivary gland tissue, negative for carcinoma. I. Inferior skin margin, excision: - Squamous mucosa, negative for carcinoma. J. Anterior skin margin, excision: - Squamous mucosa, negative for carcinoma. K. Superior skin margin, excision: - Squamous mucosa, negative for carcinoma. L. Ear lobe skin margin, excision: - Squamous mucosa, negative for carcinoma. M. Zone 3 lymph node, excision: - One lymph node, negative for carcinoma (0/1). N. Neck dissection: Lateral zones 2 and 3, excision: Thirteen lymph nodes, negative for carcinoma (0/13). O. Anterior zones 2A and 3, excision: - One of three lymph nodes with metastatic poorly differentiated. squamous cell carcinoma (0.6 cm in length) (1/3). - Extranodal extension: Absent. P. Submandibular gland, right, excision: - Benign salivary gland tissue, negative for carcinoma. COMMENT: Invasive poorly differentiated squamous cell carcinoma (greater than 5.0 cm) is. identified in the parotid glands. No squamous cell carcinoma in situ is. seen. The invasive squamous cell carcinoma could be from the overlying. skin, metastatic from other organs or primary tumor from parotid. However, primary parotid squamous cell carcinoma is very uncommon. Correlation with complete clinical information is required. Reviewed CT + PET scen I wk prior. CLINICAL HISTORY: The patient has right parotid cancer. Operative Procedure: Right parotidectomy with radical neck dissection. and margins. Multiple frozen sections.",test,
4449,TCGA-BQ-5876.6dd5e138-f74b-4777-9001-533eece6076a,"Clinical Diagnosis & History: Right renal mass. Specimens Submitted: 1: Right kidney; partial nephrectomy. DIAGNOSIS: 1. Right kidney; partial nephrectomy: PAPILLARY RENAL CELL CARCNIOMA, TYPE 8, (HIGH GRADE). TUMOR MEASURES 1.3 CM. TUMO IS CONFINED WITHIN THE RENAL CAPSULE. - NO INVASION OF THE RENAL VEIN IS IDENTIFIED. - SURGICAL MARGIN IS FREE OF TUMOR (TUMOR IS 0.2 CM FROM THE RESECTION MARGIN). - INCIDENTAL PAPILLARY ""ADENOMA"" (1.0 MM). IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (ANDIOR OTHER MATERIAL), AND THAT THAVE. REVIEWED AND APPROVED THIS REPORT. 1). The specimen is received fresh for frozen section, labeled ""Right Kidney Tumor"". It consists of a piece of renal cortex. measuring 4 x 3.5 x 1 cm. Sectioning of the tissue reveals a well-circumscribed, cystic tumor measuring 1.3 x 0.5 x 2 cm, filled. with gray-tan, soft, cheesy material. The tissue surgical margin is inked black. The tumor is 0.2 cm away from the surgical. margin. A portion of tissue is submitted for TPS. Photographs are taken. Representative sections are submitted for histologic. examination. Summary of Sections: FSC - frozen section control. T tumor. Summary of Sections: Part 1: Right kidnoy; partial nephrectomy. Block. Sect. Site. PCs. 1. fsc. 1. ss. 4. 3. 3. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the lissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: RENAL CORTICAL NEOPLASM; STITCHED MARGIN IS FREE OF TUMOR. PERMANENT DIAGNOSIS: SAME.",test,
4460,TCGA-78-7154.00bdbfd9-ca96-4c34-b4c1-eae63818fa93,"HISTORY. Left lobe lobectomy upper. MACROSCOPIC. Two specimens submitted. 1: The specimen is labelled ""left upper lobe"" and consists of a left upper lobe of lung measuring 220 X. 90 X 17 mm. A large area of parietal pleural adhesion is noted on the anterolateral surface. Beneath. this a firm mass is palpable within the anterior segment. On sectioning a mass is confirmed within the. lung. The mass measures 40 X 17 X 32 mm and has a cream to tan cut surface with black streaking. The tumour lies adjacent to the area of thickened and adherent pleura. The tumour is over 25 mm away. from the medial pleural surface and is well clear of the posterior pleural surface. The tumour is at least. 40 mm away from the bronchial resection margin. The uninvolved lung tissue appears unremarkable. [1A, bronchial resection margin; 1B, peribronchial lymph nodes; 1C, tumour with adherent lateral. pleura; 1D, adjacent medial pleural margin; 1E-1F, further sections through tumour; 1G, uninvolved. lung]. 2: The specimen is labelled ""lymph node No. 5"" and consists of a single fragment of cream fatty tissue. containing grey-black lymph nodes. The specimen measures 25 X 18 X 7 mm. No obvious. involvement by tumour is noted on sectioning. [Bisected and BIT, 2A-B]. MICROSCOPIC. 1: Sections show a moderately to poorly differentiated adenocarcinoma which invades into the. overlying adherent parietal pleura but appears clear of the soft tissue resection margin. Definite. vascular or lymphatic invasion is not identified. Metastatic adenocarcinoma is present in one of the. peribronchial lymph nodes with transcapsular extension into adjacent hilar fibrofatty tissue and. perineural and intraneural invasion in this region. The bronchial resection margin is clear of. malignancy but shows several foci of squamous metaplasia and low-grade dysplasia. Distant lung. parenchyma shows focal organising pneumonia, congestion and emphysema. 2: Sections show partial replacement of the lymph nodes by metastatic carcinoma with transcapsular. extension into the adjacent fibrofatty tissue. SUMMARY. Left upper lobectomy and lymph node No 5: Moderately to poorly differentiated adenocarcinoma, 40 mm in diameter. Invasion of parietal pleura present. No vascular invasion identified. Metastatic adenocarcinoma present in peribronchial and No 5 lymph nodes. Perineural and intraneural invasion present in hilar soft tissue. Pathological stage T3 N2. T-28000 M-81403 P1-03000. SUPPLEMENTARY REPORT. Elastic stains demonstrate unequivocal vascular invasion by tumour.",test,
4569,TCGA-EM-A3AN.44BB965E-D260-47EA-9FA9-C5CEEED6C0F6,"Amended. Facility: Specimen(e). 1. Neck: Right neck contents single stitch marks superior, double stitch marks anterior. 2. Lymph node: Left jugulodigastric node. 3. Neck: Left neck contents stitch marks apex. 4. Parathyroid: Right upper parathyrold/QS. 5. Lymph node: Left paratracheal node. 6. Thyrold: Total thyroid, stitch marks upper pole, left lobe, with left paratracheal node. Diagnosis. 1. Metastatic papillary thyroid carcinoma with extranodal extension: Lymph nodes, 12 of 37 (Right neck) dissection specimen. 2. No pathological diagnosis: Lymph node, 1 (left jugulodigastric) excision. 3. Metastatic papillary thyroid carcinoma: Lymph nodes, 7 of 31 (left neck) dissection specimen. 4. No pathological diagnosis: Parathyroid (right upper) biopsy. 5. Metastatic papillary thyroid carcinoma with extranodal extension: Lymph node, 1 of 2 (left paratracheal) excision. 6. Widely invasive papillary carcinoma, 1.2 cm, right, mixed classical and follicular variant, with psammomatous intrathyroidal. dissemination involving isthmus and left; and focal involvement of right resection margin; mild nonspecific chronic. thyroiditis; mild follicular nodular disease: Thyroid. Metastatic papillary thyroid carcinoma with extranodal extension: Lymph nodes, 7 of 9, isthmus and central neck. No pathological diagnosis: parathyroid, central compartment. No pathological diagnosis: Thymus. - total thyroidectomy and central compartment dissection specimen. See Comment. Comment. The papillary carcinoma is widely invasive with psammomatous dissemination in the right and left lobes, filling lymphatic channels. throughout the thyroid and in adjacent peri-thyroidal soft tissue. The largest single focus of tumor measures 1.2 cm and is in the. right lobe. Although there are foci that are suspicious of angioinvasion, no definitive vascular invasion is identified. Because the. tumor involves the painted margin of resection, the presence of extrathyroidal extension cannot be accurate assessed. Clinical. correlation is recommended. Synoptic Data. Procedure: Total thyroidectomy with bilateral neck dissection. Other: Total thyroidectomy with bilateral neck dissection and central compartment dissection. Fresh. Specimen Integrity: Intact. Specimen Size: Right lobe: 4.0 cm. 2.7 cm. 1.3 cm. Left lobe: 4.0 cm. 2.7 cm. 1.1 cm. Isthmus +/- pyramidal lobe: 2.0 cm. 0.8 cm. 0.5 cm. Central compartment: 4.5 cm. 2.5 cm. 1.5 cm. Right neck dissection: 14.8 cm. 4.3 cm. 1.5 cm. Left neck dissection: 11.0 cm. 3.0 cm. 1.8 cm. Specimen Weight: 22.3 g. Tumor Focality: Unifocal. DOMINANT TUMOR. Tumor Laterality: Right lobe. Tumor Size: Greatest dimension: 1.2cm. Additional dimension: 1.0 cm. Additional dimension: 1.0 cm. Histologic Type: Papillary carcinoma, classical (usual). Papillary carcinoma, follicular variant. Classical (papillary) architecture. Follicular architecture. Classical cytomorphology. Histologic Grade: Not applicable. Margins: Margin(s) involved by carcinoma. Tumor Capsule: Totally encapsulated. Tumor Capsular Invasion: Present, extent widely invasive. Lymph-Vascular Invasion: Indeterminate. Perineural Invasion: Not identified. Extrathyroidal Extension: Cannot be assessed. TNM Descriptors: Not applicable. Primary Tumor (pT): pT1b: Turnor more than 1 cm but not more than 2 cm in greatest dimension, limited to the. thyrold. Regional Lymph Nodes (pN): pN1b: Metastases to unilateral, bilateral or contralateral cervial or superior medastinal. lymph nodes. Number of regional lymph nodes examined: 80. Number of regional lymph nodes involved: 27. Lymph Node, Extranodal Extension Present. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: Adenomatoid nodule(s) or Nodular follicular disease. Thyroiditis, focal (nonspecific). Parathyroid gland(s), within normal limits. Other. Thymus with no pathological diagnosis. Pathologic Staging is based on AJCC/UICC TNM, 7th Edition. Gross Description. 1. The specimen labeled with the patient's name and as ""right neck contents, single stitch marks superior, double stitch marks. anterior"" consists of an oriented right neck dissection with overall dimensions of 14.8 cm SI x 1.5 cm ML x 4.3 cm AP. The. specimen is painted with silver nitrate. The internal jugular vein, stemocleidomastoid and submandibular gland are not identified. Multiple lymph nodes ranging from 0.2 to 3.8 cm are identified; 4 of these are partially calcified. Tissue is stored frozen. Representative sections are submitted from superior to inferior: 1A. multiple lymph nodes. 1B. one lymph node bisected. 1C-D. multiple lymph nodes. 1E. one lymph node bisected. 1F. representative section from largest partly calcified tymph node submitted for decaicification. 1G. 1 lymph node bisected. 1H. 1 lymph node serially sectioned. 11. multiple lymph nodes. 1J. query one lymph node bisected. 1K. lymph node bisected. 1L-M. one lymph node bisected. 1N. multiple lymph nodes. 10. one lymph node bisected. 1P-R. one partly calcifled lymph node trisected and submitted for decalcification. 1S. multiple lymph nodes. 1T-U. one lymph node serially sectioned. 2. The specimen labeled with the patient's name and as ""left jugulodigastric node"" consists of a piece of tan-brown tissue that. measures 1.1 x 0.4 x 0.2 cm received in 10% buffered formalin. 2A. submitted in. 3. The specimen labeled with the patient's name and as ""left neck contents, stitch marks apex"" consists of an oriented left neck. dissection with overall dimensions of 11.0 cm apex to base by 3.0 cm x 1.8 cm. There is a suture indicating the apex. The. specimen is painted with silver nitrate. The internal jugular vein, stemocleidomastoid and submandibular gland are not identified. Multiple lymph nodes ranging from 0.3 to 3.0 cm are identified in multiple levels. Representative sections are submitted from apex. o base. 3A-D. multiple lymph nodes. BE. one lymph node bisected. 3F. multiple lymph nodes. IG. 1 lymph node bisected. 3H. multiple lymph nodes. II-K. one lymph node serially sectioned (K submitted for decalcification). I. The specimen labeled with the patient's name and as ""right upper parathyroid QS consists of a piece of tissue that measures. 1.1 cm in maximum dimension and weighs 0.004 g. It is frozen for intraoperative consultation. IA. frozen tissue resubmitted. i. The specimen labeled with the patient's name and as ""left paratracheal node' consists of one piece of tan-brown tissue that. neasures 1.5 x 1.7 x 0.4 cm received in 10% buffered formalin. The specimen is painted with silver nitrate. Tissue is stored. rozen. iA. submitted in. i. The specimen labeled with the patient's name and as ""total thyroid, stitch marks upper pole, left lobe with left paratracheal. ode"" consists of a thyroid gland that is oriented with a suture and weighs 22.3 g. Attached to the thyroid is a piece of soft tissue. that measures 2.5 cm SI x 4.5 cm ML x 1.5 cm AP. It contains multiple lymph nodes, the largest measuring 2.5 x 1.4 x 1.0 cm;. one is partially calcified. The right thyroid lobe measures 4.0 cm SI x 2.7 cm ML x 1.3 cm AP, the left lobe measures 4.0 cm SI x. 2.7 cm ML x 1.1 cm AP and the isthmus measures 2.0 cm SI x 0.8 cm ML x 0.5 cm AP. The external surfaces have fibrous. adhesions and are painted with silver nitrate. No parathyroid glands are identified grossly. The right upper lobe contains a well. delineated nodule that measures 1.0 cm SI x 1.2 cm ML x 1.0 cm AP. The remainder of the thyroid tissue is grossly. unremarkable. Tissue is stored frozen. The remainder of the specimen is submitted as follows: 6A-I. right lobe superior to inferior. 6J. isthmus. 6K-R. left lobe superior to inferior. 6S. multiple lymph nodes. 6T. one lymph node bisected. 6U-V. one lymph node serially sectioned. 6W. one partly calcified lymph node section for decaicification. whish. Right upper parathyrold: Parathyroid tissue present. called at. , MO.",test,
4581,TCGA-H7-A6C4.AEC9F6D0-E697-47C8-9654-F0EF52454EF8,"Operative Procedure: Glossectomy, neck dissection. A: Right vocal cord biopsy (FS). B: Level 1 neck dissection-left. C: Base of tongue at hyoid (FS). D: Distal lingual nerve margin (FS). E: Left lingual artery biopsy (FS). F: Deep tongue base margin #1 (FS). G: Tongue base mucosa margin (FS). H: Anterior mucosa margin (FS). I: Anterior inferior mucosa margin (FS). J: Posterior medial mucosa margin (FS). K: Deep medial margin (FS). L: Posterior deep base of tongue (FS). M: Proximal lingual nerve biopsy (FS). N: Left tongue lesion. O: Left neck dissection level 2-4. P: Left neck dissection 2B. Final Pathologic Diagnosis: Left tongue, partial glossectomy: Keratinizing squamous cell carcinoma, moderately. differentiated. Histologic type/grade: Keratinizing squamous cell carcinoma,. moderately differentiated. Tumor size: 3.0 cm (greatest dimension). Depth of invasion: 0.8 cm (greatest dimension). Lymph-vascular invasion: Present. Perineural invasion: Present. Tumor site: Left lateral tongue. Tumor focality: Single focus. Margins: Deep surgical margin transected by carcinoma on. the resected specimen (frozen section margins are negative). Margins uninvolved by carcinoma in situ. Lymph nodes, extranodal extension: Left level 1-4 lymph node. dissection: Metastatic squamous cell carcinoma (5/30 lymph nodes positive,. extracapsular spread present, maximal dimension 4.8 cm). Pathologic Staging (pTNM): Primary tumor (pT): pT2. Regional lymph nodes (pN): pN2b. Number examined: 30. Number involved: 5. Size of the largest positive lymph node: 4.8 cm (greatest. dimension). Distant metastasis (pM): pMX. Additional pathologic findings: None. Specimen: Tongue, lateral surface. In formalin. Procedure: Partial glossectomy with left neck dissection. levels 1-4. Specimen size: 5.6 x 4.9 x 2.3 cm (greatest dimensions). Specimen laterality: Left. A. Right vocal cord biopsy: Moderate epithelial dysplasia, frozen section diagnosis confirmed. B. Level 1 neck dissection, left: Metastatic squamous cell carcinoma (2/8 lymph nodes positive, maximal. dimension 2.7 cm, no extracapsular spread). C. Base of tongue at hyoid, biopsy: Detached fragment of squamous cell carcinoma, frozen section diagnosis. confirmed. D. Distal lingual nerve margin (FS): No evidence of malignancy, frozen section diagnosis confirmed. E. Left lingual artery biopsy (FS): No evidence of malignancy, frozen section diagnosis confirmed. F. Deep tongue base margin #1 (FS): No evidence of malignancy, frozen section diagnosis confirmed. G. Tongue base mucosa margin (FS): No evidence of malignancy, frozen section diagnosis confirmed. H. Anterior mucosa margin (FS): No evidence of malignancy, frozen section diagnosis confirmed. I. Anterior inferior mucosa margin (FS): No evidence of malignancy, frozen section diagnosis confirmed. J. Posterior medial mucosa margin (FS): No evidence of malignancy, frozen section diagnosis confirmed. No epithelium is present on the frozen or permanent sections. K. Deep medial margin (FS): No evidence of malignancy, frozen section diagnosis confirmed. L. Posterior deep base of tongue (FS): No evidence of malignancy, frozen section diagnosis confirmed. M. Proximal lingual nerve biopsy (FS): No evidence of malignancy, frozen section diagnosis confirmed. N. Left tongue lesion, partial glossectomy: Keratinizing squamous cell carcinoma, moderately differentiated (see. Synoptic Report for details). O. Left neck dissection level 2-4: Metastatic squamous cell carcinoma (3/15 lymph nodes positive, maximal. dimension 4.8 cm, extracapsular spread present). P. Left neck lymph node dissection levvel 2B: No evidence of malignancy (0/7 lymph nodes positive). The examination of this case material and the preparation of this report were. Intraoperative Consult Diagnosis: FSA: Right vocal cord biopsy: Low grade squamous dysplasia with focal moderate dysplasia. F/S TAT: 6 mins. FSC: Basal tongue at hyoid: Detached fragment of squamous mucosa with at least mild to moderate. dysplasia. Carcinoma in situ cannot be excluded (poor. orientation). F/S TAT: 19 mins. FSD: Distal lingual nerve margin: Negative for tumor. FSE: Left lingual artery biopsy: Negative for tumor. FSF: Deep tongue base margin #1: Negative for tumor. FSG: Tongue base mucosa margin: Mild squamous dysplasia. FSH: Anterior mucosa margin: Negative for tumor. FSI: Anterior inferior mucosa margin: Negative for tumor. FSJ: Posterior medial mucosa margin: Negative for tumor (squamous mucosa not present). FSK: Deep medial margin: Negative for tumor. FSL: Posterior deep base of tongue: Negative for tumor. FSM: Proximal lingual nerve biopsy: Negative for tumor. F/S TAT: 30 mins. Gross Description: The specimen is received in sixteen parts, each labeled with the patient's name. Part A received fresh for intraoperative consultation labeled ""right vocal cord. biopsy"" and consists of a 0.2 cm in greatest dimension irregular, gray-tan soft. tissue, which has been submitted in toto for frozen section diagnosis and the. residue resubmitted for permanent sections in cassette A. Note, it is. questionable as to whether this specimen will survive processing. Part B received in formalin labeled ""level 1 neck dissection, left"" and consists. of a portion of irregular, ragged, focally fragmented, gray-yellow to red-brown,. focally cauterized fibrofatty tissue, which has dimensions of 8.5 x 5.2 X 2.8. cm. The fat contains a gray-yellow, lobulated salivary gland, which has. dimensions of 4.8 x 2.7 x 1.6 cm. There are no focal lesions identified within. the salivary gland. Sectioning through the remainder of the fat reveals eleven. probable lymph nodes that range from 0.4 to 2.7 cm in greatest dimension. The. largest lymph node is grossly positive. Representative sections are submitted as labeled: B1. salivary gland;. B2. four lymph nodes submitted in toto;. B3. one bisected lymph node;. B4. one bisected lymph node;. B5. a representative section of the largest grossly positive lymph node;. B6. one bisected lymph node;. B7. one bisected lymph node;. B8. one bisected lymph node;. B9. one bisected lymph node. Part C received fresh for intraoperative consultation labeled ""base of tongue. at. hyoid"" and consists of three irregular, gray-tan soft tissues, which have. greatest dimensions of approximately 0.3 cm each, which have been submitted in. toto for frozen section diagnosis and the residue resubmitted for permanent. sections in cassette C. Part D received fresh for intraoperative consultation labeled ""distal lingual. nerve margin"" and consists of a 0.4 cm in greatest dimension irregular gray-tan. soft tissue, which has been submitted in toto for frozen section diagnosis and. the residue resubmitted for permanent sections in cassette D. Part E received fresh for intraoperative consultation labeled ""left lingual. artery biopsy"" and consists of two irregular, gray-tan soft tissues, which have. greatest dimensions of 0.2 and 0.6 cm, which have been submitted in toto for. frozen section diagnosis and the residue resubmitted for permanent sections in. cassette E. Part F received fresh for intraoperative consultation labeled ""deep tongue base. margin #1"" and consists of a 0.8 cm in greatest dimension irregular, gray-tan. soft tissue, which has been submitted in toto for frozen section diagnosis and. the residue resubmitted for permanent sections in cassette F. Part G received fresh for intraoperative consultation labeled ""tongue base. mucosa margin"" and consists of two irregular, gray-tan soft tissues, which have. greatest dimensions of 0.3 and 0.7 cm, which have been submitted in toto for. frozen section diagnosis and the residue resubmitted for permanent sections in. cassette G. Part H received fresh for intraoperative consultation labeled ""anterior mucosa. margin"" and consists of three irregular, gray-tan soft tissues, which have. greatest dimensions of 0.3, 0.7 and 0.9 cm, which have been submitted in toto. for frozen section diagnosis and the residue resubmitted for permanent sections. in cassette H. Part I received fresh for intraoperative consultation labeled ""anterior inferior. mucosa margin"" and consists of an irregular, gray-tan soft tissue, which has a. greatest dimension of 1.0 cm. The specimen has been submitted in toto for frozen. section diagnosis and the residue resubmitted for permanent sections in cassette. I. Part J received fresh for intraoperative consultation labeled ""posterior medial. mucosa margin"" and consists of an irregular, gray-tan soft tissue, which has a. greatest dimension of 1.1 cm, which has been submitted in toto for frozen. section diagnosis and the residue resubmitted for permanent sections in cassette. J. Part K received fresh for intraoperative consultation labeled ""deep medial. margin"" and consists of an irregular, gray-tan soft tissue, which has a greatest. dimension of 0.6 cm. The specimen has been submitted in toto for frozen section. diagnosis and the residue resubmitted for permanent sections in cassette K. Part L received fresh for intraoperative consultation labeled ""posterior deep. base of tongue"" and consists of three irregular, gray-tan soft tissues, which. have greatest dimensions of 0.1, 0.6 and 0.8 cm, which have been submitted in. toto for frozen section diagnosis and the residue resubmitted for permanent. sections in cassette L. Part M received fresh for intraoperative consultation labeled ""proximal lingual. nerve biopsy"" and consists of a 0.7 cm in greatest dimension irregular, gray-tan. soft tissue, which has been submitted in toto for frozen section diagnosis and. the residue resubmitted for permanent sections in cassette M. Part N is received in formalin labeled ""left tongue lesion"" and consists of a. previously inked and incised portion of left tongue, which has dimensions of 5.6. X 4.9 X 2.3 cm. The specimen was initially received fresh with tissue submitted. to the Tissue Bank. The deep surface is irregular, gray-brown and focally. cauterized. The mucosa is gray-tan and diffusely granular. The lateral border of. the tongue is remarkable for an ulceration, which has dimensions of 1.8 X 1.2. cm. This ulceration extends to within 0.2 cm of the nearest inferior lateral. mucosal edge. The specimen is further sectioned to reveal a gray-white, granular. indurated mass, which has dimensions of 3.6 x 2.2 x 1.3 cm. This mass is. contiguous with the aforementioned ulceration. This mass extends to the soft. tissue edge at numerous sites. There is some loosely attached soft tissue at the. inferior lateral aspect of the specimen, which has dimensions of 3.0 X 2.6 X 0.8. cm. This tissue is sectioned to reveal a gray-tan, lobulated cut surface that is. grossly suggestive of salivary gland. Also, the soft tissue is remarkable for. focal granularity, fibrosis and induration. These foci are highly suspicious. Representative sections are submitted as labeled: N1-4 mass to include ulceration and close mucosal edges in cassettes N1. and N2, as well as deep soft tissue edges in. cassettes N3 and N4;. N5. apparent salivary gland;. N6. associated soft tissue with suspicious appearing foci. Part O received in formalin labeled ""left neck dissection level 2-4"" and. consists of a portion of irregular, ragged, gray-yellow to red-brown, lobulated. fibrofatty and fibromuscular tissue, which has dimensions of 11.4 x 4.0 x 1.8. cm. The fat contains 16 probable lymph nodes that range from 0.3 to 4.8 cm in. greatest dimension. The largest lymph node is grossly positive. The lymph nodes are submitted as labeled: O1. six lymph nodes submitted in toto;. O2. three lymph nodes submitted in toto;. O3. five lymph nodes submitted in toto;. O4-5 one trisected lymph node;. 06. representative section of the largest, grossly positive lymph node. Part P received in formalin labeled ""left neck dissection level 2B"" and consists. of a portion of irregular, ragged, gray-yellow to red-brown, focally cauterized,. lobulated fat, which has dimensions of 2.6 x 2.2 X 0.9 cm. The fat contains. eight probable lymph nodes that range from 0.6 to 0.8 cm in greatest dimension. The lymph nodes are submitted in toto in cassettes P1 and P2. Microscopic Description: Histologic examination reveals a left glossectomy specimen and left neck. dissection specimen. The glossectomy specimen is notable for a deeply invasive. keratinizing squamous cell carcinoma exhibiting moderate differentiation. Both. perineural and lymphovascular invasion are prominent. The neck dissection. demonstrates multiple metastatic nodes, the largest of which is 4.8 cm with. extracapsular spread. (Age: , Gender: F.",test,
4605,TCGA-EY-A547.59662419-D77B-4C25-A888-CE993D412FD1,"SURG. Case I. Diagnosis: A: Lymph node, left para-aortic, excision. - Fibroadipose and vascular tissue with no tumor identified; no. lymphoid tissue. identified. B: Lymph nodes, right para-aortic, excision. - No tumor identified in eight lymph nodes (0/8). C: Lymph node, left pelvic, dissection. - No tumor identified in four lymph nodes (0/4). D: Lymph nodes, right pelvic, dissection. - No tumor identified in six lymph nodes (0/6). E: Uterus and cervix, hysterectomy: Location of tumor: primary endometrial cancer. Histologic type: endometrioid adenocarcinoma. Histologic grade (FIGO) : overall FIGO grade 3 (architectural. grade 3,. nuclear grade 3). Extent of invasion: see below. Myometrial invasion: Inner half. Depth: 5 mm Wall thickness : 35 mm. Percent: 14%. Serosal involvement: not identified. Lower uterine segment involvement: not identified. Cervical involvement: not identified. Adnexal involvement (see below) : not identified. Other sites: not identified. Cervical/vaginal margin and distance: negative, widely free. Lymphovascular space invasion: not definitively identified i. artifacts. present. Regional lymph nodes (see other specimens) : Total number involved: 0. Total number examined: 18. Other pathologic findings : benign endocervical polyp; leiomyomas. Tumor estrogen receptor and progesterone receptor. immunohistochemistry. results: pending on block E5, addendum to follow. AJCC Pathologic Stage: pTla pNO. FIGO (2008 classification) Stage grouping: IA, grade 3. These stages are based on information available at the time of. this report, and. are subject to change pending additional information and. clinical review. Ovary, right, oophorectomy: - Not identified grossly or microscopically, (history of prior. oophorectomy per. Ovary, left, oophorectomy : - Benign mature cystic teratoma. - No primary or metastatic malignancy identified. Fallopian tube, right, salpingectomy: - No tumor identified. Fallopian tube, left, salpingectomy: - No tumor identified. Clinical History: year-old female with endometrial cancer. Gross Description: Received are five appropriately labeled containers. Container A is additionally labeled ""left para-aortic lymph. node. "" It holds a. 0. 4 X 0.3 X 0.3 cm firm tan lymph node candidate. (Block A1,. Container B is additionally labeled ""right para-aortic lymph. node. "" It holds a. 4.6 6 X 2.4 X 1.2 cm aggregate of bright yellow lobulated fat. containing multiple. lymph node candidates ranging from 0.5 to 1.7 cm in greatest. dimension. Block Summary: B1,B2 - largest lymph node candidate, serially sectioned. B3,B4 - multiple lymph node candidates. B5 - fatty tissue,. Container C is additionally labeled ""left pelvic lymph node. "" It. holds a 2.5 X. 1.6 x 0.9 cm aggregate of yellow lobulated fat containing. multiple lymph node. candidates ranging from 0.4 to 0.6 cm. Block summary: C1,C2 - multiple lymph node candidates with associated fatty. tissue,. Container D is additionally labeled ""right pelvic lymph node."". It holds a 3. 6 X. 2.5 X 1.4 cm aggregate of bright yellow lobulated fat containing. multiple lymph. node candidates ranging from 0.3 to 3.1 cm in greatest. dimension. Block summary: D1-D3 - - largest lymph node candidate, serially sectioned. D4 - multiple lymph node candidates. D5 - fatty tissue,. Container E: Adnexa: Left: present and detached; Right: present and detached. Weight: 950 grams (uterus: 650 grams; attached/detached left. ovary : 300. grams). Shape distorted. Dimensions: height: 18.6 cm. anterior to posterior width: 8.6 cm. breadth at fundus: : 9.4 cm. Serosa: light pink, smooth and glistening. Cervix: 1.5 X 1.5 cm with a patent cervical os (0.4 cm). length of endocervical canal: ectocervix: erythematous and irregular. endocervix: tan and trabeculated. Endomyometrium: length of endometrial cavity: 6.2 cm. width of endometrial cavity at fundus: 5.0 cm. tumor findings. dimensions: 5.2 X 3.1 X 1.1 cm. appearance: The lesion is a tan friable exophytic mass on the. endometrial surface. location and extent: The lesion is on the posterior corpus and. extends to within 1.9 cm of the endocervical canal. myometrial invasion: no apparent invasion. thickness of myometrial wall at deepest gross invasion: 4.4 cm. other findings or comments: There are multiple tan rubbery,. roughly. spherical nodules within the myometrium ranging from 0.5. to 2.9 cm in greatest dimension. Adnexa: Right ovary: Cannot be positively identified. dimensions: 1.2 X 1.0 X 0.6 cm. external surface: brown and irregular with numerous fibrous. adhesions. cut surface: brown and firm. Right fallopian tube: dimensions: 7.7 cm long, 0.8 cm in diameter. other findings: The external surface of the fallopian tube is. faint. pink, smooth and glistening and the lumen is dilated with a. thin fallopian tube wall (0.1 cm thick) There are edematous. faint. pink papillary structures within the fallopian tube. that might represent fimbria. Left ovary: dimensions: 10.0 X 8.5 X 5.9 cm. external surface: faint pink, smooth and glistening with no. disruptions or papillary projections. cut surface: A single smooth walled cyst without papillary. excrescences that is filled with faint yellow gelatinous. material and. hair. No remnant normal ovarian tissue is identified. Left fallopian tube: dimensions: 3.5 cm long, 0.5 cm in diameter. other findings: The external surface is light pink, smooth and. glistening and the lumen is patent. Lymph nodes: See Parts A-D of this case. Other comments: none. Digital photograph taken: not taken. Tissue submitted for special investigations: A section of. endometrial lesion is. submitted to Tissue Procurement. Block Summary: : E1,E2 - anterior cervix and lower uterine segment. E3,E4 - posterior cervix and lower uterine segment. E5,E6 - representative sections of endometrial lesion. E7 - representative section of endometrial lesion at most. suspicious area of. myometrial invasion. E8 - candidate right ovary. E9 - right fallopian tube. E10, E11 - representative sections of left ovary. E12 - left fallopian tube. For cases in which immunostains are performed, the following. applies: Appropriate internal and/or external positive and negative. controls have been. evaluated. Some of the immunohistochemical reagents used in this. case may be. classified as analyte specific reagents (ASR) These were. developed and have. performance characteristics determined by the Anatomic Pathology. Department . These reagents have not been cleared or. approved by the US Food and Drug Administration (FDA) . The FDA. has determined. that such clearance or approval is not necessary. These tests. are used for. clinical purposes. They should not be regarded as. investigational or for. research. This laboratory is certified under the Clinical. Laboratory. Improvement Amendments of 1988 (CLIA-88) as qualified to perform. high complexity. clinical laboratory testing. Procedures/Addenda. Addendum. Addendum. The endometrial adenocarcinoma is estrogen receptor positive. (2+, 70%) and. progesterone receptor positive (2-3+, 70%) by. Immunohistochemistry.",test,
4980,TCGA-AZ-6605.48827545-d4c3-42d1-9154-34e299a21ea8,"PATIENT HISTORY: PRE-OP DIAGNOSIS: Colon cancer. POST-OP DIAGNOSIS: Same. PROCEDURE: Laparoscopic right hernicolectomy. AMENDEDICORRECTED REPORT: This amendment reflects: 1. The following change: Include the ""gross examination only"" intraoperative consultation remarks. 2. Where: In the intraoperative consultation field. 3. For the following reason: They were inadvertently omitted from the original report. 4. The Final Diagnosis and Synoptic Data remain unchanged. This Arnended/Corrected Report supersedes all prior reports under this accession number and should be the only one used for. patient management. All reports, both original and amended/corrected, are maintained in electronic archives and are available. upon request. FINAL DIAGNOSIS: COLON, RIGHT HEMICOLECTOMY -. A. MODERATELY DIFFERENTIATED ADENOCARCINOMA OF THE ASCENDING COLON, 3.5 CM, INVASIVE INTO. SUBSEROSA WITH PERFORATION OF THE VISCERAL PERITONEUM: B. PROXIMAL TERMINAL ILEAL AND DISTAL COLONIC MARGINS ARE FREE OF TUMOR. C. METASTATIC ADENOCARCINOMA IN ONE OF TWENTY-TWO LYMPH NODES (1/22). D. PATHOLOGIC STAGE: pT4b N1 Mx. E. FIBROUS OBLITERATION OF THE APPENDIX. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY COLON, RECTAL, APPENDIX TUMORS. SPECIMEN TYPE: Right hemicolectomy. TUMOR SITE: Right (ascending) colon. TUMOR CONFIGURATION: infiltrative. TUMOR SIZE: Greatest dimension: 3.5 cm. Additional dimensions: 2.2x0.8 cm. INTACTNESS OF MESORECTUM: Not applicable. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: Low-grade (well to moderately differentiated). PATHOLOGIC STAGING (pTNM): pT4b. pN1: Metastasis in 1 to 3 regional lymph nodes. Number of nodes examined: 22. Number of nodes involved: 1. pMX. MARGINS: Proximal margin uninvolved by invasive carcinoma. Distal margin uninvolved by invasive carcinoma. Circumferential (radial) margin - Not applicable. Mesenteric margin uninvolved by invasive carcinoma. ANGIOLYMPHATIC INVASION: Present. PERINEURAL INVASION: Absent. TUMOR BORDER CONFIGURATION: Infiltrating. ADDITIONAL TUMOR CHARACTERISTICS: None. ADDITIONAL PATH FINDINGS (check all that apply): None identified.",test,
4990,TCGA-CJ-6027.4c7adee8-16bd-418c-8127-036988083453,"(A) RIGHT KIDNEY: RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL TYPE), FUHRMAN'S NUCLEAR GRADE 4. (SEE COMMENT). TUMOR MEASURES 2.4 CM IN MAXIMUM DIMENSION. Vascular and ureteral margins of resection free of tumor. No unequivocal lymphatic/vascular invasion present. COMMENT. The tumor focally pushes into the perinephric adipose tissue as a polypoid nodule surrounded by a fibrous capsule. No invasion. into the adipose tissue is identified. Multiple additional deeper sections were examined. GROSS DESCRIPTION. (A) RIGHT KIDNEY - A nephrectomy specimen (11.0 X 9.0 X 7.0 cm) with attached perinephric fat tissue, unremarkable segment. of ureter (7.0 cm in length and 0.4 cm in circumference), and unremarkable segments of artery and vein (< 1.0 cm in length and. 0.4 cm in circumference each). A well circumscribed, bulging tumor (2.4 X 2.0 X 2.0 cm) with soft tan-brown to yellow cut surfaces and areas of hemorrhage is. identified at the lower pole. The tumor bulges into the perinephric adipose tissue. The tumor is 3.5 cm away from the renal pelvis. The non-neoplastic kidney parenchyma is unremarkable. A portion of the tumor and normal kidney is sent to the tissue bank and. is sectioned for special studies. SECTION CODE: A1, margin (artery, vein, and ureter); A2, tumor in relation with fat; A3, A4 tumor in relation to fat; A5,. A6 tumor in relation with adjacent fat (one slice divided in two cassettes); A7, tumor in relation with adjacent fat; A8, fat with a. portion of tumor; A9, A10 tumor in relation with a normal kidney; A11, normal kidney. CLINICAL HISTORY. Right renal mass. SNOMED CODES. T-71000, M-83123. 1.",test,
5031,TCGA-DK-AA77.382A39E0-F94D-4828-8B30-22A4080724BB,"M. Urology. Clinical Diagnosis & History: HG T1 UC. Specimens Submitted: 1: Urethral margin (fs). 2: Right distal pelvic lymph nodes. 3: Left distal pelvic lymph nodes. 4: Bladder, prostate, seminal vesicles and peri-vesicle lymph nodes. 5: Left distal ureter. 6: Right distal ureter. DIAGNOSIS: 1. Urethral margin (fs): - Benign prostatic tissue and urothelium. 2. Right distal pelvic lymph nodes: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 18. 3. Left distal pelvic lymph nodes: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 22. 4. Bladder, prostate, seminal vesicles and peri-vesicle lymph nodes: a. Tumor Type: Invasive urothelial carcinoma, NOS. Histologic Grade: High grade. Pattern of growth of the Non-Invasive component: Papillary and flat. Pattern of growth of the Invasive component: Infiltrating. Tumor Multicentricity: Identified. Bladder Local Invasion: Superficial half of muscularis propria. Extravesical Tumor Extension: Urethra uninvolved. Carcinoma in-situ present at right and left ureteral orifice, with focal lamina propria invasion at left ureteral orifice. Vascular Invasion: Not identified. Perineural Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Mucosa: Exhibiting prior procedure-related changes. Prostate: Other See 4b. Seminal Vesicles: Not involved. Perivesical Lymph Nodes: Not involved (0/1). The Pathologic Stage is (AJCC 2002): pT2a (Invades superficial half of muscularis propria). PRO (No involvement of prostate). b. Tumor Type: Adenocarcinoma. Gleason's Grade: Primary Gleason grade:3. Secondary Gleason grade:3. Total Gleason score:6. Tumor Location: Involves Left posterior. Minute focus. Vascular Invasion: Not Identified. Perineural Invasion: Not identified. Tumor Multicentricity: Not identifed. High Grade Prostatic Intraepithelial Neoplasia: Identified. Capsule: Tumor confined to prostate. Seminal Vesicles: Not involved. Bladder Neck: Not Involved. Surgical Margins: Free of tumor. Non-Neoplastic Prostate: Unremarkable. Staging (AJCC 1997): pT2a (confined to the prostate & capsule, involving one lobe). 5. Left distal ureter: - Benign segment of ureter. 6. Right distal ureter: - Benign segment of ureter. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1) The specimen is received fresh for frozen section consultation, labeled ""urethral margin"" and consists of tissue measuring 1.3 x. 1.0 x 0.3 cm. Entirely submitted for frozen section. Summary of sections: FSC1-1 -- frozen section control1. 2) The specimen is received fresh, labeled, ""Right distal pelvic lymph nodes"", and consists of a piece of tan-yellow fatty tissue. measuring 7.0 x 3.0 X 2.0 cm. Sectioning reveals multiple tan-yellow fatty lymph nodes ranging from 0.4 to 2.2 cm in greatest. dimension. The specimen is entirely submitted. Summary of sections: BLN1-6- bisected lymph nodes. MLN - multiple lymph nodes. RT - remaining tissue. 3) The specimen is received fresh, labeled, ""Left distal pelvic lymph nodes"", and consists of a piece of tan-yellow fatty tissue. measuring 7.0 x 5.0 x 2.0 cm. Sectioning reveals multiple tan-yellow fatty lymph nodes ranging from 0.1 to 2.5 cm in greatest. dimension. The specimen is entirely submitted. Summary of sections: BLN1-4- bisected lymph nodes. MLN - multiple lymph nodes. RT - remaining tissue. 4) The specimen is received fresh labeled, ""Bladder, prostate, seminal vesicles, and peri-vesicle lymph nodes' "". It consists of a. bladder with attached bladder and adnexa measuring 16.5 cm from superior to inferior, 12.3 cm laterally and 4.3 cm from anterior. to posterior. The anterior aspect of the bladder is inked black and the posterior blue. The prostatic urethral margin is shaved and. submitted. The bladder is opened along the anterior midline to reveal a pink-tan papillary mass measuring 4.7 x 3.4 x 2.0 cm. predominately on the left posterior wall. The lesion lies 0.5 cm from the left ureteral orifice and 1.5 from the right. Adjacent to the. papillary mass is a 1.6 x 1.6 cm pink-tan scar lesion, which measures 0,1 cm from the left ureteral orifice, and 3.5 cm from the. right. There is a 0.4 x 0.2 x 0.1 cm papillary area adjacent to the right ureteral orifice which measures 2.0 cm from the tumor. Both. ureters are probe patent, measuring up to 0.2 cm in maximum diameter. Sectioning of the scar lesion reveals a tan cut which does. not extend to the inked fat. The mass is sectioned to reveal a white- tan slightly irregular cut surface. Extension to the inked fat is. grossly not identified. The remaining bladder mucosa is tan-pink with the normal folds. A perivesical lymph nods is identified. The. prostate is serially sectioned to reveal white-tan prostatic parenchyma. Representative sections are submitted including sections. from each prostatic quadrant and transition zone. TPS is submitted. Gross photograph is taken. Summary of sections: UM - urethral margin. RUM - right ureter margin. LUM - left ureter margin. M--mass. SL--scar lesion (entirely submitted). RUO - right ureter orifice (with papillary area). LUO - left ureter orifice (with scar lesion). LPW - left posterior wall. LAW - left anterior wall. RPW - right posterior wall. RAW - right anterior wall. TRI trigone. DOM dome. F - perivesical fat. RSV - right seminal vesicle. LSV - left seminal vesicle. RAP - right apex prostate. LAP - left apex prostate. RAM - right anterior mid prostate. RPM - right posterior mid prostate. LAM - left anterior mid prostate. LPM - left posterior mid prostate. RAB - right anterior base prostate. RPB - right posterior base prostate. LAB - left anterior base prostate. LPB - left posterior base prostate. LN--lymph node. 5) The specimen is received in formalin, labeled ""Left distal ureter, unclipped end in the margin"" and consists of a tan-white tubular. tissue fragment measuring 3.3 cm in length and 1.2 cm in diameter, with attached adipose tissue measuring 1.1 cm in thickness. There is a clip at one end of the specimen. On cut section, the mucosa appears is tan-pink and unremarkable. The specimen is. sequentially sectioned from the clipped end to the non-clipped end and submitted entirely. Summary of sections: CE - clipped end. NCE - non-clipped end. SS - sequential sections from clipped to non-clipped end. 6) The specimen is received in formalin, labeled ""Right distal ureter, unclipped ended margin"" and consists of a tan-white tubular. tissue fragment measuring 5.0 cm in length and 1.0 cm in diameter, with attached adipose tissue measuring 1.3 cm in thickness. There is a clip at one end of the specimen. On cut section, the mucosa appears tan-pink and unremarkable. The specimen is. sequentially sectioned from the clipped end to the non-clipped end and submitted entirely. Summary of sections: CE - clipped end. NCE - non-clipped end. SS - sequential sections from clipped to non-clipped end. Summary of Sections: Part 1: Urethral margin (fs). Blocks Block Designation. PCs. 1. {not entered}. Part 2: Right distal pelvic lymph nodes. Blocks Block Designation. PCs. 2. BLN1. 2. 1. BLN2. 2. 1. BLN3. 2. 1. BLN4. 2. 1. BLN5. 2. 1. BLN6. 2. 2. MLN. 10. 4. RT. 4. Part 3: Left distal pelvic lymph nodes. Blocks Block Designation. PCs. 2. BLN1. 2. 1. BLN2. 2. 1. BLN3. 2. 1. BLN4. 2. 3. MLN. 12. 9. RT. 9. Part 4: Bladder, prostate, seminal vesicles and peri-vesicle lymph nodes. Blocks Block Designation. PCs. 1. DOM. 2. 1. F. 2. 1. LAB. 1. 1. LAM. 1. 1. LAP. 1. 1. LAW. 2. 1. LN. 1. 1. LPB. 1. 1. LPM. 1. 1. LPW. 2. 1. LSV. 1. 1. LUM. 1. 1. LUO. 1. 4. M. 4. 1. RAB. 1. 1. RAM. 1. 1. RAP. 1. 1. RAW. 2. 1. RPB. 1. 1. RPM. 1. 1. RPW. 2. 1. RSV. 1. 1. RUM. 1. 1. RUO. 1. 4. SL. 4. 1. TRI. 2. 1. UM. 1. Part 5: Left distal ureter. Blocks Block Designation. PCs. 1. CE. 1. 1. NCE. 1. 2. SS. 5. Part 6: Right distal ureter. Blocks Block Designation. PCs. 1. CE. 1. 1. NCE. 1. 3. SS. 6. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative consultation. 1. Frozen Section Diagnosis: Urethral margin (fs): Benign. Permanent Diagnosis: Same.",test,
5228,TCGA-QR-A6GT.ECF9DE13-4F2B-4BFA-A560-D7D8AB3146B4,"DIAGNOSIS: 1. SOFT TISSUE, PERITONEUM, ""NODULE ANTERIOR TO LEFT RENAL VEIN"" (EXCISION): LOOSE. FIBROCONNECTIVE TISSUE AND FRAGMENTS OF ADIPOSE TISSUE. 2. LYMPH NODE, AORTOCAVAL, ""BELOW RENAL VEIN"" (EXCISION): HYPERPLASTIC LYMPH NODE WITH. VASCULAR MEDULLARY ACCENTUATION. 3. LYMPH NODE, AORTOCAVAL (EXCISION): BENIGN LYMPH NODE. 4. KIDNEY AND ADRENAL GLAND, RIGHT (RADICAL NEPHRECTOMY): PERIRENAL MASS CONSISTENT. WITH PHEOCHROMOCYTOMA MEASURING 10 X 5 X 5 CM; THE TUMOR MASS IS ADJACENT TO BUT NOT. INVOLVING THE ADRENAL GLAND. DIAGNOSTIC FEATURES SUGGESTIVE OF MALIGNANT. PHEOCHROMOCYTOMA INCLUDE TUMOR SIZE, TUMOR PERFORATION INTO THE RENAL VEIN (BLOCK. 4C), AND FAINT TO ABSENT STAINING FOR S-100, SEE NOTE. NOTE: IMMUNOHISTOCHEMICAL STUDIES WERE PERFORMED. NEOPLASTIC CELLS ARE NEGATIVE FOR. AE1/3, CAM5.2, HMB-45, AND MART-1. NEOPLASTIC CELLS ARE POSITIVE FOR SYNAPTOPHYSIN,. CHROMOGRANIN, MELAN. A, AND INHIBIN. S-100 STAINS RETICULOENDOTHELIAL CELLS WITHOUT A. SUSTENTACULAR PATTERN, WHILE NEOPLASTIC CELLS ARE NEGATIVE FOR THIS MARKER. INHIBIN AND. MELAN A POSITIVITY IN THIS NEOPLASM ARE APPARENTLY DISPARATE STAINING RESULTS BECAUSE. PHEOCHROMOCYTOMAS HAVE NOT ORDINARILY BEEN REPORTED IN THE LITERATURE TO BE POSITIVE. FOR THEM. HOWEVER, WE PLACE MORE EMPHASIS ON THE CHROMOGRANIN RESULT WHICH CLEARLY. IS NEGATIVE IN THE PATIENT'S OWN ADRENAL CORTEX, BUT POSITIVE IN THE PATIENT'S ADRENAL. MEDULLA AND TUMOR. THIS FINDING ALONE POINTS STRONGLY TO PHEOCHROMOCYTOMA. BECAUSE. OF POTENTIAL FOR MALIGNANCY, CONTINUING CLINICAL EVALUATION FOR BONE METASTASES IS. RECOMMENDED. CLINICAL INFORMATION: HISTORY:RETROPERITONEAL MASS, CLINICAL PHEO EXAM IS RELATED TO. PROCEDURE: PREOP DX:#PHEOCHROMOCYTOMA POSTOP DX: PHEO OPERATIVE FINDINGS: LARGE. RETROPERITONEAL MASS, KIDNEY HILUM, URETER ENCASED. SPECIMENS SUBMITTED: 1) PERITONEAL BIOPSY, NODULE ANTERIOR TO LT VEIN (1FS) 2) LYMPH. NODES, INTERAORTIC CAVAL BELOW RENAL VEIN (2FS) 3) LYMPH NODES, INTRAAORTIC CAVAL (3FS). 4). ADRENAL GLAND, RIGHT, AND KIDNEY. INTRAOPERATIVE CONSULTATION: 1FS DIAGNOSIS: FIBROADIPOSE TISSUE WITH FOCAL FAT NECROSIS, NO TUMOR SEEN (DRS. 2FS DIAGNOSIS: LYMPH NODE AND FAT, NO TUMOR SEEN (DRS. 3FS DIAGNOSIS: LYMPH NODE, NO TUMOR SEEN (ONLY ONE FROZEN SECTION PERFORMED DUE TO. EXHAUSTION OF BLOCK). Do not file in Medical Record. GROSS DESCRIPTION: RECEIVED FRESH FROM THE OPERATING ROOM ARE 4 CONTAINERS LABELED WITH THE PATIENT'S. NAME AND MEDICAL RECORD NUMBER. 1. SPECIMEN 1 IS LABELED ""PERITONEAL NODULE ANTERIOR TO LEFT RENAL VEIN. THE SPECIMEN. CONSISTS OF TAN/RED, FLOCCULENT TISSUE, MEASURING 0.3 X 0.2 X 0.2 CM. THE SPECIMEN IS. FROZEN IN TOTO AS 1FS. THE FROZEN SECTION CONTROL IS RECEIVED BY MYSELF IN FORMALIN AND. TRANSFERRED FROM A SINGLE GREEN CASSETTE LABELED WITH THE PATIENT'S NAME AND 1FS1 TO A. SINGLE ORANGE CASSETTE LABELED 1FS. 2. SPECIMEN 2 IS LABELED ""INTRAAORTIC CAVAL NODE BELOW RENAL VEIN"". THE SPECIMEN CONSISTS. OF A 4.5 X 2.5 X 0.5 CM. FRAGMENT OF FATTY WITHIN WHICH THERE IS A 1.3 X 0.8 X 0.4 CM. LYMPH. NODE. THE LYMPH NODE SPECIMEN IS FROZEN AS 2FS1. A TOUCH PREP IS LABELED 2TP. THE FROZEN. SECTION CONTROL IS RECEIVED BY MYSELF IN FORMALIN AND TRANSFERRED FROM A GREEN. CASSETTE LABELED WITH THE PATIENT'S NAME AND 2FS1 TO A SINGLE ORANGE CASSETTE LABELED. 2FS. THE REMAINING UNFROZEN TISSUE IS BISECTED AND ENTIRELY SUBMITTED IN TWO WHITE. CASSETTES LABELED 2A AND B. 3. SPECIMEN 3 IS LABELED ""INTERAORTOCAVAL NODE"". THE SPECIMEN CONSISTS OF A SINGLE. FRAGMENT OF FATTY TISSUE MEASURING 2 X 1.8 X 0.6 CM. WITH A STAPLE AND A LYMPH NODE,. MEASURING 0.8 X 0.6 X 0.3 CM. THE LYMPH NODE IS BISECTED AND FROZEN IN TOTO AS 3FS1. THE. FROZEN SECTION CONTROL IS RECEIVED BY MYSELF IN FORMALIN AND TRANSFERRED FROM A. GREEN CASSETTE LABELED WITH THE PATIENT'S NAME AND 3FS TO A SINGLE ORANGE CASSETTE. LABELED 3FS. THE RESIDUAL UNFROZEN PORTION OF TISSUE IS BISECTED AND ENTIRELY IN. SUBMITTED IN WHITE CASSETTE LABELED #3. 4. SPECIMEN 4 IS LABELED ""RIGHT ADRENAL AND KIDNEY"". THE SPECIMEN CONSISTS OF A 431 GRAM. KIDNEY AND ADRENAL MEASURING 15 X 12 X 6 CM. THERE IS A TUMOR ABUTTING THE ADRENAL GLAND. MEASURING 10 X5X5CM. THE TUMOR IS YELLOW AND NECROTIC ON CUT SURFACE. 2X2X2CM. OF. TUMOR ARE PROCURED BY THE UROLOGIC ONCOLOGY BRANCH AS WELL AS 2 X 1 X 1 CM. OF NORMAL. KIDNEY AND 1 X 0.5 X 0.5 CM. OF NORMAL ADRENAL. THE PREVIOUS DESCRIPTION WAS PROVIDED BY. DR. THE SPECIMEN IS RECEIVED BY MYSELF AND MEETS THE ABOVE. DESCRIPTION AS MENTIONED, THE TUMOR is MULTINODULAR AND YELLOWISH/TAN IN COLOR WITH. FOCAL DARK BROWN TO PURPLISH/BLACK AREAS. IN PLACES, THERE IS APPARENT NECROSIS AND IN. OTHERS THERE IS TRANSLUCENT, MYXOID- APPEARING, CENTRAL STROMA. THERE IS NO GROSS. EVIDENCE OF DIRECT INVOLVEMENT OF THE KIDNEY PARENCHYMA, BUT RATHER THE KIDNEY. APPEARS EXTERNALLY COMPRESSED BY THIS MASS. RESIDUAL NORMAL ADRENAL IS IDENTIFIED IN. THE SUPERIOR POLE OF THE SPECIMEN AND THERE ARE MASSES OF APPARENT TUMOR NODULE. ADJACENT TO THESE AREAS OF APPARENT NORMAL ADRENAL. THE RENAL HILUM IS DISTORTED BY. THE PRESENCE OF THE LARGE TUMOR MASS. CLIPS ARE IDENTIFIED ON VASCULAR STRUCTURES. SURROUNDING THE TUMOR AND THE HILUM AND THE CUT SURFACES OF THE VASCULAR STRUCTURES. ARE TAKEN AS MARGINAL SECTIONS. IN ADDITION, THE URETER IS IDENTIFIED AND THE CUT MARGIN. TAKEN. APPROXIMATELY A 6 CM. PORTION OF URETER REMAINS. ALSO AT THE HILUM IS AN OPENED. LUMINAL SPACE WHICH MAY REPRESENT PORTIONS OF THE RENAL VEIN, NOT ENTIRELY CONTIGUOUS. TO THE MORE DISTAL MARGIN WHICH WAS PREVIOUSLY IDENTIFIED. THIS WAS DISCUSSED WITH THE. PROCUREMENT TEAM AND THIS DISCONTINUITY WAS PRESENT AT TIME OF PROCUREMENT IT IS ALSO. POSSIBLE THAT THIS COULD REPRESENT A DISTAL DILATATION OF THE CALYCEAL SYSTEM. WITHIN. THIS STRUCTURE ARE SEVERAL TAN-COLORED EXCRESCENCES INTO THE LUMEN MEASURING 0.3 CM. IN GREATEST DIMENSION. NO OBVIOUS HILAR LYMPH NODES ARE IDENTIFIED. SECTIONS ARE. SUBMITTED AS FOLLOWS: 4A: VASCULAR AND URETERAL MARGINS. 4B: STRUCTURE AT HILUM, POSSIBLE RENAL VEIN OR DILATED PELVIS. Do not file in Medical Record. 4C: AND 40: LUMINAL STRUCTURE AT PELVIS WITHIN INTRALUMINAL NODULAR EXCRESCENCES. 4E THROUGH 4H: APPARENT TUMOR ADJACENT TO GROSSLY UNREMARKABLE ADRENAL. 41 THROUGH 4M: TUMOR WITH OVERLYING GREEN INKED MARGINAL SURFACE. 4N AND 40: RELATIONSHIP OF TUMOR TO RENAL PELVIS. 4P THROUGH 4R: TUMOR ADJACENT TO NORMAL-APPEARING RENAL PARENCHYMA. 4S: NORMAL-APPEARING RENAL PARENCHYMA. 4T: ADDITIONAL TUMOR ADJACENT TO GREEN INKED OVERLYING MARGIN. 4U AND 4V: TUMOR, CENTRAL TRANSLUCENT AREA. 4W: TUMOR WITH DARK BROWN NODULE AND PALE, TRANSLUCENT NODULAR AREA AND OTHER. NECROTIC-APPEARING AREA. REVIEWED BY: SURGICAL PATH CASE CONF,. Do not file in Medical Record.",test,
5388,TCGA-DK-A6B1.D475F198-6FFF-4869-922E-5E0F5BC564C9,"(Age: M. Urology. Clinical Diagnosis & History: year old male with newly diagnosed bladder carcinoma. Specimens Submitted: 1: Bladder, prostate, seminal vesicles, cytoprostatectomy. 2: Soft tissue, left pelvic, resection. 3: Lymph nodes, right pelvic, resection: 4: SP: Left pelvic lymph nodes #2. 5: SP: Distal margin of urethra. 6: SP: Pelvic floor (. 7: SP: Distal left ureter 1. 8: SP: Distal right ureter ,. DIAGNOSIS: 1. Bladder, prostate, seminal vesicles, cytoprostatectomy: Tumor Type: Invasive urothelial carcinoma, NOS. Histologic Grade: High grade. Pattern of growth of the Non-Invasive component: Papillary and flat. Pattern of growth of the Invasive component: Inverted/Nodular. Tumor Multicentricity: Identified. The intervening urothelium is also involved by carcinoma. Bladder Local Invasion: Superficial half of muscularis propria. Extravesical Tumor Extension: Right ureter uninvolved. Left ureter uninvolved. Urethra uninvolved. Vascular Invasion: Not identified. Perineural Invasion: Not identified. Surgical Margins: Free of tumor. See part 5,7, and 8 for the urethral and ureteral margins. Non-Neoplastic Mucosa: Unremarkable. Prostate: Nodular hyperplasia. Other High-grade prostatic intraepithelial neoplasia. Seminal Vesicles: Not involved. Perivesical Lymph Nodes: Not identified. The Patholagic Stage ts. pT2a (Invades superficial half of muscularis propria). PRO (No involvement of prostate). 2. Soft tissue, left pelyic, resection: Fibroadipose tissue negative for tumor. 3. Lymph nodes, right pelvic, resection:: Lymph Nodes: Not involved. Number of nodes examined:3. 4. Soft tissue, left pelvic ""lymph nodes #2"", resection: Fibroadipose tissue negative for tumor. 5. Urethra, distal margin, resection: Segment of urethra and prostatic tissue negative for tumor. 6. Soft tissue, pelvic floor, resection: Prostatic tissue negative for tumor. 7. Ureter, left distal, resection: Segment of ureter negative for tumor. 8. Ureter, right distal, resection: Segment of ureter negative for tumor. 1 ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh, labeled ""Cystoprostatectomy"". It consists of a urinary bladder, prostate, urachus, perivesical. soft tissues, seminal vesicles and lymph nodes with bladder totally measuring 12.1 cm from superior to inferior, 12.6 cm laterally. and 4.5 cm from anterior to posterior. The bladder measures 7.5 x 7.1 X 4.1 cm, the prostate measures 5.6 X 3.9 x 3.6 cm, the. right seminal vesicle measures 3.5 x 2 0 x 1.0 cm, the right vas deferens measures 6.8 x 0.3 X 0.3 cm, the left seminal vesicle. measures 4.3 x 1.4 x 1.0 cm and the left vas deferens measures 7.2 x 0.3 x 0.3 cm. The anterior aspect of the bladder is inked. blue and the posterior black. The prostatic urethral margin is shaved and submitted. The bladder is opened along the anterior. midline to reveal a fungating, nodular and papillary mass measuring 7.1 x 6.4 x 3.1 cm which is situated within the anterior wall and. extending to involve the bladder dome. The lesion measures 0.6 cm from the left orifice and 0.8 cm from the right. Both ureters. are probe patent measuring up to 0.2 cm in maximum diameter with the right ureter 4.6 cm long and left ureter 5.5 cm long. The. lesion is sectioned to reveal involvement of the bladder wall. Extension to the inked fat is grossly not identified. An additional. papillary lesion is noted on the right posterior wall, close to the prostatic urethra, 1.2 cm from the right ureteric orifice and. measuring 1.2 X 0.7 X 0.4 cm. The remaining bladder mucosa is congested. Discrete perivesical lymph nodes are grossly not. identified. The prostate is serially sectioned to reveal multiple nodules ranging from 0.2 to 0.5 cm located periurethrally. Representative sections are submitted including three sections from each prostatic quadrant and transition zone. TPS. is. submitted. Summary of sections: UM -- urethral margin. RUM-- -- right ureter margin. LUM -- left ureter margin. L-- lesion. RUO -- right ureter orifice. LUO-- left ureter orifice. LP -- left posterior wall. LA -- left anterior wall. RP -- right posterior wall. RA-- right anterior wall. TRI -- trigone. DOM- dome. RSV -- right seminal vesicle. LSV -- left seminal vesicle. RAP -- right apex prostate. LA P-- left apex prostate. RAM -- right anterior mid prostate. RPM -- right posterior mid prostate. LAM -- left anterior mid prostate. LPM -- left posterior mid prostate. RAB -- right anterior base prostate. RPB -- right posterior base prostate. LAB -- left anterior base prostate. LPB -- left posterior base prostate. UR -- urachus. 2). The specimen is received fresh, labeled ""left pelvic lymph nodes"" and consists of multiple yellow lobulated tissue fragments. aggregating 5.1 x 2.0 x 0.3 cm in greatest dimension. No definite lymph nodes are identified. Tissue entirely submitted. Summary of sections: LN -- lymph nodes. 3). The specimen is received fresh, labeled ""right pelvic lymph"" and consists of multiple pink-tan firm lymph nodes ranging from. 0.3 to 1.4 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN -- lymph nodes. BLN-- bisected lymph nodes. 4). The specimen is received fresh, labeled ""left pelvic lymph nodes number two"" and consists of multiple pink-tan firm lymph. nodes ranging from 0.7 to 1.9 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN -- lymph nodes. BLN-- bisected lymph node. 5). The specimen is received in formalin, labeled ""distal margin of urethra"" and consists of a 1.5 x 0.9 x 0.7 cm red-tan, irregular. unoriented soft tissue fragment. Serially sectioned and entirely submitted. Summary of sections: U-undesignated. 6). The specimen is received in formalin, labeled ""pelvic floor"" and consists of a 1.2 x 0.7 x 0.7 cm red-tan soft tissue fragment. Entirely submitted. Summary of sections: U-undesignated. 7). The specimen is received in formalin in, labeled ""distal left ureter"" and consists of a red-tan tubular structure, 0.6 cm in length. by 0.4 cm in diameter. Section and entirely submitted. Summary of sections: U-undesignated. 8). The specimen is received in formalin, labeled ""distal right ureter, clip on proximal margin"" and consists of a gray-white tubular. structure and surrounding adipose tissue. The tubular structure measures 1.5 cm in length by 0.3 cm in diameter, and a clip. marks the proximal margin, which a submitted separately. The remaining of the ureter is serially sectioned and entirely submitted. Summary of sections. PM - proximal margin. R - remaining ureter. Summary of Sections: Part 1: Bladder, prostate, seminal vesicles, cytoprostatectomy. Block. Sect. Site. PCs. 1. DOM. 1. 11. L. 11. 1. LA. 1. 1. LAB. 1. 1. LAM. 1. 1. LAP. 1. 1. LP. 1. 1. LPB. 1. 1. LPM. 1. 1. LSV. 1. 1. LUM. 1. 1. LUO. 1. 2. RA. 2. 1. RAB. 1. 1. RAM. 1. 1. RAP. 1. 2. RP. 2. 1. RPB. 1. 1. RPM. 1. 1. RSV. 1. 1. RUM. 1. 1. RUO. 1. 1. TRI. 1. 1. UM. 1. 1. UR. 1. Part 2: Soft tissue, left pelvic, resection. Block. Sect. Site. PCs. 4. LN. 4. Part 3: Lymph nodes, right pelvic, resection: Block. Sect. Site. PCs. 2. BLN. 2. 2. LN. 2. Part 4: SP: Left pelvic lymph nodes #2. Block. Sect. Site. PCs. 1. bIn. 1. 2. In. 2. Part 5: SP: Distal margin of urethra. Block. Sect. Site. PCs. u. 1. Part 6: SP: Pelvic floor. Block. Sect. Site. PCs. 1. u. 1. Part 7: SP: Distal left ureter. Block. Sect. Site. PCs. 1. u. 1. Part 8: SP: Distal right ureter. Block. Sect. Site. PCs. 1. pm. 1. 1. 1.",test,
5400,TCGA-DX-A7EO.9D1732CC-080D-4C90-AB74-02EC31824176,"Clinical Diagnosis and History: Synovial sarcoma of left flank. Specimens Submitted: SP: Lt. flank, synovial sarcoma. DIAGNOSIS: 1). SKIN AND SOFT TISSUE, LEFT FLANK; EXCISION: - BIPHASIC SYNOVIAL SARCOMA, INVOLVING SOFT TISSUE AND. SKELETAL MUSCLE. - THE TUMOR SIZE IS 7.1 CM. - THE TUMOR IS ASSOCIATED WITH FOCAL SCLEROSIS AND FIBROSIS. NO APPARENT TUMOR NECROSIS SEEN. - ALL SURGICAL MARGINS ARE FREE OF TUMOR. NOTE: THE TUMOR CELLS SHOW AN IMMUNOSTAINING PATTERN COMPATIBLE. WITH THAT SEEN IN SYNOVIAL SARCOMA (IMMUNOREACTIVITY FOR AE1:AR3. AND CMA 5.2 MAINLY SEEN IN THE EPITHELIAL COMPONENT AND VERY. FOCALLY IN SPINDLE CELLS; EMA STAINING SEEN PREDOMINANTLY IN. EPITHELIAL CELLS BUT ALSO IN SOME SPINDLE CELLS) MOLECULAR. STUDIES FOR THE SYT-SSX FUSION TRANSCRIPT ASSOCIATED WITH T(X;18). WILL BE PERFORMED AND WILL BE REPORTED SEPARATELY. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION. OF THE SLIDES (AND/OR OTHER. MATERIAL) . AND THAT I HAVE REVIEWED AND APPROVED THIS REPORT. Special Studies: Stain/Procedure Name. Comment. KERATIN (CAM5.2). AE1:AE3. EMA. PROLIF ANTIGEN (Ki67). BCL2. CD34. VIMENTIN. NEGATIVE CONTROL. IMMUNO RECUT. Gross Description: 1). The specimen is received fresh, labeled, ""Left flank. synovial sarcoma, short stitch marks superior, long stitch. posterior"". It consists of a 12.0 x 1.5 cm ellipse of skin. incised to a depth of 13.2 cm including 6.2 cm of subcutaneous. adipose tissue and 7.0 cm of skeletal muscle. There is a long. stitch marking the posterior margin and a short marking the. superior margin. The specimen is inked as follows: Superior -. blue, inferior - green, anterior - yellow, posterior - red, deep. black. The skin is grossly unremarkable. A 7.1 x 6.5 x 4.8. cm, well-defined, fleshy, soft tan, white intramuscular mass is. present 1.6 cm from the deep surgical margin, the closest. surgical margin. In reference to the other surgical margins is. 0.2 cm from the inferior margin, 2.0 cm from the superior margin,. 2.5 cm from the posterior margin, and 3.5 cm from the anterior. margin, and 3.0 cm from the surface of the skin. The photo is. sent for TPS and for. and tissue was taken. Representative sections of the specimen are submitted. Summary of Sections: DM - deep surgical margin. INS - inferior surgical margin. SUP - superior surgical margin. PR - posterior surgical margin. ANT - anterior surgical margin. SKI - skin. MA mass. Summary of Sections: Part. Sect. Site. Blocks. Pieces. All. 1. SKI. 1. N. ant. 1. 1. dem. 3. 3. inf. 2. 2. ma. 8. M. po. 2. 2. ski. 1. 1. su. 1. 1.",test,
5408,TCGA-85-A50M.22D952B9-47B2-409A-8177-56A2537BE21D,"Gross Description: Tumor is located in right upper lobes, ill - margins with 7x7x7cm in size, soft and. necrotic-gray surface. Paratracheal, subcarinall and interlobar lymph nodes are 1.5cm in maximum size, black in color. Tumor is. located in right upper lobes, ill - margins with 7x7x7cm in size, soft and necrotic-gray surface. Paratracheal, subcarinall and interlobar lymph nodes are 1.5cm in maximum size, black in color. Microscopic Description: Tumor tissue arranges in the form of group or sheets or trabeculae of tumor. cells, invading in begnin brochus tissue. The malignant cells have moderate, eosinophilic cytoplasm. The. nuclei are enlarged, variability in size and shape, containing coarse clumped chromatin with prominent. nucleoli. Mitotic figures are common. Tumor is invasion of lymphocytes. Diagnosis Details: Squamous cell carcinoma, grade II. Comments: Formatted Path Reports: LUNG TISSUE CHECKLIST. Specimen type: Pneumonectomy. Tumor site: Lung. Tumor size: 7x7x7cm. Histologic type: Squamous cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: 0/3 positive for metastasis (Paratracheal, subcarinal and interlobar lymph node 0/3). Lymphatic invasion: Present. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Right-upper.",test,
5753,TCGA-66-2791.402c71d9-26d5-4e94-82a6-6ae5ea39a391,"Material examined: Right lung. Clinical diagnosis and question. Bronchial carcinoma right central lower lobe, large-cell carcinoma. REPORT ON FINDINGS. Macroscopy. 1.) Right lung: inflated, fixed right lung measuring 14 x 12 cm at the base and up to 26 cm high, central. bronchus resection plane located 1 cm upstream of the upper lobe bronchus. Dorsomedial and basal pleura over. S10 shows an area of max. 7.5 x 4 cm with roughening or residual adhesion, in the basal region over S7 is a 3. cm similar area, Intermediate bronchus in the region of the middle lobe bronchus bifurcation and proximal. sections of the bronchi of the basal group narrowed by a moderately firm, predominantly pale brownish-white. tumor with small patches of grayish-black pigmentation, max. 4.7 cm in size, with unclear and arcuate. demarcation, with the main mass in S10 and adjacent sections of S6, S7 and S9, extending to within 0.2 cm of. the medial visceral pleura over S10. Truncation of B9 and B10 and also a subsegmental branch of B7 in the. tumor. Focal crossing of lower pleural fissure and infiltration of middle lobe. In the tumor environment some. satellite foci up to 0.2 cm in size. Peripheral sections of basal bronchial branches dilated and filled with thick. mucus. Parenchyma below the adhesion zone over S10 shows diffuse induration and a brown vitreous. appearance. In the mediocaudal region of the upper lobe bronchus bifurcation next to the pulmonary artery a 2.5. cm node firmly adherent to the vascular wall with predominantly whitish section surfaces and extension right up. to the hilar resection surface, not continuity wit tumor. At the intermediate bronchus a 0.7 cm node part. suggestive of a tumor, next to the lower lobe bronchus part a 0.5 cm grayish-black node. Apical parenchyma in. S1 shows a seam-like area of induration and grayish-brown discoloration up to 0.4 cm wide. 2.) Paraesophageal LN (station 8): 1.2 cm node. 3.) Low paratracheal LN (station 4) right: 1.4 cm node part with abundant surrounding tissue. 4.) High paratracheal LN (station 2) right: 1.4 cm node with abundant surrounding tissue and in parts whitish. section surfaces suggestive of tumor. 5.) Subcarinal LN (station 7): 3.8 cm node with some surrounding tissue and in parts whitish section surfaces. suggestive of tumor. 6.) Hilar LN (station 10) left: 1.2 cm node part and a 0.9 cm lesioned node. Examined: 1.) a: Tumor with rest of parenchyma and satellite focus, b: tumor with B10, c: 2 sections of tumor with pleura,. d: lower pleural fissure (middle lobe part color-marked), e: node at upper lobe bronchus bifurcation with hilar. resection surface (color-marked), f: S10 mediobasal, g: S1 apical and node part intermediate bronchus, h: central bronchus resection plane and resection margins of vessels and also node at lower lobe bronchus,. 2.), 3.) + 6.) All material (in 3.) lamellated),. 4.) Node (lamellated),. 5.) 2 sections,. 13 blocks, partly Elastica-van Gieson, PAS, diastase-PAS. Microscopy. Re 1.) Tumor made up to solid structures of large atypical epithelia, densely packed in parts, with copious,. mostly stained cytoplasm with the inclusion of isolated very large, otherwise often round, occasionally. deformed nuclei containing granular chromatin and always prominent nucleoli. Apoptoses, not uncommonly. several mitoses per markedly enlarged visual field (field length 0.61 mm). Occasionally a vague epidermoid. layer, often intercellular fissures and isolated visible bridges. No mucin inclusion. In places a dissociation of the. tumor cell structures. Smaller areas of necrosis. Affected lung parenchyma partly destroyed, likewise a. relatively a large bronchus here, strand of cartilage remaining. A further large bronchus partially infiltrated and. involved in the tumor, likewise in this area smaller bronchi and bronchioles whose lumen is partly dilated, the. original respiratory epithelium replaced by tumor epithelium. In adjacent region tumor cell nests and formations. of small tumor lie freely in alveoli, also tumor cell structures in dilated lymph vessels. Vascularized interlobular. septa. between the tumor formations partly loose, partly fiber-rich, collagenous connective tissue with. accumulation of inflammatory cells. Isolated small vessels here, walls thickened by elastosis and containing. tumor cells. A larger vein surrounded, loose capillary-containing fiber tissue in the lumen. Between peripheral. tumor margin and visceral pleura on the medial side a strip of free lung parenchyma with partly deficient. atelectasis and thickened alveolar septa. Lower pleural fissure and partly fused visceral pleura demarcating or. covering this fissure transcended by tumor, where large bronchi are invaded to within close proximity of the. mucosa. Large tumor node next to the upper lobe bronchus bifurcation, enclosed anthracotic pigment, tumor. cell nests here at the resection margin. In the mediastinal tissue a further tumor-compromised lymph node with. anthracotic pigment deposits and otherwise fibrous growth of connective tissue. In subpleural region of S1 a flat. remodeling zone of the lung parenchyma with development of collagenous and elastic connective tissue, with. alveolar stroma still partly recognizable. Nearby tiny radial areas of interstitial fibrosis with small patches. of. accumulated anthracotic pigment. In the basal lower lobe am relatively large area of nonoxygenated, fibrosed. lung parenchyma with inclusion of partly obliterated smaller, partly patent vessels and bronchioles. Overlying. pleura markedly enlarged and fibrotic. Otherwise here and there in dilated peripheral airways mucus and. leukocytes and also a small cluster of pigment-storing macrophages in the alveoli. At the bronchus resection. margin, sections of mucosal epithelium are interrupted, otherwise regular. Here as in the walls of the large. pulmonary vessels no evidence of tumor cells. Lymph node at the hilus with isolated secondary follicles, slight. plaque of anthracotic pigment and foci of large macrophages. Re 2.) - b.) Partly preserved lymph nodes with few secondary follicles, varying degrees of anthracotic pigment. deposits, accumulation of macrophages and isolated secondary follicles. In parts, lymph nodes are largely. occupied by solid epithelial tumor. In places, tumor manifestation also in the paranodal tissue. At one point and. in a larger lymph node only very small areas occupied by tumor cell nests. EVALUATION. Primary diagnosis/diagnoses: Central bronchopulmonary, histologically largely undifferentiated, large-cell squamous cell carcinoma of the. right lower lobe of the lung (C4) with overgrowth of the interlobar fissure and continuous growth into the. adjacent section of the middle lobe and also several in some cases large lymph node metastases. Tumor. classification according to this picture pT2 pN3 L1 V1 R1, stage III. C34.3 M8070/3. Secondary diagnosis/diagnoses: Peripheral bronchiolectasia in the lower lobe, relatively large fibrous cicatricial remodeling zone in S10. mediobasal and similar flat subpleural cicatricial zones in S1 apical. Local high-grade pleural fibrosis over S10. Tumor-associated inflammation and small tumor necroses. Slight anthracotic pigment deposits in the lung. parenchyma and relatively marked in some lymph nodes. Remark/addendum: The main mass of the carcnoma lies in S10. Centrally it has grown as far as the bifurcations of the lower lobe. main bronchus and the middle lobe bronchus, without these being destroyed or constricted. The tumor invasion. of small blood vessels only concerns the focal region, the lymphangioinvasion is more marked and is also. located in the vicinity of the tumor focus. The R1 classification is based on the finding that carcinoma nests in. the large involved lymph nodes next to the bifurcation of the upper lobe bronchus extend to the mediastinal. resection plane. Further lymph node metastases are seen at the intermediate bronchus in the mediastinum and. also in the lymph nodes located under 4.) - 6.). The pN3 classification is also made with regard to the previous. finding with carcinoma cell structures in the fine needle aspiration biopsy from LN4 left (according to clinical. data).",test,
5759,TCGA-CI-6619.9060bc33-42b3-4ee3-8137-9fe5913c480d,"STRESFY. RESTILL. POSTOPERATIVE DIAGNOSIS: poure, LEGION :N RECTUM. ATESTORY: A. TRANSVERSE COLOS - pours. "", MECTOM . 13% OF. ADRNOMATONIS WITH GRACE DYSPLABIA, TRANAVERGE COLOR. a. BIOPSY GPECIMINN, RECTEM, ABIONING. INFILTRATING. or QUANTITATIVE : ARE. MICROSCOFECI.",test,
5762,TCGA-DY-A0XA.47B69AE9-9AA3-4B40-A574-96DA72155DEE,Date of Birth: l. Vital Status: Date of Death: Race: White. Ethnicity: Not Hispanic or Latino. Specific Ethnicity: Histologic Subtype: Rectal adenocarcinoma. Date of Initial Path Dx: Primary Site: Colons. Anatomic Site: Rectosigmoid Colon. T Stage: 3. N Stage: 0. M Stage: 0. Overall Stage: IIA. Date of Normal Procurement:,test,
5793,TCGA-VQ-A8PD.DE2703ED-489C-4185-A971-493A005DA974,"PRIMARY SITE: Stomach (Body). 1 - ""12a lymph node"": - Metastasis of carcinoma in one lymph node (1/1). 2 - ""8a lymph node"": 5 of 6 lymph nodes involved by metastatic carcinoma (5/6). 3 - ""Stomach + omentum"": - Moderately differentiated adenocarcinoma, extending from the esophagogastric. junction to the duodenum, measuring 8.7 x 6.5cm (measured macroscopically). infiltrating the segment wall until the adipose perigastric tissue;. - Perineural invasion present;. - Angiolymphatic invasion present;. - Moderate peritumoral desmoplasia;. - Sparse peritumoral lymphocitary infiltrate;. - Surgical margins uninvolved by neoplasia;. - Congested non-neoplatic segment;. - Omentum segment uninvolved by neoplasia;. - Carcinoma metastasis on the 13 lymph nodes dissected in small curvature (13/13) and. six nodes of six dissected of greater curvature (6/6). 4 - ""Spleen"". - Spleen congested. 5 - ""11p lymph node"": - 1 metastatic of 2 lymph nodes dissected (1/2). 6 - ""Esophageal margin"": - Margin uninvolved by neoplasia. Pathological Staging pT3 pN3b.",test,
5798,TCGA-FB-AAPS.0369BABC-3B58-4386-9CF6-71889B1F651B,"Gross Description: D: Whipple (paired silk prior pancreatic margin, long single silk portal. vein, long single blue SMA margin, looped blue suture deep radial margin): Received is a Whipple specimen that comprises a pancreas, duodenum, and. gallbladder. The specimen is oriented by the surgeon with a paired silk. suture designated as prior pancreatic margin, a long single silk suture. designated as portal vein, a long single blue suture designated as superior. mesenteric artery margin, and a looped blue suture designated as deep. radial margin. The pancreas measures 5.5 x 5.5 X 4 cm. The neck margin is inked blue and. the radial margin is inked black. The pancreas is sectioned to reveal an. ill-defined, indurated, white-yellow mass that measures. 3 x 3 X 2.7 cm that abuts and possibly invades the common bile duct, is. less than 0.1 cm to the superior mesenteric artery margin, and less than. 0.1 cm to the deep radial margin, less than 0.4 cm to the portal vein. margin, and greater than 2 cm from the pancreatic neck margin. The common. bile duct and pancreatic duct are both probe patent. The remaining. pancreatic parenchyma is tan-yellow with normal lobular architecture. The duodenum measures 19.5 cm in length X 3.3 cm in diameter and has. smooth, red-purple serosa. Both ends are stapled shut. The staples are. inked and opened to reveal a tan-brown mucosal surface with normal. appearing longitudinal folds. The distal 6.5 cm of duodenum is dark brown. and focally hemorrhagic with a slightly dusky appearance. There is an. ill-defined, erythematous lesion at the opening of the pancreatic duct in. the duodenum that measures approximately 2 X 1 cm in circumference. The. remaining duodenal mucosa is unremarkable. No other masses or lesions are. identified. The gallbladder measures 10.2 X 4.2 X 1.6 cm and has a smooth-to-roughened,. red-tan serosal surface. The gallbladder is opened and is filled with. viscous, red-black bile fluid. A cystic duct remnant is identified and. measures 1.5 cm in length X 0.4 cm in diameter. The serosal surface is. bile-stained and grossly unremarkable. In addition, there is a. crystallized calculus, 1.5 cm in greatest dimension, identified. No masses. or lesions are identified. The pancreatic duct and common bile duct enter the duodenum at different. locations approximately. 1.5 cm apart from each other. Sectioning through the fat closely reveals five possible lymph nodes. The. largest measures. 1.5 cm in greatest dimension. Representative sections are submitted. Microscopic Description: Diagnosis Details: SOURCE OF SPECIMEN:A Common bile duct - FS. SOURCE OF SPECIMEN:B Gastroduodenal lymph node. SOURCE OF SPECIMEN:C Pancreatic neck margin - FS. SOURCE OF SPECIMEN:D Whipple. Final Pathologic Diagnosis: A: Common bile duct, biopsy: - Bile duct, negative for malignancy. B: Gastroduodenal lymph node, biopsy: - Two lymph nodes, negative for malignancy (0/2). C: Pancreatic neck margin, biopsy: - Pancreas, negative for malignancy. D: Pancreas, duodenum, and gallbladder, Whipple procedure: - Ductal adenocarcinoma of the head of. pancreas, moderately differentiated. Comments: Formatted Path Reports: PANCREAS TISSUE CHECKLIST. Specimen type: Pancreatoduodenectomy. Tumor site: Head. Tumor size: 3 X 3 x 2.7 cm. Histologic type: Adenocarcinoma, ductal type. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: 1/7 positive for metastasis (Regional 1/7). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",test,
5800,TCGA-LL-A8F5.79A10C4B-1B5F-47BB-99EA-E694FB341696,"RUN DATE: RUN TIME. RUN USER: LOC: AGE/SX : ROOM. REG DR: BED: SPEC # : RECD. PERFORMED AT. COLL. TIME IN FORMALIN. hrs. COLD ISCHEMA TIME: mins. CLINICAL INFORMATION: Pre-Op Diagnosis: Remarks. Specimen (s) : A. Right breast lumpectomy. B. 1st sentinel lymph node. C. 2nd sentinel lymph node. MICROSCOPIC DIAGNOSIS. A. RIGHT BREAST LUMPECTOMY: INVASIVE DUCTAL CARCINOMA. SEE COMMENT FOR DETAILS. B. FIRST SENTINEL LYMPH NODE. TWO REACTIVE LYMPH NODES. C. SECOND SENTINEL LYMPH NODE. ONE REACTIVE LYMPH NODE. COMMENT (S). COLLEGE OF AMERICAN PATHOLOGISTS' PROTOCOL FOR EXAMINATION OF SPECIMENS WITH INVASIVE. CARCINOMA OF THE BREAST, BASED ON AJCC/UICC TNM. 7TH EDITION. The following classification should be adjusted based on additional clinical information. PROCEDURE. Right breast lumpectomy and sentinel lymph node. biopsies. LYMPH NODE SAMPLING: Sentinel lymph nodes. SPECIMEN LATERALITY. Right. HISTOLOGIC TYPE: Invasive ductal carcinoma. TUMOR SIZE : 4 cm. HISTOLOGIC GRADE: Tubular lifferentiation Score 3. Nuclear pleomorphism: Score 3. Mitotic rate: Score 3. Overall grade: Grade 3. TUMOR FOCALITY : Single focus of invasive carcinoma. DUCTAL CARCINOMA IN SITU: Indeterminate. EXTENT OF TUMOR : Skin: Uninvolved by invasive carcinoma. MARGINS : Margins uninvolved by invasive carcinoma. RUN DATE : RUN TIME : Specimen Inquiry. RUN USER : Lab Database: SPEC #: COMMENT (s). Distance from closest margin 6 mm,. deep/posterior. LYMPH NODES: Number of sentinel lymph nodes examined : 3. Total number of lymph nodes examined : 3. Number of lymph nodes with macrometastasis: 0. Number of lymph nodes with micrometastasis: 0. Number of lymph nodes with isolated tumor cells: 0. Number of lymph nodes without tumor cells. identified 3. PATHOLOGIC STAGING: Primary tumor pT2. Regional lymph nodes pNO (i-). Distant metastasis: Not applicable. GROSS DESCRIPTION: . Received fresh in the operating room labeled with the patient's name and ""right breast. lumpectomy"" with request for gross evaluation of margins as well as selection of tissue for. tissue banking is a lumpectomy specimen which weighs 131 grams and measures 9 x 8 x 5 cm. It is partially covered by a 9 x 1.5 cm ellipse of dark brown skin. Two sutures orient the. specimen as follows: long suture is 10:30 and short suture is 4:30.  palpable mass is. present within the specimen. The tissue surrounding the mass moves easily. The specimen. is inked as follows: 10:30-4:30 blue, 4:30-10:30 black, 4:30 edge red. 10:30 edge yellow,. and. deep/posterior green The specimen is serially sectioned revealing a fairly well. circumscribed grayish-tan mass with hemorrhagic needle tracts which measures 4 cm in. length. 3 cm in depth, and 3 cm in width. Towards the 4:30 aspect. the tumor has a. somewhat more lobulated appearance. The margins are negative with the closest. margin deep which measures 1.5 cm. A portion of the tumor is provided to the tissue bank. coordinator. The specimen is placed in formalin with sections to be hold overnight for. optimum formalin fixation. A1. skin and underlying breast tissue. A2-A3. the tumor as it most closely approximates to green. inked margin. A4. tumor as it most closely approximates to blue, inked margin. A5. additional representative section of tumor. A6. tumor grossly extending into surrounding ducts. A7. section of fibrotic area near the red, inked margin. B. In. formalin. labeled with the patient's name and ""first sentinel lymph node"" is a 2.5 x. 2 x 1 cm ovoid tan lymph node covered by a small amount of adipose tissue On cross. section, the node is largely composed of adipose tissue. It is totally submitted in blocks. B1 through B3 per sentinel lymph node protocol The specimen was evaluated late in the day. and is found to be unfixed. It is hold for overnight fixation prior to tissue processing. C. In formalin, labeled with the patient's name and ""second sentinel lymph node"" is a 1.5 x. 1.5 x 1 cm ovoid portion of fatty tissue which contains a 1.5 x 1 x 0.5 cm fatty lymph. node. The lymph node is submitted in block C1 to be held for overnight formalin fixation,. prior to further tissue processing. RUN DATE. RUN TIME. RUN USER: SPEC #. MICROSCOPIC DESCRIPTION: The tumor is a well delineated nodular, necrotic. poorly differentiated carcinoma with. bizarre nuclei, increased mitotic activity. There is very little tubular differentiation. Clinical and radiographic correlation is recommended. INTRAOPERATIVE CONSULTATION: RIGHT BREAST LUMPECTOMY. GROSS TUMOR PRESENT WITH CLOSEST MARGIN DEEP MEASURING 1.5 CM. TUMOR TISSUE PROVIDED TO TISSUE BANK COORDINATOR. RESULTS GIVEN TO DR. IN OPERATING ROOM AT. PHOTO DOCUMENTATION. Image. Picture Copy Error. (signature on file).",test,
5805,TCGA-E2-A1LL.3327975F-94BE-460E-9900-E063340927BE,"SPECIMENS: A. ADDITIONAL AXILLARY NODES. B. LEFT BREAST WITH AXILLARY CONTENTS LEVELS 1 & 2. SPECIMEN(S): A. ADDITIONAL AXILLARY NODES. B. LEFT BREAST WITH AXILLARY CONTENTS LEVELS 1 & 2. GROSS DESCRIPTION: A. ADDITIONAL AXILLARY NODES LEFT. Received in formalin are multiple tan-pink fragments of fibrofatty tissue aggregating to 4.0 x 4.0 x 2.0. cm. Dissection reveals 7 possible lymph nodes ranging from 0.2 x 0.2 x 0.2 cm to 2.0 x 1.5 x 1.5 cm. A1: 4 possible lymph nodes. A2: 4 possible lymph nodes. A3:2 possible lymph nodes. A4-A5: 1 lymph node serially sectioned. B. LEFT BREAST WITH AXILLARY CONTENTS LEVELS 1 & 2. Received fresh is a 2,422 gm oriented radical mastectomy specimen, 31 x 27 x 10 cm. The specimen. is partially surfaced with a tan-brown ellipse of skin, 27 x 14.5 cm. The centrally located darkened. areola rim measures 3.0 cm and the partially flattened nipple measures 1.0 cm. The skin surface is. remarkable for a gray-white linear well healed scar, 3.5 cm in length and measuring 6.0 cm from the. nipple in the upper outer quadrant. The specimen is inked as follows: anterior/superior-blue,. anterior/inferior-orange, posterior-black. The specimen is serially sectioned from medial to lateral into. 13 slices; slice 1 being most medial, slice 13 being most lateral. The nipple is located in slice four. The. cut surface reveals a gray-white firm/necrotic ill defined mass located in the upper outer central outer. quadrant in slice 6, 7 8 and 9, measuring 0.6 cm from the closest deep margin. The mass measures. 9.0 x 8.0 x 4.0 cm, and corresponds to the scar on the skin surface. The remainder of the specimen. reveals yellow lobulated adipose tissue interdispersed with gray-white fibrous tissue. The axillary tail. measures 8.0 x 5.0 x 4.0 cm. Dissection reveals 27 possible lymph nodes ranging from 0.1 x 0.1 x 0.1. cm to 2.0 x 1.5 x 1.5 cm. Slice 11 and 12 are remarkable for 3 large firm lymph nodes, ranging from 1.0. x 0.8 x 0.8 cm to 5.0 x 2.0 x 2.0 cm. Portion of the specimen is submitted for tissue procurement. Representative sections are submitted as follows: B1: 1 lymph node, serially sectioned slice 11. B2-B5: 1 lymph node, serially sectioned slice 11 & 12. B6-B12: 1 lymph node, serially sectioned slice 11 & 12. B13: 5 possible lymph nodes. B14: 4 possible lymph nodes. B15: 5 possible lymph nodes. B16: 4 possible lymph nodes. B17: 3 possible lymph nodes. B18: 2 possible lymph nodes. B19: 2 possible lymph nodes. B20: 1 lymph node, trisected. B21-B22: 1 lymph node, serially sectioned. B23-B24: nipple serially sectioned slice 4. B25: base of nipple slice 4. B26: scar with skin slice 7. B27: upper inner quadrant slice 2. B28: upper inner quadrant slice 3. B29: lower inner quadrant slice 2. B30: lower inner quadrant slice 3. B31: lower inner quadrant with inferior margin slice 3. B31: upper central slice 4. B32: lower central slice 4. B33: upper outer quadrant with superior margin slice 5. B34: upper outer quadrant slice 5. B35: area immediately adjacent to mass slice 5. B36: area immediately adjacent to mass slice 5. B37: mass with deep margin and muscle slice 6 upper outer quadrant at deep margin. B38: mass slice 6. B39: deep margin slice 6. B40: mass with deep margin slice 7. B41: mass with deep margin slice 7 upper outer quadrant mass with skin slice 7. B42: mass slice 7 upper outer quadrant. B43: skin, slice 8 upper outer quadrant. B44: mass with deep margin slice 8 upper outer quadrant. B45: mass with deep margin slice 8 upper outer quadrant. B46: mass with deep margin slice 9 upper outer quadrant. B47: lower outer quadrant with inferior margin slice 7. B48: inferior margin slice 8. B49: area immediately adjacent to mass upper outer quadrant slice 10. B50: deep margin upper outer quadrant slice 10. DIAGNOSIS: A. LYMPH NODES, ADDITIONAL, LEFT AXILLARY, DISSECTION: - TEN LYMPH NODES, NEGATIVE FOR METASTASES (0/10). B. BREAST, LEFT, MASTECTOMY AND AXILLARY CONTENTS LEVELS 1 AND 2 DISSECTION: - INVASIVE, DUCTAL CARCINOMA, SBR GRADE 3 WITH SQUAMOUS. FEATURES AND NECROSIS, MEASURING 9-CM. - SURGICAL RESECTION MARGINS NEGATIVE FOR TUMOR. - LOBULAR CARCINOMA IN SITU. - METASTATIC CARCINOMA TO FIVE OF THIRTY FOUR LYMPH NODES. (5/34), WITH EXTRANODAL EXTENSION, LARGEST MEASURING 1.5-CM. - SEE SYNOPTIC REPORTS. SYNOPTIC REPORT - BREAST. Specimen Type: Mastectomy. Needle Localization: Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 9cm. Tumor Site: Upper outer quadrant. Central. Margins: Negative. Tubular Score: 3. Nuclear Grade: 3. Mitotic Score: 3. Modified Scarff Bloom Richardson Grade: 3. Necrosis: Present. /ascular/Lymphatic Invasion: None identified. Lobular neoplasia: LCIS. Lymph nodes: Axillary dissection. Lymph node status: Positive 5/44 Extranodal extension. DCIS not present. ER/PR/HER2 Results. ER: Negative. PR: Negative. HER2: Negative. Pathological staging (pTN): pT 3 N 2a. SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimen: Surgical Excision. Block Number: B44. ER: Negative Allred Score: 0 = Proportion Score 0 + Intensity Score 0. PR: Negative Allred Score: 0 = Proportion Score 0 + Intensity Score 0. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the. proportion score (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of. cells staining, 4 = 31-60% of cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak. intensity of staining, 2 = intermediate intensity of staining, 3 = strong intensity of staining), with a scoring. range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score. of less than or equal to 2. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Immunohistochemistry was performed using the mouse anti-human ER (ER 1D5, 1:100) and PR (PGR. 136, 1:100) provided by. following the manufacturer s instructions. This. assay was not modified. Interpretation of the ER/PR immunohistochemical stain is guided by published. results in the medical literature, information provided by the reagent manufacturer and by internal. review of staining performance. SYNOPTIC REPORT - BREAST HER-2 RESULTS. Specimen: Surgical Excision. Block Number: B44. Interpretation: NEGATIVE. Intensity: 1+. % Tumor Staining: 5%. Fish Ordered: METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Her2 analysis was performed using the FDA approved Dako HercepTest (TM) test kit. using rabbit anti-human HER2. This assay was not modified. External kit-slides. provided by the manufacturer (cell lines with high, low and negative HER2 protein expression) and in-. house known HER2 amplified control tissue were evaluated along with the test tissue. Adequate, well. preserved, clear-cut invasive carcinoma was identified for HER2 evaluation. Interpretation of the HER2. immunohistochemical stain is guided by published results in the medical literature, information provided. by the reagent manufacturer and by internal review of staining performance. This assay has been validated according to the 2007 joint recommendations and guidelines from. ASCO and CAP and from the NCCN HER2 testing in Breast Cancer Task Force. The Pathology. Department takes full responsibility for this test's performance. CLINICAL HISTORY: year old with left breast ca. PRE-OPERATIVE DIAGNOSIS: Left breast ca. Microscopic/Diagnostic Dictation: Pathologist,. Microscopic/Diagnostic Dictation: Pathologist, (. Final Review:., Pathologist,. Final Review: Pathologist,. Final Review: Pathologist,. Final: Pathologist,.",test,
5816,TCGA-XU-AAXW.3D1B36F9-8DA7-4303-ABB6-31C62324FC7E,"(Age: ). Resulted: Facility: SPECIMEN (S) RECEIVED. 1. Thymus THYMUS GLAND, THYMOMA, AND PERICARDIUM (long stitch on. pericardium, short stitch on left lobe of gland). DIAGNOSIS. 1. Thymus gland. a) Thymom with focal microscopic extension beyond limiting capsule. into immediately adjacent. mediastinal fat, 3.0 cm maximum dimension. See comment. b) Background non-neoplastic thymus shows involution consistent with. patient's age. c) No significant lymphoid hyperplasia evident. COMMENT. The sections show a ""predominantly mixed"" (Lattes/Bernatz), ""cortical. type"" (Muller Hemelink) ""Type B2"" (WHO) thymoma. In most areas this. lobulated tumor is confined by an external capsule and is well within the. external margin of the specimen as indicated by prior AgNO3 application. However, the tumor does extend directly through the capsule into the. adjacent mediastinal connective tissue in several areas and in at least 2. such areas the tumor appears to be essentially juxtaposed to the external. margin of the specimen. By convention therefore the tumor is considered. to be a malignant thymoma and consideration should be given to the. possibility of incomplete resection. There is no tumor extension to or. into the patch of pericardium which was marked by a long stitch. CLINICAL HISTORY. MEDIASTINAL MASS. Page: 1 of 2. (Age: Resulted: Gender:1 F. Facility: GROSS DESCRIPTION. The specimen container labeled with the patient' S name and as ""thymus. gland, thymoma and pericardium (long stitch on pericardium, short stitch. on left lobe of gland"", contains a single piece of oriented yellow fatty. soft tissue measuring 13. o x 11.0 x 2.5 cm in thickness received in 10%. buffered formalin. The specimen weighs 63.2 grams. The entire specimen. is painted with silver nitrate. The specimen is oriented as short stitch. on left lobe and long stitch on pericardium. A piece of grayish-tan. pericardium tissue measures 2.4 x 1.5 cm. The edges of the pericardium. are over coated with green dye. On sectioning, there is a tumour on the. mid aspect of the left lobe measuring 3.0 x 1.3 cm maximum dimension. Sections are submitted as follows: 1A to 1H - Representative transverse sections of the tumour in relations. to the adjacent soft tissue and pericardium. 1I - Representative section from the lower left lobe. 1J - Representative section from the upper left lobe. 1K - Representative section from the upper right lobe. 1L - Representative section from the lower right lobe. Three pieces of tumoral tissue and three pieces of thymic tissue are. taken for tissue frozen. Page : 2 of 2.",test,
5871,TCGA-KM-A7QH.030DC904-C959-4D06-AE70-C99AFAAB31E0,"MEDICAL RECORD. PROCEDURE DATE: SEX: M. SIGN-OUT DATE: ATTENDING: REQUESTING: ROOM: CONTACT NO: COPIES TO: DIAGNOSIS: 1. Kidney, right (specimens 1&2, excision): Renal cell carcinoma with chromophobe features, Fuhrman nuclear. Grade II/IV. 2. Rib (biopsy): A piece of unremarkable rib; gross diagnosis only. CLINICAL INFORMATION: HISTORY: MAN WITH BHD. PROCEDURE: PREOP DX:#SOLID RENAL MASS POSTOP DX: SOLID RENAL MASS OPERATIVE FINDINGS: 3 CM SOLID MASS IN MID POLE OF RIGHT KIDNEY AND .5 CM MASS IN POSTERIOR ASPECT OF RIGHT. KIDNEY. SPECIMENS SUBMITTED: 1) KIDNEY, RIGHT. 2) KIDNEY, RIGHT. 3) RIB. GROSS DESCRIPTION: Received are three (3) containers labeled with the patient's name and number. 1. ""Solid"" contains a single fragment of yellow-white soft tissue measuring 0.9 X 0.7 X 0.5 cm. The fragment. of tissue has been previously incised and has a gold-mahogany cut surface. A portion is retained in. and the remainder is submitted in cassettes labeled 1A and 1B. 2. ""Solid #2"" contains a single fragment of soft, red-tan-gold soft tissue measuring 4.2 X 3.5 x 2.5 cm. overall. The specimen represents a solitary mass measuring 2.8 X 3.5 X 2.5 cm. with attached fibroadipose tissue in. grossly-appearing normal kidney. The specimen has been previously incised and reveals a red, friable cut. surface with areas of gold-tan tissue. No discernable capsule is appreciated. Representative portions are. retained in. and representative portions are submitted in cassettes 2A-2F. MEDICAL RECORD. 3. ""Right rib"" consists of a single fragment of tissue, consistent with rib with minimal sott tissue measuring 1.0. X 0.5 X 7.0 cm. The specimen is submitted for gross diagnosis only. Printed.",test,
5928,TCGA-ZM-AA0E.42E5710C-CA70-4996-ADAC-D2FA1932B20E,"Pathohistological diagnosis. Seminoma, left testicle. Material received as urgent biopsy. A gray-yellow piece, size 2.8:2:1 cm, was received. Histologically, the material was defined. as seminoma. 1. A cut testicle with tumor, size 5:3.5:2.5 cm, with 11 cm long funiculus up to 2.5 cm in. diameter was received. On testicular cut we see white, irregular tumor 3:2.5:2 cm in. size. Histologically, the tumor is made of solid cell clusters with round and oval bright. nucleus containing nucleolus and moderately abundant bright to pink cytoplasm and. surrounding those seats we see connecting tissue containing abundant lymphocyte. clusters. On the edges of the testicle we find individual channels that are. histochemically PLAP positive, which corresponds with unclassified intratubular germ. cell neoplasia (IGCNU). The tumor does not infiltrate funiculus nor capsule and is not found within vascular. areas. The tumor is also not present in rete testis. 2. Material received as urgent biopsy. A red sample, 1 cm in diameter, 0.6 cm thick was received. Histologically, the material was. defined as seminoma.Histologically, in permanent material we find two separate tumor seats,. each 0.4 cm in diameter and they are made of tumor cells described above. Immunohistochemically, tumor cells are CD117 positive and partially PLAP positive.",test,
6006,TCGA-DB-A64P.3D2EEE2E-B4EB-4603-B4D2-AA4B0F790200,"Final Diagnosis: A-C. Brain, left frontal masses #1-#3 and CUSA, resection: Oligodendroglioma with early anaplastic. transformation (WHO grade III). Immunohistochemical stains were performed on paraffin embedded tissue using antibodies to IDH1 (R132H), p53. and Ki67. Neoplastic cells are positive with antibodies to IDHI (R132H) consistent with IDHI mutation. p53. protein is positive in scattered cells. Ki67 labeling index varies from low to moderate. The findings support the. above diagnosis. Fluorescence in situ hybridization (FISH) studies for 1p19q deletion have been ordered on paraffin sections and. will be performed hv the. For interpretation, see. Preliminary Frozen Section Consultation: A-B. Brain, left frontal masses #1-#2, smears: Diffuse glioma, favor astrocytoma. Hold over for final typing and. grading. Intraoperative cytologic smear(s) interpretation performed by: Gross Description: A. Received fresh labeled ""left frontal brain mass"" is a 3.2 x 2.6 x 2.0 cm portion of brain. Smears prepared. All. submitted. Grossed by. B. Received fresh labeled ""#2 left frontal brain mass"" is a 3.2 x 2.0 x 1.5 cm portion of brain. Smears prepared. All submitted. Grossed by. C. Received fresh within a (. rap labeled ""CUS? specimen trap - left frontal brain mass"" is a 4.1 x 4.0 x 0.8. cm aggregate of brain. All submitted. Grossed by. Block Summary: Part A: Left frontal brain mass. 1 Lifrontal brain mass 1. 2 Lifrontal brain mass 2. 3 Lifrontal brain mass 3. 4 Lt frontal brain mass 4. 5 Lt frontal brain mass 5. 6 Lt frontal brain mass 6. 7 Lt frontal brain mass 7. Part B: #2 left frontal brain mass. 1 Lt frontal brain mass #2-1. 2 Lt frontal brain mass #2-2. 3 Lt frontal brain mass #2-3. 4 Lt frontal brain mass #2-4. 5 Lt frontal brain mass #2-5. Part C: specimen trap - left frontal brain mass. 1. trap Lt frontal 1. 2. trap LI frontal 2. 3. trap Lt frontal 3. 4. trap Lt frontal 4. 5. trap Lt frontal 5. Page of 2.",test,
6077,TCGA-XU-AAY0.FE9A7EDE-B8DF-411D-87EE-B2C9DD2793BB,"(Age: ). Resulted: Gender: F. Facility: SPECIMEN (s) RECEIVED. 1. Thymus anterior mediastinal tumor and total thymus-stitch marks open. biopsy site. DIAGNOSIS. 1. Mediastinum, resection (anterior mediastinal tumor and total thymus) : a) Thymoma, WHO type AB, with: (see Comment). i) Greatest tumor dimension = 8.6 cm. ii) Focal microscopic transcapsular invasion present. iii) Resection margins negative for tumor. b) Organizing hematoma with surrounding foreign body giant cell. reaction and fibrosis, consistent with biopsy site. c) Thymic tissue with involutional changes. SYNOPTIC DATA. specimen: Thymus. Procedure: Thymectomy. Specimen Integrity: Intact. Specimen Weight : 234 (g). Tumor Size: Greatest dimension: 8.6 cm. Additional Dimension: 8.5 cm. Additional Dimension: 4.7 cm. Histologic Type: Type AB thymoma. Tumor Extension: Other: microscopic transcapsular. invasion. Margins. Margins uninvolved by tumor. Distance of tumor from closest. margin: 6 mm. Treatment Effect: Not applicable. Lymph-Vascular Invasion: Not identified. Regional Lymph Nodes: Cannot be assessed. Number examined: 0. Page: 1 of 3. (Age: ). Resulted: Facility: Number involved: 0. Pathologic Staging (Modified Masaoka) : Stage IIa: Microscopic transcapsular. invasion. Implants/Distant Metastasis: Cannot be assessed. Additional Pathologic Findings: Age-appropriate involution changes. Other resolving hematoma and. foreign body giant cell reaction at previous biopsy site. COMMENT. Sections show an encapsulated tumor composed predominantly of nodular. proliferations of small lymphocytes admixed with lesser numbers of bland. epithelioid cells (90-95% of the tumor). separated by fibrous septae. These are admixed with scattered areas composed of bland spindle cells. containing few lymphocytes (5-10% of the tumor) The tumor appears to be. completely encapsulated, but a single focus of microscopic transcapsular. invasion is identified (block 1H) However, the tumor appears to be. covered with ample adipose tissue at this point (approx. 0.8 cm from the. tumor to the painted surface) An area overlying the tumor marked with a. stitch shows a resolving hematoma with surrounding foreign body giant. cell response and dense fibrosis, consistent with the previous open. biopsy site. The tumor appears encapsulated in this area, with tumor. cells 0.6 cm from the cauterized margin of this site. [mmunohistochemical staining confirming thymic derivation were previously. performed. and were not repeated here. The overall findings. remain of a WHO type AB thymoma, with focal microscopic transcapsular. invasion (modified Masaoka stage IIa). GROSS DESCRIPTION. 1. The specimen container labeled with the patient's name and as. ""anterior mediastinal tumor and total thymus-stitch marks open biopsy. site n contains an oval-shaped encapsulated mass with attached. fibroadipose tissue, grossly consistent with thymus received in 10%. buffered formalin. It measures 13.5 x 10 x 5.2 cm in overall dimension. Page: 2 of 3. (Age: Resulted: Facility: and weighs 234 g. There is a stitch attached to a portion of adherent. fibrous tissue indicating the open biopsy site. This portion of fibrous. tissue measures 2.7 X 1.8 x 0.7 cm. The entire surface of the specimen is. painted with Silver nitrate and the adherent fibrous tissue over-coated. with India ink. The mass measures 8.6 x 8.5 x 4.7 cm and is firm,. multilobular, homogeneous tan with whitish fibrotic areas admixed. The. capsule is overall smooth except for the stitch area. Sections of the. mass and thymic tissue stored frozen. Representative sections submitted. as follows: 1A-1H sections from the open biopsy surface (1A-1D-includes the open. biopsy site) -. 1I-1M sections from the opposite (deep) surface, with overlying fatty. tissue. 1N, 10 sections from mid tumor. 1P, 1Q sections from fibrofatty tissue consistent with thymic tissue. Page: 3 of 3.",test,
6180,TCGA-30-1861.446be880-d1d8-4b63-b4d5-5aa0468ccafe,"Report Status: Final. Type: Surgical Pathology. TISSUE FOR SPECIAL STUDIES ONLY. DIAGNOSIS: SPECIMEN LABELED ""RECTUS MUSCLE"": Tissue entirely submitted for special studies from frozen section lab. SPECIMEN LABELED ""OMENTAL TUMOR"" (including frozen section A). METASTATIC ADENOCARCINOMA. SPECIMEN LABELED ""RIGHT ADNEXAL TUMOR"" (including frozen section B) : PAPILLARY SEROUS ADENOCARCINOMA, grade 3 (of 3) - periovarian mass. SPECIMEN LABELED ""ADDITIONAL RIGHT ADNEXAL TUMOR"": METASTATIC ADENOCARCINOMA in fallopian tube and on surface of atrophic. ovary with ovarian lymphovascular invasion. SPECIMEN LABELED ""LEFT TUBE AND OVARY WITH TUMOR"": PAPILLARY SEROUS ADENOCARCINOMA grade 3 of 3, periovarian mass with. metastases to fallopian tube and surface of atrophic ovary. SPECIMEN LABELED ""UTERUS AND CERVIX"" (17gm) : Cervix: METASTATIC ADENOCARCINOMA in paracervical soft tissue. Endometrium: Inactive endometrium. Myometrium: Leiomyomata (1.0 cm). Serosa: METASTATIC ADENOCARCINOMA. SPECIMEN LABELED ""TUMOR FROM CUL DE SAC"": METASTATIC ADENOCARCINOMA. CLINICAL DATA: History: with ascites, increased CA125 and peritoneal nodules. Operation: TAH/BSO, omental biopsy. Clinical Diagnosis: ?Ovarian cancer. TISSUE SUBMITTED: 1. Rectus muscle (for research). 2. Omental tumor (FS). 3. Right adnexal tumor (FS). 4. Additional right adnexal tumor. 5. Left tube and ovary with tumor. 6. Uterus and cervix. 7. Tumor from cul-de-sac. O.R. CONSULTATION: SPECIMEN LABELED ""#2 OMENTAL TUMOR"" (FSA) : Metastatic poorly differentiated carcinoma. SPECIMEN LABELED ""#3 RIGHT ADNEXAL MASS"" (FSB) : Poorly differentiated carcinoma, consistent with papillary serous. carcinoma. GROSS DESCRIPTION: The specimen is received fresh, in 7 parts, each labeled with the patient's. name and unit number. Part 1, ""rectus muscle"", consists of a single fragment of red/tan muscle (2.5 x. 1.4 x 0.6 cm) The entire specimen was submitted for special studies from the. frozen section lab. Part 2, ""omental tumor -. consists of a single piece of fibroadipose tissue. Page: 1 of 2. (3 o x 2.0 x 0.5 cm) with a 0.8 cm white, firm nodule. Representative sections. of the nodule were submitted as ""FSA"". Micro 1. FSA remnant, 1 frag,. 1. Micro 2. omental tumor, 1 frag. Part 3, ""right adnexal mass"", consists of a firm, white, ovoid mass (7.0 x 2.5. X 3.0 cm) with a focally granular surface and soft, white, solid interior. No areas of hemorrhage or focal necrosis are seen within the ovoid mass. Additionally, several fragments of blood clot and soft tissue, ranging in size. from 2.5 x 0.4 x 0.4 cm up to 4. 0 x 2.0 x 0.6 cm were present. Representative. sections of the ovoid mass were submitted as ""FSB"" and additional tissue was. sent to the tissue bank for special studies from the frozen section lab. Micro 3. FSB remnant, 1 frag,. Micro 4-5 - tumor, 2 frags. Part 4, ""additional right adnexal tumor"", consists of a pink/tan, fimbriated. fallopian tube (3.5 cm in length by 0.5 cm in diameter) and an attached ovary. (2.0 x 1.8 X 0.7 cm). The surface of the ovary is white and smooth with a. single clear fluid-filled cyst. No tumor is grossly visible on either the. ovary or the fallopian tube. The entire specimen is submitted for histologic. evaluation. Micro 6-7. - right fallopian tube, multiple frags,. Micro 8-9. right ovary, multiple frags,. Part 5, ""left tube and ovary with tumor"", consists of a brown/tan segment of. fimbriated fallopian tube (3.0 cm in length by 0.6 cm in diameter) with an. attached ovary (1.7 x 0.9 x 0.4 cm). Also firmly attached to the fallopian. tube is a white/tan, firm nodule (3.0 x 2.5 x 2.0 cm) The tumor is grossly. similar to that submitted in part 3. Representative sections of tumor and. associated adnexal structures are submitted for histologic evaluation. Micro 10 - tumor & associated soft tissue, 1 frag. Micro 11-13 - fallopian tube, multiple frags,. 1. Micro 14. - ovary, multiple frags,. Part 6, ""uterus and cervix"", consists of a 17g uterus and attached cervix (5.4. x. 3.5 x 2.4 cm) The exocervix (1.7 x 1.5 cm) has a smooth, glistening mucosal. surface with a 0.4 cm external os. The endocervix (1.2 cm in length by 0.4 cm. in width) has a smooth, tan herringbone-lik mucosal surface. The endometrial. cavity (1.0 cm from cornu to cornu by 2.3 cm in length by 0.2 cm in thickness). is tan/brown and smooth and is distorted by the presence of an intramural. leiomyoma (1. 0 x 0.8 x 0.6 cm) deep to the posterior side, near the left horn. of the uterus. The myometrium has a maximum thickness of 0.9 cm. The serosal. surface is unremarkable. Micro 15. anterior cervix, 1 frag,. Micro 16. - posterior cervix, 1 frag. Micro 17. - posterior LUS, 1 frag,. Micro 18-19 - anterior endometrium, 2 Trags,. Micro 20. posterior endometrium, 1 frag,. Part 7, ""tumor from cul de sac"", consists of multiple fragments of firm,. white/tan soft tissue (ranging in size from 0.6 x 0.4 x 0.2 cm up to 5.5 x. 4. x 2.7 cm) with a diffusely hemorrhagic, granular surface. The tissue. is. grossly similar to that submitted in part 3. Micro 21-22 - tumor from cul de sac, 2 frags,. Reports to: SPECIMEN TYPE: TISSUE FOR SPECIAL STUDIES ONLY. ADDITIONAL SPECIMEN TYPE: OMENTUM BIOPSY. ADDITIONAL SPECIMEN TYPE: UTERUS WITH OR WITHOUT TUBES & OVARIES, NEOPLASTIC. ADDITIONAL SPECIMEN TYPE: SOFT TISSUE MASS OR SIMPLE EXCISION. Page: 2 of 2.",test,
6284,TCGA-AD-6548.b2b633b9-bb9e-4320-bac3-67c05313d7d3,"QC Pathologist: FINAL PATHOLOGIC DIAGNOSIS: Right colectomy with attached portion of terminal ileum: Two carcinomas of colon. Tumor Characteristics: 1. Histologic type for both: Adenocarcinoma. 2. Histologic grade for both: Moderately differentiated. 3. Tumor site for both: Splenic flexure area. 4. Tumor size: Largest: 2.9 x 2.6 x 0.5 cm, smallest 1.6. X 1.4x0.3 cm. 5. Lymphovascular space invasion: Not identified. 6. Microscopic tumor extension: a. Largest tumor exhibits invasion not quite completely. through the muscularis propria. b. Smallest tumor does not invade muscularis propria. 7. Treatment effect None identified. Surgical Margin Status: 1. Proximal margin nearest to largest tumor: 14.3 cm. 2. Distal margin nearest to smaller tumor: Approximately. 4.0 cm. 3. Circumferential (radial) margin which is closest to. largest tumor. 0.4 cm. 4. Distance of tumor from closest margin: 0.4 cm. Lymph Node Status: 1. Total number of lymph nodes received: 12. 2. Total number of lymph nodes containing metastatic. carcinoma: None (D/12). Other: 1. Other significant findings: A separate tubular adenoma. without high grade dysplasia is noted. 2. pTNM stage: pT2, NO (largest tumor). pT1, NO (smallest. tumor). COMMENTS: CLINICAL HISTORY: Preoperative Diagnosis: Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: Right colon. CCA-AD-6548 -. GROSS DESCRIPTION: Received in formalin and labeled. and #1 right. colon is an 18.1 cm segment of previously opened colon with. an attached 2.6 cm segment of small bowel, a moderate amount. of pericolic fat, and a 16.6 X 5.3 x 0.7 cm portion of. omentum. The appendix is not present. The serosa is smooth and tan-pink. There is a 2.9 X 2.6 cm. granular tan-pink mucosal mass with raised borders, 5.8 cm,. 7.9 cm, and 14.3 cm from the distal margin; ileocecal valve,. and proximal margins, respectively. The cut surface of the. mass is gray-white and appears to extend into the muscularis. to a depth of 0.2 cm. The mass does not grossly appear to. involve the pericolic fat. At 1.3 cm distal to the mass, is a 1.6 X 1.4 cm, tan mucosal. polyp, 4.1 cm from the distal margin. The polyp does not. appear to extend into the underlying muscularis. The remainder of the mucosa is tan with the normal folds,. with a 1.3 X 0.6 cm, ill-defined, firm, tan nodule in the. cecal pouch. No additional obvious mucosal lesions are. identified. The proximal and distal inner circumferences average 4.5 cm. and 3.8 cm, respectively, and the wall thickness averages. 0.3 cm. There are multiple irregular, tan-yellow firm. tissues consistent with probable lymph node, ranging from. 0.2 x 0.2 x 0.1 cm to 0.7 X 0.5 x 0.4 cm. The specimen is inked, sectioned, and representative. sections are submitted as labeled: 1, proximal and distal. margins; 2, ileocecal valve; 3 and 4, mass to inked serosa. (perpendicular); 5, mass to uninvolved mucosa; 6 and 7,. mass; 8-11, mucosal polyp, entirely submitted; 12, nodule in. cecum, entirely submitted; 13, omentum; 14-16, five whole. possible lymph nodes in each; 17 and 18, three whole. probable lymph nodes in each. The blocks are labeled. Also received in the same container are green,. yellow and blue cassettes labeled. for genomic. research study. 1 or more Final Results Received.",test,
6732,TCGA-XM-AAZ2.63C3FEA5-DB7A-455F-9AD6-A6BC7B5B4195,"Service: Thoracic. M. Clinical Diagnosis & History: male with history of cough. Found to have an anterior. mediastinal mass. Biopsy showing thymoma. Specimens Submitted: 1: Mediastinal tumor and pericardium. 2: Mediastinal lymph node. DIAGNOSIS: 1. Mediastinal tumor and pericardium, excision: - Thymoma, WHO Type A. (see note). - The tumor measures 3.5 x 3 x 1.5cm. - The tumor is encapsulated. - Non neoplastic thymus is unremarkable. - The margins are free of tumor. Note: The tumor has focal B1-B2 areas; however, they comprise less than 10%. of the tumor. 2. Mediastinal lymph node, excision: - Three benign lymph nodes (0/3). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1). The specimen is received fresh and placed in formalin, labeled. ""Mediastinal tumor and pericardium"", and consists of a soft tissue resection. measuring 10 x 10 x 6 cm in overall dimension and weighing 364 g after. fixation. The attached pericardium is tan, smooth, ovoid in shaped and. measures 5 cm in diameter. There is an attached scant uninvolved adipose. Service: Thoracic. tissue. The specimen was previously inked: green=resection margin;. blue=pericardium; blackeremaining specimen. Sectioning reveals a. yellow-tan, lobular, homogenous, firm mass with a 3.5 x 3 x 1.5 em cavity. filled with clotted blood. Representative sections of the specimen are. submitted. TPS and photo is taken. Summary of sections: TP - tumor with pericardium. TR - tumor with resection margin. TF - tumor with fat. TC - tumor with cavity. 2). The specimen is received in formalin, labeled ""Mediastinal lymph node"". and consists of three firm tan lymph nodes ranging from 0.1 to 1.6 cm. in. greatest dimension. The lymph nodes are entirely submitted. Summary of sections: LN - lymph nodes. Summary of Sections: Part 1: Mediastinal tumor and pericardium. Block. Sect. Site. PCs. 1. TC. 1. 3. TF. 3. 3. TP. 3. 3. TR. 3. Part 2: Mediastinal lymph node. Block. Sect. site. PCs. 2. LN. 3.",test,
6868,TCGA-AA-3976.7ab12244-c3c7-4297-8375-7324c8fae99c,"Diagnosis: Resected rectosigmoid sample including a moderately differentiated adenocarcinoma of the. colorectal type, located 3.5 cm aborally of the aboral resection margin, measuring max 2.3. cm in diameter, with infiltration of the tunica muscularis propria and two regional lymph. node metastases. Stage of tumor: pT2, pN1 (2/16) MX; G2, V0, R0.",test,
6944,TCGA-FD-A43U.FB7CF869-AA10-4C3E-9BDA-5686130DB4C6,"Gender: Male. Race: White. Report Date: FINAL PATHOLOGIC DIAGNOSIS. A. Right pelvic lymph nodes; dissection: - Six of twenty three lymph nodes with metastatic urothelial carcinoma. (6/23). - Largest nodal tumor focus measures 3 mm, with extranodal tumor extension. B. Left pelvic lymph nodes; dissection: One of ten lymph nodes with metastatic urothelial carcinoma (1/10). - Largest nodal tumor focus measures 1.4 cm, with extranodal tumor. extension. C. Urinary bladder, prostate, seminal vesicles and vasa deferentia;. cystoprostatectomy: - Invasive high grade urothelial carcinoma, see pathologic parameters. - Tumor invades thru the bladder wall and into the perivesical fat,. periprostatic tissue and focally the prostate. - Tumor involves the right periprostatic soft tissue margin. - One perivesical lymph node, no tumor (0/1). D. Left distal ureter; resection: - Segment of ureteral wall, no tumor. E. Distal right ureter; resection. - Segment of ureter, no tumor. Urothelial Carcinoma Pathologic Parameters. 1. Tumor type: Invasive urothelial carcinoma. 2. Grade of tumor: High grade. 3. Depth of invasion: Extravesicular soft tissue, periprostatic tissue and. prostate. 4. Tumor distribution: Solitary, 3.5 cm, mass involves bladder posterior, left. and right lateral, anterior and trigone walls and prostate. 5. Ureteral margins: Negative for tumor. 6. Distal urethral margin: Negative for tumor. 7. Soft tissue margin or serosa: Positive for tumor (at right periprostatic soft. tissue margin, 5 mm [slide C23]). 8. Lymph nodes: Positive for tumor (7/34). 9. pTNM: pT4a,N2,MX, R1. this Checklist utilizes the 7th edition TNM staging. system for Bladder of the American Joint Committee on Cancer (AJCC) and the. International Union Against Cancer (UICC). MD. Interpretation performed by the Attending Pathologist and reviewed with the. Resident/Fellow, M.D. Clinical History: This is a. year-old man with history of urothelial carcinoma, high grade. invasive into the prostatic stroma and lamina propria. He now undergoes. cystoprostatectomy and lymph node dissection. Specimens Received: A: Right pelvic lymph nodes. B: Left pelvic lymph nodes. C: Bladder, prostate, seminal vesicales & vas deferens. D: Left distal ureter. E: Distal right ureter. Gross Description: The specimens are received in five containers each labeled with the patient's. name and medical record number. A. The first container is additionally identified as, ""1. Right pelvic lymph. node"". Received fresh and placed in formalin is a 7.5 x 6 x 2.5 cm aggregate of. yellow-brown lobular tissue from which multiple lymph node candidates measuring. 0.3-1.1 cm are identified. A1-A2: 5 candidate lymph nodes. A3-A4: 6 candidate lymph nodes. A5: One candidate lymph node, bisected. A6: One candidate lymph node, sectioned. B. The second container is additionally identified as, ""2. Left pelvic lymph. nodes"". Received fresh and placed in formalin is a 7 x 4.5 x 3 cm aggregate of. yellow-brown lobular tissue from which multiple lymph node candidates measuring. 0.3-3.5 cm are identified. B1: 4 candidate lymph nodes. B2: 5 candidate lymph nodes. B3: 3 candidate lymph nodes. B4: One candidate lymph node, bisected. B5-B8: One candidate lymph node, sectioned. B9-B11: One candidate lymph node, grossly involved by tumor, representative. sections. C. The third container is additionally identified as, ""3. Bladder, prostate,. seminal vesicles, vas deferens"". Received fresh and placed in formalin is a 17.5. x 9 x 6 cm cystoprostatectomy specimen consisting of a 0.2 x 6 x 4.5 cm bladder. with attached mesenteric fat and an approximately 5 x 4 x 3 cm prostate. The. right seminal vesicles measure 4.5 x 3 x 1 cm and right vas deferens measures 8. x 0.6 cm. The left seminal vesicles measures 4 x 3.1 x 1.3 cm and left vas. deferens measures 2.5 x 0.6 cm. The right ureteral stump measures 3 x 0.6 cm,. the left measures 2.2 x 0.6 cm, and both demonstrate intact, patent lumens. The right half of the prostate and bladder is inked blue and the left half is. inked black. The outer surface of the bladder is inked black. The bladder and. prostate are opened anteriorly along the urethra. The capsule is absent and the. apex of the prostate is disrupted. Sectioning demonstrates ill-defined broad. areas of firm, yellow-tan indurations throughout the prostate parenchyma focally. extending to ink. The seminal vesicles demonstrate cystic cut surface with. gold-brown thick secretion. The left seminal vesicle is focally grossly involved. by the lesion. The opened bladder reveals a red-brown lesion with shaggy and ulcerated surface. involving the entire posterior wall extending to the left and right lateral. walls as well as the inferior anterior wall. The lesion measures 3.5 x 1.5 cm. On cut section, the bladder demonstrates firm yellow-tan cut surface grossly. consistent with tumor involvement/possible fibrosis with maximal thickness of. 2.2 cm. The lesion extends through the lamina propria into the perivesicular. fat to within 0.2 cm of the ink. On one section it surrounds the right ureter. The surrounding bladder mucosa is edematous, wrinkled, tan-brown with wall. thickness of 1.3 cm. Bilateral ureteral orifices, adjacent to the trigone, are. identified and probe patent. Received separately in the same container is a 3 x. 3 x 1 cm aggregate of yellow lobular adipose tissue from which one candidate. lymph node measuring 0.2 cm identified. Representative sections are submitted as follows: C1: Distal prostatic urethral margin (apex). C2: Right ureter resection margin. C3: Left ureter resection margin. C4: Prostatic apical margin. C5-C6: Lesion, left lateral wall, closest extension to ink. C7: Lesion, anterior wall, closest extension to ink. C8-C10: Lesion, posterior wall,. C11: Lesion, trigone. C12: Lesion, right lateral wall. C13: Lesion, surrounding right ureter. C14: Uninvolved dome. C15-C19: Left prostate, apex to base. C20: Left seminal vesicle and vas deferens. C21-C25: Right prostate, apex to base. C26-C27: Right seminal vesicle and vas deferens. C28: One candidate lymph node. D. The fourth container is additionally identified as, ""4. Distal left ureter"". Received fresh and placed in formalin is a soft and rubbery, tan-pink, and. oriented, 1.0 x 0.4 x 0.2 cm tissue grossly consistent with mucosa with minimal. attached adipose tissue. A lumen is not identified. The specimen is submitted in. toto as E1. E. The fifth container is additionally identified as, ""5. Distal right ureter,. stitch on non-margin side"". Received fresh and placed in formalin is a soft and. rubbery, 1.2 x 0.9 x 0.6 cm tissue containing a segment of ureter with wall. thickness of 0.1 cm and a patent lumen of 0.2 cm. B. margins side is trimmed and. submitted as E1. , M.D.",test,
6950,TCGA-IM-A3U3.56E8B18F-9149-4B45-AF96-DFC3B9DAE916,"and Clinics Laboratory. (Age. Pathologic Interpretation: A. RIGHT LOBE OF THYROID, 9.6 GRAMS: PAPILLARY THYROID CARCINOMA, TALL CELL VARIANT, WITH SCLEROSIS, 1.3 cm in the mid pole. The tumor approaches less than 1 cm from the inked margin. Lymphovascular invasion is present. PAPILLARY THYROID MICROCARCINOMA, FOLLICULAR VARIANT, WITH SCLEROSIS, 0.3 cm, inferior. pole. PAPILLARY THYROID MICROCARCINOMA, FOLLICULAR VARIANT, < 1 cm, inferior pole. Multinodular hyperplasia. Mild lymphocytic thyroiditis. One lymph node, negative for metastatic carcinoma (0/1). No parathyroid gland present. B. LEFT LOBE OF THYROID, 16 GRAMS: PAPILLARY THYROID MICROCARCINOMA, FOLLICULAR VARIANT, WITH SCLEROSIS, at least 5 foci,. from 0.1 cm to 0.6 cm, throughout the left lobe. Lymphovascular invasion is present. Multinodular hyperplasia with focal adenomatous changes. No parathyroid gland present. No lymph nodes. C. R/O PARATHYROID FS: Minute fragment of lymph node. No parathyroid gland present. Negative for metastatic carcinoma. D. RIGHT CENTRAL MIDLINE COMPARTMENT DISSECTION PERMANENT: Eight lymph nodes, negative for metastatic carcinoma (0/8). Thymus and fibroadipose tissue. AJCC: pT1b, pNo, pMx (see Tumor Summary). Surgical Pathology Cancer Case Summary. Procedure: Thyroid lobectomy (Right and Left). Specimen Integrity: Intact. Specimen Size: Right lobe: 5.5 x 2.3 X 1.0 cm. Left lobe: 5.0 x 3.0 x 2.0 cm. Specimen Weight: Right lobe: 9.6 grams. Left lobe: 16 grams. Tumor Focality: Multifocal: Bilateral. Dominant Tumor: Tumor Laterality: Right lobe. Tumor Size: Greatest dimension: 1.3 cm. Histologic Type: Papillary carcinoma. Variant, specify: Tall cell variant. Cytomorphology: Tall cell. Margins: Margins uninvolved by carcinoma. Distance of invasive carcinoma to closest margin: < 1 mm. Tumor Capsule: None. Lymph-Vascular Invasion: Present: Extensive (4 or more vessels). Perineural Invasion: Not identified. Extrathyroidal Extension: Not identified. Other Tumors: Tumor Laterality (multifocal): Right and left lobes, multiple. Tumor Size: Greatest dimension: from 0.1 cm to 0.6 cm. Histologic Type: Papillary carcinoma. Variant, specify: Follicular variant with sclerosis. Architecture: Follicular. Cytomorphology: Classical. Margins: Margins uninvolved by carcinoma. Distance of invasive carcinoma to closest margin: 1 mm. Tumor Capsule: None. Lymph-Vascular Invasion: Present: Extensive (4 or more vessels). Perineural Invasion: Not identified. Extrathyroidal Extension: Not identified. Pathologic Staging (pTNM): Primary Tumor (pT): pT 1b: Tumor more than 1 cm but not more than 2 cm in greatest dimension, limited to the thyroid. Regional Lymph Nodes (pN): pNO: No regional lymph node metastasis. Number examined: 8. Number involved: 0. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: Adenomatoid nodules or Nodular follicular disease (eg. nodular hyperplasia, goitrous thyroid). Thyroiditis: Focal (nonspecific). NOTE: Some immunohistochemical antibodies are analyte specific reagents (ASRs) validated by our laboratory (Her 2, Parvo, H. pylori, HBcore). These ASRs are clinically. useful indicators that do not require FDA approval. These clones are used: ID5=ER, PgR 636=PR, A485=HER2, H-11=EGFR, CCH2/DDG9=CMV, F39.4 1=AR and HPV by. ISH. All immunohistochemical stains are used with formalin or molecular fixed, paraffin embedded tissue. Detection is by. The results are read by a pathologist as positive. or negative. Procedures/Addenda. Addendum. Date Complete: Addendum Diagnosis. Immunohistochemistry performed at. reveal the following profile: POSITIVE (A5-A13): IgG. IGg4 (20/hpf). HBME1. Galectin 3. Ki67 proliferation index 5% (A5) and 3% (A13). Immunohistochemistry performed at. reveal the following profile: POSITIVE (B8,B11): IgG. IgG4 (3/HPF). HBME1. Galectin 3. Ki67 proliferation index 2% (B8) and 10% (B11). Intraoperative Consultation. CFS: Minute tissue fragment, possible parathyroid tissue. Dr. concurs. Communicated to surgeon. Clinical History: Patient is a i years old. : with thyroid cancer. Pre Operative Diagnosis: Not provided. Specimen(s) Received/Processing Information: Fee. Codes: A: Right lobe of thyroid (suture marks upper pole) (Fresh) H&E, Initial x 1, H&E, Initial x. 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial. x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E,. Initial x 1. B: Left lobe of thyroid -stich superior permanent H&E, Initial x 1, H&E, Initial x 1, H&E,. Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x. 1,. H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial. x. 1. C: R/O parathyroid fs Frozen section x 1, FS Perm x 1. D: Right central midline compartment dissection permanent H&E, Initial x 1, H&E,. Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1. Gross Description: A. Received in formalin labeled ""Right lobe of thyroid suture mark upper pole"" is a 9.6 grams of right lobe of thyroid. measuring 5.5 x 2.3 x 1.0 cm. The external surface is inked in black. The parathyroid gland is not present grossly. Cut. sections reveal grey-white well-defined tumor mass measuring 1.3 x 1.0 x 0.7 cm and less than 0.1 cm from the. capsule, 2.0 cm from isthmus resection margin. This tumor is located in the mid pole. Toward inferior pole, there are. multiple grey-tan cystic cavities measuring from 0.3 to 0.8 cm in greatest dimension. Specimen submitted in toto in 14. cassettes as follows: Cassette #1: Resection margin. Cassettes #2-4: Superior pole. Cassettes #5-8: Mid pole, the lesion in toto. Cassettes #9-14: Inferior pole. B. Received in formalin labeled ""Left lobe of thyroid stitch superior"" is 16.0 grams of left lobe of thyroid measuring 5.0. x 3.0 x 2.0 cm. The external surface is inked in black. Parathyroid gland is not present. Cut sections reveal grey-tan. well defined nodule (3.2 x 2.0 x 1.8 cm) with hemorrhagic and cysts, located at less than 0.1 cm from capsule and 0.5. cm from the isthmus resection margin. This nodule is extending from superior to inferior pole. Specimen submitted in. toto in 12 cassettes as follows: Cassettes #1-5: Superior pole. Cassettes #6-9: Mid pole. Cassettes #10-12: Inferior pole. C. Received fresh labeled ""R/O parathyroid"" is a grey-tan tiny fragment measuring 0.2 x 0.2 x 0.1 cm. Submitted in. toto in 1 cassette for frozen section. D. Received in formalin labeled ""Right central midline compartment"" is yellow fibroadipose tissue measuring 4.0 x 3.0. x 1.0 cm. There are 5 possible lymph nodes measuring up to 1.0 cm in greatest dimension. Specimen submitted in. toto in 6 cassettes as follows: Cassette #1: Largest bisected. Cassette #2,3: Two lymph nodes per cassette. Cassette #4-6: Adipose tissue.",test,
6968,TCGA-CG-4475.5f6dc898-0d32-4721-bd04-745083d0357c,"Diagnosis: 1.: Gastric stump resection material with a poorly differentiated ulcerous and mucinous. adenocarcinoma in the region of anastomosis, predominantly of the intestinal type, but very. focally of the diffuse type, with infiltration of the perigastric fatty tissue, a carcinomatous. lymphangitis of the subserosa, tumor-free resection margins in the region of the mucosa,. a. tumor-free omentum and two lymph node metastases (15 lymph nodes examined). 2.: Tumor-free lymph node tissue (5 lymph nodes examined). Tumor classification: mucinous adenocarcinoma (diffuse type. pT3 N1 (2/20) L1 V0 R0.",test,
7026,TCGA-B6-A0IM.4A86A028-C56D-455E-A5CD-47D8A34B5734,"Putient: CLINICAL HISTORY: Not provided. GROSS EXAMINATION: A. ""Right breast mass #1"", received fresh labeled with the patient's name and. record number for frozen section is a 4 x 2.9 x 2.2 cm specimen with a 2 x 2 x. 1.3 cm tumor. The frozen section remnant is submitted in A1. A2-A4 represent. full cross sections of the tumor and adjacent tissue. B. ""Right breast, long lateral short superior"", received fresh is a right. mastectomy specimen weighing 2040 grams. The skin ellipse measures 34.5 x. 17.5 cm, has a 4 cm areola and a 0.9 cm nipple. A suture marks the lateral. aspect of the specimen. The breast measures 35 x 23 x 6 cm with an 8 x 6.5 x. 1 cm axillary tail. In the upper outer quadrant is a recent sutured surgical. incision 7 cm. The soft tissue margins are inked blue. Sectioning shows a. recent biopsy cavity approximately 5 cm in diameter deep to the suture. On. the medial aspect of this biopsy cavity, another tumor is identified. While. contiguous with the cavity, the bulk of the tumor is more medial. This is felt. to represent a single ""dumbell"" shaped tumor rather than two separate tumors. Maximal dimensions of this tumor are 5 x 3.5 x 3 cm. This tumor is also. located in the upper lateral quadrant and is 2 cm from the deep resection. margin. Further firm tissue suspicious for tumor is identified in the lateral. aspect of the biopsy cavity and measures 2 cm. Again this is 2 cm from the. deep resection margin. Measuring from the medially located tumor to the. lesion present at the lateral aspect of the biopsy cavity the maximum tumor. diameter is 7 cm. The axilla is sampled from medial to lateral. BLOCK SUMMARY: B1 - lateral aspect of biopsy cavity. B2 - medial aspect of the biopsy cavity. B3&B4 - tumor in upper outer quadrant. B5 - tissue from lower lateral quadrant. B6 - tissue, upper inner quadrant. B7 - tissue, lower inner quadrant. B8&B9 - nipple. B10&B11 - deep margin. B12 - one lymph node, serially sectioned. B13 - two lymph nodes, one inked red. B14 - three node candidates. B15 - one lymph node. B16 - highest node (near suture). INTRA OPERATIVE CONSULTATION: A. ""Right breast mass (AF1) "" - infiltrating ductal carcinoma present. (Dr. REVISED DIAGNOSIS. This report is being revised to correct the specimen ""B"" site from ""left"" to. ""right"" breast. The remainder of the diagnosis is unchanged. A. ""RIGHT BREAST MASS"", (INCISIONAL BIOPSY) : INFILTRATE DUCTAL CARCINOMA WITH PROMINENT CRIBRIFORM PATTERN. TUMOR SIZE; 2 CM. B. ""RIGHT BREAST"", (MASTECTOMY) : sult for: 1 of 2. INFILTRATING CARCINOMA, PRESENT. HISTOLOGIC TYPE, DUCTAL WITH A PROMINENT. CRIBRIFORM COMPONENT. N.S.A.B.P. HISTOLOGIC GRADE 1 OF 3. N.S.A.B.P. NUCLEAR GRADE 2 OF 3. GROSS TUMOR SIZE; 7 CM. SEE COMMENT. INVASION TUMOR SIZE, 7 CM. SEE COMMENT. LOCATION, UPPER OUTER QUADRANT. MULTIFOCAL TUMOR, NO. IN-SITU CARCINOMA, ABSENT. STATUS OF NON-NEOPLASTIC BREAST TISSUE; SCLEROSING ADENOSIS WITH. MICROCALCIFICATIONS. LYMPHATIC/VASCULAR INVASION ABSENT. SURGICAL MARGIN STATUS, NEGATIVE. NIPPLE STATUS; PAGET'S DISEASE ABSENT. SKIN STATUS; FREE OF TUMOR. MUSCLE STATUS; NOT SAMPLED. LYMPH NODES STATUS; 9 LYMPH NODES, NO CARCINOMA IDENTIFIED (0/9). ESTROGEN/PROGESTERONE AND CELL CYCLE ANALYSIS PENDING, YES. METHODOLOGY, FRESH TISSUE. RESULTS WILL BE ISSUED IN AN ADDENDUM. COMMENT: The tumor size in the mastectomy specimen is 7 cm in greatest. dimension and the size of the tumor in the incisional biopsy is 2 cm. The. overall tumor size is mostly likely 9 cm in greatest dimension. The results of this revision has been discussed withr=. on. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es) . Darte. ADDENDUM 1: Tissue was sent to the. for assay of the estrogen. and progesterone receptors. The estrogen receptor activity was judged to be. positive with an estimated FMOL value of 113. The progesterone receptor. activity was judged as borderline with an estimated FMOL of value of 14. Please refer to. for a complete report. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). 2 of 2.",test,
7100,TCGA-24-1930.746ac85a-ea6d-4d60-859f-69bf580a707c,"Final Dx: OVARY, LEFT, OOPHORECTOMY. - ADENOCARCINOMA, PAPILLARY SEROUS TYPE. (SEE MICROSCOPIC COMMENT). OVARY, RIGHT, OOPHORECTOMY. - ADENOCARCINOMA, PAPILLARY SEROUS TYPE. OMENTUM, OMENTECTOMY. - METASTATIC ADENOCARCINOMA. LYMPH NODE, RIGHT ILIAC, EXCISION. - METASTATIC ADENOCARCINOMA (1/1). LYMPH NODE, LEFT PARA-AORTIC, EXCISION. - METASTATIC ADENOCARCINOMA (1/1). Frozen Sect: FS: Left ovary, neoplasm, oophorectomy - Poorly-differentiated. adenocarcinoma of mullerian. origin, by. Gross The specimens are received in six formalin-filled containers labeled with the. patient's name. The first container is additionally labeled ""FS' and contains a single. irregularly- shaped fragment of nodular tan-white soft tissue measuring 2.8 x 2.0 x 0.2 cm. in greatest dimension. The second container is additionally labeled ""X - left tube and ovary"" and contains a. previously serially sectioned ovary which, upon reconstruction, conforms to the above stated. dimensions. The ovarian surface is gray-white, lobulated and there is gross evidence of. tumor on the surface of the ovary. On cut surface, tumor is tan and multilobulated with. intervening fibrous strands. Densely adherent to the ovarian tumor is a 5.0 cm long x 0.1 cm. densely hemorrhagic and fibrous structure which is consistent with fallopian tube. Labeled XA through XG - sections of ovarian tumor; Xh - section of possible fallopian tube. The third container is additionally labeled ""omentum"" and contains a 25 x 19 x 4 cm. irregularly-shaped fragment of firm, nodular tan-white t: sue, grossly consistent with. omentum. The tissue is diffusely and extensively involved by pink-tan tumor. Labeled A1 and. The fourth container is additionally labeled ""right ovary"" and contains numerous pink-white,. friable tumor fragments measuring 10 x 7 x 4 cm. The largest fragment measures 7 x 5 x 5 cm. and. appears to represent an ovary involved by tumor. The serosal surface is irregularly nodular. suggesting tumor involvement. No fallopian tube can be grossly identified on the surface. of the specimen. The largest fragment is serially sectioned to show lobulated, partially. necrotic tan-white tumor, diffusely involving the entire fragment. Despite extensive. sectioning, a fallopian tube is not identified. Labeled B1 through B6. Jar 2. The fifth container is additionally labeled ""para-aortic lymph node"" and contains a. single irregularly-shaped fragment of fibroadipose tissue measuring 1.3 x 0.8 x 0.4 cm in. aggregate. It is submitted in toto. The sixth container is additionally labeled ""right iliac lymph node"" and contains a lymph. node measuring 2.5 x 1.5 x 0.4 cm in maximum dimension. It is submitted in toto. Labeled D. Jar 0. Comment: Sections of both the left and right ovaries show a poorly differentiated. adenocarcinoma, most consistent with papillary serous adenocarcinoma. The surfaces of both. ovaries are involved. There is also diffuse omental involvement by tumor. Both the right. iliac and para-aortic lymph nodes show involvement by metastatic adenocarcinoma. Sections. of the adnexal structure attached to the left ovary which were submitted as possible. right fallopian tube showed diffuse involvement by adenocarcinoma. Whether this represents. replacement of the fallopian tube epithelium by tumor, or simply tumor present on the. ovarian surface in the absence of the left fallopian tube, cannot be determined. SYNOPTIC REPORTING FORM FOR MALIGNANT OVARIAN NEOPLASMS 1. A neoplasm is PRESENT. 2. The HISTOLOGIC DIAGNOSIS is: Serous adenocarcinoma. 3. The LOCATION (s) OF THE PRIMARY TUMOR (S) is/are: Right and left ovary (synchronous primary tumors). 4. The FIGO GRADE of the tumor is: III (Tumor composed of greater than 50% solid cellular. nests). 5. The NUCLEAR (BRODERS') GRADE of the tumor is: G3 (Poorly-differentiated). Tumor IS identified on the ovarian surface of both. ovaries. The presence of tumor invasion of the mesovarium CANNOT. BE EVALUATED. 8. Invasion of adjacent fallopian tube CANNOT BE EVALUATED. 9. Tumor invasion of the pelvic soft tissue CANNOT BE. EVALUATED. 10. Tumor involvement of the pelvic peritoneum CANNOT BE. EVALUATED. 11. Metastatic involvement of the EXTRAPELVIC peritoneum. CANNOT BE EVALUATED. 12. Metastatic involvement of the omentum is PRESENT. 13. Metastatic involvement of the uterine serosa CANNOT BE. EVALUATED. $. 14. Metastatic involvement of the endometrium CANNOT BE. EVALUATED. 15. Regional lymph node metastases are PRESENT. 16. The total number of regional lymph nodes examined is 2. 17. The total number of metastatically-involved regional lymph. nodes is 2. Extranodal extension by tumor metastases is ABSENT. 18. DETAILED STAGING INFORMATION: Based on the above information, the PRIMARY TUMOR is. classified as : TNM SCHEME. FIGO SCHEME. DEFINITION. T3c. IIIC. Macroscopic peritoneal. metastasis beyond true pelvis. measuring greater than 2 cm in. greatest dimension, OR. Regional lymph node metastasis. OR Metastasis to capsule of. liver. THE REGIONAL LYMPH NODES are classified as: N1 (Nodes contain metastatic tumor). THE STATUS OF DISTANT TUMOR SITES is classified as: MX (Status cannot be assessed). 19. The FINAL AJCC/FIGO STAGE IS: AJCC SCHEME. FIGO SCHEME. X. Insufficient data to assign stage. The pathologic stage assigned here should be regarded as. provisional, and may change after integration of clinical. data not provided with this specimen. History: The patient is a. with a left ovarian mass. Operative procedure: Left salpingo-oophorectomy and omentectomy. An intraoperative non-microscopic consultation was obtained and interpreted as: Called. to O.R. to pickup left ovary and tube consisting of 8.5 x 7 x 4.0 cm adnexa which is. tan-yellow, multilobulated and nodular with irregular surface. The cut surface shows. intervening soft, fibrous strands. Section frozen as FS is small cystic area containing. clear, serous fluid. The fallopian tube is 5.0 cm long and 1.0 cm in maximum diameter. It is. serially sectioned to show that it is grossly unremarkable,.",test,
7102,TCGA-MA-AA43.662EBBFF-1A0B-4217-8E3D-C453AAA4BDAD,"Component. Burgical Pathology. (note). Hospital Number. ADDENDUM- IMMUNOHISTOCHEMISTRY. Interpretation. Immunohistochemical stains with appropriate controls were performed on block. A1 and A3. The poorly differentiated squamous carcinoma is positive for P63. and. CK5/6(squamous markers) . The adenocarcinoma is positive for CEA,. negative for ER and vimentin. Both tumors are strongly positive for P16. The immuno-staining results support the original diagnosis: invasive. cervical adenocarcinoma and poorly differentiated squamous carcinoma. End of Addendum Report or Additional Results. PATHOLOGIC DIAGNOSIS. CERVIX, BIOPSY: - INVASIVE POORLY DIFFERENTIATED SQUAMOUS CELL CARCINOMA WITH. A DEPTH OF INVASION OF 2 MM. - INVASIVE ADENOCARCINOMA OF CERVIX, MODERATELY DIFFERENTIATED. WITH GREATEST TULMOR THICKNESS 3MM. - SEE COMMENT. Comment. Immuno-stains of P16, CEA, ER, vimentin, p63 and Ck5/6 were requested on. block 1 and 3. The results will be followed in an addendum report. Dr. is notified on. Pertinent Clinical Information. Not provided. Specimen (s) and Procedure: Cervical biopsy. Gross Description. Received in formalin, labeled with the patient's name and medical record. number are five pieces of tan-white to pink-red fragments ranging from 0.5 x. 0.3 X 0.2 cm to 0.7 x 0.5 x 0.5 cm. The specimen is sectioned and entirely. submitted in cassettes A1-A3. Pathology Resident. Microscopic Description. Biopsy shows moderately differentiated adenocarcinoma and poorly. differentiated squamous cell carcinoma of the cervix. There are glandular. formations as well as sheet-like areas with squamous features. There are. multiple mitoses and pleomorphic nuclei with prominent red nucleoli. One. biopsy endocervical fragment shows is entirely replaced by tumor with the. greatest thickness of 3 mm. Result History. SURGICAL PATHOLOGY (Order. ) on. Resulting Lab. Result Date and Time. Priority. Edited Result -. Routine. Received Date/Time. Authorizing Provider. Encounter Provider. Encounter. View Encounter. i (Order. Administration Details. No Administrations. Recorded. Release Date/Time. Start Date/Time. End Date/Time. None. None. Frequency. Duration. Priority. None. None. Routine. Normal. Quantity. 1. Comments. Authorizing Provider. Unknown, Provider. Attending Provider(s). Encounter. There are no order-level documents. View Encounter. None.",test,
7125,TCGA-B0-4690.dd5521f2-076a-43a4-8dca-a16545c9e77d,"FINAL DIAGNOSIS. LYMPH NODE, EXCISION -. NO EVIDENCE OF NEOPLASIA IN 3 (0/3) LYMPH NODES. PART 2: KIDNEY, RIGHT, NEPHRECTOMY -. A. RENAL CELL CARCINOMA, CLEAR CELL TYPE WITH SARCOMATOID FEATURES. B. FUHRMAN NUCLEAR GRADE IS 3 of 4. C. THE GREATEST DIAMETER OF THE NEOPLASM IS 12.0 cm. D. THE NEOPLASM EXTENDS INTO THE PERIRENAL AND PERIPELVIC FAT. E. NO EVIDENCE OF ANGIOLYMPHATIC INVASION IS IDENTIFIED. F. CARCINOMA GROSSLY EXTENDS INTO THE RENAL VEIN. G. ALL OTHER SURGICAL MARGINS ARE FREE OF THE NEOPLASM. H. NON-NEOPLASTIC KIDNEY SHOWS CHRONIC INTERSTITIAL INFLAMMATION, GLOMERULOSCLEROSIS, AND. THYROIDIZATION. I. ADRENAL GLAND WITH RENAL CELL CARCINOMA (See Comment). J. NO EVIDENCE OF NEOPLASIA IN 3 (0/3) LYMPH NODES. K. TNM STAGE: pT3b NO MX. Final Diagnosis. ESOPHAGUS, NODULE, BIOPSY -. A. REACTIVE / HYPERPLASTIC GASTRIC MUCOSA AND SCANT INFLAMED SQUAMOUS MUCOSA. B. NEGATIVE FOR INTESTINAL METAPLASIA,.",test,
7280,TCGA-EL-A3GV.96FB4A04-40F7-4E07-9FAD-334AFFEF232C,"Pathology. bort. athology. Sex: F. Case type: Surgical Case. DIAGNOSIS. (A) TOTAL THYROIDECTOMY. PAPILLARY THYROID CARCINOMA, CONVENTIONAL TYPE. Location: Left lobe. Multi-focal: No. Size = 1.9 cm. Extrathyroidal extension: Present, into soft tissue. Lymphovascular invasion: Absent. Resection Margins: Negative. Lymph nodes: No tumor present in 1 lymph nodes (0/1). (B) LEFT INFERIOR PARATHYROID: Parathyroid tissue, no tumor present. GROSS DESCRIPTION. (A) TOTAL THYROIDECTOMY - A total thyroid with right lobe (2.5 x 2.2 x 1.1 cm), isthmus (1.2 x 1.5 x 0.5 cm) and left lobe. (3.5 x 2.0 x 1.5 cm). The right lobe and isthmus are unremarkable. Within the soft tissues in the superior aspect of the. isthmus are several possible lymph nodes. The left lobe contains a well-circumscribed solid mass at lower portion (1 9 X 1.5 x. 1.0 cm). The nodule is confined to the thyroid. SECTION CODE: A1, A2, representative sections from right lobe, superior to inferior; A3, possible Ivmph nodes; A4,. section of isthmus; A5-A10, sections of left lobe from superior to inferior including the dominant nodule. (B) LEFT INFERIOR PARATHYROID, P/S RULE OUT - Received are two fragments of pale yellow and pink soft tissue. fragments both measuring 0.3 cm in greatest dimension and has a combined weight of 0.0092 grams. The specimen is. submitted entirely in B for frozen section evaluation. Touch preps are performed. FS/DX: PARATHYROID TISSUE PRESENT. CLINICAL HISTORY. Papillary thyroid carcinoma. SNOMED CODES. T-86000, M-80503, T-C4200, M-00110,. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been specifically cleared or approved by the U.S. Food and Drug Administration."". Sex: F. Case type: Surgical Case. Entire report and diagnosis completed by:",test,
7656,TCGA-2G-AAHL.81F00ECA-C7BD-4EDD-ABE1-EED08C0E5F36,Summary pathology report. Left orchidectomy; seminoma; diameter 9.0 cm; no invasion of rete testis; angio-invasion. present; no invasion of tunica albuginea; epididymis free of tumor; surgical margin of spermatic. cord free of tumor. = date of orchidectomy): pathologist.,test,
7958,TCGA-EX-A69M.808A38A8-4E74-42A4-8258-C883A7F6CA0C,"Diagnosis: A: Uterus, cervix, bilateral tubes and ovaries, abdominal. hysterectomy and bilateral salpingo-oophorectomy. Histologic type: invasive non-keratinizing squamous cell. carcinoma of the cervix with lymphocytic response. Histologic grade: poorly differentiated. Tumor site: cervix, tumor involves the cervix circumferentially. Myometrium: uninvolved. Parametrium/serosal involvement : absent. Tumor size: tumor size grossly 5.8 cm; tumor invades to 2.4 out. of 2.6 cm, invading most deeply within the posterior cervix (92%. through the cervical wall, A2). Adnexal involvement: absent. Cervical/vaginal margin and distance: - Tumor extends most closely to 1.6 cm from the cervical/vaginal. cuff margin. - CIN 3 extends to 1.5 cm from the cervical/vaginal cuff margin. Lymphovascular space invasion: absent. Regional lymph nodes (see other specimens) : Total number involved: 0. Total number examined: 11. Additional pathologic findings: - CIN 3 with HPV effect. - Atrophic endometrium. - Myometrium with vascular calcifications. Right ovary: atrophic ovary, no tumor seen. Left ovary: atrophic ovary with simple cyst, no tumor seen. Right fallopian tube: paratubal cyst, no tumor seen. Left fallopian tube: paratubal cyst, no tumor seen. AJCC Pathologic Stage: pT1b2 pNO pMx. FIGO (2009 classification Stage Grouping : IB2. Note: This pathologic stage assessment is based on information. available at the time of this report, and is subject to change. pending clinical review and additional information. B: Lymph node, left pelvic, dissection. - Five lymph nodes, no tumor seen (0/5). C: Lymph node, right pelvic, dissection. - Six lymph nodes, no tumor seen (0/6). Clinical History: The patient is a. -year-old female with a clinical diagnosis of. adenocarcinoma. Gross Description: Received are three appropriately labeled containers. Container A is additionally labeled ""uterus, cervix, bilateral. tubes and ovaries, parametrium. "". Specimen fixation: formalin. Specimen type: hysterectomy and bilateral salpingectomy. Adnexa: present and attached bilaterally. Weight: 155 grams. Shape: cylindrical. Dimensions: Height: 11.5 cm. Anterior to posterior width: ranging from 2.5 to 4.5 cm. Breadth at fundus: 4.4 cm. Serosa: tan/pink with a defect at the fundus (0.8 cm X 0.4 cm). Cervix: Ectocervix: tan with focal hemorrhage and cautery artifact. (diameter is 4.0 cm) with a centrally located os (1.5 cm). Tumor size: 5.8 X 4.9 X 3.0 cm. Tumor site: The tumor comes within 0.1 cm of the black inked. margin. The tumor is located circumferentially within each. quadrant of the cervix. Endocervix: tan with involvement by tumor. Other features: none. Endometrium. Length of endometrial cavity: 3.5 cm. Width at fundus: 1.0 cm. Endometrial surface: red/tan and velvety; It is 0.1 cm thick. Other findings : none. Myometrium: Thickness of wall: 1.2 cm. Other findings: none. Adnexa: Right ovary: Measurement: 2.0 X 0.8 X 1.0 cm. External surface: tan/pink, smooth and glistening. Cut surface: homogeneous, tan/pink, unremarkable ovarian. parenchyma. Right fallopian tube: Measurement: length, 5.0 cm; diameter, 0.8 cm. Other findings: fimbria present, fallopian tube patent. Left ovary: Measurement: 1.5 X 1.2 X 0.9 cm. External surface: tan/pink, smooth and glistening. Cut surface: homogeneous unremarkable ovarian parenchyma. compressed a cyst (1.0 cm in greatest dimension) ; The. cyst walls are 0.1 cm thick with a shiny smooth interior. The. cyst is filled with a serous fluid. Left fallopian tube: Measurement: length, 5.0 cm; width, 0.6 cm. Other findings: fimbria present, patent fallopian tube lumen. Other organs present: Vagina: no. Urinary bladder: no. Rectum: no. Other comments: Right Parametrium (3.0 X 4.5 X 1.5 cm) and Left. parametrium (2.0 X 3.8 X 2.0 cm) are present. Digital picture: not taken. Tissue give to tissue procurement: Tissue was given to Tissue. Block summary: A1 - perpendicular section of anterior cervix, tumor and margin. A2 - perpendicular section of posterior cervix, tumor and margin. A3 - cervical margin, en face (9 o' clock to 3 o' clock). A4 - cervical margin, en face (6 o' clock to 9 o' , clock). A5 - cervical margin, en face (3 o' clock to 6 o' clock). A6 - anterior lower uterine segment. A7 - posterior lower uterine segment. A8 - anterior corpus. A9 - posterior corpus. A10 - representative sections of right ovary and representative. sections of right fallopian tube. A11 - bisected right fimbria and soft tissue. A12 - representative sections of left ovary. A13 - fimbria candidate, bisected. A14-A18 - right parametrium. A19-A26 - left parametrium. Tissue remains in the container. Container B is additionally labeled ""left pelvic nodes"" and. holds two fragments of yellow adipose tissue (in aggregate 4.6 X. 3.7 X 1.8 cm). Within the fatty tissue, there are multiple firm to. lymph node candidates ranging in greatest dimension from 0.6. 1.5 cm. Block Summary: B1 - Serially sectioned lymph node candidate. B2 - Three lymph node candidates. B3 - One lymph node candidate. B4 - One lymph node candidate. Tissue remains in container. Container C is additionally labeled ""right pelvic lymph nodes"". and holds multiple fragments of yellow adipose tissue in. aggregate 3.9 X 2.5 X 1.4 cm. Within the fatty tissue, there are multiple firm tan lymph node. candidates (ranging in greatest dimension from 0.5 to 1.7 cm) . Block Summary : C1 - Three lymph node candidates. C2 - Two lymph node candidates. C3-C4 - - Serially sectioned largest lymph node candidates. Tissue remains in container.",test,
7970,TCGA-BP-5008.d5ff5d2d-9935-4e27-82f9-91d000cc6252,"net ovarce. Clinical Diagnosis & History: Right renal mass. Specimens Submitted: 1: KIDNEY, RIGHT; NEPHRECTOMY. DIAGNOSIS: 1. KIDNEY, RIGHT; NEPHRECTOMY: Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. Fuhrman Nuclear Grade: Nuclear grade II/IV. Tumor Size: Greatest diameter is 2.5 cm. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: Not Identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Mild chronic interstitial inflammation and fibrosis. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT1 Tumor <= 7.0 cm in greatest dimension limited to the kidney. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT THAVE. REVIEWED AND APPROVED THIS REPORT. SURGICAL PATHOLOGY REPORI. Gross Description: 1). The specimen is received in fresh state, labeled as ""right kidney"", and il consists of a right kidney measuring 8.5 x 6.1 X 4.0. cm and perirenal fat weighing in total 298 g. A segment of ureter measuring 7.5 cm in length and 0.6 cm In circumference is. attached. Adrenal gland is not identified. The specimen Is prevlously sectioned multiple times for TPS. The specimen surface is. inked. There is a 2.5x2.0 x 1.6 cm completely encapsulated severely hemorrhagic mass in the anterior mid portion of the renal. cortex. The tumor is medially bosselated, but renal capsule or adjacent sinus fat is grossly uninvolved. No vascular tumor. thrombi are grossly identified. Background renal parenchyma is grossly unremarkable. Mucosa of pelvis and ureter appears. grossly unremarkable. There is no lymph node identified in the perirenal fat. The specimen is photographed. TPS is taken. Summary of sections: UM -- ureteral margin. VM -- vascular margin. T -- tumor with capsule and sinus fat, entirely submitted. P -- pelvic mucosa. K - background renal parenchyma. Summary of Sections: Part 1: KIDNEY, RIGHT; NEPHRECTOMY. Block. Sect, Site. PCs. 1. 1. 1. p. 1. 5. 5. um. 1. 1. vm. 1.",test,
8079,TCGA-BJ-A45I.AD17A97F-3FB4-4D09-8F84-97BEBD06DB0D,"FINAL DIAGNOSIS: THYROID, TOTAL THYROIDECTOMY (15 GRAMS) -. A. PAPILLARY THYROID CARCINOMA, LOCATED IN THE RIGHT LOBE (2.1 M) AND LEFT LOBE (0.3 CM). B. 2.1 CM FOCUS IS TALL CELL VARIANT WITH EXTRATHYROIDAL EXTENSION AND EXTENSION TO RESECTION. MARGIN. C. NO ANGIOLYMPHATIC INVASION. D. FIVE RIGHT PARATHYROIDAL AND ONE LEFT PARATHYROIDAL LYMPH NODES, FREE OF TUMOR (0/6). E. PATHOLOGIC STAGE: pT3, NO. F. NODULAR THYROID HYPEROPLASIA WITH CHRONIC LYMPHOCYTIC THYROIDITIS. Addendum. Prior molecular testing of Right Thyrold, Fine Needle Aspiration (. itified a BRAF mutation. Therefore, molecular testing was not repeated on the total thyroldectomy specimen. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY THYROID TUMORS. SPECIMEN TYPE: Total Thyroidectomy. TUMOR SITE: Right Lobe, Left Lobe. TUMOR FOCALITY: Multifocal. TUMOR SIZE (largest nodule): Greatest Dimension: 2.1 cm. HISTOLOGIC TYPE. Papillary carcinoma, tall cell variant. PRIMARY TUMOR (pT): pT3. REGIONAL LYMPH NODES (pN): pNO. Number of regional lvmph nodac. Number of regional lymph nodes involved: 0. DISTANT METASTASIS (pM): Not applicable. EXTRATHYROIDAL EXTENSION: Present. MARGINS: Margin(s) involved by carcinoma. LYMPH-VASCULAR INVASION: Not identified. ADDITIONAL PATHOLOGIC FINDINGS: Thyroiditis. Other: Nodular thyroid.",test,
8160,TCGA-IN-7808.c5e11794-6234-4a87-8b4d-53c60ba59f08,"ADDENDA: Addendum. HER2 FISH STUDIES PERFORMED ON THE ADENOCARCINOMA ARE NEGATIVE. # Cells Analyzed: 74. % Hyperdiploid: 9(12.2%). HER2 IMMUNOPEROXIDASE STUDIES PERFORMED ON THE ADENOCARCINOMA ARE NEGATIVE. IHC score; 0. This result should be Integrated with all clinical and pathologic data in the determination of a comprehensive diagnostic. and treatment plan. FINAL DIAGNOSIS: PART 1:SKIN, LEFT CHEST WALL, EXCISION- -. ANGIOMA. PART 2:LYMPH NODE, LEVEL 8, EXCISION -. THREE (3) LYMPH NODES, NEGATIVE FOR METASTATIC CARCINOMA. PART 3: :LYMPH NODE, GASTRIC, EXCISION - -. METASTATIC SIGNET RING CELL CARCINOMA TO ONE (1) LYMPM NODE. PART 4:LIVER, WEDGE RESECTION-. A. CAUTERIZED LIVER WITH FOCAL CHRONIC INFLAMMATION. B. NEGATIVE FOR MALIGNANCY. PART 5:LYMPH NODES, ILIAC, EXCISION-. METASTATIC SIGNET RING CELLCARCINOMA TO THREE (3) LYMPH NODES. PART 6:LYMPH NODE, GASTRIC, EXCISION -. METASTATIC SIGNET RING CELL CARCINOMA TO ONE (1) LYMPH NODE. PART 7:ESOPHAGUS AND STOMACH, ESOPHAGOGASTRECTOMY -. A. POORLY DIFFERENTIATED INVASIVE SIGNET RING CELL ADENOCARCINOMA WITH FOCAL MUCINOUS. FEATURES, ARISING AT THE GASTROESOPHAGEAL JUNCTION. B. CARCINOMA MEASURES GROSSLY 3.5 x 3.0 CM (SEE COMMENT) AND INVADES THROUGH ESOPHAGEAL. ADVENTITIA AND GASTRIC SEROSA. C. EXTENSIVE LYMPHVASCULAR AND PERINEURAL SPACE INVASION IDENTIFIED. D. META STATIC CARCINOMA TO SIXTEEN OF SIXTEEN LYMPH NODES WITH EXTENSIVE EXTRACAPSULAR. SPACE EXTENSION (16/16). E. CARCINOMA EXTENDS TO BOTH PROXIMAL AND DISTAL MARGINS (SEE PART 8 FOR FINAL MUCOSAL. MARGINS). F. CARCINOMA INVOLVES SEROSALIADENTITIAL CIRCUMFERENTIAL MARGIN. G. OMENTUM WITH MINUTE FOCUS OF METASTATIC SIGNET RING CELL CARCINOMA. H. AJCC 7TH EDITION PATHOLOGIC TUMOR STAGE: pT3 N3 M1. PART 8:ESOPHAGUS AND SMALL BOWEL, ANASTOMOTIC RING, ESOPHAGOGASTRECTOMY -. ESOPHAGEAL AND SMALL BOWEL SEGMENTS, NEGATIVE FOR CARCINOMA. PART 9: SMALL BOWEL, SEGMENTAL RESECTION -. SMALL BOWEL WITH FOCAL ACUTE SEROSITIS, NEGATIVE FOR METASTATIC CARCINOMA. COMMENT: Although the carcinoma measures 3.5 cm grossly it extends from the esophageal proximal margin to the distal margin. of. part 7 (esophagogastrectomy), which Is a length of approximately 20 cm. An immunohistochemical stain for AE1/3 is. performed on block 8 (anastomotic rings), which is negative for carcinoma. All controls reacted appropriately. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY ESOPHAGEAL TUMORS. MACROSCOPIC. SPECIMEN TYPE: Esophagogestrectomy. TUMOR SITE: Tumor midpoint in proximal stomach or cardia (within 5cm of EGJ) AND tumor. involves esophagogastric junction. TUMOR SIZE: Greatest dimension: 3.5 cm. Additional dimensions: 3.0 cm. MICROSCOPIC. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: PATHOLOGIC STAGING (pTNM). pT3. pN3. Number of lymph nodes examined: 20. Number of lymph nodes involved: 23. pM1. Specify site(s): Iliac lymph nodes. PRIOR TREATMENT: Treatment history not known. MARGINS. Proximal margin uninvolved by invasive carcinoma. Distal margin uninvolved by invasive carcinoma. Circumferential (adventitial) margin involved by invasive carcinoma. ANGIOLYMPHATIC INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: Other: Linitus plastica type growth. PATIENT HISTORY: PRE-OP DIAGNOSIS: Esophageal cancer. POST-OP DIAGNOSIS: PROCEDURE: Esophagectomy.",test,
8411,TCGA-44-7659.ca4281d7-0cd7-4ebc-8050-9dd81fbbefbc,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Lung, left upper lobe, lobectomy: Invasive moderately differentiated adenocarcinoma. Bronchial and vascular margins of resection free of tumor. 11 hilar lymph nodes negative for metastatic carcinoma (0/11). Lymphovascular invasion by tumor is present. B. Lymph node, level V, resection: Negative for metastatic carcinoma. C. Lymph node, level II, resection: Negative for metastatic carcinoma. D. Lymph node, level VII, resection: Negative for metastatic carcinoma. E. Lymph node, level VI, resection: Negative for metastatic carcinoma. Note: Many of the sampled lymph nodes also contained old hyalinized. granulomas. Microscopic Description: Histologic type: Adenocarcinoma. Histologic grade: Moderately differentiated. Primary tumor (pT) : Tumor measures 2.9 cm maximally and is confined to. the lung (pT1b). Margins of resection: Negative. Direct extension of tumor: Absent. Venous (large vessel) invasion: Negative. Arterial (large vessel) invasion: Negative. Lymphatic (small vessel) invasion: Positive. Regional lymph nodes (pN) : All hilar lymph nodes and mediastinal lymph. nodes are negative for metastatic carcinoma (pNO). Distant metastasis (pM) : pMx. Specimen. A. Left upper lobe. B. Level V. C. level XI. D. level VII. E. Level VI. Clinical Information. Lung nodule. Gross Description. A. Received fresh subsequently fixed in formalin labeled ""left upper. lobe"" is a lobe of lung which is heavily stapled and is 22.0 X 11.0. X. 4.5 cm partially covered with a violaceous pink-tan smooth glistening. pleura showing diffuse stippling present. Specimen shows a 2.9 X 2.9 X. 2.5 cm gray-tan tumor which comes within 0.3 cm of the pleura. There is. a the pleura in this area is inked blue. There is a stapled margin in. this area which is inked black. The tumor mass comes within 0.2 cm of. the surgical margin (inked black) The remainder of the pleura is. pink-tan and fleshy showing diffuse black stippling present. The tumor. comes within 5.5 cm of the hilar my margin. Possible hilar lymph nodes. which are black and are grossly identified. Rep. sections of the. specimen are submitted as follows; 1-Rep. section of tumor to surgical. margin and pleura, 2 through 3-representative section of tumor to. pleura, 4-Rep. section of tumor to normal, 5-representative section of. normal near apex, 6 - vascular and bronchial margins, 7 through 9. possible hilar nodes. RS 9. B. Received fresh, subsequently fixed in formalin labeled ""level V"" is. a 2.2 X 1.0 X 0.6 cm gray-pink irregular soft tissue fragment which is. bisected to show black cut surface. Specimen is entirely submitted in. one cassette. AS1. C. Received fresh, subsequently fixed in formalin labeled ""level XI"". are 2 pink red irregular soft tissue fragments which show black. discoloration. These are 0.9 cm and 0.6 cm in greatest dimension. Vessels and are entirely submitted in one cassette. AS1. D. Received fresh and subsequently fixed in formalin labeled level VII. and a 1.4 X 0.4 X 0.3 cm black red irregular soft tissue fragment which. is entirely submitted in one cassette. AS1. E. Received fresh and subsequently fixed in formalin labeled ""level VI"". are multiple gray-pink irregular soft tissue fragments which have an. aggregate measurement of 1.5 X 0.6 X 0.3 cm. The specimen are entirely. submitted in one cassette. AS1.",test,
8520,TCGA-L5-A8NI.72D3550D-D524-4965-8C7A-F10060DEA06A,"OPER DATE: REQ DOC: PROCEDURE: Source of specimen: Thoracic esophagus. ear-old male with one-year history of dysphagia, treated with. over-the-counter medications, then multiple PPIS. Barium swallow, then EGD,. positive for cancer. No radiation or chemotherapy. Clinical Diagnosis: Esophageal cancer. Operative Procedure: Transhiatal esophagectomy. PREVIOUS DIAGNOSIS INQUIRY. 3. REPORT DATE: PATIENT N8R: SEX: M. ADM DATE: BIRTHDATE: OPER DATE: REQ DOC: PROCEDURE: 1. ""Thoracic esophagus."" Received in formalin in a medium container is a 9 x. 4.5 cm distal portion of esophagus, in continuity with 7 x 6 cm portion of. stomach. There is a 6.5 x 5 x 1.1 cm tan-brown, ulcerative tumor with rolled. edge at the GE junction. The tumor involves circumferentially 80% of the. organ, 6 cm from the esophageal surgical margin and 3.2 cm from the distal. gastric surgical margin. The tumor invades through the muscular layer and. approaches the serosal surface. The proximal half of the esophagus and. stomach are grossly unremarkable. The serosal surface is inked black,. serially sectioned and sampled. 1A. Tumor at esophageal edge. 1B-1C. Tumor. 1D. Tumor at gastric edge. 1E. Normal esophagus and stomach. 1F-1G. Largest lymph node, 2.2 x 1.7 x 1.3 cm. 1H. One lymph node, bisected. 11. Two lymph nodes, inked yellow or orange, bisected. 1J. Two Lymph nodes, inked yellow or orange, bisected. 1K. Possible Lymph nodes. 1L. Possible Lymph nodes. 2. ""Esophageal margin."" A ring of esophagus, 1.2 cm in diameter, 0.7 cm in. length. Margin inked. 3. ""Lower left paraesophageal lymph node."" Received in formalin in a small. container is a 2.7 x 1.9 x 0.6 cm portion of adipose tissue. Serially. sectioned. 3A. Lymph nodes. 38. Remaining adipose tissue. PROCEDURE: ESOPHAGEAL, CARDIAC AND GASTROESOPHAGEAL JUNCTION CARCINOMA: Type of carcinome: Adenocarcinoma: If adenocarcinoma, it is arising in: Arising at GE junction, not otherwise. specified. Depth of invasion: Adventitia. Number of positive lymph nodes:4/19. Extranodal metastasis: Unknown. Specify site;. PREVIOUS DIAGNOSIS INQUIRY. 4. REPORT DATF. SEX: M. PATIENT NBR: ADM DATE: BIRTHDATE: REQ DOC: OPER DATE: Pattern of invasion: Infiltrative. Esophageal and gastric resection margins involved: No. Deep resection margin involved: No. TNM classification: T3 N1 MX. PROCEDURE: 1. Esophagus, excision: Transmurally invasive, poorly-differentiated. adenocarcinoma with metastasis to four of nineteen !ymph nodes. surgical. margins free. No Barrett's mucosa identified. Please see template. 2. Esophageal margin, excision: No significant abnormality. 3. Lower left periesophageal lymph node, excision: Benign fibroadipose tissue,. no lymph node present. igning staff pathologist, have personally. 1,. examined and interpreted the slides from this case. Code: END OF PREVIOUS DIAGNOSIS INQUIRY.",test,
8534,TCGA-KM-A7QG.47DE599A-EEED-4A9E-B1C2-9F63598A9C4A,"Admit Date: Gender: Female. Birth Date: Attending: DIAGNOSIS: 1. Liver, segment 2-3 hepatectomy (1FS): Telangiectatic adenoma with. changes of steatohepatitis; Adjacent liver shows steatohepatitis with. moderate steatosis, prominent ballooning injury, numerous Mallory. bodies, moderate inflammation, and bridging fibrosis, see Note. 2. Liver, segment 4-5 resection, wedge biopsy: Telangiectatic. adenoma with changes of steatohepatitis; Adjacent liver shows. steatohepatitis with moderate steatosis, prominent ballooning injury,. numerous Mallory bodies, moderate inflammation, and bridging fibrosis,. see Note. 3. Adrenal gland, left, resection: Macro and micronodular. hyperplasia. 4. Fat, left perinephric, resection: Fibroadipose tissue, no tumor. seen. 5. Kidney, mass, resection: Renal cell carcinoma chromophobe type,. margins of resection are free of tumor. 6. Lymph node, preaortic, resection: Reactive lymph nodes, no tumor. seen (0/10). 7. Lymph node, intraaortic caval, resection: Reactive lymph nodes,. no tumor seen (0/10). 8. Lymph node, periaortic, resection: Reactive lymph nodes, no tumor. seen (0/16). NOTE: Sections from specimen #1 and specimen #2 through the nodules in. both wedge sections show a proliferation of hepatocytes with irregular. fibrous septa and hemangioma-like collections of blood vessels. The. lesion is partly encapsulated. Many normal arteries are present. The. hepatocyte plates are 1-2 cells thick as demonstrated by reticulin stain. in specimen #1 but not encapsulated in specimen #2. There is no. ductalar reaction. No mitotic activity is seen. Changes of. steatohepatitis are present including steatosis, ballooning injury, and. Mallory bodies. is positive in sinusoidal endothelial. cells in the tumor. CK7 and CK19 are positive in scattered small cells. probably representing hepatic stem cells. The liver adjacent to the. nodule shows hepatic architecture distorted by the bridging fibrosis and. early regenerative nodule formation. There is moderate macrovesicular. steatosis. This is associated with prominent ballooning hepatocellular. injury in zone 3 and frequent foci of lobular inflammation. There is. mild portal chronic inflammation associated with mild focal interface. hepatitis. Numerous Mallory bodies are seen as highlighted by ubiquitin. immunostaining. The iron stain is positive in reticuloendothelial cells,. The copper stain is negative. This patient has an advanced liver. disease and is at risk for developing cirrhosis. JobID: Do not file in Medical Record. Gender: Female. Birth Date: Specimen #1 and #2 are evaluated by. The immunoperoxidase tests performed here were developed and their. performance characteristics determined by the. They have not been cleared or. approved by the U.S. Food and Drug Administration. The FDA has also. determined that such clearance or approval is not necessary. This. laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (CLIA) as qualified to perform high complexity. clinical laboratory testing. CLINICAL INFORMATION: Allocate Order to Protocol: Brief. Clinical History: renal. mass, liver mass Specimen Taken For Protocol: PROCEDURE: Pre-Operative Diagnosis: renal mass, liver mass. Post-Operative. Diagnosis: renal mass, liver mass Operative Findings: renal mass,. liver mass. SPECIMENS SUBMITTED: 1. LIVER, Segment 2-3 hepatectomy (1FS). 2. LIVER WEDGE BIOPSY, Segment- 4-5 resection. 3. ADRENAL GLAND, LEFT, Left. 4. FAT, Left perinephric. 5. LIVER WEDGE BIOPSY, Renal mass. 6. LYMPH NODES, Pre-aortic. 7. LYMPH NODES, Intra-aortic caval. 8. LYMPH NODES, Para - aortic. INTRAOPERATIVE CONSULTATION: 1FS ""Segment 2 and 3 hepatectomy"": 1FS diagnosis: Benign hepatocellular nodule. GROSS DESCRIPTION: Received are 8 formalin-filled containers. labeled with the patient's name, medical record number, and further. specified as follows: 1. ""Segment 2 and 3 hepatectomy"", consists of a red-tan tissue. measuring 14x8x3cm. Approximately 0.6 x 0.3: x 0.1 from tumor area. is frozen as 1FS. In Surgical Pathology, the frozen tissue is. transferred to an orange cassette labeled. FS and the liver is. inked in black on the upper surface and yellow on the bottom surface,. blue in the staple resection margin. There is a nodule measuring 1.7 x. 1.1 x 2.2 cm. Representative sections are submitted in white cassettes. labeled. A-1G (representative staple sections in 1A-1C; The. tumor nodule in 1D-1F; The normal hepatic parenchyma in 1G) for. permanent processing. Approximately 3 x 2 x 0.4 cm of tissue is. procured for. Additional sections from the tumor are submitted. in white cassettes. I-1M for permanent processing. JobID: Do not file in Medical Record. Gender: Female. Birth Date: 2. ""Segment 4 and 5 wedge resection"", consists of a tan-brown liver. tissue measuring 8 x 3 x 2 cm. The specimen is serially sectioned. No. gross lesion is noted. The surgical resection margin is inked in blue. and four representative sections are submitted in white cassettes. labeled. for permanent processing. 3. ""Left adrenal"". The specimen is an adrenal gland with fat,. weighing 53.2 grams, measuring 7 x 2.5 x 3 cm. The fat measures 9 x 5x. 1 cm. The specimen is inked black and then bisected revealing a yellow. nodule measuring up to 0.5 x 0.5 x 0.4 cm. The nodule is procured for. In Surgical Pathology, the specimen received matches the above. description and representative sections of the adrenal are submitted in. 3A-3C for the adrenal tumor, and 3D-3E for fatty tissue. margins. 4. ""Left perinephric fat"", consists of a specimen of adipose tissue. measuring 18 x 9 x 4.5 cm. No lymph nodes were noted in the gross. examination. Three representative sections are submitted in white. cassettes labeled. for permanent processing. 5. ""Left renal mass"", consists of a tan soft tissue measuring 5 x 4.5. x 3.5 cm. The staple section is inked in red and the capsule was inked. in blue. The pelvis and artery and veins from the surgical section. margin is submitted in white cassette. There is a nodule. measuring 1.7 x 1.5 x 1.2 noted in the cut surface. The nodule is close. to the capsule and representative tumor is submitted in white cassettes. 5B-5E, and the normal kidney parenchyma is submitted in white. cassettes labeled. for permanent processing. 6. ""Preaortic lymph node"", consists of a piece of lymphoid adipose. tissue measuring 5x 2.5 x 1 cm. There are 6 lymph nodes measuring up. to 0.8 cm in greatest dimension. They re.submitted in white cassettes. labeled. for permanent processing. 7. ""Intra-aortic lymph node"", consists of a piece of adipose tissue. measuring 3.5x1.8x1cm. There are multiple lymph nodes measuring up to. 0.7cm in the greatest demention. They are sarially secetioned and. entirely submitted in white cassettes labeled. for. permanent processing. 8. ""Para-aortic lymph node"", consists of adipose tissue measuring 6 x. 3 x 2.5 cm. There are multiple lymph nadag in the specimen. They are. submitted in white cassettes labeled. BA-8D for permanent. processing. The procurements were done by. Gross description dictated by. Reviewed by: JobID: Do not file in Medical Record. Gender: Female. Birth Date: Surgical Pathology [OrderII: JobID: Do not file in Medical Record.",test,
8626,TCGA-DD-A1EL.C8A1098A-0717-4801-A3E5-C13C42C65936,"DIAGNOSIS: A. Liver, segment III, resection: Grade 3 (of 4). hepatocellular carcinoma forming a 0.8 X 0.7 X 0.7 cm mass. All. surgical resection margins are negative for tumor (minimum tumor. free margin, 0.8 cm) . There is no vascular space involvement. The histological features of the adjacent liver parenchyma will. be reported in an addendum. B. Gallbladder, cholecystectomy: Mild chronic cholecystitis. A single benign cystic duct lymph node is identified. C. Liver, segments VII and VIII, resection: Grade 3 (of 4). hepatocellularVcarcinoma forming multiple (2) well-. circumscribed masses (7.5 X 7.5 X 6.8 cm and 1.5 X 1.1 X 0.6. cm) There is no vascular space involvement. ADDENDUM: The adjacent liver parenchyma shows mild steatosis and mild. portal lymphocytic infiltrates. GROSS DESCRIPTION: A. Received fresh labeled ""portion liver. segment III"" is a 3.56 gram, 2.5 X 2.1 X 1.6 cm partial. hepatectomy specimen. A single 0.8 X 0.7 x 0.7 cm mass is. present 0.8 from the surgical margin. Representative sections. are submitted. B. Received fresh labeled ""gallbladder"" is a. 7.2 x 3.0 X 1.5 cm gallbladder with a 0.2 maximum wall thickness. and patent cystic duct. A cystic duct lymph node is is. identified. No stones are present within the lumen. No masses. are identified. Cholesterolosis is not identified. Representative sections are submitted. C. Received fresh labeled ""portion liver segment VII and VIII"". is a 370.0 gram, 11.3 X 11.0 X 7.5 cm partial hepatectomy. specimen. There are multiple (2) masses (7.5 x 7.5 X 6.8 cm and. 1.5 X 1.1 X 0.6 cm) which are 1.1 cm from the closest resection. margin. Representative sections are submitted. BLOCK SUMMARY: Part A: Portion liver segment 3. 1 Liver Segment 3 mass. Part B: Gallbladder. 1 Gallbladder. 2 Cystic duct LN 1 (B1). Part C: Portion liver segment 7 and 8. 1 Liver segment 7/8 mass #1. 2 Liver segment 7/8 mass #2. 3 Uninvolved liver. DIAGNOSIS: A. Liver, segment III, resection: Grade 3 (of 4). hepatocellular carcinoma forming a 0.8 X 0.7 X 0.7 cm mass. All. surgical resection margins are negative for tumor (minimum tumor. free margin, 0.8 cm) . There is no vascular space involvement. The histological features of the adjacent liver parenchyma will. be reported in an addendum. B. Gallbladder, cholecystectomy : Mild chronic cholecystitis. A single benign cystic duct lymph node is identified. C. Liver, segments VII and VIII, resection: Grade 3 (of. 4). hepatocellular carcinoma forming multiple (2) well-. circumscribed masses (7.5 X 7.5 X 6.8 cm and 1.5 X 1.1 x 0.6. cm) There is no vascular space involvement. ADDENDUM: The adjacent liver parenchyma shows mild steatosis and mild. portal lymphocytic infiltrates. GROSS DESCRIPTION: A. Received fresh labeled ""portion liver. segment III"" is a 3.56 gram, 2.5 x 2. 1 X 1.6 cm partial. hepatectomy specimen. A single 0.8 X 0.7 x 0.7 cm mass is. present 0.8 from the surgical margin. Representative sections. are submitted. B. Received fresh labeled ""gallbladder"" is a. 7.2 X 3.0 X 1.5 cm gallbladder with a 0.2 maximum wall thickness. and patent cystic duct. A cystic duct lymph node is is. identified. No stones are present within the lumen. No masses. are identified. Cholesterolosis is not identified. Representative sections are submitted. C. Received fresh labeled ""portion liver segment VII and VIII"". is a 370.0 gram, 11.3 X 11.0 X 7.5 cm partial hepatectomy. specimen. There are multiple (2) masses (7.5 X 7.5 x 6.8 cm and. 1.5 X 1.1 x 0.6 cm) which are 1.1 cm from the closest resection. margin. Representative sections are submitted. BLOCK SUMMARY : Part A: Portion liver segment 3. 1 Liver Segment 3 mass. Part B: Gallbladder. 1 Gallbladder. 2 Cystic duct LN 1 (B1). Part C: Portion liver segment 7 and 8. 1 Liver segment 7/8 mass #1. 2 Liver segment 7/8 mass #2. 3 Uninvolved liver.",test,
8786,TCGA-35-3615.ffc829b9-9e11-41c9-9532-b6303ad48a9f,Ethnicity. Clinical. Index. (Race). Diagnosis. Lung. 1. cancer. Lung. cancer. Tissue. Anatomical. Tumor. Specimen. Specimen. Number of. Amount/per. Specificati. Container. Site. Matrix. Format. containers. container. t. on. Lung. Primary. Tumor. Tissue. OCT. block. 1. n/a. Blood. n/a. Normal. Blood. frozen. tube. 1. n/a. Type of. Histological description. Grade. TNM Stage. TNM Stage. TNM Stage. Treatment. Procureme. (Source). (source). (T). (N). (M). type. nt. n/a. Adenocarcinoma. 2. 2. 0. 0. none. n/a. blood draw. n/a. n/a. n/a. n/a. n/a. none. Component. of treatment. Tumor cell. (Chemo /. %. Horm Th. Details). n/a. over 50. n/a. n/a.,test,
8852,TCGA-QK-AA3J.94EF76C0-AEB3-472D-B4E0-CB7C48EDF816,"Anat Path Reports. Document Date: Acc #: Head and Neck. M. Client: Submitting Phys: Final Surgical Pathology Report. Final Pathologic Diagnosis. ARYTENOID, RIGHT, BIOPSY: - INVASIVE SQUAMOUS CELL CARCINOMA, POORLY DIFFERENTIATED WITH BASALOID FEATURES. Clinical History. Panendoscopy. Specimen(s) Received. A: Right arytenoid. Gross Description. The specimen is received fresh for frozen section diagnosis labeled with the patient's name, medical record number. and ""panendoscopy"" on the container and consists of multiple pink-red soft tissue fragments, collectively 1.0 x 0.8 x. 0.2 cm. Approximately 2/3 of the specimen is submitted for frozen section diagnosis in cassette A1FS. The. remaining specimen is submitted to tissue procurement services. (Dictated by. Intraoperative Consult Diagnosis. A1FS (2 slides): (FROZEN SECTION): invasive carcinoma, consistent with squamous cell carcinoma. Frozen section results were communicated to the surgical team and were repeated back by. on.",test,
8874,TCGA-KK-A8IG.D1F786EC-03F5-458B-99AC-3B89EFFF2297,"MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A) PROSTATE AND SEMINAL VESICLES: Supplemental report to follow. (B) BILATERAL PELVIC LYMPH NODES: Nineteen benign lymph nodes(0/19). Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) PROSTATE AND SEMINAL VESICLES - Supplemental report to follow. (B) BILATERAL PELVIC LYMPH NODES - Two unoriented, irregular pieces of adipose tissue (aggregate measurement 6.0 x 3.5. x 2.0 cm). Nineteen possible unremarkable lymph nodes are identified (sizes range from 0.2 to 2.5 cm). SECTION CODE: B1, five possible lymph nodes; B2, three possible lymph nodes; B3, two possible lymph nodes; B4, two. possible lymph nodes; B5, two possible lymph nodes; B6, one possible lymph node; B7, one possible lymph node, bisected; B8,. one possible lymph node, bisected; B9, one possible lymph node, bisected; B10, one possible lymph node, bisected. CLINICAL HISTORY. Prostate cancer. SNOMED CODES. T-92000, T-C4600, M-Y1973. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by: Start of ADDENDUM. Page: 2. ADDENDUM. This modified report is being issued to provide additional information/results. Addendum completed by. DIAGNOSIS. (A) PROSTATE AND SEMINAL VESICLES: PROSTATIC ADENOCARCINOMA, GLEASON SCORE 7 (4 + 3) WITH TERTIARY GLEASON. GRADE 5. (SEE COMMENT.). TUMOR EXTENDING FOCALLY INTO EXTRAPROSTATIC TISSUE. TUMOR EXTENDING TO THE MARGIN OF RESECTION. PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN), HIGH GRADE. Right and left seminal vesicles, no tumor present. Segments of right and left vasa deferentia, no tumor present. COMMENT. The prostate gland contains three foci of prostatic adenocarcinoma, one in the transition zone and two in the peripheral zone. The. dominant tumor focus and the one of the highest histologic grade is located in the right and left transition zone. This tumor focus. measures 3.0 x 1.5 cm in the largest cross-sectional dimension, and it is present in four cross sections and extensively in the. apical region. This tumor focus exhibits predominately Gleason grades 4 and 3. A minor (tertiary) component of Gleason grade 5. is. also. present. This tumor exhibits focal extraprostatic extension (less than 1.0 mm) in the right anterior surface of the prostate. and. extends. to the margin of resection in the anterior apical region. The extent of marginal involvement is 6.0 mm. The two. peripheral zone foci are located in the left posterolateral and right lateral peripheral zone. The tumor located in the left. posterolateral. peripheral zone measures 0.8 x 0.4 cm in the largest cross-sectional dimension, and it is present in the first cross. section of the prostate. The third tumor focus is located in the right lateral peripheral zone. This tumor measures 0.5 x 0.2 cm in. the. largest cross-sectional dimension, and it is present in one cross section. The non-dominant tumor foci are of lower histologic. grade (Gleason score 6/3 + 3) and are confined to the prostate with negative margins. GROSS DESCRIPTION. (A). PROSTATE AND SEMINAL VESICLES - A specimen consisting of a prostate, attached right and left seminal vesicles and. attached segments of right and left vasa deferentia. The. prostate gland (2.5 x 2.2 x 4.0 cm, 31 grams, post fixation) has the usual shape. The soft tissue present along the. right and left posterolateral aspects of the prostate appears symmetrical. A palpable and visible nodule is observed in the left mid. region of the prostate. Serial cross sections after fixation demonstrate firm areas consistent with tumor in the right transition zone. and right peripheral zone of the first three of the four cross sections of the prostate. The seminal vesicles and segments of vasa deferentia are grossly free of tumor. SECTION CODE: A1, A2, base of right seminal vesicle and right vas deferens; A3, A4, base of left seminal vesicle and. left vas deferens; A5, prostatic base, right border; A6, A7, prostatic base, right posterior border; A8, A9, prostatic base, central. portion;. A10, prostatic base, left border; A11, A12, prostatic base, left posterior border; A13, A14, apex anterior; A15, apex left;. Page: 3. A16-A18, apex posterior; A19, apex right; A20-A35, sections of the four cross sections of the prostate according to specimen. radiograph. The anterior aspect of the prostate is inked in green, left surface in red, right surface in yellow and posterior surface in. black. SNOMED CODES. T-92000, M-Y1973. Entire report and diagnosis completed by:",test,
8919,TCGA-61-1998.788d25c6-75c4-4c85-be93-98dec021219a,"PARI 1: BLAUDER FLAP, DIUPST -. METASTATIC ADENOCARCINOMA. PART 2: RECTOVAGINAL SEPTUM NODULE, EXCISION -. METASTATIC ADENOCARCINOMA (2 CM). PART 3: UTERUS WITH CERVIX, BILATERAL ADNEXA, RECTOSIGMOID COLON, AND PORTION OF BLADDER, TOTAL. ABDOMINAL HYSTERECTOMY WITH BILATERAL SALPINGO-OOPHORECTOMY, PARTIAL COLECTOMY, AND. EXCISION -. A. RIGHT ADNEXA WITH PAPILLARY SEROUS ADENOCARCINOMA (12 CM). B. THE RIGHT ADNEXAL MASS IS ADHERENT TO THE UTERUS AND COLON; THE COLON IS ALSO. ADHERENT TO THE UTERUS. C. ADENOCARCINOMA IS ASSOCIATED WITH PSAMMOMA BODY CALCIFICATIONS. D. LYMPHOVASCULAR SPACE INVASION IS PRESENT. E. CAPSULE IS NOT INTACT; TUMOR OBLITERATES THE RIGHT ADNEXA (NO RESIDUAL RIGHT OVARIAN. TISSUE IDENTIFIED. F. REMNANT OF RIGHT FALLOPIAN TUBE TISSUE IS ADHERENT TO TUMOR. G. LEFT OVARY WITH ADENOCARCINOMA DEPOSITS (3 CM) AND BENIGN SIMPLE CYST WITH DENUDED. LINING (8 CM). H. LEFT FALLOPIAN TUBE WITH TUMOR NODULES MEASURING UP TO APPROXIMATELY 1 CM. I. APPARENT BLADDER FLAP TISSUE WITH METASTATIC ADENOCARCINOMA; NO BLADDER MUCOSA IS. IDENTIFIED. J. UTERUS WITH SEROSAL INVOLVEMENT BY TUMOR INVADING TO A DEPTH OF APPROXIMATELY 0.2 CM. WITH LYMPHOVASCULAR SPACE INVASION DEEP TO THE TUMOR INVASION. K. WEAKLY PROLIFERATIVE ENDOMETRIUM, ENDOMETRIUM IS NEGATIVE FOR TUMOR. L. CERVIX IS NEGATIVE FOR TUMOR. M. LEIOMYOMATA. N. COLON WITH INVOLVEMENT BY NUMEROUS NODULES OF METASTATIC ADENOCARCINOMA THAT. INVADE INTO THE MUSCULARIS PROPRIA BUT DO NOT INVOLVE THE COLONIC MUCOSA. O. COLONIC MUCOSA WITH TUBULAR ADENOMAS. P. COLONIC DISTAL AND PROXIMAL MARGINS ARE NEGATIVE FOR TUMOR. Q. PATHOLOGIC STAGE: pT3c pN1 pMX (FIGO STAGE: IIIC). PART 4: RIGHT COMMON ILIAC LYMPH NODE, BIOPSY -. A. TWO (2) LYMPH NODES, POSITIVE FOR METASTATIC ADENOCARCINOMA MEASURING UP TO 1.5 MM. B. NO EXTRACAPSULAR EXTENSION IS PRESENT. PART 5: LEFT COMMON ILIAC LYMPH NODE, BIOPSY -. ONE (1) LYMPH NODE, NEGATIVE FOR NEOPLASM (0/1). PART 6: APPENDIX, APPENDECTOMY- -. APPENDIX WITH SEROSAL ADHESIONS, NEGATIVE FOR NEOPLASM. PART 7: DIAPHRAGM NODULES, EXCISION -. METASTATIC ADENOCARCINOMA, MEASURING UP TO APPROXIMATELY 1 CM. PART 8: OMENTUM, OMENTECTOMY -. OMENTUM WITH APPROXIMATELY 80% DIFFUSE INVOLVEMENT BY METASTATIC ADENOCARCINOMA. (OMENTUM MEASURED 10 CM). PART 9: LEFT EXTERNAL ILIAC LYMPH NODE, BIOPSY -. A. ONE (1) LYMPH NODE, POSITIVE FOR METASTATIC ADENOCARCINOMA (1/2). B. TUMOR MEASURES 0.5 CM; NO EXTRACAPSULAR EXTENSION WAS PRESENT. SYNOPTIC - PRIMARY OVARIAN TUMORS INCLUDING BORDERLINE TUMORS. TUMOR LOCATION: Bilateral. PROCEDURE: Other: Colectomy and debulking. TUMOR SIZE: Maximum dimension: 10 cm. TUMOR TYPE: Papillary serous carcinoma. HISTOLOGIC GRADE (serous tumors): High grade. VASCULAR INVASION: TUMOR CAPSULE: Ruptured. MALIGNANT CELLS IN ASCITES OR. PERITONEAL WASHING: LYMPH NODES EXAMINED: Total number of lymph nodes examined: 5. LYMPH NODES POSITIVE: Number of positive lymph nodes, Right: 2. Number of positive lymph nodes, Left: 1. LYMPH NODE GROUPS INVOLVED: Common iliac, Right, External iliac, Left. EXTRANODAL EXTENSION: T STAGE, PATHOLOGIC: T STAGE, PATHOLOGIC. T STAGE, PATHOLOGIC continued. pT3c. N STAGE, PATHOLOGIC: pN1.",test,
9037,TCGA-DE-A0XZ.DDD69861-E047-4D17-862A-06626959C9AD,"Diagnosis: A: Thyroid, total thyroidectomy. Tumor histologic type: papillary thyroid carcinoma. Tumor size: 2.0 cm (gross), largest in any one slide 1.1 cm. Tumor growth pattern: papillary. Extent of invasion: Extra-capsular: not identified. Vascular: not identified. Tumor multicentricity: Multifocal. Surgical margins: Close, but negative (to <0.5 mm of the R lobe anterior margin (A1)). Background thyroid: Lymphocytic thyroiditis, nodular hyperplasia. Lymph nodes: Specimen A: metastatic papillary thyroid carcinoma (1/3). Total: metastatic papillary thyroid carcinoma (5/7). Largest metastasis : 1.1 cm (B1). Extra-nodal extension: present (B1). AJCC Stage: pTl pN1 pMx. B: Lymph nodes, right central neck, dissection. - Metastatic papillary thyroid carcinoma (4/4). Clinical History: papillary thyroid cancer. Gross Description: Received are two appropriately labeled containers. Container A is additionally labeled ""total thyroid."". Specimen fixation: formalin. Type of specimen: total thyroidectomy. Size and weight of specimen: 6.2 grams; 4.3 cm medial to lateral, 4.9 cm superior to inferior, and 1.2 cm. anterior to posterior. Orientation: As per the requisition, the stitch designates the left superior pole. The specimen is inked as. follows: posterior=green, anterior=violet, isthmus=yellow. Tumor location: right inferior thyroid gland. Tumor description: solitary, rounded, red/tan, gritty cut surface, circumscribed, non-encapsulated. Tumor size: 2 x 1.2x1.6 cm. Confinement/non-confinement to the thyroid gland: confined. Distance of tumor from surgical margins: The tumor abuts the anterior and posterior margins of the right. thyroid lobe. Appearance of thyroid gland away from tumor: multinodular appearance. Tissue submitted for special investigations: representative tumor is submitted to Tissue Procurement. Lymph nodes: See Specimen B. Digital photograph taken: no. Block Summary: A1-A2 - right superior thyroid nodule, submitted in contiguous sections, inferior to superior. A3 - representative right middle thyroid adjacent to right inferior thyroid nodule. A4 - representative right superior thyroid. A5 - isthmus. A6 - representative left thyroid lobe. Tissue remains. Container B is additionally labeled ""right central neck dissection."" The specimen consists of two red/brown. fibrofatty tissue fragments measuring 3.4 x 1.8 x 1.1 cm in aggregate. Isolated from the tissue fragment are. four lymph node candidates ranging in size from 1.2 cm to 1.6 cm in greatest dimension. The specimen is. otherwise grossly unremarkable. Block summary: B1 - one lymph node candidate, trisected. B2 - three lymph node candidates. Grossing Pathologist: Light Microscopy: Light microscopic examination is performed. Resident Physician: Attending Pathologist: I have personally conducted the evaluation of the above specimens and have rendered the above. diagnosis(es).",test,
9249,TCGA-ET-A39P.B37A8A96-8B16-45CD-BDC9-57C00FE33F65,"FINAL DIAGNOSIS. 1) THYROID (TOTAL THYROIDECTOMY): SPECIMEN TYPE: Total thyroidectomy. TUMOR SITE: Left lobe. HISTOLOGIC TYPE: Papillary carcinoma. TUMOR SIzE: Greatest dimension 5.3 cm. FOCALITY: Unifocal. LYMPH NODES: Two (2) associated lymph nodes are negative for tumor. EXTENT OF INVASION. PRIMARY TUMOR: pT3: Tumor >4 cm, with multiple foci of extrathyroidal extension. REGIONAL LYMPH NODES: pNO: No regional lymph node metastasis. DISTANT METASTASIS: pMx: Cannot be assessed. MARGINS: Involved by invasive carcinoma, Specify margin: left lobe, superior, mid. VENOUS/LYMPHATIC INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: Nodular hyperplasia. SEE NOTE. NOTE: Dr. has seen representative slides (A-D) of this case and concurs.",test,